Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Neurons,0.7750191360904816,2.049959037499806,0.0,0.0,0.0,82/259,10.71%,NPY;CDH22;SLITRK1;SLC32A1;CCK;SPOCK3;CA10;IGF1;PROX1;RGS7BP;TAGLN3;STMN2;TESC;NCALD;SH3GL2;VSTM2B;TMEM191C;PCSK2;CNTN2;RIT2;SNCB;SYT4;GAP43;ZDHHC22;SCN3B;SCN1A;NRGN;C11ORF87;SYT5;RIMS3;CNTNAP2;STMN4;OPCML;PCP4;SCN2A;ELAVL4;OLFM3;ATP2B3;GAD2;VSNL1;KCNK1;SRRM4;SYNPR;ARHGDIG;GABBR2;RAB3C;GNG2;CDK5R2;HPCA;CPLX2;GABRA1;ST8SIA3;GRM5;PDE1A;SYP;VGF;ZIC1;MAP7D2;MEG3;TCEAL5;NRN1;RYR2;GRIA3;LUZP2;VSTM2A;SULT4A1;MATN2;GABRG2;NECAB2;KIF5A;CELF3;PCLO;KCNC1;TMEM130;CPLX1;BEX1;KCNQ2;PACSIN1;LY6H;DNER;NWD2;ADAM12
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.8178145903201404,2.0401820119477914,0.0,0.0,0.0,44/117,8.58%,NPY;CDH22;SLITRK1;CCK;CA10;RGS7BP;TAGLN3;STMN2;ZNF536;SH3GL2;VSTM2B;CNTN2;RIT2;SNCB;SYT4;GAP43;SCN3B;PLP1;KCNC2;PLPPR4;NRGN;C11ORF87;STMN4;OPCML;SCN2A;ELAVL4;OLFM3;ATP2B3;GAD2;SYNPR;ARHGDIG;RAB3C;HPCA;CPLX2;GABRA1;ST8SIA3;GRM5;TCEAL5;VSTM2A;GFAP;SULT4A1;GABRG2;CELF3;KCNC1
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),-0.7190683187722989,-1.9744798050015224,0.0,0.030350630620699794,0.04,29/87,14.26%,TMA7;RPL35A;RPS24;RPL34;RPL39;RPL13;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPS26;RPL6;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;FTSJ1;RPL14;RPL15;RPS2;RPL11;RPL23A;RPS21;RWDD1;RPS23
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.7766735401410862,1.9669809778606597,0.0,0.0,0.0,54/143,10.46%,CDH22;SLITRK1;SLC32A1;CA10;SLC24A2;PCDH8;STMN2;VSTM2B;CNTN2;RIT2;SNCB;GRID2;SYT4;GAP43;ZDHHC22;PLP1;SHISA8;C11ORF87;CNTNAP2;STMN4;OPCML;PCP4;ELAVL4;OLFM3;ATP2B3;GAD2;IGSF21;SRRM4;SYNPR;RAB3C;HPCA;ITPR3;CPLX2;GABRA1;ST8SIA3;GRM5;PDE1A;SYP;TCEAL5;GRIA3;GRIN1;VSTM2A;SULT4A1;HIVEP2;GABRG2;KIF5A;CELF3;KCNC1;HCN1;CPLX1;KCNQ2;NRIP3;LY6H;PDE1B
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Brain,0.8198845561045096,1.9601008464463026,0.0,0.0,0.0,43/91,9.36%,CDH22;SLITRK1;SHISA7;SLC32A1;CA10;STMN2;GNG3;VSTM2B;CNTN2;RIT2;SNCB;SYT4;ZDHHC22;SCN3B;KCNC2;VWC2L;C11ORF87;CACNG3;STMN4;OPCML;ELAVL4;OLFM3;ATP2B3;GAD2;SRRM4;SYNPR;RAB3C;CDK5R2;HPCA;CPLX2;GABRA1;ST8SIA3;GRM5;SYP;TCEAL5;DIRAS2;VSTM2A;GABRG2;KIF5A;CELF3;KCNC1;HCN1;KCNQ2
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.7918823178693983,1.9590424272015485,0.0,0.0,0.0,38/114,8.58%,NPY;RIMBP2;CDH22;SIX3;CA10;CHGB;PROX1;STMN2;SH3GL2;NPTX2;PCSK2;CNTN4;SYT4;SCN3B;KCNB2;ABCC8;PLPPR1;PCP4;ELAVL4;PAK3;GAD2;IGSF21;FGF12;UNC5D;RAB3C;NKX6-2;CPLX2;ST8SIA3;SYP;ROBO2;MEG3;TCEAL5;VSTM2A;SYT13;PIR;SULT4A1;CELF3;KCNC1
prerank,CellMarker_Augmented_2021__Neuron:Adipose Tissue,0.7818018660261429,1.9403775675843167,0.0,0.0,0.0,36/96,9.82%,SLITRK1;ELAVL2;TAGLN3;STMN2;SH3GL2;NMNAT2;CNTN2;SNCB;CAMKV;SYT4;PLPPR5;SYT1;GAP43;ZDHHC22;C11ORF87;STMN4;OPCML;CDK5R2;DNM1;HPCA;CPLX2;ST8SIA3;PHYHIP;MAP1B;SULT4A1;GABRG2;GABRA5;NYAP1;MAPK8IP1;KIF5A;CELF3;KCNC1;SRRM3;KCNQ2;PNMA2;TTC9B
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.7886523701158508,1.940256379354754,0.0,0.0,0.0,46/123,9.05%,SLITRK1;CA10;SLC24A2;PROX1;STMN2;ZNF536;VSTM2B;PCSK2;CNTN2;CNTN4;SYT4;ZDHHC22;SCN3B;VWC2L;SCN1A;C11ORF87;CACNG3;CNTNAP2;CNTNAP5;STMN4;OPCML;SV2B;SCN2A;OLFM3;ATP2B3;PAK3;GAD2;SRRM4;SYNPR;B3GALT2;RAB3C;NTRK3;GABRA1;ST8SIA3;GRM5;SYP;TCEAL5;VSTM2A;GABRG2;FAM135B;CELF3;KCNC1;TMEM130;GRIA1;GRM6;HCN1
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.7818214441104041,1.9379627613706507,0.0,0.0,0.0,51/155,10.71%,SLITRK1;ELAVL2;CNR1;FLRT3;EDIL3;PCDH8;TAGLN3;EPHA7;STMN2;ZNF536;SH3GL2;KCNH7;NLGN1;ATRNL1;CNTN2;SNCB;GRID2;CAMKV;NEFL;SYT4;PLPPR5;SYT1;GAP43;ZDHHC22;RELN;CLSTN2;SLITRK5;LINGO2;CNTNAP2;STMN4;ACHE;OPCML;EFNB3;OLFM3;TCEAL7;NAP1L3;FSD1;ST8SIA3;NRG1;MAP1B;SULT4A1;KIF5A;CELF3;KIF5C;KCNC1;KCNQ2;PNMA2;RGMB;HMGCLL1;SMAD1;ADAM12
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.8070045405781892,1.9321099296658448,0.0,0.0,0.0,40/104,11.36%,RIMBP2;MYT1;CDH22;SLITRK1;PCDH8;STMN2;ATRNL1;CNTN2;SNCB;SRCIN1;CAMKV;SYT4;GAP43;ZDHHC22;PRKCG;KCNB2;ABCC8;STMN4;SCN2A;OLFM3;GAD2;PRR36;CDK5R2;HPCA;CPLX2;ST8SIA3;SYP;VSTM2A;SYT13;SULT4A1;GABRG2;KIF5A;CELF3;KCNC1;SMAD3;KCNQ2;HMGCLL1;LY6H;MAPT;NR4A2
prerank,PanglaoDB_Augmented_2021__Interneurons,0.7228783603301139,1.9218758040643569,0.0,0.0,0.0,82/265,10.56%,NPY;CDH22;SLITRK1;CCK;L1CAM;SPOCK3;CA10;SHISA9;RGS7BP;PCDH8;TAGLN3;STMN2;NCALD;SH3GL2;GRIN2D;ZIC4;ELMO1;VSTM2B;PCSK2;PTPRO;CNTN2;RIT2;SNCB;CAMKV;SYT4;PLPPR5;SYT1;GAP43;PRKCB;ZDHHC22;PRKCG;SHISA8;RELN;KCNC2;NRGN;C11ORF87;STMN4;OPCML;SV2B;ELAVL4;OLFM3;ATP2B3;GAD2;IGSF21;VLDLR;FGF12;SYNPR;GABBR2;RAB15;KCNQ5;RAB3C;CDK5R2;LHX6;HPCA;CPLX2;ST8SIA3;PDP1;GRM5;PDE1A;SYP;VGF;TCEAL5;NRN1;VSTM2A;SYT13;RAMP3;SULT4A1;HIVEP2;GABRG2;ADGRL2;GABRA5;KIF5A;CELF3;CACNA1E;KCNC1;CPLX1;KCNQ2;NRIP3;GDA;PACSIN1;LY6H;CDKL5
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.7993181137674117,1.9182177312000286,0.0,0.0,0.0,37/101,8.77%,CDH22;SLITRK1;CA10;GRIN2A;STMN2;GRIN2B;CNTN2;RIT2;GAP43;SCN3B;KCNC2;SCN1A;C11ORF87;CACNG3;CNTNAP5;STMN4;OPCML;SCN2A;OLFM3;ATP2B3;GAD2;SRRM4;SYNPR;HPCA;NTRK3;CPLX2;GABRA1;ST8SIA3;GRM5;DIRAS2;GRIN1;VSTM2A;GABRG2;CELF3;KCNC1;TMEM130;GRIA1
prerank,"Reactome_2022__Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.7356252868575186,-1.9180129676810929,0.0,0.09105189186209937,0.19,33/91,14.43%,NDUFAF3;UQCRFS1;NDUFS5;COX18;UCP3;LRPPRC;COX7C;NDUFA12;NDUFB4;UQCRB;NDUFB1;ATP5PF;COX20;ATP5MC1;NDUFAF4;NDUFV3;COX7B;PM20D1;ATP5PB;ATP5PD;TMEM186;NDUFA8;COX5B;ETFB;DMAC2L;ATP5MC3;COX19;NDUFS3;NDUFC1;COQ10A;ETFDH;ATP5F1B;TACO1
prerank,Reactome_2022__Neuronal System R-HSA-112316,0.7104011751527197,1.9114909075899122,0.0,0.0,0.0,85/317,11.19%,IL1RAPL2;SLITRK1;SLC32A1;GRIN3A;GRIK1;GRIN2A;KCNH8;IL1RAPL1;GNG3;KCNJ2;NCALD;CHRNA5;GRIN2D;KCNV1;GRIN2B;KCNH7;NLGN1;GABRB2;PPFIBP1;NEFL;KCNK10;SYT1;PRKCB;ADCY5;KCNQ1;PRKCG;KCNC2;SLITRK5;DLGAP3;RPS6KA1;KCNB2;GLRA2;NRGN;ABCC8;CACNG3;GABRG3;KCNF1;ACHE;APBA2;GAD2;KCNK1;KCNMB4;SHANK3;GABBR2;PRKAR1B;KCNQ5;GNG2;KCND3;LRRTM2;NTRK3;GABRA1;GRM5;NRG1;ABCC9;ADCY7;KCNH2;CACNG8;ADCY2;GRIA3;NPTN;GABRG2;GABRA5;SHANK1;NRXN3;CACNA1E;PTPRD;KCNC1;LRRTM4;GRIA1;KIF17;HCN1;CPLX1;KCNQ2;ARHGEF7;DNAJC5;CACNG4;EPB41L1;RNASE1;GPRIN1;SIPA1L1;HOMER1;SLITRK4;MAPT;KCNAB3;SYN2
prerank,Reactome_2022__Respiratory Electron Transport R-HSA-611105,-0.7323239652429029,-1.9064039656619762,0.0,0.09611033029888268,0.26,24/74,14.43%,NDUFAF3;UQCRFS1;NDUFS5;COX18;LRPPRC;COX7C;NDUFA12;NDUFB4;UQCRB;NDUFB1;COX20;NDUFAF4;NDUFV3;COX7B;TMEM186;NDUFA8;COX5B;ETFB;COX19;NDUFS3;NDUFC1;COQ10A;ETFDH;TACO1
prerank,CellMarker_Augmented_2021__Glutamatergic neuron:Dorsolateral Prefrontal Cortex,0.7874777552128769,1.9055686383941863,0.0,0.0,0.0,38/94,10.41%,SLITRK1;TTLL7;GRIN2A;IL1RAPL1;PDE1C;GRIN2B;GRIK2;CNTN2;SYT16;SYT1;GAP43;SCN3B;OPALIN;KCNC2;C11ORF87;CACNG3;EPHA5;STMN4;OPCML;SCN2A;ATP2B3;GAD2;SRRM4;SYNPR;GABBR2;HPCA;NTRK3;GABRA1;GRM5;PHYHIP;GRIA3;MAP1B;GFAP;GABRG2;TMEM130;GRIA1;PNMA2;FRMPD4
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.6756999893640518,-1.8993136097452985,0.0,0.08346423420692442,0.28,48/179,12.26%,IMP4;PAK1IP1;RPL35A;RIOK2;RPS24;FCF1;RPL34;RPL39;EXOSC8;RPL13;RPL37;ZNF658;RPS28;RBIS;RPL18;POP5;DDX52;RPL12;RPL23;RPL31;PIH1D2;MRPL36;NOP56;NOC2L;RPL6;RPF1;RRP1B;EXOSC4;RPL41;RPL22;RPL29;RPL30;NOL8;SNU13;RIOK1;RPL14;URB2;EXOSC5;RPL15;RPS2;DCAF13;MDN1;IMP3;UTP20;RRP36;RPL11;RPL23A;NIP7
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.7957958795477547,1.8912344690797271,0.0,0.0,0.0,45/97,12.25%,CDH22;CCK;MOBP;ST18;MOG;SLC24A2;PROX1;SLC4A10;PCSK2;CNTN2;XKR4;PRKCB;SCN3B;KCNQ1;KCNC2;SCN1A;CACNG3;RPH3A;CNTNAP5;STMN4;SV2B;GAD2;KCNT1;SRRM4;SYNPR;UNC13C;CPLX2;GABRA1;ST8SIA3;SYP;KCNH2;ADCY2;VSTM2A;FAM135B;CELF3;CACNA1E;MYT1L;MYO15A;HCN1;CNDP1;PDE1B;FGF13;TCEAL6;SLC7A14;CABP1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),-0.6983242888556821,-1.8860602741118384,0.0,0.08953436033106439,0.34,31/97,14.26%,RPL35A;RPS24;RPL34;SRPRA;RPL39;RPL13;RPL37;SRPRB;RPS28;RPL18;RPL12;RPL23;RPL31;RPS26;RPL6;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;SPCS1;RPL15;RPS2;ZFAND2B;RPL11;RPL23A;RPS21;SPCS2;RPS23
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.7800165117669373,1.8798357116683884,0.0,0.0,0.0,38/116,11.44%,NPY;RIMBP2;CDH22;CHGB;TTLL7;RGS7BP;TAGLN3;STMN2;PLD1;SERPINE1;DOC2B;CNTN2;SYT4;GAP43;PLPPR4;OPCML;ELAVL4;TCEAL7;SYNPR;UNC5D;RAB3C;CPLX2;ST8SIA3;GUCY1A2;PHYHIP;TCEAL5;VSTM2A;MAP1B;SULT4A1;CELF3;PTPRD;PCLO;KALRN;PLD2;NACAD;ASXL3;CRMP1;FAM13C
prerank,CellMarker_Augmented_2021__Immature neuron:Undefined,0.7972075195752091,1.8708843250875777,0.0,0.0,0.0,35/91,9.82%,MYT1;SLITRK1;ELAVL2;PCDH8;TAGLN3;RIMS2;STMN2;SH3GL2;SNCB;CAMKV;SYT4;PLPPR5;SYT1;GAP43;ZDHHC22;STMN4;CAMK2N2;OLFM3;GABBR2;WASF1;CDK5R2;HPCA;ST8SIA3;SYP;VGF;SULT4A1;GABRG2;KIF5A;CELF3;KCNC1;SRRM3;B4GALNT1;KCNQ2;PNMA2;TTC9B
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.7833184510603437,1.8703437109643266,0.0,0.0,0.0,49/121,8.77%,CDH22;SLITRK1;SHISA7;SLC32A1;CCK;CA10;GRIN2A;SPINK8;TAGLN3;STMN2;GRIN2D;GRIN2B;VSTM2B;CNTN2;RIT2;SNCB;SYT4;GAP43;KCNC2;KCNB2;NRGN;C11ORF87;CACNG3;STMN4;OPCML;PCP4;ELAVL4;OLFM3;ATP2B3;GAD2;IGSF21;SRRM4;SYNPR;RAB3C;OXTR;KCND3;HPCA;CPLX2;GABRA1;ST8SIA3;GRM5;TCEAL5;GRIA3;VSTM2A;GFAP;GABRG2;CELF3;KCNC1;GRIA1
prerank,KEGG_2021_Human__Ribosome,-0.6723828009993523,-1.8571685082951241,0.0,0.12519635131038664,0.5,35/120,11.83%,MRPL10;RPL35A;RPS24;RPL34;RPL39;MRPS21;RPL13;RPL37;RPS28;MRPS7;RPL18;RPL12;RPL23;RPL31;MRPL36;MRPL15;MRPS16;MRPL18;MRPS10;RPS26;RPL6;RPS27L;RPL41;MRPS9;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;MRPL21;RPL11;RPL23A
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.7586914751957512,1.856705520919501,0.0,0.0,0.0,46/133,11.67%,SLITRK1;SCN9A;CA10;RGS7BP;TAGLN3;STMN2;ZNF536;SH3GL2;CNTN2;SYT4;GAP43;SCN3B;PLP1;PLPPR4;C11ORF87;ADD2;STMN4;OPCML;SCN2A;ELAVL4;OLFM3;ATP2B3;TCEAL7;PIEZO2;SYNPR;RAB3C;ST8SIA3;GRM5;TCEAL5;VSTM2A;MAP1B;SULT4A1;KIF5A;CLGN;PTPRD;KCNC1;DHCR24;LY6H;VWA5A;NACAD;ASXL3;FGF13;TCEAL6;CRMP1;FAM13C;NEFM
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.7435141343034114,1.849826037576092,0.0,0.0,0.0,35/121,9.36%,SLITRK1;PROX1;PCDH8;EPHA7;STMN2;ZNF536;ATRNL1;CNTN2;CAMKV;SYT4;GAP43;ZDHHC22;SCN3B;STMN4;OPCML;ELAVL4;OLFM3;ATP2B3;PAK3;GAD2;SRRM4;SYNPR;RAB3C;LHX6;NTRK3;ST8SIA3;ROBO2;VSTM2A;SULT4A1;HIVEP2;KIF5A;CELF3;PCLO;KCNC1;KCNQ2
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex7:Brain,0.7691839030082301,1.8493633663508482,0.0,0.0,0.0,30/98,8.53%,KCNT2;PRRX1;CHST8;PDGFRA;PCDH18;STMN2;ZNF536;NLGN1;CSMD2;GRID2;GAP43;ZDHHC22;SLIT2;PLP1;PLPPR4;THY1;OPCML;IGSF21;TCEAL7;NAP1L3;GUCY1A2;LDB2;ROBO2;CACNA1C;GRIA3;MAP1B;BOC;TENM4;PTPRD;GALNT16
prerank,Reactome_2022__Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.6455822794454109,-1.842982416601808,0.0,0.14850129982270968,0.58,43/163,14.27%,IMP4;BUD23;RPL35A;RIOK2;RPS24;FCF1;RPL34;RPL39;EXOSC8;RPL37;RPS28;RPL18;DDX52;RPL12;RPL23;RPL31;NOP56;RPL6;RPS27L;RRP1B;EXOSC4;RPL41;RPS13;RPL22;RPL29;RPL30;SNU13;RIOK1;RPSA;RPL14;EXOSC5;RPL15;RPS2;DCAF13;UTP20;RRP36;RPL11;RPL23A;NIP7;RPS21;NOL6;RPS23;KRR1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.7238081311509774,1.840433084039407,0.0,0.0,0.0,59/229,10.44%,NPY;RIMBP2;SLC32A1;HTR2C;GRIK1;GRIN2A;HRH1;CHRM3;TBC1D24;CHRM1;CHRNA5;GRIN2D;NPTX2;GRIN2B;NLGN1;GRIK2;MBP;RIT2;SNCB;GABRB2;GRID2;SYT1;PLP1;RPS6KA1;GLRA2;NRGN;SYT5;GABRG3;APBA2;CBLN2;CDH8;GAD2;KCNMB4;GABRD;GABBR2;PRKAR1B;UNC13C;PTCHD1;GABRA1;DVL1;GRM5;HCRTR2;DTNA;SNCA;GRIA3;GRIN1;GABRG2;GABRA5;KIF5A;CACNA1E;NPTX1;GRIA1;CPLX1;PDLIM4;KCNQ2;DNAJC5;MINK1;FCHSD1;HOMER1
prerank,Reactome_2022__Prolonged ERK Activation Events R-HSA-169893,-0.9420640885243409,-1.839637685912433,0.0,0.13468092337935533,0.59,1/13,0.09%,NGF
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.7762034463373195,1.8386509795715558,0.0,0.0,0.0,40/100,11.44%,KCNT2;RIMBP2;CDH22;CHGB;PROX1;RGS7BP;STMN2;NPTX2;PCSK2;RCAN2;CNTN4;SYT4;SHC2;PLPPR4;KCNB2;ABCC8;PLPPR1;ELAVL4;GAD2;IGSF21;BAIAP3;UNC5D;RAB3C;CPLX2;ST8SIA3;TCEAL5;MAOB;GRIA3;VSTM2A;SYT13;GABRG2;CELF3;PTPRD;KALRN;ATP1B1;HMGCLL1;LY6H;SORBS1;ASXL3;FAM13C
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.6600743145617002,-1.8375843986596867,0.0,0.12393174170119081,0.6,40/149,11.83%,IMP4;RPL35A;RPS24;FCF1;RPL34;RPL39;EXOSC8;RPL13;RPL37;NIFK;RPS28;RPL18;POP5;DDX52;RPL12;RPL23;RPL31;PIH1D2;NOP56;RPL6;RPF1;RRP1B;EXOSC4;RPL41;RPL22;RPL29;RPL30;NOL8;SNU13;RPL14;EXOSC5;RPL15;RPS2;DCAF13;MDN1;IMP3;UTP20;RRP36;RPL11;RPL23A
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.7452336821130933,1.8292810117975256,0.0,0.0,0.0,48/146,11.98%,RIMBP2;CCK;CA10;RGS7BP;TAGLN3;STMN2;ZNF536;NMNAT2;ATRNL1;CNTN2;CASZ1;SYT4;GAP43;PLPPR4;STMN4;OPCML;ELAVL4;OLFM3;ATP2B3;TCEAL7;GFRA2;CDK5R2;CPLX2;ST8SIA3;GUCY1A2;TCEAL5;VSTM2A;MAP1B;SULT4A1;CELF3;CACNA1E;PCLO;KCNC1;KALRN;ARHGAP26;AHDC1;RGMB;HMGCLL1;LY6H;SCN3A;NACAD;MFSD6;ASXL3;VSTM2L;CRMP1;FAM13C;NEFM;SLC7A14
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),-0.6991946723357501,-1.827426448906494,0.0,0.1343015404965966,0.66,25/88,11.83%,RPL35A;RPS24;RPL34;SRPRA;RPL39;RPL13;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPS26;RPL6;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;RPL11;RPL23A
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.7842159038164976,1.8272297201640109,0.0,0.0,0.0,36/103,8.71%,NPY;ENPP2;RIMBP2;CDH22;CCK;CA10;CHGB;VWA5B2;TAGLN3;STMN2;SH3GL2;PCSK2;SYT4;GAP43;KCNB2;ABCC8;OPCML;PLPPR1;ELAVL4;OLFM3;GAD2;UNC5D;RAB3C;CDK5R2;HPCA;CPLX2;ST8SIA3;SYP;TCEAL5;VSTM2A;SYT13;GLP1R;SULT4A1;CELF3;KCNC1;SCG5
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.7309493126035143,1.8255372999095336,0.0,0.0,0.0,33/105,12.80%,RIMBP2;FLRT3;PROX1;RGS7BP;STMN2;RCAN2;CNTN4;PDZRN4;SYT4;SHC2;PLPPR4;ABCC8;PLPPR1;PCP4;FGF12;ATP9A;ST8SIA3;ABCC9;GUCY1A2;MAOB;SYT13;SYBU;LIMCH1;ADGRL2;PTPRD;PCLO;KALRN;ATP1B1;HMGCLL1;ASXL3;FAM13C;PXK;TMEM196
prerank,KEGG_2021_Human__Adherens junction,0.8084937798888975,1.8249299074836776,0.0,0.0,0.0,14/64,11.20%,LEF1;TGFBR2;MET;WAS;PTPRB;WASF1;FYN;BAIAP2;PARD3;CTNNB1;SMAD3;SORBS1;ACTN1;CTNNA1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.665109483477816,-1.8234625036406735,0.0,0.12830039307841273,0.67,45/161,12.22%,IMP4;RPL35A;RIOK2;RPS24;FCF1;RPL34;RPL39;EXOSC8;RPL13;RPL37;NSA2;RPS28;RPL18;POP5;DDX52;RPL12;RPL23;RPL31;PIH1D2;NOP56;RPL6;RPF1;RRP1B;EXOSC4;RPL41;RPL22;THUMPD1;RPL29;RPL30;NOL8;SNU13;RIOK1;RPL14;EXOSC5;RRP15;RPL15;RPS2;DCAF13;MDN1;IMP3;UTP20;RRP36;RPL11;RPL23A;SRFBP1
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.7335284743519407,1.8200816893332485,0.0,0.0012879110728709914,0.03,47/178,9.61%,NPY;HTR2C;GRIK1;GRIN2A;HRH1;CHRM3;CHRM1;CHRNA5;NPTX2;GRIN2B;NLGN1;GRIK2;MBP;RIT2;SNCB;GABRB2;SYT1;PLP1;RPS6KA1;GLRA2;NRGN;SYT5;GABRG3;APBA2;GAD2;KCNMB4;GABRD;GABBR2;PRKAR1B;UNC13C;PTCHD1;GABRA1;GRM5;HCRTR2;DTNA;SNCA;GRIA3;GRIN1;GABRG2;GABRA5;KIF5A;CACNA1E;NPTX1;GRIA1;CPLX1;KCNQ2;MINK1
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.7012697234273654,-1.8186775423573933,0.0,0.12962248494257203,0.69,25/85,11.83%,RPL35A;RPS24;RPL34;RPL39;RPL13;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPS26;RPL6;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;ZFAND2B;RPL11;RPL23A
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.736873898405766,1.8185572118920446,0.0,0.0012419142488398845,0.03,53/160,11.41%,ENPP2;CDH22;ANLN;MOBP;ST18;HAPLN2;MYRF;CA10;MOG;ADAMTS4;TMEM235;RGS7BP;CREB5;VSTM2B;MBP;FAM163B;CNTN2;SNCB;SRCIN1;ZDHHC9;ADCY5;FA2H;OPALIN;PLP1;STMN4;OPCML;BCAS1;EFNB3;IGSF21;VLDLR;SYNPR;NINJ2;MCAM;PLLP;NKX6-2;FAM107A;HPCA;CPLX2;ST8SIA3;GRM5;PHYHIP;TCEAL5;GFAP;MAG;TF;TPPP;SLC25A29;LY6H;KLK6;SORBS1;KIF13B;LGI3;TCEAL6
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.7756007630894346,1.817326744661912,0.0,0.0011990896195695436,0.03,42/105,11.41%,CDH22;SLITRK1;SLC32A1;CA10;RGS7BP;STMN2;ZNF536;SH3GL2;VSTM2B;CNTN2;SNCB;GAP43;KCNC2;PLPPR4;C11ORF87;ABCC8;STMN4;OPCML;SEMA3C;OLFM3;ATP2B3;GAD2;IGSF21;SYNPR;GABBR2;CDK5R2;HPCA;ST8SIA3;GRM5;PHYHIP;TCEAL5;VSTM2A;GFAP;SULT4A1;GABRG2;CELF3;KCNC1;HMGCLL1;LY6H;SYN2;LGI3;TCEAL6
prerank,CellMarker_Augmented_2021__Neuron:Embryo,0.7528495915117029,1.8132227633907037,0.0,0.0011591199655838923,0.03,35/93,12.55%,CDH22;SLC32A1;CA10;VSTM2B;CNTN2;RIT2;SNCB;NEFL;GAP43;ZDHHC22;SCN3B;STMN4;OPCML;APBA2;ATP2B3;NAP1L3;CPLX2;GABRA1;ST8SIA3;SYP;TCEAL5;JPH4;CACNG8;GABRA5;KIF5A;KIF5C;KCNC1;TMEM130;MYT1L;KCNQ2;PNMA2;TCEAL6;NEFM;PIANP;FXYD7
prerank,CellMarker_Augmented_2021__Oligodendrocyte Precursor cell:Brain,0.770663089662105,1.8107418377642397,0.0,0.0011217289989521539,0.03,35/102,8.77%,CA10;GRIN2A;PDGFRA;STMN2;ZNF536;GRIN2B;CNTN2;CSMD2;GABRB2;GRID2;GAP43;PLP1;PLPPR4;SCN1A;CNTNAP5;STMN4;OPCML;SCN2A;SYNPR;RAB3C;LHFPL3;LRRTM2;NTRK3;ST8SIA3;MEGF11;RFX4;GRM5;ROBO2;ADCY2;GRIA3;VSTM2A;GFAP;FAM135B;PTPRD;GRIA1
prerank,Reactome_2022__SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.6739894923620152,-1.805752143419675,0.0,0.14241449752789903,0.74,30/101,14.26%,RPL35A;RPS24;RPL34;SRPRA;RPL39;RPL37;SRPRB;RPS28;RPL18;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;DDOST;RPSA;RPL14;SPCS1;RPL15;RPS2;RPL11;RPL23A;RPS21;SPCS2;RPS23
prerank,CellMarker_Augmented_2021__Thecal cell:Ovary,0.819372291501282,1.8004225221717902,0.0,0.002458739320935529,0.07,15/52,8.28%,TGFBR2;IL13RA1;TLR2;TYMP;CTSS;SLC15A3;ICAM1;SIGLEC1;IL1R1;C1RL;TNFRSF1A;SLC7A7;MYD88;TMBIM1;MVP
prerank,CellMarker_Augmented_2021__Zymogenic Chief cell:Gastric Epithelium,0.819372291501282,1.8004225221717902,0.0,0.002458739320935529,0.07,15/52,8.28%,TGFBR2;IL13RA1;TLR2;TYMP;CTSS;SLC15A3;ICAM1;SIGLEC1;IL1R1;C1RL;TNFRSF1A;SLC7A7;MYD88;TMBIM1;MVP
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.8842393449340732,-1.8002655710725877,0.0,0.1479593242759115,0.76,1/16,0.06%,SLC2A5
prerank,CellMarker_Augmented_2021__Anterior Foregut Endoderm cell:Lung,0.8131151103375133,1.7992324031500218,0.0,0.0023182399311677845,0.07,11/57,3.65%,HLA-DRA;C3;GPNMB;TLR2;ABCA6;CTSS;PLD1;SP100;GPR34;CSF2RA;SIGLEC1
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Embryonic Stem Cell,0.8131151103375133,1.7992324031500218,0.0,0.0023182399311677845,0.07,11/57,3.65%,HLA-DRA;C3;GPNMB;TLR2;ABCA6;CTSS;PLD1;SP100;GPR34;CSF2RA;SIGLEC1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In1:Brain,0.7761649769319755,1.7990586553492065,0.0,0.002253844377524235,0.07,36/89,11.67%,RIMBP2;CNR1;KCNH8;PCDH8;STMN2;ZNF536;CNTN2;NEFL;GAP43;ZDHHC22;MGAT3;CNTNAP2;STMN4;ELAVL4;NAP1L3;NELL2;KHDRBS2;UNC5D;RAB3C;SEMA5B;ST8SIA3;TMEM132C;GALNT8;TCEAL5;JPH4;KIF5A;CELF3;CACNA1E;KIF5C;KCNC1;LRRC55;KCNQ2;LY6H;DCX;ASXL3;NEFM
prerank,Reactome_2022__Peptide Chain Elongation R-HSA-156902,-0.6806573941781389,-1.798008624632027,0.0,0.142647963917289,0.77,24/79,11.83%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;EEF1A1;RPS2;RPL11;RPL23A
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex3:Brain,0.7537367364915998,1.7962578585333593,0.0,0.0025062053309922,0.08,35/101,8.77%,CA10;SLC24A2;ZNF536;ZNF385D;PCSK2;VWC2;CNTN2;XKR4;GABRB2;GRID2;CNTN4;TRPC3;SCN3B;SLITRK5;SCN1A;DOK6;STMN4;OPCML;OLFM3;PAK3;FGF12;SRRM4;SYNPR;UNC5D;RAB3C;PTCHD1;NTRK3;GABRA1;TMEM132C;RYR2;ADCY2;ST8SIA1;VSTM2A;KIF5C;GRIA1
prerank,GO_Biological_Process_2021__translation (GO:0006412),-0.6729271532632072,-1.7941098795139954,0.0,0.1398974380172881,0.77,69/191,18.61%,TMA7;MRPL10;RPL35A;RPS24;RPL34;RPL39;MRPS21;RPL13;RPL37;MRPL52;RPS28;AIMP1;MRPS7;RPL18;KARS1;VARS1;RPL12;RPL23;RPL31;MRPL36;MRPS16;MRPL18;RPS26;RPL6;MRPL47;FASTKD2;RPL41;RPS13;RPL22;GATC;RPL29;RPL30;ASMT;RPSA;FTSJ1;EEFSEC;RPL14;RPL15;EEF1A1;RPS2;IGF2BP3;EPRS1;APEH;NOA1;EEF1B2;RPL11;RPL23A;NARS1;WARS2;MRPS18B;RPS21;MRPS34;MRPS33;RWDD1;RPS23;YARS2;MRPS12;RPS25;MRPS5;RARS1;MRPL27;RPL10;MRPL3;AIMP2;TNIP1;LARS1;RPL8;PTCD3;RPL32
prerank,Reactome_2022__rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.6290722711888606,-1.792188785156826,0.0,0.1356851721866579,0.77,44/172,14.27%,IMP4;BUD23;RPL35A;RIOK2;RPS24;FCF1;RPL34;RPL39;EXOSC8;RPL37;RPS28;RPL18;DDX52;RPL12;RPL23;RPL31;NOP56;RPL6;RPS27L;RRP1B;EXOSC4;RPL41;RPS13;RPL22;THUMPD1;RPL29;RPL30;SNU13;RIOK1;RPSA;RPL14;EXOSC5;RPL15;RPS2;DCAF13;UTP20;RRP36;RPL11;RPL23A;NIP7;RPS21;NOL6;RPS23;KRR1
prerank,CellMarker_Augmented_2021__Glial cell:Sympathetic Ganglion,0.7858569069274592,1.792154203484718,0.0,0.002261697493822229,0.08,37/91,8.77%,SLC32A1;MOBP;HAPLN2;CA10;MOG;SLC24A2;TMEM235;GRIN2B;VSTM2B;CNTN2;RIT2;SNCB;OPALIN;PLP1;KCNC2;SCN1A;CACNG3;RPH3A;STMN4;OPCML;ATP2B3;GAD2;SYNPR;FAM107A;NTRK3;GABRA1;ST8SIA3;RFX4;GRM5;SYP;DIRAS2;GFAP;MAG;SNTG1;GABRG2;TMEM130;GRIA1
prerank,CellMarker_Augmented_2021__Glial cell:Brain,0.7858569069274592,1.792154203484718,0.0,0.002261697493822229,0.08,37/91,8.77%,SLC32A1;MOBP;HAPLN2;CA10;MOG;SLC24A2;TMEM235;GRIN2B;VSTM2B;CNTN2;RIT2;SNCB;OPALIN;PLP1;KCNC2;SCN1A;CACNG3;RPH3A;STMN4;OPCML;ATP2B3;GAD2;SYNPR;FAM107A;NTRK3;GABRA1;ST8SIA3;RFX4;GRM5;SYP;DIRAS2;GFAP;MAG;SNTG1;GABRG2;TMEM130;GRIA1
prerank,CellMarker_Augmented_2021__Astrocyte:Spinal Cord,0.7858569069274592,1.792154203484718,0.0,0.002261697493822229,0.08,37/91,8.77%,SLC32A1;MOBP;HAPLN2;CA10;MOG;SLC24A2;TMEM235;GRIN2B;VSTM2B;CNTN2;RIT2;SNCB;OPALIN;PLP1;KCNC2;SCN1A;CACNG3;RPH3A;STMN4;OPCML;ATP2B3;GAD2;SYNPR;FAM107A;NTRK3;GABRA1;ST8SIA3;RFX4;GRM5;SYP;DIRAS2;GFAP;MAG;SNTG1;GABRG2;TMEM130;GRIA1
prerank,CellMarker_Augmented_2021__Schwann cell:Intervertebral Disc,0.7858569069274592,1.792154203484718,0.0,0.002261697493822229,0.08,37/91,8.77%,SLC32A1;MOBP;HAPLN2;CA10;MOG;SLC24A2;TMEM235;GRIN2B;VSTM2B;CNTN2;RIT2;SNCB;OPALIN;PLP1;KCNC2;SCN1A;CACNG3;RPH3A;STMN4;OPCML;ATP2B3;GAD2;SYNPR;FAM107A;NTRK3;GABRA1;ST8SIA3;RFX4;GRM5;SYP;DIRAS2;GFAP;MAG;SNTG1;GABRG2;TMEM130;GRIA1
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.8450930870913416,1.7919067516076923,0.0,0.0022078475534931283,0.08,13/35,6.17%,HLA-DRA;GPNMB;TLR2;CTSS;MYO1F;PLEK;NAPSB;PRKCB;SIGLEC1;ACHE;PTPRC;AHR;CIITA
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.6671357248522999,-1.7909029698289975,0.034482758620689655,0.12983325321077133,0.78,31/105,15.97%,RPL35A;RPS24;RPL34;RPL39;RPL13;RPL37;RPS28;RPL18;RBM8A;RPL12;RPL23;RPL31;RPS26;RPL6;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;PYM1;RPL11;RPL23A;RPS21;RPS23;EIF3E;PNRC2;RPS25
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.7558291469568391,1.7907493766687708,0.0,0.0021565022615514275,0.08,34/96,11.74%,STMN2;SH3GL2;CNTN2;GRID2;NEFL;GAP43;ZDHHC22;SCN3B;PLP1;OPCML;PAK3;TCEAL7;SRRM4;UNC5D;RAB3C;SEMA5B;GJC1;NTRK3;ST8SIA3;GUCY1A2;ROBO2;TCEAL5;MAP1B;SULT4A1;PTPRD;GRIA1;KCNQ2;PNMA2;DCX;NACAD;ASXL3;CRMP1;NEFM;RUNX1T1
prerank,Reactome_2022__rRNA Processing R-HSA-72312,-0.6275339215726677,-1.7893397517320058,0.0,0.12899018013797411,0.78,46/180,14.27%,IMP4;BUD23;RPL35A;RIOK2;RPS24;FCF1;RPL34;RPL39;EXOSC8;RPL37;RPS28;RPL18;DDX52;TRMT10C;RPL12;RPL23;RPL31;NOP56;RPL6;RPS27L;RRP1B;EXOSC4;RPL41;RPS13;RPL22;THUMPD1;RPL29;RPL30;SNU13;RIOK1;RPSA;RPL14;EXOSC5;RPL15;RPS2;DCAF13;MTERF4;UTP20;RRP36;RPL11;RPL23A;NIP7;RPS21;NOL6;RPS23;KRR1
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.7491029711357657,1.7833088558340022,0.0,0.0028977999139597303,0.11,20/63,13.49%,NR4A3;HPN;IGF1;SGPP2;NR4A1;ZFP36;DAB2IP;DUSP10;TGFA;EPB41L4B;LAMB1;CDK6;NLRC3;YAP1;TGFB2;CDKN1C;B2M;DEAF1;FUT2;FGF2
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.6926937386291545,1.7810607879183162,0.0,0.0028334043603161813,0.11,50/211,10.76%,TGFBR2;IL1RAPL2;SIX3;COL4A1;C3;HAPLN2;MYRF;CHST8;CA10;MOG;GRIK1;GRIN2A;PROX1;PCDH18;TAGLN3;EPHA7;SH3GL2;GRIN2D;GRIN2B;ZIC4;MBP;SH3GL3;CNTN4;UGT8;RELN;LSR;CNTNAP2;SHROOM4;CIC;SOX4;APOD;MFSD2A;ZBTB16;NNAT;ZIC1;ROBO2;EIF2B2;SYNJ2;GLIS2;GRIN1;AATK;ADGRL2;THOC6;NPTX1;PBX3;TPPP;STAT3;KLK6;DNER;DCX
prerank,CellMarker_Augmented_2021__Fibroblast:Pancreas,0.7618397773279064,1.778266659856448,0.0,0.002771808613352786,0.11,39/95,14.24%,KCNT2;COL4A1;PRRX1;EDIL3;PDGFRA;PCDH18;STMN2;NLGN1;CALD1;CSMD2;SULF1;COL4A2;GAP43;SLIT2;PLPPR4;C11ORF87;THY1;OPCML;TCEAL7;ANGPTL2;POSTN;GRIA3;MAP1B;BOC;ADGRL2;BGN;GLI2;PCDHB15;NACAD;CRMP1;SPARC;RUNX1T1;PRICKLE2;MEIS3;MMP16;IGDCC4;COL5A1;PCDHB5;THBS2
prerank,Reactome_2022__Assembly Of Pre-Replicative Complex R-HSA-68867,-0.6889512354036007,-1.7777105259701411,0.0,0.1464417927448765,0.85,22/81,20.20%,H2AC20;CDC26;H3-3B;H2BC4;H2BC21;H2AC6;MCM6;SLC25A15;PSMD10;MCM4;ANAPC15;PSMD12;PSMB5;H2AJ;PSMB6;ORC6;PSME3;SEM1;H2BC5;PSMD2;UBB;PSMB4
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,0.7784971612591753,1.7756286009761097,0.0,0.002712833962004854,0.11,35/94,10.64%,SLITRK1;SHISA7;SLC32A1;PCDH8;TAGLN3;STMN2;GNG3;VSTM2B;CNTN2;SNCB;ARHGAP39;CAMKV;GAP43;PRKCG;C11ORF87;OPCML;CAMK2N2;EFNB3;PRR36;B4GALNT4;CDK5R2;HPCA;GRM5;PHYHIP;GRIN1;SULT4A1;NYAP1;MAPK8IP1;KIF5A;CELF3;KCNC1;SRRM3;KCNQ2;LY6H;DNER
prerank,Reactome_2022__Eukaryotic Translation Termination R-HSA-72764,-0.6794274915827309,-1.7745515495763244,0.0,0.14705603169791448,0.87,24/82,11.83%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;APEH;RPL11;RPL23A
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.8197546942561775,1.7717955569502188,0.0,0.0028977999139597308,0.12,2/52,0.12%,LEF1;CDKN2A
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),0.7271779626158232,1.7704167800165274,0.0,0.0030752162352225714,0.13,25/117,10.27%,LEF1;GGT5;ANXA1;IL1RAPL1;SP100;TIMP2;IRAK2;APP;NLRP12;IL1R1;PLSCR1;OSMR;CIITA;PID1;CDK9;SNCA;PML;MYD88;BCL2L1;CHI3L1;SMAD3;PTPN9;IKBKE;HDAC4;STAT3
prerank,Reactome_2022__Selenocysteine Synthesis R-HSA-2408557,-0.6795113259792464,-1.7656342495425714,0.0,0.15968570428845458,0.9,25/83,11.83%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;EEFSEC;RPL14;SECISBP2;RPL15;RPS2;RPL11;RPL23A
prerank,Reactome_2022__Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.7426335257877604,-1.7656142326499105,0.0,0.1527428475802609,0.9,8/55,5.51%,H2AC20;H3-3B;H2BC4;H2BC21;POLR2K;AAAS;NUP50;H2AC6
prerank,Reactome_2022__Eukaryotic Translation Elongation R-HSA-156842,-0.6675429987019914,-1.7644388074748516,0.0,0.14954008628740625,0.9,25/82,11.83%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;EEF1A1;RPS2;EEF1B2;RPL11;RPL23A
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.7349182762273134,1.7637224137212262,0.0,0.003941007882985233,0.16,16/92,9.00%,LEF1;TGFBR2;CACNA1H;IL1RAPL1;SLIT2;NLRP12;SLIT3;PID1;CDK9;ROBO2;GHR;RAMP3;CYP1B1;CTNNB1;SMAD3;PTPN9
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.6726119987883039,-1.7612584859149658,0.0,0.148718090041429,0.91,23/85,11.83%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;RPL11;RPL23A
prerank,Reactome_2022__L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.6639271892682312,-1.7591397958110897,0.0,0.1467919923289615,0.91,32/99,15.97%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPL6;EIF2S1;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;EIF3D;RPL11;RPL23A;EIF1AX;RPS21;RPS23;EIF3J;EIF3M;EIF3E;RPS25
prerank,Reactome_2022__Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.6694639245546394,-1.7572956628386078,0.0,0.14500856852112123,0.91,31/90,15.97%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;EIF3D;RPL11;RPL23A;EIF1AX;RPS21;RPS23;EIF3J;EIF3M;EIF3E;RPS25
prerank,Reactome_2022__NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.7701375788718403,-1.7549267634323347,0.0,0.1447074709951222,0.91,12/54,6.82%,H2AC20;DPEP2;H3-3B;DNMT3B;H2BC4;H2BC21;GTF2H5;POLR2K;GTF2H2;H2AC6;POLR1F;TAF1D
prerank,CellMarker_Augmented_2021__Macrophage:Undefined,0.9116987378324897,1.7548237633323454,0.0,0.0054546821909830226,0.2,4/15,3.65%,CXCL2;GPNMB;TLR2;SIGLEC1
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Pancreas,0.7645922036051234,1.7542308119288477,0.0,0.005349784456541042,0.2,32/89,11.92%,SLITRK1;LZTS1;MLLT11;TAGLN3;STMN2;SNCB;CNTNAP1;CAMKV;NEFL;GAP43;ZDHHC22;C11ORF87;OPCML;ATP2B3;TCEAL7;NAP1L3;FSD1;TRIM46;TCEAL5;JPH4;SULT4A1;NYAP1;KIF5A;KIF5C;KCNC1;BEX1;PNMA2;NACAD;CRMP1;NEFM;PIANP;ENO2
prerank,Reactome_2022__GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.6592253410530263,-1.7510460741891856,0.0,0.14992164953156017,0.92,33/100,16.21%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPL6;EIF2S1;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;EIF3D;RPL11;RPL23A;EIF1AX;RPS21;RPS23;EIF3J;EIF3M;EIF3E;RPS25;EIF5B
prerank,Reactome_2022__Protein-protein Interactions At Synapses R-HSA-6794362,0.7496797776765498,1.748221014732385,0.0,0.007217162049861971,0.26,27/85,10.50%,IL1RAPL2;SLITRK1;GRIN2A;IL1RAPL1;GRIN2D;GRIN2B;NLGN1;PPFIBP1;SYT1;SLITRK5;DLGAP3;APBA2;SHANK3;LRRTM2;NTRK3;GRM5;GRIA3;SHANK1;NRXN3;PTPRD;LRRTM4;GRIA1;EPB41L1;GPRIN1;SIPA1L1;HOMER1;SLITRK4
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lung,-0.7507509210531766,-1.7449521549186842,0.0,0.15782327922763892,0.93,24/72,15.70%,TMA7;CDC26;COMMD6;TMEM126A;SCNM1;LSM3;MRPL52;POP5;BLOC1S2;MED10;VPS29;PTRHD1;SLC25A19;LSM5;MED11;TPRKB;HAUS1;GTF2A2;ANAPC15;DERL2;NGDN;COA6;PPIE;TMEM11
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.7428578109181867,1.7445639079409119,0.0,0.007298162746268951,0.27,36/111,11.67%,MYT1;ELAVL2;CNR1;PCDH8;TAGLN3;EPHA7;STMN2;DRAXIN;GRID2;CAMKV;SYT4;PLPPR5;GAP43;ZDHHC22;EFNB3;PRR36;VLDLR;UNC5D;B4GALNT4;SEMA5B;CDK5R2;GRM5;CCKBR;MAP1B;SULT4A1;NYAP1;KIF5A;CELF3;KIF5C;KCNC1;C2CD4C;KCNQ2;EPHA4;DCX;CRMP1;NEFM
prerank,Reactome_2022__Ca2+ Pathway R-HSA-4086398,0.7819630163977369,1.7422442656608657,0.0,0.007376217962806587,0.28,6/48,8.12%,LEF1;GNG3;PRKG2;GNG2;ITPR3;CTNNB1
prerank,KEGG_2021_Human__Morphine addiction,0.75079465207557,1.7421515869163744,0.0,0.007244499784899326,0.28,19/76,8.03%,SLC32A1;PDE1C;GNG3;GABRB2;PRKCB;ADCY5;PRKCG;GABRG3;GABRD;GABBR2;GNG2;GABRA1;PDE1A;ADCY7;PDE8B;ADCY2;GABRG2;GABRA5;GRK2
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.706586850208335,-1.74207815198991,0.0,0.15713794240717152,0.94,31/84,18.52%,MRPL10;MRPS21;MRPL52;MRPS7;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;MRPS9;MTRF1L;APEH;MRPS26;MRPL21;MTRF1;MRPS18B;MRPS34;MRPS33;MRPL19;MRPS12;MRPL50;MRPS5;OXA1L;MRPL27;MRPS31;MRPL3;MRPL17;PTCD3
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.8264995019852034,1.7414662149624442,0.0,0.007320757677371952,0.28,11/26,11.38%,NPY;PROX1;DRAXIN;GRID2;MDGA2;SOX4;CTNNB1;AGTPBP1;MAPT;NR4A2;OPHN1
prerank,Reactome_2022__Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.6381735831061612,-1.7413301806227617,0.0,0.15388718181901692,0.95,41/135,15.66%,NDUFAF3;UQCRFS1;NDUFS5;COX18;UCP3;LRPPRC;COX7C;LDHC;NDUFA12;NDUFB4;UQCRB;NDUFB1;ATP5PF;COX20;MPC2;ATP5MC1;NDUFAF4;NDUFV3;COX7B;PM20D1;PDPR;ATP5PB;ATP5PD;TMEM186;NDUFA8;COX5B;ETFB;PDHA1;DMAC2L;CS;MPC1;ATP5MC3;COX19;NDUFS3;NDUFC1;COQ10A;ETFDH;ATP5F1B;TACO1;SUCLA2;ATP5F1A
prerank,CellMarker_Augmented_2021__Bulge Stem cell:Scalp,0.7402914747654762,1.7408361135029506,0.0,0.007194537717417262,0.28,27/88,8.74%,RIMBP2;CNR1;KCNH8;STMN2;ITM2A;ELMO1;SYT4;PLP1;OPCML;ACKR1;ELAVL4;PAK3;TCEAL7;NAP1L3;KHDRBS2;FYN;RAB3C;GNG2;ST8SIA3;TMEM132C;GALNT8;LDB2;TCEAL5;CACNA1C;JPH4;PPP1R16B;LRRC55
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.739999537379191,1.7393602486095159,0.0,0.007661979433520645,0.3,38/110,11.74%,KCNT2;RIMBP2;CHGB;PDGFRA;PCDH18;STMN2;ZNF536;ZNF385D;PCSK2;SULF1;CNTN4;PDZRN4;SYT4;GAP43;PLPPR4;C11ORF87;THY1;OPCML;OLFM3;PAK3;GAD2;TCEAL7;UNC5D;RAB3C;ST8SIA3;ROBO2;TCEAL5;CACNA1C;GRIA3;CELF3;PTPRD;TMEM130;GRIA1;SCN3A;ASXL3;FAM13C;NEFM;RUNX1T1
prerank,CellMarker_Augmented_2021__Neuronal Progenitor cell:Undefined,0.7436205706337465,1.738909937303644,0.0,0.007727466437225949,0.3,28/94,10.64%,SLITRK1;PCDH8;TAGLN3;SH3GL2;ATRNL1;CNTN2;SNCB;CAMKV;SYT4;PLPPR5;SYT1;GAP43;ZDHHC22;STMN4;OPCML;EFNB3;FGF12;ST8SIA3;GRM5;MAP1B;SULT4A1;KIF5A;CELF3;PCLO;KCNC1;KCNQ2;PNMA2;DNER
prerank,Reactome_2022__Transmission Across Chemical Synapses R-HSA-112315,0.6706802503474825,1.7371594790435863,0.0,0.008930924324990645,0.33,47/207,11.19%,SLC32A1;GRIN3A;GRIK1;GRIN2A;GNG3;KCNJ2;NCALD;CHRNA5;GRIN2D;GRIN2B;GABRB2;NEFL;SYT1;PRKCB;ADCY5;PRKCG;RPS6KA1;GLRA2;NRGN;CACNG3;GABRG3;ACHE;GAD2;GABBR2;PRKAR1B;GNG2;GABRA1;NRG1;ADCY7;CACNG8;ADCY2;GRIA3;NPTN;GABRG2;GABRA5;CACNA1E;GRIA1;KIF17;CPLX1;ARHGEF7;DNAJC5;CACNG4;EPB41L1;RNASE1;GPRIN1;MAPT;SYN2
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Placenta,0.7644663988649579,1.7340169338786007,0.0,0.010469470656886769,0.36,22/66,9.54%,GGT5;PDGFRA;DCN;OGN;ACTA2;ABCA8;ITGA8;ASPN;PODN;SHROOM4;MYH11;POSTN;OLFML1;SLIT3;ABCC9;TNS1;CACNA1C;NEXN;RAMP3;ITGA11;BGN;RASL12
prerank,KEGG_2021_Human__Glutamatergic synapse,0.7400615697124616,1.7323547243474664,0.0,0.010487275879092359,0.37,25/91,9.14%,GRIN3A;GRIK1;GRIN2A;GNG3;PLD1;GRIN2D;GRIN2B;GRIK2;PRKCB;ADCY5;PRKCG;SHANK3;GNG2;ITPR3;GRM5;ADCY7;CACNA1C;ADCY2;GRIA3;GRIN1;GRK2;SHANK1;GRIA1;GRM6;PLD2
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Placenta,0.7340796024873837,1.7320541105840643,0.0,0.010685637182726507,0.39,23/60,10.37%,GGT5;ENPP2;TMEM204;PDGFRA;DCN;ACTA2;FLT1;THY1;SIGLEC1;PODN;ACKR1;MYH11;PTPRC;IGFBP7;CFH;TNS1;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;FLI1
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Embryonic Stem Cell,0.7220369229003943,1.7309051240625832,0.0,0.01071307846979052,0.4,39/89,15.13%,ENPP2;COL4A1;GPNMB;IL13RA1;PDGFRA;FAM20C;TBC1D9;TIMP2;APP;NRP2;IL1R1;POSTN;FAP;IGFBP7;TNS1;PID1;C1R;EMP1;MRAS;BGN;ARHGEF10L;MMP14;RIN2;PXDC1;GLIS3;SPARC;CCL2;DOCK4;RGL1;PRICKLE2;STARD13;FN1;LPAR1;KCNMA1;THBS2;KCTD12;SPP1;SERPING1;PDCD1LG2
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Embryonic Stem Cell,0.7220369229003943,1.7309051240625832,0.0,0.01071307846979052,0.4,39/89,15.13%,ENPP2;COL4A1;GPNMB;IL13RA1;PDGFRA;FAM20C;TBC1D9;TIMP2;APP;NRP2;IL1R1;POSTN;FAP;IGFBP7;TNS1;PID1;C1R;EMP1;MRAS;BGN;ARHGEF10L;MMP14;RIN2;PXDC1;GLIS3;SPARC;CCL2;DOCK4;RGL1;PRICKLE2;STARD13;FN1;LPAR1;KCNMA1;THBS2;KCTD12;SPP1;SERPING1;PDCD1LG2
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.6747429387504611,1.7286836449089786,0.0,0.011245193695963133,0.41,58/211,11.69%,SLITRK1;CCK;L1CAM;SCN1B;ANK3;EPHA7;DRAXIN;PTPRO;CNTN2;CNTN4;SHTN1;EPHA2;SLIT2;RELN;IRS2;SLITRK5;APP;PLPPR4;DOK6;NRP2;EPHA5;EFNA1;EFNB3;SEMA3C;PAK3;SH3KBP1;VLDLR;EMB;SHANK3;FYN;SLIT3;UNC5D;GFRA2;SEMA5B;SEMA3D;ANOS1;BAIAP2;RAP1GAP;PARD3;SEMA3B;ROBO2;NEXN;MAP1B;DCC;NPTN;LAMA5;KIF5A;NRXN3;KIF5C;GAB2;GLI2;EPHA4;SLITRK4;LAMA2;VSTM2L;OPHN1;ENAH;B4GALT5
prerank,Reactome_2022__Frs2-mediated Activation R-HSA-170968,-0.9485774297768605,-1.7284818283550722,0.023255813953488372,0.18095413862492982,0.96,1/11,0.09%,NGF
prerank,KEGG_2021_Human__Amphetamine addiction,0.7794483150865824,1.7225104583850546,0.0,0.012954870203584677,0.48,15/53,9.59%,FOSB;GRIN3A;GRIN2A;CREB5;GRIN2D;GRIN2B;PRKCB;ADCY5;PRKCG;CACNA1C;MAOB;GRIA3;GRIN1;GRIA1;PPP1CB
prerank,KEGG_2021_Human__Osteoclast differentiation,0.7358306571671748,1.7221774763543105,0.0,0.012935106862313,0.48,23/81,17.07%,TGFBR2;FOSL2;FOSB;SOCS3;TEC;IL1R1;MAP3K14;NFATC2;FYN;TNFRSF1A;GAB2;PPARG;TGFB2;SYK;TYK2;RELB;IKBKG;PIK3CD;MAPK11;TNFRSF11B;TAB1;CTSK;MAPK9
prerank,Reactome_2022__Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.6238265071907878,-1.7214983450936971,0.0,0.19660959982968026,0.96,32/126,14.76%,RPL35A;RPS24;RPL34;RPL39;RPL37;POLR2K;RPS28;AAAS;RPL18;NUP50;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;POLR2C;RPL11;RPL23A;NUP54;GTF2F1;RPS21;RPS23;POLR2D
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.7249202815096031,1.7188722831889873,0.0,0.013247085320958769,0.5,25/118,7.97%,TGFBR2;SIX3;COL4A1;CA10;GRIN2A;PROX1;PCDH18;EPHA7;GRIN2D;GRIN2B;CNTN4;RELN;CNTNAP2;SHROOM4;CIC;SHANK3;APOD;MFSD2A;NNAT;ZIC1;ROBO2;SYNJ2;GRIN1;AATK;ADGRL2
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.6297294588594764,-1.7178380688833084,0.0,0.19944700122174147,0.96,42/188,11.83%,IMP4;RPL35A;RPS24;FCF1;TRPT1;RPL34;RPL39;EXOSC8;RPL13;RPL37;RPS28;RPL18;POP5;DDX52;KARS1;RPL12;RPL23;RPL31;PIH1D2;NOP56;RPL6;RPF1;RRP1B;EXOSC4;RPL41;RPL22;RPL29;RPL30;NOL8;SNU13;METTL3;RPL14;EXOSC5;RPL15;RPS2;DCAF13;MDN1;IMP3;UTP20;RRP36;RPL11;RPL23A
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.7701909086637527,1.717738816304366,0.0,0.013060506654466392,0.5,2/54,0.12%,LEF1;CDKN2A
prerank,CellMarker_Augmented_2021__Epidermal Transit Amplifying cell:Foreskin,-0.6643304367200762,-1.7177076339012243,0.0,0.19390680674335978,0.96,17/80,7.21%,TMA7;NDUFS5;CSTB;NMB;POMP;SNRPB2;TIMM8B;PRDX1;NIFK;COX7C;POLR2K;ENY2;PDCL3;MRPL15;SF3B6;VDAC2;MRPL47
prerank,KEGG_2021_Human__Neuroactive ligand-receptor interaction,0.6758837227236535,1.7176900134628608,0.0,0.012879110728709914,0.5,43/161,8.78%,NPY;CCK;CNR1;C3;GRIN3A;NPY1R;HTR2C;P2RY6;GRIK1;GRIN2A;HRH1;CHRM3;CHRM1;CHRNA5;GRIN2D;GRIN2B;P2RY13;GRIK2;GABRB2;GRID2;GLRA2;GABRG3;MCHR2;GABRD;GABBR2;GIPR;OXTR;RXFP1;GABRA1;TAC3;PARD3;GRM5;GHR;CCKBR;HCRTR2;APLNR;GRIA3;GRIN1;GLP1R;GABRG2;GABRA5;GRIA1;GRM6
prerank,Reactome_2022__Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.840185343203755,-1.7170281357540311,0.0,0.1896914413793737,0.96,2/19,2.79%,DAO;PXMP2
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.8413017161885012,1.716935601182589,0.0,0.013179035225131926,0.5,3/30,8.12%,LEF1;GNG2;CTNNB1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.8140655555001398,1.7164288201371922,0.0,0.013000940154522035,0.5,23/53,9.70%,SHISA7;SHISA9;GRIN2A;NPTX2;GRIN2B;NLGN1;PSCA;NEFL;SHISA8;RELN;DLGAP3;APP;CACNG3;NETO1;CACNG8;GRIA3;GRIN1;SHANK1;NPTX1;CAPN1;GRIA1;MINK1;CACNG4
prerank,Reactome_2022__PI-3K cascade:FGFR2 R-HSA-5654695,-0.8730424136590562,-1.7158654656291263,0.0,0.18689598855904607,0.96,1/14,0.15%,FGF6
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.7518399790411652,1.714564927192185,0.0,0.013291242272028634,0.51,17/65,7.85%,ENPP2;CSPG4;IGF1;IL15;EPHA7;DMTN;RELN;TEC;APP;EFNA1;PTPRC;FYN;TNFRSF14;CD44;GHR;PDGFA;RAP2B
prerank,CellMarker_Augmented_2021__Neuron:Spinal Cord,0.7387314171507287,1.7122758517198702,0.0,0.014488999569798655,0.54,38/97,17.27%,TTLL7;TAGLN3;STMN2;TMEFF2;NMNAT2;NLGN1;ATRNL1;PLPPR5;SYT1;GAP43;PLPPR4;OPCML;EFNB3;TCEAL7;NUAK1;ATP9A;GUCY1A2;MAP1B;LIMCH1;ADGRL2;PCLO;EPB41L1;PCDHB15;DNER;CRMP1;ENAH;FAM13C;STK32A;PRICKLE2;MMP16;CAP2;RBFOX2;DIP2C;PFN2;NPAS3;PCDHB12;MAPK4;MAGI1
prerank,Reactome_2022__Assembly Of ORC Complex At Origin Of Replication R-HSA-68616,-0.8304084919127497,-1.711478767062905,0.020833333333333332,0.19513899046514033,0.97,5/18,5.51%,H2AC20;H3-3B;H2BC4;H2BC21;H2AC6
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.7465068514345268,1.7103186491053266,0.0,0.015204041107009495,0.57,26/80,8.95%,ECM2;COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;ABCA8;SULF1;ITGA8;COL4A2;SLIT2;ASPN;THY1;PODN;ANGPTL2;MYH11;POSTN;SLIT3;COL12A1;FAP;SEMA3D;C1R;ITGA11;BGN
prerank,Reactome_2022__Apoptosis Induced DNA Fragmentation R-HSA-140342,-0.9303526431061923,-1.708873553479308,0.0,0.19671002471041052,0.97,2/10,3.59%,H1-2;H1-4
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.7343922463016282,1.7083180260190858,0.0,0.015900748245830317,0.57,32/101,8.75%,KCNT2;RIMBP2;CHGB;EDIL3;PROX1;RGS7BP;STMN2;SH3GL2;DEPP1;PCSK2;RCAN2;CNTN4;SYT4;SHC2;PLPPR4;KCNB2;ABCC8;PLPPR1;TCEAL7;RAB3C;FAP;ST8SIA3;RAI2;PGR;LDB2;GRIA3;SYT13;GLP1R;CELF3;PTPRD;SCG5;PKDCC
prerank,Reactome_2022__Viral mRNA Translation R-HSA-192823,-0.6697884653498213,-1.7080806338503935,0.0,0.1933927377965322,0.97,23/81,11.83%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;RPL11;RPL23A
prerank,CellMarker_Augmented_2021__Colony-forming cell:Prostate,0.7429161450456583,1.7061841570352532,0.0,0.017313437460620165,0.6,35/82,18.34%,TGFBR2;MET;COL4A1;ALS2CL;THBS1;CALD1;EPHA2;APP;TGFA;OSMR;COL12A1;LAMB1;ITGA2;LPP;MYO1B;EMP1;ITGA3;CNN3;YAP1;PHLDB2;NPAS2;BACE2;PAM;NTN4;LAMA3;SLC44A3;CTDSPL;FSTL1;MYOF;CACHD1;SRPX2;PCDH1;DOCK9;KIAA1671;F3
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.7149360257293218,-1.7047242425953069,0.0,0.19745975755014805,0.98,30/78,18.52%,MRPL10;MRPS21;MRPL52;MRPS7;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;MRPS9;MTRF1L;MRPS26;MRPL21;MTRF1;MRPS18B;MRPS34;MRPS33;MRPL19;MRPS12;MRPL50;MRPS5;OXA1L;MRPL27;MRPS31;MRPL3;MRPL17;PTCD3
prerank,KEGG_2021_Human__Nicotine addiction,0.842001084411335,1.703554473376683,0.0,0.018401029453644288,0.64,14/33,8.77%,SLC32A1;GRIN3A;GRIN2A;GRIN2D;GRIN2B;GABRB2;GABRG3;GABRD;GABRA1;GRIA3;GRIN1;GABRG2;GABRA5;GRIA1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),-0.6950781504901564,-1.7034866447653632,0.0,0.19551452748683354,0.98,23/74,16.25%,NDUFAF3;UQCRFS1;NDUFS5;COX18;DMAC2;TMEM126A;NDUFA12;NDUFB4;NDUFB1;COX20;NDUFAF4;NDUFV3;NDUFA8;LYRM7;FOXRED1;COX19;NDUFS3;NDUFC1;SAMM50;SLC25A33;SMIM20;OXA1L;NDUFAF8
prerank,Reactome_2022__Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.783346188447196,-1.7034355554871181,0.0,0.19124346226338673,0.98,1/24,0.15%,FGF6
prerank,CellMarker_Augmented_2021__Interstitial cell:Bladder,0.7372171036821973,1.7019314530817902,0.0,0.01843419704302094,0.64,30/95,15.20%,KCNT2;SLC6A15;COL4A1;EDIL3;PCDH18;NLGN1;CALD1;COL4A2;GAP43;SLIT2;TRAM1L1;EFNB3;TCEAL7;NUAK1;LARP6;MAP1B;ADGRL2;PTPRD;CNN3;GLI2;NACAD;CRMP1;ENAH;MMP16;CAP2;FGF2;FMN2;RBFOX2;RGS4;SMARCA1
prerank,CellMarker_Augmented_2021__Mesothelial cell:Lung,0.7372171036821973,1.7019314530817902,0.0,0.01843419704302094,0.64,30/95,15.20%,KCNT2;SLC6A15;COL4A1;EDIL3;PCDH18;NLGN1;CALD1;COL4A2;GAP43;SLIT2;TRAM1L1;EFNB3;TCEAL7;NUAK1;LARP6;MAP1B;ADGRL2;PTPRD;CNN3;GLI2;NACAD;CRMP1;ENAH;MMP16;CAP2;FGF2;FMN2;RBFOX2;RGS4;SMARCA1
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Germ,0.7372171036821973,1.7019314530817902,0.0,0.01843419704302094,0.64,30/95,15.20%,KCNT2;SLC6A15;COL4A1;EDIL3;PCDH18;NLGN1;CALD1;COL4A2;GAP43;SLIT2;TRAM1L1;EFNB3;TCEAL7;NUAK1;LARP6;MAP1B;ADGRL2;PTPRD;CNN3;GLI2;NACAD;CRMP1;ENAH;MMP16;CAP2;FGF2;FMN2;RBFOX2;RGS4;SMARCA1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.8161972924128023,1.7017006895360454,0.0,0.018490723260504948,0.64,11/29,12.55%,SCN1B;ANK3;YWHAH;SCN3B;FGF12;HECW2;NETO1;PRKCE;FGF13;HECW1;FXYD7
prerank,Reactome_2022__Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.637772923846767,-1.7008953412623333,0.0,0.19356957751424092,0.98,24/103,11.83%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;RPL18;RBM8A;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;RPL11;RPL23A
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.8358072692537393,1.6991574802310885,0.0,0.01909138766844058,0.65,7/29,7.47%,TLR2;CTSS;P2RY13;MYO1F;PLEK;SIGLEC1;SLC7A7
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.8774018492099214,1.6985988064365438,0.0,0.01913895757126892,0.66,2/27,0.25%,LEF1;HPN
prerank,CellMarker_Augmented_2021__Natural Killer cell:Breast,0.7244786814625999,1.698501447520285,0.0,0.018493824169990195,0.66,31/97,12.18%,PCDH8;STMN2;ZNF536;VSTM2B;CNTN2;NEFL;GAP43;ZDHHC22;SCN3B;PLP1;STMN4;OPCML;RTN1;ELAVL4;ATP2B3;PAK3;TCEAL7;NAP1L3;RAB3C;ST8SIA3;TMEM132C;TCEAL5;CACNA1C;JPH4;CELF3;KIF5C;KCNC1;DCX;ASXL3;NEFM;PLXNA4
prerank,CellMarker_Augmented_2021__Chromaffin cell:Adrenal Gland,0.7244786814625999,1.698501447520285,0.0,0.018493824169990195,0.66,31/97,12.18%,PCDH8;STMN2;ZNF536;VSTM2B;CNTN2;NEFL;GAP43;ZDHHC22;SCN3B;PLP1;STMN4;OPCML;RTN1;ELAVL4;ATP2B3;PAK3;TCEAL7;NAP1L3;RAB3C;ST8SIA3;TMEM132C;TCEAL5;CACNA1C;JPH4;CELF3;KIF5C;KCNC1;DCX;ASXL3;NEFM;PLXNA4
prerank,CellMarker_Augmented_2021__Definitive Zone cell:Adrenal Gland,0.7244786814625999,1.698501447520285,0.0,0.018493824169990195,0.66,31/97,12.18%,PCDH8;STMN2;ZNF536;VSTM2B;CNTN2;NEFL;GAP43;ZDHHC22;SCN3B;PLP1;STMN4;OPCML;RTN1;ELAVL4;ATP2B3;PAK3;TCEAL7;NAP1L3;RAB3C;ST8SIA3;TMEM132C;TCEAL5;CACNA1C;JPH4;CELF3;KIF5C;KCNC1;DCX;ASXL3;NEFM;PLXNA4
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.6593853426642865,1.6955930437325464,0.0,0.020220203844074566,0.68,48/186,11.08%,CACNA1H;SLC6A15;HPN;SCN1B;SCN9A;CACNA1G;SLC24A2;KCNH8;KCNJ2;KCNV1;KCNH7;TRPC3;KCNK10;SCN3B;KCNQ1;SLC39A14;KCNC2;SCN1A;KCNB2;ABCC8;KCNF1;SCN2A;KCNK1;ASIC3;TRPM4;KCNQ5;SLC9A9;ASIC4;KCND3;SLC39A11;ABCC9;KCNH2;CACNA1C;ATP1A1;SLC9A1;KCNC1;LRRC55;HCN1;KCNQ2;KCNK12;ATP1B1;ORAI1;ATP1B3;SLC4A11;MCOLN2;SCN3A;GAS6;KCNAB3
prerank,Reactome_2022__Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.723877531216354,-1.6954792721354848,0.022222222222222223,0.20206262233889807,0.99,12/57,6.82%,H2AC20;DPEP2;H3-3B;DNMT3B;H2BC4;H2BC21;GTF2H5;POLR2K;GTF2H2;H2AC6;POLR1F;TAF1D
prerank,Reactome_2022__L1CAM Interactions R-HSA-373760,0.7302415544659749,1.694877366830988,0.0,0.020125379622225822,0.68,24/91,10.76%,L1CAM;SCN1B;SCN9A;ANK3;SH3GL2;CD24;CNTN2;CNTNAP1;SHTN1;GAP43;SCN3B;RPS6KA1;SCN1A;NRP2;SCN2A;LAMB1;ITGA2;DNM1;DPYSL2;KCNQ2;RNASE1;ITGA9;DCX;SCN3A
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.8221733569940783,1.6930485996832751,0.0,0.02015860809711117,0.68,12/34,10.44%,GRIN3A;GRIK1;GRIN2A;GRIN2B;GRIK2;GRID2;APP;GRM5;GRIA3;GRIN1;GRM6;HOMER1
prerank,Reactome_2022__Cap-dependent Translation Initiation R-HSA-72737,-0.6236426103148743,-1.6902716434207454,0.0,0.21116289814827305,0.99,34/107,16.21%,RPL35A;RPS24;RPL34;RPL39;EIF4EBP1;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPL6;EIF2S1;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;EIF3D;RPL11;RPL23A;EIF1AX;RPS21;RPS23;EIF3J;EIF3M;EIF3E;RPS25;EIF5B
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreas,0.7136851151666525,1.6892988739805108,0.0,0.022559216534482205,0.71,42/98,16.70%,CHGB;TTLL7;VWA5B2;ASPHD1;NMNAT2;SRCIN1;ARHGAP39;SYT1;CAMK2N2;NOS1AP;EFNB3;EPB41L4B;CDK5R2;ATP9A;HPCA;PTPN21;VGF;CKMT1B;LARP6;MAP1B;SYT13;SULT4A1;MAPK8IP1;PCLO;SRRM3;B4GALNT1;PNMA2;EPB41L1;CMTM4;TEAD1;ENAH;PLEKHH1;MEIS3;CAP2;KIAA1549;RBFOX2;BCAR1;MTCL1;SEZ6L2;MAPK8IP2;SLC8A2;SPIRE2
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.6869645618618648,1.6890407771073446,0.0,0.02244253550385834,0.71,41/126,13.35%,TGFBR2;CDH6;CDH22;SLITRK1;L1CAM;FLRT3;CDH9;IL1RAPL1;CDH19;CDH23;NLGN1;CNTN2;GRID2;CLDN16;CNTN4;ICAM1;CDH8;IGSF21;EMB;CDH7;UNC5D;CDH18;FAT2;KIRREL3;ROBO2;NEXN;NPTN;TENM4;MAG;PTPRD;TGFB2;LRRC4;CLDN18;VSTM2L;ITGAL;CLDN20;SDK2;ROBO4;CDH4;PCDHB2;HMCN1
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.831015947831619,1.6878315232382453,0.0,0.02257233617189685,0.72,2/32,0.06%,LEF1;TGFBR2
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Subcutaneous Adipose Tissue,0.7543716497943587,1.6869747380459637,0.0,0.02282017432243288,0.73,12/57,6.88%,TGFBR2;FOSL2;IL13RA1;TLR2;DYSF;IL1R1;BCL6;IGFBP7;TNFRSF1A;TNS1;PID1;STEAP4
prerank,CellMarker_Augmented_2021__Neural cell:Embryoid Body,0.73397747329646,1.6851330468077272,0.0,0.02330189621534629,0.73,23/82,11.43%,PCDH8;TAGLN3;EPHA7;NLGN1;GRID2;CAMKV;SYT4;PLPPR5;GAP43;ZDHHC22;PLP1;OPCML;EFNB3;TCEAL7;UNC5D;SEMA5B;ST8SIA3;TCEAL5;CCKBR;PTPRD;KCNQ2;DCX;CRMP1
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.7126122718137764,-1.68420222143399,0.0,0.21956784339662502,0.99,18/44,16.95%,TIMM8B;ATP5PF;ATP5MC1;TIMM13;APOO;ATP5PB;ATP5PD;DMAC2L;MICOS10;ATP5MC3;SAMM50;ATP5F1B;TIMM10;ATP5F1A;TMEM11;LETM1;ATP5MC2;AFG3L2
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.7868030644757423,1.683447461924409,0.0,0.02412861969174633,0.76,14/25,7.50%,SCN1B;CACNA1G;KCNJ2;PKP2;SCN3B;KCNQ1;KCNE4;SCN1A;FGF12;GJC1;KCNH2;CACNA1C;RYR2;ATP1A1
prerank,Reactome_2022__Translation R-HSA-72766,-0.6183697053600747,-1.6833793080701018,0.0,0.21663536856305612,0.99,87/257,19.04%,MRPL10;RPL35A;RPS24;PARS2;RPL34;SRPRA;RPL39;MRPS21;EIF4EBP1;RPL37;SRPRB;MRPL52;RPS28;AIMP1;MRPS7;RPL18;MTIF2;KARS1;VARS1;RPL12;RPL23;RPL31;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;RPL6;EIF2S1;MRPL40;RPS27L;MRPL47;RPL41;MRPS9;RPS13;MTRF1L;RPL22;RPL29;RPL30;DDOST;RPSA;RPL14;SPCS1;MTIF3;RPL15;EEF1A1;RPS2;EIF3D;EPRS1;APEH;MRPS26;MRPL21;EEF1B2;RPL11;RPL23A;EIF1AX;NARS1;WARS2;MRPS18B;RPS21;MRPS34;MRPS33;SPCS2;RPS23;MTFMT;MRPL19;YARS2;EIF3J;EIF3M;MRPL50;EIF3E;RPS25;MRPS5;EIF5B;OXA1L;RARS1;MRPS31;MRPL3;AIMP2;MRPL17;LARS1;RPL8;PTCD3;RPL32;EIF2B3;EIF2B1
prerank,CellMarker_Augmented_2021__M2 macrophage:Serum,0.8254367547011225,1.6828198639452987,0.0,0.023870985429846496,0.76,9/34,4.31%,HLA-DRA;TLR2;CTSS;P2RY13;MYO1F;SLA;GPR34;SIGLEC1;PTPRC
prerank,CellMarker_Augmented_2021__M2 macrophage:Brain,0.8254367547011225,1.6828198639452987,0.0,0.023870985429846496,0.76,9/34,4.31%,HLA-DRA;TLR2;CTSS;P2RY13;MYO1F;SLA;GPR34;SIGLEC1;PTPRC
prerank,CellMarker_Augmented_2021__Kupffer cell:Fetal Liver,0.8254367547011225,1.6828198639452987,0.0,0.023870985429846496,0.76,9/34,4.31%,HLA-DRA;TLR2;CTSS;P2RY13;MYO1F;SLA;GPR34;SIGLEC1;PTPRC
prerank,Reactome_2022__NF-kB Is Activated And Signals Survival R-HSA-209560,-0.9519517619805755,-1.6806224042949345,0.018867924528301886,0.21989031884697,0.99,1/12,0.09%,NGF
prerank,CellMarker_Augmented_2021__Decidual cell:Blood,0.7327274809489838,1.6798474198224902,0.0,0.025341544345608626,0.78,36/81,15.37%,FOSL2;CXCL2;C3;ANXA1;SOCS3;TYMP;ADGRE5;SP100;ZFP36;DUSP1;CD55;ICAM1;IRAK2;DUSP10;IL1R1;TNFRSF14;AHR;KLF10;BIRC3;CD44;TMBIM1;MVP;CSRNP1;NDRG1;PARP9;APOL3;NR4A2;KLF6;ANXA11;IL4R;PRDM1;IFIH1;HLA-E;S100A6;PFKFB3;STAT6
prerank,Reactome_2022__Neurexins And Neuroligins R-HSA-6794361,0.7384098700713428,1.679795100581149,0.0136986301369863,0.02509550993448621,0.78,19/56,12.79%,GRIN2A;GRIN2D;GRIN2B;NLGN1;SYT1;DLGAP3;APBA2;SHANK3;LRRTM2;GRM5;SHANK1;NRXN3;LRRTM4;EPB41L1;GPRIN1;SIPA1L1;HOMER1;SYT12;DLGAP1
prerank,Reactome_2022__RNA Polymerase I Transcription R-HSA-73864,-0.7316413613192159,-1.6797189158193837,0.02564102564102564,0.21736407518059997,0.99,12/58,6.82%,H2AC20;DPEP2;H3-3B;H2BC4;H2BC21;GTF2H5;POLR2K;GTF2H2;H2AC6;CHD4;POLR1F;TAF1D
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.7009302578587853,1.6776921608112656,0.0,0.026414560754171392,0.81,33/112,11.98%,KCNT2;EDIL3;RGS7BP;PCDH18;STMN2;RCAN2;GAP43;ADCY5;SHC2;SLIT2;PLPPR4;THY1;OPCML;EFNB3;TCEAL7;COL23A1;SEMA5B;CCDC3;GUCY1A2;LDB2;MAP1B;BOC;ADGRL2;PTPRD;RASL12;TGFB2;PCDHB15;NACAD;ASXL3;CRMP1;FAM13C;RUNX1T1;PRICKLE2
prerank,Reactome_2022__Smooth Muscle Contraction R-HSA-445355,0.7673485200850054,1.676940222245187,0.0,0.02682534777494151,0.81,12/38,11.18%,CACNA1H;ANXA1;CACNA1G;ACTA2;CALD1;DYSF;MYH11;GUCY1A2;TPM4;GUCY1A1;SORBS1;GUCY1B1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.8694269745083424,1.6769160699011292,0.0,0.026572278456309984,0.81,11/26,9.70%,CALD1;DMTN;ADD2;BAIAP2L1;NEDD9;BAIAP2;FAM107A;RHOD;PAWR;MYO1B;FSCN1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.8701418758797166,1.6752324223556503,0.0,0.026757255280301064,0.81,11/26,9.70%,CALD1;DMTN;ADD2;BAIAP2L1;NEDD9;BAIAP2;FAM107A;RHOD;PAWR;MYO1B;FSCN1
prerank,CellMarker_Augmented_2021__Neuron:Brain,0.8310888356916137,1.6748682957542067,0.015625,0.026724154762073068,0.81,12/27,8.66%,SLITRK1;DCN;NELL1;CNTN4;RELN;GLRA2;KCNK1;SYP;LNX1;GRIA3;GFAP;TMEM130
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.6921392197382965,1.674516648449723,0.0,0.026585320311557165,0.81,24/99,12.43%,GGT5;CXCL2;TLR2;ANXA1;HRH1;ADGRE5;THBS1;TRAF3IP2;NOD1;SIGLEC1;ACKR1;TPST1;CIITA;CD44;TNFRSF1A;CHI3L1;HDAC4;STAT3;APOL3;HDAC9;CCL2;ITGAL;PXK;RELB
prerank,KEGG_2021_Human__Regulation of lipolysis in adipocytes,0.8087049349395518,1.6737186269830548,0.0,0.02676513375075533,0.81,8/40,8.61%,NPY;NPY1R;ADCY5;IRS2;PRKG2;ADCY7;ADCY2;PLAAT3
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.7185871449546809,1.672499733102025,0.0,0.0275682586409142,0.82,22/95,9.36%,SIX3;PCDH8;TAGLN3;ZNF536;SNCB;CAMKV;GAP43;ZDHHC22;OPCML;EFNB3;LGR5;UNC5D;SEMA5B;CDK5R2;HPCA;MAP1B;SULT4A1;CELF3;PCLO;KCNC1;SRRM3;KCNQ2
prerank,CellMarker_Augmented_2021__Neutrophil:Vagina,0.8833385957728112,1.6723772213313268,0.0,0.027529099182617443,0.82,5/20,2.50%,TLR2;CTSS;CD24;P2RY13;MYO1F
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.7059475785896377,-1.6719012950177177,0.0,0.23215314094967965,1.0,33/78,21.93%,MRPL10;MRPS21;MRPL52;MRPS7;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;MRPS9;MRPS26;MRPL21;MRPS18B;MRPS34;MRPS33;MRPL19;MRPS12;MRPL50;MRPS5;OXA1L;MRPL27;MRPS31;MRPL3;MRPL17;PTCD3;MRPL54;TSFM;MRPL9;MRPL24;MRPL58
prerank,KEGG_2021_Human__Circadian entrainment,0.7182356955541205,1.6710007092717951,0.0,0.028208671728811533,0.83,22/79,8.88%,CACNA1H;CACNA1G;GRIN2A;GNG3;GRIN2D;GRIN2B;PRKCB;ADCY5;PRKCG;NOS1AP;PRKG2;GNG2;ITPR3;GUCY1A2;ADCY7;CACNA1C;RYR2;ADCY2;GRIA3;GRIN1;GRIA1;GUCY1A1
prerank,CellMarker_Augmented_2021__Hair Follicle cell:Hair Follicle,0.732753665865639,1.6709033348206548,0.0,0.027961227239962316,0.83,18/62,11.13%,GGT5;TGFBR2;FOSL2;CTSS;SP100;ZFP36;MYH11;TNFRSF14;GAB3;IGFBP7;CIITA;CFH;CD44;NLRC5;ETV6;FLI1;SYNE3;APOL3
prerank,CellMarker_Augmented_2021__Macrophage:Brain,0.7995995222028254,1.6701470477662066,0.0,0.02842363741692675,0.84,8/30,6.51%,FOSL2;PIM1;EMB;NFIL3;SYNGR2;CIITA;SAMHD1;PLAC8
prerank,CellMarker_Augmented_2021__Basophil:Lung,0.7953216206568482,1.6688656797861694,0.0,0.029177847409525566,0.85,9/37,5.23%,FRMD4B;HLA-DRA;TLR2;CTSS;P2RY13;SLA;GPR34;SIGLEC1;SLC9A9
prerank,Reactome_2022__Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,0.7201096622420025,1.6684294867655634,0.0,0.029324744428447187,0.85,1/75,0.01%,LEF1
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.6924247281703766,1.6668400191367323,0.0,0.02986207368961892,0.86,33/101,14.64%,CACNA1H;ANK3;RAPGEF5;CD24;SRCIN1;ADCY5;SHC2;KCNQ1;PLPPR1;CP;BAIAP3;EPB41L4B;ATP9A;ZNF704;FAAH;RAP1GAP;RAI2;MAOB;SYT13;SYBU;HOOK1;ZBTB7C;KALRN;SLC22A23;TPPP;PODXL;SORBS1;PLEKHH1;DLG3;NEBL;COBL;PATJ;CAMSAP3
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Fetal Pancreas,0.7314139282302622,1.6667562590485228,0.0,0.02961113189390784,0.86,37/94,16.53%,TAGLN3;GNG3;TMCC2;VSTM2B;SNCB;CNTNAP1;NEFL;GAP43;PRR36;NAP1L3;CDK5R2;HPCA;FSD1;TRIM46;SYP;SYNGR3;NYAP1;KIF5A;CELF3;KIF5C;KCNQ2;TTC9B;NACAD;FBXL16;NEFM;PIANP;ENO2;DPYSL4;CCDC184;CELSR3;PSD;PTPRN;PSD2;STX1B;TCEAL2;SLC8A2;KIF3C
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.847591343713742,1.6659359592259042,0.0,0.029847339113785225,0.86,8/21,11.24%,TLR2;THBS1;DMTN;APOD;FAM107A;ROBO2;DUSP22;PHLDB2
prerank,Reactome_2022__Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,0.7427445082522093,1.6658626277307895,0.0,0.029696461928182365,0.86,24/59,16.66%,IL13RA1;ANXA1;SOCS3;ICAM1;FOXO1;BCL6;FOXO3;LAMA5;BCL2L1;FSCN1;STAT3;FGF13;TYK2;CCL2;BCL2;FN1;IL4R;CDKN1A;CCND1;IL12A;STAT6;TP53;ZEB1;RORA
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Cartilage,0.7059697983818979,1.6657539997325603,0.0,0.029548058139064793,0.86,41/92,18.09%,COL4A1;EDIL3;CALD1;PPFIBP1;COL4A2;EPHA2;APP;ARHGEF17;MCAM;OSMR;NUAK1;COL12A1;LAMB1;PTPN21;LARP6;MAP1B;SCARA3;MYO1B;ADGRL2;SH3PXD2B;KITLG;CNN3;YAP1;TANC1;TGFB2;TEAD1;ENAH;STARD13;FN1;CAP2;PALLD;PLOD2;NTN4;RBFOX2;BCAR1;SMARCA1;FSTL1;FAM114A1;WWTR1;SRPX2;CTTNBP2NL
prerank,Reactome_2022__Influenza Infection R-HSA-168255,-0.6094093147372228,-1.6653810426289897,0.0,0.24423667848544264,1.0,34/145,14.76%,KPNA2;RPL35A;RPS24;RPL34;RPL39;RPL37;POLR2K;RPS28;AAAS;RPL18;NUP50;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;HSPA1A;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;POLR2C;RPL11;RPL23A;NUP54;GTF2F1;RPS21;RPS23;POLR2D
prerank,KEGG_2021_Human__Axon guidance,0.6579588038033101,1.6647747166403584,0.0,0.02959054221084083,0.87,49/166,18.87%,MET;L1CAM;EPHA7;TRPC3;EPHA2;SLIT2;EPHA5;EFNA1;EFNB3;SEMA3C;PAK3;NFATC2;FYN;SLIT3;UNC5D;SEMA5B;SEMA3D;PARD3;SEMA3B;DPYSL2;ROBO2;RHOD;PAK4;DCC;BOC;SSH2;LIMK2;EPHA4;LRRC4;ENAH;PLXNA4;CAMK2B;PAK1;DPYSL5;NTN4;PIK3CD;PLXNA1;PLXNA2;NGEF;RGMA;UNC5C;GNAI1;WNT5A;NCK2;SEMA4D;CAMK2A;NEO1;PRKCA;NFATC3
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),0.7146757041021781,1.6647745927262767,0.0,0.029351908805914692,0.87,18/74,11.04%,OPTC;COL4A1;COL11A2;P4HA2;COL4A2;TLL1;COL8A1;COL21A1;COL23A1;COL12A1;COL27A1;SCX;CYP1B1;LOXL1;TGFB2;COL9A1;P3H2;COL4A4
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.8407726651888803,1.664669640722411,0.0,0.029117093535467372,0.87,6/24,3.47%,CACNA1H;CACNA1G;DOC2B;SYT4;SYT1;SYT5
prerank,KEGG_2021_Human__Spliceosome,-0.6387282592773895,-1.664268386369384,0.0,0.2419619718928011,1.0,30/120,14.93%,RP9;SNRNP27;LSM7;SNRPB2;DHX16;LSM3;SF3B4;SF3A1;RBM8A;LSM2;CRNKL1;U2AF1;SF3B6;BUD31;PRPF18;HSPA1A;LSM5;DDX46;SNU13;PPIH;PQBP1;SYF2;LSM4;PRPF8;PPIL1;SRSF2;RBM22;PRPF3;PPIE;RBMX
prerank,Reactome_2022__Pre-NOTCH Expression And Processing R-HSA-1912422,-0.6556775598561302,-1.6635664822106373,0.0,0.23921815225587925,1.0,8/53,7.36%,H2AC20;H3-3B;H2BC4;H2BC21;SIRT6;H2AC6;POFUT1;MAML3
prerank,Reactome_2022__p75NTR Signals Via NF-kB R-HSA-193639,-0.8772104755989817,-1.6631488988631304,0.03773584905660377,0.23657232617741888,1.0,1/15,0.09%,NGF
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),0.7120071096104513,1.6628929356805724,0.0,0.030725878452779364,0.89,35/106,15.65%,LEF1;ARHGAP39;CEP170B;APP;DAB2IP;EFNB3;ARHGEF17;NUAK1;PTPN21;SEMA3B;PHYHIP;LARP6;MAP1B;GFAP;SCARA3;NYAP1;MAPK8IP1;SH3PXD2B;SRRM3;YAP1;EPB41L1;CMTM4;TEAD1;NACAD;TNFRSF19;LGI3;MEIS3;CAP2;SLC13A4;GPR37;RBFOX2;BCAR1;MTCL1;SEZ6L2;NGEF
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),0.7296259504954687,1.6627755742931045,0.016666666666666666,0.030575211690598736,0.89,6/63,3.55%,GGT5;NPNT;ZFP36;YBX3;DAB2IP;ERBIN
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.7335947350419869,1.662033044856498,0.0,0.03097023658044462,0.89,19/84,10.44%,ARHGAP4;SPOCK3;TMEFF2;SERPINE1;SULF1;SLIT2;WAS;THY1;DUSP10;PODN;CLIC4;FOXO3;LIMCH1;CYP1B1;RAP2B;DUSP22;LDLRAD4;DLG5;EPHA4
prerank,Reactome_2022__Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,0.6819206611850585,1.6608838511305728,0.0,0.03153884557518963,0.89,43/150,13.10%,GRIN3A;GRIK1;GRIN2A;GNG3;KCNJ2;NCALD;CHRNA5;GRIN2D;GRIN2B;GABRB2;NEFL;PRKCB;ADCY5;PRKCG;RPS6KA1;GLRA2;NRGN;CACNG3;GABRG3;GABBR2;PRKAR1B;GNG2;GABRA1;NRG1;ADCY7;CACNG8;ADCY2;GRIA3;NPTN;GABRG2;GABRA5;GRIA1;KIF17;ARHGEF7;CACNG4;EPB41L1;RNASE1;GPRIN1;MAPT;GRIP2;CAMK2B;RPS6KA6;PICK1
prerank,Reactome_2022__Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.7912141655518635,-1.6603127740513486,0.0,0.2386784241355909,1.0,1/21,0.15%,FGF6
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.7032117259729509,-1.6602454683044017,0.0,0.2345632788918738,1.0,38/93,20.22%,MRPL10;MRPS21;MRPL52;MRPS7;MTIF2;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;FASTKD2;MRPS9;MTRF1L;GATC;MTIF3;MRPS26;NOA1;MRPL21;MTRF1;MRPS18B;MRPS34;MRPS33;MRPL19;MRPS12;MRPL50;MRPS5;OXA1L;MRPL27;MRPS31;MRPL3;MRPL17;PTCD3;QRSL1;MRPL54;TSFM
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),0.8576176672386866,1.6594656849060958,0.0,0.03218786981352193,0.89,4/23,3.05%,NR4A3;C3;IGF1;IRS2
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.7553255276731394,1.6591032288461522,0.0,0.03203064332376863,0.89,19/62,7.53%,SHISA7;SLC24A2;GRIN2A;RIMS2;PLK2;GRIN2D;GRIN2B;NLGN1;GRIK2;SYT1;RELN;CLSTN2;APP;CACNG3;RIMS3;BAIAP3;SHANK3;CACNG8;NPTN
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.7997441995631001,1.6586702156699105,0.03508771929824561,0.0322270475279764,0.89,9/31,7.99%,GRIN2A;GRIN2D;GRIN2B;GRID2;GABRG3;GABRA1;GRIN1;GABRG2;GABRA5
prerank,Reactome_2022__RNA Polymerase I Promoter Clearance R-HSA-73854,-0.7345753465210995,-1.6584558337231943,0.02564102564102564,0.2348315742093128,1.0,12/57,6.82%,H2AC20;DPEP2;H3-3B;H2BC4;H2BC21;GTF2H5;POLR2K;GTF2H2;H2AC6;CHD4;POLR1F;TAF1D
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.8213811714513249,1.6576413964729413,0.0,0.03250765016261593,0.89,7/28,7.91%,CDKN2A;THBS1;SERPINE1;DMTN;APOD;FAM107A;DUSP22
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),0.8036272609752529,1.6576390344228746,0.0,0.0322650557584173,0.89,1/38,0.01%,LEF1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.6587923753167132,1.6574682304586466,0.0,0.032197776821774785,0.89,57/175,15.21%,L1CAM;SCN1B;EPHA7;DRAXIN;PTPRO;CNTN2;CNTN4;GAP43;EPHA2;SLIT2;RELN;IRS2;DOK6;NRP2;EPHA5;EFNA1;EFNB3;SEMA3C;SH3KBP1;VLDLR;EMB;SHANK3;FYN;SLIT3;UNC5D;GFRA2;SEMA5B;SEMA3D;ANOS1;RAP1GAP;SEMA3B;ROBO2;NEXN;DCC;NPTN;LAMA5;KIF5A;NRXN3;KIF5C;GAB2;GLI2;EPHA4;LAMA2;VSTM2L;OPHN1;ENAH;PLXNA4;KLF7;ROBO4;GAB1;PALLD;NTN4;PIK3CD;PLXNA1;NOTCH3;LAMA3;PLXNA2
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone Marrow,0.8530230368444034,1.657424028707602,0.0,0.03196102846279114,0.89,9/28,4.31%,HLA-DRA;TLR2;CTSS;P2RY13;MYO1F;PLEK;SLA;SIGLEC1;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),0.8947723362290839,1.65720933558805,0.0,0.03181234358098858,0.89,4/13,4.64%,SHISA7;RELN;APP;SHANK3
prerank,Reactome_2022__Potassium Channels R-HSA-1296071,0.7679080974515633,1.6571943071342756,0.0,0.031581819352140834,0.89,22/67,9.36%,KCNH8;GNG3;KCNJ2;KCNV1;KCNH7;KCNK10;KCNQ1;KCNC2;KCNB2;ABCC8;KCNF1;KCNK1;KCNMB4;GABBR2;KCNQ5;GNG2;KCND3;ABCC9;KCNH2;KCNC1;HCN1;KCNQ2
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Membrane,0.7167931013212272,1.656824889466113,0.0,0.0316881717209985,0.89,30/81,15.54%,TGFBR2;COL4A1;GPNMB;ANXA1;HRH1;SERPINE1;NRP2;OSMR;POSTN;COL12A1;FAP;IGFBP7;CFH;CD44;OLFML2A;C1R;EMP1;MMP14;RIN2;PXDC1;P3H2;SPARC;STOM;ROBO4;COPZ2;LPAR1;CAST;PDCD1LG2;CD59;EVC2
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.7246650696559043,1.6566328693531183,0.0,0.031461827637277076,0.89,28/73,12.58%,SHISA7;ANK3;SHISA9;CTSS;GRIN2A;GRIN2B;NLGN1;NEFL;SHISA8;RELN;APP;CACNG3;FGF12;NETO1;HPCA;JPH4;CACNG8;GRIA3;GRIN1;SHANK1;CAPN1;GRIA1;MINK1;CACNG4;HOMER1;FGF13;CAMK2B;DLG3
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.8117852432942715,-1.6563289936225405,0.0,0.2366084578805388,1.0,3/31,2.65%,ACP3;ATP10B;TPP1
prerank,KEGG_2021_Human__Cocaine addiction,0.8134828482013123,1.6560556825250592,0.0,0.031731936646481024,0.9,9/40,7.26%,FOSB;GRIN3A;GRIN2A;CREB5;GRIN2D;GRIN2B;ADCY5;MAOB;GRIN1
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.6746880297384188,1.6556938125778984,0.0,0.031671728637081,0.9,34/146,18.66%,TGFBR2;VRK2;SBK1;PLK2;CAMKV;PRKCB;PRKCG;RPS6KA1;STK32B;GRK2;PRKCE;PRKCH;IKBKE;HIPK3;GAS6;STK32A;CDC7;PRKCD;HIPK1;MAPKAPK5;RPS6KA6;STK32C;RPS6KB2;HIPK2;NEK6;PINK1;CDK2;MAPK9;CAMK1D;PDK3;CAMK2A;PRKCA;CAMK1G;RPS6KA4
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.7057583569882068,1.6555627275703126,0.0,0.03153130535749189,0.9,35/118,11.43%,C1QL1;CSPG4;HAPLN2;CA10;PDGFRA;TAGLN3;STMN2;ZNF536;VSTM2B;CNTN2;SNCB;GAP43;ADCY5;PLP1;PLPPR4;C11ORF87;STMN4;OPCML;IGSF21;TCEAL7;FYN;LHFPL3;NKX6-2;HPCA;ST8SIA3;NNAT;PHYHIP;TCEAL5;GFAP;NYAP1;LY6H;NACAD;LGI3;TCEAL6;CRMP1
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.7267330830914104,-1.6554986618402914,0.0,0.23471983598877258,1.0,13/38,13.47%,RIOK2;RPS24;RPS28;MRPS7;DDX52;RPS27L;SNU13;RIOK1;RPSA;RRP36;LOC102724159;SRFBP1;NOM1
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),0.8109777375246537,1.654655921601722,0.0,0.03211728237972035,0.9,6/26,2.82%,TGFBR2;MET;COL4A1;NPNT;EPHA2;SLIT2
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),0.8101848991830845,1.6539805588891332,0.0,0.03245535903634898,0.92,12/26,10.76%,CACNA1H;SCN1B;SCN9A;CACNA1G;YWHAH;SCN3B;SCN1A;SCN2A;KCNH2;CACNA1E;CACNG4;SCN3A
prerank,Reactome_2022__PI-3K cascade:FGFR4 R-HSA-5654720,-0.8828229194760484,-1.6532259830247285,0.0,0.236685966211425,1.0,1/11,0.15%,FGF6
prerank,CellMarker_Augmented_2021__Serotonergic neuron:Undefined,0.8112301520235987,1.6526377300973873,0.017241379310344827,0.03413846473979957,0.92,16/39,9.19%,NPY;RIMBP2;MYT1;CHGB;VWA5B2;SYT4;ABCC8;ELAVL4;PDIA2;CDK5R2;SYP;VGF;KCNH2;CKMT1B;CELF3;CPLX1
prerank,Reactome_2022__Regulation Of Insulin Secretion R-HSA-422356,0.7196680149066274,1.6523577391322595,0.0,0.03422163707914349,0.92,13/60,8.48%,CHRM3;GNG3;ADCY5;KCNC2;SYT5;ABCC8;PRKAR1B;GNG2;ITPR3;CACNA1C;GLP1R;CACNA1E;GNA14
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.7799611045575364,1.651709757884326,0.0,0.03477359896751677,0.93,8/35,10.25%,CLIC1;SLC4A10;CLIC4;SLC26A8;ANO9;TTYH3;CLCN4;SLC4A11
prerank,KEGG_2021_Human__Type II diabetes mellitus,0.785403516686252,1.649309419595598,0.0,0.036173878120571136,0.93,11/34,14.53%,SOCS3;CACNA1G;IRS2;ABCC8;CACNA1C;HK2;CACNA1E;PRKCE;PRKCD;HK1;PIK3CD
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.8169727543429627,-1.649115974914062,0.02702702702702703,0.246538654287986,1.0,4/21,3.99%,AR;CEBPA;ZC3H8;BRF2
prerank,Reactome_2022__RNA Polymerase I Promoter Escape R-HSA-73772,-0.7787713183450401,-1.6489461434528783,0.021739130434782608,0.24292360211646047,1.0,10/39,6.82%,H2AC20;H3-3B;H2BC4;H2BC21;GTF2H5;POLR2K;GTF2H2;H2AC6;POLR1F;TAF1D
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.6904195282545039,1.6485514987617038,0.0,0.036319092254961965,0.93,45/118,15.20%,COL4A1;EDIL3;CALD1;COL4A2;GAP43;ADCY5;SHC2;SLIT2;PLPPR4;DAB2IP;ABCC8;THY1;IL1R1;EFNB3;TCEAL7;ANGPTL2;ASIC3;ARHGEF17;NUAK1;GFRA2;PTPN21;TNFRSF1A;GUCY1A2;LARP6;MAP1B;LIMCH1;SCARA3;BOC;ADGRL2;PKDCC;SRRM3;BGN;EPB41L1;HMOX2;TEAD1;NACAD;CRMP1;FAM13C;PRICKLE2;MEIS3;CAP2;RBFOX2;BCAR1;PDZRN3;SMARCA1
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR2 R-HSA-5654696,-0.8057889847313391,-1.648533536108222,0.023255813953488372,0.24093731385047834,1.0,1/20,0.15%,FGF6
prerank,Reactome_2022__Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.7208657992430968,1.6482321142254042,0.0,0.03630885720007822,0.93,16/56,14.22%,COL4A1;COL11A2;P4HA2;COL4A2;TLL1;COL8A1;COL21A1;COL23A1;COL12A1;COL27A1;COL9A1;P3H2;COL4A4;COL4A5;COL5A1;PLOD2
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.6633127406870444,1.646970430029947,0.0,0.03690881995675025,0.93,32/119,12.93%,NPY;L1CAM;FLRT3;TBC1D24;STMN2;SH3GL2;NLGN1;CNTN4;BICDL1;PLP1;APP;CNTNAP2;EPHA5;STMN4;SRRM4;LAMB1;UGDH;TENM4;MYT1L;MICALL1;PBX3;TGFB2;GLI2;GPRIN1;HS6ST1;DCX;FRY;MAPT;OPHN1;B4GALT5;ATP8A2;ALK
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.8464186503537444,1.646377397917436,0.0,0.03704638321375969,0.93,6/20,8.06%,NR4A3;KCNQ1;GNG2;SNCA;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.7920134506303989,1.6462500790758268,0.0,0.03695635734426566,0.93,9/34,13.04%,GGT5;ANXA1;WNT8B;CYP1B1;CTNNB1;STAT3;ABCA2;CCL2;ALPL
prerank,CellMarker_Augmented_2021__Blast cell:Bone Marrow,0.696088057822936,1.6461786479108844,0.0,0.03671792923236717,0.93,10/50,6.48%,GGT5;TGFBR2;DCN;DYSF;SIGLEC1;IL1R1;PODN;IGFBP7;CFH;TNS1
prerank,Reactome_2022__PRC2 Methylates Histones And DNA R-HSA-212300,-0.8304593599046655,-1.6457887864956031,0.021739130434782608,0.2432649030053059,1.0,6/23,5.51%,H2AC20;H3-3B;DNMT3B;H2BC4;H2BC21;H2AC6
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),0.795324310502881,1.645172433741658,0.0,0.03707697838630527,0.94,4/35,2.65%,CDKN2A;THBS1;PTPRO;DMTN
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.7426440426328167,1.6451316083853171,0.0,0.036914648585474275,0.94,2/53,0.86%,TGFBR2;SBK1
prerank,KEGG_2021_Human__Arrhythmogenic right ventricular cardiomyopathy,0.7333804342548436,1.6442271387534189,0.0,0.037561355846769166,0.95,17/61,11.20%,LEF1;PKP2;ITGA8;CACNG3;ITGA2;CACNA1C;CACNG8;RYR2;ITGA11;CTNNB1;ITGA3;LMNA;CACNG4;ITGA9;LAMA2;ITGB8;CTNNA1
prerank,"Reactome_2022__FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",0.831917750389339,1.6440706253883925,0.0,0.037398021531102936,0.95,6/21,9.82%,NPY;ABCA6;FOXO1;FOXO3;SMAD3;FBXO32
prerank,Reactome_2022__Transcriptional Regulation By VENTX R-HSA-8853884,0.8114465731223035,1.64373916946044,0.0,0.037743843879325494,0.95,2/35,0.12%,LEF1;CDKN2A
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.9162637519101724,1.6427032414599818,0.0,0.03808537029775646,0.97,2/16,0.25%,LEF1;HPN
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.6125028505065331,1.6422202680135474,0.0,0.038279579110332244,0.97,52/304,10.44%,LEF1;ENPP2;ARHGAP4;GPNMB;ANXA1;IGF1;KIF14;PDGFRA;EGF;TMEFF2;THBS1;SERPINE1;SRCIN1;SULF1;FLT1;SLIT2;MGAT3;TMSB10;THY1;DUSP10;PODN;SEMA3C;NEDD9;CLIC4;SEMA5B;LAMB1;SEMA3D;FAM107A;NTRK3;DOCK10;LDB2;SEMA3B;FOXO3;RHOD;NEXN;LIMCH1;CYP1B1;PDGFA;MYO1C;RAP2B;DUSP22;MGAT5;LDLRAD4;LMNA;GNA12;MMP14;CYRIB;MINK1;DLG5;STAT3;PODXL;EPHA4
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.9126646426510415,-1.6410473939925208,0.0,0.25175168608140164,1.0,3/10,4.87%,H1-2;H1-4;ATAD2
prerank,Reactome_2022__RAC1 GTPase Cycle R-HSA-9013149,0.6618352531586039,1.640702759166457,0.0,0.03932474484465598,0.97,44/154,20.12%,VRK2;ARHGAP4;NHS;ARHGAP39;EPHA2;WAS;PLEKHG6;ERBIN;BAIAP2L1;MCAM;WASF1;BAIAP2;DOCK10;CDC42EP1;PAK4;MCF2;KALRN;ARHGAP26;PLD2;ARHGEF7;RNASE1;NOXA1;TRIO;PLEKHG2;OPHN1;DOCK4;FGD5;IQGAP1;ARHGAP17;ARHGAP22;NGEF;VAV2;WIPF3;NISCH;FMNL1;MCF2L;TFRC;DOCK9;AMIGO2;VAV1;WIPF1;DOCK3;FARP1;ARHGEF6
prerank,"Reactome_2022__mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.6881642382340875,-1.6402888694171263,0.0,0.24983478661671632,1.0,16/53,15.97%,RPS24;EIF4EBP1;RPS28;EIF2S1;RPS27L;RPS13;RPSA;RPS2;EIF3D;EIF1AX;RPS21;RPS23;EIF3J;EIF3M;EIF3E;RPS25
prerank,CellMarker_Augmented_2021__Stem cell:Stomach,0.7162480432274099,1.6395867586811734,0.0,0.03969107760938782,0.97,25/75,10.81%,TGFBR2;FOSL2;PRRX1;ANXA1;PDGFRA;HRH1;DCN;S100A10;SERPINE1;ACTA2;LGR5;OSMR;POSTN;AHR;FAP;IGFBP7;CD44;EMP1;MVP;MMP14;NDRG1;RIN2;GLIS3;ADAM12;LAMA2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovarian Cortex,0.7162480432274099,1.6395867586811734,0.0,0.03969107760938782,0.97,25/75,10.81%,TGFBR2;FOSL2;PRRX1;ANXA1;PDGFRA;HRH1;DCN;S100A10;SERPINE1;ACTA2;LGR5;OSMR;POSTN;AHR;FAP;IGFBP7;CD44;EMP1;MVP;MMP14;NDRG1;RIN2;GLIS3;ADAM12;LAMA2
prerank,Reactome_2022__FRS-mediated FGFR2 Signaling R-HSA-5654700,-0.8328084760550745,-1.6394929908040299,0.0,0.24940300814401134,1.0,1/15,0.15%,FGF6
prerank,CellMarker_Augmented_2021__M2 macrophage:Lung,0.8354935199370574,1.639385632799978,0.0,0.03952180123617367,0.97,7/30,3.65%,HLA-DRA;TLR2;TYMP;CTSS;PLEK;GPR34;SIGLEC1
prerank,Reactome_2022__NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.7109043247386719,1.6387335550563973,0.0,0.03970159403077763,0.97,12/50,11.04%,CACNA1H;COL4A1;CACNA1G;CNTN2;COL4A2;FYN;GFRA2;AGRN;CACNA1C;COL9A1;ST8SIA4;COL4A4
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.7115690405574039,1.6376133418508183,0.0,0.04029321785124959,0.97,9/50,8.06%,S100A10;THBS1;DMTN;THY1;APOD;FAM107A;LIMCH1;DUSP22;SLC9A1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.9437010032637183,1.637156850658388,0.0,0.040397731344906075,0.97,2/11,0.06%,LEF1;TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),0.9257003752248695,1.6359949398728475,0.0,0.041114667014534534,0.99,3/13,1.50%,NR4A3;C3;ACSL5
prerank,"Reactome_2022__Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.6824688021118377,-1.6357929920429592,0.025,0.2548369021045186,1.0,15/46,15.97%,RPS24;RPS28;EIF2S1;RPS27L;RPS13;RPSA;RPS2;EIF3D;EIF1AX;RPS21;RPS23;EIF3J;EIF3M;EIF3E;RPS25
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.6737542690421524,1.635644879162249,0.0,0.041484293505107725,0.99,21/74,11.44%,COL4A1;CSPG4;PRRX1;TEAD2;PCDH18;CALD1;COL4A2;SLIT2;DAB2IP;COL12A1;LAMB1;PTPN21;RHBDF1;PDGFRL;SCARA3;BOC;YAP1;PPARG;GLI2;TEAD1;ENAH
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.6954439160737631,1.6347255119667743,0.0,0.042590919665640686,0.99,22/87,11.07%,ENPP2;CSPG4;SOCS3;IGF1;IL15;PTK6;SRCIN1;RELN;TEC;EFNA1;PTPRC;TNFRSF14;NEDD9;GRM5;CD44;TNFRSF1A;GHR;STAT3;EPHA4;DOK7;PARP9;GAS6
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),0.9042484089792785,1.634489479869543,0.0,0.04261273399487604,0.99,3/13,3.52%,HPN;CCBE1;MYH9
prerank,CellMarker_Augmented_2021__Neutrophil:Kidney,-0.7713184708325456,-1.6343396592238495,0.0,0.25616359717541337,1.0,6/28,5.08%,FTL;G0S2;RGS2;PADI4;SAT1;MSRB1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.8449506723890308,1.6343101390077528,0.05454545454545454,0.042501065404742716,0.99,7/17,4.33%,CACNA1H;SCN9A;ANK3;CACNA1G;SCN1A;SCN2A;KCNMB4
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.7811857519603442,1.6342421277222878,0.0,0.04225820217385847,0.99,8/25,10.32%,MET;COL4A1;SLIT2;TBX20;RYR2;CTNNB1;GLI2;PODXL
prerank,CellMarker_Augmented_2021__Cancer cell:Esophagus,0.7177794507938061,1.63382321226625,0.0,0.042479112375091506,0.99,22/74,10.23%,CXCL2;MET;C3;PAPSS2;A4GALT;HRH1;THBS1;SERPINE1;P4HA2;SAMD4A;IL1R1;OSMR;IGFBP7;CFH;TNS1;CDC42EP1;EMP1;ITGA3;ADGRF5;MMP14;RIN2;PXDC1
prerank,Reactome_2022__Activated PKN1 Stimulates Transcription Of Androgen Receptor Regulated KLK2 And KLK3 R-HSA-5625886,-0.8781653203292511,-1.632970675561969,0.0,0.2562942141303538,1.0,5/15,5.51%,H2AC20;H3-3B;H2BC4;H2BC21;H2AC6
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.618835704892889,1.6327240122351214,0.0,0.04328690944920637,0.99,36/175,14.40%,TGFBR2;BOK;TLR2;ELMO1;SEPTIN4;APP;FOXO1;SCN2A;PLSCR1;FAS;AHR;FAP;ZBTB16;CASP10;PAK4;PAWR;DCC;MYD88;DAPK2;HK2;BCL2L1;CSRNP1;DHCR24;PRKCE;PDE1B;BBC3;TNFRSF19;GADD45A;MX1;PRKCD;BCL2;TNFRSF10B;FADD;RNF152;TRAIP;IKBKG
prerank,KEGG_2021_Human__Cushing syndrome,0.6600259797672148,1.6316465783713339,0.0,0.04408563015170198,0.99,21/125,8.93%,LEF1;CACNA1H;CDKN2A;CACNA1G;CREB5;NR4A1;ADCY5;WNT8B;AHR;ITPR3;AIPL1;DVL1;ADCY7;PDE8B;CACNA1C;ADCY2;LDLR;CDK6;MRAP;CTNNB1;CYP21A2
prerank,KEGG_2021_Human__Non-small cell lung cancer,0.7271175961079049,1.6313323255762768,0.0,0.044098362936459815,0.99,19/68,15.88%,CDKN2A;MET;EGF;PRKCB;PRKCG;TGFA;FOXO3;CDK6;KIF5A;KIF5C;STAT3;RASSF1;GADD45A;ALK;CDKN1A;CCND1;PIK3CD;TP53;RXRA
prerank,Reactome_2022__RAC3 GTPase Cycle R-HSA-9013423,0.7274044220269688,1.6312593994391025,0.0,0.04398216313854436,0.99,18/77,11.38%,VRK2;NHS;ARHGAP39;EPHA2;SLITRK5;ERBIN;BAIAP2L1;MCAM;WASF1;BAIAP2;DOCK10;CDC42EP1;PAK4;MCF2;ARHGAP26;NOXA1;TRIO;OPHN1
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.8271929351132217,1.6308898268461531,0.0,0.04405936664760873,0.99,8/27,1.52%,NPY;CNR1;NPY1R;HTR2C;ANXA1;HRH1;CHRM3;CHRM1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestine,0.6918245341083188,1.6290879016125512,0.0,0.04455756856948833,1.0,32/99,17.00%,STMN2;NMNAT2;NLGN1;ATRNL1;CNTN2;GAP43;ZDHHC22;SLIT2;PLP1;PLPPR4;OPCML;TCEAL7;NUAK1;GUCY1A2;MAP1B;BOC;ADGRL2;PTPRD;PCDHB15;CRMP1;ENAH;FAM13C;RUNX1T1;PRICKLE2;ERC2;MMP16;PDZRN3;LRFN5;LSAMP;NOVA2;NPAS3;PCDHB12
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Esophagus,0.6918245341083188,1.6290879016125512,0.0,0.04455756856948833,1.0,32/99,17.00%,STMN2;NMNAT2;NLGN1;ATRNL1;CNTN2;GAP43;ZDHHC22;SLIT2;PLP1;PLPPR4;OPCML;TCEAL7;NUAK1;GUCY1A2;MAP1B;BOC;ADGRL2;PTPRD;PCDHB15;CRMP1;ENAH;FAM13C;RUNX1T1;PRICKLE2;ERC2;MMP16;PDZRN3;LRFN5;LSAMP;NOVA2;NPAS3;PCDHB12
prerank,CellMarker_Augmented_2021__Esophageal Mucosal cell:Esophagus,0.6918245341083188,1.6290879016125512,0.0,0.04455756856948833,1.0,32/99,17.00%,STMN2;NMNAT2;NLGN1;ATRNL1;CNTN2;GAP43;ZDHHC22;SLIT2;PLP1;PLPPR4;OPCML;TCEAL7;NUAK1;GUCY1A2;MAP1B;BOC;ADGRL2;PTPRD;PCDHB15;CRMP1;ENAH;FAM13C;RUNX1T1;PRICKLE2;ERC2;MMP16;PDZRN3;LRFN5;LSAMP;NOVA2;NPAS3;PCDHB12
prerank,CellMarker_Augmented_2021__Small Intestinal Stem cell:Small Intestinal Crypt,0.6918245341083188,1.6290879016125512,0.0,0.04455756856948833,1.0,32/99,17.00%,STMN2;NMNAT2;NLGN1;ATRNL1;CNTN2;GAP43;ZDHHC22;SLIT2;PLP1;PLPPR4;OPCML;TCEAL7;NUAK1;GUCY1A2;MAP1B;BOC;ADGRL2;PTPRD;PCDHB15;CRMP1;ENAH;FAM13C;RUNX1T1;PRICKLE2;ERC2;MMP16;PDZRN3;LRFN5;LSAMP;NOVA2;NPAS3;PCDHB12
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Colon,0.6918245341083188,1.6290879016125512,0.0,0.04455756856948833,1.0,32/99,17.00%,STMN2;NMNAT2;NLGN1;ATRNL1;CNTN2;GAP43;ZDHHC22;SLIT2;PLP1;PLPPR4;OPCML;TCEAL7;NUAK1;GUCY1A2;MAP1B;BOC;ADGRL2;PTPRD;PCDHB15;CRMP1;ENAH;FAM13C;RUNX1T1;PRICKLE2;ERC2;MMP16;PDZRN3;LRFN5;LSAMP;NOVA2;NPAS3;PCDHB12
prerank,Reactome_2022__GABA Receptor Activation R-HSA-977443,0.7507708501264159,1.6290252396129294,0.0,0.044319292801737055,1.0,13/45,7.99%,GNG3;KCNJ2;GABRB2;ADCY5;GABRG3;GABBR2;GNG2;GABRA1;ADCY7;ADCY2;NPTN;GABRG2;GABRA5
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Peripheral Blood,0.687156026523962,1.627986662496208,0.0,0.04507003695967155,1.0,22/65,13.30%,TGFBR2;COL4A1;DCN;THBS1;SERPINE1;ACTA2;IL1R1;PODN;POSTN;FAP;IGFBP7;CFH;TNS1;C1R;EMP1;ADGRF5;BGN;MMP14;SPARC;CCL2;ROBO4;COPZ2
prerank,Reactome_2022__Interaction Between L1 And Ankyrins R-HSA-445095,0.8210886101069345,1.6276526656562984,0.016129032258064516,0.04495422935306841,1.0,7/24,3.98%,L1CAM;SCN1B;SCN9A;ANK3;SCN3B;SCN1A;SCN2A
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.6152455827721063,1.626516390316854,0.0,0.0457547354835747,1.0,57/290,13.49%,LEF1;CXCL2;IL13RA1;TLR2;ANXA1;SOCS3;IL1RAPL1;NPNT;STAT4;NUMBL;ZFP36;DUSP1;SLA;ICAM1;CSF2RA;TEC;IRAK2;PIM1;YBX3;DAB2IP;FOXO1;IL27RA;ERBIN;NLRP12;IL1R1;MYLK3;OSMR;FYN;BCL6;TNFRSF1A;PID1;CDK9;GHR;FOXO3;LAMA5;BCL2L1;CHI3L1;SMAD3;PTPN9;GAB2;FSCN1;SHMT1;STAT3;SYK;PDE1B;INPPL1;GAS6;TYK2;CCL2;STX4;CDKN1B;BCL2;FN1;IL4R;CDKN1A;CCND1;FGF2
prerank,CellMarker_Augmented_2021__Amacrine cell:Eye,0.7218177926728122,1.6255675329162065,0.0,0.045939990259005574,1.0,24/62,11.56%,CHST8;PCDH8;EPHA7;STMN2;GRID2;CAMKV;SYT4;PLPPR5;GAP43;ZDHHC22;PCP4;EFNB3;PRR36;ZMAT4;UNC5D;PRIMA1;SEMA5B;ADAMTS19;TCEAL5;C2CD4C;KCNQ2;CACNG4;DCX;PCDHA1
prerank,KEGG_2021_Human__GABAergic synapse,0.7185716881875953,1.624696233559109,0.0,0.04684776527568231,1.0,17/74,7.99%,SLC32A1;GNG3;GABRB2;PRKCB;ADCY5;PRKCG;GABRG3;GAD2;GABRD;GABBR2;GNG2;GABRA1;ADCY7;CACNA1C;ADCY2;GABRG2;GABRA5
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.933574224875843,-1.6243562322566634,0.0,0.2780408798300409,1.0,1/12,0.06%,SLC2A5
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.7698685264665329,1.6240589115043924,0.0,0.0472056110336238,1.0,8/29,13.56%,LZTS1;YWHAH;IL1RAPL1;HECW2;PTPRD;CDKL5;HECW1;SS18L1
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),0.8427278229998532,1.6240563740301772,0.0,0.046962283141697904,1.0,1/27,0.01%,LEF1
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex R-HSA-170834,0.6885497306069686,1.6233440052995125,0.0,0.047137545267078286,1.0,11/80,10.89%,TGFBR2;SERPINE1;LTBP4;ITGA8;PMEPA1;PARD3;CDK9;SMAD3;PPP1CB;TGFB2;ITGB8
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.6856639429786953,1.6231753353689296,0.0,0.04689704758714421,1.0,34/137,11.99%,LEF1;COL4A1;TEAD2;CD24;COL4A2;FBLIM1;EPHA2;THY1;FRAS1;LAMB1;GJC1;PARD3;PTPN21;ZIC1;PAWR;PML;MYO1B;ADGRL2;CTNNB1;SH3PXD2B;KITLG;SMAD3;YAP1;LMNA;GLI2;RBPMS;STAT3;PODXL;SMAD1;TEAD1;NR6A1;CTNNA1;ENAH;CD276
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.7482846757384283,1.623030168585332,0.0,0.046717830084954844,1.0,1/66,0.01%,LEF1
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),-0.6857135221718641,-1.6223500941841966,0.03333333333333333,0.27669658249204643,1.0,13/50,13.26%,NDUFAF3;NDUFS5;DMAC2;TMEM126A;NDUFA12;NDUFB4;NDUFB1;NDUFAF4;NDUFV3;NDUFA8;FOXRED1;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),-0.6857135221718641,-1.6223500941841966,0.03333333333333333,0.27669658249204643,1.0,13/50,13.26%,NDUFAF3;NDUFS5;DMAC2;TMEM126A;NDUFA12;NDUFB4;NDUFB1;NDUFAF4;NDUFV3;NDUFA8;FOXRED1;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.9303392721155487,1.622175147833135,0.0,0.04712583698459764,1.0,1/11,0.53%,PTP4A3
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.8451800919409107,1.6219018492705684,0.0,0.04706376543677312,1.0,7/18,9.61%,PTK6;SRCIN1;THY1;PTPRC;DUSP22;MVP;ZFYVE28
prerank,Reactome_2022__ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.7473370602781438,-1.6216274731506952,0.023255813953488372,0.27495275239936584,1.0,6/25,5.99%,H2AC20;H3-3B;H2BC4;H2BC21;H2AC6;CHD4
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.8523800806063742,1.6216246563762409,0.0,0.04717618259926442,1.0,6/25,10.27%,GGT5;ANXA1;WNT8B;RAMP3;CTNNB1;STAT3
prerank,Reactome_2022__Defective Pyroptosis R-HSA-9710421,-0.8450320106012189,-1.6215751130166414,0.0,0.27157901945015783,1.0,6/22,5.51%,H2AC20;H3-3B;DNMT3B;H2BC4;H2BC21;H2AC6
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.8310156117784342,1.6214596099479324,0.0,0.04705681054310727,1.0,4/24,2.65%,ANXA1;THBS1;SERPINE1;DMTN
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Spinal Cord,0.7597257536414674,1.6213584001639656,0.0,0.046881238211982174,1.0,26/58,8.58%,RIMBP2;MYT1;CHGB;PCDH8;STMN2;ZNF536;CNTN2;NELL1;CAMKV;SYT4;GAP43;KCNB2;GLRA2;STMN4;ELAVL4;OLFM3;ATP2B3;SRRM4;KLHL1;SEMA5B;CDK5R2;HCRTR2;VSTM2A;DCC;CELF3;KCNC1
prerank,Reactome_2022__Signaling By FGFR4 R-HSA-5654743,-0.7343225585775472,-1.6213212166501987,0.024390243902439025,0.26858362546074394,1.0,1/30,0.15%,FGF6
prerank,KEGG_2021_Human__Insulin secretion,0.7076619667241415,1.6210981618712474,0.015625,0.046821594668905994,1.0,20/66,10.24%,CCK;RIMS2;CHRM3;CREB5;PRKCB;ADCY5;PRKCG;ABCC8;KCNMB4;TRPM4;ITPR3;ADCY7;CACNA1C;RYR2;ADCY2;GLP1R;ATP1A1;PCLO;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.6415145172006315,1.6209395023964126,0.0,0.046819355472604275,1.0,31/157,14.91%,LEF1;GPNMB;IGF1;PDGFRA;EGF;THBS1;FLT1;SEMA3C;NEDD9;SEMA5B;LAMB1;SEMA3D;FAM107A;NTRK3;SEMA3B;RHOD;PDGFA;MYO1C;MGAT5;MMP14;STAT3;PODXL;STX4;CFAP20;PAK1;PDPN;CEMIP;WASHC1;TRIM32;PIK3CD;BCAR1
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.8519024136878627,1.620824140460451,0.0,0.04664751081008347,1.0,5/15,7.26%,GRIN2A;GRIN2D;GRIN2B;GRID2;GRIN1
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.8328050867671165,1.620270093699647,0.018867924528301886,0.047490157813242964,1.0,11/21,7.01%,CACNA1H;SCN1B;SCN9A;CACNA1G;YWHAH;KCNJ2;SCN3B;SCN1A;SCN2A;KCNH2;CACNA1C
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.7948251119494076,-1.6191530959902178,0.0,0.27219521259197216,1.0,5/16,10.54%,RTRAF;TRPT1;C2ORF49;CPSF1;CLP1
prerank,Reactome_2022__FGFR2c Ligand Binding And Activation R-HSA-190375,-0.9007115378819726,-1.6184147548033117,0.0,0.27163814405526315,1.0,1/6,0.15%,FGF6
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.73395154031406,1.617313335035389,0.0,0.049836558906747055,1.0,14/58,9.55%,CLIC1;SLC4A10;GABRB2;GLRA2;GABRG3;GABRD;CLIC4;GABRA1;GABRG2;GABRA5;SLC26A8;ANO9;TTYH3;CLCN4
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.7486368240644112,1.6172124574748163,0.0,0.04959696006584924,1.0,8/31,11.07%,TLR2;IL15;SFTPD;DYSF;PTPRC;PLSCR1;SYK;GAS6
prerank,Reactome_2022__Transcriptional Regulation By RUNX3 R-HSA-8878159,0.7086027478656008,1.6164312389391624,0.0,0.05030247888921485,1.0,14/85,14.00%,LEF1;CDKN2A;TEAD2;FOXO3;MAMLD1;CTNNB1;SMAD3;YAP1;HDAC4;TEAD1;ITGAL;CDKN1A;CCND1;MAML2
prerank,CellMarker_Augmented_2021__FOXN4+ cell:Lung,0.6836750369500753,1.613760591987733,0.0,0.05260196796197378,1.0,6/57,5.14%,CDKN2A;NETO2;YWHAH;TYMS;PRPS2;BTG3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Kidney,0.6906801113041762,1.613718194690943,0.0,0.05235266953561372,1.0,33/92,13.09%,RIMBP2;KCNH8;NCALD;ELMO1;PTPRO;CNTN4;PDZRN4;PRKCB;RTN1;ELAVL4;NELL2;KHDRBS2;RAB3C;GFRA2;GNG2;SEMA5B;ST8SIA3;TMEM132C;GALNT8;TCEAL5;JPH4;CACNA1E;KIF5C;LDLRAD4;PPP1R16B;LRRC55;LY6H;DCX;LRRC4;ASXL3;SDK2;GLT1D1;RASGEF1B
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR4 R-HSA-5654716,-0.8141157913067796,-1.6134947796232262,0.021739130434782608,0.28449032467612734,1.0,1/17,0.15%,FGF6
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.6313106406179115,1.6130420258105467,0.0,0.05270715315202227,1.0,30/202,10.32%,LEF1;ENPP2;GPNMB;IGF1;PDGFRA;EGF;THBS1;FLT1;SHTN1;DMTN;DAB2IP;SEMA3C;PTPRC;NEDD9;SEMA5B;LAMB1;SEMA3D;FAM107A;NTRK3;SEMA3B;RHOD;PDGFA;MYO1C;MGAT5;PRKCE;ARHGEF7;MMP14;TGFB2;STAT3;PODXL
prerank,CellMarker_Augmented_2021__Hepatoblast:Liver,0.6863374008108961,1.6129127151800142,0.0,0.05245970172877334,1.0,21/77,9.94%,ENPP2;PRRX1;IGF1;PDGFRA;DCN;OGN;ABCA8;FLT1;RELN;COLEC12;ASPN;ANGPTL2;PTPRC;OLFML1;SERPINF1;LDB2;CACNA1C;APLNR;ITGA11;RASL12;ITGA9
prerank,Reactome_2022__EPH-Ephrin Signaling R-HSA-2682334,0.7060063702018438,1.6126249340070218,0.0,0.05259371432625978,1.0,18/78,10.44%,EPHA7;GRIN2B;EPHA2;MYH9;EPHA5;EFNA1;EFNB3;MYH11;FYN;DNM1;CLTB;KALRN;LIMK2;ARPC3;ARHGEF7;RNASE1;GPRIN1;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.8743288862050254,1.6120675094885535,0.0,0.05283430540800997,1.0,2/13,0.90%,NR4A3;IGF1
prerank,Reactome_2022__Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.6015988503708593,-1.6117458323478224,0.0,0.28675793991935566,1.0,25/89,11.83%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;TRIB3;RPL6;EIF2S1;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;RPL11;RPL23A
prerank,Reactome_2022__Negative Regulation Of MET Activity R-HSA-6807004,0.7547950370959491,1.6115734457556505,0.01694915254237288,0.053179994717298014,1.0,3/21,4.12%,SH3GL2;SH3GL3;SH3KBP1
prerank,Reactome_2022__Paracetamol ADME R-HSA-9753281,0.9235950634190182,1.6112145945818013,0.0,0.05357591361661954,1.0,1/15,0.01%,GGT5
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.6676321599358939,-1.6103488775116546,0.0,0.2872339801513215,1.0,35/92,20.22%,MRPL10;MRPS21;MRPL52;MRPS7;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;MRPS9;EEFSEC;MTRES1;EEF1A1;MRPS26;MRPL21;EEF1B2;MRPS18B;MRPS34;MRPS33;MRPL19;MRPS12;MRPL50;MRPS5;OXA1L;MRPL27;MRPS31;MRPL3;MRPL17;PTCD3;EEF2;MRPL54;TSFM
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.9112845061821901,-1.610337062320156,0.0,0.28381452800666296,1.0,2/9,3.59%,H1-2;H1-4
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.7118993594730487,1.6101879855428982,0.0,0.05439356535744595,1.0,15/56,12.85%,ANK3;YWHAH;KCNJ2;CHRM1;SYT4;SYT1;SYT5;SNCA;SYT13;ATP1A1;TF;PXK;SYT12;PER1;B2M
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.7539456648751147,1.6098864073412373,0.016129032258064516,0.05446276002675001,1.0,15/32,12.58%,PTK6;SRCIN1;RELN;APP;THY1;EFNA1;PTPRC;NEDD9;GRM5;RAP2B;MVP;EPHA4;DOK7;GAS6;DLG3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.6887982574951503,-1.6097045374294858,0.0,0.28163599884796425,1.0,16/56,13.47%,PAK1IP1;RPL35A;RIOK2;RPS24;ZNF658;RPS28;RBIS;MRPL36;NOC2L;RIOK1;RPL14;URB2;RRP36;RPL11;NIP7;NOM1
prerank,Reactome_2022__Peptide Ligand-Binding Receptors R-HSA-375276,0.717630784617879,1.6092188806459586,0.0,0.05495282382290907,1.0,15/61,7.04%,NPY;CXCL2;C3;NPY1R;GPNMB;ANXA1;APP;ACKR1;MCHR2;OXTR;RXFP1;TAC3;ECE1;CCKBR;APLNR
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),0.8161997392048368,1.609020912124497,0.0,0.05480906624593518,1.0,8/18,16.03%,TRPC3;THY1;SNCA;APLNR;GRIN1;RAMP3;CEMIP;P2RX7
prerank,PanglaoDB_Augmented_2021__Podocytes,0.645390627925233,1.6087599930659622,0.0,0.054875454226516705,1.0,47/163,15.20%,MET;COL4A1;CALD1;PTPRO;SULF1;COL4A2;DAB2IP;ANGPTL2;TDRD5;ARHGEF17;NUAK1;COL12A1;LAMB1;PTPN21;RHPN1;RHBDF1;LIMCH1;SCARA3;MYO1B;ENPEP;ADGRL2;KITLG;ITGA3;YAP1;TANC1;EPB41L1;PODXL;TEAD1;MAPT;CDKN1C;COL4A4;ENAH;WSB2;PRICKLE2;PARD3B;STARD13;CAP2;OPTN;COL4A5;NEBL;PALLD;PLOD2;NTN4;RBFOX2;LAMA3;BCAR1;SMARCA1
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.8068695466051202,-1.6086814627045065,0.023809523809523808,0.28118447612840186,1.0,5/20,7.16%,ASIP;BLOC1S4;BLOC1S2;PMEL;SNAPIN
prerank,KEGG_2021_Human__Colorectal cancer,0.7239283607898047,1.608553884416344,0.014925373134328358,0.054941246799200635,1.0,15/79,14.53%,LEF1;TGFBR2;EGF;TGFA;DCC;CTNNB1;SMAD3;TGFB2;BBC3;GADD45A;BCL2;CDKN1A;CCND1;RPS6KB2;PIK3CD
prerank,Reactome_2022__Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.6566675279913939,-1.6078987248856376,0.05405405405405406,0.27934790194856735,1.0,15/52,15.97%,RPS24;RPS28;EIF2S1;RPS27L;RPS13;RPSA;RPS2;EIF3D;EIF1AX;RPS21;RPS23;EIF3J;EIF3M;EIF3E;RPS25
prerank,Reactome_2022__Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,0.68325229953812,1.607404291578245,0.0,0.05619661976000478,1.0,23/113,7.04%,NPY;CXCL2;C3;NPY1R;GPNMB;HTR2C;ANXA1;P2RY6;CHRM3;CHRM1;P2RY13;PLPPR5;APP;PLPPR4;PLPPR1;ACKR1;MCHR2;OXTR;RXFP1;TAC3;ECE1;CCKBR;APLNR
prerank,CellMarker_Augmented_2021__Myotube:Muscle,-0.716764638251935,-1.606843426999493,0.030303030303030304,0.2800535461819117,1.0,6/33,6.96%,SLC2A5;CCDC141;PYGM;TTN;CACNA1S;AGBL1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.9290756147840149,-1.606674331072857,0.024390243902439025,0.2773331500256641,1.0,3/10,3.12%,AR;CEBPA;ZC3H8
prerank,CellMarker_Augmented_2021__Paneth cell:Undefined,-0.5963709420741526,-1.6064830959617769,0.030303030303030304,0.2751790509610115,1.0,16/82,13.10%,C1ORF53;GOLT1A;REEP6;TMEM177;PARS2;PXMP2;PHYH;RETSAT;MPC2;ICMT;ADH5;MOCS2;ARL1;PEX11A;TMED2;PCYOX1
prerank,Reactome_2022__Phase II - Conjugation Of Compounds R-HSA-156580,0.7096830260160077,1.605229449717288,0.0,0.05893481069457657,1.0,8/62,7.56%,GGT5;PAPSS2;GSTT2;GLYATL2;TPST1;GGCT;UGDH;SULT4A1
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.7993723652267014,-1.6033903728226582,0.0,0.281326999214948,1.0,5/15,10.54%,RTRAF;TRPT1;C2ORF49;CPSF1;CLP1
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.9243787306863963,1.6024110159737808,0.0,0.06190521232122822,1.0,3/6,7.04%,CCBE1;PROX1;APLNR
prerank,CellMarker_Augmented_2021__Syncytiotrophoblast:Placenta,0.9310062590046673,1.6022543486097454,0.0,0.06183675234899091,1.0,2/15,1.27%,OPTC;GLDN
prerank,KEGG_2021_Human__Serotonergic synapse,0.6940431572982375,1.6020084438023354,0.0,0.062328117447625085,1.0,14/76,7.09%,HTR2C;GNG3;GABRB2;DUSP1;PRKCB;ADCY5;PRKCG;APP;CYP4X1;ALOX12;GNG2;ITPR3;CACNA1C;MAOB
prerank,Reactome_2022__G Alpha (I) Signaling Events R-HSA-418594,0.6387645791850267,1.6017688915817987,0.0,0.062410258408949315,1.0,39/145,15.05%,NPY;CXCL2;C3;NPY1R;ANXA1;PDE1C;GNG3;P2RY13;ADCY5;PRKCG;APP;RGS6;MCHR2;GABBR2;PRKAR1B;GNG2;ITPR3;PDE1A;RGSL1;ADCY7;APLNR;ADCY2;GRK2;GNA14;GRM6;GNAZ;PDE1B;P2RY12;S1PR3;HTR1E;CAMK2B;PRKCD;RGR;LPAR1;GPR37;RGS14;GPR183;RGS4;PRKAR1A
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.9435867876595412,1.601532807938583,0.0,0.06254208162128741,1.0,3/11,1.87%,APOLD1;MAFF;CD24
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.9555823233786216,-1.6012499864700278,0.022222222222222223,0.2837124166717589,1.0,3/9,2.08%,ACP3;TMEM100;SCN11A
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",0.8698898439419928,1.6006801879742316,0.0,0.06347561716292743,1.0,5/16,5.13%,GRIK1;GRIK2;GRID2;CDH8;UNC13C
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),0.7729643568191935,1.6006107377122696,0.0,0.06335190156725756,1.0,1/46,0.01%,LEF1
prerank,Reactome_2022__Beta-catenin Independent WNT Signaling R-HSA-3858494,0.6434623807396663,1.5998381003190187,0.0,0.06427394830619694,1.0,10/121,8.12%,LEF1;GNG3;PRKCB;PRKCG;PRKG2;GNG2;ITPR3;CLTB;DAAM1;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),0.8689890889392742,1.599606178005328,0.0,0.0643460186022853,1.0,3/15,2.60%,NR4A3;IGF1;TRPC3
prerank,Reactome_2022__Activated Point Mutants Of FGFR2 R-HSA-2033519,-0.893489976639968,-1.599380242481637,0.022727272727272728,0.28743352601270256,1.0,1/8,0.15%,FGF6
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreas,0.6976265504164633,1.5990769817578538,0.0,0.0648120695649887,1.0,37/97,17.72%,NMNAT2;ARHGAP39;CEP170B;APP;DAB2IP;EFNB3;ARHGEF17;EPB41L4B;NUAK1;B4GALNT4;PTPN21;PHYHIP;LARP6;LIMCH1;SCARA3;NYAP1;MAPK8IP1;LAMA5;SH3PXD2B;SRRM3;YAP1;EPB41L1;DLG5;DNER;TEAD1;ENAH;MEIS3;CAP2;COL4A5;GPR37;RBFOX2;BCAR1;SEZ6L2;PFN2;CTXN1;MAGI1;PCDH1
prerank,Reactome_2022__rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.6439271159310074,-1.5979630067198969,0.0,0.28929962804411713,1.0,13/56,14.27%,IMP4;BUD23;FCF1;DDX52;NOP56;THUMPD1;SNU13;RPS2;DCAF13;UTP20;RRP36;NOL6;KRR1
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),-0.9568555612763097,-1.597957649019869,0.02127659574468085,0.28625436880154753,1.0,3/8,2.08%,ACP3;TMEM100;SCN11A
prerank,CellMarker_Augmented_2021__Macrophage:Intervertebral Disc,0.8183472015457255,1.5974609047992898,0.0,0.0660108997349471,1.0,7/26,4.31%,HLA-DRA;CTSS;MYO1F;PLEK;SLA;SIGLEC1;PTPRC
prerank,Reactome_2022__DNA Replication Pre-Initiation R-HSA-69002,-0.6329121158075708,-1.597387103568661,0.0,0.2853275430748079,1.0,23/94,19.54%,H2AC20;CDC26;H3-3B;H2BC4;H2BC21;H2AC6;MCM6;SLC25A15;PSMD10;MCM4;ANAPC15;PSMD12;PRIM1;PSMB5;POLR1B;H2AJ;PSMB6;ORC6;PSME3;SEM1;H2BC5;PSMD2;UBB
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.7792484614234878,1.5970154340808398,0.01694915254237288,0.06602582082439894,1.0,9/32,7.26%,HTR2C;SLC24A2;GRIN2A;GRIN2D;GRIN2B;PTPRC;ITPR3;RYR2;GRIN1
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),0.8459336178205624,1.5968534255489217,0.0,0.06604061652654444,1.0,11/23,9.70%,SHISA7;SHISA9;NLGN1;SHISA8;RELN;CACNG3;SHANK3;CACNG8;SHANK1;MINK1;CACNG4
prerank,KEGG_2021_Human__Bladder cancer,0.7926273520817457,1.5960864107055168,0.0,0.06668577207857121,1.0,4/32,1.68%,CDKN2A;TYMP;EGF;THBS1
prerank,Reactome_2022__SHC-mediated cascade:FGFR2 R-HSA-5654699,-0.8310410172844447,-1.59598180086434,0.0,0.28637540902675757,1.0,1/13,0.15%,FGF6
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,0.6954681904568257,1.5954431003890603,0.015384615384615385,0.0674221446647964,1.0,25/80,9.70%,RIMBP2;CACNA1H;TMEM74B;STMN2;FAM163B;SYT4;SYT1;ADCY5;SHC2;ABCC8;PLPPR1;PRR36;DUSP8;SEMA5B;CPLX2;ST8SIA3;FAAH;RAP1GAP;KCNH2;SYT13;CELF3;C2CD4C;CPLX1;FTCD;CACNG4
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.6422920062968237,1.5951412199426882,0.0,0.06752715484148485,1.0,28/145,12.93%,SCN1B;IL1RAPL1;STMN2;PTK6;CSMD3;PTPRO;RIT2;SRCIN1;PLPPR5;RELN;RTN4RL1;DAB2IP;PAK3;SHANK3;NTRK3;MFSD2A;DCC;NPTN;MAG;ZNF804A;PTPN9;SIPA1L1;EPHA4;CDKL5;KIF13B;CRMP1;CAMK2B;PAK1
prerank,Reactome_2022__RAC2 GTPase Cycle R-HSA-9013404,0.7150925469265769,1.5950129590389828,0.0,0.06753550212699537,1.0,18/76,11.86%,VRK2;NHS;VAPB;ARHGAP39;EPHA2;SLITRK5;ERBIN;BAIAP2L1;MCAM;DOCK10;CDC42EP1;PAK4;MCF2;ARHGAP26;PLD2;TRIO;OPHN1;DOCK4
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Vein,0.6972378275211462,1.5946701731326727,0.0,0.06768688194088655,1.0,24/71,8.95%,GGT5;ECM2;PRRX1;PDGFRA;DCN;ACTA2;ABCA8;ASPN;THY1;PODN;SHROOM4;ANGPTL2;PTPRC;POSTN;SLIT3;FAP;IGFBP7;CFH;TNS1;LDB2;APLNR;C1R;ADGRF5;BGN
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),-0.8972765441966524,-1.5944397246726918,0.0,0.28871811628721816,1.0,3/8,8.80%,HEY2;HEYL;HEY1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.6596224598121209,1.5935733511738963,0.0,0.0686921094358323,1.0,38/124,11.44%,NPY;HAPLN2;RCAN2;CNTN2;GAP43;ADCY5;SHC2;PLP1;PLPPR4;DAB2IP;THY1;OPCML;BCAS1;CTHRC1;TCEAL7;PRIMA1;APOD;SEPTIN9;FAM107A;TMEM132C;SEMA3B;PHYHIP;NRN1;APLNR;GFAP;MATN2;MAG;BAG3;RASL12;EPB41L1;ART3;NDRG1;ZCCHC24;NACAD;SORBS1;LGI3;TCEAL6;FAM13C
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.7942099592092802,1.5929621838923238,0.0,0.06931064284001642,1.0,7/29,7.50%,SCN1B;ANK3;YWHAH;PKP2;SCN3B;FGF12;ATP1A1
prerank,CellMarker_Augmented_2021__Mesodermal Embryonic Stem cell:Germ,0.6953599943828315,1.592490603286704,0.0,0.06982991012176132,1.0,20/61,9.94%,GGT5;ENPP2;PDGFRA;DCN;ABCA8;FLT1;PODN;ACKR1;SHROOM4;PCDH12;FAM107A;IGFBP7;TNS1;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,Reactome_2022__Transcriptional Regulation By MECP2 R-HSA-8986944,0.733318728041105,1.5924490061404368,0.01694915254237288,0.06959412586886285,1.0,17/54,18.53%,MOBP;GRIN2A;GRIN2B;TRPC3;GAD2;FKBP5;TBL1X;PPARG;GPRIN1;CAMK2B;HIPK2;SLC2A3;GPS2;NCOR1;TBL1XR1;CAMK2A;PRKCA
prerank,KEGG_2021_Human__Cortisol synthesis and secretion,0.7176980628564487,1.5924166724159357,0.0,0.06931350439358518,1.0,14/50,9.98%,CACNA1H;CACNA1G;CREB5;NR4A1;ADCY5;ITPR3;ADCY7;PDE8B;CACNA1C;ADCY2;LDLR;MRAP;CYP21A2;ORAI1
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.6731268533065592,1.5920386658045345,0.0,0.06954719793503354,1.0,16/85,6.63%,CDH6;CDH22;SLITRK1;FLRT3;CDH9;CDH19;PKP2;NLGN1;FBLIM1;ACHE;CDH8;SHANK3;CDH7;CDH18;GJC1;KIRREL3
prerank,Reactome_2022__ARMS-mediated Activation R-HSA-170984,-0.9640068607458367,-1.5919002013949728,0.0,0.29400257338637475,1.0,1/6,0.09%,NGF
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.7783922247232824,1.5917828012707131,0.0,0.06950083313641019,1.0,3/27,7.04%,TGFBR2;TBX20;APLNR
prerank,Reactome_2022__RNA Polymerase I Promoter Opening R-HSA-73728,-0.897749682094386,-1.5913903964344214,0.020833333333333332,0.2925042026069943,1.0,6/13,5.51%,H2AC20;DPEP2;H3-3B;H2BC4;H2BC21;H2AC6
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.7726272111015782,1.5908944272587706,0.0,0.07014753895306503,1.0,5/30,4.42%,SCN1B;YWHAH;CHRM3;SCN3B;FGF12
prerank,CellMarker_Augmented_2021__Retinal Progenitor cell:Retina,0.6797428742707855,1.5907027063766286,0.0,0.07000534811905879,1.0,27/86,12.18%,ENPP2;PDGFRA;RGS7BP;STMN2;ITM2A;RCAN2;FLT1;ITGA8;PLP1;PLPPR4;TCEAL7;NAP1L3;RAB3C;TMEM132C;GALNT8;LDB2;ROBO2;CACNA1C;APLNR;PTPRD;ITGA9;EPHA4;LRRC4;ASXL3;METTL24;RUNX1T1;PLXNA4
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Periodontal Ligament,0.6797428742707855,1.5907027063766286,0.0,0.07000534811905879,1.0,27/86,12.18%,ENPP2;PDGFRA;RGS7BP;STMN2;ITM2A;RCAN2;FLT1;ITGA8;PLP1;PLPPR4;TCEAL7;NAP1L3;RAB3C;TMEM132C;GALNT8;LDB2;ROBO2;CACNA1C;APLNR;PTPRD;ITGA9;EPHA4;LRRC4;ASXL3;METTL24;RUNX1T1;PLXNA4
prerank,Reactome_2022__Mitochondrial Translation Initiation R-HSA-5368286,-0.6575381526040227,-1.5906815372107599,0.043478260869565216,0.2920872570625762,1.0,29/73,18.52%,MRPL10;MRPS21;MRPL52;MRPS7;MTIF2;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;MRPS9;MTIF3;MRPS26;MRPL21;MRPS18B;MRPS34;MRPS33;MTFMT;MRPL19;MRPL50;MRPS5;OXA1L;MRPS31;MRPL3;MRPL17;PTCD3
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Germ,0.6919576071969138,1.5898420805925466,0.0,0.07105314119740631,1.0,22/65,13.67%,MOBP;CA10;GRIN2A;GRIN2B;GABRB2;NELL1;OPALIN;KCNC2;VWC2L;ATP2B3;GAD2;ERICH3;GABRA1;RFX4;GRM5;GABRG2;CACNA1E;CNTN5;SLC9C2;ERC2;DLGAP1;PCDH15
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.8535183805736897,1.5896405083993905,0.0,0.07095081976835778,1.0,6/15,11.24%,THBS1;DMTN;APOD;FAM107A;DUSP22;PHLDB2
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.8535183805736897,1.5896405083993905,0.0,0.07095081976835778,1.0,6/15,11.24%,THBS1;DMTN;APOD;FAM107A;DUSP22;PHLDB2
prerank,Reactome_2022__SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.6760808717607971,-1.587529632369797,0.02564102564102564,0.2980015349669691,1.0,10/42,15.97%,RPS24;RPS28;GEMIN4;RPS27L;RPS13;RPSA;RPS2;RPS21;RPS23;RPS25
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),0.8203374784433363,1.587319391951637,0.03389830508474576,0.07369657680015876,1.0,5/16,9.86%,THBS1;SLIT2;SLIT3;YAP1;TGFB2
prerank,Reactome_2022__RHOD GTPase Cycle R-HSA-9013405,0.7344132480929518,1.586963514627245,0.0,0.07403991097993234,1.0,11/46,14.59%,VRK2;VAPB;ARHGAP39;STEAP3;LMNB1;MCAM;RHOD;ARHGAP26;ACTN1;ARHGAP17;PLXNA1
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.9500667174487653,1.5866218014294893,0.0,0.07433584026389363,1.0,1/10,0.01%,GGT5
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),-0.8784074448358132,-1.586145242824828,0.017543859649122806,0.29901264487723417,1.0,2/10,0.96%,EYS;REEP6
prerank,Reactome_2022__p75NTR Recruits Signaling Complexes R-HSA-209543,-0.8795528964300484,-1.5857818047134382,0.0196078431372549,0.2966482310186667,1.0,1/12,0.09%,NGF
prerank,Reactome_2022__Intrinsic Pathway For Apoptosis R-HSA-109606,0.693007687029628,1.5856962423138448,0.03125,0.07525363468867731,1.0,9/47,12.47%,CDKN2A;YWHAH;SEPTIN4;BCL2L1;YWHAG;STAT3;BBC3;GSDMD;BCL2
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.7460072887348329,1.5848442358444752,0.01639344262295082,0.07594234257273777,1.0,10/37,9.58%,HPN;ADAMTS4;CTSS;TIMP2;TLL1;CD44;CAPN1;SH3PXD2B;SCUBE3;MMP14
prerank,Reactome_2022__Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.6858230902104417,-1.583823615248492,0.041666666666666664,0.2998931358950098,1.0,7/41,7.36%,H2AC20;H3-3B;H2BC4;H2BC21;SIRT6;H2AC6;MAML3
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,0.6934111441808455,1.5836365242164536,0.015384615384615385,0.07768758242615706,1.0,22/73,11.67%,MYT1;PCDH8;STMN2;CAMKV;SYT4;PLPPR5;GAP43;ZDHHC22;KCNB2;ACHE;EFNB3;CDK5R2;VGF;SULT4A1;NYAP1;KIF5A;CELF3;C2CD4C;KCNQ2;CACNG4;CRMP1;NEFM
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gastrointestinal Tract,0.6702187870300038,1.5833465931656556,0.0,0.07715802336943343,1.0,33/89,18.34%,PAPSS2;PLK2;TBC1D9;APP;TRAM1L1;SEMA3C;TPST1;CLIC4;ITGA2;MYO1B;SH3PXD2B;KITLG;ITGA3;ATP1B1;TGFB2;PXDC1;GLIS3;TRIO;CTNNA1;CD276;STARD13;FN1;CCND1;LPAR1;PALLD;PLOD2;SPATA18;MYOF;SCRN1;FAM114A1;SRPX2;CTTNBP2NL;F3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Intestine,0.6702187870300038,1.5833465931656556,0.0,0.07715802336943343,1.0,33/89,18.34%,PAPSS2;PLK2;TBC1D9;APP;TRAM1L1;SEMA3C;TPST1;CLIC4;ITGA2;MYO1B;SH3PXD2B;KITLG;ITGA3;ATP1B1;TGFB2;PXDC1;GLIS3;TRIO;CTNNA1;CD276;STARD13;FN1;CCND1;LPAR1;PALLD;PLOD2;SPATA18;MYOF;SCRN1;FAM114A1;SRPX2;CTTNBP2NL;F3
prerank,CellMarker_Augmented_2021__Mucous Acinar cell:Salivary Gland,0.6702187870300038,1.5833465931656556,0.0,0.07715802336943343,1.0,33/89,18.34%,PAPSS2;PLK2;TBC1D9;APP;TRAM1L1;SEMA3C;TPST1;CLIC4;ITGA2;MYO1B;SH3PXD2B;KITLG;ITGA3;ATP1B1;TGFB2;PXDC1;GLIS3;TRIO;CTNNA1;CD276;STARD13;FN1;CCND1;LPAR1;PALLD;PLOD2;SPATA18;MYOF;SCRN1;FAM114A1;SRPX2;CTTNBP2NL;F3
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.8578374442518922,-1.5833451854789196,0.0,0.2984240072115505,1.0,4/14,6.53%,H1-2;H1-4;M1AP;NOC2L
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.8852513638493107,-1.5830995088685977,0.02631578947368421,0.2967696008122164,1.0,3/12,4.40%,ID2;TNFAIP3;FOXJ1
prerank,CellMarker_Augmented_2021__Macrophage:Synovium,0.8066153122706651,1.5830487752129034,0.015625,0.07704225936662863,1.0,7/28,3.65%,TLR2;TYMP;CTSS;P2RY13;MYO1F;PLEK;SIGLEC1
prerank,Reactome_2022__Signaling By TGFB Family Members R-HSA-9006936,0.6512871030194387,1.582524712214438,0.0,0.07710101344108587,1.0,13/100,10.89%,TGFBR2;AMH;SERPINE1;LTBP4;ITGA8;PMEPA1;PARD3;CDK9;SMAD3;PPP1CB;TGFB2;SMAD1;ITGB8
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.7844049916668883,1.5825188260107195,0.0,0.0768133230924251,1.0,4/38,2.75%,LEF1;PDGFRA;NR4A1;EPHA2
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Uterus,0.6692334275259367,1.5824654531861158,0.0,0.07652777170546442,1.0,24/81,13.44%,C3;SOCS3;TYMP;MAP3K6;ZFP36;ITPKC;ICAM1;IL1R1;C1RL;EPS8L2;TNFRSF1A;PML;C1R;MYD88;TMBIM1;MVP;PLD2;HSD3B7;FLVCR2;GSDMD;RAB20;RELB;IL4R;RHBDF2
prerank,CellMarker_Augmented_2021__Periosteum-derived Progenitor cell:Periosteum,0.6837618034537266,1.582325556006945,0.0,0.07650191772853689,1.0,38/79,18.34%,C3;PRRX1;GPNMB;PDGFRA;DCN;TIMP2;NRP2;THY1;IL1R1;ANGPTL2;PTPRC;POSTN;FAP;IGFBP7;TNS1;C1R;EMP1;GNA14;BGN;MMP14;RIN2;PXDC1;SPARC;CCL2;RGL1;LPAR1;KCNMA1;THBS2;SPP1;SERPING1;PDCD1LG2;FSTL1;MYOF;FAM114A1;SRPX2;RARRES1;DKK3;F3
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Visceral Adipose Tissue,0.6852404252836504,1.5819969208805194,0.013513513513513514,0.07636555067376231,1.0,32/91,13.31%,COL4A1;EDIL3;PDGFRA;RGS7BP;TAGLN3;STMN2;RCAN2;PLP1;PLPPR4;NRP2;THY1;OPCML;SHROOM4;TCEAL7;ANGPTL2;POSTN;FAM107A;TMEM132C;LDB2;PHYHIP;TCEAL5;TENM4;PTPRD;CNN3;RASL12;NACAD;LAMA2;ITGB8;ARMCX2;PRICKLE2;PDPN;ARMCX1
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Visceral Adipose Tissue,0.6852404252836504,1.5819969208805194,0.013513513513513514,0.07636555067376231,1.0,32/91,13.31%,COL4A1;EDIL3;PDGFRA;RGS7BP;TAGLN3;STMN2;RCAN2;PLP1;PLPPR4;NRP2;THY1;OPCML;SHROOM4;TCEAL7;ANGPTL2;POSTN;FAM107A;TMEM132C;LDB2;PHYHIP;TCEAL5;TENM4;PTPRD;CNN3;RASL12;NACAD;LAMA2;ITGB8;ARMCX2;PRICKLE2;PDPN;ARMCX1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.9254184813405741,1.581700975580969,0.0,0.07672270248388621,1.0,5/10,2.67%,CACNA1H;CACNA1G;DOC2B;SYT4;SYT1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Breast,0.6770586406416954,1.5801648694953434,0.0,0.07865155839198339,1.0,28/77,14.24%,COL4A1;CSPG4;PRRX1;PDGFRA;DCN;SERPINE1;COL4A2;TIMP2;THY1;PODN;ANGPTL2;POSTN;COL12A1;FAP;IGFBP7;C1R;EMP1;BGN;MMP14;PXDC1;LAMA2;GAS6;SPARC;FN1;ROBO4;COPZ2;COL5A1;THBS2
prerank,CellMarker_Augmented_2021__Stem cell:Placenta,0.6770586406416954,1.5801648694953434,0.0,0.07865155839198339,1.0,28/77,14.24%,COL4A1;CSPG4;PRRX1;PDGFRA;DCN;SERPINE1;COL4A2;TIMP2;THY1;PODN;ANGPTL2;POSTN;COL12A1;FAP;IGFBP7;C1R;EMP1;BGN;MMP14;PXDC1;LAMA2;GAS6;SPARC;FN1;ROBO4;COPZ2;COL5A1;THBS2
prerank,Reactome_2022__Muscle Contraction R-HSA-397014,0.6525953825386509,1.5801156516824633,0.0,0.0784505831779243,1.0,43/136,12.55%,CACNA1H;SCN1B;SCN9A;ANXA1;CACNA1G;KCNJ2;ACTA2;CALD1;KCNK10;SCN3B;KCNQ1;KCNE4;SCN1A;DYSF;SCN2A;ATP2B3;KCNK1;MYH11;FGF12;KCNIP4;KCND3;ITPR3;ABCC9;GUCY1A2;KCNH2;CACNA1C;TPM4;CACNG8;RYR2;GUCY1A1;KCNK12;ATP1B1;CACNG4;TCAP;ORAI1;ATP1B3;SCN3A;SORBS1;GUCY1B1;FGF13;CAMK2B;HIPK1;FXYD7
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.604701717850613,1.5795112878140214,0.0,0.07904612328476435,1.0,62/268,15.18%,OPTC;COL4A1;KIF14;COL11A2;STMN2;ELMO1;CORO6;CORO7;P4HA2;MYO1F;NEFL;COL4A2;APP;TLL1;STMN4;SHROOM4;COL8A1;MYH11;COL21A1;COL23A1;COL12A1;COL27A1;FSD1;SNCA;RHOD;POF1B;TPM4;SCX;GFAP;CYP1B1;CLIP2;MYO1B;MYO1C;CLRN1;HOOK1;MYO15A;LOXL1;TGFB2;COL9A1;TPPP;P3H2;INPPL1;TLE6;MAPT;COL4A4;ACTN1;B4GALT7;FGF13;TSPAN14;B2M;COL4A5;KATNAL1;MTM1;PPP1R9B;COL5A1;PLOD2;ARHGAP17;RHOBTB2;CAMSAP3;LAMA3;BCAR1;CGNL1
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.7825325273792039,-1.5793959232569614,0.023809523809523808,0.3052627084419921,1.0,2/29,2.65%,ACP3;TPP1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.9305540535819469,1.5790257392405869,0.01818181818181818,0.07955398900482254,1.0,3/6,3.05%,ACSL5;THBS1;IRS2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.6962761310615337,1.578948109012181,0.0,0.07935194029624495,1.0,20/70,12.25%,SLITRK1;CCK;ANK3;CNTN4;SHTN1;SLITRK5;APP;PLPPR4;PAK3;BAIAP2;MFSD2A;DVL1;PARD3;MAP1B;DCC;MINK1;SLITRK4;OPHN1;CDHR1;KLF7
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Mammary Gland,0.7074037429482242,1.5787350268768878,0.0,0.07935832050086862,1.0,25/75,16.02%,TGFBR2;ANXA1;ZYX;DYSF;MYH9;C1RL;TNFRSF1A;ECE1;LASP1;TMBIM1;MVP;BCL2L1;CAPN1;PYGL;ACTN1;ABTB1;PXN;SPARC;IL4R;BMX;SIPA1;HLA-E;S100A6;ETS1;PPP1R18
prerank,Reactome_2022__Voltage Gated Potassium Channels R-HSA-1296072,0.8044845060997939,1.577733177026009,0.016666666666666666,0.08014840189072962,1.0,14/30,12.06%,KCNH8;KCNV1;KCNH7;KCNQ1;KCNC2;KCNB2;KCNF1;KCNQ5;KCND3;KCNH2;KCNC1;KCNQ2;KCNAB3;KCNH3
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.7237383853458405,-1.5774828801511838,0.03125,0.30865756002794237,1.0,2/19,1.88%,BUD23;TFB2M
prerank,Reactome_2022__PI-3K cascade:FGFR1 R-HSA-5654689,-0.8544703744024646,-1.5769781967698777,0.04878048780487805,0.30736911374054154,1.0,1/13,0.15%,FGF6
prerank,Reactome_2022__Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,0.767042873381448,1.5767686703903727,0.0,0.08080956923184157,1.0,2/36,4.92%,LEF1;SOX4
prerank,Reactome_2022__InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,0.8318137349577962,1.576547221276872,0.019230769230769232,0.08068785626149357,1.0,3/15,4.12%,SH3GL2;SH3GL3;SH3KBP1
prerank,Reactome_2022__Collagen Chain Trimerization R-HSA-8948216,0.7627921082501534,1.575809878818686,0.0,0.08113839759087248,1.0,12/35,14.02%,COL4A1;COL11A2;COL4A2;COL8A1;COL21A1;COL23A1;COL12A1;COL27A1;COL9A1;COL4A4;COL4A5;COL5A1
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.7076402504047726,1.57550852916547,0.017241379310344827,0.08134175197079946,1.0,16/61,11.38%,KIF14;PROX1;TMEFF2;ATRNL1;SRCIN1;ITGA8;EPHA2;RELN;EFNA1;LAMB1;POF1B;LAMA5;RADIL;ACTN1;PXN;OPHN1
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Pluripotent Stem Cell,0.6941100617961207,1.5752012500216412,0.0,0.08158421296225088,1.0,25/67,17.85%,IL13RA1;TLR2;FAM20C;SLC15A3;LMO2;TIMP2;DYSF;SIGLEC1;TNS1;PID1;MRAS;CHI3L1;ARHGEF10L;RIN2;SPARC;TNFAIP6;LPAR1;KCTD12;SERPING1;RXRA;BST1;SLC8A1;RASSF4;ARHGEF40;RHOQ
prerank,KEGG_2021_Human__Kaposi sarcoma-associated herpesvirus infection,0.6520596141071181,1.5751372968424866,0.0,0.08138072232235342,1.0,26/138,14.71%,LEF1;CXCL2;C3;GNG3;ZFP36;ICAM1;IRF7;NFATC2;FAS;GNG2;ITPR3;TNFRSF1A;CDK6;CTNNB1;IKBKE;STAT3;SYK;TYK2;CDKN1A;CCND1;FGF2;FADD;IKBKG;PIK3CD;MAPK11;HLA-E
prerank,Reactome_2022__CDC42 GTPase Cycle R-HSA-9013148,0.6545498799082554,1.5750635405446056,0.014925373134328358,0.0812188920329269,1.0,43/130,21.88%,ARHGAP4;ARHGAP39;STEAP3;CDC42EP3;WAS;MAP3K11;ARHGDIG;BAIAP2;DOCK10;CDC42EP1;PAK4;DAAM1;MCF2;ARHGAP26;ARHGEF7;KCTD3;TRIO;PLEKHG2;OPHN1;STARD13;FMNL3;STOM;IQGAP1;ARHGAP17;PLEKHG4B;ARHGAP22;NGEF;VAV2;WIPF3;FMNL1;MCF2L;SCRIB;TFRC;DOCK9;CDC42SE2;WIPF1;SH3PXD2A;FARP1;ARHGEF6;ARHGAP35;RAB7A;ARHGAP9;PREX1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.7664665167501019,1.5748461503538216,0.0,0.0811785055481591,1.0,16/34,18.27%,LZTS1;CSMD3;DAB2IP;VLDLR;HECW2;MFSD2A;DCC;PACSIN1;CDKL5;HECW1;ALK;COBL;BCL11A;KIAA0319;CAMK1D;SEMA4D
prerank,PanglaoDB_Augmented_2021__Macrophages,0.6983431850801584,1.5745746621562142,0.0,0.08133824586080073,1.0,18/80,5.50%,NR4A3;CXCL2;HLA-DRA;GPNMB;TLR2;P2RY6;CTSS;ADGRE5;SLC15A3;MYO1F;PLEK;SLA;GPR34;NRP2;MARCHF1;SIGLEC1;PTPRC;AHR
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.7283139452578068,1.5741803837179118,0.0,0.08169604980799187,1.0,16/46,14.07%,ANXA1;IL1RAPL1;RIMS2;SYT1;SEPTIN4;SEPTIN5;RAB15;RAB3C;CPLX2;SNCA;CPLX1;SYTL4;LGI3;STX4;HAP1;RAB27B
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),0.9485498924187115,1.5741304215563927,0.0,0.08149566059396339,1.0,4/8,2.81%,SCN1B;ANK3;PKP2;SCN3B
prerank,CellMarker_Augmented_2021__Monocyte:Liver,0.8464129853273145,1.5737275919109817,0.031746031746031744,0.08181092453336142,1.0,6/21,3.65%,TLR2;TYMP;CTSS;P2RY13;MYO1F;SIGLEC1
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.7427631413467164,1.5728135553328568,0.0,0.08291256080350086,1.0,5/34,3.51%,ECM2;NPNT;PTPRO;DMTN;THY1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.6922267049768722,-1.572557256900057,0.02631578947368421,0.31963862338376625,1.0,10/24,15.37%,NIFK;NSA2;DDX18;RPL7L1;RPF1;SNU13;RRP15;ZNHIT3;RPF2;MAK16
prerank,Reactome_2022__Mitochondrial Protein Import R-HSA-1268020,-0.6498418779367569,-1.572238353026704,0.034482758620689655,0.3176654173671012,1.0,19/57,16.36%,GRPEL2;TIMM8B;COA4;SLC25A4;CHCHD10;ATP5MC1;TIMM13;GFER;TIMM23;CS;COX19;SAMM50;ATP5F1B;TIMM50;COA6;TIMM10;CHCHD2;ATP5F1A;IDH3G
prerank,KEGG_2021_Human__Glycosaminoglycan biosynthesis,0.684301147551473,1.5712624060333775,0.0,0.08459611138651255,1.0,16/48,16.70%,NDST4;B3GNT2;CHSY3;CHST15;CHST6;CHPF2;UST;HS6ST1;HS3ST3B1;HS3ST3A1;B4GALT7;CHST4;CHST2;NDST1;HS2ST1;HS6ST2
prerank,Reactome_2022__Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,0.786496376180346,1.571111532947475,0.0,0.08438863262950297,1.0,4/26,9.59%,TGFBR2;PMEPA1;SMAD3;PPP1CB
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.7771444173050565,1.571024215372846,0.0,0.0842606062523779,1.0,10/29,16.46%,NLGN1;SRCIN1;RELN;EFNA1;SHANK3;SIPA1L1;EPHA4;CAMK2B;NGEF;CUX2
prerank,KEGG_2021_Human__Malaria,0.7593999226805724,1.570532991522755,0.017241379310344827,0.08483357868921038,1.0,12/26,15.58%,MET;TLR2;THBS1;ICAM1;ACKR1;MYD88;TGFB2;CCL2;ITGAL;IL12A;THBS2;THBS3
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Amniotic Membrane,0.6775697420164702,1.5705068214337168,0.0,0.08426802149794897,1.0,36/80,18.13%,COL4A1;PRRX1;HRH1;THBS1;SERPINE1;COL4A2;TIMP2;THY1;ANGPTL2;OSMR;POSTN;COL12A1;FAP;IGFBP7;C1R;EMP1;BGN;MMP14;PXDC1;ADAM12;GAS6;STARD13;FN1;COPZ2;LPAR1;THBS2;NTN4;RGS4;PDCD1LG2;CD59;TNFRSF11B;FSTL1;MYOF;FAM114A1;SRPX2;DKK3
prerank,CellMarker_Augmented_2021__Dental Pulp cell:Dental Pulp,0.6775697420164702,1.5705068214337168,0.0,0.08426802149794897,1.0,36/80,18.13%,COL4A1;PRRX1;HRH1;THBS1;SERPINE1;COL4A2;TIMP2;THY1;ANGPTL2;OSMR;POSTN;COL12A1;FAP;IGFBP7;C1R;EMP1;BGN;MMP14;PXDC1;ADAM12;GAS6;STARD13;FN1;COPZ2;LPAR1;THBS2;NTN4;RGS4;PDCD1LG2;CD59;TNFRSF11B;FSTL1;MYOF;FAM114A1;SRPX2;DKK3
prerank,Reactome_2022__SHC-mediated cascade:FGFR4 R-HSA-5654719,-0.8398997928148622,-1.570243650800322,0.0,0.32163610768396467,1.0,1/10,0.15%,FGF6
prerank,Reactome_2022__Translation Initiation Complex Formation R-HSA-72649,-0.6671896542714517,-1.5701334030203429,0.0,0.31921408872121976,1.0,15/52,15.97%,RPS24;RPS28;EIF2S1;RPS27L;RPS13;RPSA;RPS2;EIF3D;EIF1AX;RPS21;RPS23;EIF3J;EIF3M;EIF3E;RPS25
prerank,Reactome_2022__RHOG GTPase Cycle R-HSA-9013408,0.7100837271836741,1.570046944982023,0.0,0.08429613304528706,1.0,15/68,11.86%,VRK2;VAPB;ARHGAP39;EPHA2;MAP3K11;ERBIN;ARHGDIG;MCAM;CDC42EP1;PAK4;MCF2;KALRN;TRIO;OPHN1;DOCK4
prerank,Reactome_2022__Mitochondrial Translation R-HSA-5368287,-0.6492573513430971,-1.5689117730166975,0.02040816326530612,0.3200671937848146,1.0,30/79,18.52%,MRPL10;MRPS21;MRPL52;MRPS7;MTIF2;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;MRPS9;MTRF1L;MTIF3;MRPS26;MRPL21;MRPS18B;MRPS34;MRPS33;MTFMT;MRPL19;MRPL50;MRPS5;OXA1L;MRPS31;MRPL3;MRPL17;PTCD3
prerank,Reactome_2022__NCAM1 Interactions R-HSA-419037,0.7375819157331536,1.5688463344059642,0.03389830508474576,0.0856290279211147,1.0,11/31,11.04%,CACNA1H;COL4A1;CACNA1G;CNTN2;COL4A2;GFRA2;AGRN;CACNA1C;COL9A1;ST8SIA4;COL4A4
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.6779695286916727,1.568687071303833,0.0,0.08557595257462597,1.0,2/70,1.67%,LEF1;SP100
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),0.9437314777265116,1.5680626550466934,0.01639344262295082,0.08605703165535673,1.0,1/8,0.62%,ST6GAL1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),0.877905181433615,1.5680601707727295,0.0,0.08577487745320803,1.0,3/10,8.55%,NLGN1;SHANK1;PCLO
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.8039459834230872,1.567757433156742,0.01694915254237288,0.08572184582079569,1.0,7/18,16.70%,NDST4;UGDH;HS6ST1;HS3ST3B1;NDST1;HS2ST1;HS6ST2
prerank,Reactome_2022__Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.6428817296022986,-1.56774820365678,0.030303030303030304,0.32201757445195056,1.0,6/57,5.51%,H2AC20;H3-3B;H2BC4;H2BC21;POLR2K;H2AC6
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Brain,0.6471417167346564,1.5675885483936849,0.0,0.08566915967133068,1.0,46/132,16.56%,MYT1;MOBP;CSPG4;ADAMTS4;KCNH8;TAGLN3;TMEFF2;GRIK2;MBP;ZDHHC9;GAP43;UGT8;FA2H;OPALIN;PLP1;TMSB10;THY1;OPCML;PLPPR1;ANGPTL2;LHFPL3;APOD;PID1;PHACTR3;MAG;DHCR24;RGMB;ZCCHC24;KLK6;SNX22;LGI3;CDHR1;RGR;LPAR1;NAP1L1;MAML2;GPR37;HIPK2;BIN1;DPYD;CNP;OLIG2;P2RX7;SERINC5;NEU4;PPP1R14A
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.8192052142002813,1.5674981577333114,0.019230769230769232,0.08550391434437024,1.0,5/21,7.26%,GRIN2A;GRIN2D;GRIN2B;GRID2;GRIN1
prerank,Reactome_2022__Integration Of Energy Metabolism R-HSA-163685,0.666103407085426,1.5674850776367915,0.0,0.08526471462045912,1.0,26/83,19.68%,CHRM3;GNG3;ADCY5;KCNC2;SYT5;ABCC8;PRKAR1B;GNG2;ITPR3;ADCY7;CACNA1C;ADCY2;GLP1R;CACNA1E;GNA14;MLXIPL;ADIPOR2;IQGAP1;PRKAR1A;GNAI1;RAP1A;STK11;ITPR1;PRKCA;CACNB2;AHCYL1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.7540311126178477,-1.5673686163928502,0.023809523809523808,0.32056232298743387,1.0,13/25,16.95%,ATP5PF;ATP5MC1;APOO;ATP5PB;ATP5PD;DMAC2L;ATP5MC3;SAMM50;ATP5F1B;ATP5F1A;LETM1;ATP5MC2;AFG3L2
prerank,CellMarker_Augmented_2021__Stromal cell:Amniotic Membrane,0.6819856260290346,1.5671185698086612,0.0,0.08558792262004934,1.0,33/84,17.68%,ANXA1;SOCS3;RFTN1;PRDM8;CDC42EP3;ITPRIP;ADAMTS10;FYN;STK32B;GNG2;IGFBP7;DOCK10;SH3RF3;AGPAT4;FLI1;ADAM12;JAZF1;SPARC;CCL2;IFFO1;FMNL3;TNFAIP6;KCTD12;CHST2;SLC2A3;PDCD1LG2;ETS1;PPP1R18;ZEB1;FHL1;SRGN;RCN3;CMTM3
prerank,Reactome_2022__TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,0.7493559322528147,1.5669654905461412,0.0,0.08542453251184184,1.0,8/40,10.89%,TGFBR2;LTBP4;ITGA8;PMEPA1;SMAD3;PPP1CB;TGFB2;ITGB8
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Anterior Cruciate Ligament,0.673572547763948,1.5665054363366786,0.0,0.08578230770939768,1.0,34/74,18.47%,COL4A1;ANXA1;HRH1;DCN;THBS1;SERPINE1;TIMP2;THY1;COL8A1;OSMR;POSTN;COL12A1;FAP;IGFBP7;CD44;C1R;EMP1;BGN;MMP14;PXDC1;ADAM12;SPARC;CCL2;FN1;COPZ2;THBS2;S100A6;PDCD1LG2;FSTL1;MYOF;FAM114A1;SRPX2;DKK3;LOXL2
prerank,Reactome_2022__FGFR2 Ligand Binding And Activation R-HSA-190241,-0.8327806365766084,-1.566442241246241,0.06521739130434782,0.32093219794049294,1.0,2/9,7.01%,FGF6;FGFBP3
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.8043785702358253,1.5662299337279582,0.03076923076923077,0.08576747093585606,1.0,2/25,1.67%,LEF1;SP100
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),0.9015874888745433,1.5657003871962283,0.0,0.0859742165555696,1.0,4/13,5.47%,HPN;COL4A1;CTSS;LAMB1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),-0.9230604779507114,-1.56558182282062,0.0,0.3205944763884003,1.0,1/9,0.06%,SLC2A5
prerank,Reactome_2022__RHOB GTPase Cycle R-HSA-9013026,0.6848381986431495,1.5651028739129664,0.0,0.08673161139305505,1.0,15/61,12.92%,ANLN;ARHGAP39;ERBIN;ARHGEF17;ARHGDIG;MCAM;ARHGEF3;DAAM1;MCF2;ARHGEF10L;ARHGAP26;OPHN1;STARD13;STOM;MYO9A
prerank,CellMarker_Augmented_2021__Stem cell:Esophagus,0.6494638313734947,1.5647952574692243,0.0,0.08697067843036102,1.0,36/99,15.20%,PCDH18;GAP43;SHC2;SLIT2;PLP1;PLPPR4;DAB2IP;THY1;EFNB3;TCEAL7;LGR5;NUAK1;PRIMA1;FRAS1;SEMA5B;CCDC3;PTPN21;GUCY1A2;MAP1B;SCARA3;BOC;ADGRL2;PTPRD;CNN3;EPB41L1;PCDHB15;TEAD1;NACAD;CRMP1;ENAH;FAM13C;CAP2;IGDCC4;RBFOX2;PDZRN3;SMARCA1
prerank,KEGG_2021_Human__Oxidative phosphorylation,-0.6506549719657636,-1.5647044829194205,0.0,0.3210211492943601,1.0,26/90,14.29%,UQCRFS1;NDUFS5;COX7C;NDUFA12;NDUFB4;UQCRB;NDUFB1;ATP5PF;ATP5MC1;NDUFC2-KCTD14;UQCRHL;NDUFV3;COX7B;ATP5PB;ATP6V1E2;ATP12A;ATP6V1G1;ATP5PD;NDUFA8;COX5B;COX11;ATP5MC3;NDUFS3;NDUFC1;ATP6V1F;ATP5F1B
prerank,Reactome_2022__Apoptotic Factor-Mediated Response R-HSA-111471,0.8199285029932553,1.5646183010209176,0.03571428571428571,0.08687914947089363,1.0,2/19,3.12%,CDKN2A;SEPTIN4
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Undefined,0.6824389634308377,1.5645337015737502,0.01818181818181818,0.08686109679202564,1.0,34/78,12.14%,ENPP2;KCNT2;GRIN2A;PDGFRA;RGS7BP;DCN;ZNF385D;RCAN2;SULF1;FLT1;CNTN4;PDZRN4;SHROOM4;POSTN;HECW2;TMEM132C;TNS1;LDB2;CACNA1C;APLNR;GRIA3;RAMP3;PTPRD;ADGRF5;BGN;RASL12;RNASE1;ITGA9;LAMA2;ASXL3;SPARC;RUNX1T1;RGL1;FGD5
prerank,CellMarker_Augmented_2021__M1 macrophage:Lung,0.731955435810511,1.564424465608025,0.015384615384615385,0.08662514100163007,1.0,16/39,14.71%,TLR2;TYMP;CTSS;SLC15A3;PLEK;ICAM1;SIGLEC1;TNFRSF14;SLC7A7;PARP9;APOL3;MX1;B2M;HLA-DMA;IFIH1;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.8332547094648446,1.563825008948116,0.01818181818181818,0.08744111240373487,1.0,3/13,2.91%,SPOCK3;SP100;WAS
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),0.8799895645572355,1.5634234456753329,0.0,0.08799923227812916,1.0,1/14,0.01%,LEF1
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Retina,0.6835465467515763,1.563180124135442,0.0,0.08830190296823875,1.0,40/93,17.01%,ANLN;C1QL1;SH2D5;L1CAM;ASPHD1;ARHGAP39;CAMK2N2;EFNB3;WASF1;B4GALNT4;VGF;AGRN;RHBDF1;GLIS2;LARP6;MAP1B;NYAP1;MAPK8IP1;SH3PXD2B;C2CD4C;SRRM3;B4GALNT1;FSCN1;EPB41L1;GPRIN1;TEAD1;ENAH;ACOT7;CD276;MEIS3;FAM131C;RBFOX2;PLXNA1;BCAR1;MTCL1;SEZ6L2;NRSN2;PFN2;KIF3C;CTXN1
prerank,CellMarker_Augmented_2021__Monocyte:Plasma,0.8063128878518919,1.5629484519221901,0.014084507042253521,0.08811458256892367,1.0,5/25,3.65%,TLR2;TYMP;CTSS;P2RY13;SIGLEC1
prerank,CellMarker_Augmented_2021__Monocyte:Synovium,0.8063128878518919,1.5629484519221901,0.014084507042253521,0.08811458256892367,1.0,5/25,3.65%,TLR2;TYMP;CTSS;P2RY13;SIGLEC1
prerank,PanglaoDB_Augmented_2021__Pericytes,0.6302074757448771,1.5629135631997995,0.0,0.08787912600611417,1.0,35/111,10.81%,ECM2;COL4A1;CSPG4;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;ABCA8;COL4A2;ICAM1;ASPN;THY1;PODN;ANGPTL2;MCAM;POSTN;SLIT3;FAP;SLC38A11;COLEC11;ABCC9;TNS1;ZIC1;LDB2;STEAP4;APLNR;C1R;MYO1B;ADGRF5;BGN;PDZD2;RASL12;LHFPL6;LAMA2
prerank,Reactome_2022__FRS-mediated FGFR4 Signaling R-HSA-5654712,-0.8417051133257086,-1.5622692438223822,0.0,0.32720989789010646,1.0,1/12,0.15%,FGF6
prerank,CellMarker_Augmented_2021__Proerythroblast:Germ,0.7480468350937637,1.5613214926263304,0.015625,0.08992068690066453,1.0,9/33,6.83%,CTSS;SLC15A3;PLEK;ICAM1;SIGLEC1;EHBP1L1;TNFRSF14;GAB3;ADCY7
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.7463725484746334,1.5611576536052587,0.015873015873015872,0.08992927684056069,1.0,9/37,11.51%,MTMR7;SGPP2;PLPPR5;PLPPR4;PLPPR1;MTMR11;SYNJ2;PLPP4;INPP5J
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.8557470431778139,1.5610173575446236,0.0,0.08972578026272873,1.0,7/19,9.86%,TGFBR2;NRP2;SEMA3C;TBX20;ROBO2;ZFPM2;TGFB2
prerank,KEGG_2021_Human__Aldosterone synthesis and secretion,0.6627378655957682,1.5607903480955305,0.014492753623188406,0.08977014201543336,1.0,21/75,12.22%,CACNA1H;CACNA1G;CREB5;NR4A1;PRKCB;ADCY5;PRKCG;ATP2B3;ITPR3;ADCY7;CACNA1C;ADCY2;ATP1A1;LDLR;CYP21A2;PRKCE;ATP1B1;ORAI1;ATP1B3;NR4A2;CAMK2B
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.6400721798996131,1.5599006956015122,0.0,0.09097335487461458,1.0,24/120,11.49%,MRAP2;ANK3;TESC;FYB1;PKP2;S100A10;EPHA2;ZDHHC22;SCN3B;KCNB2;KCNIP4;RAB15;RAB3C;TNFRSF1A;RAMP3;RAB40B;MRAP;PLEKHF1;ATP1B1;PACSIN1;ATP1B3;GAS6;FGF13;TSPAN14
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.7333722728709184,1.5598783359841537,0.01694915254237288,0.09076854836233984,1.0,12/36,4.33%,CACNA1H;SCN9A;ANK3;CACNA1G;YWHAH;KCNJ2;SCN3B;KCNQ1;KCNE4;SCN1A;SCN2A;KCNMB4
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.7156653891915037,1.559435907226689,0.0,0.09112358765584214,1.0,12/59,6.82%,LEF1;EPHA7;GRID2;CAMKV;ZDHHC22;CNTNAP2;EFNB3;UNC5D;FRAS1;SEMA5B;ADAMTS19;CCKBR
prerank,CellMarker_Augmented_2021__Endometrial Stromal Stem cell:Endometrium Stroma,0.6790902539061294,1.5589958269003108,0.015873015873015872,0.09161572821071484,1.0,18/65,8.95%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;CALD1;COL4A2;THY1;PODN;ANGPTL2;POSTN;COL12A1;FAP;IGFBP7;TNS1;LDB2;C1R;BGN
prerank,Reactome_2022__Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.6282922501725212,-1.5589858140522943,0.030303030303030304,0.33634469343595175,1.0,13/93,6.82%,H2AC20;DPEP2;H3-3B;DNMT3B;H2BC4;H2BC21;GTF2H5;POLR2K;GTF2H2;H2AC6;CHD4;POLR1F;TAF1D
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.7771842480508565,1.558569971890519,0.0,0.09213962600674352,1.0,8/29,7.39%,RIMS2;SYT4;SYT1;SYT5;RIMS3;SEPTIN5;RAB15;SYT13
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),0.8166342053247724,1.5585122607913218,0.017857142857142856,0.09193378353899707,1.0,7/18,7.26%,TGFBR2;GRIN3A;GRIN2A;GRIN2B;SLIT2;SLIT3;GRIN1
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.5932420160101932,1.558448681060132,0.0,0.09186715679612813,1.0,54/217,11.55%,OPTC;ECM2;COL4A1;ADAMTS4;CTSS;COL11A2;NPNT;ADAMTSL2;DCN;THBS1;SERPINE1;P4HA2;ITGA8;COL4A2;TIMP2;ICAM1;APP;TLL1;ADAMTS10;COL8A1;COL21A1;POSTN;COL23A1;COL12A1;LAMB1;ITGA2;COL27A1;ADAMTS19;CD44;AGRN;SCX;CYP1B1;PDGFA;ITGA11;LAMA5;CAPN1;SH3PXD2B;SCUBE3;ITGA3;BGN;LOXL1;MMP14;ADAM19;TGFB2;ITGA9;COL9A1;P3H2;ADAM12;LAMA2;ITGB8;COL4A4;GAS6;MMP17;SPARC
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.6126818083894702,1.55841032870791,0.0,0.09162894920817476,1.0,36/168,13.10%,MRAP2;ANK3;RFTN1;TESC;FYB1;PKP2;S100A10;NLGN1;EPHA2;ZDHHC22;SCN3B;KCNB2;THY1;SHANK3;KCNIP4;RAB15;RAB3C;DVL1;TNFRSF1A;AGRN;RAMP3;RAB40B;MRAP;SH3PXD2B;PLEKHF1;ATP1B1;PACSIN1;ATP1B3;SYNE3;LRRC4;GAS6;FGF13;TSPAN14;ITGAL;DLG3;PICK1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Blood,0.789083780607764,1.558377707236006,0.015151515151515152,0.09139215113257612,1.0,9/26,10.41%,CTSS;CD24;P2RY13;MYO1F;SLA;PRKCB;PTPRC;ADAM28;SYK
prerank,KEGG_2021_Human__Glioma,0.7012232932366883,1.5579152456365177,0.0,0.09156705804819068,1.0,24/66,18.64%,CDKN2A;IGF1;PDGFRA;EGF;PRKCB;SHC2;PRKCG;TGFA;PDGFA;CDK6;GADD45A;CAMK2B;CDKN1A;CCND1;PIK3CD;TP53;CALM3;SHC1;CAMK1D;IGF1R;DDB2;CAMK2A;PRKCA;CAMK1G
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.8797212758166932,-1.5578255937808656,0.023255813953488372,0.3324001065579041,1.0,1/8,0.74%,AKR7A2
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.8797212758166932,-1.5578255937808656,0.023255813953488372,0.3324001065579041,1.0,1/8,0.74%,AKR7A2
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.8797212758166932,-1.5578255937808656,0.023255813953488372,0.3324001065579041,1.0,1/8,0.74%,AKR7A2
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.9147948427108522,1.557600629850199,0.0,0.091809119626983,1.0,1/7,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.7813119175906409,1.5571729779092451,0.014925373134328358,0.0921517368533118,1.0,9/29,5.22%,CDH6;CDH22;CDH9;CDH19;CDH23;NLGN1;CDH8;CDH7;CDH18
prerank,Reactome_2022__G Alpha (Q) Signaling Events R-HSA-416476,0.6509855801322468,1.5568004958143529,0.0,0.09252624286678439,1.0,26/117,9.25%,RASGRP2;GPNMB;HTR2C;ANXA1;P2RY6;CHRM3;GNG3;CHRM1;RASGRP1;TRPC3;APP;RPS6KA1;MCHR2;OXTR;GNG2;ITPR3;TAC3;GRM5;RGSL1;CCKBR;GRK2;DGKG;GNA14;KALRN;PRKCE;PRKCH
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.8791306664105994,1.5566037185662212,0.0,0.09256062932169914,1.0,3/16,1.03%,NR4A3;IGF1;P2RY6
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.6159120302768236,1.5565477192976842,0.0,0.09235894842050724,1.0,35/195,11.49%,C3;TLR2;IGF1;KLF2;P2RY6;CCBE1;RIMS2;NLGN1;SULF1;DMTN;PRKCB;SLC39A14;RELN;DAB2IP;PTPRC;SHANK3;FAS;NTRK3;GRIN1;NPTN;MYO1C;NECAB2;SHANK1;MGAT5;YAP1;CTBP2;TGFB2;DLG5;STAT3;KLK6;HOMER1;SORBS1;GAS6;TSPAN14;ASXL1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord Blood,0.7264899386635985,1.556503417537443,0.013888888888888888,0.09209124132363619,1.0,21/54,15.37%,TMEM204;HLA-DRA;RFTN1;CTSS;SP100;ZFP36;PLEK;SLA;TNFRSF14;GAB3;DOCK10;NLRC5;MVP;FLI1;APOL3;TRIM22;B2M;HLA-E;CD4;DPYD;STAT6
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.7913649879008109,1.5558674766948621,0.03333333333333333,0.09272959724671138,1.0,6/27,7.48%,EGF;PTK6;ERBIN;PTPRR;NRG1;NRG2
prerank,KEGG_2021_Human__Focal adhesion,0.617769324905056,1.5555568975705125,0.0,0.09296342548184358,1.0,66/170,20.24%,MET;COL4A1;IGF1;PDGFRA;EGF;THBS1;FLT1;ITGA8;COL4A2;ZYX;PRKCB;SHC2;PRKCG;RELN;PAK3;MYLK3;FYN;LAMB1;ITGA2;BIRC3;PAK4;PDGFA;ITGA11;LAMA5;CTNNB1;ITGA3;PPP1CB;ITGA9;COL9A1;LAMA2;ITGB8;COL4A4;ACTN1;PXN;BCL2;FN1;PAK1;CHAD;CCND1;COL4A5;THBS2;PIK3CD;SPP1;LAMA3;BCAR1;THBS3;PIP5K1C;VAV2;MAPK9;VASP;SHC1;TLN2;IGF1R;RAP1A;COL4A3;TNR;FLNA;PRKCA;CAV3;VAV1;ITGB4;CCND2;RAP1B;ACTN4;AKT3;VEGFD
prerank,CellMarker_Augmented_2021__Endoderm Progenitor cell:Adipose Tissue,0.6936146111554565,1.555141454570315,0.015625,0.09339575814647225,1.0,14/47,9.94%,GGT5;HLA-DRA;FLT1;SLA;SIGLEC1;ACKR1;SHROOM4;MYH11;FAM107A;APLNR;RAMP3;ADGRF5;RNASE1;ITGA9
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.788611680255483,1.5545428055012394,0.0,0.09432380235697004,1.0,13/29,12.58%,GRIN2A;GRIN2B;NLGN1;NEFL;RELN;APP;GRIA3;GRIN1;CAPN1;GRIA1;CCL2;CAMK2B;DLG3
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.9146692804538664,-1.5544843548972433,0.0,0.3351610654871809,1.0,3/8,4.87%,H1-2;H1-4;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.9146692804538664,-1.5544843548972433,0.0,0.3351610654871809,1.0,3/8,4.87%,H1-2;H1-4;ATAD2
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.9146692804538664,-1.5544843548972433,0.0,0.3351610654871809,1.0,3/8,4.87%,H1-2;H1-4;ATAD2
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),-0.8700176988775109,-1.5540989383925667,0.043478260869565216,0.3339157558792882,1.0,5/11,9.03%,CHAMP1;IK;KNL1;SPDL1;MIS12
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.7068432870039818,1.553745607366004,0.0,0.09514719031778636,1.0,8/47,3.57%,IL1RAPL1;S100A10;NLGN1;GRID2;EPHA2;CLSTN2;THY1;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.7985172122311522,1.5536233328523676,0.0,0.09510727922739629,1.0,4/18,9.86%,EPHA7;FOXO3;CTNNB1;TGFB2
prerank,Reactome_2022__Vitamin B5 (Pantothenate) Metabolism R-HSA-199220,0.8090163895211131,1.5536154646484366,0.018867924528301886,0.09483708809322755,1.0,1/15,0.08%,ENPP2
prerank,Reactome_2022__TGF-beta Receptor Signaling In EMT (Epithelial To Mesenchymal Transition) R-HSA-2173791,0.8404413785523035,1.5534858605108894,0.0,0.09476544534490405,1.0,2/14,6.20%,TGFBR2;PARD3
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.6346021513212488,1.5534291661295985,0.0,0.09459597685231257,1.0,35/115,14.24%,COL4A1;CSPG4;PRRX1;GPNMB;CALD1;PPFIBP1;COL4A2;NRP2;ANGPTL2;OSMR;POSTN;COL12A1;LAMB1;AHR;FAP;PTPN21;MLANA;RHBDF1;TYR;EMP1;SH3PXD2B;YAP1;TANC1;PPARG;MMP14;PXDC1;TEAD1;KLC2;PRICKLE2;STARD13;FN1;CCND1;HMCN1;PALLD;THBS2
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.6368778404680276,1.5531207692016347,0.0,0.09478662704478982,1.0,25/115,10.99%,SLITRK1;L1CAM;FLRT3;ANK3;NLGN1;CNTN2;SNCB;ARHGAP39;PPFIBP1;APP;ACHE;CBLN2;PAK3;SHANK3;UNC13C;DVL1;GRM5;AGRN;KIRREL3;SNCA;PTPRD;DNER;DOK7;MAPT;LRRC4
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.741104999143923,1.5528765305049792,0.0,0.09484596797038984,1.0,5/33,2.81%,SCN1B;ANK3;CHRM1;PKP2;SCN3B
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.7184034701280805,1.5528480696376565,0.0,0.09464522968283043,1.0,5/54,7.89%,NR4A3;THBS1;PRKCB;ZBTB16;CDK6
prerank,CellMarker_Augmented_2021__DCLK1+ Progenitor cell:Large Intestine,0.6757486205462385,1.551326769779733,0.0,0.09729484627317309,1.0,38/80,17.64%,C3;ADAMTS4;ZNF469;DCN;OGN;ICAM1;COLEC12;ASPN;CERCAM;CTHRC1;COL8A1;TPST1;PIEZO2;OLFML1;GFRA2;SERPINF1;PDGFRL;C1R;BOC;MATN2;BASP1;LAMA2;SPARC;CCL2;MX1;PRICKLE1;PDPN;TNFAIP6;LPAR1;COL5A1;THBS2;SERPING1;HAPLN3;GSTM5;ADAMTS1;VASN;RCN3;SVEP1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.6962545226343122,1.5511442129250828,0.0,0.09734670463051351,1.0,9/56,9.61%,CDKN2A;THBS1;THY1;SKAP1;LIMCH1;CDK6;SLC9A1;PLEKHA2;MINK1
prerank,Reactome_2022__Sensory Perception Of Taste R-HSA-9717189,0.8854550014011078,1.5506530182732876,0.0,0.0976880548772647,1.0,6/14,5.89%,SCN1B;SCN9A;KCNJ2;SCN2A;TRPM4;ITPR3
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Muscle,0.6720533935125766,1.5502079802647124,0.030303030303030304,0.097931188228002,1.0,28/79,14.24%,COL4A1;CSPG4;PRRX1;EDIL3;PDGFRA;DCN;SERPINE1;CALD1;COL4A2;THY1;ANGPTL2;MCAM;POSTN;COL12A1;LAMB1;FAP;IGFBP7;C1R;EMP1;BGN;MMP14;PXDC1;LAMA2;SPARC;FN1;ROBO4;COL5A1;THBS2
prerank,CellMarker_Augmented_2021__Epithelial cell:Endometrium,0.786041482608357,1.549989442053484,0.0,0.09814095841200636,1.0,9/34,7.47%,CTSS;PRSS57;MYO1F;ATP8B4;LAT2;ADCY7;CASP10;TLDC2;SLC7A7
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.7755060089335424,1.5499366812108952,0.0,0.0979025293245238,1.0,5/30,9.88%,PROX1;SULF1;ITGA8;TGFB2;GLI2
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Large Intestine,0.8315228917949695,1.5498722091573347,0.0,0.09776094215226785,1.0,2/15,0.99%,ARHGAP4;TYMP
prerank,Reactome_2022__Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,0.7871593810614229,1.549632750733927,0.017857142857142856,0.09777891435706314,1.0,4/22,5.37%,GRIK1;GNG3;NCALD;GNG2
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),-0.8040413002830082,-1.5492609074222004,0.022727272727272728,0.3475147206070126,1.0,1/10,0.12%,DAO
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.8441580102770216,1.5490614618536351,0.019230769230769232,0.09846185718580112,1.0,3/14,3.70%,KIF14;STMN2;STMN4
prerank,Reactome_2022__Complex I Biogenesis R-HSA-6799198,-0.6788812839296141,-1.548930829072513,0.03225806451612903,0.3457886732930873,1.0,11/43,13.26%,NDUFAF3;NDUFS5;NDUFA12;NDUFB4;NDUFB1;NDUFAF4;NDUFV3;TMEM186;NDUFA8;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),-0.9529968049177457,-1.5484879511228395,0.038461538461538464,0.345353387820387,1.0,1/5,0.06%,SLC2A5
prerank,CellMarker_Augmented_2021__Endothelial cell:Undefined,0.7865497057612746,1.5483489542110496,0.0,0.09964641665986868,1.0,5/20,4.85%,A4GALT;FLT1;ICAM1;PTPRC;MCAM
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.7010713187601504,1.548088678561657,0.0,0.09994259920645898,1.0,17/71,7.42%,SLITRK1;CCK;L1CAM;ANK3;CNTN4;SHTN1;GAP43;PLP1;SLITRK5;RTN4RL1;APP;PLPPR4;PAK3;BAIAP2;PARD3;MAP1B;DCC
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.6598938438897926,1.5477982459784132,0.015625,0.10004870163644165,1.0,15/74,13.18%,CDKN2A;SH3GL2;SLIT2;IRS2;DAB2IP;NTRK3;PID1;HDAC4;NIBAN1;TERF2IP;MAPT;CDKN1C;FBP1;CDKN1B;CDKN1A
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.6887413292981893,1.5475412652592553,0.0,0.10027954080632538,1.0,31/70,19.88%,NPNT;SH3GL2;CEP170B;APP;ABCC8;PCP4;PRR36;ARHGEF17;CYS1;CDK5R2;GLIS2;SCG5;EPB41L1;GLIS3;CRMP1;INPP5J;CD276;STARD13;CAMSAP3;SPP1;BCAR1;PDZRN3;SCAMP5;SEZ6L2;SLC8A2;LRP2;SLC7A8;CAMK1G;TMEM151A;ARNT2;FGFR1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),0.9137775404934508,1.5475198170260895,0.03636363636363636,0.10007173179960127,1.0,1/7,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.7648394084160791,1.5474391041829696,0.0,0.0999585174621808,1.0,12/29,12.58%,EGF;SRCIN1;RELN;EFNA1;TGFA;FYN;NEDD9;GRM5;EPHA4;DOK7;GAS6;DLG3
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.8261674480462865,-1.547299981145891,0.05405405405405406,0.34680729989329706,1.0,2/11,6.59%,APOE;ZNF502
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),0.9261247371458403,1.5472152009425653,0.0,0.10006343938820732,1.0,3/10,2.13%,SIX3;KIF14;NUMBL
prerank,KEGG_2021_Human__Pancreatic cancer,0.7181459387795689,1.5469817029138642,0.0,0.10022978525931305,1.0,17/72,14.53%,TGFBR2;CDKN2A;EGF;PLD1;TGFA;CDK6;BCL2L1;SMAD3;PLD2;TGFB2;STAT3;GADD45A;CDKN1A;CCND1;RPS6KB2;IKBKG;PIK3CD
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.6849495404388264,1.546712650572334,0.014492753623188406,0.10039524395243951,1.0,36/93,17.27%,COL4A1;CSPG4;BOK;TEAD2;AMH;COL4A2;EPHA2;DAB2IP;ARHGEF17;MCAM;NUAK1;COL12A1;LAMB1;PTPN21;RHBDF1;GLIS2;LARP6;SCARA3;YAP1;GLI2;TEAD1;ENAH;CD276;MEIS3;CAP2;COL4A5;RBFOX2;BCAR1;MTCL1;SMARCA1;SEZ6L2;FZD7;FSTL1;FHL1;ADAMTS1;MAGI1
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.8027375146668232,1.5466848933541837,0.0196078431372549,0.10018989064222472,1.0,8/27,6.38%,SHISA7;SHISA9;SLC4A10;GRIK2;SHISA8;APP;NETO1;SYP
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.7956305359015343,1.546542174114462,0.0,0.10004711851485372,1.0,7/24,8.28%,SOCS3;PTK6;SRCIN1;DMTN;THY1;PTPRC;MVP
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR2 R-HSA-5654221,-0.8930698480591373,-1.5464284009934897,0.025,0.346767279703667,1.0,1/9,0.15%,FGF6
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.9291024142641084,1.546283988045492,0.0,0.10008908909168847,1.0,2/12,0.42%,NR4A3;MET
prerank,CellMarker_Augmented_2021__CD1C+ B Dendritic cell:Blood,0.7947965973046102,1.5462774126296497,0.0,0.09982500178537797,1.0,10/29,11.36%,IL13RA1;ANXA1;CREB5;IL27RA;NLRP12;LAT2;MTMR11;PID1;LMNA;NR4A2
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),-0.6694899943237138,-1.5460858714187395,0.0,0.3453789354892597,1.0,14/52,13.26%,UQCRFS1;NDUFS5;COX7C;NDUFA12;NDUFB4;UQCRB;NDUFB1;UQCRHL;NDUFV3;COX7B;NDUFA8;COX5B;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.7727205343821765,1.5458951713834794,0.0,0.10041639280795193,1.0,8/29,12.81%,CLIC1;PDGFRA;PLEK;MYH9;RAP2B;P2RY12;ACTN1;FN1
prerank,Reactome_2022__FOXO-mediated Transcription R-HSA-9614085,0.7134413950420674,1.5457126325364452,0.0,0.10030494820288959,1.0,14/54,13.18%,NPY;ABCA6;FOXO1;BCL6;FOXO3;YWHAG;SMAD3;FBXO32;BBC3;GADD45A;PLXNA4;CDKN1B;KLF4;CDKN1A
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.8287769596148222,1.5454424833780325,0.017241379310344827,0.10040649125960995,1.0,7/20,7.39%,RIMS2;DOC2B;SYT4;SYT1;SYT5;RIMS3;SYT13
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.7795963672294322,1.545337642817766,0.0,0.10035618292104927,1.0,3/25,7.04%,TGFBR2;TBX20;APLNR
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.6334906785672694,1.545033063330796,0.0,0.10075891784164148,1.0,34/120,17.81%,TGFBR2;KIF14;SRCIN1;RELN;DAB2IP;EFNA1;AGAP2;PAK3;PTPRC;INCENP;NEDD9;GRM5;SNCA;PAK4;MMD;MINK1;TGFB2;EPHA4;DOK7;GAS6;PRKCD;DLG3;PAK1;CDKN1A;IQGAP1;NOX4;CD4;STK3;SYAP1;SLC8A2;CALM3;MAP2K3;RAP1A;STK11
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.6921978185330222,1.5445696592211233,0.027777777777777776,0.10161116581417239,1.0,10/53,5.57%,CDH6;CDH22;CDH9;CDH19;PKP2;CNTNAP1;CDH8;CDH7;CDH18;GJC1
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.6310771025270291,1.5444510922590684,0.0,0.1015280985398741,1.0,24/123,11.49%,MRAP2;ANK3;TESC;FYB1;PKP2;S100A10;EPHA2;ZDHHC22;SCN3B;KCNB2;KCNIP4;RAB15;RAB3C;TNFRSF1A;RAMP3;RAB40B;MRAP;PLEKHF1;ATP1B1;PACSIN1;ATP1B3;GAS6;FGF13;TSPAN14
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.7527648524915227,1.5443667364440183,0.017241379310344827,0.10153531481471305,1.0,3/22,3.84%,EGF;PTK6;TGFA
prerank,Reactome_2022__Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.8023463297254044,1.544273739612372,0.03278688524590164,0.10130350008492213,1.0,8/18,10.50%,IL1RAPL2;SLITRK1;IL1RAPL1;PPFIBP1;SLITRK5;NTRK3;PTPRD;SLITRK4
prerank,Reactome_2022__Signaling By GPCR R-HSA-372790,0.5758840632816504,1.5437847295442622,0.0,0.10187740777201355,1.0,72/361,11.72%,NPY;CXCL2;C3;RASGRP2;NPY1R;GPNMB;HTR2C;ANXA1;P2RY6;ADGRE5;PDE1C;CHRM3;GNG3;CHRM1;RASGRP1;P2RY13;CD55;TRPC3;PLPPR5;PRKCB;ADCY5;PRKCG;APP;PLPPR4;RPS6KA1;WNT8B;PLPPR1;ACKR1;RGS6;MCHR2;ARHGEF17;GABBR2;PRKAR1B;GIPR;OXTR;RXFP1;ARHGEF3;GNG2;ITPR3;TAC3;GRM5;PDE1A;RGSL1;ECE1;CCKBR;ADCY7;PDE8B;APLNR;ADCY2;RAMP3;GLP1R;OBSCN;GRK2;MCF2;DGKG;GNA14;GRM6;KALRN;ARHGEF10L;PRKCE;PRKCH;GNA12;ARHGEF7;GNAZ;PDE1B;P2RY12;TRIO;S1PR3;PLEKHG2;HTR1E;CCL2;PDE10A
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),-0.9507954129551116,-1.5426752769791698,0.018867924528301886,0.3565083265924112,1.0,1/5,0.04%,ACP3
prerank,CellMarker_Augmented_2021__Monocyte:Lung,0.8213231643038642,1.5426559180546688,0.01639344262295082,0.10339944513503489,1.0,6/26,3.65%,TLR2;TYMP;CTSS;P2RY13;PLEK;SIGLEC1
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.6653081689075306,1.5421274942532914,0.0,0.10399470177156762,1.0,20/72,16.77%,CACNA1G;SLC24A2;GRIN2A;GRIN2D;GRIN2B;TRPC3;ATP2B3;TRPM4;CACNA1C;GRIN1;ORAI1;MCOLN2;GAS6;MCUB;STOML2;SLC24A1;P2RX7;ATP2B4;SLC8A2;SLC8A1
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.8304797508369128,1.5421124334700456,0.016129032258064516,0.1037294091650075,1.0,6/19,9.86%,PROX1;PKP2;NRG1;RYR2;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.7442300260657166,1.5417878991177698,0.016666666666666666,0.1039373729953597,1.0,7/43,6.55%,SERPINA10;SPOCK3;SERPINE1;TIMP2;SERPINE3;BIRC3;SERPINF1
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.7736213612274688,1.5407861990701646,0.0,0.105144536979615,1.0,4/29,7.18%,TGFBR2;TBX20;APLNR;RYR2
prerank,CellMarker_Augmented_2021__Epithelial cell:Bone,0.6742884876192041,1.5406207132370255,0.014084507042253521,0.10487694032038095,1.0,26/66,17.99%,TGFBR2;TMEM204;ZNF469;SLC15A3;ICAM1;HIC1;TNFRSF14;IGFBP7;TNS1;PML;EMP1;MVP;BGN;MMP14;APOL3;CCL2;GSDMD;ROBO4;COPZ2;PDCD1LG2;STAT6;CTSZ;CTSK;SRGN;RCN3;PLAC9
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Whartons Jelly,0.6742884876192041,1.5406207132370255,0.014084507042253521,0.10487694032038095,1.0,26/66,17.99%,TGFBR2;TMEM204;ZNF469;SLC15A3;ICAM1;HIC1;TNFRSF14;IGFBP7;TNS1;PML;EMP1;MVP;BGN;MMP14;APOL3;CCL2;GSDMD;ROBO4;COPZ2;PDCD1LG2;STAT6;CTSZ;CTSK;SRGN;RCN3;PLAC9
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.78814276977124,1.5406174846792782,0.012658227848101266,0.10461276666718101,1.0,6/28,11.16%,CHST8;IGF1;PXYLP1;UGDH;HS3ST3B1;B4GALT7
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.6362647954041177,-1.5405707185733786,0.0,0.36116142751383823,1.0,6/43,6.53%,H1-2;H2BC21;PADI4;H1-4;M1AP;NOC2L
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.7412885870842667,1.5405577773342727,0.0,0.10443729137145323,1.0,12/42,10.04%,IL1RAPL2;SLITRK1;TLR2;IL1RAPL1;NLGN1;GRID2;CLSTN2;APP;ROBO2;SNCA;PTPRD;DLG5
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.9354853135166165,1.5405264561113758,0.0,0.10429174627684645,1.0,6/11,5.13%,RIMS2;DOC2B;SYT1;SYT5;RIMS3;UNC13C
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.5719317420030173,1.5405058778471648,0.0,0.10405999491029394,1.0,83/337,18.66%,TGFBR2;VRK2;MAP3K6;EPHA7;PLK2;FAM20C;PTK6;PIM3;PRKCB;PRKCG;TEC;APP;PIM1;MAP3K11;NUAK2;NEK10;PAK3;PRKG2;MYLK3;PRKAR1B;FYN;NUAK1;CDK9;STK25;PAK4;AATK;DAPK2;CDK6;GRK2;DGKG;SIK2;LIMK2;PRKCE;PRKCH;IKBKE;MINK1;MAK;HIPK3;HUNK;TGFB2;STAT3;SYK;CDKL5;MAP3K21;PGK1;GAS6;TYK2;PDK4;CCL2;PXK;CAMK2B;PRKCD;HIPK1;ALK;PAK1;PICK1;HK1;GRK5;HIPK2;PDK1;BMX;PIK3CD;NEK6;RARA;MAP3K5;STK3;PINK1;CDK2;CDK19;CILK1;LIPE;CDC25B;MAPK9;CDK18;CDK20;FAM20A;STK11;STK24;PDK3;CAMK2A;PRKCA;NEK4;RPS6KA4
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Heart,0.6675746640221951,1.5400567668116658,0.013157894736842105,0.10440751410695809,1.0,31/77,16.70%,SLC6A15;FLRT3;ARHGAP39;EPHA2;SLIT2;KCNB2;DAB2IP;TRAM1L1;EFNB3;TUSC3;FRAS1;PTPN21;CKMT1B;MYO1B;ADGRL2;PCLO;KITLG;YAP1;GLI2;DLG5;TEAD1;ENAH;CD276;GPR37;KIAA1549;RBFOX2;BCAR1;SLC44A3;SEZ6L2;PFN2;HS6ST2
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),-0.8077027219582403,-1.54003478600734,0.02564102564102564,0.36024878954134976,1.0,2/15,3.73%,DAO;THNSL2
prerank,KEGG_2021_Human__JAK-STAT signaling pathway,0.6523415963255849,1.5396758333079967,0.0,0.1048974735023433,1.0,24/87,15.37%,IL13RA1;SOCS3;PDGFRA;IL15;EGF;STAT4;CSF2RA;PIM1;IL27RA;OSMR;GHR;GFAP;PDGFA;BCL2L1;STAT3;TYK2;BCL2;IL4R;CDKN1A;CCND1;IL12A;PIK3CD;THPO;STAT6
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6910322022544435,1.5396749181934708,0.0,0.10463718200481886,1.0,29/86,12.06%,HPN;SLC24A2;KCNH8;KCNJ2;KCNV1;KCNH7;KCNK10;KCNQ1;KCNC2;KCNB2;ABCC8;KCNF1;KCNK1;KCNMB4;KCNQ5;SLC9A9;KCND3;ABCC9;KCNH2;SLC9A1;KCNC1;LRRC55;HCN1;KCNQ2;KCNK12;ATP1B3;KCNAB3;SLC9C2;KCNH3
prerank,Reactome_2022__Cellular Response To Starvation R-HSA-9711097,-0.5600077002871671,-1.539139839492928,0.03333333333333333,0.36022268249280204,1.0,34/135,14.74%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;TRIB3;RPL6;EIF2S1;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;ATP6V1E2;ATP6V1G1;RPSA;RPL14;RRAGC;RPL15;RPS2;RPL11;RPL23A;RPS21;SLC38A9;ATP6V1F;RPS23;RRAGA;CEBPG
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.6302593574624553,1.5385568310850444,0.014705882352941176,0.10598488002145787,1.0,21/123,8.08%,CDKN2A;ARHGAP4;RASGRP2;IGF1;PLD1;PLK2;RASGRP1;ELMO1;RIT2;SHTN1;CDC42EP3;SHC2;WAS;EPS8L2;ARHGDIG;WASF1;ARHGEF3;RHOD;CDC42EP1;RAP2B;MRAS
prerank,CellMarker_Augmented_2021__Stem cell:Molar,0.6900936405975927,1.5385041165483524,0.0,0.1057518092057403,1.0,21/72,9.58%,COL4A1;CSPG4;PRRX1;PDGFRA;PCDH18;DCN;THBS1;SERPINE1;CALD1;COL4A2;THY1;ANGPTL2;POSTN;COL12A1;FAP;IGFBP7;GLT8D2;C1R;EMP1;BGN;MMP14
prerank,CellMarker_Augmented_2021__Epithelial cell:Undefined,0.8019070772000841,1.53839051666248,0.031746031746031744,0.10566263528635432,1.0,5/18,3.76%,ST6GAL1;CD24;ICAM1;SFTPD;IL1R1
prerank,Reactome_2022__Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,0.7872842436580185,1.5382226170776667,0.03636363636363636,0.10574477720425042,1.0,4/19,8.12%,SH3GL2;SH3GL3;SH3KBP1;CTNNB1
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.6323065131578427,1.5379783565844027,0.0,0.10605379489031054,1.0,34/141,11.41%,CA10;SOCS3;GRIN2A;TMEM235;RGS7BP;STMN2;VSTM2B;RCAN2;CNTN2;GAP43;ADCY5;OPALIN;PLP1;PLPPR4;C11ORF87;OPCML;IGSF21;TCEAL7;SYNPR;FAM107A;TMEM132C;GRM5;PHYHIP;TCEAL5;GRIA3;LUZP2;GFAP;ALDH1L1;LY6H;TEAD1;NACAD;SORBS1;LGI3;TCEAL6
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.7073258724945349,1.5377527854608444,0.015873015873015872,0.10616291909724353,1.0,9/51,9.38%,ECM2;NPNT;S100A10;DMTN;NEDD9;SKAP1;CDK6;PLEKHA2;ARHGEF7
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.7518981124303374,1.536796079712051,0.07575757575757576,0.10743063095655588,1.0,6/31,6.55%,SERPINA10;SPOCK3;SERPINE1;TIMP2;SERPINE3;SERPINF1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.6964946981245774,1.5365804898701714,0.0,0.10747946931484703,1.0,18/64,12.92%,L1CAM;SNCB;PPFIBP1;FBLIM1;APP;TJP3;CBLN2;PAK3;DVL1;GRM5;AGRN;SNCA;SMAD3;TGFB2;MAPT;OPHN1;SDK2;MYO9A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.7830813303221618,1.5362791125976563,0.0,0.1077250084519593,1.0,8/30,13.49%,NR4A3;IGF1;P2RY6;PPARG;CDKN1B;MEF2D;CDKN1A;FGF2
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Skin,0.6766861003231113,1.536270754873215,0.014285714285714285,0.10746417308040492,1.0,32/78,17.68%,COL4A1;PAPSS2;IL13RA1;SERPINE1;FAM20C;STEAP3;COL4A2;FBLIM1;TIMP2;EPHA2;ARHGEF17;POSTN;CDC42EP1;EMP1;SH3PXD2B;BGN;MMP14;RBPMS;PXDC1;PODXL;SLCO2A1;FN1;ROBO4;NTN4;NDST1;PLXNA2;FSTL1;MYOF;FAM114A1;RCN3;ARHGEF40;SRPX2
prerank,CellMarker_Augmented_2021__Colonic Stem cell:Colon,0.6660111182884593,1.5361199630416453,0.0,0.10740058425072006,1.0,29/89,16.31%,TEAD2;ARHGAP39;FBLIM1;EPHA2;DAB2IP;EFNB3;TUSC3;FRAS1;LAMB1;PARD3;PTPN21;RHBDF1;SCARA3;MYO1B;SH3PXD2B;CNN3;YAP1;TANC1;LOXL1;GLI2;DLG5;TEAD1;ENAH;MEIS3;RBFOX2;NOTCH3;SMARCA1;FSTL1;PFN2
prerank,Reactome_2022__Signaling By ERBB2 ECD Mutants R-HSA-9665348,0.8268667076688331,1.5356406615671043,0.03278688524590164,0.1077841914985118,1.0,2/15,3.55%,EGF;ERBIN
prerank,KEGG_2021_Human__Chagas disease,0.6656504328753557,1.5355857304255818,0.029411764705882353,0.10760868526646616,1.0,15/72,14.62%,TGFBR2;C3;TLR2;SERPINE1;FAS;TNFRSF1A;MYD88;GNA14;TGFB2;CCL2;FADD;IL12A;IKBKG;PIK3CD;MAPK11
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.8812786037920818,1.5355660467513585,0.018518518518518517,0.10735063086534753,1.0,1/9,0.06%,TGFBR2
prerank,KEGG_2021_Human__Ether lipid metabolism,0.7820580836236596,1.5351976860406118,0.016666666666666666,0.10781479488493238,1.0,6/32,9.14%,ENPP2;PLD1;UGT8;LPCAT4;PLAAT3;PLD2
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone Marrow,0.6437840951803364,1.5351793286530677,0.0,0.10758514429966008,1.0,29/88,12.14%,ENPP2;PDGFRA;RGS7BP;STMN2;RCAN2;PDZRN4;PLP1;PLPPR4;THY1;SHROOM4;TCEAL7;ANGPTL2;FAM107A;TMEM132C;LDB2;TCEAL5;CACNA1C;APLNR;PTPRD;ADGRF5;KALRN;BGN;RASL12;ITGA9;SORBS1;ASXL3;FAM13C;RUNX1T1;FGD5
prerank,KEGG_2021_Human__Thyroid cancer,0.7535130120967873,1.5349718679267788,0.014925373134328358,0.10763256823279001,1.0,1/34,0.01%,LEF1
prerank,Reactome_2022__Regulation Of Commissural Axon Pathfinding By SLIT And ROBO R-HSA-428542,0.9126459472433692,1.5346327368317456,0.0,0.10809275498532925,1.0,5/9,7.42%,SLIT2;NELL2;SLIT3;ROBO2;DCC
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.8899162119499093,1.5337403468130921,0.0,0.10942971428640348,1.0,6/15,4.83%,CACNA1H;CACNA1G;DOC2B;NLGN1;SYT4;RAB15
prerank,Reactome_2022__Initial Triggering Of Complement R-HSA-166663,0.9056772626258285,1.5337348708878793,0.01639344262295082,0.10917101519825595,1.0,3/9,7.49%,C3;COLEC11;C1R
prerank,KEGG_2021_Human__MicroRNAs in cancer,0.6131145596577077,1.53312515960513,0.0,0.10981568164505885,1.0,35/135,16.24%,CDKN2A;MET;PDGFRA;THBS1;PRKCB;ABCB1;PRKCG;IRS2;PIM1;EFNA1;SOX4;CD44;PAK4;CYP1B1;ZFPM2;PDGFA;CDK6;PRKCE;HDAC4;FSCN1;TGFB2;STAT3;RASSF1;CDKN1B;BCL2;MMP16;CDKN1A;CCND1;SLC7A1;PIK3CD;NOTCH3;TP53;STMN1;BRCA1;ZEB1
prerank,CellMarker_Augmented_2021__Secretory cell:Lung,0.7788537125154669,1.5329673356558489,0.0,0.10983002591544315,1.0,12/35,10.32%,CXCL2;HLA-DRA;C3;CTSC;PLK2;IL1R1;CP;PLAAT4;CFH;STEAP4;PPP1R16B;PODXL
prerank,KEGG_2021_Human__Adipocytokine signaling pathway,0.6922353283728119,1.5328385892329282,0.0,0.10984430284183505,1.0,5/55,6.47%,NPY;SOCS3;ACSL5;IRS2;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.8175412798043311,1.5327634073780552,0.018518518518518517,0.10977707589745339,1.0,4/19,4.42%,SCN1B;YWHAH;SCN3B;FGF12
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.6413994646330672,1.5325018980182386,0.0,0.10995390327735052,1.0,20/107,11.24%,ARHGAP4;TMEFF2;SERPINE1;SULF1;SLIT2;DAB2IP;THY1;DUSP10;PODN;PTPRR;CLIC4;FOXO3;LIMCH1;CYP1B1;RAP2B;DUSP22;LDLRAD4;DLG5;EPHA4;PHLDB2
prerank,Reactome_2022__NRIF Signals Cell Death From Nucleus R-HSA-205043,-0.8570208977711234,-1.5321114791881951,0.0196078431372549,0.3845858480080102,1.0,1/13,0.09%,NGF
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.7932175699819013,1.5321096985870484,0.0,0.11048115476159756,1.0,7/24,8.06%,PLEK;WAS;SHANK3;FHOD1;SYNPO2L;SLC9A1;SHANK1
prerank,Reactome_2022__Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.7217160527034083,-1.5319494539551406,0.08333333333333333,0.38239642055087364,1.0,4/21,9.99%,SOD3;PRDX1;GPX7;NUDT2
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.5731867605074623,1.5318117724176885,0.0,0.11065552229585762,1.0,78/376,15.54%,CXCL2;HLA-DRA;ST18;IL13RA1;ANXA1;SOCS3;IL15;SP100;STAT4;NUMBL;SLA;ICAM1;CSF2RA;TRAF3IP2;TEC;IRS2;IRAK2;LMNB1;PIM1;IRF7;FOXO1;NOD1;IL27RA;IL1R1;MAP3K14;OSMR;FYN;TNFRSF14;TRIM5;BCL6;CIITA;SAMHD1;BIRC3;CD44;TNFRSF1A;GHR;FOXO3;TCP1;PML;MYD88;LAMA5;BCL2L1;YAP1;GAB2;FSCN1;STAT3;SYK;INPPL1;TYK2;CCL2;HLA-DRB1;EIF5A;STX4;MX1;CAMK2B;PRKCD;CDKN1B;TRIM22;BCL2;IL17RE;ADIPOR2;FN1;B2M;IL4R;CDKN1A;CCND1;FGF2;TNIP2;CD70;IL12A;IKBKG;PIK3CD;HLA-E;INPP5D;CD4;STAT6;TP53;TNFRSF11B
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.7696502330962002,1.5318079324957858,0.016129032258064516,0.11039878094482315,1.0,4/29,1.71%,GGT5;CSPG4;DCN;OGN
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.6206232024379119,1.5317063631930108,0.0,0.11033104857594825,1.0,51/144,12.84%,SLITRK1;CA10;PCDH8;TAGLN3;STMN2;SH3GL2;VSTM2B;CNTN2;SNCB;SYT16;NELL1;CAMKV;NEFL;SYT4;PLPPR5;GAP43;ZDHHC22;C11ORF87;STMN4;OPCML;OLFM3;RTN2;ATP2B3;FGF12;GRIP1;GALNTL6;CDK5R2;HPCA;ST8SIA3;MTUS2;TCEAL5;SULT4A1;NYAP1;KIF5A;CELF3;KCNC1;SRRM3;KCNQ2;RBPMS;LY6H;DNER;BBC3;NACAD;CRMP1;NEFM;PIANP;SLC29A4;FXYD7;ERC2;TMEM196;CCDC184
prerank,Reactome_2022__Signaling By FGFR2 In Disease R-HSA-5655253,-0.6951279164500389,-1.5316546836562164,0.025,0.3809324748150859,1.0,6/33,14.76%,FGF6;POLR2K;POLR2C;GTF2F1;NRAS;POLR2D
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.6679170906208526,1.531361246269012,0.0,0.11063840225769576,1.0,35/92,17.57%,COL4A1;COL4A2;EPHA2;SLIT2;DAB2IP;NUAK1;COL12A1;LAMB1;PTPN21;RHBDF1;LARP6;SCARA3;MYO1B;ADGRL2;KITLG;PKDCC;YAP1;TANC1;GLI2;TEAD1;ENAH;CD276;FN1;CAP2;CCND1;PLOD2;RBFOX2;BCAR1;SMARCA1;FZD7;FSTL1;MESP1;MAGI1;WWTR1;WNT5A
prerank,Reactome_2022__FRS-mediated FGFR1 Signaling R-HSA-5654693,-0.815889622526152,-1.5313549903897334,0.07317073170731707,0.3798073671030928,1.0,1/14,0.15%,FGF6
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.7357973062745428,1.5308613780392466,0.029411764705882353,0.11134495706265546,1.0,13/26,9.40%,SCN1B;CACNA1G;KCNJ2;PKP2;SCN3B;KCNQ1;SCN1A;FGF12;KCND3;KCNH2;CACNA1C;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),0.9572634346991327,1.5306502551299892,0.0,0.11140874887600583,1.0,1/7,0.08%,ENPP2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),-0.6617548124314723,-1.530474299933673,0.0,0.38112172097139163,1.0,15/53,14.38%,UQCRFS1;NDUFS5;COX7C;NDUFA12;NDUFB4;UQCRB;NDUFB1;UQCRHL;NDUFV3;COX7B;NDUFA8;COX5B;NDUFS3;NDUFC1;COA6
prerank,CellMarker_Augmented_2021__Chondrocyte:Cartilage,0.6411104850394971,1.529946814899202,0.0,0.11240273427726369,1.0,23/88,9.88%,COL4A1;PRRX1;PCDH18;CALD1;SULF1;COL4A2;SLIT2;THY1;ANGPTL2;POSTN;COL12A1;LAMB1;COL27A1;PTPN21;LARP6;MAP1B;SCARA3;BOC;ADGRL2;BGN;CNN3;YAP1;GLI2
prerank,Reactome_2022__Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,0.8316331018427031,1.5297944722954802,0.03636363636363636,0.112490338078748,1.0,4/17,9.09%,VRK2;CCNB2;LMNB1;LMNA
prerank,Reactome_2022__FGFR4 Ligand Binding And Activation R-HSA-190322,-0.9037358918939988,-1.5293439598732084,0.038461538461538464,0.38315054724959285,1.0,1/5,0.15%,FGF6
prerank,KEGG_2021_Human__Cell adhesion molecules,0.6545728396736045,1.5292929895814462,0.034482758620689655,0.11300096468135207,1.0,28/92,15.13%,L1CAM;HLA-DRA;CD22;NLGN1;CNTN2;CNTNAP1;CLDN16;ITGA8;ICAM1;CNTNAP2;SIGLEC1;PTPRC;MAG;NRXN3;ITGA9;ITGB8;LRRC4;CLDN18;HLA-DRB1;CD276;ITGAL;CLDN20;CDH4;HLA-DMA;CD99;HLA-E;CD4;PDCD1LG2
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),-0.6002846260875252,-1.5292590407189737,0.03125,0.3808380499802878,1.0,15/49,15.37%,PAK1IP1;RPL35A;NSA2;NOC2L;RPL6;RPF1;SNU13;RPL14;RRP15;MDN1;RPL11;RPL23A;NIP7;RPF2;MAK16
prerank,Reactome_2022__DNA Methylation R-HSA-5334118,-0.8905231205921348,-1.5288974210093633,0.02127659574468085,0.37953773291497545,1.0,6/14,5.51%,H2AC20;H3-3B;DNMT3B;H2BC4;H2BC21;H2AC6
prerank,CellMarker_Augmented_2021__Flk1+ Mesodermal cell:Pluripotent Stem Cell,0.6686498969125966,1.52830070327336,0.0,0.11459181436524128,1.0,26/88,19.02%,FLRT3;PKP2;DAB2IP;NOS1AP;EPB41L4B;FRAS1;ZNF704;CKMT1B;PCLO;YAP1;ATP1B1;EPB41L1;TEAD1;ENAH;PLEKHH1;COL4A5;NEBL;COBL;RBFOX2;CAMSAP3;SLC44A3;TOX3;MAGI1;KIAA1671;KIAA1217;CXADR
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Undefined,0.6875374969301971,1.5280688539961813,0.057971014492753624,0.11464750205047952,1.0,18/57,13.04%,CSPG4;PDGFRA;ADGRE5;ACTA2;CD55;ICAM1;THY1;PTPRC;MCAM;ITGA2;ZBTB16;CD44;TNFRSF1A;ITGA3;CD276;FN1;IL4R;ALPL
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.6413539627361657,1.5280671918832585,0.0,0.1143875303905011,1.0,44/123,20.30%,PROX1;GAS2L3;ELMO1;CORO6;CORO7;MYO1F;DMTN;WAS;SHROOM4;BAIAP2L1;NEDD9;BAIAP2;FHOD1;RHOD;POF1B;TPM4;MYO1B;MYO1C;CLRN1;MYO15A;TCAP;INPPL1;TLE6;ACTN1;ENAH;NEBL;PPP1R9B;COBL;SPIRE1;ARHGAP17;RHOBTB2;BCAR1;CGNL1;NEB;SPIRE2;ERMN;MPRIP;FLNA;DSTN;CAPG;FHOD3;RHOB;SAMD14;MYO1E
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.613249447098565,1.5274826549181157,0.014285714285714285,0.11512526355007438,1.0,17/120,9.59%,MTMR7;PTPRO;DUSP1;PTPRB;DUSP10;PTPRR;PTPRC;DUSP8;DUSP16;PDP1;PTPN21;SBF1;DUSP22;PTPRD;SSH2;PTPN9;PPP1CB
prerank,Reactome_2022__Stabilization Of P53 R-HSA-69541,0.6906375969804467,1.5273904971336643,0.013888888888888888,0.11499621328986924,1.0,1/50,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.688930414013701,1.5271814671351718,0.03125,0.11510270108692298,1.0,19/61,11.84%,SLC6A15;SCN1B;SCN9A;SLC24A2;SCN3B;SCN1A;SCN2A;KCNK1;ASIC3;TRPM4;SLC9A9;ASIC4;ATP1A1;SLC9A1;HCN1;ATP1B1;ATP1B3;SCN3A;SLC9C2
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.6984831575459991,1.5271357280226485,0.0,0.1149221862506996,1.0,17/60,11.20%,SLC6A15;SCN1B;SCN9A;SLC24A2;SCN3B;SCN1A;SCN2A;KCNK1;ASIC3;SLC5A4;ASIC4;HCN1;ATP1B1;ATP1B3;SLC4A11;SCN3A;FGF13
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.6717718977918297,1.5268410491721218,0.0,0.11528825487287324,1.0,16/56,18.53%,EGF;PTK6;ERBIN;TGFA;PTPRR;REPS2;NRG1;NRG2;MVP;GAB1;IQGAP1;BCAR1;SHC1;NCK2;ADAM17;PRKCA
prerank,Reactome_2022__Signaling By PDGF R-HSA-186797,0.681899880218108,1.5266176550721169,0.0,0.11544523684070444,1.0,16/46,17.98%,COL4A1;PDGFRA;THBS1;COL4A2;PDGFA;COL9A1;STAT3;COL4A4;COL4A5;THBS2;BCAR1;STAT6;THBS3;CXXC1;COL4A3;NCK2
prerank,CellMarker_Augmented_2021__Monocyte:Undefined,0.8005793594344855,1.5263452705752525,0.01694915254237288,0.11554977156914424,1.0,5/23,3.65%,TLR2;CTSS;P2RY13;MYO1F;SIGLEC1
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.6918786096070557,1.5263212599174398,0.03076923076923077,0.11539568476971043,1.0,15/47,19.98%,EGF;SP100;ZSWIM4;NRG1;NRG2;CDK6;YTHDF1;ACTN1;ARHGAP18;PDPN;ETS1;INPP5F;ADAM17;TGFBR3;ACTN4
prerank,CellMarker_Augmented_2021__Langerhans cell:Skin,0.8220542488809933,1.5261780009185384,0.0,0.11529379924341114,1.0,4/21,3.65%,HLA-DRA;P2RY13;NAPSB;SIGLEC1
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.886714366135816,1.5258525354642647,0.0196078431372549,0.11547507772435538,1.0,1/9,0.11%,CACNA1H
prerank,Reactome_2022__MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.8179014098509221,1.5250929640373438,0.018518518518518517,0.11688647794538454,1.0,5/17,10.13%,GRIN2A;GRIN2B;TRPC3;FKBP5;GPRIN1
prerank,KEGG_2021_Human__cAMP signaling pathway,0.6062371124319684,1.5248866305653264,0.0,0.1170122649583916,1.0,30/157,10.24%,NPY;GRIN3A;NPY1R;GRIN2A;CREB5;AMH;CHRM1;PLD1;GRIN2D;GRIN2B;ADCY5;ATP2B3;GABBR2;GIPR;OXTR;ADCY7;CACNA1C;RYR2;ADCY2;GRIA3;GRIN1;GLP1R;ATP1A1;SLC9A1;GRIA1;PLD2;ATP1B1;PPP1CB;ORAI1;ATP1B3
prerank,Reactome_2022__B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.7551820079147806,-1.5245740467718816,0.023809523809523808,0.3934815709693765,1.0,8/39,6.82%,H2AC20;H3-3B;H2BC4;H2BC21;POLR2K;H2AC6;POLR1F;TAF1D
prerank,KEGG_2021_Human__Taste transduction,0.729047905664682,1.5244638843532061,0.020833333333333332,0.1174183418881128,1.0,13/36,11.66%,SCN9A;PDE1C;CHRM3;SCN2A;GABBR2;ITPR3;GABRA1;PDE1A;CACNA1C;GABRA5;PDE1B;SCN3A;HTR1E
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,0.6561795987616487,1.5243564638252722,0.0,0.11733860574680019,1.0,22/73,11.55%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;ABCA8;THY1;PODN;ANGPTL2;POSTN;FAP;IGFBP7;TNS1;LDB2;C1R;ITGA11;BGN;ZCCHC24;LAMA2;SPARC
prerank,Reactome_2022__CRMPs In Sema3A Signaling R-HSA-399956,0.7931875332830596,1.5243070057832224,0.06349206349206349,0.11720838073042385,1.0,8/16,15.21%,FYN;DPYSL2;CRMP1;DPYSL4;PLXNA4;DPYSL5;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.7926796956407823,1.5239862237998667,0.015873015873015872,0.11738308973134035,1.0,7/28,7.53%,EPHA7;SLIT2;SEMA3C;SLIT3;SEMA3D;SEMA3B;PDGFA
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.8454044007667744,-1.523878428510711,0.07894736842105263,0.39374341603901136,1.0,2/9,1.79%,OTUD3;TNFAIP3
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Peripheral Blood,-0.8009558417654948,-1.5234272368408996,0.023255813953488372,0.39258540707875184,1.0,5/13,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,Reactome_2022__Drug ADME R-HSA-9748784,0.7190393791484079,1.5232552518029039,0.015625,0.11839220958518447,1.0,4/48,4.20%,GGT5;ABCB1;SLC28A3;GLYATL2
prerank,Reactome_2022__Extracellular Matrix Organization R-HSA-1474244,0.5804819048816839,1.5231942212304086,0.0,0.11826054027950693,1.0,53/209,12.87%,OPTC;COL4A1;SPOCK3;ADAMTS4;CTSS;COL11A2;DCN;THBS1;SERPINE1;P4HA2;LTBP4;ITGA8;COL4A2;TIMP2;ICAM1;ASPN;TLL1;COL8A1;COL21A1;COL23A1;COL12A1;LAMB1;ITGA2;COL27A1;CD44;AGRN;PDGFA;ITGA11;CAPN8;LAMA5;CAPN1;SCUBE3;ITGA3;BGN;LOXL1;MMP14;ADAM19;TGFB2;ITGA9;COL9A1;P3H2;ADAM12;LAMA2;ITGB8;COL4A4;ACTN1;FGF13;MMP17;SPARC;ITGAL;ERC2;FN1;MMP16
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.7104642003580688,-1.5227780181676773,0.022222222222222223,0.39264872130819234,1.0,4/27,7.42%,AR;RNF6;HEYL;TRIM68
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),-0.864992434290512,-1.5226508890037094,0.0,0.3903151000382429,1.0,2/9,5.98%,SLC25A5;SLC25A4
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Brain,0.6665883213056216,1.5225515798109002,0.014925373134328358,0.11911217559380563,1.0,25/94,11.74%,COL4A1;CSPG4;PRRX1;EDIL3;PDGFRA;PCDH18;PDE1C;COL4A2;GAP43;SLIT2;PLP1;PLPPR4;THY1;TCEAL7;ANGPTL2;LDB2;BOC;MRAS;BGN;RASL12;ZCCHC24;NACAD;LAMA2;SPARC;RUNX1T1
prerank,CellMarker_Augmented_2021__Acinar cell:Salivary Gland,0.6983317903184406,1.5222717296428856,0.03571428571428571,0.11938181337510456,1.0,19/55,14.43%,PAPSS2;IL13RA1;TBC1D9;CALD1;YBX3;EGFL7;CHST15;LGALSL;ECE1;SNCA;SH3RF3;SEC14L1;PXDC1;INPP5A;PYGL;PDK4;GRK5;KCTD12;BMX
prerank,Reactome_2022__Glucagon Signaling In Metabolic Regulation R-HSA-163359,0.7758058541346285,1.5221614956436618,0.0,0.11947465965607132,1.0,6/23,7.19%,GNG3;ADCY5;PRKAR1B;GNG2;ADCY7;ADCY2
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.7875798990008418,1.52209134747187,0.047619047619047616,0.11934178997707158,1.0,6/25,8.17%,SOCS3;EGF;PTPRC;GHR;CYP1B1;OCIAD2
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.729390132586637,1.521205626610797,0.03225806451612903,0.12073333607040843,1.0,11/37,11.19%,SLC32A1;RIMS2;SYT1;GAD2;CPLX2;DVL1;SNCA;PCLO;CPLX1;DNAJC5;SYN2
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.6864092235223187,1.5208577728275454,0.0,0.12122151382009609,1.0,8/62,7.87%,ANLN;ANK3;SEPTIN4;SEPTIN5;INCENP;SEPTIN8;SEPTIN9;TRIM36
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.7688087998538042,1.520702093962995,0.01694915254237288,0.12118524618722581,1.0,12/31,12.05%,RIMS2;DOC2B;SYT1;SYT5;RIMS3;UNC13C;CPLX2;SNCA;PCLO;CPLX1;DNAJC5;STX4
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.7148945857871081,1.520202039822285,0.028169014084507043,0.12176964777632925,1.0,19/50,16.17%,STMN2;NLGN1;PTPRO;RTN4RL1;THY1;EFNA1;EFNB3;DCC;MAG;MCF2;PTPN9;EPHA4;CRMP1;LPAR1;BCL11A;STX1B;NGEF;PTPRS;KIAA0319
prerank,CellMarker_Augmented_2021__Abnormal Plasma cell:Peripheral Blood,0.664842633022225,1.5201113872387264,0.0,0.12173236390694082,1.0,23/93,11.02%,ENPP2;RIMBP2;PROX1;PDGFRA;STMN2;ZNF536;NCALD;RCAN2;CNTN4;PDZRN4;RTN1;ELAVL4;CP;GFRA2;KCND3;FAM107A;TMEM132C;PTPRD;ZBTB7C;ITGA9;LY6H;SCN3A;ASXL3
prerank,Reactome_2022__GPCR Ligand Binding R-HSA-500792,0.6068265831402507,1.520079119051798,0.0,0.12149752133924123,1.0,33/174,7.44%,NPY;CXCL2;C3;NPY1R;GPNMB;HTR2C;ANXA1;P2RY6;ADGRE5;CHRM3;GNG3;CHRM1;P2RY13;CD55;PLPPR5;APP;PLPPR4;WNT8B;PLPPR1;ACKR1;MCHR2;GABBR2;GIPR;OXTR;RXFP1;GNG2;TAC3;GRM5;ECE1;CCKBR;APLNR;RAMP3;GLP1R
prerank,CellMarker_Augmented_2021__Neural Crest cell:Germ,0.6580803017455183,1.5193760805639211,0.013888888888888888,0.12286671635189256,1.0,24/88,12.79%,C10ORF105;LZTS1;RASGRP2;CDH23;ELMO1;PRKCB;ADAMTS10;NELL2;FYN;GFRA2;GNG2;GALNT8;ITPKB;JPH4;PPP1R16B;NHSL2;PDE1B;LRRC4;IFFO1;FMNL3;SDK2;FXYD7;GLT1D1;INPP4A
prerank,KEGG_2021_Human__Endometrial cancer,0.6982454405888886,1.51929402097736,0.029850746268656716,0.12272890166384015,1.0,2/56,1.45%,LEF1;EGF
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.8417138809583079,1.5190954930280147,0.030303030303030304,0.12288636245300417,1.0,4/13,9.40%,ANK3;TESC;SLC9A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.8298656225272392,1.519014301415256,0.0,0.12287161749339612,1.0,3/18,3.34%,TMEM204;PRKCB;DAB2IP
prerank,Reactome_2022__Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,0.7900738372929841,1.5189074060066257,0.03508771929824561,0.12280802673338201,1.0,7/19,13.20%,KCNH8;EGF;TGFA;FOXO3;CDKN1B;BCL2;CCND1
prerank,Reactome_2022__Mitochondrial Translation Termination R-HSA-5419276,-0.6448497522980409,-1.5187751370456348,0.0425531914893617,0.40075726478084156,1.0,27/73,18.52%,MRPL10;MRPS21;MRPL52;MRPS7;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;MRPS9;MTRF1L;MRPS26;MRPL21;MRPS18B;MRPS34;MRPS33;MRPL19;MRPL50;MRPS5;OXA1L;MRPS31;MRPL3;MRPL17;PTCD3
prerank,KEGG_2021_Human__Relaxin signaling pathway,0.6312403388264378,1.5184473019581837,0.0,0.12320835171016994,1.0,12/100,7.19%,TGFBR2;COL4A1;GNG3;CREB5;ACTA2;COL4A2;ADCY5;SHC2;RXFP1;GNG2;ADCY7;ADCY2
prerank,Reactome_2022__Protein Localization R-HSA-9609507,-0.5772636858567687,-1.5181958087364946,0.0,0.40037211757111446,1.0,34/141,16.36%,DAO;ABCD2;GRPEL2;PXMP2;TIMM8B;PHYH;NUDT7;PIPOX;COA4;SLC25A4;ABCD1;CHCHD10;ATP5MC1;TIMM13;GFER;ACOT2;ECH1;PEX10;SERP1;TIMM23;PEX11B;HMGCL;CS;COX19;SAMM50;ATP5F1B;TIMM50;COA6;TIMM10;CHCHD2;ATP5F1A;GNPAT;PEX13;IDH3G
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Embryo,0.7018892010084394,1.5178827204150491,0.016666666666666666,0.12416707362420729,1.0,6/44,6.28%,GGT5;FLT1;KCNQ1;SIGLEC1;PODN;RAI2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.5946288406253454,1.5173426402870835,0.0,0.1251946763666292,1.0,49/147,11.55%,GGT5;APOLD1;TGFBR2;COL4A1;PROX1;PDGFRA;DCN;S100A10;ABCA8;CASZ1;CD55;FLT1;ICAM1;PTPRB;NRP2;PODN;ACKR1;SHROOM4;PCDH12;ANGPTL2;EGFL7;MCAM;POSTN;CLIC4;SEMA3D;IGFBP7;MFSD2A;CFH;TNS1;PLAC8;LDB2;ECE1;APLNR;RAMP3;C1R;CYP1B1;EMP1;ADGRF5;SPNS2;BGN;PRKCH;RASL12;RNASE1;PODXL;FLI1;SLCO2A1;CDKN1C;USHBP1;SPARC
prerank,Reactome_2022__Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,0.6453645055577397,1.51727992033024,0.0,0.12507825904773465,1.0,16/79,11.07%,SERPINA10;C3;IGF1;CHGB;SGPP2;FAM20C;APP;CP;LAMB1;IGFBP7;NOTUM;VGF;SHISA5;ITIH2;TF;GAS6
prerank,CellMarker_Augmented_2021__Cholinergic neuron:Undefined,0.6790663570667589,1.5170421024369132,0.016129032258064516,0.1252769115204136,1.0,24/77,10.79%,RIMBP2;MYT1;PCDH8;STMN2;CAMKV;SYT4;PLPPR5;GAP43;SHC2;STMN4;ACHE;ELAVL4;OLFM3;SEMA5B;CDK5R2;SULT4A1;NYAP1;CELF3;KCNC1;C2CD4C;KCNQ2;LY6H;DCX;NACAD
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),0.7828850947384753,1.516994908231756,0.0,0.12518495628306037,1.0,3/21,3.84%,IGF1;EGF;TGFA
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.8809280394093714,1.516844077874263,0.0,0.12533436467779258,1.0,4/13,4.01%,NR4A3;C3;PRKCB;RTN2
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.6166245926397077,1.5167437450922427,0.0,0.12533886432828312,1.0,34/127,11.98%,COL4A1;PRRX1;TLR2;EDIL3;PDGFRA;RGS7BP;PCDH18;KCNJ2;RCAN2;COL4A2;PLP1;PLPPR4;THY1;OPCML;TCEAL7;ANGPTL2;SYNPR;POSTN;FAM107A;PTPN21;CD44;LDB2;APLNR;SCARA3;BOC;ADGRL2;PTPRD;BGN;RASL12;COL9A1;DBI;FAM13C;SPARC;PRICKLE2
prerank,CellMarker_Augmented_2021__Granulosa cell:Ovary,0.680563937271455,1.5164495804282607,0.01639344262295082,0.12582331220613555,1.0,14/58,14.92%,ANLN;SH2D5;GRIN2D;COL4A2;GLIS2;TUBB6;FSCN1;GLI2;TEAD1;CD276;FGF2;MTHFD1L;BCAR1;MTCL1
prerank,KEGG_2021_Human__Staphylococcus aureus infection,0.7467957008509949,1.5163637594987878,0.029411764705882353,0.12575493676200453,1.0,8/21,13.76%,HLA-DRA;C3;ICAM1;CFH;C1R;HLA-DRB1;ITGAL;HLA-DMA
prerank,Reactome_2022__Digestion And Absorption R-HSA-8963743,-0.8688308954289555,-1.516347771088534,0.022222222222222223,0.40522987141637556,1.0,4/9,4.98%,SLC2A5;CEL;PMEL;MGAM
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),-0.7899149116300632,-1.5160041952677243,0.05263157894736842,0.40384821481357425,1.0,2/10,2.63%,PYGM;PPP1R3C
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.6592223111443594,1.515974544063198,0.0,0.12661891912708167,1.0,16/89,9.98%,GGT5;CSPG4;PAPSS2;DCN;OGN;B3GNT2;CHSY3;CHST15;GGCT;CHST6;CHPF2;UGDH;BGN;GSS;OMD;UST
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.8137703690821643,1.5155468281697326,0.0,0.12721699375359016,1.0,8/19,7.26%,GRIN2A;GRIN2D;GRIN2B;ITPR3;CACNA1C;JPH4;RYR2;GRIN1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tooth,0.8873527135575054,1.5141078783429485,0.0,0.12993092180949625,1.0,3/8,4.85%,CD24;THY1;MCAM
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.7731185560722135,1.5140860591729617,0.0,0.12971217483716466,1.0,7/23,17.04%,P2RY6;THY1;SNCA;APLNR;CEMIP;HAP1;CALM3
prerank,CellMarker_Augmented_2021__Fibroblast:Heart,0.6567079309952847,1.5140840786240546,0.0,0.12947061865069978,1.0,26/83,14.91%,COL4A1;TEAD2;PAPSS2;FAM20C;TBC1D9;CALD1;FBLIM1;TIMP2;EPHA2;APP;SEMA3C;TPST1;RAB11FIP5;CDC42EP1;MYO1B;SH3PXD2B;YAP1;LOXL1;RGMB;PXDC1;ACTN1;CD276;CCND1;PALLD;NTN4;NDST1
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),0.9370206602039904,1.5138095428891762,0.0,0.1297031585978874,1.0,1/8,0.01%,LEF1
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.6114503427203936,1.5136924881603202,0.0,0.1299111440042395,1.0,36/156,18.66%,TGFBR2;VRK2;SBK1;PLK2;CAMKV;PRKCB;PRKCG;RPS6KA1;STK32B;GRK2;GALNT16;PRKCE;PRKCH;IKBKE;HIPK3;GAS6;STK32A;CDC7;PRKCD;HIPK1;MAPKAPK5;RPS6KA6;STK32C;RPS6KB2;HIPK2;NEK6;PINK1;CDK2;MAPK9;CAMK1D;PDK3;HPF1;CAMK2A;PRKCA;CAMK1G;RPS6KA4
prerank,Reactome_2022__Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.622434928512138,-1.5135533285000695,0.0,0.41021680367595514,1.0,11/48,20.20%,APOBEC3G;ELOC;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,KEGG_2021_Human__Type I diabetes mellitus,0.8127830346805199,1.513360289350585,0.03508771929824561,0.130259640034824,1.0,9/18,14.72%,HLA-DRA;GAD2;ICA1;FAS;HLA-DRB1;HLA-DMA;IL12A;HLA-E;PTPRN
prerank,Reactome_2022__Signaling By Interleukins R-HSA-449147,0.5814075134109846,1.513238851174893,0.0,0.13020702574855164,1.0,56/303,15.46%,CXCL2;IL13RA1;ANXA1;SOCS3;IL15;KCNH8;IL1RAPL1;STAT4;ICAM1;CSF2RA;TEC;IRS2;IRAK2;LMNB1;APP;RPS6KA1;FOXO1;NOD1;IL27RA;IL1R1;OSMR;FYN;BCL6;TNFRSF1A;FOXO3;TCP1;NLRC5;MYD88;LAMA5;BCL2L1;SMAD3;PTPN9;GAB2;FSCN1;STAT3;SYK;INPPL1;FGF13;TYK2;CCL2;GSDMD;STX4;BCL2;IL17RE;FN1;IL4R;CDKN1A;CCND1;TNIP2;IL12A;IKBKG;MAPK11;INPP5D;CD4;STAT6;TP53
prerank,Reactome_2022__Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.6778602914174657,-1.5127451656528463,0.07894736842105263,0.4114143236195176,1.0,9/53,6.82%,H2AC20;H3-3B;H2BC4;H2BC21;POLR2K;H2AC6;CHD4;POLR1F;TAF1D
prerank,Reactome_2022__Amine Ligand-Binding Receptors R-HSA-375280,0.7952597065796935,1.5123582822805461,0.0,0.13165631835812186,1.0,3/20,1.52%,HTR2C;CHRM3;CHRM1
prerank,KEGG_2021_Human__Human cytomegalovirus infection,0.5861230462420047,1.5121494332127494,0.0,0.13171817790726048,1.0,41/164,18.87%,CDKN2A;PDGFRA;GNG3;CREB5;PRKCB;ADCY5;PRKCG;IL1R1;NFATC2;FAS;GNG2;ITPR3;TNFRSF1A;ADCY7;ADCY2;CDK6;CTNNB1;GNA12;STAT3;PXN;CCL2;CGAS;B2M;CDKN1A;CCND1;FADD;RPS6KB2;IKBKG;PIK3CD;MAPK11;HLA-E;BCAR1;TP53;ADCY3;TRAF5;CALM3;GNAI1;ITPR1;TSC2;PRKCA;NFATC3
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),0.9699850571664947,1.5121012665883364,0.0,0.13166294125200906,1.0,2/5,1.69%,THBS1;ATF3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.8875750640714732,1.5121004110778566,0.014925373134328358,0.13139802587725652,1.0,2/12,0.90%,NR4A3;IGF1
prerank,KEGG_2021_Human__Taurine and hypotaurine metabolism,0.9417574263201544,1.5116123384190432,0.03636363636363636,0.13197209246708172,1.0,2/7,4.11%,GGT5;GAD2
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.7647642681554399,1.5113320125802736,0.03125,0.13228834076152837,1.0,7/30,8.74%,ANK3;P2RY6;CTSS;RELN;SHANK3;STAC2;LRRC55
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.857343696032159,1.5110329800942568,0.0,0.132696053660044,1.0,6/14,7.01%,SCN1B;CACNA1G;KCNJ2;SCN3B;TRPM4;CACNA1C
prerank,Reactome_2022__G Alpha (Z) Signaling Events R-HSA-418597,0.737355665610599,1.5110068096782379,0.0,0.132431191277489,1.0,16/35,18.53%,GNG3;PRKCB;ADCY5;PRKCG;GNG2;RGSL1;ADCY7;ADCY2;PRKCE;PRKCH;GNAZ;PRKCD;RGS4;RGS16;GNAI1;PRKCA
prerank,Reactome_2022__RHOC GTPase Cycle R-HSA-9013106,0.6709385917076394,1.5108671611481663,0.0,0.13230592435848013,1.0,20/67,17.79%,ANLN;VAPB;ARHGAP39;ERBIN;ARHGEF17;MCAM;DAAM1;MCF2;ARHGEF10L;ARHGAP26;OPHN1;STARD13;ARHGAP18;FMNL3;STOM;IQGAP1;VAV2;MCF2L;ARHGEF40;TFRC
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Brown Adipose Tissue,0.6284936066854584,1.5105705636285176,0.0,0.13280334715029762,1.0,26/99,12.00%,KCNT2;FLRT3;PROX1;EPHA7;ZNF385B;FGF12;EPB41L4B;FRAS1;PTPN21;GUCY1A2;DTNA;MAOB;MAP1B;LIMCH1;ADGRL2;PTPRD;PCLO;KALRN;YAP1;PCDHB15;SORBS1;ASXL3;ENAH;FAM13C;RUNX1T1;PARD3B
prerank,KEGG_2021_Human__Proteoglycans in cancer,0.6049455495357928,1.5104128477018557,0.0,0.1327698325657899,1.0,48/160,20.21%,MET;ANK3;TLR2;IGF1;DCN;THBS1;PRKCB;PRKCG;WNT8B;FAS;ITGA2;ITPR3;CD44;SLC9A1;MRAS;CTNNB1;PPP1CB;TGFB2;STAT3;PXN;CAMK2B;FN1;PAK1;CDKN1A;CCND1;FGF2;GAB1;RPS6KB2;IQGAP1;PIK3CD;MAPK11;TP53;VAV2;FZD7;IGF1R;WNT5A;ITPR1;FLNA;CAMK2A;PRKCA;CAV3;SMAD2;VAV1;HIF1A;FGFR1;RRAS2;AKT3;TFAP4
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lymph Node,0.7228636041866803,1.5103567375712217,0.0,0.13257578061807052,1.0,10/50,5.37%,IPCEF1;RASGRP2;ELMO1;P2RY13;MYO1F;SLA;PRKCB;NLRP12;FYN;GNG2
prerank,Reactome_2022__Cristae Formation R-HSA-8949613,-0.760480148017849,-1.5103062432289085,0.0,0.4182278722638568,1.0,13/26,16.79%,ATP5PF;ATP5MC1;APOO;ATP5PB;ATP5PD;DMAC2L;MICOS10;ATP5MC3;SAMM50;ATP5F1B;ATP5F1A;TMEM11;ATP5MC2
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),0.9536986901722964,1.5100190208881719,0.0,0.13295518340412868,1.0,1/6,0.25%,HPN
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.7368298427820696,1.5099102923124479,0.014925373134328358,0.13287584299750654,1.0,11/26,7.01%,SCN1B;CACNA1G;KCNJ2;PKP2;SCN3B;KCNQ1;KCNE4;TRPM4;KCND3;KCNH2;CACNA1C
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.5622728645712394,1.5097521339520696,0.0,0.13295653620979017,1.0,90/354,14.23%,IL1RAPL2;SLITRK1;MOBP;MET;L1CAM;HAPLN2;FLRT3;CHST8;MOG;GRIK1;PROX1;TAGLN3;CHRM3;CHRM1;SH3GL2;RAPGEF5;ZIC4;NLGN1;NUMBL;WDR62;MBP;NELL1;SH3GL3;CNTN4;UGT8;IGF2BP2;RELN;NRGN;WNT8B;ACHE;APBA2;EFNB3;SCN2A;VLDLR;FGF12;SRRM4;NINJ2;SHANK3;GFRA2;DVL1;NRSN1;NRG1;ZBTB16;NEUROD2;ZIC1;LDB2;KIRREL3;DPYSL2;ROBO2;EIF2B2;GLIS2;THOC6;NPTX1;MYT1L;KALRN;YAP1;ARHGAP26;TRAK1;NEURL1;KCNQ2;GSS;HDAC4;GDA;STAT3;ST8SIA4;LY6H;KLK6;PCDHB15;DNER;TEAD1;GFRAL;DCX;FGF13;OPHN1;CRMP1;PCDHA1;NPAS2;DPYSL4;SDK2;FN1;RPS6KA6;JARID2;RAPGEFL1;PCDHB2;FGF2;DPYSL5;LPAR1;HAP1;PCDHB5;ALDH3A2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),0.8147155616766588,1.5096311114973044,0.0,0.13294582237875766,1.0,5/16,8.31%,MRAP2;PID1;MRAP;TMBIM1;BCL2L1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.6942201385782379,1.5094776376039898,0.0,0.13295787840521117,1.0,32/95,12.06%,KCNT2;HPN;SLC24A2;KCNH8;KCNJ2;KCNV1;KCNH7;KCNK10;KCNQ1;KCNC2;KCNE4;KCNB2;ABCC8;KCNF1;KCNK1;KCNQ5;SLC9A9;KCND3;ABCC9;KCNH2;ATP1A1;SLC9A1;KCNC1;LRRC55;HCN1;KCNQ2;KCNK12;ATP1B1;ATP1B3;KCNAB3;SLC9C2;KCNH3
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.7584676361600439,1.5094462791467338,0.018518518518518517,0.13276573695817068,1.0,9/17,7.50%,SCN1B;CACNA1G;KCNJ2;PKP2;SCN3B;SCN1A;FGF12;CACNA1C;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.9078916537054508,1.509290599657851,0.0,0.1328460148055914,1.0,1/10,0.15%,NR4A3
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.9526767715195525,1.5091889752689758,0.03389830508474576,0.1328581948856391,1.0,2/7,0.32%,CACNA1H;SERPINA10
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),-0.717044266677572,-1.5088718653009017,0.04878048780487805,0.4217789199070375,1.0,4/36,6.79%,RITA1;NXT2;AAAS;GEMIN4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.7792953273670835,1.508804453992629,0.0,0.13329879604214762,1.0,5/16,13.23%,THY1;SNCA;APLNR;RAMP3;CEMIP
prerank,KEGG_2021_Human__Hepatocellular carcinoma,0.6515350533667456,1.508682637010141,0.0136986301369863,0.13331004963404647,1.0,15/140,8.94%,LEF1;TGFBR2;CDKN2A;MET;GSTT2;PRKCB;SHC2;PRKCG;WNT8B;TGFA;DVL1;CDK6;CTNNB1;BCL2L1;SMAD3
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Lung,0.6639520947671038,1.5085552778368476,0.0136986301369863,0.1333437231725966,1.0,21/86,6.59%,TGFBR2;FOSL2;COL4A1;PAPSS2;IL13RA1;HRH1;THBS1;SERPINE1;FAM20C;TBC1D9;COL4A2;TIMP2;NRP2;IL1R1;SEMA3C;FAP;IGFBP7;CFH;TNFRSF1A;TNS1;PID1
prerank,CellMarker_Augmented_2021__Amniotic Fluid Stem cell:Amniotic Fluid,0.668578652496113,1.5083284824853802,0.0,0.13310895943892095,1.0,33/77,15.22%,TGFBR2;PRRX1;ANXA1;HRH1;DCN;THBS1;SERPINE1;TIMP2;THY1;IL1R1;COL8A1;OSMR;POSTN;FAP;IGFBP7;CFH;CD44;C1R;EMP1;MVP;BGN;MMP14;PXDC1;ADAM12;SPARC;CCL2;ROBO4;COPZ2;LPAR1;THBS2;S100A6;PDCD1LG2;CD59
prerank,CellMarker_Augmented_2021__Progenitor cell:Bone,0.668578652496113,1.5083284824853802,0.0,0.13310895943892095,1.0,33/77,15.22%,TGFBR2;PRRX1;ANXA1;HRH1;DCN;THBS1;SERPINE1;TIMP2;THY1;IL1R1;COL8A1;OSMR;POSTN;FAP;IGFBP7;CFH;CD44;C1R;EMP1;MVP;BGN;MMP14;PXDC1;ADAM12;SPARC;CCL2;ROBO4;COPZ2;LPAR1;THBS2;S100A6;PDCD1LG2;CD59
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovial Fluid,0.668578652496113,1.5083284824853802,0.0,0.13310895943892095,1.0,33/77,15.22%,TGFBR2;PRRX1;ANXA1;HRH1;DCN;THBS1;SERPINE1;TIMP2;THY1;IL1R1;COL8A1;OSMR;POSTN;FAP;IGFBP7;CFH;CD44;C1R;EMP1;MVP;BGN;MMP14;PXDC1;ADAM12;SPARC;CCL2;ROBO4;COPZ2;LPAR1;THBS2;S100A6;PDCD1LG2;CD59
prerank,Reactome_2022__RHO GTPase Cycle R-HSA-9012999,0.5567415017932408,1.5082638315714674,0.0,0.13305359758788948,1.0,94/386,20.29%,ANLN;VRK2;ARHGAP4;KIF14;NHS;STMN2;VAPB;ARHGAP39;STEAP3;CDC42EP3;EPHA2;WAS;PLEKHG6;SLITRK5;LMNB1;MAP3K11;ERBIN;BAIAP2L1;ARHGEF17;ARHGDIG;MCAM;WASF1;ARHGEF3;BAIAP2;DOCK10;RHPN1;RHOD;CDC42EP1;TPM4;PAK4;OBSCN;DAAM1;MCF2;TRIP10;KALRN;ARHGEF10L;BASP1;ARHGAP26;PLD2;ARHGEF7;RNASE1;DLG5;KCTD3;NOXA1;HMOX2;TRIO;ACTN1;PLEKHG2;OPHN1;DOCK4;KCTD13;FGD5;STARD13;ARHGAP18;FMNL3;STOM;MYO9A;TEX2;GPS1;TUBA1B;IQGAP1;ALDH3A2;ARHGAP17;RHOBTB2;PLXNA1;PLEKHG4B;UBXN11;ARHGAP22;NGEF;VAV2;WIPF3;PKP4;NISCH;FMNL1;MCF2L;SCRIB;ARHGEF40;TFRC;DOCK9;RHOQ;NCK2;AMIGO2;CDC42SE2;VAV1;WIPF1;SH3PXD2A;TJP2;DOCK3;RHOB;RTKN;FARP1;RRAS2;ARHGEF6;DDRGK1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.7479591103676027,1.5079055927994944,0.04918032786885246,0.1333989119700771,1.0,8/29,13.18%,CDKN2A;GPNMB;FAM107A;CDK6;GFI1B;CCL2;KLF4;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.6541003713654221,1.5078802478515345,0.0,0.13323217995217151,1.0,17/70,12.93%,MET;PROX1;STMN2;PSRC1;PLEK;CDC42EP3;APP;BAIAP2L1;MYLK3;BAIAP2;CDC42EP1;SYNPO2L;PRKCE;FCHSD1;MAPT;ARF6;PAK1
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.9031806629144637,-1.5078434428471286,0.04,0.4235421077456973,1.0,2/6,6.81%,PGP;MST1
prerank,KEGG_2021_Human__Rheumatoid arthritis,0.7189256021853954,1.507787433337249,0.031746031746031744,0.13319906296671497,1.0,6/44,2.81%,CXCL2;HLA-DRA;TLR2;IL15;FLT1;ICAM1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.8065378256882512,1.507746686115771,0.017241379310344827,0.13301122811175464,1.0,4/18,3.77%,RIMS2;NLGN1;RIMS3;SEPTIN5
prerank,KEGG_2021_Human__Leishmaniasis,0.6934214916566311,1.507341075742668,0.06557377049180328,0.13353062003526436,1.0,11/43,14.62%,HLA-DRA;C3;TLR2;PRKCB;MYD88;TGFB2;HLA-DRB1;EEF1A2;HLA-DMA;IL12A;MAPK11
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.9307590713184744,1.5073095955686457,0.0,0.1333428690446413,1.0,1/8,0.71%,BOK
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.675489670303822,1.506993633993327,0.0,0.13401362334540146,1.0,15/71,10.44%,EPHA7;GRIN2B;EPHA2;EPHA5;EFNA1;EFNB3;PAK3;FYN;DNM1;GRIN1;KALRN;ARPC3;ARHGEF7;SIPA1L1;EPHA4
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.9379998094321687,-1.5067955157641895,0.06,0.42561138958379474,1.0,1/5,0.29%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.9257468906876297,1.5067574569532243,0.0,0.13424277631714965,1.0,1/7,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6852592532443675,1.506660138260252,0.029411764705882353,0.13416430149849098,1.0,7/43,5.22%,CDH6;CDH22;CDH9;CDH19;CDH8;CDH7;CDH18
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.6974701654327037,1.5066425933805632,0.03389830508474576,0.1339330314950143,1.0,9/42,8.41%,HTR2C;KCNC2;ABCC8;GIPR;ITPR3;CACNA1C;HADH;GLP1R;CACNA1E
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.6375890036351638,1.505838597368704,0.014705882352941176,0.1354489526638051,1.0,32/87,16.85%,IL13RA1;TLR2;P2RY6;FAM20C;SLC15A3;SLC39A14;DYSF;NRP2;SIGLEC1;IL1R1;EGFL7;ITGA2;ITPR3;TNS1;SERPINF1;PID1;SLC7A7;CHI3L1;ARHGEF10L;MMP14;RNASE1;RIN2;CCL2;TNFAIP6;KCNMA1;KCTD12;SPP1;SERPING1;TNFRSF11B;CTSZ;RASSF4;CTSK
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.6126754695501654,1.5051481777602713,0.0,0.13643626361816416,1.0,22/105,13.49%,LZTS1;GPNMB;SP100;SRCIN1;EPHA2;PAK3;WTIP;SHANK3;HECW2;BCL6;PID1;CTNNB1;CYRIB;SIPA1L1;EPHA4;MAPT;KIF13B;PHLDB2;SPARC;HECW1;PAK1;FGF2
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Deciduous Tooth,0.6863482454292367,1.5049062266665572,0.0,0.13674571001109784,1.0,21/56,10.37%,GGT5;ABCA6;DCN;ABCA8;FLT1;PTPRB;PLXDC1;PODN;ACKR1;SHROOM4;PCDH12;MYH11;PTPRC;MCAM;CFH;APLNR;RAMP3;ADGRF5;ABCA9;RNASE1;FLI1
prerank,CellMarker_Augmented_2021__Intermediate Progenitor cell:Undefined,0.6801721344575536,1.5044888163484984,0.0,0.1372710610927441,1.0,26/80,11.42%,MYT1;SLC32A1;CNR1;SBK1;KCNH8;PCDH8;SLC4A10;RASGRP1;VSTM2B;DLGAP3;STMN4;RTN1;ELAVL4;NELL2;CPLX2;RFX4;JPH4;CELF3;CACNA1E;KIF5C;KCNQ2;PACSIN1;DCX;TERF2IP;NAP1L2;FBXL16
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.6202890077609936,1.5044556821649162,0.0,0.1370578112576393,1.0,28/118,7.74%,COL4A1;PRRX1;SOCS3;COL11A2;PDGFRA;PCDH18;NPNT;DCN;ACTA2;CALD1;SULF1;COL4A2;FOXO1;NOD1;THY1;PODN;ANGPTL2;OSMR;POSTN;FAS;OLFML1;COL12A1;FAP;ITGA2;IGFBP7;CD44;C1R;EMP1
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.8185879716814499,1.5043563115965948,0.0,0.13706161085579682,1.0,5/13,9.86%,ANXA1;RELN;GCM2;CDK6;TGFB2
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.8518197666996176,1.5034647668663823,0.05660377358490566,0.1385331832237881,1.0,3/12,8.06%,WAS;FHOD1;SLC9A1
prerank,KEGG_2021_Human__Dopaminergic synapse,0.6266841609163514,1.5032006116992094,0.0,0.13896512598542946,1.0,17/108,9.59%,GRIN2A;GNG3;CREB5;GRIN2B;PRKCB;ADCY5;PRKCG;SCN1A;GNG2;ITPR3;CACNA1C;MAOB;GRIA3;KIF5A;KIF5C;GRIA1;PPP1CB
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.8043268205564215,1.5030156350882666,0.0,0.13911590087870498,1.0,6/18,8.06%,RIMS2;NLGN1;RELN;SHANK3;GRIN1;SHANK1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.877786342821059,-1.501854976724725,0.047619047619047616,0.4459028998706799,1.0,4/11,8.06%,CSKMT;SMYD2;METTL18;KMT5A
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.6442381597366789,1.5017458307757756,0.015384615384615385,0.14119798395575636,1.0,22/86,16.14%,ANK3;YWHAH;EPHA2;FYN;STAC2;RAMP3;MYO1C;NECAB2;YWHAG;ITGA3;PTPN9;PRKCE;PRKCH;BBC3;SORBS1;STX4;ARF6;BCL2;CEMIP;MTCL1;TP53;ATP2B4
prerank,CellMarker_Augmented_2021__Granulosa cell:Undefined,0.6442289646038457,1.5016007413675698,0.02857142857142857,0.14125837214592607,1.0,21/90,9.03%,COL4A1;CSPG4;PRRX1;EDIL3;PCDH18;CALD1;SULF1;COL4A2;SLIT2;THY1;ANGPTL2;MCAM;POSTN;COL12A1;LAMB1;COL27A1;PTPN21;MAP1B;ADGRL2;BGN;CNN3
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.8422669479089077,1.5015241370237966,0.0,0.141190221638097,1.0,4/15,3.17%,HPN;KLF2;EGF;APP
prerank,Reactome_2022__Activation Of Ca-permeable Kainate Receptor R-HSA-451308,0.8426982040099708,1.5010625353904692,0.0196078431372549,0.14197618583975077,1.0,2/9,1.59%,GRIK1;NCALD
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.8228701478254755,1.5009149836114253,0.018518518518518517,0.14214134725018648,1.0,1/16,0.08%,ENPP2
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.8756357747365439,-1.50091128266965,0.04,0.4477180678605365,1.0,1/12,0.09%,NGF
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6823500612397201,1.5006515914735505,0.016129032258064516,0.14239097558870017,1.0,8/52,5.71%,ELMO1;SULF1;FLT1;SHC2;DAB2IP;NRP2;FYN;BAIAP2
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.5575174557569819,1.500310228311705,0.0,0.14300058769547802,1.0,101/408,18.73%,TGFBR2;VRK2;TLR2;SBK1;PDGFRA;MAP3K6;PLK2;FAM20C;PTK6;PIM3;CAMKV;FLT1;PRKCB;PRKCG;RELN;TEC;APP;RPS6KA1;PIM1;MAP3K11;DAB2IP;NUAK2;NEK10;PAK3;INCENP;PRKG2;MYLK3;PRKAR1B;FYN;NUAK1;STK32B;CDK9;STK25;PAK4;AATK;DAPK2;CDK6;GRK2;SIK2;PKDCC;LIMK2;PRKCE;PRKCH;IKBKE;MINK1;MAK;HIPK3;HUNK;TGFB2;SYK;EPHA4;CDKL5;MAP3K21;GAS6;TYK2;STK32A;PDK4;CCL2;CDC7;PXK;CAMK2B;PRKCD;HIPK1;MAPKAPK5;ALK;PAK1;RPS6KA6;PICK1;STK32C;RPS6KB2;GRK5;HIPK2;PDK1;BMX;PIK3CD;NEK6;RARA;MAP3K5;STK3;PINK1;CDK2;CDK19;CILK1;LIPE;CDC25B;MAPK9;CDK18;CAMK1D;IGF1R;PRDX4;CDK20;FAM20A;STK11;STK24;PDK3;CAMK2A;PRKCA;NEK4;CAMK1G;RPS6KA4;SMAD2
prerank,"KEGG_2021_Human__Glycine, serine and threonine metabolism",-0.6827284437497911,-1.4996191140873063,0.05714285714285714,0.45084482212930416,1.0,5/30,5.95%,DAO;SDSL;BPGM;PIPOX;ALAS1
prerank,Reactome_2022__GPCR Downstream Signaling R-HSA-388396,0.5688302087768153,1.49933018527903,0.0,0.14437082862016562,1.0,63/323,11.72%,NPY;CXCL2;C3;RASGRP2;NPY1R;GPNMB;HTR2C;ANXA1;P2RY6;PDE1C;CHRM3;GNG3;CHRM1;RASGRP1;P2RY13;TRPC3;PRKCB;ADCY5;PRKCG;APP;RPS6KA1;RGS6;MCHR2;ARHGEF17;GABBR2;PRKAR1B;GIPR;OXTR;RXFP1;ARHGEF3;GNG2;ITPR3;TAC3;GRM5;PDE1A;RGSL1;CCKBR;ADCY7;PDE8B;APLNR;ADCY2;RAMP3;GLP1R;OBSCN;GRK2;MCF2;DGKG;GNA14;GRM6;KALRN;ARHGEF10L;PRKCE;PRKCH;GNA12;ARHGEF7;GNAZ;PDE1B;P2RY12;TRIO;S1PR3;PLEKHG2;HTR1E;PDE10A
prerank,CellMarker_Augmented_2021__Myofibroblast:Liver,0.6482213338053803,1.4989400933022197,0.0,0.1451438175882604,1.0,21/82,7.61%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;SULF1;COL4A2;NRP2;THY1;PODN;TCEAL7;ANGPTL2;POSTN;SLIT3;FAP;IGFBP7;LDB2;C1R;BOC
prerank,CellMarker_Augmented_2021__Endothelial Stem cell:Blood Vessel,0.8544600156891407,1.4987550564707042,0.03333333333333333,0.14511168530889057,1.0,4/12,6.47%,ICAM1;PTPRC;MCAM;TNFRSF1A
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.7613103184060042,1.4987252279694916,0.06666666666666667,0.14486892078952138,1.0,5/25,5.16%,LEF1;HLA-DRA;DUSP10;SOX4;BCL6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.6443116385002599,1.4986298938084566,0.014492753623188406,0.14473222074804318,1.0,9/65,9.24%,IGF1;KIF14;EGF;TGFA;PLSCR1;NUDT16;CDC14A;CENPV;PRKCE
prerank,KEGG_2021_Human__FoxO signaling pathway,0.6384755018825673,1.498271940437464,0.0,0.14526796959980737,1.0,30/114,18.55%,TGFBR2;IGF1;KLF2;EGF;PLK2;CCNB2;IRS2;FOXO1;AGAP2;BCL6;FOXO3;SMAD3;FBXO32;TGFB2;STAT3;HOMER1;GADD45A;CDKN1B;CDKN1A;CCND1;PIK3CD;MAPK11;CDK2;MAPK9;GABARAPL1;IGF1R;CCNB1;STK11;PRMT1;PLK3
prerank,Reactome_2022__Metallothioneins Bind Metals R-HSA-5661231,-0.8262677652428765,-1.4976062064557172,0.06976744186046512,0.45631076127476805,1.0,5/8,11.72%,MT1E;MT1A;MT1G;MT1F;MT2A
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.8087716989945524,1.4972447202932813,0.05555555555555555,0.146891730900758,1.0,5/13,9.86%,TGFBR2;SLIT3;TBX20;APLNR;TGFB2
prerank,CellMarker_Augmented_2021__Purkinje cell:Brain,0.6275825509086025,1.4969896176210902,0.0,0.14706596097633895,1.0,28/91,20.98%,CNTNAP1;CEP170B;ARHGEF17;CHD3;SBF1;RAI1;AHDC1;DLG5;FAM168A;TRIO;MAPKBP1;KLC2;ZC3H7B;KLC1;PLXNA1;MTCL1;PKD1P6;MAP4;PLEC;ANKRD52;DYNC1LI2;ANO8;SCRIB;DCTN1;MPRIP;TNPO2;PACS2;ARHGAP35
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Oral Mucosa,0.6303603634954462,1.4969176113494176,0.014492753623188406,0.1469262875294177,1.0,20/66,9.54%,GGT5;PRRX1;PDGFRA;DCN;ACTA2;ABCA8;THY1;PODN;SHROOM4;ANGPTL2;POSTN;FAP;IGFBP7;TNS1;LDB2;APLNR;C1R;ADGRF5;BGN;RASL12
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.928144154481626,1.4967915091602366,0.0,0.1469955913189213,1.0,3/8,2.53%,TGFBR2;HLA-DRA;CD55
prerank,KEGG_2021_Human__Gap junction,0.6396386839422495,1.496710036645828,0.0,0.14698140604881563,1.0,16/75,9.11%,HTR2C;PDGFRA;EGF;PRKCB;ADCY5;PRKCG;PRKG2;TUBB1;ITPR3;GRM5;GUCY1A2;ADCY7;ADCY2;PDGFA;GUCY1A1;TUBB6
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.6451026859110733,1.4965554052393903,0.0,0.14713345369589084,1.0,23/89,15.53%,TGFBR2;IGF1;KIF14;ADCY5;PAK3;PRKAR1B;NTRK3;NRG1;GHR;ADCY7;PAK4;ADCY2;CHI3L1;MINK1;TGFB2;GAS6;PRR5;PRKCD;PAK1;TNFRSF10B;PRKAR1A;STK3;PINK1
prerank,Reactome_2022__RHOBTB3 ATPase Cycle R-HSA-9706019,-0.8200262217224953,-1.4964764410180802,0.05128205128205128,0.45803099893304583,1.0,2/8,9.27%,CCNE1;PLIN3
prerank,Reactome_2022__Condensation Of Prophase Chromosomes R-HSA-2299718,-0.7487661250664893,-1.496447631031308,0.0392156862745098,0.4554401178260963,1.0,6/22,8.06%,H2AC20;H3-3B;H2BC4;H2BC21;H2AC6;KMT5A
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.8126910040389974,-1.4963028425491252,0.08163265306122448,0.45355335877264685,1.0,2/9,9.03%,CHAMP1;MIS12
prerank,Reactome_2022__Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,0.6582039767898589,1.4962115830183682,0.0,0.1478240829096166,1.0,12/48,13.20%,GPNMB;SOCS3;EGF;PTK6;ELMO1;KHDRBS2;NRG1;NRG2;RNASE1;STAT3;CDKN1B;CCND1
prerank,Reactome_2022__Repression Of WNT Target Genes R-HSA-4641265,0.8986958009111842,1.496023322621158,0.0,0.14797408274927223,1.0,1/13,0.01%,LEF1
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),-0.8720881587260843,-1.4959693926372533,0.022222222222222223,0.45249219593037426,1.0,2/8,3.73%,DAO;THNSL2
prerank,CellMarker_Augmented_2021__Limbal Mesenchymal cell:Sclerocorneal Tissue,0.638970633464462,1.4958974743851554,0.013888888888888888,0.1478342843806194,1.0,29/74,14.24%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;COL4A2;TIMP2;THY1;PODN;ANGPTL2;POSTN;STK32B;FAP;IGFBP7;TNS1;LDB2;C1R;SH3RF3;BGN;ZCCHC24;ADAM12;LAMA2;SPARC;CCL2;ROBO4;ARMCX1;COL5A1;THBS2
prerank,CellMarker_Augmented_2021__Cartilage Progenitor cell:Cartilage,0.6515895693061083,1.4958708555436049,0.0,0.14759185896295965,1.0,30/95,15.20%,COL4A1;TEAD2;PCDH18;CALD1;COL4A2;SLIT2;DAB2IP;EFNB3;TUSC3;MCAM;FRAS1;LAMB1;COL27A1;PTPN21;MAP1B;ADGRL2;PKDCC;CNN3;YAP1;GLI2;PCDHB15;TEAD1;CRMP1;ENAH;CAP2;COL4A5;IGDCC4;RBFOX2;BCAR1;SMARCA1
prerank,Reactome_2022__Interleukin-2 Family Signaling R-HSA-451927,0.7413016618164272,1.4957487414674138,0.018867924528301886,0.14759735405454572,1.0,7/28,10.55%,IL15;STAT4;CSF2RA;GAB2;STAT3;SYK;INPPL1
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),-0.8363314709347003,-1.4956256513988844,0.0625,0.4518427947523187,1.0,3/12,5.10%,RPP25L;POP5;TRMT10C
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),-0.7294151525708341,-1.495167967410297,0.027777777777777776,0.4512009447507522,1.0,5/24,9.23%,DAO;IDO1;THNSL2;ACMSD;TDO2
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.692003602778432,1.4949583504614508,0.038461538461538464,0.1488770395512361,1.0,5/41,10.04%,LEF1;TBX20;CTNNB1;TGFB2;DLG5
prerank,Reactome_2022__Mitochondrial Translation Elongation R-HSA-5389840,-0.6361431610031786,-1.4947361439498212,0.0851063829787234,0.4507419521516356,1.0,26/73,18.52%,MRPL10;MRPS21;MRPL52;MRPS7;MRPL36;MRPL15;MRPS22;MRPS16;MRPL18;MRPS10;MRPL40;MRPL47;MRPS9;MRPS26;MRPL21;MRPS18B;MRPS34;MRPS33;MRPL19;MRPL50;MRPS5;OXA1L;MRPS31;MRPL3;MRPL17;PTCD3
prerank,Reactome_2022__Recycling Pathway Of L1 R-HSA-437239,0.7503443274907109,1.4946908327863575,0.015873015873015872,0.14900333292098777,1.0,6/27,6.70%,L1CAM;SH3GL2;SHTN1;RPS6KA1;DNM1;DPYSL2
prerank,CellMarker_Augmented_2021__Naive CD8+ T cell:Peripheral Blood,0.6652975562586506,1.4945175042730883,0.015625,0.14919061747842147,1.0,6/74,4.71%,LEF1;TMEM204;RASGRP2;CD55;APBA2;NELL2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),0.7904270326382894,1.4943332783654428,0.015625,0.14917281109110514,1.0,3/21,0.90%,NR4A3;MLIP;IGF1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.6633017007065135,1.4941885176530503,0.015151515151515152,0.14935913781881177,1.0,27/74,21.03%,ENPP2;PROX1;EGF;THBS1;NRP2;EPB41L4B;MAPRE2;PRKCE;TGFB2;RIN2;SPARC;ARF6;FGF2;PIK3CD;BCAR1;ETS1;WNT5A;PRKCA;RAB11A;TEK;HIF1A;RTN4;GLIPR2;RHOB;SCARB1;ADAM9;PPM1F
prerank,Reactome_2022__Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.746020194071779,-1.4940838151858353,0.04878048780487805,0.4516400593945227,1.0,6/30,5.51%,H2AC20;H3-3B;H2BC4;H2BC21;POLR2K;H2AC6
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.8954388401371077,-1.4940549392330136,0.05128205128205128,0.44910261709886923,1.0,2/8,6.59%,APOE;ZNF502
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),0.8562966796159552,1.493744581116501,0.01694915254237288,0.1500948313958193,1.0,3/10,1.69%,HPN;THBS1;SERPINE1
prerank,Reactome_2022__Inwardly Rectifying K+ Channels R-HSA-1296065,0.7709263514522873,1.4936664675808105,0.04918032786885246,0.14995351975816879,1.0,6/24,6.45%,GNG3;KCNJ2;ABCC8;GABBR2;GNG2;ABCC9
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.7625364921569316,1.4934304130089628,0.03278688524590164,0.1502186995677899,1.0,6/25,18.30%,LZTS1;SMCR8;PHF23;MTM1;PINK1;TSC2
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.6109697755060612,1.4928403989039176,0.014084507042253521,0.15147590459334956,1.0,24/124,9.04%,LEF1;COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;SULF1;ITGA8;COL4A2;THY1;PODN;ANGPTL2;POSTN;COL12A1;FAP;TNS1;LDB2;PAWR;PML;C1R;BGN;YAP1
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,0.6735630324203741,1.4927461037883016,0.014492753623188406,0.1515958991637991,1.0,26/65,18.57%,TYMP;ADGRE5;TC2N;ZFP36;PIM3;CD55;RPS6KA1;IRF7;OSTF1;ANO9;DTX2;ABTB1;PRKCD;FRAT2;TFAP2C;IL4R;RHBDF2;IFIH1;HLA-E;ST6GALNAC2;TBC1D10A;VASP;MAP2K3;IFI35;LITAF;SBNO2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",-0.8339751078338663,-1.4925651657563752,0.047619047619047616,0.45314698644059015,1.0,6/13,12.24%,CHAMP1;IK;KNL1;SPDL1;MIS12;CENPA
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.9240450395686824,1.4925469448311894,0.018518518518518517,0.15175586308994687,1.0,1/7,1.16%,PROX1
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.8482633771652028,-1.4924961522423545,0.07894736842105263,0.45062970209716974,1.0,2/8,8.77%,SAMD9;VPS11
prerank,Reactome_2022__RHO GTPases Activate CIT R-HSA-5625900,0.7845385990641618,1.4921024650278676,0.05263157894736842,0.15233860138986913,1.0,6/17,12.36%,KIF14;MYH9;MYH11;PPP1CB;RNASE1;CDKN1B
prerank,CellMarker_Augmented_2021__Liver Stem cell:Fetal Liver,0.6515725443359339,1.491867301550024,0.0,0.15271808018778052,1.0,30/86,15.20%,COL4A1;PCDH18;CALD1;COL4A2;FBLIM1;THY1;ANGPTL2;POSTN;NUAK1;COL12A1;LAMB1;PTPN21;RHBDF1;SCARA3;MYO1B;ADGRL2;SH3PXD2B;BGN;YAP1;GLI2;TEAD1;ENAH;CD276;FN1;PALLD;COL5A1;THBS2;RBFOX2;NOTCH3;SMARCA1
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.8846828656167207,-1.4915754098382812,0.07894736842105263,0.4516787669338974,1.0,3/6,8.94%,RFT1;NPC2;CPTP
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.796089490597544,1.4914942961008282,0.05084745762711865,0.153578373256306,1.0,9/22,10.69%,TESC;SERPINE1;EPHA2;ADA;EFNA1;CYP1B1;TGFB2;SYK;P2RY12
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.7432547001512816,1.4912838233894663,0.046875,0.15367363834376066,1.0,3/20,6.43%,TLR2;IRF7;BIRC3
prerank,Reactome_2022__Signaling By ERBB2 In Cancer R-HSA-1227990,0.7700017217848243,1.4909519028921328,0.06557377049180328,0.15430909662729952,1.0,4/22,7.48%,EGF;ERBIN;NRG1;NRG2
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.6540045800385113,1.4908959589912596,0.0,0.15422290990363616,1.0,18/83,12.05%,RIMS2;PLD1;CD22;RIT2;SYT1;SEPTIN4;SEPTIN5;PTPRC;RAB15;RAB3C;ATP9A;CPLX2;CPLX1;PACSIN1;SYK;LGI3;OPHN1;STX4
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),0.8978148761059419,1.4908709516240526,0.01818181818181818,0.15397741642644544,1.0,1/8,0.62%,ST6GAL1
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.6893871460181601,1.4907603994098542,0.031746031746031744,0.15385226347311975,1.0,10/58,9.86%,LEF1;TGFBR2;HPN;DAB2IP;EFNA1;ZNF750;CTNNB1;LDLRAD4;SMAD3;TGFB2
prerank,"Reactome_2022__Platelet Activation, Signaling And Aggregation R-HSA-76002",0.5744898440817854,1.490519162868342,0.0,0.15420470759980565,1.0,60/192,20.44%,RASGRP2;IGF1;SGPP2;EGF;GNG3;THBS1;SERPINE1;RASGRP1;PLEK;TRPC3;PRKCB;PRKCG;APP;FYN;GNG2;ITPR3;PDGFA;DGKG;GNA14;PRKCE;PRKCH;GNA12;SYTL4;CYRIB;RNASE1;TGFB2;TF;SYK;P2RY12;GAS6;ACTN1;SPARC;STX4;PRKCD;GP6;FN1;PDPN;RAB27B;ABCC4;BCAR1;SERPING1;THPO;TAGLN2;VAV2;SRGN;SHC1;GNAI1;RAP1A;GTPBP2;ITPR1;FLNA;PRKCA;VAV1;DGKI;RHOB;RAP1B;APBB1IP;ACTN4;VEGFD;DGKZ
prerank,KEGG_2021_Human__Glutathione metabolism,0.7254458265674684,1.489954535402724,0.0,0.1552506227876234,1.0,4/40,5.59%,GGT5;GSTT2;PGD;GGCT
prerank,KEGG_2021_Human__HIF-1 signaling pathway,0.6292876502384007,1.4897332737604247,0.0,0.15528244735523014,1.0,36/87,20.20%,IGF1;EGF;SERPINE1;FLT1;PRKCB;PRKCG;ALDOB;HK2;LDHA;PFKL;TF;STAT3;PGK1;ENO2;CAMK2B;CDKN1B;BCL2;HK1;CDKN1A;RPS6KB2;PDK1;PIK3CD;PFKFB3;ANGPT2;IGF1R;ENO3;TFRC;CAMK2A;PRKCA;TEK;HIF1A;ARNT;EGLN3;IL6R;AKT3;PFKP
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.6220643654931567,1.4897261662696222,0.0,0.15501746024370244,1.0,25/106,13.18%,TGFBR2;FLRT3;PKP2;FGF12;SOX4;TBX19;NTRK3;ECE1;CACNA1C;APLNR;ALPK2;ZFPM2;SYNPO2L;SH3PXD2B;PDLIM4;TGFB2;GLI2;TCAP;IFT122;HDAC9;CDKN1B;FN1;SMYD4;MEF2D;CDKN1A
prerank,Reactome_2022__Signaling By MET R-HSA-6806834,0.6414946074861105,1.4896562403566709,0.017857142857142856,0.15493109454806164,1.0,13/58,13.05%,HPN;SH3GL2;SH3GL3;SH3KBP1;LAMB1;ITGA2;LAMA5;ITGA3;RNASE1;STAT3;LAMA2;ARF6;LRIG1
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),0.901237583112535,1.4896127699878252,0.0,0.1548450226132904,1.0,3/6,7.95%,HRH1;GABRB2;GABRG2
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7602133063928417,1.4894598430182104,0.015873015873015872,0.1547986018553972,1.0,13/38,11.71%,GRIK1;NLGN1;SYT1;RELN;CACNG3;SHANK3;GRM5;CACNG8;GRM6;CACNG4;HOMER1;OPHN1;CCL2
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Eye,0.633524132693293,1.4894111519790165,0.015384615384615385,0.15437281301371938,1.0,32/98,15.20%,COL4A1;TEAD2;PCDH18;COL4A2;SLIT2;DAB2IP;ANGPTL2;ARHGEF17;NUAK1;LAMB1;PTPN21;RHBDF1;MAP1B;SCARA3;ADGRL2;SH3PXD2B;PKDCC;YAP1;EPB41L1;GLI2;PCDHB15;TEAD1;CRMP1;ENAH;CD276;MEIS3;MMP16;CAP2;IGDCC4;RBFOX2;BCAR1;SMARCA1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Spinal Cord,0.633524132693293,1.4894111519790165,0.015384615384615385,0.15437281301371938,1.0,32/98,15.20%,COL4A1;TEAD2;PCDH18;COL4A2;SLIT2;DAB2IP;ANGPTL2;ARHGEF17;NUAK1;LAMB1;PTPN21;RHBDF1;MAP1B;SCARA3;ADGRL2;SH3PXD2B;PKDCC;YAP1;EPB41L1;GLI2;PCDHB15;TEAD1;CRMP1;ENAH;CD276;MEIS3;MMP16;CAP2;IGDCC4;RBFOX2;BCAR1;SMARCA1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.7920387208705879,1.48935912117549,0.03508771929824561,0.15422952650176214,1.0,7/17,16.84%,RIMS2;SYT4;SYT1;CPNE9;RASAL1;SMURF1;SYT17
prerank,Reactome_2022__Gene Silencing By RNA R-HSA-211000,-0.6020235939372605,-1.4892145860162374,0.06451612903225806,0.45898970441471687,1.0,8/80,5.51%,H2AC20;H3-3B;H2BC4;H2BC21;POLR2K;AAAS;NUP50;H2AC6
prerank,Reactome_2022__Phase 0 - Rapid Depolarisation R-HSA-5576892,0.7456575999589957,1.4889188384290357,0.046875,0.15473176471436914,1.0,12/26,12.22%,SCN1B;SCN9A;SCN3B;SCN1A;SCN2A;FGF12;CACNA1C;CACNG8;CACNG4;SCN3A;FGF13;CAMK2B
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.6295133345750176,1.4888708837859181,0.0,0.15468592537345982,1.0,27/92,11.60%,ENPP2;CA10;GRIN2A;RGS7BP;OPALIN;PLP1;OPCML;RTN1;TGFA;IGSF21;SYNPR;KCND3;FAM107A;TMEM132C;GRM5;TNS1;PID1;APLNR;MAOB;GRIA3;GFAP;RAMP3;CHI3L1;RNASE1;P2RY12;TCEAL6;PDK4
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.8146532629370684,1.4880128298003754,0.0,0.15641301182643816,1.0,5/16,6.12%,DUSP1;DUSP10;DUSP8;DUSP16;PDP1
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),0.8027782154426315,1.4875759739306622,0.03278688524590164,0.15698685171465065,1.0,5/18,1.85%,SLC24A2;GRIN2A;PLK2;GRIN2D;GRIN2B
prerank,Reactome_2022__Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,0.7650342300951671,1.48740590944211,0.0,0.1570927913155657,1.0,6/23,10.41%,CD22;SH3KBP1;FYN;ITPR3;ORAI1;SYK
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),-0.96394181100325,-1.4870212765945654,0.0,0.4662194092568607,1.0,1/6,0.06%,SLC2A5
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.7926498951236043,1.4868728916899687,0.09259259259259259,0.15805124079215815,1.0,4/15,7.52%,IGF1;PIM1;TBX20;ZFPM2
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),0.7115520158548225,1.48684657773185,0.0,0.1578260841285847,1.0,16/47,15.01%,LEF1;TGFBR2;IL15;EPHA2;MYH9;PML;PIR;GAB2;PPARG;PDE1B;HLA-DRB1;CDKN1A;PIK3CD;GPR183;RARA;CD4
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),0.9559068245397231,1.4867247138020279,0.0,0.15775622731596775,1.0,1/6,0.01%,LEF1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In2:Brain,0.6229651919258775,1.4866936996366318,0.0,0.1575323107968258,1.0,26/100,11.20%,TTLL7;SLC24A2;IL1RAPL1;RIMS2;GRIN2B;ATRNL1;GRID2;SYT16;SCN3B;SCN1A;CNTNAP5;CDH8;GAD2;FGF12;SRRM4;SYNPR;SLCO1A2;GABRA1;ST8SIA3;MAP1B;GABRG2;LRRTM4;HCN1;FBXL2;HOMER1;FGF13
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.7268551637315457,1.4866224997281352,0.03225806451612903,0.15752093751564492,1.0,8/32,13.18%,CDKN2A;GPNMB;FAM107A;CDK6;GFI1B;CCL2;KLF4;CDKN1A
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.7974069285329094,1.4865355394123856,0.014925373134328358,0.1573365989768517,1.0,7/27,6.72%,THBS1;SLIT2;SEMA3C;SEMA5B;SEMA3D;SEMA3B;ROBO2
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),0.8534483061400465,1.4864670478165125,0.0,0.15724882447010619,1.0,3/10,11.00%,CACNA1H;ADAM12;ERVW-1
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.8507289363997173,1.4862368576028253,0.0,0.15750620226554016,1.0,2/14,0.90%,CACNA1H;IGF1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.6046553570990773,1.4861370957616893,0.0,0.15762883888410653,1.0,30/124,10.74%,SLITRK1;CCK;FLRT3;ANK3;NLGN1;CNTNAP1;CNTN4;SHTN1;SLITRK5;APP;PLPPR4;DAB2IP;CNTNAP2;PAK3;SHANK3;NYAP2;BAIAP2;DVL1;PARD3;DOCK10;FLRT1;MAP1B;DCC;SHANK1;NYAP1;CTNNB1;MINK1;PACSIN1;SLITRK4;TRIO
prerank,KEGG_2021_Human__Cholinergic synapse,0.6302617899692363,1.485997997861059,0.028985507246376812,0.15778926318978093,1.0,17/92,7.19%,CHRM3;GNG3;KCNJ2;CREB5;CHRM1;PRKCB;ADCY5;KCNQ1;PRKCG;ACHE;FYN;KCNQ5;GNG2;ITPR3;ADCY7;CACNA1C;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.7891148664705769,1.4858914641303569,0.0,0.15773945057962377,1.0,7/18,16.46%,IL1RAPL1;RELN;PTPRD;CDKL5;CAMK2B;SS18L1;CUX2
prerank,KEGG_2021_Human__Th17 cell differentiation,0.6533587956330011,1.4855820367822905,0.0,0.15805143176040462,1.0,20/69,17.07%,TGFBR2;HLA-DRA;IL27RA;IL1R1;NFATC2;AHR;SMAD3;STAT3;TYK2;HLA-DRB1;IL4R;HLA-DMA;IKBKG;MAPK11;RARA;CD4;STAT6;RXRA;RORA;MAPK9
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),0.8164893454741786,1.4851943721615688,0.0,0.15879943528499327,1.0,6/17,8.75%,MRAP2;PID1;MRAP;TMBIM1;BCL2L1;PKDCC
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.7574531065524458,-1.4851914242820168,0.02857142857142857,0.47114742754978584,1.0,3/23,9.03%,SGO2;CHAMP1;MIS12
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Adipose Tissue,0.6660945420387809,1.4846625865195247,0.038461538461538464,0.15971572815467738,1.0,22/58,9.78%,GGT5;ADAMTS4;DCN;ABCA8;FLT1;PTPRB;DYSF;PODN;ACKR1;SHROOM4;PCDH12;MYH11;MCAM;FAM107A;IGFBP7;CFH;TNS1;APLNR;RAMP3;ADGRF5;BGN;RNASE1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.9047155188357179,1.4846237436102592,0.0,0.1595305142175347,1.0,4/9,2.54%,ANXA1;MSMP;PTPRO;FLT1
prerank,CellMarker_Augmented_2021__HES1High Progenitor cell:Stomach,0.645659296428107,1.4845629381790375,0.014084507042253521,0.15942154045412393,1.0,31/84,14.90%,ECM2;PRRX1;ALS2CL;DCN;PTPRB;PLXDC1;ASPN;PODN;MYH11;OSMR;POSTN;SLIT3;COL12A1;APOD;FAP;LPP;OLFML2A;C1R;MATN2;ADGRF5;PDZD2;FBXO32;OMD;LAMA2;NPAS2;BACE2;ROBO4;KIAA1755;THBS2;NTN4;LAMA3
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),-0.8454110958416109,-1.4838180559424563,0.0,0.4756460779554449,1.0,1/17,0.09%,NGF
prerank,GO_Biological_Process_2021__somite development (GO:0061053),-0.8128405565494286,-1.4837257075139927,0.09302325581395349,0.4735444703811644,1.0,2/8,7.09%,MEOX2;SFRP2
prerank,Reactome_2022__GAB1 Signalosome R-HSA-180292,0.8472041555134809,1.483596567792757,0.03773584905660377,0.1615594245190057,1.0,3/12,10.22%,EGF;TGFA;PAG1
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.6518355533490354,1.4834986023026926,0.03333333333333333,0.1615228960171375,1.0,23/81,14.57%,RASGRP2;THBS1;NLGN1;SYT4;TRPC3;DMTN;SYT1;SYT5;KCNMB4;CLIC4;HPCA;ITPR3;NEUROD2;ITPKB;RYR2;SYT13;CPNE2;HOMER1;SYT12;ANXA11;IQGAP1;KCNMA1;CPNE9
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.8682391850563149,1.4832943032575203,0.03571428571428571,0.16178755623523225,1.0,4/8,9.38%,THBS1;DMTN;PRKCE;ARHGEF7
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.6952692058795144,1.4829305390885938,0.03333333333333333,0.16223922241138564,1.0,11/37,13.63%,ADAMTS4;CTSS;TIMP2;TLL1;CD44;CAPN1;SH3PXD2B;SCUBE3;MMP14;MMP16;WASHC1
prerank,CellMarker_Augmented_2021__Epithelial cell:Corneal Epithelium,0.6556162582935123,1.482847345558961,0.04225352112676056,0.16210799130326184,1.0,14/73,8.40%,TGFBR2;FOSB;KLF2;CTSS;ADGRE5;SP100;ZFP36;DUSP1;TNFRSF14;BIRC3;CD44;NLRC5;MVP;CSRNP1
prerank,Reactome_2022__SHC-mediated cascade:FGFR1 R-HSA-5654688,-0.8141930634084071,-1.4827726476138916,0.06976744186046512,0.4747234506868152,1.0,1/12,0.15%,FGF6
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.9251991411665861,1.4827661697659302,0.019230769230769232,0.16195845851914517,1.0,3/6,6.64%,CCBE1;PROX1;TBX20
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Small Intestine,0.630436127265053,1.4827643422938477,0.0,0.161697235198953,1.0,27/83,14.56%,COL4A1;PRRX1;PCDH18;DCN;CALD1;SULF1;COL4A2;ANGPTL2;POSTN;COL12A1;LAMB1;FAP;PTPN21;SCARA3;BGN;YAP1;TANC1;TEAD1;CLDN18;ENAH;PARD3B;FN1;HMCN1;PALLD;COL5A1;THBS2;RBFOX2
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),-0.8599030484073009,-1.4826237030989768,0.11428571428571428,0.47264955036884376,1.0,1/7,1.84%,AGER
prerank,KEGG_2021_Human__Viral myocarditis,0.7063879617746063,1.4822785118001651,0.016129032258064516,0.16250077971615728,1.0,10/37,14.71%,HLA-DRA;CD55;ICAM1;FYN;LAMA2;HLA-DRB1;ITGAL;CCND1;HLA-DMA;HLA-E
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),-0.7795238996851517,-1.482253383889359,0.047619047619047616,0.47206652895529294,1.0,6/16,16.23%,COX18;COX20;COX19;COA6;SMIM20;OXA1L
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periosteum,0.6401094571390926,1.4818811834179906,0.014705882352941176,0.16302220995060915,1.0,37/91,18.13%,COL4A1;EDIL3;SERPINE1;CALD1;COL4A2;APP;THY1;OSMR;POSTN;COL12A1;FAP;LARP6;SCARA3;MYO1B;KITLG;ITGA3;BGN;CNN3;YAP1;RGMB;PXDC1;GLIS3;PRICKLE2;STARD13;PAM;FN1;LPAR1;PALLD;THBS2;NTN4;RGS4;TNFRSF11B;FSTL1;FAM114A1;WWTR1;SRPX2;DKK3
prerank,Reactome_2022__Axon Guidance R-HSA-422475,0.5445403489493784,1.4817664414350462,0.0,0.1629651970874689,1.0,78/463,11.44%,CACNA1H;COL4A1;L1CAM;SCN1B;SCN9A;FLRT3;ANK3;CACNA1G;EPHA7;SH3GL2;GRIN2B;CD24;CNTN2;ARHGAP39;CNTNAP1;TRPC3;COL4A2;SHTN1;GAP43;EPHA2;SCN3B;SLIT2;RELN;IRS2;RPS6KA1;SCN1A;DOK6;NRP2;MYH9;EPHA5;EFNA1;EFNB3;SCN2A;AGAP2;SH3KBP1;MYH11;PTPRC;VLDLR;SHANK3;NELL2;FYN;SLIT3;UNC5D;GFRA2;LAMB1;ITGA2;DNM1;RAP1GAP;CLTB;AGRN;LDB2;DPYSL2;ROBO2;CACNA1C;EIF4A3;PAK4;DCC;RPL39L;KALRN;LIMK2;ARPC3;GAB2;KCNQ2;ARHGEF7;RPL3;RNASE1;ITGA9;COL9A1;RGMB;GPRIN1;ST8SIA4;EPHA4;TRIO;DCX;SCN3A;COL4A4;CRMP1;ENAH
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.6043835409929346,1.4816383738437164,0.0,0.16296409387928668,1.0,32/127,9.94%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;OGN;ACTA2;CALD1;ABCA8;SULF1;ITGA8;COL4A2;NRP2;THY1;PODN;ANGPTL2;MYH11;POSTN;FAS;SLIT3;COL12A1;GJC1;SLC38A11;TNS1;LDB2;NEXN;C1R;OBSCN;MAP3K7CL;BGN;RASL12;ITGA9
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),0.9642524898381826,1.4815876868022861,0.018518518518518517,0.16298154012081992,1.0,1/5,0.15%,NR4A3
prerank,KEGG_2021_Human__AGE-RAGE signaling pathway in diabetic complications,0.6536384975555972,1.481383308353437,0.0,0.1632396424375015,1.0,23/82,14.73%,TGFBR2;COL4A1;SERPINE1;COL4A2;PRKCB;ICAM1;PIM1;FOXO1;SMAD3;PRKCE;TGFB2;STAT3;COL4A4;CCL2;PRKCD;CDKN1B;BCL2;FN1;CCND1;COL4A5;PIK3CD;MAPK11;NOX4
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.7707035356789433,1.4810828925961725,0.016666666666666666,0.16379270965029163,1.0,11/22,15.19%,MYRF;TLR2;PRDM8;APP;SOX4;EIF2B2;CDK6;TPPP;PICK1;SOX10;EIF2B5
prerank,CellMarker_Augmented_2021__Fibroblast:Peripheral Blood,0.6525629155861818,1.4805052096320657,0.0,0.1650638511499482,1.0,19/75,8.95%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;CALD1;SULF1;COL4A2;THY1;ANGPTL2;POSTN;SLIT3;COL12A1;LAMB1;FAP;GLT8D2;C1R;BOC;BGN
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.840930993876835,-1.4803975274598835,0.11904761904761904,0.47737322092584633,1.0,2/6,14.17%,RAE1;LDB1
prerank,GO_Biological_Process_2021__dorsal aorta morphogenesis (GO:0035912),-0.888141583648996,-1.4801991776133279,0.038461538461538464,0.47316472552323774,1.0,2/5,8.80%,HEY2;HEY1
prerank,GO_Biological_Process_2021__dorsal aorta development (GO:0035907),-0.888141583648996,-1.4801991776133279,0.038461538461538464,0.47316472552323774,1.0,2/5,8.80%,HEY2;HEY1
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.6162532671996006,1.4798874699387181,0.014084507042253521,0.16625723894273253,1.0,34/94,17.27%,C1QL1;FLRT3;NPNT;SLC7A2;SHC2;DAB2IP;ABCC8;EFNB3;PRR36;EPB41L4B;PRIMA1;CKMT1B;CTNNB1;ASS1;PCLO;C2CD4C;YAP1;ATP1B1;CACNG4;EPB41L1;TEAD1;ENAH;INPP5J;CD276;COBL;CAMSAP3;BCAR1;SLC44A3;SEZ6L2;RGS16;TOX3;HS6ST2;MAPK4;MAGI1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.5592888153999849,1.4796426903381072,0.0,0.16660049664066895,1.0,34/231,14.40%,LEF1;BOK;TEAD2;CTSC;BLM;DMTN;WAS;ADD2;TGFA;WASF1;FAS;PARD3;REPS2;TNFRSF1A;TMED10;PML;SLC9A1;SHANK1;CTNNB1;SH3PXD2B;GRIA1;YAP1;TCAP;PEX14;TEAD1;TLE3;GSDMD;FN1;FADD;ANKRD28;STOML2;RSPH4A;BCL9;IKBKG
prerank,Reactome_2022__Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.684752619685822,-1.4796360710702758,0.023809523809523808,0.4732701624814648,1.0,1/24,0.15%,FGF6
prerank,CellMarker_Augmented_2021__Stem cell:Ovarian Cortex,0.6762133313139628,1.479547419197536,0.0,0.1665936444988957,1.0,13/43,11.20%,SHISA9;DRAXIN;GRID2;ZDHHC22;CNTNAP2;PTCHD1;SLCO1A2;CHST6;ADCY2;TSSC2;COL9A1;NR6A1;FGF13
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Pancreas,0.6538633945473818,1.4795342288368274,0.0,0.16478398256811763,1.0,27/89,11.98%,COL4A1;PRRX1;EDIL3;PDGFRA;PCDH18;DCN;SULF1;COL4A2;GAP43;PLPPR4;THY1;OPCML;TCEAL7;ANGPTL2;POSTN;SLIT3;LDB2;MAP1B;SCARA3;BOC;BGN;RASL12;NACAD;CRMP1;SPARC;RUNX1T1;PRICKLE2
prerank,CellMarker_Augmented_2021__Retinal Ganglion cell:Embryonic Stem Cell,0.6538633945473818,1.4795342288368274,0.0,0.16478398256811763,1.0,27/89,11.98%,COL4A1;PRRX1;EDIL3;PDGFRA;PCDH18;DCN;SULF1;COL4A2;GAP43;PLPPR4;THY1;OPCML;TCEAL7;ANGPTL2;POSTN;SLIT3;LDB2;MAP1B;SCARA3;BOC;BGN;RASL12;NACAD;CRMP1;SPARC;RUNX1T1;PRICKLE2
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Blood Vessel,0.6538633945473818,1.4795342288368274,0.0,0.16478398256811763,1.0,27/89,11.98%,COL4A1;PRRX1;EDIL3;PDGFRA;PCDH18;DCN;SULF1;COL4A2;GAP43;PLPPR4;THY1;OPCML;TCEAL7;ANGPTL2;POSTN;SLIT3;LDB2;MAP1B;SCARA3;BOC;BGN;RASL12;NACAD;CRMP1;SPARC;RUNX1T1;PRICKLE2
prerank,CellMarker_Augmented_2021__Fibroblast:Synovium,0.6538633945473818,1.4795342288368274,0.0,0.16478398256811763,1.0,27/89,11.98%,COL4A1;PRRX1;EDIL3;PDGFRA;PCDH18;DCN;SULF1;COL4A2;GAP43;PLPPR4;THY1;OPCML;TCEAL7;ANGPTL2;POSTN;SLIT3;LDB2;MAP1B;SCARA3;BOC;BGN;RASL12;NACAD;CRMP1;SPARC;RUNX1T1;PRICKLE2
prerank,CellMarker_Augmented_2021__Testis Somatic cell:Testis,0.6538633945473818,1.4795342288368274,0.0,0.16478398256811763,1.0,27/89,11.98%,COL4A1;PRRX1;EDIL3;PDGFRA;PCDH18;DCN;SULF1;COL4A2;GAP43;PLPPR4;THY1;OPCML;TCEAL7;ANGPTL2;POSTN;SLIT3;LDB2;MAP1B;SCARA3;BOC;BGN;RASL12;NACAD;CRMP1;SPARC;RUNX1T1;PRICKLE2
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Embryo,0.6538633945473818,1.4795342288368274,0.0,0.16478398256811763,1.0,27/89,11.98%,COL4A1;PRRX1;EDIL3;PDGFRA;PCDH18;DCN;SULF1;COL4A2;GAP43;PLPPR4;THY1;OPCML;TCEAL7;ANGPTL2;POSTN;SLIT3;LDB2;MAP1B;SCARA3;BOC;BGN;RASL12;NACAD;CRMP1;SPARC;RUNX1T1;PRICKLE2
prerank,CellMarker_Augmented_2021__Fibroblast:Embryonic Stem Cell,0.6538633945473818,1.4795342288368274,0.0,0.16478398256811763,1.0,27/89,11.98%,COL4A1;PRRX1;EDIL3;PDGFRA;PCDH18;DCN;SULF1;COL4A2;GAP43;PLPPR4;THY1;OPCML;TCEAL7;ANGPTL2;POSTN;SLIT3;LDB2;MAP1B;SCARA3;BOC;BGN;RASL12;NACAD;CRMP1;SPARC;RUNX1T1;PRICKLE2
prerank,Reactome_2022__Long-term Potentiation R-HSA-9620244,0.7645136243104512,1.479126712273741,0.04918032786885246,0.16526982795672682,1.0,9/23,12.22%,GRIN2A;GRIN2D;GRIN2B;NEFL;NRGN;NRG1;GRIA1;GPRIN1;CAMK2B
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.745570265872802,-1.479024514358812,0.02564102564102564,0.473414221344083,1.0,9/28,13.05%,LSM7;EXOSC8;LSM3;LSM2;EXOSC4;LSM5;EXOSC5;LSM4;CNOT7
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.9233475948872796,1.4788256554726855,0.08888888888888889,0.1656817100806476,1.0,1/5,2.35%,ZFP36
prerank,CellMarker_Augmented_2021__Gonadal Endothelial cell:Fetal Gonad,0.5390685497627945,1.4783871560553195,0.0,0.16659863093485805,1.0,119/401,18.03%,GGT5;CLIC1;TGFBR2;TMEM204;ST6GAL1;SOCS3;EDIL3;CREB5;ITM2A;RAPGEF5;SP100;CD24;PIM3;ITGA8;FBLIM1;LMO2;IGF2BP2;EPHA2;TRAF3IP2;APP;MAP3K11;DAB2IP;NRP2;THY1;ITPRIP;EFNA1;RBMS1;ICA1;PIEZO2;EGFL7;SHANK3;DENND3;SMAGP;CHST15;PMEPA1;NEDD9;ARHGEF3;LAMB1;CHPF2;TNFRSF1A;LDB2;FAM107B;TNFAIP8L1;CDC42EP1;LIMCH1;MYO1B;FKBP5;TUBB6;PLD2;ETV6;ARHGEF7;CRIP2;FSCN1;ITGA9;ZDHHC7;PIP4K2A;TP53I3;PXDC1;ZCCHC24;CPNE2;SMAD1;TFPI;DIP2B;PHLDB2;PXN;ARMCX2;PDK4;SLC27A3;PRR5;DOCK4;RGL1;TBC1D1;KLF6;FMNL3;ZNF667;ANXA11;FN1;MMP16;KLF4;CCND1;CKS1B;GAB1;ELF1;MAML2;MAN1A1;HIPK2;SMTN;HLA-E;PLXNA2;ETS1;TP53;CTDSPL;TAGLN2;PIP5K1C;PGM2L1;CD200;ZEB1;FSTL1;B4GALT6;HAPLN3;TAB1;DIMT1;ANKRD6;KIF3C;GRAMD1A;HMGA1;CDYL;SH2D3C;SHC1;WWTR1;ABCG1;TP53I11;HDAC7;GTPBP2;PIGK;TPST2;DOCK9;SH3TC1;MIDN
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),-0.8779478752190458,-1.4783798928729948,0.0425531914893617,0.47367533674441104,1.0,5/9,9.03%,CHAMP1;IK;KNL1;SPDL1;MIS12
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.8688399146004351,1.478000240630407,0.01694915254237288,0.16745853085343618,1.0,3/11,7.32%,NR4A3;WNT8B;UGDH
prerank,KEGG_2021_Human__Glycosphingolipid biosynthesis,0.7615556397798838,1.4778215240503652,0.034482758620689655,0.1676307396573035,1.0,7/32,9.64%,ABO;A4GALT;B3GNT2;B3GALT2;ST8SIA1;B4GALNT1;B3GALNT1
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryo,0.7366670700009152,1.4777094635591566,0.03076923076923077,0.1676224260789253,1.0,8/31,9.78%,HLA-DRA;P2RY13;SLA;GPR34;SIGLEC1;PCDH12;RAMP3;RNASE1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.9049037340669841,1.4775484297694532,0.017543859649122806,0.1677399342443419,1.0,2/6,2.53%,TGFBR2;CD55
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),0.9542847367550604,1.477406032166965,0.018867924528301886,0.16780324950681982,1.0,4/5,4.49%,ANK3;MLLT11;DCN;TRPM4
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.7015446891932658,1.4770050376090234,0.03773584905660377,0.16822467506696676,1.0,1/37,0.01%,LEF1
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Lung,0.6797391490862119,1.4766422618392472,0.0625,0.16871635054609987,1.0,12/36,11.18%,C3;SFTPD;IL1R1;CP;CD44;CAPN8;MVP;ADGRF5;STAT3;SLCO2A1;DUOXA1;CLDN18
prerank,Reactome_2022__Signaling By ERBB2 KD Mutants R-HSA-9664565,0.771479217884024,1.476363297128656,0.06557377049180328,0.1691529305708019,1.0,4/21,7.48%,EGF;ERBIN;NRG1;NRG2
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.7017684339080318,1.4761585864563627,0.04054054054054054,0.16933851066437908,1.0,14/42,15.68%,YWHAH;STMN2;GRIN2B;PTPRO;RTN4RL1;FYN;DCC;MAG;PTPN9;EPHA4;CRMP1;LPAR1;STX1B;PTPRS
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.6248087156511003,1.4761190933616457,0.0,0.16922083184192493,1.0,21/93,11.74%,COL4A1;PCDH18;CALD1;PPFIBP1;COL4A2;SLIT2;THY1;MCAM;SLIT3;LAMB1;GJC1;PTPN21;GUCY1A2;LARP6;MAP1B;LIMCH1;ADGRL2;GLI2;ENAH;PDE10A;RUNX1T1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),0.8804234152517364,1.4760246126148737,0.03278688524590164,0.1691035139974537,1.0,1/9,0.25%,HPN
prerank,Reactome_2022__G Alpha (12/13) Signaling Events R-HSA-416482,0.6417349532410852,1.4759081327331363,0.0136986301369863,0.16911081029276787,1.0,23/64,22.22%,GNG3;ARHGEF17;ARHGEF3;GNG2;OBSCN;MCF2;KALRN;ARHGEF10L;GNA12;ARHGEF7;TRIO;PLEKHG2;NGEF;VAV2;MCF2L;ARHGEF40;ADRA1D;VAV1;RHOB;ARHGEF6;PREX1;ARHGEF18;GNG4
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.8280889331277614,-1.4758881795100058,0.06976744186046512,0.4825042611500629,1.0,3/9,6.81%,PGP;ACMSD;MST1
prerank,Reactome_2022__Hemostasis R-HSA-109582,0.5388197196848015,1.4757163810860534,0.0,0.16927759619712163,1.0,123/405,20.25%,L1CAM;RASGRP2;IGF1;MAFF;SGPP2;EGF;GNG3;S100A10;THBS1;SERPINE1;RASGRP1;PLEK;TRPC3;PRKCB;PRKCG;APP;ATP2B3;KCNMB4;PRKG2;PRKAR1B;FYN;GNG2;ITGA2;ITPR3;PDE1A;CD44;GUCY1A2;DOCK10;SLC7A7;ZFPM2;PDGFA;MAG;DGKG;KIF5A;KIF5C;GNA14;ITPK1;ITGA3;GUCY1A1;PRKCE;PRKCH;GNA12;AK3;ATP1B1;SYTL4;CYRIB;RNASE1;TGFB2;ORAI1;TF;ATP1B3;SYK;PDE1B;P2RY12;TFPI;GAS6;ACTN1;GUCY1B1;KIF13B;SPARC;PDE10A;DOCK4;ITGAL;STX4;PRKCD;GP6;KLC1;FN1;PDPN;PICK1;DEAF1;GYPE;KIFC2;TNFRSF10B;KCNMA1;RAB27B;CD99;ABCC4;SERPIND1;INPP5D;BCAR1;SERPING1;PRKAR1A;THPO;SH2B2;TP53;TAGLN2;ANGPT2;VAV2;P2RX7;ATP2B4;CDK2;SLC8A2;KIF3C;SLC8A1;SRGN;SHC1;CD99L2;GNAI1;RAP1A;GTPBP2;DOCK9;ITPR1;FLNA;F3;SLC7A8;PRKCA;VAV1;CXADR;ZFPM1;TEK;KIF19;DGKI;IRAG1;RCOR1;DOCK3;RHOB;RAP1B;AKAP10;APBB1IP;ACTN4;VEGFD;PHF21A
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.8120773063260822,1.4757080428727536,0.05357142857142857,0.16903685360698226,1.0,4/15,7.82%,CCBE1;DCN;DAB2IP;MYO1C
prerank,Reactome_2022__RHO GTPases Activate PAKs R-HSA-5627123,0.7846886980391933,1.475675399279793,0.01639344262295082,0.16886752303483626,1.0,5/20,9.78%,MYH9;MYH11;ARHGEF7;PPP1CB;RNASE1
prerank,CellMarker_Augmented_2021__Fibroblast:Lung,0.9092207121036086,1.4756522982946918,0.041666666666666664,0.16864578007635353,1.0,4/8,3.51%,PDGFRA;ADGRE5;ACTA2;THY1
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.7543832718736792,1.4756054309311335,0.015384615384615385,0.16849517432841837,1.0,12/26,18.09%,RIMS2;NLGN1;RELN;APP;SHANK3;GRIN1;SHANK1;STX1B;NLGN4X;SLC8A2;CUX2;MTMR2
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.7109787234359296,1.4754367679147409,0.03773584905660377,0.16853850546623453,1.0,11/30,9.88%,SCN1B;SCN3B;KCNQ1;STAC2;PVALEF;DTNA;KCNH2;RYR2;GRK2;ATP1B1;TCAP
prerank,Reactome_2022__Activation Of GABAB Receptors R-HSA-991365,0.7415776666404832,1.4747964003815497,0.016129032258064516,0.16981107495804024,1.0,7/30,7.19%,GNG3;KCNJ2;ADCY5;GABBR2;GNG2;ADCY7;ADCY2
prerank,Reactome_2022__Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,0.6527449157519548,1.4744419325518796,0.0136986301369863,0.17039589569710561,1.0,13/79,8.14%,SLC6A15;SLC32A1;SLC4A10;SLC15A3;SLC7A2;SLC43A1;SLC16A10;SLC9A9;SLC20A2;SLC7A7;SLC17A5;SLC9A1;SLC4A9
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR4 R-HSA-5654228,-0.9033060922985476,-1.4740601030631217,0.022727272727272728,0.48772211835067836,1.0,1/6,0.15%,FGF6
prerank,Reactome_2022__Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.6291297473912957,-1.474018395783305,0.06060606060606061,0.4854933567365017,1.0,4/36,5.98%,SLC25A5;AAAS;NUP50;SLC25A4
prerank,CellMarker_Augmented_2021__1-Cell Stage Cell (Blastomere):Embryo,-0.6707860786001851,-1.473716272597697,0.075,0.4844874262985432,1.0,1/34,0.17%,FTL
prerank,Reactome_2022__FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.7106521772858306,-1.4737132524817749,0.05128205128205128,0.4820280992614948,1.0,2/24,4.07%,FGF6;POLR2K
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.8208511886150069,1.4736620191439453,0.018518518518518517,0.17218709579383681,1.0,3/15,7.08%,SIX3;ACTA2;POF1B
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),0.9108053528054749,1.4733777637818202,0.01694915254237288,0.17276656862594303,1.0,1/6,2.41%,SULF1
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.8992584218352606,1.4733689129335874,0.0,0.17255874788850567,1.0,6/13,6.38%,SHISA7;SHISA9;SLC4A10;GRIK2;SHISA8;SYP
prerank,GO_Biological_Process_2021__response to interleukin-4 (GO:0070670),0.9927895116688905,1.4732796907633263,0.0,0.1725781470563326,1.0,1/5,0.01%,LEF1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.8611300606363836,1.4732550081518614,0.017241379310344827,0.17240604172783838,1.0,6/11,11.94%,ITM2A;NECAB1;SOAT1;NECAB2;ABCA2;BACE2
prerank,CellMarker_Augmented_2021__Theca Interna cell:Ovarian Follicle,0.6643299468389593,1.4731664196558458,0.017857142857142856,0.1723213430094434,1.0,25/71,9.87%,ECM2;PRRX1;IGF1;PDGFRA;DCN;OGN;ACTA2;ABCA8;ITGA8;ASPN;PODN;ANGPTL2;MYH11;POSTN;OLFML1;SLIT3;TNS1;SERPINF1;LDB2;RAMP3;C1R;ADGRF5;BGN;RASL12;OMD
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.8815701251230582,1.4731494195356345,0.03076923076923077,0.1720807290223871,1.0,1/10,0.15%,NR4A3
prerank,CellMarker_Augmented_2021__Muscle cell:Embryoid Body,0.6558877578012043,1.472814250413952,0.0,0.17267248994034484,1.0,23/74,11.74%,KCNT2;COL4A1;PDGFRA;PCDH18;RCAN2;COL4A2;ADCY5;SLIT2;THY1;TCEAL7;ANGPTL2;COL21A1;SEMA5B;CCDC3;LDB2;APLNR;ADGRL2;PTPRD;PKDCC;RASL12;SORBS1;FAM13C;RUNX1T1
prerank,KEGG_2021_Human__Epithelial cell signaling in Helicobacter pylori infection,0.7000771285240139,1.4725080691444654,0.0,0.17340088679175153,1.0,5/57,4.63%,CXCL2;MET;NOD1;IGSF5;MAP3K14
prerank,Reactome_2022__p75NTR Negatively Regulates Cell Cycle Via SC1 R-HSA-193670,-0.928378018255885,-1.472303472156351,0.044444444444444446,0.4856867329378146,1.0,2/5,5.99%,NGF;PRDM4
prerank,CellMarker_Augmented_2021__Macrophage:Eye,0.7748486828409056,1.4722574789121223,0.01639344262295082,0.17246196174323652,1.0,7/31,8.28%,TLR2;TYMP;CTSS;SIGLEC1;TNFRSF14;SLC7A7;MVP
prerank,CellMarker_Augmented_2021__Macrophage:Lymph Node,0.7748486828409056,1.4722574789121223,0.01639344262295082,0.17246196174323652,1.0,7/31,8.28%,TLR2;TYMP;CTSS;SIGLEC1;TNFRSF14;SLC7A7;MVP
prerank,CellMarker_Augmented_2021__Macrophage:Artery,0.7748486828409056,1.4722574789121223,0.01639344262295082,0.17246196174323652,1.0,7/31,8.28%,TLR2;TYMP;CTSS;SIGLEC1;TNFRSF14;SLC7A7;MVP
prerank,CellMarker_Augmented_2021__Monocyte:Kidney,0.7748486828409056,1.4722574789121223,0.01639344262295082,0.17246196174323652,1.0,7/31,8.28%,TLR2;TYMP;CTSS;SIGLEC1;TNFRSF14;SLC7A7;MVP
prerank,CellMarker_Augmented_2021__Macrophage:Visceral Adipose Tissue,0.7748486828409056,1.4722574789121223,0.01639344262295082,0.17246196174323652,1.0,7/31,8.28%,TLR2;TYMP;CTSS;SIGLEC1;TNFRSF14;SLC7A7;MVP
prerank,CellMarker_Augmented_2021__Macrophage:Retinal Pigment Epithelium,0.7748486828409056,1.4722574789121223,0.01639344262295082,0.17246196174323652,1.0,7/31,8.28%,TLR2;TYMP;CTSS;SIGLEC1;TNFRSF14;SLC7A7;MVP
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.6448826525052337,1.4721018401730963,0.0,0.17256676710664773,1.0,15/72,8.41%,DOC2B;ADCY5;KCNC2;IRS2;ABCC8;BMP8A;EPHA5;SOX4;GIPR;ITPR3;NNAT;CACNA1C;HADH;GLP1R;CACNA1E
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.8287806742770724,1.4717066017859768,0.06896551724137931,0.1733722060617441,1.0,5/17,3.17%,HTR2C;TYMP;NPTX2;DLGAP3;APP
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Ligament,0.8010134814345068,1.4714945603160816,0.016129032258064516,0.17362900103024698,1.0,6/15,8.72%,ADGRE5;THY1;PTPRC;MCAM;CD44;ITGA3
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.6739521586902858,1.471159079297081,0.0,0.174140728947133,1.0,14/52,17.04%,ENPP2;LPCAT4;ACHE;PLAAT4;MFSD2A;PLAAT3;CHKB;DBI;PLB1;PNPLA8;SLC44A3;PLAAT1;ABCA3;LPIN3
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.6056942917561039,-1.4711580808165423,0.06060606060606061,0.4890035649629081,1.0,17/60,13.97%,RTRAF;TRPT1;ADAT2;TRMT61A;POP5;KARS1;TRMT10C;TRMT10A;THUMPD1;C2ORF49;QTRT2;FTSJ1;CPSF1;CLP1;URM1;TRMT10B;ADAT1
prerank,CellMarker_Augmented_2021__Pericyte:Undefined,0.8621115362125005,1.4711276628973347,0.01818181818181818,0.17397011994468373,1.0,7/14,7.53%,CSPG4;PDGFRA;ACTA2;THY1;MCAM;CD44;PDGFA
prerank,CellMarker_Augmented_2021__Central Nervous System Stem cell:Fetal Brain,0.6546320128113158,1.4711014963364268,0.03225806451612903,0.17376601947404274,1.0,17/50,13.09%,ABO;HLA-DRA;ITM2A;CD24;SLA;CP;MYH11;PTPRC;APLNR;RAMP3;LDLRAD4;RNASE1;ADAM28;ITGA9;HLA-DRB1;FGD5;RASGEF1B
prerank,Reactome_2022__DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.7156956045722209,-1.4705908542007105,0.05,0.48936598047050833,1.0,7/37,5.51%,H1-2;H2AC20;CCNE1;H2BC4;H2BC21;H1-4;H2AC6
prerank,Reactome_2022__Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,0.6448332040959561,1.4700120146051066,0.02857142857142857,0.17605725509468959,1.0,18/70,12.98%,GRIN3A;GRIN2A;GRIN2D;GRIN2B;NEFL;RPS6KA1;NRGN;PRKAR1B;NRG1;GRIA3;GRIA1;KIF17;ARHGEF7;RNASE1;GPRIN1;MAPT;CAMK2B;RPS6KA6
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.6277603347752546,1.4699246702402047,0.014492753623188406,0.17605405442179908,1.0,16/106,5.47%,NPY;L1CAM;FLRT3;TBC1D24;STMN2;SH3GL2;NLGN1;CNTN4;PLEK;BICDL1;PLP1;APP;CNTNAP2;STMN4;CFAP126;LAMB1
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),-0.6802000065603521,-1.4697748780229238,0.045454545454545456,0.4902155338811039,1.0,3/21,6.81%,SELENOS;PGP;MST1
prerank,KEGG_2021_Human__Long-term potentiation,0.6556397527439382,1.469466416195878,0.02702702702702703,0.17666003563059615,1.0,14/58,12.98%,GRIN2A;GRIN2D;GRIN2B;PRKCB;PRKCG;RPS6KA1;ITPR3;GRM5;CACNA1C;GRIN1;GRIA1;PPP1CB;CAMK2B;RPS6KA6
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),-0.7687449845398906,-1.4693374830228214,0.11627906976744186,0.49019273465362906,1.0,2/10,12.60%,POMP;PSMD10
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.7839299474129475,1.4692628463555302,0.07407407407407407,0.17682493352529785,1.0,6/14,8.72%,ITGA8;TBX19;ITGA2;TBX20;SCX;ITGA3
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),-0.5830907961616066,-1.469070407160863,0.0,0.48904883133157157,1.0,5/59,3.62%,H1-2;H2BC21;PADI4;H1-4;BRDT
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.792015921009789,1.4690381663949927,0.017857142857142856,0.1770568401577491,1.0,7/18,16.84%,RIMS2;SYT4;SYT1;CPNE9;RASAL1;SMURF1;SYT17
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.6401551514441062,1.4687040438970274,0.015384615384615385,0.17745654938219677,1.0,14/56,11.85%,CACNA1H;NR4A3;CTSS;LMO2;SLIT2;SLIT3;ROBO2;GHR;RAMP3;ATP1A1;STAT3;TFPI;KLF9;SRA1
prerank,KEGG_2021_Human__Gastric acid secretion,0.6555930479383646,1.4685500035157721,0.014084507042253521,0.17755228035954135,1.0,16/58,10.24%,CHRM3;KCNJ2;KCNK10;PRKCB;ADCY5;KCNQ1;PRKCG;MYLK3;ITPR3;CCKBR;ADCY7;ADCY2;ATP1A1;SLC9A1;ATP1B1;ATP1B3
prerank,Reactome_2022__DNA Replication R-HSA-69306,-0.5766665400499217,-1.468212105978498,0.0,0.4911148611712256,1.0,32/117,20.20%,H2AC20;CDC26;CCNE1;GINS3;H3-3B;RFC3;H2BC4;H2BC21;POLD3;H2AC6;MCM6;SLC25A15;PSMD10;MCM4;ANAPC15;PSMD12;PRIM1;PSMB5;POLR1B;SLC19A1;H2AJ;PSMB6;DNA2;ORC6;PSME3;SEM1;H2BC5;PSMD2;UBB;CUL1;SKP2;PSMB4
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.7199692867605693,1.4681464618195326,0.03225806451612903,0.1782188944185437,1.0,4/29,9.70%,ENPP2;CLRN1;ARHGEF7;FSCN1
prerank,Reactome_2022__RHO GTPases Activate ROCKs R-HSA-5627117,0.7902810321214466,1.4681183385159424,0.03389830508474576,0.17802807807151733,1.0,4/18,9.59%,MYH9;MYH11;LIMK2;PPP1CB
prerank,KEGG_2021_Human__p53 signaling pathway,0.6739166314520021,1.4678419561753,0.015151515151515152,0.17817281898722342,1.0,18/62,13.54%,CDKN2A;IGF1;THBS1;SERPINE1;CCNB2;STEAP3;FAS;SHISA5;CDK6;BCL2L1;GORAB;TP53I3;BBC3;GADD45A;BCL2;CDKN1A;CCND1;TNFRSF10B
prerank,CellMarker_Augmented_2021__Endothelial cell:Heart,0.6531827902383938,1.4678012419491018,0.06349206349206349,0.1780662504127867,1.0,19/58,9.94%,GGT5;FLT1;PTPRB;DYSF;SIGLEC1;ACKR1;SHROOM4;PCDH12;MYH11;APOD;FAM107A;TNS1;LDB2;APLNR;RAMP3;ADGRF5;RASL12;RNASE1;ITGA9
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.6341448075705638,1.4677569350311555,0.0136986301369863,0.17790988290201182,1.0,5/79,8.12%,LEF1;CD24;WNT8B;DVL1;CTNNB1
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.9205845288298639,1.467660813291412,0.0,0.17807084708689522,1.0,2/6,2.91%,SHTN1;WAS
prerank,Reactome_2022__EPHB-mediated Forward Signaling R-HSA-3928662,0.7338918624298008,1.4675965807601132,0.015151515151515152,0.17796488437111313,1.0,7/30,10.13%,GRIN2B;FYN;KALRN;LIMK2;ARPC3;RNASE1;GPRIN1
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.7034579626986829,1.4675040806996738,0.08333333333333333,0.17795900648082114,1.0,5/36,3.61%,PTP4A3;TLR2;APP;NOD1;NLRP12
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.9680145559391393,1.4672165649110982,0.0,0.17870042907805536,1.0,2/5,1.86%,IL15;PTK6
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.7080094086505593,1.4671573229791854,0.05172413793103448,0.17856085535632835,1.0,7/33,9.26%,MYO1F;SYT4;BICDL1;MYO1B;MYO1C;MYO15A;TRAK1
prerank,Reactome_2022__Cell-cell Junction Organization R-HSA-421270,0.667330138833278,1.4670358194109665,0.04838709677419355,0.1785872689831754,1.0,14/41,14.51%,CDH6;CDH9;CDH19;CLDN16;CDH8;CDH18;PARD3;CTNNB1;CLDN18;CTNNA1;CLDN20;SDK2;CDH4;PATJ
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood Vessel,0.6773291633757835,1.4669238856265945,0.03076923076923077,0.1787954948339319,1.0,18/50,13.54%,IL13RA1;TYMP;A4GALT;FLT1;ICAM1;PLXDC1;COLEC12;IL1R1;EGFL7;MCAM;COLEC11;TNFRSF1A;CD160;PODXL;S1PR3;KLF4;PDPN;TNFRSF10B
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.9434840498378515,1.4668699782562884,0.0,0.17867289384021792,1.0,2/8,0.85%,CDKN2A;ANXA1
prerank,CellMarker_Augmented_2021__Paneth cell:Large Intestine,0.5868515962050855,1.466850911932135,0.0,0.17846820067539187,1.0,35/178,10.69%,NR4A3;CXCL2;HLA-DRA;TLR2;CTSC;SLC15A3;CORO7;PLEK;SLA;LMO2;GPR34;PRKCB;ICAM1;WAS;IRS2;SIGLEC1;PGD;LAT2;PTPRC;NINJ2;CD37;GFRA2;SLC9A9;MTHFD2;BIRC3;ADCY7;EIF4A3;RAP2B;CHI3L1;NAMPT;ATP1B3;FLI1;FAM168A;WDFY2;CD83
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),-0.9156992032352332,-1.4668253351775142,0.029411764705882353,0.4941230716906613,1.0,2/7,3.26%,SOD3;PRDX1
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),0.9354789696793574,1.4667021831335108,0.061224489795918366,0.17851106060881478,1.0,2/5,4.42%,TYMP;FGF12
prerank,"Reactome_2022__Sensory Perception Of Sweet, Bitter, And Umami (Glutamate) Taste R-HSA-9717207",0.8767619746826674,1.4665111161067503,0.0196078431372549,0.17865244746148332,1.0,5/11,5.89%,SCN1B;SCN9A;SCN2A;TRPM4;ITPR3
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),0.851308888289457,1.4664859697909964,0.06153846153846154,0.1784158167988691,1.0,1/9,0.92%,KLF2
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.5721166406944227,1.4663685281479129,0.0,0.17854054349658538,1.0,29/189,13.12%,GGT5;HPN;CTSC;CTSS;MMEL1;FOLH1;PRSS57;PRSS48;PCSK2;FAP;ECE1;ENPEP;CAPN8;CELA2B;CAPN1;TRHDE;TBL1X;MMP14;CNDP1;ADAM19;FBXL2;TMPRSS5;TMPRSS3;MMP17;BACE2;CPA6;TPSD1;MMP16;PHEX
prerank,KEGG_2021_Human__Chemokine signaling pathway,0.587464570220179,1.466122408184169,0.02702702702702703,0.17886137887011333,1.0,29/118,17.67%,CXCL2;RASGRP2;GNG3;ELMO1;PRKCB;ADCY5;SHC2;WAS;GNG2;PARD3;ADCY7;FOXO3;ADCY2;GRK2;CCR10;STAT3;PXN;CCL2;PRKCD;PAK1;GRK5;IKBKG;PIK3CD;BCAR1;VAV2;ADCY3;SHC1;GNAI1;RAP1A
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.7170696518712094,1.4659157193553771,0.047619047619047616,0.1793120984841203,1.0,6/30,12.85%,C3;SERPINE1;MKLN1;TF;ARF6;B2M
prerank,Reactome_2022__Glutathione Synthesis And Recycling R-HSA-174403,0.9270568359738847,1.4658065935708486,0.02127659574468085,0.17940238453241397,1.0,2/9,5.59%,GGT5;GGCT
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.7527238351045096,1.4657025373803452,0.04225352112676056,0.17949241661151413,1.0,3/28,4.87%,GGT5;AWAT1;ALOX12
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.8372826512716552,-1.4656168254821134,0.024390243902439025,0.4947739276789925,1.0,3/11,7.16%,BLOC1S4;BLOC1S2;SNAPIN
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.8372826512716552,-1.4656168254821134,0.024390243902439025,0.4947739276789925,1.0,3/11,7.16%,BLOC1S4;BLOC1S2;SNAPIN
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),0.8677464037076364,1.4655215061748703,0.01694915254237288,0.1797287137646934,1.0,6/11,7.26%,GRIN3A;GRIN2A;GRIN2B;GLRA2;ADCY7;GRIN1
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.7212051827236334,1.465460302409623,0.014492753623188406,0.1795904384264412,1.0,4/43,3.55%,GGT5;CXCL2;CD24;ERBIN
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.7695896820191368,1.4653495620235835,0.06349206349206349,0.17967982883869077,1.0,3/20,3.70%,SLC24A2;PLK2;ACHE
prerank,Reactome_2022__NADE Modulates Death Signaling R-HSA-205025,-0.9543426879700487,-1.4651479415920867,0.04081632653061224,0.49487578726011217,1.0,1/5,0.09%,NGF
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Small Intestine,0.7433667086216903,1.4651036122952736,0.034482758620689655,0.17999592976053086,1.0,10/32,12.18%,KCNT2;GABRB2;SYT16;SV2B;ZNF385B;GAD2;HCN1;KCNQ2;GLIS3;MX1
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.9447748818912216,1.4649381140099476,0.018518518518518517,0.18013307062921743,1.0,2/8,2.21%,RECQL4;BLM
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.6482419638325826,1.4647679227185801,0.0,0.18049615642599942,1.0,17/69,8.95%,ENPP2;GRIN2A;PROX1;PDGFRA;PDE1C;DCN;ABCA8;CNTN4;THY1;ANGPTL2;PIEZO2;SLC38A11;ALDOB;GRIA3;PTPRD;KALRN;BGN
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),-0.7623954647063451,-1.4646294052706534,0.06818181818181818,0.49464993086965864,1.0,3/15,2.76%,CST3;CSTB;CTSH
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.6647619109605729,1.4643726016481884,0.05263157894736842,0.18118110548395572,1.0,11/55,7.39%,RASGRP2;NLGN1;SYT4;DMTN;SYT1;SYT5;CLIC4;HPCA;NEUROD2;ITPKB;SYT13
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.7136560249964025,1.4643318688739475,0.045454545454545456,0.18099360018929567,1.0,5/34,8.65%,EGF;DMTN;APP;PARD3;CHI3L1
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.5894307221123322,1.4637433724397777,0.016129032258064516,0.1821267245923691,1.0,16/83,13.35%,NR4A3;NR4A1;ADCY5;SLC39A14;IRS2;FOXO1;PRKAR1B;RAB15;ADCY7;ADCY2;PPARG;SORBS1;HDAC9;NR4A2;PRKCD;CPEB2
prerank,KEGG_2021_Human__GnRH secretion,0.6476551346480955,1.4636842244595503,0.015151515151515152,0.18193842788506115,1.0,8/54,9.05%,CACNA1H;CACNA1G;PRKCB;PRKCG;GABBR2;ITPR3;CACNA1C;HCN1
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),0.9687780998434833,1.4636489656563128,0.0,0.18179881565473682,1.0,1/6,0.01%,LEF1
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.6704286545956486,1.4635662970172747,0.031746031746031744,0.18175578215525015,1.0,22/58,21.27%,ZFP36;IRAK2;MAP3K11;NOD1;SH2D3A;MINK1;TNFRSF19;GPS1;TNIP2;IKBKG;MAPK11;MAP3K5;TAB1;GPS2;MAPK9;SH2D3C;MAP2K3;SKP1;RPS27A;ARHGEF6;TAB2;ADORA2B
prerank,CellMarker_Augmented_2021__Follicular B cell:Undefined,0.9393603336352441,1.463258222912639,0.0,0.18227321558249468,1.0,6/9,5.16%,EBF1;CD22;CD24;FOXO1;PTPRC;BCL6
prerank,Reactome_2022__NF-kB Activation Thru FADD/RIP-1 Pathway Mediated By Caspase-8 And -10 R-HSA-933543,0.74770671356019,1.4631735685634313,0.07936507936507936,0.18222964645138212,1.0,4/12,14.66%,CASP10;FADD;IKBKG;IFIH1
prerank,Reactome_2022__ERBB2 Activates PTK6 Signaling R-HSA-8847993,0.8619187163389821,1.4631112891037446,0.06779661016949153,0.1821063681466925,1.0,4/10,7.48%,EGF;PTK6;NRG1;NRG2
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.6323067305923317,1.4630969541229504,0.0,0.18195154122755677,1.0,33/123,15.45%,VRK2;IGF1;EPHA7;EGF;RASGRP1;CD24;RIT2;DUSP1;FLT1;EPHA2;DAB2IP;NEK10;PAK3;PTPRC;FAS;TRIM5;NTRK3;PAK4;PDGFA;WDR54;MINK1;SYK;GFRAL;HLA-DRB1;FN1;PAK1;FGF2;LPAR1;IQGAP1;GPR37;CD4;THPO;STK3
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.7579580749965971,-1.4629309564537187,0.02564102564102564,0.5005686150228272,1.0,7/22,11.72%,MT1E;MT1A;MT1G;AKR1C3;MT1F;HSF1;MT2A
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.6400080701972596,1.4628590905634509,0.02702702702702703,0.1823703308488723,1.0,32/88,17.27%,C1QL1;SLIT2;DAB2IP;TRAM1L1;EFNB3;TUSC3;PTPN21;LARP6;MAP1B;SCARA3;BOC;ADGRL2;B4GALNT1;CNN3;YAP1;EPB41L1;GLI2;TEAD1;ENAH;CD276;MEIS3;CAP2;IGDCC4;KIAA1549;RBFOX2;BCAR1;SMARCA1;SEZ6L2;FZD7;PFN2;CTXN1;MAGI1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.7965615409396787,1.4628286033194493,0.015151515151515152,0.18213606592268156,1.0,7/21,10.19%,MYRF;KIF14;TYMP;NKX6-2;PARD3;TENM4;TPPP
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.6200997977543078,1.4626460758703188,0.03076923076923077,0.1823470367776085,1.0,32/107,13.13%,COL4A1;EDIL3;PCDH18;COL4A2;SLIT2;PLP1;DAB2IP;THY1;EFNB3;TCEAL7;TUSC3;NUAK1;GFRA2;PTPN21;SEMA3B;OLFML2A;LARP6;MAP1B;SCARA3;BOC;ADGRL2;YAP1;EPB41L1;GLI2;PCDHB15;TEAD1;ENAH;FAM13C;RUNX1T1;PRICKLE2;MEIS3;CAP2
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),0.8576898416305058,1.462454416441928,0.016129032258064516,0.182557430420894,1.0,3/9,5.71%,GAS2L3;BAIAP2L1;BAIAP2
prerank,CellMarker_Augmented_2021__GABAergic neuron:Undefined,0.9240336602914911,1.46242910197258,0.04,0.18232386999635158,1.0,2/5,4.75%,GAD2;GABBR2
prerank,KEGG_2021_Human__Dilated cardiomyopathy,0.6382174123814696,1.4618662806360196,0.01694915254237288,0.18348252333792497,1.0,19/71,10.89%,IGF1;ITGA8;ADCY5;CACNG3;ITGA2;ADCY7;CACNA1C;TPM4;CACNG8;RYR2;ADCY2;ITGA11;ITGA3;LMNA;CACNG4;TGFB2;ITGA9;LAMA2;ITGB8
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),0.8879593516681954,1.4617622764749587,0.038461538461538464,0.18343784087496584,1.0,3/8,7.95%,HRH1;GABRB2;GABRG2
prerank,Reactome_2022__Signaling By Activated Point Mutants Of FGFR1 R-HSA-1839122,-0.8804763393767594,-1.4616649162377198,0.04,0.5044533724492615,1.0,1/6,0.15%,FGF6
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.7297714117909864,1.461551350464083,0.016129032258064516,0.1837875384886351,1.0,9/38,6.43%,TLR2;TYMP;CTSS;SP100;PLEK;CSF2RA;PTPRC;CIITA;BIRC3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.6335425844658978,1.461548110919864,0.031746031746031744,0.18355357607174272,1.0,26/82,17.95%,BOK;MLLT11;CD24;EPHA2;DAB2IP;ZNF385B;SCN2A;HIC1;PRODH;PML;CYP1B1;BCL2L1;IKBKE;BBC3;PRKCD;BCL2;CDKN1A;TNFRSF10B;HIPK2;PDK1;MAP3K5;TP53;BRCA1;STK11;ITPR1;STK24
prerank,CellMarker_Augmented_2021__Clara cell:Undefined,0.6124121565492624,1.4615240613665392,0.0,0.1833674311905373,1.0,30/93,25.77%,MTMR7;MGAT5;SIK2;ARHGEF7;TF;FAM168A;DIP2B;DOCK4;RGL1;FAM219A;CDS2;SCAMP5;CLSTN3;ZMIZ1;NISCH;CD99L2;PHF2;MAPK8IP3;SYNJ1;TTBK2;TRIM9;STK35;RALGAPB;SNX30;CRAMP1;ZNF275;ABR;AP2A2;WNK1;FCHSD2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.8958444085950924,1.4614327247189736,0.05660377358490566,0.1833545593255604,1.0,3/9,7.62%,RFTN1;IL15;MYD88
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.7684963193107863,1.4613316685601283,0.037037037037037035,0.18343583217190287,1.0,4/23,6.83%,NPY;GLRA2;MCHR2;HCRTR2
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.8565466746152227,1.4610438840467386,0.0847457627118644,0.1837361783283656,1.0,1/8,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.7504672939904822,1.4610079577092632,0.016129032258064516,0.1835351492064212,1.0,7/30,8.12%,FLRT3;SH3GL2;NRP2;SEMA5B;FLRT1;MAP1B;CTNNB1
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.6795145378422397,1.4608750770146215,0.014285714285714285,0.18358460694800408,1.0,14/51,14.91%,ANXA1;PLEK;DMTN;THSD7B;MYH9;NEDD9;MKLN1;PDLIM4;MINK1;SIPA1L1;PAK1;PHACTR1;GAB1;BCAR1
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),0.95935762786005,1.460822287733318,0.0,0.18346232564288795,1.0,1/6,0.01%,LEF1
prerank,Reactome_2022__PI3K Events In ERBB2 Signaling R-HSA-1963642,0.8282165536499321,1.4604505414816065,0.05263157894736842,0.18391681711986355,1.0,3/13,7.48%,EGF;NRG1;NRG2
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Germ,0.691938160867237,1.4604364694093308,0.029411764705882353,0.1837166248807329,1.0,9/39,6.17%,HLA-DRA;CTSS;P2RY13;PLEK;SLA;MYH11;PTPRC;GAB3;CIITA
prerank,Reactome_2022__Regulation Of IFNG Signaling R-HSA-877312,0.8753059872233524,1.4604278460102667,0.015873015873015872,0.18348589374772364,1.0,1/11,0.88%,SOCS3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.939879358367835,1.4603972399503848,0.0,0.1833488823740197,1.0,1/6,1.68%,THBS1
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.6415689155921424,1.4603417193957446,0.03225806451612903,0.18321223734088712,1.0,8/63,7.89%,BOK;ANXA1;IL15;CHRM1;DOC2B;SFTPD;SNCA;SYNGR3
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),0.9282515114784547,1.460109435774245,0.018867924528301886,0.18352474862295567,1.0,1/5,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),0.7651516897669688,1.460106640428023,0.08620689655172414,0.18328004895812505,1.0,3/15,9.86%,THBS1;YAP1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.7265036599631512,1.4600687848755034,0.03125,0.18314404143300222,1.0,13/23,23.00%,FOXO3;SMAD3;PPARG;TGFB2;STAT3;TEAD1;KLF4;FGF2;ETS1;TP53;HIF1A;APLN;FOS
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.7195077985394186,-1.4597111945994863,0.10256410256410256,0.5123816367522855,1.0,7/20,15.33%,COX18;TIMM8B;TIMM13;SAMM50;BAD;TIMM10;BCL2L11
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),0.8952818955686721,1.4595291808021322,0.05660377358490566,0.18436481261102308,1.0,3/6,2.14%,NR4A3;SGPP2;NR4A1
prerank,GO_Biological_Process_2021__positive regulation of inositol phosphate biosynthetic process (GO:0060732),0.9073718435843341,1.459433007133874,0.01639344262295082,0.18439705269229012,1.0,3/5,6.91%,P2RY6;HRH1;SNCA
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.6852445639086163,1.459404870781038,0.0,0.18418324015465,1.0,16/46,17.57%,IGF1;PDGFRA;DYSF;MYH9;EPB41L4B;NRG1;PDGFA;SMAD3;SYTL4;TGFB2;PAK1;FGF2;FZD7;MYOF;PLEC;WNT5A
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.709065622009365,1.4586215286439748,0.01639344262295082,0.18598118229249364,1.0,4/42,7.87%,ANLN;ANK3;INCENP;TRIM36
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.6916534938354447,1.458480084074538,0.06349206349206349,0.18624114050195156,1.0,12/48,10.44%,PDGFRA;IL15;PTK6;FLT1;RELN;TEC;FYN;GHR;AATK;PKDCC;SYK;EPHA4
prerank,"Reactome_2022__Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.7359622476147153,1.4584724957230921,0.031746031746031744,0.18602573925863553,1.0,11/30,13.10%,PRKCB;PRKCG;CACNG3;CACNG8;GRIA3;GRIA1;CACNG4;EPB41L1;GRIP2;CAMK2B;PICK1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.6249313537967371,1.4584015887901345,0.03225806451612903,0.18597911637772163,1.0,18/78,13.18%,PTK6;PTPRO;SRCIN1;PTPRB;DAB2IP;THY1;DUSP10;CAMK2N2;PTPRC;SMCR8;DVL1;SNCA;MVP;YWHAG;CDKN1C;GADD45A;CDKN1B;CDKN1A
prerank,CellMarker_Augmented_2021__Adipose Multilineage-Differentiating Stress-Enduring cell:Adipose Tissue,0.6393838483524704,1.4583032937957405,0.029411764705882353,0.18591734467744803,1.0,21/70,11.71%,COL4A1;CSPG4;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;COL4A2;THY1;PODN;ANGPTL2;POSTN;FAP;IGFBP7;LDB2;C1R;BGN;MMP14;GAS6;SPARC;CCL2
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.9384575544589684,1.4581080350045588,0.0,0.1862065218396545,1.0,2/8,1.16%,MET;PROX1
prerank,"Reactome_2022__Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",0.7515687858534604,1.4577691534199648,0.03278688524590164,0.18678433821229004,1.0,8/21,12.22%,GRIN2A;GRIN2D;GRIN2B;NEFL;GRIA3;GRIA1;GPRIN1;CAMK2B
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.6455440826866271,1.4577474807174495,0.046875,0.18656963750507138,1.0,7/59,12.49%,TGFBR2;SBK1;GALNTL6;GALNT16;HIPK3;PRKCD;HIPK1
prerank,KEGG_2021_Human__Hepatitis B,0.5881600547844512,1.457386760988825,0.0136986301369863,0.18709988854693602,1.0,32/131,18.87%,TGFBR2;TLR2;CREB5;STAT4;PRKCB;PRKCG;IRF7;NFATC2;FAS;CASP10;MYD88;SMAD3;IKBKE;TGFB2;STAT3;TYK2;BCL2;CDKN1A;FADD;IKBKG;PIK3CD;MAPK11;IFIH1;STAT6;TP53;CDK2;TAB1;MAPK9;MAP2K3;DDB2;PRKCA;NFATC3
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.7031684048931268,1.4571219884638957,0.03278688524590164,0.1876894384062609,1.0,10/36,11.19%,SLC32A1;SYT1;GAD2;CPLX2;DVL1;SNCA;PCLO;CPLX1;DNAJC5;SYN2
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.8874733559058012,1.4568024045047798,0.061224489795918366,0.18806532042911464,1.0,1/9,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.9058761035909974,1.456435889364376,0.0,0.18875799543986257,1.0,1/10,0.01%,GGT5
prerank,Reactome_2022__HCMV Late Events R-HSA-9610379,-0.5814417624752002,-1.456419851319015,0.06896551724137931,0.5254720097252848,1.0,9/65,9.05%,H2AC20;H2BC4;H2BC21;SNF8;AAAS;NUP50;H2AC6;PCSK1;H2BC18
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),-0.6679952643878655,-1.456233792194145,0.06521739130434782,0.5236547472396206,1.0,6/25,15.09%,ARRDC4;FBXO5;TRIB3;RPS2;FEM1A;DCUN1D2
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.9050162925160645,-1.455782034463632,0.0,0.5234425039142084,1.0,1/6,0.68%,BUD23
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.6330408293944004,1.4557044025361745,0.016666666666666666,0.19032538261490925,1.0,16/74,7.08%,CDKN2A;ANLN;ST6GAL1;BOK;CD24;PSCA;LIPH;ICAM1;PLEKHG6;NRP2;IL1R1;INCENP;BAIAP2L1;ITGA2;PGR;POF1B
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.8111415930862305,1.4550968464100622,0.03571428571428571,0.19169248285001322,1.0,2/14,5.08%,ABO;B3GALT2
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.7248647717683142,1.454999377014089,0.04918032786885246,0.1916090117360525,1.0,7/22,12.33%,SYT4;SYT1;SYT5;SNCA;SYT13;GRK2;SYT12
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.6001831148081572,1.4548221552542666,0.0,0.191856934563204,1.0,5/108,8.12%,LEF1;GNG2;DVL1;DAAM1;CTNNB1
prerank,Reactome_2022__Amyloid Fiber Formation R-HSA-977225,-0.6302249777678617,-1.4546686356941905,0.022727272727272728,0.5267801583194608,1.0,8/42,5.51%,H2AC20;CST3;H3-3B;H2BC4;H2BC21;HSPG2;APOE;H2AC6
prerank,Reactome_2022__Regulation Of RUNX3 Expression And Activity R-HSA-8941858,0.6846585456726084,1.4545706480224794,0.0,0.19216435019576278,1.0,1/49,0.12%,CDKN2A
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.8390076211972839,1.4544619631019422,0.01694915254237288,0.192350853356156,1.0,7/14,11.71%,NLGN1;RELN;CACNG3;SHANK3;CACNG8;CACNG4;CCL2
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),0.9758788177223853,1.4542397232276656,0.0,0.19270181989286675,1.0,1/6,0.01%,LEF1
prerank,CellMarker_Augmented_2021__Immature Endothelial cell:Subcutaneous Adipose Tissue,0.6895232778545213,1.4542239451151813,0.046153846153846156,0.19176946148752813,1.0,10/38,5.76%,GGT5;HLA-DRA;ELMO1;PLEK;SLA;SIGLEC1;PCDH12;MYH11;PTPRC;GAB3
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Subcutaneous Adipose Tissue,0.6895232778545213,1.4542239451151813,0.046153846153846156,0.19176946148752813,1.0,10/38,5.76%,GGT5;HLA-DRA;ELMO1;PLEK;SLA;SIGLEC1;PCDH12;MYH11;PTPRC;GAB3
prerank,CellMarker_Augmented_2021__Endothelial cell:Lymph Node,0.6895232778545213,1.4542239451151813,0.046153846153846156,0.19176946148752813,1.0,10/38,5.76%,GGT5;HLA-DRA;ELMO1;PLEK;SLA;SIGLEC1;PCDH12;MYH11;PTPRC;GAB3
prerank,CellMarker_Augmented_2021__Inflammatory cell:Muscle,0.6895232778545213,1.4542239451151813,0.046153846153846156,0.19176946148752813,1.0,10/38,5.76%,GGT5;HLA-DRA;ELMO1;PLEK;SLA;SIGLEC1;PCDH12;MYH11;PTPRC;GAB3
prerank,KEGG_2021_Human__Tuberculosis,0.6152121187520717,1.4540863579763779,0.03125,0.19188054031818702,1.0,18/108,14.62%,HLA-DRA;C3;TLR2;CTSS;IRAK2;CIITA;TNFRSF1A;CASP10;MYD88;TGFB2;SYK;HLA-DRB1;CAMK2B;BCL2;FADD;HLA-DMA;IL12A;MAPK11
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),-0.9584655880451269,-1.4540514334186252,0.0,0.5270449946380276,1.0,1/7,0.09%,NGF
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.7744892697964176,1.4536873354632691,0.03278688524590164,0.19264603587181842,1.0,6/22,11.71%,IL15;PTK6;STAT4;GHR;STAT3;CCL2
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.6532202703804976,1.4535933203021727,0.014285714285714285,0.1926368219726153,1.0,20/65,17.21%,A4GALT;SGPP2;VAPB;ABCA8;FA2H;ST8SIA3;ST8SIA1;SPNS2;HACD1;CERS3;CYP4F22;SGMS1;ALDH3A2;ELOVL7;LARGE1;CERS5;ST6GALNAC5;ELOVL5;B4GALT6;HACD4
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.8858540763976862,1.452862621220145,0.038461538461538464,0.19439376836386457,1.0,2/9,1.17%,TGFBR2;PDGFRA
prerank,KEGG_2021_Human__Chronic myeloid leukemia,0.6617573731244802,1.4528031468344909,0.046153846153846156,0.19424894052400138,1.0,16/72,15.46%,TGFBR2;CDKN2A;SHC2;CDK6;BCL2L1;SMAD3;GAB2;CTBP2;TGFB2;GADD45A;CDKN1B;CDKN1A;CCND1;IKBKG;PIK3CD;TP53
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.8095520564530381,-1.452584177682651,0.08888888888888889,0.5310316185550651,1.0,1/8,0.09%,NGF
prerank,Reactome_2022__Packaging Of Telomere Ends R-HSA-171306,-0.7936204132801915,-1.4525241616852713,0.07142857142857142,0.528710757159679,1.0,4/15,5.51%,H2AC20;H2BC4;H2BC21;H2AC6
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Periodontal Ligament,0.917290606837009,1.4524311161894163,0.05263157894736842,0.1947114292123236,1.0,5/7,6.44%,PDGFRA;THY1;PTPRC;MCAM;CD44
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.8165542427947002,1.4521591047170845,0.05660377358490566,0.19498053706786186,1.0,1/13,0.90%,IGF1
prerank,Reactome_2022__Selenoamino Acid Metabolism R-HSA-2408522,-0.5631663501688844,-1.4519916979952108,0.0,0.5279285260352861,1.0,28/100,11.83%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;AIMP1;RPL18;KARS1;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;EEFSEC;RPL14;SECISBP2;RPL15;RPS2;EPRS1;RPL11;RPL23A
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.5960074942117676,1.4517517700576765,0.015873015873015872,0.19573623265961881,1.0,21/84,15.30%,GPNMB;ANXA1;MOG;IL15;IGF2BP2;SFTPD;IRF7;NLRP12;ACKR1;PTPRC;BCL6;NPTN;HDAC9;LURAP1;HLA-DRB1;CD276;PER1;TRIM32;PIK3CD;IFIH1;SCAMP5
prerank,CellMarker_Augmented_2021__Stromal cell:Embryoid Body,0.6454572524510973,1.4516584091632534,0.015625,0.19584113413427595,1.0,27/71,14.24%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;THBS1;ACTA2;SULF1;COL4A2;PODN;ANGPTL2;POSTN;SLIT3;COL12A1;FAP;IGFBP7;C1R;EMP1;BGN;ADAM12;LAMA2;SPARC;KLF6;FN1;COPZ2;COL5A1;THBS2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.7651252833810209,1.451598280599019,0.05357142857142857,0.19572484399802217,1.0,4/18,7.51%,C3;CCBE1;SULF1;CYP1B1
prerank,KEGG_2021_Human__Legionellosis,0.6756003103771765,1.451388157667505,0.03278688524590164,0.1960648479856307,1.0,3/42,0.81%,CXCL2;C3;TLR2
prerank,Reactome_2022__Phosphorylation Of APC/C R-HSA-176412,-0.7044876081674354,-1.4513768414108081,0.11764705882352941,0.5290760383088052,1.0,1/17,0.65%,CDC26
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.842272163626611,1.4513624340509748,0.03333333333333333,0.19588980508359466,1.0,4/14,5.87%,PDGFRA;RASGRP1;FLT1;NTRK3
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),0.8729429070690717,1.451322826968085,0.01694915254237288,0.19567118811426312,1.0,2/10,1.69%,CDKN2A;SERPINE1
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),0.8617306380549999,1.451226833013883,0.03125,0.1957462010147868,1.0,3/8,10.99%,NLGN1;SHANK3;LRRC4
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.7273872784420209,1.4508343886149428,0.0,0.19628935578801973,1.0,3/31,5.59%,GGT5;GSTT2;GGCT
prerank,Reactome_2022__Regulation Of TP53 Degradation R-HSA-6804757,0.7074738345685145,1.4507123878252612,0.02,0.19646571825237197,1.0,1/33,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),0.9065004594576976,1.4506116185874431,0.0,0.19601650573774845,1.0,2/8,2.89%,EGF;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),0.9065004594576976,1.4506116185874431,0.0,0.19601650573774845,1.0,2/8,2.89%,EGF;MGAT3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),0.9065004594576976,1.4506116185874431,0.0,0.19601650573774845,1.0,2/8,2.89%,EGF;MGAT3
prerank,Reactome_2022__Nervous System Development R-HSA-9675108,0.5323261617369149,1.4501821691465975,0.0,0.1966140880141611,1.0,82/484,11.44%,CACNA1H;COL4A1;L1CAM;SCN1B;SCN9A;FLRT3;ANK3;CACNA1G;EPHA7;SH3GL2;GRIN2B;CD24;CNTN2;ARHGAP39;CNTNAP1;TRPC3;COL4A2;SHTN1;GAP43;EPHA2;SCN3B;SLIT2;RELN;IRS2;RPS6KA1;SCN1A;DOK6;NRP2;MYH9;EPHA5;EFNA1;EFNB3;SCN2A;AGAP2;SH3KBP1;MYH11;PTPRC;VLDLR;SHANK3;NELL2;FYN;SLIT3;UNC5D;GFRA2;LAMB1;ITGA2;DNM1;RAP1GAP;CLTB;AGRN;LDB2;DPYSL2;ROBO2;CACNA1C;EIF4A3;PAK4;DCC;MAG;RPL39L;KALRN;LIMK2;YAP1;ARPC3;GAB2;KCNQ2;ARHGEF7;RPL3;RNASE1;ITGA9;COL9A1;RGMB;GPRIN1;ST8SIA4;EPHA4;TEAD1;TRIO;DCX;SCN3A;LAMA2;COL4A4;CRMP1;ENAH
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),0.8812843405794282,1.4499813646934565,0.0,0.19677441320507508,1.0,4/14,6.79%,IGF1;APP;MFSD2A;GHR
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.8004788523153794,1.4497282325994403,0.01639344262295082,0.1972825082850482,1.0,6/19,11.71%,NR4A3;THY1;SKAP1;CD44;CYRIB;CCL2
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.9327224144841414,1.4492328599460942,0.03333333333333333,0.19828195911269458,1.0,1/5,0.11%,CACNA1H
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.7792329098024334,1.4488728427397088,0.018867924528301886,0.199018438035896,1.0,8/22,9.47%,SLC32A1;NLGN1;CPLX2;SNCA;PCLO;PLD2;CPLX1;DNAJC5
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),0.873976796187514,1.4486938703968353,0.03333333333333333,0.19934840006606766,1.0,1/8,3.94%,SUV39H1
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.6948378573230437,1.4485720519446725,0.014705882352941176,0.19940327776557767,1.0,8/38,9.88%,PROX1;SULF1;ITGA8;SOX4;ZBTB16;ROBO2;TGFB2;GLI2
prerank,Reactome_2022__EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,0.6968159653133101,1.4485623085367751,0.016129032258064516,0.19918409756849573,1.0,10/41,10.44%,EPHA7;EPHA2;EPHA5;EFNA1;EFNB3;FYN;DNM1;CLTB;RNASE1;EPHA4
prerank,Reactome_2022__DCC Mediated Attractive Signaling R-HSA-418885,0.7825171522579183,1.4483773204296666,0.07272727272727272,0.1993254370630785,1.0,4/14,10.74%,FYN;DCC;RNASE1;TRIO
prerank,Reactome_2022__Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.7660976015457568,-1.4483545384370666,0.02857142857142857,0.5405351613359991,1.0,1/16,0.65%,CDC26
prerank,Reactome_2022__Signaling By EGFR In Cancer R-HSA-1643713,0.7480993149810641,1.4481196972954338,0.034482758620689655,0.19962461839044676,1.0,2/19,3.84%,EGF;TGFA
prerank,Reactome_2022__Interleukin-15 Signaling R-HSA-8983432,0.8255785251214114,1.4480948517963605,0.02,0.19940597871376922,1.0,3/12,10.27%,IL15;GAB2;STAT3
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Fetal Liver,0.641635899405808,1.4474553529926746,0.029850746268656716,0.20090934551983183,1.0,30/77,12.14%,COL4A1;PDGFRA;RGS7BP;PCDH18;RCAN2;SULF1;FLT1;THY1;SHROOM4;TCEAL7;ANGPTL2;COL21A1;POSTN;LDB2;APLNR;ADGRL2;GNA14;PTPRD;ADGRF5;KALRN;BGN;RASL12;RNASE1;ITGA9;SLCO2A1;LAMA2;SORBS1;SPARC;RUNX1T1;FGD5
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.6127449260409565,-1.4471620670791732,0.05405405405405406,0.5444399557867908,1.0,5/31,11.81%,AR;RNF6;TRIM68;RUNX1;UFL1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),0.8231391915029178,1.4467680764591373,0.08333333333333333,0.20240899572068782,1.0,3/13,3.66%,ZFP36;ZC3H12D;RBM24
prerank,KEGG_2021_Human__Inflammatory bowel disease,0.7162793388411509,1.4467130996629038,0.045454545454545456,0.20227358905590517,1.0,12/28,16.66%,HLA-DRA;TLR2;STAT4;SMAD3;TGFB2;STAT3;HLA-DRB1;IL4R;HLA-DMA;IL12A;STAT6;RORA
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.8295928303726517,1.446710797267308,0.02040816326530612,0.20202417649233437,1.0,2/8,3.17%,C3;APP
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Pluripotent Stem Cell,0.7596782190627211,1.446684466901258,0.04918032786885246,0.20154144936646867,1.0,7/25,4.31%,HLA-DRA;CTSS;P2RY13;MYO1F;PLEK;SLA;PTPRC
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Embryonic Stem Cell,0.7596782190627211,1.446684466901258,0.04918032786885246,0.20154144936646867,1.0,7/25,4.31%,HLA-DRA;CTSS;P2RY13;MYO1F;PLEK;SLA;PTPRC
prerank,Reactome_2022__PTK6 Promotes HIF1A Stabilization R-HSA-8857538,0.9488917155007647,1.4466339231442777,0.02040816326530612,0.20136505446341305,1.0,2/5,1.86%,GPNMB;PTK6
prerank,GO_Biological_Process_2021__vitamin K metabolic process (GO:0042373),-0.8765194139434569,-1.44635691676386,0.03773584905660377,0.5458032490974729,1.0,1/6,0.52%,CYP4F3
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.7308927277913245,-1.446182035525825,0.1111111111111111,0.5440519153374997,1.0,1/18,0.65%,CDC26
prerank,Reactome_2022__HATs Acetylate Histones R-HSA-3214847,-0.5961161542773775,-1.4460897248728253,0.0,0.5421817852806206,1.0,8/78,9.05%,H2AC20;H2BC4;H2BC21;MCRS1;ENY2;H2AC6;ELP6;H2BC18
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.7779528106805607,-1.4460319188773794,0.10256410256410256,0.5401275773126519,1.0,3/10,8.67%,BUD23;RIOK2;RIOK1
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.875471366577025,1.4458276961691288,0.03278688524590164,0.2031375517599354,1.0,2/10,2.91%,SPOCK3;WAS
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),0.6560049917278179,1.4457025618043433,0.015384615384615385,0.20320111651565662,1.0,13/63,9.86%,CDH6;CDH22;CDH9;CDH19;PKP2;TJP3;CDH8;CDH7;CDH18;GJC1;SMAD3;FSCN1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.6570550755894953,1.4456398110231439,0.0,0.2031226505173144,1.0,21/67,20.58%,MET;PROX1;EGF;THBS1;NRP2;RIN2;SPARC;FGF2;PIK3CD;BCAR1;ETS1;MAP2K3;WNT5A;ADAM17;PRKCA;TEK;HIF1A;RHOB;FGFR1;AKT3;SCARB1
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.6506242409947274,1.4456332381936619,0.03125,0.20288850448936638,1.0,15/40,18.79%,CACNA1H;IGF1;ITGA11;MRAS;FHL3;LAMA2;MEF2D;SMTN;LARGE1;FHL1;NEB;CHODL;CHD2;CAV3;SGCG
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.8362293041923343,-1.4454544457784917,0.0851063829787234,0.5403543743292791,1.0,2/10,4.43%,RPP25L;POP5
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),-0.5551382964146829,-1.4454208346739346,0.047619047619047616,0.5380610159929519,1.0,45/161,18.61%,RPL35A;RPS24;RPL34;RPL39;EXOSC8;RPL13;RPL37;RPS28;NBDY;RPL18;RBM8A;RPL12;RPL23;RPL31;RPS26;RPL6;EXOSC4;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;EXOSC5;RPL15;RPS2;PYM1;RPL11;RPL23A;CNOT7;RPS21;RPS23;CNOT1;POLR2D;EIF3E;PNRC2;RPS25;RC3H1;RPL10;LSM1;CNOT9;UPF3B;RPL8;RPL32
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),-0.7955535986204656,-1.4454069006986707,0.0,0.5357546100871355,1.0,4/15,6.14%,ADAMTS9;ADAMTS12;CTSL;FBXO27
prerank,Reactome_2022__Formation Of ATP By Chemiosmotic Coupling R-HSA-163210,-0.7856382307707319,-1.4453492567037995,0.0,0.5336324080778018,1.0,9/13,16.79%,ATP5PF;ATP5MC1;ATP5PB;ATP5PD;DMAC2L;ATP5MC3;ATP5F1B;ATP5F1A;ATP5MC2
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),0.9121184681370353,1.4453016879276774,0.02040816326530612,0.2039145355815961,1.0,1/5,2.12%,PCSK2
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.5878362468244143,1.4452074618637563,0.0,0.2039344358960831,1.0,39/135,15.87%,IGF1;RIMS2;EGF;THBS1;SERPINE1;PLEK;SYT4;SYT1;APP;SYT5;RIMS3;MYH9;SYNGR2;RAB11FIP5;CPLX2;SNCA;TMED10;SYT13;PDGFA;SYNGR3;PCLO;CPLX1;DNAJC5;SYTL4;CYRIB;TGFB2;TF;RAB11FIP1;GAS6;ACTN1;SPARC;SYT12;FN1;RAB27B;ABCC4;ARHGAP17;SERPING1;TAGLN2;PIP5K1C
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),-0.8653051045467799,-1.4451182283844834,0.08333333333333333,0.5323134310156356,1.0,1/5,3.70%,SF3A1
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),0.8171531689556759,1.4447174756965553,0.05084745762711865,0.20497081194088854,1.0,3/12,3.84%,IGF1;EGF;TGFA
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.6827490013883085,1.4442281898695197,0.047619047619047616,0.20593416030884626,1.0,7/42,10.56%,IL1RAPL1;S100A10;DMTN;NEDD9;PTPRD;ARHGEF7;CDKL5
prerank,Reactome_2022__Post NMDA Receptor Activation Events R-HSA-438064,0.6311330331995241,1.4441913542474925,0.043478260869565216,0.20571210470617657,1.0,15/58,12.98%,GRIN2A;GRIN2D;GRIN2B;NEFL;RPS6KA1;NRGN;PRKAR1B;NRG1;GRIA1;ARHGEF7;RNASE1;GPRIN1;MAPT;CAMK2B;RPS6KA6
prerank,KEGG_2021_Human__Apelin signaling pathway,0.5923501783087857,1.4440687165043278,0.013888888888888888,0.20589853077975037,1.0,30/107,17.94%,KLF2;GNG3;SERPINE1;ACTA2;ADCY5;MYLK3;GNG2;ITPR3;ADCY7;APLNR;RYR2;ADCY2;SLC9A1;MRAS;SMAD3;PRKCE;HDAC4;MEF2D;CCND1;RPS6KB2;SPP1;NOTCH3;SLC8A2;LIPE;SLC8A1;ADCY3;CALM3;GABARAPL1;GNAI1;ITPR1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.8376577481146998,1.443924570009848,0.016666666666666666,0.20615475460621152,1.0,4/14,8.06%,PAK3;SHANK3;DOCK10;SHANK1
prerank,Reactome_2022__Gastrulation R-HSA-9758941,0.913927828712754,1.443844776744875,0.0,0.20605953480186287,1.0,1/7,0.01%,LEF1
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.9268424016171943,1.4437183033924184,0.03636363636363636,0.20614675276672173,1.0,3/5,5.57%,SCN3B;KCNQ1;GJC1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),0.8910822476323065,1.4436703170160887,0.057692307692307696,0.20610776875956094,1.0,2/7,9.35%,IGF1;PPARG
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.7256057556985626,1.4436257625916216,0.03278688524590164,0.2059010930420796,1.0,4/18,12.47%,APP;SCN2A;FAS;BCL2
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.8906434409953621,1.4434992930282282,0.0625,0.20596025605338844,1.0,2/8,1.78%,ANXA1;DOC2B
prerank,Reactome_2022__Collagen Formation R-HSA-1474290,0.6221694788869307,1.443209729141208,0.0,0.20656326799436656,1.0,18/72,14.22%,COL4A1;CTSS;COL11A2;P4HA2;COL4A2;TLL1;COL8A1;COL21A1;COL23A1;COL12A1;COL27A1;LOXL1;COL9A1;P3H2;COL4A4;COL4A5;COL5A1;PLOD2
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.6353022951538928,1.4428095188710128,0.014705882352941176,0.20742953326416555,1.0,9/60,12.46%,SLC6A15;SLC32A1;SYT1;GAD2;DVL1;CPLX1;DNAJC5;SYN2;SLC29A4
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.6753302476033561,1.4427539119971424,0.016129032258064516,0.20731966827412257,1.0,9/64,3.42%,PROX1;EGF;DCN;SP100;THBS1;EPHA2;SLIT2;DAB2IP;NRP2
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Adipose Tissue,0.6352698527136588,1.4427507882063313,0.028169014084507043,0.2058646794656207,1.0,34/91,16.25%,COL4A1;CSPG4;EDIL3;CALD1;PPFIBP1;COL4A2;DAB2IP;ANGPTL2;MCAM;NUAK1;COL12A1;LAMB1;COL27A1;PTPN21;LARP6;MAP1B;SCARA3;ADGRL2;BGN;CNN3;YAP1;TEAD1;ENAH;MXRA7;FN1;CAP2;FGF2;COL5A1;PLOD2;RBFOX2;BCAR1;SMARCA1;MAP4;FSTL1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone Marrow,0.6352698527136588,1.4427507882063313,0.028169014084507043,0.2058646794656207,1.0,34/91,16.25%,COL4A1;CSPG4;EDIL3;CALD1;PPFIBP1;COL4A2;DAB2IP;ANGPTL2;MCAM;NUAK1;COL12A1;LAMB1;COL27A1;PTPN21;LARP6;MAP1B;SCARA3;ADGRL2;BGN;CNN3;YAP1;TEAD1;ENAH;MXRA7;FN1;CAP2;FGF2;COL5A1;PLOD2;RBFOX2;BCAR1;SMARCA1;MAP4;FSTL1
prerank,CellMarker_Augmented_2021__Progenitor cell:Fetal Liver,0.6352698527136588,1.4427507882063313,0.028169014084507043,0.2058646794656207,1.0,34/91,16.25%,COL4A1;CSPG4;EDIL3;CALD1;PPFIBP1;COL4A2;DAB2IP;ANGPTL2;MCAM;NUAK1;COL12A1;LAMB1;COL27A1;PTPN21;LARP6;MAP1B;SCARA3;ADGRL2;BGN;CNN3;YAP1;TEAD1;ENAH;MXRA7;FN1;CAP2;FGF2;COL5A1;PLOD2;RBFOX2;BCAR1;SMARCA1;MAP4;FSTL1
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Bone,0.6352698527136588,1.4427507882063313,0.028169014084507043,0.2058646794656207,1.0,34/91,16.25%,COL4A1;CSPG4;EDIL3;CALD1;PPFIBP1;COL4A2;DAB2IP;ANGPTL2;MCAM;NUAK1;COL12A1;LAMB1;COL27A1;PTPN21;LARP6;MAP1B;SCARA3;ADGRL2;BGN;CNN3;YAP1;TEAD1;ENAH;MXRA7;FN1;CAP2;FGF2;COL5A1;PLOD2;RBFOX2;BCAR1;SMARCA1;MAP4;FSTL1
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Molar,0.6352698527136588,1.4427507882063313,0.028169014084507043,0.2058646794656207,1.0,34/91,16.25%,COL4A1;CSPG4;EDIL3;CALD1;PPFIBP1;COL4A2;DAB2IP;ANGPTL2;MCAM;NUAK1;COL12A1;LAMB1;COL27A1;PTPN21;LARP6;MAP1B;SCARA3;ADGRL2;BGN;CNN3;YAP1;TEAD1;ENAH;MXRA7;FN1;CAP2;FGF2;COL5A1;PLOD2;RBFOX2;BCAR1;SMARCA1;MAP4;FSTL1
prerank,CellMarker_Augmented_2021__Tumor-propagating cell:Undefined,0.6352698527136588,1.4427507882063313,0.028169014084507043,0.2058646794656207,1.0,34/91,16.25%,COL4A1;CSPG4;EDIL3;CALD1;PPFIBP1;COL4A2;DAB2IP;ANGPTL2;MCAM;NUAK1;COL12A1;LAMB1;COL27A1;PTPN21;LARP6;MAP1B;SCARA3;ADGRL2;BGN;CNN3;YAP1;TEAD1;ENAH;MXRA7;FN1;CAP2;FGF2;COL5A1;PLOD2;RBFOX2;BCAR1;SMARCA1;MAP4;FSTL1
prerank,KEGG_2021_Human__Primary immunodeficiency,0.7523321202297878,1.4426036430772236,0.030303030303030304,0.20589558341044356,1.0,6/16,15.01%,ADA;PTPRC;CIITA;ORAI1;IKBKG;CD4
prerank,Reactome_2022__SIRT1 Negatively Regulates rRNA Expression R-HSA-427359,-0.7521800316943152,-1.4425701863214273,0.061224489795918366,0.5398960354727272,1.0,6/18,6.82%,H2AC20;H3-3B;H2BC4;H2BC21;H2AC6;TAF1D
prerank,Reactome_2022__RHOA GTPase Cycle R-HSA-8980692,0.5975488529246957,1.4423855714460958,0.0,0.2062847624838777,1.0,45/128,22.53%,ANLN;ARHGAP4;VAPB;ARHGAP39;PLEKHG6;ERBIN;ARHGEF17;MCAM;ARHGEF3;RHPN1;OBSCN;DAAM1;MCF2;KALRN;ARHGEF10L;ARHGAP26;ARHGEF7;HMOX2;TRIO;OPHN1;STARD13;ARHGAP18;FMNL3;STOM;MYO9A;TEX2;IQGAP1;ARHGAP22;NGEF;VAV2;MCF2L;ARHGEF40;TFRC;VAV1;TJP2;RTKN;FARP1;DDRGK1;ARHGAP35;ARHGAP9;PREX1;ARHGEF18;FLOT2;TAGAP;PGRMC2
prerank,Reactome_2022__Glutathione Conjugation R-HSA-156590,0.7618106732895943,1.4423494899762497,0.06666666666666667,0.20617743140795672,1.0,3/27,5.59%,GGT5;GSTT2;GGCT
prerank,CellMarker_Augmented_2021__Pancreatic Endoderm cell:Embryonic Stem Cell,0.6289164175824286,1.4422453936681174,0.0,0.2062078543755828,1.0,33/82,18.34%,MET;HRH1;PLK2;P4HA2;EPHA2;OSMR;COL12A1;ITGA2;PTPN21;RHBDF1;SCARA3;MYO1B;EMP1;KITLG;ITGA3;YAP1;PDLIM4;MMP14;EPB41L1;TGFB2;PXDC1;TEAD1;CD276;PALLD;NTN4;LAMA3;SLC44A3;MYOF;FAM114A1;WWTR1;SRPX2;CTTNBP2NL;F3
prerank,KEGG_2021_Human__Peroxisome,-0.5947409306156705,-1.441961233883323,0.06666666666666667,0.5401180066762782,1.0,14/69,11.86%,DAO;ABCD2;PXMP2;PHYH;PRDX1;PMVK;NUDT7;PIPOX;ABCD1;ECH1;PEX10;PEX11B;HMGCL;PEX11A
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.7952866418794236,1.44165214069296,0.07936507936507936,0.20763903743676382,1.0,2/14,3.31%,CHRM3;KCNB2
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),0.8340231439649076,1.4412327775863574,0.0,0.2083260936961251,1.0,5/13,10.19%,MYRF;RIMS2;PARD3;TENM4;TPPP
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),0.7766311258913196,1.4411940611109375,0.017857142857142856,0.208230558356312,1.0,9/20,14.90%,DUSP1;COL4A2;COL8A1;COL12A1;LAMB1;TBX20;MMP14;FN1;LAMA3
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.8327584505619463,1.4410512072471864,0.0196078431372549,0.20828578366218228,1.0,2/9,6.17%,TRIM5;CIITA
prerank,KEGG_2021_Human__MAPK signaling pathway,0.5593401868892841,1.4408462681088503,0.012987012987012988,0.20862792493758195,1.0,40/239,9.86%,TGFBR2;CACNA1H;MET;RASGRP2;IGF1;CACNA1G;PDGFRA;MAP3K6;EGF;RASGRP1;NR4A1;DUSP1;FLT1;PRKCB;EPHA2;PRKCG;RPS6KA1;MAP3K11;CACNG3;DUSP10;EFNA1;IL1R1;TGFA;PTPRR;DUSP8;MAP3K14;FAS;DUSP16;TNFRSF1A;CACNA1C;CACNG8;PDGFA;MYD88;MRAS;MAPK8IP1;CACNA1E;KITLG;GNA12;CACNG4;TGFB2
prerank,Reactome_2022__GPER1 Signaling R-HSA-9634597,0.6912443671230778,1.4406030131240333,0.01694915254237288,0.20891464915623936,1.0,15/34,22.59%,GNG3;ADCY5;PRKAR1B;GNG2;ADCY7;ADCY2;GNAZ;PRKAR1A;SHC1;GNAI1;PRKCA;ADCY9;ADCY8;GNG4;PRKAR2B
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.7339690819509403,-1.4405674288030494,0.125,0.5445032284973205,1.0,2/14,8.07%,TNFAIP3;IFNLR1
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.9330690945622067,-1.4404173174817807,0.0,0.54077268123865,1.0,1/5,3.49%,SMYD5
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.9330690945622067,-1.4404173174817807,0.0,0.54077268123865,1.0,1/5,3.49%,SMYD5
prerank,Reactome_2022__Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,0.7466566078452515,1.4403692831611934,0.03225806451612903,0.2091870620241989,1.0,5/24,2.59%,GRIN3A;GRIN2A;GRIN2D;GRIN2B;NEFL
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.7388072228405755,1.4403565041709192,0.05555555555555555,0.20896849015262137,1.0,8/23,14.71%,HLA-DRA;RASGRP1;CYRIB;CD160;HLA-DRB1;FADD;IL12A;HLA-E
prerank,CellMarker_Augmented_2021__Periodontal Ligament Stem cell:Periodontal Ligament,0.6877693997143941,1.4402598466669068,0.02857142857142857,0.20894089708259878,1.0,8/34,5.76%,HLA-DRA;CTSS;ELMO1;MYO1F;PLEK;SLA;PTPRC;GAB3
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.6118883269552929,1.4402038600688776,0.016666666666666666,0.20889977996390596,1.0,17/72,16.40%,PDGFRA;DMTN;EPHA5;PAK3;BAIAP2;FAM107A;RHOD;PDGFA;FSCN1;ARHGAP18;PRKCD;PAK1;IQGAP1;ARHGAP17;RHOBTB2;BST1;NEB
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.7547809865213295,1.4401729613177867,0.057692307692307696,0.20875017647166583,1.0,7/20,16.36%,THBS1;DMTN;PRKCE;GNA12;ARHGEF7;FGF2;RFFL
prerank,Reactome_2022__Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,0.7538183660423471,1.4400950190327801,0.07272727272727272,0.20868226468108603,1.0,4/21,2.59%,GRIN2A;GRIN2D;GRIN2B;NEFL
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.7641926214477468,-1.4396956109202004,0.05128205128205128,0.5418161422256228,1.0,2/18,4.67%,FAM47E;MCM9
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.7610656754299736,-1.4396321321247065,0.02631578947368421,0.5398983518155028,1.0,7/21,11.72%,MT1E;MT1A;MT1G;AKR1C3;MT1F;HSF1;MT2A
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.8429372461273116,1.439535105608626,0.0,0.2097113423714689,1.0,3/15,2.84%,RFTN1;S100A10;FA2H
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Liver,0.6404038501985125,1.4395108448376734,0.05172413793103448,0.20953426495712554,1.0,26/70,12.14%,ENPP2;ABCA6;ADAMTS4;PDGFRA;DCN;ELMO1;ABCA8;FLT1;ITGA8;COLEC12;SHROOM4;MYH11;HECW2;LDB2;CACNA1C;APLNR;RAMP3;PPP1R16B;ADGRF5;ABCA9;RASL12;RNASE1;ITGA9;SORBS1;RUNX1T1;FGD5
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),0.8665971591356604,1.439073331975731,0.019230769230769232,0.2102357214966962,1.0,2/9,7.51%,ENPP2;CYP1B1
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.7988747580676143,1.4389920737604553,0.05172413793103448,0.2102473595315789,1.0,2/15,5.08%,ABO;B3GALT2
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Brain,0.6569814991852803,1.4387846484127884,0.09375,0.21052853328395812,1.0,11/44,9.78%,GGT5;FLT1;LMO2;PTPRB;DYSF;SIGLEC1;PCDH12;APLNR;RAMP3;ADGRF5;RNASE1
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.7312694720173738,1.4386790579358046,0.06666666666666667,0.21052634171661913,1.0,9/24,9.86%,TGFBR2;PROX1;SLIT2;SOX4;SLIT3;ROBO2;APLNR;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__adenosine metabolic process (GO:0046085),-0.8824258039590362,-1.4383144402140007,0.09302325581395349,0.544256360557653,1.0,1/5,0.04%,ACP3
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.8259331590892162,-1.4382704457802102,0.06521739130434782,0.5421869397500737,1.0,1/11,0.29%,RAB7B
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),-0.9250429586076235,-1.4382272952885,0.02702702702702703,0.5403854532518191,1.0,2/6,3.26%,SOD3;PRDX1
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.8292763628227722,1.4381979250107895,0.0847457627118644,0.21149232968333476,1.0,4/9,12.85%,CDKN2A;LMNA;CGAS;B2M
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.6880516404828052,1.4381057824859955,0.027777777777777776,0.21151588896888918,1.0,8/35,3.65%,CXCL2;GPNMB;TLR2;TYMP;CTSS;MYO1F;PLEK;SIGLEC1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.7735507898382696,1.4375765633136197,0.015873015873015872,0.2123175066589199,1.0,6/17,11.71%,EGF;FYN;CTNNB1;GRM6;PLPP4;CCL2
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.5933383554707508,1.4366496311451913,0.0273972602739726,0.21428309097863607,1.0,32/145,11.38%,NPY;L1CAM;FLRT3;TBC1D24;STMN2;SH3GL2;NLGN1;CNTNAP1;CNTN4;SHTN1;BICDL1;PLP1;APP;DAB2IP;CNTNAP2;STMN4;PAK3;SHANK3;NYAP2;LAMB1;DOCK10;SHANK1;NYAP1;MICALL1;MINK1;PACSIN1;GPRIN1;EPHA4;TRIO;FRY;MAPT;OPHN1
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.7985203511230343,1.436548256674496,0.04918032786885246,0.21422303751928629,1.0,2/14,0.74%,MET;GPNMB
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.754174517007256,-1.4364655545392047,0.10256410256410256,0.5466860503160617,1.0,3/13,11.16%,SETDB1;SIRT6;ZNF304
prerank,CellMarker_Augmented_2021__Stem cell:Fetal Liver,0.6371906660829312,1.436421448617541,0.0,0.21425670782523018,1.0,25/85,11.74%,KCNT2;COL4A1;PDGFRA;PCDH18;STMN2;COL4A2;GAP43;PLPPR4;THY1;OPCML;TCEAL7;ANGPTL2;SEMA5B;LDB2;GRIA3;MAP1B;PTPRD;PKDCC;BGN;RASL12;PCDHB15;NACAD;CRMP1;SPARC;RUNX1T1
prerank,Reactome_2022__Constitutive Signaling By EGFRvIII R-HSA-5637810,0.7715322049579191,1.4362406405628128,0.07142857142857142,0.21439713188305753,1.0,1/14,1.45%,EGF
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.7591195775418824,1.435533383147873,0.13114754098360656,0.2160311503175687,1.0,1/17,0.08%,ENPP2
prerank,KEGG_2021_Human__Pathways in cancer,0.5299576600587597,1.4355312288869273,0.0,0.21582280830452266,1.0,74/406,13.84%,LEF1;TGFBR2;CDKN2A;MET;COL4A1;RASGRP2;IL13RA1;IGF1;PDGFRA;IL15;EGF;GNG3;PLD1;RASGRP1;STAT4;GSTT2;COL4A2;PRKCB;ADCY5;CSF2RA;PRKCG;PIM1;FOXO1;WNT8B;TGFA;FAS;GNG2;LAMB1;ITGA2;DVL1;ZBTB16;BIRC3;ADCY7;ADCY2;DCC;PML;PDGFA;DAPK2;CDK6;LAMA5;CTNNB1;BCL2L1;KITLG;ITGA3;SMAD3;PLD2;GNA12;PPARG;CTBP2;TGFB2;GLI2;STAT3;RASSF1;BBC3;LAMA2;COL4A4;CTNNA1;RUNX1T1;GADD45A;CAMK2B;CDKN1B;FRAT2;BCL2;FN1;ALK;IL4R;CDKN1A;CCND1;CKS1B;COL4A5;FGF2;FADD;LPAR1;RPS6KB2
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.7529367386392097,-1.4352731346525425,0.04878048780487805,0.5500118891273742,1.0,3/13,8.40%,SNF8;SMPD3;VPS4B
prerank,CellMarker_Augmented_2021__Endothelial cell:Blood,0.6549942283488873,1.435107818922264,0.04,0.2165598071176427,1.0,19/53,12.46%,HLA-DRA;RFTN1;ELMO1;PLEK;SLA;PTPRC;MCAM;SLC9A9;GNG2;GAB3;DOCK10;NLRC5;PPP1R16B;FLI1;SYNE3;APOL3;IFFO1;FMNL3;TRIM22
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.8302169536503596,1.435034506969231,0.04,0.2165640192579447,1.0,2/11,3.34%,BOK;DAB2IP
prerank,Reactome_2022__Post-translational Protein Phosphorylation R-HSA-8957275,0.6257203041320133,1.4349832046205315,0.016129032258064516,0.21640889254354936,1.0,15/74,11.07%,SERPINA10;C3;CHGB;SGPP2;FAM20C;APP;CP;LAMB1;IGFBP7;NOTUM;VGF;SHISA5;ITIH2;TF;GAS6
prerank,Reactome_2022__Interleukin-6 Family Signaling R-HSA-6783589,0.7740775366981492,1.434939126107925,0.03508771929824561,0.21625412081019393,1.0,4/17,11.45%,SOCS3;OSMR;STAT3;TYK2
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.9575987138627189,1.4348422876802953,0.019230769230769232,0.21620567952336806,1.0,1/5,0.71%,BOK
prerank,Reactome_2022__Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,0.7732987687559565,1.4347896510190095,0.08196721311475409,0.21607795705462285,1.0,4/18,7.48%,EGF;ERBIN;NRG1;NRG2
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.8678793921732293,1.434200082167949,0.07547169811320754,0.21737794839177052,1.0,3/6,11.35%,GHR;STAT3;PXN
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.815605047627211,1.4340475957976526,0.05357142857142857,0.2175660254307807,1.0,3/14,9.30%,C3;VSTM2A;IKBKE
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7739898355472438,1.4339654925116831,0.03278688524590164,0.21746356487422033,1.0,7/20,16.70%,SULF1;UGDH;HS6ST1;HS3ST4;HS3ST3B1;HS2ST1;HS6ST2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Pancreas,0.9204002676637799,1.4339542168565975,0.0,0.21722961900465398,1.0,5/7,6.44%,MET;CD24;THY1;LGR5;CD44
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.7229088560607341,1.4339027267210782,0.057692307692307696,0.217114616027984,1.0,4/26,4.31%,C3;IL15;SFTPD;PTPRC
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.898298082100009,1.4338848449665862,0.07407407407407407,0.21693416408042301,1.0,2/8,1.17%,TGFBR2;PDGFRA
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),0.8764765356239262,1.433515525970332,0.047619047619047616,0.21741047417894022,1.0,4/9,7.01%,SCN3B;KCNQ1;GJC1;CACNA1C
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6848754781873135,1.4333251603307102,0.046875,0.2176365745335005,1.0,15/31,24.40%,FOXO3;SMAD3;PPARG;TGFB2;STAT3;TEAD1;KLF4;FGF2;ETS1;TP53;NFATC3;HIF1A;APLN;FOS;NFATC4
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Undefined,0.6475830246058214,1.432844837156237,0.01694915254237288,0.21889685858535132,1.0,19/58,9.54%,COL4A1;PRRX1;PDGFRA;DCN;ACTA2;ABCA8;SULF1;ITGA8;ASPN;PODN;ANGPTL2;MYH11;POSTN;OLFML1;SLIT3;TNS1;C1R;BGN;RASL12
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),-0.8708136288831027,-1.432618147470746,0.0425531914893617,0.5603098052956128,1.0,2/6,4.53%,ATF5;RGCC
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.5568256508026457,1.4325417759482655,0.0,0.2194870842280018,1.0,54/164,14.35%,ENPP2;PAPSS2;CDH9;A4GALT;PDGFRA;PDE1C;DCN;GRIK2;ABCA8;DUSP1;CD55;PLEK;SLA;GPR34;ACHE;IL1R1;PODN;SHROOM4;ESYT3;POSTN;STK32B;IGFBP7;CFH;TNS1;LDB2;PID1;APLNR;MAOB;RAMP3;C1R;CSRNP1;ADGRF5;RASL12;RNASE1;ITGA9;RIN2;GNAZ;VWA5A;LAMA2;HS3ST3A1;ENAH;SPARC;PDK4;CCL2;RGL1;ENO2;STARD13;LTC4S;OPTN;COPZ2;LPAR1;RAB27B;COBL;KCTD12
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.6974690444850173,1.4325003651271804,0.037037037037037035,0.2193964498555577,1.0,17/38,21.27%,IRAK2;MAP3K11;NOD1;SH2D3A;MINK1;TNFRSF19;GPS1;IKBKG;MAP3K5;TAB1;GPS2;MAPK9;SH2D3C;RPS27A;ARHGEF6;TAB2;ADORA2B
prerank,CellMarker_Augmented_2021__Neutrophil:Undefined,0.83946007696847,1.4324102015981475,0.0,0.2193451790728798,1.0,5/12,6.44%,TLR2;CD24;CD55;CSF2RA;CD44
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.9133936517753631,1.43219772913248,0.017543859649122806,0.21951567762171442,1.0,4/8,6.45%,CACNA1H;ABCC8;TRPM4;ABCC9
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.8262562154154303,1.4319035464352825,0.0,0.22007650762288328,1.0,2/11,6.17%,TRIM5;CIITA
prerank,Reactome_2022__mRNA Decay By 5 To 3 Exoribonuclease R-HSA-430039,-0.7625046458447408,-1.4318474295296901,0.04081632653061224,0.5611165368412303,1.0,5/15,12.23%,LSM7;LSM3;LSM2;LSM5;LSM4
prerank,CellMarker_Augmented_2021__Endothelial cell:Intervertebral Disc,0.6623350304577492,1.431818024396344,0.03125,0.22003765541959547,1.0,17/51,9.94%,GGT5;DCN;FLT1;GPR34;SIGLEC1;PODN;ACKR1;SHROOM4;PCDH12;MYH11;TNS1;LDB2;APLNR;RAMP3;ADGRF5;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Alveolar Epithelial Progenitor cell:Lung,0.6316031362575286,1.4317611471339917,0.016129032258064516,0.21999889032887104,1.0,31/82,17.68%,MET;PLK2;SERPINE1;P4HA2;EPHA2;OSMR;COL12A1;LAMB1;ITGA2;PTPN21;RHBDF1;SCARA3;EMP1;ITGA3;YAP1;LMNA;TANC1;PXDC1;TEAD1;NPAS2;PSORS1C1;CCND1;PLOD2;NTN4;LAMA3;BCAR1;CD59;MYOF;FAM114A1;WWTR1;SRPX2
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),0.8087457381463002,1.431742321820262,0.04918032786885246,0.21976551105600092,1.0,1/10,0.62%,ST6GAL1
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.7995632702480917,1.4317072897930434,0.031746031746031744,0.21967527490926048,1.0,3/14,3.58%,RECQL4;BLM;RPA1
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.8719043214172237,-1.4316220146151615,0.04081632653061224,0.560165738227187,1.0,1/5,3.38%,ADAMTS12
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.5848325450304649,1.4315096296699195,0.0,0.21993491905637608,1.0,31/134,15.32%,HLA-DRA;MOG;RFTN1;FYB1;PRKCB;WAS;TEC;THY1;PAK3;LAT2;PTPRC;NFATC2;FYN;SKAP1;EIF2B2;NFKBID;PAG1;SYK;HLA-DRB1;CD276;BCL2;PAK1;STOML2;IKBKG;BMX;PIK3CD;INPP5D;BCAR1;CD4;EIF2B5;SH2B2
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.6210692904803343,1.431444210046314,0.06557377049180328,0.21987056847169453,1.0,16/56,17.85%,DMTN;EPHA5;PAK3;BAIAP2;FAM107A;RHOD;PDGFA;FSCN1;ARHGAP18;PRKCD;PAK1;IQGAP1;ARHGAP17;RHOBTB2;BST1;RHOQ
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),-0.9340874776556596,-1.431409919296488,0.06,0.5588554626186516,1.0,2/5,5.74%,HEY2;HEYL
prerank,Reactome_2022__Peroxisomal Protein Import R-HSA-9033241,-0.6217605570247591,-1.4314026052378717,0.0,0.556672008211791,1.0,8/53,11.77%,DAO;PHYH;NUDT7;PIPOX;ACOT2;ECH1;PEX10;HMGCL
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.6986965877526379,1.430891311076135,0.05172413793103448,0.22107273546498585,1.0,7/32,12.16%,ANLN;PTP4A3;FAP;FAT2;CYP1B1;PXN;STARD13
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.9451780585763152,1.4308493705040966,0.019230769230769232,0.22094272217037286,1.0,2/7,2.21%,RECQL4;BLM
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),0.9119399155541223,1.4306614540904095,0.0,0.221019293103883,1.0,1/5,5.12%,NUAK1
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),0.8919011966161514,1.4306184261246342,0.019230769230769232,0.22061873795558457,1.0,3/5,8.84%,KIF5A;KIF5C;KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),0.8919011966161514,1.4306184261246342,0.019230769230769232,0.22061873795558457,1.0,3/5,8.84%,KIF5A;KIF5C;KIF17
prerank,KEGG_2021_Human__Human T-cell leukemia virus 1 infection,0.573185165379442,1.4304788788554577,0.0,0.22093957392775898,1.0,33/172,15.46%,TGFBR2;CDKN2A;HLA-DRA;IL15;CREB5;CCNB2;ZFP36;ADCY5;ICAM1;IL1R1;MAP3K14;NFATC2;TNFRSF1A;ADCY7;MSX2;ADCY2;BCL2L1;SMAD3;TGFB2;VAC14;HLA-DRB1;ITGAL;RELB;B2M;CDKN1A;CCND1;HLA-DMA;IKBKG;PIK3CD;HLA-E;CD4;ETS1;TP53
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Endometrium,0.6582635769998753,1.4302617119912726,0.0,0.221272535622759,1.0,21/69,12.38%,TGFBR2;FOSL2;ANXA1;SOCS3;S100A10;SLC28A3;CP;PLSCR1;AHR;IGFBP7;CD44;EMP1;TMBIM1;MVP;ETV6;MMP14;ADAM28;VWA5A;ITGB8;GSDMD;KLF6
prerank,Reactome_2022__Expression And Translocation Of Olfactory Receptors R-HSA-9752946,0.8668546891906588,1.4300361834148756,0.0,0.221630404923867,1.0,4/12,8.52%,EBF1;OR51M1;LDB2;OR52N2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.7717459228385095,1.4288996676403023,0.05454545454545454,0.22428010737391751,1.0,4/17,7.51%,C3;CCBE1;SULF1;CYP1B1
prerank,Reactome_2022__RHOF GTPase Cycle R-HSA-9035034,0.6986900030105709,1.4287813313983586,0.0,0.2242884339586227,1.0,7/38,11.14%,ARHGAP39;STEAP3;LMNB1;BAIAP2L1;MCAM;BASP1;ACTN1
prerank,KEGG_2021_Human__Hippo signaling pathway,0.5987215250231923,1.4285764823233391,0.0,0.22460345529368145,1.0,25/131,11.20%,LEF1;TGFBR2;TEAD2;YWHAH;AMH;SERPINE1;BMP8A;WNT8B;WTIP;DVL1;PARD3;BIRC3;CTNNB1;YWHAG;SMAD3;YAP1;PPP1CB;TGFB2;GLI2;DLG5;RASSF1;SMAD1;BBC3;TEAD1;CTNNA1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.6910318260184405,1.4285716715486971,0.04838709677419355,0.22438162593687308,1.0,6/35,10.32%,EPHA7;ADA;PTPRR;RNASE10;MINK1;PODXL
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),-0.7148864497510911,-1.4281361114566753,0.05,0.5690439735075005,1.0,3/17,6.01%,MID1IP1;ABCD2;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),0.7305058796857542,1.4276999359403149,0.06153846153846154,0.22649382649836186,1.0,3/21,3.17%,IGF1;EGF;APP
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),0.875270313856658,1.427456239788493,0.03389830508474576,0.22684359853937958,1.0,3/8,7.26%,GRIN3A;APP;GRIN1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.7275314364916903,-1.4271151451654185,0.02702702702702703,0.5713415525211415,1.0,13/30,20.34%,LSM7;EXOSC8;LSM3;LSM2;EXOSC4;LSM5;EXOSC5;LSM4;CNOT7;LSM1;PATL1;DIS3;POLR2G
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),-0.7612881561237466,-1.4270156103695342,0.07142857142857142,0.5696464094375192,1.0,5/12,20.25%,HUS1;RAD9B;CLSPN;DNA2;RAD17
prerank,CellMarker_Augmented_2021__Oligodendrocyte Progenitor cell:Embryonic Prefrontal Cortex,0.577291278378771,1.4268770368915964,0.0,0.22795601869814505,1.0,27/104,11.55%,C2ORF80;CA10;MLLT11;PDGFRA;STMN2;CD24;GRID2;SHTN1;SYT1;TMSB10;SCN1A;RTN1;ELAVL4;ANGPTL2;SOX4;PLLP;LHFPL3;APOD;NEUROD2;ENC1;LUZP2;OCIAD2;COL9A1;DCX;ITGB8;DBI;SPARC
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.8434498660904421,1.4268523030301277,0.07936507936507936,0.22780774411322027,1.0,1/12,0.15%,NR4A3
prerank,CellMarker_Augmented_2021__Megakaryocyte:Fetal Kidney,0.8900794113001946,1.4264565194144125,0.01694915254237288,0.22862466966303102,1.0,3/6,2.58%,RASGRP2;FYB1;PLEK
prerank,Reactome_2022__Phospholipase C-mediated Cascade: FGFR1 R-HSA-5654219,-0.8736468157452619,-1.4263034247685356,0.0975609756097561,0.5706638334492843,1.0,1/8,0.15%,FGF6
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),0.874396579095266,1.4262391574435165,0.01639344262295082,0.22891985228396983,1.0,1/7,1.88%,NMNAT2
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.6734993211588076,-1.426227757416436,0.046511627906976744,0.568596361451181,1.0,10/27,20.27%,BRF2;POLR2K;POLR3E;POLR3B;SNAPC5;POLR3F;BDP1;POLR3H;POLR3K;POLR2L
prerank,Reactome_2022__Activation Of G Protein Gated Potassium Channels R-HSA-1296041,0.7553749280713448,1.4261476861752351,0.04838709677419355,0.22892302620837726,1.0,4/19,5.37%,GNG3;KCNJ2;GABBR2;GNG2
prerank,CellMarker_Augmented_2021__Pericyte:Brain,0.6270708159020397,1.425548913968694,0.015151515151515152,0.23014099142002456,1.0,20/78,7.49%,COL4A1;CSPG4;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;SULF1;COL4A2;THY1;PODN;ANGPTL2;ARHGEF17;POSTN;SLIT3;COL12A1;FAP;GLT8D2;C1R
prerank,CellMarker_Augmented_2021__Lymphoid cell:Peripheral Blood,0.6760455325016254,1.4255430861581502,0.028985507246376812,0.22989001978270718,1.0,15/47,12.99%,RASGRP2;CD22;ELMO1;P2RY13;PTPRO;PLEK;NAPSB;PRKCB;CD37;GNG2;CACNA1E;PPP1R16B;PDE1B;GLT1D1;PHACTR1
prerank,Reactome_2022__Blood Group Systems Biosynthesis R-HSA-9033658,0.8033303261032875,1.425508876538925,0.07017543859649122,0.22972798097857663,1.0,2/11,5.08%,ABO;B3GALT2
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell development (GO:0097084),-0.9210056504304467,-1.4254444554316588,0.038461538461538464,0.5701455228659105,1.0,1/6,1.34%,HEY2
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.6179683901516593,1.4253963451067533,0.015151515151515152,0.22970503605238135,1.0,15/74,7.53%,HTR2C;PDGFRA;CD24;CD55;TRPC3;ADCY5;TRPM4;ITPR3;CCKBR;CACNA1C;JPH4;RYR2;GRIN1;GLP1R;NPTN
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.795441923028182,1.4251780717399485,0.14285714285714285,0.2301735070788275,1.0,4/13,11.69%,NPY;LHX6;MAPT;B4GALT5
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.9248957684050794,1.4251238970925544,0.04838709677419355,0.23002427373481868,1.0,2/6,4.36%,HTR2C;FABP3
prerank,"Reactome_2022__Base-Excision Repair, AP Site Formation R-HSA-73929",-0.7066542220773575,-1.4245996430170167,0.04878048780487805,0.5720382529096738,1.0,4/24,5.51%,H2AC20;H2BC4;H2BC21;H2AC6
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),-0.7189607168812842,-1.4244226705586325,0.07142857142857142,0.5707571898437436,1.0,3/18,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,CellMarker_Augmented_2021__Unrestricted Somatic Stem cell:Embryo,0.9073021943341388,1.4240341328074866,0.06,0.23280459352150237,1.0,2/5,4.31%,THY1;PTPRC
prerank,CellMarker_Augmented_2021__Cancer cell:Brain,-0.5614069507289637,-1.4238559578584074,0.07142857142857142,0.5709859433148124,1.0,20/89,14.74%,KPNA2;RFC3;LRPPRC;DSCC1;PIGW;WDHD1;EIF2S1;POFUT1;SPDL1;NOC3L;SUPT16H;URB2;STT3A;GART;PAICS;NEMP1;MCM4;SMC2;NCL;MRPL19
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.7094965680344966,1.4236856581771098,0.1,0.23370772003809576,1.0,8/27,8.71%,ANXA1;TYMP;TSPYL2;IGFBP7;RYR2;GRK2;YWHAG;SCG5
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),0.7896692534515379,1.4236811849584852,0.04477611940298507,0.23325253015544403,1.0,6/16,8.52%,IL1RAPL2;SLITRK1;IL1RAPL1;APP;SNCA;PTPRD
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),0.7896692534515379,1.4236811849584852,0.04477611940298507,0.23325253015544403,1.0,6/16,8.52%,IL1RAPL2;SLITRK1;IL1RAPL1;APP;SNCA;PTPRD
prerank,Reactome_2022__CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,0.7028414368758441,1.4235083748144512,0.05970149253731343,0.2334011973896032,1.0,7/27,12.98%,GRIN2D;GRIN2B;NEFL;RPS6KA1;GPRIN1;CAMK2B;RPS6KA6
prerank,CellMarker_Augmented_2021__Urine-derived Stem cell:Urine,0.811439723649295,1.4234098047736328,0.08928571428571429,0.23341199997361942,1.0,5/12,6.44%,CD24;THY1;PTPRC;MCAM;CD44
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.8261785283021641,1.4233989118269,0.03278688524590164,0.2331979499725352,1.0,5/11,14.03%,CD24;PTPRO;BASP1;PODXL;IQGAP1
prerank,Reactome_2022__Activation Of Matrix Metalloproteinases R-HSA-1592389,0.7924970732013643,1.4233133967788563,0.04918032786885246,0.2332089480810391,1.0,5/15,12.87%,SPOCK3;TIMP2;MMP14;MMP17;MMP16
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.6257703116022527,1.4229358777493004,0.0,0.23414223304794624,1.0,15/63,9.88%,COL4A1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;ITGA8;COL4A2;POSTN;COL12A1;IGFBP7;GLT8D2;BGN;LOXL1;GLI2
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.5860999900359468,1.4228407061448896,0.0,0.2341023921898381,1.0,24/119,15.19%,HLA-DRA;MOG;RFTN1;FYB1;WAS;TEC;THY1;PAK3;PTPRC;FYN;SKAP1;EIF2B2;NFKBID;PAG1;HLA-DRB1;CD276;PAK1;STOML2;IKBKG;PIK3CD;INPP5D;BCAR1;CD4;EIF2B5
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Bone Marrow,0.6183635961606622,1.4227249129021269,0.028985507246376812,0.23421187974115726,1.0,19/83,9.03%,COL4A1;PRRX1;EDIL3;PDGFRA;PCDH18;SERPINE1;CALD1;COL4A2;THY1;ANGPTL2;OSMR;POSTN;COL12A1;LAMB1;FAP;C1R;SCARA3;BGN;CNN3
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Heart,0.8996362501287096,1.4227224307540682,0.0784313725490196,0.2339732723670037,1.0,2/5,2.12%,ACTA2;CALD1
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.7371436311050139,1.422700191094348,0.03636363636363636,0.23375999648541965,1.0,3/24,1.98%,MET;STMN2;PSRC1
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.5763220254342851,1.422637376581906,0.015384615384615385,0.2336835438637045,1.0,31/172,15.78%,CDKN2A;HPN;RASGRP2;KIF14;TP53TG5;PSRC1;LTBP4;SLIT2;RPS6KA1;TSPYL2;SLIT3;BCL6;FAM107A;MFSD2A;BAP1;PAK4;PML;SMAD3;MMP14;TGFB2;FBP1;CDKN1B;BCL2;TMC8;CDKN1A;PPP1R9B;TRIM32;SIPA1;BCAR1;TP53;H3-3A
prerank,Reactome_2022__Cleavage Of Damaged Pyrimidine R-HSA-110329,-0.7148127772264937,-1.4225633327003453,0.07317073170731707,0.5752264789936683,1.0,4/23,5.51%,H2AC20;H2BC4;H2BC21;H2AC6
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),-0.7898467957303271,-1.422213414053318,0.0425531914893617,0.5745316009901122,1.0,5/16,12.15%,RPS28;MRPS7;RPS27L;RPSA;LOC102724159
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.7223793610411201,1.4220709422679871,0.047619047619047616,0.2350933058402202,1.0,9/29,9.86%,TGFBR2;PROX1;SLIT2;SOX4;SLIT3;ROBO2;APLNR;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.7555250911342467,1.4217033028838792,0.034482758620689655,0.23568360282075046,1.0,6/17,12.33%,SYT4;SYT1;SYT5;SNCA;SYT13;SYT12
prerank,CellMarker_Augmented_2021__Cardiomyocyte Progenitor cell:Myocardium,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Keratinocyte:Epithelium,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Peripheral Blood,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Bone Marrow,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Umbilical Cord Blood,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Monocyte:Umbilical Cord Blood,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Periodontal Ligament,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Mature Endothelial cell:Blood,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Stromal Vascular Fraction cell:Adipose Tissue,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Adipose Tissue,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Progenitor-like Angiogenesis-Promoting cell:Blood,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Dendritic cell:Umbilical Cord Blood,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Endothelial cell:Corpus Luteum,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Endothelial cell:Bladder,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,CellMarker_Augmented_2021__Submandibular Gland Stem cell:Submandibular Gland,0.6522392183822454,1.4212937343879095,0.0,0.23309025862539953,1.0,20/58,9.94%,GGT5;DCN;ABCA8;FLT1;ITGA8;PTPRB;ASPN;PODN;ACKR1;SHROOM4;PCDH12;MYH11;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1;ITGA9
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),0.913589163993691,1.4211924038434423,0.0,0.23312541847163132,1.0,3/8,6.72%,NPNT;SLIT2;ROBO2
prerank,CellMarker_Augmented_2021__Vascular Smooth Muscle cell:Embryonic Stem Cell,0.6402816769789746,1.4210730441911512,0.0,0.2331726547119547,1.0,23/74,11.55%,ENPP2;COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;COL4A2;THY1;PODN;ANGPTL2;POSTN;FAP;TNS1;LDB2;CACNA1C;C1R;BGN;RASL12;ZCCHC24;LAMA2;SPARC
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.9415158131095787,1.4210091645034248,0.0196078431372549,0.23304986868247451,1.0,1/5,0.52%,COL4A1
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),0.8390463604053469,1.4209265361948684,0.10526315789473684,0.23298796295669535,1.0,4/8,10.90%,IGF1;NECAB1;NECAB2;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.7481965808004155,1.420899232446235,0.07936507936507936,0.23284140249095867,1.0,6/18,9.58%,IGF1;PROX1;RBM24;MYLK3;NRG1;MMP14
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),0.9543866704025434,1.4206896064180567,0.017543859649122806,0.2332517191704204,1.0,1/5,0.11%,CACNA1H
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.7072198158453437,1.4206757489867128,0.05084745762711865,0.23303266878474915,1.0,8/36,11.14%,CLIC1;PDGFRA;PLEK;MYH9;MEGF11;RAP2B;P2RY12;ACTN1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Tooth,0.6912688187653707,1.4204367844900094,0.030303030303030304,0.23349022806730532,1.0,12/42,8.63%,IPCEF1;RASGRP2;ITM2A;ELMO1;MYO1F;PLEK;SLA;PRKCB;PTPRC;GAB3;TESPA1;PPP1R16B
prerank,Reactome_2022__Binding Of TCF/LEF:CTNNB1 To Target Gene Promoters R-HSA-4411364,0.9418518395357883,1.420313155492777,0.0,0.23362117183552977,1.0,1/6,0.01%,LEF1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.6595329952374748,1.4202840919405748,0.08333333333333333,0.23345061676910514,1.0,11/44,9.44%,MET;ANXA1;EPHA2;FA2H;LSR;ALOX12;CLIC4;PDGFA;DHCR24;ITGA3;CERS3
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.7317362331630017,1.4202339394225723,0.05172413793103448,0.2333165255750589,1.0,4/19,7.18%,HTR2C;PTPRC;ITPR3;RYR2
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.8934808029921788,-1.4202334080350174,0.0196078431372549,0.5812843479510462,1.0,1/5,1.74%,VAMP8
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.8664427574325786,1.4201290248735505,0.0625,0.23347129016330329,1.0,1/7,0.49%,NDST4
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),0.9483752518685384,1.419732890888235,0.0,0.2340821750186414,1.0,2/6,1.52%,ANXA1;AMH
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.7908676228732874,1.419662213195008,0.07042253521126761,0.23406783818473068,1.0,2/14,6.35%,IGF1;NRG1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.9812692425144616,1.4194790383113873,0.02,0.23440114712505705,1.0,1/5,0.29%,ANLN
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation In TLR7/8 Or 9 Signaling R-HSA-975110,0.8458264077630475,1.4194610789735294,0.04081632653061224,0.2341829459392994,1.0,2/6,7.62%,IRF7;MYD88
prerank,Reactome_2022__Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,0.703974322826748,1.419144488333063,0.018518518518518517,0.23474272656984835,1.0,7/33,7.44%,GNG3;ADCY5;KCNC2;PRKAR1B;GNG2;ITPR3;GLP1R
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.5639489027748721,1.4191377551078839,0.04225352112676056,0.23452462313968525,1.0,44/155,13.49%,ECM2;COL4A1;ADAMTS4;COL11A2;NPNT;ADAMTSL2;DCN;THBS1;SERPINE1;ITGA8;COL4A2;ICAM1;APP;ADAMTS10;COL8A1;POSTN;COL23A1;LAMB1;ITGA2;COL27A1;ADAMTS19;CD44;AGRN;PDGFA;ITGA11;LAMA5;ITGA3;BGN;LOXL1;MMP14;ADAM19;ITGA9;COL9A1;ADAM12;LAMA2;ITGB8;COL4A4;MMP17;SPARC;ITGAL;FN1;MMP16;COL4A5;FGF2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.8732088798774803,1.4191087632682315,0.041666666666666664,0.23440246801447281,1.0,1/9,2.21%,BLM
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.7953601299504007,-1.419069785944745,0.021739130434782608,0.5845102841770838,1.0,3/11,7.44%,UQCRFS1;UQCRB;UQCRHL
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.6268575716949236,1.418971576010836,0.030303030303030304,0.23455484159536602,1.0,23/69,10.81%,COL4A1;PDGFRA;DCN;ACTA2;CALD1;SULF1;COL4A2;FBLIM1;ASPN;PODN;ANGPTL2;MYH11;POSTN;SLIT3;COL12A1;TNS1;C1R;MATN2;BGN;RASL12;RBPMS;SLCO2A1;LAMA2
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),0.9480153189228565,1.418747953372305,0.0,0.23484985613073847,1.0,1/5,0.57%,C3
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),-0.7728591594162564,-1.4186439550153307,0.11538461538461539,0.584249639448471,1.0,3/13,3.49%,APOBEC3G;TEX15;SMYD5
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.8281751273827781,1.4184548738228877,0.0392156862745098,0.23526327104340825,1.0,3/12,2.44%,IGF1;SULF1;DUSP1
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),-0.6166389245513594,-1.4183988773685021,0.0,0.583416146751501,1.0,14/51,14.54%,SLC25A5;COX18;TIMM8B;SLC25A4;AIP;TIMM13;BCAP31;BAK1;ABCB10;TIMM23;BAD;TSPO;TIMM10;SLC25A24
prerank,Reactome_2022__FGFR1 Mutant Receptor Activation R-HSA-1839124,-0.7110558067093143,-1.418097055431196,0.13043478260869565,0.5821880871798951,1.0,1/24,0.15%,FGF6
prerank,Reactome_2022__IRS-mediated Signaling R-HSA-112399,-0.6634606855075595,-1.4180700114752922,0.12195121951219512,0.5801420353043162,1.0,4/31,5.54%,FGF6;FLT3;THEM4;TRIB3
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.8401055179738465,1.4180292689630307,0.03508771929824561,0.23611570909191473,1.0,7/11,12.22%,APP;SHANK3;NETO1;SYP;NPTN;NEURL1;CAMK2B
prerank,KEGG_2021_Human__Wnt signaling pathway,0.5900151967112912,1.417883995580366,0.02702702702702703,0.23630133150842936,1.0,21/131,13.20%,LEF1;PRKCB;PRKCG;WNT8B;LGR5;NFATC2;NOTUM;DVL1;SERPINF1;DAAM1;CTNNB1;TBL1X;SMAD3;CTBP2;TLE6;TLE3;PRICKLE2;PRICKLE1;CAMK2B;FRAT2;CCND1
prerank,Reactome_2022__Metalloprotease DUBs R-HSA-5689901,-0.7117319711592143,-1.4176122406524012,0.0784313725490196,0.5803847651372208,1.0,3/20,7.38%,H2AC20;H2AC6;ABRAXAS1
prerank,Reactome_2022__PTK6 Expression R-HSA-8849473,0.8641660443478368,1.417415439613772,0.07142857142857142,0.2375662046146557,1.0,1/5,1.86%,PTK6
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.6000926763922495,-1.4173653271075757,0.0967741935483871,0.57969138242428,1.0,5/70,5.88%,NUP62CL;RITA1;RBM8A;RAE1;U2AF1
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.596124271614284,1.417308479862855,0.04918032786885246,0.23760774100230952,1.0,14/68,11.26%,HPN;NPY1R;PROX1;ABCA8;FAM124A;COL12A1;GRAMD2A;ALDOB;MAOB;MATN2;ENPEP;KALRN;SORBS1;VSTM2L
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.7386715417186702,1.4168071936127726,0.06060606060606061,0.23876213713957886,1.0,5/16,5.78%,ANXA1;ZFP36;SLIT2;SLIT3;FAM107A
prerank,Reactome_2022__DEx/H-box Helicases Activate Type I IFN And Inflammatory Cytokines Production R-HSA-3134963,0.8446744006211752,1.4166960676066067,0.07547169811320754,0.23890881821254123,1.0,2/7,7.62%,IRF7;MYD88
prerank,GO_Biological_Process_2021__pericardium morphogenesis (GO:0003344),0.9168287018609473,1.416669081710606,0.0392156862745098,0.23872436069986708,1.0,2/5,6.64%,FLRT3;TBX20
prerank,Reactome_2022__Platelet Homeostasis R-HSA-418346,0.6299155727793636,1.4165451748098263,0.028985507246376812,0.2389297998304394,1.0,19/62,16.77%,GNG3;TRPC3;ATP2B3;KCNMB4;PRKG2;GNG2;ITPR3;PDE1A;GUCY1A2;GUCY1A1;ORAI1;PDE1B;GUCY1B1;PDE10A;KCNMA1;P2RX7;ATP2B4;SLC8A2;SLC8A1
prerank,Reactome_2022__ERBB2 Regulates Cell Motility R-HSA-6785631,0.809247544480348,1.4165128595242136,0.0847457627118644,0.23879286289968873,1.0,3/12,7.48%,EGF;NRG1;NRG2
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.6425339132690583,1.416263866324364,0.031746031746031744,0.2391627302972537,1.0,15/37,24.66%,EGF;ERBIN;TGFA;REPS2;GAB1;IQGAP1;BCAR1;SHC1;NCK2;ADAM17;DGKD;PTPN11;RPS6KA5;CBL;PLCE1
prerank,CellMarker_Augmented_2021__Myometrial Stem cell:Myometrium,0.6415269173222452,1.4161639946554945,0.02857142857142857,0.23761374471076457,1.0,26/78,15.37%,TGFBR2;FOSL2;ANXA1;ADGRE5;S100A10;SP100;FAS;AHR;BIRC3;CD44;DOCK10;NLRC5;EMP1;MVP;PARP9;GSDMD;KLF6;B2M;PRDM1;IFIH1;HLA-E;S100A6;PDCD1LG2;DPYD;ETS1;STAT6
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Myometrium,0.6415269173222452,1.4161639946554945,0.02857142857142857,0.23761374471076457,1.0,26/78,15.37%,TGFBR2;FOSL2;ANXA1;ADGRE5;S100A10;SP100;FAS;AHR;BIRC3;CD44;DOCK10;NLRC5;EMP1;MVP;PARP9;GSDMD;KLF6;B2M;PRDM1;IFIH1;HLA-E;S100A6;PDCD1LG2;DPYD;ETS1;STAT6
prerank,CellMarker_Augmented_2021__Serous Acinar cell:Salivary Gland,0.6415269173222452,1.4161639946554945,0.02857142857142857,0.23761374471076457,1.0,26/78,15.37%,TGFBR2;FOSL2;ANXA1;ADGRE5;S100A10;SP100;FAS;AHR;BIRC3;CD44;DOCK10;NLRC5;EMP1;MVP;PARP9;GSDMD;KLF6;B2M;PRDM1;IFIH1;HLA-E;S100A6;PDCD1LG2;DPYD;ETS1;STAT6
prerank,CellMarker_Augmented_2021__Muller Glia Precursor cell:Retina,0.6415269173222452,1.4161639946554945,0.02857142857142857,0.23761374471076457,1.0,26/78,15.37%,TGFBR2;FOSL2;ANXA1;ADGRE5;S100A10;SP100;FAS;AHR;BIRC3;CD44;DOCK10;NLRC5;EMP1;MVP;PARP9;GSDMD;KLF6;B2M;PRDM1;IFIH1;HLA-E;S100A6;PDCD1LG2;DPYD;ETS1;STAT6
prerank,CellMarker_Augmented_2021__Prostate Stem cell:Prostate,0.6415269173222452,1.4161639946554945,0.02857142857142857,0.23761374471076457,1.0,26/78,15.37%,TGFBR2;FOSL2;ANXA1;ADGRE5;S100A10;SP100;FAS;AHR;BIRC3;CD44;DOCK10;NLRC5;EMP1;MVP;PARP9;GSDMD;KLF6;B2M;PRDM1;IFIH1;HLA-E;S100A6;PDCD1LG2;DPYD;ETS1;STAT6
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Amniotic Fluid,0.6415269173222452,1.4161639946554945,0.02857142857142857,0.23761374471076457,1.0,26/78,15.37%,TGFBR2;FOSL2;ANXA1;ADGRE5;S100A10;SP100;FAS;AHR;BIRC3;CD44;DOCK10;NLRC5;EMP1;MVP;PARP9;GSDMD;KLF6;B2M;PRDM1;IFIH1;HLA-E;S100A6;PDCD1LG2;DPYD;ETS1;STAT6
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Oral Cavity,0.6415269173222452,1.4161639946554945,0.02857142857142857,0.23761374471076457,1.0,26/78,15.37%,TGFBR2;FOSL2;ANXA1;ADGRE5;S100A10;SP100;FAS;AHR;BIRC3;CD44;DOCK10;NLRC5;EMP1;MVP;PARP9;GSDMD;KLF6;B2M;PRDM1;IFIH1;HLA-E;S100A6;PDCD1LG2;DPYD;ETS1;STAT6
prerank,Reactome_2022__Interleukin-10 Signaling R-HSA-6783783,0.8327309963460324,1.415916411100184,0.0,0.23793507922565324,1.0,8/13,14.19%,CXCL2;ICAM1;IL1R1;TNFRSF1A;STAT3;TYK2;CCL2;IL12A
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Salivary Gland,0.6158170149636117,1.4157955639315973,0.05970149253731343,0.23802230834059562,1.0,27/72,18.34%,MET;COL4A1;SERPINE1;COL4A2;FBLIM1;EPHA2;OSMR;COL12A1;LAMB1;ITGA2;MYO1B;YAP1;TUBB6;PDLIM4;MMP14;P3H2;CD276;FN1;PDPN;PALLD;FSTL1;FAM114A1;WWTR1;WNT5A;SRPX2;CTTNBP2NL;F3
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation R-HSA-76046,-0.6366593155129636,-1.4157780482296205,0.047619047619047616,0.585039432810348,1.0,13/35,23.13%,BRF2;POLR2K;POLR3E;POLR3B;SNAPC5;POLR3F;BDP1;POLR3H;GTF3A;POLR3K;POLR2L;POLR2E;GTF3C6
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Prostate,0.7488673304743525,1.4156997194130496,0.031746031746031744,0.23805105611096156,1.0,7/24,8.72%,A4GALT;CD24;PSCA;CSF2RA;ITGA2;CD44;ITGA3
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),0.6899544151931628,1.4154206332148092,0.0,0.238545723972476,1.0,11/32,17.44%,STMN2;STMN4;FAM107A;MAPRE2;TRIM36;TPPP;MAPT;PHLDB2;CAMSAP3;STMN1;SKA2
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.5629383746475977,1.4153504531922658,0.041666666666666664,0.23860880175066812,1.0,44/155,13.49%,ECM2;COL4A1;ADAMTS4;COL11A2;NPNT;ADAMTSL2;DCN;THBS1;SERPINE1;ITGA8;COL4A2;ICAM1;APP;ADAMTS10;COL8A1;POSTN;COL23A1;LAMB1;ITGA2;COL27A1;ADAMTS19;CD44;AGRN;PDGFA;ITGA11;LAMA5;ITGA3;BGN;LOXL1;MMP14;ADAM19;ITGA9;COL9A1;ADAM12;LAMA2;ITGB8;COL4A4;MMP17;SPARC;ITGAL;FN1;MMP16;COL4A5;FGF2
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.9640407005138537,1.41532326835427,0.018518518518518517,0.23849736182535575,1.0,4/5,3.57%,ANK3;CNTN2;CNTNAP1;CNTNAP2
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.6052987510626989,1.4152640421134974,0.03076923076923077,0.23836291636952128,1.0,22/86,15.01%,MET;PDGFRA;EPHA7;FLT1;EPHA2;RELN;EPHA5;AGAP2;PTPRC;NTRK3;MMD;VAC14;EPHA4;MAPT;GAS6;HLA-DRB1;EEF1A2;ALK;CDKN1A;IQGAP1;MRE11;CD4
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.8880065105795104,1.4149991807701183,0.08333333333333333,0.23884368860404828,1.0,3/7,9.30%,C3;VSTM2A;IKBKE
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.6824703463729319,1.4149379292360889,0.015384615384615385,0.2387439393113143,1.0,11/37,14.07%,SLC6A15;SLC7A2;SLC43A1;SLC16A10;SLC25A45;SLC38A11;SLC7A7;SLC25A29;SLC7A14;PDPN;SLC7A1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.9064865695089148,1.4146780951652609,0.038461538461538464,0.23928126841983569,1.0,1/7,0.08%,ENPP2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.6383987860915477,1.4145286903930785,0.04918032786885246,0.23934323441048633,1.0,13/58,12.19%,TBC1D24;PLD1;DMTN;GAP43;EPHA2;WAS;PPP1R16B;FSCN1;PODXL;CDKL5;USP6NL;ARF6;TBC1D1
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.6195049399752248,1.4144351580068317,0.04477611940298507,0.23933573765944577,1.0,9/66,7.62%,TLR2;RFTN1;CTSS;SFTPD;IRAK2;COLEC12;BIRC3;SCARA3;MYD88
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.7872414502592067,1.4141852822811412,0.015384615384615385,0.2396976964686531,1.0,4/19,10.96%,SOCS3;NLRC5;PPARG;PARP9
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Parotid Gland,0.6015941080302364,1.4139979340981237,0.04,0.24000126730184296,1.0,26/87,15.15%,COL4A1;PDGFRA;PCDH18;SULF1;COL4A2;SLIT2;NRP2;THY1;TCEAL7;ANGPTL2;POSTN;SEMA5B;ANOS1;BOC;TENM4;PTPRD;PDLIM4;RASL12;CRMP1;SPARC;RUNX1T1;PDPN;IGDCC4;THBS2;NOTCH3;PDZRN3
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.8415874859908095,1.4139897008540447,0.037037037037037035,0.23979726365538734,1.0,2/12,1.68%,MET;THBS1
prerank,CellMarker_Augmented_2021__Pericyte:Skeletal Muscle,0.6061600452386259,1.4138401025690464,0.015151515151515152,0.23991596268783585,1.0,21/81,7.43%,ENPP2;ADAMTS4;DCN;ELMO1;ABCA8;FLT1;ITGA8;PLXDC1;PODN;ACKR1;SHROOM4;PCDH12;MYH11;PTPRC;MCAM;FAM107A;TMEM132C;LDB2;CACNA1C;APLNR;RAMP3
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.8490665916821694,1.4137113113360378,0.1346153846153846,0.24011492064838547,1.0,4/8,13.10%,CNTN2;CNTNAP2;AGRN;PICK1
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),0.7196118242190225,1.4136089130066227,0.01639344262295082,0.24002628900802622,1.0,8/29,16.24%,DAB2IP;FAS;DAPK2;NR4A2;TPD52L1;BCL2;SGMS1;MAPK8IP2
prerank,CellMarker_Augmented_2021__Purkinje cell:Undefined,0.7417997414565911,1.4135375148564693,0.06666666666666667,0.23992635644056287,1.0,7/22,10.46%,PDE1C;MBP;PCP4;ITPR3;GRIN1;GFAP;PDE1B
prerank,CellMarker_Augmented_2021__Endothelial cell:White Adipose Tissue,0.6250502330759026,1.4135157062734873,0.0,0.23973490089376054,1.0,24/59,12.14%,GGT5;COL4A1;DCN;COL4A2;PTPRB;DYSF;PODN;SHROOM4;ANGPTL2;MCAM;POSTN;IGFBP7;CFH;TNS1;LDB2;APLNR;RAMP3;ADGRF5;BGN;RASL12;RNASE1;SLCO2A1;SPARC;FGD5
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.8185028385806682,1.4134200214287949,0.05555555555555555,0.2398072600734185,1.0,4/9,6.91%,ANXA1;IL1RAPL1;ATP9A;SNCA
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Undefined,0.7059042220187784,1.4134112228663867,0.06779661016949153,0.2395819727482284,1.0,12/37,8.72%,CSPG4;ADGRE5;ACTA2;CD55;ICAM1;THY1;PTPRC;MCAM;ITGA2;CD44;TNFRSF1A;ITGA3
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.7433846653698375,1.4132979446610547,0.07142857142857142,0.2396429088609538,1.0,2/14,2.81%,SCN1B;SCN3B
prerank,KEGG_2021_Human__Hepatitis C,0.5982721234988442,1.4131015019272937,0.03389830508474576,0.24002348213440639,1.0,25/110,16.30%,SOCS3;YWHAH;EGF;CLDN16;IRF7;FAS;TNFRSF1A;LDLR;CDK6;CTNNB1;YWHAG;IKBKE;STAT3;CLDN18;TYK2;MX1;CLDN20;CDKN1A;CCND1;FADD;IKBKG;PIK3CD;TP53;RXRA;CDK2
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),0.7993516950835404,1.4128808538552817,0.06779661016949153,0.24020935900953597,1.0,3/13,9.80%,NMNAT2;AK3;AK5
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.8664559313700876,1.4128011292672162,0.03773584905660377,0.2401555240395103,1.0,3/9,8.06%,CTSS;RAB11FIP5;SLC9A1
prerank,Reactome_2022__RMTs Methylate Histone Arginines R-HSA-3214858,-0.6472973204481484,-1.412450119044263,0.047619047619047616,0.5979074232277859,1.0,5/34,12.97%,H2AC20;H2AC6;RPS2;SMARCD1;WDR77
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.6505751068071339,1.4123694633658241,0.031746031746031744,0.24112655708418554,1.0,17/61,14.12%,SLITRK1;FLRT3;NLGN1;GABRB2;GRID2;ACHE;SHANK3;GABRA1;DVL1;KIRREL3;GABRG2;DNER;LRRC4;FGF13;SDK2;PCDHB2;PCDHB5
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.6283543170419078,1.4123035977489462,0.014705882352941176,0.2410378024604777,1.0,18/74,15.88%,GGT5;ANXA1;FOXO1;ERBIN;WNT8B;FOXO3;SNCA;CTNNB1;PPARG;STAT3;ABCA2;ASXL1;ALPL;IL12A;SPP1;RARA;RARG;RXRA
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.6105399422091519,1.4122117621981243,0.047619047619047616,0.24105149715652474,1.0,11/86,10.51%,TGFBR2;SKOR1;ADAMTSL2;VWC2;VWC2L;ASPN;PMEPA1;LDLRAD4;SMAD3;PPARG;SMAD1
prerank,Reactome_2022__Signaling By ERBB2 R-HSA-1227986,0.6651323972700808,1.412199131811684,0.08771929824561403,0.24083810920564827,1.0,8/45,12.29%,EGF;PTK6;ERBIN;FYN;NRG1;NRG2;PRKCE;PRKCD
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.8078453453260039,1.412056046356364,0.01694915254237288,0.24113551456241814,1.0,3/13,2.82%,SERPINE1;DUSP1;SLIT2
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),0.9158941192612883,1.4118809031975459,0.018867924528301886,0.24146633026938738,1.0,3/7,3.66%,PTPRO;PTPRB;DUSP10
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),0.8883302571087124,1.4117688160450208,0.03278688524590164,0.24161538735730648,1.0,2/6,3.99%,RBM24;ELAVL4
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.9257762307310101,1.4117365478795603,0.041666666666666664,0.2412912692489354,1.0,1/5,2.28%,STPG4
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.9257762307310101,1.4117365478795603,0.041666666666666664,0.2412912692489354,1.0,1/5,2.28%,STPG4
prerank,CellMarker_Augmented_2021__Peritubular Myoid cell:Testis,0.6178611673231011,1.4116825321889495,0.05,0.24025600062587563,1.0,20/69,8.95%,ECM2;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;ABCA8;SULF1;ITGA8;ASPN;PODN;ANGPTL2;POSTN;OLFML1;SLIT3;FAP;IGFBP7;C1R;ITGA11;BGN
prerank,CellMarker_Augmented_2021__Smooth Muscle cell:Blood Vessel,0.6178611673231011,1.4116825321889495,0.05,0.24025600062587563,1.0,20/69,8.95%,ECM2;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;ABCA8;SULF1;ITGA8;ASPN;PODN;ANGPTL2;POSTN;OLFML1;SLIT3;FAP;IGFBP7;C1R;ITGA11;BGN
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Undefined,0.6178611673231011,1.4116825321889495,0.05,0.24025600062587563,1.0,20/69,8.95%,ECM2;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;ABCA8;SULF1;ITGA8;ASPN;PODN;ANGPTL2;POSTN;OLFML1;SLIT3;FAP;IGFBP7;C1R;ITGA11;BGN
prerank,CellMarker_Augmented_2021__Myofibroblast:Undefined,0.6178611673231011,1.4116825321889495,0.05,0.24025600062587563,1.0,20/69,8.95%,ECM2;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;ABCA8;SULF1;ITGA8;ASPN;PODN;ANGPTL2;POSTN;OLFML1;SLIT3;FAP;IGFBP7;C1R;ITGA11;BGN
prerank,CellMarker_Augmented_2021__Fibroblast:Corneal Endothelium,0.6178611673231011,1.4116825321889495,0.05,0.24025600062587563,1.0,20/69,8.95%,ECM2;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;ABCA8;SULF1;ITGA8;ASPN;PODN;ANGPTL2;POSTN;OLFML1;SLIT3;FAP;IGFBP7;C1R;ITGA11;BGN
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),-0.6781930736572225,-1.4116188649832226,0.07894736842105263,0.5990329724445314,1.0,11/21,15.16%,MT1E;MT1A;SLC30A8;SLC39A10;MT1G;MT1F;SLC30A5;MT2A;SLC39A8;SLC39A6;MT3
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.6025714038289834,1.411574889386613,0.04477611940298507,0.24034891611947393,1.0,18/75,12.93%,MET;PDGFRA;EPHA7;FLT1;EPHA2;IRS2;EPHA5;TSPYL2;NTRK3;LDB2;NLRC5;VAC14;EPHA4;MAPT;CDKN1C;HLA-DRB1;CDKN1B;ALK
prerank,CellMarker_Augmented_2021__Leydig cell:Testis,0.6512060385765434,1.4114482738275465,0.015384615384615385,0.24045287262824033,1.0,14/57,17.02%,SHISA7;CDH9;PRSS57;ADD2;GABRG3;ASIC4;TSSC2;NR6A1;ZNF850;JARID2;USP49;SLC1A6;MEIOB;ATAD5
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.6605527125425562,1.4112541100183866,0.08955223880597014,0.24074719904138947,1.0,9/33,6.95%,ANK3;CTSS;KCNJ2;KCNQ1;NOS1AP;KCNMB4;GABBR2;GNG2;KCNH2
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5784627577261344,-1.411082408025319,0.13333333333333333,0.5991459967567924,1.0,19/55,18.97%,BUD23;TFB2M;TRMT61A;TRMT10C;TRMT10A;METTL8;METTL2A;METTL3;FTSJ1;MTERF4;TRMT61B;TRMT5;VIRMA;TFB1M;MEPCE;TGS1;FBL;LCMT2;TRDMT1
prerank,Reactome_2022__Signaling By PDGFRA Extracellular Domain Mutants R-HSA-9673770,0.8150732063725294,1.4104797988191773,0.03278688524590164,0.2428440322098659,1.0,2/10,10.27%,PDGFRA;STAT3
prerank,CellMarker_Augmented_2021__Hematopoietic Progenitor cell:Undefined,0.6235589086330765,1.4102540467924207,0.04838709677419355,0.24350470010586708,1.0,28/65,12.14%,COL4A1;PDGFRA;RGS7BP;RCAN2;SULF1;FLT1;CNTN4;SHROOM4;ANGPTL2;POSTN;RAI2;LDB2;ALDOB;APLNR;RAMP3;ENPEP;ADGRL2;GNA14;PTPRD;ADGRF5;BGN;RASL12;RNASE1;ITGA9;SLCO2A1;SORBS1;RUNX1T1;FGD5
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex5:Brain,0.8985234744460258,1.4100952661764863,0.01639344262295082,0.24369463345863088,1.0,3/7,6.45%,IL1RAPL2;TLL1;ABCC9
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.8262158562065262,1.4098716153188042,0.08333333333333333,0.244007036300324,1.0,4/10,12.18%,IL27RA;STAT3;TYK2;MX1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.6221693695440467,1.4095806263958368,0.056338028169014086,0.24485433113219704,1.0,10/84,5.47%,NR4A3;HPN;IGF1;PROX1;EGF;NR4A1;NRP2;TGFA;EGFL7;LAMB1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),0.7604387090537358,1.4094242887134922,0.04477611940298507,0.24513158195242432,1.0,8/20,14.75%,IGF1;PDGFRA;PDGFA;CDK6;GAS6;FN1;CDKN1A;S100A6
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),-0.8783006389346866,-1.4091562529848822,0.020833333333333332,0.6066235017650125,1.0,2/9,3.43%,RTRAF;SIDT1
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),-0.6912453426111564,-1.408980278584706,0.12244897959183673,0.6054064659030464,1.0,2/20,4.40%,CFAP53;FOXJ1
prerank,CellMarker_Augmented_2021__Multilymphoid Progenitor cell:Umbilical Cord Blood,0.5352268307900181,1.4088591900490384,0.0,0.24657744128583378,1.0,80/441,14.15%,LEF1;FOSB;ARHGAP4;CDH9;IGF1;GRIK1;CHRM3;PIM3;DUSP1;CNTNAP1;CASZ1;SYT4;ZYX;ICAM1;CSF2RA;SLITRK5;TMSB10;MAP3K11;NUAK2;SEMA3C;HIC1;MDGA2;NFATC2;CD37;SOX4;PLLP;HECW2;BCL6;NEDD9;TBX19;CHD3;DNM1;ATP9A;DVL1;ZNF608;RGL4;SERPINF1;RHPN1;ITPKB;CSMD1;CACNA1C;ACAP1;DUSP22;OCIAD2;CSRNP1;MAP3K7CL;PPP1R16B;PLEKHA2;SSH2;ABCA9;BASP1;YTHDF1;AFF1;GNA12;TSC22D3;ARHGEF7;ATP10A;CFAP251;RBPMS;PAG1;SPATA21;DIP2B;MAPKBP1;FMN1;KLF7;FMNL3;RELB;TMC8;PER1;PAK1;JARID2;TMEM156;AKAP8;ARPP21;SLC13A4;VPS37B;PALLD;MAML2;RSPH4A;FAM219A
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.7452348820375803,1.4088298319503578,0.08620689655172414,0.2464520425864792,1.0,7/25,13.78%,P2RY6;PDGFRA;FLT1;NTRK3;P2RY12;FGF2;LPAR1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.7653650150828094,1.4087681266544099,0.11475409836065574,0.24633799767145312,1.0,3/20,8.38%,CDKN2A;SUV39H1;CENPV
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.6527258484269681,1.4081195077552713,0.06779661016949153,0.24790067616434047,1.0,11/31,17.46%,IGF1;EFNA1;RTN1;RTN2;TMED10;EPHA4;ABCA2;HAP1;BIN1;SLC2A13;ABCG1
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.6295462195330319,1.408001934183646,0.04838709677419355,0.24800730440660526,1.0,10/52,10.90%,ENPP2;PLPPR5;PLPPR4;LPCAT4;PLPPR1;PLAAT4;AGPAT4;PLAAT3;PIP4K2A;ABCA2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.8177287850247512,1.407815705091513,0.029411764705882353,0.24834643928012054,1.0,4/13,7.53%,IGF1;SERPINE1;SLIT2;PDGFA
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.725385238018016,1.4077753790190555,0.05,0.24816459549692962,1.0,3/23,3.70%,KIF14;STMN2;STMN4
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.6060611413759754,1.4077638932412346,0.017543859649122806,0.2479499178288139,1.0,10/95,2.79%,CDKN2A;RASGRP2;IGF1;PLD1;PLK2;RAPGEF5;RASGRP1;RIT2;SHTN1;SHC2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),0.9469905829105856,1.4076863132836608,0.02,0.24797874421004493,1.0,2/6,0.90%,CDKN2A;IGF1
prerank,Reactome_2022__GRB2 Events In ERBB2 Signaling R-HSA-1963640,0.8221703451116806,1.40762269188726,0.05454545454545454,0.24794128025727827,1.0,3/12,7.48%,EGF;NRG1;NRG2
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),-0.8380621600821718,-1.4076148633494205,0.08163265306122448,0.6091923395222097,1.0,1/9,1.53%,CEP72
prerank,CellMarker_Augmented_2021__Marginal Zone B cell:Undefined,0.931768830963946,1.4076103234379036,0.037037037037037035,0.24780462898862488,1.0,2/6,4.31%,EBF1;PTPRC
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.7037462642230673,1.4076010951620568,0.12727272727272726,0.24761314626014083,1.0,5/24,6.64%,TGFBR2;PROX1;PKP2;SOX4;TBX20
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),-0.769374444096831,-1.4075628677240857,0.058823529411764705,0.6071775614934561,1.0,4/13,8.80%,SPRY1;HEY2;HEYL;HEY1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),0.6711040184302295,1.4075317034350923,0.04411764705882353,0.24758714402576357,1.0,6/32,8.28%,GPNMB;EPHA7;NLRP12;NEK10;PDGFA;MVP
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.5190820800091951,1.407500886309994,0.0,0.24745121770021974,1.0,69/413,13.99%,LEF1;TGFBR2;HPN;MYRF;IL13RA1;TLR2;IGF1;KIF14;PROX1;PDGFRA;IL15;EGF;THBS1;PTK6;ZFP36;FLT1;TRPC3;IRS2;SFTPD;RPS6KA1;COLEC12;PRAME;TGFA;TRPM4;EPB41L4B;OSMR;SOX4;NTRK3;MFSD2A;PARD3;PRODH;NRG1;CCKBR;RHOD;SCX;RYR2;GRIN1;RAMP3;PDGFA;TENM4;CAPN1;KITLG;LMNA;GAB2;MMP14;HDAC4;NAMPT;TGFB2;TPPP;EPHA4;NOXA1;MAPT;GAS6;S1PR3;STX4;CDC7;MLXIPL;PRKCD;CDKN1B;BCL2;MEIS3;FN1;PAK1;PDPN;CCND1;FGF2;NAP1L1;TRIM32;GRK5
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.8379409225860566,1.4074994677152168,0.04,0.24721666678296833,1.0,1/10,0.81%,TLR2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.6813703717787644,1.4074386088656332,0.06779661016949153,0.2471142782688463,1.0,12/41,14.38%,KIF14;TMEFF2;ATRNL1;SRCIN1;ITGA8;EFNA1;LAMB1;LAMA5;RADIL;PXN;FN1;NTN4
prerank,Reactome_2022__RUNX3 Regulates p14-ARF R-HSA-8951936,0.7910659971103836,1.4072887399999077,0.15,0.24714367705169518,1.0,1/9,0.12%,CDKN2A
prerank,CellMarker_Augmented_2021__Endothelial cell:Skin,0.66466403409803,1.407278330698845,0.06557377049180328,0.2469210376590715,1.0,14/45,9.78%,GGT5;FLT1;GPR34;DYSF;SIGLEC1;ACKR1;SHROOM4;PCDH12;MYH11;TNS1;APLNR;RAMP3;ADGRF5;RNASE1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),0.7795995561340825,1.4072584147972682,0.06666666666666667,0.24675354583685805,1.0,4/14,6.11%,KIF14;PLEK;FBLIM1;SKAP1
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.930345496287589,1.4072370272780084,0.038461538461538464,0.2465426296608909,1.0,1/5,1.87%,CD24
prerank,CellMarker_Augmented_2021__Megakaryocyte:Blood,0.7363542160607572,1.4072003142568854,0.109375,0.24648505809145876,1.0,4/20,2.58%,TLR2;CTSS;MYO1F;PLEK
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.719553499036185,1.406934435538398,0.06153846153846154,0.24701697797640917,1.0,12/20,15.32%,RFTN1;PRKCB;TEC;LAT2;PTPRC;NFATC2;SYK;BCL2;BMX;PIK3CD;BCAR1;SH2B2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.8263190366710681,1.4069316812969734,0.08620689655172414,0.24678460076288478,1.0,5/7,15.24%,DPYSL2;CRMP1;DPYSL4;DPYSL5;DPYD
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),0.8672242446185592,1.4067125934139137,0.07317073170731707,0.24711914754985914,1.0,4/7,11.38%,PROX1;GRID2;AGTPBP1;OPHN1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.6104463972668471,-1.4064607101144835,0.05714285714285714,0.6102996843223748,1.0,6/51,6.82%,H1-2;H1-4;POLR2K;ATAD2;POLR1F;TAF1D
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.6735597756057548,1.4063084524231915,0.046875,0.24822581272367916,1.0,3/33,1.69%,C3;EGF;SERPINE1
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),0.849317240297849,1.4060639172569096,0.12,0.2487323565922283,1.0,3/7,4.92%,DRAXIN;MDGA2;SOX4
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),-0.6758246072372064,-1.4058356896441335,0.09090909090909091,0.6090523053320537,1.0,5/17,18.31%,GSTT2B;AKR1A1;GSTM3;GSTP1;ESD
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),-0.6758246072372064,-1.4058356896441335,0.09090909090909091,0.6090523053320537,1.0,5/17,18.31%,GSTT2B;AKR1A1;GSTM3;GSTP1;ESD
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.7258876226592176,1.405109271609192,0.03571428571428571,0.25098695112324504,1.0,5/29,8.10%,YWHAH;THY1;EFNB3;MAG;MCF2
prerank,CellMarker_Augmented_2021__M1 macrophage:Peripheral Blood,0.9412829721151403,1.4048320622400892,0.017857142857142856,0.25142484197300047,1.0,2/5,3.76%,TLR2;IL1R1
prerank,Reactome_2022__Cleavage Of Damaged Purine R-HSA-110331,-0.7622382156803701,-1.4047022258688264,0.09090909090909091,0.6125136642139977,1.0,4/17,5.51%,H2AC20;H2BC4;H2BC21;H2AC6
prerank,Reactome_2022__Interleukin-27 Signaling R-HSA-9020956,0.8249884688963364,1.4047008518010249,0.08196721311475409,0.25162336689747244,1.0,3/9,11.45%,IL27RA;STAT3;TYK2
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),0.821293072154655,1.404645289456003,0.046153846153846156,0.2515723641192031,1.0,2/12,10.96%,SOCS3;PARP9
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.8399634256124909,1.4046223990658269,0.07142857142857142,0.25138076041659263,1.0,1/8,0.02%,APOLD1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.920692880183362,1.40455386162177,0.019230769230769232,0.2510526374666324,1.0,3/6,2.65%,THBS1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.920692880183362,1.40455386162177,0.019230769230769232,0.2510526374666324,1.0,3/6,2.65%,THBS1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.6352119562396069,1.4045176578999072,0.046153846153846156,0.25095918584471366,1.0,18/58,17.98%,PROX1;PLEK;CDC42EP3;BAIAP2L1;MYLK3;BAIAP2;NTRK3;CDC42EP1;SYNPO2L;PRKCE;FCHSD1;ARF6;BIN1;P2RX7;PFN2;VASP;CRACD;NCK2
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.7288665102193361,-1.4040319734011244,0.15625,0.6133851647507264,1.0,3/12,8.59%,ALG3;ALG11;ALG9
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.6036314728848947,1.40397995766625,0.014925373134328358,0.2519872892622843,1.0,29/97,11.37%,L1CAM;RGS7BP;STMN2;ZNF536;RCAN2;CNTN2;ADCY5;SHC2;PLP1;PLPPR4;THY1;ACKR1;IGSF21;PRIMA1;APOD;CCDC3;FAM107A;TMEM132C;PHYHIP;TCEAL5;APLNR;MAOB;GFAP;RAMP3;PTPRD;RASL12;SORBS1;CRTAC1;LGI3
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.6607627053870342,1.4038847206205685,0.043478260869565216,0.2519254601779266,1.0,4/53,8.12%,LEF1;WNT8B;DVL1;CTNNB1
prerank,Reactome_2022__CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.5768330640094975,-1.4036689719550224,0.0967741935483871,0.6127706221239513,1.0,12/63,20.20%,CDC26;CCNE1;PSMD10;ANAPC15;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.830072033029035,-1.4033855371088564,0.10638297872340426,0.611919118954268,1.0,2/6,14.33%,NBDY;CNOT1
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.7758404382835106,1.403285013918399,0.04838709677419355,0.25361803146689343,1.0,2/14,9.33%,IMPDH1;AK3
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.7039343059747187,1.4032168727824819,0.0967741935483871,0.25360856686699146,1.0,7/25,10.56%,IL1RAPL1;SRCIN1;SHANK3;SIPA1L1;HOMER1;EPHA4;CDKL5
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.8881881036004549,1.4029373858438012,0.031746031746031744,0.2539428810605897,1.0,1/7,0.15%,NR4A3
prerank,Reactome_2022__Loss Of Function Of SMAD2/3 In Cancer R-HSA-3304349,0.9075115089800789,1.402916348685904,0.09090909090909091,0.2535052194850544,1.0,1/7,0.06%,TGFBR2
prerank,Reactome_2022__Signaling By TGF-beta Receptor Complex In Cancer R-HSA-3304351,0.9075115089800789,1.402916348685904,0.09090909090909091,0.2535052194850544,1.0,1/7,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.5699834899546184,1.402805279998924,0.0,0.253624447182982,1.0,39/170,15.27%,GPNMB;HTR2C;IGF1;P2RY6;PDGFRA;NPNT;EGF;RASGRP1;CD24;RIT2;FLT1;ICAM1;APP;DAB2IP;NEK10;PTPRC;TRIM5;NTRK3;CD44;STK25;DIRAS2;RAMP3;PDGFA;NECAB2;CHI3L1;TGFB2;DIRAS1;GFRAL;GAS6;CCL2;HLA-DRB1;TPD52L1;FGF2;LPAR1;IQGAP1;GPR37;GPR183;CD4;THPO
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),-0.8748890479186247,-1.4027307050116913,0.0851063829787234,0.6134514345791268,1.0,1/6,3.20%,PHYH
prerank,Reactome_2022__HuR (ELAVL1) Binds And Stabilizes mRNA R-HSA-450520,0.8889013187555459,1.4022054501068275,0.038461538461538464,0.25516693535997764,1.0,1/8,0.08%,ENPP2
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.91378993974774,1.4021604689151308,0.034482758620689655,0.2551133223145803,1.0,1/5,0.42%,MET
prerank,Reactome_2022__Cardiac Conduction R-HSA-5576891,0.6176321921270229,1.4021464686710485,0.045454545454545456,0.2548888779618994,1.0,30/87,12.55%,SCN1B;SCN9A;KCNJ2;KCNK10;SCN3B;KCNQ1;KCNE4;SCN1A;SCN2A;ATP2B3;KCNK1;FGF12;KCNIP4;KCND3;ITPR3;ABCC9;KCNH2;CACNA1C;CACNG8;RYR2;KCNK12;ATP1B1;CACNG4;ORAI1;ATP1B3;SCN3A;FGF13;CAMK2B;HIPK1;FXYD7
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.8728251861938913,1.4019813122668139,0.016666666666666666,0.25509177879792844,1.0,5/9,12.22%,RELN;DAB2IP;NEUROD2;NEURL1;CAMK2B
prerank,KEGG_2021_Human__TNF signaling pathway,0.606381893610268,1.4019701529781894,0.04054054054054054,0.25487843070272487,1.0,22/87,17.50%,CXCL2;SOCS3;IL15;CREB5;ICAM1;DAB2IP;MAP3K14;FAS;BIRC3;TNFRSF1A;CASP10;MMP14;CCL2;FADD;IKBKG;PIK3CD;MAPK11;MAP3K5;TAB1;TRAF5;MAPK9;MAP2K3
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.531080236157103,1.4019634710838567,0.0,0.2546761284676741,1.0,26/275,8.62%,LEF1;HPN;MET;ANXA1;IGF1;KIF14;PLK2;THBS1;PIM3;RPS6KA1;PIM1;FOXO1;NUAK2;PRAME;FAS;BIRC3;CD44;SNCA;SCX;MYD88;NAA38;CTNNB1;BAG3;THOC6;BCL2L1;DHCR24
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.5935459182347277,-1.4018536719440022,0.04,0.6155320876759466,1.0,18/90,16.61%,RP9;PDCD7;SCNM1;DHX16;SF3B4;ZCRB1;RBM8A;U2AF1;PRPF18;RRAGC;YJU2;SNRNP25;LSM4;PRPF8;SRSF2;PRPF3;TARDBP;RNPC3
prerank,KEGG_2021_Human__Prostate cancer,0.6397679831190515,1.4017895061301657,0.029411764705882353,0.2548999534968141,1.0,7/82,3.84%,LEF1;IGF1;PDGFRA;EGF;CREB5;FOXO1;TGFA
prerank,Reactome_2022__Synthesis Of PIPs At Golgi Membrane R-HSA-1660514,-0.7736354372584917,-1.4014546217859982,0.09090909090909091,0.615369647943297,1.0,3/15,7.29%,PI4K2A;PIK3C2G;PIK3C2A
prerank,CellMarker_Augmented_2021__MKI67+ Progenitor cell:Large Intestine,0.5944343488434052,1.4014073219781646,0.04838709677419355,0.25583585442217693,1.0,19/61,10.80%,APOLD1;ANLN;EBF1;CCNB2;FLT1;PTPRB;EGFL7;LDB2;NRN1;CASP10;APLNR;RAMP3;ADGRF5;BGN;SEC14L1;PODXL;NCAPD3;SLCO2A1;TFPI
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.7784612387611547,-1.40135427329915,0.16666666666666666,0.6137542594595345,1.0,2/8,8.80%,CHAMP1;KIF20B
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.8919919570752493,-1.4013420369603784,0.05660377358490566,0.6116758603479054,1.0,2/6,6.97%,DIRAS3;KDM1B
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.5971685011045109,1.4012519411849027,0.02857142857142857,0.25599445986016395,1.0,29/114,11.43%,SLITRK1;PCDH8;TAGLN3;STMN2;ZNF536;CNTN2;CAMKV;PLPPR5;GAP43;ZDHHC22;PLP1;OPCML;EFNB3;SEMA5B;CDK5R2;ZIC1;GFAP;SULT4A1;NYAP1;MGAT5;CELF3;SRRM3;KCNQ2;CACNG4;LY6H;DNER;DCX;NACAD;CRMP1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.6755457078255962,1.4012177796593925,0.09836065573770492,0.25583433526101623,1.0,4/26,6.95%,CHRM3;KCNJ2;KCNQ1;KCNH2
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.6503771604844505,-1.4011675386715396,0.07692307692307693,0.6104257456152856,1.0,4/30,7.19%,CFAP53;FOXJ1;ENKUR;PKD1L1
prerank,Reactome_2022__Downregulation Of ERBB2 Signaling R-HSA-8863795,0.7304231448363765,1.400993282496624,0.08771929824561403,0.25617293585219125,1.0,4/26,7.48%,EGF;ERBIN;NRG1;NRG2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Meniscus,0.9334582815071674,1.4008537368884282,0.07547169811320754,0.25636258397868245,1.0,3/5,6.44%,THY1;PTPRC;CD44
prerank,Reactome_2022__N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.7519599318272051,1.4007604235411835,0.09803921568627451,0.25644603001128197,1.0,5/21,11.69%,ST6GAL1;CHST8;ST8SIA3;MGAT5;B4GALT5
prerank,Reactome_2022__SHC1 Events In EGFR Signaling R-HSA-180336,0.8446113944210447,1.4006870278324286,0.05172413793103448,0.2564552923854362,1.0,2/8,3.84%,EGF;TGFA
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),0.5748042458478724,1.4005891673418502,0.06153846153846154,0.2564539716015191,1.0,26/114,12.46%,SCN9A;KCNJ2;KCNV1;SCN3B;SCN1A;KCNB2;ABCC8;KCNF1;SCN2A;KCNK1;KCNMB4;PIEZO2;TRPM4;SLC5A4;KCND3;ABCC9;GRIN1;KCNC1;ATP1B1;SLC25A29;SLC4A11;SCN3A;KCNAB3;FGF13;KCNH3;SLC29A4
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.657156228183772,1.4003464708379876,0.07462686567164178,0.25690658909334796,1.0,11/34,20.08%,PAK3;SHANK3;DVL1;DOCK10;SHANK1;MINK1;KLF7;PHACTR1;MAPK8IP2;FARP1;CTNNA2
prerank,Reactome_2022__Role Of Second Messengers In Netrin-1 Signaling R-HSA-418890,0.8168776005279341,1.4003445362738522,0.05357142857142857,0.25668337217848214,1.0,2/9,7.42%,TRPC3;DCC
prerank,CellMarker_Augmented_2021__Myofibroblast:Lung,0.6040544217157219,1.4001331521369274,0.02857142857142857,0.25692420909878605,1.0,17/73,5.54%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;SULF1;COL4A2;ASPN;THY1;PODN;ANGPTL2;POSTN;SLIT3;COL12A1;FAP
prerank,CellMarker_Augmented_2021__Eosinophil:Undefined,0.7932887185081516,1.3999026006815667,0.041666666666666664,0.2572593594823614,1.0,3/10,4.31%,CD24;CSF2RA;PTPRC
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.568751473679172,-1.399885256478684,0.06451612903225806,0.6140769833343311,1.0,11/58,20.20%,CDC26;PSMD10;ANAPC15;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.7026879132153419,1.3995611878050498,0.09375,0.2578673781874293,1.0,8/26,8.95%,CSPG4;DCN;PXYLP1;CHSY3;CHST15;CHPF2;UGDH;BGN
prerank,CellMarker_Augmented_2021__Preadipocyte Progenitor cell:Adipose Tissue,0.6003701996709601,1.3993775767686227,0.046153846153846156,0.2580539426552861,1.0,28/72,12.14%,ECM2;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;ABCA8;ITGA8;ASPN;THY1;PODN;SHROOM4;ANGPTL2;POSTN;OLFML1;SLIT3;TNS1;LDB2;APLNR;C1R;ADGRF5;BGN;RASL12;ITGA9;LAMA2;SPARC;RUNX1T1;FGD5
prerank,Reactome_2022__GPVI-mediated Activation Cascade R-HSA-114604,0.7212870636659668,1.3992270524360273,0.06153846153846154,0.2581666742186805,1.0,9/22,22.15%,FYN;RNASE1;SYK;GP6;PDPN;VAV2;VAV1;RHOB;PTPN11
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.7181443407927756,1.399193145387464,0.017857142857142856,0.25805891650071794,1.0,4/23,8.41%,CACNA1H;CACNA1G;CACNA1C;CACNA1E
prerank,Reactome_2022__Signaling By FGFR1 In Disease R-HSA-5655302,-0.6877714343490952,-1.3991553967070534,0.13953488372093023,0.6150174608680807,1.0,1/30,0.15%,FGF6
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Synovium,0.8691294287395445,1.3991066753849437,0.08928571428571429,0.25809807768928134,1.0,3/7,6.44%,THY1;PTPRC;CD44
prerank,Reactome_2022__Degradation Of Extracellular Matrix R-HSA-1474228,0.6068449434074398,1.3989130444899038,0.0,0.25847223442130424,1.0,17/75,10.02%,OPTC;SPOCK3;ADAMTS4;CTSS;DCN;TIMP2;TLL1;COL23A1;COL12A1;LAMB1;CD44;CAPN8;LAMA5;CAPN1;SCUBE3;MMP14;COL9A1
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.757138492310049,1.3987068517592616,0.05357142857142857,0.2587411020648593,1.0,7/23,3.97%,DCN;SP100;THBS1;SLIT2;DAB2IP;DUSP10;PTPRR
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.7993407443972819,-1.3986198588452576,0.10416666666666667,0.6155357347115896,1.0,6/9,16.79%,ATP5MC1;ATP5PB;ATP5PD;ATP5MC3;ATP5F1A;ATP5MC2
prerank,KEGG_2021_Human__Retrograde endocannabinoid signaling,0.5864245779053864,1.398619215351791,0.0410958904109589,0.2587899941195417,1.0,21/114,8.77%,SLC32A1;CNR1;GNG3;GABRB2;PRKCB;ADCY5;PRKCG;GABRG3;GABRD;GNG2;ITPR3;GABRA1;FAAH;GRM5;ADCY7;CACNA1C;ADCY2;GRIA3;GABRG2;GABRA5;GRIA1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.8430560964749356,-1.3985054793061504,0.1,0.61403054833397,1.0,1/12,0.92%,PTCD2
prerank,CellMarker_Augmented_2021__Osteogenic Precursor-Like cell:Dermis,0.5847508403558033,1.3984498126490885,0.030303030303030304,0.2589223382581316,1.0,21/98,13.13%,TTLL7;TMEFF2;NLGN1;SLITRK5;TRAM1L1;EPHA5;FGF12;TUSC3;NEUROD2;LARP6;MAP1B;LCA5;LIMCH1;PCLO;TGFB2;ENAH;FAM13C;PDE10A;PRICKLE2;RPS6KA6;CAP2
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),0.7785787710837495,1.3983817153546088,0.01694915254237288,0.2588875141854069,1.0,2/19,0.46%,NR4A3;MRAP2
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.8833491461342828,1.398311396799842,0.07272727272727272,0.2585993518905088,1.0,1/5,0.11%,CACNA1H
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.8833491461342828,1.398311396799842,0.07272727272727272,0.2585993518905088,1.0,1/5,0.11%,CACNA1H
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.7084464576784333,1.3974568063831727,0.10714285714285714,0.2605522716174708,1.0,5/24,4.94%,THBS1;ELMO1;XKR4;MYH9;XKR6
prerank,KEGG_2021_Human__Graft-versus-host disease,0.7935507820980577,1.3973144718725021,0.13793103448275862,0.2606304632928589,1.0,5/11,14.71%,HLA-DRA;FAS;HLA-DRB1;HLA-DMA;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.6986796123559976,1.3973089231081708,0.09090909090909091,0.2604073098308185,1.0,5/22,14.92%,ANK3;FYN;MYO1C;CEMIP;MTCL1
prerank,Reactome_2022__Viral Messenger RNA Synthesis R-HSA-168325,-0.5829994696351855,-1.3972278983763189,0.09302325581395349,0.6182134403811589,1.0,14/44,22.92%,POLR2K;AAAS;NUP50;POLR2C;NUP54;GTF2F1;POLR2D;GTF2F2;POLR2L;POLR2G;NUP85;NUP42;POM121C;POLR2E
prerank,Reactome_2022__Cytosolic Sulfonation Of Small Molecules R-HSA-156584,0.768392704215568,1.397050899179369,0.06557377049180328,0.2609005745273968,1.0,3/15,7.56%,PAPSS2;TPST1;SULT4A1
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.6924240418767162,1.3968745751706744,0.078125,0.26119596863108224,1.0,8/31,10.96%,SOCS3;IGF1;IL15;PTK6;TNFRSF1A;GHR;STAT3;PARP9
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.7616552646534229,1.396810452803153,0.06557377049180328,0.26113864461456593,1.0,4/17,8.84%,MYO1F;MYO1B;MYO1C;MYO15A
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.7086211805684584,1.3967457086759263,0.029411764705882353,0.26108142296236475,1.0,19/37,22.03%,NPY1R;CHRM3;CHRM1;ADCY5;ADCY7;ADCY2;P2RY12;HTR1E;LPAR1;GPR37;ADCY3;GRM7;GNAI1;FLNA;HTR1F;PDE2A;ADCY9;ADCY8;HRH3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.7514333860473785,1.396719073641136,0.08771929824561403,0.26090022276193375,1.0,2/16,3.51%,S100A10;THY1
prerank,KEGG_2021_Human__Calcium signaling pathway,0.5328285080043361,1.396417515952959,0.013888888888888888,0.2615251508801803,1.0,33/167,8.48%,CACNA1H;MET;HTR2C;CACNA1G;GRIN2A;PDGFRA;HRH1;PDE1C;CHRM3;EGF;CHRM1;GRIN2D;FLT1;PRKCB;ITPKC;PRKCG;ATP2B3;MYLK3;OXTR;NTRK3;ITPR3;GRM5;PDE1A;ITPKB;CCKBR;ADCY7;CACNA1C;RYR2;ADCY2;GRIN1;PDGFA;CACNA1E;GNA14
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.5885676750879992,1.3963278980782277,0.0,0.26151934610862937,1.0,31/100,11.71%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;SULF1;COL4A2;RELN;THY1;PODN;ANGPTL2;POSTN;SLIT3;COL12A1;FAP;IGFBP7;COLEC11;SYP;PTPN21;LDB2;MEG3;GFAP;C1R;BGN;PPARG;RASL12;LAMA2;SPARC;CCL2
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.7808370564005253,-1.3962570125052014,0.08888888888888889,0.6209018840539772,1.0,3/12,8.80%,HEY2;HEYL;HEY1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6392593457251157,1.3961609687296699,0.11320754716981132,0.26177136304609894,1.0,9/38,7.51%,TGFBR2;COL4A1;CCBE1;PROX1;FLT1;EGFL7;TBX20;APLNR;CYP1B1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Peripheral Blood,0.6642399168558795,1.396069493086293,0.0273972602739726,0.26174474316171736,1.0,15/52,8.28%,TGFBR2;FOSL2;ANXA1;S100A10;SP100;CD55;IL1R1;TGFA;SLC28A3;PLSCR1;AHR;CD44;EMP1;TMBIM1;MVP
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.8078778791060354,1.3958504824988986,0.07692307692307693,0.2621608185037743,1.0,3/12,4.82%,TLR2;DYSF;PLSCR1
prerank,Reactome_2022__Na+/Cl- Dependent Neurotransmitter Transporters R-HSA-442660,0.8030395532872552,1.3957342155695127,0.10909090909090909,0.2622676053450688,1.0,1/11,0.20%,SLC6A15
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),0.8529924602724328,1.395691562553006,0.03636363636363636,0.26212758157871907,1.0,3/13,4.47%,HPN;SCN1A;PIEZO2
prerank,CellMarker_Augmented_2021__Oviduct-derived Stem cell:Oviduct,0.8152226106330488,1.395442793476415,0.06666666666666667,0.26243954437781625,1.0,5/14,6.44%,ICAM1;THY1;PTPRC;MCAM;CD44
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Brain,0.6628279914680117,1.3952437762800791,0.04918032786885246,0.2628432743196607,1.0,11/40,10.37%,GGT5;FLT1;GPR34;SIGLEC1;PCDH12;MYH11;APLNR;RAMP3;ADGRF5;RNASE1;FLI1
prerank,Reactome_2022__Activation Of RAC1 R-HSA-428540,0.8179960427452084,1.3948812266549295,0.03508771929824561,0.2635435005746224,1.0,4/11,9.78%,SLIT2;PAK4;ARHGEF7;RNASE1
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.7760864636935629,-1.3944126959878482,0.07692307692307693,0.6275966972015143,1.0,5/14,16.23%,COX18;COX20;COX19;SMIM20;OXA1L
prerank,Reactome_2022__RUNX3 Regulates WNT Signaling R-HSA-8951430,0.9294627348598895,1.3940000276414344,0.0,0.2655429157905219,1.0,1/6,0.01%,LEF1
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.8889179089071434,-1.3938206961510156,0.07317073170731707,0.62831936825378,1.0,2/5,7.78%,DSCAM;SEMA5A
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.8259867112822172,-1.3937908801103909,0.06666666666666667,0.6262872998132153,1.0,1/10,0.29%,RAB7B
prerank,Reactome_2022__Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,0.7020731994134578,1.3937733208171919,0.03389830508474576,0.2658916849560932,1.0,6/29,7.19%,GNG3;ADCY5;PRKAR1B;GNG2;ADCY7;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.8773620540262048,1.393739477967561,0.031746031746031744,0.2657185416694785,1.0,5/8,12.22%,RELN;DAB2IP;NEUROD2;NEURL1;CAMK2B
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.8276052841323931,1.3935531449376535,0.06779661016949153,0.26611760408092566,1.0,1/7,3.36%,LPCAT4
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),0.6108684729859261,1.3931571377327678,0.06349206349206349,0.2670669540421901,1.0,15/62,12.85%,HLA-DRA;TLR2;SP100;ICAM1;IRF7;TRIM5;CIITA;CD44;PML;CCL2;HLA-DRB1;CAMK2B;PRKCD;TRIM22;B2M
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.7401863776429454,1.3929127683752154,0.06451612903225806,0.26747432310487756,1.0,3/17,10.25%,YBX3;SCN2A;SLC4A11
prerank,Reactome_2022__SUMOylation Of Transcription Factors R-HSA-3232118,0.8112468193869371,1.3928929211461,0.046875,0.2673309544526787,1.0,2/16,4.08%,CDKN2A;HIC1
prerank,Reactome_2022__Loss Of Function Of TGFBR1 In Cancer R-HSA-3656534,0.909024945536487,1.3928715223180184,0.07692307692307693,0.2669432945301711,1.0,1/6,0.06%,TGFBR2
prerank,Reactome_2022__SMAD2/3 Phosphorylation Motif Mutants In Cancer R-HSA-3304356,0.909024945536487,1.3928715223180184,0.07692307692307693,0.2669432945301711,1.0,1/6,0.06%,TGFBR2
prerank,Reactome_2022__Maturation Of Protein 3A R-HSA-9683673,0.8326914791253052,1.3928569705173635,0.10909090909090909,0.2667804506240017,1.0,1/8,0.62%,ST6GAL1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.8467725708806055,1.3927675101614039,0.09090909090909091,0.2665975920842952,1.0,4/8,8.06%,KCNQ1;SNCA;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.8467725708806055,1.3927675101614039,0.09090909090909091,0.2665975920842952,1.0,4/8,8.06%,KCNQ1;SNCA;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.8793666536359314,1.3927507286193117,0.0625,0.26641521306873134,1.0,1/8,0.88%,SOCS3
prerank,Reactome_2022__TNF Receptor Superfamily (TNFSF) Members Mediating Non-Canonical NF-kB Pathway R-HSA-5676594,0.7960044583684005,1.3927333269669315,0.08823529411764706,0.2662331526191335,1.0,2/10,6.43%,MAP3K14;BIRC3
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),0.8744956713210934,1.392599783955073,0.09836065573770492,0.2663750734172547,1.0,1/5,4.64%,SHANK3
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.952403709162364,1.3923113227898363,0.0,0.2667592827508109,1.0,2/6,0.85%,CDKN2A;ANXA1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.5774511435812594,1.3922694122841675,0.04225352112676056,0.26663797953954205,1.0,32/107,10.95%,CDH6;COL4A1;C3;IGF1;PDGFRA;DCN;THBS1;CALD1;CLDN16;COL4A2;NRGN;SHROOM4;ANGPTL2;KCNT1;POSTN;IGFBP7;TNS1;LDB2;ENC1;APLNR;MAOB;C1R;ADGRF5;BGN;ARHGEF10L;RASL12;RNASE1;RIN2;PXDC1;SLCO2A1;LAMA2;CDKN1C
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),0.6844536504538229,1.3919846267650064,0.06060606060606061,0.267182700509046,1.0,14/37,15.46%,IGF1;PDGFRA;DAB2IP;PDGFA;CDK6;CTNNB1;NLRC3;GAS6;B4GALT7;FN1;CDKN1A;TRIM32;S100A6;TP53
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.7267585934704545,1.391796021988527,0.13432835820895522,0.2673132226717427,1.0,7/18,8.03%,MET;MRAP2;PLEK;ADA;SNCA;MRAP;GRK2
prerank,Reactome_2022__mRNA Splicing - Minor Pathway R-HSA-72165,-0.6396688629280108,-1.3916191947682144,0.07692307692307693,0.6352569701738945,1.0,13/46,17.00%,PDCD7;SF3B4;POLR2K;ZCRB1;SF3B6;POLR2C;SNRNP25;GTF2F1;PRPF8;SRSF2;POLR2D;RNPC3;GTF2F2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),-0.8103789053726,-1.3916081084294976,0.09302325581395349,0.6331900313243494,1.0,4/10,17.12%,METAP1D;NAA11;METAP2;METAP1
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.8070120311683427,1.3915701435194376,0.125,0.2675534635836917,1.0,4/12,4.87%,MET;FA2H;LSR;ALOX12
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.8070120311683427,1.3915701435194376,0.125,0.2675534635836917,1.0,4/12,4.87%,MET;FA2H;LSR;ALOX12
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),0.8699593302724519,1.3915577376332837,0.10344827586206896,0.26736162605987523,1.0,1/8,0.06%,TGFBR2
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Bone Marrow,0.6762165721664469,1.3913083086139475,0.125,0.26784309360710634,1.0,7/26,4.31%,IPCEF1;CTSS;P2RY13;MYO1F;PLEK;SLA;PTPRC
prerank,Reactome_2022__Growth Hormone Receptor Signaling R-HSA-982772,0.8043058430742077,1.391119316446414,0.08196721311475409,0.26816315671313584,1.0,4/15,10.27%,SOCS3;IRS2;GHR;STAT3
prerank,CellMarker_Augmented_2021__Mast cell:Undefined,0.7958723954823961,1.3911085887211883,0.07547169811320754,0.2679512356427193,1.0,3/9,4.31%,CD24;CSF2RA;PTPRC
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.5791490904582176,1.39088297672529,0.029850746268656716,0.26835079860095196,1.0,56/186,17.21%,CARNS1;SCN9A;IMPDH1;PDE1C;TESC;SRCIN1;ARHGAP39;CNTN4;CEP170B;CLSTN2;EFNB3;PRR36;DUSP8;FGF12;EPB41L4B;CFAP126;CDK5R2;ATP9A;HPCA;NRG1;FLRT1;LARP6;SYBU;NYAP1;MAPK8IP1;WDR54;CLGN;PCLO;C2CD4C;SRRM3;EML2;EPB41L1;KLHL5;DNER;VSTM2L;MORN5;MACROD1;MEIS3;STOM;CCDC184;CAP2;FAM131C;CYB561;CERS5;RARG;SCAMP5;SEZ6L2;NRSN2;MAPK8IP2;PFN2;LRRC45;TTC9;IFT140;CTXN1;CALB2;CMIP
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.5890057311418001,1.3906852839531756,0.03389830508474576,0.2685394683651525,1.0,18/77,16.77%,CACNA1H;ACTA2;CALD1;DYSF;MYH11;OXTR;GJC1;DTNA;TPM4;TCAP;SORBS1;PXN;TPCN2;SMTN;CHRNE;NEB;MYOF;SLC8A1
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.6860735529512265,-1.3906437535883793,0.1951219512195122,0.6362036674461972,1.0,4/18,10.03%,SETD9;SMYD2;KMT5A;TTC5
prerank,Reactome_2022__Deposition Of New CENPA-containing Nucleosomes At Centromere R-HSA-606279,-0.6299817755680668,-1.3905065562416616,0.07142857142857142,0.6349010230008971,1.0,9/31,12.81%,H2AC20;H2BC4;H2BC21;H2AC6;KNL1;ITGB3BP;MIS18BP1;CENPA;CENPQ
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.7492137962908747,1.3904169218721154,0.05263157894736842,0.26906784774865433,1.0,3/24,2.21%,RECQL4;ANXA1;BLM
prerank,GO_Biological_Process_2021__organic hydroxy compound catabolic process (GO:1901616),-0.8095800208794017,-1.3902058235178592,0.07692307692307693,0.6341829376808764,1.0,4/7,13.52%,CYP4F3;HSD17B6;ADH4;CYP4F12
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.8508931381867636,1.3901548126769632,0.03636363636363636,0.2695153768252478,1.0,3/8,9.04%,BOK;ZFP36;YAP1
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.5913155328406893,1.3900768873895653,0.02857142857142857,0.2695328312736291,1.0,19/83,13.44%,FOSL2;IL13RA1;TYMP;ZFP36;ICAM1;IL1R1;AHR;SYNGR2;TNFRSF1A;TMBIM1;MVP;DTX2;FBP1;RAB20;RELB;ANXA11;KLF4;IL4R;RHBDF2
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.7288623797558588,1.389856880911828,0.08620689655172414,0.2698495121254342,1.0,7/23,17.57%,IGF1;NTRK3;NRG1;GAS6;PRR5;PINK1;WNT5A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Lung,0.7804444812964293,1.3898133973290188,0.05084745762711865,0.2697171496872854,1.0,8/20,12.96%,MET;CD24;ABCB1;THY1;CD44;CTNNB1;KLF4;PDPN
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6469743274261811,1.3897120319639193,0.03225806451612903,0.2697841761821204,1.0,6/45,9.86%,ENPP2;DAB2IP;DUSP10;PTPRR;PRKCE;TGFB2
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.803169940733904,1.389531358429518,0.08064516129032258,0.2699505828860272,1.0,5/18,6.62%,CHRM3;KCNMB4;TRPM4;OXTR;ECE1
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),0.8866906560540988,1.3892251680716636,0.05084745762711865,0.2703520680653639,1.0,3/7,9.70%,CACNG3;CACNG8;CACNG4
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),0.8866906560540988,1.3892251680716636,0.05084745762711865,0.2703520680653639,1.0,3/7,9.70%,CACNG3;CACNG8;CACNG4
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Heart,0.8401843674091812,1.3891490869705785,0.078125,0.2704183214229065,1.0,3/9,11.14%,KCNJ2;FABP3;ACTN1
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),0.7977093786223345,1.3887884109074045,0.015873015873015872,0.271228122656816,1.0,5/15,7.18%,P2RY6;TRPC3;ABCC9;VGF;RYR2
prerank,Reactome_2022__Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.5674595010585519,-1.3885967561446628,0.038461538461538464,0.6393599950492154,1.0,18/78,20.20%,CDC26;CCNE1;MCM6;SLC25A15;PSMD10;MCM4;ANAPC15;PSMD12;PSMB5;PSMB6;ORC6;PSME3;SEM1;PSMD2;UBB;CUL1;SKP2;PSMB4
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Small Intestine,0.8947849673226738,1.3885931305070462,0.0392156862745098,0.2715312821942164,1.0,2/9,4.39%,CD24;LGR5
prerank,Reactome_2022__Cell-Cell Communication R-HSA-1500931,0.5758929374121097,1.3885151478089177,0.0,0.2715171704181568,1.0,20/87,14.51%,CDH6;CDH9;CDH19;FYB1;CLDN16;FBLIM1;CDH8;FYN;CDH18;PARD3;KIRREL3;CTNNB1;ACTN1;CLDN18;CTNNA1;CLDN20;SDK2;CDH4;IQGAP1;PATJ
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.6057955143646779,1.3884320664026866,0.07352941176470588,0.27152286292781724,1.0,6/87,3.55%,GGT5;CXCL2;SERPINE1;ZFP36;DAB2IP;ERBIN
prerank,CellMarker_Augmented_2021__T Helper cell:Liver,0.8803410652201533,1.3882963783319957,0.018867924528301886,0.2717360608149314,1.0,3/7,2.80%,SLC4A10;DUSP1;ABCB1
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.9059578421560787,1.388086010338227,0.08,0.2719048817990538,1.0,1/5,0.81%,TLR2
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.9059578421560787,1.388086010338227,0.08,0.2719048817990538,1.0,1/5,0.81%,TLR2
prerank,CellMarker_Augmented_2021__Endothelial cell:Brain,0.9413424167184727,1.3879861518367693,0.0,0.272038359269689,1.0,2/5,2.54%,APOLD1;FLT1
prerank,Reactome_2022__Developmental Biology R-HSA-1266738,0.49755821705733744,1.3879210416519812,0.0,0.2719844962573996,1.0,107/707,11.44%,LEF1;CACNA1H;COL4A1;L1CAM;SCN1B;SCN9A;FLRT3;ANK3;CACNA1G;EBF1;EPHA7;AMH;PKP2;SH3GL2;GRIN2B;CD24;CNTN2;ARHGAP39;CNTNAP1;TRPC3;COL4A2;SHTN1;GAP43;EPHA2;SCN3B;SLIT2;RELN;IRS2;RPS6KA1;SCN1A;DOK6;FOXO1;NRP2;CACNG3;MYH9;EPHA5;EFNA1;EFNB3;SCN2A;AGAP2;SH3KBP1;MYH11;PTPRC;VLDLR;SHANK3;NELL2;FYN;SLIT3;UNC5D;GFRA2;LAMB1;ITGA2;DNM1;RAP1GAP;CLTB;AGRN;LDB2;DPYSL2;ROBO2;FOXO3;CACNA1C;CACNG8;EIF4A3;PAK4;MAMLD1;DCC;PML;ZFPM2;BOC;MAG;CTNNB1;RPL39L;CAPN1;KALRN;TBL1X;SMAD3;LIMK2;YAP1;ARPC3;GAB2;PPARG;KCNQ2;ARHGEF7;RPL3;CACNG4;RNASE1;ITGA9;COL9A1;RGMB;GPRIN1;STAT3;ST8SIA4;FLI1;EPHA4;TEAD1;TRIO;DCX;SCN3A;LAMA2;NR6A1;COL4A4;CTNNA1;FGF13;LGI3;ADAM11;CRMP1;ENAH
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.8680184017506791,1.3877517595985243,0.10714285714285714,0.27207367198955584,1.0,2/5,9.35%,SOAT1;PPARG
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.8680184017506791,1.3877517595985243,0.10714285714285714,0.27207367198955584,1.0,2/5,9.35%,SOAT1;PPARG
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),0.8871460458819248,1.3875365242214401,0.023809523809523808,0.2724030149627705,1.0,1/5,3.94%,SLC28A3
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.8328974048094462,1.387458557485426,0.11864406779661017,0.27237846981273645,1.0,3/7,11.38%,SHTN1;P2RY12;OPHN1
prerank,KEGG_2021_Human__Hypertrophic cardiomyopathy,0.6146959657342371,1.3870330691486752,0.08196721311475409,0.2732365448482571,1.0,16/63,10.89%,IGF1;ITGA8;CACNG3;ITGA2;CACNA1C;TPM4;CACNG8;RYR2;ITGA11;ITGA3;LMNA;CACNG4;TGFB2;ITGA9;LAMA2;ITGB8
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),0.9390572256938801,1.3869163008687526,0.034482758620689655,0.27336810684522905,1.0,2/5,4.38%,RELN;VLDLR
prerank,CellMarker_Augmented_2021__Liver Progenitor cell:Fetal Liver,0.5999445501394655,1.3866786096040047,0.015151515151515152,0.2739302006503623,1.0,27/90,15.15%,TEAD2;COL4A2;DAB2IP;EFNB3;ARHGEF17;COL12A1;PTPN21;RHBDF1;SCARA3;BOC;MYO1B;ADGRL2;LAMA5;SH3PXD2B;YAP1;EPB41L1;DLG5;TEAD1;ENAH;CD276;MEIS3;COL4A5;PALLD;RBFOX2;NOTCH3;BCAR1;PDZRN3
prerank,Reactome_2022__Protein Methylation R-HSA-8876725,-0.696754873071441,-1.3866611004193627,0.046511627906976744,0.6461201462957501,1.0,12/17,28.89%,KIN;EEF1A1;RPS2;ETFB;EEF2;VCPKMT;CALM1;VCP;EEF1AKMT1;EEF1AKMT2;ETFBKMT;PRMT3
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.696846533790025,1.3866476905309515,0.017543859649122806,0.2738066335580111,1.0,2/33,2.75%,TGFBR2;EPHA2
prerank,KEGG_2021_Human__Necroptosis,-0.5401782110870005,-1.3863865517241234,0.03571428571428571,0.6453476409594222,1.0,14/100,8.70%,FTL;H2AC20;SLC25A5;TNFAIP3;FTH1;PYGM;H2AC6;SLC25A4;VDAC2;IL33;SPATA2L;GLUD1;VPS4B;PLA2G4C
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.7529190696682202,1.3863004711576044,0.11320754716981132,0.2745335567727785,1.0,8/19,9.88%,SCN1B;SCN3B;KCNQ1;KCNH2;RYR2;GRK2;ATP1B1;TCAP
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Liver,0.8393939147841499,1.386196131688427,0.03125,0.2745756966494346,1.0,5/13,8.12%,CD24;ICAM1;THY1;CD44;CTNNB1
prerank,CellMarker_Augmented_2021__Vascular Endothelial cell:Placenta,0.6550016872566214,1.385918385042151,0.05172413793103448,0.27539831774891366,1.0,14/46,9.78%,GGT5;FLT1;ICAM1;SIGLEC1;PODN;ACKR1;PCDH12;MYH11;CFH;TNS1;APLNR;RAMP3;ADGRF5;RNASE1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029),-0.918969867847508,-1.3857919741667286,0.0,0.6459889515742919,1.0,3/5,7.64%,SLC25A5;FZD9;HSPA1A
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.6639652312411479,1.3857022221660693,0.06666666666666667,0.2758003611970891,1.0,13/43,12.85%,HLA-DRA;SP100;ICAM1;IRF7;TRIM5;CIITA;CD44;PML;HLA-DRB1;CAMK2B;PRKCD;TRIM22;B2M
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.8675324941347455,1.3856023172911411,0.046875,0.27584133029722896,1.0,3/6,10.76%,AGTPBP1;STAT3;DCX
prerank,Reactome_2022__Signaling By Leptin R-HSA-2586552,0.8540824075587238,1.3855419710729986,0.06451612903225806,0.27573624571723626,1.0,3/8,10.27%,SOCS3;IRS2;STAT3
prerank,Reactome_2022__Reactions Specific To Complex N-glycan Synthesis Pathway R-HSA-975578,0.8909256095811603,1.3855373913506297,0.058823529411764705,0.2755049233634466,1.0,1/7,0.78%,CHST8
prerank,CellMarker_Augmented_2021__Ovarian Somatic cell:Ovary,0.5909003572089728,1.3855138234181756,0.046875,0.27419282725110117,1.0,31/95,15.20%,FLRT3;PROX1;PCDH18;RAPGEF5;SLIT2;DAB2IP;ANGPTL2;LGR5;FRAS1;LAMB1;CCDC3;ZNF704;PTPN21;GUCY1A2;SCARA3;ADGRL2;PTPRD;PKDCC;KALRN;CNN3;YAP1;TEAD1;SORBS1;ENAH;FAM13C;PARD3B;CAP2;IGDCC4;RBFOX2;PDZRN3;SMARCA1
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Gastrointestinal Tract,0.5909003572089728,1.3855138234181756,0.046875,0.27419282725110117,1.0,31/95,15.20%,FLRT3;PROX1;PCDH18;RAPGEF5;SLIT2;DAB2IP;ANGPTL2;LGR5;FRAS1;LAMB1;CCDC3;ZNF704;PTPN21;GUCY1A2;SCARA3;ADGRL2;PTPRD;PKDCC;KALRN;CNN3;YAP1;TEAD1;SORBS1;ENAH;FAM13C;PARD3B;CAP2;IGDCC4;RBFOX2;PDZRN3;SMARCA1
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Gland,0.5909003572089728,1.3855138234181756,0.046875,0.27419282725110117,1.0,31/95,15.20%,FLRT3;PROX1;PCDH18;RAPGEF5;SLIT2;DAB2IP;ANGPTL2;LGR5;FRAS1;LAMB1;CCDC3;ZNF704;PTPN21;GUCY1A2;SCARA3;ADGRL2;PTPRD;PKDCC;KALRN;CNN3;YAP1;TEAD1;SORBS1;ENAH;FAM13C;PARD3B;CAP2;IGDCC4;RBFOX2;PDZRN3;SMARCA1
prerank,CellMarker_Augmented_2021__Stem cell:Gastric Gland,0.5909003572089728,1.3855138234181756,0.046875,0.27419282725110117,1.0,31/95,15.20%,FLRT3;PROX1;PCDH18;RAPGEF5;SLIT2;DAB2IP;ANGPTL2;LGR5;FRAS1;LAMB1;CCDC3;ZNF704;PTPN21;GUCY1A2;SCARA3;ADGRL2;PTPRD;PKDCC;KALRN;CNN3;YAP1;TEAD1;SORBS1;ENAH;FAM13C;PARD3B;CAP2;IGDCC4;RBFOX2;PDZRN3;SMARCA1
prerank,CellMarker_Augmented_2021__Somatic Stem cell:Endometrium,0.5909003572089728,1.3855138234181756,0.046875,0.27419282725110117,1.0,31/95,15.20%,FLRT3;PROX1;PCDH18;RAPGEF5;SLIT2;DAB2IP;ANGPTL2;LGR5;FRAS1;LAMB1;CCDC3;ZNF704;PTPN21;GUCY1A2;SCARA3;ADGRL2;PTPRD;PKDCC;KALRN;CNN3;YAP1;TEAD1;SORBS1;ENAH;FAM13C;PARD3B;CAP2;IGDCC4;RBFOX2;PDZRN3;SMARCA1
prerank,CellMarker_Augmented_2021__Corneal Limbal Stem cell:Limbal Epithelium,0.5909003572089728,1.3855138234181756,0.046875,0.27419282725110117,1.0,31/95,15.20%,FLRT3;PROX1;PCDH18;RAPGEF5;SLIT2;DAB2IP;ANGPTL2;LGR5;FRAS1;LAMB1;CCDC3;ZNF704;PTPN21;GUCY1A2;SCARA3;ADGRL2;PTPRD;PKDCC;KALRN;CNN3;YAP1;TEAD1;SORBS1;ENAH;FAM13C;PARD3B;CAP2;IGDCC4;RBFOX2;PDZRN3;SMARCA1
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.7957366873463562,1.385272416796607,0.038461538461538464,0.2746891968482128,1.0,2/10,7.04%,PDGFRA;APLNR
prerank,KEGG_2021_Human__Basal cell carcinoma,0.6453339079086318,1.3851733053831792,0.05555555555555555,0.27463415717901024,1.0,5/50,9.88%,LEF1;WNT8B;DVL1;CTNNB1;GLI2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.7121933629384026,1.3850952845302908,0.046153846153846156,0.2745792091662093,1.0,6/32,6.65%,MET;NRP2;SEMA3C;SEMA5B;SEMA3D;SEMA3B
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.6517390589863102,1.384935969964429,0.04225352112676056,0.27487150997506876,1.0,12/45,13.58%,TLR2;ANXA1;SERPINE1;NOD1;PTPRC;MYD88;CHI3L1;STAT3;SYK;MAPKBP1;KLF4;FADD
prerank,CellMarker_Augmented_2021__Endometrial Stem cell:Endometrium,0.7970276141193304,1.3848841864595964,0.04918032786885246,0.27475864454356,1.0,6/18,6.44%,ICAM1;THY1;PTPRC;LGR5;MCAM;CD44
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.8280350988011215,-1.3846986406153785,0.06666666666666667,0.6492867050642562,1.0,2/8,5.43%,RAB7B;PTPN22
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),-0.5513745092955111,-1.3845464162165664,0.038461538461538464,0.6478484528041445,1.0,20/71,15.16%,FTL;MT1E;FTH1;MT1A;SLC30A8;SLC39A10;MT1G;CCDC22;MT1F;SLC31A2;SLC30A5;ATP6V1G1;SLC46A1;MT2A;ISCU;SLC39A8;COX19;HFE;SLC39A6;MT3
prerank,Reactome_2022__Glycosaminoglycan Metabolism R-HSA-1630316,0.5670565096399981,1.3844118215507446,0.0,0.27593601705619203,1.0,22/98,11.69%,NDST4;CSPG4;PAPSS2;DCN;OGN;B3GNT2;CHSY3;CHST15;CHST6;CHPF2;CD44;AGRN;SLC9A1;BGN;OMD;UST;HS6ST1;HS3ST4;HS3ST3B1;HS3ST3A1;B4GALT7;B4GALT5
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.545199474223087,1.384103505099005,0.02702702702702703,0.2766112342766009,1.0,53/165,14.24%,FOSL2;FOSB;COL4A1;PRRX1;IGF1;KLF2;PDGFRA;PCDH18;DCN;ACTA2;NR4A1;SULF1;CD55;COL4A2;ASPN;THY1;IL1R1;PODN;ADAMTS10;CTHRC1;COL8A1;ANGPTL2;POSTN;SLIT3;COL12A1;LAMB1;FAP;IGFBP7;CD44;TNS1;TBX20;C1R;CYP1B1;BGN;MMP14;PIP4K2A;STAT3;FLI1;LAMA2;COL4A4;NR4A2;SPARC;KLF9;ITGAL;PRKCD;KLF6;FN1;KLF4;COPZ2;FGF2;PALLD;COL5A1;THBS2
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.6553865386105763,1.3840751954316253,0.12280701754385964,0.27648759577074483,1.0,15/39,17.89%,IL1RAPL1;NLGN1;NUMBL;GRID2;CLSTN2;SERPINF1;PTPRD;DLG5;NAP1L1;TRIM32;RGS14;CLSTN3;CUX2;SRPX2;LRP2
prerank,CellMarker_Augmented_2021__Pericyte:Subcutaneous Adipose Tissue,0.6220373499263664,1.3840584300417098,0.08333333333333333,0.27628733562426333,1.0,21/58,9.78%,GGT5;DCN;ABCA8;FLT1;PTPRB;PODN;ACKR1;SHROOM4;PCDH12;MYH11;MCAM;FAM107A;IGFBP7;CFH;TNS1;LDB2;APLNR;RAMP3;ADGRF5;BGN;RNASE1
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.6340918918179141,1.3840553905822262,0.03225806451612903,0.27605862094245515,1.0,21/53,19.36%,MET;PSRC1;CDC42EP3;BAIAP2L1;BAIAP2;CDC42EP1;PRKCE;FCHSD1;TPPP;MAPT;ARF6;PAK1;BIN1;PINK1;PFN2;VASP;DCTN1;CRACD;NCK2;CAV3;CDK5RAP2
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.6973793947931628,-1.3839977565749966,0.11363636363636363,0.6484754900522745,1.0,5/15,14.94%,TRPT1;POP5;KARS1;ADAT1;YARS2
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.7479980730884573,1.3836373956185506,0.08771929824561403,0.27680820220296226,1.0,6/18,15.46%,CDKN2A;PLEK;CDKN1C;CDKN1B;CDKN1A;TP53
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),0.9074254247081438,1.3836153790143098,0.01639344262295082,0.2766177531090948,1.0,2/7,1.51%,LEF1;TESC
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.8832784367814306,1.3834045739491934,0.04838709677419355,0.2766777277585974,1.0,3/7,5.05%,SLIT2;NRP2;SLIT3
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.8832784367814306,1.3834045739491934,0.04838709677419355,0.2766777277585974,1.0,3/7,5.05%,SLIT2;NRP2;SLIT3
prerank,Reactome_2022__Rap1 Signaling R-HSA-392517,0.7902557275743332,1.3833397873557836,0.09433962264150944,0.2766216386127165,1.0,8/14,19.81%,RASGRP2;RASGRP1;RAP1GAP;RAP1GAP2;SIPA1;RAP1A;PRKCA;RAP1B
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.6915338002271283,-1.3832486254112935,0.12121212121212122,0.6500012065889742,1.0,8/15,19.57%,GDE1;PLA2G4C;ENPP6;LYPLA2;GPCPD1;GDPD1;PRDX6;PLA2G4A
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.9394402148468806,1.383145968051446,0.0784313725490196,0.27683298420213653,1.0,1/5,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.7246603744576829,1.3831183937567542,0.05172413793103448,0.2766623786167315,1.0,9/27,10.44%,IGF1;GRIN2A;ICAM1;APP;FYN;GRM5;GRIN1;RAMP3;EPHA4
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8758690573964689,1.3829163108887341,0.08163265306122448,0.2770544555896039,1.0,3/5,7.81%,OXTR;ECE1;ENPEP
prerank,CellMarker_Augmented_2021__Oogenesis Phase Fetal Germ cell:Fetal Gonad,0.49303229384493996,1.3827704926532753,0.0,0.27725540014911343,1.0,158/708,17.46%,ELAVL2;BOK;SPOCK3;ANK3;IMPDH1;RFTN1;CCBE1;COBLL1;YWHAH;KCNH8;TESC;SH3GL2;RASGRP1;MAEL;GRIK2;B3GNT2;SH3GL3;CNTN4;SHTN1;CFAP58;ADCY5;FA2H;RELN;ADA;DYSF;CNTNAP2;RPA1;SAMD4A;BCAS1;TGFA;TMEM200A;SH3KBP1;MDGA2;ADARB2;VLDLR;MAP1LC3A;EMB;BAIAP2L1;GABBR2;ESYT3;DNAH3;UNC13C;ZNF330;CCNI2;GNG2;FBXW12;ANKRD45;FAT2;PSMG4;BAIAP2;ATP9A;COLEC11;MEGF11;PTPN21;SBF1;SERPINF1;LSM11;FOXO3;PDE8B;PDGFRL;MAP1B;PHACTR3;TTC39A;PCGF3;GSE1;DUSP22;DAAM1;RAB40B;OSTF1;ACOT4;NECAB2;HOOK1;CRISPLD1;NRXN3;MVP;MAP3K7CL;PLAAT3;KPNA7;ITIH2;KALRN;CNN3;AFF1;FTCD;TRAK1;PDZD2;STAG3;MINK1;B3GALNT1;FBXO32;ITGA9;RADIL;FBXL2;TLE6;LAMA2;MAPT;JAZF1;KIF13B;ENAH;L3MBTL3;RUNX1T1;FMN1;GADD45A;PXK;PRICKLE1;ARHGAP18;CDKN1B;STAU1;SLC29A4;ANXA11;ZFAND3;FN1;DNAJB13;JARID2;PHEX;POMZP3;NLRP2;NOL4L;USP53;PCDH15;PALLD;HAP1;MAN1A1;ABCC4;TAFA1;DIP2C;CAST;LCMT1;CD59;UBXN11;ZNF215;CHRNE;BAALC;FAM228A;P2RX7;C3ORF70;WEE2;SLCO3A1;PKP4;PFN2;SARDH;B4GALT6;HAPLN3;CUX2;MYOF;MESP1;SLC8A1;MICALL2;PDE4D;TRAF5;MCTP1;CDH17;CALB2;FSTL4;CYSTM1;TDRD1;EPN1;UNC5C;RCN3
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.5815161027249688,1.3826068485450145,0.08620689655172414,0.2776273132674786,1.0,11/56,9.61%,EGF;SH3GL2;PTK6;DAB2IP;TGFA;SH3KBP1;RHBDF1;WDR54;MVP;ARHGEF7;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.8056438534314357,1.3825484769898124,0.07936507936507936,0.27758973876366344,1.0,5/9,14.19%,THBS1;APLNR;PPP1R16B;FGF2;IL12A
prerank,Reactome_2022__Depolymerisation Of Nuclear Lamina R-HSA-4419969,0.7805401652921437,1.3823507195821938,0.07272727272727272,0.2779702691236716,1.0,6/13,18.53%,PRKCB;LMNB1;LMNA;LPIN3;CCNB1;PRKCA
prerank,Reactome_2022__Maturation Of Spike Protein R-HSA-9683686,-0.857805590039119,-1.3816688054855684,0.10638297872340426,0.6555541658746663,1.0,3/5,11.51%,MOGS;MOGAT1;GANAB
prerank,Reactome_2022__Regulation Of TP53 Expression And Degradation R-HSA-6806003,0.6841941593483708,1.3816606357534433,0.06382978723404255,0.27992604770820834,1.0,1/34,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.8199286255675281,-1.3814792644984712,0.12244897959183673,0.6544294123294021,1.0,2/7,7.29%,PIK3C2G;PIK3C2A
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.6018219667309798,1.3814175624680387,0.0547945205479452,0.2803135288292568,1.0,22/80,9.54%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;SULF1;COL4A2;THY1;PODN;ANGPTL2;POSTN;SLIT3;COL12A1;FAP;TNS1;LDB2;GFAP;C1R;BGN;RASL12
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.6013579922233566,1.3811390697038253,0.014705882352941176,0.28076672003644504,1.0,20/78,17.67%,SCN1B;STMN2;PTK6;RIT2;PLPPR5;RELN;DAB2IP;VLDLR;NTRK3;NPTN;ZNF804A;PACSIN1;CAMK2B;ALK;COBL;CUX2;CAMK1D;WNT5A;ALKAL2;RAP1A
prerank,Reactome_2022__Effects Of PIP2 Hydrolysis R-HSA-114508,0.7355605726051844,1.380657991060319,0.07142857142857142,0.28173054719052937,1.0,8/25,12.29%,RASGRP2;RASGRP1;TRPC3;ITPR3;DGKG;PRKCE;PRKCH;PRKCD
prerank,Reactome_2022__NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.561706986084547,-1.3806160898024278,0.027777777777777776,0.656694854895014,1.0,3/39,5.18%,KPNA2;AAAS;NUP50
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),-0.7767118944667966,-1.380582174214215,0.05,0.6547546361363982,1.0,1/6,8.86%,GPLD1
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),0.8353578065983026,1.3804691714247532,0.13333333333333333,0.2818885134262019,1.0,4/7,12.47%,CHRM3;PIM1;SNCA;BCL2
prerank,KEGG_2021_Human__Leukocyte transendothelial migration,0.5907842317443686,1.380385645570236,0.0,0.28188549570867655,1.0,33/75,23.59%,CLDN16;PRKCB;ICAM1;PRKCG;THY1;CTNNB1;ACTN1;CLDN18;CTNNA1;PXN;ITGAL;CLDN20;CD99;SIPA1;PIK3CD;MAPK11;BCAR1;VAV2;CTNNA3;VASP;CD99L2;GNAI1;RAP1A;PRKCA;VAV1;RAP1B;ACTN4;CTNNA2;ARHGAP35;PTPN11;PECAM1;VCL;CXCL12
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.7054303825646987,1.3803448066722512,0.1,0.28178801510515017,1.0,5/17,12.47%,BOK;FAS;DCC;BCL2L1;BCL2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.8671350475649737,-1.3802709757531404,0.16326530612244897,0.6540032644113926,1.0,4/7,12.85%,NUDT16L1;TFIP11;HSF1;ERCC6
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.551801462767129,1.3801281051604346,0.029411764705882353,0.2820588176838589,1.0,23/128,12.29%,SH3GL2;DMTN;SLIT2;DAB2IP;THY1;NLRP12;CAMK2N2;PTPRC;PMEPA1;SMCR8;NTRK3;DVL1;PARD3;PID1;SNCA;MVP;YWHAG;LDLRAD4;NIBAN1;TERF2IP;INPP5J;MLXIPL;PRKCD
prerank,Reactome_2022__GRB2 Events In EGFR Signaling R-HSA-179812,0.8930224899113959,1.3800002187068994,0.01818181818181818,0.2822914539454148,1.0,2/7,3.84%,EGF;TGFA
prerank,CellMarker_Augmented_2021__Nucleus Pulposus cell:Intervertebral Disc,0.5887007917279389,1.3798440746227238,0.046875,0.28239177958282047,1.0,24/83,12.00%,COL4A1;PRRX1;PDGFRA;DCN;CALD1;SULF1;ITGA8;COL4A2;SLIT2;COLEC12;ANGPTL2;COL12A1;CCDC3;GUCY1A2;LIMCH1;BOC;BGN;TANC1;GLI2;SLCO2A1;FAM13C;PDE10A;RUNX1T1;PARD3B
prerank,CellMarker_Augmented_2021__Osteoblast:Bone,0.7387324533845512,1.379641539097171,0.12727272727272726,0.28274617649515127,1.0,4/14,6.44%,THY1;PTPRC;NFIL3;CD44
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.6520987866088035,-1.379638399828868,0.13636363636363635,0.6554347936014372,1.0,15/33,19.37%,TFB2M;MRPS21;MRPS7;MRPS16;MRPL47;FASTKD2;GATC;NOA1;MRPS18B;MRPS34;SLC25A33;MRPS12;TEFM;PTCD3;QRSL1
prerank,CellMarker_Augmented_2021__Epithelial cell:Epithelium,0.6492897455793386,1.3795969218601085,0.03278688524590164,0.2826578013477019,1.0,10/47,9.94%,GGT5;ABO;SIGLEC1;ACKR1;MYH11;APLNR;RAMP3;ADGRF5;RNASE1;ITGA9
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),0.8072129473342227,1.3795710953687892,0.10344827586206896,0.28248496225328773,1.0,3/10,8.22%,EGF;PTPRC;MGAT5
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.8120572004101475,-1.3790986276191077,0.11627906976744186,0.6555688492953826,1.0,3/6,14.47%,SLC25A19;ABCC11;SLC25A33
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Corneal Endothelium,0.5792441750993916,1.378972368237507,0.027777777777777776,0.28410650307172125,1.0,16/81,11.55%,COL4A1;ANXA1;THBS1;SERPINE1;COL4A2;TIMP2;COL8A1;CLIC4;FAP;IGFBP7;TPM4;EMP1;TUBB6;MMP14;ADAM12;SPARC
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),0.9125570619227372,1.3786771721450506,0.0,0.2844439132372576,1.0,2/6,6.20%,CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),0.9125570619227372,1.3786771721450506,0.0,0.2844439132372576,1.0,2/6,6.20%,CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.6150395167877993,1.378675772699082,0.03225806451612903,0.2842139666622881,1.0,13/62,7.44%,GGT5;PLK2;ADCY5;MYH9;PRKAR1B;FYN;GIPR;RXFP1;GNG2;ADCY7;ADCY2;RAMP3;GLP1R
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.6895090506177227,1.3783723639440282,0.05970149253731343,0.28472405616644725,1.0,4/32,1.68%,NR4A3;IGF1;P2RY6;THBS1
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.5440344297880059,1.3783500212740465,0.028985507246376812,0.2844942546683306,1.0,33/215,12.63%,NR4A3;CXCL2;TLR2;P2RY6;PDGFRA;TESC;SERPINE1;PTK6;ZFP36;DMTN;KCNQ1;SLIT2;KCNC2;GLRA2;DAB2IP;FOXO1;WNT8B;GNG2;AHR;PID1;RAMP3;MYD88;HCN1;NEURL1;SHMT1;P2RY12;MAPT;GUCY1B1;PXN;PDK4;CCL2;PRKCD;AGAP3
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),-0.9006837637229634,-1.3782175312528335,0.046511627906976744,0.6558344471390122,1.0,1/5,1.61%,SELENOS
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),-0.9006837637229634,-1.3782175312528335,0.046511627906976744,0.6558344471390122,1.0,1/5,1.61%,SELENOS
prerank,Reactome_2022__Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,0.6957797311651068,1.378210768384874,0.14035087719298245,0.2846293857424511,1.0,5/19,12.22%,GRIN2D;GRIN2B;NEFL;GPRIN1;CAMK2B
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.7417188630923038,1.3775748330320976,0.018867924528301886,0.2863147737712219,1.0,2/22,1.51%,LEF1;TESC
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,-0.6059062877809666,-1.3775165789723238,0.1388888888888889,0.6572187957772095,1.0,6/39,15.25%,FIP1L1;AAAS;NUP50;CPSF1;NUP54;CPSF3
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),0.9002757163524923,1.377430593247433,0.05555555555555555,0.28646688682445715,1.0,1/6,0.25%,HPN
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.7694514078359046,1.3772977835594957,0.08196721311475409,0.28653482849956763,1.0,4/15,8.84%,MYO1F;MYO1B;MYO1C;MYO15A
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),-0.7939054830695721,-1.3771941098388438,0.07692307692307693,0.6568743627194312,1.0,5/9,14.54%,SLC25A5;SLC25A4;CR1;CD47;SLC25A24
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.6335852002459017,1.377185993430875,0.04477611940298507,0.28661197862830007,1.0,10/47,12.17%,EPHA2;STAC2;RAMP3;ITGA3;PTPN9;PRKCE;PRKCH;SORBS1;STX4;ARF6
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7160881655410187,1.3771803377958192,0.08955223880597014,0.2863910784042258,1.0,4/20,8.55%,NLGN1;TJP3;SHANK1;PCLO
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.8096548855061622,1.377079999197347,0.07547169811320754,0.28650543097955633,1.0,5/13,12.66%,SP100;APOD;BARD1;CABP1;RANGAP1
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Lymphoid Tissue,0.7105404956527301,1.3766072056434884,0.0273972602739726,0.287456174303784,1.0,8/29,4.66%,HLA-DRA;CTSS;PLEK;LMO2;NAPSB;WAS;PTPRC;CD37
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.646369253833666,1.3764556436988122,0.09375,0.2876809440223997,1.0,6/37,9.14%,PLD1;LIPH;LPCAT4;DGKG;AGPAT4;PLD2
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.7050154813262628,1.3761187051239736,0.15789473684210525,0.28845289647941186,1.0,8/16,23.72%,RELN;EPHA5;CD200;CAMK1D;RPS6KA4;CRTC3;ADCY8;RPS6KA5
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.7855354682309917,1.3760824436798857,0.12727272727272726,0.2883241367191997,1.0,4/11,10.69%,NLGN1;EPS8L2;PLEKHM1;P2RY12
prerank,"Reactome_2022__Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",0.732134704343182,1.3760784823124435,0.08064516129032258,0.2881121928843416,1.0,4/20,7.01%,GNG3;ADCY5;GNG2;CACNA1C
prerank,Reactome_2022__Extra-nuclear Estrogen Signaling R-HSA-9009391,0.6399242974444994,1.3758825620006452,0.0,0.288391269392478,1.0,15/54,18.26%,KCNH8;EGF;GNG3;TGFA;GNG2;FOXO3;ZDHHC7;S1PR3;CDKN1B;BCL2;CCND1;SHC1;IGF1R;GNAI1;PRMT1
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.658214492963278,1.3755545421310977,0.015384615384615385,0.28908618455304574,1.0,10/42,3.65%,HLA-DRA;TLR2;TYMP;CTSS;SLC15A3;P2RY13;MYO1F;PLEK;IRF7;SIGLEC1
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.5865369446416533,-1.375487555269188,0.05128205128205128,0.663321019223452,1.0,4/34,7.38%,TPX2;AAAS;KIF4A;ABRAXAS1
prerank,"Reactome_2022__GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",0.7677807223414915,1.37534206536543,0.05660377358490566,0.28948420320698837,1.0,5/18,9.47%,SLC32A1;SYT1;GAD2;CPLX1;DNAJC5
prerank,Reactome_2022__RHOJ GTPase Cycle R-HSA-9013409,0.6205092760894202,1.3751972714120404,0.045454545454545456,0.28976151936464906,1.0,18/50,24.83%,STEAP3;WAS;CDC42EP1;PAK4;ARHGAP26;ARHGEF7;TRIO;OPHN1;FMNL3;STOM;SCRIB;TFRC;ARHGAP35;RAB7A;PREX1;OCRL;DEPDC1B;ARHGAP1
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.7900608957247353,1.3750568419079863,0.1206896551724138,0.2898907353417295,1.0,3/12,5.78%,ANXA1;ZFP36;FAM107A
prerank,Reactome_2022__FCERI Mediated Ca+2 Mobilization R-HSA-2871809,0.7228824785544704,1.3746854378791749,0.06451612903225806,0.2908773285153405,1.0,10/21,19.68%,TEC;NFATC2;ITPR3;SYK;VAV2;SHC1;ITPR1;NFATC3;VAV1;AHCYL1
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.807270914186558,1.3746545625031181,0.09433962264150944,0.29049811178767715,1.0,4/11,17.35%,IL15;STAT3;CD4;SHC1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.807270914186558,1.3746545625031181,0.09433962264150944,0.29049811178767715,1.0,4/11,17.35%,IL15;STAT3;CD4;SHC1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.8762741102613542,1.3746477724614612,0.12244897959183673,0.29028595646031524,1.0,1/7,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.7073483929828625,1.3746365741974884,0.08196721311475409,0.2900833296899007,1.0,7/17,18.06%,THY1;SH3KBP1;CYRIB;CCL2;TNIP2;IL12A;TNFSF4
prerank,Reactome_2022__DAP12 Signaling R-HSA-2424491,0.7151711788757391,1.37458956269231,0.07142857142857142,0.2899728718973777,1.0,7/18,17.35%,FYN;RNASE1;SYK;B2M;HLA-E;VAV2;SHC1
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.7407071503006246,-1.3742325624927851,0.11627906976744186,0.6671284062437307,1.0,2/13,6.13%,FBXO5;IK
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.8717534527881774,1.3742269809361385,0.08620689655172414,0.2907986954037309,1.0,2/6,5.73%,SHANK3;LHX6
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.6022897639455119,1.3741187245755544,0.08196721311475409,0.29088959199593867,1.0,12/57,16.25%,SKOR1;VWC2;SULF1;VWC2L;TBX20;ITGA3;PPARG;SMAD1;ELAPOR2;HIPK2;SMURF1;FSTL1
prerank,CellMarker_Augmented_2021__Luminal progenitor:Breast,0.8971046369580389,1.3738843683815554,0.07352941176470588,0.29117276795540986,1.0,2/5,6.44%,CD24;CD44
prerank,Reactome_2022__Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.5945147496933387,-1.3738429992246646,0.08888888888888889,0.6670368211261644,1.0,19/51,21.07%,ERCC8;COPS8;GTF2H5;POLR2K;GTF2H2;COPS7A;ERCC2;POLR2C;HMGN1;ERCC6;POLR2D;PPIE;XPA;ERCC3;UBB;COPS3;POLR2L;POLR2G;COPS6
prerank,Reactome_2022__RET Signaling R-HSA-8853659,0.6649268587255089,1.3736675456105651,0.08620689655172414,0.2917484810689631,1.0,13/30,22.15%,IRS2;DOK6;SHANK3;GFRA2;RAP1GAP;GAB2;SHC1;PRKCA;GFRA1;DOK1;GRB10;PSPN;PTPN11
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.762832240352256,1.3734986944565806,0.12727272727272726,0.2919481952779256,1.0,6/13,11.38%,SHTN1;PTPRC;ITGA2;ITGA11;P2RY12;OPHN1
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),-0.8659138507270383,-1.3733566797780432,0.10416666666666667,0.6673647483031634,1.0,2/6,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.6529785458611912,1.3733349161885082,0.10294117647058823,0.2921750184541984,1.0,6/33,6.55%,SERPINA10;SPOCK3;SERPINE1;TIMP2;SERPINE3;SERPINF1
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.6220395704770856,-1.3732659067618094,0.07692307692307693,0.6656951390498902,1.0,9/31,15.70%,SLC25A5;SLC25A4;BAK1;APOO;MICOS10;SAMM50;BAD;TIMM50;TMEM11
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),0.8762773665955984,1.373263200976193,0.07017543859649122,0.29217313112003124,1.0,3/7,3.68%,GRIN3A;NLGN1;EFNA1
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.6944376716853381,1.3732350064853391,0.07692307692307693,0.29199783510964933,1.0,9/25,16.31%,STMN2;SLIT2;SNCA;SSH2;CYRIB;EML2;PRKCD;STMN1;PFN2
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),0.712005629815743,1.3731166956157328,0.03278688524590164,0.292105527125508,1.0,5/19,11.14%,THY1;RHOD;ARHGEF7;SORBS1;ACTN1
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),0.7436414503704064,1.3725951696467336,0.0425531914893617,0.29319720827564255,1.0,2/16,4.31%,HLA-DRA;PTPRC
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),0.8963867738564522,1.3725803546162492,0.022727272727272728,0.2930215209148094,1.0,3/7,3.05%,THBS1;PRKCB;IRS2
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.705576381603029,1.372455211894921,0.06451612903225806,0.29308266445332753,1.0,7/21,21.03%,S100A10;THY1;MAPRE2;ARF6;TEK;PTPRJ;PPM1F
prerank,KEGG_2021_Human__Melanogenesis,0.6105838603576025,1.3724483936978311,0.06944444444444445,0.2928709779708635,1.0,11/78,8.69%,LEF1;PRKCB;ADCY5;PRKCG;WNT8B;DVL1;ADCY7;ADCY2;TYR;CTNNB1;KITLG
prerank,KEGG_2021_Human__Toxoplasmosis,0.5735961015228229,1.372323760991649,0.0547945205479452,0.2930048157516336,1.0,25/85,17.55%,HLA-DRA;TLR2;LAMB1;CIITA;BIRC3;TNFRSF1A;MYD88;LDLR;LAMA5;BCL2L1;TGFB2;STAT3;LAMA2;TYK2;HLA-DRB1;BCL2;HLA-DMA;IL12A;IKBKG;MAPK11;LAMA3;TAB1;MAPK9;MAP2K3;GNAI1
prerank,Reactome_2022__Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.5719181776824738,-1.372319194664175,0.10714285714285714,0.6681765357075402,1.0,11/57,20.20%,CDC26;PSMD10;ANAPC15;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,Reactome_2022__Interleukin-35 Signaling R-HSA-8984722,0.8014860160614741,1.3722849527787095,0.11864406779661017,0.29288429075564176,1.0,5/11,14.19%,STAT4;IL27RA;STAT3;TYK2;IL12A
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.7361675379005427,1.3722647482251145,0.08620689655172414,0.2927004658006524,1.0,3/19,5.87%,PDGFRA;FLT1;NTRK3
prerank,Reactome_2022__Presynaptic Function Of Kainate Receptors R-HSA-500657,0.7559083373620934,1.3721694132773918,0.1,0.29272537051102204,1.0,2/14,5.37%,GNG3;GNG2
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),-0.642512737277447,-1.3721428207681878,0.10810810810810811,0.6669758644001809,1.0,11/23,15.16%,MT1E;MT1A;SLC30A8;SLC39A10;MT1G;MT1F;SLC30A5;MT2A;SLC39A8;SLC39A6;MT3
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),0.7522386066102226,1.3719055372370843,0.10909090909090909,0.29332979629057376,1.0,4/15,9.88%,SIX3;WNT8B;TBX20;GLI2
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),0.9302528823115892,1.371691194196298,0.037037037037037035,0.2934689223316847,1.0,2/5,4.64%,CNTNAP2;SHANK3
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),0.9302528823115892,1.371691194196298,0.037037037037037035,0.2934689223316847,1.0,2/5,4.64%,CNTNAP2;SHANK3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Uterus,0.5815137461360911,1.3715686196269496,0.045454545454545456,0.29355639159561503,1.0,29/75,17.91%,COL4A1;DCN;PPFIBP1;FBLIM1;PTPRB;SHROOM4;OSMR;POSTN;COL12A1;ITGA2;IGFBP7;CFH;EMP1;ADGRF5;BGN;YAP1;TANC1;SYTL4;SLCO2A1;NPAS2;PARD3B;ROBO4;NTN4;LAMA3;FSTL1;FAM114A1;WWTR1;SRPX2;MECOM
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.6217679497608417,-1.3715112847485131,0.11764705882352941,0.6675759162434831,1.0,8/30,13.26%,NDUFS5;NDUFA12;NDUFB4;NDUFB1;NDUFV3;NDUFA8;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.7621601167488363,-1.371234798486639,0.18604651162790697,0.6667281658633334,1.0,3/8,17.12%,METAP1D;METAP2;METAP1
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),-0.6076983360893293,-1.3711189556120842,0.07317073170731707,0.6653598714310489,1.0,13/41,17.77%,RPS28;MRPS7;RPL6;RPS27L;RPSA;MDN1;RPL11;MTERF3;RPL23A;LOC102724159;RPF2;RPL10;DHX29
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),-0.8859271624997609,-1.3710295344420662,0.058823529411764705,0.6616482910388335,1.0,2/5,0.96%,EYS;REEP6
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),-0.8859271624997609,-1.3710295344420662,0.058823529411764705,0.6616482910388335,1.0,2/5,0.96%,EYS;REEP6
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),-0.8491492833701425,-1.370571283701193,0.0,0.6615078491851927,1.0,1/7,1.13%,ERCC8
prerank,Reactome_2022__RHOV GTPase Cycle R-HSA-9013424,0.6659587433518022,1.3705605597096175,0.07142857142857142,0.2961082086535612,1.0,8/35,14.03%,EPHA2;MAP3K11;TPM4;PAK4;ARHGEF7;DLG5;MYO9A;IQGAP1
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.5767686534095293,1.37053901983287,0.041666666666666664,0.2959589577494747,1.0,10/77,5.46%,HLA-DRA;C3;CTSS;C1ORF87;KCNJ2;PLD1;IL1R1;CP;CLMN;ERICH3
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.5800915809725329,1.3704346550061883,0.07692307692307693,0.2960262599507914,1.0,24/92,9.78%,COL4A1;PRRX1;PDGFRA;DCN;ACTA2;CALD1;ABCA8;COL4A2;ASPN;PODN;ANGPTL2;MYH11;POSTN;COL12A1;PTPN21;TNS1;TPM4;C1R;CYP1B1;MATN2;ADGRF5;BGN;RASL12;RNASE1
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.6463639034392488,1.3703780100353191,0.06349206349206349,0.2959313428838814,1.0,6/38,9.14%,PLD1;LIPH;LPCAT4;DGKG;AGPAT4;PLD2
prerank,Reactome_2022__Downstream Signal Transduction R-HSA-186763,0.7044462419350713,1.3702489129709,0.03389830508474576,0.29600756139740203,1.0,6/25,17.98%,PDGFRA;PDGFA;STAT3;BCAR1;STAT6;NCK2
prerank,"KEGG_2021_Human__Parathyroid hormone synthesis, secretion and action",0.5829511953315334,1.3702468243923223,0.05084745762711865,0.29579590494892594,1.0,24/82,18.53%,CREB5;PLD1;PRKCB;ADCY5;PRKCG;GCM2;ITPR3;ADCY7;ADCY2;PLD2;GNA12;MMP14;NR4A2;MMP17;BCL2;MMP16;MEF2D;CDKN1A;RXRA;PDE4D;ADCY3;GNAI1;ITPR1;PRKCA
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.6685743743809867,1.3702379599908425,0.03636363636363636,0.2956205183543415,1.0,13/41,18.09%,TLR2;EGF;DYSF;PLSCR1;NRG1;SNCA;PXK;SCAMP5;MCTP1;LRSAM1;NDFIP2;MTMR2;CTTNBP2NL
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.6559403462914063,-1.3700597951545495,0.08108108108108109,0.6616392310683655,1.0,4/20,10.70%,BUD23;TFB2M;THUMPD1;MTERF4
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.7864609197763917,-1.3698242794895317,0.08888888888888889,0.6608917363571224,1.0,3/11,10.43%,COX7C;COX7B;COX5B
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.7295390939608964,1.3697673135544295,0.05357142857142857,0.2966934102456988,1.0,8/21,15.19%,MYRF;RELN;SOX4;TPPP;STAT3;PICK1;SOX10;EIF2B5
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6493285811708788,1.36965401922375,0.043478260869565216,0.2968316035705005,1.0,9/31,13.18%,TGFBR2;THBS1;PID1;GRIN1;SYK;MAPT;GADD45A;PRKCD;CDKN1A
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.5778530198596309,1.3695390765640052,0.03278688524590164,0.2969068310915585,1.0,32/128,8.99%,GRIN3A;CA10;GRIN2A;RGS7BP;GRIN2B;CNTN2;GAP43;OPALIN;PLP1;SEPTIN4;PLPPR4;SCN1A;C11ORF87;STMN4;OPCML;SCN2A;SYNPR;KCND3;LRRTM2;FAM107A;NTRK3;ST8SIA3;RFX4;GRM5;TCEAL5;ADCY2;GRIA3;VSTM2A;GFAP;NRXN3;GRIA1;ALDH1L1
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.6246573982566326,1.3695376077336285,0.06451612903225806,0.2966952975275864,1.0,12/60,13.20%,CDKN2A;GPNMB;ANXA1;KIF14;FAM107A;LSM11;CDK6;GFI1B;CCL2;KLF4;CDKN1A;CCND1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PLC Beta R-HSA-418217,0.7620473845580762,1.3694591937817875,0.08196721311475409,0.29667205605620167,1.0,2/13,5.37%,GNG3;GNG2
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreatic Islet,0.5952283229738278,1.3694583065565573,0.03333333333333333,0.2964431424327015,1.0,19/72,14.22%,SPOCK3;MLLT11;CERCAM;FGF12;EGFL7;RAB3C;FAP;VGF;GRIA3;TTC39A;ITPK1;PLAAT3;PRKCE;ASXL3;YIPF2;PALLD;KCNMA1;CDS2;PLOD2
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.6312433131567632,1.3693587422950189,0.058823529411764705,0.2964111942831223,1.0,10/53,12.05%,ECM2;NPNT;EPB41L4B;RNASE10;RHOD;TGFB2;SYK;EPHA4;P2RY12;STX4
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.6531368550566858,1.3690459986864125,0.09259259259259259,0.29710262908302076,1.0,14/33,18.06%,GPNMB;ANXA1;IL15;SFTPD;PTPRC;DLG5;HLA-DRB1;CD276;SLC7A1;CD70;PDCD1LG2;TFRC;NCK2;TNFSF4
prerank,KEGG_2021_Human__Spinocerebellar ataxia,0.5619833236344601,1.3689791905228978,0.013513513513513514,0.29703452974870365,1.0,15/125,8.77%,GRIN3A;GRIN2A;GRIN2D;GRIN2B;TRPC3;PRKCB;PRKCG;RELN;CIC;VLDLR;KCND3;ITPR3;GRIA3;GRIN1;GRIA1
prerank,Reactome_2022__Polo-like Kinase Mediated Events R-HSA-156711,0.7805240778590465,1.3689252157057357,0.10606060606060606,0.2970378656420138,1.0,1/12,1.73%,CCNB2
prerank,Reactome_2022__PI3K Cascade R-HSA-109704,-0.6782546497385722,-1.3687975582145562,0.13157894736842105,0.663695557914933,1.0,4/28,5.54%,FGF6;FLT3;THEM4;TRIB3
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Blood,-0.7645001962753757,-1.3686998232823768,0.10204081632653061,0.6545294889251205,1.0,3/9,6.16%,CD247;PYHIN1;P2RY10
prerank,CellMarker_Augmented_2021__Memory B cell:Peripheral Blood,-0.7645001962753757,-1.3686998232823768,0.10204081632653061,0.6545294889251205,1.0,3/9,6.16%,CD247;PYHIN1;P2RY10
prerank,CellMarker_Augmented_2021__Non-switched B cell:Blood,-0.7645001962753757,-1.3686998232823768,0.10204081632653061,0.6545294889251205,1.0,3/9,6.16%,CD247;PYHIN1;P2RY10
prerank,CellMarker_Augmented_2021__Plasma cell:Sinonasal Mucosa,-0.7645001962753757,-1.3686998232823768,0.10204081632653061,0.6545294889251205,1.0,3/9,6.16%,CD247;PYHIN1;P2RY10
prerank,CellMarker_Augmented_2021__Memory B cell:Liver,-0.7645001962753757,-1.3686998232823768,0.10204081632653061,0.6545294889251205,1.0,3/9,6.16%,CD247;PYHIN1;P2RY10
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.8334352108259142,1.3686407741450397,0.058823529411764705,0.29752230692320136,1.0,1/9,6.12%,PDP1
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.9252738094258623,1.3685785689084764,0.037037037037037035,0.297507457833199,1.0,1/6,1.16%,PROX1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.7988903849286079,1.368420943408403,0.09090909090909091,0.2977061302243326,1.0,4/12,7.62%,ZFP36;YBX3;ELAVL4;MYD88
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),0.8617489838113809,1.3679988235127538,0.05357142857142857,0.2986956150576345,1.0,4/9,11.07%,ANXA1;NLRP12;TMED10;GAS6
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),0.9226690352699594,1.3679794653499808,0.01694915254237288,0.2985289045461657,1.0,1/6,0.15%,NR4A3
prerank,CellMarker_Augmented_2021__Osteocyte:Bone,0.8592766144885023,1.3678608173459013,0.10606060606060606,0.2987529644833032,1.0,6/7,13.12%,CD44;BGN;SPARC;FN1;PDPN;PHEX
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.8458875434782556,1.3673152576860408,0.06451612903225806,0.299916748248784,1.0,4/10,12.96%,ENPP2;CD44;ARHGEF7;PDPN
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),0.7506857967930923,1.367282010868857,0.11320754716981132,0.2997317629659326,1.0,3/15,3.17%,TLR2;DMTN;APP
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),0.8329117849105081,1.3671469010211168,0.109375,0.2999809554933959,1.0,3/8,7.18%,SIX3;DAB2IP;RYR2
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.7199749630496713,1.3671345677978477,0.1076923076923077,0.2997608106416114,1.0,4/26,9.88%,NPY;PKDCC;TGFB2;GLI2
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.822571338917383,1.366759207802898,0.09090909090909091,0.30061082250078064,1.0,2/9,2.53%,TGFBR2;CD55
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),0.9079199323339715,1.3667395891739111,0.02,0.3002323755486869,1.0,3/5,9.00%,CD24;PTPRO;BASP1
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),0.9079199323339715,1.3667395891739111,0.02,0.3002323755486869,1.0,3/5,9.00%,CD24;PTPRO;BASP1
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.8207459857731597,-1.3667330722905955,0.14893617021276595,0.661758444681857,1.0,4/6,17.12%,METAP1D;METAP2;FKBP7;METAP1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.4854760372713974,-1.3665328383357005,0.029411764705882353,0.6605880734227093,1.0,52/254,15.40%,SNRNP27;FIP1L1;PDCD7;LSM7;SNRPB2;SCNM1;DHX16;LSM3;SF3B4;SF3A1;POLR2K;ZCRB1;RBM8A;PPWD1;LSM2;CRNKL1;U2AF1;SF3B6;IK;BUD31;GEMIN4;TFIP11;LSM5;FRG1;DDX46;SNU13;METTL3;PPIH;PQBP1;SYF2;CPSF1;CLP1;PPIL3;POLR2C;SNRNP25;GPATCH1;LSM4;WDR77;GTF2F1;PRPF8;PPIL1;SRSF2;PNN;RBM22;PRPF3;POLR2D;ESS2;PPIE;RBMX;CWF19L1;CPSF3;SUGP1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.6303023927530141,1.3663278740539249,0.014285714285714285,0.30133590581693886,1.0,13/62,14.40%,VRK2;SOCS3;CD24;IRAK2;PTPRC;BIRC3;TNFRSF1A;SYK;GAS6;HIPK1;FADD;ELF1;IKBKG
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),0.887668500125293,1.3662931563979892,0.07936507936507936,0.3012389720443309,1.0,1/5,2.80%,ABCB1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.7103638620084378,1.3662594044533436,0.06896551724137931,0.30105410656274656,1.0,10/24,18.06%,HLA-DRA;CD55;CYRIB;HLA-DRB1;B2M;FADD;IL12A;HLA-E;ZBTB1;TNFSF4
prerank,KEGG_2021_Human__Long-term depression,0.6544185681217652,1.3661608471313174,0.0625,0.3011687631155293,1.0,13/51,11.18%,IGF1;GRID2;PRKCB;PRKCG;PRKG2;ITPR3;GUCY1A2;GRIA3;GRIA1;GUCY1A1;GNA12;GNAZ;GUCY1B1
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.7888246001274222,1.3659907931274642,0.1111111111111111,0.3013623965148956,1.0,3/14,7.62%,RFTN1;IL15;MYD88
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.6392843983274537,1.3659663573921323,0.06349206349206349,0.3012042215344041,1.0,6/38,7.62%,TLR2;CTSS;SFTPD;IRAK2;NOD1;MYD88
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.5624049820499805,1.3656463669067076,0.046153846153846156,0.3019244073990225,1.0,41/118,22.72%,ARHGAP4;ARHGAP39;SLIT2;RELN;ARHGEF17;ARHGDIG;ARHGEF3;RHOD;OBSCN;MCF2;TRIP10;KALRN;ARHGAP26;ARHGEF7;CYRIB;TRIO;PLEKHG2;OPHN1;STARD13;ARHGAP18;MYO9A;ARHGAP17;CGNL1;ARHGAP22;NGEF;VAV2;RHOT1;RHOT2;MCF2L;RHOQ;VAV1;BCR;RHOB;ARHGEF6;ARHGAP35;ARHGAP9;PREX1;ARHGEF18;TAGAP;ITGAV;OCRL
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.561650517174539,1.365574550504787,0.043478260869565216,0.30189766491960174,1.0,31/120,17.54%,BOK;SLC7A2;ZDHHC9;SLC39A14;CEP170B;DAB2IP;ARHGEF17;EPB41L4B;PTPN21;RHBDF1;GPT2;SCARA3;MYO1B;ADGRL2;ASS1;FKBP5;DHCR24;PKDCC;YAP1;EPB41L1;KCTD3;TEAD1;CD276;CAP2;RBFOX2;BCAR1;SMARCA1;RORA;ADAMTS1;MAGI1;NR2F6
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.6535586023733929,-1.365418613811793,0.16129032258064516,0.6632402257893386,1.0,2/26,6.19%,CDC26;ANAPC13
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.7213184878911657,-1.365317381321019,0.14634146341463414,0.6616350009518259,1.0,3/13,15.80%,EIF4EBP1;EIF2AK1;EIF3E
prerank,Reactome_2022__SUMOylation Of DNA Methylation Proteins R-HSA-4655427,-0.7467201223002756,-1.36529668018619,0.13333333333333333,0.6598645726328006,1.0,2/13,4.99%,DNMT3B;RNF2
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",0.8967671164455209,1.365257306257684,0.07547169811320754,0.30269514804729736,1.0,1/5,0.57%,C3
prerank,Reactome_2022__Signal Transduction R-HSA-162582,0.4777381443657727,1.3649574106115616,0.0,0.30333372221047256,1.0,276/1818,12.94%,LEF1;NPY;TGFBR2;HPN;ANLN;FOSB;CXCL2;VRK2;COL4A1;ARHGAP4;C3;RASGRP2;NPY1R;FLRT3;GPNMB;HTR2C;ANXA1;SOCS3;IGF1;KIF14;NHS;P2RY6;PDGFRA;YWHAH;ADGRE5;KCNH8;PDE1C;KREMEN2;CHRM3;STMN2;EGF;GNG3;AMH;CHRM1;SH3GL2;GRIN2D;THBS1;SERPINE1;RASGRP1;GRIN2B;PTK6;VAPB;ACTA2;ELMO1;P2RY13;NR4A1;RASGEF1A;RIT2;GABRB2;ARHGAP39;SH3GL3;ZDHHC9;CD55;LTBP4;FLT1;STEAP3;NEFL;TRPC3;ITGA8;COL4A2;PLPPR5;CDC42EP3;PRKCB;EPHA2;ADCY5;SHC2;CSF2RA;PRKCG;WAS;PLEKHG6;TEC;IRS2;SLITRK5;LMNB1;APP;PLPPR4;RPS6KA1;MAP3K11;DAB2IP;FOXO1;NRP2;MYH9;ERBIN;GABRG3;WNT8B;DUSP10;PLPPR1;TGFA;ACKR1;RGS6;MCHR2;SH3KBP1;MYH11;DUSP8;LGR5;INCENP;BAIAP2L1;ARHGEF17;ARHGDIG;PRKG2;GABBR2;KHDRBS2;PRKAR1B;MCAM;WASF1;FYN;SOX4;GIPR;RDH13;PMEPA1;GFRA2;OXTR;RXFP1;ARHGEF3;GNG2;CDK5R2;APOD;DUSP16;LAMB1;ITGA2;ANOS1;BAIAP2;CHD3;DNM1;NTRK3;ITPR3;NOTUM;GABRA1;TAC3;PARD3;GRM5;PDE1A;RGSL1;CLTB;NRG1;BIRC3;TNFRSF1A;VGF;DOCK10;PGR;ECE1;CDK9;RHPN1;CENPP;CCKBR;ADCY7;FOXO3;PDE8B;RHOD;CASP10;APLNR;CDC42EP1;TPM4;PAK4;ADCY2;FLRT1;MAMLD1;GFAP;PML;RAMP3;GLP1R;NRG2;PDGFA;BOC;MYD88;OBSCN;MAG;DAAM1;GABRG2;ERCC6L;GRK2;MRAS;MCF2;LAMA5;CTNNB1;DGKG;KIF5A;BCL2L1;CDC14A;YWHAG;TRIP10;FKBP5;GNA14;KITLG;ITGA3;GRM6;KALRN;TBL1X;SMAD3;ARHGEF10L;LIMK2;BASP1;YAP1;ARHGAP26;PLD2;ARPC3;PRKCE;PRKCH;TRAK1;GAB2;GNA12;PDZD2;PPARG;NEURL1;ARHGEF7;CTBP2;PPP1CB;HDAC4;RNASE1;TGFB2;GLI2;ZDHHC7;COL9A1;TF;PIP4K2A;DLG5;GNAZ;GPRIN1;PAG1;STAT3;KCTD3;SYK;PDE1B;NOXA1;SMAD1;HMOX2;DNER;P2RY12;ADAM12;TRIO;LAMA2;ITGB8;DTX2;IFT122;COL4A4;S1PR3;ACTN1;HDAC9;CTNNA1;FGF13;PLEKHG2;TLE3;OPHN1;TYK2;SPARC;PDK4;HTR1E;PRR5;CCL2;PDE10A;DOCK4;KCTD13;HECW1;FGD5;STARD13;ARF6;PRICKLE1;CAMK2B;ARHGAP18;PRKCD;CDKN1B;CENPH;FMNL3;FRAT2;BCL2;KLC1;HNRNPH1;RANGAP1;MAPKAPK5;SYVN1;FN1;STOM;CAB39L;MYO9A;ALK;MEF2D
prerank,Reactome_2022__APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.5499761173819847,-1.3649458715270057,0.034482758620689655,0.6594957229572403,1.0,12/63,20.20%,CDC26;PSMD10;ANAPC15;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;SKP2;PSMB4
prerank,CellMarker_Augmented_2021__Adventitial cell:Undefined,0.8339980566139265,1.3648892588111492,0.10344827586206896,0.30327971184106645,1.0,3/5,6.44%,CSPG4;THY1;CD44
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),0.8995896042252449,1.364843026659408,0.037037037037037035,0.30319953877111033,1.0,3/6,8.20%,IGF1;ALOX12;BAG3
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.6426850066824217,1.36478789898963,0.047619047619047616,0.30316319401519587,1.0,12/57,10.66%,ALS2CL;CHRM3;CD24;KCNQ1;FA2H;EFNA1;TJP3;LGR5;FAAH;AATK;ARHGEF10L;SLCO2A1
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),-0.680943084285638,-1.364785249605184,0.11428571428571428,0.6583051781629785,1.0,4/30,5.37%,H1-2;KPNA2;H1-4;SIRT6
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",0.8025274650289186,1.3647108722804335,0.13793103448275862,0.3031181691461358,1.0,1/6,5.85%,ATP9A
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.8801318865608555,1.3646161781151283,0.0392156862745098,0.30320413678052144,1.0,1/8,0.06%,TGFBR2
prerank,Reactome_2022__Methionine Salvage Pathway R-HSA-1237112,-0.8812138682167088,-1.3644415371263883,0.1568627450980392,0.6578780211394278,1.0,1/5,0.95%,GOLT1A
prerank,Reactome_2022__Amino Acid Transport Across Plasma Membrane R-HSA-352230,0.7090747577365621,1.3643586557574094,0.08064516129032258,0.30367373184123375,1.0,6/25,10.20%,SLC6A15;SLC7A2;SLC43A1;SLC16A10;SLC7A7;SLC25A29
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Embryonic Prefrontal Cortex,0.5392270262375916,1.3643528767630595,0.058823529411764705,0.3034541209147785,1.0,13/120,5.37%,APOLD1;CLIC1;STMN2;CREB5;CCNB2;SHTN1;SLA;SYT1;GAP43;RTN1;GINS2;BTG3;GNG2
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),0.8144476989359892,1.3643198252235738,0.038461538461538464,0.3033480523004036,1.0,3/9,6.35%,EGF;KCNQ1;NRG1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.6670795317480053,1.3642655813538158,0.08064516129032258,0.30325954715189984,1.0,13/33,16.36%,SP100;THBS1;SERPINE1;ICAM1;FAS;TMBIM1;BCL2L1;STX4;TMC8;TNFRSF10B;FADD;BRCA1;RFFL
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.824582928862738,1.3641393280455905,0.07142857142857142,0.3033537818406577,1.0,2/10,0.52%,TGFBR2;COL4A1
prerank,CellMarker_Augmented_2021__Trophectoderm cell:Embryo,0.6045892090000908,1.3640939637081055,0.07246376811594203,0.30327409414373757,1.0,28/66,19.47%,FRMD4B;CD24;SLC7A2;SH3GL3;EFNA1;SLC28A3;FABP3;SUN3;OLFML1;PLAC8;SYBU;PDGFA;ENPEP;BASP1;GAB2;TEAD1;ACTN1;PALLD;CAST;S100A6;TAGLN2;ANKRD6;MYOF;TFRC;LRP2;TSPAN15;GLIPR2;TGFBR3
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),0.9250116140839016,1.363904928704031,0.06451612903225806,0.3033146257246473,1.0,1/5,0.15%,NR4A3
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),0.9250116140839016,1.363904928704031,0.06451612903225806,0.3033146257246473,1.0,1/5,0.15%,NR4A3
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.8656393170235065,1.3639020174950978,0.08163265306122448,0.3030877636261247,1.0,2/7,3.34%,DCN;DAB2IP
prerank,CellMarker_Augmented_2021__Pigment Epithelial cell:Eye,0.592266555701799,1.363632494759701,0.05263157894736842,0.3035629500300835,1.0,19/92,11.60%,C1QL1;IL1RAPL1;TAGLN3;GRIN2B;GAP43;EPHA5;OPCML;LHFPL3;RFX4;GRM5;MAP1B;PCLO;CNN3;CNTNAP3P2;TGFB2;DNER;ITGB8;STK32A;MORN5
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.7056787814110261,-1.3633703051878487,0.125,0.6587505500230783,1.0,2/18,2.54%,DNMT3B;TEX15
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.7056787814110261,-1.3633703051878487,0.125,0.6587505500230783,1.0,2/18,2.54%,DNMT3B;TEX15
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.6027530153988252,1.363307054912156,0.014925373134328358,0.30427981172721297,1.0,23/69,16.77%,HTR2C;SLC24A2;KCNJ2;VAPB;CLDN16;ATP2B3;GCM2;RYR2;ATP1A1;NPTN;SLC9A1;ATP1B1;ATP1B3;LETM2;TMPRSS3;TPCN2;STOML2;KCNMA1;SLC24A1;ATP13A1;ATP2B4;SLC8A2;SLC8A1
prerank,Reactome_2022__Prostacyclin Signaling Thru Prostacyclin Receptor R-HSA-392851,0.7745839390510793,1.3632581818720597,0.05660377358490566,0.30413923873081833,1.0,2/12,5.37%,GNG3;GNG2
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.6589980432657745,1.363113779507362,0.06896551724137931,0.30441377291523875,1.0,8/42,16.25%,SKOR1;VWC2;VWC2L;PPARG;SMAD1;HIPK2;SMURF1;FSTL1
prerank,Reactome_2022__Meiotic Recombination R-HSA-912446,-0.6661623141758262,-1.3630210906428557,0.1951219512195122,0.6582614526781859,1.0,6/30,5.51%,H2AC20;H3-3B;TEX15;H2BC4;H2BC21;H2AC6
prerank,"KEGG_2021_Human__Growth hormone synthesis, secretion and action",0.5726269635692868,1.3628427539577315,0.05555555555555555,0.30490382939699684,1.0,13/98,7.19%,SOCS3;IGF1;CREB5;PRKCB;ADCY5;SHC2;PRKCG;IRS2;ITPR3;GHR;ADCY7;CACNA1C;ADCY2
prerank,PanglaoDB_Augmented_2021__B Cells,0.5913010604397946,1.3627859843908379,0.012987012987012988,0.3047976290736795,1.0,26/71,16.87%,HLA-DRA;EBF1;CTSS;CD22;CD24;CD55;PLEK;NAPSB;WAS;PTPRC;CD37;BIRC3;ACAP1;FLI1;CD5;ITGAL;PXK;TMC8;CD70;BCL11A;CRELD2;TXNDC11;IRAG2;BST1;HMGA1;BACH2
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.659396893411238,1.3625562111368328,0.06896551724137931,0.3052607974839424,1.0,6/34,10.05%,S100A10;THY1;SKAP1;CDK6;PLEKHA2;RIN2
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),0.8054865185253329,1.3624061306717923,0.08771929824561403,0.3054130294448146,1.0,2/9,11.94%,ITM2A;BACE2
prerank,CellMarker_Augmented_2021__Beta cell:Pancreas,0.7781784440897267,1.3621588093144654,0.10526315789473684,0.30591811038188843,1.0,5/11,10.95%,SIX3;NPTX2;SYT13;PIR;CDKN1C
prerank,CellMarker_Augmented_2021__Pericyte:Adipose Tissue,0.9301738672047988,1.3620891627903713,0.0196078431372549,0.30595776077457526,1.0,3/5,4.85%,CSPG4;PTPRC;MCAM
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.8484528601067414,1.3620328167835103,0.125,0.3059285618363778,1.0,2/7,1.60%,SLC24A2;PLK2
prerank,Reactome_2022__Canonical Retinoid Cycle In Rods (Twilight Vision) R-HSA-2453902,-0.7676984194644888,-1.361890914193506,0.07692307692307693,0.6614513843794341,1.0,6/11,14.78%,HSD17B6;CYP4V2;LRAT;RDH10;RDH11;NAPEPLD
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.5398183832902516,1.3617752199667466,0.0,0.30661257859077545,1.0,38/209,11.38%,TLCD2;SYCE1;TEAD2;ANK3;PKP2;NLGN1;CALD1;DMTN;FBLIM1;WAS;ADD2;BAIAP2L1;WASF1;FAS;NEDD9;BAIAP2;FAM107A;DVL1;PARD3;REPS2;STK25;RHOD;PAWR;PML;PDGFA;MYO1B;SHANK1;PCLO;YAP1;YTHDF1;STAG3;FSCN1;TCAP;PEX14;TEAD1;DCX;GAS6;OPHN1
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.6199492743113554,1.3616570542107558,0.045454545454545456,0.30675465933641277,1.0,21/59,19.70%,CACNA1H;KCNQ1;ATP2B3;ITPR3;ABCC9;RYR2;ATP1A1;TMEM65;ATP1B1;TGFB2;ATP1B3;FXYD7;ATP2B4;SLC8A2;SLC8A1;PDE4D;CALM3;ITPR1;CAV3;AHCYL1;CELF2
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),-0.8343907866202525,-1.3616106149591534,0.09090909090909091,0.660616429837493,1.0,5/7,16.47%,MGME1;POLG2;PRIMPOL;TEFM;DNA2
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),0.8962909541217629,1.3614011448136218,0.05263157894736842,0.3071539213020233,1.0,2/5,3.99%,RBM24;ELAVL4
prerank,CellMarker_Augmented_2021__Eosinophil:Peripheral Blood,-0.7924303850059518,-1.3612993988123612,0.23809523809523808,0.6602537396582906,1.0,1/5,4.85%,IL5
prerank,CellMarker_Augmented_2021__Stem cell:Eye,0.9315276741892313,1.3610411945268637,0.05263157894736842,0.3078526606818521,1.0,3/5,6.44%,CSF2RA;THY1;CD44
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),0.7505206767161893,1.3609619684944694,0.06382978723404255,0.3078821383825124,1.0,1/15,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.6139234204882541,-1.3609029074759993,0.05405405405405406,0.660168605149132,1.0,3/31,4.10%,H1-2;H1-4;TTN
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.48399560553358384,-1.3608767569631892,0.0,0.658477644141993,1.0,53/231,17.03%,SNRNP27;FIP1L1;PDCD7;LSM7;SNRPB2;DHX16;LSM3;SF3B4;SF3A1;POLR2K;ZCRB1;RBM8A;PPWD1;LSM2;CRNKL1;U2AF1;SF3B6;IK;BUD31;TFIP11;LSM5;FRG1;DDX46;SNU13;METTL3;PPIH;PQBP1;SYF2;CPSF1;CLP1;PPIL3;POLR2C;SNRNP25;GPATCH1;LSM4;GTF2F1;PRPF8;PPIL1;SRSF2;PNN;RBM22;PRPF3;POLR2D;ESS2;PPIE;RBMX;CWF19L1;CPSF3;SUGP1;DNAJC8;RNPC3;GTF2F2;SRSF9
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),0.7375672271755261,1.3608729645664253,0.10606060606060606,0.3079201332502734,1.0,2/16,4.36%,NR4A3;FABP3
prerank,CellMarker_Augmented_2021__Megakaryocyte:Umbilical Cord Blood,0.6490575859049224,1.3603457069597136,0.09836065573770492,0.30903592528917856,1.0,10/29,11.65%,P2RY13;LMO2;GMPR;DYSF;GAB3;TUBB1;TM6SF1;FLI1;P2RY12;GFI1B
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),-0.772471451891675,-1.360082620605453,0.13333333333333333,0.66027375378796,1.0,1/9,1.48%,MID1IP1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.5636945202114801,-1.3600081745109927,0.030303030303030304,0.6587810356957019,1.0,7/40,15.32%,BUD23;RIOK2;HSPA1A;RIOK1;ZPR1;RBM22;NMD3
prerank,PanglaoDB_Augmented_2021__Basophils,0.5837478268091203,1.3598645096770199,0.043478260869565216,0.3103894179226896,1.0,18/69,13.02%,L1CAM;TLR2;CTSS;P2RY13;MYO1F;PLEK;TEC;SIGLEC1;NFIL3;IGFBP7;CD44;SLC26A8;LAMA5;GRM6;JAZF1;ITGAL;IL4R;LTC4S
prerank,KEGG_2021_Human__Transcriptional misregulation in cancer,0.5702183316058417,1.3597936851366652,0.029411764705882353,0.310425481129328,1.0,26/124,12.36%,TGFBR2;NR4A3;MET;IGF1;FLT1;LMO2;FOXO1;BAIAP3;BCL6;ZBTB16;BIRC3;CDK9;GRIA3;PML;PDGFA;BCL2L1;AFF1;PPARG;ETV6;PBX3;FLI1;KLF3;SMAD1;RUNX1T1;GADD45A;CDKN1B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),0.8808493805936451,1.3597624315576538,0.11538461538461539,0.3102651748819918,1.0,4/5,9.09%,MLIP;TRPC3;FOXO1;LMNA
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Undefined,0.6011137284327308,1.3596892072587186,0.03125,0.3103353932874902,1.0,22/82,12.96%,MET;L1CAM;CD24;CD55;FLT1;ABCB1;ICAM1;THY1;ABCA5;PTPRC;LGR5;ITGA2;CD44;GFAP;MYD88;CTNNB1;GLI2;STAT3;PODXL;BCL2;KLF4;PDPN
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),0.7585646791646605,1.3596404290265915,0.08823529411764706,0.31022652667123596,1.0,6/12,18.53%,CCNB2;PRKCB;NEK6;CCNB1;DCTN1;PRKCA
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.7855620876863463,1.3593114495767424,0.018518518518518517,0.311088721402519,1.0,10/15,16.35%,MYRF;PRDM8;CNTNAP1;PLP1;EIF2B2;TPPP;B4GALT5;SOX10;EIF2B5;B4GALT6
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.6455519469902511,1.3588021357967384,0.08620689655172414,0.3123496400650515,1.0,3/31,10.80%,ABO;ALDOB;TFPI
prerank,KEGG_2021_Human__ErbB signaling pathway,0.5764212664466289,1.3587549549365667,0.08823529411764706,0.31222252689983143,1.0,21/78,18.53%,EGF;PRKCB;SHC2;PRKCG;TGFA;PAK3;NRG1;PAK4;NRG2;CAMK2B;CDKN1B;PAK1;CDKN1A;GAB1;RPS6KB2;PIK3CD;MAPK9;SHC1;NCK2;CAMK2A;PRKCA
prerank,Reactome_2022__Miscellaneous Substrates R-HSA-211958,-0.842965716899047,-1.3585564252873772,0.1346153846153846,0.6635637183633384,1.0,2/5,2.98%,CYP4F3;CYP3A43
prerank,Reactome_2022__Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,0.6938300787883379,1.358527019115582,0.10526315789473684,0.3126649625639894,1.0,1/18,1.45%,EGF
prerank,Reactome_2022__Butyrate Response Factor 1 Binds And Destabilizes mRNA R-HSA-450385,-0.6959986113481711,-1.3580919430078415,0.07142857142857142,0.6638468855942181,1.0,3/16,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.7210436239564424,1.3579146355253073,0.09615384615384616,0.3143210661251851,1.0,8/23,9.88%,SCN1B;SCN3B;KCNQ1;KCNH2;RYR2;GRK2;ATP1B1;TCAP
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.5662642946054329,1.357706008793408,0.04225352112676056,0.3147104047113865,1.0,21/112,11.71%,NR4A3;P2RY6;HRH1;BLM;GABRB2;DMTN;ADCY5;KCNQ1;GNG2;AHR;ADCY2;RAMP3;ATP1A1;CYP1B1;GABRG2;CTNNB1;HCN1;P2RY12;TFPI;CTNNA1;CCL2
prerank,KEGG_2021_Human__Aldosterone-regulated sodium reabsorption,0.7203366620227697,1.3574748242006744,0.07246376811594203,0.3151500494576191,1.0,6/25,10.24%,IGF1;PRKCB;PRKCG;ATP1A1;ATP1B1;ATP1B3
prerank,KEGG_2021_Human__Mineral absorption,-0.5820257531107892,-1.3571836014933178,0.09090909090909091,0.6660879470150007,1.0,7/42,7.01%,FTL;MT1E;FTH1;MT1A;MT1G;ATP1B2;MT1F
prerank,Reactome_2022__APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.6967657444038838,-1.357180571199316,0.13513513513513514,0.664283836633193,1.0,1/20,0.65%,CDC26
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.729799761056441,1.3571534827417777,0.1320754716981132,0.3158262982249561,1.0,5/15,13.10%,C3;APP;SRRM4;B4GALT5;PICK1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.7604226061551126,1.3569618068888611,0.11538461538461539,0.3161713495605092,1.0,4/18,8.47%,GGT5;ECE1;ENPEP;TRHDE
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.6569774144593776,-1.3569127877209834,0.08108108108108109,0.6636712691669826,1.0,6/18,20.54%,EIF2S3B;EIF3D;EIF3M;DHX29;EIF2B3;EIF5
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.5653475746248302,1.3568880574073268,0.06451612903225806,0.316092860687695,1.0,37/113,17.68%,MET;COL4A1;CSPG4;COL4A2;EPHA2;DAB2IP;ARHGEF17;NFATC2;NUAK1;COL12A1;LAMB1;PTPN21;RHBDF1;LIMCH1;SCARA3;BOC;SH3PXD2B;KITLG;YAP1;EPB41L1;TEAD1;ENAH;CD276;PARD3B;CAP2;TRIM32;PALLD;NTN4;RBFOX2;NOTCH3;BCAR1;FZD7;FSTL1;MESP1;WWTR1;SCRIB;SRPX2
prerank,CellMarker_Augmented_2021__Basophil:Undefined,0.7505789150004161,1.3568644589611363,0.11475409836065574,0.31592994072894887,1.0,5/15,6.44%,TLR2;CD22;ICAM1;PTPRC;CD44
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.8661982673936793,1.3565413950036296,0.11320754716981132,0.3166205462841657,1.0,1/6,0.85%,ANXA1
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.6774462329410773,1.356403705744911,0.11666666666666667,0.31649711607577063,1.0,8/19,22.88%,YWHAH;YWHAG;BBC3;BCL2;TP53;YWHAE;PPP3CC;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.6774462329410773,1.356403705744911,0.11666666666666667,0.31649711607577063,1.0,8/19,22.88%,YWHAH;YWHAG;BBC3;BCL2;TP53;YWHAE;PPP3CC;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),0.9030778170442195,1.3563797961556732,0.1509433962264151,0.3163090861719186,1.0,2/5,7.82%,CCBE1;MYO1C
prerank,CellMarker_Augmented_2021__Effector CD8+ Memory T (Tem) cell:Peripheral Blood,0.6257446453070414,1.3563331626339827,0.07352941176470588,0.31613817724126375,1.0,20/59,21.39%,SAMD3;MBP;MYO1F;PLEK;PRKCB;GAB3;RAP2B;AGTPBP1;RASSF1;PXN;RAP1GAP2;TAGLN2;TPST2;FLNA;LITAF;DSTN;TGFBR3;RAP1B;MTSS1;GK5
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.66834187937583,1.3559129713591243,0.07936507936507936,0.31721333902006826,1.0,4/36,1.67%,LEF1;IGF1;EGF;SP100
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.585200493233371,1.355839628609062,0.0,0.3171766077087941,1.0,13/77,13.18%,TGFBR2;HPN;EGF;THBS1;PID1;ECE1;SNCA;RAMP3;PPARG;GADD45A;KLF4;PICK1;CDKN1A
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.6154925793249221,1.3558371317099773,0.06666666666666667,0.3169466029171271,1.0,16/50,13.97%,ANXA1;RIMS2;SYT1;SEPTIN4;SEPTIN5;KCNMB4;RAB15;RAB3C;CPLX2;RHBDF1;SCG5;CPLX1;LGI3;STX4;RHBDF2;HAP1
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),0.8395035475225784,1.3555783508129566,0.03571428571428571,0.31734688796877253,1.0,2/8,8.28%,NLRP12;MVP
prerank,Reactome_2022__PKA Activation In Glucagon Signaling R-HSA-164378,0.7574257436909884,1.3555423996324594,0.12727272727272726,0.31720941969089095,1.0,9/14,22.59%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;PRKCA;ADCY9;ADCY8;PRKAR2B
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.8383335403727433,1.355396576905204,0.09615384615384616,0.31731223352860566,1.0,1/9,2.35%,ZFP36
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.8383335403727433,1.355396576905204,0.09615384615384616,0.31731223352860566,1.0,1/9,2.35%,ZFP36
prerank,Reactome_2022__Complement Cascade R-HSA-166658,0.705593288347767,1.3553921119787378,0.09836065573770492,0.3170997119720905,1.0,8/27,15.22%,C3;CD55;COLEC11;CFH;C1R;CPNE2;SERPING1;CD59
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.9001960172830261,1.355269952472528,0.12962962962962962,0.3172473684865603,1.0,1/5,4.96%,FAS
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),0.5365309225840836,1.3552140548662799,0.02857142857142857,0.31721918769525703,1.0,33/158,15.27%,GPNMB;HTR2C;P2RY6;PDGFRA;NPNT;EPHA7;RASGRP1;PSCA;EPHA2;ICAM1;APP;DAB2IP;DUSP10;NEK10;PTPRR;PTPRC;NTRK3;CD44;RAMP3;PDGFA;NECAB2;CHI3L1;SYK;GAS6;CCL2;HLA-DRB1;FN1;RPS6KA6;FGF2;RGS14;GPR183;CD4;THPO
prerank,Reactome_2022__Transport And Synthesis Of PAPS R-HSA-174362,0.9247388019971089,1.3551988419890533,0.09836065573770492,0.31658411903784106,1.0,1/5,0.73%,PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),0.9247388019971089,1.3551988419890533,0.09836065573770492,0.31658411903784106,1.0,1/5,0.73%,PAPSS2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),0.9247388019971089,1.3551988419890533,0.09836065573770492,0.31658411903784106,1.0,1/5,0.73%,PAPSS2
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.5226601548399772,1.3551377936594022,0.0,0.3164814455671934,1.0,41/238,14.78%,MET;IGF1;PDGFRA;EGF;RASGRP1;GRIN2B;MBP;RASGEF1A;RIT2;ZFP36;ZDHHC9;NEFL;SHC2;CSF2RA;IRS2;DAB2IP;TGFA;SHANK3;PRKG2;FYN;GFRA2;NRG1;GRIN1;NRG2;PDGFA;MRAS;BCL2L1;KITLG;PPP1CB;MINK1;FGF13;CCL2;RGL1;CAMK2B;DLG3;PAK1;FGF2;TNIP2;IKBKG;MAPK11;RASAL1
prerank,Reactome_2022__Infection With Mycobacterium Tuberculosis R-HSA-9635486,0.7053833323640105,1.3550551999606808,0.11666666666666667,0.3165955776594451,1.0,4/20,12.85%,TLR2;DUSP16;PGK1;B2M
prerank,CellMarker_Augmented_2021__Circulating Precursor cell:Peripheral Blood,0.6255064987870252,1.3549299485741495,0.04918032786885246,0.3167678348475348,1.0,15/44,13.09%,HLA-DRA;ITM2A;ELMO1;PLEK;SLA;GPR34;MYH11;PTPRC;LDLRAD4;PPP1R16B;RNASE1;ADAM28;HLA-DRB1;FGD5;RASGEF1B
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.5474105850328583,1.3549187906103128,0.039473684210526314,0.31657371924364097,1.0,23/103,14.12%,TLR2;IGF1;EGF;PLD1;THBS1;IRS2;NLRP12;SAMD4A;SOX4;CIITA;EIF4A3;LARP6;NLRC5;YTHDF1;NAMPT;TGFB2;GLI2;NIBAN1;SORBS1;CCL2;KLF4;FGF2;HSPH1
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.7015849786498327,1.3549165827203105,0.08196721311475409,0.31634662188406876,1.0,8/24,19.01%,MTMR7;MTMR11;SYNJ2;INPP5J;MTM1;INPP5F;MTMR2;MTMR3
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.6564612607852833,1.354649084299558,0.05084745762711865,0.3169258331706152,1.0,7/29,9.19%,RIMS2;RIMS3;SEPTIN5;BAIAP3;KCNMB4;CPLX2;CPLX1
prerank,KEGG_2021_Human__Sulfur metabolism,0.8240986368308759,1.3546116146650822,0.09302325581395349,0.3167569309961311,1.0,2/10,1.04%,PAPSS2;SQOR
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.9307574730311413,1.3546070313255445,0.03636363636363636,0.31655508179639696,1.0,1/5,0.04%,NPY
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.6524297928896752,1.3545767384937022,0.031746031746031744,0.3164115602761981,1.0,9/43,10.69%,HTR2C;P2RY6;HRH1;CHRM1;GRM5;CCKBR;GNA14;HOMER1;P2RY12
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.6605327239091338,1.3543210215437562,0.12280701754385964,0.31696421303343375,1.0,4/22,13.97%,BICDL1;KIF5A;TRAK1;HAP1
prerank,Reactome_2022__Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,0.6802896259950949,1.3542812176562247,0.06451612903225806,0.3168288837357057,1.0,3/27,7.41%,STAT4;LMNB1;TCP1
prerank,Reactome_2022__DAP12 Interactions R-HSA-2172127,0.693379696181051,1.3542810806854735,0.10526315789473684,0.3166027389221899,1.0,7/21,17.35%,FYN;RNASE1;SYK;B2M;HLA-E;VAV2;SHC1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),-0.5486090586074798,-1.3542440742037147,0.11428571428571428,0.674495213467105,1.0,5/58,9.03%,TPX2;SGO2;AAAS;ABRAXAS1;MIS12
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),0.8065882687991972,1.3542147707840388,0.11320754716981132,0.3163744829798259,1.0,2/10,9.29%,SYCE1;STAG3
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),0.8065882687991972,1.3542147707840388,0.11320754716981132,0.3163744829798259,1.0,2/10,9.29%,SYCE1;STAG3
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.7120593867421917,1.3539058820984118,0.11940298507462686,0.317024264091321,1.0,1/18,0.08%,ENPP2
prerank,CellMarker_Augmented_2021__Cardiovascular Progenitor cell:Heart,0.5983624693093893,1.3537235115044342,0.06896551724137931,0.31712862261241864,1.0,20/63,12.14%,COL4A1;EPHA7;FLT1;COL4A2;SHC2;SLIT2;MCAM;CCDC3;TBX20;RYR2;ENPEP;ADGRL2;PTPRD;PKDCC;GLI2;SLCO2A1;CRTAC1;ASXL3;RUNX1T1;FGD5
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.7352615414335911,-1.3537062436006049,0.1111111111111111,0.6751365822311101,1.0,7/12,23.30%,GUCA1B;PPEF1;NMT2;METAP2;METAP1;FNTB;CALM1
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),-0.738685689801508,-1.3536032626192347,0.13513513513513514,0.6737593244700877,1.0,4/15,9.85%,HSD17B8;SLC25A1;PPCS;GCDH
prerank,Reactome_2022__Integrin Signaling R-HSA-354192,0.7074310720243693,1.353459814080788,0.14035087719298245,0.31759557293139307,1.0,9/23,19.92%,RASGRP2;RASGRP1;SYK;FN1;BCAR1;SHC1;RAP1A;RAP1B;APBB1IP
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.7056246995393134,1.353366850686687,0.0967741935483871,0.31765818587739375,1.0,5/23,7.35%,SLIT2;NRP2;SLIT3;SEMA5B;MAP1B
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.8591799224160247,1.3533260732711458,0.10714285714285714,0.31752313261768983,1.0,4/7,11.23%,ANK3;THBS1;SNCA;FBP1
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.9033271710216217,1.3532687403344836,0.07272727272727272,0.31748698957969596,1.0,2/6,1.66%,RFTN1;S100A10
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),0.808841722491736,1.353202848099212,0.07142857142857142,0.31744267709944685,1.0,2/11,7.08%,MET;POF1B
prerank,Reactome_2022__SEMA3A-Plexin Repulsion Signaling By Inhibiting Integrin Adhesion R-HSA-399955,0.7787840531430187,1.3529357538991222,0.1,0.3180145436405644,1.0,6/14,15.87%,FYN;RNASE1;PLXNA4;PLXNA1;PLXNA2;PIP5K1C
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),0.8683974858370007,1.352796837529446,0.0196078431372549,0.31814231066716536,1.0,2/8,8.12%,MET;CTNNB1
prerank,CellMarker_Augmented_2021__Epithelial cell:Airway Epithelium,0.8782005463059562,1.352776744801522,0.125,0.3175415289462474,1.0,1/5,1.87%,CD24
prerank,CellMarker_Augmented_2021__Epithelial cell:Skin,0.8782005463059562,1.352776744801522,0.125,0.3175415289462474,1.0,1/5,1.87%,CD24
prerank,CellMarker_Augmented_2021__Epithelial cell:Lung,0.8782005463059562,1.352776744801522,0.125,0.3175415289462474,1.0,1/5,1.87%,CD24
prerank,Reactome_2022__Interleukin-12 Family Signaling R-HSA-447115,0.6418100270748307,1.3526560250748048,0.08333333333333333,0.3176610832235065,1.0,7/41,14.19%,STAT4;LMNB1;IL27RA;TCP1;STAT3;TYK2;IL12A
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.5465395578996216,1.3526299808244064,0.06349206349206349,0.31753506580123875,1.0,45/155,18.96%,TMEM204;SP100;PTK6;CD24;SULF1;CD55;IRAK2;APP;NLRP12;RGS6;TSPYL2;PLSCR1;FYN;TRIM5;IGFBP7;ZIC1;GRK2;SIK2;YWHAG;ITGA3;LRIT3;ZDHHC7;HOMER1;PXN;USP20;NCLN;ELF1;GRK5;RGS14;RGS4;RGS16;MAPK8IP2;BST1;SLC8A2;RORA;UBASH3B;FRRS1L;WWTR1;CBFB;NCK2;TSC2;TSPAN15;CAV3;CDC42SE2;LFNG
prerank,Reactome_2022__RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.6582306505061828,-1.3525690965566506,0.13953488372093023,0.6770241346701236,1.0,13/26,23.09%,GTF2H5;POLR2K;GTF2H2;ERCC2;POLR2C;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;POLR2E;GTF2H3
prerank,Reactome_2022__Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.5488695219640221,-1.352552346901506,0.0967741935483871,0.6734046168967766,1.0,11/60,20.20%,CDC26;PSMD10;ANAPC15;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,Reactome_2022__APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.5488695219640221,-1.352552346901506,0.0967741935483871,0.6734046168967766,1.0,11/60,20.20%,CDC26;PSMD10;ANAPC15;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.7455739819648249,1.3524063590491326,0.11864406779661017,0.3179977778642072,1.0,6/19,3.49%,ANK3;RIMS2;GRIK2;SYT1;CLSTN2;RIMS3
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.781566275764967,1.3522130394720766,0.12280701754385964,0.3183373092231844,1.0,5/12,13.58%,IRF7;AHR;SKAP1;ADCY7;FADD
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),-0.7939169255106429,-1.3520093839406568,0.11764705882352941,0.67379620512697,1.0,4/8,17.18%,CES2;AKR1C3;PTGR1;GSTP1
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.8623125618202603,1.35198103037928,0.10909090909090909,0.31875799053557036,1.0,1/5,2.72%,TIMP2
prerank,CellMarker_Augmented_2021__Leydig Precursor cell:Fetal Gonad,0.5426963312864556,1.3519039900270393,0.041666666666666664,0.31876206907169136,1.0,35/184,9.33%,IGF1;CTSC;EBF1;PDGFRA;PCDH18;RIMS2;DCN;OGN;NLGN1;CALD1;SULF1;LTBP4;NEFL;SYT1;FBLIM1;THY1;CERCAM;SCN2A;POSTN;OLFML1;ABCA10;COLEC11;CFH;ENC1;CDC42EP1;GLT8D2;C1R;CYP1B1;MATN2;ITGA11;SCG5;PKDCC;BGN;CNN3;TSC22D3
prerank,Reactome_2022__PKA-mediated Phosphorylation Of CREB R-HSA-111931,0.7452152374491053,1.3518804500449366,0.08771929824561403,0.3186357204970067,1.0,11/17,22.59%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;NBEA;PRKCA;PRKX;ADCY9;ADCY8;PRKAR2B
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.6918583552031249,1.3518196223010297,0.06521739130434782,0.318550277541035,1.0,8/18,17.50%,GPNMB;SFTPD;TNFRSF14;DLG5;HLA-DRB1;PRKAR1A;PDCD1LG2;SCRIB
prerank,Reactome_2022__Formation Of Early Elongation Complex R-HSA-113418,-0.6553798609878599,-1.3517114671644395,0.1951219512195122,0.6731713065678073,1.0,14/31,24.01%,GTF2H5;POLR2K;GTF2H2;ERCC2;POLR2C;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;POLR2E;GTF2H3;CTDP1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),0.7134510754436875,1.3516355293309874,0.08620689655172414,0.31881496974736173,1.0,7/21,17.86%,SP100;BAG3;GAS6;BARD1;RANGAP1;TP53;YWHAE
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.4765639562900056,-1.3515830244812617,0.07407407407407407,0.672205766987259,1.0,66/320,15.25%,MRPL10;RPL35A;RPS24;FIP1L1;RPL34;RPL39;MRPS21;RPL13;RPL37;MRPL52;POLR2K;RPS28;AAAS;MRPS7;RPL18;RBM8A;RAE1;NUP50;M1AP;RPL12;RPL23;RPL31;MRPL36;MRPS16;MRPL18;U2AF1;RPS26;RPL6;FASTKD2;RPL41;RPS13;RPL22;RPL29;TFIP11;RPL30;RNASEL;ASMT;RPSA;RPL14;RRAGC;RPL15;EEF1A1;CPSF1;RPS2;DDX25;CLP1;POLR2C;IGF2BP3;TSPAN33;RPL11;RPL23A;NUP54;MRPS18B;RPS21;MRPS33;MCM3AP;SRSF2;RBM39;RPS23;NFKBIB;POLR2D;YARS2;MLF1;MRPS12;THAP1;CPSF3
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.8307138401818778,1.3515492465823393,0.07142857142857142,0.3188515335503368,1.0,3/8,5.08%,UGT8;FA2H;B3GALT2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.8378028039473,1.3513975933979605,0.13559322033898305,0.31908312937584643,1.0,2/6,5.06%,APP;TNFRSF14
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),0.7194629443534951,1.351327181314014,0.08196721311475409,0.31901385794212883,1.0,7/23,14.90%,COL4A2;COL8A1;COL12A1;LAMB1;MMP14;FN1;LAMA3
prerank,Reactome_2022__HDACs Deacetylate Histones R-HSA-3214815,-0.60023566936993,-1.3511528901985173,0.075,0.672698318976747,1.0,7/36,10.74%,H2AC20;H2BC4;H2BC21;H2AC6;CHD4;H2BC18;SAP18
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.6903074035753318,1.3509017074757503,0.14,0.320243417382222,1.0,3/22,7.51%,ENPP2;FAAH;CYP1B1
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),-0.7841054357123631,-1.3507464073875366,0.1794871794871795,0.672725350462129,1.0,2/8,15.09%,UBE2M;DCUN1D2
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),0.8916444563291057,1.3505658962377782,0.05454545454545454,0.3209683487624536,1.0,2/6,1.52%,CHRM3;CHRM1
prerank,Reactome_2022__Adherens Junctions Interactions R-HSA-418990,0.6839246198146004,1.3503285780495256,0.125,0.32159499744434217,1.0,6/25,8.12%,CDH6;CDH9;CDH19;CDH8;CDH18;CTNNB1
prerank,Reactome_2022__Aquaporin-mediated Transport R-HSA-445717,0.684324534663941,1.350201330493171,0.08333333333333333,0.32173476612852686,1.0,6/31,7.19%,GNG3;ADCY5;PRKAR1B;GNG2;ADCY7;ADCY2
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),-0.7038496686423815,-1.3502005204865972,0.15555555555555556,0.6734748729861764,1.0,9/15,16.79%,ATP5PF;ATP5MC1;ATP5PB;ATP5PD;DMAC2L;ATP5MC3;ATP5F1B;ATP5F1A;ATP5MC2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7955671545263945,1.3501910668746488,0.09523809523809523,0.3215424686651853,1.0,5/15,12.89%,KLF2;NOS1AP;ASS1;SMAD3;KLF4
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),-0.647807905002587,-1.350075513154769,0.13636363636363635,0.6723385409861221,1.0,5/19,15.34%,SGO2;BRDT;ZSCAN21;BCL2L11;FOXJ2
prerank,PanglaoDB_Augmented_2021__Myocytes,0.5721748926505534,1.3500407673102635,0.07142857142857142,0.3216659014052662,1.0,26/82,19.15%,COL4A1;PRRX1;PLD1;SULF1;ANGPTL2;FABP3;LAMB1;ITGA3;ARHGAP26;RASL12;TCAP;ADAM12;TRIO;LAMA2;PXN;MEF2D;IL4R;WASHC1;NOTCH3;NEB;CHODL;ENO3;LDB3;CAV3;SGCG;WIPF1
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.5570974029018858,1.3500277550685358,0.046875,0.3214900864098197,1.0,13/127,8.65%,ST18;NPNT;ZFP36;YBX3;DAB2IP;ERBIN;MAP3K14;TNFRSF14;BIRC3;TNFRSF1A;PID1;FOXO3;CHI3L1
prerank,CellMarker_Augmented_2021__Microglial cell:Embryonic Prefrontal Cortex,0.5146868611008238,1.3498303584411637,0.0,0.3218557083530019,1.0,81/350,15.01%,IPCEF1;FOSB;ARHGAP4;C3;IL13RA1;IGF1;KLF2;CTSC;MLLT11;CTSS;TAGLN3;SP100;CD24;SLC15A3;P2RY13;NR4A1;ZFP36;DUSP1;MYO1F;PLEK;SYT1;GPR34;TIMP2;WAS;RPS6KA1;MYH9;RTN1;ATP8B4;ELAVL4;RBMS1;LAT2;PTPRC;EGFL7;CD37;SOX4;SLC9A9;SYNGR2;NNAT;TNFRSF1A;SERPINF1;RAB3IL1;SLC7A7;OSTF1;TMBIM1;OCIAD2;TM6SF1;CNN3;BEX1;TSC22D3;ADAM28;RIN2;PAG1;P3H2;FLI1;SYK;CD83;P2RY12;DCX;GAS6;NR4A2;PDK4;MED12L;DOCK4;KLF6;FMNL3;ANXA11;STOM;B2M;PDPN;LTC4S;CCND1;RHBDF2;ELF1;KCTD12;BCL11A;BIN1;SPP1;HLA-E;INPP5D;GPR183;CD4
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.8131516694866077,1.349697546848691,0.1346153846153846,0.32199480882386516,1.0,5/11,7.99%,GABRB2;GABRG3;GABRA1;GABRG2;GABRA5
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.7284333338187409,1.349560617384192,0.06666666666666667,0.3222627756785502,1.0,4/23,3.41%,MET;ANXA1;PROX1;LSR
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",-0.8380632998145288,-1.3495497151896172,0.09302325581395349,0.6712388484715791,1.0,3/7,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),-0.8380632998145288,-1.3495497151896172,0.09302325581395349,0.6712388484715791,1.0,3/7,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,Reactome_2022__YAP1- And WWTR1 (TAZ)-stimulated Gene Expression R-HSA-2032785,0.8012901965276958,1.3494652920202015,0.10526315789473684,0.3222724293741975,1.0,6/10,17.38%,TEAD2;YAP1;TEAD1;HIPK1;HIPK2;WWTR1
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.6629224043488331,1.3494084896077905,0.09375,0.3221934642348166,1.0,8/37,10.96%,SOCS3;IGF1;IL15;PTK6;TNFRSF1A;GHR;STAT3;PARP9
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.6724101857911736,1.3492021787841875,0.05454545454545454,0.32246878431427994,1.0,15/31,18.06%,ANXA1;IGF1;IL15;CD24;IL27RA;PTPRC;SYK;CD276;FADD;SLC7A1;CD70;PDCD1LG2;TFRC;NCK2;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5998298932361846,1.3491300010080443,0.03125,0.3224541433751665,1.0,13/61,7.44%,GGT5;PLK2;ADCY5;MYH9;PRKAR1B;FYN;GIPR;RXFP1;GNG2;ADCY7;ADCY2;RAMP3;GLP1R
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.9115131061678925,1.3485515026257664,0.0847457627118644,0.3238622982897019,1.0,1/6,0.08%,ENPP2
prerank,Reactome_2022__Assembly Of Collagen Fibrils And Other Multimeric Structures R-HSA-2022090,0.6179401371738625,1.3485415327713675,0.06557377049180328,0.3236940904583098,1.0,12/43,14.02%,COL4A1;CTSS;COL11A2;COL4A2;TLL1;COL8A1;COL27A1;LOXL1;COL9A1;COL4A4;COL4A5;COL5A1
prerank,KEGG_2021_Human__Renin secretion,0.628706997195403,1.3484775059608431,0.05084745762711865,0.3236545499469705,1.0,12/46,11.18%,PDE1C;KCNJ2;ADCY5;PRKG2;ITPR3;PDE1A;GUCY1A2;CACNA1C;GUCY1A1;ORAI1;PDE1B;GUCY1B1
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.7765435356264215,1.348459572894741,0.125,0.32345463233383587,1.0,4/13,6.44%,DMTN;EPHA2;WAS;CD44
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),0.8134389186818787,1.348442024776671,0.08196721311475409,0.3232790393639889,1.0,2/10,2.82%,SH3GL2;SLIT2
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5938861027315877,1.348346045169423,0.09836065573770492,0.32339206724662967,1.0,16/59,15.81%,MRAP2;C3;PLEK;SLC39A14;RGS6;SYP;RAMP3;MRAP;ZDHHC7;KLK6;USP20;PPP1R9B;GRK5;RGS14;RGS4;RGS16
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.8478460762077784,1.3481888325505027,0.14285714285714285,0.3235769837626526,1.0,5/6,15.24%,DPYSL2;CRMP1;DPYSL4;DPYSL5;DPYD
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.7795307533109599,1.3481029770028177,0.1346153846153846,0.3235376605109767,1.0,8/11,16.35%,MYRF;CNTNAP1;PLP1;TENM4;ABCA2;B4GALT5;SOX10;B4GALT6
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.7558930388222145,1.3478278634774543,0.1694915254237288,0.3241778756160247,1.0,5/10,20.02%,TLR2;PGK1;B2M;RPS27A;MRC1
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5292508287049793,1.347826223750497,0.027777777777777776,0.32395445874792267,1.0,22/138,10.90%,IGF1;KLF2;EGF;PLD1;THBS1;IRS2;SAMD4A;NOS1AP;FABP3;SOX4;MFSD2A;SNCA;EIF4A3;LARP6;LDLR;ASS1;SMAD3;YTHDF1;GLI2;NIBAN1;SORBS1;DUOXA1
prerank,CellMarker_Augmented_2021__B cell:Bone Marrow,0.8603777170042836,1.3474952671149187,0.09803921568627451,0.32465736832184106,1.0,4/5,12.47%,CD24;LMO2;BCL6;BCL2
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.731114262580707,1.3474841154670973,0.18,0.3244658386799288,1.0,3/11,10.41%,LDLR;PPARG;SYK
prerank,"Reactome_2022__PTK6 Regulates RHO GTPases, RAS GTPase And MAP Kinases R-HSA-8849471",0.731083704436577,1.3473174213718473,0.15384615384615385,0.3247210010875425,1.0,4/13,14.91%,PTK6;ELMO1;RNASE1;BCAR1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6418843965748401,1.3471792046370035,0.10344827586206896,0.3250156450576745,1.0,9/41,10.44%,PDGFRA;FLT1;RELN;TEC;TPST1;FYN;PKDCC;SYK;EPHA4
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.6351243314248748,1.3469950613762147,0.056338028169014086,0.3252621183644306,1.0,16/53,14.24%,DCN;THBS1;SULF1;COL4A2;ISM1;DAB2IP;SERPINF1;PML;CTNNB1;PPARG;CD160;TGFB2;PGK1;SPARC;KLF4;THBS2
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),0.7992446035888442,1.3468858931381917,0.05357142857142857,0.32537300941946196,1.0,5/11,13.90%,RFTN1;COLEC12;SCARA3;FADD;TNIP2
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.7552904626313216,1.346768836697263,0.16363636363636364,0.3254678482238612,1.0,9/14,22.59%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;ADCY3;ADCY9;ADCY8;PRKAR2B
prerank,Reactome_2022__Creation Of C4 And C2 Activators R-HSA-166786,0.8689304666243577,1.3466791277175638,0.06557377049180328,0.3255069446874793,1.0,2/6,7.49%,COLEC11;C1R
prerank,Reactome_2022__TYSND1 Cleaves Peroxisomal Proteins R-HSA-9033500,-0.817983662287534,-1.3465646647035865,0.1590909090909091,0.6830282298128297,1.0,1/7,3.20%,PHYH
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Adipose Tissue,0.5752539932769476,1.3464970798830787,0.078125,0.32570477115122726,1.0,15/86,9.04%,MET;PAPSS2;THBS1;SERPINE1;FBLIM1;EPHA2;OSMR;COL12A1;CLIC4;LAMB1;ITGA2;MYO1B;MYO1C;ITGA3;YAP1
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),0.9096179582960529,1.346495049754923,0.1016949152542373,0.32548977212898544,1.0,1/5,0.42%,MET
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.6863237307736259,1.346494652474134,0.13846153846153847,0.325282995540191,1.0,4/21,9.24%,KIF14;CDC14A;CENPV;PRKCE
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),0.7790779645462633,1.3464462927106686,0.125,0.32522703668662467,1.0,5/10,15.24%,DPYSL2;CRMP1;DPYSL4;DPYSL5;DPYD
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Chorionic Villus,0.6676666203788495,1.346432004516247,0.04285714285714286,0.3250603094741276,1.0,14/44,12.46%,HLA-DRA;CTSS;SP100;PLEK;SLA;PTPRC;TNFRSF14;GAB3;CIITA;CD44;NLRC5;FLI1;APOL3;TRIM22
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.5906291645622983,1.346366812428378,0.05,0.325020403182394,1.0,26/98,9.54%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;CALD1;SULF1;COL4A2;SLIT2;THY1;TCEAL7;ANGPTL2;POSTN;SLIT3;LAMB1;PTPN21;NNAT;GUCY1A2;ZIC1;MAP1B;SCARA3;BOC;ADGRL2;PKDCC;BGN;RASL12
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.8054404914318584,1.346225544471537,0.06666666666666667,0.32520193850249307,1.0,4/13,11.77%,ANXA1;ZFP36;FAM107A;KLF9
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.7191749789287631,-1.3460279173065137,0.21568627450980393,0.6836816336294711,1.0,2/11,4.15%,APOBEC3G;SETDB1
prerank,CellMarker_Augmented_2021__Ionocyte cell:Lung,0.5252654412505318,1.3460066878595764,0.014084507042253521,0.3256360677682955,1.0,48/243,15.44%,LEF1;TGFBR2;IGF1;PDE1C;NCALD;THBS1;TBC1D9;RCAN2;CORO7;APP;SEMA3C;PALM2AKAP2;CHST15;POSTN;SLC35F3;STAC2;ZNF704;ITPKB;TPD52;ATP1A1;MGAT5;CLGN;CNN3;NEURL1;NRIP3;HDAC4;FBXO32;UST;INPPL1;TFPI;TSPAN14;DOCK4;PHF23;TBC1D1;CAMK2B;CDKN1B;BCL2;KLC1;MEF2D;USP53;KCNMA1;TRIM47;AKIRIN1;MTHFD1L;NDST1;CGNL1;ETS1;RAB37
prerank,Reactome_2022__mRNA Capping R-HSA-72086,-0.6537170849978997,-1.3458566128072567,0.14285714285714285,0.6827311127645957,1.0,13/28,23.09%,GTF2H5;POLR2K;GTF2H2;ERCC2;POLR2C;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;POLR2E;GTF2H3
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.7915989813571067,1.345779598427285,0.07547169811320754,0.325864311850458,1.0,1/11,1.84%,RASGRP1
prerank,CellMarker_Augmented_2021__Cancer cell:Blood,0.8071890214766422,1.3457734777673853,0.07017543859649122,0.3256740466950958,1.0,4/11,6.44%,FOLH1;CD24;PTPRC;CD44
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.779371081829447,1.3457555165386839,0.12727272727272726,0.32549192557372436,1.0,4/12,15.53%,SMCR8;PHF23;MTM1;PINK1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.584449619711813,1.3457081368192703,0.07575757575757576,0.3253967299713585,1.0,7/64,3.34%,SKOR1;THBS1;VWC2;SULF1;SLIT2;VWC2L;DAB2IP
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.707791979582506,-1.345617356673472,0.1794871794871795,0.6818643624772541,1.0,4/14,9.23%,PMVK;NUDT7;PPCS;TDO2
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.628602220280664,1.345574804603123,0.08620689655172414,0.3255142740306178,1.0,12/34,22.21%,SLC39A14;FOXO1;SOX4;HK2;GAS6;HK1;IGF1R;PDK3;HIF1A;KCNB1;ADCY8;FOXK1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru BTK R-HSA-8964315,0.7778599577090776,1.3455479000441912,0.05357142857142857,0.32537197784767674,1.0,2/11,5.37%,GNG3;GNG2
prerank,Reactome_2022__JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,0.708452533012074,1.3455092240375492,0.07692307692307693,0.32521414719597996,1.0,6/16,20.32%,IRAK2;NOD1;IKBKG;TAB1;MAPK9;TAB2
prerank,KEGG_2021_Human__Aminoacyl-tRNA biosynthesis,-0.611634912712307,-1.3454272107350131,0.15384615384615385,0.6808055316821999,1.0,13/41,19.37%,PARS2;KARS1;VARS1;GATC;EPRS1;NARS1;WARS2;MTFMT;YARS2;RARS1;LARS1;TARS3;QRSL1
prerank,CellMarker_Augmented_2021__Basal cell:Undefined,0.6301437327875185,1.345427179269099,0.04225352112676056,0.32521369936083927,1.0,15/76,8.28%,FOSL2;GPNMB;IL13RA1;ANXA1;TYMP;S100A10;CD55;ICAM1;IL1R1;PLSCR1;AHR;CD44;EMP1;TMBIM1;MVP
prerank,Reactome_2022__PI3K Events In ERBB4 Signaling R-HSA-1250342,0.8395663112860787,1.3454266300873639,0.10714285714285714,0.32499336487617747,1.0,2/7,7.48%,NRG1;NRG2
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.6627604081480315,1.3452029957395264,0.08064516129032258,0.3254011526944517,1.0,12/41,11.97%,TGFBR2;TEAD2;MFSD2A;PDGFA;KITLG;PKDCC;PBX3;TGFB2;GLI2;TEAD1;IFT122;RNF112
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),0.9222509336406558,1.3451889951663216,0.0,0.3252123594914266,1.0,2/5,1.51%,LEF1;TESC
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.5612265039256276,1.34481479061639,0.05714285714285714,0.3260504930911878,1.0,24/103,15.22%,NPNT;CEP170B;DAB2IP;ARHGEF17;EPB41L4B;RAP1GAP;PTPN21;AGRN;RHBDF1;ATP1A1;LAMA5;CTNNB1;ASS1;ARHGEF10L;ATP1B1;EPB41L1;CMTM4;CTNNA1;INPP5J;GPRC5C;COBL;CAMSAP3;BCAR1;SLC44A3
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),-0.8037774060318021,-1.3446035300047268,0.14285714285714285,0.6829284016668057,1.0,2/8,11.76%,ZC3H8;SNAPC5
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.8739377219320686,1.3444065951245614,0.12962962962962962,0.32715377839439425,1.0,3/6,6.91%,ANXA1;DOC2B;SNCA
prerank,Reactome_2022__Neurofascin Interactions R-HSA-447043,0.8477446415583636,1.344378531811462,0.1346153846153846,0.32698766402518187,1.0,2/7,10.76%,CNTNAP1;DCX
prerank,Reactome_2022__DAG And IP3 Signaling R-HSA-1489509,0.6426416464274777,1.3442173664918653,0.09836065573770492,0.3271268054017969,1.0,23/37,22.59%,PDE1C;ADCY5;PRKCG;PRKAR1B;ITPR3;PDE1A;ADCY7;ADCY2;GRK2;PRKCE;PDE1B;CAMK2B;PRKCD;PRKAR1A;ITPR1;NBEA;CAMK2A;PRKCA;AHCYL1;PRKX;ADCY9;ADCY8;PRKAR2B
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),-0.757610618022557,-1.3440813823446378,0.20454545454545456,0.6835540868015081,1.0,3/10,12.77%,ADCY10;SPAG17;SPEF2
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.7467489942051504,1.344028679828236,0.13793103448275862,0.32738299985466557,1.0,2/15,8.12%,SIX3;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.8363820941539638,1.3437622506514977,0.12280701754385964,0.32797471263387895,1.0,1/8,1.69%,SERPINE1
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.6294631293817968,1.343681168647621,0.06944444444444445,0.32794118676122325,1.0,8/43,13.11%,NR4A3;ALDOB;HK2;LDHA;PFKL;PGK1;ENO2;HK1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.7239139077399053,1.3433806037058433,0.14754098360655737,0.32856292860245434,1.0,2/12,5.50%,ZC3H12D;NUDT16
prerank,Reactome_2022__Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.5459238098428164,-1.3432346418685936,0.09090909090909091,0.6852493601129849,1.0,19/54,25.39%,CFTR;PSMD10;PSMD12;DERL2;ERLIN2;PSMB5;RNF5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4;ERLIN1;VCP;ERLEC1;PSMA1;DERL1;PSMD11
prerank,GO_Biological_Process_2021__gas transport (GO:0015669),0.9048543084036389,1.3432340346449567,0.12280701754385964,0.32877069797196923,1.0,1/5,0.15%,IPCEF1
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.5634311387195783,1.34317863244738,0.012987012987012988,0.3287211251859857,1.0,29/141,14.19%,ENPP2;DCN;NLGN1;RELN;RPS6KA1;DAB2IP;VLDLR;TRPM4;SHANK3;GRIP1;DVL1;ZBTB16;NEUROD2;SCX;SHANK1;BASP1;LMNA;NEURL1;ARHGEF7;DLG5;PACSIN1;TLE6;PHLDB2;B4GALT5;CAMK2B;ELAPOR2;ALK;COBL;SPIRE1
prerank,Reactome_2022__Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.4989559239020735,-1.34306071572628,0.05,0.6843678094318819,1.0,31/151,14.26%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;ELOC;RPL18;RBM8A;RPL12;RPL23;RPL31;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;DAG1;RPL11;RPL23A;PSMD10;PSMD12;RPS21;PSMB5;RPS23
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),0.7635264923730982,1.3429260878072566,0.07272727272727272,0.3292165377065708,1.0,4/16,13.44%,EGF;RHBDF1;WDR54;RHBDF2
prerank,Reactome_2022__Neurotoxicity Of Clostridium Toxins R-HSA-168799,0.7812708157570065,1.3426290836199377,0.11666666666666667,0.3297890785301876,1.0,2/9,3.86%,SYT1;SV2B
prerank,Reactome_2022__Neurotransmitter Release Cycle R-HSA-112310,0.6082528377666864,1.3426221370873395,0.10606060606060606,0.3295834402476801,1.0,6/45,11.19%,SLC32A1;SYT1;GAD2;CPLX1;DNAJC5;SYN2
prerank,CellMarker_Augmented_2021__Myogenic Endothelial cell:Skeletal Muscle,0.6202690266794018,1.342600005456948,0.0967741935483871,0.3294091532220014,1.0,19/55,9.78%,ELMO1;FLT1;SLA;GPR34;PLXDC1;SIGLEC1;ACKR1;SHROOM4;PCDH12;MYH11;PTPRC;FAM107A;LDB2;APLNR;RAMP3;LDLRAD4;PPP1R16B;ADGRF5;RNASE1
prerank,KEGG_2021_Human__Proteasome,-0.5983081176324887,-1.3425023325163152,0.0,0.6849462010154858,1.0,8/40,20.20%,POMP;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;PSMB4
prerank,Reactome_2022__p75NTR Regulates Axonogenesis R-HSA-193697,-0.8334491306197491,-1.342493537067157,0.1951219512195122,0.6831988892782014,1.0,1/8,0.09%,NGF
prerank,Reactome_2022__MAPK Family Signaling Cascades R-HSA-5683057,0.5087739612463474,1.342241683184646,0.0,0.3300735789470809,1.0,40/252,12.81%,PDGFRA;EGF;GRIN2D;RASGRP1;GRIN2B;RASGEF1A;ZDHHC9;NEFL;CDC42EP3;SHC2;CSF2RA;IRS2;MAP3K11;DAB2IP;FOXO1;DUSP10;TGFA;DUSP8;PRKG2;FYN;GFRA2;DUSP16;NRG1;FOXO3;NRG2;PDGFA;MRAS;BCL2L1;CDC14A;KITLG;KALRN;ARHGEF7;PPP1CB;RNASE1;GPRIN1;FGF13;TYK2;CAMK2B;MAPKAPK5;FN1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.7773879343136667,1.3421331995949761,0.1111111111111111,0.33010867667780086,1.0,4/12,7.18%,SCN3B;KCNQ1;TRPM4;RYR2
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.5747984683058174,1.342009790694978,0.10144927536231885,0.33029879367116655,1.0,17/81,11.07%,CACNA1H;GRIN3A;CACNA1G;SLC24A2;CDH23;TRPC3;CACNG3;TRPM4;FYN;CACNA1C;CACNG8;RYR2;RAMP3;CACNA1E;ORAI1;MCOLN2;GAS6
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.609547219327526,1.3419648048204302,0.08064516129032258,0.33021747201350204,1.0,12/52,12.85%,HPN;THBS1;SULF1;DAB2IP;DUSP10;CDK6;NLRC3;TGFB2;CDKN1C;SPARC;KLF9;B2M
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.45991970209057653,-1.3418762032917433,0.0,0.6838545398124597,1.0,54/274,15.40%,SNRNP27;FIP1L1;PDCD7;LSM7;SNRPB2;DHX16;LSM3;SF3B4;SF3A1;GTF2H5;POLR2K;ZCRB1;RBM8A;PPWD1;LSM2;CRNKL1;GTF2H2;U2AF1;SF3B6;IK;BUD31;PRPF18;TFIP11;LSM5;FRG1;DDX46;SNU13;METTL3;KIN;ERCC2;PPIH;PQBP1;SYF2;CPSF1;CLP1;PPIL3;POLR2C;SNRNP25;GPATCH1;LSM4;GTF2F1;PRPF8;PPIL1;SRSF2;PNN;RBM22;PRPF3;POLR2D;ESS2;PPIE;RBMX;CWF19L1;CPSF3;SUGP1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.7968585740970637,1.3417860098247036,0.07407407407407407,0.3304072623339736,1.0,3/7,19.77%,CTNNB1;STARD13;RHOB
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.726236913568512,-1.3416122091644065,0.18867924528301888,0.6834669293963425,1.0,2/10,4.15%,APOBEC3G;SETDB1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.7639775581122974,1.3413333288056057,0.09259259259259259,0.33144795544583466,1.0,7/12,14.71%,HLA-DRA;CD55;SYK;HLA-DRB1;HSPH1;IL12A;HLA-E
prerank,CellMarker_Augmented_2021__Mesenchymal Progenitor cell:Osteoarthritic Cartilage,0.9321555189673506,1.3410644785758394,0.031746031746031744,0.33188411556277964,1.0,3/5,6.44%,ICAM1;THY1;CD44
prerank,CellMarker_Augmented_2021__Adventitial cell:Skeletal Muscle,0.6609423804287379,1.3410065607893311,0.1111111111111111,0.33180195388160777,1.0,9/39,5.76%,HLA-DRA;ELMO1;P2RY13;MYO1F;PLEK;SLA;PRKCB;PTPRC;GAB3
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.5562702682487454,1.3409493392728031,0.0273972602739726,0.33178168022216087,1.0,13/126,8.94%,TGFBR2;ANXA1;STMN2;NR4A1;ZFP36;FLT1;DAB2IP;NTRK3;CD44;VSTM2A;DUSP22;CTNNB1;SMAD3
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.6509482347120652,1.3409391020819077,0.07692307692307693,0.33159165566716836,1.0,10/44,9.28%,ARHGAP4;SHTN1;CDC42EP3;WAS;EPS8L2;ARHGDIG;ARHGEF3;RHOD;CDC42EP1;GNA12
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),0.5796746642190347,1.340893457116743,0.1095890410958904,0.3314327321419385,1.0,26/82,19.88%,PROX1;EGF;RASGRP1;CD24;PSRC1;FLT1;DAB2IP;NEK10;INCENP;SNCA;DIRAS2;PDGFA;DIRAS1;TPD52L1;CCND1;CEMIP;FGF2;ATP2B4;SYAP1;SLC8A2;CALM3;WNT5A;ADAM17;TELO2;CCND2;FGFR1
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.6253076269221319,1.3407393865991692,0.07042253521126761,0.33159771036710467,1.0,16/61,11.55%,KLF2;DCN;THBS1;SERPINE1;SULF1;COL4A2;ISM1;DAB2IP;SERPINF1;PML;CTNNB1;PPARG;CD160;TGFB2;PGK1;SPARC
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),0.9327311837141989,1.3407267946866344,0.03333333333333333,0.3313850814563331,1.0,3/5,6.72%,GAP43;APP;ROBO2
prerank,Reactome_2022__HIV Transcription Initiation R-HSA-167161,-0.6370776304527829,-1.3404598167219868,0.10526315789473684,0.6867502502029357,1.0,17/42,23.09%,GTF2H5;POLR2K;GTF2H2;TAF13;ERCC2;GTF2A2;TAF11;POLR2C;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;TAF12;POLR2E;GTF2H3
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),0.8238196569465001,1.340069719240599,0.15517241379310345,0.332896791178184,1.0,3/7,7.95%,COL4A2;ITGA2;ITGA11
prerank,Reactome_2022__Activation Of ATR In Response To Replication Stress R-HSA-176187,-0.6192899499616091,-1.3397594880657018,0.12195121951219512,0.6878135021409473,1.0,10/30,16.97%,RFC3;ATRIP;HUS1;MCM6;SLC25A15;MCM4;RAD9B;CLSPN;POLR1B;ORC6
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.895918776562344,1.3395702711603643,0.17777777777777778,0.3340219160279475,1.0,2/5,8.02%,IL15;TMBIM1
prerank,GO_Biological_Process_2021__proline metabolic process (GO:0006560),-0.8589111311949352,-1.3395484233280224,0.1,0.6868645864273987,1.0,1/5,0.12%,DAO
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),0.5418463655403328,1.339378116639607,0.029411764705882353,0.3342692908707713,1.0,25/120,15.17%,LEF1;GPNMB;ANXA1;THBS1;ZFP36;SFTPD;NLRP12;PTPRC;APOD;ADCY7;NPTN;NLRC5;NLRC3;IKBKE;GAS6;HDAC9;MAPKBP1;HLA-DRB1;FN1;KLF4;IL12A;IFIH1;RARA;PDCD1LG2;OTUD7B
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.811401189809692,-1.3393537770361987,0.1111111111111111,0.6863017284639269,1.0,2/6,12.24%,MIS12;CENPA
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.8243572081574854,1.3391948092834298,0.11904761904761904,0.3345470633603397,1.0,1/7,2.35%,ZFP36
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.8685439090174106,-1.3390210937448166,0.08163265306122448,0.6862741590475027,1.0,1/6,0.76%,DCXR
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.6272705327214931,1.3388150953710827,0.1111111111111111,0.33554603930862975,1.0,9/38,11.54%,PAPSS2;IMPDH1;ADCY5;ADCY7;ADCY2;GUCY1A1;AK5;GUCY1B1;ACOT7
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.6055579134209198,1.3386221683556943,0.09523809523809523,0.3358609552163731,1.0,12/71,10.69%,ANLN;NLGN1;PLPPR5;CDC42EP3;EPS8L2;PLEKHM1;AGRN;CDC42EP1;CLRN1;NEURL1;FSCN1;P2RY12
prerank,Reactome_2022__Nuclear Envelope Breakdown R-HSA-2980766,0.6234450106503117,1.33841404649503,0.13846153846153847,0.33629811276609906,1.0,4/49,3.09%,VRK2;CCNB2;PRKCB;LMNB1
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.5914523757626223,1.3380038573381632,0.06944444444444445,0.33729395059327183,1.0,17/73,14.30%,SLC6A15;SLC7A2;SLC43A1;SLC16A10;SLC25A45;SLCO1A2;MFSD2A;SLC7A7;SLC26A8;SLC25A29;SLC51A;SLC27A3;SLC7A14;SLC27A5;PDPN;SLC7A1;ABCC4
prerank,KEGG_2021_Human__Platelet activation,0.5661374833875326,1.3379215414542978,0.06153846153846154,0.3373161596014578,1.0,33/91,21.85%,RASGRP2;RASGRP1;ADCY5;PRKG2;MYLK3;FYN;ITGA2;ITPR3;GUCY1A2;ADCY7;ADCY2;GUCY1A1;PPP1CB;ORAI1;SYK;P2RY12;GUCY1B1;GP6;PIK3CD;MAPK11;ADCY3;VASP;TLN2;GNAI1;RAP1A;ITPR1;RAP1B;APBB1IP;AKT3;ARHGAP35;ADCY9;MYLK4;ADCY8
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.7957801543141785,1.3378736482797509,0.14035087719298245,0.337223574937793,1.0,4/10,14.19%,STAT4;IL27RA;STAT3;IL12A
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.5410010578195438,-1.3378587755336702,0.12121212121212122,0.6903440626119547,1.0,12/91,13.73%,NUP62CL;FIP1L1;AAAS;RBM8A;RAE1;NUP50;U2AF1;CPSF1;DDX25;NUP54;MCM3AP;SRSF2
prerank,Reactome_2022__Inactivation Of CDC42 And RAC1 R-HSA-428543,0.87394630064588,1.3377506699546728,0.08620689655172414,0.3373834274495702,1.0,3/7,9.78%,ARHGAP39;SLIT2;RNASE1
prerank,Reactome_2022__Role Of LAT2/NTAL/LAB On Calcium Mobilization R-HSA-2730905,0.7959613654244059,1.3375396579625614,0.08771929824561403,0.3377417318308451,1.0,5/12,18.37%,FYN;GAB2;SYK;SHC1;SLC7A8
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.7294341293790825,1.3374161548882066,0.13043478260869565,0.3378857607186247,1.0,2/18,2.44%,CXCL2;DUSP1
prerank,CellMarker_Augmented_2021__Epithelial cell:Embryoid Body,0.578325774822495,1.3374080377043764,0.014492753623188406,0.33767095192266505,1.0,30/97,18.68%,COL4A1;PCDH18;SULF1;COL4A2;SLIT2;TUSC3;COL21A1;COL12A1;PTPN21;SCARA3;BOC;ADGRL2;YAP1;EPB41L1;TEAD1;ENAH;PRICKLE2;TFAP2C;PDPN;CAP2;COL4A5;PALLD;NOTCH3;PDZRN3;FSTL1;MAGI1;WNT5A;SVEP1;CTTNBP2NL;KIAA1217
prerank,Reactome_2022__Integrin Cell Surface Interactions R-HSA-216083,0.6318159400870954,1.3372816966845373,0.078125,0.33771570260426487,1.0,17/45,12.81%,COL4A1;THBS1;ITGA8;COL4A2;ICAM1;COL23A1;ITGA2;CD44;AGRN;ITGA11;ITGA3;ITGA9;COL9A1;ITGB8;COL4A4;ITGAL;FN1
prerank,Reactome_2022__G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,0.697611389579222,1.337255929892786,0.13559322033898305,0.337577495828203,1.0,2/17,5.37%,GNG3;GNG2
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),-0.7033231928539645,-1.3371913472903278,0.1951219512195122,0.6921798121794384,1.0,2/11,11.16%,SETDB1;ZNF304
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Skeletal Muscle,0.82016581801942,1.3371622135666357,0.1,0.3376146333396815,1.0,5/10,6.44%,PDGFRA;THY1;PTPRC;MCAM;CD44
prerank,CellMarker_Augmented_2021__Brown Adipogenic Precursor cell:Adipose Tissue,0.5496225690024954,1.3369522091542512,0.11290322580645161,0.3378028487627493,1.0,23/80,13.38%,PRRX1;PDGFRA;PCDH18;DCN;SULF1;ITGA8;SLIT2;COLEC12;ASPN;ANGPTL2;POSTN;SLIT3;GUCY1A2;MAP1B;BOC;GALNT16;GLI2;ENAH;FAM13C;RUNX1T1;CEP112;HMCN1;IGDCC4
prerank,CellMarker_Augmented_2021__Beige Adipogenic Precursor cell:Adipose Tissue,0.5496225690024954,1.3369522091542512,0.11290322580645161,0.3378028487627493,1.0,23/80,13.38%,PRRX1;PDGFRA;PCDH18;DCN;SULF1;ITGA8;SLIT2;COLEC12;ASPN;ANGPTL2;POSTN;SLIT3;GUCY1A2;MAP1B;BOC;GALNT16;GLI2;ENAH;FAM13C;RUNX1T1;CEP112;HMCN1;IGDCC4
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.702731875969294,-1.336923949242965,0.1,0.6917414562301161,1.0,1/13,0.12%,DAO
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.72112899785691,1.3369189403736434,0.10144927536231885,0.33763454420460376,1.0,3/22,2.41%,CHST8;IGF1;SULF1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.7015842873322349,1.3368608877885948,0.04838709677419355,0.3375272266755297,1.0,5/23,10.81%,MBP;LSR;TJP3;MFSD2A;LAMA2
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.6672433407941782,1.336582025881492,0.13636363636363635,0.3380349070555461,1.0,4/25,9.24%,KIF14;CDC14A;CENPV;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),0.8694409345985985,1.336528230715715,0.1076923076923077,0.337965397295115,1.0,2/7,1.91%,NR4A3;NLGN1
prerank,Reactome_2022__PI3K/AKT Activation R-HSA-198203,-0.8321528230538726,-1.3363810873905293,0.1568627450980392,0.6928303384494484,1.0,1/7,0.09%,NGF
prerank,Reactome_2022__Transcriptional Regulation Of Testis Differentiation R-HSA-9690406,0.8798317187977662,1.336349543445981,0.12727272727272726,0.33818405274491453,1.0,2/5,7.52%,AMH;ZFPM2
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),0.8411585932999917,1.3362392642558463,0.08771929824561403,0.3382433274733597,1.0,2/7,9.86%,NRG1;TGFB2
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.6600949597587448,1.3361973704107293,0.12727272727272726,0.33813596278842456,1.0,6/29,12.96%,WTIP;MFSD2A;CD44;SPARC;MYO9A;PDPN
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.7863609662633828,-1.3359890190419812,0.1388888888888889,0.6929747636212624,1.0,2/7,8.80%,CHAMP1;KIF20B
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.870668003820221,1.3359128788967753,0.11475409836065574,0.33880047610235714,1.0,2/7,2.75%,PROX1;EPHA2
prerank,Reactome_2022__Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,-0.7076189318615127,-1.3357321129476425,0.09090909090909091,0.6922004626808611,1.0,2/14,3.59%,H1-2;H1-4
prerank,CellMarker_Augmented_2021__Trophoblast cell:Placenta,0.5866080984748548,1.3353829053651376,0.06349206349206349,0.34000096211618325,1.0,17/78,10.23%,COL4A1;ANXA1;HRH1;SERPINE1;COL4A2;EPHA2;OSMR;COL12A1;LAMB1;FAP;EMP1;ITGA3;LMNA;TUBB6;PDLIM4;MMP14;PXDC1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.7001620697355166,1.3353552792047285,0.14035087719298245,0.3398548806523254,1.0,5/20,9.40%,P2RY6;STAC2;RYR2;SLC9A1;ATP1B1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.5600425596606771,1.3353207169851211,0.05970149253731343,0.3397089895226226,1.0,15/95,18.97%,NR4A3;TEC;LAT2;NFATC2;GAB2;SYK;PAK1;IKBKG;VAV2;TAB1;MAPK9;SHC1;SKP1;NFATC3;VAV1
prerank,GO_Biological_Process_2021__protein sulfation (GO:0006477),0.7935143140349996,1.3350606799044245,0.1875,0.3401292649010234,1.0,4/5,17.79%,TPST1;UST;CHST4;TPST2
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),-0.8726939619511037,-1.3349989721870308,0.08333333333333333,0.6936539446538753,1.0,1/7,0.79%,ID2
prerank,CellMarker_Augmented_2021__Glial cell:Undefined,0.7800419402955135,1.3349856723906337,0.0967741935483871,0.3400437166439669,1.0,5/13,7.36%,PDGFRA;MBP;NEFL;PTPRC;GFAP
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.6875112638167401,1.3349819738027882,0.0847457627118644,0.339837694981202,1.0,8/16,20.67%,PLEK;FHOD1;ARF6;FMNL3;FMNL1;RHOQ;FHOD3;STRIP1
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),0.8903883120569887,1.3348762977318664,0.06779661016949153,0.33990308022612775,1.0,2/6,6.72%,SLIT2;ROBO2
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),0.8802746060219568,1.3348067148563811,0.08163265306122448,0.3399006397779415,1.0,5/7,9.34%,GRIN2A;GRIN2D;GRIN2B;GRIN1;PDLIM4
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5840499328391722,1.3347564387094675,0.0625,0.3398380275475682,1.0,9/82,8.94%,TGFBR2;ADAMTSL2;THBS1;LTBP4;ASPN;PMEPA1;LDLRAD4;ITGA3;SMAD3
prerank,Reactome_2022__Platelet Aggregation (Plug Formation) R-HSA-76009,0.7065490259911407,1.3346707061900294,0.11666666666666667,0.33989576837747637,1.0,10/26,19.92%,RASGRP2;RASGRP1;SYK;FN1;BCAR1;THPO;SHC1;RAP1A;RAP1B;APBB1IP
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.8447226218156532,1.3345716762434885,0.14285714285714285,0.33999099496021634,1.0,2/7,4.92%,CCBE1;SOX4
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.7262890257476432,1.3345079063733036,0.1076923076923077,0.33989841685088285,1.0,8/19,20.36%,STAT4;GHR;STAT3;CCL2;THPO;STAT6;PIAS1;NMI
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.6712249590355884,1.3338393351549096,0.1,0.3412689255306155,1.0,7/41,6.35%,SIX3;MET;ANXA1;PROX1;LSR;GCM2;NRG1
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.57451701336781,1.3337777312454442,0.07462686567164178,0.3413030987924317,1.0,16/83,5.54%,COL4A1;CSPG4;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;CALD1;SULF1;COL4A2;THY1;PODN;ANGPTL2;POSTN;COL12A1;FAP
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.6741388940022072,-1.333720786556489,0.17073170731707318,0.6973747172165339,1.0,4/12,22.07%,SETDB1;ZNF304;TET1;TRIM28
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),0.7140635298269112,1.3334963533766793,0.06060606060606061,0.34212396088252167,1.0,4/16,6.62%,TYMS;GMPR;ADA;POLD1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.663977993215794,1.333463444203286,0.09523809523809523,0.3419853169776972,1.0,7/32,10.41%,TLR2;SERPINE1;NOD1;MYD88;CHI3L1;STAT3;SYK
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),0.8284309165993563,1.3333307611868481,0.08928571428571429,0.34214617292700006,1.0,4/8,14.15%,RASGRP1;PTPRC;BCL2;CD70
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.8507058430199311,1.3329569443823073,0.07407407407407407,0.3428302948530836,1.0,2/7,3.34%,TLR2;DAB2IP
prerank,Reactome_2022__FLT3 Signaling By CBL Mutants R-HSA-9706377,-0.8129192240811532,-1.3328331487793375,0.10416666666666667,0.699161739084074,1.0,1/6,1.01%,FLT3
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),0.8518027176251043,1.3328002229214329,0.1016949152542373,0.34283661662476156,1.0,3/6,13.63%,CDC42EP3;CDC42EP1;WASHC1
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),0.8518027176251043,1.3328002229214329,0.1016949152542373,0.34283661662476156,1.0,3/6,13.63%,CDC42EP3;CDC42EP1;WASHC1
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.6917300584612303,-1.3327813326102078,0.10416666666666667,0.6975636075604724,1.0,4/13,16.29%,ENY2;DDX25;MCM3AP;DDX19A
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.8394031936049163,1.3326585148991923,0.0847457627118644,0.34299651009921295,1.0,3/9,7.18%,SYT1;KCNMB4;RYR2
prerank,Reactome_2022__Serotonin Receptors R-HSA-390666,0.8262353163498359,1.3326175628611447,0.14516129032258066,0.3429324294574327,1.0,1/5,0.82%,HTR2C
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),-0.6910041531721288,-1.3325509271444547,0.11428571428571428,0.6969356088688619,1.0,2/20,2.25%,HEY2;ADAMTS9
prerank,Reactome_2022__Regulation Of Complement Cascade R-HSA-977606,0.6976000386256911,1.33243196369026,0.15873015873015872,0.3432411386189163,1.0,7/23,15.22%,C3;CD55;CFH;C1R;CPNE2;SERPING1;CD59
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),-0.7701647551929002,-1.3322655416479312,0.21428571428571427,0.6963660504944015,1.0,7/9,19.24%,ALDH1A1;ADH6;ADH4;ADH5;SULT1C4;ALDH2;ACSS1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),0.7474703534414083,1.332256614808766,0.12307692307692308,0.3435717990533078,1.0,2/11,3.20%,GMPR;ADA
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.7524192048708988,1.3322352395887953,0.125,0.3433734700872925,1.0,9/16,22.59%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;ADCY3;ADCY9;ADCY8;PRKAR2B
prerank,Reactome_2022__Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.5948631574062577,-1.3319632984548848,0.11428571428571428,0.696075506638331,1.0,6/40,15.25%,FIP1L1;AAAS;NUP50;CPSF1;NUP54;CPSF3
prerank,Reactome_2022__Cellular Responses To Stimuli R-HSA-8953897,-0.45468974277955465,-1.3319372307631898,0.0,0.6944635819990631,1.0,78/614,10.43%,H1-2;H2AC20;SOD3;ID1;MT1E;CDC26;EPX;ATF5;CCNE1;RPL35A;RPS24;COX18;H3-3B;RPL34;TRIM21;H2BC4;SRPRA;MT1A;RPL39;H2BC21;EXOSC8;PRDX1;LRPPRC;RPL37;H1-4;COX7C;SRPRB;RPS28;AAAS;ELOC;RPL18;RNF2;NUP50;CREB3L4;RPL12;RPL23;MT1G;RPL31;H2AC6;TRIB3;MRPL18;NR1D1;COX20;MUL1;BLVRA;RPL6;BRIP1;EIF2S1;MT1F;RPS27L;EXOSC4;RPL41;HSPA1A;RPS13;RPL22;MAPK7;COX7B;RPL29;LY96;RPL30;ATP6V1E2;ATP6V1G1;RPSA;CREB3L1;HSF1;RPL14;CDKN2C;RRAGC;HSPA13;EXOSC5;SERP1;GPX7;NUDT2;RPL15;EEF1A1;RPS2;SLC46A1;COX5B
prerank,CellMarker_Augmented_2021__Activated B cell:Undefined,0.6791719364747236,1.3317039578866325,0.05970149253731343,0.34462615562116217,1.0,9/27,4.66%,HLA-DRA;CTSS;MYO1F;PLEK;NAPSB;WAS;LAT2;PTPRC;CD37
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.7424421602601023,1.3316988972216195,0.11475409836065574,0.34441253473856726,1.0,7/16,18.23%,EGF;APP;TGFA;ZFYVE28;SHC1;NCK2;ADAM17
prerank,Reactome_2022__Purine Salvage R-HSA-74217,0.776448589632717,1.3316196265746234,0.16923076923076924,0.34441466515839847,1.0,2/10,3.20%,GMPR;ADA
prerank,KEGG_2021_Human__Sphingolipid signaling pathway,0.5582556837484274,1.3316111849212082,0.04225352112676056,0.34422372994601214,1.0,19/102,15.46%,SGPP2;PLD1;PRKCB;PRKCG;FYN;TNFRSF1A;PLD2;PRKCE;GAB2;GNA12;CERS3;S1PR3;BCL2;SGMS1;PIK3CD;MAPK11;CERS5;MAP3K5;TP53
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.7301573089190512,1.3315389563319464,0.12,0.344181454057276,1.0,4/17,9.64%,NDST4;B3GNT2;B3GALT2;B3GALNT1
prerank,Reactome_2022__Synthesis Of PA R-HSA-1483166,0.6533852153630174,1.3315332861011722,0.05357142857142857,0.3439909123711378,1.0,4/28,9.14%,LIPH;LPCAT4;AGPAT4;PLD2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Breast,0.5684982131075438,1.33143413117382,0.08064516129032258,0.3438401615480295,1.0,27/74,12.14%,ENPP2;PDGFRA;RGS7BP;RCAN2;FLT1;PDZRN4;ITGA8;ACKR1;SHROOM4;FAM107A;TMEM132C;RAI2;LDB2;CACNA1C;APLNR;RAMP3;GNA14;PTPRD;ADGRF5;KALRN;RASL12;RNASE1;ITGA9;SORBS1;ASXL3;RUNX1T1;FGD5
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Corneal Endothelium,0.5684982131075438,1.33143413117382,0.08064516129032258,0.3438401615480295,1.0,27/74,12.14%,ENPP2;PDGFRA;RGS7BP;RCAN2;FLT1;PDZRN4;ITGA8;ACKR1;SHROOM4;FAM107A;TMEM132C;RAI2;LDB2;CACNA1C;APLNR;RAMP3;GNA14;PTPRD;ADGRF5;KALRN;RASL12;RNASE1;ITGA9;SORBS1;ASXL3;RUNX1T1;FGD5
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7031787715951099,1.3314236916266395,0.11538461538461539,0.34363539924775083,1.0,7/17,21.03%,DMTN;INPP5J;GADD45A;MLXIPL;PDE4D;NCK2;PPM1F
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.6457429360624543,1.3311993985078152,0.1076923076923077,0.3440818399432056,1.0,3/23,7.62%,TLR2;IRAK2;MYD88
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.5447285550366218,1.3311870424311647,0.043478260869565216,0.3438919693811395,1.0,31/105,15.22%,FLRT3;HTR2C;SLC4A10;ADCY5;SHC2;CEP170B;DAB2IP;EFNB3;ARHGEF17;EPB41L4B;ATP9A;PTPN21;ADGRL2;ARHGEF10L;ATP1B1;CHMP1A;EPB41L1;CMTM4;TEAD1;PRICKLE2;PARD3B;SLC29A4;SLC13A4;COBL;DIP2C;NOTCH3;BCAR1;PDZRN3;CGNL1;SMARCA1;SLC44A3
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),0.5872059460498943,1.3310782371035326,0.07142857142857142,0.343975683349596,1.0,12/59,12.99%,ZYX;MYH9;EPB41L4B;MYLK3;OBSCN;EPB41L4A;SYNPO2L;EPB41L1;TCAP;SORBS1;KCTD13;PHACTR1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.5887977704600209,1.3310676279692504,0.08955223880597014,0.3437935052062391,1.0,16/62,16.31%,MET;TMEFF2;S100A10;WAS;FHOD1;LIMCH1;SYNPO2L;SLC9A1;ARHGEF10L;PHLDB2;PXN;PAK1;LPAR1;CGNL1;STMN1;PFN2
prerank,PanglaoDB_Augmented_2021__Stromal Cells,0.5686091901051075,1.33090923355988,0.06153846153846154,0.3439435793485597,1.0,23/89,9.58%,COL4A1;PRRX1;TLR2;PDGFRA;PCDH18;DCN;ACTA2;SULF1;COL4A2;ICAM1;THY1;PODN;ANGPTL2;POSTN;FAP;IGFBP7;CFH;TNS1;LDB2;C1R;B4GALNT1;BGN;MMP14
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.5504057439441934,1.3308482603749403,0.030303030303030304,0.3439754859700291,1.0,15/103,8.65%,GPNMB;HTR2C;P2RY6;PDGFRA;NPNT;RASGRP1;ICAM1;APP;PTPRC;NTRK3;CD44;RAMP3;PDGFA;NECAB2;CHI3L1
prerank,Reactome_2022__Carnitine Metabolism R-HSA-200425,-0.6911029447201658,-1.3306415864390853,0.20454545454545456,0.6991091817793439,1.0,1/10,1.48%,MID1IP1
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),-0.6459466326888279,-1.3305461867505692,0.10810810810810811,0.6979913702264068,1.0,7/22,8.54%,MT1E;MT1A;SLC30A8;ZNF658;MT1G;MT1F;SLC30A5
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.845777757059178,1.3301535945775496,0.15254237288135594,0.3456519302707189,1.0,3/6,5.08%,UGT8;FA2H;B3GALT2
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.845777757059178,1.3301535945775496,0.15254237288135594,0.3456519302707189,1.0,3/6,5.08%,UGT8;FA2H;B3GALT2
prerank,KEGG_2021_Human__Purine metabolism,0.5452427179136077,1.3301381329436575,0.045454545454545456,0.3454619066950698,1.0,20/106,11.72%,PAPSS2;IMPDH1;PDE1C;ADCY5;GMPR;ADA;PRPS2;NUDT16;PDE1A;GUCY1A2;ADCY7;PDE8B;ADCY2;GUCY1A1;AK3;AK5;GDA;PDE1B;GUCY1B1;PDE10A
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Stomach,0.8966490371470477,1.3300172079876742,0.045454545454545456,0.3456472201940393,1.0,2/6,6.44%,CD24;CD44
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.6711883222101931,1.3299025547409866,0.1111111111111111,0.34572939645636996,1.0,6/36,1.91%,TLCD2;ANK3;RFTN1;IL1RAPL1;S100A10;NLGN1
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.8758602667647459,1.3297482844575195,0.07936507936507936,0.3460832520816545,1.0,1/7,0.85%,ANXA1
prerank,Reactome_2022__CD163 Mediating An Anti-Inflammatory Response R-HSA-9662834,0.8170868378294576,1.3293702774839273,0.09259259259259259,0.34715606264995474,1.0,2/6,3.52%,PLK2;MYH9
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),0.912373694337097,1.329337134443968,0.0847457627118644,0.3470023694437855,1.0,2/5,5.05%,SLIT2;SLIT3
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),0.6977991508653494,1.3293227516132609,0.16071428571428573,0.3468268759766705,1.0,2/18,3.05%,IGF1;IRS2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.704069544594109,-1.3290936544382006,0.1111111111111111,0.7022413638987757,1.0,9/14,16.79%,ATP5PF;ATP5MC1;ATP5PB;ATP5PD;DMAC2L;ATP5MC3;ATP5F1B;ATP5F1A;ATP5MC2
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.8185858226236068,1.3288161002017902,0.1,0.34790450901276837,1.0,1/8,0.06%,TGFBR2
prerank,Reactome_2022__Cytokine Signaling In Immune System R-HSA-1280215,0.49735029633425654,1.3287569094913945,0.0,0.3478677910610206,1.0,84/477,15.54%,CXCL2;HLA-DRA;IL13RA1;ANXA1;SOCS3;IL15;KCNH8;IL1RAPL1;SP100;STAT4;ICAM1;CSF2RA;TEC;IRS2;IRAK2;LMNB1;APP;RPS6KA1;IRF7;FOXO1;NOD1;IL27RA;IL1R1;MAP3K14;OSMR;FYN;TNFRSF14;TRIM5;BCL6;TRIM46;CIITA;SAMHD1;BIRC3;CD44;TNFRSF1A;GHR;FOXO3;EIF4A3;TCP1;PML;NLRC5;MYD88;LAMA5;BCL2L1;KPNA7;TRIM17;SMAD3;PTPN9;GAB2;PDZD2;FSCN1;STAT3;SYK;INPPL1;FGF13;TYK2;CCL2;GSDMD;HLA-DRB1;STX4;MX1;CAMK2B;PRKCD;CDKN1B;RELB;TRIM22;BCL2;IL17RE;FN1;B2M;IL4R;CDKN1A;CCND1;TNIP2;CD70;IL12A;IKBKG;MAPK11;HLA-E;INPP5D;CD4;STAT6;TP53;TNFRSF11B
prerank,Reactome_2022__Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.7618478835613548,1.3287346523865136,0.125,0.34769208361586523,1.0,6/16,13.10%,PRKCB;PRKCG;GRIA3;GRIA1;GRIP2;PICK1
prerank,Reactome_2022__Cyclin A/B1/B2 Associated Events During G2/M Transition R-HSA-69273,0.6894110945500674,1.3285921735808837,0.15151515151515152,0.3479334422876015,1.0,7/21,20.93%,CCNB2;LCMT1;CDK2;CDC25B;CCNB1;PPME1;CCNA2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),0.8070853573181058,1.3285289301806424,0.12280701754385964,0.3480502529697459,1.0,2/7,16.96%,IRF7;UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.6771291781556843,1.3284567925098318,0.109375,0.3480573587897593,1.0,5/23,10.24%,ANK3;CTSS;ABCB1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.5591234838755311,1.3283273756403162,0.058823529411764705,0.34818124356622954,1.0,7/101,9.35%,GGT5;IGF1;FA2H;ALOX12;ACOT4;LDHA;PPARG
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),0.7707152840414822,1.328266321174494,0.14516129032258066,0.3481955526571172,1.0,2/8,10.04%,PLEKHM1;PIP4K2A
prerank,CellMarker_Augmented_2021__Endothelial cell:Cornea,0.7920063766163254,1.3281951242505663,0.1206896551724138,0.34818797356111864,1.0,5/11,6.44%,ICAM1;THY1;LGR5;MCAM;CD44
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.6541876695789587,1.327739854259438,0.11290322580645161,0.3492877970458111,1.0,10/34,15.38%,EPHA7;GRIN2B;FYN;FOXO3;SNCA;CTNNB1;TGFB2;MAPT;ZNF746;MAP3K5
prerank,KEGG_2021_Human__Protein digestion and absorption,0.6182847343795104,1.327507126043099,0.034482758620689655,0.3497455192637428,1.0,17/66,11.04%,COL4A1;COL11A2;COL4A2;KCNQ1;COL8A1;COL21A1;SLC16A10;COL23A1;COL12A1;COL27A1;SLC7A7;ATP1A1;CELA2B;ATP1B1;COL9A1;ATP1B3;COL4A4
prerank,KEGG_2021_Human__Synaptic vesicle cycle,0.5865085530842218,1.3271222763484682,0.047619047619047616,0.3505082728320255,1.0,7/61,9.19%,SLC32A1;SYT1;UNC13C;DNM1;CPLX2;CLTB;CPLX1
prerank,Reactome_2022__FGFR1 Ligand Binding And Activation R-HSA-190242,-0.7674998801295261,-1.3271145564924076,0.1590909090909091,0.7098917883908762,1.0,1/8,0.15%,FGF6
prerank,CellMarker_Augmented_2021__Astroglial Progenitor cell:Embryo,0.5916446461507955,1.327034747883692,0.1,0.35048471832630135,1.0,11/67,16.07%,TMEM204;KLF2;TNFRSF14;ITPKB;TSC22D3;APOL3;ABTB1;USP20;B2M;HLA-E;CBX7
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.6197383273698127,-1.326711473564781,0.1282051282051282,0.7100450163632135,1.0,12/39,18.67%,PARS2;AIMP1;KARS1;VARS1;EPRS1;NARS1;WARS2;YARS2;RARS1;AIMP2;LARS1;TARS3
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),-0.7224247732863156,-1.3266729294234227,0.21052631578947367,0.7084952699309419,1.0,3/11,12.77%,ADCY10;SPAG17;SPEF2
prerank,KEGG_2021_Human__NF-kappa B signaling pathway,0.5928324031640128,1.326655455985241,0.030303030303030304,0.35115157828848703,1.0,13/71,12.47%,CXCL2;PRKCB;ICAM1;IL1R1;MAP3K14;BIRC3;TNFRSF1A;MYD88;BCL2L1;SYK;GADD45A;RELB;BCL2
prerank,Reactome_2022__Signaling By FGFR2 R-HSA-5654738,-0.5595197414075638,-1.3266277128076294,0.09090909090909091,0.7071154959076253,1.0,7/56,14.76%,FGF6;POLR2K;FGFBP3;POLR2C;GTF2F1;NRAS;POLR2D
prerank,CellMarker_Augmented_2021__Stem cell:Limbal Epithelium,0.6011471508174338,1.3264780185153497,0.06349206349206349,0.35090579834200225,1.0,20/71,15.65%,MET;PAPSS2;SLC7A2;EFNA1;EPB41L4B;RAP1GAP;MATN2;MYO1B;ENPEP;KITLG;YAP1;PPARG;ATP1B1;EPB41L1;COBL;GPR37;PLOD2;NTN4;SLC44A3;NGEF
prerank,CellMarker_Augmented_2021__Stem cell:Lacrimal Gland,0.6011471508174338,1.3264780185153497,0.06349206349206349,0.35090579834200225,1.0,20/71,15.65%,MET;PAPSS2;SLC7A2;EFNA1;EPB41L4B;RAP1GAP;MATN2;MYO1B;ENPEP;KITLG;YAP1;PPARG;ATP1B1;EPB41L1;COBL;GPR37;PLOD2;NTN4;SLC44A3;NGEF
prerank,CellMarker_Augmented_2021__Corneal Epithelial Progenitor cell:Embryonic Stem Cell,0.6011471508174338,1.3264780185153497,0.06349206349206349,0.35090579834200225,1.0,20/71,15.65%,MET;PAPSS2;SLC7A2;EFNA1;EPB41L4B;RAP1GAP;MATN2;MYO1B;ENPEP;KITLG;YAP1;PPARG;ATP1B1;EPB41L1;COBL;GPR37;PLOD2;NTN4;SLC44A3;NGEF
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.6300347004930296,-1.326350446276419,0.14285714285714285,0.7069317906569648,1.0,11/27,23.13%,POLR2K;POLR3E;POLR3B;POLR3F;BDP1;POLR3H;GTF3A;POLR3K;POLR2L;POLR2E;GTF3C6
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.7790935255722412,-1.3261976614659918,0.1702127659574468,0.7059398456338359,1.0,3/7,13.16%,TRMT10C;TRMT10A;TRMT10B
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.9027950640966803,1.326162024531165,0.08928571428571429,0.351570726772065,1.0,1/5,0.20%,SLC6A15
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.6297642124964322,1.3260208099793818,0.12962962962962962,0.35182913205363586,1.0,5/26,12.47%,BOK;YWHAH;YWHAG;BBC3;BCL2
prerank,Reactome_2022__Interleukin-21 Signaling R-HSA-9020958,0.8783289030402286,1.3260090907672049,0.017543859649122806,0.35168177594152134,1.0,2/7,10.27%,STAT4;STAT3
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.6733712961460023,1.3259876354991185,0.13114754098360656,0.35150566197272826,1.0,10/27,20.87%,RPA1;GAR1;TERF2IP;ANKRD28;MRE11;TINF2;CDK2;TELO2;WRAP53;ACD
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.6572811728456808,1.32598339225335,0.15873015873015872,0.3512936130255562,1.0,4/28,5.87%,PDGFRA;BAIAP2L1;BAIAP2;NTRK3
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.5650095618292102,1.325918961198645,0.05084745762711865,0.35124803645368247,1.0,13/72,12.29%,PLD1;THBS1;EFNA1;SAMD4A;SOX4;TNFRSF1A;EIF4A3;LARP6;YTHDF1;EPHA4;NIBAN1;ABCA2;PRKCD
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.6288921318928213,1.3258822096429503,0.1206896551724138,0.35110863156879807,1.0,12/38,19.36%,MET;STMN2;PSRC1;SNCA;EML2;MAPT;PAK1;CAMSAP3;STMN1;DCTN1;CAV3;CDK5RAP2
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),0.8680239391065826,1.3258615829696836,0.07407407407407407,0.3509694002890007,1.0,2/6,3.26%,PLEK;RPS6KA1
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.8860598154703163,1.325637336830223,0.09230769230769231,0.35127754476603074,1.0,2/5,2.65%,ANK3;DMTN
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),0.8579776390616902,1.325603765325978,0.12280701754385964,0.35111675624145405,1.0,2/6,5.98%,ST6GAL1;ST8SIA3
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.8347764412029669,1.3255255643186816,0.12962962962962962,0.35112906303619945,1.0,1/5,10.92%,MAPT
prerank,Reactome_2022__Bicarbonate Transporters R-HSA-425381,0.8280707501584876,1.325218485751367,0.1836734693877551,0.351969297375561,1.0,2/8,8.14%,SLC4A10;SLC4A9
prerank,Reactome_2022__Nucleotide Biosynthesis R-HSA-8956320,-0.7454332314403304,-1.32506728709657,0.13513513513513514,0.7087912637980682,1.0,3/11,12.51%,ADSS2;GART;PAICS
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.7517334268804001,1.3250114214289208,0.08620689655172414,0.35236239649000595,1.0,2/17,2.82%,THBS1;SLIT2
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.6740172663497466,1.324763380955853,0.07936507936507936,0.3528197230229829,1.0,4/29,9.38%,S100A10;DMTN;NEDD9;ARHGEF7
prerank,CellMarker_Augmented_2021__Endothelial Precursor cell:Peripheral Blood,0.6318782479286695,1.3246679132785288,0.15254237288135594,0.3527806407343115,1.0,15/51,9.94%,GGT5;FLT1;GPR34;DYSF;SIGLEC1;ACKR1;SHROOM4;PCDH12;MYH11;LDB2;APLNR;RAMP3;ADGRF5;RNASE1;ITGA9
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),-0.8240899425307255,-1.3246364870843728,0.10638297872340426,0.7090343961219023,1.0,2/6,11.69%,IDO1;PRELID1
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.7806949350635557,1.3245781946959863,0.12727272727272726,0.35231939102422777,1.0,1/7,0.81%,TLR2
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.7806949350635557,1.3245781946959863,0.12727272727272726,0.35231939102422777,1.0,1/7,0.81%,TLR2
prerank,Reactome_2022__Modulation By Mtb Of Host Immune System R-HSA-9637628,0.7806949350635557,1.3245781946959863,0.12727272727272726,0.35231939102422777,1.0,1/7,0.81%,TLR2
prerank,Reactome_2022__Signaling By NTRK2 (TRKB) R-HSA-9006115,0.6789864504919515,1.3245138589392829,0.16393442622950818,0.352230536480493,1.0,3/21,9.78%,GRIN2B;FYN;RNASE1
prerank,Reactome_2022__Nuclear Receptor Transcription Pathway R-HSA-383280,0.6224616079632365,1.3244263802242475,0.08955223880597014,0.3522277586394513,1.0,13/43,17.54%,NR4A3;NR4A1;PGR;NR1I3;PPARG;NR6A1;NR4A2;RARA;RARG;RXRA;RORA;NCOR1;NR2F6
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.5351453728640718,-1.3243114416584374,0.15151515151515152,0.7087050783054699,1.0,19/69,20.20%,H2AC20;H3-3B;H2BC4;H2BC21;H2AC6;KMT2A;RUNX1;PSMD10;PSMD12;LMO1;PSMB5;H2AJ;PSMB6;PSME3;SEM1;H2BC5;PSMD2;UBB;PSMB4
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.6283434382481271,1.3243090734522482,0.08928571428571429,0.3523037385203963,1.0,6/28,10.69%,PTPRO;DMTN;WASF1;RHOD;ARHGEF7;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.7398516547553462,1.3240465868995386,0.1,0.3527659979208805,1.0,2/22,5.48%,CACNA1H;RNASE10
prerank,CellMarker_Augmented_2021__Podocyte:Renal Glomerulus,0.6342879903716273,1.3239831487324432,0.109375,0.3525168235652763,1.0,9/41,8.79%,CLIC1;LSR;TJP3;EPS8L2;BAIAP2L1;SYNGR2;ITPR3;ANO9;SH2D3A
prerank,CellMarker_Augmented_2021__Glomerular Epithelial cell:Renal Glomerulus,0.6342879903716273,1.3239831487324432,0.109375,0.3525168235652763,1.0,9/41,8.79%,CLIC1;LSR;TJP3;EPS8L2;BAIAP2L1;SYNGR2;ITPR3;ANO9;SH2D3A
prerank,KEGG_2021_Human__Endocytosis,0.49581186576583175,1.3239723769459493,0.0136986301369863,0.35232104831906697,1.0,48/220,19.40%,TGFBR2;PDGFRA;PLD1;SH3GL2;ARPC5L;SH3GL3;AGAP2;SH3KBP1;RAB11FIP5;DNM1;PARD3;CLTB;ACAP1;PML;LDLR;GRK2;KIF5A;KIF5C;SMAD3;PLD2;ARPC3;CHMP1A;RAB11FIP1;ACAP3;ARF6;AGAP3;WASHC1;VPS37B;GRK5;PSD;BIN1;HLA-E;PSD2;IST1;PIP5K1C;WIPF3;SMURF1;EPN1;IGF1R;TFRC;SH3GLB2;CAV3;SMAD2;RAB11A;WIPF1;DNM2;LDLRAP1;RAB11FIP4
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.7019473317394774,1.3239302773768757,0.16129032258064516,0.35222543831034175,1.0,10/23,23.59%,TRPC3;GRIN1;GRM6;ORAI1;CCL2;P2RX7;CAMK2A;CACNB2;CACNA1D;CXCL12
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),0.68226395672634,1.3236910953219119,0.12698412698412698,0.3524580660888079,1.0,3/28,3.59%,TESC;PTK6;WNT8B
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.5705875497260637,1.3236504459108227,0.07462686567164178,0.35234823209664856,1.0,25/78,16.70%,CSPG4;DCN;OGN;B3GNT2;PXYLP1;CHSY3;CHST15;CHST6;CHPF2;AGRN;UGDH;BGN;OMD;UST;HS6ST1;HS3ST3B1;HS3ST3A1;B4GALT7;B4GALT5;CEMIP;CHST2;NDST1;HS2ST1;B4GALT6;HS6ST2
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.5918471855892433,1.32333363734442,0.10526315789473684,0.35287971810265123,1.0,15/64,17.50%,SIX3;ANXA1;PROX1;BASP1;CNN3;PPARG;ZDHHC7;OVOL3;PGK1;DEUP1;TAGLN2;FZD7;FSTL1;MESP1;SCRIB
prerank,Reactome_2022__tRNA Aminoacylation R-HSA-379724,-0.618744015478401,-1.3232631556772194,0.10256410256410256,0.7111736968446604,1.0,11/38,18.34%,PARS2;AIMP1;KARS1;VARS1;EPRS1;NARS1;WARS2;YARS2;RARS1;AIMP2;LARS1
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.5583684226777582,1.3231744947365311,0.12162162162162163,0.3532183138367131,1.0,18/76,18.91%,CTSS;TESC;MMEL1;PCSK2;NNAT;ECE1;MMP14;ADAM19;TSPAN14;MMP16;PHEX;SRGN;PCSK5;ADAM17;F3;TSPAN15;MMS19;PCSK7
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.5826662661742975,1.3230268796458653,0.08695652173913043,0.35350668514532446,1.0,17/72,17.38%,SH3GL2;SLIT2;DAB2IP;NTRK3;PID1;PPP1R16B;TPPP;NIBAN1;TERF2IP;MAPT;DBI;XRCC1;ATP2B4;TINF2;CDYL;MFHAS1;WWTR1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.8345573351233405,-1.3228173406747874,0.17777777777777778,0.7110186083290754,1.0,3/6,6.31%,TNFAIP3;GREM1;IL33
prerank,Reactome_2022__Wax And Plasmalogen Biosynthesis R-HSA-8848584,0.8550070545425955,1.3227801106785575,0.07462686567164178,0.3540649269105644,1.0,1/6,2.05%,AWAT1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7345860082610272,1.3227522563437069,0.1,0.3539189103990057,1.0,4/13,8.22%,GHR;CYP1B1;OCIAD2;MGAT5
prerank,Reactome_2022__G Beta:Gamma Signaling Thru CDC42 R-HSA-8964616,0.7452255883778796,1.322720091663383,0.06779661016949153,0.3538298924354065,1.0,2/14,5.37%,GNG3;GNG2
prerank,Reactome_2022__Metabolism Of RNA R-HSA-8953854,-0.4414956585042516,-1.3225969206055679,0.0,0.7102614866750679,1.0,125/605,16.45%,IMP4;BUD23;SNRNP27;RTRAF;RPL35A;RIOK2;RPS24;FIP1L1;FCF1;PDCD7;ADAT2;RPL34;TRMT61A;LSM7;RPL39;EXOSC8;SNRPB2;RPL37;DHX16;LSM3;SF3B4;SF3A1;GTF2H5;POLR2K;RPS28;AAAS;RPL18;POP5;ZCRB1;RBM8A;DDX52;PPWD1;LSM2;TRMT10C;CRNKL1;NUP50;RPL12;RPL23;GTF2H2;RPL31;TRMT10A;U2AF1;SF3B6;NOP56;RPL6;BUD31;GEMIN4;RPS27L;RRP1B;EXOSC4;RPL41;HSPA1A;RPS13;RPL22;THUMPD1;RPL29;TFIP11;LSM5;QTRT2;RPL30;DDX46;SNU13;RIOK1;METTL3;RPSA;FTSJ1;RPL14;EXOSC5;ERCC2;PPIH;PQBP1;APOBEC4;SYF2;RPL15;CPSF1;RPS2;DCAF13;PPIL3;POLR2C;MTERF4;IGF2BP3;EPRS1;UTP20;URM1;RRP36;RPL11;TRMT61B;SNRNP25;RPL23A;LSM4;NIP7;OSGEP;NUP54;PSMD10;TRMT5;PSMD12;WDR77;CNOT7;GTF2F1;PRPF8;RPS21;PPIL1;NOL6;SRSF2;ADAT1;RBM22;PSMB5;RPS23;KRR1;CNOT1;PRPF3;POLR2D;PPIE;RBMX;CPSF3;SUGP1;TFB1M;LSM10;PNRC2;RPS25;RPP38;DNAJC8;TRNT1;DDX56;PSMB6
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.6745576121845077,1.3225894892286447,0.12307692307692308,0.35391133793026863,1.0,5/33,7.62%,ZFP36;YBX3;RBM24;ELAVL4;MYD88
prerank,CellMarker_Augmented_2021__Progenitor cell:Breast,0.8895143633199631,1.3225313029341055,0.08196721311475409,0.3538366210729777,1.0,2/5,6.44%,CD24;CD44
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),0.7231023646513391,1.3222518087890862,0.05263157894736842,0.35453474225617654,1.0,8/24,10.44%,IGF1;GRIN2A;ICAM1;APP;FYN;GRM5;GRIN1;EPHA4
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),-0.847812896644176,-1.3221223160248252,0.125,0.7106575398250102,1.0,1/6,1.84%,AGER
prerank,Reactome_2022__Adenylate Cyclase Activating Pathway R-HSA-170660,0.8270744558253686,1.322102662905004,0.15384615384615385,0.35476439435645873,1.0,3/8,7.19%,ADCY5;ADCY7;ADCY2
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.7536195793258239,1.3220079745417108,0.11666666666666667,0.3547530201326731,1.0,7/12,22.15%,LSR;TJP3;CGNL1;SCRIB;TJP2;ARHGEF18;TJP1
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Eye,0.5759712380238237,1.3217903878528507,0.05128205128205128,0.35525116307840393,1.0,21/84,11.74%,RGS7BP;PCDH18;STMN2;RCAN2;GAP43;ADCY5;PLP1;THY1;IGSF21;TCEAL7;NAP1L3;SEMA5B;ANOS1;TMEM132C;LDB2;TCEAL5;PTPRD;RASL12;ARMCX2;CRMP1;RUNX1T1
prerank,Reactome_2022__Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,0.5482196048932271,1.3216376938798207,0.029411764705882353,0.3554941019524436,1.0,22/111,20.32%,RASGRP2;RASGRP1;TEC;NFATC2;FYN;ITPR3;GAB2;RNASE1;SYK;IKBKG;VAV2;TAB1;MAPK9;SHC1;ITPR1;SKP1;SLC7A8;NFATC3;VAV1;AHCYL1;RPS27A;TAB2
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),-0.6212861127925176,-1.3215667453377986,0.10810810810810811,0.7116517051935014,1.0,7/31,11.41%,TRIM21;CTSH;PYHIN1;NR1D1;MUL1;ISOC2;RAD23A
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.8770255986292428,1.3213454974756431,0.1,0.35612547381631454,1.0,2/5,11.86%,CHRM3;DOCK4
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.7108194548914393,1.3213382452384015,0.04918032786885246,0.3557128810339363,1.0,9/20,22.21%,ALDOB;HK2;PFKL;PGK1;ENO2;HK1;ENO3;PFKP;FOXK1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.7108194548914393,1.3213382452384015,0.04918032786885246,0.3557128810339363,1.0,9/20,22.21%,ALDOB;HK2;PFKL;PGK1;ENO2;HK1;ENO3;PFKP;FOXK1
prerank,CellMarker_Augmented_2021__Eosinophil:Lung,0.7356150928804737,1.321237035859372,0.15,0.3558138494474961,1.0,6/15,4.28%,TSPAN16;PRSS57;P2RY13;MYO1F;NLRP12;LAT2
prerank,Reactome_2022__Synaptic Adhesion-Like Molecules R-HSA-8849932,0.7235765610056263,1.3212065725071913,0.1,0.3556749743542885,1.0,7/21,10.13%,GRIN2A;GRIN2D;GRIN2B;GRIA3;PTPRD;GRIA1;GPRIN1
prerank,Reactome_2022__Signaling By Insulin Receptor R-HSA-74752,-0.5759186738220973,-1.3210382841609538,0.125,0.7119898806223676,1.0,6/55,8.81%,FGF6;FLT3;THEM4;TRIB3;ATP6V1E2;ATP6V1G1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.6822325825817338,1.320731224524356,0.09230769230769231,0.356832791350358,1.0,7/33,11.11%,SGPP2;PLPPR5;PLPPR4;PLPPR1;ALOX12;DGKG;PLPP4
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.7976455161435138,1.320616870546728,0.12698412698412698,0.3569188112737181,1.0,2/11,2.82%,SERPINE1;SLIT2
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.5638998201437501,1.3205051673207158,0.08571428571428572,0.3570117645060091,1.0,21/101,14.52%,ARHGAP4;CNTNAP1;DMTN;THY1;SH3KBP1;WTIP;NEDD9;DPYSL2;RHOD;PAK4;PCLO;PLD2;PACSIN1;SYNE3;CCL2;FGD5;FMNL3;PALLD;SIPA1;RHOBTB2;BIN1
prerank,Reactome_2022__EPHA-mediated Growth Cone Collapse R-HSA-3928663,0.7582664629901945,1.3204617297605077,0.06451612903225806,0.35692173406262256,1.0,3/14,4.92%,MYH9;MYH11;FYN
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.6439410486693976,-1.3204610633700566,0.15789473684210525,0.711172051449469,1.0,13/30,23.09%,GTF2H5;POLR2K;GTF2H2;ERCC2;POLR2C;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;POLR2E;GTF2H3
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.6439410486693976,-1.3204610633700566,0.15789473684210525,0.711172051449469,1.0,13/30,23.09%,GTF2H5;POLR2K;GTF2H2;ERCC2;POLR2C;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;POLR2E;GTF2H3
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),0.8522915685905728,1.3204162433386784,0.10909090909090909,0.356838842042852,1.0,3/6,12.25%,TRPM4;PLAAT3;KLF7
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.5495663019853999,1.3202572948751268,0.04411764705882353,0.35701597436932725,1.0,18/82,11.10%,PDGFRA;CDH23;CD24;CD55;TRPC3;ADCY5;ATP2B3;TRPM4;ITPR3;CCKBR;HCRTR2;CACNA1C;RYR2;GLP1R;NPTN;SMAD3;CCR10;S1PR3
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),0.8266394056860451,1.3200327525435598,0.24528301886792453,0.3573964928407851,1.0,1/5,6.91%,SNCA
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.725437690286949,1.3198739362162748,0.12727272727272726,0.3576502542718386,1.0,4/13,13.49%,PIM1;TBX20;ZFPM2;FGF2
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.7447041214243798,1.3198737857265173,0.15517241379310345,0.35743388993168623,1.0,1/10,0.25%,HPN
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),0.7993001655740082,1.3196811884754505,0.12244897959183673,0.35779244161357693,1.0,1/9,1.60%,PLK2
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),0.7532502181401164,1.3194031382266225,0.11627906976744186,0.3583116461587428,1.0,6/9,23.72%,INCENP;PRKCD;CDK2;RPS6KA4;CCNA2;RPS6KA5
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),-0.8117134269809191,-1.3190815365072879,0.13157894736842105,0.7137979921036074,1.0,4/5,18.58%,GDE1;NAAA;NAPEPLD;GDPD1
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),-0.8117134269809191,-1.3190815365072879,0.13157894736842105,0.7137979921036074,1.0,4/5,18.58%,GDE1;NAAA;NAPEPLD;GDPD1
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),0.7760048887316833,1.3189494360206482,0.08333333333333333,0.3592571941640027,1.0,9/14,16.38%,A4GALT;ST8SIA3;ST8SIA1;B4GALNT1;ST8SIA4;LARGE1;ST6GALNAC5;B4GALT6;ST6GALNAC3
prerank,Reactome_2022__Termination Of O-glycan Biosynthesis R-HSA-977068,0.7459552578651046,1.3189328665219033,0.15384615384615385,0.35909634467883844,1.0,1/11,0.62%,ST6GAL1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.5027991505261507,1.3188540258887758,0.012345679012345678,0.35915241249663027,1.0,75/385,16.69%,LEF1;MYRF;TEAD2;IGF1;KLF2;MLLT11;YWHAH;EGF;CREB5;TESC;SP100;ACTA2;PSRC1;BLM;CASZ1;RPS6KA1;IRF7;FOXO1;NFATC2;NFIL3;SOX4;AHR;SKAP1;CIITA;ZBTB16;ZIC1;FOXO3;KCNH2;GLIS2;SCX;PML;CTNNB1;TBL1X;SMAD3;YAP1;RAI1;PPARG;HDAC4;GLI2;RGMB;STAT3;FLI1;TEAD1;CDKN1C;PARP9;NPAS2;HLA-DRB1;MLXIPL;KLF6;BRD4;KLF4;DEAF1;FGF2;SS18L1;ELF1;HIPK2;SPP1;SOX10;PRDM16;RARA;CD4;SMARCA1;ETS1;MAP3K5;TP53;RXRA;BRCA1;FZD7;ZMIZ1;CXXC1;HMGA1;NPAS3;RORA;TFEB;MESP1
prerank,Reactome_2022__G-protein Beta:Gamma Signaling R-HSA-397795,0.6588308500033846,1.3188310745026934,0.13846153846153847,0.35899182008237474,1.0,2/22,5.37%,GNG3;GNG2
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.6218171631971577,1.3187930727047719,0.11594202898550725,0.35888728235611633,1.0,10/52,9.86%,TLR2;IGF1;DOC2B;IRS2;ACHE;SOX4;NNAT;TMED10;SYTL4;TGFB2
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.727551487718914,-1.3187533245953775,0.21951219512195122,0.7135008628543984,1.0,1/11,4.32%,AAAS
prerank,Reactome_2022__RND1 GTPase Cycle R-HSA-9696273,0.6365148051155125,1.3183767064969245,0.1076923076923077,0.3596691332100771,1.0,13/36,22.35%,KIF14;STMN2;EPHA2;DLG5;ALDH3A2;PLXNA1;UBXN11;PKP4;TFRC;RRAS2;ARHGAP35;DST;FLOT2
prerank,"Reactome_2022__SMAC, XIAP-regulated Apoptotic Response R-HSA-111469",0.8504877722541475,1.318049392489681,0.14,0.36034542949331255,1.0,1/7,3.12%,SEPTIN4
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),0.8531604253332675,1.3178895505649377,0.09836065573770492,0.360491188334329,1.0,3/6,4.64%,SHISA7;NLGN1;SHANK3
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.827394359085246,1.3173756546925353,0.09836065573770492,0.3616816517610989,1.0,2/8,2.58%,STMN2;PLEK
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone Marrow,0.7353180561630321,1.3173399563656387,0.13793103448275862,0.36156885076594963,1.0,5/15,6.44%,PDGFRA;THY1;PTPRC;MCAM;CD44
prerank,GO_Biological_Process_2021__regulation of chloride transport (GO:2001225),0.867474003363558,1.3172993553798535,0.07142857142857142,0.3614005251638037,1.0,2/5,6.22%,ABCB1;GRM5
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.6824497705802984,1.3171878747075234,0.18333333333333332,0.36145490804407604,1.0,2/17,4.69%,SGPP2;PRKG2
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.6763165648046242,1.3171304393082799,0.13333333333333333,0.3613841408286855,1.0,10/26,20.87%,RPA1;GAR1;TERF2IP;ANKRD28;MRE11;TINF2;CDK2;TELO2;WRAP53;ACD
prerank,Reactome_2022__SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,0.5293935243477886,1.3168048644209938,0.08333333333333333,0.3621676930213829,1.0,24/145,16.66%,CDKN2A;SP100;BLM;UHRF2;HIC1;INCENP;PMEPA1;CHD3;PGR;PML;IKBKE;PPARG;HDAC4;NR4A2;RANGAP1;TFAP2C;HIPK2;IKBKG;MRTFA;RARA;TP53;RXRA;BRCA1;RORA
prerank,KEGG_2021_Human__Toll-like receptor signaling pathway,0.5699655209116242,1.3167512157082926,0.09230769230769231,0.3620688203873278,1.0,18/62,21.09%,TLR2;IRF7;MYD88;IKBKE;FADD;IL12A;IKBKG;PIK3CD;MAPK11;SPP1;TAB1;CTSK;MAPK9;MAP2K3;TLR3;AKT3;TAB2;TBK1
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.7974232746914227,-1.316644080762882,0.14545454545454545,0.7203934007167244,1.0,2/7,2.01%,VAMP8;NMB
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.6082402541248825,1.3166182221612837,0.0958904109589041,0.3622267234160699,1.0,8/56,13.91%,HPN;RFTN1;RPS6KA1;MFSD2A;MMP14;TGFB2;BCL2;TRIM32
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),-0.5629037162316359,-1.3166179313992947,0.09090909090909091,0.7189219011181743,1.0,13/40,14.78%,HSPG2;APOE;ALDH1A1;AKR1C3;SDC3;APOM;ADH4;CYP4V2;GPC6;LRAT;RDH10;RDH11;NAPEPLD
prerank,Reactome_2022__Sialic Acid Metabolism R-HSA-4085001,0.6791316137131372,1.3164644013852942,0.078125,0.36245376292238424,1.0,12/28,16.45%,ST6GAL1;EGFL7;ST8SIA3;ST8SIA1;SLC17A5;ST8SIA4;CMAS;NANS;ST6GALNAC2;ST6GALNAC5;ST6GALNAC3;NEU4
prerank,Reactome_2022__TRP Channels R-HSA-3295583,0.7489074999504746,1.3164223103499681,0.034482758620689655,0.36237568176888413,1.0,3/16,10.33%,TRPC3;TRPM4;MCOLN2
prerank,Reactome_2022__PKA Activation R-HSA-163615,0.7449896886468561,1.3164038567967395,0.1111111111111111,0.3621869058530266,1.0,10/15,22.59%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;NBEA;PRKCA;ADCY9;ADCY8;PRKAR2B
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),-0.7281751564278092,-1.3163467208616364,0.1590909090909091,0.718062043927661,1.0,1/12,4.60%,NAA11
prerank,CellMarker_Augmented_2021__Villous Stromal cell:Placenta,0.5862279674052897,1.3160802406457843,0.03278688524590164,0.3629325714329123,1.0,19/70,10.81%,COL4A1;CSPG4;PRRX1;GPNMB;PDGFRA;DCN;COL4A2;PODN;ANGPTL2;POSTN;COL12A1;FAP;RHBDF1;C1R;EMP1;BGN;MMP14;PXDC1;LAMA2
prerank,Reactome_2022__RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,-0.5823982273336167,-1.3154595426483142,0.0975609756097561,0.7203618709764161,1.0,13/39,23.13%,BRF2;POLR2K;POLR3E;POLR3B;SNAPC5;POLR3F;BDP1;POLR3H;GTF3A;POLR3K;POLR2L;POLR2E;GTF3C6
prerank,KEGG_2021_Human__Yersinia infection,0.5435386895202009,1.3154380791293874,0.03225806451612903,0.3647769896465204,1.0,31/110,20.32%,FYB1;ELMO1;ARPC5L;WAS;RPS6KA1;NFATC2;BAIAP2;MYD88;ARPC3;ARHGEF7;PXN;CCL2;ARF6;FN1;RPS6KA6;IKBKG;PIK3CD;MAPK11;BCAR1;CD4;PIP5K1C;VAV2;WIPF3;TAB1;MAPK9;MAP2K3;NFATC3;VAV1;WIPF1;AKT3;TAB2
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.7190614398724897,-1.3153923078872125,0.16216216216216217,0.7191241255231114,1.0,1/10,2.26%,EIF2S3B
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.5855519394854827,1.3153155937913639,0.09836065573770492,0.36487050604178944,1.0,12/58,12.36%,CDKN2A;NR4A1;DUSP1;TSPYL2;BTG3;CDK6;HECA;SMAD3;GMNC;CHMP1A;CDKN1C;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),0.8344634433908339,1.3153125422742078,0.0625,0.3646668778494592,1.0,5/9,14.09%,DAB2IP;VLDLR;PACSIN1;ALK;COBL
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6846139797259282,1.3152808610663949,0.0847457627118644,0.36458085397549345,1.0,4/27,3.34%,ANXA1;NR4A1;FLT1;DAB2IP
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.5541979998791032,1.315210313338127,0.08571428571428572,0.36453632965252947,1.0,21/97,15.21%,KIF14;EPHA7;TESC;DUSP1;EPHA2;EFNA1;EPB41L4B;ARHGDIG;NUAK1;RHOD;PPP1CB;MINK1;PODXL;EPHA4;STX4;PLXNA4;FUT2;IL12A;SIPA1;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.53070536598567,-1.315181315508496,0.05555555555555555,0.7182868135923759,1.0,9/50,20.20%,ATF5;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;PSMD2;CUL1;PSMB4
prerank,Reactome_2022__SHC1 Events In ERBB2 Signaling R-HSA-1250196,0.7001197449456172,1.3148851928574619,0.18518518518518517,0.36526414525228995,1.0,7/18,18.53%,EGF;NRG1;NRG2;PRKCE;PRKCD;SHC1;PRKCA
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.6829838802666875,1.314800403356973,0.0967741935483871,0.36530196346989624,1.0,7/24,16.60%,CDKN2A;NUAK1;CDK6;CGAS;B2M;NEK6;HMGA1
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.7197209071615869,1.3146309774397211,0.16981132075471697,0.365670323545521,1.0,5/11,17.50%,ZDHHC7;OPHN1;MYO9A;CAMSAP3;SCRIB
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.6999039083117174,1.3145252395169225,0.10204081632653061,0.3656872062443054,1.0,3/23,10.44%,IL1RAPL1;ZNF804A;HOMER1
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.8613228301222369,1.3141770275582096,0.09523809523809523,0.36650891778245814,1.0,3/5,13.76%,HLA-DRA;HLA-DRB1;HLA-DMA
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),-0.7746762956349663,-1.3140632960203684,0.09523809523809523,0.721084395672382,1.0,2/10,8.58%,TAX1BP3;GOPC
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.6953837205467375,1.3138589632845827,0.12280701754385964,0.3673090296634081,1.0,8/23,14.92%,PDGFRA;THBS1;ZSWIM4;YTHDF1;CYRIB;P2RY12;STX4;GPR183
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.8746673937503243,1.3137066720526982,0.1509433962264151,0.36762723034123385,1.0,1/5,0.81%,TLR2
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.6748672201289645,1.3136329973870784,0.10526315789473684,0.36764978055309,1.0,7/26,10.04%,IL1RAPL1;NLGN1;GRID2;CLSTN2;AGRN;PTPRD;DLG5
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),0.6836823107954171,1.3134597953980727,0.11290322580645161,0.367905637862563,1.0,2/22,9.80%,NMNAT2;AK5
prerank,CellMarker_Augmented_2021__Germ cell:Ovary,-0.8621970071637336,-1.3134306287102258,0.12195121951219512,0.7219553722984703,1.0,1/5,1.78%,GDF9
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.9036918348859287,1.3133088293633073,0.09259259259259259,0.3680857467040872,1.0,1/5,1.45%,EGF
prerank,KEGG_2021_Human__Carbohydrate digestion and absorption,-0.5906533314388258,-1.3131438635365982,0.1891891891891892,0.7217652776259675,1.0,4/28,6.20%,SLC2A5;PLCB4;MGAM;ATP1B2
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.6489432226513598,1.3129828618446722,0.15,0.3687180488984219,1.0,4/23,4.64%,EGF;RELN;TGFA;SHANK3
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.6822763807991282,1.3129366971469214,0.1864406779661017,0.36862344106444245,1.0,2/21,3.73%,ZFP36;SAMD4A
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.637732445312417,1.3125333970798054,0.0392156862745098,0.3696243920967371,1.0,3/33,3.58%,RECQL4;BLM;RPA1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.4721029858948797,1.3124180253914257,0.0,0.3696935809948767,1.0,165/835,19.07%,TGFBR2;MTMR7;SERPINA10;VRK2;C3;ANXA1;SOCS3;CHGB;MAP3K6;CHRM3;PLK2;THBS1;FAM20C;PTK6;PTPRO;B3GNT2;PIM3;DUSP1;PRKCB;PRKCG;PTPRB;TEC;APP;PIM1;MAP3K11;ASB16;NUAK2;DUSP10;NEK10;PTPRR;PAK3;CP;PTPRC;DUSP8;PRKG2;MYLK3;PRKAR1B;FYN;B3GALT2;NUAK1;FBXW12;DUSP16;LAMB1;IGFBP7;NOTUM;ST8SIA3;PDP1;ZBTB16;PTPN21;BAP1;SBF1;VGF;CDK9;STK25;PAK4;ST8SIA1;AATK;SHISA5;DAPK2;CDK6;GRK2;SIK2;PTPRD;ITIH2;SSH2;LIMK2;PTPN9;PRKCE;PRKCH;IKBKE;LOXL1;PPP1CB;MINK1;B3GALNT1;MAK;HIPK3;HUNK;FBXO32;ART3;TGFB2;UST;TF;KLHL5;ST8SIA4;FBXL2;SYK;CDKL5;PARP9;MAP3K21;GAS6;B4GALT7;FBXL16;TYK2;WSB2;PDK4;CHST4;B4GALT5;CCL2;PXK;CAMK2B;MACROD1;PRKCD;SPSB1;HIPK1;FN1;PAK1;PICK1;PHEX;FUT2;MSRA;MTM1;GPS1;ATG4B;GRK5;PLOD2;HIPK2;PDK1;SERPIND1;BMX;PIK3CD;NEK6;SPP1;PPM1D;LCMT1;RARA;ST6GALNAC2;LARGE1;MAP3K5;STK3;PINK1;PTPRS;HIF3A;FSTL1;CDK2;CDK19;TAB1;CILK1;LIPE;CDC25B;MAPK9;CDK18;ANO8;CDK20;FAM20A;PIGK;STK11;STK24;FN3KRP;DDB2;MTMR2;CTTNBP2NL;PDK3;SKP1;CAMK2A;LOXL2;PRKCA;NEK4;B3GALT5;RPS6KA4;DCAF5;FBXO41;FBXO31;MTMR3;RAB11A;GAN
prerank,CellMarker_Augmented_2021__Hematopoietic Precursor cell:Fetal Liver,0.9104334019358478,1.3123994575463382,0.08163265306122448,0.36953701888036794,1.0,2/5,4.31%,THY1;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.5911108453944595,1.3123727717160032,0.13559322033898305,0.3693874758247536,1.0,3/47,1.48%,BOK;MLLT11;DCN
prerank,CellMarker_Augmented_2021__Neutrophil:Blood,0.8683268137585795,1.312342305888559,0.1016949152542373,0.36923810901316473,1.0,1/6,0.81%,TLR2
prerank,CellMarker_Augmented_2021__Trophoblast Stem cell:Undefined,-0.6152248958387612,-1.3122253350387239,0.09523809523809523,0.724434166530627,1.0,2/26,0.22%,LYPD6B;TRIM29
prerank,CellMarker_Augmented_2021__Stem cell:Submandibular Gland,0.5746427209077891,1.3121596297101252,0.06779661016949153,0.3695599386149304,1.0,22/60,12.14%,GGT5;DCN;ABCA8;FLT1;PTPRB;ACKR1;SHROOM4;CFH;LDB2;APLNR;MAOB;RAMP3;ENPEP;ADGRF5;BGN;RASL12;RNASE1;ITGA9;SLCO2A1;SORBS1;PDK4;FGD5
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5978759505559658,1.3120422892260217,0.06153846153846154,0.36962213946676936,1.0,13/58,12.93%,NR4A3;ELMO1;WAS;FYN;BAIAP2;MYO1C;PLD2;ARPC3;PRKCE;SYK;PLPP4;PRKCD;PAK1
prerank,CellMarker_Augmented_2021__Stem cell:Hair Follicle,0.8325330888458626,1.311711641813816,0.20930232558139536,0.37029110053488246,1.0,4/5,16.20%,LGR5;CTNNB1;LRIG1;CD200
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),-0.7998994000213557,-1.311669063705993,0.14893617021276595,0.7252408799045853,1.0,4/7,16.31%,TRMT10C;TRMT10A;TRMT10B;TRNT1
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.7140559437755134,1.3111695519101332,0.14754098360655737,0.37154530866252883,1.0,2/15,1.17%,NR4A3;PDGFRA
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.7124994671229429,1.3110372756901574,0.08620689655172414,0.3717560608773674,1.0,2/22,2.04%,SLC6A15;SLC43A1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5538538944989756,1.3106781315991278,0.06756756756756757,0.37247023485973524,1.0,26/109,11.74%,RGS7BP;STMN2;ZNF536;NLGN1;RCAN2;CNTN2;GAP43;SLIT2;PLP1;PLPPR4;C11ORF87;OPCML;EFNB3;TCEAL7;SEMA5B;GUCY1A2;MAP1B;GFAP;BOC;PTPRD;LY6H;NACAD;ASXL3;CRMP1;FAM13C;RUNX1T1
prerank,Reactome_2022__IL-6-type Cytokine Receptor Ligand Interactions R-HSA-6788467,0.7528536011725822,1.3105413442952822,0.125,0.37265298752689185,1.0,2/11,11.45%,OSMR;TYK2
prerank,Reactome_2022__Elevation Of Cytosolic Ca2+ Levels R-HSA-139853,0.7626349516085866,1.310183482772399,0.20689655172413793,0.3734745714329426,1.0,6/11,21.51%,TRPC3;ITPR3;ORAI1;P2RX7;ITPR1;P2RX6
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.7357289372543139,1.3097416327867708,0.05357142857142857,0.3745126120923196,1.0,7/18,15.19%,MYRF;PRDM8;EIF2B2;TPPP;SOX13;SOX10;EIF2B5
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),0.8035596857800695,1.3097334894667794,0.1509433962264151,0.37431358513676904,1.0,2/7,10.20%,SLC25A45;SLC25A29
prerank,Reactome_2022__Regulation Of Gene Expression By Hypoxia-inducible Factor R-HSA-1234158,-0.7348492186108242,-1.3094236874212932,0.10526315789473684,0.733411471968841,1.0,1/9,0.91%,EPX
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.8380703232394764,-1.3094181976093577,0.15384615384615385,0.7317949378612381,1.0,1/6,1.13%,ERCC8
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.6089569385366327,1.3093711384311382,0.125,0.37525490923279464,1.0,5/53,3.61%,PTP4A3;TLR2;APP;NOD1;NLRP12
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),0.7237463554240327,1.3092419443803582,0.109375,0.3754422802510027,1.0,5/21,17.04%,EGF;APP;CHI3L1;CEMIP;CALM3
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.7083135144391484,1.3092199015860297,0.14516129032258066,0.3752498372792906,1.0,8/20,16.95%,CXCL2;ANXA1;TGFB2;SYK;CCL2;PIK3CD;PIP5K1C;ADGRE2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.638308953566121,1.3089151500976932,0.12307692307692308,0.3758231397471187,1.0,7/32,17.81%,BOK;ZNF385B;PML;HIPK1;HIPK2;TP53;STK11
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.7017848833862171,1.3084367977998983,0.11538461538461539,0.376991581797177,1.0,5/15,15.13%,GPNMB;SFTPD;DLG5;HLA-DRB1;PDCD1LG2
prerank,CellMarker_Augmented_2021__Eosinophil:Blood,0.8187001199364453,1.308387711514166,0.16666666666666666,0.3769000705372026,1.0,4/8,13.02%,ICAM1;CSF2RA;CD44;IL4R
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.47427070951088574,1.30822814052948,0.0,0.37709269778835136,1.0,149/669,20.29%,LEF1;NR4A3;MLIP;FOSL2;MET;ST18;TLR2;IGF1;KLF2;MAFF;PROX1;DCN;SERPINE1;ATF3;NR4A1;CASZ1;LMO2;WAS;APP;RPS6KA1;IRF7;DAB2IP;FOXO1;PPARGC1B;PLSCR1;SOX4;AHR;SSBP4;KLF10;DVL1;SKAP1;RFX4;CIITA;ZNF750;TNFRSF1A;PLAC8;AGRN;PGR;LDB2;PID1;CDK9;FHOD1;FOXO3;GLIS2;SCX;GRIN1;ZFPM2;NLRC5;SLC9A1;CTNNB1;CSRNP1;TBL1X;SMAD3;NR1I3;YAP1;BEX1;PPARG;CTBP2;HDAC4;NAMPT;TGFB2;GLI2;STAT3;GLIS3;SMAD1;TEAD1;ASXL3;NR4A2;ASXL1;NPAS2;EIF5A;MLXIPL;KLF7;KLF6;MEIS3;BRD4;PER1;TFAP2C;KLF4;MEF2D;FGF2;SS18L1;FADD;TNIP2;ELF1;MAML2;ZNF746;HIPK2;BCL9;IKBKG;AKIRIN1;PTPRN;NOTCH3;MRTFA;RARA;IER5;SMARCA1;RARG;ETS1;STAT6;TP53;ZNF513;RXRA;BRCA1;ZMIZ1;TOX3;HMGA1;ZBTB38;RORA;TFEB;MESP1;GPS2;RGMA;LPIN3;DOT1L;UBP1;WWTR1;WNT5A;MLXIP;LAGE3;RHOQ;NCK2;TBL1XR1;RLF;BCLAF1;NFIA;LITAF;SBNO2;RPS6KA4;SMAD2;NFATC3;CRTC3;ZFPM1;MED24;HIF1A;METTL23;POU2F3;TLR3;ARNT;SMAD9;MAP2K5;NOTCH4;ARNT2;RPS27A;MRTFB;BMP6;SMARCD2;HJV;DDRGK1
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.6548761418213461,1.308204870632445,0.15789473684210525,0.3769606819852828,1.0,6/24,11.24%,MET;TMEFF2;WAS;SHANK3;SHANK1;PHLDB2
prerank,Reactome_2022__Signaling To RAS R-HSA-167044,-0.7148330723377894,-1.3080711368106415,0.14705882352941177,0.7359184852446902,1.0,1/18,0.09%,NGF
prerank,Reactome_2022__Sema3A PAK Dependent Axon Repulsion R-HSA-399954,0.7740775986055894,1.3080510696542909,0.06779661016949153,0.37718006852120606,1.0,6/16,15.21%,FYN;ARHGEF7;RNASE1;PLXNA4;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.7601571350276819,-1.3075539944785546,0.26666666666666666,0.7368271722085188,1.0,3/9,6.01%,MID1IP1;ABCD2;ABCD1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7815423343352088,1.3075531951649388,0.1,0.3784455803766303,1.0,3/10,6.20%,CHRM1;GAP43;PARD3
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),0.6968399104148499,1.3075401297459832,0.1206896551724138,0.3782725261375233,1.0,3/15,14.96%,BIRC3;SEC14L1;PUM1
prerank,Reactome_2022__Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.5510803970808182,-1.3071850218601588,0.09375,0.7369596431854766,1.0,12/61,20.20%,OTUD3;PSMD10;PSMD12;FRK;PSMB5;PSMB6;AKT2;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),0.8706969070355977,1.307177548060097,0.1016949152542373,0.3790976357480629,1.0,3/5,11.71%,TGFB2;P2RY12;CCL2
prerank,Reactome_2022__SUMOylation R-HSA-2990846,0.524882224757685,1.3071578856808785,0.0821917808219178,0.3789244036328552,1.0,24/150,16.66%,CDKN2A;SP100;BLM;UHRF2;HIC1;INCENP;PMEPA1;CHD3;PGR;PML;IKBKE;PPARG;HDAC4;NR4A2;RANGAP1;TFAP2C;HIPK2;IKBKG;MRTFA;RARA;TP53;RXRA;BRCA1;RORA
prerank,Reactome_2022__Phase 4 - Resting Membrane Potential R-HSA-5576886,0.7921260258263085,1.307086597730043,0.09090909090909091,0.37896016260048393,1.0,4/8,9.37%,KCNJ2;KCNK10;KCNK1;KCNK12
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),0.7703285857010728,1.3069266008035703,0.09090909090909091,0.3791237736444923,1.0,3/13,7.88%,C3;MFSD2A;LDLR
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Cartilage,0.7098122979039967,1.3068969203546832,0.11290322580645161,0.3789777373256123,1.0,5/20,6.47%,THY1;PTPRC;MCAM;CD44;TNFRSF1A
prerank,Reactome_2022__Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,0.7023283716376917,1.3068519875767084,0.06060606060606061,0.3788789344581409,1.0,4/23,9.28%,GNG3;GNG2;GNA14;GNA12
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4924434462617683,1.3064798932988602,0.013333333333333334,0.3797680179414773,1.0,49/309,11.60%,NR4A3;HPN;MET;FLRT3;IGF1;PDGFRA;EPHA7;GRIN2B;PTK6;ELMO1;SULF1;FLT1;COL4A2;SLA;EPHA2;SHC2;SLC39A14;IRS2;FOXO1;NRP2;EPHA5;EFNA1;EFNB3;PAK3;FYN;GFRA2;NEDD9;ANOS1;BAIAP2;DNM1;NTRK3;NRG1;GHR;FLRT1;GRIN1;PDGFA;MVP;KALRN;ARPC3;ARHGEF7;NAMPT;SIPA1L1;STAT3;SYK;EPHA4;GFRAL;SORBS1;PXN;PDK4
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.524739645407792,1.306466954952012,0.06756756756756757,0.3795882839785536,1.0,17/107,8.52%,SLITRK1;SCN1B;IL1RAPL1;STMN2;PTK6;RIT2;PLPPR5;SLIT2;RELN;DAB2IP;GRIP1;NTRK3;DVL1;ROBO2;NPTN;ZNF804A;PTPRD
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),0.672262389693477,1.3062916010199577,0.1,0.37982488692737726,1.0,12/29,18.39%,CDKN2A;IL15;TGFB2;HOMER1;PRKCD;CGAS;B2M;IFIH1;IER5;HMGA1;WNT5A;BCLAF1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),0.7697918337060713,1.3058177475644595,0.1568627450980392,0.38097348637347894,1.0,4/12,11.60%,FOXO1;PID1;FOXO3;PDK4
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.6694398040641676,-1.3056590464292663,0.11627906976744186,0.7417647224269814,1.0,6/16,11.72%,MT1E;MT1A;MT1G;MT1F;HSF1;MT2A
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5949312137868128,1.3056251405618828,0.125,0.3813565022685929,1.0,6/56,8.94%,TGFBR2;ADAMTSL2;ASPN;PMEPA1;LDLRAD4;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.752551692072015,-1.3054947525174303,0.1702127659574468,0.7408662471283045,1.0,1/8,1.84%,AGER
prerank,Reactome_2022__Ub-specific Processing Proteases R-HSA-5689880,-0.4605430375492909,-1.3054576175322832,0.06666666666666667,0.7394881122221492,1.0,31/152,20.20%,H2AC20;H2BC4;H2BC21;CFTR;H2AC6;MUL1;VDAC2;IL33;H2BC18;POLG2;BECN1;PSMD10;FOXO4;PSMD12;USP19;PSMB5;TADA2B;CLSPN;PSMB6;RUVBL1;PTRH2;PSME3;SEM1;H2BC5;PSMD2;MAT2B;TADA3;USP18;UBB;SKP2;PSMB4
prerank,Reactome_2022__Thromboxane Signaling Thru TP Receptor R-HSA-428930,0.7464971064182457,1.3054257470332398,0.10344827586206896,0.3816184732934206,1.0,3/16,8.48%,GNG3;GNG2;GNA14
prerank,CellMarker_Augmented_2021__Primitive Endoderm cell:Embryo,0.5876798310946939,1.3053104745237316,0.10606060606060606,0.3817395204968604,1.0,12/65,12.96%,COL4A1;FLRT3;IGF1;PDGFRA;COL4A2;SYT13;RNASE1;VWA5A;SLCO2A1;PHLDB2;FN1;PDPN
prerank,CellMarker_Augmented_2021__Ectoderm cell:Germ,0.5670123461990906,1.3052565471767932,0.058823529411764705,0.3816797337019661,1.0,24/96,13.77%,C10ORF105;CDH23;RTN1;ADAMTS10;CIC;FYN;GFRA2;GNG2;SEMA5B;TMEM132C;GALNT8;ITPKB;JPH4;AATK;CACNA1E;NHSL2;HDAC4;ABCA2;LRRC4;PLXNA4;SDK2;INPP4A;TMEM132D;MAP7D1
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),-0.8783009197793837,-1.305198905892595,0.125,0.7387483265719346,1.0,1/5,0.60%,SPRY1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.7469663812266942,1.305095376672487,0.14516129032258066,0.3819143106453563,1.0,4/10,17.49%,TEC;AATK;BMX;IGF1R
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.7483629295843588,1.3048939462683615,0.2037037037037037,0.38232241817534685,1.0,9/15,22.59%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;ADCY3;ADCY9;ADCY8;PRKAR2B
prerank,KEGG_2021_Human__Pathogenic Escherichia coli infection,0.5245837947238714,1.3046216787352842,0.02702702702702703,0.38300396833982114,1.0,31/146,14.62%,ARPC5L;MYO1F;CLDN16;MYH9;IL1R1;PAK3;MYH11;BAIAP2L1;WASF1;FYN;FAS;BAIAP2;TUBB1;TNFRSF1A;TMED10;MYD88;MYO1B;MYO1C;TUBB6;ARPC3;GNA12;CLDN18;ARF6;CLDN20;PAK1;TNFRSF10B;FADD;LPAR1;TUBA1B;IKBKG;MAPK11
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.755342483564886,1.3044371697287778,0.1694915254237288,0.38328411580862765,1.0,2/10,11.10%,TNFRSF1A;S1PR3
prerank,Reactome_2022__Sensory Perception R-HSA-9709957,0.5427257095348201,1.304365505321737,0.08955223880597014,0.38326365056617884,1.0,22/144,9.77%,RIMBP2;SCN1B;SCN9A;EBF1;KCNJ2;CDH23;MYH9;SCN2A;EPS8L2;TRPM4;OR51M1;ITPR3;SYP;AGRN;LDB2;LDLR;OR52N2;PCLO;MYO15A;CTBP2;DNAJC5;EPB41L1
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.7261484884595215,1.3042125187885256,0.15,0.3835566647911118,1.0,9/24,18.09%,PAK3;SHANK3;FYN;DOCK10;SHANK1;ITGA3;PICK1;IGF1R;MTMR2
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),-0.7335069077785389,-1.304203880579992,0.1111111111111111,0.7393327471124288,1.0,3/6,19.42%,MOCS2;NFS1;MOCOS
prerank,Reactome_2022__Molybdenum Cofactor Biosynthesis R-HSA-947581,-0.7335069077785389,-1.304203880579992,0.1111111111111111,0.7393327471124288,1.0,3/6,19.42%,MOCS2;NFS1;MOCOS
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.7044537971071151,-1.304012211640448,0.15,0.7384824192366677,1.0,6/13,11.72%,MT1E;MT1A;MT1G;MT1F;HSF1;MT2A
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),-0.8109488830267186,-1.3038370398790722,0.17391304347826086,0.7342947484044847,1.0,2/5,16.51%,FLAD1;SLC52A1
prerank,Reactome_2022__Vitamin B2 (Riboflavin) Metabolism R-HSA-196843,-0.8109488830267186,-1.3038370398790722,0.17391304347826086,0.7342947484044847,1.0,2/5,16.51%,FLAD1;SLC52A1
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),-0.8109488830267186,-1.3038370398790722,0.17391304347826086,0.7342947484044847,1.0,2/5,16.51%,FLAD1;SLC52A1
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),0.7473434954917326,1.3037887504477235,0.16363636363636364,0.38445589703802946,1.0,2/9,1.48%,MLLT11;DCN
prerank,CellMarker_Augmented_2021__Stem cell:Amniotic Fluid,0.7841504986417145,1.303695457995184,0.15254237288135594,0.38448808651497424,1.0,3/8,6.44%,FLT1;THY1;CD44
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),-0.7950886240402456,-1.3036644874053778,0.18421052631578946,0.73356097615754,1.0,3/7,20.25%,HUS1;CLSPN;RAD17
prerank,CellMarker_Augmented_2021__Bipolar cell:Eye,0.5678138306429283,1.3036585275358232,0.0625,0.38438708336005756,1.0,39/93,19.52%,PDE1C;CNTNAP1;DOK6;C11ORF87;EPHA5;SCN2A;DNM1;KIRREL3;DPYSL2;SYNJ2;GRIA3;MAP1B;GFAP;SHANK1;KIF5A;PNMA2;AK5;FRMPD4;GLIS3;PITPNM2;SLC7A14;HECW1;KIAA1755;FGF2;KATNAL1;FMN2;STX1B;RGS4;ZEB1;SYNM;KIF3C;DKK3;MPRIP;PRKCA;ZC3H12B;DRP2;SPOCK1;MAP1A;DGKI
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.7702506394618256,1.3034073380092974,0.11363636363636363,0.3848517828326129,1.0,3/13,9.86%,TGFBR2;TBX20;TGFB2
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.6608687574588861,1.3033050074965098,0.1016949152542373,0.38481718834467876,1.0,10/27,19.62%,THY1;RHOD;ARHGEF7;SORBS1;ACTN1;FN1;LAMA3;PLEC;ITGB4;BCR
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.677752411150065,1.3032757279702112,0.08333333333333333,0.3847361092187774,1.0,7/23,13.11%,ALDOB;HK2;LDHA;PFKL;PGK1;ENO2;HK1
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.5532512552278869,1.3032456727227506,0.06451612903225806,0.38462191041377713,1.0,32/136,19.09%,RASGRP2;S100A10;RASGRP1;DAB2IP;THY1;EPHA5;RGS6;RAP1GAP;DOCK10;AGRN;MAPRE2;ARHGEF7;SIPA1L1;EPHA4;CDKL5;USP6NL;CCL2;FGD5;PLXNA4;CPEB2;PLXNA1;PLXNA2;NGEF;RGS16;TBC1D10B;VAV2;PKP4;RAP1A;DOCK9;SEMA4D;VAV1;SNX13
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.7131116109754694,1.3030509120183602,0.18032786885245902,0.3850256623365922,1.0,4/17,10.69%,NLGN1;EPS8L2;PLEKHM1;P2RY12
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),0.8110445961432876,1.3029398929349836,0.078125,0.3850374919448451,1.0,1/9,2.21%,BLM
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.7989399420479512,1.3027156693201982,0.125,0.3854339130409825,1.0,3/8,13.63%,DAB2IP;PIP4K2A;WASHC1
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.8575879125514023,1.3026712772759275,0.14035087719298245,0.3853858497350996,1.0,1/6,0.40%,SIX3
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.8375420113445401,1.3026680558051438,0.11764705882352941,0.3851722527921972,1.0,3/6,10.58%,VAPB;GRAMD2A;TLE6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.6845999039028144,1.3024442016425377,0.13333333333333333,0.3856010165349042,1.0,5/18,16.92%,ANXA1;PTPRC;STOML2;CD4;PDE4D
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),0.8420883945720011,1.3023617495409203,0.1346153846153846,0.3855926360397284,1.0,2/6,4.92%,EFNA1;SOX4
prerank,KEGG_2021_Human__Lipid and atherosclerosis,0.5244126871960727,1.302201416005088,0.07692307692307693,0.3857826313293018,1.0,42/150,20.63%,CXCL2;TLR2;ICAM1;IRF7;VLDLR;NFATC2;FAS;TNFRSF1A;MYD88;LDLR;BCL2L1;IKBKE;PPARG;STAT3;CCL2;CAMK2B;BCL2;TNFRSF10B;IL12A;IKBKG;PIK3CD;MAPK11;MAP3K5;TP53;RXRA;VAV2;TAB1;CALM3;MAPK9;ABCG1;MAP2K3;RAP1A;ITPR1;CAMK2A;PRKCA;NFATC3;VAV1;POU2F3;RAP1B;AKT3;TAB2;HSPA4
prerank,CellMarker_Augmented_2021__Platelet:Peripheral Blood,0.7101844126166944,1.3020254312231516,0.1323529411764706,0.38598364620335185,1.0,7/24,5.77%,RASGRP2;TSPAN16;PRSS57;NRGN;NLRP12;ALOX12;TUBB1
prerank,CellMarker_Augmented_2021__Platelet:Plasma,0.7101844126166944,1.3020254312231516,0.1323529411764706,0.38598364620335185,1.0,7/24,5.77%,RASGRP2;TSPAN16;PRSS57;NRGN;NLRP12;ALOX12;TUBB1
prerank,KEGG_2021_Human__ECM-receptor interaction,0.5799044723373702,1.301982571739421,0.06944444444444445,0.38589585596810894,1.0,28/67,15.58%,COL4A1;NPNT;THBS1;ITGA8;COL4A2;RELN;SV2B;FRAS1;LAMB1;ITGA2;CD44;AGRN;ITGA11;LAMA5;ITGA3;ITGA9;COL9A1;LAMA2;ITGB8;COL4A4;GP6;FN1;CHAD;COL4A5;THBS2;SPP1;LAMA3;THBS3
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.6399778597587147,1.3017512318420388,0.11594202898550725,0.38626336929389243,1.0,11/33,16.38%,FA2H;ST8SIA3;B4GALNT1;CERS3;CYP4F22;ST8SIA4;SGMS1;CERS5;ST6GALNAC5;B4GALT6;ST6GALNAC3
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.7569232270555373,1.3017153446262193,0.21666666666666667,0.38612936600961023,1.0,2/7,5.50%,PTPRC;AHR
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),-0.7619396502913438,-1.3016472980765115,0.1282051282051282,0.7408595475597004,1.0,4/10,23.22%,HUS1;CLSPN;RAD17;CHEK2
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),0.7807243412398959,1.3016399657540612,0.15873015873015872,0.3861536667607509,1.0,2/10,2.74%,CCNB2;PRKCB
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.6624482918426706,1.3016119751253914,0.13559322033898305,0.38600012035722686,1.0,11/33,13.02%,IL13RA1;CTSS;CD24;P2RY13;IRF7;PTPRC;KLF3;GFI1B;CAMK2B;KLF6;IL4R
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.8439034329368051,1.3015348306996963,0.12962962962962962,0.38581196221092,1.0,2/8,8.06%,IGF1;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.8439034329368051,1.3015348306996963,0.12962962962962962,0.38581196221092,1.0,2/8,8.06%,IGF1;SLC9A1
prerank,Reactome_2022__Signaling By FGFR4 In Disease R-HSA-5655291,-0.727725797841919,-1.3014611989841556,0.21568627450980393,0.7402127187348412,1.0,1/9,13.52%,NRAS
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),0.787572824366101,1.301322544267843,0.22388059701492538,0.38615854826207785,1.0,3/6,20.30%,PODXL;IQGAP1;MYO1E
prerank,KEGG_2021_Human__beta-Alanine metabolism,0.6693352943937315,1.3012255019606638,0.13432835820895522,0.3861301957914187,1.0,5/22,15.24%,CARNS1;GAD2;CNDP1;ALDH3A2;DPYD
prerank,Reactome_2022__NrCAM Interactions R-HSA-447038,0.8006619192245632,1.3009469316563729,0.10869565217391304,0.3866403901064367,1.0,2/7,3.42%,CNTN2;NRP2
prerank,CellMarker_Augmented_2021__Oligodendrocyte:Undefined,0.8765768051200903,1.3009365707626908,0.12,0.38648052623712525,1.0,2/5,2.18%,MOG;MBP
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.8169072412435056,1.3009055679974453,0.18518518518518517,0.3863274031303462,1.0,3/7,5.08%,UGT8;FA2H;B3GALT2
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.5532167591202323,1.3008061353680316,0.06666666666666667,0.38638424870863514,1.0,22/99,16.45%,ENPP2;SGPP2;VAPB;UGT8;FA2H;ESYT3;B4GALNT1;SPNS2;HACD1;CERS3;B3GALNT1;ABCA2;SERINC1;TEX2;SGMS1;ALDH3A2;ELOVL7;STS;CERS5;ELOVL5;ST6GALNAC3;NEU4
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.5299812516341748,1.3007324616346123,0.0547945205479452,0.38634274398393137,1.0,35/143,14.53%,GPNMB;DCN;SP100;THBS1;SERPINE1;SULF1;FLT1;COL4A2;PRKCB;EPHA2;ISM1;DAB2IP;SERPINF1;APLNR;PAK4;PML;CYP1B1;HK2;CTNNB1;PPP1R16B;CHI3L1;PPARG;CD160;TGFB2;ADAM12;ITGB8;PGK1;SPARC;HIPK1;KLF4;FGF2;GAB1;THBS2;HIPK2;PIK3CD
prerank,Reactome_2022__Cellular Responses To Stress R-HSA-2262752,-0.4463166983461706,-1.3005661301770506,0.0,0.7421575878173264,1.0,74/604,10.43%,H1-2;H2AC20;SOD3;ID1;CDC26;EPX;ATF5;CCNE1;RPL35A;RPS24;COX18;H3-3B;RPL34;TRIM21;H2BC4;SRPRA;RPL39;H2BC21;EXOSC8;PRDX1;LRPPRC;RPL37;H1-4;COX7C;SRPRB;RPS28;AAAS;ELOC;RPL18;RNF2;NUP50;CREB3L4;RPL12;RPL23;RPL31;H2AC6;TRIB3;MRPL18;NR1D1;COX20;MUL1;BLVRA;RPL6;BRIP1;EIF2S1;RPS27L;EXOSC4;RPL41;HSPA1A;RPS13;RPL22;MAPK7;COX7B;RPL29;LY96;RPL30;ATP6V1E2;ATP6V1G1;RPSA;CREB3L1;HSF1;RPL14;CDKN2C;RRAGC;HSPA13;EXOSC5;SERP1;GPX7;NUDT2;RPL15;EEF1A1;RPS2;SLC46A1;COX5B
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7465273514079999,1.3003319774203888,0.11864406779661017,0.387368724317618,1.0,4/13,15.37%,GHR;STAT3;PXN;STAT6
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.8648566690003405,1.3003063443711511,0.09259259259259259,0.3872481705460314,1.0,1/5,5.60%,PLEKHM1
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Germ,0.7975168511811884,1.3002644222509825,0.1568627450980392,0.38718662462119735,1.0,2/10,10.32%,CD24;PODXL
prerank,Reactome_2022__Sema4D In Semaphorin Signaling R-HSA-400685,0.6649562524831787,1.3001738751366516,0.16666666666666666,0.38721013717768066,1.0,4/23,9.78%,MYH9;MYH11;LIMK2;RNASE1
prerank,Reactome_2022__VEGFA-VEGFR2 Pathway R-HSA-4420097,0.5630824773906864,1.300070548228753,0.08695652173913043,0.38729896257037894,1.0,22/77,20.13%,ELMO1;PRKCB;SHC2;WASF1;FYN;BAIAP2;ITPR3;CTNNB1;ARHGEF7;RNASE1;CTNNA1;PRR5;PRKCD;MAPK11;BCAR1;VAV2;ITPR1;NCK2;PRKCA;VAV1;AHCYL1;AKT3
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),-0.777128065558273,-1.2998129010380561,0.13333333333333333,0.7440941276960323,1.0,4/7,21.35%,MGME1;PRIMPOL;DNA2;PARP1
prerank,KEGG_2021_Human__Vascular smooth muscle contraction,0.5379199459923822,1.299730404371394,0.08695652173913043,0.3879754106775786,1.0,20/91,9.59%,ACTA2;CALD1;PRKCB;ADCY5;PRKCG;MYH9;MYH11;KCNMB4;MYLK3;ITPR3;GUCY1A2;ADCY7;CACNA1C;ADCY2;RAMP3;GUCY1A1;PRKCE;PRKCH;GNA12;PPP1CB
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.7581933071685422,-1.2996641439315513,0.11428571428571428,0.743136487783331,1.0,3/9,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.5627738556386914,1.2995924126683285,0.08196721311475409,0.38812897090826853,1.0,22/103,12.85%,CACNA1H;RASGRP2;ANK3;NLGN1;SYT4;DMTN;SYT1;GLRA2;SYT5;CLIC4;HPCA;NEUROD2;ITPKB;ADCY7;SNCA;SYT13;TF;CPNE2;FBP1;SYT12;CDKN1B;B2M
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.6727335902211201,-1.2995707550298334,0.13157894736842105,0.7419887911285471,1.0,4/13,16.10%,SLC25A5;SLC25A4;SLC25A24;SLC19A1
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.6603306968153153,-1.2994743653400214,0.16666666666666666,0.7409751299089782,1.0,1/20,0.65%,CDC26
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.7614049960655641,1.2994256296745093,0.12903225806451613,0.3884193392831966,1.0,1/16,0.01%,LEF1
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),-0.7763149262320463,-1.299425599934996,0.21052631578947367,0.7396113600992292,1.0,6/7,19.24%,ALDH1A1;ADH6;ADH4;ADH5;ALDH2;ACSS1
prerank,Reactome_2022__G-protein Activation R-HSA-202040,0.7624764557280004,1.2991672446406528,0.05660377358490566,0.38889191961178815,1.0,3/15,8.48%,GNG3;GNG2;GNA14
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),0.7747124487666881,1.2989934588374328,0.16666666666666666,0.3891750171125682,1.0,1/7,6.64%,TBX20
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.8076313667018196,1.2989893306551996,0.17391304347826086,0.388969403282343,1.0,2/7,3.80%,SH3GL2;TJP3
prerank,KEGG_2021_Human__C-type lectin receptor signaling pathway,0.5610127490990556,1.2988981571337426,0.12121212121212122,0.3889006936747079,1.0,24/70,23.21%,MAP3K14;NFATC2;ITPR3;MRAS;IKBKE;SYK;PRKCD;RELB;PAK1;IL12A;IKBKG;PIK3CD;MAPK11;CALM3;MAPK9;ITPR1;PLK3;NFATC3;RRAS2;AKT3;PPP3CC;PTPN11;MAPKAPK2;PPP3CB
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.6081120745078853,1.298726105384101,0.03571428571428571,0.3892483556704337,1.0,15/52,21.09%,TLR2;IRAK2;DAB2IP;MAP3K14;BIRC3;TNFRSF1A;NLRC3;RELB;IKBKG;TAB1;PRDX4;TLR3;RPS27A;TAB2;TBK1
prerank,Reactome_2022__RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,0.6509161183517435,1.298565090112857,0.09523809523809523,0.3895436200659137,1.0,5/30,9.78%,WAS;WASF1;BAIAP2;ARPC3;RNASE1
prerank,Reactome_2022__TRAIL Signaling R-HSA-75158,0.8289967495542399,1.2985326518010132,0.08771929824561403,0.389403233729481,1.0,3/6,13.58%,CASP10;TNFRSF10B;FADD
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Undefined,0.6179409414100012,1.2983471963505886,0.14925373134328357,0.3898084729077617,1.0,14/48,12.46%,HLA-DRA;CTSS;ELMO1;PLEK;SLA;GPR34;THY1;MYH11;PTPRC;CIITA;PPP1R16B;FLI1;APOL3;TRIM22
prerank,Reactome_2022__Interleukin-7 Signaling R-HSA-1266695,0.7386633184715093,1.2982594892876225,0.07352941176470588,0.3898498164202622,1.0,2/15,10.27%,IRS2;STAT3
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),0.8133894374956294,1.2982225757445511,0.08823529411764706,0.3897159808181948,1.0,1/8,2.21%,BLM
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.7055535431600587,1.298143718503347,0.08928571428571429,0.38974436426679865,1.0,4/20,4.94%,ANXA1;THBS1;XKR4;XKR6
prerank,Reactome_2022__Signaling By VEGF R-HSA-194138,0.563462711261474,1.2981138454519126,0.07246376811594203,0.3895718623290257,1.0,25/84,20.24%,ELMO1;FLT1;PRKCB;SHC2;NRP2;WASF1;FYN;BAIAP2;ITPR3;CTNNB1;ARHGEF7;RNASE1;CTNNA1;PRR5;PRKCD;MAPK11;BCAR1;VAV2;ITPR1;NCK2;PRKCA;VAV1;AHCYL1;AKT3;VEGFD
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),0.7759934865741345,1.2980461719724454,0.1864406779661017,0.38950963714992576,1.0,3/6,15.82%,RNF112;PRKCD;XRCC1
prerank,Reactome_2022__SARS-CoV-2 Targets Host Intracellular Signaling And Regulatory Pathways R-HSA-9755779,0.7273275021166572,1.2977647882763517,0.12727272727272726,0.390178807845459,1.0,2/11,8.34%,YWHAH;YWHAG
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.48168058070742015,1.2975317620588767,0.012195121951219513,0.39061437277704053,1.0,42/345,12.96%,LEF1;HPN;ANXA1;IGF1;KIF14;PLK2;THBS1;PIM3;PRKCG;RPS6KA1;PIM1;FOXO1;NUAK2;PRAME;AGAP2;ALOX12;FAS;BIRC3;CD44;SNCA;SCX;MYD88;MAG;NAA38;CTNNB1;BAG3;THOC6;BCL2L1;DHCR24;YAP1;PRKCH;HIPK3;GAS6;VSTM2L;NR4A2;PDK4;BARD1;CCL2;PRKCD;BCL2;KLF4;PDPN
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.6250568574991386,1.2974868998304905,0.13333333333333333,0.3902822827262821,1.0,7/38,14.71%,SP100;IRF7;SAMHD1;MYD88;TYK2;MX1;HLA-E
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.6250568574991386,1.2974868998304905,0.13333333333333333,0.3902822827262821,1.0,7/38,14.71%,SP100;IRF7;SAMHD1;MYD88;TYK2;MX1;HLA-E
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.6720153795164263,-1.2974174421169422,0.14,0.7462268397314006,1.0,6/15,15.01%,TRMT61A;TRMT10C;METTL8;METTL3;TRMT61B;VIRMA
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.8535587638587001,1.297337915589184,0.13725490196078433,0.39045876233423754,1.0,1/5,4.82%,PLSCR1
prerank,Reactome_2022__RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.6235328087657365,-1.2972120138382648,0.16279069767441862,0.7455475204691562,1.0,10/26,23.13%,POLR2K;POLR3E;POLR3B;POLR3F;BDP1;POLR3H;POLR3K;POLR2L;POLR2E;GTF3C6
prerank,KEGG_2021_Human__Gastric cancer,0.5615583306601544,1.2971313809036895,0.07246376811594203,0.3909900097717336,1.0,21/115,13.84%,LEF1;TGFBR2;MET;EGF;SHC2;ABCB1;WNT8B;DVL1;CTNNB1;SMAD3;TGFB2;CTNNA1;GADD45A;CDKN1B;FRAT2;BCL2;CDKN1A;CCND1;FGF2;GAB1;RPS6KB2
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.48555295861534853,1.2969677985600527,0.012658227848101266,0.3912046009610322,1.0,79/391,15.53%,MET;PTP4A3;BOK;TLR2;IGF1;PDGFRA;EGF;DCN;PLK2;THBS1;NLGN1;RIT2;FLT1;PRKCB;TRAF3IP2;RELN;IRS2;SEPTIN4;APP;DAB2IP;NOD1;NLRP12;NOS1AP;TGFA;PTPRC;MAP3K14;FYN;TRIM5;SMCR8;NTRK3;NRG1;BIRC3;TNFRSF1A;NEUROD2;CASP10;RAMP3;NRG2;PDGFA;SHISA5;MYD88;UNC5CL;BCL2L1;CHI3L1;KITLG;GAB2;IKBKE;TGFB2;DLG5;BBC3;P2RY12;GFRAL;TERF2IP;GAS6;APOL3;TNFRSF19;LURAP1;HLA-DRB1;TRIM22;BCL2;CGAS;BRD4;FN1;FGF2;TNFRSF10B;FADD;GAB1;LPAR1;TNIP2;TRIM32;IQGAP1;GPR37;IKBKG;PIK3CD;NEK6;PUM1;CD4;THPO;TP53;PINK1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.5315462957351847,1.2965118714239352,0.028169014084507043,0.39227636699562995,1.0,26/138,11.97%,CCK;SIX3;MET;IL1RAPL1;HES7;RELN;WNT8B;ANOS1;LHX6;NEUROD2;MAP1B;CDK6;CTNNB1;PTPRD;MYT1L;YAP1;TGFB2;CDKL5;DNER;DCX;MAPT;ASTN2;FGF13;NR4A2;OPHN1;RNF112
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.6577956653980741,1.2964903176354161,0.10606060606060606,0.3921227458892168,1.0,10/32,22.15%,PRKCB;PID1;SIK2;PIP4K2A;SORBS1;PRKCD;TSC2;PTPRE;GRB10;PTPN11
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),0.6967665242025626,1.2964145372184865,0.1016949152542373,0.39212384480166634,1.0,6/20,11.20%,KIF14;STMN2;STMN4;TPPP;MAPT;FGF13
prerank,Reactome_2022__Interleukin-6 Signaling R-HSA-1059683,0.7773626963576131,1.296359741604233,0.11290322580645161,0.39211850651396013,1.0,3/10,11.45%,SOCS3;STAT3;TYK2
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),0.7467048138323861,1.2962857139313015,0.171875,0.3921067417428574,1.0,5/9,17.50%,ECE1;SNCA;RAMP3;INPP5F;SCRIB
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.7658922422418565,1.2962726301731637,0.12280701754385964,0.3919342690062229,1.0,4/11,9.67%,STMN2;SNCA;ARHGEF7;EML2
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.8184971508264658,1.2962484769903113,0.125,0.39177483803499025,1.0,2/6,6.49%,CPLX2;NEUROD2
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.7911629052181173,1.2959979049635322,0.18518518518518517,0.3921935382720501,1.0,2/11,6.79%,IGF1;GHR
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.7541408394386392,-1.295958330309251,0.1702127659574468,0.7494012513228168,1.0,1/7,0.12%,DAO
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.8401425355334797,1.2957207122423486,0.14545454545454545,0.3927401380620683,1.0,2/5,12.93%,YAP1;PAK1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.6460583215277568,1.295509085874169,0.12121212121212122,0.3931065238012046,1.0,8/28,9.00%,PTPRO;DUSP1;PTPRB;DUSP10;DUSP8;DUSP16;DUSP22;PTPN9
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.5592594851472059,1.2954861623397635,0.06557377049180328,0.39295961930585777,1.0,19/86,13.18%,TGFBR2;FLRT3;PKP2;FGF12;SOX4;NTRK3;ECE1;CACNA1C;APLNR;ZFPM2;SH3PXD2B;PDLIM4;TGFB2;GLI2;HDAC9;CDKN1B;FN1;SMYD4;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),0.654790948590299,1.295450788437585,0.07017543859649122,0.39281287722565233,1.0,9/37,13.58%,HLA-DRA;IL15;PTPRC;PLSCR1;SKAP1;TGFB2;HLA-DRB1;STX4;FADD
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.6502094160041814,1.2954417773417322,0.1044776119402985,0.3926342774028399,1.0,5/24,9.70%,NLGN1;PLPPR5;AGRN;NEURL1;FSCN1
prerank,Reactome_2022__APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.5235360275429991,-1.2954377511600024,0.15625,0.7501078487825373,1.0,11/61,20.20%,CDC26;PSMD10;ANAPC15;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,CellMarker_Augmented_2021__Transitional B cell:Blood,0.6561310557507527,1.2954001298084445,0.12962962962962962,0.39257108276691355,1.0,4/25,1.87%,HLA-DRA;CTSS;TC2N;CD24
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),-0.8537554508059402,-1.295298505068575,0.13157894736842105,0.7493290148203023,1.0,2/5,5.98%,SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),0.6679352599632672,1.2949956697343799,0.109375,0.39348028809619645,1.0,9/28,19.55%,IGF1;APP;PID1;MLXIPL;PFKFB3;PINK1;P2RX7;HIF1A;ARNT
prerank,Reactome_2022__Mitochondrial Iron-Sulfur Cluster Biogenesis R-HSA-1362409,-0.7235072093650076,-1.2945932687078072,0.18421052631578946,0.7509554093147884,1.0,5/11,13.71%,SLC25A37;SLC25A28;ISCU;ISCA2;NFS1
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6840602867702261,1.294070987952747,0.15384615384615385,0.39583978791594654,1.0,6/14,26.40%,PPARG;CDKN1B;CDKN1A;APLN;TAFA5;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),0.7927390409525862,1.2937331424258616,0.13725490196078433,0.396541713474119,1.0,3/12,10.89%,IGF1;IRS2;SORBS1
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),0.7894259344870982,1.293584931601552,0.21428571428571427,0.396776663040009,1.0,5/9,16.81%,TYMS;MTHFD2;SHMT1;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.6814811910071444,-1.2935826315912844,0.11904761904761904,0.7531782017212154,1.0,5/14,7.01%,MT1E;MT1A;ZNF658;MT1G;MT1F
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.626147854784916,1.293537835230086,0.1267605633802817,0.39671136134876467,1.0,11/41,16.11%,BOK;EPHA2;HIC1;PML;BCL2L1;IKBKE;BCL2;HIPK1;HIPK2;TP53;BRCA1
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.6340743149236748,1.293509380488049,0.10144927536231885,0.39663337292338197,1.0,7/41,2.58%,CXCL2;TLR2;CTSS;CD24;P2RY13;MYO1F;PLEK
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.6047509767936753,1.2934878159210585,0.1206896551724138,0.3964662091303805,1.0,10/54,13.78%,MET;RIT2;EPS8L2;ARHGEF3;SYNPO2L;ITGA3;OPHN1;KCTD13;STARD13;LPAR1
prerank,Reactome_2022__Acetylcholine Regulates Insulin Secretion R-HSA-399997,0.8110286286619146,1.2934605691912224,0.10416666666666667,0.3963438351807968,1.0,2/8,8.48%,CHRM3;GNA14
prerank,Reactome_2022__Insulin Receptor Signaling Cascade R-HSA-74751,-0.6360183190873927,-1.293313680347459,0.17647058823529413,0.7529522574601896,1.0,4/36,5.54%,FGF6;FLT3;THEM4;TRIB3
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.551751290936001,1.293280383739825,0.09230769230769231,0.39661646075130164,1.0,23/100,18.27%,RASGRP2;S100A10;RASGRP1;THY1;RGS6;RAP1GAP;DOCK10;AGRN;MAPRE2;ARHGEF7;CDKL5;USP6NL;CCL2;MTCL1;PINK1;RGS16;PKP4;CD200;CALM3;RCN3;RAP1A;DOCK9;SEMA4D
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.5559145443593018,1.2932610060991414,0.04918032786885246,0.3964495816389981,1.0,34/109,14.24%,COL4A1;CSPG4;PRRX1;PDGFRA;PCDH18;DCN;CALD1;SULF1;COL4A2;NRP2;THY1;PODN;ANGPTL2;POSTN;SLIT3;COL12A1;FAP;IGFBP7;C1R;BOC;EMP1;CTNNB1;BGN;MMP14;PBX3;COL9A1;LAMA2;CRTAC1;SPARC;FN1;CHAD;HMCN1;COL5A1;THBS2
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.7264740370437799,1.2929376860847448,0.11290322580645161,0.3972117085135098,1.0,4/18,6.65%,SEMA3C;SEMA5B;SEMA3D;SEMA3B
prerank,Reactome_2022__Glycerophospholipid Biosynthesis R-HSA-1483206,0.5392525155758353,1.2928633147072133,0.06349206349206349,0.3972163603398624,1.0,23/102,17.43%,LIPH;LPCAT4;ACHE;PLAAT4;MFSD2A;AGPAT4;PLAAT3;PLD2;CHKB;PITPNM3;PITPNM2;DGAT2L6;DGAT1;PLAAT5;CDS2;PLB1;PNPLA8;SLC44A3;CPNE7;PLAAT1;LPIN3;SH2D3C;PITPNM1
prerank,CellMarker_Augmented_2021__Granulocyte:Peripheral Blood,0.7913227667054599,1.2927527280125264,0.21428571428571427,0.39739894214796445,1.0,2/8,6.44%,PTPRC;CD44
prerank,Reactome_2022__Deadenylation-dependent mRNA Decay R-HSA-429914,-0.5715589075738765,-1.29259874463704,0.08571428571428572,0.7545293233266888,1.0,14/52,20.26%,LSM7;EXOSC8;LSM3;LSM2;EXOSC4;LSM5;EXOSC5;LSM4;CNOT7;CNOT1;LSM1;CNOT9;PATL1;DIS3
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.7775994252461322,1.2924902098783324,0.20689655172413793,0.39789253963799504,1.0,4/8,11.20%,GABRB2;GABRA1;GABRG2;FGF13
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7918677129605672,1.2923286539274077,0.11538461538461539,0.39809994261570764,1.0,3/10,8.31%,BOK;FAP;BCL2L1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.6199291773617157,1.2922480544418151,0.12307692307692308,0.3980279654123517,1.0,9/48,11.36%,CCK;RELN;MAP1B;CDKL5;DNER;DCX;ASTN2;FGF13;NR4A2
prerank,CellMarker_Augmented_2021__8-Cell Stage Cell (Blastomere):Embryo,-0.6762661523429659,-1.2921372688465351,0.17142857142857143,0.7553426434568441,1.0,3/14,11.73%,LBHD1;SNU13;C19ORF53
prerank,Reactome_2022__RAF-independent MAPK1/3 Activation R-HSA-112409,0.6999041066190935,1.2921021647517248,0.1935483870967742,0.39827945381996643,1.0,4/17,11.45%,DUSP10;DUSP8;DUSP16;TYK2
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),0.6746780591894412,1.2920695372704523,0.1694915254237288,0.39813774520435685,1.0,6/17,21.09%,IRF7;NLRC3;IFIH1;PTPRS;TLR3;TBK1
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),0.6715565974691717,1.2920215034354214,0.140625,0.3978358007490668,1.0,7/19,19.55%,IGF1;APP;MLXIPL;PFKFB3;P2RX7;HIF1A;ARNT
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),0.6715565974691717,1.2920215034354214,0.140625,0.3978358007490668,1.0,7/19,19.55%,IGF1;APP;MLXIPL;PFKFB3;P2RX7;HIF1A;ARNT
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),-0.7038921708321002,-1.2920055242722477,0.18604651162790697,0.754295029471707,1.0,1/9,1.20%,GALNT3
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.5940904547694225,1.2917449327307158,0.12244897959183673,0.3984285069473191,1.0,11/47,11.71%,ANXA1;IRAK2;APP;DAB2IP;IL1R1;MYLK3;SNCA;MYD88;CHI3L1;HDAC4;CCL2
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),-0.6215491331889644,-1.2915824980358634,0.20930232558139536,0.7546341838129171,1.0,3/19,10.46%,ATF5;VPS4B;CEP131
prerank,KEGG_2021_Human__Protein export,-0.6414416377219807,-1.291457654988303,0.21951219512195122,0.753451269763147,1.0,12/23,27.95%,SRPRA;SRPRB;SPCS1;SPCS2;OXA1L;SRP14;SEC62;SEC61A1;SRP54;SRP9;SEC63;SRP72
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.5452997775102022,1.2914304204500369,0.04838709677419355,0.3992165987303694,1.0,23/92,16.32%,DMTN;EPHA5;PAK3;CLIC4;BAIAP2;FAM107A;RHOD;NEXN;PDGFA;TRIM36;FSCN1;TPPP;MAPT;PHLDB2;ARHGAP18;PRKCD;PAK1;IQGAP1;ARHGAP17;RHOBTB2;CAMSAP3;P2RX7;BST1
prerank,Reactome_2022__Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,0.5877541964466036,1.2913272480104052,0.10526315789473684,0.3992011689540642,1.0,10/46,11.16%,NDST4;CSPG4;DCN;AGRN;BGN;HS6ST1;HS3ST4;HS3ST3B1;HS3ST3A1;B4GALT7
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),0.7880169971967665,1.29124769248489,0.16363636363636364,0.3991731225348388,1.0,1/7,0.15%,NR4A3
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.5591755588243245,1.291052327273022,0.12857142857142856,0.3994292046980485,1.0,19/80,12.96%,COL4A1;PCDH18;CALD1;COL4A2;FBLIM1;EPHA2;SLIT2;NRP2;PTPN21;ADGRL2;CNN3;YAP1;PDLIM4;LOXL1;GLI2;P3H2;ENAH;CD276;PDPN
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.8177306531812012,1.2907770905845746,0.1724137931034483,0.40008883863787625,1.0,2/8,11.60%,SLC9A1;PDK4
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),0.8047485550963973,1.2905190795933303,0.22413793103448276,0.4005018044305563,1.0,2/7,3.51%,ICAM1;THY1
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),-0.7756412493049285,-1.290495815052577,0.2,0.7559966615897299,1.0,5/7,21.42%,NT5E;AMPD3;PRTFDC1;PNP;NT5C1A
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.6354658692529367,1.290185451945366,0.11666666666666667,0.4011538347448984,1.0,6/29,9.70%,DMTN;EPHA2;SLIT2;WAS;CLRN1;FSCN1
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.7961363371075055,1.2901033683728413,0.16666666666666666,0.4011059046122695,1.0,6/6,20.41%,PLSCR1;PLSCR2;ANO7;P2RX7;PLSCR4;ANO6
prerank,Reactome_2022__Signaling To ERKs R-HSA-187687,-0.5925984023327172,-1.2900102113651257,0.11428571428571428,0.7564707332637691,1.0,1/32,0.09%,NGF
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.6168815698828195,1.2898417015407666,0.07272727272727272,0.40159949486566315,1.0,15/37,18.06%,ANXA1;IL15;THY1;PTPRC;CYRIB;CCL2;CD276;SLC7A1;CD70;PDCD1LG2;ZMIZ1;ZBTB1;TFRC;NCK2;TNFSF4
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.6965133768890099,1.2897428968997642,0.125,0.4016394729823969,1.0,7/20,8.95%,CSPG4;DCN;CHSY3;CHST15;CHPF2;UGDH;BGN
prerank,Reactome_2022__Synthesis Of PIPs At Late Endosome Membrane R-HSA-1660517,0.7467900856227287,1.2895907727599802,0.1896551724137931,0.4018492191048139,1.0,1/11,0.23%,MTMR7
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.6394549934015078,1.289587982710522,0.08620689655172414,0.4016312965348005,1.0,14/32,17.98%,CDC42EP3;BAIAP2L1;BAIAP2;CDC42EP1;PRKCE;FCHSD1;ARF6;SPIRE1;BIN1;PFN2;SPIRE2;VASP;CRACD;NCK2
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.6771860698381608,-1.2895384889784454,0.21621621621621623,0.7570986620901772,1.0,4/14,14.69%,FBXO5;RPL23;RPL11;BAG2
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),-0.7058572107161353,-1.2892855398795753,0.23255813953488372,0.7569154965401058,1.0,1/8,1.61%,SELENOS
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.736563678057949,1.2889561587948422,0.10909090909090909,0.4033988779953481,1.0,5/14,9.24%,TMEM204;SULF1;SLIT2;ITGA3;LRIT3
prerank,CellMarker_Augmented_2021__Lymphoid cell:Blood,0.5991653498797468,1.28873269631967,0.06349206349206349,0.4037140746869792,1.0,9/59,5.37%,IPCEF1;RASGRP2;SAMD3;ELMO1;SLA;PRKCB;NELL2;FYN;GNG2
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),0.6258065750274956,1.2885471821738643,0.125,0.40402893007195984,1.0,8/42,7.26%,IGF1;GRIN2A;ICAM1;APP;NOD1;FYN;GRM5;GRIN1
prerank,CellMarker_Augmented_2021__Myeloid cell:Blood,0.6585498903935312,1.28834065665605,0.13432835820895522,0.40433090011598727,1.0,9/30,13.27%,RASGRP2;NRGN;NLRP12;CD37;ALOX12;TUBB1;GFI1B;GP6;MFSD2B
prerank,Reactome_2022__FGFR1c Ligand Binding And Activation R-HSA-190373,-0.772453585890729,-1.2883318769097216,0.11363636363636363,0.7597122831391016,1.0,1/7,0.15%,FGF6
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.6017664529416077,1.288326770915429,0.1206896551724138,0.4041373002774299,1.0,12/43,16.32%,TGFBR2;THBS1;PID1;SNCA;CYP1B1;NOXA1;GADD45A;CDKN1A;TP53;PINK1;BRCA1;BST1
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.6726165399353088,1.2882413225371823,0.11538461538461539,0.4042571854023693,1.0,3/21,2.91%,MET;TMEFF2;WAS
prerank,Reactome_2022__SHC-related Events Triggered By IGF1R R-HSA-2428933,0.8063305030899802,1.2882367921513889,0.13114754098360656,0.40404504818694703,1.0,1/7,0.90%,IGF1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.5423548047338008,-1.28819492432227,0.15151515151515152,0.7586573704081352,1.0,16/63,20.34%,KPNA2;POLR2K;NT5E;METTL3;DNASE1L1;POLR2C;DNASE2;GTF2F1;POLR2D;RBMX;DNA2;GTF2F2;LSM1;DDX24;POLR2L;POLR2G
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),0.822319027700239,1.288130322376192,0.18181818181818182,0.4041898886469102,1.0,3/7,8.72%,ITGA8;ITGA2;ITGA3
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),0.9081620743743133,1.2877816680322955,0.01818181818181818,0.4049913865720342,1.0,3/5,5.57%,SLIT2;SLIT3;PADI2
prerank,KEGG_2021_Human__Ras signaling pathway,0.5070000163640102,1.2877625142134703,0.06944444444444445,0.4048479685619468,1.0,29/169,9.27%,MET;RASGRP2;IGF1;GRIN2A;PDGFRA;EGF;GNG3;PLD1;RAPGEF5;RASGRP1;GRIN2B;FLT1;PRKCB;EPHA2;SHC2;PRKCG;EFNA1;TGFA;PAK3;GNG2;PAK4;GRIN1;PDGFA;MRAS;BCL2L1;PLAAT3;KITLG;PLD2;GAB2
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex1:Brain,0.757094588538365,1.2876819878967047,0.10526315789473684,0.4048234290583183,1.0,3/13,8.02%,CDH9;PCDH8;NECAB2
prerank,CellMarker_Augmented_2021__Fibroblast:Undefined,0.7336538119105781,1.2876228356939585,0.10714285714285714,0.40478642548124993,1.0,5/17,6.44%,PDGFRA;THY1;IL1R1;PTPRC;CD44
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.6817880593889347,1.2876198940869594,0.13846153846153847,0.40457468868759056,1.0,7/21,16.31%,SLIT2;TMSB10;SSH2;CYRIB;PRKCD;PFN4;PFN2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.7582811991315963,1.287483928743401,0.13793103448275862,0.4047874002524804,1.0,3/8,12.03%,HECW2;PRKCE;HECW1
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.6794394258842016,1.2872748292085618,0.15384615384615385,0.4051557624727043,1.0,4/20,7.18%,HTR2C;PTPRC;ITPR3;RYR2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.6552196673646085,1.287236518690257,0.15384615384615385,0.40505010969385075,1.0,9/23,19.15%,STMN2;STMN4;MAPRE2;MAP1B;MAPT;CAMSAP3;STMN1;SKA2;MAP1A
prerank,Reactome_2022__Activation Of BAD And Translocation To Mitochondria R-HSA-111447,0.6673936227187837,1.287014705638146,0.12727272727272726,0.4055362759761807,1.0,7/14,22.88%,YWHAH;YWHAG;BCL2;YWHAE;AKT3;PPP3CC;YWHAQ
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),0.7710008020255813,1.2868811908998086,0.1746031746031746,0.40556748527277436,1.0,3/8,5.16%,HLA-DRA;DUSP10;BCL6
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.7378023179594501,1.286821683336991,0.14545454545454545,0.40548666879781764,1.0,3/10,13.49%,ITPKC;ITPKB;FGF2
prerank,Reactome_2022__Purine Ribonucleoside Monophosphate Biosynthesis R-HSA-73817,-0.7605669775301542,-1.2867902468629122,0.21875,0.7630000184655965,1.0,3/9,12.51%,ADSS2;GART;PAICS
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.643646314051748,1.2867018198752636,0.14285714285714285,0.40567955104486036,1.0,8/19,23.66%,ABCA5;PRKCH;PPARG;MAPK9;ABCG1;CSF1;ITGAV;MSR1
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Fetal Liver,0.8676936197987822,1.2865710327357163,0.11764705882352941,0.40581629036354017,1.0,2/6,4.31%,THY1;PTPRC
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.6171980188023324,1.28655042118187,0.0784313725490196,0.40566092900565964,1.0,11/33,14.07%,CACNA1H;SLC7A2;ABCC8;TRPM4;ABCC9;ATP1B1;SFXN3;SLC25A29;SLC29A4;MFSD12;SLC7A1
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.7640178950655245,-1.286425851434746,0.2,0.7615514978412,1.0,1/8,6.51%,SCPEP1
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.7640178950655245,-1.286425851434746,0.2,0.7615514978412,1.0,1/8,6.51%,SCPEP1
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.5184510475167382,-1.2862811049019673,0.075,0.76068571937761,1.0,8/59,6.23%,DAO;SOD3;OSGIN1;C6;APOE;SERPINF2;PPIC;ADH6
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.8070929655401483,1.2861722244902145,0.14814814814814814,0.4065239219414445,1.0,1/6,2.37%,P4HA2
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.7348664743860086,1.2860334325893235,0.16071428571428573,0.40674065644570956,1.0,3/14,9.30%,C3;VSTM2A;IKBKE
prerank,Reactome_2022__G0 And Early G1 R-HSA-1538133,-0.6164600116131366,-1.2859632947877735,0.16666666666666666,0.7604365830617656,1.0,1/19,1.41%,CCNE1
prerank,Reactome_2022__Signaling By FGFR In Disease R-HSA-1226099,-0.5827191340021296,-1.28579766131658,0.18181818181818182,0.759515352664881,1.0,7/50,14.76%,FGF6;POLR2K;POLR2C;GTF2F1;ERLIN2;NRAS;POLR2D
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),0.7295434181889427,1.2856972085829144,0.16129032258064516,0.4073292681625707,1.0,7/13,16.38%,ST8SIA3;B4GALNT1;ST8SIA4;B4GALT5;ST6GALNAC5;B4GALT6;ST6GALNAC3
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.8155962086866736,1.285617162922394,0.19672131147540983,0.40728500309422894,1.0,1/5,1.65%,SH3GL2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.6232412413457857,1.2855206667134549,0.13559322033898305,0.40725317572201136,1.0,9/40,19.96%,ANXA1;STAT4;EIF2B2;STAT3;EIF2B5;STAT6;GNAI1;TGFBR3;SORT1
prerank,KEGG_2021_Human__Bacterial invasion of epithelial cells,0.5826160449930816,1.2854127743730808,0.08064516129032258,0.40732045243592513,1.0,17/70,14.91%,MET;ELMO1;ARPC5L;SHC2;WASF1;SEPTIN8;SEPTIN9;DNM1;CLTB;CTNNB1;ARPC3;CTNNA1;PXN;FN1;GAB1;PIK3CD;BCAR1
prerank,Reactome_2022__mRNA Decay By 3 To 5 Exoribonuclease R-HSA-429958,-0.7030559264604278,-1.2854010524506863,0.1956521739130435,0.7594222429403771,1.0,3/14,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,CellMarker_Augmented_2021__Lymphoblast:Fetal Liver,0.7879974826230581,1.2852741187646877,0.16393442622950818,0.40755474881736686,1.0,1/9,0.01%,LEF1
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.7608635824442465,1.2851980318432246,0.19672131147540983,0.4075413842708489,1.0,2/10,10.41%,ANK3;SYK
prerank,Reactome_2022__Dissolution Of Fibrin Clot R-HSA-75205,0.799838738641905,1.2851956461158702,0.18867924528301888,0.40733021083905424,1.0,2/8,1.69%,S100A10;SERPINE1
prerank,Reactome_2022__N-Glycan Antennae Elongation R-HSA-975577,0.7390352603118662,1.285155334956778,0.19148936170212766,0.40723665741809345,1.0,7/14,20.58%,ST6GAL1;ST8SIA3;MGAT5;B4GALT5;B4GALT6;B4GALT3;MGAT4A
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.8837051220022086,1.2851229888217215,0.10526315789473684,0.40709997597861974,1.0,4/5,10.32%,PLD1;RAP1GAP;FSCN1;PODXL
prerank,Reactome_2022__Chk1/Chk2(Cds1) Mediated Inactivation Of Cyclin B:Cdk1 Complex R-HSA-75035,0.7484778945712046,1.2851074047367834,0.14285714285714285,0.40691406331743796,1.0,4/12,17.86%,YWHAH;YWHAG;CCNB1;YWHAE
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.7779904209066211,1.2850259178711703,0.16923076923076924,0.40690724411838586,1.0,4/14,5.44%,FLRT3;GAP43;RTN4RL1;APOD
prerank,Reactome_2022__Interleukin-23 Signaling R-HSA-9020933,0.8312171896211504,1.2849169726965386,0.15789473684210525,0.40688130296423836,1.0,3/6,11.45%,STAT4;STAT3;TYK2
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.8312171896211504,1.2849169726965386,0.15789473684210525,0.40688130296423836,1.0,3/6,11.45%,STAT4;STAT3;TYK2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.7750052609571795,1.284861797605844,0.1111111111111111,0.4069361018387828,1.0,1/11,0.42%,MET
prerank,Reactome_2022__Nitric Oxide Stimulates Guanylate Cyclase R-HSA-392154,0.7202214016795786,1.2848521251961234,0.21568627450980393,0.4067507698666323,1.0,12/17,20.78%,KCNMB4;PRKG2;PDE1A;GUCY1A2;GUCY1A1;PDE1B;GUCY1B1;PDE10A;KCNMA1;ITPR1;IRAG1;PDE2A
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.7254064219079489,1.2848100240556166,0.1016949152542373,0.40662715905186103,1.0,2/14,3.17%,C3;APP
prerank,Reactome_2022__Signaling By Rho GTPases R-HSA-194315,0.46673585819886043,1.2847232917587832,0.011494252873563218,0.4066328121174092,1.0,111/538,18.29%,ANLN;VRK2;ARHGAP4;KIF14;NHS;YWHAH;STMN2;VAPB;ARHGAP39;STEAP3;CDC42EP3;PRKCB;EPHA2;WAS;PLEKHG6;SLITRK5;LMNB1;MAP3K11;MYH9;ERBIN;MYH11;INCENP;BAIAP2L1;ARHGEF17;ARHGDIG;MCAM;WASF1;ARHGEF3;BAIAP2;DOCK10;RHPN1;CENPP;RHOD;CDC42EP1;TPM4;PAK4;OBSCN;DAAM1;ERCC6L;MCF2;CTNNB1;KIF5A;YWHAG;TRIP10;KALRN;ARHGEF10L;LIMK2;BASP1;ARHGAP26;PLD2;ARPC3;PDZD2;ARHGEF7;PPP1CB;RNASE1;DLG5;KCTD3;NOXA1;HMOX2;TRIO;ACTN1;CTNNA1;PLEKHG2;OPHN1;DOCK4;KCTD13;FGD5;STARD13;ARHGAP18;PRKCD;CDKN1B;CENPH;FMNL3;KLC1;RANGAP1;STOM;MYO9A;TEX2;GPS1;TUBA1B;IQGAP1;ALDH3A2;ARHGAP17;RHOBTB2;PLXNA1;MAPK11;MRTFA;PLEKHG4B;UBXN11;ARHGAP22;NGEF;VAV2;WIPF3;PKP4;PFN2;NISCH;PPP1R14A;FMNL1;MCF2L;DYNC1LI2;SKA2;SCRIB;ARHGEF40;TFRC;DOCK9;RHOQ;YWHAE;NCK2;AMIGO2;CKAP5;FLNA
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.565387991162328,1.284466270991197,0.07272727272727272,0.4070686733853845,1.0,17/61,14.91%,FYB1;PLEK;ZYX;TEC;THY1;MYH9;ERBIN;NEDD9;ITGA2;ITGA11;LAMA5;SYK;ITGB8;ADAM11;FN1;LAMA3;BCAR1
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.5367108647464205,-1.2844349883644925,0.05555555555555555,0.7618130175878463,1.0,6/39,11.81%,SLC25A5;CEBPA;SNRK;SLC25A38;RUNX1;UFL1
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),-0.6676097975007791,-1.2844134154990041,0.2,0.7603015439206465,1.0,3/12,9.23%,IDO1;ACMSD;TDO2
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.6320958629918378,1.2843550315960672,0.14705882352941177,0.4071109424432329,1.0,8/31,16.86%,CLDN16;LSR;PARD3;POF1B;CLDN18;CLDN20;PATJ;MICALL2
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,0.691929968833631,1.284189722039633,0.11666666666666667,0.40740488239502914,1.0,3/18,8.48%,GNG3;GNG2;GNA14
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),-0.7723203349202522,-1.2836846072567496,0.16666666666666666,0.7617553026336338,1.0,1/6,2.46%,TRIM21
prerank,Reactome_2022__CaM Pathway R-HSA-111997,0.6304731970578242,1.2833018454556553,0.09230769230769231,0.4097725320364866,1.0,11/31,12.29%,PDE1C;ADCY5;PRKCG;PRKAR1B;PDE1A;ADCY7;ADCY2;GRK2;PDE1B;CAMK2B;PRKCD
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.6031258641726427,1.2832772782106043,0.16393442622950818,0.4096538477309083,1.0,4/37,3.84%,IGF1;EGF;DUSP1;TGFA
prerank,CellMarker_Augmented_2021__PDX1+ Pancreatic Progenitor cell:Embryonic Stem Cell,0.6215123244798352,1.2830593960064847,0.12698412698412698,0.4100992182835787,1.0,10/39,8.19%,NPNT;PKP2;CD24;FA2H;LSR;TJP3;BAIAP2L1;EPB41L4B;CKMT1B;HOOK1
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),0.7626042543392203,1.2827610633521223,0.10344827586206896,0.41091170365561747,1.0,3/11,13.90%,IRAK2;MYD88;TNIP2
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.5334927823405514,1.2825485914858137,0.1111111111111111,0.4113743087576473,1.0,23/79,12.01%,HLA-DRA;C3;IL15;CD22;NPDC1;ICAM1;SFTPD;COLEC12;IRF7;PLSCR1;BCL6;AHR;SAMHD1;BIRC3;ADCY7;CD160;TGFB2;SYK;PIANP;HLA-DRB1;CD276;PILRA;ITGAL
prerank,Reactome_2022__AKT Phosphorylates Targets In Nucleus R-HSA-198693,0.7234888521567554,1.2823927019200734,0.18032786885245902,0.4115610272732374,1.0,3/10,6.87%,NR4A1;FOXO1;FOXO3
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),-0.8129819839144226,-1.2823392906635331,0.22916666666666666,0.764494295898593,1.0,6/7,18.10%,CEL;APOE;SCARF1;CYP46A1;MT3;SNX17
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),-0.8129819839144226,-1.2823392906635331,0.22916666666666666,0.764494295898593,1.0,6/7,18.10%,CEL;APOE;SCARF1;CYP46A1;MT3;SNX17
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.814581707404962,1.2823186515994134,0.14285714285714285,0.41155181342681285,1.0,1/10,1.03%,TTLL7
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.8077901540610816,1.2821540668481233,0.1724137931034483,0.41180548988254745,1.0,2/6,10.74%,PTPRD;TRIO
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.8859543820775059,1.2818147362733152,0.08620689655172414,0.41258438289995336,1.0,1/5,2.72%,TIMP2
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.6896195921232009,1.2817462717679668,0.15384615384615385,0.41258685856102306,1.0,8/21,12.22%,GRIN3A;NLGN1;SHANK3;SHANK1;NEURL1;DLG5;ARF6;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.8273663445984242,1.2816519898018564,0.1320754716981132,0.41261374699055053,1.0,2/7,7.51%,SERPINE1;CYP1B1
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),-0.8171305190323127,-1.2814543613033622,0.17777777777777778,0.7667003737215147,1.0,5/8,8.98%,CEL;APOE;SCARF1;CYP46A1;ADH4
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),0.7928838467461022,1.281448015490097,0.18,0.4129944437375408,1.0,3/11,10.89%,IGF1;IRS2;SORBS1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.5456460749304894,1.2813951225185132,0.07352941176470588,0.4129235307170267,1.0,5/83,7.62%,ST18;IRAK2;NOD1;IL1R1;MYD88
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.5988037376652667,1.281326915315353,0.16901408450704225,0.41293191707693677,1.0,13/48,13.49%,EGF;RASGRP1;CD24;FLT1;MAP3K11;DAB2IP;NEK10;DIRAS2;PDGFA;DIRAS1;TPD52L1;PAK1;FGF2
prerank,CellMarker_Augmented_2021__Stem cell:Periodontal Ligament,0.7397831729653424,1.281249066229103,0.1,0.41297074969305253,1.0,5/16,6.44%,PDGFRA;THY1;PTPRC;MCAM;CD44
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),0.7679693855473667,1.2812267159759472,0.1864406779661017,0.4128390827001369,1.0,5/8,20.20%,HK2;PFKL;FBP1;HK1;PFKP
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.746730103600133,1.2810820985542783,0.15873015873015872,0.41293876947147734,1.0,3/13,2.54%,ANXA1;RIMS2;LTBP4
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.8794863523366863,1.2810629127233306,0.1590909090909091,0.41280117599091826,1.0,2/5,9.25%,CHRM1;PRKCH
prerank,Reactome_2022__Ca-dependent Events R-HSA-111996,0.6223384818331412,1.2810539620988943,0.08955223880597014,0.4126272573866183,1.0,11/33,12.29%,PDE1C;ADCY5;PRKCG;PRKAR1B;PDE1A;ADCY7;ADCY2;GRK2;PDE1B;CAMK2B;PRKCD
prerank,KEGG_2021_Human__Antigen processing and presentation,0.5882369133717744,1.281039187382478,0.1044776119402985,0.41244137098247396,1.0,8/42,15.01%,HLA-DRA;CTSS;CIITA;HLA-DRB1;B2M;HLA-DMA;HLA-E;CD4
prerank,Reactome_2022__RAF/MAP Kinase Cascade R-HSA-5673001,0.4937682451792757,1.2810343952900287,0.0375,0.4122313918461059,1.0,28/215,10.13%,PDGFRA;EGF;GRIN2D;RASGRP1;GRIN2B;RASGEF1A;ZDHHC9;NEFL;SHC2;CSF2RA;IRS2;MAP3K11;DAB2IP;DUSP10;TGFA;DUSP8;PRKG2;FYN;GFRA2;DUSP16;NRG1;NRG2;PDGFA;MRAS;BCL2L1;KITLG;PPP1CB;GPRIN1
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),-0.6506219029538216,-1.2809137859330364,0.11428571428571428,0.7676180327818656,1.0,5/19,6.61%,MID1IP1;ABCD2;NPC2;ABCD1;ARV1
prerank,KEGG_2021_Human__Human immunodeficiency virus 1 infection,0.5046542266029156,1.2809098406643251,0.04411764705882353,0.412337204510982,1.0,44/163,18.87%,TLR2;GNG3;CCNB2;PRKCB;PRKCG;PAK3;NFATC2;FAS;TRIM5;GNG2;ITPR3;SAMHD1;TNFRSF1A;PAK4;MYD88;APOBEC3H;AP1S1;BCL2L1;LIMK2;PXN;BCL2;CGAS;B2M;PAK1;FADD;RPS6KB2;IKBKG;PIK3CD;MAPK11;HLA-E;CD4;WEE2;TAB1;TRAF5;CALM3;MAPK9;MAP2K3;CCNB1;GNAI1;ITPR1;SKP1;PRKCA;AP1G2;NFATC3
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.6102410085319601,1.2807800285923958,0.09523809523809523,0.41253995467934507,1.0,9/37,6.22%,HLA-DRA;MGAT3;APP;SHROOM4;TUSC3;PTCHD1;FAM107A;MFSD2A;GRM5
prerank,CellMarker_Augmented_2021__Mucosal-associated Invariant T cell:Liver,0.6084669060525237,1.2806990976494905,0.08064516129032258,0.4126333705934499,1.0,15/44,18.38%,SLC4A10;TC2N;DUSP1;B3GALT2;ZBTB16;CD160;ADAM12;APOL3;IKZF2;P2RY14;RORA;GPR171;PDK3;DKK3;TSPAN15
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Fetal Liver,0.5660750374517558,1.28067770594291,0.07575757575757576,0.41249038106144614,1.0,28/80,14.24%,COL4A1;PRRX1;PDGFRA;PCDH18;DCN;ACTA2;SULF1;COL4A2;ASPN;THY1;PODN;ANGPTL2;POSTN;SLIT3;COL12A1;FAP;LDB2;C1R;ITGA11;BGN;RASL12;LAMA2;SPARC;RUNX1T1;FN1;HMCN1;COL5A1;THBS2
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),0.8647105129792113,1.2806698380741517,0.11538461538461539,0.4122930368701744,1.0,2/6,8.74%,NOS1AP;LRRC55
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.8064813411585011,1.280615366629734,0.19230769230769232,0.41219274431486935,1.0,4/7,18.53%,PLEKHM1;SYK;SPP1;PRKCA
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),0.689444280637435,1.2806070477299714,0.18032786885245902,0.4119957614623916,1.0,1/12,1.34%,SGPP2
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.4854430342104636,1.2805342670639808,0.013888888888888888,0.4120227057632634,1.0,38/311,9.86%,LEF1;TGFBR2;NR4A3;IL13RA1;IGF1;KIF14;PROX1;PDGFRA;IL15;EGF;THBS1;FLT1;IRS2;PIM1;PRAME;TGFA;PTPRC;TRPM4;OSMR;SOX4;LAMB1;NTRK3;NRG1;PID1;TBX20;CCKBR;SCX;ZFPM2;PDGFA;CDK6;CAPN1;KITLG;YAP1;PRKCH;GAB2;HDAC4;NAMPT;TGFB2
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of CaMKII/CaMKK/CaMKIV Cascasde R-HSA-442729,-0.7625084419136545,-1.280439546759029,0.13333333333333333,0.7684419071609259,1.0,1/8,1.25%,KPNA2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),-0.6861042670000762,-1.2804103030830558,0.1951219512195122,0.7671331824573913,1.0,2/13,7.32%,TRMT10C;FASTKD2
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.58789391304815,1.2801362822913944,0.08450704225352113,0.4129742588538857,1.0,5/47,5.17%,ANXA1;RIMS2;STEAP3;RAB15;RAB3C
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),0.7572242252666219,1.2797421173857433,0.25,0.4138704581648917,1.0,2/6,9.88%,ACHE;GLI2
prerank,CellMarker_Augmented_2021__Neural Crest Stem cell:Hair Follicle,0.5776718596024628,1.2795609128412364,0.12857142857142856,0.41427672019946804,1.0,21/85,17.68%,LZTS1;PCDH18;GAP43;APBA2;TCEAL7;NAP1L3;STK32B;GNG2;CRISPLD1;BEX1;NACAD;ARMCX2;CRMP1;SPARC;IFFO1;CCDC184;CHST2;ZIK1;FHL1;ATP8B2;CMTM3
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.7550707765571104,1.2795376718105247,0.1509433962264151,0.41413347068133716,1.0,3/9,17.58%,CLMN;SYNE3;DCTN1
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.7368413690912045,1.2795082071094097,0.21311475409836064,0.4139903702261804,1.0,8/13,21.60%,TRPM4;SLC9A9;SLC9A1;SLC9C2;SLC8A1;SLC9A5;SLC9A2;SLC9A6
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.7276658397400475,1.2794748329212717,0.14285714285714285,0.41380522494695676,1.0,4/16,15.78%,MET;ITGA3;KCTD13;STMN1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),-0.650926725634152,-1.2793960218030944,0.19444444444444445,0.7700799059263947,1.0,9/28,23.13%,ZC3H8;POLR2K;SNAPC5;POLR3H;GTF3A;POLR3K;POLR2L;RO60;GTF3C6
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.669733464807648,1.2793087121660427,0.171875,0.4140600629657762,1.0,6/23,10.75%,ANK3;PPFIBP1;UNC13C;DVL1;AGRN;DOK7
prerank,Reactome_2022__Sema4D Induced Cell Migration And Growth-Cone Collapse R-HSA-416572,0.6981203589080311,1.2792599839097172,0.14,0.41400152329205464,1.0,3/19,8.98%,MYH9;MYH11;LIMK2
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.6879768800688776,1.2792265739060555,0.0967741935483871,0.4139249895790703,1.0,10/29,11.38%,TBC1D24;NLGN1;SNCB;SYT1;SYT5;SYNJ2;SNCA;PLD2;PACSIN1;OPHN1
prerank,CellMarker_Augmented_2021__Delta cell:Pancreas,-0.6491061421138389,-1.2790578491013223,0.1956521739130435,0.7702667426719922,1.0,5/14,10.34%,RGS2;POU3F1;PCSK1;BHLHE41;EHF
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),-0.7262955549609844,-1.279041553165493,0.2,0.7688428904190631,1.0,5/8,24.33%,CTH;TXN2;MPST;TST;BLMH
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Death Genes With Uncertain Roles In P53-Dependent Apoptosis R-HSA-6803205,0.752831054746652,1.2789214524032457,0.19642857142857142,0.41450418696619623,1.0,4/10,15.46%,BCL6;NDRG1;TP53I3;TP53
prerank,Reactome_2022__Mitochondrial tRNA Aminoacylation R-HSA-379726,-0.6627228497343657,-1.278836732462732,0.15555555555555556,0.7683321652670585,1.0,4/18,14.94%,PARS2;KARS1;WARS2;YARS2
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),0.6679026117720372,1.2787679170529422,0.18032786885245902,0.4147220615451663,1.0,7/21,12.22%,NLGN1;RELN;SHANK3;SHANK1;NEURL1;DLG5;CAMK2B
prerank,Reactome_2022__MAPK1/MAPK3 Signaling R-HSA-5684996,0.48726941841493837,1.2786162856035201,0.036585365853658534,0.41492168348125114,1.0,30/219,11.45%,PDGFRA;EGF;GRIN2D;RASGRP1;GRIN2B;RASGEF1A;ZDHHC9;NEFL;SHC2;CSF2RA;IRS2;MAP3K11;DAB2IP;DUSP10;TGFA;DUSP8;PRKG2;FYN;GFRA2;DUSP16;NRG1;NRG2;PDGFA;MRAS;BCL2L1;KITLG;PPP1CB;GPRIN1;FGF13;TYK2
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Intestine,0.5737798664623573,1.2785642577642524,0.09523809523809523,0.41488086643800665,1.0,23/82,13.20%,MET;HRH1;PLK2;SERPINE1;P4HA2;PPFIBP1;FBLIM1;EPHA2;NRP2;OSMR;LAMB1;ITGA2;RHBDF1;MYO1B;EMP1;ITGA3;YAP1;LMNA;MMP14;TEAD1;CD276;FN1;CCND1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.7401638533103098,1.278504806005631,0.13725490196078433,0.41493013206121676,1.0,1/11,0.99%,TYMP
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6682897256342285,1.278464855800442,0.0967741935483871,0.41483535662698057,1.0,10/28,11.89%,RIMS2;GRIK2;SYT1;CLSTN2;RIMS3;ECE1;SNCA;RAMP3;HOMER1;KCTD13
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),-0.6462410188198542,-1.2782642776875648,0.2564102564102564,0.7693380008413394,1.0,1/9,6.17%,MUL1
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryoid Body,0.5641210553968671,1.2782590423175066,0.09090909090909091,0.41504166296114037,1.0,15/55,17.62%,C10ORF105;P2RY13;DYSF;LDB2;NECAB2;NHSL2;LRRC4;GLT1D1;OAZ2;ALPL;TMEM132D;SERPING1;PPP1R14A;TP53I11;ARHGEF40
prerank,CellMarker_Augmented_2021__Osteoblast:Bone Marrow,0.5641210553968671,1.2782590423175066,0.09090909090909091,0.41504166296114037,1.0,15/55,17.62%,C10ORF105;P2RY13;DYSF;LDB2;NECAB2;NHSL2;LRRC4;GLT1D1;OAZ2;ALPL;TMEM132D;SERPING1;PPP1R14A;TP53I11;ARHGEF40
prerank,Reactome_2022__mRNA Splicing R-HSA-72172,-0.4761818795195951,-1.278181641948212,0.06451612903225806,0.7681317804356015,1.0,45/181,17.03%,SNRNP27;FIP1L1;PDCD7;LSM7;SNRPB2;DHX16;LSM3;SF3B4;SF3A1;POLR2K;ZCRB1;RBM8A;PPWD1;LSM2;CRNKL1;U2AF1;SF3B6;BUD31;TFIP11;LSM5;DDX46;SNU13;PPIH;PQBP1;SYF2;CPSF1;PPIL3;POLR2C;SNRNP25;LSM4;GTF2F1;PRPF8;PPIL1;SRSF2;RBM22;PRPF3;POLR2D;PPIE;RBMX;CPSF3;SUGP1;DNAJC8;RNPC3;GTF2F2;SRSF9
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.6829932264162644,-1.2780487723286684,0.1590909090909091,0.7674035668247505,1.0,1/21,0.06%,SLC2A5
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.6810106977617965,1.2778983383814524,0.17543859649122806,0.4158754708561329,1.0,2/17,4.49%,KREMEN2;TRPM4
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.7469381220736386,1.2778594691541612,0.15625,0.41574447980464824,1.0,5/16,12.89%,KLF2;NOS1AP;ASS1;SMAD3;KLF4
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.7694323038378559,1.2778247842027346,0.125,0.41567944909302784,1.0,3/9,12.17%,EPB41L4B;MAPRE2;ARF6
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.8009741056087529,1.277794956215663,0.1,0.4155606563919961,1.0,1/8,1.16%,PROX1
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.5688600061339454,-1.2777650793441848,0.14285714285714285,0.7656314906967404,1.0,5/33,13.54%,AAAS;RAE1;NUP50;NUP54;NOL6
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.5688600061339454,-1.2777650793441848,0.14285714285714285,0.7656314906967404,1.0,5/33,13.54%,AAAS;RAE1;NUP50;NUP54;NOL6
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),-0.7249510539311756,-1.277724057357796,0.11904761904761904,0.7642800516041045,1.0,5/13,18.19%,UQCRFS1;ETFB;ETFDH;SLC25A22;ETFRF1
prerank,Reactome_2022__Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.6838923731850852,1.2776967972826272,0.18518518518518517,0.41559741231213704,1.0,6/19,8.95%,CSPG4;DCN;CHSY3;CHST15;CHPF2;BGN
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.6922858690156952,1.2774676941870424,0.15789473684210525,0.4160762688831499,1.0,4/18,5.05%,TGFBR2;EFNA1;SOX4;SLIT3
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),-0.4926346104466258,-1.2774460115043118,0.09090909090909091,0.7638144197406673,1.0,23/120,17.79%,EIF2S3B;RPS28;MRPS7;CRNKL1;RPL6;PRPF18;GEMIN4;RPS27L;RPSA;CLP1;MDN1;RPL11;RPL23A;LOC102724159;LSM4;WDR77;KHDC4;POLR2D;RPF2;SRSF9;RPL10;DHX29;TGS1
prerank,Reactome_2022__Opioid Signaling R-HSA-111885,0.5724590502611461,1.2774388316718726,0.109375,0.4159216247449095,1.0,29/72,22.59%,PDE1C;GNG3;ADCY5;PRKCG;PRKAR1B;GNG2;ITPR3;PDE1A;ADCY7;ADCY2;GRK2;GNA14;PDE1B;CAMK2B;PRKCD;PRKAR1A;PDE4D;GNAI1;ITPR1;NBEA;CAMK2A;PRKCA;AHCYL1;PRKX;PPP3CC;ADCY9;ADCY8;GNG4;PRKAR2B
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex6:Brain,0.6566461031510262,1.2767739036892163,0.09836065573770492,0.41755774743727053,1.0,8/32,7.22%,ABO;ZNF385D;SULF1;ITGA8;CNTNAP3;GHR;HCRTR2;LUZP2
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.49569833186945716,1.276675664931853,0.0410958904109589,0.4176948153900535,1.0,48/238,15.01%,CDKN2A;PROX1;THBS1;CCNB2;PTK6;NR4A1;PIM3;DUSP1;DAB2IP;UHRF2;TSPYL2;PTPRC;FAP;BAP1;BIRC3;CDK9;PML;CDK6;CDC14A;DHCR24;SMAD3;GMNC;CHMP1A;TGFB2;STAT3;RASSF1;PES1;TTLL12;BARD1;SRA1;GADD45A;RNF112;MLXIPL;CDKN1B;CDKN1A;CCND1;CKS1B;PPP1R9B;TRIM32;GRK5;IQGAP1;IL12A;HIPK2;SIPA1;BIN1;NEK6;PUM1;RARA
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.6708429746120392,1.2765300484858157,0.18333333333333332,0.4178555925314772,1.0,3/18,10.92%,CENPV;TERF2IP;MAPT
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.6359771613156395,1.2764856053141784,0.12121212121212122,0.41780762235041397,1.0,6/33,6.91%,NELL1;TIMP2;PRKCG;DAB2IP;AGAP2;SNCA
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.5630224370291506,-1.276214208769015,0.14285714285714285,0.7673934303030122,1.0,5/35,13.54%,AAAS;RAE1;NUP50;NUP54;NOL6
prerank,Reactome_2022__Alpha-Linolenic (Omega3) And Linoleic (Omega6) Acid Metabolism R-HSA-2046104,-0.6717481810906302,-1.2761042651270467,0.18604651162790697,0.7663388034084015,1.0,3/12,9.35%,MUSK;ABCD1;ELOVL2
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.6184583198300182,1.276077371262713,0.12857142857142856,0.4187842062706696,1.0,8/26,22.72%,ACHE;MFSD2A;CHKB;SLC44A3;LPIN3;SLC44A5;SLC44A1;SLC27A1
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),0.8437082546643659,1.2759925231949996,0.14814814814814814,0.41881320215131607,1.0,2/5,10.92%,PLSCR1;MAPT
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),0.8236548912357506,1.2759767333067287,0.2553191489361702,0.41862795718012913,1.0,1/6,0.20%,SLC6A15
prerank,Reactome_2022__Serotonin Neurotransmitter Release Cycle R-HSA-181429,0.6916625208466156,1.2756741664745108,0.13114754098360656,0.4191684673900375,1.0,8/17,26.11%,SYT1;CPLX1;SYN2;PPFIA2;SNAP25;RAB3A;PPFIA1;SYN3
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.812752186290489,1.275656974085834,0.21311475409836064,0.4189713418164875,1.0,2/8,3.14%,GAP43;RTN4RL1
prerank,KEGG_2021_Human__Hematopoietic cell lineage,0.5721551392605925,1.2756084131566272,0.11428571428571428,0.4188754180088506,1.0,18/43,15.27%,HLA-DRA;CD22;CD24;CD55;CSF2RA;IL1R1;CD37;ITGA2;CD44;KITLG;ITGA3;CD5;HLA-DRB1;IL4R;HLA-DMA;CD4;CD59;THPO
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),0.7951332926429828,1.2755115221083764,0.17307692307692307,0.41891023100451463,1.0,1/5,6.65%,CDK9
prerank,"Reactome_2022__Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",0.6049371108439737,1.2752292021475777,0.11940298507462686,0.4196868926079558,1.0,10/33,18.97%,CSF2RA;TEC;FYN;GAB2;SYK;INPPL1;INPP5D;SHC1;PRKCA;VAV1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),0.7689212574993685,1.2750826421873227,0.11864406779661017,0.41995853614898493,1.0,3/9,16.46%,RELN;CAMK2B;CUX2
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.536924012673695,1.2750471449632053,0.07462686567164178,0.4198326586342477,1.0,22/100,13.21%,HAPLN2;PAPSS2;IGF1;ADAMTS4;COL11A2;SULF1;TLL1;SOX4;NOTUM;ZBTB16;CD44;SH3PXD2B;CHI3L1;PKDCC;MMP14;TGFB2;GLI2;ITGB8;MMP16;ALPL;PHEX;DEAF1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.7816074036231138,-1.275035882004255,0.20512820512820512,0.7693884862347398,1.0,2/5,5.43%,TNFAIP3;PTPN22
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),-0.6501994342491045,-1.275023734637715,0.2,0.7680136783985622,1.0,4/12,11.69%,CBFA2T3;IFNLR1;NOA1;PRELID1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),0.8182539065144584,1.2749798685331655,0.22580645161290322,0.41984320716609197,1.0,1/8,0.88%,SOCS3
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),0.7402363562064435,1.2748763324612058,0.1896551724137931,0.41991297434867464,1.0,4/10,18.59%,NUAK1;LMNA;NEK6;NEK4
prerank,CellMarker_Augmented_2021__Dendritic cell:Bone Marrow,0.663827134631678,1.2747215460947703,0.12698412698412698,0.4201957873194314,1.0,5/25,4.31%,HLA-DRA;CTSS;PLEK;NAPSB;PTPRC
prerank,CellMarker_Augmented_2021__Responder T cell:Blood,0.6587782814232944,1.274695738438774,0.15254237288135594,0.42005821192801057,1.0,7/28,4.66%,HLA-DRA;CTSS;MYO1F;PLEK;SLA;PTPRC;CD37
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Adipose Tissue,0.6989700648619496,1.2744720695892724,0.13846153846153847,0.42049442302505863,1.0,9/20,15.22%,CD55;ICAM1;THY1;PTPRC;MCAM;CD44;ITGAL;KLF4;CD59
prerank,Reactome_2022__RHOU GTPase Cycle R-HSA-9013420,0.585265193094943,1.274366410379943,0.13333333333333333,0.42068784390890757,1.0,11/38,25.95%,EPHA2;PAK4;ARHGEF7;DLG5;IQGAP1;NCK2;ARHGEF6;DST;CLTC;DEPDC1B;SRGAP2
prerank,CellMarker_Augmented_2021__CD4-CD28- T cell:Peripheral Blood,0.8371870389152272,1.274312133403155,0.1320754716981132,0.42043637182630816,1.0,3/5,12.47%,PTPRC;FAS;BCL2
prerank,CellMarker_Augmented_2021__CD4-CD28+ T cell:Peripheral Blood,0.8371870389152272,1.274312133403155,0.1320754716981132,0.42043637182630816,1.0,3/5,12.47%,PTPRC;FAS;BCL2
prerank,CellMarker_Augmented_2021__Stromal cell:Undefined,0.7228357215973583,1.2742430688999629,0.14285714285714285,0.42041115900408854,1.0,5/20,3.51%,TLR2;PDGFRA;TIMP2;ICAM1;THY1
prerank,KEGG_2021_Human__Phospholipase D signaling pathway,0.532536294325774,1.2740942816509189,0.09859154929577464,0.42064552033479574,1.0,42/116,22.51%,PDGFRA;EGF;PLD1;ADCY5;SHC2;FYN;DNM1;GRM5;ADCY7;ADCY2;PDGFA;MRAS;DGKG;AGPAT4;KITLG;GRM6;PLD2;GAB2;GNA12;SYK;ARF6;GAB1;LPAR1;PIK3CD;PIP5K1C;ADCY3;GRM7;SHC1;TSC2;PRKCA;DNM2;DGKI;RRAS2;AKT3;RHEB;DGKZ;DGKD;RALGDS;ADCY9;ADCY8;PTPN11;PLPP1
prerank,Reactome_2022__RNA Polymerase III Chain Elongation R-HSA-73780,-0.6759583113834557,-1.2740558077155335,0.20512820512820512,0.770408895367677,1.0,8/17,22.92%,POLR2K;POLR3E;POLR3B;POLR3F;POLR3H;POLR3K;POLR2L;POLR2E
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.6859054469796575,1.274031128782386,0.1509433962264151,0.42057895597623074,1.0,3/16,7.89%,ZFP36;ZBTB16;CDK6
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),0.8111242914659134,1.2740233462278978,0.19298245614035087,0.4203710313415991,1.0,3/6,8.02%,SHANK3;FYN;NECAB2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.7717908634269455,1.2739144050263662,0.14583333333333334,0.4204754793853357,1.0,2/9,4.96%,ST18;FAS
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),-0.552480116608136,-1.2738840706975765,0.07894736842105263,0.7695306641410891,1.0,10/48,14.43%,GRPEL2;TIMM8B;AIP;TIMM13;BCAP31;TIMM23;SAMM50;TSPO;TIMM50;TIMM10
prerank,KEGG_2021_Human__Renal cell carcinoma,0.5880736066403468,1.2738794329724685,0.09375,0.42033846065305563,1.0,17/63,20.13%,MET;TGFA;PAK3;PAK4;TGFB2;PAK1;CDKN1A;GAB1;PIK3CD;ETS1;RAP1A;HIF1A;ARNT;EGLN3;RAP1B;ARNT2;AKT3
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.518076397459067,1.273559197136957,0.06756756756756757,0.4210370888185389,1.0,31/129,10.81%,ECM2;C3;TLR2;PDGFRA;DCN;ACTA2;ABCA8;ASPN;IL1R1;PODN;ANGPTL2;POSTN;OLFML1;FAP;IGFBP7;CFH;ZBTB16;TNS1;SERPINF1;STEAP4;MAOB;C1R;CYP1B1;MYO1C;TRIP10;ADGRF5;BGN;PPARG;PXDC1;ADAM12;LAMA2
prerank,Reactome_2022__Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,-0.6229198124819291,-1.2733680790910455,0.19444444444444445,0.7702920546272645,1.0,5/19,8.59%,MOGS;RFT1;ALG3;ALG11;ALG9
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Undefined,0.780598844335493,1.2732433698337375,0.17857142857142858,0.42159974800968664,1.0,7/7,21.97%,BCL6;STAT3;CD4;TNFSF4;IL6R;MAF;IL12RB2
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.7367799737698794,1.2730327945020958,0.17307692307692307,0.4219561103923472,1.0,3/10,15.01%,IL15;HLA-DRB1;CD4
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.6907441413058425,1.2729584815216572,0.16326530612244897,0.42195961686820815,1.0,4/22,7.04%,TGFBR2;EGFL7;TBX20;APLNR
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.6432848060082704,1.2727698195067239,0.16666666666666666,0.42221561299566457,1.0,7/22,20.08%,NRG1;BOC;CTNNB1;CTNNA1;MAPK11;MESP1;CTNNA2
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.6872545562017421,1.272665889359471,0.18518518518518517,0.4223011499928555,1.0,5/15,16.81%,FOLH1;ASS1;NAT8L;MSRA;MTHFR
prerank,Reactome_2022__Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,0.6497819435133947,1.2725745341899872,0.171875,0.42245112632315374,1.0,7/24,13.84%,NR4A1;FOXO1;FOXO3;PRR5;CDKN1B;CDKN1A;RPS6KB2
prerank,Reactome_2022__O-linked Glycosylation R-HSA-5173105,0.5526417315747482,1.2725041035392857,0.1076923076923077,0.42247782741549883,1.0,13/78,6.28%,ST6GAL1;ADAMTS4;GCNT7;ADAMTSL2;THBS1;B3GNT2;THSD7B;ADAMTS10;GALNT12;GALNTL6;SEMA5B;GALNT8;ADAMTS19
prerank,Reactome_2022__SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,0.5736616869317908,1.2724991041543834,0.078125,0.42227595915053223,1.0,5/69,7.43%,CDKN2A;SP100;BLM;PMEPA1;PML
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.6804252377013605,1.2723616219657754,0.1694915254237288,0.4224667205538179,1.0,4/20,6.62%,CACNA1H;KCNQ1;KCNMB4;ECE1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Bone Marrow,0.7050431475085907,1.2723415089458772,0.16393442622950818,0.42227677008819653,1.0,4/12,6.44%,THY1;PTPRC;FAP;CD44
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),0.8546746820566199,1.272325457566921,0.06896551724137931,0.42211626732535673,1.0,2/5,10.99%,NLGN1;LRRC4
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),0.7366183558542838,1.2723149891965166,0.19298245614035087,0.4219734712247233,1.0,3/11,10.90%,IGF1;SOAT1;ABCA2
prerank,CellMarker_Augmented_2021__B cell:Fetal Liver,0.8002356850119532,1.272092510837968,0.10526315789473684,0.42228675135472876,1.0,2/7,2.72%,CD24;NAPSB
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),0.6895692946055428,1.2717977768299131,0.14814814814814814,0.42294441365178786,1.0,2/14,6.52%,HPN;ZIC1
prerank,Reactome_2022__Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.5131139435722287,-1.2717658440382595,0.16129032258064516,0.77475043097773,1.0,11/62,20.20%,CDC26;PSMD10;ANAPC15;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.590412333101158,-1.271463688281037,0.17073170731707318,0.7745180890145501,1.0,12/35,19.37%,AIMP1;KARS1;VARS1;GATC;EPRS1;NARS1;WARS2;YARS2;RARS1;AIMP2;LARS1;QRSL1
prerank,Reactome_2022__Signaling By SCF-KIT R-HSA-1433557,0.6311798680855555,1.2714601915542665,0.140625,0.4235313405732983,1.0,12/33,22.33%,TEC;FYN;KITLG;GAB2;RNASE1;STAT3;SH2B2;PRKCA;VAV1;GRB10;PTPN11;SH2B3
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.6528185526459954,1.2714402071942463,0.17543859649122806,0.42338228309879716,1.0,7/27,8.95%,CSPG4;DCN;CHSY3;CHST15;CHPF2;UGDH;BGN
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.7873579642274221,1.2713861334591425,0.15517241379310345,0.42332671194006993,1.0,5/11,17.11%,APOD;CCDC3;ASXL3;ALK;NCOR1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5563265027425488,1.271366244887909,0.10144927536231885,0.4231779073546948,1.0,8/80,13.18%,CDKN2A;GPNMB;FAM107A;CDK6;GFI1B;CCL2;KLF4;CDKN1A
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.7673454484337336,1.2712977988979663,0.14545454545454545,0.4232157372580866,1.0,2/9,12.18%,SP100;MX1
prerank,KEGG_2021_Human__Thyroid hormone signaling pathway,0.5404800820234665,1.2712805878790767,0.13636363636363635,0.4230263649271144,1.0,29/102,20.43%,RCAN2;PRKCB;PRKCG;FOXO1;SLC16A10;DIO1;ATP1A1;SLC9A1;CTNNB1;ATP1B1;PFKL;ATP1B3;MED12L;CCND1;PIK3CD;NOTCH3;TP53;RXRA;MED13L;NCOR1;TSC2;PRKCA;MED24;HIF1A;NOTCH4;AKT3;PFKP;THRA;RHEB
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.8314474365507454,-1.2712263863711413,0.17647058823529413,0.7695173332515257,1.0,3/5,12.62%,DCXR;AKR1A1;XYLB
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.8314474365507454,-1.2712263863711413,0.17647058823529413,0.7695173332515257,1.0,3/5,12.62%,DCXR;AKR1A1;XYLB
prerank,Reactome_2022__Formation Of Xylulose-5-Phosphate R-HSA-5661270,-0.8314474365507454,-1.2712263863711413,0.17647058823529413,0.7695173332515257,1.0,3/5,12.62%,DCXR;AKR1A1;XYLB
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.8314474365507454,-1.2712263863711413,0.17647058823529413,0.7695173332515257,1.0,3/5,12.62%,DCXR;AKR1A1;XYLB
prerank,Reactome_2022__rRNA Processing In Mitochondrion R-HSA-8868766,-0.703671007541321,-1.2710556703977112,0.2641509433962264,0.7687254592757942,1.0,3/8,15.52%,TRMT10C;MTERF4;TFB1M
prerank,Reactome_2022__Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,0.5332414924577782,1.270847409559244,0.07042253521126761,0.42405393858947826,1.0,22/98,15.04%,IGF1;SGPP2;EGF;THBS1;SERPINE1;PLEK;PRKCB;PRKCG;APP;PDGFA;SYTL4;CYRIB;TGFB2;TF;GAS6;ACTN1;SPARC;STX4;FN1;RAB27B;ABCC4;SERPING1
prerank,Reactome_2022__Base Excision Repair R-HSA-73884,-0.573337496878217,-1.270832062332663,0.15789473684210525,0.7683216501584106,1.0,6/50,5.51%,H2AC20;RFC3;H2BC4;H2BC21;POLD3;H2AC6
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),-0.7019538825452769,-1.2707977624746956,0.15789473684210525,0.7670082679233978,1.0,3/10,15.47%,MAL;GOPC;VANGL2
prerank,Reactome_2022__TRAF6 Mediated IRF7 Activation R-HSA-933541,0.6786363219747052,1.270707446416793,0.2,0.42418437375067564,1.0,3/14,14.66%,IRF7;IKBKE;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.7186843115475553,1.2706376068006717,0.1568627450980392,0.42419254294945696,1.0,6/15,14.71%,HLA-DRA;CYRIB;HLA-DRB1;FADD;IL12A;HLA-E
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.700426557790064,1.2706169154044151,0.22580645161290322,0.4240495649418946,1.0,1/14,1.60%,PLK2
prerank,Reactome_2022__Signal Regulatory Protein Family Interactions R-HSA-391160,0.7445203090157648,1.2705361992705095,0.18181818181818182,0.4240577935243406,1.0,1/9,1.58%,FYB1
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),0.7983837401931466,1.270521244812956,0.20634920634920634,0.4238743757912519,1.0,1/7,10.77%,TERF2IP
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),0.7884912375161057,1.2704515635133653,0.21818181818181817,0.4239059010840681,1.0,2/11,4.36%,LIPH;FABP3
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.7466186617818442,-1.2704305780190364,0.20408163265306123,0.7671349234929593,1.0,4/11,8.80%,TMEM100;HEY2;ASB4;HEY1
prerank,Reactome_2022__Signaling By MAPK Mutants R-HSA-9652817,0.8628373871507589,1.2703762388731685,0.17543859649122806,0.42393739482003473,1.0,3/6,5.47%,DUSP10;DUSP8;DUSP16
prerank,Reactome_2022__Inositol Phosphate Metabolism R-HSA-1483249,0.6038405061577086,1.2699619192220375,0.15789473684210525,0.42474585592288994,1.0,12/42,15.60%,MTMR7;ITPKC;PLCH2;ITPKB;ITPK1;NUDT4;INPPL1;INPP5A;INPP5J;INPP4A;INPP5D;IMPA1
prerank,Reactome_2022__Signaling By ERBB4 R-HSA-1236394,0.5552840757523262,1.2698453194788941,0.14285714285714285,0.42488701458443157,1.0,11/51,11.55%,EGF;GABRB2;GABRG3;GABRA1;NRG1;PGR;GFAP;NRG2;GABRG2;YAP1;SPARC
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.6448123870325995,1.269843167976752,0.16393442622950818,0.42467467724580865,1.0,4/25,6.43%,CD55;TRIM5;SAMHD1;BIRC3
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6866118585779483,1.2697861473308596,0.21818181818181817,0.42464203614295415,1.0,2/19,8.06%,IGF1;SLC9A1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),-0.7860214956017619,-1.2697826680939168,0.18181818181818182,0.7676865817139528,1.0,2/9,7.50%,FICD;BAK1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.6989568010276906,1.269731090970865,0.17543859649122806,0.42463257531010906,1.0,5/15,22.17%,NEFL;KIF5A;HAP1;MAP1A;DST
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),0.6871983536593216,1.2691899212771192,0.16666666666666666,0.4260228596061955,1.0,5/15,17.57%,GRIP1;MFSD2A;DVL1;MYO9A;WNT5A
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.7275237359435742,1.268907285190707,0.13793103448275862,0.42667177027408276,1.0,5/12,12.73%,RIMBP2;TBC1D24;DTNA;FCHSD1;ERC2
prerank,CellMarker_Augmented_2021__Secretory Progenitor cell:Esophagus,0.5807823231236495,1.2687872298655025,0.08196721311475409,0.426811546649323,1.0,13/45,14.38%,CDKN2A;LIPH;DUSP10;PDP1;STEAP4;AGFG2;GPT2;SPNS2;ADAM28;HDAC9;USP6NL;TMPRSS11D;NTN4
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.7033966178409841,1.2687620517749982,0.2459016393442623,0.42664508827891817,1.0,2/12,9.04%,PTPRC;YAP1
prerank,Reactome_2022__Cell Junction Organization R-HSA-446728,0.5744348297409554,1.2686003905017504,0.10909090909090909,0.4267905112322962,1.0,15/61,13.26%,CDH6;CDH9;CDH19;CLDN16;FBLIM1;CDH8;CDH18;PARD3;CTNNB1;ACTN1;CLDN18;CTNNA1;CLDN20;SDK2;CDH4
prerank,Reactome_2022__Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,0.7302153046995411,1.2685165035383823,0.1016949152542373,0.4269011715954096,1.0,11/21,17.92%,CDKN2A;LMNB1;APP;FOXO3;CAPN1;LMNA;ERC2;TP53;CDC25B;YWHAE;CAPNS1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),-0.7440739963885464,-1.2682814101924922,0.14634146341463414,0.7717185766266087,1.0,1/7,1.63%,CFAP53
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),0.8204911370011978,1.2681647279465966,0.10204081632653061,0.4276287658104873,1.0,4/8,10.99%,NLGN1;GRID2;SHANK3;LRRC4
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.8024128787659406,-1.2680592438540985,0.22727272727272727,0.7711857861485912,1.0,2/6,16.65%,BNIPL;PRUNE1
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.7678654366667783,1.2678700669844518,0.19298245614035087,0.4281423721709175,1.0,4/6,18.73%,TBX19;SCX;MESP1;SMAD2
prerank,Reactome_2022__Glutamate Neurotransmitter Release Cycle R-HSA-210500,0.6946045128368674,1.2678014164081841,0.14814814814814814,0.4281657801300221,1.0,8/20,24.49%,SYT1;CPLX1;SLC1A6;PPFIA2;SNAP25;RAB3A;PPFIA1;SLC17A7
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.6348464743986024,1.2677808363849437,0.1724137931034483,0.4280106615092712,1.0,9/30,13.13%,HTR2C;RIMS2;EPHA5;AHR;ADCY2;GLP1R;NUDT4;GUCY1B1;CAP2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.6607209199647847,1.2676172756701036,0.12903225806451613,0.4282873453768169,1.0,2/23,1.69%,KLF2;ATF3
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.8323529531787593,1.2672210134594002,0.1896551724137931,0.42939210834247965,1.0,2/5,11.93%,AHR;HLA-DRB1
prerank,Reactome_2022__Generation Of Second Messenger Molecules R-HSA-202433,0.6652062577953033,1.2672061666342007,0.24074074074074073,0.4292136138432695,1.0,6/16,11.93%,HLA-DRA;FYB1;WAS;ARHGEF7;ENAH;HLA-DRB1
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.5333513231417658,1.2668172925672585,0.07575757575757576,0.43008695202924396,1.0,26/100,15.21%,ENPP2;SPOCK3;KIF14;EGF;SRCIN1;MGAT3;WAS;TMSB10;NRG1;DOCK10;LDB2;NEXN;NRG2;CDK6;LMNA;CYRIB;MINK1;PLXNA4;ARHGAP18;CFAP20;ROBO4;FGF2;TRIM32;PLXNA1;CAMSAP3;PLXNA2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Breast,0.7019386635804064,1.266734825039424,0.1527777777777778,0.43006337553598994,1.0,3/15,6.44%,CD24;LGR5;CD44
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.6689334767481987,1.2665128314168324,0.09615384615384616,0.4303728038634517,1.0,3/31,5.58%,ANXA1;DOC2B;SMCR8
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.6460248638048043,1.2663210975873018,0.18333333333333332,0.4306589729556272,1.0,2/18,2.35%,MAFF;ZFP36
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),0.6956972179137422,1.266275874782085,0.1694915254237288,0.43057205925917635,1.0,3/13,8.42%,NLGN1;KIF5A;KIF5C
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.4611250969286696,1.266071569302033,0.012345679012345678,0.4309266372545616,1.0,116/545,20.29%,LEF1;HPN;BOK;ANXA1;IGF1;KIF14;MLLT11;PLK2;THBS1;GRID2;PIM3;STEAP3;SLIT2;SEPTIN4;RPS6KA1;PIM1;MAP3K11;DAB2IP;FOXO1;NUAK2;PRAME;KLF11;ARHGEF17;SOX4;FAS;BCL6;ARHGEF3;TFPT;BIRC3;CD44;FOXO3;SNCA;CASP10;ALPK2;SCX;PAWR;CYP1B1;MYD88;OBSCN;DAPK2;NAA38;MCF2;CTNNB1;BAG3;THOC6;BCL2L1;DHCR24;KALRN;NEURL1;ARHGEF7;HIPK3;PNMA2;NDRG1;TP53I3;TRIO;PXT1;GAS6;ACTN1;PLEKHG2;BARD1;SRA1;GADD45A;BCL2;ALK;PDPN;TNFRSF10B;FADD;GRK5;KCNMA1;FMN2;BIN1;MRE11;BCAR1;LCMT1;RARG;MAP3K5;STK3;TP53;PINK1;NGEF;VAV2;FSTL1;TOX3;MCF2L;SHC1;IGF1R;SCRIB;WNT5A;TFRC;LRP2;RNF122;SEMA4D;FLNA;BCLAF1;BFAR;CAPN13;PLK3;RBM5;VAV1;DNM2;TEK;RTN4;VIP;EGLN3;CCND2;RHOB;DNAJA3;RTKN;ING5;DDX42;RPS27A;ACTN4;ARHGEF6;TFAP4;ANGPTL4;DDRGK1
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.6617974878567376,-1.265735894089626,0.1111111111111111,0.7797940137774686,1.0,4/16,8.67%,BUD23;RIOK2;METTL18;RIOK1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),-0.7314379735486178,-1.2656679265259514,0.16666666666666666,0.778699203810125,1.0,4/8,14.69%,FBXO5;RPL23;RPL11;BAG2
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),0.7502703555017267,1.2655767781487592,0.1568627450980392,0.4320772941407876,1.0,5/12,10.80%,THBS1;SERPINE1;DMTN;FAP;TFPI
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),0.7031947992235823,1.2654275246252915,0.14545454545454545,0.43230478676892925,1.0,4/13,7.18%,DMTN;PTPRC;GRM5;RYR2
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Peripheral Blood,0.5787185410564465,1.2652128565114769,0.08196721311475409,0.43277818882914243,1.0,27/65,13.08%,PDGFRA;DCN;ABCA8;PODN;ACKR1;SHROOM4;ANGPTL2;MCAM;POSTN;FAM107A;IGFBP7;TNS1;LDB2;APLNR;MAOB;RAMP3;C1R;ADGRF5;BGN;RASL12;RNASE1;ITGA9;SLCO2A1;SORBS1;SPARC;FGD5;ROBO4
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.7574957246080837,-1.26492393212833,0.15625,0.7802641288738238,1.0,3/10,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.6673629751304565,1.2646984961862549,0.2,0.4341665193892637,1.0,2/18,7.04%,ROBO2;APLNR
prerank,KEGG_2021_Human__Shigellosis,0.47995740017096516,1.2645551631017702,0.0547945205479452,0.43429543180167673,1.0,44/193,18.13%,C3;ELMO1;ARPC5L;FOXO1;NOD1;IL1R1;WASF1;SEPTIN8;SEPTIN9;ITPR3;CD44;TNFRSF1A;FOXO3;MYD88;HK2;BCL2L1;CAPN1;ARPC3;PRKCE;ACTN1;PXN;ARF6;PRKCD;BCL2;CGAS;HK1;RPS6KB2;IKBKG;PIK3CD;CAST;MAPK11;BCAR1;PFN4;TP53;H3-3A;PFN2;TAB1;TRAF5;MAPK9;GABARAPL1;TLN2;CAPNS1;ITPR1;SKP1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.8374691192417736,1.2643568099775726,0.14754098360655737,0.43472714291080294,1.0,1/5,0.85%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7570647339210902,1.2643011315928825,0.12698412698412698,0.434695694535286,1.0,1/10,3.34%,DAB2IP
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.8138337468823857,1.2642142871405255,0.14545454545454545,0.43477276620420846,1.0,3/7,2.95%,MYRF;CNTNAP1;PLP1
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),-0.7066541492381849,-1.2640948670661176,0.16279069767441862,0.7819915715747401,1.0,3/7,15.19%,ALDH1A1;NAGK;GNPDA2
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.8340701067917823,1.2635927614385596,0.1694915254237288,0.43635644671892293,1.0,3/6,12.29%,IL15;SYK;PRKCD
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.5954107652423326,1.2635864353461264,0.16216216216216217,0.4361588173647145,1.0,7/39,9.00%,YWHAH;MBP;PLP1;PADI2;MAOB;SYNGR3;BASP1
prerank,Reactome_2022__Activation Of RAC1 Downstream Of NMDARs R-HSA-9619229,0.7763461727719373,1.2633966878752534,0.21052631578947367,0.43639469830689187,1.0,2/7,9.78%,ARHGEF7;RNASE1
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.6056903585996659,1.2633674085435305,0.13636363636363635,0.43631691762519725,1.0,11/34,18.66%,ABO;B3GALT2;ST8SIA3;ST8SIA1;ST8SIA4;FUT2;ST6GALNAC5;ST6GALNAC3;NEU4;B3GALT5;MAN2C1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.7876125368059764,1.2632484242872226,0.1935483870967742,0.43645565839229156,1.0,1/12,0.88%,SOCS3
prerank,CellMarker_Augmented_2021__Basophil:Blood,0.8181317952357725,1.2632215937139417,0.12244897959183673,0.4363209929388483,1.0,2/6,10.51%,CD22;SMAD1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.7522729793077505,1.2630002415010233,0.18181818181818182,0.43681239586687237,1.0,4/12,19.74%,RBM24;BOC;AKIRIN1;BTG1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.706025094029951,1.2629642248731983,0.1935483870967742,0.4367630005745037,1.0,4/11,18.09%,NECAB2;WDR54;ANKRD13A;MTMR2
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.7164131478718043,-1.262913524970177,0.1388888888888889,0.7855465572044867,1.0,4/8,21.42%,ADSS2;AMPD3;PNP;NT5C1A
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),0.5834716082743927,1.2628832259133447,0.18032786885245902,0.43673639272166803,1.0,12/35,20.67%,NLGN1;PLEK;FHOD1;RHOD;ARF6;FMNL3;RHOBTB2;FMNL1;RHOQ;FHOD3;RHOB;STRIP1
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),0.7513743185277771,1.262705815613188,0.18181818181818182,0.43703936467066784,1.0,3/8,14.66%,IRF7;CLPB;IFIH1
prerank,Reactome_2022__Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.6193033318863728,1.2626924869000136,0.0847457627118644,0.43687066806732444,1.0,9/33,11.16%,CSPG4;PAPSS2;DCN;OGN;CHST6;AGRN;BGN;OMD;B4GALT7
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.6764192520084381,1.262630111901614,0.18333333333333332,0.4368667521609575,1.0,7/15,25.70%,SYNGR2;SYP;STX4;STX1B;SYNGR1;SNAP25;STX3
prerank,CellMarker_Augmented_2021__CD8+ Cytotoxic T cell:Peripheral Blood,-0.7000574312087566,-1.2623749727508506,0.24444444444444444,0.783394327704659,1.0,5/12,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Liver,-0.7000574312087566,-1.2623749727508506,0.24444444444444444,0.783394327704659,1.0,5/12,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__CD8+ T cell:Liver,-0.7000574312087566,-1.2623749727508506,0.24444444444444444,0.783394327704659,1.0,5/12,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.6857786133964382,1.2623713718936482,0.2222222222222222,0.43730538221884324,1.0,9/19,24.44%,APP;WDR54;ABCA2;ARF6;ANKRD13A;MTMR2;ITGAV;RIN3;PSEN1
prerank,Reactome_2022__WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,0.7027762551864751,1.262354700070872,0.12698412698412698,0.43714247390900157,1.0,3/15,6.30%,PRKCB;PRKCG;CLTB
prerank,KEGG_2021_Human__Ribosome biogenesis in eukaryotes,-0.56286476632158,-1.26233151986233,0.1875,0.7821124044564947,1.0,11/69,11.00%,IMP4;RPP25L;RIOK2;FCF1;NXT2;POP5;NOP56;SNU13;RIOK1;MDN1;IMP3
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.6020585776064051,1.2621954554076893,0.13846153846153847,0.4374501745908735,1.0,6/35,12.85%,KCNJ2;TRPM4;SAMHD1;HCN1;SHMT1;B2M
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.7460148831137399,-1.2620440999591813,0.21818181818181817,0.7819448805847661,1.0,2/7,12.75%,IGSF1;FSTL3
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.7706114122863076,1.262019751699183,0.15789473684210525,0.43764993382854966,1.0,3/8,12.17%,EPB41L4B;MAPRE2;ARF6
prerank,Reactome_2022__Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,0.5384871190693004,1.261928014431199,0.11764705882352941,0.4376966095737085,1.0,2/80,2.35%,ENPP2;ZFP36
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.7229682992237092,1.2618667351971897,0.14285714285714285,0.437613065131575,1.0,2/13,2.41%,PDGFRA;SULF1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6268148399329657,1.2618047307585056,0.09375,0.4375239452327448,1.0,13/39,20.13%,ANXA1;THBS1;HDAC9;FGF2;ETS1;MAP2K3;HDAC7;SRPX2;ADAM17;PRKCA;HIF1A;FGFR1;AKT3
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),-0.7060342711492609,-1.2617191737201985,0.16666666666666666,0.781930275110757,1.0,1/17,0.09%,NGF
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.6795819722075014,1.2616711821498867,0.18032786885245902,0.437666736273274,1.0,5/20,13.70%,C3;NOS1AP;PDK4;ADIPOR2;MFSD12
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),0.8058812914103877,1.2615162170509544,0.16666666666666666,0.43786590294251004,1.0,1/7,8.75%,PKDCC
prerank,Reactome_2022__CREB3 Factors Activate Genes R-HSA-8874211,-0.7791942217412273,-1.261505453057479,0.16279069767441862,0.7813490671724235,1.0,3/7,17.72%,CREB3L4;CREB3L1;CREB3L3
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.640905032457985,1.261458906032264,0.1875,0.4378106825172766,1.0,7/25,10.27%,ANXA1;STAT4;ERBIN;FYN;EIF2B2;RAMP3;STAT3
prerank,Reactome_2022__Nephrin Family Interactions R-HSA-373753,0.6608391002808633,1.2609040758038352,0.16176470588235295,0.43905973757248606,1.0,6/18,19.98%,FYN;KIRREL3;ACTN1;IQGAP1;NCK2;ACTN4
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),-0.7311789354646603,-1.2607416306596873,0.25,0.7831980231671581,1.0,2/11,6.61%,NPC2;ARV1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.6670899333287661,1.2607047933966586,0.21052631578947367,0.439376443039904,1.0,6/15,15.24%,TYMP;DPYSL2;CRMP1;DPYSL4;DPYSL5;DPYD
prerank,KEGG_2021_Human__Acute myeloid leukemia,0.5792606145970483,1.2606318043488478,0.11428571428571428,0.43941645644208055,1.0,11/58,15.01%,LEF1;PIM1;ZBTB16;PML;STAT3;RUNX1T1;CCND1;RPS6KB2;IKBKG;PIK3CD;RARA
prerank,Reactome_2022__Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,0.6280552141462468,1.2605035001111586,0.18032786885245902,0.43957482352420274,1.0,6/28,10.25%,GNG3;RGS6;GNG2;TCP1;GNA14;CCT4
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),0.8823923315106491,1.2604930037674327,0.125,0.43918143069178606,1.0,1/5,0.85%,ANXA1
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),0.8823923315106491,1.2604930037674327,0.125,0.43918143069178606,1.0,1/5,0.85%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.5352829078676835,1.2604828824816985,0.047619047619047616,0.43898502086579083,1.0,14/90,8.51%,GGT5;PLK2;ADCY5;MYH9;PRKAR1B;FYN;GIPR;RXFP1;GNG2;ADCY7;ADCY2;RAMP3;GLP1R;NLRC3
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.8246699250266698,-1.2604254815407232,0.11538461538461539,0.7829058088378609,1.0,1/5,1.81%,COX18
prerank,KEGG_2021_Human__Pertussis,0.5898193444311232,1.2603997254735457,0.17647058823529413,0.43905888793451997,1.0,10/46,17.55%,C3;NOD1;C1R;MYD88;IL12A;MAPK11;SERPING1;CALM3;MAPK9;GNAI1
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),0.79795492882073,1.260377066728805,0.2459016393442623,0.4388852244263474,1.0,3/6,14.71%,ANXA1;STOML2;HLA-E
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.8797299997930005,1.2603324057485465,0.03333333333333333,0.4386002072390199,1.0,2/5,10.27%,STAT4;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.8797299997930005,1.2603324057485465,0.03333333333333333,0.4386002072390199,1.0,2/5,10.27%,STAT4;STAT3
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.7343082982030348,1.2603272493837465,0.17543859649122806,0.4383933230299195,1.0,3/13,2.69%,HPN;CTSS;LMO2
prerank,KEGG_2021_Human__RIG-I-like receptor signaling pathway,0.5563576230563864,1.2603262127411308,0.11864406779661017,0.4381810260211883,1.0,9/46,17.07%,IRF7;CASP10;IKBKE;FADD;IL12A;IKBKG;MAPK11;IFIH1;MAPK9
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.6490182921166533,-1.260239433978785,0.15,0.7822435178273477,1.0,8/20,24.13%,TRMT10C;FASTKD2;MTG2;TSFM;MALSU1;ALKBH1;RPUSD4;COA3
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.8719009047659781,1.2602328103058773,0.13793103448275862,0.43822140499432066,1.0,3/5,10.92%,SH3GL2;WASF1;MAPT
prerank,Reactome_2022__Interleukin-9 Signaling R-HSA-8985947,0.8110718553858115,1.2602115310628113,0.12698412698412698,0.43763641542540804,1.0,1/6,10.27%,STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.8110718553858115,1.2602115310628113,0.12698412698412698,0.43763641542540804,1.0,1/6,10.27%,STAT3
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.8110718553858115,1.2602115310628113,0.12698412698412698,0.43763641542540804,1.0,1/6,10.27%,STAT3
prerank,CellMarker_Augmented_2021__Neuron:Undefined,0.6175688646597749,1.2602065131622602,0.19298245614035087,0.4374305964805918,1.0,6/28,12.47%,L1CAM;CD24;THY1;SYP;NEFM;BCL2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colorectum,0.7427947716370876,1.2600571906478182,0.1896551724137931,0.43754959705191665,1.0,3/13,6.44%,CD24;LGR5;CD44
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.8128945326353868,1.2599098353691311,0.04,0.4377747727160593,1.0,3/10,6.95%,KCNJ2;KCNQ1;KCNH2
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.7158344390323481,1.2598949929242833,0.1935483870967742,0.43761950847285735,1.0,3/13,5.78%,ANXA1;RIMS2;RAB11FIP5
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.7762422055179559,-1.2597998074404286,0.17073170731707318,0.7829694329745085,1.0,2/5,17.95%,IDH3G;IDH1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),0.5989101012274624,1.2597401687055885,0.1724137931034483,0.4378332556596322,1.0,17/40,18.06%,ANXA1;IL15;IRS2;PTPRC;NFATC2;CD276;BCL2;SLC7A1;CD70;IL12A;HLA-E;GPR183;PDCD1LG2;BST1;TFRC;NCK2;TNFSF4
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex2:Brain,0.7589360217981268,1.2596968994340263,0.27450980392156865,0.4377395602076383,1.0,4/8,10.81%,PCED1B;CLMN;TRHDE;LAMA2
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.6422304157491954,1.2596497661383552,0.19047619047619047,0.43769062245706597,1.0,5/24,10.27%,ST18;SOCS3;PID1;YAP1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.580660862117584,1.2595136002688467,0.11666666666666667,0.4377700888796209,1.0,7/49,13.63%,MET;LZTS1;SMCR8;SNCA;STAT3;BCL2;WASHC1
prerank,CellMarker_Augmented_2021__Large Granular lymphocyte:Peripheral Blood,0.5384258271314842,1.2594555507261909,0.1527777777777778,0.4377211835384947,1.0,22/81,17.58%,CAMKV;TRAM1L1;EFNB3;NAP1L3;WASF1;FSD1;MAPK8IP1;CRISPLD1;B4GALNT1;DIRAS1;ADAM11;CRMP1;PIANP;DPYSL4;NAT8L;MMP16;PNMA6A;STMN1;NRSN2;ZKSCAN2;KIF3C;DCTN1
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Undefined,0.5610223317837252,1.2593314502496646,0.15384615384615385,0.43787303865830757,1.0,13/54,16.87%,CTSS;SP100;PTPRC;GAB3;MAP3K7CL;TM6SF1;HIPK3;DENND4A;FLI1;GYPE;DPYD;BACH1;SRGN
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.6895195214410498,-1.2592930899855819,0.24390243902439024,0.7835694622928049,1.0,4/14,5.85%,RAB7B;TNFAIP3;PTPN22;NR1D1
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.6994343743510579,1.2592279747527477,0.21052631578947367,0.437874285075742,1.0,4/11,8.52%,IL1RAPL1;NLGN1;CNTN2;PTPRD
prerank,KEGG_2021_Human__Pancreatic secretion,0.5470609242063191,1.2592216735915978,0.1044776119402985,0.4376805797964973,1.0,16/65,10.24%,CCK;CHRM3;PRKCB;ADCY5;KCNQ1;PRKCG;ATP2B3;ITPR3;ADCY7;RYR2;ADCY2;ATP1A1;SLC9A1;CELA2B;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6935256134085888,1.2591417937603357,0.203125,0.4376429460834975,1.0,4/14,8.03%,CHRM3;CHRM1;AGRN;GRK2
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),0.8271447231371456,1.259135489886813,0.09615384615384616,0.43745510251774616,1.0,4/7,10.19%,MYRF;PARD3;TENM4;TPPP
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),-0.7280938354975597,-1.2590955297384454,0.2,0.7829779127378818,1.0,3/8,12.64%,TRMT10C;TRMT61B;TRMT5
prerank,Reactome_2022__Synthesis Of PC R-HSA-1483191,0.6397031962157987,1.2589551597774191,0.15,0.4377235228958097,1.0,8/23,21.46%,ACHE;MFSD2A;CHKB;SLC44A3;LPIN3;SH2D3C;SLC44A5;SLC44A1
prerank,CellMarker_Augmented_2021__Common Lymphoid progenitor:Undefined,0.6161416692177792,1.2589365661701748,0.23880597014925373,0.43756361751164025,1.0,9/41,6.17%,HLA-DRA;CTSS;P2RY13;MYO1F;PLEK;SLA;PTPRC;GAB3;CIITA
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.7041515513246335,1.2586664068126951,0.27450980392156865,0.438087335027009,1.0,6/11,25.48%,DUSP1;LRCH1;SH2B3;CXCL12;OXSR1;WNK1
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.8614722701325508,1.258551334989588,0.22807017543859648,0.43819955459816934,1.0,1/5,2.18%,MBP
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),0.730300272465935,1.258444789158898,0.19047619047619047,0.43821729388518615,1.0,2/13,2.98%,TRPC3;SLC39A14
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),0.8088683234533084,1.2582396563056042,0.24074074074074073,0.43862897271121243,1.0,1/6,0.82%,HTR2C
prerank,Reactome_2022__Activated NTRK2 Signals Thru FYN R-HSA-9032500,0.8337549800321651,1.2581156440135717,0.203125,0.4387740482161227,1.0,3/6,9.78%,GRIN2B;FYN;RNASE1
prerank,Reactome_2022__Transcriptional Regulation Of Pluripotent Stem Cells R-HSA-452723,0.7620385295771819,1.2579767993672342,0.16666666666666666,0.4389467018402436,1.0,6/12,18.73%,STAT3;NR6A1;FGF13;KLF4;HIF3A;SMAD2
prerank,"Reactome_2022__Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",0.45695308470673857,1.2577623767272217,0.033707865168539325,0.4393463601864682,1.0,114/552,18.29%,ANLN;VRK2;ARHGAP4;KIF14;NHS;YWHAH;STMN2;VAPB;ARHGAP39;STEAP3;CDC42EP3;PRKCB;EPHA2;WAS;PLEKHG6;SLITRK5;LMNB1;MAP3K11;MYH9;ERBIN;MYH11;INCENP;BAIAP2L1;ARHGEF17;ARHGDIG;MCAM;WASF1;ARHGEF3;BAIAP2;DOCK10;RHPN1;CENPP;RHOD;CDC42EP1;TPM4;PAK4;OBSCN;DAAM1;ERCC6L;MCF2;CTNNB1;KIF5A;YWHAG;TRIP10;KALRN;ARHGEF10L;LIMK2;BASP1;ARHGAP26;PLD2;ARPC3;TRAK1;PDZD2;ARHGEF7;PPP1CB;RNASE1;DLG5;KCTD3;NOXA1;HMOX2;TRIO;ACTN1;CTNNA1;PLEKHG2;OPHN1;DOCK4;KCTD13;FGD5;STARD13;ARHGAP18;PRKCD;CDKN1B;CENPH;FMNL3;KLC1;RANGAP1;STOM;MYO9A;TEX2;GPS1;TUBA1B;IQGAP1;ALDH3A2;ARHGAP17;RHOBTB2;PLXNA1;MAPK11;MRTFA;PLEKHG4B;UBXN11;ARHGAP22;NGEF;VAV2;WIPF3;PKP4;PFN2;NISCH;PPP1R14A;RHOT1;FMNL1;RHOT2;MCF2L;DYNC1LI2;SKA2;SCRIB;ARHGEF40;TFRC;DOCK9;RHOQ;YWHAE;NCK2;AMIGO2;CKAP5;FLNA
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.8283569048744862,1.2576830008888302,0.13114754098360656,0.4393025903008919,1.0,2/7,10.25%,PDGFRA;SLC4A11
prerank,Reactome_2022__Activated NTRK3 Signals Thru PI3K R-HSA-9603381,0.8306285822045354,1.2576693850760647,0.23529411764705882,0.4391149409256877,1.0,1/5,5.87%,NTRK3
prerank,Reactome_2022__Fanconi Anemia Pathway R-HSA-6783310,-0.63061342866837,-1.2574334834229624,0.18421052631578946,0.7880246468352916,1.0,3/31,3.15%,DCLRE1B;FANCF;ATRIP
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),0.721221431097131,1.2572714540465364,0.234375,0.43997870120841187,1.0,2/10,7.32%,CARNS1;UGDH
prerank,KEGG_2021_Human__Small cell lung cancer,0.5441263223628301,1.2570242808788834,0.12307692307692308,0.44044346631184883,1.0,28/82,18.08%,COL4A1;COL4A2;LAMB1;ITGA2;BIRC3;CDK6;LAMA5;BCL2L1;ITGA3;LAMA2;COL4A4;GADD45A;CDKN1B;BCL2;FN1;CDKN1A;CCND1;CKS1B;COL4A5;IKBKG;PIK3CD;LAMA3;TP53;RXRA;CDK2;TRAF5;COL4A3;DDB2
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.5473579728841731,1.2568122777887818,0.1746031746031746,0.4408414579646054,1.0,27/85,18.47%,RASGRP1;APP;MAP3K11;DAB2IP;DUSP10;DUSP22;UNC5CL;MAPK8IP1;SH3RF3;MINK1;TNFRSF19;GADD45A;TPD52L1;PER1;HIPK2;MAP3K5;PINK1;FZD7;MAPK8IP2;ANKRD6;GPS2;TRAF5;NCOR1;MFHAS1;IGF1R;MECOM;MAPK8IP3
prerank,CellMarker_Augmented_2021__Stem cell:Liver,0.765646526880196,1.2566885922912145,0.13846153846153847,0.44094625154059114,1.0,3/14,6.44%,THY1;LGR5;CD44
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),-0.5877336362590168,-1.2566792636207167,0.21875,0.7895795565695698,1.0,6/23,18.33%,SELENOS;TMED9;DERL2;AUP1;RANGRF;PREB
prerank,CellMarker_Augmented_2021__Plasma cell:Salivary Gland,0.5512032966953182,1.2566469062140069,0.14285714285714285,0.4408190108275359,1.0,20/73,10.71%,MET;EPHA2;CEP170B;DAB2IP;EPS8L2;BAIAP2L1;EPB41L4B;PARD3;PTPN21;AGRN;RHBDF1;RHOD;MYO1B;MYO1C;LAMA5;ASS1;DHCR24;YAP1;DLG5;TEAD1
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.6154441962636696,1.2563538505393832,0.17142857142857143,0.4414260006076486,1.0,9/29,13.35%,IL1RAPL1;NLGN1;GRID2;ICAM1;IGSF21;TENM4;PTPRD;ITGAL;HMCN1
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),0.7276987726041434,1.256329554599915,0.18333333333333332,0.44125451674138644,1.0,5/13,10.41%,PDGFRA;PLEK;TEC;PDGFA;SYK
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.6486346265855929,1.2563081691821403,0.15555555555555556,0.44111628224033245,1.0,5/15,17.46%,EFNA1;EPHA4;ABCA2;SLC2A13;ABCG1
prerank,Reactome_2022__Regulation Of IFNA/IFNB Signaling R-HSA-912694,0.7745221859494527,1.2560951218623213,0.27692307692307694,0.4414907714848777,1.0,2/9,11.45%,SOCS3;TYK2
prerank,GO_Biological_Process_2021__cardiac muscle cell myoblast differentiation (GO:0060379),0.8428712015016533,1.2560905898584211,0.10416666666666667,0.44129195571863566,1.0,1/5,6.35%,NRG1
prerank,Reactome_2022__Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.6412664841739796,-1.256073370816726,0.25,0.7906665627559186,1.0,1/17,0.65%,CDC26
prerank,CellMarker_Augmented_2021__Pancreatic Polypeptide cell:Pancreas,-0.7409459853482152,-1.2560718857574995,0.23076923076923078,0.7892657060383859,1.0,2/10,7.28%,ID2;ID4
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.46321386408454207,1.25602377248006,0.011627906976744186,0.44127504361993525,1.0,79/523,13.18%,LEF1;TGFBR2;CDKN2A;NR4A3;SIX3;ST18;BOK;GPNMB;IL13RA1;IGF1;KIF14;PROX1;PDGFRA;IL15;EGF;TESC;CHRM1;THBS1;STAT4;FLT1;IRS2;APP;DAB2IP;PRAME;TGFA;PODN;FABP3;KLF11;TRPM4;OSMR;SOX4;NUAK1;BTG3;BCL6;CLMN;NTRK3;IGFBP7;KLF10;NRG1;BAP1;CCKBR;SCX;PML;CYP1B1;PDGFA;CDK6;DUSP22;CTNNB1;CAPN1;ZBTB7C;KITLG;YAP1;LMNA;GAB2;NEURL1;CTBP2;HDAC4;NAMPT;TGFB2;DLG5;STAT3;P3H2;S1PR3;STX4;CDC7;MLXIPL;CDKN1B;BCL2;MEIS3;DLG3;ATP8A2;FN1;TFAP2C;KLF4;ALK;PAK1;PDPN;TRAPPC14;CDKN1A
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.788020903036025,1.2559636988925373,0.24528301886792453,0.44120310864736934,1.0,4/9,12.79%,NPTX2;DLGAP3;NPTX1;DLGAP1
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),-0.7491530175628318,-1.2558143139352573,0.14634146341463414,0.7888589577534655,1.0,3/9,10.84%,PGP;COQ3;GK
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.7139377838665517,1.2556715351181031,0.16363636363636364,0.4418244033979077,1.0,1/15,0.71%,BOK
prerank,Reactome_2022__DNA Repair R-HSA-73894,-0.46183512706561974,-1.2556367565767537,0.038461538461538464,0.7881696295858555,1.0,68/262,21.64%,H2AC20;ERCC8;DCLRE1B;KPNA2;FANCF;RFC3;H2BC4;H2BC21;COPS8;ATRIP;HUS1;GTF2H5;POLR2K;MCRS1;POLD3;SIRT6;GTF2H2;H2AC6;CETN2;BRIP1;ABRAXAS1;COPS7A;ERCC2;POLG2;POLR2C;RAD23A;HMGN1;ERCC6;RAD9B;PNKP;RMI2;POLR2D;PPIE;CLSPN;POLR1B;RNF168;SLC19A1;XPA;H2AJ;RNF8;DNA2;RUVBL1;FANCM;SEM1;BRCC3;MUS81;ERCC3;H2BC5;NFRKB;APEX1;RAD51;SMARCA5;UBB;UBE2V2;COPS3;RAD17;POLR2L;POLR2G;SLX4;FANCE;MSH3;XRCC2;MPG;COPS6;PARP1;BRCA2;RCHY1;UBE2T
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.7233119187488241,1.2555870660782615,0.14285714285714285,0.4417797694255534,1.0,2/12,8.12%,MET;CTNNB1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),0.8694036305724332,1.2554214015724652,0.09259259259259259,0.4419110518386575,1.0,1/5,6.91%,SNCA
prerank,Reactome_2022__Adenylate Cyclase Inhibitory Pathway R-HSA-170670,0.7510309649645213,1.2553496238607287,0.1864406779661017,0.44194882100106225,1.0,3/11,7.19%,ADCY5;ADCY7;ADCY2
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),0.8625895691095368,1.2549808070884445,0.12727272727272726,0.4427662561098452,1.0,3/6,5.57%,SLIT2;SLIT3;PADI2
prerank,KEGG_2021_Human__Longevity regulating pathway,0.538182036498203,1.2548508026520935,0.11267605633802817,0.4429298145002274,1.0,18/89,18.30%,IGF1;CREB5;ADCY5;IRS2;FOXO1;ADCY7;FOXO3;ADCY2;CLPB;PPARG;ADIPOR2;RPS6KB2;PIK3CD;TP53;ADCY3;IGF1R;STK11;TSC2
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.5823756025755117,1.2548319029688357,0.15,0.4427585928168817,1.0,9/37,13.58%,PIEZO2;MAP3K14;FAS;TNFRSF1A;MYD88;SLC9A1;GADD45A;TNFRSF10B;FADD
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.530653516258654,1.2547899637789366,0.12307692307692308,0.44268622829397686,1.0,26/101,12.00%,COL4A1;IGF1;PDGFRA;DCN;CALD1;ABCA8;COL4A2;ANGPTL2;COL21A1;POSTN;COL12A1;PTPN21;MLANA;MAOB;C1R;MATN2;ASS1;ADGRF5;BGN;YAP1;RASL12;SLCO2A1;LAMA2;GAS6;PRICKLE2;PARD3B
prerank,CellMarker_Augmented_2021__Fat Cell (adipocyte):Adipose Tissue,0.7048860385137983,1.2544974140730907,0.18333333333333332,0.44339215931725406,1.0,6/14,12.70%,VSTM2B;ZIC1;VSTM2A;PPARG;ADIPOR2;SLC27A5
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.671072280442053,1.2543240597123588,0.16981132075471697,0.4437304049723895,1.0,6/18,17.67%,ACSL5;CTNNB1;FBP1;IL4R;CDH17;RAP1A
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.5650314685874367,1.2542452214435982,0.14035087719298245,0.4437069616012634,1.0,18/62,23.80%,DAB2IP;EPHA5;RAP1GAP;SIPA1L1;EPHA4;FGD5;PLXNA4;PLXNA1;PLXNA2;NGEF;TBC1D10B;VAV2;CAMK2A;VAV1;ARHGAP9;EPHA3;OCRL;TDG
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.6877665296038447,1.2542430808079872,0.1896551724137931,0.4435029409393439,1.0,4/17,12.41%,WNT8B;DVL1;CTNNB1;FRAT2
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.718284807046347,-1.2541006859160044,0.275,0.7932477542209055,1.0,5/8,26.66%,MTRES1;MTG2;TSFM;ALKBH1;METTL4
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.8403743175266596,1.2539807953108473,0.1276595744680851,0.44401022938388174,1.0,2/6,10.06%,DENND3;DENND4A
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.7654441478836438,1.2539296807296287,0.14,0.44391560908359345,1.0,7/11,17.95%,PRODH;STK25;CYP1B1;PRKCD;PDK1;MAP3K5;STK24
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),-0.7854782873187948,-1.2539236092916808,0.2926829268292683,0.7924991706878374,1.0,1/5,4.36%,APOE
prerank,Reactome_2022__Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.4472680259939028,-1.2538318979892933,0.03333333333333333,0.7916321620628713,1.0,45/228,15.40%,SNRNP27;FIP1L1;PDCD7;LSM7;SNRPB2;DHX16;LSM3;SF3B4;SF3A1;POLR2K;AAAS;ZCRB1;RBM8A;PPWD1;LSM2;CRNKL1;NUP50;U2AF1;SF3B6;BUD31;TFIP11;LSM5;DDX46;SNU13;METTL3;PPIH;PQBP1;SYF2;CPSF1;PPIL3;POLR2C;SNRNP25;LSM4;NUP54;GTF2F1;PRPF8;PPIL1;SRSF2;RBM22;PRPF3;POLR2D;PPIE;RBMX;CPSF3;SUGP1
prerank,CellMarker_Augmented_2021__Nephron Epithelial cell:Kidney,0.7269517266851452,1.2537559142107766,0.18867924528301888,0.4442528105718066,1.0,3/9,10.32%,PTPRO;CLDN16;PODXL
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.7632089620233162,1.2537322427546944,0.23333333333333334,0.4441144659841318,1.0,2/14,6.91%,NOS1AP;SNCA
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Umbilical Cord Blood,0.5712535463839032,1.2536656192246667,0.13636363636363635,0.4440909079635546,1.0,13/42,10.90%,C1ORF87;CP;POSTN;AHR;ITGA2;LPP;CFH;POF1B;CAPN8;GNA14;ADGRF5;SLCO2A1;DUOXA1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),-0.6652034797090006,-1.2536305496195412,0.17073170731707318,0.791050241629071,1.0,4/13,18.19%,UQCRFS1;ETFB;ETFDH;ETFRF1
prerank,Reactome_2022__TICAM1-dependent Activation Of IRF3/IRF7 R-HSA-9013973,0.7030756957971406,1.253604647606089,0.22413793103448276,0.4440946583772147,1.0,5/12,21.09%,IRF7;IKBKE;TLR3;RPS27A;TBK1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.5921600366631733,1.2535091846347919,0.18840579710144928,0.4441856801761295,1.0,16/54,11.23%,CXCL2;C3;TYMP;SFTPD;SIGLEC1;IL1R1;SOAT1;NRN1;STEAP4;GRK2;CAPN8;ADGRF5;RNASE1;DUOXA1;CLDN18;FBP1
prerank,Reactome_2022__Disinhibition Of SNARE Formation R-HSA-114516,0.816634742515007,1.2534839435333975,0.23333333333333334,0.44408034015415615,1.0,3/5,12.05%,PRKCB;PRKCG;STX4
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.704339902965618,-1.2534145876884584,0.28888888888888886,0.7902290738508793,1.0,2/9,17.60%,PDZD11;SLC5A6
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),0.7959061259365365,1.2532413233606763,0.23214285714285715,0.44459089869407936,1.0,2/7,12.01%,ICAM1;ITGAL
prerank,CellMarker_Augmented_2021__Cancer Stem-Like cell:Endometrium,0.6072014940013746,1.2532409262490816,0.18461538461538463,0.44438197439958027,1.0,15/47,13.09%,HLA-DRA;ST6GAL1;ITM2A;ELMO1;PLEK;SLA;PRKCB;KCNQ1;PTPRC;LDLRAD4;PPP1R16B;ADAM28;HLA-DRB1;ITGAL;RASGEF1B
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.652370334584503,1.2531758742606063,0.16393442622950818,0.44441280145944756,1.0,4/17,16.11%,BLM;BARD1;MRE11;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),0.8119807485894367,1.252990135076471,0.13953488372093023,0.44478099599562565,1.0,3/6,18.09%,SNCA;NDFIP2;CTTNBP2NL
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),0.8274363448030048,1.2528374012772707,0.18518518518518517,0.44506725510997847,1.0,1/5,4.82%,PLSCR1
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),-0.8412174301208755,-1.2525261613524614,0.15217391304347827,0.7922076640717843,1.0,1/5,3.91%,SRI
prerank,KEGG_2021_Human__Phagosome,0.5318315921463149,1.252437878593093,0.14754098360655737,0.4460274055184659,1.0,11/100,7.49%,HLA-DRA;C3;TLR2;CTSS;THBS1;SFTPD;COLEC12;ITGA2;TUBB1;COLEC11;C1R
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.8246199423960299,1.2521285839292615,0.15789473684210525,0.4467529840160214,1.0,2/6,17.14%,HOOK1;HOOK2
prerank,CellMarker_Augmented_2021__Ito Cell (Hepatic Stellate cell):Liver,0.8679113342321848,1.2521037699054032,0.12727272727272726,0.446587087396167,1.0,4/5,7.36%,ACTA2;FAP;SYP;GFAP
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),-0.8117886362682932,-1.2519455381909006,0.23404255319148937,0.7926163368171661,1.0,1/5,3.74%,ORMDL1
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.6110183164635282,1.2519118958383542,0.2153846153846154,0.44692625558251065,1.0,3/28,9.35%,KLF2;GLRA2;NEURL1
prerank,Reactome_2022__Tryptophan Catabolism R-HSA-71240,-0.6455170827991147,-1.2517675359669915,0.26666666666666666,0.7920901178554247,1.0,4/13,9.23%,IDO1;SLC3A2;ACMSD;TDO2
prerank,KEGG_2021_Human__Arachidonic acid metabolism,0.6143186090106492,1.2517243592298337,0.140625,0.44723797323765013,1.0,1/31,0.01%,GGT5
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.6214810824508009,-1.2516275006962319,0.13793103448275862,0.7913261350342631,1.0,4/24,5.88%,PYGM;PPP1R3C;NR1D1;AGL
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.548581020058851,1.2515418627843695,0.14705882352941177,0.4475222788976612,1.0,15/53,15.77%,PTK6;PSCA;TJP3;SYNGR2;CAPN1;ANO9;SH2D3A;DTX2;PRKCD;ANXA11;IL4R;RHBDF2;RPS6KB2;PRRG4;ABHD11
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.6484702526370252,1.2515143339380912,0.2153846153846154,0.4473617543504231,1.0,10/33,12.18%,NLGN1;SNCB;SYT1;SYT5;DNM1;SYNJ2;SNCA;PACSIN1;OPHN1;MX1
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),-0.8401906138560871,-1.2515135276868616,0.06666666666666667,0.7903389259180127,1.0,1/6,6.62%,BCAP31
prerank,GO_Biological_Process_2021__regulation of gap junction assembly (GO:1903596),0.8730276735340005,1.2511736180095405,0.13043478260869565,0.44810093068769347,1.0,2/5,7.04%,CNTNAP2;APLNR
prerank,Reactome_2022__Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.6257521589506747,-1.2509602316443973,0.17777777777777778,0.7910000454162276,1.0,3/26,4.91%,DCXR;PPP1R3C;PMEL
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.6671255718178817,1.2509411901621388,0.09836065573770492,0.44850901285128125,1.0,9/21,22.21%,ALDOB;HK2;PFKL;PGK1;ENO2;HK1;ENO3;PFKP;FOXK1
prerank,CellMarker_Augmented_2021__Parietal Progenitor cell:Stomach,0.8208570781390879,1.2508638764379905,0.2,0.44844028897374777,1.0,3/5,12.14%,ANXA1;CFH;FGD5
prerank,KEGG_2021_Human__Alcoholism,0.5368473922504574,1.2508564896070202,0.1,0.44824716726972985,1.0,16/102,9.67%,NPY;FOSB;GRIN3A;GRIN2A;GNG3;CREB5;GRIN2D;GRIN2B;ADCY5;SHC2;GNG2;MAOB;GRIN1;PKIA;PPP1CB;HDAC4
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.6539195119627318,1.2505033076162122,0.16129032258064516,0.44872107287079044,1.0,4/21,10.01%,ZDHHC9;ZDHHC22;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.6539195119627318,1.2505033076162122,0.16129032258064516,0.44872107287079044,1.0,4/21,10.01%,ZDHHC9;ZDHHC22;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.7300191887376264,1.250499644271364,0.24074074074074073,0.44852809036547425,1.0,3/11,4.94%,THBS1;XKR4;XKR6
prerank,Reactome_2022__TRAF3-dependent IRF Activation Pathway R-HSA-918233,0.6754480339230572,1.2504089243463394,0.23728813559322035,0.44857294511545515,1.0,3/13,14.66%,IRF7;IKBKE;IFIH1
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.5298960682800552,1.2503391694679544,0.09375,0.4485421750379177,1.0,26/118,18.30%,RASGRP2;KIF14;CD22;RIT2;LTBP4;DAB2IP;FAM107A;BAP1;PAK4;GFAP;PACSIN1;SLITRK4;OPHN1;ANGPTL7;TMC8;NCLN;CAMSAP3;BCAR1;PINK1;WNT5A;RAP1A;TFRC;STK11;ERMN;SEMA4D;TSC2
prerank,KEGG_2021_Human__Melanoma,0.5735318581169235,1.2500486859860196,0.13043478260869565,0.44909962763386335,1.0,5/57,1.45%,CDKN2A;MET;IGF1;PDGFRA;EGF
prerank,Reactome_2022__Glycogen Metabolism R-HSA-8982491,-0.6018802764151968,-1.2498405570108704,0.21875,0.7945588521526394,1.0,3/22,5.88%,PYGM;PPP1R3C;AGL
prerank,Reactome_2022__PLC Beta Mediated Events R-HSA-112043,0.5770688617913405,1.2495991904239663,0.16666666666666666,0.4500503062278008,1.0,13/43,12.29%,PDE1C;ADCY5;PRKCG;PRKAR1B;ITPR3;PDE1A;ADCY7;ADCY2;GRK2;GNA14;PDE1B;CAMK2B;PRKCD
prerank,CellMarker_Augmented_2021__Lymphoid Stem cell:Peripheral Blood,-0.48606601892810253,-1.2495737926299368,0.08571428571428572,0.7940602706382562,1.0,16/93,11.98%,PAK1IP1;SLC25A5;POLR2K;TRMT10C;MED10;PDCL3;MRPL15;MRPL18;SF3B6;MRPL47;TPRKB;NDUFA8;PPIH;TIMM23;MRPL21;VBP1
prerank,CellMarker_Augmented_2021__Mesothelial cell:Undefined,0.6115613933546893,1.2494463058076595,0.18840579710144928,0.4502776722119381,1.0,12/39,10.97%,EPHA2;PLEKHG6;LSR;EPS8L2;BAIAP2L1;AGRN;RHOD;PAK4;LAMA5;ITGA3;DOK7;DTX2
prerank,CellMarker_Augmented_2021__Natural Killer cell:Liver,0.656294163019773,1.2493052392870059,0.16176470588235295,0.450423995552279,1.0,4/22,3.65%,P2RY13;MYO1F;SLA;SIGLEC1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.5782281853297809,-1.249258670402124,0.11764705882352941,0.7938405377739383,1.0,9/49,11.55%,HEY2;NRARP;HEYL;ASCL1;POFUT1;MAML3;HEY1;NCSTN;HES5
prerank,CellMarker_Augmented_2021__Side-population cell:Undefined,0.6419954030464528,1.249154300151319,0.14516129032258066,0.45060250037554483,1.0,13/37,8.72%,TGFBR2;ALS2CL;ANXA1;S100A10;THBS1;CD24;EPHA2;TGFA;AHR;ITGA2;CD44;EMP1;ITGA3
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.7075432362675765,1.2487960321328637,0.171875,0.4515453309496155,1.0,3/17,9.24%,ANXA1;DMTN;PRKCE
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.8212403059216907,1.2486725653655562,0.2037037037037037,0.4516747182510864,1.0,2/8,9.80%,AK3;AK5
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),0.6824572222849047,1.2484881585932077,0.14925373134328357,0.4519276966511564,1.0,7/22,21.17%,PRKCB;PID1;PIP4K2A;PRKCD;TSC2;PTPRE;GRB10
prerank,Reactome_2022__Transport Of Organic Anions R-HSA-879518,0.7610205538923857,1.2483989342036608,0.20408163265306123,0.45196001403884734,1.0,3/7,16.10%,SLCO1A2;SLCO2A1;SLCO3A1
prerank,CellMarker_Augmented_2021__Dendritic cell:Thymus,0.6628698977624236,1.2483764599304152,0.15,0.45180959363188183,1.0,10/26,12.01%,CTSS;MYO1F;PLEK;WAS;LAT2;PTPRC;CD37;CD83;PILRA;ITGAL
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.7148806192178105,1.2483375738816551,0.2153846153846154,0.45167542644075576,1.0,2/9,1.68%,KLF2;THBS1
prerank,PanglaoDB_Augmented_2021__Motor Neurons,0.5902477547407017,1.2483327018811978,0.14285714285714285,0.4514662205924737,1.0,19/61,16.31%,C1QL1;ARHGAP39;EFNB3;CDK5R2;VGF;C2CD4C;SRRM3;B4GALNT1;GLI2;TEAD1;ENAH;MEIS3;IGDCC4;FAM131C;RBFOX2;BCAR1;SEZ6L2;FZD7;PFN2
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.5022961113029779,-1.248266643515122,0.08571428571428572,0.7961903061396337,1.0,20/97,14.87%,ERCC8;RFC3;COPS8;HUS1;GTF2H5;POLR2K;POLD3;GTF2H2;CETN2;BRIP1;GTF2H2C;COPS7A;ERCC2;POLR2C;RAD23A;HMGN1;ERCC6;PNKP;POLR2D;PPIE
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.49981312480185397,1.2477440016609114,0.0547945205479452,0.45289929507122106,1.0,24/182,10.05%,LEF1;TGFBR2;IGF1;NPNT;VWC2;ZFP36;NELL1;RPS6KA1;RBM24;PCP4;TRPM4;ZBTB16;NEUROD2;BOC;CTNNB1;KITLG;PKDCC;SMAD3;YAP1;PRKCH;PPARG;MMD;TGFB2;RIN2
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),0.7712996782776333,1.2477206894986397,0.21568627450980393,0.45277017369212175,1.0,2/10,3.61%,PTK6;NLRP12
prerank,CellMarker_Augmented_2021__Stem cell:Cartilage,0.764149598478087,1.2475856296657217,0.1935483870967742,0.45298429700346277,1.0,3/7,6.44%,THY1;MCAM;CD44
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.6119236847961826,-1.2473192094304442,0.1794871794871795,0.7984530286081672,1.0,6/21,13.90%,ISCU;CIAO3;ISCA2;CIAO2B;NFS1;NFU1
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.6732865676567172,1.247199490839353,0.1864406779661017,0.4538144904552563,1.0,3/17,7.56%,PAPSS2;TPST1;SULT4A1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.7388674158707212,1.2471299751663667,0.24074074074074073,0.4538190345845438,1.0,4/10,14.96%,ZFP36;WTIP;STAT3;PUM1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.5380341656606568,1.2471279036476308,0.1323529411764706,0.453614772305131,1.0,11/76,13.76%,HLA-DRA;CTSS;SH3GL2;MARCHF1;AP1S1;KIF5A;ACTR1A;HLA-DRB1;KLC2;KLC1;HLA-DMA
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),0.7331581607313935,1.2469654842917386,0.23076923076923078,0.4539083817212638,1.0,2/13,3.34%,SHTN1;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.8353725564812267,1.2468583085237992,0.23636363636363636,0.4539556679241983,1.0,2/5,10.41%,MMP14;SYK
prerank,CellMarker_Augmented_2021__Monocyte:Bone Marrow,0.6597481141823831,1.2467772866092746,0.14925373134328357,0.45400825699948055,1.0,6/21,2.63%,TLR2;CTSS;P2RY13;MYO1F;PLEK;SLA
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.8304613235021259,1.246757049324794,0.19047619047619047,0.4538630684973462,1.0,3/7,5.44%,GAP43;RTN4RL1;APOD
prerank,CellMarker_Augmented_2021__Erythroid precursor:Bone Marrow,0.5492158932478884,1.2466877572405783,0.1346153846153846,0.4538034788760864,1.0,14/61,14.59%,ARHGAP4;SLC43A1;WAS;RPS6KA1;IL27RA;LAT2;CD37;THOC6;IKBKE;NFKBID;TMC8;SIPA1;RGS14;MIIP
prerank,Reactome_2022__Abacavir ADME R-HSA-2161522,0.8413376768465327,1.2466155734507154,0.12727272727272726,0.45381335253201144,1.0,1/7,2.80%,ABCB1
prerank,CellMarker_Augmented_2021__CD14+ Endothelial Progenitor cell:Blood,0.5761301523814256,1.246576613845132,0.19672131147540983,0.45371648413433213,1.0,20/57,15.04%,C3;FLT1;GPR34;DYSF;SIGLEC1;ACKR1;IGFBP7;TNS1;LDB2;PID1;APLNR;RAMP3;ADGRF5;RNASE1;ITGA9;PDK4;FGD5;ROBO4;KCTD12;SERPING1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.7192120234325876,1.2464680916421205,0.22033898305084745,0.45377439646689427,1.0,3/12,10.65%,HRH1;NFATC2;INPP5A
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Corneal Epithelium,0.5458860059296181,1.246422064142916,0.12121212121212122,0.4531056916453341,1.0,19/93,12.56%,L1CAM;TEAD2;SHC2;DAB2IP;EFNB3;ARHGEF17;PRIMA1;SEMA5B;CCDC3;BOC;ADGRL2;MAPK8IP1;C2CD4C;SRRM3;CNN3;PCDHB15;NACAD;CRMP1;MEIS3
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Corneal Epithelium,0.5458860059296181,1.246422064142916,0.12121212121212122,0.4531056916453341,1.0,19/93,12.56%,L1CAM;TEAD2;SHC2;DAB2IP;EFNB3;ARHGEF17;PRIMA1;SEMA5B;CCDC3;BOC;ADGRL2;MAPK8IP1;C2CD4C;SRRM3;CNN3;PCDHB15;NACAD;CRMP1;MEIS3
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Liver,0.5458860059296181,1.246422064142916,0.12121212121212122,0.4531056916453341,1.0,19/93,12.56%,L1CAM;TEAD2;SHC2;DAB2IP;EFNB3;ARHGEF17;PRIMA1;SEMA5B;CCDC3;BOC;ADGRL2;MAPK8IP1;C2CD4C;SRRM3;CNN3;PCDHB15;NACAD;CRMP1;MEIS3
prerank,CellMarker_Augmented_2021__Epithelial Stem cell:Laryngeal Squamous Epithelium,0.5458860059296181,1.246422064142916,0.12121212121212122,0.4531056916453341,1.0,19/93,12.56%,L1CAM;TEAD2;SHC2;DAB2IP;EFNB3;ARHGEF17;PRIMA1;SEMA5B;CCDC3;BOC;ADGRL2;MAPK8IP1;C2CD4C;SRRM3;CNN3;PCDHB15;NACAD;CRMP1;MEIS3
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.552789909846548,1.2462846940508105,0.15384615384615385,0.45333937570400684,1.0,4/40,2.82%,CCBE1;THBS1;NR4A1;SLIT2
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),0.8155278959473762,1.2460521906453919,0.16363636363636364,0.4538441399895408,1.0,1/6,6.40%,BAP1
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),-0.42827870670847046,-1.2460222064526294,0.041666666666666664,0.802913330732639,1.0,66/271,15.31%,MRPL10;RPL35A;RPS24;RFC3;RPL34;RPL39;MRPS21;ATRIP;RPL13;RPL37;HUS1;GAL3ST2;MRPL52;POLR2K;RPS28;APOE;MRPS7;RPL18;MCM9;POLD3;RPL12;RPL23;RPL31;MRPL36;MRPS16;MRPL18;ALAS1;RPS26;RPL6;BRIP1;RPL41;MCM6;RPS13;RPL22;RPL29;RPL30;ASMT;RPSA;KIN;EEFSEC;RPL14;RRAGC;RPL15;EEF1A1;RPS2;ATR;POLR2C;GAL3ST4;IGF2BP3;EEF1B2;RPL11;RPL23A;MCM4;MRPS18B;RPS21;MRPS33;RAD9B;RPS23;NFKBIB;RMI2;POLR2D;YARS2;MLF1;MRPS12;THAP1;CLSPN
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.6552897682001647,1.2459869322620212,0.24074074074074073,0.45377419826984466,1.0,1/13,0.99%,TYMP
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.7005383443312347,1.2459190422931372,0.2028985507246377,0.4535282633442933,1.0,4/14,12.99%,ZYX;SORBS1;KCTD13;PHACTR1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.7005383443312347,1.2459190422931372,0.2028985507246377,0.4535282633442933,1.0,4/14,12.99%,ZYX;SORBS1;KCTD13;PHACTR1
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),0.754795417518904,1.2458363040984937,0.20754716981132076,0.45361254539547374,1.0,4/10,10.90%,CNTNAP1;TENM4;TPPP;ABCA2
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),0.7973519339974947,1.2456604348932958,0.19607843137254902,0.45384535538908144,1.0,4/6,18.06%,TNFRSF14;MAPK8IP1;SYK;TNFSF4
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.7666848149435528,-1.2456587585450227,0.2653061224489796,0.8029812351695851,1.0,2/7,7.09%,SMYD5;SFRP2
prerank,Reactome_2022__Cellular Senescence R-HSA-2559583,-0.49082888090880106,-1.245614849008202,0.18181818181818182,0.8018322637947981,1.0,11/126,5.51%,H1-2;H2AC20;ID1;CDC26;CCNE1;H3-3B;H2BC4;H2BC21;H1-4;RNF2;H2AC6
prerank,Reactome_2022__PTK6 Regulates RTKs And Their Effectors AKT1 And DOK1 R-HSA-8849469,0.7427813464943952,1.2455290262294954,0.17391304347826086,0.4539930739344142,1.0,1/9,1.86%,PTK6
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),0.707276191975826,1.2454935080427134,0.21666666666666667,0.45386492888450714,1.0,4/10,18.06%,SYK;HLA-E;RARA;TNFSF4
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.6864228979370067,1.2454370363700429,0.1935483870967742,0.4538217017516524,1.0,5/14,16.87%,CD55;STAT3;HLA-DRB1;CD70;BACH2
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.7490334230146687,1.2453575388583429,0.2692307692307692,0.4539056570895498,1.0,4/8,18.30%,DAPK2;IKBKG;STK11;TSC2
prerank,KEGG_2021_Human__Nucleotide excision repair,-0.5332387224420704,-1.245353845678387,0.1282051282051282,0.801523065281768,1.0,10/42,12.85%,ERCC8;RFC3;GTF2H5;POLD3;GTF2H2;CETN2;GTF2H2C;ERCC2;RAD23A;ERCC6
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),-0.7955615081776923,-1.2451787794699172,0.21818181818181817,0.799723499035223,1.0,2/6,13.38%,ASIP;CDH3
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),-0.7955615081776923,-1.2451787794699172,0.21818181818181817,0.799723499035223,1.0,2/6,13.38%,ASIP;CDH3
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.7716213589585735,1.2451679977847103,0.22807017543859648,0.4541430966117063,1.0,1/7,6.47%,TNFRSF1A
prerank,Reactome_2022__cGMP Effects R-HSA-418457,0.7258972516484549,1.2450232890250026,0.24074074074074073,0.4542532924485733,1.0,9/13,20.78%,KCNMB4;PRKG2;PDE1A;PDE1B;PDE10A;KCNMA1;ITPR1;IRAG1;PDE2A
prerank,Reactome_2022__SUMOylation Of Intracellular Receptors R-HSA-4090294,0.6383131016059327,1.2449956993098936,0.15,0.4541729343925676,1.0,10/24,21.11%,PGR;PPARG;HDAC4;NR4A2;RARA;RXRA;RORA;PIAS1;THRA;UBE2I
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),0.5487384472334568,1.2448305269216589,0.1076923076923077,0.4545474138760301,1.0,21/75,17.13%,RASGRP1;APP;MAP3K11;DAB2IP;RELL1;STK25;DUSP22;UNC5CL;MAPK8IP1;SH3RF3;MINK1;TGFB2;TNFRSF19;GADD45A;TPD52L1;HIPK2;MAP3K5;FZD7;ANKRD6;TRAF5;MFHAS1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.6375499663319845,1.2448264271558438,0.1694915254237288,0.45435599854775444,1.0,1/20,1.17%,PDGFRA
prerank,Reactome_2022__Signaling By B Cell Receptor (BCR) R-HSA-983705,0.5325564260358644,1.2447693259250125,0.11267605633802817,0.4542387216086485,1.0,9/94,10.41%,CD22;RASGRP1;PRKCB;SH3KBP1;NFATC2;FYN;ITPR3;ORAI1;SYK
prerank,Reactome_2022__Signaling By Receptor Tyrosine Kinases R-HSA-9006934,0.4627292185314529,1.244619570200347,0.037037037037037035,0.45444895671170205,1.0,74/402,13.24%,HPN;FOSB;COL4A1;FLRT3;IGF1;PDGFRA;KCNH8;EGF;SH3GL2;THBS1;GRIN2B;PTK6;ELMO1;RIT2;GABRB2;SH3GL3;FLT1;COL4A2;PRKCB;SHC2;TEC;IRS2;RPS6KA1;NRP2;ERBIN;GABRG3;TGFA;SH3KBP1;WASF1;FYN;CDK5R2;LAMB1;ITGA2;ANOS1;BAIAP2;DNM1;NTRK3;ITPR3;GABRA1;NRG1;VGF;PGR;FLRT1;GFAP;NRG2;PDGFA;GABRG2;LAMA5;CTNNB1;KITLG;ITGA3;YAP1;PRKCE;GAB2;ARHGEF7;RNASE1;COL9A1;TF;PAG1;STAT3;ADAM12;LAMA2;COL4A4;CTNNA1;FGF13;SPARC;PRR5;ARF6;PRKCD;HNRNPH1;ALK;MEF2D;LRIG1;COL4A5
prerank,KEGG_2021_Human__Cellular senescence,0.5194139463240811,1.24459324509073,0.1111111111111111,0.45431063095524227,1.0,35/132,18.87%,TGFBR2;CDKN2A;SERPINE1;CCNB2;TRAF3IP2;FOXO1;NFATC2;ITPR3;FOXO3;CDK6;MRAS;CAPN1;SMAD3;PPP1CB;HIPK3;TGFB2;GADD45A;HIPK1;CDKN1A;CCND1;HIPK2;MRE11;PIK3CD;MAPK11;HLA-E;ETS1;TP53;CDK2;CALM3;MAP2K3;CCNB1;ITPR1;TSC2;SMAD2;NFATC3
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),-0.7354509126692728,-1.2445773843345407,0.2,0.8004848900564789,1.0,2/7,13.49%,VAMP8;ATG14
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.6727085332884045,1.24450542432551,0.23809523809523808,0.4543676402187091,1.0,4/17,10.27%,ST18;SOCS3;YAP1;STAT3
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),0.7643162803829626,1.2443884107060332,0.20689655172413793,0.4544615122570003,1.0,2/9,6.20%,CNTNAP1;PARD3
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.8078957732682546,1.2438681433759704,0.1896551724137931,0.45582036845778573,1.0,2/6,7.88%,MGAT3;LDLR
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.5817680442327959,1.2438331196032357,0.1791044776119403,0.45572382065065614,1.0,4/35,9.10%,ZFP36;ZC3H12D;RBM24;YTHDF1
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),-0.798049677431856,-1.2437279603051277,0.18604651162790697,0.8024628913983229,1.0,2/5,14.46%,TMEM126A;ERBB3
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6554918210029482,1.2436919342144956,0.20967741935483872,0.4558854109074749,1.0,3/19,11.65%,CD24;SCX;GFI1B
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.7118084449200601,1.2436673223938906,0.21311475409836064,0.4557257539528859,1.0,5/22,15.46%,ZFP36;WTIP;STAT3;PUM1;TP53
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),-0.7175379546869186,-1.2436479139031904,0.3333333333333333,0.8014172063300311,1.0,3/8,12.80%,GINS3;MCM6;MCM4
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),-0.7223305404124118,-1.2434225261723784,0.18604651162790697,0.8009438352429391,1.0,1/8,1.48%,MID1IP1
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.5834698186254785,1.2432542628884118,0.1791044776119403,0.45678166051822794,1.0,14/39,19.68%,ATP2B3;ITPR3;ABCC9;RYR2;ATP1A1;TMEM65;ATP1B1;ATP1B3;FXYD7;ATP2B4;SLC8A2;SLC8A1;ITPR1;AHCYL1
prerank,CellMarker_Augmented_2021__Microglial cell:Undefined,0.7760076400340647,1.2432295885263303,0.2545454545454545,0.456658555951066,1.0,4/7,21.56%,PTPRC;P2RY12;P2RX7;C5AR1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.7094713335385396,1.2430681264868795,0.17543859649122806,0.4568667401763995,1.0,4/12,15.01%,IRF7;CDK6;HLA-DRB1;CD4
prerank,CellMarker_Augmented_2021__Epithelial cell:Cornea,-0.7682771373472245,-1.243059786649893,0.2127659574468085,0.8010785707068122,1.0,1/6,0.22%,TRIM29
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.7004837462520772,-1.2430297003173487,0.2553191489361702,0.7998988570166011,1.0,2/12,10.22%,FIP1L1;CPSF1
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.572494454411269,1.2427849413381138,0.1388888888888889,0.45728491153581396,1.0,6/36,11.92%,SLC39A14;CHST15;ALDOB;PGK1;FBP1;ENO2
prerank,KEGG_2021_Human__Choline metabolism in cancer,0.5323221506422928,1.242550925063365,0.136986301369863,0.45778673620369004,1.0,27/87,21.46%,PDGFRA;EGF;PLD1;PRKCB;PRKCG;WAS;WASF1;PDGFA;DGKG;PLD2;CHKB;RPS6KB2;PIK3CD;SLC44A3;PIP5K1C;MAPK9;TSC2;PRKCA;HIF1A;DGKI;AKT3;RHEB;DGKZ;DGKD;RALGDS;SLC44A5;SLC44A1
prerank,Reactome_2022__Cytosolic tRNA Aminoacylation R-HSA-379716,-0.6395380088369067,-1.242378864710079,0.175,0.8010251605258082,1.0,8/23,18.34%,AIMP1;KARS1;VARS1;EPRS1;NARS1;RARS1;AIMP2;LARS1
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.7446505062599669,1.2423632628485826,0.21666666666666667,0.45778154838148455,1.0,5/10,16.77%,SLC24A2;SLC24A1;ATP2B4;SLC8A2;SLC8A1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.7446505062599669,1.2423632628485826,0.21666666666666667,0.45778154838148455,1.0,5/10,16.77%,SLC24A2;SLC24A1;ATP2B4;SLC8A2;SLC8A1
prerank,CellMarker_Augmented_2021__Stem cell:Pancreas,0.5549204469856895,1.24229828648921,0.14925373134328357,0.45772126423758497,1.0,18/76,12.75%,SHISA9;GRID2;CNTNAP2;CDH8;LGR5;PTCHD1;SLCO1A2;CHST6;ADCY2;LRRTM4;TSSC2;HUNK;COL9A1;CDKL5;ASTN2;FGF13;ZNF850;MAPKAPK5
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),0.8477861371893971,1.242271412588718,0.22580645161290322,0.4576086094793613,1.0,2/7,4.85%,SULF1;MCAM
prerank,KEGG_2021_Human__Salmonella infection,0.47597764383984364,1.2422468326158433,0.0945945945945946,0.4574960565789661,1.0,33/211,14.62%,LEF1;TLR2;S100A10;ELMO1;ARPC5L;NOD1;PAK3;PTPRC;PLEKHM1;TUBB1;BIRC3;TNFRSF1A;FHOD1;MYD88;CTNNB1;KIF5A;KIF5C;TUBB6;ARPC3;PODXL;ACTR1A;GSDMD;KLC2;ARF6;BCL2;KLC1;PAK1;TNFRSF10B;FADD;TUBA1B;IKBKG;PIK3CD;MAPK11
prerank,Reactome_2022__Tight Junction Interactions R-HSA-420029,0.6753539026128573,1.241790660853989,0.21311475409836064,0.458619720680188,1.0,5/14,14.51%,CLDN16;PARD3;CLDN18;CLDN20;PATJ
prerank,KEGG_2021_Human__Rap1 signaling pathway,0.49757072234280414,1.2417121707399488,0.11428571428571428,0.4586848167332248,1.0,27/169,8.69%,MET;CNR1;RASGRP2;IGF1;GRIN2A;PDGFRA;EGF;FYB1;RAPGEF5;THBS1;GRIN2B;FLT1;PRKCB;EPHA2;ADCY5;PRKCG;EFNA1;SKAP1;RAP1GAP;PARD3;ADCY7;ADCY2;GRIN1;PDGFA;MRAS;CTNNB1;KITLG
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.775319053806625,-1.2416175814766337,0.18,0.802866618386405,1.0,2/9,7.46%,FBXO5;FBXO43
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.59136806871672,1.2416024976315596,0.16901408450704225,0.4588388158120147,1.0,10/38,12.29%,NLGN1;PLPPR5;DMTN;GAP43;AGRN;PPP1R16B;NEURL1;FSCN1;ARF6;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.6049728224326609,1.2415647628568316,0.15,0.45873637229996816,1.0,10/47,12.17%,EPHA2;STAC2;RAMP3;ITGA3;PTPN9;PRKCE;PRKCH;SORBS1;STX4;ARF6
prerank,Reactome_2022__Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.5785410189188278,-1.241384918878968,0.225,0.8025229669275746,1.0,15/42,20.34%,GTF2H5;POLR2K;ELOC;GTF2H2;ELOA;SUPT16H;ERCC2;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",0.7751752898552549,1.2411974134661752,0.24,0.4594705534302122,1.0,4/6,16.70%,HS6ST1;HS3ST3B1;HS2ST1;HS6ST2
prerank,Reactome_2022__Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.5314252894858283,-1.2410082534739826,0.16666666666666666,0.8028458340201554,1.0,13/39,23.09%,GTF2H5;GTF2H2;CETN2;ERCC2;RAD23A;POLR1B;XPA;ERCC3;UBB;UBE2V2;PARP1;PIAS3;GTF2H3
prerank,Reactome_2022__EGFR Downregulation R-HSA-182971,0.61296228350801,1.2408250702241965,0.1346153846153846,0.4605176306907943,1.0,5/26,4.12%,EGF;SH3GL2;SH3GL3;TGFA;SH3KBP1
prerank,KEGG_2021_Human__RNA polymerase,-0.6295334388663476,-1.2407059706325234,0.16216216216216217,0.802643886806259,1.0,12/29,20.34%,POLR2K;POLR1F;POLR2C;POLR3E;POLR3B;POLR3F;POLR2D;POLR1B;POLR3H;POLR3K;POLR2L;POLR2G
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.8068403630118435,1.2406629321061098,0.1509433962264151,0.46072276234564796,1.0,2/7,5.54%,BOK;FAP
prerank,Reactome_2022__Synthesis Of DNA R-HSA-69239,-0.4863658533087872,-1.240555499416664,0.12,0.8018687619452113,1.0,25/102,20.20%,CDC26;CCNE1;GINS3;RFC3;POLD3;MCM6;SLC25A15;PSMD10;MCM4;ANAPC15;PSMD12;PRIM1;PSMB5;POLR1B;SLC19A1;PSMB6;DNA2;ORC6;PSME3;SEM1;PSMD2;UBB;CUL1;SKP2;PSMB4
prerank,KEGG_2021_Human__IL-17 signaling pathway,0.5839175367820211,1.2404212792565459,0.11475409836065574,0.4612044360358395,1.0,12/53,17.07%,FOSB;CXCL2;TRAF3IP2;IKBKE;CCL2;IL17RE;FADD;IKBKG;MAPK11;TRAF5;MAPK4;MAPK9
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.6540814000090485,-1.2403602455067089,0.25,0.8011598930204017,1.0,5/12,19.42%,MOCS2;NFS1;LIAS;NOXRED1;MOCOS
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Peripheral Blood,0.6977844722428908,1.2403117142374933,0.234375,0.46132035226394674,1.0,2/17,2.81%,CD24;ICAM1
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.6114788953193254,1.239993296564834,0.14516129032258066,0.46195782030714294,1.0,13/37,16.80%,SLIT2;PTPRC;SLIT3;CCDC3;PADI2;SAMHD1;NLRC5;PPARG;GAS6;TTLL12;TRAIP;RFFL;GPS2
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.7747771376548938,-1.2399817914270914,0.2564102564102564,0.8016481054313311,1.0,3/7,14.36%,CCDC22;PSMD10;NFKBIB
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.7563636387832375,1.239910863994079,0.22033898305084745,0.46201593697927096,1.0,2/6,19.36%,BRCA1;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.6202683616455912,1.2398701711660354,0.1724137931034483,0.4619280690184369,1.0,7/25,10.44%,SHISA7;RELN;APP;SHANK3;FAM107A;YTHDF1;EPHA4
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.7407611392078739,1.239781564401241,0.2692307692307692,0.4619809372942902,1.0,3/9,17.13%,PLSCR1;CD200;MFHAS1
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),0.7788841978947717,1.239473543819233,0.21666666666666667,0.4627367283989784,1.0,1/8,0.15%,NR4A3
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.7100325640940489,1.239410151959448,0.22413793103448276,0.46270070363932125,1.0,4/13,18.50%,APP;BAG3;CAMSAP3;APBA1
prerank,Reactome_2022__Interleukin-17 Signaling R-HSA-448424,0.5548079676968339,1.2393947524312237,0.15942028985507245,0.46252944587179506,1.0,14/59,20.32%,KCNH8;IRAK2;RPS6KA1;NOD1;IL17RE;TNIP2;IKBKG;MAPK11;TAB1;MAPK9;MAP2K3;SKP1;RPS27A;TAB2
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.6358378709048446,1.239319753985049,0.21311475409836064,0.4624883462500432,1.0,5/25,7.49%,HLA-DRA;C3;CD55;CFH;C1R
prerank,CellMarker_Augmented_2021__Lymphocyte:Peripheral Blood,0.6730566177619237,1.239216791183324,0.21311475409836064,0.46257203182604184,1.0,5/21,2.91%,CTSS;MYO1F;PLEK;SLA;WAS
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),0.8258962756979807,1.2389301980736411,0.2222222222222222,0.46319597620663716,1.0,3/5,11.20%,RELN;LHX6;FGF13
prerank,CellMarker_Augmented_2021__Stem cell:Bone,0.7959575161343366,1.2388176552495234,0.1702127659574468,0.463346781224579,1.0,3/6,4.85%,THY1;PTPRC;MCAM
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Lymph,0.5331563313976275,1.2386601458934905,0.109375,0.46315529542044526,1.0,29/93,23.84%,IL13RA1;PGD;ZSWIM4;AGRN;LASP1;ZNF787;YWHAG;TTYH3;YTHDF1;CTBP2;DNAJC5;B4GALT5;ZFAND3;SMURF1;MIDN;SBNO2;RCOR1;ACTN4;CPD;UBE2E1;ACVR1B;ADAM9;STK35;PHC2;CARM1;PITPNA;FNDC3B;OXSR1;C22ORF23
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Kidney,0.5331563313976275,1.2386601458934905,0.109375,0.46315529542044526,1.0,29/93,23.84%,IL13RA1;PGD;ZSWIM4;AGRN;LASP1;ZNF787;YWHAG;TTYH3;YTHDF1;CTBP2;DNAJC5;B4GALT5;ZFAND3;SMURF1;MIDN;SBNO2;RCOR1;ACTN4;CPD;UBE2E1;ACVR1B;ADAM9;STK35;PHC2;CARM1;PITPNA;FNDC3B;OXSR1;C22ORF23
prerank,CellMarker_Augmented_2021__EBV+ B Lymphoma cell:Liver,0.5331563313976275,1.2386601458934905,0.109375,0.46315529542044526,1.0,29/93,23.84%,IL13RA1;PGD;ZSWIM4;AGRN;LASP1;ZNF787;YWHAG;TTYH3;YTHDF1;CTBP2;DNAJC5;B4GALT5;ZFAND3;SMURF1;MIDN;SBNO2;RCOR1;ACTN4;CPD;UBE2E1;ACVR1B;ADAM9;STK35;PHC2;CARM1;PITPNA;FNDC3B;OXSR1;C22ORF23
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.7691802915157724,1.2386542292306886,0.21428571428571427,0.4629533436781533,1.0,2/10,9.47%,GGCT;GSS
prerank,Reactome_2022__CaMK IV-mediated Phosphorylation Of CREB R-HSA-111932,-0.6900467512200184,-1.238592874572263,0.20689655172413793,0.8057635647729597,1.0,1/10,1.25%,KPNA2
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.7691184849445214,-1.2385383466058335,0.24489795918367346,0.8045703900268648,1.0,1/7,10.58%,KMT2A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.7659542687494929,1.2382576842801252,0.19642857142857142,0.46369462047446103,1.0,4/9,10.44%,NELL1;DAB2IP;EFNA1;EPHA4
prerank,CellMarker_Augmented_2021__Pancreatic Ductal Stem cell:Pancreas,-0.6402122936268826,-1.2382171689193993,0.19444444444444445,0.804405526313372,1.0,7/20,11.41%,GOLT1A;KRT8;IL20RA;TMEM54;CPA1;EHF;B3GNT3
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.5626541555045106,1.2379003227208023,0.19696969696969696,0.4644196970238697,1.0,12/52,12.85%,KCNJ2;GRIN2B;TRPM4;SAMHD1;SNCA;GRIN1;KCNC1;HCN1;SHMT1;HOMER1;HLA-DRB1;B2M
prerank,Reactome_2022__Signaling By FLT3 Fusion Proteins R-HSA-9703465,0.6458120480253863,1.2377411017261741,0.13793103448275862,0.46468337700227863,1.0,4/18,14.73%,GAB2;ETV6;CDKN1A;NOX4
prerank,Reactome_2022__Sodium/Proton Exchangers R-HSA-425986,0.7806576148449176,1.2377174521639225,0.21428571428571427,0.46451215156504133,1.0,4/6,19.22%,SLC9A9;SLC9A1;SLC9A5;SLC9A2
prerank,CellMarker_Augmented_2021__Progenitor cell:Undefined,-0.5089115440691063,-1.2375786977069112,0.16129032258064516,0.8058698432403861,1.0,18/84,16.94%,KPNA2;CCDC86;EIF4EBP1;CCDC51;CCT7;PRDX1;POFUT1;DDOST;PPP1R14B;DOLK;GANAB;STT3A;TMED9;PSMB5;ARF4;SIGMAR1;MARVELD1;ALDH18A1
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),0.7412937716131063,1.237523852072353,0.2641509433962264,0.4648479676347861,1.0,1/5,6.43%,BIRC3
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.6331603494600062,1.2374651979472375,0.109375,0.46485260243329396,1.0,3/27,2.65%,ANXA1;SERPINE1;DMTN
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),-0.6818537287931656,-1.237373111043464,0.22,0.805489099284494,1.0,1/9,1.61%,SELENOS
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.613419566725582,1.237298153107066,0.19047619047619047,0.4650484388000894,1.0,6/31,15.53%,IGF1;MLLT11;BCL2L1;BBC3;TP53;PINK1
prerank,Reactome_2022__Histidine Catabolism R-HSA-70921,0.8447174229056662,1.2371372465752808,0.23636363636363636,0.46520277727473675,1.0,3/6,9.22%,CARNS1;HECA;FTCD
prerank,Reactome_2022__Retrograde Neurotrophin Signaling R-HSA-177504,-0.6713182497485413,-1.2370091330076256,0.18181818181818182,0.8055626126478358,1.0,1/12,0.09%,NGF
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.5939373289373916,1.2369376330530704,0.22807017543859648,0.4655376873801213,1.0,5/25,10.69%,PTPRO;DMTN;RHOD;ARHGEF7;P2RY12
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.6701177132580454,1.2368963753971416,0.1896551724137931,0.46544395127373145,1.0,6/24,16.14%,KLF2;NOS1AP;ASS1;SMAD3;KLF4;ATP2B4
prerank,Reactome_2022__Basigin Interactions R-HSA-210991,0.63404396170776,1.2367313804767937,0.2413793103448276,0.46570107811741274,1.0,7/22,13.21%,L1CAM;SLC7A7;MAG;ITGA3;ATP1B1;ATP1B3;DEAF1
prerank,Reactome_2022__Cyclin D Associated Events In G1 R-HSA-69231,0.5907632168642327,1.2366348383457184,0.1746031746031746,0.46576203955157025,1.0,8/44,13.23%,CDKN2A;PTK6;CDK6;CDKN1C;CDKN1B;CDKN1A;CCND1;CKS1B
prerank,Reactome_2022__Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.6911653877696446,1.236553892455919,0.2,0.46576109955454137,1.0,2/16,10.27%,GAB2;STAT3
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.6675139101159653,1.236474515083693,0.23214285714285715,0.46574985710448236,1.0,3/15,14.58%,THBS1;P2RY12;AKIRIN1
prerank,CellMarker_Augmented_2021__Monocyte:Spleen,0.6585272030296776,1.2364324568454441,0.16666666666666666,0.4656716830193165,1.0,7/25,3.65%,TLR2;CTSS;P2RY13;MYO1F;PLEK;SLA;SIGLEC1
prerank,Reactome_2022__Acetylcholine Neurotransmitter Release Cycle R-HSA-264642,0.712121447359048,1.236297195060725,0.21428571428571427,0.46577887284879554,1.0,7/14,24.24%,SYT1;CPLX1;SH2D3C;PPFIA2;SNAP25;RAB3A;PPFIA1
prerank,CellMarker_Augmented_2021__Multipotent Progenitor cell:Stomach,0.5864927745256552,1.236247699941293,0.1864406779661017,0.4656956104958844,1.0,8/39,15.83%,PTP4A3;PLD1;ECE1;GPT2;C2CD2;PITPNM2;MAML2;ZNF571
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,0.5998173387700727,1.2362414234717911,0.1864406779661017,0.46550957198130033,1.0,8/34,15.46%,STEAP3;BCL6;CASP10;NDRG1;TP53I3;BBC3;TNFRSF10B;TP53
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.8116268325511019,1.236157200625283,0.2641509433962264,0.4655190268875371,1.0,1/5,9.35%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.4840839845648227,1.2357999468297647,0.11594202898550725,0.4663608201955618,1.0,39/210,15.37%,C3;TLR2;ANXA1;RFTN1;CCBE1;IL15;SERPINE1;RASGRP1;MBP;SULF1;APP;IRF7;NOD1;IL1R1;PTPRC;TNFRSF14;TMED10;CYP1B1;MYD88;CTNNB1;CHI3L1;CYRIB;STAT3;SYK;LURAP1;CD276;CGAS;FADD;STOML2;IL12A;MRE11;PIK3CD;MAPK11;IFIH1;HLA-E;RARA;CD4;SCAMP5;STAT6
prerank,CellMarker_Augmented_2021__Stem cell:Gastrointestinal Tract,0.517270926646389,1.2357451759305775,0.05970149253731343,0.4663236685643908,1.0,13/95,10.57%,FLRT3;APP;LCA5;MYO1B;ADGRL2;CTNNB1;KITLG;CNN3;YAP1;ATP1B1;TGFB2;KCTD3;CMTM4
prerank,Reactome_2022__Nuclear Envelope (NE) Reassembly R-HSA-2995410,0.5681697398264072,1.235418444165058,0.13636363636363635,0.46693849065312854,1.0,8/63,14.86%,VRK2;CCNB2;LMNB1;LMNA;TUBB6;RANGAP1;TUBA1B;IST1
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.5649891103930096,1.2353884143923315,0.11320754716981132,0.4668190182775182,1.0,16/67,16.20%,GPNMB;KIF14;GRIN2B;SNCB;GRID2;FYN;SNCA;DCC;DHCR24;INPP5A;MAPT;ZNF746;IKBKG;MAP3K5;CTSZ;CD200
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),-0.8158820530369122,-1.2353255866764214,0.1951219512195122,0.8093710525234963,1.0,2/5,7.89%,AR;NCOA4
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),-0.8158820530369122,-1.2353255866764214,0.1951219512195122,0.8093710525234963,1.0,2/5,7.89%,AR;NCOA4
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.7216501544321272,1.235264204993858,0.18032786885245902,0.4669048056058833,1.0,3/11,10.24%,ANK3;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),0.6576761991760154,1.235248858374222,0.1791044776119403,0.46675469432353406,1.0,7/23,21.17%,PRKCB;PID1;PIP4K2A;PRKCD;TSC2;PTPRE;GRB10
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.8144916892452696,1.2351450232638397,0.16666666666666666,0.4668096883501142,1.0,2/7,10.92%,TPPP;MAPT
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),-0.6521239163764392,-1.2350919494523653,0.1951219512195122,0.8091498156898117,1.0,3/17,9.85%,HSD17B8;SLC25A1;GCDH
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.7020975980475138,1.2347992107078167,0.21875,0.46752025620254245,1.0,8/13,17.57%,CD55;ICAM1;CFH;TGFB2;NOXA1;CD59;FZD7;WNT5A
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),0.7861879541560006,1.2345723847994858,0.2631578947368421,0.4679025299234872,1.0,3/6,19.47%,GNG2;TNFSF4;TGFBR3
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),0.704270758845687,1.2344863557417927,0.1568627450980392,0.467982531976822,1.0,2/12,10.78%,TYMP;PUDP
prerank,Reactome_2022__Signaling By CSF3 (G-CSF) R-HSA-9674555,0.6101163304322148,1.2343896396790621,0.14705882352941177,0.46802665653602743,1.0,5/25,11.45%,SOCS3;GAB2;STAT3;SYK;TYK2
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.5677481566523697,1.2341874715242593,0.18181818181818182,0.468362183888027,1.0,9/41,13.78%,S100A10;PLEK;FHOD1;LIMCH1;SYNPO2L;ARHGEF10L;PXN;PAK1;LPAR1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.6440872271056056,1.2341198168372807,0.2222222222222222,0.4683447730429555,1.0,5/29,11.94%,NR4A3;MYH9;PLEKHM1;SYTL4;KLC2
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.6116611090784284,-1.2335877560689001,0.2,0.8136669062448891,1.0,6/22,13.90%,ISCU;CIAO3;ISCA2;CIAO2B;NFS1;NFU1
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.627333699314603,1.2335298770327334,0.22033898305084745,0.46984460376662546,1.0,4/29,9.86%,KREMEN2;NOTUM;ZBTB16;TGFB2
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),-0.6182287815056157,-1.233472147629697,0.1388888888888889,0.8128777451109793,1.0,3/15,14.30%,SELENOS;DERL2;AUP1
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.6754729338390906,1.2334282674282748,0.14285714285714285,0.4699235740648459,1.0,2/15,3.76%,CD55;IL1R1
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.7957317839866651,1.233272147841574,0.23728813559322035,0.47017601105073786,1.0,2/5,13.41%,SLC4A11;SLC12A5
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Brain,0.6552564851278039,1.2330708491298124,0.14754098360655737,0.47062209271662553,1.0,6/22,8.12%,CD24;THY1;SOX4;CD44;BOC;CTNNB1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.6124224070089613,-1.2325906268086453,0.1282051282051282,0.815044007928702,1.0,9/20,26.48%,PPP1R35;ZCCHC9;PTPA;PPP6R1;BMP2;PPP1R26;SH3RF2;GPATCH2;PPP1R2
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),0.8265651810516947,1.2325177272029257,0.2807017543859649,0.4720774860272665,1.0,3/6,14.76%,ANXA1;ABCC4;PNPLA8
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.5220827047639687,1.2324200248075157,0.10606060606060606,0.47212984913035366,1.0,24/134,14.66%,VRK2;PDGFRA;PTK6;PIM3;FLT1;TEC;PIM1;MAP3K11;STK25;AATK;DAPK2;SIK2;MINK1;MAK;EPHA4;CDKL5;MAP3K21;CAMK2B;MAPKAPK5;ALK;PAK1;GRK5;BMX;NEK6
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),0.8234450022326933,1.2323674218764336,0.22033898305084745,0.47208026554362875,1.0,5/7,17.39%,RTN4RL1;THY1;EPHA4;PTPRS;INPP5F
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.7933447437101437,1.2320903535936558,0.22916666666666666,0.47255528333288127,1.0,2/7,8.26%,SYT4;KIF5A
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.6513162765362671,-1.2320790013993135,0.24324324324324326,0.8159219735921324,1.0,6/13,26.48%,SNF8;TMEM50B;TMEM50A;VPS25;VPS28;VTA1
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.7684884247011023,1.2320619674777957,0.22413793103448276,0.4724699225548432,1.0,2/6,13.58%,SKAP1;FADD
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.7985188221611503,-1.2319802078945719,0.24074074074074073,0.815058485895413,1.0,1/6,2.37%,DNMT3B
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.7257835995795616,-1.2317997861599317,0.25,0.8146193565903104,1.0,4/7,9.60%,APOBEC3G;CDADC1;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.7741128593636092,1.2317616598416972,0.2545454545454545,0.4731020902548689,1.0,1/6,3.46%,UHRF2
prerank,Reactome_2022__Cell Surface Interactions At Vascular Wall R-HSA-202733,0.5332070729701349,1.231576404271899,0.11940298507462686,0.4734743125762865,1.0,24/80,19.21%,L1CAM;FYN;CD44;SLC7A7;MAG;ITGA3;ATP1B1;ATP1B3;GAS6;ITGAL;GP6;FN1;PICK1;DEAF1;GYPE;TNFRSF10B;CD99;INPP5D;ANGPT2;SHC1;CD99L2;SLC7A8;CXADR;TEK
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.7446883930342858,-1.23134337626623,0.23404255319148937,0.8150109798488406,1.0,1/6,1.79%,TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.5527308134427321,1.2313319885516152,0.16666666666666666,0.4739275501388667,1.0,8/78,7.16%,IGF1;TYMS;IGF2BP2;SAMD4A;RTN1;RTN2;ENC1;EIF4A3
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.4621927259501073,1.2312656509340092,0.04878048780487805,0.4739535333190639,1.0,59/429,13.21%,LEF1;CDKN2A;SIX3;PROX1;MAEL;ZNF93;TYMS;IGF2BP2;DAB2IP;FOXO1;PRAME;SAMD4A;SUV39H1;CIC;ZNF282;TSPYL2;TCEAL7;NFIL3;BCL6;NKX6-2;AHR;GZF1;KLF10;CIITA;NRG1;ZBTB16;BAP1;ENC1;TBX20;MSX2;GLIS2;EIF4A3;PML;HMBOX1;ZFPM2;CTNNB1;GMNC;BASP1;PPARG;CTBP2;CHMP1A;HDAC4;PEX14;SHMT1;CDKN1C;GAS6;DBI;HDAC9;L3MBTL3;RUNX1T1;PRICKLE1;MLXIPL;CDKN1B;PER1;KLF4;JARID2;CDKN1A;SOX13;DEAF1
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreas,0.5336615724226124,1.2311902354485942,0.1791044776119403,0.4739439378998082,1.0,27/87,17.00%,GRID2;PLP1;CNTNAP2;SHROOM4;LGR5;UNC5D;RAB3C;SEMA5B;ST8SIA3;ROBO2;CCKBR;ADCY2;PTPRD;KALRN;RASL12;HUNK;ITGA9;COL9A1;SORBS1;ASXL3;RUNX1T1;SORCS1;LSAMP;HIF3A;NLGN4X;TOX3;RGMA
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),0.6134480573981436,1.2311211097643429,0.16666666666666666,0.47390388781252957,1.0,3/35,2.45%,IGF1;NPNT;NELL1
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.7307009294648696,1.2310630110913265,0.26666666666666666,0.4738334230589811,1.0,1/9,5.92%,AIPL1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.5247416089493,-1.2310304619485846,0.1282051282051282,0.8149193752652389,1.0,13/48,18.79%,ABCD2;MCAT;ACOXL;ABCD1;GCDH;ETFB;ETFDH;CPT2;ECHS1;MTLN;EHHADH;ACADS;DECR1
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.6178286456743854,1.231000761351847,0.2857142857142857,0.4738188200672362,1.0,4/24,6.91%,KCNJ2;PRKCB;PIM1;SNCA
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.7045145446412131,1.2306861730068686,0.23076923076923078,0.47453438416054117,1.0,1/14,0.82%,HTR2C
prerank,PanglaoDB_Augmented_2021__Decidual Cells,-0.6880749116623722,-1.2306285495763183,0.2916666666666667,0.8152352111886098,1.0,4/8,6.16%,CD247;CD96;PYHIN1;P2RY10
prerank,Reactome_2022__Linoleic Acid (LA) Metabolism R-HSA-2046105,-0.7462102531426981,-1.2305932553756356,0.20512820512820512,0.8140719065430394,1.0,3/7,9.35%,MUSK;ABCD1;ELOVL2
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.7566262946090616,1.2304697800657174,0.26229508196721313,0.47494015625245023,1.0,1/11,0.62%,SCN9A
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.5295517493548301,1.2303426219653142,0.12121212121212122,0.47513279813031695,1.0,11/85,8.06%,SLC32A1;SLC24A2;SLC15A3;PIEZO2;SLC9A9;LASP1;GRIN1;SLC20A2;SLC17A5;SLC26A8;SLC9A1
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),0.8867966112627036,1.2303376466894567,0.15789473684210525,0.47494041752779936,1.0,2/5,3.81%,THBS1;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),0.6584709170488949,1.2302042467389684,0.21818181818181817,0.47513289104539036,1.0,2/15,9.88%,EGF;GLI2
prerank,CellMarker_Augmented_2021__Natural Killer cell:Splenic Red Pulp,-0.5567887893601454,-1.2299090236707058,0.1891891891891892,0.8127619399456784,1.0,8/26,6.37%,DPEP2;CD247;CD96;PADI4;RHOH;PYHIN1;PRAM1;CR1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Gut,-0.5567887893601454,-1.2299090236707058,0.1891891891891892,0.8127619399456784,1.0,8/26,6.37%,DPEP2;CD247;CD96;PADI4;RHOH;PYHIN1;PRAM1;CR1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Lung,-0.5567887893601454,-1.2299090236707058,0.1891891891891892,0.8127619399456784,1.0,8/26,6.37%,DPEP2;CD247;CD96;PADI4;RHOH;PYHIN1;PRAM1;CR1
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),0.8373685423151993,1.2294398744989674,0.16666666666666666,0.47703529059381433,1.0,2/6,9.58%,RBM24;MMP14
prerank,KEGG_2021_Human__Regulation of actin cytoskeleton,0.49445442941973833,1.2293569552523134,0.07246376811594203,0.4771255373168076,1.0,43/169,16.31%,PDGFRA;CHRM3;EGF;CHRM1;ARPC5L;ITGA8;MYH9;PAK3;MYH11;MYLK3;WASF1;ITGA2;BAIAP2;PAK4;PDGFA;ITGA11;SLC9A1;MRAS;ITGA3;SSH2;LIMK2;ARPC3;GNA12;ARHGEF7;PPP1CB;ITGA9;PIP4K2A;ITGB8;ACTN1;PXN;ENAH;ITGAL;FN1;PAK1;FGF2;LPAR1;IQGAP1;PIK3CD;BCAR1;PFN4;PIP5K1C;VAV2;PFN2
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),0.8476906565226159,1.2293003495932326,0.22033898305084745,0.4770488891064872,1.0,1/5,2.74%,PRKCB
prerank,CellMarker_Augmented_2021__CD4+ Cytotoxic T cell:Liver,0.5588449104259157,1.229098457001846,0.16666666666666666,0.4774270627206854,1.0,10/57,12.61%,SAMD3;MBP;MYO1F;PLEK;RAP2B;AGPAT4;RASSF1;ABCA2;PXN;TMEM181
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),0.7457409352364889,1.2290281658451578,0.22807017543859648,0.47741095750247237,1.0,3/10,2.65%,THBS1;SERPINE1;DMTN
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryoid Body,0.5352506127228333,1.2289774025613016,0.13043478260869565,0.4773090429707956,1.0,20/60,12.14%,COL4A1;PDGFRA;PCDH18;CALD1;FLT1;COL4A2;PTPRB;SHROOM4;ANGPTL2;POSTN;IGFBP7;LDB2;APLNR;RAMP3;ADGRF5;BGN;RASL12;LAMA2;SPARC;FGD5
prerank,Reactome_2022__Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.5719644834568369,-1.2289680083339045,0.16666666666666666,0.8151714334734647,1.0,8/32,14.94%,HSPG2;CTSL;ZCRB1;SDC3;GPC6;BECN1;ISCU;RNF103-CHMP3
prerank,Reactome_2022__Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,0.5604579402987009,1.2289325991817566,0.13636363636363635,0.4772425408146758,1.0,13/53,17.85%,ST6GAL1;EGFL7;ST8SIA3;ST8SIA1;SLC17A5;ST8SIA4;CMAS;NANS;ST6GALNAC2;ST6GALNAC5;ST6GALNAC3;NEU4;GMPPA
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.49105728269725446,1.2286840625965614,0.075,0.4776351040079875,1.0,28/222,13.02%,LEF1;TGFBR2;IL15;EGF;SERPINE1;NLGN1;ACHE;TRPM4;PPARGC1B;OXTR;PLAAT4;ZBTB16;PLAC8;GHR;HADH;SCX;CTNNB1;SMAD3;PRKCH;TGFB2;SYK;TLE6;GAS6;B4GALT5;LURAP1;ADIPOR2;PDPN;IL4R
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.4932455255086345,1.2283566028283177,0.13636363636363635,0.4782037902380836,1.0,14/96,10.71%,TEAD2;DMTN;WAS;ADD2;WASF1;FAS;PARD3;REPS2;PML;SHANK1;YAP1;TCAP;PEX14;TEAD1
prerank,Reactome_2022__CD28 Dependent Vav1 Pathway R-HSA-389359,0.7941899781089898,1.2282924168988498,0.15625,0.4781672237155012,1.0,3/8,9.78%,FYN;ARHGEF7;RNASE1
prerank,Reactome_2022__Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,0.6587599057177509,1.2282656677946218,0.16666666666666666,0.4780702394341944,1.0,4/20,11.45%,SOCS3;STAT3;SYK;TYK2
prerank,Reactome_2022__Type I Hemidesmosome Assembly R-HSA-446107,-0.743655753624018,-1.2281003598264175,0.22448979591836735,0.8169866813418243,1.0,1/6,1.26%,LAMA4
prerank,KEGG_2021_Human__Salivary secretion,0.5569530502621826,1.2279401297071033,0.16923076923076924,0.4788243006395945,1.0,25/58,18.53%,CHRM3;PRKCB;ADCY5;PRKCG;ATP2B3;PRKG2;ITPR3;GUCY1A2;ADCY7;PRH2;ADCY2;ATP1A1;SLC9A1;GUCY1A1;ATP1B1;ATP1B3;GUCY1B1;KCNMA1;ATP2B4;BST1;ADCY3;CALM3;ITPR1;ADRA1D;PRKCA
prerank,Reactome_2022__Signal Amplification R-HSA-392518,0.6337122992940806,1.2279067757945976,0.2153846153846154,0.4787220821819883,1.0,4/24,10.69%,GNG3;GNG2;GNA14;P2RY12
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.5849274506898111,-1.2279040161124952,0.15789473684210525,0.8164661203550792,1.0,2/33,1.73%,PTCD2;RBM23
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.6267701509601071,-1.2278873457400066,0.21951219512195122,0.8152164769649038,1.0,2/20,2.54%,DNMT3B;TEX15
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),-0.7958808837495285,-1.2278738801509324,0.22727272727272727,0.8140316373809083,1.0,1/7,0.79%,ID2
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.6208686632005483,1.2278624777088953,0.24528301886792453,0.478630014260939,1.0,2/27,1.98%,MET;PSRC1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.735919006489646,1.2276182042867725,0.3064516129032258,0.47911632902807344,1.0,7/10,23.95%,FYN;ITGA3;PICK1;IGF1R;MTMR2;SUPV3L1;PRNP
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),0.7638516584910476,1.2275672884078048,0.30612244897959184,0.47900909037416567,1.0,3/5,17.98%,PXN;MAPK8IP2;NCK2
prerank,Reactome_2022__Leishmania Infection R-HSA-9658195,0.5070849851843495,1.227360960440848,0.0945945945945946,0.4794194538190265,1.0,25/147,10.48%,GGT5;C3;GNG3;PLK2;ELMO1;ADCY5;WAS;MYH9;PRKAR1B;WASF1;FYN;GIPR;RXFP1;GNG2;BAIAP2;ITPR3;ADCY7;ADCY2;RAMP3;GLP1R;ARPC3;RNASE1;GNAZ;SYK;NOXA1
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.5081858911258195,1.2272787771041649,0.140625,0.47941262042752497,1.0,14/95,13.02%,GGT5;ACSL5;LIPH;FA2H;ALOX12;FAAH;ACOT4;PPARG;ACOT7;SLC27A3;ACSM5;ADIPOR2;SLC27A5;LTC4S
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.8497305076870599,1.2272062298741158,0.16666666666666666,0.47940579295494207,1.0,4/5,14.12%,NLRP12;CIITA;NLRC5;HSPH1
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),-0.7501550937143446,-1.2272032609092292,0.3333333333333333,0.8152664994809895,1.0,1/5,5.04%,OAT
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.7616270888579983,1.227004217885699,0.15789473684210525,0.47971007718521946,1.0,5/10,13.97%,NEFL;SYBU;TRAK1;MAPT;HAP1
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.4837860315768148,-1.2269742870069822,0.1388888888888889,0.8150186715521064,1.0,17/50,14.88%,HSPG2;APOE;RETSAT;ALDH1A1;AKR1C3;ADH6;SDC3;SCPEP1;APOM;ADH4;CYP4V2;GPC6;LRAT;RDH10;RDH11;NAPEPLD;CYP2C8
prerank,CellMarker_Augmented_2021__Retinoid Acid Signaling-Responsive Fetal Germ cell:Fetal Gonad,0.4928871795154601,1.2268277643174081,0.13924050632911392,0.47995391011115635,1.0,8/172,4.17%,LEF1;NPY;SPOCK3;CD24;MYO1F;ADA;MAP3K11;TSPYL2
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.6351120967514994,-1.2268157936289197,0.175,0.8143117761032254,1.0,12/23,26.23%,SUPT16H;HMGN1;ERCC6;CCNT1;LDB1;HTATSF1;TSFM;WDR43;THOC1;EAF1;CCAR2;CCNK
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),0.5920411381057873,1.2267697251720224,0.15625,0.4798716549560027,1.0,3/45,1.68%,NR4A3;TESC;THBS1
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Germ,0.5898521396458484,1.2267173445390698,0.16417910447761194,0.4796222021810376,1.0,7/36,6.17%,HLA-DRA;CTSS;MYO1F;PLEK;SLA;PTPRC;CIITA
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Germ,0.5898521396458484,1.2267173445390698,0.16417910447761194,0.4796222021810376,1.0,7/36,6.17%,HLA-DRA;CTSS;MYO1F;PLEK;SLA;PTPRC;CIITA
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.680164202510305,1.2266386833898097,0.2222222222222222,0.47965035085561364,1.0,5/15,10.34%,CHRM3;CHRM1;AGRN;GRK2;LY6H
prerank,Reactome_2022__Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,0.5795626692359329,1.2264905630257354,0.16129032258064516,0.47983862996699334,1.0,12/51,18.13%,PPFIBP1;MYH9;TPM4;STAT3;KLC1;FN1;ALK;BCL11A;PRKAR1A;SHC1;DCTN1;SKP1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6622249488157639,1.2264828685067235,0.22641509433962265,0.47966655390640806,1.0,2/19,1.98%,PROX1;PSRC1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Bone,0.6691712799410127,1.2262600696583161,0.24193548387096775,0.4795908819670836,1.0,4/18,6.47%,THY1;PTPRC;CD44;TNFRSF1A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Muscle,0.6691712799410127,1.2262600696583161,0.24193548387096775,0.4795908819670836,1.0,4/18,6.47%,THY1;PTPRC;CD44;TNFRSF1A
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Tendon,0.6691712799410127,1.2262600696583161,0.24193548387096775,0.4795908819670836,1.0,4/18,6.47%,THY1;PTPRC;CD44;TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),0.8235202636610883,1.2262452601124458,0.2549019607843137,0.47941920920345754,1.0,3/5,12.49%,THBS1;PDE10A;CGAS
prerank,Reactome_2022__Defective GALNT3 Causes HFTC R-HSA-5083625,-0.7793831747435227,-1.2259695429802597,0.2549019607843137,0.8163618866038308,1.0,1/5,1.20%,GALNT3
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),-0.6849381083703954,-1.2259403321403237,0.2391304347826087,0.8151122661650659,1.0,3/10,14.43%,TIMM8B;TIMM13;TIMM10
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.6211422501353209,1.225841171316207,0.22413793103448276,0.480395822084263,1.0,10/25,16.17%,THY1;EFNB3;TRIM46;DCC;MAG;MCF2;DIP2B;FGF13;PTPRS;KIAA0319
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),-0.7964430861774897,-1.225489694067449,0.2553191489361702,0.8155045833167476,1.0,1/6,0.60%,SPRY1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.7475282794535464,1.2254773265780967,0.14754098360655737,0.4809898972504897,1.0,2/11,10.27%,IRS2;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.7475282794535464,1.2254773265780967,0.14754098360655737,0.4809898972504897,1.0,2/11,10.27%,IRS2;STAT3
prerank,Reactome_2022__tRNA Processing R-HSA-72306,-0.4753811639411693,-1.225349543678537,0.10714285714285714,0.814717225215639,1.0,17/95,12.64%,RTRAF;ADAT2;TRMT61A;AAAS;POP5;TRMT10C;NUP50;TRMT10A;QTRT2;FTSJ1;CPSF1;EPRS1;URM1;TRMT61B;OSGEP;NUP54;TRMT5
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.7307124919711917,1.2252715679042736,0.288135593220339,0.48128655155930233,1.0,2/8,15.78%,SUV39H1;H3-3A
prerank,GO_Biological_Process_2021__negative regulation of cardiocyte differentiation (GO:1905208),-0.7659621763052386,-1.2250123603669079,0.2765957446808511,0.8148928217484172,1.0,1/6,1.34%,HEY2
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.7289929122459767,1.2249063397977011,0.26785714285714285,0.48202646616938405,1.0,1/10,2.80%,ABCB1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),0.560875038629641,1.224833763100685,0.21311475409836064,0.481993662354079,1.0,18/56,17.13%,RASGRP1;APP;MAP3K11;DAB2IP;DUSP22;UNC5CL;MAPK8IP1;SH3RF3;MINK1;TNFRSF19;GADD45A;TPD52L1;HIPK2;MAP3K5;FZD7;ANKRD6;TRAF5;MFHAS1
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.7075225429850729,-1.2247277553034095,0.20833333333333334,0.8146603115618563,1.0,2/8,5.85%,ADAMTS12;GREM1
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.6306488162266728,-1.2245551120652405,0.24444444444444444,0.8138540749603501,1.0,3/13,18.58%,HMGB3;MTERF1;ERCC3
prerank,Reactome_2022__Interleukin-12 Signaling R-HSA-9020591,0.5924801327807249,1.2245072885813464,0.18333333333333332,0.48265297295449217,1.0,5/35,14.19%,STAT4;LMNB1;TCP1;TYK2;IL12A
prerank,Reactome_2022__Acyl Chain Remodelling Of PE R-HSA-1482839,0.6727530856060915,1.2243132163178545,0.21311475409836064,0.4828936577960855,1.0,6/17,15.55%,LPCAT4;PLAAT4;PLAAT3;PLAAT5;PNPLA8;PLAAT1
prerank,Reactome_2022__Interleukin-20 Family Signaling R-HSA-8854691,0.6900746713763594,1.224167891451832,0.15942028985507245,0.4830097669462286,1.0,4/15,11.45%,SOCS3;STAT4;STAT3;TYK2
prerank,CellMarker_Augmented_2021__CD1C-CD141- Dendritic cell:Blood,0.49430760109573435,1.224020696627507,0.125,0.48318047540049613,1.0,38/225,12.01%,PTP4A3;TLR2;IMPDH1;TYMP;CTSS;TESC;CDH23;P2RY13;NR4A1;DUSP1;SLA;CDC42EP3;FOXO1;PTPRC;KLF11;DENND3;CHST15;TNFRSF14;ARHGEF3;GNG2;NUDT16;PDP1;SLC7A7;TMBIM1;ZFAND5;TTYH3;SSH2;CORO2A;TSC22D3;NAMPT;PAG1;ATP1B3;KLF3;PYGL;CDKN1C;TSPAN14;PILRA;ITGAL
prerank,Reactome_2022__Semaphorin Interactions R-HSA-373755,0.5631511201244139,1.2238247724878124,0.16666666666666666,0.4835051228652364,1.0,15/61,15.87%,MYH9;MYH11;PTPRC;FYN;DPYSL2;LIMK2;ARHGEF7;RNASE1;CRMP1;DPYSL4;PLXNA4;DPYSL5;PLXNA1;PLXNA2;PIP5K1C
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.6800331597976752,-1.2237472365287054,0.21428571428571427,0.8156911215320671,1.0,3/10,9.17%,M1AP;NOC2L;SUPT16H
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.7494735202419814,1.2237066971008381,0.19607843137254902,0.4837152195854358,1.0,3/8,16.10%,SLCO1A2;SLCO2A1;SLCO3A1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Colon,0.7476397092219282,1.22361367307749,0.20634920634920634,0.48373641922750227,1.0,3/11,6.44%,CD24;LGR5;CD44
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex8:Brain,0.581613286489486,1.2234646568132441,0.13559322033898305,0.48385191882424833,1.0,18/53,11.36%,SPOCK3;GAS2L3;CREB5;TESC;TRPM4;SYNPR;POSTN;KLHL1;STK32B;FRAS1;ITGA11;MGAT5;CDC14A;ATP10A;RIN2;ITGB8;CRTAC1;NR4A2
prerank,Reactome_2022__Abacavir Transmembrane Transport R-HSA-2161517,0.8643599288576181,1.223268638823236,0.17307692307692307,0.4841558750082069,1.0,1/5,2.80%,ABCB1
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.7263276320991555,1.2232533353993145,0.2,0.48398838408918177,1.0,5/9,19.98%,PPARG;RARA;RARG;RXRA;ACTN4
prerank,GO_Biological_Process_2021__tricuspid valve morphogenesis (GO:0003186),0.8049101634273019,1.2232265190887632,0.25862068965517243,0.4838706138623708,1.0,1/5,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.7145403389756262,1.2231613286784506,0.2727272727272727,0.4839115242381424,1.0,2/13,3.66%,YBX3;RBM24
prerank,Reactome_2022__Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.599275125430451,-1.2231611423529882,0.2564102564102564,0.8165560386018775,1.0,4/18,11.21%,ABCD2;PXMP2;ABCD1;PEX11B
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.6664621580532829,1.223132865530313,0.2222222222222222,0.4837938875157351,1.0,12/20,26.96%,CD55;TNFRSF14;CD160;B2M;HLA-E;WNT5A;TNFSF4;HLA-F;SCIMP;FZD5;HLA-A;MAP3K7
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucose-dependent Insulinotropic Polypeptide (GIP) R-HSA-400511",-0.7370551929300011,-1.2230640287051024,0.1951219512195122,0.8155957728531928,1.0,4/8,15.00%,PCSK1;SPCS1;SPCS2;PAX6
prerank,CellMarker_Augmented_2021__Macrophage:Lung,0.7852388856369419,1.2230307217413003,0.2698412698412698,0.4838546012679347,1.0,5/7,17.79%,ICAM1;CD83;CCL2;ITGAL;TFRC
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.573626530886547,1.2229816818636106,0.18309859154929578,0.48381132841882063,1.0,12/43,11.69%,MYRF;MBP;CNTNAP1;PLP1;BCAS1;SCN2A;PLLP;PARD3;EIF2B2;TPPP;KLK6;B4GALT5
prerank,KEGG_2021_Human__Amoebiasis,0.5490394336569042,1.222810452311464,0.11940298507462686,0.4840797636892184,1.0,19/62,14.90%,CXCL2;COL4A1;TLR2;COL4A2;PRKCB;PRKCG;IL1R1;LAMB1;LAMA5;GNA14;TGFB2;LAMA2;COL4A4;ACTN1;FN1;COL4A5;IL12A;PIK3CD;LAMA3
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.644933621375299,1.2226989882472923,0.2542372881355932,0.48416500303051757,1.0,5/21,7.44%,RIMS2;EPHA5;AHR;ADCY2;GLP1R
prerank,Reactome_2022__Acyl Chain Remodelling Of PG R-HSA-1482925,0.7537172743602137,1.2226945280231936,0.25,0.4839585360782658,1.0,1/7,3.36%,LPCAT4
prerank,Reactome_2022__RSK Activation R-HSA-444257,0.76604376027683,1.2224837973273592,0.3389830508474576,0.484236447003327,1.0,2/7,12.98%,RPS6KA1;RPS6KA6
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.6986092221119097,1.2224442707459648,0.2727272727272727,0.484138777614927,1.0,1/11,5.85%,ATP9A
prerank,CellMarker_Augmented_2021__CD1C+ A Dendritic cell:Blood,0.7463633273834666,1.2222190588832338,0.17647058823529413,0.48442131168149993,1.0,5/16,15.06%,CREB5;PID1;NR4A2;PER1;SLC2A3
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.5835662313927505,1.2221606865033816,0.21666666666666667,0.48433351580242745,1.0,8/33,9.61%,EGF;SH3GL2;DAB2IP;TGFA;SH3KBP1;MVP;ARHGEF7;ZFYVE28
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.5694407092708085,-1.2221107303864114,0.14285714285714285,0.8176949875886419,1.0,1/21,1.39%,CSKMT
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.5200411886431703,1.2220914187269065,0.15492957746478872,0.4843197810240339,1.0,25/95,15.68%,TGFBR2;TLR2;MAFF;P2RY13;LMO2;ABCB1;DYSF;THY1;SIGLEC1;PTPRC;CD44;TNS1;KITLG;RNASE1;TGFB2;FLI1;GFI1B;FGD5;ROBO4;ELF1;HLA-E;SERPING1;CD59;BAALC;PTPRS
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),-0.7673353027226932,-1.2220285946682004,0.21739130434782608,0.8166884478992528,1.0,2/7,10.04%,MTIF2;MTIF3
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.7708282651933135,1.2219902578354005,0.20408163265306123,0.4844391767689345,1.0,2/6,16.39%,PADI2;SPTY2D1
prerank,Reactome_2022__SLC-mediated Transmembrane Transport R-HSA-425407,0.4849099023883063,1.2217495385565766,0.06666666666666667,0.48494287301624395,1.0,20/180,8.14%,SLC6A15;SLC32A1;SLC4A10;SLC15A3;SLC7A2;SLC43A1;SLC39A14;SLC28A3;CP;EMB;SLC16A10;SLC5A4;SLC9A9;APOD;SLCO1A2;SLC20A2;SLC7A7;SLC17A5;SLC9A1;SLC4A9
prerank,CellMarker_Augmented_2021__Germinal Center B cell:Tonsil,0.5560355027051946,1.2217087628121257,0.078125,0.4848697831385098,1.0,29/66,19.22%,IL13RA1;A4GALT;S100A10;EPHA2;SEMA3C;ITGA2;RHBDF1;RHOD;CDC42EP1;EMP1;MYO1C;KITLG;LMNA;PXDC1;CTNNA1;BACE2;SPSB1;KLF4;CCND1;LAMA3;CD59;SLC44A3;CTDSPL;MYOF;FAM114A1;PCDH1;TSPAN15;ITGB4;DSTN
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.7851645205266639,1.2216723989726619,0.26,0.4847869072711595,1.0,3/6,16.14%,CHRM3;LY6H;ATP2B4
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),0.7964829940571276,1.2215259803429437,0.11538461538461539,0.48498465311596106,1.0,3/5,12.22%,SHANK3;FRMPD4;CAMK2B
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),0.537907597869999,1.2214471792774644,0.2,0.4849805166697698,1.0,17/70,12.17%,MRAP2;EPHA2;STAC2;PID1;RAMP3;MRAP;TMBIM1;BCL2L1;ITGA3;PTPN9;PRKCE;PRKCH;MMP14;ZDHHC7;SORBS1;STX4;ARF6
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),-0.6132045017682154,-1.2214047375958148,0.16666666666666666,0.8179376395127732,1.0,3/18,2.89%,SLC2A5;SELENOS;SLC30A8
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.7922767870779531,-1.2213587971789754,0.2545454545454545,0.8168036523869531,1.0,2/5,15.22%,NOL8;RPF2
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.6613158533668038,1.2213354306878814,0.26,0.4851189992574826,1.0,4/16,9.88%,PROX1;PKP2;TBX20;TCAP
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.5668462716794751,1.2213106388232784,0.15873015873015872,0.4850115798316383,1.0,18/60,17.72%,HTR2C;SLC24A2;VAPB;ATP2B3;GCM2;SNCA;RYR2;GRIN1;NPTN;ATP1B1;TPCN2;STOML2;SLC24A1;ATP13A1;ATP2B4;SLC8A2;SLC8A1;FAM20A
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.6059504744643516,1.2212909336189792,0.1791044776119403,0.48485511540464665,1.0,5/38,10.02%,C3;SERPINE1;NLGN1;SNCA;TF
prerank,CellMarker_Augmented_2021__PP cell:Pancreas,0.6644598248908005,1.2211784350544377,0.30158730158730157,0.48495909441435564,1.0,6/18,8.71%,CHGB;ABCC8;CDK5R2;VGF;GLP1R;SCG5
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),0.5448379565411627,1.221127520526773,0.1746031746031746,0.484920611438449,1.0,15/72,14.84%,BOK;BLM;KCNC2;SNCA;UGDH;SLC9A1;KCNC1;HOMER1;GSDMD;POLQ;HLA-DRB1;RNF112;GLRA3;STOML2;ATL3
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.5747943900173285,-1.2210828424594025,0.24390243902439024,0.8167014319126157,1.0,9/31,16.83%,ATRIP;HUS1;BRIP1;ATR;ERCC6;RAD9B;CLSPN;DNA2;HINFP
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.7061780917047716,-1.2209845456513853,0.2127659574468085,0.8158207029401555,1.0,2/9,5.85%,ADAMTS12;GREM1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),-0.6701032424409448,-1.2209555339901688,0.225,0.814683503454545,1.0,2/10,9.24%,ID2;HSF1
prerank,Reactome_2022__Signal Transduction By L1 R-HSA-445144,0.6975941907594834,1.2208603871061137,0.16666666666666666,0.4854857671262255,1.0,3/18,9.94%,L1CAM;RNASE1;ITGA9
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.5466464622003665,-1.2208038308405331,0.20512820512820512,0.8140086187712956,1.0,5/24,7.89%,AR;FSHR;AKR1C3;WNT2B;NCOA4
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.5764422296365292,-1.2205900391080629,0.20930232558139536,0.8134180427149081,1.0,6/21,6.16%,CD247;CD96;PYHIN1;IL5;CD6;P2RY10
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.6834969863754835,1.2205455585137477,0.1746031746031746,0.4861730767200623,1.0,3/16,3.41%,MET;PROX1;LSR
prerank,Reactome_2022__MHC Class II Antigen Presentation R-HSA-2132295,0.5240945226690557,1.220458155744949,0.1076923076923077,0.4861586451252475,1.0,13/82,13.76%,HLA-DRA;CTSC;CTSS;SH3GL2;DNM1;AP1S1;KIF5A;KIF5C;ACTR1A;HLA-DRB1;PRICKLE1;KLC1;HLA-DMA
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.5373756244557838,1.2203642885497032,0.19047619047619047,0.48618343486676935,1.0,7/66,9.35%,IGF1;NPNT;NELL1;TRPM4;CDK6;YAP1;PPARG
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),-0.7438216208787706,-1.2202502231403223,0.2619047619047619,0.8134273919947288,1.0,1/8,6.62%,BCAP31
prerank,Reactome_2022__Transcription Of HIV Genome R-HSA-167172,-0.5356713924121349,-1.2202397867672752,0.21428571428571427,0.812218940202485,1.0,19/63,21.19%,GTF2H5;POLR2K;ELOC;GTF2H2;ELOA;TAF13;SUPT16H;ERCC2;GTF2A2;TAF11;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;TAF12
prerank,Reactome_2022__O-linked Glycosylation Of Mucins R-HSA-913709,0.6075479982293767,1.2201784088094914,0.2,0.4865511385543714,1.0,6/35,6.25%,ST6GAL1;GCNT7;B3GNT2;GALNT12;GALNTL6;GALNT8
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),-0.48642338893426557,-1.2201519502996738,0.12121212121212122,0.811236347268535,1.0,16/54,26.89%,MCM6;PSMD10;MCM4;PSMD12;PSMB5;PSMB6;ORC6;PSME3;PSMD2;UBB;PSMB4;ORC2;PSMA1;PSMD11;ORC3;MCM3
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",-0.6227643494318335,-1.2200410949772762,0.25,0.8103151442948063,1.0,3/14,17.03%,SCNM1;PQBP1;SRSF9
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),-0.7796971597772995,-1.220027505911629,0.3,0.809117042123264,1.0,2/6,4.40%,ZC3H8;FOXJ1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.49342451755935673,1.2199150309284619,0.1323529411764706,0.4870752355590885,1.0,36/153,17.43%,MTMR7;PLD1;LIPH;LPCAT4;ACHE;PLSCR1;MFSD2A;SBF1;SYNJ2;DGKG;AGPAT4;PLEKHA2;PLD2;CHKB;PIP4K2A;VAC14;PITPNM3;INPPL1;PITPNM2;INPP5J;PLEKHA4;PLEKHA8;INPP4A;FGF2;MTM1;CDS2;BMX;PIK3CD;INPP5D;SLC44A3;CPNE7;IMPA1;PIP5K1C;LPIN3;INPP5F;PITPNM1
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.6839924272918815,1.219886175149913,0.25,0.48693807405555084,1.0,1/16,0.90%,IGF1
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.6185851245942218,1.2198529510577802,0.21568627450980393,0.4868157069471058,1.0,4/24,10.44%,CTSC;EFNA1;RHBDF1;EPHA4
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.6967914479085824,1.2197508989985792,0.21568627450980393,0.48684994875140497,1.0,1/13,2.44%,DUSP1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.7069687809903734,1.2196551196600998,0.2692307692307692,0.48687438419428686,1.0,5/12,14.71%,HLA-DRA;ABCB9;HLA-DRB1;B2M;HLA-E
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.7466267587921801,-1.2195267662788707,0.275,0.8087304330783712,1.0,3/8,14.47%,UQCRFS1;LYRM7;SLC25A33
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.7466267587921801,-1.2195267662788707,0.275,0.8087304330783712,1.0,3/8,14.47%,UQCRFS1;LYRM7;SLC25A33
prerank,Reactome_2022__ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,0.686637921467684,1.219470333990506,0.16393442622950818,0.4872457531551615,1.0,3/15,10.69%,GNG3;GNG2;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.6501385714509413,1.2194264022924401,0.16981132075471697,0.48698174493416946,1.0,5/19,18.23%,THBS1;CDKN1C;HIPK2;STK11;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.6501385714509413,1.2194264022924401,0.16981132075471697,0.48698174493416946,1.0,5/19,18.23%,THBS1;CDKN1C;HIPK2;STK11;ADAM17
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.6637483488177239,1.219416783527138,0.22413793103448276,0.4868108635247617,1.0,3/20,6.08%,LIPH;FABP3;FAAH
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.6626559230995365,1.2193584440394283,0.25396825396825395,0.48682550709420114,1.0,3/17,4.01%,IGF1;RTN1;RTN2
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),0.6875480579813276,1.2193092075364207,0.29508196721311475,0.4866840935849171,1.0,2/12,3.61%,PTK6;NLRP12
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.5882094523713778,1.2192934953808963,0.1,0.4865281759663189,1.0,12/39,19.17%,EGF;GRAMD2A;CTNNB1;ORAI1;HOMER1;PLPP4;CAMK2B;BCL2;CD4;CAMK2A;CAV3;CACNB2
prerank,Reactome_2022__Signaling By WNT In Cancer R-HSA-4791275,0.6047914398257994,1.2192011673833687,0.17543859649122806,0.4865088138019454,1.0,3/27,9.43%,KREMEN2;CTNNB1;CTBP2
prerank,Reactome_2022__Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,0.5857919374325077,1.219155540216178,0.2,0.48647972740438583,1.0,3/23,12.41%,WNT8B;CTNNB1;FRAT2
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.8141958903041399,1.219083216263554,0.21428571428571427,0.4866113162531252,1.0,4/6,18.50%,APP;MAPT;DCTN1;APBA1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.7056561654973028,1.2190777333838057,0.296875,0.48642649403749566,1.0,2/10,14.15%,CD55;CD70
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),0.7994976518826522,1.2189426409673605,0.2711864406779661,0.48664554895819245,1.0,5/7,18.53%,PRKCH;GAS6;CCL2;PRKCD;PRKCA
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.5368066042038994,-1.218892252675323,0.20588235294117646,0.8098142268061336,1.0,5/37,13.54%,AAAS;RAE1;NUP50;NUP54;NOL6
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.5263814317264414,1.2188876854864477,0.208955223880597,0.48663590232953274,1.0,14/87,11.20%,P2RY6;HRH1;GABRB2;DMTN;KCNQ1;SLIT2;GLRA2;AHR;GABRG2;CTNNB1;HCN1;NEURL1;P2RY12;CTNNA1
prerank,CellMarker_Augmented_2021__Stem cell:Dental Pulp,0.7371886114547272,1.218851123006417,0.2982456140350877,0.4865630832470917,1.0,4/9,6.44%,THY1;PTPRC;MCAM;CD44
prerank,CellMarker_Augmented_2021__Goblet Progenitor cell:Large Intestine,0.734662190640568,1.2188336085368476,0.28,0.48639802311046126,1.0,4/9,18.75%,ICA1;CHKB;TSPAN15;ELAPOR1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.8468782149733041,1.218681335372565,0.2,0.4865293154243039,1.0,2/6,4.29%,NLGN1;BAIAP3
prerank,Reactome_2022__VEGFR2 Mediated Cell Proliferation R-HSA-5218921,0.6626578866385074,1.2185740906224651,0.2033898305084746,0.48657798086261184,1.0,6/17,19.68%,PRKCB;ITPR3;PRKCD;ITPR1;PRKCA;AHCYL1
prerank,Reactome_2022__Telomere Maintenance R-HSA-157579,-0.5423620898404559,-1.2185149122586008,0.17647058823529413,0.809967974427225,1.0,9/67,5.51%,H2AC20;H3-3B;RFC3;H2BC4;H2BC21;POLR2K;DSCC1;POLD3;H2AC6
prerank,Reactome_2022__DARPP-32 Events R-HSA-180024,0.6353524125834638,1.2180975082054126,0.1694915254237288,0.48770372834056797,1.0,10/20,28.47%,PRKAR1B;PRKAR1A;PDE4D;PRKCA;PPP3CC;PRKAR2B;PPP3CB;PPP3CA;PPP2R1B;PPP1CA
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.7497943408877948,1.2178522130893688,0.2542372881355932,0.4881204521178093,1.0,2/13,2.21%,ANXA1;BLM
prerank,Reactome_2022__LGI-ADAM Interactions R-HSA-5682910,0.697736911988158,1.2178510913351612,0.23214285714285715,0.48792115088298627,1.0,6/13,14.94%,CACNG3;CACNG8;CACNG4;LGI3;ADAM11;STX1B
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.690658584247984,1.2177748707824094,0.30357142857142855,0.48792554069666433,1.0,5/12,25.76%,DMTN;BST1;FLNA;LIMS1;EMP2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Germ,0.7705384329988122,1.2177628742576803,0.2222222222222222,0.48775555024822903,1.0,3/6,6.44%,THY1;PTPRC;CD44
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.5886478290388442,1.2176163290712505,0.18309859154929578,0.4878955751543762,1.0,8/28,12.68%,RASGRP1;DUSP1;DAB2IP;DUSP10;RELL1;MINK1;GADD45A;PER1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),0.6445576427103374,1.217392783371709,0.25396825396825395,0.4883258680895581,1.0,1/13,0.15%,NR4A3
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.7750796731048382,-1.2173238242220494,0.2765957446808511,0.8135449524914408,1.0,2/5,8.23%,GREM1;EFNB2
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.5677980647756831,1.217225722004508,0.18055555555555555,0.48852842856660345,1.0,8/56,6.91%,TLR2;IL15;SERPINE1;APP;NLRP12;PLSCR1;TNFRSF1A;SNCA
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Subcutaneous Adipose Tissue,0.8388160121421118,1.2171786674499565,0.19642857142857142,0.4884841987627136,1.0,2/6,6.44%,THY1;CD44
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.7104800021178104,-1.217045937117575,0.3137254901960784,0.813172851078422,1.0,2/8,8.80%,HEY2;HEY1
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.7890931291150342,-1.2169511806057687,0.2,0.8121791853636503,1.0,1/7,4.95%,FBXO5
prerank,CellMarker_Augmented_2021__Neural Stem cell:Inferior Colliculus,0.5277828217762686,1.2169022648040124,0.125,0.48907805353521183,1.0,26/93,17.58%,EPHA7;GAP43;PLP1;DAB2IP;EFNB3;UNC5D;FRAS1;SEMA5B;PTPN21;MAP1B;ADGRL2;CRISPLD1;PTPRD;CNN3;EPB41L1;PODXL;PCDHB15;CRMP1;ENAH;RBFOX2;SMARCA1;NLGN4X;TOX3;MAPK4;MAGI1;CACHD1
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),-0.7391080016223094,-1.2167914233060841,0.2708333333333333,0.811476382733566,1.0,2/5,11.58%,FASTKD2;MTERF3
prerank,Reactome_2022__Axonal Growth Inhibition (RHOA Activation) R-HSA-193634,0.7810956408752866,1.2167717854847209,0.2807017543859649,0.48913509677317774,1.0,3/7,19.35%,MAG;MCF2;RTN4
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),0.542296787783898,1.2166632644766715,0.12280701754385964,0.4892548781399144,1.0,19/73,12.81%,ECM2;L1CAM;NPNT;ITGA8;ZYX;THY1;SIGLEC1;ITGA2;CD44;RHOD;ITGA11;ITGA3;MKLN1;ARHGEF7;ITGB8;SORBS1;ACTN1;ITGAL;FN1
prerank,Reactome_2022__RHOQ GTPase Cycle R-HSA-9013406,0.5452157932032234,1.2164754081547633,0.19672131147540983,0.48959663186043495,1.0,15/55,17.85%,STEAP3;CDC42EP3;CDC42EP1;PAK4;OBSCN;TRIP10;ARHGAP26;ARHGEF7;OPHN1;STOM;IQGAP1;ARHGAP17;SCRIB;TFRC;RHOQ
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.5772265402426354,1.2164655668756423,0.23076923076923078,0.48942658263717537,1.0,6/31,12.47%,BOK;SEPTIN4;BCL2L1;BBC3;EIF5A;BCL2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.6880663233433679,1.2163724984538995,0.25862068965517243,0.48945444406074723,1.0,4/16,16.34%,HELB;POLQ;CGAS;RADX
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.771561601858391,-1.2160617917743255,0.19148936170212766,0.8128450709871053,1.0,1/8,0.60%,SPRY1
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5839967677436567,1.2160417524226128,0.22058823529411764,0.49017659709313505,1.0,11/59,14.32%,SIX3;SLC4A10;CDH23;TYR;CLRN1;EML2;RP2;CABP1;MYO9A;PCDH15;SLC24A1
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.6144874517069839,1.2160213355991485,0.26229508196721313,0.4900450758447959,1.0,3/27,8.22%,ST6GAL1;TUSC3;MGAT5
prerank,GO_Biological_Process_2021__regulation of macrophage apoptotic process (GO:2000109),0.7834544646784551,1.2160072986843045,0.2641509433962264,0.48986067007703965,1.0,2/5,3.31%,CDKN2A;IRF7
prerank,Reactome_2022__Negative Regulation Of FLT3 R-HSA-9706369,-0.6626567757425069,-1.2156625967167458,0.24489795918367346,0.8131994608289012,1.0,1/13,1.01%,FLT3
prerank,Reactome_2022__Regulation Of MECP2 Expression And Activity R-HSA-9022692,0.6032026918242882,1.2155284292122208,0.21875,0.4909862664355501,1.0,8/28,18.53%,TBL1X;CAMK2B;HIPK2;GPS2;NCOR1;TBL1XR1;CAMK2A;PRKCA
prerank,CellMarker_Augmented_2021__Bone Marrow Stem cell:Bone Marrow,0.7429334647269386,1.2153246032039653,0.21818181818181817,0.4913407485342386,1.0,3/8,6.44%,THY1;PTPRC;CD44
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.6100382963367307,1.2152571157389351,0.17857142857142858,0.49134849948331394,1.0,5/24,3.34%,DCN;SP100;THBS1;SLIT2;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.5765165254453639,1.2151685698593468,0.2153846153846154,0.4914331980226778,1.0,10/44,17.86%,YWHAH;BAP1;YWHAG;ARIH2;BBC3;BCL2;TP53;PINK1;MICALL2;YWHAE
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),-0.742970918194858,-1.2149695642283165,0.3090909090909091,0.8131725897900464,1.0,2/6,9.32%,GBA2;FUCA2
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),-0.742970918194858,-1.2149695642283165,0.3090909090909091,0.8131725897900464,1.0,2/6,9.32%,GBA2;FUCA2
prerank,Reactome_2022__mRNA Splicing - Major Pathway R-HSA-72163,-0.45765287850858044,-1.214935874857449,0.12903225806451613,0.8120507770326766,1.0,38/173,15.40%,SNRNP27;FIP1L1;LSM7;SNRPB2;DHX16;LSM3;SF3B4;SF3A1;POLR2K;RBM8A;PPWD1;LSM2;CRNKL1;U2AF1;SF3B6;BUD31;TFIP11;LSM5;DDX46;SNU13;PPIH;PQBP1;SYF2;CPSF1;PPIL3;POLR2C;LSM4;GTF2F1;PRPF8;PPIL1;SRSF2;RBM22;PRPF3;POLR2D;PPIE;RBMX;CPSF3;SUGP1
prerank,KEGG_2021_Human__Metabolism of xenobiotics by cytochrome P450,-0.5353837571357175,-1.2148688142271078,0.15789473684210525,0.8111377183554692,1.0,8/34,12.89%,AKR7A2;GSTT2B;CBR3;ADH6;HSD11B1;ADH4;ADH5;EPHX1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.5972077288724933,-1.2147556822528012,0.2222222222222222,0.810455259183454,1.0,7/22,15.01%,TRMT61A;TRMT10C;METTL8;METTL3;TRMT61B;RPUSD2;VIRMA
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),0.8376256586722505,1.214600275185985,0.14814814814814814,0.49274857997756066,1.0,2/6,11.94%,ITM2A;BACE2
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.7431561764640608,1.2145702723644307,0.21052631578947367,0.49219863791276913,1.0,2/7,17.35%,SYK;SHC1
prerank,Reactome_2022__Interleukin-2 Signaling R-HSA-9020558,0.7431561764640608,1.2145702723644307,0.21052631578947367,0.49219863791276913,1.0,2/7,17.35%,SYK;SHC1
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.7431561764640608,1.2145702723644307,0.21052631578947367,0.49219863791276913,1.0,2/7,17.35%,SYK;SHC1
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.4387806465667965,1.2145661016617426,0.011235955056179775,0.49200442829015995,1.0,181/886,19.55%,LEF1;NR4A3;MLIP;FOSL2;MET;ST18;MYRF;TEAD2;TLR2;IGF1;KLF2;MAFF;MLLT11;PROX1;YWHAH;EGF;DCN;CREB5;TESC;SP100;SERPINE1;ATF3;ACTA2;PSRC1;NR4A1;BLM;CASZ1;LMO2;WAS;APP;RPS6KA1;IRF7;DAB2IP;FOXO1;PPARGC1B;NFATC2;NFIL3;PLSCR1;SOX4;AHR;PADI2;SSBP4;KLF10;DVL1;SKAP1;RFX4;CIITA;ZNF750;ZBTB16;TNFRSF1A;PLAC8;ZIC1;AGRN;PGR;LDB2;PID1;CDK9;FHOD1;FOXO3;KCNH2;GLIS2;SCX;GRIN1;PML;ZFPM2;NLRC5;SLC9A1;CTNNB1;CSRNP1;TBL1X;SMAD3;NR1I3;YAP1;RAI1;BEX1;PPARG;CTBP2;HDAC4;NAMPT;GLI2;RGMB;STAT3;FLI1;GLIS3;SMAD1;TEAD1;CDKN1C;PARP9;ASXL3;NR4A2;ASXL1;NPAS2;HLA-DRB1;EIF5A;MLXIPL;KLF7;KLF6;MEIS3;BRD4;PER1;TFAP2C;KLF4;MEF2D;DEAF1;FGF2;SS18L1;FADD;TNIP2;ELF1;MAML2;ZNF746;HIPK2;BCL9;IKBKG;AKIRIN1;SPP1;PTPRN;SOX10;MRTFA;PRDM16;RARA;CD4;IER5;SMARCA1;RARG;ETS1;STAT6;MAP3K5;TP53;ZNF513;RXRA;BRCA1;FZD7;ZMIZ1;TOX3;CXXC1;HMGA1;NPAS3;ZBTB38;RORA;TFEB;MESP1;GPS2;UTP15;RGMA;LPIN3;DOT1L;SHC1;UBP1;WWTR1;MAP2K3;WNT5A;MLXIP;LAGE3;RHOQ;RNF187;MECOM;NCK2;TBL1XR1;RLF;BCLAF1;NFIA;LITAF;MMS19;SBNO2;NEK4;RPS6KA4;SMAD2;NFATC3;ARID1A;CRTC3;ZFPM1;DNM2;MED24;HIF1A;CDK5RAP2;METTL23;WAC;POU2F3;TLR3;ARNT
prerank,CellMarker_Augmented_2021__Muscle Satellite cell:Muscle,0.5510934144857504,1.2144952759249927,0.11428571428571428,0.4919495122144319,1.0,26/72,15.52%,TAGLN3;C1ORF87;MAP1LC3A;FAM107A;CHST6;IGFBP7;BOC;TENM4;EMP1;ZBTB7C;PDLIM4;RIN2;LY6H;VWA5A;DNER;ITGB8;DUOXA1;VSTM2L;PDPN;FUT2;LPAR1;KCNMA1;C6ORF118;PLXNA2;NWD1;ANKRD65
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.6633557730480488,1.2144907781300645,0.23728813559322035,0.49175556636714063,1.0,4/16,14.26%,PTP4A3;TCP1;CCT4;CCT8
prerank,Reactome_2022__Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.585104205153634,-1.214464419394537,0.23076923076923078,0.8104005152878683,1.0,15/40,20.34%,GTF2H5;POLR2K;ELOC;GTF2H2;ELOA;SUPT16H;ERCC2;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.635194223780156,1.2138963116605082,0.19298245614035087,0.49299030761213014,1.0,12/25,19.13%,FOXO1;ZFPM2;SMAD3;YAP1;TRIO;ASXL1;RUNX1T1;RORA;GPS2;WWTR1;WNT5A;ZFPM1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:White Adipose Tissue,0.6152720287502882,1.2138898315373217,0.18571428571428572,0.4928008835903672,1.0,8/33,11.35%,IGF1;C1ORF167;GHR;STEAP4;DAPK2;ABCA9;SYNE3;USHBP1
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.7156843685699988,-1.2138682188853391,0.225,0.8112432780428066,1.0,4/7,22.83%,SLC30A5;DNAJC30;SPHK2;ANTKMT
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.8095754171185156,1.2138236241962213,0.1836734693877551,0.49276488817894737,1.0,2/6,10.55%,SCX;INPPL1
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.6510970846048671,1.2137765914631378,0.22033898305084745,0.49266668144794756,1.0,4/18,15.53%,MLLT11;BBC3;TP53;PINK1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.6065275262625044,1.2137577535373578,0.21666666666666667,0.4925111262518742,1.0,5/20,20.85%,PTK6;HAP1;RTN4;DOK1;DGKD
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.7186245828012519,1.2134417979464702,0.208955223880597,0.49333159905422574,1.0,2/11,8.61%,LPCAT4;PLAAT3
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.4928191429209357,-1.2133133346664084,0.13513513513513514,0.8107808574730448,1.0,13/50,22.92%,POLR2K;AAAS;RAE1;NUP50;POLR2C;NUP54;POLR2D;POLR2L;POLR2G;NUP85;NUP42;POM121C;POLR2E
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.4928191429209357,-1.2133133346664084,0.13513513513513514,0.8107808574730448,1.0,13/50,22.92%,POLR2K;AAAS;RAE1;NUP50;POLR2C;NUP54;POLR2D;POLR2L;POLR2G;NUP85;NUP42;POM121C;POLR2E
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),0.6397925548457917,1.2132493155616269,0.21212121212121213,0.4936540827023644,1.0,3/22,9.78%,ZC3H12D;NUDT16;RNASE1
prerank,Reactome_2022__Signaling By EGFR R-HSA-177929,0.5469514848654999,1.2130836693900495,0.13793103448275862,0.49383768397635225,1.0,8/44,10.71%,EGF;SH3GL2;SH3GL3;TGFA;SH3KBP1;ARHGEF7;PAG1;ADAM12
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.6492650815600981,1.2130058842166913,0.2833333333333333,0.4938204618422225,1.0,6/16,22.65%,THBS1;AKIRIN1;BST1;CAMK1D;CSF1;RARRES2
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial cell proliferation (GO:1905563),0.8061809296109042,1.2128858152185322,0.2857142857142857,0.4939322042054047,1.0,4/5,17.70%,FLT1;PPARG;CCL2;COL4A3
prerank,KEGG_2021_Human__Insulin resistance,0.532330685714293,1.2127977545546225,0.19672131147540983,0.49389586144747594,1.0,19/92,14.53%,SOCS3;CREB5;PRKCB;IRS2;RPS6KA1;FOXO1;PPARGC1B;TNFRSF1A;PRKCE;PPP1CB;STAT3;PYGL;SLC27A3;MLXIPL;PRKCD;SLC27A5;RPS6KA6;RPS6KB2;PIK3CD
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.5287759897899661,1.2126315328543336,0.1323529411764706,0.4942317649878886,1.0,25/78,23.91%,HLA-DRA;CTSS;SH3GL2;AP1S1;KIF5A;MFSD6;ACTR1A;HLA-DRB1;KLC2;KLC1;HLA-DMA;HLA-E;KIF3C;DYNC1LI2;DCTN1;DNM2;DYNC1LI1;ACTR1B;CAPZB;RAB7A;HLA-F;DCTN3;DYNC1I1;DCTN6;CLTC
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.49885557490568994,1.212460035009192,0.125,0.4944147507521417,1.0,18/103,13.10%,SLC6A15;SLC15A3;SLC7A2;SLC43A1;MYH9;AMN;SLC16A10;SLC25A45;SLC35F3;RAMP3;SLC7A7;SEC14L1;CHMP1A;SLC25A29;SLC7A14;SLC29A4;PDPN;PICK1
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.6300388020315646,1.2124250783997759,0.27419354838709675,0.4943019650848068,1.0,4/17,14.64%,PARD3;OPHN1;MYO9A;CAMSAP3
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),-0.7526427950256636,-1.2123106894294484,0.3157894736842105,0.8135642588065823,1.0,3/6,22.96%,NUP54;INTS13;PLK1
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.4574374003646224,1.212140775330374,0.10126582278481013,0.4949327866204511,1.0,49/362,13.21%,LEF1;CDKN2A;SIX3;PROX1;MAEL;ZNF93;DAB2IP;FOXO1;PRAME;SUV39H1;CIC;ZNF282;TCEAL7;NFIL3;BCL6;NKX6-2;AHR;GZF1;KLF10;CIITA;NRG1;ZBTB16;BAP1;TBX20;MSX2;GLIS2;PML;HMBOX1;ZFPM2;CTNNB1;BASP1;PPARG;CTBP2;CHMP1A;HDAC4;PEX14;CDKN1C;GAS6;HDAC9;L3MBTL3;RUNX1T1;PRICKLE1;MLXIPL;CDKN1B;PER1;KLF4;JARID2;SOX13;DEAF1
prerank,Reactome_2022__Interferon Alpha/Beta Signaling R-HSA-909733,0.5967485954365975,1.2120128820474143,0.19298245614035087,0.49515337189901637,1.0,6/42,14.71%,SOCS3;IRF7;SAMHD1;TYK2;MX1;HLA-E
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.7657466400703359,1.2116678682593511,0.25862068965517243,0.4959738133756418,1.0,1/5,12.76%,ATP8A2
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Stomach,0.7724234186446917,1.2116666152851037,0.26785714285714285,0.49496180933004014,1.0,3/7,15.13%,CD83;CD4;PDCD1LG2
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Lung,0.7724234186446917,1.2116666152851037,0.26785714285714285,0.49496180933004014,1.0,3/7,15.13%,CD83;CD4;PDCD1LG2
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Intestine,0.7724234186446917,1.2116666152851037,0.26785714285714285,0.49496180933004014,1.0,3/7,15.13%,CD83;CD4;PDCD1LG2
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Skin,0.7724234186446917,1.2116666152851037,0.26785714285714285,0.49496180933004014,1.0,3/7,15.13%,CD83;CD4;PDCD1LG2
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Blood,0.7724234186446917,1.2116666152851037,0.26785714285714285,0.49496180933004014,1.0,3/7,15.13%,CD83;CD4;PDCD1LG2
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.7103388384070222,1.211599978888702,0.22950819672131148,0.4949394748126598,1.0,2/11,1.69%,THBS1;SERPINE1
prerank,Reactome_2022__Condensation Of Prometaphase Chromosomes R-HSA-2514853,0.7722760780769695,1.2115793966577846,0.28846153846153844,0.49481743913848386,1.0,1/7,1.73%,CCNB2
prerank,Reactome_2022__RUNX3 Regulates YAP1-mediated Transcription R-HSA-8951671,0.8300015592651748,1.2115244389855309,0.24074074074074073,0.4946955034116251,1.0,3/5,10.71%,TEAD2;YAP1;TEAD1
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7354508001449671,1.211466193375641,0.24528301886792453,0.4946733053287393,1.0,6/12,9.40%,PKP2;GJC1;CACNA1C;RYR2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of memory T cell differentiation (GO:0043382),0.8280178905160744,1.2114591031642443,0.22033898305084745,0.49429236847296093,1.0,1/5,0.56%,HLA-DRA
prerank,GO_Biological_Process_2021__regulation of memory T cell differentiation (GO:0043380),0.8280178905160744,1.2114591031642443,0.22033898305084745,0.49429236847296093,1.0,1/5,0.56%,HLA-DRA
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.5116823544729401,1.2112872684192317,0.15,0.4945736481117273,1.0,24/100,16.27%,CDKN2A;TP53TG5;PSRC1;SLIT2;TSPYL2;SLIT3;BCL6;TRIM46;DCC;PML;MAG;SMAD3;TGFB2;DIP2B;FGF13;FBP1;CDKN1B;CDKN1A;PPP1R9B;SIPA1;TP53;PTPRS;KIAA0319;FHL1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",-0.5321406916285092,-1.211163992301433,0.14634146341463414,0.8162942115786799,1.0,26/66,24.68%,FIP1L1;GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;ERCC2;CPSF1;CLP1;CPSF3;POLR1B;LSM10;MTERF1;MTERF2;ERCC3;POLR3K;TTF1;POLR2L;CSTF2;SSU72;CSTF2T;POLR2E;GTF2H3;CPSF7;UBTF;SLBP
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),0.8093617110446489,1.2111534290492219,0.23529411764705882,0.4946841693741603,1.0,2/6,14.72%,RAB11FIP5;PTPRN
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),-0.6924878527317518,-1.2109032135068531,0.21739130434782608,0.8160959871765804,1.0,2/13,10.22%,FIP1L1;CPSF1
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),0.7792271314472561,1.2106891910107351,0.24528301886792453,0.4958836427927691,1.0,4/6,16.69%,RBM24;NRG1;HDAC9;MESP1
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.7181491134275193,-1.2106341844721755,0.3469387755102041,0.8157407438451512,1.0,2/7,11.11%,PTPN22;SPSB4
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.6714027785518102,1.210588088253693,0.21739130434782608,0.49596040765063015,1.0,8/22,20.78%,MET;ICAM1;PPP1R16B;ROBO4;PDE4D;RAP1A;RAP1B;PDE2A
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.647078694689343,1.2105253029290697,0.20967741935483872,0.4959046389900915,1.0,6/19,15.87%,CXCL2;TGFB2;SYK;CCL2;PIK3CD;PIP5K1C
prerank,Reactome_2022__Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,0.5798761512187387,1.2104912698713837,0.2459016393442623,0.49581108246340616,1.0,6/29,19.96%,SERPINE1;SMAD3;NCOR1;WWTR1;SMAD2;RPS27A
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.6672761386798763,1.210484557673167,0.21666666666666667,0.49561833014564444,1.0,3/15,13.78%,P2RY6;P2RY12;LPAR1
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.5250342767842547,1.2104322218073154,0.18309859154929578,0.4955627691424587,1.0,26/84,15.22%,RIMBP2;ANK3;NPNT;ADCY5;SHC2;KCNQ1;LGR5;PRIMA1;ZNF704;TMEM132C;RAI2;APLNR;MAOB;SYT13;ZBTB7C;KALRN;RASL12;ITGA9;ASXL3;TNFRSF19;DLG3;LRIG1;NEBL;COBL;PDZRN3;SLC44A3
prerank,Reactome_2022__Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.6650855598633711,1.2103725727130055,0.20689655172413793,0.4955733808846634,1.0,8/17,22.45%,IRAK2;NOD1;IKBKG;MAPK11;TAB1;MAP2K3;TAB2;MAPKAPK2
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.6723507167370607,1.2102873799640173,0.22950819672131148,0.49558870544811917,1.0,6/17,15.87%,CXCL2;TGFB2;SYK;CCL2;PIK3CD;PIP5K1C
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),-0.4861368638992758,-1.2102315997167392,0.16129032258064516,0.8160272886218817,1.0,25/70,26.02%,SELENOS;SEL1L2;TMUB2;FBXO27;UBXN8;FOXRED2;DERL2;ERLIN2;USP19;AUP1;RNF5;RNF103-CHMP3;UBE4A;YOD1;DNAJB9;TMUB1;DNAJC10;RHBDD2;ERLIN1;VCP;FAM8A1;DERL1;DNAJB12;UBXN4;DNAJC18
prerank,CellMarker_Augmented_2021__Mitotic Arrest Phase Fetal Germ cell:Fetal Gonad,0.4381546290228531,1.2099955954891306,0.024691358024691357,0.4961373259855093,1.0,103/781,13.09%,LEF1;ELAVL2;BOK;IL13RA1;IMPDH1;SHISA9;NPNT;TESC;PLK2;SH3GL2;C5ORF47;MAEL;CSMD3;ARHGAP39;P4HA2;CD55;CDC42EP3;ADA;MAP3K11;YBX3;CYP4X1;MYH9;ABCA5;CNTNAP2;PRAME;DUSP10;EFNA1;APBA2;SEMA3C;CTHRC1;CIC;CCDC122;TSPYL2;TDRD5;EMB;BAIAP2L1;EGFL7;EPB41L4B;NELL2;PRKAR1B;WASF1;DNAH3;STK32B;BAIAP2;LHX6;CHD3;ATP9A;KLF10;NOTUM;COLEC11;PARD3;NRG1;ZBTB16;ABCC9;SERPINF1;MAP7D2;EIF2B2;RHOD;PAK4;RYR2;LCA5;LIMCH1;DBX2;TRIM36;SYNGR3;CDK6;DUSP22;ACOT4;MRAS;CLGN;ZFAND5;MYT1L;SURF2;FTCD;STAG3;KCNQ2;ETV6;ATP1B1;TAF4B;B3GALNT1;EPB41L1;ART3;NDRG1;COL9A1;RGMB;LY6H;SMAD1;TEAD1;PRR5;L3MBTL3;RUNX1T1;FMN1;KCTD13;CAMK2B;KLF6;PAM;KLC1;AGAP3;ANXA11;ZFAND3;FN1;LRIG1;RASGEF1B
prerank,CellMarker_Augmented_2021__Intestinal Stem cell:Intestinal Crypt,0.5745989202064292,1.2099284580066594,0.2647058823529412,0.4961335380569622,1.0,16/46,10.05%,IL13RA1;ANXA1;PLK2;S100A10;THBS1;CD24;TGFA;SEMA3C;OSMR;AHR;ITGA2;CD44;EMP1;KPNA7;ITGA3;RIN2
prerank,Reactome_2022__G-protein Mediated Events R-HSA-112040,0.5729939653089241,1.209836879990711,0.1746031746031746,0.4961721945436957,1.0,23/47,21.85%,PDE1C;ADCY5;PRKCG;PRKAR1B;ITPR3;PDE1A;ADCY7;ADCY2;GRK2;GNA14;PDE1B;CAMK2B;PRKCD;PRKAR1A;GNAI1;ITPR1;NBEA;CAMK2A;PRKCA;AHCYL1;PRKX;ADCY9;ADCY8
prerank,CellMarker_Augmented_2021__Schwann cell:Undefined,0.8189805315725175,1.2096999972129907,0.2753623188405797,0.4963569469541207,1.0,3/6,7.36%,MBP;GAP43;GFAP
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),-0.6765035038757701,-1.20969830428966,0.28888888888888886,0.8167282864218194,1.0,3/13,14.53%,LSM2;PRPF8;PRPF3
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.5896077333102452,1.2096529370545872,0.24074074074074073,0.4962965319308365,1.0,7/26,6.91%,ANXA1;IL1RAPL1;SYT4;SERGEF;TNFRSF1A;RHBDF1;SNCA
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),-0.8050641747364179,-1.2095350076231823,0.2653061224489796,0.8161383202247924,1.0,2/5,6.00%,PDCD7;AKR1C3
prerank,CellMarker_Augmented_2021__Neural Crest cell:Undefined,0.7029212693522734,1.2095233441426372,0.23529411764705882,0.49643398412233986,1.0,1/11,0.61%,CSPG4
prerank,Reactome_2022__Platelet Degranulation R-HSA-114608,0.5035994286643695,1.209315457426886,0.1111111111111111,0.49674081417055604,1.0,19/93,15.04%,IGF1;SGPP2;EGF;THBS1;SERPINE1;PLEK;APP;PDGFA;SYTL4;CYRIB;TGFB2;TF;GAS6;ACTN1;SPARC;FN1;RAB27B;ABCC4;SERPING1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),0.7545634334876544,1.2092001102786494,0.3050847457627119,0.496629277137407,1.0,4/7,16.30%,KCNC2;FOXO1;GUCY1B1;CDK2
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),0.7545634334876544,1.2092001102786494,0.3050847457627119,0.496629277137407,1.0,4/7,16.30%,KCNC2;FOXO1;GUCY1B1;CDK2
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.704960333524961,1.2091871065041728,0.2545454545454545,0.49647953024859437,1.0,4/11,11.49%,KLF2;PRAME;CTBP2;ASXL1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.7019438095304703,1.208972262355961,0.2807017543859649,0.49692215588630784,1.0,2/13,12.15%,SMCR8;PHF23
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),-0.7833688853508161,-1.2089461532171017,0.22727272727272727,0.8170944848372171,1.0,1/7,0.06%,SLC2A5
prerank,Reactome_2022__SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.47597575195951036,-1.2089093432534346,0.10526315789473684,0.8160363774214295,1.0,3/42,5.18%,AAAS;RNF2;NUP50
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.7366305942842001,1.2088569762177368,0.3191489361702128,0.4969838441817439,1.0,4/7,21.91%,TFPI;SERPING1;F3;F10
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.5255971397338615,1.2088481006545175,0.2,0.49680125947932957,1.0,13/89,18.23%,ST18;MAP3K14;TNFRSF14;BIRC3;TNFRSF1A;FOXO3;EIF5A;CD70;TP53;TNFRSF11B;TRAF5;TNFSF4;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.4992765655402878,1.208768676445712,0.09333333333333334,0.4968394732998919,1.0,23/124,18.55%,ANK3;YWHAH;FYN;BAP1;ZIC1;MYO1C;BAG3;YWHAG;ARIH2;SMAD3;BBC3;GAS6;PRKCD;BCL2;OAZ2;CEMIP;MTCL1;TP53;PINK1;MICALL2;YWHAE;FLNA;PLK3
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),-0.5277737860919722,-1.2087485519684256,0.20454545454545456,0.815595089690739,1.0,14/42,18.00%,PMVK;TM7SF2;DHRS11;AKR1C3;ABCB11;OSBPL3;HSD11B1;CYP46A1;SRD5A1;CYP7B1;SC5D;DHCR7;OSBPL6;PRLR
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.7659574347162953,1.208619286554566,0.2653061224489796,0.49703251835972617,1.0,1/6,4.82%,PLSCR1
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.7609970013611496,-1.2083025825741485,0.2857142857142857,0.8161355882289425,1.0,3/6,14.38%,NDUFA12;NDUFV3;COA6
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.5735920404466222,-1.208110738027111,0.25,0.8155285651607537,1.0,2/28,0.52%,DAO;CYP4F3
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.7199785816255377,1.2081089744246234,0.22641509433962265,0.4981917313835358,1.0,3/10,3.50%,IGF1;CD24;IL27RA
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),0.7574444434550521,1.2080880382737536,0.3090909090909091,0.4980370874778622,1.0,2/6,5.16%,IRS2;BCL6
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.712418969121634,1.207930193994385,0.26,0.4981872301736608,1.0,4/10,24.19%,HR;KDM3A;PHF8;KDM4C
prerank,Reactome_2022__Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,0.5259963184621937,1.2076919515647575,0.16666666666666666,0.4985808822052364,1.0,14/71,12.29%,ELMO1;WAS;MYH9;WASF1;FYN;BAIAP2;ITPR3;PLD2;ARPC3;PRKCE;RNASE1;SYK;PLPP4;PRKCD
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Fat Pad,0.8634258860662845,1.207691337820117,0.18333333333333332,0.49837943538414337,1.0,2/5,6.44%,THY1;CD44
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.8132013189521815,1.2075076591041756,0.17307692307692307,0.4986275677474618,1.0,2/5,13.97%,SEPTIN9;HAP1
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),-0.802867194506913,-1.2074359145001676,0.2631578947368421,0.8163342017826728,1.0,2/5,11.01%,WDR11;C17ORF75
prerank,"Reactome_2022__Inactivation, Recovery And Regulation Of Phototransduction Cascade R-HSA-2514859",-0.6478613883345685,-1.207321349129566,0.16666666666666666,0.8155178949968442,1.0,6/17,17.12%,GUCA1B;PPEF1;NMT2;METAP2;GNGT1;METAP1
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.6152148773757999,1.207263299452868,0.2698412698412698,0.49907204008688777,1.0,3/26,8.22%,ST6GAL1;TUSC3;MGAT5
prerank,KEGG_2021_Human__Selenocompound metabolism,0.6614746190743704,1.2072347841283793,0.27419354838709675,0.49894548123071614,1.0,1/14,0.73%,PAPSS2
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.5877398694656052,1.2072020721986776,0.2,0.4988237002355239,1.0,7/34,9.35%,NR4A3;IGF1;THBS1;OGN;APOD;CTNNB1;PPARG
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.5642189100871094,1.2070853522882297,0.18333333333333332,0.49891234163811526,1.0,11/43,16.08%,GRIN2A;GRIN2B;NOD1;FYN;GRIN1;SYK;USP50;NLRP2;FADD;MAP3K5;TBC1D10A
prerank,Reactome_2022__Ca2+ Activated K+ Channels R-HSA-1296052,0.7921255280555768,1.207066442840898,0.23404255319148937,0.49875796826242813,1.0,2/6,14.04%,KCNMB4;KCNMA1
prerank,"Reactome_2022__Activation Of NIMA Kinases NEK9, NEK6, NEK7 R-HSA-2980767",0.7683427251662098,1.2069468191894281,0.3018867924528302,0.49888859566263044,1.0,3/6,17.53%,CCNB2;NEK6;CCNB1
prerank,GO_Biological_Process_2021__response to vitamin D (GO:0033280),0.7799114345410477,1.2068773145946974,0.3076923076923077,0.49889774402704856,1.0,3/5,19.53%,ALPL;SPP1;CDKN2D
prerank,KEGG_2021_Human__Histidine metabolism,0.7317925876377265,1.2065520416563316,0.26153846153846155,0.4995508405620693,1.0,4/15,9.60%,CARNS1;MAOB;FTCD;CNDP1
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),0.7645006033014509,1.2064113621959764,0.23333333333333334,0.49978360946646805,1.0,3/7,10.32%,PLD1;FSCN1;PODXL
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),0.6523451629585038,1.2064087370836902,0.22580645161290322,0.49958723279317335,1.0,3/12,18.06%,STAT3;SYK;TNFSF4
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),-0.7633872616833812,-1.2063098008656323,0.29545454545454547,0.8143056549818277,1.0,1/5,2.84%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),-0.7633872616833812,-1.2063098008656323,0.29545454545454547,0.8143056549818277,1.0,1/5,2.84%,EXOSC8
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),-0.7633872616833812,-1.2063098008656323,0.29545454545454547,0.8143056549818277,1.0,1/5,2.84%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),-0.7633872616833812,-1.2063098008656323,0.29545454545454547,0.8143056549818277,1.0,1/5,2.84%,EXOSC8
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.7011247480695968,1.2061969825039436,0.29310344827586204,0.49998758563708573,1.0,5/12,13.28%,PROX1;PDGFRA;MYLK3;TCAP;NEBL
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.7467350642312525,-1.2061963874214265,0.24074074074074073,0.8135092288032345,1.0,3/5,24.01%,RPAP2;SSU72;CTDP1
prerank,KEGG_2021_Human__Retinol metabolism,-0.5560017500532871,-1.2061750497762065,0.2,0.8123412265262083,1.0,11/24,14.88%,RETSAT;ALDH1A1;HSD17B6;ADH6;ADH4;AOX1;ADH5;LRAT;RDH10;RDH11;CYP2C8
prerank,Reactome_2022__MAP Kinase Activation R-HSA-450294,0.5505098526904529,1.206164289359473,0.13432835820895522,0.4998471909465265,1.0,13/56,20.32%,KCNH8;IRAK2;RPS6KA1;NOD1;TNIP2;IKBKG;MAPK11;TAB1;MAPK9;MAP2K3;SKP1;RPS27A;TAB2
prerank,Reactome_2022__Regulation Of Localization Of FOXO Transcription Factors R-HSA-9614399,0.6673479825354371,1.206074964603907,0.26,0.4998186763608775,1.0,3/12,8.34%,FOXO1;FOXO3;YWHAG
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.5818514521862133,1.2060481487102146,0.16666666666666666,0.49969242757297894,1.0,11/42,15.49%,GABRB2;GLRA2;GABRG3;GABRD;GABRA1;GABRG2;GABRA5;ANO9;SLC12A5;GLRA3;ANO7
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),0.7960989783638922,1.206046029518442,0.27450980392156865,0.4995057881395765,1.0,2/5,9.43%,PPARG;CTBP2
prerank,Reactome_2022__Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.5327616105499254,-1.2060028158052303,0.16216216216216217,0.8118793691037194,1.0,4/33,12.49%,AAAS;NUP50;HSPA1A;NUP54
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),-0.7657951916602896,-1.205988554768074,0.22916666666666666,0.8108048164300097,1.0,3/6,11.69%,IDO1;ZC3H8;PRELID1
prerank,Reactome_2022__Atorvastatin ADME R-HSA-9754706,0.7835945540090495,1.2058273788887108,0.2,0.49991467311821824,1.0,1/6,2.80%,ABCB1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.5913928555100263,-1.205825785167723,0.22916666666666666,0.8101932229581251,1.0,9/20,23.09%,GTF2H5;GTF2H2;CETN2;ERCC2;XPA;ERCC3;UBB;PARP1;GTF2H3
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.6063498986728784,1.2056159255333898,0.23943661971830985,0.5002581370919909,1.0,3/23,10.99%,RFX4;GLIS2;IFT122
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.7184095122326464,-1.2053154897816813,0.2978723404255319,0.8108079131235939,1.0,1/5,5.24%,SLC6A13
prerank,KEGG_2021_Human__Thyroid hormone synthesis,0.5470773880675229,1.2052823858600075,0.1791044776119403,0.501154394101488,1.0,10/54,10.24%,CREB5;PRKCB;ADCY5;PRKCG;ITPR3;ADCY7;ADCY2;ATP1A1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6675793420038136,1.2052512679600036,0.3018867924528302,0.5010232171879554,1.0,2/16,1.98%,PROX1;PSRC1
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.5500695600360989,1.2049716603605898,0.22580645161290322,0.50151907325013,1.0,13/56,15.49%,GABRB2;GLRA2;GABRG3;GABRD;GABRA1;SLC20A2;GABRG2;GABRA5;ANO9;SLC12A5;GLRA3;SLC37A2;ANO7
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.5213109093080618,1.2045564322512623,0.15942028985507245,0.5024833792334562,1.0,22/74,23.91%,HLA-DRA;CTSS;SH3GL2;AP1S1;KIF5A;ACTR1A;HLA-DRB1;KLC2;KLC1;HLA-DMA;KIF3C;DYNC1LI2;DCTN1;DNM2;DYNC1LI1;ACTR1B;CAPZB;RAB7A;DCTN3;DYNC1I1;DCTN6;CLTC
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.6548628436012944,1.2045242280343647,0.23636363636363636,0.5023657484146298,1.0,4/17,11.17%,RBM24;MMP14;HDAC4;HDAC9
prerank,KEGG_2021_Human__Neutrophil extracellular trap formation,-0.4719874082378328,-1.2045002739269233,0.1794871794871795,0.8125780886575773,1.0,13/91,6.37%,H2AC20;H4C3;SLC25A5;AGER;H3-3B;H2BC4;H2BC21;PLCB4;PADI4;H2AC6;SLC25A4;VDAC2;CR1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.5506785820638498,1.2044182452104821,0.19047619047619047,0.5024105534699899,1.0,14/51,20.27%,FSD1;CLIP2;HOOK1;LIMK2;TPPP;MAPT;KATNAL1;CAMSAP3;HOOK2;DCTN1;PLK3;RAB11A;TUBGCP6;FIGN
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.7594310432437028,-1.2044043985744712,0.30612244897959184,0.8118248600688404,1.0,1/6,2.70%,RNF6
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.6504481127774239,1.2041949917181791,0.2692307692307692,0.5027845127515315,1.0,1/15,2.35%,ZFP36
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),0.5782599961450658,1.2041503447086845,0.23728813559322035,0.5026947103840739,1.0,4/32,4.31%,ANXA1;ZFP36;SFTPD;PTPRC
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.5349801929303691,1.2037098063694702,0.17142857142857143,0.5037724387592247,1.0,14/59,10.69%,HLA-DRA;CTSS;MYO1F;PLEK;SLA;NAPSB;WAS;IRF7;PTPRC;CD37;SERPINF1;ETV6;PACSIN1;CD83
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.53317271800518,1.2036618998930018,0.23880597014925373,0.503654527914257,1.0,10/60,10.79%,RFTN1;ZDHHC9;ZDHHC22;PARD3;MYO1C;MICALL1;ZDHHC7;ZDHHC1;SYNE3;NACAD
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),0.765469357354842,1.2035407403373433,0.25862068965517243,0.5037265032544249,1.0,1/5,0.25%,HPN
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Skin,0.5245602412032769,1.2035111032501187,0.13432835820895522,0.5036318410144368,1.0,15/85,11.02%,TAGLN3;EPHA7;GRID2;GAP43;ZDHHC22;PLP1;EFNB3;UNC5D;SEMA5B;SYT13;CRISPLD1;PTPRD;CACNG4;LY6H;ASXL3
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.6773197785540972,1.2032124860399087,0.23214285714285715,0.5041801819973704,1.0,8/17,17.94%,CD22;RIT2;PLEK;NEUROD2;MAPT;BST1;SLC8A2;ITPR1
prerank,Reactome_2022__Ketone Body Metabolism R-HSA-74182,0.758536938355593,1.2030244648239057,0.2786885245901639,0.5044506734943381,1.0,3/8,10.34%,SOAT1;OXCT1;HMGCLL1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.7610928917956958,1.202919314148088,0.21818181818181817,0.5045545684320538,1.0,2/7,10.90%,GRIN1;DUOXA1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),-0.6051527623808652,-1.202909193457069,0.24324324324324326,0.8160814291537876,1.0,1/21,0.12%,DAO
prerank,GO_Biological_Process_2021__mammary gland duct morphogenesis (GO:0060603),0.7941395192019722,1.20281061800482,0.15384615384615385,0.5047276782780845,1.0,1/5,2.75%,EPHA2
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.6494064185149366,1.2028094773421811,0.2631578947368421,0.504535827569333,1.0,6/15,21.30%,EPHA2;GAB2;GPR183;SNX10;SBNO2;CSF1
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),0.6226182090458461,1.2024561957613336,0.21153846153846154,0.5052950604251056,1.0,2/27,3.31%,TLR2;IRF7
prerank,KEGG_2021_Human__Viral carcinogenesis,0.4789509391904006,1.2024430780958728,0.09836065573770492,0.5051446655747032,1.0,22/152,14.71%,CDKN2A;HPN;C3;YWHAH;CREB5;SP100;IRF7;CDK6;YWHAG;HDAC4;VAC14;STAT3;SYK;ACTN1;HDAC9;PXN;CDKN1B;CDKN1A;CCND1;IKBKG;PIK3CD;HLA-E
prerank,KEGG_2021_Human__PI3K-Akt signaling pathway,0.46741409199603795,1.2023809540016397,0.11392405063291139,0.5051466027491092,1.0,61/252,16.30%,MET;COL4A1;TLR2;IGF1;PDGFRA;YWHAH;EGF;GNG3;CREB5;CHRM1;THBS1;NR4A1;FLT1;ITGA8;COL4A2;EPHA2;RELN;EFNA1;TGFA;OSMR;GNG2;LAMB1;ITGA2;GHR;FOXO3;PDGFA;CDK6;ITGA11;LAMA5;BCL2L1;YWHAG;KITLG;ITGA3;ITGA9;COL9A1;SYK;LAMA2;ITGB8;COL4A4;CDKN1B;BCL2;FN1;IL4R;CHAD;CDKN1A;CCND1;COL4A5;FGF2;LPAR1;RPS6KB2;THBS2;IKBKG;PIK3CD;SPP1;LAMA3;TP53;THBS3;RXRA;ANGPT2;BRCA1;CDK2
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Undefined,0.7046419815944708,1.2022500681359702,0.24528301886792453,0.5052269196052178,1.0,3/11,15.37%,STAT4;CD4;STAT6
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.7906174921671729,1.2022194805721922,0.2037037037037037,0.5050905577267193,1.0,2/7,8.51%,DAB2IP;NLRC3
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.6047264251180265,1.2019544972470406,0.2463768115942029,0.5055347856258016,1.0,7/28,16.86%,CLDN16;PARD3;POF1B;CLDN18;CLDN20;PATJ;MICALL2
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Liver,0.4550923591105164,1.2017884074952632,0.10526315789473684,0.5057714281294483,1.0,71/327,18.09%,CDKN2A;PTP4A3;TYMP;CTSC;ACTA2;PIM3;SLA;ZC3H12D;FOXO1;DUSP10;IL1R1;TSPYL2;LAT2;ICA1;MAP1LC3A;NINJ2;SOX4;FAS;BTG3;NEDD9;DUSP16;SYNGR2;BIRC3;DPYSL2;LASP1;NPTN;CTNNB1;OCIAD2;LDLRAD4;TTYH3;HACD1;GOLGA8A;SEC14L1;ATP1B1;PPP1CB;NAMPT;CD83;RAB11FIP1;PGK1;CTNNA1;PLEKHG2;SRA1;GADD45A;MX1;FMNL3;CDKN1A;SGMS1;HLA-DMA;PRDM1;CD70;ALDH3A2;STAMBPL1;IKZF2;MIIP;PRKAR1A;CD59;C21ORF91;BACH1;ADCY3;CALM3;GABARAPL1;INPP5F;WHRN;MAP2K3;HDAC7;RAP1A;TFRC;NDFIP2;RNF187;DDB2;CTTNBP2NL
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.5810178493434481,1.2015324158657334,0.1791044776119403,0.5063301161815071,1.0,14/42,16.45%,A4GALT;UGT8;ESYT3;ST8SIA3;ST8SIA1;B4GALNT1;B3GALNT1;ABCA2;STS;LARGE1;ST6GALNAC5;B4GALT6;ST6GALNAC3;NEU4
prerank,Reactome_2022__Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,0.5234232654255873,1.2015286850912952,0.13043478260869565,0.5061337132769712,1.0,15/81,7.44%,GGT5;GNG3;PLK2;ADCY5;MYH9;PRKAR1B;FYN;GIPR;RXFP1;GNG2;ITPR3;ADCY7;ADCY2;RAMP3;GLP1R
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.7476677013035964,-1.2013435706814788,0.3111111111111111,0.8206410482872023,1.0,3/7,18.26%,PPP1R3C;PPP1R3G;PPP1R3E
prerank,Reactome_2022__RAS Processing R-HSA-9648002,0.6348474964026785,1.2013143948666143,0.2786885245901639,0.5064250325824863,1.0,3/17,8.31%,ZDHHC9;PRKG2;BCL2L1
prerank,GO_Biological_Process_2021__detection of virus (GO:0009597),0.7853376370715541,1.2012019016349322,0.19298245614035087,0.5064724343075291,1.0,3/5,19.54%,IFIH1;SERINC5;TLR3
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),0.7504267801936063,1.2011213154050402,0.3050847457627119,0.5064416658511288,1.0,4/8,16.30%,KCNC2;FOXO1;GUCY1B1;CDK2
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),0.7606523146267232,1.2010136271979355,0.2692307692307692,0.5065119944733417,1.0,2/5,6.21%,NUDT16;SAMHD1
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),0.804278855879232,1.2009851974197778,0.3137254901960784,0.506403164044912,1.0,4/5,15.22%,CD55;CFH;TGFB2;CD59
prerank,KEGG_2021_Human__Ubiquinone and other terpenoid-quinone biosynthesis,-0.7120622109245921,-1.2009379643693543,0.2558139534883721,0.8207153538409332,1.0,6/9,25.80%,COQ3;GGCX;COQ6;NQO1;VKORC1L1;COQ7
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.8072287257725239,1.200933625343598,0.2222222222222222,0.5063770501529822,1.0,2/5,12.00%,PARD3;PARD3B
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.5886286355786565,1.2008452142601216,0.1746031746031746,0.5064151995322184,1.0,8/33,19.01%,SMCR8;PIP4K2A;PHF23;MTM1;PINK1;LRSAM1;ELAPOR1;MTMR3
prerank,Reactome_2022__Dual Incision In TC-NER R-HSA-6782135,-0.529431877613842,-1.2002815755625331,0.17142857142857143,0.8221660649819494,1.0,19/62,20.34%,ERCC8;RFC3;GTF2H5;POLR2K;POLD3;GTF2H2;ERCC2;POLR2C;HMGN1;ERCC6;POLR2D;PPIE;POLR1B;SLC19A1;XPA;ERCC3;UBB;POLR2L;POLR2G
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.687007300551692,1.20024786801264,0.21875,0.5078385748700239,1.0,4/14,14.76%,LPCAT4;PLAAT4;PLAAT3;PNPLA8
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),0.825720289175393,1.2000918188747063,0.25,0.5081420532668879,1.0,3/8,8.72%,SULF1;MCAM;ITGA3
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.5712484429749137,-1.200055045576043,0.3333333333333333,0.8219240856572178,1.0,4/23,8.06%,CSKMT;SMYD2;METTL18;KMT5A
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.6772821838869637,1.2000546101954304,0.1864406779661017,0.5080740432774662,1.0,7/19,19.47%,LTBP4;ITGA3;SMAD3;BCL9;DKK3;SMAD2;TGFBR3
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.7096709363246072,1.200001122933561,0.25,0.5079969240472015,1.0,10/19,19.02%,PKP2;NOS1AP;TRPM4;CACNA1C;RYR2;FGF13;CALM3;CTNNA3;CAV3;CXADR
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.8035676315561561,1.1999087766222771,0.3125,0.5080664158906023,1.0,1/5,2.35%,ZFP36
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.508793233359703,1.1998611194676783,0.15873015873015872,0.5079618932906346,1.0,22/98,17.18%,HTR2C;SLC24A2;CDH23;VAPB;TRPC3;ATP2B3;GCM2;HCRTR2;RYR2;PML;NPTN;ATP1B1;TPCN2;MCUB;BCL2;STOML2;SLC24A1;ATP13A1;ATP2B4;SLC8A2;SLC8A1;CALB2
prerank,KEGG_2021_Human__GnRH signaling pathway,0.5232211945508524,1.199753914178068,0.15873015873015872,0.5080450723215747,1.0,19/73,18.53%,PLD1;PRKCB;ADCY5;ITPR3;ADCY7;CACNA1C;ADCY2;PLD2;MMP14;CAMK2B;PRKCD;MAPK11;ADCY3;CALM3;MAPK9;MAP2K3;ITPR1;CAMK2A;PRKCA
prerank,Reactome_2022__Ethanol Oxidation R-HSA-71384,-0.7699305497371293,-1.199712103235115,0.3235294117647059,0.8219638200898707,1.0,5/6,19.24%,ALDH1A1;ADH6;ADH5;ALDH2;ACSS1
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.7601466295918895,1.1996455251594211,0.2923076923076923,0.5081281857021354,1.0,5/7,18.09%,FYN;ITGA3;PICK1;IGF1R;MTMR2
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.7711755776560735,1.1995682531336498,0.2962962962962963,0.5080969218763223,1.0,2/9,9.47%,GGCT;GSS
prerank,CellMarker_Augmented_2021__Non-classical monocyte:Blood,0.644106133298576,1.199485095964646,0.234375,0.5074608035226811,1.0,6/21,3.65%,TLR2;CTSS;P2RY13;MYO1F;SLA;SIGLEC1
prerank,CellMarker_Augmented_2021__Intermediate monocyte:Blood,0.644106133298576,1.199485095964646,0.234375,0.5074608035226811,1.0,6/21,3.65%,TLR2;CTSS;P2RY13;MYO1F;SLA;SIGLEC1
prerank,CellMarker_Augmented_2021__Classical monocyte:Blood,0.644106133298576,1.199485095964646,0.234375,0.5074608035226811,1.0,6/21,3.65%,TLR2;CTSS;P2RY13;MYO1F;SLA;SIGLEC1
prerank,CellMarker_Augmented_2021__CD14++CD16- monocyte:Blood,0.644106133298576,1.199485095964646,0.234375,0.5074608035226811,1.0,6/21,3.65%,TLR2;CTSS;P2RY13;MYO1F;SLA;SIGLEC1
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),0.8217942087573114,1.199447463848205,0.25,0.5073385947000931,1.0,4/6,17.39%,RTN4RL1;EPHA4;PTPRS;INPP5F
prerank,Reactome_2022__Sema4D Mediated Inhibition Of Cell Attachment And Migration R-HSA-416550,0.7119888007870842,1.1994340055281512,0.2641509433962264,0.5071891120560609,1.0,5/8,25.49%,RNASE1;SEMA4D;ARHGAP35;RNMT;PLXNB1
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.6021856266432438,1.1992903249541964,0.2698412698412698,0.5073543783268756,1.0,8/21,12.25%,PIM3;ADCY5;EPHA5;BAIAP3;TRPM4;HLA-DRB1;STX4;KLF7
prerank,GO_Biological_Process_2021__protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947),-0.768857242388287,-1.1991284867103027,0.2894736842105263,0.8229964208602346,1.0,1/5,1.79%,TNFAIP3
prerank,Reactome_2022__FCERI Mediated NF-kB Activation R-HSA-2871837,0.5329156383549056,1.1990987086056073,0.14925373134328357,0.5077291863403671,1.0,2/70,1.84%,RASGRP2;RASGRP1
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.6644822691808199,-1.198813882905263,0.2608695652173913,0.8228728503654785,1.0,2/9,8.43%,DCLRE1B;TFIP11
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.6627021933843773,-1.198786572391922,0.1794871794871795,0.8218348064527078,1.0,4/12,16.63%,CCDC22;PSMD10;NFKBIB;NFKBIE
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.6715606129631148,1.198772487393778,0.3148148148148148,0.508340626730461,1.0,6/10,30.58%,PPARG;NFATC3;NFATC4;NFIB;PPARD;SRF
prerank,GO_Biological_Process_2021__retinal cone cell differentiation (GO:0042670),0.7924681588120396,1.1987108649016234,0.1568627450980392,0.5080915412376024,1.0,1/5,3.51%,THY1
prerank,GO_Biological_Process_2021__retinal cone cell development (GO:0046549),0.7924681588120396,1.1987108649016234,0.1568627450980392,0.5080915412376024,1.0,1/5,3.51%,THY1
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),-0.5946066181522516,-1.198588706285224,0.2894736842105263,0.8214015570392507,1.0,4/20,11.21%,ABCD2;PXMP2;ABCD1;PEX11B
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.5454638080648322,1.1985381238500334,0.22535211267605634,0.5083471472149664,1.0,8/53,6.91%,TLR2;IL15;SERPINE1;APP;NLRP12;OSMR;TNFRSF1A;SNCA
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.6429968994795406,1.198495542524088,0.19642857142857142,0.5082568181900547,1.0,5/18,13.91%,THBS1;P2RY12;STX4;CFAP20;TRIM32
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.5983932543030867,1.1983642135570294,0.15254237288135594,0.5083984749793831,1.0,9/35,16.57%,A4GALT;ST8SIA3;PGAP4;ST8SIA1;PIGA;LARGE1;ST6GALNAC5;B4GALT6;PIGB
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",-0.5859664092409591,-1.1979097550148503,0.24324324324324326,0.82253643282591,1.0,4/17,17.30%,SELENOS;DERL2;AUP1;HM13
prerank,CellMarker_Augmented_2021__Epithelial cell:Thymus,0.549834438254892,1.1978854674513197,0.2153846153846154,0.5092718571926373,1.0,17/55,17.27%,NPNT;PKP2;EFNA1;BAIAP2L1;EPB41L4B;PTPN21;RHOD;TTC39A;LAMA5;YAP1;TEAD1;GPRC5C;LAMA3;BCAR1;SLC44A3;LPIN3;MAGI1
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),-0.6671908111111254,-1.1978490702456808,0.3076923076923077,0.8216640180291075,1.0,6/8,30.95%,GLUD1;GLYATL1;SIRT4;GLUL;CPS1;NIT2
prerank,Reactome_2022__Hydrolysis Of LPC R-HSA-1483115,-0.8014288159638867,-1.1976802670276923,0.30952380952380953,0.8211686312259929,1.0,4/5,19.57%,PLA2G4C;PLA2G15;GPCPD1;PLA2G4A
prerank,Reactome_2022__Crosslinking Of Collagen Fibrils R-HSA-2243919,0.7406349552218424,1.1975966157477567,0.20408163265306123,0.5099264529112203,1.0,4/9,18.59%,TLL1;LOXL1;LOXL2;PCOLCE
prerank,CellMarker_Augmented_2021__B cell:Kidney,0.43878560664912875,1.197587225392977,0.03488372093023256,0.5097402644888286,1.0,76/515,14.92%,CNR1;HLA-DRA;RASGRP2;ST6GAL1;IL13RA1;IGF1;KLF2;EBF1;COBLL1;GNG3;RAPGEF5;SP100;CD22;CD24;NR4A1;PIM3;CD55;DMTN;UGT8;PRKCB;MOB3B;FA2H;SHISA8;THY1;NUAK2;EGFL7;CD37;KHDRBS2;GALNTL6;NKX6-2;SYNGR2;CIITA;REPS2;BIRC3;PLAC8;ECE1;TPD52;PAWR;LARP6;DUSP22;DAAM1;MGAT5;BASP1;OXCT1;CCSER1;STAG3;ADAM19;CCR10;ADAM28;NFKBID;RGMB;KLHL5;SYK;CD83;SNX22;COL4A4;HDAC9;ABCB9;HLA-DRB1;PXK;RAB30;SYVN1;PHACTR1;ALPL;TMEM156;GLRA3;HLA-DMA;NAP1L1;IL12A;MAN1A1;BCL11A;RHOBTB2;NEK6;HLA-E;INPP5D;GPR183
prerank,CellMarker_Augmented_2021__T cell:Placenta,-0.6282541234181128,-1.1973166560499091,0.28888888888888886,0.8214334056441792,1.0,5/14,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),-0.6164697529717528,-1.1970164676886343,0.30434782608695654,0.8212598910149695,1.0,6/17,14.23%,ALAS1;HMBS;ABCB10;SLC25A38;FECH;TSPO
prerank,Reactome_2022__Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,0.6719191450283604,1.1970093127016679,0.22641509433962265,0.5111932438896263,1.0,6/17,24.24%,SYT1;CPLX1;PPFIA2;SNAP25;RAB3A;PPFIA1
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.7919462304803814,1.1969117911963056,0.25925925925925924,0.5112517815311663,1.0,3/6,18.63%,SNCA;ATP2B4;CAV3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Dental Pulp,0.7703775772595963,1.1969064964976721,0.26785714285714285,0.511060756332646,1.0,3/7,6.44%,THY1;PTPRC;CD44
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),0.7165812854554274,1.1968578064966393,0.23404255319148937,0.5109560436708463,1.0,4/6,27.01%,COLGALT1;AEBP1;CHADL;EMILIN1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.8279415538846626,1.196548019463866,0.22413793103448276,0.5114951166079721,1.0,2/5,10.92%,TPPP;MAPT
prerank,KEGG_2021_Human__Allograft rejection,0.7060728995157501,1.1964947673724269,0.2641509433962264,0.511426566832136,1.0,6/13,14.71%,HLA-DRA;FAS;HLA-DRB1;HLA-DMA;IL12A;HLA-E
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.5221677362562094,1.1964902247734706,0.17647058823529413,0.5112538902518715,1.0,34/96,15.22%,MET;A4GALT;NPNT;FBLIM1;EPHA2;ICAM1;CEP170B;DAB2IP;OSMR;COL12A1;PTPN21;SEMA3B;RHBDF1;OLFML2A;GRAMD2A;RHOD;SCARA3;LAMA5;ITGA3;YAP1;EPB41L1;RADIL;PXDC1;SLCO2A1;TEAD1;COL4A4;CLDN18;PDPN;PALLD;NTN4;NOTCH3;LAMA3;SMARCA1;SLC44A3
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Adipose Tissue,0.6138115291557089,1.1964662245547186,0.2537313432835821,0.5111311545112064,1.0,10/21,23.19%,THY1;PTPRC;CD44;TNFRSF1A;PODXL;CD70;TFRC;NCAM1;ITGAV;PECAM1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.7643431981216853,1.196454387233636,0.2641509433962264,0.5109632541766026,1.0,4/9,7.18%,PKP2;TRPM4;CACNA1C;RYR2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Umbilical Cord,0.7199671170799926,1.196313080764477,0.1896551724137931,0.5110533687448294,1.0,3/9,6.44%,THY1;PTPRC;CD44
prerank,Reactome_2022__RUNX3 Regulates CDKN1A Transcription R-HSA-8941855,0.7865447952994491,1.1962611218181334,0.25862068965517243,0.5110032151045243,1.0,3/6,15.46%,SMAD3;CDKN1A;TP53
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.6445854151412085,1.1962536055948059,0.3387096774193548,0.5108129573760559,1.0,3/19,4.01%,IGF1;RTN1;RTN2
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),0.5132012028014369,1.1959258857927766,0.1864406779661017,0.5114272275439603,1.0,19/86,14.19%,IGF1;KCNC2;ABCC8;ACHE;GIPR;ITPR3;SERGEF;RHBDF1;CACNA1C;HADH;TMED10;GLP1R;CACNA1E;SYTL4;TGFB2;ARF6;PICK1;RHBDF2;IL12A
prerank,Reactome_2022__Digestion Of Dietary Carbohydrate R-HSA-189085,-0.7924971966495142,-1.1958387813477542,0.2,0.824454419712015,1.0,2/5,4.98%,PMEL;MGAM
prerank,Reactome_2022__Aflatoxin Activation And Detoxification R-HSA-5423646,0.6779550969975796,1.195655463046648,0.2786885245901639,0.5119190538572104,1.0,1/11,0.01%,GGT5
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.5730067263457442,-1.1955813341636634,0.1956521739130435,0.8242558710012908,1.0,4/25,15.09%,ARRDC4;TRIB3;RPS2;DCUN1D2
prerank,Reactome_2022__Defective LFNG Causes SCDO3 R-HSA-5083630,0.7753374670807033,1.1955078665809098,0.2765957446808511,0.5121260226593796,1.0,3/5,19.74%,NOTCH3;LFNG;NOTCH4
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.6146734909085168,1.195378389601236,0.19117647058823528,0.5122606109583954,1.0,2/20,5.04%,TEKT2;DNAH3
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.5451574236941349,-1.1951934060886804,0.1794871794871795,0.824429822452125,1.0,5/24,7.89%,AR;FSHR;AKR1C3;WNT2B;NCOA4
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.7421511529576847,1.1950797092753738,0.32075471698113206,0.5129410404336504,1.0,1/8,0.79%,ANK3
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),0.7402790401689715,1.194740769726893,0.3090909090909091,0.5133837869341161,1.0,6/8,21.96%,KIF5A;KIF5C;RAB27B;MAPK8IP3;MAP1A;HSPB1
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),0.7402790401689715,1.194740769726893,0.3090909090909091,0.5133837869341161,1.0,6/8,21.96%,KIF5A;KIF5C;RAB27B;MAPK8IP3;MAP1A;HSPB1
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),0.7402790401689715,1.194740769726893,0.3090909090909091,0.5133837869341161,1.0,6/8,21.96%,KIF5A;KIF5C;RAB27B;MAPK8IP3;MAP1A;HSPB1
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.44898174569262655,-1.1946243095801377,0.13793103448275862,0.8252718501678185,1.0,27/162,14.53%,RP9;PDCD7;SCNM1;DHX16;LSM3;SF3B4;SF3A1;ZCRB1;RBM8A;M1AP;U2AF1;PRPF18;FASTKD2;TFIP11;LSM5;RNASEL;METTL3;KIN;RRAGC;CLP1;YJU2;SNRNP25;LSM4;PRPF8;SRSF2;RBM39;PRPF3
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),0.6117484755587007,1.1945933620260458,0.22950819672131148,0.5135806939620134,1.0,6/21,8.31%,MRAP2;DMTN;PID1;MRAP;TMBIM1;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.708637494010611,1.194370189012574,0.23809523809523808,0.5139350594879288,1.0,6/15,17.39%,SERPINE1;RTN4RL1;EPHA4;FGF2;PTPRS;INPP5F
prerank,CellMarker_Augmented_2021__Stem cell:Adipose Tissue,0.739310290989128,1.1939069126508874,0.2909090909090909,0.5147933106955537,1.0,3/8,6.44%,THY1;PTPRC;CD44
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.519522009135277,-1.193740865210197,0.1891891891891892,0.8272666301586272,1.0,14/52,18.97%,APOBEC3G;ADAT2;TRMT61A;THUMPD1;QTRT2;METTL3;FTSJ1;URM1;TFB1M;MEPCE;DTWD2;DTWD1;LCMT2;TRDMT1
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.6574927793126784,-1.1936384183951225,0.23076923076923078,0.8265467240689529,1.0,4/12,19.85%,LSM3;LSM4;RC3H1;PATL1
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.5043900774423206,1.193428083014252,0.11428571428571428,0.5158128843741394,1.0,14/86,14.84%,KCNJ2;BLM;KCNC2;TRPM4;SAMHD1;STEAP4;HCN1;SHMT1;GSDMD;POLQ;RNF112;B2M;GLRA3;ATL3
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.5217324980916905,1.193295356553752,0.14285714285714285,0.5159860534416834,1.0,8/86,3.26%,HPN;L1CAM;IGF1;RIMS2;SYT4;SHTN1;SYT1;RPS6KA1
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),-0.6862662206028336,-1.1932387623219878,0.25,0.8255350422689439,1.0,3/8,9.23%,IDO1;ACMSD;TDO2
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),-0.6862662206028336,-1.1932387623219878,0.25,0.8255350422689439,1.0,3/8,9.23%,IDO1;ACMSD;TDO2
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),0.7102328886658208,1.1930128897273256,0.2777777777777778,0.516451341066052,1.0,2/10,10.78%,TYMP;PUDP
prerank,Reactome_2022__ERK/MAPK Targets R-HSA-198753,0.6783846407439431,1.1926429654079618,0.23809523809523808,0.5170376181496913,1.0,2/19,3.26%,KCNH8;RPS6KA1
prerank,CellMarker_Augmented_2021__Epithelial cell:Placenta,0.5609072430549097,1.1925283524397832,0.203125,0.5170888079026282,1.0,11/40,8.72%,MET;A4GALT;PSCA;EPHA2;EPS8L2;BAIAP2L1;OSMR;ITGA2;RHOD;MYO1C;ITGA3
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.6166865469243845,1.192528189583151,0.2545454545454545,0.5168884635369163,1.0,5/17,12.47%,BOK;GGCT;BCL2L1;BBC3;BCL2
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.6334007564867787,1.192494487785603,0.22413793103448276,0.51678703748304,1.0,4/18,13.24%,SERPINE1;TNFRSF14;GSDMD;OPTN
prerank,Reactome_2022__Zinc Efflux And Compartmentalization By SLC30 Family R-HSA-435368,-0.7771554221636072,-1.1924478124668905,0.2826086956521739,0.8273286831627285,1.0,3/6,8.54%,SLC30A8;SLC30A6;SLC30A5
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Endometrium,0.7220516890867608,1.1924051806089275,0.23076923076923078,0.5167933898433519,1.0,2/6,4.31%,THY1;PTPRC
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.768417991410433,1.1923289329441549,0.25925925925925924,0.516768336978311,1.0,3/7,7.36%,PKP2;NEFL;GFAP
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),-0.6827728261990855,-1.1921997490089589,0.25,0.8257830686574541,1.0,2/8,3.47%,EXOSC8;ERI2
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",-0.6827728261990855,-1.1921997490089589,0.25,0.8257830686574541,1.0,2/8,3.47%,EXOSC8;ERI2
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.7099506391120768,-1.1919725654628017,0.32,0.8242355132687074,1.0,3/8,23.20%,ABHD17A;LYPLA2;ABHD17C
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.7099506391120768,-1.1919725654628017,0.32,0.8242355132687074,1.0,3/8,23.20%,ABHD17A;LYPLA2;ABHD17C
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.6032661345388393,1.1918793090714683,0.22857142857142856,0.5177208205274686,1.0,5/25,16.26%,ZFP36;DAB2IP;DUSP22;IQGAP1;SYAP1
prerank,Reactome_2022__WNT Mediated Activation Of DVL R-HSA-201688,-0.7713544209990584,-1.191798201157707,0.3333333333333333,0.8235695947600372,1.0,2/5,13.32%,PIP5K1B;DVL2
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),0.7743121034867809,1.1916862557155148,0.2631578947368421,0.5180629761105425,1.0,1/6,1.91%,NLGN1
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.7028456789153621,1.1913267731185573,0.3448275862068966,0.5187677922506154,1.0,3/10,12.89%,KLF2;ASS1;KLF4
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5739329397641746,-1.1913181740873164,0.24390243902439024,0.824180571665897,1.0,9/24,23.09%,GTF2H5;GTF2H2;CETN2;ERCC2;XPA;ERCC3;UBB;PARP1;GTF2H3
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.7112277447232623,1.191226190658879,0.30357142857142855,0.5188091975787316,1.0,3/8,14.64%,OPHN1;MYO9A;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),0.7479648644575801,1.1911857818531892,0.36363636363636365,0.5187207351584215,1.0,3/7,18.39%,RPS6KA1;RGS14;BCLAF1
prerank,CellMarker_Augmented_2021__Corneal Endothelial cell:Corneal Endothelium,0.5307059891333887,1.1911156525869333,0.14754098360655737,0.5186815700821482,1.0,24/82,12.14%,COL4A1;PROX1;PDGFRA;SULF1;FLT1;COL4A2;CYP4X1;SHROOM4;ANGPTL2;COL21A1;LDB2;APLNR;ADGRL2;PTPRD;PKDCC;ADGRF5;BGN;RASL12;ITGA9;RBPMS;SLCO2A1;SORBS1;RUNX1T1;FGD5
prerank,Reactome_2022__Diseases Associated With TLR Signaling Cascade R-HSA-5602358,0.6003660774084981,1.191068732499225,0.3064516129032258,0.5186200670405614,1.0,2/21,7.62%,TLR2;MYD88
prerank,KEGG_2021_Human__Pentose and glucuronate interconversions,-0.6225802321719666,-1.1910493487506446,0.2978723404255319,0.8238609798164303,1.0,3/12,12.62%,DCXR;AKR1A1;XYLB
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.6133981046500945,-1.1910386524872985,0.23684210526315788,0.8227605704663603,1.0,13/29,24.17%,GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;ERCC2;POLR1B;ERCC3;TTF1;POLR2L;POLR2E;GTF2H3;UBTF
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),-0.6683469872529483,-1.1910225400073051,0.3111111111111111,0.8217464465483091,1.0,3/12,8.80%,HEY2;HEYL;HEY1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.7573977024773542,1.1909776767246096,0.2711864406779661,0.518679353118107,1.0,1/8,0.56%,HLA-DRA
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Undefined,0.6354897894799374,1.1909379946649263,0.23529411764705882,0.5185419051590109,1.0,6/16,15.01%,ADA;IL1R1;ITGA2;SMAD3;IKZF2;CD4
prerank,Reactome_2022__Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.529973333670029,-1.1908392118799322,0.3055555555555556,0.8212028333731604,1.0,24/55,26.67%,GTF2H5;POLR2K;ELOC;GTF2H2;ELOA;SUPT16H;ERCC2;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;POLR2E;GTF2H3;EAF1;CTDP1;CTR9;LEO1;CCNK;SKIC8;NELFCD
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.47422555079302153,-1.190784168651417,0.13333333333333333,0.8202247545411484,1.0,12/94,8.15%,G0S2;RPP25L;AR;GOLT1A;CEBPA;C6;FGL1;TM7SF2;LEPR;ADH6;APOM;HSD11B1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.4987133520721786,1.1905915678205126,0.13636363636363635,0.5192625085606855,1.0,18/109,9.35%,GGT5;IGF1;PLK2;ADCY5;MYH9;NLRP12;PRKAR1B;FYN;GIPR;RXFP1;GNG2;TNFRSF1A;ADCY7;ADCY2;RAMP3;GLP1R;NLRC3;PPARG
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.7393668218497091,1.190503958122306,0.19642857142857142,0.519250010632741,1.0,4/12,11.69%,SCX;TENM4;TLE6;B4GALT5
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.5678022110923254,1.190418529813334,0.26229508196721313,0.5192643124712801,1.0,5/36,9.60%,KLF2;LTBP4;APP;LDLR;CNDP1
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.4759846811463544,1.1902861570129653,0.11475409836065574,0.5194125024060835,1.0,22/135,11.85%,HPN;SIX3;PKP2;CNTN4;DAB2IP;FOXO1;ABCA5;PRAME;EFNA1;TRPM4;ZNF750;ZBTB16;ZFPM2;CDK6;LDLRAD4;SMAD3;YAP1;PPARG;TRIO;ASXL1;RUNX1T1;SRA1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589),0.8153706754490714,1.1902785065231112,0.21666666666666667,0.5192393440902747,1.0,2/5,8.63%,APLNR;PPP1R16B
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.5734395817801997,-1.1902724984371222,0.28125,0.8207834646307622,1.0,5/27,11.21%,ABCD2;PXMP2;ABCD1;PEX10;PEX11B
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.5090444127413917,1.1902146576495343,0.2,0.5192045749649095,1.0,11/81,10.69%,ANXA1;PDGFRA;CD55;IL1R1;TRIM5;BCL6;SAMHD1;BIRC3;MYD88;CYRIB;P2RY12
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.5534105483221211,1.190103714287099,0.3,0.5192946608890113,1.0,4/32,15.51%,ABCA8;AGPAT4;SGMS1;CPNE7
prerank,Reactome_2022__Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.5554011328179294,1.1900905574292182,0.1935483870967742,0.519152942678568,1.0,9/44,11.16%,CSPG4;DCN;CHSY3;CHST15;CHPF2;AGRN;BGN;UST;B4GALT7
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.5668385492858182,-1.1899205389035254,0.2571428571428571,0.8209058868053738,1.0,5/25,11.21%,ABCD2;PXMP2;ABCD1;PEX10;PEX11B
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),0.8491983593984258,1.1899056384453672,0.2978723404255319,0.5194835344604152,1.0,2/5,9.80%,AK3;AK5
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.6404399802676528,1.1897270926045356,0.2631578947368421,0.5197381709684579,1.0,10/21,22.59%,ADCY5;PRKAR1B;ADCY7;ADCY2;PRKAR1A;ADCY3;RAB11A;ADCY9;ADCY8;PRKAR2B
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.798361343335195,1.1895880513189228,0.18,0.5199391962365288,1.0,3/6,16.21%,SEPTIN9;HAP1;MAP4
prerank,GO_Biological_Process_2021__gap junction assembly (GO:0016264),0.7774140313243901,1.189537784075194,0.3333333333333333,0.5198641921651765,1.0,1/5,5.57%,GJC1
prerank,Reactome_2022__Degradation Of Cysteine And Homocysteine R-HSA-1614558,0.701703672233886,1.1894995872299932,0.29310344827586204,0.519735870984182,1.0,1/10,1.04%,SQOR
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),0.7776809515169972,1.189441995450753,0.3191489361702128,0.5192981843512412,1.0,2/5,17.19%,SLC28A3;SLC29A1
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),0.7776809515169972,1.189441995450753,0.3191489361702128,0.5192981843512412,1.0,2/5,17.19%,SLC28A3;SLC29A1
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),0.7776809515169972,1.189441995450753,0.3191489361702128,0.5192981843512412,1.0,2/5,17.19%,SLC28A3;SLC29A1
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",0.7902817926996167,1.1893844934464541,0.27586206896551724,0.5192324517096029,1.0,4/6,19.03%,GRIP1;GRIP2;SCRIB;RAB11A
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.5646829498388093,1.189331980654005,0.2413793103448276,0.5191800875337825,1.0,4/45,3.58%,RECQL4;ANXA1;BLM;RPA1
prerank,Reactome_2022__Nucleotide Excision Repair R-HSA-5696398,-0.463022798498477,-1.189205362378177,0.13513513513513514,0.8222477895780252,1.0,34/101,23.21%,ERCC8;RFC3;COPS8;GTF2H5;POLR2K;MCRS1;POLD3;GTF2H2;CETN2;COPS7A;ERCC2;POLR2C;RAD23A;HMGN1;ERCC6;POLR2D;PPIE;POLR1B;SLC19A1;XPA;RUVBL1;ERCC3;NFRKB;UBB;UBE2V2;COPS3;POLR2L;POLR2G;COPS6;PARP1;PIAS3;POLR2E;GTF2H3;YY1
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.5828465759675511,1.1891662367253975,0.23076923076923078,0.519376273093444,1.0,11/30,19.54%,RASGRP1;IL1R1;CYRIB;CD276;FADD;IL12A;PDE4D;SCRIB;TNFSF4;ZFPM1;TLR3
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.4858559419141839,1.1891599077476822,0.14492753623188406,0.5191863787674655,1.0,32/136,18.09%,IGF1;PROX1;NELL1;IGF2BP2;APP;YBX3;TRIM61;PTPRC;TRIM5;AHR;APLNR;ALPK2;LDLR;CDK6;MKLN1;TRIM17;AFF1;ATP1B1;NFKBID;TRIM22;PRDM1;KDM6A;STX1B;ZNF513;NOVA2;CDK2;SLC8A2;TFEB;SLC8A1;RNF187;FUBP1;MTMR2
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.6745268869184083,-1.1891461561093295,0.2972972972972973,0.8213871686961224,1.0,3/13,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.690706852251453,-1.1891248958485319,0.39473684210526316,0.8203123907911286,1.0,3/7,20.68%,GTF2H2;CHTOP;MSH3
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6323391052023463,1.1890309182670147,0.28125,0.519293726279893,1.0,6/17,17.72%,ANK3;SNCA;GRIN1;TMC8;SLC8A1;FAM20A
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.6620503437678341,1.1889877917483787,0.3392857142857143,0.5191704974721949,1.0,3/15,8.17%,GHR;CYP1B1;OCIAD2
prerank,CellMarker_Augmented_2021__Epithelial cell:Ovary,0.8141389319214012,1.1889736774400421,0.2903225806451613,0.5190119157823747,1.0,1/5,1.87%,CD24
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.558374885490582,1.1888258708265245,0.23076923076923078,0.5192742286782192,1.0,8/37,12.36%,PLK2;BTG3;BCL6;HECA;CTNNB1;SMAD3;CDKN1C;CDKN1B
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.515022229308877,-1.1887664840112706,0.25,0.820393606391141,1.0,23/62,26.67%,GTF2H5;POLR2K;ELOC;GTF2H2;ELOA;SUPT16H;ERCC2;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;POLR2E;GTF2H3;EAF1;CTDP1;CTR9;LEO1;CCNK;NELFCD
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.7485826193300229,1.1885609603013843,0.3508771929824561,0.519850693808507,1.0,2/6,12.81%,CD24;FN1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),0.5325577266541861,1.1884567580023475,0.14285714285714285,0.5199000471826645,1.0,15/60,12.19%,CHRM3;RCAN2;DMTN;LAT2;PTPRC;TRPM4;GRM5;CACNA1C;RYR2;SLC9A1;NUDT4;ATP1B1;CCR10;P2RY12;TPCN2
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),0.7623646857448829,1.1884553759287504,0.24,0.5197148844161701,1.0,2/8,2.82%,DUSP1;SLIT2
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.6642683894211449,1.188397162146266,0.26153846153846155,0.5196492686608322,1.0,8/23,11.38%,NLGN1;SNCB;SYT1;SYT5;SYNJ2;SNCA;PACSIN1;OPHN1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),-0.7281753660330561,-1.1883866814703845,0.34210526315789475,0.820392350863184,1.0,3/6,20.78%,TTN;MYOM1;RDX
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.6726609584496736,1.1883534349034583,0.2692307692307692,0.5195748614608713,1.0,1/13,2.35%,ZFP36
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.5741031392732362,1.188325303484779,0.24561403508771928,0.5194651584992457,1.0,7/25,16.80%,ABCA8;ABCA5;PPARG;ABCA2;RXRA;ABCA3;GPS2
prerank,KEGG_2021_Human__Adrenergic signaling in cardiomyocytes,0.49325899206089113,1.1881474416788929,0.14864864864864866,0.5197354336535976,1.0,30/116,18.53%,SCN1B;CREB5;ADCY5;KCNQ1;CACNG3;ATP2B3;ADCY7;CACNA1C;TPM4;CACNG8;RYR2;ADCY2;ATP1A1;SLC9A1;ATP1B1;PPP1CB;CACNG4;ATP1B3;CAMK2B;BCL2;MAPK11;ATP2B4;SLC8A2;SLC8A1;ADCY3;CALM3;GNAI1;CAMK2A;ADRA1D;PRKCA
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.6279802470883217,1.1881402696177346,0.23728813559322035,0.51955510198311,1.0,6/18,20.82%,ABCA8;ABCB1;SLC29A4;ABCA3;ABCC3;ABCC1
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.6588416210312424,1.1881012076305246,0.2786885245901639,0.5194543599002636,1.0,6/21,18.97%,PLEK;RAP1GAP2;RARG;VAV2;CAV3;VAV1
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5647657463071046,1.188041267555006,0.16417910447761194,0.5194816521814007,1.0,16/52,13.95%,L1CAM;CNTN2;CNTN4;IGSF21;EMB;FAT2;KIRREL3;ROBO2;NEXN;NPTN;VSTM2L;SDK2;ROBO4;CDH4;HMCN1;PALLD
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",0.7209782551846804,1.1879813746340349,0.30357142857142855,0.5194648171485652,1.0,4/11,15.18%,NLGN1;BAIAP3;HAP1;USP46
prerank,Reactome_2022__RNA Polymerase I Transcription Termination R-HSA-73863,-0.611874906894186,-1.1879047429639666,0.275,0.8208325997874982,1.0,13/29,24.17%,GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;ERCC2;POLR1B;ERCC3;TTF1;POLR2L;POLR2E;GTF2H3;UBTF
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.7889989199038367,1.187778619817133,0.24561403508771928,0.5198227579395454,1.0,4/5,20.41%,SHANK3;KCNMA1;P2RX7;ANO6
prerank,CellMarker_Augmented_2021__Monocyte:Fetal Kidney,0.43656393619190326,1.1876196028942831,0.0898876404494382,0.5200393929242257,1.0,113/574,15.88%,CLIC1;TLCD2;FOSB;HLA-DRA;PRRX1;TLR2;ANXA1;SOCS3;TYMP;CTSS;TESC;S100A10;THBS1;SLC15A3;P2RY13;ZFP36;PIM3;DUSP1;MYO1F;CD55;PLEK;ZYX;SHTN1;SLA;CDC42EP3;PRKCB;CSF2RA;WAS;ITPRIP;NLRP12;CARD19;PGD;RBMS1;SH3KBP1;PALM2AKAP2;LAT2;PTPRC;TRPM4;CD37;MTMR11;PLSCR1;DENND3;POSTN;BCL6;AHR;NUDT16;PADI2;SAMHD1;CLTB;RGL4;CD44;TNFRSF1A;PLAC8;FOXO3;STEAP4;SLC7A7;CYP1B1;MYD88;LDLR;HK2;ZFAND5;CSRNP1;BASP1;ARHGAP26;SMCO4;CORO2A;ARPC3;TSC22D3;CYRIB;NAMPT;NFKBID;CD83;RAB11FIP1;PYGL;PGK1;ACTN1;FBP1;ABTB1;SPARC;SRA1;RAB20;HLA-DRB1;PILRA;KLF6;GLT1D1;PDXK;ANXA11;KLF4;PAK1;PHACTR1;CDKN1A;TNFAIP6;TNFRSF10B;HLA-DMA;MAP7D1;ELF1;IQGAP1;CWC25;CAST;HEBP2;HLA-E;S100A6;PNPLA8;CD4;SLC2A3;DPYD;SH2B2;STAT6;OLIG2;BACH1;RAB3D;TAGLN2;RXRA
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),0.7123107378220445,1.1875464438989873,0.2459016393442623,0.5200487988500715,1.0,1/8,0.15%,NR4A3
prerank,Reactome_2022__Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.5035541563764139,-1.1875331740842274,0.21428571428571427,0.8208717687842443,1.0,23/74,21.07%,ERCC8;RFC3;COPS8;GTF2H5;POLR2K;POLD3;GTF2H2;COPS7A;ERCC2;POLR2C;HMGN1;ERCC6;POLR2D;PPIE;POLR1B;SLC19A1;XPA;ERCC3;UBB;COPS3;POLR2L;POLR2G;COPS6
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle contraction (GO:0045986),0.7989707322587152,1.187507109493589,0.3220338983050847,0.5199569067501058,1.0,2/5,14.04%,DOCK4;KCNMA1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.7725225827935192,-1.1872997795498483,0.2708333333333333,0.8205729201823206,1.0,1/6,10.58%,KMT2A
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.553905576473837,1.1870799850883775,0.2,0.521058101961546,1.0,5/35,10.01%,ZDHHC9;ZDHHC22;FOXO1;ZDHHC7;ZDHHC1
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),-0.7296578455699883,-1.1869121305718355,0.2549019607843137,0.8207759488341806,1.0,3/8,13.37%,KDM1B;RIOX1;RIOX2
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.7169329804088816,1.1868595985601917,0.33962264150943394,0.5214103577910898,1.0,1/8,0.90%,IGF1
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),-0.6423424466968707,-1.1868511415146152,0.2926829268292683,0.8199061509569732,1.0,5/16,7.50%,SLC25A5;THEM4;SLC25A4;MUL1;BAK1
prerank,Reactome_2022__Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,0.555338629182916,1.1868210963499002,0.2,0.5212916599679452,1.0,21/52,23.93%,CDH23;MYH9;EPS8L2;SYP;PCLO;MYO15A;CTBP2;DNAJC5;EPB41L1;CABP1;PCDH15;KCNMA1;ATP2B4;WHRN;CACNB2;MYO1E;CAPZB;CACNA1D;CIB2;SNAP25;RAB3A
prerank,CellMarker_Augmented_2021__Endothelial cell:Lung,0.7815494508582601,1.1867363124103514,0.2692307692307692,0.5212741893783859,1.0,2/6,4.85%,FLT1;MCAM
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.7452387190088792,-1.1865791265814547,0.2653061224489796,0.8197525837674223,1.0,2/6,17.35%,AKR1C3;BMP2
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.4991575863639843,1.1865391709813768,0.1780821917808219,0.5214896988885377,1.0,14/75,13.94%,MYRF;CTSS;MMEL1;PCSK2;C1RL;ECE1;C1R;ATP23;MMP14;ADAM19;KLK6;MMP16;PHEX;STOML2
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.5585090751944786,1.186449849371143,0.27692307692307694,0.5215204997540476,1.0,12/39,14.39%,CD24;PLEK;NAPSB;CD37;CCR10;ABCB9;ITGAL;KLF4;TMEM156;PRDM1;MAN1A1;PDK1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),0.7974361951946773,1.1863957841201993,0.2857142857142857,0.5214414705350077,1.0,2/5,18.06%,GNG2;TNFSF4
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.718198222631041,-1.1863087769832963,0.3111111111111111,0.8197725700201767,1.0,5/9,24.91%,PPP1R3C;PPP1R3G;PPP1R3E;PPP1R3D;RUBCNL
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),0.7162515650589445,1.1861606318548916,0.32075471698113206,0.5217576557203101,1.0,3/10,15.12%,TYMP;MACROD1;NME4
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.6790813167651133,1.1860551098862449,0.23636363636363636,0.5217532085901081,1.0,6/14,17.50%,ECE1;SNCA;RAMP3;OPTN;INPP5F;SCRIB
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.8060008032824088,-1.1859543718408456,0.2909090909090909,0.8199552406562783,1.0,3/5,15.20%,SELENON;RYR1;MYORG
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.7466975618555154,1.1858995967203227,0.21428571428571427,0.5219461925268148,1.0,1/7,6.90%,STK25
prerank,KEGG_2021_Human__Terpenoid backbone biosynthesis,-0.5946731034008627,-1.1858454263292304,0.28888888888888886,0.8191826165656616,1.0,4/19,17.71%,PMVK;ICMT;PCYOX1;ZMPSTE24
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),0.6325723740682173,1.1857934574526783,0.24193548387096775,0.5220293898728031,1.0,9/17,19.69%,CD24;IRAK2;PARP9;KLF4;ELF1;IFIH1;WNT5A;CBFB;MAP2K5
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.7136254345023338,1.185713335663929,0.2037037037037037,0.5220774525773623,1.0,4/14,12.85%,TLR2;ROBO2;ELAPOR2;B2M
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),-0.4903052525465478,-1.1855336694359864,0.16666666666666666,0.8192438603572716,1.0,2/45,2.56%,FTL;FTH1
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.53296711261328,1.1855124089912414,0.2318840579710145,0.5224804457343651,1.0,22/84,14.11%,CNR1;NPY1R;ADGRE5;ADCY5;GPR12;LGR5;GIPR;RXFP1;ADCY7;ADCY2;RAMP3;GLP1R;ADGRL2;GNA14;GNA12;GNAZ;P2RY12;S1PR3;HTR1E;LPAR1;GRK5;GPR37
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.7844085133622581,1.1854992184260487,0.2711864406779661,0.5223136497978029,1.0,1/6,1.48%,KCNJ2
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),0.7686424196722115,1.1853583495581048,0.3064516129032258,0.5224491305397923,1.0,1/7,1.37%,NPNT
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),0.4772790021012258,1.1851948614580914,0.1038961038961039,0.5227727346291069,1.0,17/163,10.52%,PLD1;THBS1;TYMS;IGF2BP2;APP;RPS6KA1;SAMD4A;SOX4;GRM5;ENC1;EIF2B2;FOXO3;EIF4A3;LARP6;YTHDF1;SHMT1;NIBAN1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.5678106644342131,1.1851243517748284,0.21311475409836064,0.5227372879143606,1.0,8/43,12.89%,PTK6;PIM3;SLIT2;THY1;NLRP12;CDK6;KLF7;KLF4
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),0.6871400776850434,1.1850667530737204,0.2537313432835821,0.5226931198766398,1.0,4/14,6.48%,TYMS;TRPC3;ABCC9;VGF
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.6768140189458605,1.1850394982268422,0.31343283582089554,0.5225484202448003,1.0,5/16,17.13%,APOD;CTNNA1;CABP1;OTUD7B;MFHAS1
prerank,CellMarker_Augmented_2021__Multipotent Mesenchymal Stroma cell:Bone Marrow,0.7209858581106378,1.1850210615278403,0.3137254901960784,0.5224082004768067,1.0,2/6,4.31%,THY1;PTPRC
prerank,PanglaoDB_Augmented_2021__Monocytes,0.5497920262074079,1.1849141313034834,0.15492957746478872,0.5224821718971555,1.0,14/62,6.44%,HLA-DRA;TLR2;TYMP;CTSS;P2RY13;MYO1F;PLEK;ICAM1;IRF7;DYSF;PTPRC;PLSCR1;TNFRSF14;CD44
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.7277265516721361,1.1849082433455984,0.25,0.5222984083052452,1.0,1/9,0.06%,TGFBR2
prerank,Reactome_2022__BH3-only Proteins Associate With And Inactivate Anti-Apoptotic BCL-2 Members R-HSA-111453,0.6897622118834763,1.1842593735990563,0.3076923076923077,0.5239527850456485,1.0,4/7,12.47%,BCL2L1;STAT3;BBC3;BCL2
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.7427509326903943,1.1842359981309385,0.25,0.5237947910742091,1.0,2/8,4.96%,FOXO1;FAS
prerank,CellMarker_Augmented_2021__Germline Stem cell:Ovarian Cortex,0.5205294562146008,1.1841224326864217,0.1746031746031746,0.5237844208663707,1.0,20/76,11.55%,C3;SCN1B;C1ORF87;ZYX;IL1R1;MAP1LC3A;POSTN;IGFBP7;CFH;PID1;MAOB;C1R;GNA14;ADGRF5;BGN;RNASE1;RIN2;PXDC1;LAMA2;SPARC
prerank,CellMarker_Augmented_2021__Germinal Stem cell:Ovary,0.5205294562146008,1.1841224326864217,0.1746031746031746,0.5237844208663707,1.0,20/76,11.55%,C3;SCN1B;C1ORF87;ZYX;IL1R1;MAP1LC3A;POSTN;IGFBP7;CFH;PID1;MAOB;C1R;GNA14;ADGRF5;BGN;RNASE1;RIN2;PXDC1;LAMA2;SPARC
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.4899257519287189,1.1839375600183357,0.18571428571428572,0.5240320771070736,1.0,28/110,17.43%,MTMR7;SOCS3;ITPKC;SBF1;ITPKB;PGAP4;SYNJ2;PLEKHA2;PIGA;PIP4K2A;VAC14;PITPNM3;INPPL1;PITPNM2;INPP5J;PLEKHA4;PLEKHA8;INPP4A;FGF2;MTM1;BMX;PIK3CD;INPP5D;IMPA1;PIP5K1C;PIGB;INPP5F;PITPNM1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),0.6998097022066785,1.1839205347258601,0.2777777777777778,0.523874290911508,1.0,2/11,3.05%,NR4A3;IRS2
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.6618014749041501,-1.1837614057660553,0.29545454545454547,0.8242789591837383,1.0,2/13,5.17%,AR;ESR2
prerank,Reactome_2022__Metabolism Of Non-Coding RNA R-HSA-194441,-0.4921461195467393,-1.1836521627905672,0.15151515151515152,0.8235441281389417,1.0,13/48,27.28%,AAAS;NUP50;GEMIN4;NUP54;WDR77;NUP85;NUP42;POM121C;LIN9;PHAX;SNUPN;SNRPB;NUP210
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.7429538730924216,-1.1836083886567963,0.33962264150943394,0.8203940712532849,1.0,2/5,13.28%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.7429538730924216,-1.1836083886567963,0.33962264150943394,0.8203940712532849,1.0,2/5,13.28%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.7429538730924216,-1.1836083886567963,0.33962264150943394,0.8203940712532849,1.0,2/5,13.28%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.5854610602660896,1.1834868574107724,0.3076923076923077,0.52481432428966,1.0,11/29,19.36%,ANK3;CLDN16;SNCA;KCNH2;GRIN1;LETM2;SLC12A5;SLC8A1;FAM20A;SLC7A8;SLC12A7
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),0.7554016064462815,1.1833207335377958,0.2978723404255319,0.5250874404574064,1.0,1/6,2.58%,PLEK
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.6200634863390082,1.1833072139426513,0.23333333333333334,0.524929435709545,1.0,8/29,17.47%,SCN9A;CDH23;ASIC3;CLRN1;CCL2;PCDH15;P2RX7;WHRN
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.6884948495401523,1.1831961623079905,0.2978723404255319,0.5250326126391783,1.0,4/16,18.55%,PLK2;ZFYVE19;WEE2;PLK3
prerank,KEGG_2021_Human__NOD-like receptor signaling pathway,0.48005828025850544,1.18307091615948,0.22727272727272727,0.5251183144646907,1.0,26/116,17.94%,CXCL2;IRF7;NOD1;ERBIN;NLRP12;ITPR3;BIRC3;MYD88;BCL2L1;IKBKE;NAMPT;TYK2;CCL2;GSDMD;PRKCD;BCL2;FADD;IKBKG;MAPK11;P2RX7;TAB1;TRAF5;MAPK9;GABARAPL1;YWHAE;ITPR1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),0.7354939325473324,1.182808725363794,0.35185185185185186,0.5255300360090841,1.0,1/7,2.35%,ZFP36
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.6274252410892288,-1.1828062242319306,0.2564102564102564,0.8222042189103633,1.0,3/13,21.05%,NIFK;GTF3A;RPAP2
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),-0.7550586518588024,-1.1827094688152469,0.4,0.8203903925052912,1.0,2/5,12.80%,GINS3;MCM4
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),-0.7550586518588024,-1.1827094688152469,0.4,0.8203903925052912,1.0,2/5,12.80%,GINS3;MCM4
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Ovary,0.7253576374987485,1.182684854927441,0.2698412698412698,0.525737179440649,1.0,3/11,7.62%,CD24;CD44;MYD88
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.629538083769503,-1.1826257687231687,0.13793103448275862,0.8196073533205487,1.0,4/22,8.20%,RAB7B;TNFAIP3;NR1D1;LY96
prerank,PanglaoDB_Augmented_2021__Pinealocytes,0.5223697727005566,1.1823487406401496,0.22058823529411764,0.5263395196045297,1.0,16/64,11.98%,SLC24A2;XKR4;SCN3B;GABRG3;SV2B;SRRM4;CDH7;PMEPA1;UNC13C;AIPL1;MYT1L;GRM6;MYO15A;HCN1;PDE10A;SLC7A14
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.7581249312312854,1.1823464622311386,0.24528301886792453,0.5261466577386817,1.0,2/6,5.16%,IRS2;BCL6
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5743214916106119,1.1822284155894958,0.24193548387096775,0.526175345275897,1.0,8/35,9.61%,EGF;SH3GL2;DAB2IP;TGFA;SH3KBP1;MVP;ARHGEF7;ZFYVE28
prerank,Reactome_2022__Fatty Acids R-HSA-211935,-0.7886803472579793,-1.1821173246222083,0.28,0.820107673315532,1.0,1/5,0.52%,CYP4F3
prerank,Reactome_2022__Activation Of BH3-only Proteins R-HSA-114452,0.5959402824172093,1.181939194623779,0.25925925925925924,0.5267291087334726,1.0,9/24,22.88%,YWHAH;YWHAG;BBC3;BCL2;TP53;YWHAE;AKT3;PPP3CC;YWHAQ
prerank,"Reactome_2022__Defective CHST14 Causes EDS, Musculocontractural Type R-HSA-3595174",0.6968777325467297,1.1818346017450732,0.2708333333333333,0.5268616693865826,1.0,2/8,1.48%,CSPG4;DCN
prerank,CellMarker_Augmented_2021__Fibroblast:Vocal Fold,0.7199709517094977,1.1818275352602734,0.24561403508771928,0.5264849459235499,1.0,3/8,6.44%,THY1;PTPRC;CD44
prerank,CellMarker_Augmented_2021__Adipose-derived Stem cell:Abdominal Adipose Tissue,0.7199709517094977,1.1818275352602734,0.24561403508771928,0.5264849459235499,1.0,3/8,6.44%,THY1;PTPRC;CD44
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.4271268144765672,1.181731525954198,0.07954545454545454,0.5265871170750748,1.0,90/735,13.21%,LEF1;CDKN2A;NR4A3;SKOR1;MLIP;FOSB;SIX3;KLF2;PROX1;ZNF536;SP100;ATF3;MAEL;ZNF93;ZFP36;IRF7;DAB2IP;FOXO1;ZNF140;PRAME;EFNA1;SUV39H1;HIC1;CIC;ZNF282;TCEAL7;KLF11;NFIL3;BCL6;NKX6-2;AHR;GZF1;CHD3;KLF10;CIITA;ZNF608;ZNF750;NRG1;ZBTB16;BAP1;LDB2;TBX20;FOXO3;SNCA;MSX2;GLIS2;PML;HMBOX1;ZFPM2;DUSP22;CTNNB1;MYT1L;TBL1X;SMAD3;BASP1;NR1I3;YAP1;PPARG;ETV6;CTBP2;CHMP1A;HDAC4;GLI2;PEX14;STAT3;GLIS3;TLE6;NR6A1;CDKN1C;PARP9;JAZF1;GAS6;HDAC9;FBP1;NR4A2;GFI1B;L3MBTL3;RUNX1T1;GADD45A;PRICKLE1;MLXIPL;KLF7;CDKN1B;PER1;TFAP2C;KLF4;JARID2;SOX13;CCND1;DEAF1
prerank,CellMarker_Augmented_2021__CD4+ Memory T cell:Lymphoid Tissue,-0.5840639678265278,-1.1816290027652565,0.2777777777777778,0.8209165792753639,1.0,7/24,7.17%,DPEP2;GMFG;CD247;RHOH;PYHIN1;P2RY10;CD72
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.7885720316618783,1.181499177284964,0.3448275862068966,0.5269577673134305,1.0,1/5,5.87%,NTRK3
prerank,GO_Biological_Process_2021__isoleucine metabolic process (GO:0006549),-0.7403274182202179,-1.1814935148861643,0.22857142857142856,0.8203555814053557,1.0,2/5,15.06%,SDSL;SDS
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),0.7790394295369616,1.1810490427903073,0.29508196721311475,0.5279906186152403,1.0,1/6,1.37%,NPNT
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.6767994060719987,1.1810065273189647,0.3333333333333333,0.5278843544532379,1.0,4/9,22.60%,ABCA5;PPARG;ABCG1;ITGAV
prerank,Reactome_2022__Ephrin Signaling R-HSA-3928664,0.641897024618856,1.180983057466274,0.24561403508771928,0.5277002892216269,1.0,4/18,9.78%,EFNB3;FYN;ARHGEF7;RNASE1
prerank,KEGG_2021_Human__Inflammatory mediator regulation of TRP channels,0.5149278949331956,1.1809566416112565,0.16176470588235295,0.5275552870226151,1.0,16/70,9.59%,HTR2C;IGF1;HRH1;PRKCB;ADCY5;PRKCG;IL1R1;ASIC3;ALOX12;ASIC4;ITPR3;ADCY7;ADCY2;PRKCE;PRKCH;PPP1CB
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.4424669842230962,1.1808619503467135,0.07894736842105263,0.5275833314445029,1.0,40/332,11.07%,LEF1;HPN;ANK3;TLR2;IGF1;IL15;RIMS2;EGF;TESC;AMH;PLD1;THBS1;ACTA2;APP;RBM24;SAMD4A;NOS1AP;ELAVL4;EPB41L4B;PLSCR1;SOX4;NTRK3;PID1;SCX;EIF4A3;VSTM2A;LARP6;RAMP3;MYD88;MYO1C;ZNF804A;SMAD3;YAP1;YTHDF1;ADAM19;STAT3;SMAD1;NIBAN1;ITGB8;GAS6
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),-0.6480760747480621,-1.1808600298274172,0.1875,0.8214511842797615,1.0,2/17,2.08%,CYP4F3;CEL
prerank,Reactome_2022__Dermatan Sulfate Biosynthesis R-HSA-2022923,0.6707062682411615,1.1807053690167224,0.26666666666666666,0.527788550772075,1.0,4/11,9.98%,CSPG4;DCN;BGN;UST
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.6870921084482686,1.1806624665978414,0.3103448275862069,0.5277041611486235,1.0,1/11,3.51%,THY1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Lymph,0.7247627351986727,1.1806591852644326,0.21428571428571427,0.5273240364844411,1.0,3/7,6.44%,THY1;PTPRC;CD44
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Tonsil,0.7247627351986727,1.1806591852644326,0.21428571428571427,0.5273240364844411,1.0,3/7,6.44%,THY1;PTPRC;CD44
prerank,"Reactome_2022__WNT5A-dependent Internalization Of FZD2, FZD5 And ROR2 R-HSA-5140745",0.6370951697633139,1.180496076430608,0.288135593220339,0.5275419929738216,1.0,5/11,25.43%,CLTB;RORA;WNT5A;CLTC;AP2A2
prerank,CellMarker_Augmented_2021__Circulating Stem Like cell:Peripheral Blood,0.5581820059122036,1.180448994247326,0.21875,0.5274707621576867,1.0,5/41,6.44%,HELB;IL15;SP100;NLRP12;CD44
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),-0.716455891785758,-1.180214787316619,0.3023255813953488,0.8228028080114975,1.0,1/6,3.35%,RHOH
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.4607300386592999,1.1802010711424622,0.12987012987012986,0.5278997998020093,1.0,17/170,9.38%,TLCD2;GOLGA8O;ALS2CL;ANK3;A4GALT;VAPB;DYSF;ATP8B4;SUN3;SYNGR2;DNM1;SYP;TMED10;HOOK1;PLEKHF1;GOLGA8A;ARHGEF7
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),-0.6829320049793296,-1.1795302685976594,0.29545454545454547,0.8242105558565594,1.0,2/8,19.87%,ABCD1;PEX1
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),-0.6985476768597773,-1.179491841031107,0.30952380952380953,0.8232509240974043,1.0,3/6,24.24%,CTH;MPST;TST
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),0.6383790928378549,1.1792117786205583,0.3137254901960784,0.5303243254959282,1.0,4/20,8.12%,GPNMB;SP100;EPHA2;CTNNB1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.49217600807834966,1.179085473640036,0.15151515151515152,0.5304546626142732,1.0,31/145,18.27%,RASGRP2;S100A10;RASGRP1;TBC1D9;EPHA2;THY1;RGS6;NTRK3;RAP1GAP;DOCK10;AGRN;MAPRE2;ARHGEF7;SIPA1L1;CDKL5;USP6NL;CCL2;TBC1D1;RANGAP1;RAP1GAP2;SIPA1;ARHGAP22;NGEF;RGS16;TBC1D10B;TBC1D10A;PKP4;SCRIB;RAP1A;DOCK9;SEMA4D
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6811227885302682,1.1790638429552178,0.24074074074074073,0.5303006148008002,1.0,3/9,9.24%,IRS2;SNCA;PRKCE
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.5316768771313894,-1.1788368846587165,0.10810810810810811,0.8247039983169759,1.0,6/35,11.81%,ID2;SLC25A5;ALAS1;ABCB10;SLC25A38;UFL1
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),-0.8289789225344514,-1.1787701312349341,0.2631578947368421,0.8238353779676831,1.0,1/5,0.62%,DSCAM
prerank,Reactome_2022__CASP8 Activity Is Inhibited R-HSA-5218900,0.7243997163901708,1.1786807783303608,0.3269230769230769,0.5309096561265368,1.0,2/9,13.58%,TNFRSF10B;FADD
prerank,Reactome_2022__Dimerization Of Procaspase-8 R-HSA-69416,0.7243997163901708,1.1786807783303608,0.3269230769230769,0.5309096561265368,1.0,2/9,13.58%,TNFRSF10B;FADD
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),0.7110845324873607,1.1786533714430663,0.32075471698113206,0.5306059811285848,1.0,2/9,10.78%,TYMP;PUDP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),0.7110845324873607,1.1786533714430663,0.32075471698113206,0.5306059811285848,1.0,2/9,10.78%,TYMP;PUDP
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),0.7699735188904604,1.1785679455831992,0.26229508196721313,0.5304016062018513,1.0,2/6,12.17%,MAPRE2;ARF6
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),0.7699735188904604,1.1785679455831992,0.26229508196721313,0.5304016062018513,1.0,2/6,12.17%,MAPRE2;ARF6
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.7275644084140892,-1.1785346466316164,0.32558139534883723,0.8235329032859828,1.0,2/5,15.71%,ENTR1;CCDC66
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),0.7578311022562445,1.1783297365865577,0.27419354838709675,0.5309439652584127,1.0,3/10,6.72%,NPNT;SLIT2;ROBO2
prerank,KEGG_2021_Human__Autoimmune thyroid disease,0.671012140130612,1.1781792417572212,0.3389830508474576,0.531142352217686,1.0,5/14,14.71%,HLA-DRA;FAS;HLA-DRB1;HLA-DMA;HLA-E
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.8132919131862386,-1.178144849352392,0.2830188679245283,0.8241105151676603,1.0,2/6,5.85%,LEPR;GREM1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),0.7542008658390129,1.1776374958527556,0.3191489361702128,0.532310818565219,1.0,3/7,5.57%,DUSP1;SLIT2;PADI2
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.6756171448334836,1.1773021102198844,0.3,0.5329419887670005,1.0,2/15,6.20%,DMTN;PARD3
prerank,CellMarker_Augmented_2021__Stromal cell:Bone Marrow,0.7248163137932371,1.177178587281896,0.30357142857142855,0.533027879658384,1.0,4/10,6.44%,THY1;PTPRC;MCAM;CD44
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.49568547017791137,-1.177060777420182,0.18421052631578946,0.8268376122834921,1.0,14/62,16.10%,ERCC8;RFC3;GTF2H5;POLR2K;POLD3;GTF2H2;ERCC2;POLR2C;HMGN1;ERCC6;POLR2D;PPIE;POLR1B;SLC19A1
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.5719866535517688,1.1769207378115598,0.23529411764705882,0.5333452736942857,1.0,4/33,7.47%,ABCB1;SLC25A21;SLC38A11;SLC7A7
prerank,Reactome_2022__Nuclear Events Mediated By NFE2L2 R-HSA-9759194,0.5321607931912774,1.1768337558078297,0.208955223880597,0.5334180918542797,1.0,1/69,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6796355404706582,1.1768070439075,0.2641509433962264,0.5332894564023902,1.0,1/12,1.68%,THBS1
prerank,KEGG_2021_Human__VEGF signaling pathway,0.5509793559421213,1.1767987922201912,0.2,0.533109513808976,1.0,13/46,23.21%,PRKCB;SHC2;PRKCG;NFATC2;PXN;PIK3CD;MAPK11;PRKCA;AKT3;PPP3CC;HSPB1;MAPKAPK2;PPP3CB
prerank,CellMarker_Augmented_2021__Neuron:Embryonic Prefrontal Cortex,0.7006928564034878,1.1766820614772986,0.2916666666666667,0.533165210619425,1.0,3/9,12.85%,SLA;NEUROD2;B2M
prerank,CellMarker_Augmented_2021__Stem cell:Muscle,0.7023636057468967,1.1766015917475727,0.288135593220339,0.5331737823967001,1.0,3/13,6.44%,CSPG4;THY1;CD44
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.4800723816499064,1.1764213283352676,0.13043478260869565,0.5335289285662115,1.0,22/107,12.93%,MET;IL1RAPL1;WNT8B;EPHA5;SOX4;ANOS1;LHX6;NEUROD2;UGDH;TENM4;CTNNB1;PTPRD;MYT1L;PBX3;TGFB2;GLI2;HS6ST1;NR4A2;OPHN1;RNF112;ATP8A2;ALK
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.5710311924633988,1.1763607957087685,0.23728813559322035,0.5335116966315174,1.0,7/34,11.09%,L1CAM;SHTN1;TRIM46;MAG;CDKL5;MAPT;DIP2B
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),0.7185129491944606,1.1762719182305295,0.3076923076923077,0.533490201791701,1.0,1/6,8.97%,JADE2
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.6012701013921729,1.176198988962458,0.2037037037037037,0.5334559006800234,1.0,6/28,20.33%,ZFP36;WTIP;ZC3H7B;PUM1;NOTCH4;XPO5
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),-0.7796524792088879,-1.176160572548958,0.21153846153846154,0.8290156504833938,1.0,4/5,21.35%,MGME1;PRIMPOL;DNA2;PARP1
prerank,GO_Biological_Process_2021__tricuspid valve development (GO:0003175),0.7660184851279882,1.1760391086343365,0.34,0.5336737003357317,1.0,2/5,6.64%,TGFBR2;TBX20
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.6295952508805052,1.1759848665771917,0.2545454545454545,0.5336051897570062,1.0,2/17,2.55%,SIX3;CNTN4
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),0.7762087788725228,1.1758563658921262,0.27586206896551724,0.5337587342071064,1.0,1/6,4.64%,NFATC2
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.83685276039107,1.1758405354568573,0.32075471698113206,0.5334042267829211,1.0,2/5,9.22%,CARNS1;FTCD
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.83685276039107,1.1758405354568573,0.32075471698113206,0.5334042267829211,1.0,2/5,9.22%,CARNS1;FTCD
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),0.8363361471497245,1.1757593975662393,0.2857142857142857,0.5333998852662653,1.0,2/5,10.44%,OPALIN;EPHA4
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),0.5432163281405331,1.1757328120397648,0.21212121212121213,0.5333273383389954,1.0,5/44,6.62%,RECQL4;SP100;BLM;RPA1;POLD1
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.565869538018511,1.1756420116934136,0.22950819672131148,0.5334082576916757,1.0,6/35,4.58%,MET;PROX1;PKP2;EFNA1;BAIAP2L1;EPB41L4B
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.636333130609257,1.1754207794024292,0.35,0.5337915707734481,1.0,4/10,19.47%,KCNH2;BIN1;CAV3;VIP
prerank,CellMarker_Augmented_2021__Vascular Progenitor cell:Blood,0.5509675252056973,1.1754071672990443,0.22033898305084745,0.5334250500449824,1.0,4/53,2.14%,ANLN;KIF14;CCNB2;TYMS
prerank,CellMarker_Augmented_2021__Vascular Stem cell:Blood,0.5509675252056973,1.1754071672990443,0.22033898305084745,0.5334250500449824,1.0,4/53,2.14%,ANLN;KIF14;CCNB2;TYMS
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.4918758076879077,-1.1753226925055433,0.2962962962962963,0.8308927991812783,1.0,12/69,20.20%,CDC26;FBXO5;PSMD10;ANAPC15;PSMD12;PSMB5;PSMB6;PSME3;PSMD2;UBB;SKP2;PSMB4
prerank,KEGG_2021_Human__Ovarian steroidogenesis,0.5829181182430251,1.1752174295036417,0.21311475409836064,0.5337355961936607,1.0,7/29,7.99%,IGF1;ADCY5;ADCY7;ADCY2;CYP1B1;LDLR;ACOT4
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),-0.7448398252641568,-1.1752069357988044,0.3541666666666667,0.8301998274835719,1.0,1/5,8.40%,VPS4B
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.6318767653259778,1.1749243191011716,0.3018867924528302,0.5341650166535561,1.0,6/14,7.18%,PKP2;SCN3B;KCNQ1;KCNE4;KCNH2;RYR2
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.7445043843943737,1.17491951073623,0.3220338983050847,0.5339818209757549,1.0,3/8,11.59%,SOAT1;MFSD2A;DGAT1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),0.5528859640157141,1.174709428888851,0.25396825396825395,0.5342705686617797,1.0,6/37,15.68%,TLR2;IRF7;NLRC3;RELB;IFIH1;PTPRS
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.5083838097484014,1.1745950834645966,0.17142857142857143,0.5344018926371602,1.0,14/81,14.48%,PLK2;PRKCG;DAB2IP;FOXO1;AGAP2;HECW2;GFAP;BARD1;HECW1;EEF1A2;CDKN1B;OAZ2;TRIM32;FMN2
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),0.813674216539255,1.1744929722830615,0.3191489361702128,0.5345118832866961,1.0,1/5,0.90%,IGF1
prerank,KEGG_2021_Human__Basal transcription factors,-0.5478791806052231,-1.1742138223234295,0.23255813953488372,0.8322669046144547,1.0,15/38,23.09%,GTF2H5;GTF2H2;GTF2H2C;TAF13;ERCC2;GTF2A2;TAF11;GTF2F1;GTF2F2;ERCC3;TAF5L;TAF12;TAF6L;TBPL1;GTF2H3
prerank,Reactome_2022__Release Of Hh-Np From Secreting Cell R-HSA-5362798,0.7281438192935903,1.174194668193337,0.32075471698113206,0.5350293959822616,1.0,2/5,18.23%,NOTUM;ADAM17
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.7158724292820028,1.1741416432471294,0.30612244897959184,0.53498628129593,1.0,6/9,26.23%,P4HA2;P3H2;EGLN3;CRTAP;P4HA1;OGFOD1
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.6948292011594519,1.1740178988207153,0.2545454545454545,0.5351595785465749,1.0,8/14,24.38%,ARPC5L;ARPC3;WASHC1;SPIRE1;SPIRE2;ARPC2;JMY;ACTR3
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),0.7126785433931292,1.173971718838281,0.3333333333333333,0.535107965377805,1.0,3/13,12.25%,PIM3;BMP8A;KLF7
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),0.7998465675714063,1.1737696762299505,0.3076923076923077,0.5354633962446234,1.0,1/5,2.61%,COL4A2
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.8040690267237939,-1.1737075301714885,0.23404255319148937,0.8330248181505054,1.0,2/5,13.47%,RPL23;MCM3AP
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6143088305453246,1.1734070274148498,0.22580645161290322,0.5361660912833045,1.0,6/20,15.61%,ACSL5;HACD1;ACOT7;DGAT1;ELOVL7;ELOVL5
prerank,Reactome_2022__Stimuli-sensing Channels R-HSA-2672351,0.5041124797019715,1.1733992461881206,0.24561403508771928,0.535982833793423,1.0,14/75,12.82%,TRPC3;ASIC3;TRPM4;ASIC4;RYR2;BEST3;ANO9;TTYH3;TSC22D3;CLCN4;MCOLN2;SLC9C2;TPCN2;STOM
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.7949509704433533,1.1733053325547222,0.2222222222222222,0.5360199303032067,1.0,1/5,4.88%,OSMR
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5272434904793744,1.1732904877632018,0.22388059701492538,0.5358622607877207,1.0,18/78,14.53%,IGF1;PDGFRA;EGF;DCN;FLT1;IRS2;DAB2IP;NTRK3;PDGFA;NLRC3;PPP1R16B;TGFB2;PIP4K2A;FBXL2;FN1;FGF2;GAB1;PIK3CD
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.7132505461928673,1.173290406328962,0.3111111111111111,0.535666619217517,1.0,1/7,2.60%,SYT4
prerank,Reactome_2022__Lysosphingolipid And LPA Receptors R-HSA-419408,0.7508979779323229,1.1731204343704738,0.27419354838709675,0.535894156935169,1.0,5/8,13.78%,PLPPR5;PLPPR4;PLPPR1;S1PR3;LPAR1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In3:Brain,0.7082150658377042,1.1729852643011376,0.3269230769230769,0.535994663983317,1.0,1/11,2.99%,SHISA8
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.6706573444639892,-1.1729852557800644,0.32608695652173914,0.8344367410231041,1.0,4/13,19.75%,SAP18;RBMX;SRSF9;PCBP4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.6639316638198571,1.17295159738529,0.27419354838709675,0.5358921883190009,1.0,6/16,17.04%,CACNA1C;RYR2;SLC9A1;ATP1B1;SLC8A1;CALM3
prerank,KEGG_2021_Human__PD-L1 expression and PD-1 checkpoint pathway in cancer,0.5313212975704997,1.1728386014626198,0.2,0.5359292367305036,1.0,12/69,15.01%,TLR2;EGF;RASGRP1;NFATC2;MYD88;STAT3;ALK;RPS6KB2;IKBKG;PIK3CD;MAPK11;CD4
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.5708386448258208,1.1726197808260295,0.2463768115942029,0.5362535036113117,1.0,7/41,9.99%,SEMA3C;SEMA5B;SEMA3D;FAT2;SEMA3B;CENPV;RADIL
prerank,Reactome_2022__Eicosanoids R-HSA-211979,-0.7167123189943498,-1.1726008886920478,0.29411764705882354,0.8346912316159915,1.0,3/7,13.52%,CYP4F3;PTGIS;CYP4F12
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.6075463551156223,-1.172587703799563,0.225,0.8336267482518207,1.0,3/13,5.53%,SGO2;TERB1;RNF212
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.568357284646441,1.172471046081813,0.16417910447761194,0.536501526365502,1.0,12/53,17.21%,SGPP2;VAPB;FA2H;SPNS2;HACD1;CERS3;SGMS1;ALDH3A2;ELOVL7;CERS5;ELOVL5;HACD4
prerank,Reactome_2022__RND2 GTPase Cycle R-HSA-9696270,0.5769025738978205,1.1724688452829768,0.2,0.5363145929616221,1.0,10/38,17.79%,KIF14;EPHA2;DLG5;KCTD13;ALDH3A2;UBXN11;PKP4;NISCH;SCRIB;TFRC
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.7703460812901607,1.1724137690564143,0.23214285714285715,0.5362754811284604,1.0,2/5,21.30%,P2RY12;CSF1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.6425366324434562,1.1723586762425116,0.1935483870967742,0.5362490519090662,1.0,9/21,10.24%,KCNT2;KCNQ1;KCNE4;KCND3;KCNH2;ATP1A1;SLC9A1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),-0.4875433821701817,-1.1721661192450827,0.1951219512195122,0.8340376701224309,1.0,23/69,26.23%,ZC3H8;POLR2K;TAF13;GTF2A2;TAF11;POLR2C;SNAPC5;CCNT1;GTF2F1;POLR2D;GTF2F2;NABP2;INTS3;POLR2L;POU2F2;POLR2G;RPAP2;INTS13;POLR2E;PHAX;TAF6;NABP1;CCNK
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.6257238955732298,1.171796761248075,0.31343283582089554,0.5374749468643621,1.0,5/13,22.08%,SLC43A1;KCNH2;BIN1;CAV3;SLC43A2
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.5673543772894125,1.1716481965952015,0.21568627450980393,0.537688354653363,1.0,16/40,18.06%,BLM;ADCY5;GLRA2;GNG2;AHR;ADCY7;ADCY2;CTNNB1;CTNNA1;KLF9;BRCA1;GRAMD1A;ADCY3;GNAI1;OSBPL7;TNFSF4
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.7786738371718535,1.1716182944139122,0.3,0.5375476775326332,1.0,4/5,19.98%,PPARG;RXRA;PDK3;ACTN4
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),0.7015946273809854,1.171505870750793,0.22033898305084745,0.5376261224091219,1.0,6/10,19.50%,FHOD1;ACTN1;COBL;SPIRE1;SPIRE2;FHOD3
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),0.75812925286416,1.1713416095493838,0.25,0.5378687154500947,1.0,4/8,18.06%,ANXA1;NFKBID;RARA;TNFSF4
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.5076976477141769,-1.1712996311159307,0.2,0.8355871466809927,1.0,21/69,21.07%,ERCC8;RFC3;COPS8;GTF2H5;POLR2K;POLD3;GTF2H2;COPS7A;ERCC2;POLR2C;HMGN1;ERCC6;POLR2D;PPIE;XPA;ERCC3;UBB;COPS3;POLR2L;POLR2G;COPS6
prerank,KEGG_2021_Human__Riboflavin metabolism,-0.7354265065143852,-1.1712531264648591,0.2972972972972973,0.8347007086665919,1.0,3/7,18.84%,FLAD1;ACP2;ENPP3
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),0.7735107457403225,1.1712280093177247,0.28846153846153844,0.5379638222259854,1.0,2/5,11.23%,ALDOB;FBP1
prerank,Reactome_2022__RHO GTPases Activate IQGAPs R-HSA-5626467,0.6854745414504525,1.171217518754166,0.3137254901960784,0.5377937980429396,1.0,4/10,14.03%,CTNNB1;RNASE1;CTNNA1;IQGAP1
prerank,Reactome_2022__Lipophagy R-HSA-9613354,-0.6917665485582687,-1.1708818094494686,0.3617021276595745,0.8349143707687895,1.0,4/7,26.03%,PLIN3;PLIN2;PRKAB2;PRKAB1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.6554256746871865,1.1708368166352374,0.32142857142857145,0.5385491744305219,1.0,5/14,22.28%,ITPKC;ITPKB;FGF2;ACER3;ISYNA1
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.5842388081650138,-1.170828493422068,0.2564102564102564,0.83399224863843,1.0,7/12,18.61%,TFB2M;SLC25A33;TFB1M;TEFM;MTERF1;MTERF2;FASTKD1
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),0.7531166786280422,1.1708172355435784,0.28846153846153844,0.538379061272562,1.0,3/7,5.54%,THBS1;SERPINE1;FAP
prerank,Reactome_2022__Myoclonic Epilepsy Of Lafora R-HSA-3785653,-0.7265849646353003,-1.1707303054946308,0.29545454545454547,0.8332759822616073,1.0,1/7,2.63%,PPP1R3C
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.6667537345984276,1.1707292380437118,0.2698412698412698,0.5384528312931208,1.0,3/12,9.48%,DYSF;MYH9;SYTL4
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),-0.7003069038851948,-1.1707240079257986,0.3090909090909091,0.8322421646477092,1.0,5/8,27.90%,GBA2;FUCA2;FUCA1;GBA3;GUSB
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),-0.6182574985219579,-1.1705385595093598,0.3111111111111111,0.8297735147301549,1.0,7/12,34.49%,IK;PLK1;MAD2L2;ZNF207;ATM;TEX14;TPR
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),-0.6182574985219579,-1.1705385595093598,0.3111111111111111,0.8297735147301549,1.0,7/12,34.49%,IK;PLK1;MAD2L2;ZNF207;ATM;TEX14;TPR
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),-0.6182574985219579,-1.1705385595093598,0.3111111111111111,0.8297735147301549,1.0,7/12,34.49%,IK;PLK1;MAD2L2;ZNF207;ATM;TEX14;TPR
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.6827064400819206,1.1705374228069565,0.352112676056338,0.5387492131446757,1.0,1/13,0.86%,IMPDH1
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.6944991063473657,1.1704610119756633,0.24242424242424243,0.5387430011053163,1.0,1/10,3.21%,PXYLP1
prerank,Reactome_2022__Synthesis Of Pyrophosphates In Cytosol R-HSA-1855167,0.7504170703143573,1.170419759111491,0.25,0.5386360370313095,1.0,2/8,8.76%,ITPK1;NUDT4
prerank,"Reactome_2022__Synthesis, Secretion, And Deacylation Of Ghrelin R-HSA-422085",0.7023377373259869,1.170336908185736,0.3333333333333333,0.5386550504800482,1.0,2/12,3.70%,IGF1;ACHE
prerank,Reactome_2022__Late Phase Of HIV Life Cycle R-HSA-162599,-0.4577761598776194,-1.1702359403923488,0.15625,0.8299337575598781,1.0,28/126,21.19%,GTF2H5;POLR2K;AAAS;ELOC;NUP50;GTF2H2;ELOA;VPS4B;TAF13;SUPT16H;ERCC2;GTF2A2;TAF11;POLR2C;NMT2;NUP54;CCNT1;GTF2F1;POLR2D;RNF103-CHMP3;GTF2F2;ERCC3;UBB;POLR2L;POLR2G;NUP85;NUP42;TAF12
prerank,Reactome_2022__ECM Proteoglycans R-HSA-3000178,0.5363521429518687,1.1702351187193507,0.2459016393442623,0.5386698550158108,1.0,14/41,11.55%,DCN;SERPINE1;ITGA8;ASPN;LAMB1;ITGA2;AGRN;LAMA5;BGN;TGFB2;ITGA9;COL9A1;LAMA2;SPARC
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.6002251806202724,-1.1700523317104168,0.2857142857142857,0.8294204179795611,1.0,6/31,9.66%,GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;ERCC2
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),0.6633473491510777,1.1699082377409682,0.3050847457627119,0.5392843382569689,1.0,2/14,1.45%,IGF1;EGF
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),0.7399780185614319,1.1698149564902511,0.2923076923076923,0.5393492098809851,1.0,4/5,23.81%,NTRK3;ANGPT2;F3;CDH13
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.8218819366642406,1.1697499804536242,0.22641509433962265,0.5393469849982259,1.0,1/6,2.80%,ABCB1
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),0.6397904222094233,1.1696970407305614,0.2653061224489796,0.5392526018420069,1.0,2/13,1.31%,GPNMB;IL15
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),0.686083890657084,1.169659758255539,0.3333333333333333,0.5391666620259699,1.0,3/11,13.62%,WASF1;PID1;MTM1
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.690191368410549,-1.1695207971496715,0.2830188679245283,0.8302050030354585,1.0,5/9,24.36%,PIH1D2;ZNHIT3;RUVBL1;NUFIP1;ZNHIT6
prerank,Reactome_2022__Chemokine Receptors Bind Chemokines R-HSA-380108,0.6560798307589241,1.1694948477505478,0.31746031746031744,0.5393947387696368,1.0,1/13,0.33%,CXCL2
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.571335611556685,-1.169216053004422,0.22857142857142856,0.8302585752570889,1.0,7/16,19.53%,NSA2;RPF1;EXOSC4;RRP15;MAK16;LAS1L;NOL9
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.5191692172064724,1.1689234444242431,0.20634920634920634,0.5406060197608253,1.0,5/58,3.34%,CXCL2;TLR2;SERPINE1;ZFP36;DAB2IP
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5809955428628787,1.1684669704261788,0.25,0.5414327971996159,1.0,8/26,21.09%,IRF7;BIRC3;IKBKE;FADD;IKBKG;TLR3;RPS27A;TBK1
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5809955428628787,1.1684669704261788,0.25,0.5414327971996159,1.0,8/26,21.09%,IRF7;BIRC3;IKBKE;FADD;IKBKG;TLR3;RPS27A;TBK1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In6:Brain,0.5114050613922141,1.168425145031188,0.21052631578947367,0.5413587661836836,1.0,22/82,15.88%,SCN1B;FAM20C;DMTN;ABCC8;EGFL7;GABRD;ATP9A;RAI2;TNS1;MAOB;AATK;RAMP3;ARHGEF10L;RNASE1;PDK4;GPRC5C;CAMK2B;COBL;PLXNA2;PINK1;CTDSPL;RXRA
prerank,CellMarker_Augmented_2021__Muller cell:Retina,0.5433529635570788,1.1682577236086789,0.27419354838709675,0.5416483193177477,1.0,13/58,10.99%,TLR2;CDH23;P2RY13;LMO2;SIGLEC1;RTN1;PADI2;FOXO3;CHI3L1;TM6SF1;RNASE1;FRY;LRRC4
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.7807713496234262,1.1681483061529605,0.2127659574468085,0.541699574258424,1.0,2/7,4.96%,ST18;FAS
prerank,Reactome_2022__Clathrin-mediated Endocytosis R-HSA-8856828,0.49442506443370204,1.1681278755087392,0.20967741935483872,0.541583772103958,1.0,27/119,17.89%,EGF;SH3GL2;SH3GL3;SYT1;TGFA;SH3KBP1;DNM1;CLTB;REPS2;SYNJ2;LDLR;GRK2;TRIP10;ARPC3;TF;PACSIN1;ARF6;SYT12;GPS1;BIN1;CD4;PIP5K1C;KIAA0319;EPN1;WNT5A;TFRC;LRP2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),-0.7452453730681458,-1.1681198512748097,0.2826086956521739,0.8327837491587595,1.0,2/8,7.60%,APOE;APOM
prerank,Reactome_2022__Signaling By ALK R-HSA-201556,0.6405236779434558,1.1680957400282503,0.23333333333333334,0.5414513573480104,1.0,5/21,19.28%,STAT3;ALK;PRDM1;SHC1;HIF1A
prerank,Reactome_2022__Synthesis Of PG R-HSA-1483148,0.7749403606299713,1.1679316732100364,0.2727272727272727,0.5416737002595424,1.0,2/6,14.16%,PLD2;CDS2
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.5710989089494446,1.167606461183571,0.2857142857142857,0.5423171538149811,1.0,6/28,12.75%,APP;GRM5;FOXO3;TMED10;PRKCD;MAPKAPK5
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5208051535512976,1.167591193076964,0.23809523809523808,0.5421804486500051,1.0,12/58,7.97%,CNR1;ADGRE5;ADCY5;GPR12;LGR5;RXFP1;GNG2;ADCY7;ADCY2;RAMP3;GLP1R;ADGRL2
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.7361369528878853,1.167501364649126,0.38461538461538464,0.5420114956250086,1.0,1/5,2.98%,SLC39A14
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.7361369528878853,1.167501364649126,0.38461538461538464,0.5420114956250086,1.0,1/5,2.98%,SLC39A14
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Gall Bladder,0.5319229647012609,1.167345961577609,0.15873015873015872,0.5421832577788314,1.0,15/50,16.32%,GRID2;FAM124A;UNC5D;FRAS1;SEMA5B;CHST6;ADCY2;COL9A1;PODXL;NR6A1;GDPD2;PLEKHG4B;CGNL1;NLGN4X;TOX3
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5026656079659084,1.1673372273214586,0.19117647058823528,0.5420051620679278,1.0,15/78,15.14%,ST6GAL1;B3GNT2;GALNT12;GALNTL6;GALNT8;GALNT16;TRAK1;POMGNT1;CHST4;B4GALT5;TMTC1;PLOD2;POMGNT2;ST6GALNAC2;LARGE1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.5837639924544789,-1.167245937154397,0.3488372093023256,0.8348145713728925,1.0,6/20,8.69%,GDF9;FSHR;MCM9;M1AP;DMC1;METTL3
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.695084806308059,-1.1671098966706968,0.27450980392156865,0.8343174297767052,1.0,5/9,15.50%,ID2;ASCL1;POU3F2;PAX6;EPOP
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.550950977103656,1.1670323554710635,0.27941176470588236,0.5425597081275267,1.0,12/41,9.71%,FOSL2;MAFF;S100A10;SERPINE1;CD55;PLEKHG6;IL1R1;SMAGP;MLANA;GPR87;SH2D3A;ADAM19
prerank,Reactome_2022__SOS-mediated Signaling R-HSA-112412,0.7780170559028956,1.166916127592948,0.2545454545454545,0.5426603597669514,1.0,1/6,3.05%,IRS2
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.71448130030856,1.166838081940554,0.3333333333333333,0.5426694406508298,1.0,2/7,26.37%,MAPT;BAG6
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.5278114571993436,1.1668377639671297,0.2459016393442623,0.542474795944714,1.0,16/61,9.58%,COL4A1;ACTA2;COL4A2;FBLIM1;EPHA2;MYH11;OSMR;POSTN;COL12A1;RHBDF1;RHOD;EMP1;MYO1C;ITGA3;YAP1;MMP14
prerank,Reactome_2022__Phase I - Functionalization Of Compounds R-HSA-211945,-0.4970293177251087,-1.1668306383403748,0.2222222222222222,0.8342128520132909,1.0,17/56,15.05%,CYP4F3;CES2;CYP3A43;CBR3;ALDH1A1;ADH6;VDAC2;NQO2;CYP46A1;CYP4V2;ADH5;PTGIS;CYP7B1;EPHX1;CYP4F12;CYP2C8;BPHL
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5323447209281901,1.1665771397661824,0.21621621621621623,0.5429452574538534,1.0,10/63,9.86%,TGFBR2;FLT1;PLEK;PTPRC;ZBTB16;KIRREL3;ARIH2;KITLG;ETV6;TGFB2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.5755185114718853,1.1664801438681016,0.2909090909090909,0.5429583810113222,1.0,5/26,10.89%,IGF1;IRS2;RTN2;PID1;SORBS1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.5958928009648803,1.1664286681097495,0.22580645161290322,0.5428759747088128,1.0,5/20,18.06%,PTPRC;STX4;HLA-E;TFRC;TNFSF4
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.6736339818583946,1.166131585385418,0.3333333333333333,0.5434329701110328,1.0,1/13,1.69%,ATF3
prerank,GO_Biological_Process_2021__ammonium transport (GO:0015696),-0.7121960978004143,-1.1661090798206963,0.3333333333333333,0.8353667917951152,1.0,1/5,6.98%,RHCE
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),-0.7312831369566543,-1.1660098629571882,0.2926829268292683,0.8336439660619844,1.0,3/8,9.78%,RFC3;DSCC1;POLG2
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),-0.7312831369566543,-1.1660098629571882,0.2926829268292683,0.8336439660619844,1.0,3/8,9.78%,RFC3;DSCC1;POLG2
prerank,Reactome_2022__Glycogen Storage Diseases R-HSA-3229121,-0.5911344151328822,-1.1660016241383215,0.3111111111111111,0.8326385926759503,1.0,4/12,19.54%,PPP1R3C;G6PC3;GAA;UBB
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.7162320912776481,1.1659357780769017,0.2542372881355932,0.5437405612990905,1.0,3/9,12.09%,MFSD2A;DCX;CDHR1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.41677230444982916,1.165848084806664,0.08333333333333333,0.5437326384011714,1.0,80/776,11.07%,LEF1;SKOR1;MYT1;HPN;ELAVL2;PTP4A3;TEAD2;ANK3;TLR2;IGF1;MOG;PROX1;RIMS2;EGF;ZNF536;TESC;AMH;SH3GL2;ACTA2;PRDM8;NELL1;CASZ1;IGF2BP2;SFTPD;APP;YBX3;NOS1AP;TRIM61;HIC1;ZNF282;WTIP;PTPRC;SRRM4;PPARGC1B;EPB41L4B;NFATC2;NFIL3;PLSCR1;SOX4;TRIM5;BCL6;NKX6-2;AHR;CCDC3;SMCR8;GZF1;CHD3;NTRK3;DVL1;ZNF114;PGR;MBNL2;PID1;APLNR;ALPK2;SCX;VSTM2A;PML;RAMP3;MYD88;FAM50A;CDK6;ZNF804A;TRIM17;SMAD3;YAP1;AFF1;ATP1B1;HDAC4;ADAM19;TGFB2;NFKBID;DENND4A;STAT3;SMAD1;TERF2IP;ITGB8;MAPT;PARP9;GAS6
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.6324532350027896,-1.1657576540489878,0.23255813953488372,0.8322617144799331,1.0,5/14,15.22%,NIFK;DDX18;RPL7L1;ZNHIT3;RPF2
prerank,KEGG_2021_Human__Cytokine-cytokine receptor interaction,0.49460637451724937,1.1652987283417728,0.203125,0.5447739424652281,1.0,14/107,6.79%,TGFBR2;CXCL2;IL13RA1;IL15;AMH;CSF2RA;IL27RA;BMP8A;IL1R1;OSMR;FAS;TNFRSF14;TNFRSF1A;GHR
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.794559063199822,1.1647954608814572,0.28888888888888886,0.5457896278575886,1.0,1/5,6.65%,CDK9
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),0.639823747156163,1.1646736183917954,0.31666666666666665,0.5458887288757176,1.0,3/13,10.43%,CTU2;GTPBP3;TRMT9B
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.43568876216124663,1.1645699659360165,0.1780821917808219,0.5458800495532148,1.0,38/273,11.07%,ENPP2;C3;CSPG4;GPNMB;IGF1;IL15;EGF;RASGRP1;RELN;TEC;APP;BMP8A;EFNA1;NEK10;AGAP2;PTPRC;FAS;TNFRSF14;NTRK3;CD44;CDK9;GHR;SNCA;APLNR;RAMP3;LIMCH1;PDGFA;NPTN;CHI3L1;SH2D3A;LIMK2;MMD;TGFB2;RBPMS;NIBAN1;WDFY2;TERF2IP;GAS6
prerank,Reactome_2022__Apoptotic Execution Phase R-HSA-75153,-0.5147859533327084,-1.164422580925954,0.2894736842105263,0.8354285787551115,1.0,4/41,9.00%,H1-2;H1-4;BCAP31;VIM
prerank,KEGG_2021_Human__Influenza A,0.4838765325186864,1.1643758837298803,0.19117647058823528,0.5462192366579129,1.0,26/113,14.66%,HLA-DRA;SOCS3;PRKCB;ICAM1;IRF7;FAS;CIITA;TNFRSF1A;PML;MYD88;CDK6;KPNA7;IKBKE;TYK2;CCL2;HLA-DRB1;MX1;TPSD1;TNFRSF10B;FADD;HLA-DMA;IL12A;TMPRSS11D;IKBKG;PIK3CD;IFIH1
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.5085309955918008,-1.1642564053888085,0.2619047619047619,0.8349545524216392,1.0,7/31,12.64%,TRMT61A;TRMT10C;TRMT10A;METTL2A;FTSJ1;TRMT61B;TRMT5
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.6932729770036266,-1.1640560818330539,0.32558139534883723,0.8346045455180355,1.0,3/6,17.92%,ACMSD;ASMT;PNPO
prerank,CellMarker_Augmented_2021__Dendritic Cell progenitor:Bone Marrow,0.6950650381402715,1.1640361676925792,0.3114754098360656,0.5469680131882249,1.0,4/9,4.31%,CD22;CSF2RA;SIGLEC1;PTPRC
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.5210394408454472,1.1638312930560428,0.2037037037037037,0.547290016738311,1.0,4/37,6.91%,TLR2;SP100;CIITA;SNCA
prerank,PanglaoDB_Augmented_2021__Merkel Cells,-0.5574582026341793,-1.163642898074564,0.2777777777777778,0.8349915253195446,1.0,4/29,5.27%,ID2;GOLT1A;CFTR;KRT8
prerank,Reactome_2022__Nucleotide-like (Purinergic) Receptors R-HSA-418038,0.713321930236716,1.1633902980986344,0.27586206896551724,0.5483233130556008,1.0,2/10,2.02%,P2RY6;P2RY13
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),0.6712268387295461,1.1633871539314153,0.34615384615384615,0.5481276928939683,1.0,2/9,11.36%,CTNNB1;NR4A2
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.7585729553563147,1.1633417836090008,0.30357142857142855,0.5480479589059047,1.0,3/5,23.45%,NLGN4X;MTMR2;TMEM25
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.7285947161312725,1.1631906575139674,0.3,0.5482823392286503,1.0,3/10,15.37%,GHR;STAT3;STAT6
prerank,Reactome_2022__tRNA Processing In Nucleus R-HSA-6784531,-0.4714104293748581,-1.1628674598657982,0.0967741935483871,0.8367065619779193,1.0,15/51,22.88%,RTRAF;AAAS;POP5;NUP50;CPSF1;NUP54;RPP38;TRNT1;RPP40;NUP85;NUP42;POP7;CSTF2;POM121C;TSEN2
prerank,KEGG_2021_Human__Oxytocin signaling pathway,0.48058727027762693,1.1628608742724753,0.1917808219178082,0.5489255078640412,1.0,33/119,19.17%,KCNJ2;PRKCB;ADCY5;PRKCG;CACNG3;NFATC2;MYLK3;OXTR;ITPR3;GUCY1A2;ADCY7;CACNA1C;CACNG8;RYR2;ADCY2;GUCY1A1;PPP1CB;CACNG4;GUCY1B1;CAMK2B;CDKN1A;CCND1;ADCY3;CALM3;CAMK1D;GNAI1;ITPR1;CAMK2A;PRKCA;CAMK1G;NFATC3;EEF2K;CACNB2
prerank,Reactome_2022__RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,-0.4857804982613662,-1.1625784116389177,0.2,0.836713414878349,1.0,24/70,26.23%,ZC3H8;POLR2K;TAF13;GTF2A2;TAF11;POLR2C;SNAPC5;CCNT1;GTF2F1;POLR2D;GTF2F2;NABP2;INTS3;POLR2L;POU2F2;POLR2G;RPAP2;SSU72;INTS13;POLR2E;PHAX;TAF6;NABP1;CCNK
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),0.788121783299633,1.16233268054244,0.3508771929824561,0.5500761332933034,1.0,1/5,5.48%,RNASE10
prerank,KEGG_2021_Human__Fc gamma R-mediated phagocytosis,0.5254425450488603,1.1622933797841393,0.22580645161290322,0.5499627956365455,1.0,23/77,15.99%,PLD1;ARPC5L;PRKCB;PRKCG;WAS;PTPRC;WASF1;LIMK2;PLD2;ARPC3;PRKCE;GAB2;SYK;INPPL1;ARF6;PRKCD;PAK1;RPS6KB2;BIN1;PIK3CD;INPP5D;PIP5K1C;VAV2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),-0.6989977934241947,-1.162103592926936,0.32653061224489793,0.8371339520799274,1.0,5/7,28.16%,BCAP31;SLC25A23;FIS1;MCU;MICU1
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),-0.6328956009598629,-1.1619750972044958,0.4,0.8364077871672305,1.0,2/10,7.49%,COPS8;COPS7A
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),0.7950749303212159,1.1619720735214443,0.32727272727272727,0.5505592881742046,1.0,4/6,18.53%,PRKCH;CCL2;PRKCD;PRKCA
prerank,Reactome_2022__Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,0.514132255952604,1.161954881180622,0.19642857142857142,0.550400484440656,1.0,13/47,22.89%,YWHAH;MYH9;YWHAG;RNASE1;STX4;TBC1D1;RHOQ;YWHAE;RAB11A;EXOC2;MYO1E;YWHAQ;RALGAPB
prerank,CellMarker_Augmented_2021__Endothelial cell:Ovary,0.7745521132994708,1.1619402412786917,0.31746031746031744,0.5502417936944667,1.0,1/6,1.87%,CD24
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.534180049313464,1.1619080944119384,0.208955223880597,0.5501574126834472,1.0,3/46,8.47%,ENPP2;ENPEP;TRHDE
prerank,KEGG_2021_Human__Natural killer cell mediated cytotoxicity,0.5200023545039458,1.1617411618925284,0.2222222222222222,0.5503615324679949,1.0,18/60,19.87%,PRKCB;SHC2;ICAM1;PRKCG;NFATC2;FYN;FAS;SYK;ITGAL;PAK1;TNFRSF10B;PIK3CD;HLA-E;VAV2;SHC1;PRKCA;VAV1;SH3BP2
prerank,Reactome_2022__STAT5 Activation R-HSA-9645135,-0.7406036875214885,-1.1617267443492603,0.38461538461538464,0.836414983968908,1.0,1/6,1.01%,FLT3
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.6770978041524539,1.1617239995410085,0.27419354838709675,0.5502153820996233,1.0,1/15,0.33%,CXCL2
prerank,Reactome_2022__p53-Dependent G1 DNA Damage Response R-HSA-69563,0.5213752022054924,1.1614996549542607,0.2608695652173913,0.5506540426200138,1.0,1/58,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),0.6027737212931535,1.1613168427052378,0.22950819672131148,0.5509359762554746,1.0,3/18,10.96%,NMNAT2;NAMPT;PARP9
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.8047875302925809,-1.161262901630857,0.30952380952380953,0.8370310491088363,1.0,2/5,16.65%,BNIPL;PRUNE1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.8251210381146538,1.161245263719997,0.2037037037037037,0.55090087537167,1.0,1/5,3.33%,YBX3
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),-0.4884070889452693,-1.1612079890548628,0.23076923076923078,0.8362141379830167,1.0,23/68,26.23%,ZC3H8;POLR2K;TAF13;GTF2A2;TAF11;POLR2C;SNAPC5;CCNT1;GTF2F1;POLR2D;GTF2F2;NABP2;INTS3;POLR2L;POU2F2;POLR2G;RPAP2;INTS13;POLR2E;PHAX;TAF6;NABP1;CCNK
prerank,PanglaoDB_Augmented_2021__Acinar Cells,-0.5934146255562781,-1.1610263364333233,0.2631578947368421,0.8358664592525299,1.0,5/19,7.88%,CEL;CFTR;PRSS3;AKR1C3;CPA1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.5290697501888356,1.161001654841456,0.2923076923076923,0.5512689000265594,1.0,13/47,12.19%,HRH1;CHRM3;RCAN2;LAT2;TRPM4;RYR2;NUDT4;GUCY1A1;CCR10;INPP5A;P2RY12;GUCY1B1;TPCN2
prerank,GO_Biological_Process_2021__positive regulation of autophagosome maturation (GO:1901098),0.7757286476442394,1.1609006973145426,0.2545454545454545,0.5513323894477339,1.0,1/6,5.58%,SMCR8
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.7611308107507837,1.1608630421533421,0.3333333333333333,0.5512355300159227,1.0,3/7,12.21%,CLDN16;CLDN18;CLDN20
prerank,GO_Biological_Process_2021__chitin metabolic process (GO:0006030),0.7538335238493146,1.1608108529724572,0.32653061224489793,0.5509475459377385,1.0,3/5,16.49%,CHI3L1;CHI3L2;CTBS
prerank,GO_Biological_Process_2021__chitin catabolic process (GO:0006032),0.7538335238493146,1.1608108529724572,0.32653061224489793,0.5509475459377385,1.0,3/5,16.49%,CHI3L1;CHI3L2;CTBS
prerank,Reactome_2022__Interleukin Receptor SHC Signaling R-HSA-912526,0.6003537216771884,1.1605020587684578,0.3050847457627119,0.551577685358527,1.0,5/17,17.35%,CSF2RA;GAB2;INPPL1;INPP5D;SHC1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.7010162281487639,-1.1604965055140268,0.40476190476190477,0.8368542422713063,1.0,5/9,21.52%,GCDH;ETFB;ETFDH;ACADS;ACADM
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.46394790933415925,1.1603915918438292,0.12903225806451613,0.5516614756882856,1.0,32/140,14.71%,C3;TLR2;SP100;PTK6;SLA;SFTPD;APP;COLEC12;IRF7;TRIM61;FYN;TRIM5;COLEC11;CIITA;SNCA;PML;NLRC5;MYD88;TRIM17;CLPB;PPARG;ZDHHC1;SYK;MX1;RELB;TRIM22;B2M;TRIM32;IKBKG;PIK3CD;IFIH1;HLA-E
prerank,KEGG_2021_Human__TGF-beta signaling pathway,0.5037225607910529,1.1601641220540049,0.21875,0.552024216105102,1.0,5/71,3.53%,TGFBR2;DCN;AMH;THBS1;BMP8A
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.7371847638942263,1.1599737309880616,0.37254901960784315,0.5522718542320394,1.0,3/7,12.89%,KLF2;ASS1;KLF4
prerank,CellMarker_Augmented_2021__CD4+ T cell:Undefined,0.7939696284017771,1.159913177194674,0.2857142857142857,0.5522364049686315,1.0,3/5,15.01%,PTPRC;CD5;CD4
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.48337137099578753,1.1598376959558234,0.26666666666666666,0.5522747578595134,1.0,20/84,14.66%,TLR2;IRF7;PTPRC;MAP3K14;PLSCR1;TRIM5;SAMHD1;ABCC9;NLRC5;MYD88;APOBEC3H;BCL2L1;CLPB;RNASE1;ZDHHC1;MX1;BCL2;CGAS;FADD;IFIH1
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.5179657767694225,1.159715451428808,0.27631578947368424,0.552337667304709,1.0,13/64,15.14%,CHST8;IGF1;B3GNT2;B3GALT2;ST8SIA3;ST8SIA1;B3GALNT1;ST8SIA4;B4GALT7;B4GALT5;FUT2;ST6GALNAC2;LARGE1
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),-0.7487476010967706,-1.1596710831358363,0.358974358974359,0.8387437786396091,1.0,2/6,8.80%,DCHS1;HEY1
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),-0.6134570482828827,-1.159458919165108,0.25,0.8384128958733497,1.0,4/12,25.55%,USP19;CLU;NR1H2;EIF2AK3
prerank,Reactome_2022__RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.5141712729371555,-1.159455494447504,0.2857142857142857,0.8374226234894615,1.0,29/74,26.67%,GTF2H5;POLR2K;ELOC;GTF2H2;ELOA;TAF13;SUPT16H;ERCC2;GTF2A2;TAF11;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;TAF12;POLR2E;GTF2H3;EAF1;CTDP1;CTR9;LEO1;TAF6;CCNK;SKIC8;NELFCD
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Placenta,0.5230983726448403,1.159358971027201,0.25806451612903225,0.552973948528324,1.0,24/67,14.90%,COL4A1;FLRT3;SULF1;COL4A2;DAB2IP;THY1;POSTN;COL12A1;FAP;PTPN21;SCARA3;BOC;ADGRL2;ASS1;BGN;YAP1;PDLIM4;SLCO2A1;COL4A5;MAMDC2;PALLD;COL5A1;NOTCH3;LAMA3
prerank,Reactome_2022__Negative Regulation Of MAPK Pathway R-HSA-5675221,0.583148480711146,1.1592866719210875,0.2727272727272727,0.5530038114857747,1.0,3/35,5.47%,DUSP10;DUSP8;DUSP16
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.6701163291110432,-1.1591926057944872,0.2972972972972973,0.8360522735650714,1.0,2/7,9.65%,EEFSEC;SECISBP2
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.6701163291110432,-1.1591926057944872,0.2972972972972973,0.8360522735650714,1.0,2/7,9.65%,EEFSEC;SECISBP2
prerank,GO_Biological_Process_2021__parallel actin filament bundle assembly (GO:0030046),0.8086967704877939,1.1591571523670627,0.3404255319148936,0.5531318838591242,1.0,4/5,16.70%,FSCN1;SPIRE1;FMN2;SPIRE2
prerank,CellMarker_Augmented_2021__Basal cell:Airway Epithelium,0.49727604448241236,1.1590666645328092,0.19298245614035087,0.5532025849158733,1.0,14/83,10.23%,BOK;MAP3K6;P4HA2;STEAP3;FBLIM1;EPHA2;AGRN;RHBDF1;CDC42EP1;MYO1C;TRIP10;ITGA3;LMNA;PXDC1
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.7060219188976454,1.1585836938098029,0.296875,0.5541444165740975,1.0,4/11,15.80%,PRKG2;FTCD;MTHFD1L;GCHFR
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.7502660257286062,-1.1584155562587246,0.3409090909090909,0.8375977300936653,1.0,3/5,23.94%,ZFAND2B;SEC61A1;SRP54
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.7400402776669506,-1.158336143136664,0.3137254901960784,0.8368446134374534,1.0,5/7,24.36%,PIH1D2;ZNHIT3;RUVBL1;NUFIP1;ZNHIT6
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.49805663367008113,1.1582538981253916,0.22727272727272727,0.5548811534717897,1.0,11/71,11.38%,EGF;CLDN16;ZNF750;EPB41L4A;ZBTB7C;ADGRF5;ALDH1L1;PDZD2;ITGB8;CFAP61;OPHN1
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.4734108451438773,-1.158210641370224,0.1875,0.8363151387021146,1.0,5/39,14.09%,AAAS;RAE1;NUP50;NUP54;JMJD8
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.6765991629601236,1.1581542993800304,0.3225806451612903,0.5549552500951371,1.0,3/9,19.57%,HDAC4;HDAC9;RCOR1
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.71178911364316,1.1581351428686013,0.38,0.5548127510981089,1.0,3/7,12.11%,SAMHD1;POLQ;PMS2
prerank,Reactome_2022__Phase 1 - Inactivation Of Fast Na+ Channels R-HSA-5576894,0.7501741638889597,1.1579844617548056,0.288135593220339,0.5550216009976261,1.0,2/6,5.55%,KCNIP4;KCND3
prerank,Reactome_2022__CREB Phosphorylation R-HSA-199920,0.7791609245269828,1.1578843588934782,0.3508771929824561,0.5550710727758412,1.0,1/6,3.26%,RPS6KA1
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),-0.6209736449511933,-1.1577443596802461,0.24242424242424243,0.8368761780212542,1.0,6/15,16.85%,PYGM;MGAM;AGL;PHKG1;GAA;PGM2
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),0.7910620043295744,1.1577403196287777,0.3148148148148148,0.5552225449230139,1.0,1/5,3.97%,PTPRR
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),-0.47009931759602935,-1.1575687399696635,0.17142857142857143,0.8364032686939568,1.0,24/93,23.20%,FIP1L1;AAAS;RBM8A;ENY2;RAE1;NUP50;U2AF1;CPSF1;DDX25;NUP54;MCM3AP;SRSF2;POLR2D;CPSF3;DDX19A;SRSF9;UPF3B;CHTOP;NUP85;NUP42;POM121C;THOC3;THOC1;NXT1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),-0.4455615096086514,-1.157509549159739,0.17647058823529413,0.8356736741777147,1.0,7/79,6.01%,NUP62CL;ABCD2;PXMP2;NXT2;APOE;NUP50;ABCD1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.4941313427117232,-1.1574788476671594,0.21052631578947367,0.8347527079987741,1.0,23/64,26.67%,GTF2H5;POLR2K;ELOC;GTF2H2;ELOA;SUPT16H;ERCC2;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G;POLR2E;GTF2H3;EAF1;CTDP1;CTR9;LEO1;CCNK;NELFCD
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.7484558162897155,1.1574611494551537,0.3064516129032258,0.5557737476657438,1.0,3/7,11.71%,RAMP3;GRM6;CCL2
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.587121497637018,1.157456716044375,0.22950819672131148,0.5555985830811602,1.0,9/26,16.36%,SERPINE1;ICAM1;FAS;TMBIM1;BCL2L1;TNFRSF10B;FADD;BRCA1;RFFL
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.7734744286382673,1.157242421829408,0.36666666666666664,0.5559780275301197,1.0,4/5,22.08%,SLC43A1;GRM7;HRH3;SLC43A2
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.7517601700526624,-1.1572199971018264,0.3953488372093023,0.8345045516759905,1.0,2/7,5.85%,TNFAIP3;GREM1
prerank,Reactome_2022__Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.5072582337193678,-1.1569919634679982,0.20512820512820512,0.8343670945122247,1.0,6/30,22.33%,AAAS;NUP50;NUP54;NUP85;NUP42;POM121C
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.5126270127101427,1.1569351171929292,0.2608695652173913,0.5565080048547363,1.0,8/64,16.91%,TBC1D24;PLK2;CDKL5;USP6NL;TBC1D1;TBC1D10B;TBC1D10A;IFT140
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.6951635068558917,-1.1568915622685172,0.35555555555555557,0.8337351221322125,1.0,1/7,2.52%,DISP3
prerank,Reactome_2022__Diseases Of Glycosylation R-HSA-3781865,0.4608445358421561,1.1567396244874089,0.2054794520547945,0.5568664917258572,1.0,15/116,6.53%,CSPG4;PAPSS2;ADAMTS4;ADAMTSL2;DCN;THBS1;OGN;THSD7B;ADAMTS10;EGFL7;GALNT12;SEMA5B;CHST6;ADAMTS19;AGRN
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),-0.7375969959579347,-1.1565082408869867,0.34782608695652173,0.8341480917515368,1.0,1/5,5.39%,PDCL3
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.7247575834750258,-1.1564646327180241,0.3617021276595745,0.8332985039062194,1.0,2/6,15.32%,MCRS1;NMD3
prerank,Reactome_2022__Calcitonin-like Ligand Receptors R-HSA-419812,-0.7231539956508853,-1.1563588241480223,0.3617021276595745,0.8324966145734969,1.0,2/5,7.15%,CALCRL;CALCB
prerank,CellMarker_Augmented_2021__Morula Cell (Blastomere):Embryo,-0.46987410500459065,-1.1563498835138157,0.21875,0.8315051374618161,1.0,16/82,8.44%,RPL34;RPL39;LRPPRC;LSM3;EGFLAM;RBIS;AIMP1;MTIF2;UQCRB;RPL23;AGL;GDE1;GULP1;GLUD1;RPL22;LSM5
prerank,KEGG_2021_Human__Tight junction,0.47200729210572906,1.156290037755537,0.18032786885245902,0.5577338271504702,1.0,39/127,22.15%,ARPC5L;CLDN16;WAS;YBX3;MYH9;TJP3;MYH11;IGSF5;EPB41L4B;PARD3;ARPC3;PRKCE;ACTN1;CLDN18;CLDN20;DLG3;CCND1;TUBA1B;ARHGAP17;PATJ;CGNL1;MAP3K5;TJAP1;MICALL2;MAPK9;MAGI1;VASP;SCRIB;RAP1A;STK11;TJP2;PPP2R2D;ACTN4;HSPA4;AMOTL1;TUBA4A;AMOTL2;ARHGEF18;TJP1
prerank,Reactome_2022__Interferon Gamma Signaling R-HSA-877300,0.5325145616054758,1.1562608301218118,0.31746031746031744,0.5576234236961751,1.0,16/58,12.85%,HLA-DRA;SOCS3;SP100;ICAM1;IRF7;TRIM5;TRIM46;CIITA;CD44;PML;TRIM17;HLA-DRB1;CAMK2B;PRKCD;TRIM22;B2M
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),0.7040066431140573,1.1561270652967275,0.3333333333333333,0.5577776441128556,1.0,3/10,9.88%,RELN;SOX4;GLI2
prerank,CellMarker_Augmented_2021__Primitive Vesicle cell:Fetal Kidney,0.7664099277783776,1.1560949893657568,0.3090909090909091,0.5576550972366507,1.0,1/5,1.37%,KREMEN2
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),0.6867104237464869,1.1558812320106426,0.34615384615384615,0.5579393451181077,1.0,1/7,6.43%,BIRC3
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.5959299885563751,1.1558774436728592,0.27586206896551724,0.5577477112543888,1.0,7/24,22.35%,RBM24;BOC;SRA1;AKIRIN1;BTG1;ANKRD2;FLOT2
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6576122613488824,1.1558072618736246,0.2978723404255319,0.5576862673123791,1.0,4/15,9.98%,CSPG4;DCN;BGN;UST
prerank,Reactome_2022__NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.5577643963464306,-1.1557992313799907,0.24444444444444444,0.8322102837331917,1.0,5/22,11.55%,HEY2;HEYL;MAML3;HEY1;HES5
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),0.6490945600247906,1.1557404872945782,0.2982456140350877,0.5576411176874068,1.0,5/14,24.45%,IRF7;IFIH1;TLR3;TBK1;DHX9
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.6314420950659853,1.1556146958992664,0.34545454545454546,0.5577909462974484,1.0,4/17,13.49%,PIM1;TBX20;ZFPM2;FGF2
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.599000046088144,1.1554401810472077,0.23809523809523808,0.5580137493161013,1.0,5/28,9.88%,PDGFRA;MYLK3;OBSCN;SYNPO2L;TCAP
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),0.7543155447633112,1.1554222185469518,0.31666666666666665,0.5578548932403262,1.0,2/5,15.08%,ST8SIA3;ST6GALNAC2
prerank,Reactome_2022__RUNX2 Regulates Osteoblast Differentiation R-HSA-8940973,-0.5436803231496423,-1.1550397062302735,0.25,0.8338235300920671,1.0,3/19,9.39%,HEY2;HEY1;YES1
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.4626882689163222,1.1549396263794607,0.140625,0.5589416850492183,1.0,23/202,10.02%,TLCD2;ANK3;A4GALT;EGF;SH3GL2;VAPB;CNTN2;SYT1;DYSF;TGFA;SH3KBP1;SUN3;SYNGR2;DNM1;CLTB;REPS2;SYP;SYNJ2;LDLR;TRIP10;ARPC3;CHMP1A;TF
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),0.65856782462859,1.1549369294384386,0.3114754098360656,0.5587461141307266,1.0,2/9,12.46%,RAB40B;SLC29A4
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.5511669343026325,1.1546757999611594,0.2537313432835821,0.5592845055345658,1.0,5/38,6.62%,RECQL4;SP100;BLM;RPA1;POLD1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6870665104545812,1.1545072239072915,0.35185185185185186,0.559371605341738,1.0,4/12,14.71%,RASGRP1;CD160;IL12A;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),0.6870665104545812,1.1545072239072915,0.35185185185185186,0.559371605341738,1.0,4/12,14.71%,RASGRP1;CD160;IL12A;HLA-E
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.4696488247054259,-1.1544889720443197,0.2727272727272727,0.8346696031147119,1.0,12/52,22.33%,AAAS;RAE1;NUP50;ABCD1;NUP54;JMJD8;SLC25A33;FIS1;NUP85;NUP42;SPHK2;POM121C
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.7238068565769746,1.1542899960637152,0.2909090909090909,0.5596986120329545,1.0,3/7,18.96%,DOCK10;GPR183;LFNG
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.7179316611430243,1.1542306735953762,0.3559322033898305,0.5596326741275944,1.0,1/7,8.31%,BCL2L1
prerank,Reactome_2022__Phospholipid Metabolism R-HSA-1483257,0.4609918200824753,1.1541266595923356,0.2,0.5596720096394348,1.0,40/177,17.43%,MTMR7;LIPH;LPCAT4;ACHE;PLAAT4;MFSD2A;SBF1;SYNJ2;TNFAIP8L1;AGPAT4;PLAAT3;PLEKHA2;PLD2;CHKB;PIP4K2A;VAC14;PITPNM3;INPPL1;PITPNM2;DGAT2L6;INPP5J;DGAT1;PLAAT5;PLEKHA4;PLEKHA8;INPP4A;MTM1;CDS2;BMX;PLB1;PNPLA8;INPP5D;SLC44A3;CPNE7;PLAAT1;PIP5K1C;LPIN3;SH2D3C;INPP5F;PITPNM1
prerank,Reactome_2022__APOBEC3G Mediated Resistance To HIV-1 R-HSA-180689,-0.7737409314687818,-1.154121863325362,0.4411764705882353,0.8349146264348605,1.0,1/6,1.43%,APOBEC3G
prerank,Reactome_2022__Beta-catenin Phosphorylation Cascade R-HSA-196299,0.6286685710643432,1.1539329579159747,0.3114754098360656,0.5599904774742174,1.0,2/14,12.41%,CTNNB1;FRAT2
prerank,Reactome_2022__Sphingolipid De Novo Biosynthesis R-HSA-1660661,0.5752917509581202,1.1538959660556134,0.2903225806451613,0.559904284841012,1.0,7/41,14.23%,SGPP2;VAPB;FA2H;SPNS2;CERS3;SGMS1;ALDH3A2
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.7222152380076844,1.153859142191405,0.3559322033898305,0.5598141093635829,1.0,5/8,6.95%,KCNT2;KCNQ1;KCNE4;KCND3;KCNH2
prerank,Reactome_2022__Transport To Golgi And Subsequent Modification R-HSA-948021,0.47452989188796046,1.1538177036184567,0.13846153846153847,0.5597563292655826,1.0,20/146,17.58%,ST6GAL1;CHST8;ANK3;CTSC;CD55;TGFA;ST8SIA3;MGAT5;GRIA1;ACTR1A;B4GALT5;COPZ2;ANKRD28;MAN1A1;CD59;CTSZ;B4GALT6;SPTB;DYNC1LI2;DCTN1
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),0.6647715687357636,1.15354849862948,0.328125,0.5602318896746462,1.0,1/8,3.70%,ACHE
prerank,Reactome_2022__G1/S DNA Damage Checkpoints R-HSA-69615,0.5212905067713207,1.1535363205112126,0.21212121212121213,0.5600568806532541,1.0,1/60,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.6459595643360535,1.153491912434823,0.32142857142857145,0.559938516289899,1.0,5/17,8.55%,IL1RAPL1;NLGN1;DVL1;PTPRD;PCLO
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.6045390572207543,-1.1534219994570591,0.28888888888888886,0.8361109209702459,1.0,2/17,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.7622589650072996,1.1532207493345987,0.40384615384615385,0.5605224866998179,1.0,2/6,6.72%,LHX6;ROBO2
prerank,Reactome_2022__O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.5540808654951276,1.153052455989384,0.29310344827586204,0.5607389085161061,1.0,7/34,6.28%,ADAMTS4;ADAMTSL2;THBS1;THSD7B;ADAMTS10;SEMA5B;ADAMTS19
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),-0.44338906195532557,-1.1530293671802976,0.1875,0.8363898574957942,1.0,28/83,26.02%,SELENOS;SEL1L2;TMUB2;FBXO27;UBXN8;FOXRED2;DERL2;ERLIN2;USP19;AUP1;RNF5;RNF103-CHMP3;UBE4A;YOD1;POMT2;DNAJB9;TMUB1;DNAJC10;RHBDD2;ATXN3;ERLIN1;VCP;ERLEC1;FAM8A1;DERL1;DNAJB12;UBXN4;DNAJC18
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.5595046957257088,1.1529814848590667,0.23880597014925373,0.5607172253834285,1.0,5/36,14.19%,STAT4;LMNB1;TCP1;TYK2;IL12A
prerank,Reactome_2022__Toll-like Receptor Cascades R-HSA-168898,0.4625279028100561,1.1526856465813897,0.2,0.5613406327937771,1.0,12/131,7.62%,TLR2;CTSS;KCNH8;IRAK2;APP;RPS6KA1;IRF7;NOD1;DNM1;BIRC3;NLRC5;MYD88
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),0.7426011164311362,1.152678043925422,0.2459016393442623,0.561181724644997,1.0,2/10,15.19%,EIF2B2;EIF2B5
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.5979902486483312,1.1526646297580823,0.234375,0.561006811288596,1.0,7/29,14.85%,SEMA3C;SEMA5B;SEMA3D;SEMA3B;RADIL;FN1;SOX10
prerank,Reactome_2022__MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,0.6130835308376625,1.1526566838738133,0.2835820895522388,0.5608279919652238,1.0,2/26,3.26%,KCNH8;RPS6KA1
prerank,Reactome_2022__Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.49454971640871004,-1.15262303506161,0.32142857142857145,0.8366952601714192,1.0,13/68,20.20%,CDC26;FBXO5;PSMD10;ANAPC15;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;CUL1;PSMB4
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.739069043333265,-1.15260204114273,0.32558139534883723,0.8358166224206405,1.0,3/6,5.85%,RAB7B;TNFAIP3;NR1D1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.7440903792207056,1.1522551965130907,0.32075471698113206,0.5616598530004004,1.0,3/5,19.53%,ALPL;SPP1;CDKN2D
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),-0.6308498136828425,-1.1520869714566142,0.3125,0.8366813558981022,1.0,3/9,9.23%,IDO1;ACMSD;TDO2
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.5521995775150461,-1.1518699180369352,0.24324324324324326,0.8364626589888943,1.0,7/28,16.83%,ATRIP;HUS1;BRIP1;ATR;ERCC6;CLSPN;HINFP
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.5677893433724249,1.1516546965563519,0.26153846153846155,0.5629700782845267,1.0,6/34,9.99%,SEMA3C;SEMA5B;SEMA3D;NRG1;SEMA3B;RADIL
prerank,Reactome_2022__Platelet Calcium Homeostasis R-HSA-418360,0.6294944607205892,1.1514346561351863,0.31666666666666665,0.5633660992047362,1.0,9/20,17.94%,TRPC3;ATP2B3;ITPR3;ORAI1;P2RX7;ATP2B4;SLC8A2;SLC8A1;ITPR1
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.619510608839072,-1.151326426581346,0.34210526315789475,0.8371535597273626,1.0,2/11,14.39%,APOE;CLU
prerank,Reactome_2022__FGFR3 Ligand Binding And Activation R-HSA-190239,-0.738622036391599,-1.1512939419851835,0.34146341463414637,0.8362875332432929,1.0,1/6,1.20%,GALNT3
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6170081362093249,1.1512248236567728,0.3125,0.5637095602230144,1.0,2/14,5.09%,CD55;TRIM5
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),0.753593104431584,1.1511042716349997,0.35185185185185186,0.5637914482618733,1.0,3/5,14.07%,SLC7A2;SLC25A29;SLC7A1
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.6717766858139949,-1.1508407226434512,0.3157894736842105,0.8367704780032992,1.0,5/13,20.68%,DMC1;TPRKB;RAD54B;RAD51;MSH3
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),-0.7660615622306511,-1.150768028805948,0.3181818181818182,0.8359966403032056,1.0,1/5,9.13%,MTRES1
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.7703666003083434,1.1506731030703365,0.3695652173913043,0.5645778047965827,1.0,1/5,4.82%,PLSCR1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.7703666003083434,1.1506731030703365,0.3695652173913043,0.5645778047965827,1.0,1/5,4.82%,PLSCR1
prerank,KEGG_2021_Human__T cell receptor signaling pathway,0.487301634043139,1.15055048999108,0.2602739726027397,0.5647316012502424,1.0,18/76,18.97%,RASGRP1;TEC;PAK3;PTPRC;MAP3K14;NFATC2;FYN;PAK4;PAK1;IKBKG;PIK3CD;MAPK11;CD4;VAV2;MAPK9;NCK2;NFATC3;VAV1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.6873873611940454,1.1504811120937724,0.3448275862068966,0.5646524232761408,1.0,3/11,12.89%,KLF2;ASS1;KLF4
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.4670132576929797,1.1504154060670373,0.2631578947368421,0.5646094222940238,1.0,34/138,18.44%,PLK2;PRKCB;TRAF3IP2;NOD1;MAP3K14;TRIM5;BIRC3;TNFRSF1A;CASP10;SHISA5;MYD88;UNC5CL;IKBKE;TERF2IP;APOL3;TNFRSF19;LURAP1;HLA-DRB1;TRIM22;BRD4;TNFRSF10B;FADD;LPAR1;TNIP2;TRIM32;IKBKG;NEK6;CD4;PINK1;TRAF5;TFRC;NDFIP2;FLNA;LITAF
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),-0.78732448964615,-1.1504042215945294,0.3333333333333333,0.8351881523486848,1.0,1/6,0.86%,GMFG
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),-0.78732448964615,-1.1504042215945294,0.3333333333333333,0.8351881523486848,1.0,1/6,0.86%,GMFG
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.567412232551562,1.1502730229399016,0.26229508196721313,0.5647951455702476,1.0,6/27,15.46%,ZFP36;IRS2;MAPT;CDKN1C;CDKN1B;TP53
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.7163517379634339,1.1502416571623801,0.32075471698113206,0.5646839414343314,1.0,1/6,4.48%,ASIC3
prerank,Reactome_2022__Signaling By NTRK3 (TRKC) R-HSA-9034015,0.5981636175140617,1.1502394100897477,0.32075471698113206,0.5645006448786528,1.0,3/15,17.35%,NTRK3;PTPRS;SHC1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.5555264346317381,1.1499488748971407,0.2033898305084746,0.5650950313542136,1.0,6/51,5.54%,CTSC;CTSS;DAB2IP;VLDLR;DENND3;FAP
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.6126023638326915,1.1498711335190501,0.2833333333333333,0.5651040379740176,1.0,10/26,27.47%,SIGLEC1;CLTB;PIP5K1C;INPP5F;FCHO2;CLTC;AP2A2;FCHSD2;GAK;PICALM
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5534599995598833,1.149840883759394,0.2542372881355932,0.5650249228226859,1.0,9/38,15.53%,BOK;SEPTIN4;DAPK2;BCL2L1;BBC3;BCL2;SGMS1;TP53;PINK1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.7104121113036844,1.1496096396516975,0.39344262295081966,0.5654423420366825,1.0,3/11,9.88%,SIX3;GCM2;GLI2
prerank,KEGG_2021_Human__Folate biosynthesis,-0.5714555658373544,-1.1494865452968825,0.2857142857142857,0.8368498231538475,1.0,3/20,10.88%,DHFR2;AKR1C3;MOCS2
prerank,GO_Biological_Process_2021__negative regulation of bone resorption (GO:0045779),-0.7391232254238577,-1.1493670007958772,0.425,0.836284846785188,1.0,1/5,1.79%,TNFAIP3
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Undefined,-0.6333800348264481,-1.149220191436643,0.3469387755102041,0.8357568628764087,1.0,3/8,4.36%,FLT3;CD38;APOE
prerank,Reactome_2022__TNFs Bind Their Physiological Receptors R-HSA-5669034,0.6472239617131672,1.1492088763131503,0.35185185185185186,0.566167664405055,1.0,5/15,18.06%,TNFRSF14;TNFRSF1A;CD70;TNFRSF11B;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.5466166125337851,1.1491356160724322,0.3230769230769231,0.5662203004817746,1.0,7/30,6.95%,KCNJ2;KCNQ1;NOS1AP;KCNMB4;GABBR2;GNG2;KCNH2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.600347244431519,-1.1490591363746083,0.3404255319148936,0.8353815152915207,1.0,2/24,4.46%,NGF;BLOC1S2
prerank,GO_Biological_Process_2021__cellular hyperosmotic response (GO:0071474),0.7584692699887512,1.1489687103409083,0.4074074074074074,0.5664688867003101,1.0,1/5,3.33%,YBX3
prerank,Reactome_2022__Notch-HLH Transcription Pathway R-HSA-350054,0.5631514065141141,1.148851639889262,0.2916666666666667,0.5665653643436963,1.0,10/27,19.74%,MAMLD1;TBL1X;HDAC4;HDAC9;MAML2;NOTCH3;NCOR1;HDAC7;TBL1XR1;NOTCH4
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.7936348539159472,1.1487390427150295,0.3442622950819672,0.5664664421948472,1.0,3/5,20.13%,TCP1;CCT4;WRAP53
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.7936348539159472,1.1487390427150295,0.3442622950819672,0.5664664421948472,1.0,3/5,20.13%,TCP1;CCT4;WRAP53
prerank,CellMarker_Augmented_2021__Endothelial cell:Adipose Tissue,0.7571854418111696,1.1486248066753524,0.3269230769230769,0.5665428498910574,1.0,2/7,4.85%,PTPRC;MCAM
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.6377932270690939,1.1484300759595985,0.2711864406779661,0.5668268323605061,1.0,9/17,17.50%,ERBIN;CLIC4;PARD3;FSCN1;PARD3B;DLG3;PATJ;MTCL1;SCRIB
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.5855578373717306,1.1483954631715272,0.23728813559322035,0.5667314305557664,1.0,3/28,9.84%,BOK;ZNF385B;NDRG1
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.726477598204362,1.148198734105144,0.42857142857142855,0.5670630336277163,1.0,4/8,22.72%,ZDHHC7;SLC2A3;SORT1;SLC27A1
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.7722860467033823,1.148157956707122,0.36363636363636365,0.5669516613493767,1.0,2/6,13.58%,TNFRSF1A;FADD
prerank,Reactome_2022__RNA Polymerase III Transcription Termination R-HSA-73980,-0.5795996847004261,-1.1481520054262677,0.275,0.8373465014211472,1.0,8/21,22.92%,POLR2K;POLR3E;POLR3B;POLR3F;POLR3H;POLR3K;POLR2L;POLR2E
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.590134356288577,1.1480804260091966,0.23214285714285715,0.5669559985772552,1.0,5/24,13.18%,CDKN2A;PML;PRKCD;MAPKAPK5;CDKN1A
prerank,Reactome_2022__Mitochondrial Biogenesis R-HSA-1592230,-0.46641419113950566,-1.1480536407442492,0.21212121212121213,0.8366503170459064,1.0,22/80,17.65%,TFB2M;ATP5PF;NR1D1;ALAS1;ATP5MC1;GLUD1;APOO;ATP5PB;ATP5PD;POLG2;DMAC2L;MICOS10;ATP5MC3;SAMM50;ATP5F1B;ESRRA;TFB1M;ATP5F1A;TMEM11;ATP5MC2;MTERF1;MAPK12
prerank,KEGG_2021_Human__Bile secretion,0.5313743677348687,1.147980145578804,0.2786885245901639,0.566976276700652,1.0,15/48,16.93%,ADCY5;ABCB1;SLCO1A2;ADCY7;ADCY2;ATP1A1;LDLR;SLC9A1;ATP1B1;ATP1B3;SLC51A;SLC27A5;ABCC4;RXRA;ADCY3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.5903750969865236,-1.1477562527215819,0.35,0.8366302196303662,1.0,13/33,24.17%,GTF2H5;POLR2K;GTF2H2;POLR1F;TAF1D;ERCC2;POLR1B;ERCC3;TTF1;POLR2L;POLR2E;GTF2H3;UBTF
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),0.6451312629225935,1.1475945013039544,0.24074074074074073,0.5676261075876706,1.0,5/13,18.06%,CD22;PTPRC;STX4;HLA-E;TNFSF4
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),0.7290189769849369,1.147581569843186,0.40350877192982454,0.5674708793708221,1.0,3/5,15.29%,PML;HIPK2;ETS1
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.5151713039742111,1.1473738730761378,0.24242424242424243,0.5677258895672284,1.0,8/55,13.20%,CDKN2A;PLK2;MAP3K11;CDK6;CDC7;CDKN1B;CDKN1A;CCND1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),0.5008561706223659,1.1471273309805108,0.23333333333333334,0.5681319834059868,1.0,10/69,16.79%,RECQL4;BLM;RPA1;SAMHD1;POLQ;MRE11;ZSWIM7;XRCC1;BRCA1;MEIOB
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),-0.688653887082668,-1.147116408247724,0.325,0.837709315841079,1.0,1/7,1.02%,RGS2
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),0.7295259853173718,1.1470108883256982,0.31746031746031744,0.5681995725559625,1.0,1/8,0.06%,TGFBR2
prerank,KEGG_2021_Human__Epstein-Barr virus infection,0.47129313638419457,1.1469868670716856,0.18461538461538463,0.5680523161466675,1.0,34/151,17.50%,HLA-DRA;TLR2;ICAM1;IRF7;MAP3K14;FAS;CD44;MYD88;CDK6;IKBKE;STAT3;SYK;TYK2;HLA-DRB1;GADD45A;ITGAL;CDKN1B;RELB;BCL2;B2M;CDKN1A;CCND1;FADD;HLA-DMA;IKBKG;PIK3CD;MAPK11;HLA-E;TP53;CDK2;TAB1;TRAF5;MAPK9;MAP2K3
prerank,Reactome_2022__tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.5272986847900205,-1.146873447563739,0.24242424242424243,0.8374666860505754,1.0,10/39,13.97%,ADAT2;TRMT61A;TRMT10A;QTRT2;FTSJ1;EPRS1;URM1;OSGEP;TRMT5;ADAT1
prerank,Reactome_2022__Neurotransmitter Clearance R-HSA-112311,0.730694557198362,1.146736240822268,0.3469387755102041,0.5684618564662355,1.0,1/8,3.70%,ACHE
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.46414253275405054,-1.1466418496199529,0.1891891891891892,0.837056596777709,1.0,7/63,6.01%,ABCD2;CEL;MCAT;PHYH;NUDT7;ABHD1;ABCD1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),0.5095919418715213,1.1465806819454278,0.26785714285714285,0.5686326138434203,1.0,11/66,9.67%,HPN;OTOS;COL11A2;CDH23;KCNQ1;EPS8L2;LHFPL3;CLRN1;CDC14A;TBL1X;EML2
prerank,CellMarker_Augmented_2021__Hepatocyte:Fetal Liver,0.49536694513639795,1.1464678250110658,0.19117647058823528,0.5687515964142013,1.0,24/74,17.38%,MET;P4HA2;EPHA2;EPS8L2;BAIAP2L1;EPB41L4B;LAMB1;ITGA2;PTPN21;RHBDF1;RHOD;MYO1B;LAMA5;YAP1;TEAD1;CD276;CCND1;PLOD2;NTN4;BCAR1;SLC44A3;MAGI1;FAM114A1;WWTR1
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.7412518638649946,1.1462807628077738,0.36363636363636365,0.5690889744667949,1.0,2/5,6.22%,ABCB1;GRM5
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),0.6968790870105694,1.1462731054954074,0.3275862068965517,0.5689257818058766,1.0,3/11,13.63%,ARPC5L;ARPC3;WASHC1
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.6564696123635113,-1.1462102227892867,0.3333333333333333,0.8362569250354036,1.0,2/11,5.85%,PPP1R3C;NR1D1
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.6564696123635113,-1.1462102227892867,0.3333333333333333,0.8362569250354036,1.0,2/11,5.85%,PPP1R3C;NR1D1
prerank,Reactome_2022__Arachidonic Acid Metabolism R-HSA-2142753,0.5663822799905598,1.146190506895922,0.23809523809523808,0.5689135452998366,1.0,4/36,4.87%,GGT5;AWAT1;FA2H;ALOX12
prerank,Reactome_2022__KSRP (KHSRP) Binds And Destabilizes mRNA R-HSA-450604,-0.6146048301258333,-1.1461859005157133,0.2558139534883721,0.8353649761316418,1.0,3/16,9.60%,EXOSC8;EXOSC4;EXOSC5
prerank,Reactome_2022__MyD88 Deficiency (TLR2/4) R-HSA-5602498,0.6921875780133953,1.1460728701303358,0.38333333333333336,0.5689806817709032,1.0,2/9,7.62%,TLR2;MYD88
prerank,Reactome_2022__SUMOylation Of Immune Response Proteins R-HSA-4755510,0.668727877239747,1.1460414578666167,0.27450980392156865,0.568889097414052,1.0,3/10,21.11%,IKBKE;IKBKG;UBE2I
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.6673838508301823,1.1456605200791923,0.3392857142857143,0.5696898165437823,1.0,2/11,3.03%,HTR2C;KCNC2
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.6663843408797105,1.1456076436495908,0.3076923076923077,0.5696337297350991,1.0,5/10,22.39%,GAS6;IL12A;HLA-E;ZBTB1;HLA-F
prerank,CellMarker_Augmented_2021__Cardiac Progenitor cell:Heart,0.773034750407568,1.1455353402577668,0.3090909090909091,0.5695618300631662,1.0,1/5,8.69%,KITLG
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.5778181855497057,1.1452837820396993,0.30303030303030304,0.5700604281867849,1.0,6/23,6.72%,SLIT2;EFNA1;SLIT3;TNFRSF1A;TBX20;ROBO2
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.5457169040078281,1.145225425832016,0.2835820895522388,0.5700003121499252,1.0,13/38,16.70%,B3GNT2;PXYLP1;B3GALT2;AGRN;UGDH;B3GALNT1;HS6ST1;HS3ST3B1;HS3ST3A1;B4GALT7;NDST1;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.6472356469982078,1.145160138299415,0.32142857142857145,0.5700392057522288,1.0,4/16,11.71%,IGF1;EPHA2;GAS6;CCL2
prerank,Reactome_2022__Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.5269867999041857,-1.1446350822824456,0.2571428571428571,0.8394308406358512,1.0,2/34,1.41%,CDC26;CCNE1
prerank,CellMarker_Augmented_2021__Mast cell:Kidney,0.4999359728917226,1.144633178388955,0.25806451612903225,0.5711940571953454,1.0,17/72,13.02%,VWC2;GMPR;TSPYL2;ASIC4;SVOPL;PGAP4;MAOB;NECAB2;LMNA;BEX1;VWA5A;BACE2;PLAAT5;ARHGAP18;TPSD1;PAK1;LTC4S
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),0.7574869221329639,1.144631539035359,0.36666666666666664,0.5710030664589839,1.0,4/7,21.96%,MYO1C;GAB1;PIK3CD;HSPB1
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.6299786217821071,-1.1445180308055478,0.2972972972972973,0.8388274232324693,1.0,2/13,7.89%,AR;NCOA4
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),-0.6524768211313708,-1.1445172377644053,0.28205128205128205,0.8378565581592836,1.0,4/15,5.09%,DCLRE1B;GINS3;RFC3;POLD3
prerank,Reactome_2022__CREB1 Phosphorylation Thru Activation Of Adenylate Cyclase R-HSA-442720,0.6983415010630885,1.1443936620527722,0.3559322033898305,0.5714212284788391,1.0,6/11,22.59%,PRKAR1B;PRKAR1A;PRKCA;PRKX;ADCY8;PRKAR2B
prerank,Reactome_2022__Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.5869455736056941,-1.1442333447976472,0.2682926829268293,0.8377826674340452,1.0,9/22,24.01%,POLR2K;POLR2C;GTF2F1;POLR2D;GTF2F2;POLR2L;POLR2G;POLR2E;CTDP1
prerank,CellMarker_Augmented_2021__Goblet cell:Small Intestine,0.5966698228379432,1.1441980574341621,0.288135593220339,0.5717877118085289,1.0,6/23,9.78%,MYO1F;PLEKHG6;BCAS1;SYP;NEURL1;RNASE1
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),-0.7882508707325259,-1.1441620110648634,0.32653061224489793,0.8370605793819791,1.0,2/5,8.25%,CTSH;MICA
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),0.7461589090883484,1.14406603485977,0.40384615384615385,0.5719365855413109,1.0,1/5,5.94%,MFSD2A
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.7422184484704732,1.1439814572490017,0.37254901960784315,0.5717285180841,1.0,3/5,15.01%,ZFP36;PDE1B;CD4
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.7422184484704732,1.1439814572490017,0.37254901960784315,0.5717285180841,1.0,3/5,15.01%,ZFP36;PDE1B;CD4
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),-0.6609166047526955,-1.1436548283025387,0.2608695652173913,0.8378629395514869,1.0,4/9,26.04%,VPS35;DNM1L;FIS1;CCAR2
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.5867831512616135,1.1436371833555679,0.2727272727272727,0.5723628584824795,1.0,4/19,10.80%,PDGFRA;SERPINE1;PDGFA;TFPI
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),-0.7321862461296351,-1.1434663342450664,0.4117647058823529,0.8375095675426284,1.0,1/5,5.77%,MRPL18
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),0.618026567540071,1.1432297546662944,0.30158730158730157,0.5733795882869942,1.0,4/15,16.03%,TRPC3;ABCC9;P2RY12;P2RX7
prerank,Reactome_2022__Cargo Concentration In ER R-HSA-5694530,0.571115758310779,1.143214432871217,0.2830188679245283,0.5732120453357702,1.0,5/27,16.00%,CTSC;TGFA;GRIA1;CD59;CTSZ
prerank,Reactome_2022__NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,0.5982935601187249,1.14304345181453,0.3275862068965517,0.5735021118591906,1.0,3/21,14.79%,EGF;NEURL1;NOTCH3
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),0.647987276132034,1.1427608502919369,0.40425531914893614,0.5739969954741269,1.0,3/12,20.62%,CDK9;HPF1;MLLT3
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),0.6872455473767077,1.1422822165013138,0.3050847457627119,0.5751142591565207,1.0,2/9,9.25%,PLAAT4;PRKCH
prerank,Reactome_2022__Gap Junction Degradation R-HSA-190873,0.6873480418597031,1.1422317788091272,0.3333333333333333,0.5750803111370553,1.0,2/9,6.30%,DNM1;CLTB
prerank,Reactome_2022__HS-GAG Biosynthesis R-HSA-2022928,0.5702688062717814,1.142097170503308,0.3076923076923077,0.5751999902608509,1.0,9/26,16.70%,NDST4;AGRN;HS6ST1;HS3ST4;HS3ST3B1;HS3ST3A1;NDST1;HS2ST1;HS6ST2
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),0.7152963334058637,1.1420435258552633,0.39344262295081966,0.5751227266736954,1.0,3/7,19.17%,DNM1;MX1;DNM2
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),0.7279616443041841,1.1420185950608168,0.4307692307692308,0.5749667977330789,1.0,2/6,14.58%,FGF2;AKIRIN1
prerank,Reactome_2022__Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.5318115888175552,-1.1419046987204284,0.29411764705882354,0.841164758948894,1.0,2/32,1.41%,CDC26;CCNE1
prerank,Reactome_2022__Gain-of-function MRAS Complexes Activate RAF Signaling R-HSA-9726842,0.686861632921399,1.1417390173841415,0.32,0.5754955872574989,1.0,2/7,9.59%,MRAS;PPP1CB
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.7076284042182694,-1.1415753408556004,0.23255813953488372,0.8412270334826433,1.0,2/7,8.43%,DCLRE1B;TFIP11
prerank,Reactome_2022__Transport Of Small Molecules R-HSA-382551,0.4159529612399494,1.141469520781185,0.10126582278481013,0.5760672833367765,1.0,74/537,12.82%,SLC6A15;SLC32A1;ABCA6;GNG3;SLC4A10;SLC15A3;SLC7A2;SLC43A1;ABCA8;STEAP3;TRPC3;ADCY5;ABCB1;SLC39A14;LSR;ADD2;ABCA5;AMN;ATP8B4;SLC28A3;ATP2B3;CP;VLDLR;EMB;ASIC3;TUSC3;TRPM4;SOAT1;SLC16A10;PRKAR1B;SLC5A4;SLC9A9;ASIC4;GNG2;APOD;SLCO1A2;ABCA10;ATP9A;ABCC9;ADCY7;RYR2;ADCY2;SLC20A2;SLC7A7;SLC17A5;BEST3;LDLR;SLC9A1;SLC4A9;ANO9;TTYH3;ABCA9;NIPAL2;TSC22D3;ATP1B1;ATP10A;CLCN4;TF;SLC25A29;ATP1B3;NIPAL3;MCOLN2;HMOX2;SLCO2A1;ABCA2;ABCB9;SLC9C2;TPCN2;CAMK2B;MCUB;SLC29A4;FXYD7;ATP8A2;STOM
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.5900213226151896,1.1414689534607938,0.34375,0.5758718738105428,1.0,3/19,4.64%,SHISA7;NLGN1;SHANK3
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),0.6620871404379455,1.1414130419405422,0.37735849056603776,0.5757827217308199,1.0,4/11,18.31%,CDK9;AKAP8;MTHFR;HPF1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6813595993126438,1.1412600886691333,0.3275862068965517,0.5759293833065241,1.0,3/8,12.03%,HECW2;PRKCE;HECW1
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.43589489249943225,1.141075110423689,0.17567567567567569,0.5762016379238533,1.0,45/246,15.99%,BOK;MLLT11;EPHA7;SLIT2;SEPTIN4;MAP3K11;DAB2IP;FOXO1;KLF11;ARHGEF17;SOX4;FAS;BCL6;ARHGEF3;FAP;TFPT;FOXO3;SNCA;PAWR;CYP1B1;OBSCN;DAPK2;MCF2;CTNNB1;KALRN;NEURL1;ARHGEF7;PNMA2;TGFB2;TRIO;PXT1;PLEKHG2;BARD1;GADD45A;TPD52L1;TNFRSF10B;FADD;KCNMA1;BIN1;RARG;MAP3K5;STK3;TP53;NGEF;VAV2
prerank,Reactome_2022__Circadian Clock R-HSA-400253,0.5271971582498708,1.141024201408671,0.2857142857142857,0.5760967585045309,1.0,16/63,19.96%,SERPINE1;NFIL3;TBL1X;PPP1CB;NAMPT;NPAS2;PER1;MEF2D;RXRA;RORA;NCOR1;SKP1;TBL1XR1;CRTC3;HIF1A;RPS27A
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.7263239959967268,-1.1408574541148662,0.32608695652173914,0.8425871684544561,1.0,3/7,18.76%,SLC8B1;JAM2;MIA3
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.7385355719679603,1.1408374293401322,0.28846153846153844,0.5764080243349062,1.0,1/5,12.17%,ARF6
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),0.7643104339195128,1.140803404068804,0.29310344827586204,0.5762874504585103,1.0,1/6,2.72%,TIMP2
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.5498988334694842,1.1403844781142645,0.2676056338028169,0.5771672139966629,1.0,18/55,17.10%,SLC24A2;KCNJ2;SLC39A14;TRPM4;SLC9A9;ABCC9;KCNH2;ATP1A1;SLC9A1;ATP1B1;ATP1B3;SLC9C2;SLC12A5;SLC24A1;ATP2B4;SLC8A2;SLC8A1;SLC9A5
prerank,Reactome_2022__Defective B3GALTL Causes PpS R-HSA-5083635,0.554085801872148,1.1403355757004265,0.3157894736842105,0.577077834827756,1.0,7/33,6.28%,ADAMTS4;ADAMTSL2;THBS1;THSD7B;ADAMTS10;SEMA5B;ADAMTS19
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),0.7775616254589669,1.1401798823227878,0.3275862068965517,0.5772472307469868,1.0,2/5,16.14%,NOS1AP;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.611959840535213,-1.1398770094652526,0.34146341463414637,0.8447273136545055,1.0,3/13,8.80%,HEY2;ZNF593;HEY1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.5693383600006805,-1.139817283229454,0.28205128205128205,0.8439422202949454,1.0,3/24,6.17%,TNFAIP3;TRIM21;MUL1
prerank,Reactome_2022__Defective CHST3 Causes SEDCJD R-HSA-3595172,0.6988114514680586,1.1394304437025395,0.3488372093023256,0.5789251706404094,1.0,2/8,1.48%,CSPG4;DCN
prerank,Reactome_2022__Caspase Activation Via Dependence Receptors In Absence Of Ligand R-HSA-418889,0.6914452354936356,1.1392681221942484,0.35185185185185186,0.5791330004457189,1.0,2/10,7.68%,DCC;DAPK2
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.6956498894023454,-1.1392548658547115,0.38181818181818183,0.845103586319228,1.0,2/8,5.26%,TMEM100;ASB4
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),0.7140502242362567,1.1392080356091143,0.3333333333333333,0.5790822374007258,1.0,2/8,6.02%,GRIP1;DVL1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.6231799067713025,1.1392043798560079,0.25,0.5788984114505625,1.0,4/26,6.79%,IGF1;APP;MFSD2A;GHR
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.6598751888979255,1.1390459095007226,0.3584905660377358,0.5791647393195493,1.0,3/10,11.24%,SCX;TENM4;PHLDB2
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.688681582034715,1.138855394050261,0.37735849056603776,0.5794543593053758,1.0,6/8,27.56%,OGG1;NEIL2;NEIL1;TDG;NTHL1;UNG
prerank,Reactome_2022__Formation Of Annular Gap Junctions R-HSA-196025,0.6930356935962607,1.138795929630156,0.2903225806451613,0.5794113776681533,1.0,2/8,6.30%,DNM1;CLTB
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.5031119007571929,1.1387939582831645,0.2602739726027397,0.5792198700195826,1.0,9/78,6.91%,TLR2;IL15;THBS1;SERPINE1;APP;NLRP12;PLSCR1;TNFRSF1A;SNCA
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.6599713274517697,1.1387740760165348,0.3492063492063492,0.5790871118686971,1.0,7/12,27.52%,APLNR;AKAP8;DYRK1A;AKAP8L;CTBP1;NNMT;BRMS1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5789145357371696,1.1383324561171584,0.24615384615384617,0.5799350266635204,1.0,2/26,1.68%,TLR2;THBS1
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),-0.7719808581777214,-1.1381181118958643,0.2972972972972973,0.847771157714884,1.0,3/6,19.57%,PLA2G4C;CHPT1;PLA2G4A
prerank,Reactome_2022__CS/DS Degradation R-HSA-2024101,0.6949270404807577,1.1379986082706104,0.3673469387755102,0.5806456814120011,1.0,2/10,1.48%,CSPG4;DCN
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),0.6587001934989762,1.1378974693345658,0.3181818181818182,0.5806804524117595,1.0,4/12,9.98%,CSPG4;DCN;BGN;UST
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.5895006103564749,1.1378103930261179,0.375,0.5806722696276074,1.0,9/18,31.24%,SNCA;PXK;CAV3;VIP;HRH3;WNK1;NEDD4;NOS1;PLN
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.5681985678183954,1.1377526410510599,0.22388059701492538,0.5805938663021438,1.0,12/31,23.59%,THBS1;SERPINE1;GAS6;IL12A;AKIRIN1;ADAM17;IL6R;VEGFD;ANO6;CSF1;RARRES2;CXCL12
prerank,CellMarker_Augmented_2021__Exhausted CD4+ T cell:Liver,0.48868977286512877,1.137632798529437,0.265625,0.5807027221927406,1.0,30/91,22.53%,CDKN2A;ITM2A;MAP1LC3A;SLC9A9;ITGA2;LASP1;ST8SIA1;ADAM19;RAB11FIP1;WSB2;PHEX;RNF19A;PRKAR1A;OGG1;ZEB1;SARDH;SRGN;NDFIP2;IFI35;TRPS1;NMI;SYNJ1;FUT8;CAPZB;ARHGAP9;MAF;BBLN;PTPN11;GNG4;AHI1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.47020613950883144,-1.1376242458403938,0.28125,0.8484924158028342,1.0,5/40,14.09%,AAAS;RAE1;NUP50;NUP54;JMJD8
prerank,GO_Biological_Process_2021__regulation of antifungal innate immune response (GO:1905034),-0.765260773928639,-1.13752044520768,0.41304347826086957,0.8478190839265207,1.0,1/5,7.44%,FAM3A
prerank,Reactome_2022__Acyl Chain Remodelling Of PS R-HSA-1482801,0.6671958955848255,1.1374793528575504,0.35,0.5808271001441653,1.0,2/11,8.61%,LPCAT4;PLAAT3
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.6859491628869983,-1.1373895766254063,0.36585365853658536,0.8472596315641822,1.0,1/10,4.81%,GALT
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5187423480202066,1.1372555143994894,0.30158730158730157,0.581150167546345,1.0,16/54,23.89%,FOXO1;MAP1LC3A;FAM107A;MFSD2A;KLF10;PDK4;TFEB;STK24;ELAPOR1;RRAGD;KCNB1;WDR45;ULK1;CDKN2B;ATG7;EIF4G1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.5698858995826372,1.1370770099269005,0.28846153846153844,0.5814184709384455,1.0,4/25,8.57%,SULF1;PTPRC;NOTUM;SH3PXD2B
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.48439423210129867,1.1369466603532576,0.2318840579710145,0.5815152187553975,1.0,29/122,10.66%,C3;BOK;AMH;FAM20C;CD55;SHC2;DAB2IP;ARHGEF17;FAS;SEMA5B;PADI2;PTPN21;TNS1;SEMA3B;RHBDF1;CDC42EP1;MAOB;SCX;C1R;MATN2;LAMA5;KITLG;BGN;ARHGEF10L;YAP1;RASL12;TF;PXDC1;SLCO2A1
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),-0.6224322045662573,-1.1369072149058201,0.25,0.8478926884864155,1.0,6/14,16.85%,PYGM;MGAM;AGL;PHKG1;GAA;PGM2
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),-0.7707848621437305,-1.1368862017825694,0.3333333333333333,0.8469722857589036,1.0,2/5,7.44%,BCL10;FAM3A
prerank,Reactome_2022__MAPK6/MAPK4 Signaling R-HSA-5687128,0.4942322654377329,1.1367826549714324,0.2876712328767123,0.5816936668401154,1.0,8/76,12.75%,CDC42EP3;FOXO1;FOXO3;CDC14A;KALRN;ARHGEF7;RNASE1;MAPKAPK5
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.5726691976696442,-1.1366502767378188,0.3,0.8466740761717181,1.0,6/18,14.87%,PPWD1;PPIC;PPIH;PPIL3;PPIL1;PPIE
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex R-HSA-937042,0.6684375974901101,1.1364667571154483,0.32608695652173914,0.5823974524189127,1.0,4/10,20.32%,IRAK2;TAB1;RPS27A;TAB2
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),0.765607495278767,1.1361450508122304,0.34,0.5830229460996657,1.0,3/6,10.40%,CLDN16;SLC4A11;LETM2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),-0.649731924247512,-1.1361248230765326,0.391304347826087,0.8472884381612026,1.0,3/6,19.74%,STXBP4;CDH3;MDK
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.6556720235090601,1.136100737792614,0.32786885245901637,0.5829712183953591,1.0,7/10,31.31%,CACNA1C;ORAI1;CACNA1D;AKAP5;MAPK3;NOS1;NF1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.5863141379861906,1.1360150440661163,0.25,0.5829817391479134,1.0,2/26,3.62%,ANK3;AMN
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),0.7242855123750537,1.135878805012612,0.34615384615384615,0.5832254761774108,1.0,4/7,22.78%,SNCA;ABCG1;BMP6;PTH1R
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.4394329379216911,1.1358745974351772,0.13157894736842105,0.5830377312639461,1.0,32/207,13.49%,C3;GPNMB;EPHA7;SH3GL2;ATF3;RASGRP1;SLIT2;APP;DAB2IP;EFNA1;TSPYL2;FYN;FAS;NTRK3;GRM5;PID1;PML;LIMCH1;PDGFA;NPTN;LIMK2;NIBAN1;WDFY2;TERF2IP;GAS6;HLA-DRB1;BRD4;FN1;PAK1;AKAP8;CCND1;FGF2
prerank,CellMarker_Augmented_2021__Keratinocyte Progenitor cell:Skin,0.5014288032659956,1.1358170793004847,0.25862068965517243,0.583005490196346,1.0,18/63,10.66%,ECM2;C3;DCN;ABCA8;PTPRB;ASPN;MYH11;APOD;IGFBP7;CFH;APLNR;RAMP3;C1R;EMP1;ADGRF5;RNASE1;OMD;SLCO2A1
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),0.6918577536763206,1.1357957316918068,0.32608695652173914,0.5828567762618984,1.0,1/5,9.35%,PPARG
prerank,Reactome_2022__CLEC7A (Dectin-1) Induces NFAT Activation R-HSA-5607763,0.6933370627101153,1.1357256970406893,0.3392857142857143,0.5828246173902585,1.0,7/10,25.85%,NFATC2;ITPR3;ITPR1;NFATC3;AHCYL1;PPP3CB;PPP3CA
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.7381793551924863,1.135467378094704,0.37735849056603776,0.5833473985482563,1.0,3/6,9.37%,KCNK10;KCNK1;KCNK12
prerank,Reactome_2022__Cell Recruitment (Pro-Inflammatory Response) R-HSA-9664424,0.6228385667115351,1.1354292982921284,0.36065573770491804,0.5832258742493651,1.0,1/17,0.57%,C3
prerank,Reactome_2022__Translesion Synthesis By POLH R-HSA-110320,-0.5597038355639797,-1.135411302624211,0.24324324324324326,0.8486661895134635,1.0,7/19,25.53%,RFC3;POLR1B;SLC19A1;UBB;RCHY1;VCP;SPRTN
prerank,CellMarker_Augmented_2021__Enterocyte Progenitor cell:Small Intestine,-0.4737258433181497,-1.1353027000315057,0.29411764705882354,0.8480065761971939,1.0,10/76,6.81%,G0S2;OSGIN1;GOLT1A;PCYOX1L;SLC46A3;HDDC3;PRSS3;RGN;CHCHD10;MST1
prerank,PanglaoDB_Augmented_2021__Microglia,0.5375761100157925,1.1352990996841972,0.2698412698412698,0.5833642540741066,1.0,11/59,4.31%,HLA-DRA;P2RY6;CTSS;P2RY13;MYO1F;PLEK;SLA;GPR34;COLEC12;SIGLEC1;PTPRC
prerank,Reactome_2022__Loss Of MECP2 Binding Ability To NCoR/SMRT Complex R-HSA-9022537,0.6985100936943527,1.1351990597143238,0.3333333333333333,0.583413378262817,1.0,6/7,27.78%,TBL1X;GPS2;NCOR1;TBL1XR1;NCOR2;HDAC3
prerank,Reactome_2022__NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.49194540193056846,-1.13519575575019,0.20512820512820512,0.8474084689037703,1.0,6/32,22.33%,AAAS;NUP50;NUP54;NUP85;NUP42;POM121C
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),-0.6254700604865046,-1.1351691168867513,0.26666666666666666,0.8465119735704547,1.0,2/9,3.47%,EXOSC8;ERI2
prerank,Reactome_2022__Biotin Transport And Metabolism R-HSA-196780,-0.6595596441370376,-1.134878531920415,0.3404255319148936,0.846567026140624,1.0,2/9,17.60%,PDZD11;SLC5A6
prerank,Reactome_2022__Digestion R-HSA-8935690,-0.6862240069766694,-1.1348759588682273,0.32608695652173914,0.8456222295544917,1.0,3/8,4.98%,CEL;PMEL;MGAM
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.5836811297778863,1.1348335403947436,0.328125,0.584039898138703,1.0,8/27,18.63%,SLIT2;SHANK3;SHANK1;SSH2;CYRIB;PRKCD;PFN2;CAV3
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",-0.5372314128323901,-1.1346940661870442,0.34285714285714286,0.8453282221415491,1.0,2/27,3.49%,DNMT3B;SMYD5
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.7586642449126896,1.1346781218894315,0.33962264150943394,0.5842011115311491,1.0,2/6,3.66%,DUSP1;DUSP10
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.7465012038262022,1.134471324885701,0.42,0.5846216927652779,1.0,1/5,10.90%,ABCA2
prerank,Reactome_2022__Metabolism Of Angiotensinogen To Angiotensins R-HSA-2022377,0.7557933105903876,1.134414803469538,0.3148148148148148,0.5845812873856746,1.0,3/7,16.00%,ENPEP;AOPEP;CTSZ
prerank,Reactome_2022__Regulation Of TLR By Endogenous Ligand R-HSA-5686938,0.681361334713281,1.134394392213091,0.3389830508474576,0.5844170631151774,1.0,1/9,0.81%,TLR2
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),0.752841464817153,1.1336367591497367,0.36363636363636365,0.5859978186488607,1.0,3/6,23.85%,PLSCR1;IL6R;APOL2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.43164670542771,1.133625510542581,0.1794871794871795,0.585837098921885,1.0,31/254,11.07%,LEF1;HPN;ANK3;TLR2;IGF1;KLF2;RIMS2;EGF;TESC;AMH;ACTA2;APP;NOS1AP;EPB41L4B;PLSCR1;NTRK3;PID1;ECE1;SNCA;SCX;VSTM2A;RAMP3;MYD88;ZNF804A;SMAD3;YAP1;ADAM19;STAT3;SMAD1;ITGB8;GAS6
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4608531732203568,-1.1335470342476826,0.34285714285714286,0.8480869893975712,1.0,1/38,0.09%,NGF
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.5540951709188178,1.1333440968871555,0.3333333333333333,0.5863182939988862,1.0,8/35,16.86%,CLDN16;PARD3;POF1B;CLDN18;CTNNA1;CLDN20;PATJ;MICALL2
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),0.7398046742549008,1.1333426541661988,0.37037037037037035,0.5861266544209126,1.0,2/5,12.46%,SNCA;SLC29A4
prerank,Reactome_2022__Synthesis Of Ketone Bodies R-HSA-77111,0.717438356564625,1.1332524699511393,0.39344262295081966,0.5862017401947418,1.0,2/7,10.34%,SOAT1;HMGCLL1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.6091502220104352,-1.133233311161703,0.3157894736842105,0.8481996383509935,1.0,6/16,19.57%,CES2;AKR1C3;PTGIS;PTGR1;GSTP1;PLA2G4A
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.6110903066061246,1.1331413908495496,0.3275862068965517,0.586272913482332,1.0,2/16,4.92%,NOS1AP;FYN
prerank,Reactome_2022__Glucuronidation R-HSA-156588,0.801691490543343,1.1329802250382677,0.26785714285714285,0.5864560129669389,1.0,1/5,7.32%,UGDH
prerank,KEGG_2021_Human__B cell receptor signaling pathway,0.5108641063936931,1.1327965420656079,0.37681159420289856,0.5868667230345378,1.0,16/56,23.21%,CD22;PRKCB;NFATC2;SYK;INPPL1;IKBKG;PIK3CD;INPP5D;VAV2;NFATC3;VAV1;AKT3;PPP3CC;CARD11;FOS;PPP3CB
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),0.6912526940434435,1.1327856961581837,0.3064516129032258,0.5867330986908159,1.0,4/9,10.46%,MYH9;PIR;PPARG;PDE1B
prerank,Reactome_2022__Neutrophil Degranulation R-HSA-6798695,-0.39176939740343725,-1.1327172960759777,0.14285714285714285,0.8487288455187619,1.0,34/329,10.60%,ACP3;SLC2A5;FTL;GMFG;EPX;VAMP8;CST3;CSTB;FTH1;CHRNB4;CTSH;CHAMP1;TMED7-TICAM2;NPC2;PRSS3;CREG1;FLG2;MGAM;AGL;RAP2C;CR1;CKAP4;CAP1;HSPA1A;ABCA13;DDOST;FUCA2;JUP;AGPAT2;EEF1A1;DNASE1L1;ADA2;APRT;NCSTN
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),0.6458930448462052,1.1324486419194824,0.36363636363636365,0.587293878069802,1.0,5/13,15.68%,SLITRK1;PTPRD;LRRC4;LRFN5;PTPRS
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),0.7396355075928521,1.1324174940776222,0.38181818181818183,0.5871717685938843,1.0,3/5,9.88%,PROX1;MYH11;TCAP
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.6543090005068705,-1.1322968808232192,0.3469387755102041,0.8490954279275339,1.0,4/10,21.95%,NCL;DDX11;NOL11;PWP1
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),0.7077783925609903,1.1319703027652652,0.42,0.5881020840348258,1.0,1/6,0.90%,IGF1
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),0.6319638389719036,1.1317082853466978,0.3,0.5885693660350815,1.0,7/11,28.20%,MFSD2A;MYO9A;ERMN;SEMA4D;FAM110C;MOV10;MACF1
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),-0.5670891917702512,-1.1316349244250057,0.3191489361702128,0.8503778200252783,1.0,7/19,15.37%,ALAS1;HMBS;ABCB10;SLC25A38;FECH;TSPO;SUCLA2
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),0.7059151002951223,1.131633276541959,0.3469387755102041,0.5885509631830157,1.0,2/8,11.17%,HDAC4;HDAC9
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.7136272978892633,1.1314836400107589,0.3584905660377358,0.5887867317538698,1.0,1/5,2.98%,SLC39A14
prerank,Reactome_2022__Diseases Of Metabolism R-HSA-5668914,0.43021038453669846,1.131379044457092,0.18840579710144928,0.5888298628222551,1.0,26/186,9.87%,CSPG4;PAPSS2;ADAMTS4;ADAMTSL2;DCN;THBS1;OGN;CSF2RA;THSD7B;SFTPD;ADA;AMN;ADAMTS10;EGFL7;GALNT12;SEMA5B;CHST6;ADAMTS19;AGRN;ALDOB;CYP1B1;GALK1;CYP21A2;BGN;CYP4F22;OMD
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.5067683676195058,1.131374178335211,0.25,0.5886497615393205,1.0,25/93,12.79%,GRIK1;RIMS2;NPTX2;NLGN1;GRIK2;GRID2;SYT1;RELN;CLSTN2;DLGAP3;APP;RIMS3;BAIAP3;KCNMB4;CPLX2;GRM5;NPTX1;GRM6;CPLX1;HOMER1;LRRC4;OPHN1;KCTD13;PXK;DLGAP1
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.6457685155227382,1.1312948663617601,0.3389830508474576,0.5885774975590508,1.0,3/10,8.52%,IL1RAPL1;NLGN1;PTPRD
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.7036156025932966,1.131167725992568,0.24528301886792453,0.5886591129796419,1.0,2/8,18.14%,ACOT4;CRAT
prerank,Reactome_2022__Response To Metal Ions R-HSA-5660526,-0.6292626228168529,-1.1311662374757263,0.36585365853658536,0.8507841299747786,1.0,4/10,7.01%,MT1E;MT1A;MT1G;MT1F
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),0.7489431306228845,1.1310926453930117,0.34545454545454546,0.58866762855801,1.0,1/7,2.21%,BLM
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6492304273492369,1.1308410932186903,0.36507936507936506,0.5890412459056579,1.0,5/12,6.95%,SCN1B;KCNQ1;KCNE4;NOS1AP;KCNH2
prerank,Reactome_2022__Azathioprine ADME R-HSA-9748787,0.5893919940758195,1.1307071284956964,0.35714285714285715,0.5892148335493619,1.0,6/16,18.97%,SLC28A3;RNASE1;ABCC4;VAV2;SLC29A1;VAV1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5653472006759338,1.1306162403701199,0.2542372881355932,0.5893268551328337,1.0,9/28,17.50%,ERBIN;PARD3;OPHN1;PARD3B;DLG3;MYO9A;CAMSAP3;MTCL1;SCRIB
prerank,Reactome_2022__Defective B3GAT3 Causes JDSSDHD R-HSA-3560801,0.5677517776696392,1.130592264918282,0.3333333333333333,0.5892045980736512,1.0,4/19,8.95%,CSPG4;DCN;AGRN;BGN
prerank,Reactome_2022__GLI Proteins Bind Promoters Of Hh Responsive Genes To Promote Transcription R-HSA-5635851,0.7045957564104961,1.1305812388468044,0.41509433962264153,0.5890325260868503,1.0,5/7,28.73%,BOC;GLI2;GLI1;PTCH1;HHIP
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.7051352809894147,1.1304915672519438,0.3898305084745763,0.5890715961473995,1.0,1/7,1.10%,RFTN1
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.7448360075766463,1.130243531330097,0.4230769230769231,0.5895900910315288,1.0,1/5,0.74%,FLRT3
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.44646191747752134,1.130151199044568,0.2222222222222222,0.5896174477926956,1.0,44/178,18.44%,PLK2;PRKCB;TRAF3IP2;DAB2IP;NOD1;NLRP12;CARD19;MAP3K14;TRIM5;BIRC3;TNFRSF1A;CASP10;SHISA5;MYD88;UNC5CL;NLRC3;IKBKE;TERF2IP;APOL3;TNFRSF19;MAPKBP1;LURAP1;HLA-DRB1;TRIM22;BRD4;PER1;OPTN;TNFRSF10B;FADD;LPAR1;TNIP2;TRIM32;IKBKG;NEK6;CD4;OTUD7B;PINK1;RORA;TRAF5;WNT5A;TFRC;NDFIP2;FLNA;LITAF
prerank,Reactome_2022__Negative Regulation Of TCF-dependent Signaling By WNT Ligand Antagonists R-HSA-3772470,0.7011920104481363,1.129931390387057,0.32,0.5900319263963615,1.0,1/9,1.37%,KREMEN2
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),0.7171560130542898,1.1294684783757154,0.36666666666666664,0.590986414981603,1.0,1/6,9.20%,SEC14L1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.630751446713596,1.1294039014398325,0.29508196721311475,0.5909711472912006,1.0,5/14,6.95%,SCN1B;KCNQ1;KCNE4;NOS1AP;KCNH2
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6105859996020258,1.129172714467348,0.3548387096774194,0.591304353239405,1.0,1/18,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6530282607522699,1.1291107564354614,0.34285714285714286,0.5912468825770439,1.0,6/13,20.13%,ANXA1;HDAC9;FGF2;HDAC7;SRPX2;AKT3
prerank,Reactome_2022__RAF Activation R-HSA-5673000,0.5578488380428276,1.1290963910679859,0.30303030303030304,0.5910784743614659,1.0,4/30,12.22%,MAP3K11;MRAS;PPP1CB;CAMK2B
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.5178527628217311,1.1290333549070823,0.29850746268656714,0.5910746728790996,1.0,9/61,8.51%,CDKN2A;IRAK2;DAB2IP;ERBIN;NLRP12;TCEAL7;CYP1B1;NLRC5;NLRC3
prerank,Reactome_2022__MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.5438258969816644,-1.12902049592115,0.3,0.8564737945637098,1.0,7/24,22.92%,POLR2K;POLR2C;POLR2D;DGCR8;POLR2L;POLR2G;POLR2E
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.5171204136900525,1.128666674421852,0.2459016393442623,0.5917439359768695,1.0,19/55,17.98%,CDC42EP3;SLIT2;PAK3;BAIAP2L1;BAIAP2;CDC42EP1;SSH2;PRKCE;CYRIB;FCHSD1;PLEKHG2;ARF6;ARHGAP18;PRKCD;BIN1;PFN2;VASP;CRACD;NCK2
prerank,CellMarker_Augmented_2021__Neural Stem cell:Hippocampus,0.51171705296301,1.128357874366663,0.29310344827586204,0.5923859969229949,1.0,7/59,7.12%,CCNB2;TYMS;BLM;LMNB1;GINS2;MTFR2;MIS18A
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.6721107327847725,1.128307468309972,0.36363636363636365,0.592347372850778,1.0,1/9,0.99%,TYMP
prerank,CellMarker_Augmented_2021__Erythroblast:Blood,-0.4346965916887174,-1.1282473372657247,0.21875,0.8554072318522397,1.0,16/77,21.07%,LRPPRC;DSCC1;ATAD2;WDHD1;EIF2S1;URB2;GART;MCM4;SMC2;HMMR;FIGNL1;RFWD3;DDX21;STIL;PARPBP;WDR43
prerank,CellMarker_Augmented_2021__Mast Cell progenitor:Bone Marrow,-0.4346965916887174,-1.1282473372657247,0.21875,0.8554072318522397,1.0,16/77,21.07%,LRPPRC;DSCC1;ATAD2;WDHD1;EIF2S1;URB2;GART;MCM4;SMC2;HMMR;FIGNL1;RFWD3;DDX21;STIL;PARPBP;WDR43
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Subcutaneous Adipose Tissue,-0.4346965916887174,-1.1282473372657247,0.21875,0.8554072318522397,1.0,16/77,21.07%,LRPPRC;DSCC1;ATAD2;WDHD1;EIF2S1;URB2;GART;MCM4;SMC2;HMMR;FIGNL1;RFWD3;DDX21;STIL;PARPBP;WDR43
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Peripheral Blood,-0.4346965916887174,-1.1282473372657247,0.21875,0.8554072318522397,1.0,16/77,21.07%,LRPPRC;DSCC1;ATAD2;WDHD1;EIF2S1;URB2;GART;MCM4;SMC2;HMMR;FIGNL1;RFWD3;DDX21;STIL;PARPBP;WDR43
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.6090252226200888,1.1281532046325102,0.3148148148148148,0.5925914864261145,1.0,7/16,14.71%,HLA-DRA;PTPRC;CYRIB;HLA-DRB1;FADD;IL12A;HLA-E
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),0.7154238421334441,1.1281504615084978,0.38,0.5924038722293716,1.0,1/6,12.29%,PRKCD
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.47786657169908164,1.127911546652394,0.2112676056338028,0.5928081589466765,1.0,19/91,15.86%,IGF1;EGF;THBS1;SERPINE1;PLEK;APP;PDGFA;SYTL4;CYRIB;TGFB2;TF;GAS6;ACTN1;SPARC;FN1;RAB27B;ABCC4;SERPING1;TAGLN2
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.7128140970540593,1.1279011310408205,0.3076923076923077,0.5926434969243847,1.0,2/5,17.89%,LDLR;LRP2
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),0.6881575539179736,1.1278836033824808,0.3148148148148148,0.5924751278989293,1.0,1/8,5.94%,MFSD2A
prerank,CellMarker_Augmented_2021__B cell:Brain,0.5859212572320197,1.1278088730452809,0.36666666666666664,0.592016424908119,1.0,5/21,4.66%,CD22;PLEK;NAPSB;PTPRC;CD37
prerank,CellMarker_Augmented_2021__B cell:Salivary Gland,0.5859212572320197,1.1278088730452809,0.36666666666666664,0.592016424908119,1.0,5/21,4.66%,CD22;PLEK;NAPSB;PTPRC;CD37
prerank,CellMarker_Augmented_2021__B cell:Synovium,0.5859212572320197,1.1278088730452809,0.36666666666666664,0.592016424908119,1.0,5/21,4.66%,CD22;PLEK;NAPSB;PTPRC;CD37
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),-0.5906270640802731,-1.127705478140923,0.34210526315789475,0.8562347440979552,1.0,2/9,1.61%,AR;SELENOS
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),0.6414782620584716,1.1275746899012702,0.40384615384615385,0.5923324026625483,1.0,4/11,7.19%,EPHA2;ADCY5;ADCY7;ADCY2
prerank,Reactome_2022__Hormone Ligand-Binding Receptors R-HSA-375281,-0.747169029546435,-1.1273725194185085,0.38095238095238093,0.8564379307439208,1.0,1/5,2.14%,FSHR
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.5404831014087162,1.1272918657570368,0.3181818181818182,0.5929338579124359,1.0,9/35,16.31%,S100A10;FHOD1;LIMCH1;SYNPO2L;ARHGEF10L;PXN;PAK1;LPAR1;PFN2
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),0.7965517805848975,1.127141874497456,0.32075471698113206,0.5931350901418363,1.0,2/5,1.69%,THBS1;SERPINE1
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5939565206409019,1.1269553847222586,0.3382352941176471,0.5933970963384074,1.0,12/25,23.19%,ICAM1;TJP3;RAP2B;PPP1R16B;ROBO4;PDE4D;RAP1A;TJP2;RAP1B;PDE2A;TJP1;PECAM1
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),0.6886243935787995,1.1266594674152157,0.3888888888888889,0.5939823881417917,1.0,3/8,16.95%,GAB2;SYK;ADGRE2
prerank,Reactome_2022__Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,-0.485866193283254,-1.126494339095546,0.21052631578947367,0.8583212116952499,1.0,6/32,22.33%,AAAS;NUP50;NUP54;NUP85;NUP42;POM121C
prerank,KEGG_2021_Human__ABC transporters,0.5224307369826316,1.1264875458261205,0.2463768115942029,0.5942020987996008,1.0,10/39,11.64%,ABCA6;ABCA8;ABCB1;ABCC8;ABCA5;ABCA10;ABCC9;ABCA9;ABCA2;ABCB9
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.6970278903338738,-1.126474309116446,0.36363636363636365,0.8564746741510957,1.0,1/5,2.55%,XG
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),-0.6970278903338738,-1.126474309116446,0.36363636363636365,0.8564746741510957,1.0,1/5,2.55%,XG
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),0.7174189817624502,1.1264155991442548,0.3333333333333333,0.5941972949557663,1.0,3/7,15.68%,NLRC3;RELB;PTPRS
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.5246356313963646,1.1263800964030448,0.3389830508474576,0.5941012549085692,1.0,16/56,18.63%,IRS2;THY1;CAMK2N2;PTPRC;SMCR8;DVL1;SNCA;YWHAG;MAPT;CDKN1C;CDKN1B;TAB1;UBASH3B;WWTR1;TSC2;CAV3
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.6267036722423222,1.1262789808117883,0.37254901960784315,0.594149692784984,1.0,5/11,16.77%,ACTA2;MYH11;TPCN2;SMTN;SLC8A1
prerank,Reactome_2022__P2Y Receptors R-HSA-417957,0.7300757882505597,1.1262763698130023,0.42592592592592593,0.593954953455982,1.0,2/8,2.02%,P2RY6;P2RY13
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.6429466148847635,1.1262143476630737,0.38461538461538464,0.5939046620514821,1.0,12/18,27.16%,PRKAR1B;APLNR;CGAS;PRKAR1A;PDE4D;GNAI1;UBE2B;PDE2A;PRKAR2B;PEX5L;RNF157;RAPGEF2
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.6175317686355083,1.126128994228783,0.3235294117647059,0.5939265401118592,1.0,4/13,17.24%,GRM5;GRM6;HOMER1;GRM7
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.5064636374142449,-1.126119839460789,0.2702702702702703,0.8565510754312063,1.0,5/27,7.89%,AR;FSHR;AKR1C3;WNT2B;NCOA4
prerank,Reactome_2022__Syndecan Interactions R-HSA-3000170,0.6000879334329443,1.126068201985059,0.26666666666666666,0.5938535184513729,1.0,4/16,11.20%,THBS1;ITGA2;ACTN1;FGF13
prerank,Reactome_2022__mTORC1-mediated Signaling R-HSA-166208,-0.5458267938705855,-1.1260273324743768,0.35,0.8559580550851051,1.0,4/22,14.28%,EIF4EBP1;RRAGC;SLC38A9;RRAGA
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.5483404725394988,1.1260273084353123,0.24193548387096775,0.5937767504222009,1.0,10/33,18.66%,ALDOB;HK2;LDHA;PFKL;PGK1;ENO2;HK1;NEU4;ENO3;MAN2C1
prerank,"Reactome_2022__BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",0.601381402128496,1.1258505763656685,0.3442622950819672,0.5940565682253939,1.0,12/25,27.09%,SERPINE1;TBL1X;NAMPT;NPAS2;RXRA;TBL1XR1;NOCT;CARM1;BMAL2;CREBBP;BHLHE40;HSD17B4
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.6473233687272187,-1.1257842299717749,0.34146341463414637,0.8548844430745239,1.0,1/8,3.91%,SRI
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.6473233687272187,-1.1257842299717749,0.34146341463414637,0.8548844430745239,1.0,1/8,3.91%,SRI
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),-0.5204352832970722,-1.1257716372362971,0.2564102564102564,0.8540200523886141,1.0,4/35,5.85%,ID1;LAMA4;ALDH1A1;NR1D1
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),0.5675029435740343,1.1255877918993262,0.2923076923076923,0.5945219958249656,1.0,4/22,10.12%,GMPR;ADA;PRPS2;SHMT1
prerank,Reactome_2022__SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.46830579042106596,-1.125518401101162,0.23684210526315788,0.853807216124741,1.0,6/32,22.33%,AAAS;NUP50;NUP54;NUP85;NUP42;POM121C
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.6393355484804295,-1.1254046412826864,0.2926829268292683,0.8531871764040962,1.0,6/18,19.75%,RPS26;RPS13;SAP18;RBMX;SRSF9;PCBP4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),-0.6351410677153643,-1.1253015255726666,0.2702702702702703,0.852568494930375,1.0,5/15,5.43%,SELENOS;CD200R1;TNFAIP3;FOXJ1;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.6572091032072346,1.1252648788633979,0.39622641509433965,0.5951008325594215,1.0,2/12,11.09%,TERF2IP;DIP2B
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),-0.6700101155907263,-1.1252362511776348,0.4,0.8518349449181144,1.0,1/6,2.65%,TPP1
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood,0.49436717557922477,1.1251188336978057,0.2835820895522388,0.5952245853997389,1.0,18/58,13.08%,HLA-DRA;ITM2A;FLT1;ACKR1;SHROOM4;MYH11;PTPRC;FAM107A;LDB2;APLNR;RAMP3;ADGRF5;RASL12;RNASE1;ITGA9;SORBS1;FGD5;ROBO4
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.7485635056170461,-1.1249055449433318,0.3611111111111111,0.850952492640248,1.0,1/5,4.31%,SNF8
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.7485635056170461,-1.1249055449433318,0.3611111111111111,0.850952492640248,1.0,1/5,4.31%,SNF8
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5245325727783632,1.1247280869174647,0.3076923076923077,0.5959808489710513,1.0,13/53,14.53%,IGF1;PDGFRA;EGF;DCN;FLT1;IRS2;NTRK3;PDGFA;TGFB2;FN1;FGF2;GAB1;PIK3CD
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),-0.5477941428182104,-1.1247146652460573,0.3023255813953488,0.8505706310400315,1.0,3/21,10.96%,TPP1;USE1;BECN1
prerank,Reactome_2022__Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,0.5976577604460933,1.1246863147018187,0.19642857142857142,0.5958883894943237,1.0,7/23,14.84%,ITPKC;PLCH2;ITPKB;ITPK1;INPPL1;INPP5J;INPP5D
prerank,Reactome_2022__ROBO Receptors Bind AKAP5 R-HSA-9010642,0.7145809509422064,1.124617632602753,0.36507936507936506,0.5958679149008143,1.0,4/7,25.00%,ROBO2;PRKCA;PPP3CB;AKAP5
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.6989539854164872,1.1245897601864492,0.36363636363636365,0.5957301415021647,1.0,2/6,16.81%,PLOD2;MTHFR
prerank,CellMarker_Augmented_2021__Immature Transitional B cell:Blood,0.615339116159353,1.124257819904169,0.3728813559322034,0.5961620599499015,1.0,4/13,12.01%,CD24;NAPSB;SYK;ITGAL
prerank,CellMarker_Augmented_2021__Plasmablast:Peripheral Blood,0.615339116159353,1.124257819904169,0.3728813559322034,0.5961620599499015,1.0,4/13,12.01%,CD24;NAPSB;SYK;ITGAL
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.5233730796605534,1.1242087416752213,0.25806451612903225,0.5960923755169898,1.0,7/42,10.92%,EGF;RAB11FIP5;TRIM46;DVL1;CTNNB1;ABCA2;MAPT
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.5910188856266188,1.1239938809274315,0.36764705882352944,0.5963968900194526,1.0,4/22,9.44%,ANXA1;EPHA2;CLIC4;CERS3
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),-0.6314867260982608,-1.1239687421012523,0.36585365853658536,0.8509983266338814,1.0,1/8,4.88%,PDZD11
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),-0.6314867260982608,-1.1239687421012523,0.36585365853658536,0.8509983266338814,1.0,1/8,4.88%,PDZD11
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),-0.5485945281370899,-1.123952376165366,0.32653061224489793,0.8501145657226228,1.0,6/17,15.68%,HSD17B8;HSD17B6;SRD5A1;TSPO;STARD3NL;DHCR7
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.6926814485547992,-1.1239063819588602,0.3148148148148148,0.8493233474346316,1.0,2/7,6.97%,DIRAS3;KDM1B
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.7144191058450906,1.1237162840210282,0.39215686274509803,0.5968372174810437,1.0,3/8,8.12%,NRP2;SOX4;CTNNB1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.6790856837475809,-1.1236682467896317,0.3783783783783784,0.849233358362764,1.0,4/9,20.92%,PPCS;PDHA1;ACSS1;MLYCD
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),-0.7269335237343123,-1.1235582437334704,0.39622641509433965,0.8487571938503227,1.0,2/5,18.76%,BCAP31;MIA3
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),0.6949069002221434,1.123244706115711,0.3673469387755102,0.5976889363103649,1.0,2/11,1.48%,CSPG4;DCN
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.5305411612360105,1.122568298270802,0.2571428571428571,0.599080016088587,1.0,5/33,11.92%,SLC39A14;ALDOB;PGK1;FBP1;ENO2
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.633210039589926,-1.1224707704886452,0.3448275862068966,0.8514271605185706,1.0,3/16,10.99%,ALG3;ALG9;DOLK
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.4856991251525644,1.1221446017680496,0.27419354838709675,0.6000323588692077,1.0,34/90,17.68%,COL4A1;CSPG4;PRRX1;CALD1;COL4A2;RBM24;ACHE;ANGPTL2;POSTN;COL12A1;LAMB1;ZBTB16;PTPN21;RHBDF1;MYD88;CAPN1;PKDCC;BGN;YAP1;ADAM12;TEAD1;CCL2;FN1;CAP2;PALLD;COL5A1;BCAR1;PDZRN3;ANGPT2;FSTL1;FAM114A1;WWTR1;ENO3;SRPX2
prerank,Reactome_2022__MET Activates RAP1 And RAC1 R-HSA-8875555,0.6480850386300571,1.1221284824156412,0.4067796610169492,0.5998747676054348,1.0,5/11,27.98%,RNASE1;RAP1A;RAP1B;RNMT;DOCK7
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.6332560835526291,1.1221037652964254,0.41379310344827586,0.5997135069576303,1.0,4/15,15.38%,MAP3K11;DAB2IP;PAK1;MAP3K5
prerank,Reactome_2022__Telomere Extension By Telomerase R-HSA-171319,0.6059871051091223,1.121791874491311,0.2903225806451613,0.6002461640905579,1.0,8/20,20.93%,GAR1;TERF2IP;ANKRD28;TINF2;CDK2;WRAP53;ACD;CCNA2
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),0.7362652664100111,1.121450804137989,0.39622641509433965,0.6008161697380521,1.0,5/6,24.68%,PCLO;ERC2;CAST;RAB3A;ERC1
prerank,Reactome_2022__Constitutive Signaling By Overexpressed ERBB2 R-HSA-9634285,0.6536532943236631,1.1214189609706209,0.32786885245901637,0.6006962112931167,1.0,1/10,3.55%,ERBIN
prerank,KEGG_2021_Human__Fluid shear stress and atherosclerosis,0.4786032800240477,1.1212645845416425,0.2898550724637681,0.6008889956133177,1.0,19/100,17.07%,KLF2;GSTT2;DUSP1;ICAM1;IL1R1;TNFRSF1A;PDGFA;CTNNB1;ASS1;CCL2;BCL2;IKBKG;PIK3CD;MAPK11;MAP3K5;TP53;GSTM5;CALM3;MAPK9
prerank,Reactome_2022__Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,0.49244228943560836,1.1210942170014342,0.3064516129032258,0.601092952133105,1.0,19/84,17.89%,EGF;SH3GL2;SH3GL3;SYT1;TGFA;SH3KBP1;CLTB;REPS2;LDLR;GRK2;TF;SYT12;GPS1;CD4;KIAA0319;EPN1;WNT5A;TFRC;LRP2
prerank,Reactome_2022__Ion Homeostasis R-HSA-5578775,0.5251243806200081,1.1209851479324968,0.35294117647058826,0.601176309009493,1.0,16/39,19.68%,ATP2B3;ITPR3;ABCC9;RYR2;ATP1B1;ORAI1;ATP1B3;CAMK2B;FXYD7;ATP2B4;SLC8A2;SLC8A1;ITPR1;CAMK2A;PRKCA;AHCYL1
prerank,CellMarker_Augmented_2021__Neural Progenitor cell:Brain,0.7796072475311596,1.1209834495441193,0.34285714285714286,0.6009811218961784,1.0,2/6,10.76%,GFAP;DCX
prerank,Reactome_2022__Regulation Of FOXO Transcriptional Activity By Acetylation R-HSA-9617629,0.6801218000822375,1.1209201944428648,0.32727272727272727,0.600906450447652,1.0,2/10,6.87%,FOXO1;FOXO3
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6832489224782236,1.1208710556019166,0.3880597014925373,0.6008318274556143,1.0,1/11,0.86%,IMPDH1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.7290035912391357,1.1208308015867765,0.4,0.6007196557283917,1.0,2/8,15.53%,FYN;PINK1
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.6451803091298068,-1.1207066907231618,0.40476190476190477,0.8559123921231563,1.0,2/6,9.60%,EXOSC4;EXOSC5
prerank,Reactome_2022__Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,0.5438365038058769,1.1205428311313415,0.2923076923076923,0.6012013990105973,1.0,1/37,0.01%,LEF1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.5712649157431868,1.1204895893987818,0.2982456140350877,0.6010966947618874,1.0,10/28,24.22%,EGF;WDR54;MKLN1;PICK1;ANKRD13A;MTMR2;AHI1;FLOT1;ARRB1;RIN3
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.6589605155578756,-1.1200435116187677,0.30434782608695654,0.8572660167840802,1.0,5/11,26.00%,UTP20;RPS21;NOL9;RPP40;NOP14
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.4833400230512475,1.1199853450875816,0.26865671641791045,0.6021451686411229,1.0,17/84,10.89%,ABO;COBLL1;EGF;PLD1;CLDN16;CLMN;LPP;EPB41L4A;TRHDE;ZBTB7C;ADGRF5;ALDH1L1;PDZD2;ATP1B1;GDA;CDKL5;ITGB8
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.5878918470982828,-1.1197048267544412,0.2857142857142857,0.8574380557366253,1.0,6/9,17.25%,TFB2M;SLC25A33;TFB1M;TEFM;MTERF1;MTERF2
prerank,Reactome_2022__Netrin Mediated Repulsion Signals R-HSA-418886,0.7021049462661051,1.1195423215003344,0.36065573770491804,0.6030127307836436,1.0,4/8,22.15%,UNC5D;DCC;UNC5C;PTPN11
prerank,KEGG_2021_Human__Endocrine and other factor-regulated calcium reabsorption,0.5214230504670899,1.119444378594444,0.3484848484848485,0.6030952230257901,1.0,14/41,19.17%,PRKCB;PRKCG;ATP2B3;DNM1;CLTB;ATP1A1;ATP1B1;ATP1B3;ATP2B4;SLC8A2;SLC8A1;PRKCA;RAB11A;DNM2
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),0.5719737881563344,1.1193289025919817,0.32786885245901637,0.6031739094459423,1.0,4/26,12.99%,SHTN1;DAB2IP;CAMK2B;PHACTR1
prerank,Reactome_2022__Butyrophilin (BTN) Family Interactions R-HSA-8851680,-0.7314216707953316,-1.1192756082425688,0.3333333333333333,0.8578631909277538,1.0,1/6,6.69%,BTN2A1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.7250569802670241,1.1191969784131583,0.3488372093023256,0.6033163152904665,1.0,1/5,14.84%,ATL3
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),0.6780164433418661,1.1189855481703803,0.3793103448275862,0.6034284071802793,1.0,2/7,23.89%,STAT3;EIF4G1
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),0.6780164433418661,1.1189855481703803,0.3793103448275862,0.6034284071802793,1.0,2/7,23.89%,STAT3;EIF4G1
prerank,Reactome_2022__Plasma Lipoprotein Clearance R-HSA-8964043,0.5552678931001136,1.118493950379017,0.2857142857142857,0.6045262201366597,1.0,5/28,7.88%,LSR;AMN;VLDLR;SOAT1;LDLR
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),0.6593880826551457,1.1183728306502911,0.31666666666666665,0.6042362091910528,1.0,1/9,2.21%,BLM
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),0.6593880826551457,1.1183728306502911,0.31666666666666665,0.6042362091910528,1.0,1/9,2.21%,BLM
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),0.6593880826551457,1.1183728306502911,0.31666666666666665,0.6042362091910528,1.0,1/9,2.21%,BLM
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.7042894660052523,1.118355231664022,0.46875,0.6040822753799527,1.0,5/5,29.59%,CDK9;RPS6KA4;RPS6KA5;MAPK3;FMR1
prerank,Reactome_2022__Signaling By WNT R-HSA-195721,0.4293777281424427,1.1183434118009186,0.23376623376623376,0.603909733392398,1.0,16/228,9.78%,LEF1;KREMEN2;GNG3;PRKCB;PRKCG;WNT8B;LGR5;PRKG2;SOX4;GNG2;ITPR3;CLTB;DAAM1;CTNNB1;CTBP2;RNASE1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),-0.5226351091663909,-1.1181796861627302,0.24444444444444444,0.8603946397945043,1.0,4/33,6.17%,OTUD3;THEM4;TRIB3;MUL1
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6836862508720662,1.1181719728848991,0.3076923076923077,0.6038790674892287,1.0,1/9,4.38%,VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6836862508720662,1.1181719728848991,0.3076923076923077,0.6038790674892287,1.0,1/9,4.38%,VLDLR
prerank,Reactome_2022__Chromosome Maintenance R-HSA-73886,-0.46236735508573834,-1.1181604726860412,0.3,0.8595102781262047,1.0,21/88,16.47%,H2AC20;H3-3B;RFC3;H2BC4;H2BC21;POLR2K;DSCC1;POLD3;H2AC6;KNL1;ITGB3BP;MIS18BP1;POLR2C;CENPA;CENPQ;PRIM1;POLR2D;POLR1B;SLC19A1;H2AJ;DNA2
prerank,Reactome_2022__SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,0.5572543642121681,1.1180232539209252,0.2909090909090909,0.6040319544613358,1.0,3/31,8.94%,SERPINE1;CDK9;SMAD3
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.6965359989643956,-1.1179887976891953,0.3728813559322034,0.8591249667697229,1.0,1/6,5.85%,GREM1
prerank,Reactome_2022__Disorders Of Developmental Biology R-HSA-9675151,0.6266236905467569,1.1179403647264854,0.36666666666666664,0.6040464854820533,1.0,5/12,18.53%,TBL1X;GPS2;NCOR1;TBL1XR1;PRKCA
prerank,Reactome_2022__Acyl Chain Remodeling Of DAG And TAG R-HSA-1482883,0.7762348643700812,1.1179402044394684,0.391304347826087,0.6036572802723355,1.0,2/5,11.59%,DGAT2L6;DGAT1
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),0.7762348643700812,1.1179402044394684,0.391304347826087,0.6036572802723355,1.0,2/5,11.59%,DGAT2L6;DGAT1
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.5392059264341543,1.1179343218350253,0.3484848484848485,0.6034777979916112,1.0,6/31,9.97%,ANXA1;EPHA2;CLIC4;CTNNB1;CERS3;OVOL3
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),0.7309402807335504,1.1176896212810912,0.35,0.6038731398292259,1.0,2/7,15.53%,PID1;PINK1
prerank,Reactome_2022__Translation Of Replicase And Assembly Of Replication Transcription Complex R-HSA-9679504,-0.5969066261184454,-1.1176491366888082,0.35,0.8593592182936125,1.0,4/11,25.97%,BECN1;RNF103-CHMP3;PIK3R4;CHMP2A
prerank,CellMarker_Augmented_2021__Progenitor cell:Prostate,-0.5013489220500984,-1.1176427723744633,0.3548387096774194,0.8584462798577727,1.0,7/28,11.41%,TRIM29;KRT8;IL20RA;S100A16;SCEL;EHF;B3GNT3
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.4276119682260072,1.117511389843144,0.1927710843373494,0.6040928855717327,1.0,53/270,15.46%,CDKN2A;HPN;ST18;GPNMB;PROX1;TESC;OGN;NELL1;APP;DAB2IP;DUSP10;PODN;FABP3;KLF11;SOX4;BTG3;CLMN;APOD;FAP;IGFBP7;KLF10;BAP1;PML;CYP1B1;CDK6;CTNNB1;NLRC3;ZBTB7C;LMNA;PPARG;NEURL1;CTBP2;TGFB2;DLG5;P3H2;CDKN1C;B4GALT7;CDKN1B;DLG3;ATP8A2;B2M;KLF4;PAK1;PDPN;CDKN1A;CGREF1;TRIM32;IL12A;NOX4;PPM1D;RARG;ETS1;TP53
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.591169589489112,1.1172404354881806,0.3064516129032258,0.6045586350741496,1.0,1/20,0.12%,CDKN2A
prerank,"KEGG_2021_Human__Alanine, aspartate and glutamate metabolism",0.5613894752557567,1.1172163009008382,0.35294117647058826,0.604435017884824,1.0,5/29,12.81%,FOLH1;GAD2;GPT2;ASS1;NAT8L
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),-0.6702696404851787,-1.117178536484603,0.3409090909090909,0.8588269853663061,1.0,1/9,8.29%,GAS1
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.6259613452574293,1.1170820908947516,0.3275862068965517,0.6045611941396527,1.0,4/18,14.22%,PLSCR1;GGCT;GSS;PLOD2
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),0.7427206691924636,1.1170229078283649,0.43636363636363634,0.6045457059973642,1.0,2/5,21.41%,GPS2;TRIM44
prerank,Reactome_2022__Presynaptic Depolarization And Calcium Channel Opening R-HSA-112308,0.6408216008965619,1.1170057263808892,0.36507936507936506,0.6043849653453415,1.0,3/12,19.17%,CACNA1E;CACNG4;CACNB2
prerank,KEGG_2021_Human__Steroid hormone biosynthesis,-0.5488138464279028,-1.1169679355487554,0.34285714285714286,0.8584765137625585,1.0,7/22,11.63%,HSD17B8;DHRS11;HSD17B6;AKR1C3;HSD11B1;SRD5A1;CYP7B1
prerank,GO_Biological_Process_2021__sphingosine-1-phosphate receptor signaling pathway (GO:0003376),-0.7676297623361288,-1.1166316816900204,0.4318181818181818,0.8587915217217723,1.0,1/5,7.58%,S1PR1
prerank,Reactome_2022__Defective CHSY1 Causes TPBS R-HSA-3595177,0.7043581398250981,1.116605874698581,0.4,0.6051328575867748,1.0,2/8,1.48%,CSPG4;DCN
prerank,KEGG_2021_Human__Other glycan degradation,-0.6064996388306003,-1.1165601678009425,0.36585365853658536,0.8581179232243693,1.0,4/15,12.99%,NEU1;GBA2;FUCA2;AGA
prerank,CellMarker_Augmented_2021__Stem cell:Blood Vessel,0.7440508864635981,1.1164555925965225,0.38333333333333336,0.6052698145269749,1.0,4/6,25.32%,THY1;TFRC;PECAM1;TNFRSF8
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),0.6056085138992178,1.1164145779340737,0.3709677419354839,0.605164812593496,1.0,4/15,12.01%,ICAM1;CERCAM;SYK;ITGAL
prerank,Reactome_2022__Olfactory Signaling Pathway R-HSA-381753,0.6310334088293738,1.1160310036375676,0.36,0.605844776363242,1.0,4/17,8.52%,EBF1;OR51M1;LDB2;OR52N2
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.6134482117197873,1.1156659392065567,0.3508771929824561,0.6064610858751476,1.0,6/16,21.14%,OXTR;NRG1;GLI2;NOTCH4;ARHGAP35;APLN
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.7934475651789418,-1.1155583912796627,0.35555555555555557,0.8601960846414166,1.0,2/5,8.86%,ABCB11;GPLD1
prerank,Reactome_2022__RHO GTPases Activate NADPH Oxidases R-HSA-5668599,0.6814767085424563,1.1154106218580182,0.36363636363636365,0.6068688194410137,1.0,7/14,18.53%,PRKCB;PDZD2;RNASE1;NOXA1;PRKCD;MAPK11;PRKCA
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.4960023059193709,1.1153632520479386,0.3333333333333333,0.6068154679717866,1.0,8/46,6.95%,KCNJ2;KCNQ1;NOS1AP;KCNMB4;KCNIP4;GABBR2;GNG2;KCNH2
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),-0.7280773357521297,-1.1152088302577308,0.43859649122807015,0.8604112880355412,1.0,4/5,26.88%,DMC1;FANCM;RAD51;RAD54L
prerank,Reactome_2022__Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.3759283576808886,-1.1150096486913252,0.13333333333333333,0.8602224347386584,1.0,47/298,11.83%,DAO;GOLT1A;RPL35A;RPS24;RPL34;RPL39;PXMP2;IDO1;RPL37;SDSL;RPS28;AIMP1;SLC3A2;RPL18;KARS1;OAT;PIPOX;RPL12;RPL23;RPL31;HYKK;ACMSD;RPL6;RPS27L;RPL41;DCT;RPS13;GLUD1;RPL22;RPL29;RPL30;PPM1K;ASMT;RPSA;EEFSEC;TDO2;RPL14;SECISBP2;GCDH;RPL15;RPS2;PDHA1;EPRS1;RPL11;PHGDH;SLC25A15;RPL23A
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.6719481232510504,1.1150061505316933,0.375,0.6073788619659596,1.0,1/10,0.99%,TYMP
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.6299926164394911,1.1150011089998346,0.30303030303030304,0.6071991073798197,1.0,4/18,12.66%,SP100;PML;BARD1;RANGAP1
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),-0.6658062942880713,-1.1149951024887153,0.40476190476190477,0.8593647207841926,1.0,2/9,9.24%,ID2;HSF1
prerank,Reactome_2022__Chromatin Modifying Enzymes R-HSA-3247509,-0.3938967147479527,-1.1148944761330402,0.16666666666666666,0.8588954601156685,1.0,18/200,10.74%,H2AC20;H2BC4;H2BC21;PADI4;SETDB1;MCRS1;ENY2;SMYD2;H2AC6;CHD4;KDM1B;KMT5A;ELP6;H2BC18;RPS2;SMARCD1;KMT2A;SAP18
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.6839187658239643,1.114621385171663,0.39344262295081966,0.6078420645650785,1.0,3/8,9.64%,B3GNT2;B3GALT2;B3GALNT1
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.6839187658239643,1.114621385171663,0.39344262295081966,0.6078420645650785,1.0,3/8,9.64%,B3GNT2;B3GALT2;B3GALNT1
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.6812134657331652,1.1144392898402282,0.3888888888888889,0.6081706551818866,1.0,2/6,13.58%,TNFRSF10B;FADD
prerank,Reactome_2022__IRS-related Events Triggered By IGF1R R-HSA-2428928,-0.518820585194455,-1.1144194524704574,0.2894736842105263,0.859762879926568,1.0,4/33,5.54%,FGF6;FLT3;THEM4;TRIB3
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),0.7846277381861634,1.1142293184471959,0.44642857142857145,0.6085101630523695,1.0,3/5,19.03%,LIMK2;IKBKG;RAB11A
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",-0.46112204339939983,-1.114024475381728,0.19444444444444445,0.8600658178778443,1.0,7/75,6.97%,DIRAS3;DNMT3B;SMYD5;POLR2K;POLR1F;TAF1D;KDM1B
prerank,Reactome_2022__GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,0.5435137346602449,1.1139421142491426,0.296875,0.6090126055898759,1.0,5/25,11.16%,CSPG4;DCN;AGRN;BGN;B4GALT7
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.799106784110482,1.1139234300781915,0.3559322033898305,0.6088845688096443,1.0,3/5,11.23%,ALDOB;PFKL;FBP1
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),-0.7372821339860995,-1.1138337903603162,0.3695652173913043,0.8598060659754012,1.0,2/6,16.31%,TRMT10C;TRNT1
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.7138891677840298,1.113762226155926,0.3559322033898305,0.6090345358809943,1.0,4/6,14.73%,ALOX12;NOXA1;TAFA4;NOX4
prerank,Reactome_2022__Signaling By RNF43 Mutants R-HSA-5340588,-0.7176596231841147,-1.1136656947629755,0.39215686274509803,0.8593704060765428,1.0,1/5,5.72%,FZD8
prerank,CellMarker_Augmented_2021__Luteinizing Granulosa cell:Ovarian Follicle,0.4748603075281057,1.1136154415908794,0.25925925925925924,0.6091621804428918,1.0,20/59,13.67%,GRIN2A;GABRB2;GRID2;PDZRN4;CLSTN2;CNTNAP5;CDH8;UNC5D;MTUS2;ADAMTS19;CCKBR;RYR2;GRIA3;ASXL3;C1ORF105;HTR1E;RUNX1T1;ERC2;DLGAP1;PCDH15
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.638384888670291,1.1135073006195868,0.3684210526315789,0.6092823369254168,1.0,3/14,5.87%,BAIAP2L1;BAIAP2;NTRK3
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.5086497510062401,1.1130929703596928,0.288135593220339,0.6100687903179023,1.0,7/36,11.07%,THBS1;SLC39A14;IRS2;SOX4;EIF2B2;PFKL;GAS6
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.6509792485945717,1.1129642041077452,0.3448275862068966,0.6102181877564959,1.0,2/14,8.31%,IGF1;BCL2L1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.43190974976585245,1.1127078635500274,0.14754098360655737,0.6106153705707882,1.0,24/202,13.89%,MET;BOK;DCN;PLK2;DEPP1;FOXO1;TRIM5;SMCR8;FOXO3;GFAP;DAPK2;CAPN1;PLEKHF1;PIP4K2A;STAT3;FBXL2;MAPT;EEF1A2;TPCN2;TRIM22;BCL2;OPTN;WASHC1;RNF152
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.780089458250476,1.1126884121263492,0.45454545454545453,0.6104612186325761,1.0,2/6,7.91%,FYN;DUSP22
prerank,KEGG_2021_Human__Th1 and Th2 cell differentiation,0.5057762672744659,1.1125832271229632,0.31746031746031744,0.6104846379502992,1.0,14/60,15.37%,HLA-DRA;STAT4;NFATC2;TYK2;HLA-DRB1;IL4R;HLA-DMA;MAML2;IL12A;IKBKG;MAPK11;NOTCH3;CD4;STAT6
prerank,Reactome_2022__Dopamine Neurotransmitter Release Cycle R-HSA-212676,0.5942130200390766,1.112526537951519,0.3333333333333333,0.6104045494781629,1.0,9/22,26.11%,SYT1;CPLX1;SYN2;APBA1;PPFIA2;SNAP25;RAB3A;PPFIA1;SYN3
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.614222616340778,1.112467267510991,0.35,0.6103355970519023,1.0,9/15,27.56%,TERF2IP;OGG1;TINF2;NEIL2;NEIL1;ACD;TDG;NTHL1;UNG
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),-0.7192533333254447,-1.1124406164971037,0.4146341463414634,0.862252762639184,1.0,5/7,26.89%,MCM6;MCM4;MCMDC2;ORC3;MCM3
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.7400783991677833,1.1121991446525745,0.25862068965517243,0.6108687808425806,1.0,1/5,7.49%,C1R
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.7159979674625543,1.1121702370294098,0.4444444444444444,0.6105276814903006,1.0,3/6,22.33%,HLA-DRB1;CD4;LGALS1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.7159979674625543,1.1121702370294098,0.4444444444444444,0.6105276814903006,1.0,3/6,22.33%,HLA-DRB1;CD4;LGALS1
prerank,Reactome_2022__Class C/3 (Metabotropic Glutamate/Pheromone Receptors) R-HSA-420499,0.6983556504897006,1.1120812380723304,0.3333333333333333,0.6105916280978835,1.0,3/8,8.78%,GABBR2;GRM5;GRM6
prerank,CellMarker_Augmented_2021__B cell:Undefined,0.544079638947712,1.112065589526249,0.3389830508474576,0.6104600109005734,1.0,5/32,4.31%,IL13RA1;ADGRE5;CD22;CD24;PTPRC
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.7044127947700213,1.1118422763922489,0.40540540540540543,0.6107525907108406,1.0,8/8,29.59%,CDK9;AKAP8;RPS6KA4;RPS6KA5;MACROH2A1;MAPK3;AKAP8L;FMR1
prerank,GO_Biological_Process_2021__hydrogen sulfide metabolic process (GO:0070813),0.7830206939227807,1.1117382708846317,0.3953488372093023,0.6107758503129347,1.0,1/5,1.04%,SQOR
prerank,CellMarker_Augmented_2021__Preadipocyte:Adipose Tissue,0.538139674637173,1.111528836621344,0.3230769230769231,0.6111602835388978,1.0,8/29,5.76%,CTSS;P2RY13;MYO1F;PLEK;SLA;SIGLEC1;PTPRC;GAB3
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),0.7177847387612846,1.1111063644747117,0.4107142857142857,0.611931336948399,1.0,3/6,19.17%,DNM1;MX1;DNM2
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),-0.5736292262223647,-1.111043558880065,0.21052631578947367,0.8654171771791046,1.0,5/30,6.17%,REEP6;DISP3;SLC30A8;LEPR;MUL1
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.6913506503357167,-1.110998343503756,0.3389830508474576,0.8646491694452944,1.0,3/6,23.08%,SAT1;SRM;SAT2
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),-0.5114669022787309,-1.1108976102042096,0.275,0.8640025836907422,1.0,7/36,17.79%,LSM2;GEMIN4;LSM4;WDR77;PRPF8;PRPF3;TGS1
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.44782315607547063,1.110819355593084,0.29850746268656714,0.6123888237619151,1.0,7/111,7.62%,ST18;IRAK2;DAB2IP;NOD1;IL1R1;MYLK3;MYD88
prerank,Reactome_2022__CD209 (DC-SIGN) Signaling R-HSA-5621575,0.6082088140904577,1.110611427975116,0.3181818181818182,0.6127061007404411,1.0,4/16,18.53%,FYN;ARHGEF7;RELB;PRKCA
prerank,Reactome_2022__Defective B3GALT6 Causes EDSP2 And SEMDJL1 R-HSA-4420332,0.5678086368678391,1.110596165095535,0.3508771929824561,0.6125520191575492,1.0,4/19,8.95%,CSPG4;DCN;AGRN;BGN
prerank,Reactome_2022__Signaling By BMP R-HSA-201451,0.5916388200998018,1.1104595168368503,0.3728813559322034,0.6126372188891956,1.0,5/22,19.66%,AMH;SMAD1;SMURF1;FSTL1;SMAD9
prerank,Reactome_2022__Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,0.46007496626202365,1.110337850877681,0.2857142857142857,0.6127407574335415,1.0,12/115,9.30%,TLR2;KCNH8;IRAK2;APP;RPS6KA1;IRF7;NOD1;DNM1;BIRC3;NLRC5;MYD88;IKBKE
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.47086155941064334,1.1102957859015001,0.26666666666666666,0.6126419726726337,1.0,18/77,14.66%,TLR2;IRF7;PTPRC;MAP3K14;PLSCR1;TRIM5;SAMHD1;ABCC9;NLRC5;MYD88;APOBEC3H;BCL2L1;RNASE1;MX1;BCL2;CGAS;FADD;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),0.6487508392486889,1.1102836857787346,0.38461538461538464,0.6124954593909506,1.0,2/11,9.25%,PLAAT4;PRKCH
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.6125311506299478,-1.110153538214622,0.375,0.865607325623118,1.0,4/7,24.24%,PM20D1;MPST;CYP2D6;TST
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.5242623398665099,1.1099854435258825,0.31746031746031744,0.6129774775511546,1.0,6/38,14.93%,KIF14;PMEPA1;NLRC3;LDLRAD4;TMC8;LCMT1
prerank,Reactome_2022__Transport Of SLBP Independent Mature mRNA R-HSA-159227,-0.48551634839784596,-1.1098272779512148,0.3023255813953488,0.8657102932665887,1.0,6/32,22.33%,AAAS;NUP50;NUP54;NUP85;NUP42;POM121C
prerank,CellMarker_Augmented_2021__Lymphoid cell:Undefined,-0.5472947691781486,-1.1098130639890538,0.28125,0.86484169724876,1.0,3/18,4.91%,FLT3;CD38;LRRC36
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.637944744897532,1.1097543210633383,0.38596491228070173,0.6132497770372846,1.0,5/16,20.36%,NLRP12;NLRC3;HDAC7;IFI35;NMI
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),-0.7151952923676643,-1.1095249475848592,0.39655172413793105,0.864865716377069,1.0,2/5,12.63%,MOGAT1;PLA2G15
prerank,Reactome_2022__SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.4835998731510041,-1.109522056702768,0.3548387096774194,0.8639680430171507,1.0,11/48,20.20%,FBXO5;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;CUL1;PSMB4
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.6921589014528968,1.109501943435076,0.38181818181818183,0.6134744304387577,1.0,3/7,16.00%,ENPEP;AOPEP;CTSZ
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.6921589014528968,1.109501943435076,0.38181818181818183,0.6134744304387577,1.0,3/7,16.00%,ENPEP;AOPEP;CTSZ
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.7183311042297045,1.1093996115554718,0.2909090909090909,0.6135224180090069,1.0,4/8,21.64%,NOS1AP;BIN1;CACNB2;SESTD1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.6721375366601154,1.1093402311906249,0.41379310344827586,0.6134713051152331,1.0,3/10,12.18%,CLPB;ZDHHC1;MX1
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.6688665108668758,1.1092867727415494,0.29508196721311475,0.6134055521667644,1.0,5/12,17.11%,FABP3;PPARG;PDK4;ADIPOR2;NCOR1
prerank,Reactome_2022__Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,0.42754682197034916,1.1091389060404735,0.1780821917808219,0.613622195257333,1.0,53/359,14.40%,TGFBR2;PDGFRA;KREMEN2;EGF;NR4A1;PPFIBP1;IRS2;MAP3K11;FOXO1;MYH9;ERBIN;DUSP10;TGFA;DUSP8;FYN;DUSP16;NRG1;FOXO3;TPM4;MAMLD1;NRG2;PDGFA;MRAS;CTNNB1;BCL2L1;KITLG;TBL1X;SMAD3;LMNA;TRAK1;GAB2;NEURL1;ETV6;CTBP2;PPP1CB;HDAC4;RNASE1;STAT3;HDAC9;FGF13;PRR5;CAMK2B;CDKN1B;KLC1;SYVN1;FN1;ALK;CDKN1A;RPS6KB2;MAML2;IQGAP1;KIAA1549;BCL11A
prerank,Reactome_2022__Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.5785841039064932,1.1090395161200317,0.3442622950819672,0.6136297517993361,1.0,6/17,22.15%,PML;CDK6;CCND1;CBFB;CCND2;PTPN11
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.641871674953493,-1.1089269986238808,0.3870967741935484,0.8649294776468045,1.0,3/11,19.53%,PYHIN1;HTRA2;AIM2
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.4654210273294076,1.1087155537411384,0.25757575757575757,0.6143042647827806,1.0,26/119,16.20%,MET;PDGFRA;EPHA7;FLT1;EPHA2;EPHA5;PLAAT4;NTRK3;TCP1;HMBOX1;CTNNB1;VAC14;CCT4;EPHA4;DBI;SERINC1;HLA-DRB1;MAPKAPK5;KLF4;ALK;MRE11;CHTF18;CD4;PINK1;SERINC5;CD200
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.558270108710031,1.1086612194970378,0.3582089552238806,0.6142200143797755,1.0,6/28,13.49%,KLF2;THBS1;PPP1R16B;SMAD1;KLF4;FGF2
prerank,Reactome_2022__Adaptive Immune System R-HSA-1280218,0.4063402689561921,1.1086437149456723,0.23170731707317074,0.6140698957009414,1.0,71/543,15.13%,HLA-DRA;C3;RASGRP2;TLR2;SOCS3;CTSC;CTSS;FYB1;SH3GL2;CD22;RASGRP1;NPDC1;PRKCB;ICAM1;WAS;COLEC12;ASB16;SIGLEC1;SH3KBP1;PTPRC;MAP3K14;NFATC2;FYN;TNFRSF14;HECW2;FBXW12;DNM1;ITPR3;RAP1GAP;ZBTB16;LNX1;MYD88;TRIM36;AP1S1;KIF5A;ARIH2;KIF5C;ARHGEF7;RNASE1;FBXO32;CD160;ORAI1;KLHL5;PAG1;SYK;FBXL16;ENAH;ACTR1A;PRR5;PIANP;HLA-DRB1;PILRA;ITGAL;STX4;PRICKLE1;SPSB1;KLC1;B2M;RAP1GAP2;RNF19A;HLA-DMA;UBE2H;TRIM32;CD99;TRAIP;IKBKG;SIPA1;HLA-E;INPP5D;CD4;PDCD1LG2
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.725404937537723,-1.1082997309450637,0.3170731707317073,0.8660950462678639,1.0,3/7,16.94%,SDSL;SDS;ALDH18A1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.488411542968732,1.1081412481535065,0.296875,0.6151134066257591,1.0,13/59,16.13%,SERPINE1;PTPRO;DUSP1;DMTN;PTPRC;ARHGDIG;CYP1B1;PODXL;PLXNA4;SIPA1;PLXNA1;PLXNA2;FZD7
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.6230391541586469,1.1078888312111856,0.3188405797101449,0.6155999395368296,1.0,5/19,14.76%,LPCAT4;PLAAT3;DBI;PLB1;PNPLA8
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),0.7712488532576514,1.10773654719482,0.3469387755102041,0.6157568698485163,1.0,3/6,16.26%,PRR5;PINK1;SYAP1
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.415680185714921,1.1076483915579616,0.19480519480519481,0.6157747091385732,1.0,21/339,6.16%,SKOR1;MYT1;ELAVL2;PTP4A3;TEAD2;ZNF536;PRDM8;CASZ1;HIC1;ZNF282;WTIP;PPARGC1B;NFATC2;NFIL3;SOX4;NKX6-2;AHR;GZF1;CHD3;DVL1;ZNF114
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.7631785213519429,1.1076162632811173,0.42857142857142855,0.6156609020986016,1.0,3/6,17.89%,NLGN1;PHACTR1;LRP2
prerank,Reactome_2022__Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.47335602619623535,-1.1073453796809334,0.2702702702702703,0.8683591047394736,1.0,12/46,25.39%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4;CHEK2;PSMA1;PSMD11
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.44169451888307815,1.107288133062325,0.2191780821917808,0.6162636206803973,1.0,30/129,23.76%,KREMEN2;DRAXIN;PTPRO;DAB2IP;NOTUM;DVL1;TLE6;TLE3;HECW1;PRICKLE1;SOX13;STK3;ANKRD6;MESP1;WWTR1;WNT5A;STK11;DKK3;FRMD8;TLE2;MLLT3;AMFR;GLI1;RBMS3;AXIN2;CUL3;PSMB3;TMEM131L;PRKN;TLE4
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),0.7244881762841324,1.1070814091985457,0.3559322033898305,0.6165443874945772,1.0,4/6,25.08%,FSTL1;MESP1;PECAM1;KDM6B
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.5518246504772801,-1.106884085681126,0.21052631578947367,0.8689806467860944,1.0,2/24,3.59%,H1-2;H1-4
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.7380362738424012,1.106852558048847,0.4262295081967213,0.6169272633717053,1.0,1/5,6.79%,GHR
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),0.5309061426456094,1.1066816705840912,0.3181818181818182,0.6170944346075455,1.0,11/46,15.00%,NR4A3;NR4A1;FOXO1;PID1;STEAP4;PPARG;CTBP2;NR4A2;KLF4;TRIM32;PRDM16
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),-0.6919522567718304,-1.1065156015315807,0.45652173913043476,0.8691424729701178,1.0,2/7,10.82%,AKR1C3;PTGIS
prerank,Reactome_2022__Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.4946159645638703,-1.1063980594736984,0.25806451612903225,0.8685775685020662,1.0,11/41,25.39%,MRC2;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;PSMB4;PSMA1;PSMD11
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.6998292007154443,1.106256134311825,0.4745762711864407,0.6179222901883414,1.0,2/6,11.71%,MSMP;CCL2
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),0.5369473885094425,1.1060336559018402,0.32786885245901637,0.6181583856761251,1.0,12/35,18.06%,IRS2;SH3KBP1;PTPRC;NFATC2;MMP14;SYK;BCL2;TNIP2;GPR183;BST1;TFRC;TNFSF4
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),-0.6583374115678738,-1.1058580841495946,0.3695652173913043,0.869433566515166,1.0,1/6,1.93%,SFXN2
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.6351716447254759,1.1057714332909492,0.4067796610169492,0.6186643195597402,1.0,8/15,16.77%,KCNJ2;ATP1A1;SLC9A1;ATP1B1;ATP1B3;TMPRSS3;KCNMA1;SLC8A1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.5316927648174755,1.1057370103449917,0.3387096774193548,0.6185717737041088,1.0,10/43,14.71%,TLR2;THBS1;RASGRP1;APP;PTPRC;STAT3;SYK;FADD;IFIH1;HLA-E
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),0.7522246964351929,1.1056279700104166,0.41509433962264153,0.6186579487905497,1.0,1/5,16.26%,SYAP1
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.4745045653359678,1.105557083004564,0.28125,0.6186201386133203,1.0,10/70,13.20%,CDKN2A;PLK2;TYMS;KLF11;CDK6;CDC7;CDKN1B;BRD4;CDKN1A;CCND1
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.43376324069752653,1.1055455780546086,0.2537313432835821,0.6184511723319551,1.0,38/194,16.13%,MET;C3;GPNMB;IGF1;PDGFRA;EPHA7;EGF;THBS1;RASGRP1;FLT1;EPHA2;APP;EPHA5;EFNA1;FAS;NTRK3;LIMCH1;NPTN;LIMK2;VAC14;EPHA4;NIBAN1;WDFY2;GAS6;HLA-DRB1;MLXIPL;ALK;PAK1;CCND1;FGF2;MRE11;CD4;THPO;PFKFB3;PINK1;P2RX7;SLCO3A1;FZD7
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.7102799025089113,1.105480200337107,0.3090909090909091,0.618431664604472,1.0,3/9,20.23%,OR51M1;ADCY3;OR51I2
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.5775044094107344,1.105263049954778,0.3584905660377358,0.6187654039338757,1.0,7/23,7.44%,ADCY5;LGR5;GIPR;RXFP1;ADCY7;ADCY2;GLP1R
prerank,Reactome_2022__Interleukin-37 Signaling R-HSA-9008059,0.6134487123066646,1.1050644201721855,0.31666666666666665,0.619007922324192,1.0,6/17,22.15%,SMAD3;PTPN9;STAT3;PTPN5;TBK1;PTPN11
prerank,Reactome_2022__Regulation Of Apoptosis R-HSA-169911,-0.47096021435586677,-1.1050248139983863,0.34375,0.8707526588227924,1.0,13/46,26.28%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4;MED12;PSMA1;PSMD11;PKN2
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.7136104721672675,1.1049823536072771,0.42857142857142855,0.6189773402401068,1.0,2/7,13.35%,RBM24;CPEB2
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.714660835144977,1.1047463471761143,0.4098360655737705,0.6193615283772813,1.0,5/6,28.51%,ATP10A;DNM2;ASAP1;SH3GLB1;PLEKHM2
prerank,Reactome_2022__IRAK4 Deficiency (TLR2/4) R-HSA-5603041,0.6734800131924374,1.1044847652425638,0.3684210526315789,0.6198109418729533,1.0,2/10,7.62%,TLR2;MYD88
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.6483814743105956,1.1043260920006868,0.3508771929824561,0.6200491921292806,1.0,1/9,10.90%,ABCA2
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),-0.588820524689466,-1.1041704154203669,0.3142857142857143,0.8722894028210095,1.0,4/21,8.80%,HEY2;FBXO5;S1PR1;HEY1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6848826085213735,1.1037747443498984,0.3898305084745763,0.6211305536492147,1.0,4/7,21.17%,PRKCB;HIF1A;ARNT;GRB10
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),-0.5732386488781356,-1.1034289400535011,0.2682926829268293,0.8733905046855159,1.0,3/18,7.42%,KPNA2;TRIM21;TRIM68
prerank,Reactome_2022__Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.4622327498675266,-1.1032818751226467,0.3142857142857143,0.8729340926582483,1.0,12/44,26.28%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4;PSMA1;PSMD11;PKN2
prerank,Reactome_2022__Peroxisomal Lipid Metabolism R-HSA-390918,-0.5105816368870044,-1.103026438860465,0.3157894736842105,0.8726904826793199,1.0,4/25,6.01%,PHYH;NUDT7;ACOXL;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.7183651923669649,1.102946613827076,0.4,0.6228107820093288,1.0,2/6,12.92%,BLM;ZFYVE19
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),0.6584200295324714,1.1028453986498303,0.36363636363636365,0.6228299202097942,1.0,4/13,9.98%,CSPG4;DCN;BGN;UST
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.4868678383213594,1.1027835896540386,0.25,0.6227909451674982,1.0,14/64,18.55%,PLK2;SP100;SOX4;PML;NDRG1;GADD45A;CDKN1B;RPS6KA6;CDKN1A;HIPK2;TP53;CCNB1;PRMT1;PLK3
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),0.7015587767606605,1.1027750871961608,0.44680851063829785,0.6226249378552776,1.0,3/6,22.97%,KLF4;RBMS3;DLEC1
prerank,Reactome_2022__FCGR3A-mediated IL10 Synthesis R-HSA-9664323,0.5511758173485821,1.1027147918286289,0.3787878787878788,0.6226041966673078,1.0,15/28,22.59%,ADCY5;PRKAR1B;FYN;ITPR3;ADCY7;ADCY2;SYK;PRKAR1A;ITPR1;PRKCA;AHCYL1;PRKX;ADCY9;ADCY8;PRKAR2B
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.714187756673949,1.10250631901832,0.38596491228070173,0.6228882136181384,1.0,3/7,18.47%,ZBTB16;PKDCC;LOXL2
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),0.6505407876432935,1.1024198543927115,0.37254901960784315,0.6229145512168205,1.0,1/15,1.15%,CCBE1
prerank,Reactome_2022__Proton-coupled Monocarboxylate Transport R-HSA-433692,0.7250882517280912,1.1023994671092947,0.4406779661016949,0.622799472030462,1.0,1/5,4.40%,EMB
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.4544685784231338,1.1023286078888423,0.2835820895522388,0.6228004493004384,1.0,14/129,7.62%,CXCL2;TESC;SERPINE1;PTK6;ZFP36;ADCY5;DAB2IP;WNT8B;AHR;PID1;ADCY2;RAMP3;ATP1A1;MYD88
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.47067596556466335,1.1021764329040267,0.2878787878787879,0.6230007119803964,1.0,14/83,13.91%,KLF2;PLK2;RASGRP1;APP;DAB2IP;FOXO1;HECW2;ABCA2;BARD1;HECW1;CDKN1B;OAZ2;KLF4;TRIM32
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.6537386832719155,1.1021528806354455,0.3492063492063492,0.6228458690067196,1.0,1/11,1.69%,ATF3
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.6440375369522521,1.1020812472605124,0.2777777777777778,0.622890284285782,1.0,6/14,28.85%,OR51M1;ADCY3;OR51I2;C5AR1;CD36;UBR3
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),0.7118856761479755,1.1020576053774371,0.41509433962264153,0.6227464324778169,1.0,3/7,22.68%,LAMB1;NTN4;LAMB4
prerank,KEGG_2021_Human__Apoptosis,0.44816190356718044,1.102056766816077,0.2916666666666667,0.6225520064920294,1.0,28/117,17.07%,BOK;CTSC;CTSS;LMNB1;SEPTIN4;DAB2IP;MAP3K14;FAS;ITPR3;BIRC3;TNFRSF1A;CASP10;BCL2L1;CAPN1;LMNA;BBC3;GADD45A;BCL2;TNFRSF10B;FADD;TUBA1B;IKBKG;PIK3CD;MAP3K5;TP53;CTSZ;CTSK;MAPK9
prerank,Reactome_2022__Lewis Blood Group Biosynthesis R-HSA-9037629,0.6583111598529909,1.1019145498934186,0.36538461538461536,0.6227411810104522,1.0,3/8,18.65%,B3GALT2;FUT2;B3GALT5
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.7148694500801175,1.1016902252776108,0.3548387096774194,0.6230712848385602,1.0,3/7,12.71%,MAFF;KLF7;ELAPOR2
prerank,CellMarker_Augmented_2021__Neutrophil:Spleen,-0.5020158695295729,-1.1016588897442834,0.3157894736842105,0.8749845631625998,1.0,5/21,4.72%,DPEP2;FLT3;PADI4;C1ORF162;PRAM1
prerank,CellMarker_Augmented_2021__Neutrophil:Brain,-0.5020158695295729,-1.1016588897442834,0.3157894736842105,0.8749845631625998,1.0,5/21,4.72%,DPEP2;FLT3;PADI4;C1ORF162;PRAM1
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),0.7325029905725848,1.1014967304724161,0.34615384615384615,0.6232963340822405,1.0,1/5,25.65%,ZDHHC3
prerank,CellMarker_Augmented_2021__IL-17Ralpha T cell:Peripheral Blood,-0.5906578699984091,-1.101418536837388,0.3111111111111111,0.8747239480745189,1.0,5/13,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,Reactome_2022__Nuclear Import Of Rev Protein R-HSA-180746,-0.45246627218333013,-1.101291072573175,0.2619047619047619,0.8741434846510253,1.0,8/32,25.44%,AAAS;NUP50;NUP54;NUP85;NUP42;POM121C;KPNB1;NPM1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.5186926156397599,1.1012340646995158,0.31746031746031744,0.6235256054266868,1.0,7/47,21.55%,CCNB2;LMNA;RANGAP1;IST1;CCNB1;UBE2I;RCC1
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.5186926156397599,1.1012340646995158,0.31746031746031744,0.6235256054266868,1.0,7/47,21.55%,CCNB2;LMNA;RANGAP1;IST1;CCNB1;UBE2I;RCC1
prerank,KEGG_2021_Human__RNA transport,-0.4043795572061201,-1.101084907423315,0.23076923076923078,0.8738218212578482,1.0,38/145,20.62%,RPP25L;EIF4EBP1;NXT2;PABPC1L;AAAS;POP5;RBM8A;RAE1;NUP50;GEMIN4;EIF2S1;EIF1;EEF1A1;SAP18;EIF3D;PYM1;EIF1AY;EIF1AX;NUP54;PNN;EIF1B;NMD3;EIF3J;EIF3E;RPP38;EIF5B;DDX19A;TRNT1;TARDBP;TGS1;UPF3B;EIF2B3;EIF2B1;RPP40;NUP85;NUP42;EIF5;POP7
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),0.6790666536512366,1.1007103113691785,0.3220338983050847,0.6244113153337199,1.0,3/12,17.50%,WTIP;DLG5;MAP2K3
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.5729128199082434,1.1006424146130311,0.3620689655172414,0.6243540113684825,1.0,10/28,16.17%,DUSP10;TRIM46;DCC;MAG;DIP2B;FGF13;CDKN1B;CDKN1A;PTPRS;KIAA0319
prerank,Reactome_2022__Ubiquinol Biosynthesis R-HSA-2142789,-0.6990502969098131,-1.100592574081929,0.36363636363636365,0.8743196310204572,1.0,2/8,14.73%,COQ3;COQ6
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.7553728236203266,1.1005238533264823,0.4074074074074074,0.6244375268970193,1.0,3/5,23.69%,PINK1;HIF1A;PRKN
prerank,Reactome_2022__AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.45381122206949864,-1.1004707652540748,0.3055555555555556,0.8738582236258672,1.0,10/49,20.20%,HSPA1A;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.5108040559510292,1.1004380104695224,0.3142857142857143,0.6244307724932853,1.0,10/53,18.30%,CD22;RIT2;SNCA;PACSIN1;OPHN1;SCAMP5;MCTP1;LRSAM1;MTMR2;TSC2
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.6232636299740744,1.100339265574058,0.4126984126984127,0.6244492754522648,1.0,7/11,9.40%,KCNJ2;KCNQ1;KCNE4;KCND3;KCNH2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.7139751248413014,1.1003226994739481,0.35714285714285715,0.624287443318304,1.0,2/6,16.95%,SYK;ADGRE2
prerank,CellMarker_Augmented_2021__CD8+ T cell:Lymphoid Tissue,-0.5750885114614434,-1.1003077828050447,0.358974358974359,0.8733977627079841,1.0,6/15,9.92%,CD247;CD96;PYHIN1;CD6;P2RY10;CLEC2D
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.6726749620661442,1.1002376479423859,0.3870967741935484,0.6243204007475418,1.0,6/11,22.87%,DUSP1;LCMT1;CCNB1;CDK5RAP2;DYNC1LI1;USP44
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.6605979968295792,1.1001785628654366,0.3333333333333333,0.6243028784783841,1.0,4/7,29.59%,RAP1A;RAP1B;PRKN;FMR1
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.6488023016400049,-1.10010216112796,0.40540540540540543,0.8731714725395794,1.0,3/8,14.88%,ADH6;SCPEP1;CYP2C8
prerank,Reactome_2022__Formation Of Cornified Envelope R-HSA-6809371,0.5956281373303675,1.1000660745849555,0.3064516129032258,0.6244150790044232,1.0,6/15,22.84%,PKP2;CAPN1;PKP4;CAPNS1;PCSK6;TGM1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.5853390868110926,1.1000450101874473,0.31746031746031744,0.6242642646218458,1.0,6/21,16.31%,SLIT2;RAP1GAP;LIMK2;YAP1;PRKCD;PFN2
prerank,Reactome_2022__Synthesis Of Wybutosine At G37 Of tRNA(Phe) R-HSA-6782861,-0.7135103589145024,-1.0999961174067,0.44,0.872518500087963,1.0,5/5,28.68%,TRMT5;LCMT2;TYW1;TYW3;TYW5
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.48164358955902575,1.099701801676551,0.3466666666666667,0.6249237396307964,1.0,8/81,10.12%,TYMS;IGF2BP2;RBM24;SAMD4A;ENC1;EIF4A3;YTHDF1;SHMT1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.4985059500684992,-1.0996390263305047,0.3157894736842105,0.8727435555094939,1.0,6/25,9.75%,APOBEC3G;TNFAIP3;PTPN22;MUL1;IFNLR1;PQBP1
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),-0.5147190280774157,-1.0993580509705807,0.375,0.8726271328435163,1.0,4/31,11.27%,REEP6;AAAS;GAS1;DNAJC30
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.6123884266423923,1.0989195906057692,0.41509433962264153,0.6265475384154447,1.0,5/13,15.14%,MGAT3;CHST6;CHST4;CHST2;LARGE1
prerank,Reactome_2022__Cellular Response To Hypoxia R-HSA-1234174,-0.4117954559921978,-1.0988945893435453,0.3333333333333333,0.8729987257669347,1.0,12/64,20.20%,EPX;ELOC;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;MIA3;PSMD2;UBB;PSMB4
prerank,KEGG_2021_Human__AMPK signaling pathway,0.45085064174461686,1.0988776149517168,0.28,0.6264609778601078,1.0,26/102,20.94%,IGF1;CREB5;IRS2;FOXO1;FOXO3;PPARG;PFKL;FBP1;TBC1D1;ADIPOR2;CAB39L;CCND1;RPS6KB2;PIK3CD;PFKFB3;LIPE;IGF1R;STK11;TSC2;EEF2K;PPP2R2D;AKT3;PFKP;RHEB;CCNA2;CPT1C
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6481350338783363,-1.0988412017105003,0.4594594594594595,0.8722325726545146,1.0,2/10,8.86%,APOE;GPLD1
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.49149213022348104,1.0988276787609226,0.3387096774193548,0.6263420933830477,1.0,13/40,21.58%,TBL1X;HDAC4;MORF4L2;HDAC9;HDAC7;TBL1XR1;FLNA;MTA1;MORF4L1;MTA3;RCOR1;TRERF1;MIDEAS
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.6186695552530002,1.0983828826307434,0.35714285714285715,0.6272482568957078,1.0,2/14,9.59%,SHTN1;CYRIB
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.7023364362241185,1.09838132112123,0.4642857142857143,0.6270608915552662,1.0,4/7,25.76%,EMP1;P2RX7;ANO6;EMP2
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.5479156328473647,1.098337729339694,0.265625,0.6269527141599747,1.0,12/30,18.30%,DVL1;TGFB2;IFT122;PRICKLE1;DEAF1;COBL;MTHFD1L;MTHFR;VASP;SCRIB;LRP2;TSC2
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),-0.6736487911202034,-1.0981545325880027,0.4318181818181818,0.8736237401042317,1.0,1/7,6.00%,AKR1C3
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In4:Brain,0.7285253547589912,1.0980577850045823,0.4745762711864407,0.6273691900518944,1.0,3/6,4.26%,PDGFRA;TRPC3;MYH11
prerank,Reactome_2022__Role Of ABL In ROBO-SLIT Signaling R-HSA-428890,0.6887630001173459,1.097975413130064,0.38461538461538464,0.627357966622206,1.0,1/7,2.82%,SLIT2
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.4479855144510398,1.097744716379106,0.2894736842105263,0.6276950606688113,1.0,36/158,18.63%,THBS1;CD22;DUSP1;PLEK;EPHA2;SLIT2;DAB2IP;NLRP12;CARD19;WTIP;TNFAIP8L1;APLNR;DGKG;BCL2L1;NLRC3;CYRIB;DLG5;PDE10A;MAPKBP1;BCL2;PER1;MAPKAPK5;OTUD7B;CGNL1;PINK1;P2RX7;ATP2B4;RFFL;RORA;PDE4D;MAP2K3;HDAC7;ITPR1;IFI35;TSC2;CAV3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),0.6863813268305685,1.0976156273768234,0.3877551020408163,0.6278416908659733,1.0,3/8,12.05%,GAB2;SYK;STX4
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),-0.6210745573829226,-1.097498978779154,0.38095238095238093,0.8748962939224868,1.0,4/8,20.96%,PRDX1;PRDX3;GPX1;CAT
prerank,CellMarker_Augmented_2021__Lymphocyte:Undefined,-0.5168395816401334,-1.0972626006688406,0.3939393939393939,0.8746548985455683,1.0,7/25,6.16%,DPEP2;GMFG;CD247;CD96;PYHIN1;PTPN22;P2RY10
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),0.7060282519387155,1.0962430679313562,0.4716981132075472,0.6307212636003395,1.0,2/6,18.37%,SLC16A10;SLC7A8
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),0.7060282519387155,1.0962430679313562,0.4716981132075472,0.6307212636003395,1.0,2/6,18.37%,SLC16A10;SLC7A8
prerank,Reactome_2022__NRAGE Signals Death Thru JNK R-HSA-193648,-0.44841832876721166,-1.0962185923893975,0.225,0.8769175351774678,1.0,1/50,0.09%,NGF
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),0.6867331989760975,1.0961172759664415,0.34615384615384615,0.6308632349815426,1.0,2/6,22.49%,MAPT;KIF13A
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.49396214873159405,1.0961050394491167,0.2833333333333333,0.6306967847378881,1.0,23/77,23.69%,DCN;PLK2;FOXO1;TRIM5;FOXO3;PLEKHF1;TRIM22;OPTN;RNF152;IKBKG;PINK1;TRIM65;TFEB;STK11;TSC2;PLK3;WAC;DHRSX;TBK1;SUPT5H;SESN1;ULK1;PRKN
prerank,"Reactome_2022__Defective B4GALT7 Causes EDS, Progeroid Type R-HSA-3560783",0.5587872750008448,1.0960298448528996,0.375,0.6306666358199633,1.0,5/19,11.16%,CSPG4;DCN;AGRN;BGN;B4GALT7
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.5149825535704263,1.0958593739873088,0.328125,0.6308658213922421,1.0,9/37,10.24%,KCNJ2;KCNQ1;NOS1AP;KCNMB4;GABBR2;GNG2;KCNH2;ATP1B1;ATP1B3
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Liver,0.5179655688607168,1.0957814275977167,0.25,0.6309001140240658,1.0,4/43,5.90%,CTSC;PDGFRA;PTPRC;IGFBP7
prerank,Reactome_2022__Activation Of PUMA And Translocation To Mitochondria R-HSA-139915,0.7237030280063352,1.095749570628775,0.45098039215686275,0.6307660856892265,1.0,3/6,24.91%,BBC3;TP53;PPP1R13B
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.4250023515112624,-1.0955411995558928,0.2,0.8782521351036018,1.0,9/79,15.08%,RAB7B;VPS29;STX16;WASHC2C;ARL1;TMED9;VPS35;VTI1B;RNF126
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.4448537517698312,-1.0954044696642264,0.2682926829268293,0.8778696966741569,1.0,9/47,11.63%,HSD17B8;MCAT;ACMSD;ABCB11;ELOVL4;OSBPL3;CYP46A1;ACSM6;CYP7B1
prerank,Reactome_2022__Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,0.6437221204736663,1.0953276757856705,0.3620689655172414,0.6315628726623513,1.0,9/18,17.92%,LMNB1;APP;FOXO3;CAPN1;LMNA;ERC2;CDC25B;YWHAE;CAPNS1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.595974275292353,1.0951272302902364,0.39344262295081966,0.6318617373365852,1.0,4/16,17.47%,SLIT2;DAPK2;BST1;CAMK1D
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.5951165607779,1.09478872104696,0.35384615384615387,0.6324215772717844,1.0,8/17,21.03%,KCNQ1;KCNH2;GAS6;FBP1;TP53;TFRC;KCNE2;PPM1F
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.5881708723677325,1.0947800948814541,0.4,0.6322514806412133,1.0,8/23,12.75%,GRIN2B;MBP;EFNA1;FYN;GRIN1;STAT3;EPHA4;USP50
prerank,Reactome_2022__Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.4880870420702525,-1.0944946028559819,0.29411764705882354,0.8797458981510687,1.0,20/60,20.25%,RFC3;H2BC4;H2BC21;ATRIP;HUS1;SIRT6;BRIP1;ABRAXAS1;RAD9B;RMI2;CLSPN;POLR1B;RNF168;RNF8;DNA2;BRCC3;H2BC5;UBB;UBE2V2;RAD17
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),0.710460631248713,1.0944690800264611,0.375,0.6328644848489797,1.0,2/8,9.71%,PPARG;ADAM19
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.46286294066626754,1.0944265167689116,0.30434782608695654,0.6327765636355434,1.0,13/100,5.87%,MET;PDGFRA;EPHA7;PTK6;FLT1;SLA;EPHA2;SHC2;EPHA5;FYN;GFRA2;NEDD9;NTRK3
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.5686530102772371,-1.0944072714739377,0.38095238095238093,0.8792246258247768,1.0,1/10,4.36%,APOE
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.542589621400389,1.0944030587020264,0.36666666666666664,0.632617234237554,1.0,7/25,14.19%,THBS1;SULF1;FLT1;PPARG;SPARC;CCL2;IL12A
prerank,Reactome_2022__TCR Signaling R-HSA-202403,0.465261214465007,1.0943538075363255,0.328125,0.6325294434071804,1.0,11/92,15.01%,HLA-DRA;FYB1;WAS;PTPRC;ARHGEF7;PAG1;ENAH;HLA-DRB1;IKBKG;INPP5D;CD4
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),-0.7061683509436887,-1.0939583366914223,0.3617021276595745,0.879685437058601,1.0,1/5,4.36%,APOE
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),-0.6783633862272345,-1.093872221493063,0.4864864864864865,0.8790274595536531,1.0,2/6,7.46%,FBXO5;FBXO43
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.7569920246121624,1.0937788826944255,0.38461538461538464,0.6337129534576261,1.0,1/6,2.65%,DMTN
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5762007275220234,1.093491077080179,0.41935483870967744,0.6342852956111673,1.0,4/16,15.61%,ACSL5;HACD1;ELOVL7;ELOVL5
prerank,Reactome_2022__TP53 Regulates Transcription Of Caspase Activators And Caspases R-HSA-6803207,0.6350964052821542,1.0932163542667674,0.31666666666666665,0.6347109678539334,1.0,2/9,15.46%,CASP10;TP53
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.5768003933196033,1.093167963189536,0.39285714285714285,0.6346048025795542,1.0,6/23,19.61%,ANXA1;LSM11;CCND1;ADAMTS1;ADAM17;CCND2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.6045707416626553,-1.0929668237505448,0.34146341463414637,0.8809102262992375,1.0,2/13,4.40%,TMEM100;FOXJ1
prerank,Reactome_2022__Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,-0.5113348251559159,-1.0926915454196509,0.28205128205128205,0.8798095154552303,1.0,4/34,5.54%,FGF6;FLT3;THEM4;TRIB3
prerank,Reactome_2022__IGF1R Signaling Cascade R-HSA-2428924,-0.5113348251559159,-1.0926915454196509,0.28205128205128205,0.8798095154552303,1.0,4/34,5.54%,FGF6;FLT3;THEM4;TRIB3
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),-0.4785719655719006,-1.0925775823350896,0.2972972972972973,0.8791998131036032,1.0,17/42,23.59%,GRPEL2;TIMM8B;AIP;TIMM13;BCAP31;TIMM23;TSPO;TIMM50;TIMM10;RALA;DNAJC19;FIS1;TIMM17A;TOMM34;SLC25A6;GDAP1;TOMM70
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Placenta,0.6951631897141519,1.0925217573750514,0.4583333333333333,0.6359467109638888,1.0,4/9,6.44%,ACTA2;PTPRC;MCAM;CD44
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.4670232644496989,1.0924889915540097,0.3230769230769231,0.6358437963161151,1.0,29/90,22.32%,RELN;THY1;CAMK2N2;AGAP2;TSPYL2;PTPRC;SMCR8;DVL1;SNCA;RAP2B;YWHAG;MMD;GAS6;CDKN1A;IQGAP1;CD4;TAB1;UBASH3B;WWTR1;MAP2K3;RAP1A;TSC2;CAV3;TAB2;PPM1F;CSF1;C5AR1;HSPB1;MAPRE3
prerank,Reactome_2022__RHO GTPases Activate KTN1 R-HSA-5625970,0.6260420096468915,1.092429561544123,0.4262295081967213,0.635780152586395,1.0,3/10,12.57%,KIF5A;RNASE1;KLC1
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),0.6187175971670967,1.092404509181323,0.3709677419354839,0.6356595362446139,1.0,3/16,3.40%,BLM;KCNC2;FOXO1
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),0.6257028758635464,1.092309038809309,0.3333333333333333,0.6356636688950386,1.0,2/15,3.96%,NMNAT2;PRPS2
prerank,CellMarker_Augmented_2021__Lymphoid-primed Multipotent Progenitor cell:Umbilical Cord Blood,0.5068967119733353,1.0920858380515956,0.36507936507936506,0.6359918540503423,1.0,15/59,18.27%,EBF1;PRAME;LAT2;STK32B;PDE1A;LDB2;CDK9;ADAM19;COBL;ETS1;NKAIN2;PROX2;SSC4D;CRAT;SNX10
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.5535333601276524,1.0919540123541374,0.34285714285714286,0.6361667597352799,1.0,11/28,19.35%,SEMA3C;SEMA5B;SEMA3D;TRIM46;SEMA3B;MAG;DIP2B;PTPRS;KIAA0319;SEMA4D;RTN4
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),0.7016598533399786,1.0918799904344034,0.4528301886792453,0.6361671739880695,1.0,2/6,18.96%,DOCK10;LFNG
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.5176791366181788,1.0918642234678424,0.3333333333333333,0.6360074885438002,1.0,6/30,12.47%,BOK;GGCT;HK2;BCL2L1;BBC3;BCL2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.4877445353414176,1.0917620838165225,0.39655172413793105,0.6360577448456439,1.0,22/65,18.38%,ADGRE5;PRSS57;LMO2;LMNB1;PIM1;IL27RA;GAB3;TUBB1;CD44;ADCY7;GFI1B;TMC8;MFSD2B;ELF1;BCL11A;SIPA1;ETS1;GRSF1;ADGRE2;VASP;TFRC;RELT
prerank,Reactome_2022__HIV Life Cycle R-HSA-162587,-0.42871655952088006,-1.091579347439913,0.1935483870967742,0.8813110075266757,1.0,29/137,20.49%,GTF2H5;POLR2K;AAAS;ELOC;NUP50;GTF2H2;CXCR4;ELOA;VPS4B;TAF13;SUPT16H;ERCC2;GTF2A2;TAF11;POLR2C;NMT2;NUP54;CCNT1;GTF2F1;POLR2D;RNF103-CHMP3;GTF2F2;ERCC3;UBB;BANF1;POLR2L;POLR2G;NUP85;NUP42
prerank,"Reactome_2022__TICAM1, RIP1-mediated IKK Complex Recruitment R-HSA-168927",0.5905977469898677,1.0915238664204514,0.3090909090909091,0.6363284164438248,1.0,4/17,19.96%,BIRC3;IKBKG;TLR3;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.4215858477047301,1.091475024808274,0.25,0.6361937099052493,1.0,42/226,15.99%,BOK;MLLT11;SLIT2;SEPTIN4;MAP3K11;DAB2IP;FOXO1;KLF11;ARHGEF17;SOX4;FAS;BCL6;ARHGEF3;TFPT;FOXO3;SNCA;PAWR;CYP1B1;OBSCN;DAPK2;MCF2;CTNNB1;KALRN;NEURL1;ARHGEF7;PNMA2;SYK;TRIO;PXT1;PLEKHG2;BARD1;GADD45A;TNFRSF10B;FADD;KCNMA1;BIN1;RARG;MAP3K5;STK3;TP53;NGEF;VAV2
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.6542205009417629,1.0913191491349334,0.4262295081967213,0.6362687367182286,1.0,2/12,13.12%,APLNR;AKAP8
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.6792691206164181,1.0910770587908598,0.4166666666666667,0.6365994841323709,1.0,4/7,25.83%,B2M;HLA-E;HLA-F;HLA-A
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.4059382570000956,1.0908343662717148,0.225,0.6369868484888124,1.0,26/375,7.53%,SKOR1;MYT1;ELAVL2;PTP4A3;TEAD2;ZNF536;PRDM8;CASZ1;APP;HIC1;ZNF282;WTIP;PPARGC1B;NFATC2;NFIL3;SOX4;NKX6-2;AHR;GZF1;CHD3;DVL1;ZNF114;GRM5;FOXO3;PML;PDGFA
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),-0.442407399288848,-1.0907893184159192,0.22857142857142856,0.8826873598998556,1.0,21/88,23.20%,FIP1L1;AAAS;RBM8A;RAE1;NUP50;U2AF1;CPSF1;DDX25;NUP54;MCM3AP;SRSF2;CPSF3;SRSF9;UPF3B;CHTOP;NUP85;NUP42;POM121C;THOC3;THOC1;NXT1
prerank,CellMarker_Augmented_2021__Neural Tube cell:Germ,0.658862956470905,1.0907768303722105,0.38333333333333336,0.6369586094490989,1.0,3/11,4.96%,NELL2;MCAM;FAS
prerank,Reactome_2022__Nucleotide Salvage R-HSA-8956321,0.5913544100780257,1.0906561889526987,0.41935483870967744,0.6370581535280903,1.0,3/17,10.78%,GMPR;ADA;PUDP
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),-0.6327114802558962,-1.0905972449787487,0.45652173913043476,0.8822666782937092,1.0,2/6,10.54%,CFTR;NOX1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.4517572762332664,-1.0905584046226031,0.3103448275862069,0.8815202430179327,1.0,6/44,14.09%,AAAS;RAE1;NUP50;NOA1;NUP54;JMJD8
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.6939353819918974,1.0903728687524732,0.4032258064516129,0.6375514607150214,1.0,2/8,15.53%,PID1;PINK1
prerank,KEGG_2021_Human__Glycerophospholipid metabolism,0.46863659006011016,1.0901976437543264,0.2878787878787879,0.6377642625815167,1.0,19/76,22.89%,PLD1;LPCAT4;ACHE;DGKG;AGPAT4;PLAAT3;PLD2;CHKB;PLPP4;CDS2;PLB1;LPIN3;DGKI;DGKZ;DGKD;PNPLA6;PLPP1;ETNK2;CDS1
prerank,KEGG_2021_Human__Human papillomavirus infection,0.4236915714389196,1.0899875745641285,0.3287671232876712,0.6381364949713463,1.0,65/263,19.74%,COL4A1;EGF;CREB5;THBS1;ITGA8;COL4A2;HES7;RELN;FOXO1;WNT8B;FAS;LAMB1;ITGA2;DVL1;PARD3;TNFRSF1A;CDK6;ITGA11;LAMA5;CTNNB1;ITGA3;IKBKE;ITGA9;COL9A1;LAMA2;ITGB8;COL4A4;PXN;TYK2;MX1;CDKN1B;DLG3;FN1;CHAD;CDKN1A;CCND1;COL4A5;FADD;RPS6KB2;MAML2;THBS2;IKBKG;PATJ;PIK3CD;SPP1;HLA-E;NOTCH3;LAMA3;TP53;THBS3;FZD7;CDK2;MAGI1;SCRIB;WNT5A;COL4A3;TNR;TSC2;LFNG;ITGB4;ATP6V1B2;TLR3;CCND2;PPP2R2D;NOTCH4
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.6017324971591019,-1.0899043250384715,0.3617021276595745,0.8826570397111914,1.0,2/18,1.74%,AR;VAMP8
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.5330226239208715,1.0897300067685098,0.3387096774193548,0.6385545809179789,1.0,2/32,3.62%,ANK3;AMN
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.5086015861725249,1.089404454938547,0.39655172413793105,0.6390999817578299,1.0,11/47,19.70%,RBM24;SRRM4;KHDRBS2;MBNL2;CELF3;WTAP;RBFOX2;NOVA2;RBM5;KHDRBS3;CELF2
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),-0.46110411245716965,-1.0892885501966265,0.30303030303030304,0.8835717428326352,1.0,15/49,18.79%,ABCD2;MCAT;PHYH;ABCD1;ADH4;CYP4V2;ADH5;ADIPOR1;CPT2;ECHS1;MTLN;PEX13;EHHADH;ACADS;DECR1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),0.4815389223409654,1.0891323585774664,0.3,0.639567113284078,1.0,15/68,15.01%,TLR2;IGF1;THBS1;RASGRP1;ZFP36;APP;PTPRC;NLRC3;STAT3;SYK;GAS6;FADD;IFIH1;HLA-E;RARA
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5524066285044195,1.0891069520754517,0.3389830508474576,0.6394283696486395,1.0,3/19,4.06%,PDGFRA;FLT1;AGAP2
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.6836015673721652,1.0888490635265418,0.4426229508196721,0.6398172271848535,1.0,2/10,9.86%,RBM24;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.6679419626532586,1.0886406166028733,0.43859649122807015,0.640149218489139,1.0,3/7,18.63%,KCNH2;BIN1;CAV3
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.45109669640445665,-1.088478011534445,0.34285714285714286,0.8851282837728884,1.0,7/75,5.85%,ID2;MID1IP1;DISP3;PMVK;TM7SF2;NPC2;NR1D1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.5375908328744795,1.088257857917789,0.29310344827586204,0.6408879020943442,1.0,7/37,11.69%,ST6GAL1;B3GNT2;GALNT12;GALNT8;POMGNT1;CHST4;B4GALT5
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",-0.7171857131446492,-1.088150053949315,0.4186046511627907,0.8851384685381304,1.0,4/6,26.00%,UTP20;RPS21;RPP40;NOP14
prerank,Reactome_2022__Signaling By Erythropoietin R-HSA-9006335,-0.5155156916081869,-1.0881362699760793,0.28205128205128205,0.8842946436573911,1.0,2/22,4.64%,EPX;EPOR
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Brain,-0.5083014306316049,-1.0880921689597176,0.2702702702702703,0.883505347386948,1.0,5/27,6.16%,DPEP2;GMFG;CD247;RHOH;P2RY10
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.5448671782568698,-1.0879242694515734,0.30434782608695654,0.8830871980525331,1.0,2/23,1.79%,OTUD3;TNFAIP3
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.4435796438262028,1.0878098524987976,0.34782608695652173,0.6418560488092288,1.0,13/89,16.08%,PLD1;THBS1;SAMD4A;SOX4;EIF4A3;LARP6;YTHDF1;NIBAN1;KLF4;FADD;TRIM32;IST1;TBC1D10A
prerank,CellMarker_Augmented_2021__Megakaryocyte Progenitor cell:Peripheral Blood,0.6117537055502362,1.087647678060739,0.35714285714285715,0.6419749507984174,1.0,5/18,11.65%,P2RY13;TUBB1;MAP3K7CL;P2RY12;GFI1B
prerank,Reactome_2022__MECP2 Regulates Transcription Factors R-HSA-9022707,0.7273138570986866,1.0875912179179454,0.4074074074074074,0.6418993563603266,1.0,1/5,9.35%,PPARG
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.5881303053628668,1.0874240172433782,0.40625,0.642071181179792,1.0,8/13,10.24%,KCNJ2;KCNQ1;KCNE4;KCND3;KCNH2;ATP1A1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),0.6234605236608819,1.087389377951022,0.4444444444444444,0.6419744065407137,1.0,6/17,16.62%,AGTPBP1;STAT3;IFT122;COL5A1;RARG;C12ORF57
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432),0.688487481896819,1.0873616429211805,0.45,0.6418706273769449,1.0,2/6,3.55%,SLC15A3;ERBIN
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.543955611452454,1.0873579891049439,0.373134328358209,0.6416927673010699,1.0,3/27,3.17%,TLR2;MBP;APP
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.5272494351958472,1.0872105230072737,0.3333333333333333,0.6419103305143562,1.0,5/43,12.96%,S100A10;DMTN;NEDD9;ARHGEF7;PDPN
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),0.5258685293567564,1.0869707806925615,0.3448275862068966,0.6423183015373802,1.0,4/41,10.20%,SLC6A15;SLC16A14;SLC17A5;SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.7564586244746715,1.0863755209639003,0.38461538461538464,0.6435937768736395,1.0,3/5,11.71%,TLR2;NAMPT;CCL2
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.4834609711838836,1.0862026062542447,0.3188405797101449,0.643845826943435,1.0,7/64,4.53%,PROX1;EGF;THBS1;NR4A1;SULF1;NRP2;EGFL7
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.6299195399291944,1.0861646202080641,0.35714285714285715,0.643776921031229,1.0,8/13,26.96%,CD55;TRPM4;B2M;TNFSF4;HLA-F;FZD5;HLA-A;MAP3K7
prerank,Reactome_2022__Sensory Processing Of Sound R-HSA-9659379,0.5129771607399687,1.0860656501820083,0.31746031746031744,0.6438455020750589,1.0,12/58,14.04%,CDH23;MYH9;EPS8L2;SYP;PCLO;MYO15A;CTBP2;DNAJC5;EPB41L1;CABP1;PCDH15;KCNMA1
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),-0.6254843142147594,-1.085894717105758,0.41025641025641024,0.8882758546705702,1.0,3/11,25.71%,HES5;ZFP36L2;HES1
prerank,Reactome_2022__Defensins R-HSA-1461973,0.7299864677970471,1.085794410493553,0.3584905660377358,0.6443790986789141,1.0,1/6,0.81%,TLR2
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.6300734757662266,-1.0856047311985864,0.37209302325581395,0.888297921202267,1.0,2/9,6.01%,FBLN5;ABCD1
prerank,Reactome_2022__Regulation Of Gene Expression In Beta Cells R-HSA-210745,0.6176597127214281,1.0855942109775005,0.41818181818181815,0.6446094712281931,1.0,1/9,3.40%,FOXO1
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),0.6220823965846293,1.0854659265593987,0.37254901960784315,0.6447235101402484,1.0,1/10,4.64%,SHANK3
prerank,CellMarker_Augmented_2021__Tumor Endothelial cell:Colon,-0.646311797480458,-1.085422097899717,0.3541666666666667,0.8869896673576196,1.0,3/7,20.80%,KRT10;IL20RB;SLC10A6
prerank,CellMarker_Augmented_2021__Tumor Endothelial cell:Kidney,-0.646311797480458,-1.085422097899717,0.3541666666666667,0.8869896673576196,1.0,3/7,20.80%,KRT10;IL20RB;SLC10A6
prerank,Reactome_2022__Regulation Of Necroptotic Cell Death R-HSA-5675482,0.557432243475904,1.0852705633135094,0.36666666666666664,0.644995877599734,1.0,7/26,26.28%,BIRC3;TNFRSF10B;FADD;RPS27A;FLOT2;FLOT1;OGT
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),0.6837700549338621,1.0852129879831578,0.45454545454545453,0.6449689746567713,1.0,3/7,19.68%,PRKCD;CAMK2A;AHCYL1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),-0.6234796610728341,-1.0851287807047225,0.3888888888888889,0.8869378895877993,1.0,4/9,24.45%,MICA;CEBPG;TUBB;VAMP7
prerank,Reactome_2022__MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,0.455692616437474,1.0851121506031483,0.29850746268656714,0.6450265155977618,1.0,8/93,7.62%,TLR2;KCNH8;IRAK2;APP;RPS6KA1;NOD1;NLRC5;MYD88
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),-0.7021822398876308,-1.0848820475610736,0.4,0.8866537858972567,1.0,1/5,9.26%,ACVR1C
prerank,"Reactome_2022__Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.48742340850635646,1.0847386876035823,0.3770491803278688,0.645794404611749,1.0,4/57,4.40%,SLC6A15;SLC39A14;CP;EMB
prerank,Reactome_2022__ABC Transporters In Lipid Homeostasis R-HSA-1369062,0.5812635791919247,1.0846627374883695,0.36363636363636365,0.6457497055461103,1.0,5/15,10.90%,ABCA6;ABCA5;ABCA10;ABCA9;ABCA2
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),0.6558225334232994,1.0846163382838085,0.4153846153846154,0.6456769166687326,1.0,4/11,17.57%,NLGN1;DVL1;NLGN4X;WNT5A
prerank,Reactome_2022__Fatty Acids Bound To GPR40 (FFAR1) Regulate Insulin Secretion R-HSA-434316,0.765371966889135,1.084531047261747,0.3333333333333333,0.6457236326007072,1.0,1/5,8.48%,GNA14
prerank,CellMarker_Augmented_2021__Myeloid Dendritic cell:Thymus,0.54181900392711,1.0844322573593053,0.31343283582089554,0.6455571344222074,1.0,7/29,4.31%,CTSS;P2RY13;MYO1F;PLEK;CSF2RA;LAT2;PTPRC
prerank,CellMarker_Augmented_2021__Dendritic cell:Spleen,0.54181900392711,1.0844322573593053,0.31343283582089554,0.6455571344222074,1.0,7/29,4.31%,CTSS;P2RY13;MYO1F;PLEK;CSF2RA;LAT2;PTPRC
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.5603172577145552,1.0843318990917017,0.3508771929824561,0.6455687406139919,1.0,8/27,16.77%,ATP2B3;ITPR3;CACNA1C;JPH4;RYR2;MCUB;SLC8A2;SLC8A1
prerank,CellMarker_Augmented_2021__Beta cell:Pancreatic Islet,0.4916544266003396,1.083916784871225,0.3472222222222222,0.6464260797469431,1.0,8/75,7.39%,MRAP2;NPTX2;ELMO1;CNTN4;NECAB1;CDH18;ROBO2;SYT13
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.7063831280884943,1.0838660663571287,0.3684210526315789,0.6463356771773088,1.0,1/5,10.25%,SLC4A11
prerank,KEGG_2021_Human__Breast cancer,0.47036273965925257,1.0837588758131944,0.25757575757575757,0.6463610659522379,1.0,9/115,8.12%,LEF1;IGF1;EGF;SHC2;WNT8B;DVL1;PGR;CDK6;CTNNB1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.5992051332473357,1.0837156703790873,0.40384615384615385,0.6463198232779803,1.0,7/24,15.38%,MAP3K11;DAB2IP;DUSP10;MAPK8IP1;HIPK3;PAK1;MAP3K5
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,0.6217063217724492,1.083637437945227,0.32786885245901637,0.6463101509944852,1.0,7/15,13.18%,FOXO1;FOXO3;SMAD3;GADD45A;CDKN1B;KLF4;CDKN1A
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.46808177100605486,-1.0836040040806478,0.38461538461538464,0.889561104090708,1.0,4/39,1.74%,TRIM29;GALNT3;CEBPA;VAMP8
prerank,CellMarker_Augmented_2021__Myeloid cell:Peripheral Blood,0.6843209154647889,1.0835819475659376,0.4576271186440678,0.6463004845588035,1.0,1/5,4.31%,PTPRC
prerank,KEGG_2021_Human__Intestinal immune network for IgA production,0.5681689637770395,1.0835590605916698,0.3548387096774194,0.646196244820663,1.0,6/17,13.76%,HLA-DRA;IL15;MAP3K14;CCR10;HLA-DRB1;HLA-DMA
prerank,Reactome_2022__Glycerophospholipid Catabolism R-HSA-6814848,-0.6159333021630575,-1.0835295358154644,0.36363636363636365,0.8888559315285564,1.0,3/7,18.58%,GDE1;ENPP6;GDPD1
prerank,CellMarker_Augmented_2021__Monocyte:Subcutaneous Adipose Tissue,0.5806876188142741,1.083217540594957,0.3384615384615385,0.6466321042676991,1.0,6/25,4.31%,CTSS;P2RY13;MYO1F;PLEK;SLA;PTPRC
prerank,CellMarker_Augmented_2021__Macrophage:Subcutaneous Adipose Tissue,0.5806876188142741,1.083217540594957,0.3384615384615385,0.6466321042676991,1.0,6/25,4.31%,CTSS;P2RY13;MYO1F;PLEK;SLA;PTPRC
prerank,CellMarker_Augmented_2021__Neutrophil:Sputum,-0.5008155658820265,-1.0832131974095123,0.38095238095238093,0.8881666948395581,1.0,7/24,11.41%,TRIM29;CYP4F3;TMC5;SCEL;ATP2C2;EHF;B3GNT3
prerank,CellMarker_Augmented_2021__Neutrophil:Bronchoalveolar System,-0.5008155658820265,-1.0832131974095123,0.38095238095238093,0.8881666948395581,1.0,7/24,11.41%,TRIM29;CYP4F3;TMC5;SCEL;ATP2C2;EHF;B3GNT3
prerank,CellMarker_Augmented_2021__CD4+ T cell:Colon,-0.5213106743189978,-1.0830582490580125,0.3333333333333333,0.8876216508297136,1.0,9/26,11.84%,DPEP2;CD247;CD96;RHOH;PYHIN1;P2RY10;CLEC2D;MAP4K1;BIN2
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Gingiva,0.6861515772286704,1.082739090179836,0.32142857142857145,0.6475742865695951,1.0,2/7,6.44%,THY1;CD44
prerank,Reactome_2022__Gap Junction Trafficking R-HSA-190828,0.606195435080046,1.0825949318835537,0.4393939393939394,0.6476762116176412,1.0,2/13,6.30%,DNM1;CLTB
prerank,Reactome_2022__TCF Dependent Signaling In Response To WNT R-HSA-201681,0.44079107516376,1.0825451807018962,0.30434782608695654,0.6475996951953965,1.0,5/150,4.92%,LEF1;KREMEN2;WNT8B;LGR5;SOX4
prerank,Reactome_2022__DNA Double Strand Break Response R-HSA-5693606,-0.5065702339677396,-1.082469288423855,0.24324324324324326,0.8884491206671892,1.0,11/43,19.72%,KPNA2;H2BC4;H2BC21;ABRAXAS1;RNF168;RNF8;BRCC3;H2BC5;SMARCA5;UBB;UBE2V2
prerank,Reactome_2022__Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,0.4836628238368586,1.0823240214340888,0.3125,0.6479148431454892,1.0,12/56,11.21%,SPRN;PSCA;CNTN4;RTN4RL1;THY1;OPCML;MDGA2;NRN1;PIGA;ART3;LY6H;CNTN5
prerank,Reactome_2022__Heme Biosynthesis R-HSA-189451,-0.5998208024770431,-1.0818751905757737,0.38636363636363635,0.889103704277242,1.0,3/11,11.79%,ALAS1;HMBS;FECH
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),-0.7245933227328456,-1.0817750470146004,0.3958333333333333,0.8884626392606076,1.0,1/5,8.81%,ATP6V1G1
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.5342711078116859,1.0815720879552253,0.30434782608695654,0.6493553638317942,1.0,5/38,7.51%,GGT5;AWAT1;ALOX12;FAAH;CYP1B1
prerank,Reactome_2022__Peptide Hormone Metabolism R-HSA-2980736,0.5082152671261306,1.0812736865409136,0.3442622950819672,0.6498410221281633,1.0,9/51,12.89%,IGF1;PCSK2;ACHE;ENPEP;CTNNB1;KIF5A;KIF5C;AOPEP;KLF4
prerank,CellMarker_Augmented_2021__Liver Bud Hepatic cell:Liver,0.44946655411148334,1.0807612092403611,0.3484848484848485,0.6507386123843869,1.0,14/148,8.82%,MET;SCN9A;P2RY6;SERPINE1;STEAP3;IRAK2;IL1R1;OSMR;CFH;SERPINF1;PID1;C1R;FKBP5;ITIH2
prerank,CellMarker_Augmented_2021__Progenitor cell:Corneal Epithelium,0.5207072743050761,1.0806471448758816,0.3225806451612903,0.6507939988751478,1.0,13/48,8.72%,MET;THBS1;SERPINE1;EPHA2;SEMA3C;OSMR;COL12A1;ITGA2;GPR87;RHOD;EMP1;MYO1C;ITGA3
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.6530814854694523,1.0805603092464648,0.3728813559322034,0.6507865081469972,1.0,1/9,6.52%,ZIC1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.6517038055820341,1.080286904568984,0.4067796610169492,0.6512920921947771,1.0,1/8,0.79%,ANK3
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.6188544408467574,1.0801855708089672,0.4107142857142857,0.6513193482711704,1.0,5/11,26.57%,PIP4K2A;LRSAM1;ELAPOR1;ANXA2;SH3GLB1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.6093987067270357,1.07996889773741,0.44642857142857145,0.6516674998805716,1.0,1/12,1.14%,GRIN2A
prerank,CellMarker_Augmented_2021__Dendritic cell:Undefined,0.6529698834091358,1.07991349200756,0.47368421052631576,0.6515969871512483,1.0,4/11,10.69%,IRF7;PTPRC;ADAM19;CD83
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.6389756438063534,1.079880886412408,0.36363636363636365,0.6514811978594989,1.0,3/13,9.25%,EPHA2;MYO1C;PRKCH
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5037747792602505,1.0798222156989798,0.4074074074074074,0.6513689632214594,1.0,12/41,15.60%,ITPKC;PLCH2;ITPKB;ITPK1;NUDT4;INPPL1;INPP5A;INPP5J;INPP4A;FGF2;INPP5D;IMPA1
prerank,KEGG_2021_Human__Central carbon metabolism in cancer,0.4938257843024558,1.0797999260092752,0.31343283582089554,0.6512010523810702,1.0,10/56,15.46%,MET;PDGFRA;NTRK3;HK2;LDHA;PFKL;HK1;PDK1;PIK3CD;TP53
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.5432915141260953,-1.079796413720261,0.30434782608695654,0.89334450447691,1.0,5/17,13.68%,SRPRA;SRPRB;SPCS1;ZFAND2B;SPCS2
prerank,Reactome_2022__SHC1 Events In ERBB4 Signaling R-HSA-1250347,0.6365754872207345,1.0797163526289753,0.42,0.6512073890780827,1.0,3/10,17.35%,NRG1;NRG2;SHC1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.6604209117485127,1.0793874626932578,0.40384615384615385,0.6516524396481026,1.0,1/7,2.91%,WAS
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.48777172628446924,1.0793340643931932,0.34285714285714286,0.6515716159691219,1.0,14/57,9.85%,RASGRP2;CTSS;CD22;MYO1F;PLEK;NAPSB;WAS;PTPRC;LINC00926;CD37;BIRC3;ACAP1;STAG3;ADAM28
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5354086371600486,-1.079246534359605,0.3333333333333333,0.8941334387335464,1.0,2/22,2.37%,FAM47E;DNMT3B
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.7117466856705159,1.0792388705360574,0.43859649122807015,0.6516474316272386,1.0,3/5,25.08%,KDM6A;PHF8;KDM6B
prerank,CellMarker_Augmented_2021__Eosinophil:Bronchoalveolar System,0.5789440519243655,1.0790868756982896,0.4107142857142857,0.6518275643196766,1.0,4/17,9.22%,HPN;NOTUM;ITIH2;FTCD
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.6713562305919649,1.0789865016353517,0.38181818181818183,0.6518545697843192,1.0,4/5,31.48%,PLEKHA4;MLLT3;RSPO3;SPEF1
prerank,Reactome_2022__RHOBTB1 GTPase Cycle R-HSA-9013422,-0.527253079019354,-1.0789243610288022,0.3333333333333333,0.8943348824493499,1.0,4/23,14.93%,CCT7;VIM;PDE5A;RBMX
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.5697436389023721,1.0788439281139228,0.423728813559322,0.6519823823212745,1.0,3/22,3.88%,TLR2;APP;ACKR1
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),0.7038880535111374,1.078430291996785,0.4603174603174603,0.6528573769574595,1.0,3/7,12.29%,SYK;MAPT;PRKCD
prerank,Reactome_2022__Free Fatty Acids Regulate Insulin Secretion R-HSA-400451,0.6687184216747151,1.0784110331855854,0.42592592592592593,0.6527242187490806,1.0,1/8,8.48%,GNA14
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.49326643450724206,1.0782547716049253,0.2714285714285714,0.6529107059361927,1.0,6/54,7.62%,ANXA1;IL1R1;BCL6;SAMHD1;BIRC3;MYD88
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.48028429286508784,1.078252887369238,0.29411764705882354,0.6527220515603315,1.0,7/73,5.44%,CDKN2A;PROX1;CCNB2;PSRC1;BLM;CCNI2;CDK5R2
prerank,Reactome_2022__Cobalamin (Cbl) Metabolism R-HSA-9759218,-0.6551792122308088,-1.0781922395056616,0.36363636363636365,0.895780782804448,1.0,2/6,11.37%,MMAB;MMACHC
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.4970847791997349,1.0779462565821147,0.35294117647058826,0.6533180597873369,1.0,20/61,22.94%,KIF14;PLK2;FSD1;BCL2L1;CDC14A;CENPV;PRKCE;ZFYVE19;PKP4;CALM3;CDC25B;PLK3;RAB11A;RAB11FIP4;PRPF40A;DCDC1;KIF13A;KLHL21;CUL3;PIN1
prerank,CellMarker_Augmented_2021__Unrestricted Somatic Stem cell:Undefined,0.7021556140640075,1.0779319751061494,0.39285714285714285,0.653157159768406,1.0,2/5,6.44%,THY1;CD44
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.5729996387633857,1.0776961062688641,0.2857142857142857,0.6534751305523916,1.0,2/17,4.89%,ELMO1;WASF1
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),-0.6145168029269301,-1.0775710329690487,0.27906976744186046,0.8968907452130161,1.0,5/13,23.56%,BRDT;ZSCAN21;FOXJ2;SYCP3;MOV10L1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.6019075129353216,1.0774161784156686,0.3620689655172414,0.6539767331856265,1.0,4/14,15.90%,LPCAT4;CDS2;PNPLA8;ABCA3
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.6045924501732961,1.07709004844476,0.3787878787878788,0.6545404472123818,1.0,1/12,0.99%,TYMP
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.4036255826420502,1.0769500188590209,0.2702702702702703,0.6546844056810003,1.0,78/373,17.85%,VRK2;ARHGAP4;CD24;NLGN1;BLM;RIT2;ARHGAP39;MOB3B;DAB2IP;RPA1;NLRP12;PAK3;ARHGEF17;ARHGDIG;PRKAR1B;NUAK1;ARHGEF3;CHD3;NTRK3;BIRC3;RHOD;PAK4;PML;OBSCN;DAPK2;MCF2;WDR54;TRIP10;PPP1R16B;KALRN;ARHGAP26;GNA12;ARHGEF7;TAF4B;MINK1;PIP4K2A;FBXL2;TRIO;MAPT;PLEKHG2;OPHN1;BARD1;PRR5;STARD13;ARHGAP18;HIPK1;MAPKAPK5;MYO9A;PAK1;OPTN;SGMS1;PRDM1;HIPK2;IKBKG;ARHGAP17;MRE11;MAPK11;PRKAR1A;TTI1;STK3;TP53;ARHGAP22;NGEF;PIP5K1C;VAV2;BRCA1;CDK2;BST1;RFFL;RHOT1;TRAF5;RHOT2;MCF2L;RCN3;GNAI1;WNT5A;STK11;RHOQ
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.49419627170204505,1.0769188094593714,0.3787878787878788,0.6545406638541412,1.0,7/50,21.55%,CCNB2;LMNA;RANGAP1;IST1;CCNB1;UBE2I;RCC1
prerank,Reactome_2022__Glycogen Synthesis R-HSA-3322077,-0.6231213809452452,-1.0767488658187174,0.34285714285714286,0.8987824540023167,1.0,1/11,2.63%,PPP1R3C
prerank,CellMarker_Augmented_2021__Sertoli cell:Undefined,0.6221408842416665,1.07672508494374,0.43636363636363634,0.6548923879670427,1.0,2/9,8.69%,AMH;KITLG
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.44552331888316576,1.0767164143490648,0.3188405797101449,0.6547105751229007,1.0,24/88,17.46%,ABCA6;ABCA8;ABCA5;FABP3;SLCO1A2;ABCA10;MFSD2A;LDLR;SPNS2;ABCA9;SLCO2A1;ABCA2;SLC51A;SLC27A3;PLEKHA8;SLC27A5;MFSD2B;ABCC4;NME4;RXRA;ABCA3;SLCO3A1;PITPNM1;ABCG1
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.5634017827062577,1.07668562562831,0.33962264150943394,0.6546188861786211,1.0,3/18,3.50%,IGF1;CD24;IL27RA
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),0.7241532738786733,1.076576157145409,0.5094339622641509,0.6546587735152645,1.0,2/6,14.94%,UNC13C;STX1B
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),0.7555310026747457,1.076339858836673,0.45454545454545453,0.6549823619256706,1.0,1/5,1.62%,PKP2
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),0.5471595760613371,1.0763371890029887,0.34375,0.6547903621756647,1.0,5/24,16.90%,TYMS;NUDT13;AK5;NME4;DUT
prerank,CellMarker_Augmented_2021__CD8+ Regulatory T cell:Undefined,-0.5446783231446625,-1.0762985343539417,0.3548387096774194,0.8992815015873803,1.0,7/28,6.16%,GMFG;CD247;CD96;RHOH;PYHIN1;CD6;P2RY10
prerank,Reactome_2022__Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,0.4517250081695563,1.0760251950205526,0.30158730158730157,0.6553661519015228,1.0,21/92,20.32%,KCNH8;IRAK2;APP;RPS6KA1;IRF7;NOD1;BIRC3;NLRC5;IKBKE;FADD;TNIP2;IKBKG;MAPK11;TP53;TAB1;MAPK9;MAP2K3;SKP1;TLR3;RPS27A;TAB2
prerank,Reactome_2022__RHO GTPases Activate Rhotekin And Rhophilins R-HSA-5666185,-0.6766405546245055,-1.0760177110742302,0.36,0.8991300511482944,1.0,1/8,0.63%,TAX1BP3
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),0.5644530394461851,1.0759959710423732,0.3793103448275862,0.6552536623816416,1.0,5/25,5.50%,CD22;IRS2;PTPRC;NFATC2;AHR
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.5930361103535327,-1.0759881275309098,0.38095238095238093,0.8983226253637933,1.0,2/8,13.49%,BECN1;ATG14
prerank,Reactome_2022__Synthesis Of Leukotrienes (LT) And Eoxins (EX) R-HSA-2142691,0.6264398587612773,1.0759222302661862,0.3442622950819672,0.6552483738660452,1.0,1/11,0.01%,GGT5
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.6647587338883365,1.0758580126346151,0.4444444444444444,0.6552603630182015,1.0,3/6,15.46%,MAPKAPK5;CDKN1A;TP53
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Adipose Tissue,0.6424722908021872,1.0756806307972728,0.45,0.655462308071063,1.0,4/11,12.89%,THY1;PTPRC;CD44;KLF4
prerank,Reactome_2022__Acyl Chain Remodelling Of PC R-HSA-1482788,0.6094932028702028,1.0755414061192028,0.3709677419354839,0.6555985287618254,1.0,4/16,14.76%,LPCAT4;PLAAT3;PLB1;PNPLA8
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),0.7114072441121007,1.0753612543963216,0.4262295081967213,0.6557829937509203,1.0,2/8,8.19%,SKAP1;ASS1
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),0.6643718837158016,1.0753176183671627,0.36538461538461536,0.6556705810679756,1.0,2/9,9.35%,PRKCB;PPARG
prerank,CellMarker_Augmented_2021__T cell:Spleen,-0.540297856948402,-1.0752981069251306,0.34146341463414637,0.8995425983237018,1.0,6/20,6.16%,GMFG;CD247;CD96;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),0.6042841826389431,1.0752795062469864,0.4,0.6555927329153658,1.0,2/10,1.68%,ANXA1;THBS1
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5819109812943283,1.0752644853142583,0.3333333333333333,0.6554183664961512,1.0,2/20,3.52%,ELMO1;MYH9
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.49079185863261743,1.0752509406133401,0.34375,0.6550561580109459,1.0,14/57,16.00%,ELMO1;WAS;FYN;BAIAP2;MYO1C;PLD2;ARPC3;PRKCE;SYK;PLPP4;PRKCD;PAK1;VAV2;WIPF3
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.49079185863261743,1.0752509406133401,0.34375,0.6550561580109459,1.0,14/57,16.00%,ELMO1;WAS;FYN;BAIAP2;MYO1C;PLD2;ARPC3;PRKCE;SYK;PLPP4;PRKCD;PAK1;VAV2;WIPF3
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.594938510569642,-1.0752465838843792,0.36363636363636365,0.8988025743076683,1.0,6/11,12.90%,RETSAT;ADH6;ADH4;LRAT;RDH10;RDH11
prerank,CellMarker_Augmented_2021__B cell:Peripheral Blood,0.6675933206766075,1.075112267197259,0.36363636363636365,0.6551922159803124,1.0,3/8,4.66%,CD24;PTPRC;CD37
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.5131524609192805,1.0750997780287386,0.35384615384615387,0.6550250651277914,1.0,4/26,7.82%,ANK3;DMTN;FYN;MYO1C
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.5108850073433312,1.0749239098689103,0.3225806451612903,0.6552127056793868,1.0,15/46,19.54%,RASGRP1;IL1R1;CYRIB;GAS6;HLA-DRB1;CD276;FADD;IL12A;RARA;PDCD1LG2;PDE4D;SCRIB;TNFSF4;ZFPM1;TLR3
prerank,Reactome_2022__FOXO-mediated Transcription Of Cell Death Genes R-HSA-9614657,0.6513451136211784,1.074795720127578,0.3888888888888889,0.65527974413147,1.0,6/15,17.81%,FOXO1;BCL6;FOXO3;BBC3;PINK1;STK11
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.6414675386813304,1.074629480186799,0.4,0.6554981717486225,1.0,4/6,31.90%,POLE3;BAHD1;SIRT1;EZH1
prerank,KEGG_2021_Human__Complement and coagulation cascades,0.5171988792353813,1.0745596475023333,0.4,0.6554721909268318,1.0,9/39,15.22%,C3;SERPINE1;CD55;CFH;C1R;TFPI;SERPIND1;SERPING1;CD59
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.5025913477539407,1.0745176927221374,0.373134328358209,0.6553671164461569,1.0,11/54,10.10%,TLCD2;ANK3;A4GALT;FA2H;DYSF;MYH9;PLSCR1;PLSCR2;MICALL1;SYTL4;PACSIN1
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.6444497831778179,1.0744260759443578,0.4482758620689655,0.6553790134686736,1.0,2/10,3.96%,ADA;PRPS2
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.45736650203219287,-1.0742992301773742,0.2857142857142857,0.900365279840183,1.0,2/42,2.56%,FTL;FTH1
prerank,Reactome_2022__PPARA Activates Gene Expression R-HSA-1989781,-0.42132302007508204,-1.074290760963503,0.3076923076923077,0.8995304037592883,1.0,7/96,5.95%,G0S2;MED21;MUSK;MED10;TRIB3;NR1D1;ALAS1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.610635293414483,1.073962523773747,0.3888888888888889,0.6563258993738544,1.0,4/9,29.79%,SLC27A5;SLC27A1;CD36;ACSL1
prerank,CellMarker_Augmented_2021__Circulating Fetal cell:Blood,0.5867907903023353,1.0738428923649992,0.36764705882352944,0.6563375050898274,1.0,8/23,18.34%,MCAM;CTNNB1;SMAD3;MMP14;SOX13;OLIG2;HMGA1;F3
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.6429018890786903,1.073783702385201,0.37037037037037035,0.6562907013198543,1.0,3/13,8.75%,ZBTB16;SCX;PKDCC
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),-0.5442600970861287,-1.0737429122539066,0.37142857142857144,0.9002454943296543,1.0,9/18,23.10%,RPL6;FASTKD2;MDN1;RPL11;RPL23A;RPF2;RPL10;RPLP0;RSL24D1
prerank,Reactome_2022__Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.5705040536492133,1.073678745064532,0.4307692307692308,0.6563675647484444,1.0,8/24,18.21%,OGN;B3GNT2;CHST6;OMD;B4GALT5;CHST2;B4GALT6;B4GALT3
prerank,Reactome_2022__Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.5285993866667761,-1.073511263061348,0.3953488372093023,0.9001601164308854,1.0,11/29,20.34%,POLR2K;ELOC;ELOA;SUPT16H;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;POLR2L;POLR2G
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),0.5930260389703806,1.073430941782256,0.39705882352941174,0.6568048909249627,1.0,1/16,0.01%,GGT5
prerank,CellMarker_Augmented_2021__Mesoderm cell:Germ,0.5827632536376572,1.0733296857037156,0.390625,0.6568300706368516,1.0,4/13,11.83%,ICAM1;THY1;CD44;CD5
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.4684745180240582,1.073102208111078,0.35,0.6572120988995942,1.0,12/84,16.79%,RECQL4;BLM;RPA1;GINS2;SAMHD1;POLQ;CDC7;MRE11;ZSWIM7;XRCC1;BRCA1;MEIOB
prerank,Reactome_2022__IkBA Variant Leads To EDA-ID R-HSA-5603029,0.6662103742952906,1.073090382254064,0.5,0.6570381820896016,1.0,1/7,14.40%,IKBKG
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.46044630079041043,1.073083675223501,0.32142857142857145,0.6568643681889641,1.0,8/60,12.19%,BOK;DEPP1;SMCR8;DAPK2;PIP4K2A;FBXL2;MAPT;TPCN2
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.7091431114143992,1.0728583484967649,0.35714285714285715,0.6571911939740865,1.0,2/7,16.95%,SYK;ADGRE2
prerank,Reactome_2022__rRNA Modification In Mitochondrion R-HSA-6793080,-0.6385198887797405,-1.072795871148424,0.39285714285714285,0.9016861820069582,1.0,2/5,15.52%,MTERF4;TFB1M
prerank,CellMarker_Augmented_2021__Effector Regulatory T (Treg) cell:Peripheral Blood,0.5482189498109638,1.0727270333485237,0.375,0.657288195977863,1.0,7/35,4.66%,CTSS;MYO1F;PLEK;SLA;WAS;PTPRC;CD37
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.717714521632871,1.0726865403041648,0.5,0.6572001200078227,1.0,2/5,14.94%,BAIAP3;STX1B
prerank,Reactome_2022__HIV Elongation Arrest And Recovery R-HSA-167287,-0.5200851126367888,-1.0725482551157863,0.37209302325581395,0.9015044593816731,1.0,11/31,20.34%,POLR2K;ELOC;ELOA;SUPT16H;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;POLR2L;POLR2G
prerank,KEGG_2021_Human__Fat digestion and absorption,-0.5136268205933113,-1.0725323353149672,0.35,0.9006944370327904,1.0,3/20,11.38%,CEL;AGPAT2;MTTP
prerank,CellMarker_Augmented_2021__Bipolar cell:Retina,0.5040452415324437,1.072412458915218,0.4090909090909091,0.657711522788288,1.0,20/70,17.01%,C1QL1;AMH;CHRNA5;ARHGAP39;CAMK2N2;EFNB3;WASF1;VGF;CACNG4;GPRIN1;ENAH;INPP5J;CD276;EEF1A2;FAM131C;KIAA1549;SEZ6L2;PFN2;HS6ST2;CTXN1
prerank,KEGG_2021_Human__Estrogen signaling pathway,0.45603669373400335,1.0723751784758189,0.3055555555555556,0.6576233737976063,1.0,19/92,17.94%,CREB5;ADCY5;SHC2;TGFA;GABBR2;ITPR3;PGR;ADCY7;ADCY2;FKBP5;PRKCD;BCL2;PIK3CD;RARA;ADCY3;CALM3;SHC1;GNAI1;ITPR1
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),-0.5552469443614532,-1.0721586781180987,0.45,0.9008207382879116,1.0,1/19,1.54%,TPX2
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.7131615507446271,1.0719653028379572,0.3888888888888889,0.6583027973420489,1.0,2/7,12.25%,APOD;CABP1
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.7131615507446271,1.0719653028379572,0.3888888888888889,0.6583027973420489,1.0,2/7,12.25%,APOD;CABP1
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.46474957714687626,1.071919491706984,0.31666666666666665,0.6582282368906356,1.0,19/64,15.21%,SLITRK1;IL1RAPL1;NUMBL;SLIT2;SHANK3;SERPINF1;ROBO2;NPTN;CTNNB1;PTPRD;NEURL1;CDKL5;PLXNA4;SS18L1;NAP1L1;TRIM32;RGS14;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.6902965215821693,1.0718358716102134,0.38461538461538464,0.6582255455196816,1.0,2/8,9.35%,PRKCB;PPARG
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),0.7367794447372793,1.071781940588289,0.4807692307692308,0.6581476326119466,1.0,2/5,10.92%,BAG3;MAPT
prerank,KEGG_2021_Human__Pentose phosphate pathway,0.5849126138355285,1.0716745307746303,0.35384615384615387,0.6581723123953032,1.0,5/23,11.23%,PGD;PRPS2;ALDOB;PFKL;FBP1
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),0.6045611013786977,1.071629912967669,0.48148148148148145,0.6580466200841951,1.0,3/14,17.68%,CD24;BARD1;SRPX2
prerank,CellMarker_Augmented_2021__T Helper cell:Lung,0.49577594912754236,1.0715336979989807,0.2972972972972973,0.6578910833536202,1.0,11/48,12.34%,MYO1F;WAS;CD37;ALOX12;TUBB1;RGL4;GRK2;SSH2;GFI1B;PILRA;GP6
prerank,CellMarker_Augmented_2021__Platelet:Liver,0.49577594912754236,1.0715336979989807,0.2972972972972973,0.6578910833536202,1.0,11/48,12.34%,MYO1F;WAS;CD37;ALOX12;TUBB1;RGL4;GRK2;SSH2;GFI1B;PILRA;GP6
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.5844030071851811,-1.0712966946404088,0.2826086956521739,0.9025956530310707,1.0,3/13,14.47%,CBFA2T3;ABCD1;SLC25A33
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),-0.6031096205386984,-1.0712721336644135,0.41304347826086957,0.9018233609047365,1.0,3/7,27.30%,RNF168;RNF8;MSH2
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.6905714553778467,1.0712226504905664,0.4528301886792453,0.6584108682268799,1.0,4/7,22.17%,LAMA3;PLEC;ITGB4;DST
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.55041892427008,1.0711728606006787,0.41509433962264153,0.6583535175549148,1.0,3/22,6.62%,KLF2;KCNMB4;ECE1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.6175743845930226,1.071145380242156,0.3620689655172414,0.6580376576837149,1.0,1/13,2.35%,ZFP36
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.6175743845930226,1.071145380242156,0.3620689655172414,0.6580376576837149,1.0,1/13,2.35%,ZFP36
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.6943230744911952,1.0710331239822315,0.4074074074074074,0.6580452608381753,1.0,1/6,1.69%,SERPINE1
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.6328582823405804,1.070933663935179,0.42857142857142855,0.658100587989363,1.0,5/15,11.17%,NLGN1;CNTN4;NINJ2;NRXN3;ASTN2
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.5229314964697036,1.0709155601508638,0.3492063492063492,0.657944575818891,1.0,5/38,14.19%,STAT4;LMNB1;TCP1;TYK2;IL12A
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.7285892580690563,-1.0709104202779303,0.48936170212765956,0.9020501606047092,1.0,4/5,25.32%,MUL1;OAS3;MAVS;SIRPA
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.5796795246817148,1.0709025625812982,0.38461538461538464,0.6578056912270847,1.0,5/27,18.90%,ODAD1;ZMYND10;SPAG1;ODAD4;DNAH17
prerank,Reactome_2022__FCGR3A-mediated Phagocytosis R-HSA-9664422,0.5055149661158796,1.0707634503634207,0.3333333333333333,0.6579189449084828,1.0,9/48,10.41%,ELMO1;WAS;MYH9;WASF1;FYN;BAIAP2;ARPC3;RNASE1;SYK
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.6416348443062068,-1.0707623894223746,0.4473684210526316,0.9016217898460378,1.0,2/9,6.86%,WASHC5;ARFIP2
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),-0.3637320944624451,-1.070742502273517,0.2916666666666667,0.9008163104125085,1.0,33/335,10.60%,ACP3;SLC2A5;FTL;GMFG;EPX;VAMP8;CST3;CSTB;FTH1;CHRNB4;CTSH;NEU1;NPC2;PRSS3;CREG1;FLG2;MGAM;AGL;RAP2C;CR1;CKAP4;CAP1;HSPA1A;ABCA13;DDOST;FUCA2;JUP;AGPAT2;EEF1A1;DNASE1L1;ADA2;APRT;NCSTN
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.4522664998719916,1.070736665504491,0.3287671232876712,0.6578073908094323,1.0,14/104,13.18%,CDKN2A;EGF;THBS1;CD24;APP;GRM5;LDB2;PML;NLRC5;CDKN1C;BARD1;CDKN1B;FN1;CDKN1A
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.6853132886807243,1.0705804417896907,0.4666666666666667,0.6580124900660912,1.0,4/7,26.81%,YAP1;UBR5;TRERF1;NEDD4
prerank,CellMarker_Augmented_2021__Neuroendocrine cell:Lung,0.4992777124520987,1.0705406017979182,0.3793103448275862,0.6577044691127457,1.0,6/64,4.92%,ANXA1;MAFF;MLLT11;RAPGEF5;ADA;SOX4
prerank,CellMarker_Augmented_2021__Brush Cell (Tuft cell):Lung,0.4992777124520987,1.0705406017979182,0.3793103448275862,0.6577044691127457,1.0,6/64,4.92%,ANXA1;MAFF;MLLT11;RAPGEF5;ADA;SOX4
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),0.5821454723879833,1.0705263705847823,0.42,0.6575420912746559,1.0,7/16,19.33%,TMCC2;ACHE;ADAM19;KLK6;ABCG1;ADAM17;LDLRAP1
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.5609185790920513,1.070260986646651,0.40625,0.6579578386044067,1.0,8/24,18.21%,OGN;B3GNT2;CHST6;OMD;B4GALT5;CHST2;B4GALT6;B4GALT3
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.4357532703357883,1.0702371466570018,0.35384615384615387,0.65781587677339,1.0,24/103,26.96%,LZTS1;DCN;SMCR8;CAPN1;IKBKG;PINK1;CAPNS1;TSC2;RRAGD;WAC;ATP6V1B2;RHEB;TBK1;SUPT5H;SESN1;ULK1;ATP6V1C1;ATP6V1C2;UCHL1;GNAI3;EXOC4;SH3GLB1;NEDD4;MAP3K7
prerank,PanglaoDB_Augmented_2021__Platelets,0.4817488980115412,1.070174197497873,0.3472222222222222,0.657786138194295,1.0,12/91,5.77%,RASGRP2;CTSS;ADGRE5;THBS1;SERPINE1;P2RY13;MYO1F;PLEK;NRGN;ALOX12;ITGA2;TUBB1
prerank,CellMarker_Augmented_2021__Primitive Streak cell:Primitive Streak,0.4752736404808476,1.0699500328063103,0.3728813559322034,0.6581538878440663,1.0,7/52,6.16%,CHRNA5;DRAXIN;GINS2;MAP3K15;GJC1;FSD1;ZNF114
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.5988401353484588,1.069910497731855,0.39705882352941174,0.6580187857363325,1.0,3/13,4.78%,RASGRP1;PTPRC;NFIL3
prerank,Reactome_2022__Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,0.49955288693684324,1.0698425694618894,0.35185185185185186,0.6579856186590297,1.0,12/45,27.21%,SERPINE1;CDK9;SMAD3;NCOR1;WWTR1;SMAD2;RPS27A;CDKN2B;TGIF1;MAPK3;FURIN;NCOR2
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.6655249194333037,1.0696356542755083,0.42105263157894735,0.6582036419503028,1.0,2/8,8.06%,RAB11FIP5;SLC9A1
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.6010523381078087,1.0694414412507802,0.45454545454545453,0.6584385036349296,1.0,2/15,7.37%,ODAD1;ZMYND10
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),-0.3622897696012159,-1.0694353042590437,0.3333333333333333,0.9037154399387938,1.0,33/338,10.60%,ACP3;SLC2A5;FTL;GMFG;EPX;VAMP8;CST3;CSTB;FTH1;CHRNB4;CTSH;NEU1;NPC2;PRSS3;CREG1;FLG2;MGAM;AGL;RAP2C;CR1;CKAP4;CAP1;HSPA1A;ABCA13;DDOST;FUCA2;JUP;AGPAT2;EEF1A1;DNASE1L1;ADA2;APRT;NCSTN
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),0.6587255459047705,1.0694212279424171,0.38461538461538464,0.6582899075248597,1.0,3/9,12.70%,OXCT1;HMGCLL1;SLC27A5
prerank,Reactome_2022__RORA Activates Gene Expression R-HSA-1368082,0.5838494295895478,1.069419308050759,0.40350877192982454,0.6580973124670702,1.0,6/18,26.13%,TBL1X;RXRA;RORA;TBL1XR1;CARM1;CREBBP
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.4879881863418011,1.0693421688300795,0.31746031746031744,0.6580540002331975,1.0,5/63,8.77%,CTSC;VAPB;TGFA;TMED10;GRIA1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),-0.4076352057127819,-1.0691722167598625,0.2903225806451613,0.9037074362708892,1.0,11/61,11.37%,DHFR2;CD320;FLAD1;PRSS3;PDZD11;ALDH1L2;SLC25A19;MMAB;AOX1;SLC46A1;MMACHC
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.45468331549865837,-1.0688484951006194,0.3783783783783784,0.9038588829141113,1.0,1/42,0.09%,NGF
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.5909122647783506,1.0687757026956763,0.38596491228070173,0.659217282649017,1.0,9/16,21.14%,FLT1;PPARG;CCL2;FGF2;COL4A3;ADAM17;FGFR1;AKT3;APLN
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),0.7284780802646837,1.0687632062550536,0.375,0.6590483031444692,1.0,3/5,15.68%,DCC;FGF13;PTPRS
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),0.6258655104603629,1.0687407008830458,0.40350877192982454,0.658916682247526,1.0,4/9,13.67%,CDH23;CLRN1;SHANK1;PCDH15
prerank,Reactome_2022__Gap Junction Trafficking And Regulation R-HSA-157858,0.5901155094454287,1.0683336306965805,0.421875,0.6597332936454788,1.0,6/15,23.91%,DNM1;CLTB;DNM2;TJP1;GJB7;CLTC
prerank,Reactome_2022__Uptake And Actions Of Bacterial Toxins R-HSA-5339562,0.5750267356748427,1.0683289295939267,0.39285714285714285,0.659550770370164,1.0,2/26,3.86%,SYT1;SV2B
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.3886149187512029,1.0683110054190754,0.27848101265822783,0.659371737969654,1.0,61/418,13.51%,CDKN2A;ST18;GPNMB;TLR2;PROX1;TESC;SP100;TP53TG5;PSRC1;NR4A1;BLM;DUSP1;SLIT2;APP;DAB2IP;DYSF;MYH9;PRAME;PODN;TSPYL2;FABP3;KLF11;ARHGDIG;PLSCR1;SOX4;SLIT3;BTG3;BCL6;CLMN;IGFBP7;KLF10;BAP1;PML;CYP1B1;APOBEC3H;CDK6;CTNNB1;ZBTB7C;SMAD3;GMNC;LMNA;NEURL1;CTBP2;CHMP1A;TGFB2;DLG5;PODXL;P3H2;ACTN1;FBP1;NPAS2;PLXNA4;CDKN1B;BCL2;DLG3;ATP8A2;KLF4;PDPN;CDKN1A;FGF2;CGREF1
prerank,PanglaoDB_Augmented_2021__T Cells,0.4950000144695131,1.0680740957779131,0.40298507462686567,0.659707072297833,1.0,5/55,6.11%,LEF1;MAFF;THY1;PTPRC;SKAP1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Adipose Tissue,0.6631459393371186,1.0678057250468165,0.4482758620689655,0.660153827378853,1.0,3/5,13.04%,THY1;CD44;ALPL
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),-0.3616758929484214,-1.0676570705009805,0.28,0.9065730470350488,1.0,33/337,10.60%,ACP3;SLC2A5;FTL;GMFG;EPX;VAMP8;CST3;CSTB;FTH1;CHRNB4;CTSH;NEU1;NPC2;PRSS3;CREG1;FLG2;MGAM;AGL;RAP2C;CR1;CKAP4;CAP1;HSPA1A;ABCA13;DDOST;FUCA2;JUP;AGPAT2;EEF1A1;DNASE1L1;ADA2;APRT;NCSTN
prerank,Reactome_2022__Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.44290981483581504,-1.0675281828415986,0.3142857142857143,0.9061717477432434,1.0,4/38,7.90%,CCNE1;CCT7;NOP56;FKBP9
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),0.6764767361980432,1.0670208776183152,0.4166666666666667,0.6617702620312729,1.0,1/7,1.54%,TEKT2
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.5165367783241716,1.0669729333843894,0.3728813559322034,0.6617124835898036,1.0,12/27,19.02%,IGF1;DYSF;MYH11;ALPK2;TCAP;NEBL;BIN1;NEB;MYOF;SLC8A1;CAV3;CXADR
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.6768573608992826,1.0668443412838198,0.36538461538461536,0.6618203274048997,1.0,3/8,11.59%,FAAH;DGAT2L6;DGAT1
prerank,Reactome_2022__PI3K/AKT Signaling In Cancer R-HSA-2219528,0.4756724464588215,1.0664512617324808,0.3230769230769231,0.6626747289105557,1.0,19/74,13.84%,PDGFRA;EGF;NR4A1;IRS2;FOXO1;TGFA;FYN;NRG1;FOXO3;NRG2;PDGFA;KITLG;GAB2;RNASE1;FGF13;PRR5;CDKN1B;CDKN1A;RPS6KB2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.6927632355233013,1.0664205295409672,0.41379310344827586,0.6625154157601033,1.0,3/5,17.57%,DVL1;MAPT;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.7142406859468039,1.0662325046818113,0.4406779661016949,0.6628221393643283,1.0,2/6,9.98%,CACNA1C;ORAI1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Eye,0.5204023841672749,1.0662313062801505,0.36363636363636365,0.6626291218514091,1.0,7/38,7.74%,PKP2;CD24;LSR;BAIAP2L1;EPB41L4B;CKMT1B;TTC39A
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.5114468466246601,1.066060298877337,0.36065573770491804,0.6627972817469909,1.0,9/32,19.36%,SMCR8;LIMK2;YAP1;PHF23;MTM1;PINK1;BRCA1;CAV3;CDK5RAP2
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.6776983749667438,1.0660390494535719,0.5,0.6626516122223793,1.0,2/6,15.09%,TMSB10;PFN4
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Bone Marrow,0.5074917081372005,1.065841237240449,0.3125,0.6629140970467365,1.0,8/32,10.32%,A4GALT;ABCB1;THY1;PTPRC;ZBTB16;CD44;KITLG;PODXL
prerank,Reactome_2022__IRF3-mediated Induction Of Type I IFN R-HSA-3270619,0.6326494012011316,1.0656718166143961,0.38596491228070173,0.6630685413362959,1.0,3/10,21.09%,NLRC3;MRE11;TBK1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.5871898789609968,1.065573323098771,0.38571428571428573,0.6630577405919164,1.0,7/18,14.04%,KCNJ2;KCNH2;ATP1A1;ATP1B1;ATP1B3;SLC12A5;KCNMA1
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.5622237653774752,1.0654949321113125,0.3442622950819672,0.6630806414748762,1.0,4/23,7.49%,C3;CD55;CFH;C1R
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.715468775222775,1.0653641529263191,0.4807692307692308,0.6631843743804964,1.0,1/5,6.79%,GHR
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),0.6259465201064639,1.0651907226888166,0.45161290322580644,0.6633991770487055,1.0,3/10,16.69%,HES7;BMX;MESP1
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.5058208773020528,1.0651258140124846,0.4057971014492754,0.6633209608451764,1.0,20/49,26.36%,PDGFRA;FYN;APOD;STK25;MAPT;PXN;AGAP3;PTPRN;MAPK9;STK24;PLK3;HIF1A;ADAM9;FOS;ROMO1;HMOX1;GLRX2;PTPRK;MAPK3;PDCD10
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),-0.615774746130309,-1.064978277173642,0.4897959183673469,0.9124411252269714,1.0,3/6,27.30%,RNF168;RNF8;MSH2
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.7041377437951626,1.064880448131598,0.4423076923076923,0.6636399333732957,1.0,3/6,18.73%,SMAD3;SMAD1;SMAD2
prerank,Reactome_2022__Sphingolipid Metabolism R-HSA-428157,0.4938180841773841,1.064836616325021,0.3484848484848485,0.6635684219812019,1.0,10/80,9.64%,SGPP2;VAPB;UGT8;FA2H;EGFL7;ESYT3;B4GALNT1;SPNS2;CERS3;B3GALNT1
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Myeloid Cells R-HSA-8939246,0.6833391187064322,1.0647917970649339,0.45161290322580644,0.6635003157610292,1.0,1/6,2.74%,PRKCB
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.5736074282117801,-1.0646461108099017,0.42105263157894735,0.9125114909452833,1.0,3/12,22.08%,PJVK;PIK3R4;ACBD5
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.5522232990650122,1.0646146415044002,0.38461538461538464,0.663654186735439,1.0,8/29,12.05%,DOC2B;IRS2;BAIAP3;TRPM4;SOX4;NNAT;HLA-DRB1;STX4
prerank,Reactome_2022__NLRP3 Inflammasome R-HSA-844456,0.609723347220452,1.0643494318002555,0.4482758620689655,0.6641172464065971,1.0,1/12,3.17%,APP
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),-0.6287773560760509,-1.064342710874096,0.4782608695652174,0.9125456598767961,1.0,1/5,12.96%,AMPD3
prerank,CellMarker_Augmented_2021__Plasma cell:Undefined,-0.6199823472801839,-1.064339580795596,0.4444444444444444,0.9116934563207028,1.0,2/9,7.12%,CD38;CXCR4
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.5494803912422885,1.0639341457323408,0.4,0.6648791436103814,1.0,5/20,16.09%,LPCAT4;PLSCR1;PLAAT3;SERINC1;SERINC5
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),0.6180654557531999,1.0638434217997712,0.4067796610169492,0.6648712122589207,1.0,2/9,13.94%,CDC7;STOML2
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),-0.625604808150592,-1.063809319069281,0.4318181818181818,0.9122178628397994,1.0,3/9,2.82%,WFDC10B;RPL39;H2BC21
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.651261872616109,1.0637264393739552,0.4727272727272727,0.6649203850097064,1.0,1/8,9.80%,AK5
prerank,Reactome_2022__Erythropoietin Activates Phosphoinositide-3-kinase (PI3K) R-HSA-9027276,-0.6072609863742935,-1.0636187138695699,0.40425531914893614,0.9119213766710024,1.0,2/10,4.64%,EPX;EPOR
prerank,CellMarker_Augmented_2021__Megakaryocyte-erythroid progenitor:Undefined,-0.6986835911244977,-1.0635370521277165,0.4888888888888889,0.9103968843919132,1.0,2/5,2.67%,FLT3;CD38
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Undefined,-0.6986835911244977,-1.0635370521277165,0.4888888888888889,0.9103968843919132,1.0,2/5,2.67%,FLT3;CD38
prerank,Reactome_2022__TLR3-mediated TICAM1-dependent Programmed Cell Death R-HSA-9013957,0.7009572886522293,1.0634171240257642,0.5192307692307693,0.6654463399173945,1.0,2/5,19.54%,FADD;TLR3
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",0.7273066208328111,1.0633978596247424,0.5,0.6653006203851803,1.0,1/5,1.91%,NLGN1
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.6606649841793722,1.0633646756293045,0.41379310344827586,0.6651851881245259,1.0,3/8,17.57%,ARHGAP39;PICK1;WNT5A
prerank,PanglaoDB_Augmented_2021__T Cells Naive,-0.5411834315565558,-1.0633507674503457,0.4411764705882353,0.9100886166745754,1.0,7/25,6.16%,DPEP2;GMFG;CD247;CD96;PYHIN1;CD6;P2RY10
prerank,KEGG_2021_Human__Insulin signaling pathway,0.4501726050640681,1.0631833503522266,0.33783783783783783,0.6653549896801572,1.0,24/114,18.30%,SOCS3;SHC2;IRS2;FOXO1;PRKAR1B;HK2;TRIP10;PPP1CB;INPPL1;INPP5A;SORBS1;PYGL;FBP1;HK1;RPS6KB2;PIK3CD;PRKAR1A;SH2B2;LIPE;CALM3;MAPK9;SHC1;RHOQ;TSC2
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.5011477744428214,1.062918934472447,0.36065573770491804,0.665769530232248,1.0,27/72,20.24%,THBS1;SERPINE1;FLT1;PRKCB;APLNR;PAK4;CYP1B1;HK2;CHI3L1;ADAM12;ITGB8;HIPK1;FGF2;GAB1;HIPK2;PIK3CD;ETS1;BRCA1;WNT5A;F3;PRKCA;TEK;HIF1A;BTG1;RHOB;ANGPTL4;VEGFD
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,0.5951205714697938,1.0629098142740567,0.39285714285714285,0.6655903561704579,1.0,5/17,22.61%,GADD45A;TP53;CCNB1;PRMT1;CARM1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.528281360497737,1.0626445902313155,0.3968253968253968,0.6659744209433421,1.0,7/31,9.04%,KIF14;TYMP;HES7;NKX6-2;TENM4;CTNNB1;YAP1
prerank,Reactome_2022__Synthesis Of Prostaglandins (PG) And Thromboxanes (TX) R-HSA-2162123,-0.6191159328903139,-1.0625472087768508,0.375,0.9113572150758148,1.0,2/9,10.82%,AKR1C3;PTGIS
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),-0.5679126651519942,-1.0625435644680055,0.41935483870967744,0.9105117604533944,1.0,2/16,3.26%,SOD3;PRDX1
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.47055264070722014,1.0624293186382443,0.323943661971831,0.6662275736271477,1.0,19/78,12.96%,NR4A3;HLA-DRA;ANXA1;CTSS;CD22;MYO1F;PLEK;SLA;PTPRC;PLAC8;ASS1;ETV6;ADAM19;CD83;HLA-DRB1;ITGAL;RAB30;RELB;PDPN
prerank,CellMarker_Augmented_2021__Basal cell:Lung,0.5278981609332799,1.0622798513789808,0.373134328358209,0.6663599779025781,1.0,6/44,10.24%,GPNMB;S100A10;ZYX;FAT2;TUBB6;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.6566554614294388,1.0621472839228578,0.4576271186440678,0.6664621638580277,1.0,5/10,16.80%,CCDC3;GAS6;TRAIP;RFFL;GPS2
prerank,CellMarker_Augmented_2021__Intestinal Epithelial Stem cell:Jejunum,0.5199579509712409,1.0621184144199323,0.38461538461538464,0.6661408553006338,1.0,9/34,8.28%,FOSL2;ANXA1;S100A10;CD24;TGFA;SLC28A3;AHR;CD44;MVP
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Breast,0.5199579509712409,1.0621184144199323,0.38461538461538464,0.6661408553006338,1.0,9/34,8.28%,FOSL2;ANXA1;S100A10;CD24;TGFA;SLC28A3;AHR;CD44;MVP
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6608458118022688,1.0619509890445487,0.47058823529411764,0.6664337488037504,1.0,2/9,3.34%,DCN;DAB2IP
prerank,Reactome_2022__Phototransduction Cascade R-HSA-2514856,-0.5635692987352794,-1.0617419812656463,0.34285714285714286,0.9120493227097849,1.0,6/18,17.12%,GUCA1B;PPEF1;NMT2;METAP2;GNGT1;METAP1
prerank,Reactome_2022__ZBP1(DAI) Mediated Induction Of Type I IFNs R-HSA-1606322,0.5551382791405985,1.061645973738832,0.45454545454545453,0.6668970796504289,1.0,5/18,24.45%,MYD88;IKBKG;TLR3;TBK1;DHX9
prerank,Reactome_2022__MAPK3 (ERK1) Activation R-HSA-110056,0.6148727527434041,1.0615982832425463,0.45,0.6668150290182858,1.0,8/8,38.54%,TYK2;IL6R;PTPN11;MAPK3;MAP2K1;JAK1;IL6ST;JAK2
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),0.5827362823622914,1.0615251431037074,0.484375,0.6667898617133461,1.0,1/17,4.46%,SUN3
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),0.7127773598301226,1.0612702394279667,0.4666666666666667,0.6672226081014454,1.0,1/5,12.30%,IFFO1
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.4468812392866606,1.0611296705208162,0.3389830508474576,0.6673243097335043,1.0,12/98,11.35%,TGFBR2;AMH;ZYX;BMP8A;PARD3;SCX;DUSP22;SMAD3;TGFB2;RGMB;SMAD1;PXN
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.49375032168902816,1.0609435775575917,0.3333333333333333,0.6675929729158594,1.0,12/41,21.58%,TBL1X;HDAC4;MORF4L2;HDAC9;PER1;TBL1XR1;MTA1;MORF4L1;MTA3;RCOR1;TRERF1;MIDEAS
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.5458560095996728,-1.0608172563029108,0.4222222222222222,0.9138554874768947,1.0,2/15,8.43%,DCLRE1B;TFIP11
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5088922222347722,1.0607751400193832,0.3709677419354839,0.6678080502379846,1.0,3/34,5.17%,STEAP3;RAB15;RAB3C
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.511987653975218,1.060686601710119,0.3548387096774194,0.667802664042849,1.0,5/45,4.31%,TLR2;THBS1;RASGRP1;APP;PTPRC
prerank,Reactome_2022__Nonhomologous End-Joining (NHEJ) R-HSA-5693571,-0.48148671081920646,-1.0603160242382532,0.391304347826087,0.9145161794741434,1.0,8/34,19.72%,H2BC4;H2BC21;ABRAXAS1;RNF168;RNF8;BRCC3;H2BC5;UBE2V2
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),-0.6365245787787609,-1.0601843579668089,0.4444444444444444,0.9140845472183504,1.0,3/8,19.18%,SOX8;RORB;RPGRIP1
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),0.4885181137618232,1.0596351567244455,0.4,0.6698665420455279,1.0,3/41,9.10%,ZFP36;RBM24;YTHDF1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.6737005505449085,1.0595603185193831,0.5483870967741935,0.6696244380170705,1.0,6/9,25.85%,NFATC2;NFATC3;PPP3CC;PPP3CB;NFATC4;PPP3CA
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.6737005505449085,1.0595603185193831,0.5483870967741935,0.6696244380170705,1.0,6/9,25.85%,NFATC2;NFATC3;PPP3CC;PPP3CB;NFATC4;PPP3CA
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.6626785883021559,1.0593963139395155,0.41818181818181815,0.6698452908131887,1.0,2/8,5.32%,DMTN;NEDD9
prerank,Reactome_2022__Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.4209442508385764,-1.059395020963591,0.2972972972972973,0.9155916061801342,1.0,7/98,5.95%,G0S2;MED21;MUSK;MED10;TRIB3;NR1D1;ALAS1
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.6465345967824432,1.059134036604774,0.3728813559322034,0.6703360445200145,1.0,4/8,20.87%,TERF2IP;OGG1;TINF2;ACD
prerank,Reactome_2022__Transport Of SLBP Dependant Mature mRNA R-HSA-159230,-0.4692658542290503,-1.0590884293556901,0.35714285714285715,0.9156010833168614,1.0,7/33,24.68%,AAAS;NUP50;NUP54;NUP85;NUP42;POM121C;SLBP
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.4424394363444921,-1.0587080127710262,0.3235294117647059,0.9156603211371057,1.0,13/52,14.88%,CYP3A43;DHRS11;AKR1C3;ABCB11;ARV1;HSD11B1;GBA2;CYP46A1;CYP4V2;SRD5A1;CYP7B1;TSPO;CYP2C8
prerank,CellMarker_Augmented_2021__Hepatocyte:Embryoid Body,0.5489519960468804,1.0586604351106188,0.38095238095238093,0.6711931152063484,1.0,3/19,9.22%,HPN;ITIH2;FTCD
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.48038763654025024,1.0585734773195676,0.32786885245901637,0.6712034256587197,1.0,13/60,17.85%,SLC39A14;IRS2;FOXO1;BAIAP2;NAMPT;SORBS1;PDK4;GAB1;BCAR1;SH2B2;SHC1;IGF1R;RHOQ
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.46543988843465833,1.0581445630480466,0.35384615384615387,0.6719764844157701,1.0,15/52,20.60%,SUV39H1;SCN2A;LMNA;NDRG1;PGK1;PICK1;CPEB2;HIPK2;FMN2;TP53;PINK1;RORA;HIF1A;EGLN3;HYOU1
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.7400706537980609,1.0581252940363257,0.5087719298245614,0.671823401368213,1.0,1/5,4.92%,FYN
prerank,Reactome_2022__Myogenesis R-HSA-525793,0.554867626838777,1.0581228045261095,0.38461538461538464,0.6716437751181427,1.0,8/22,20.08%,BOC;CTNNB1;CTNNA1;MEF2D;CDH4;MAPK11;NEO1;CTNNA2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.585708924184409,1.0580187396542367,0.4264705882352941,0.671657272276783,1.0,2/18,9.33%,IMPDH1;AK3
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),0.6706808543986076,1.0579663428971324,0.5102040816326531,0.6715776062366055,1.0,3/11,16.62%,GLI2;EPHA4;C12ORF57
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),0.6206019721375796,1.0578857668424744,0.4262295081967213,0.671614396816237,1.0,5/10,31.48%,FGD5;PPP1R9B;SRGAP2;DNM3;SPEF1
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.6926227531928184,1.0576793836538232,0.5,0.671804258802709,1.0,1/5,10.12%,SHMT1
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.6926227531928184,1.0576793836538232,0.5,0.671804258802709,1.0,1/5,10.12%,SHMT1
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.49360737419474454,1.057318030603709,0.4074074074074074,0.6724424456304491,1.0,11/40,15.60%,ITPKC;PLCH2;ITPKB;ITPK1;NUDT4;INPPL1;INPP5A;INPP5J;INPP4A;INPP5D;IMPA1
prerank,CellMarker_Augmented_2021__Mesenchymal Stem cell:Liver,0.6952171276579986,1.0572936801841613,0.34545454545454546,0.6722895800386575,1.0,2/6,6.44%,THY1;CD44
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.44201018117920127,-1.0571891714142811,0.34375,0.9197477269487768,1.0,13/36,28.89%,CSKMT;ICMT;EZH2;VCPKMT;TRMT112;EEF1AKMT1;PRMT2;FAM98A;EEF1AKMT2;SNRPB;ETFBKMT;ETF1;PRMT3
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5774327088176013,1.057062789111574,0.4142857142857143,0.6727279864439786,1.0,5/18,20.77%,RBM24;YTHDF1;PUM1;FTO;ZC3H18
prerank,CellMarker_Augmented_2021__Vaginal cell:Vagina,-0.5047732525613035,-1.0570269181792329,0.4375,0.91929192597534,1.0,6/23,11.41%,TRIM29;KRT8;SCEL;ATP2C2;EHF;B3GNT3
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),0.6758590503392831,1.0569862569518516,0.4489795918367347,0.6727677045733012,1.0,1/5,7.62%,MYD88
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),0.6503159081997989,1.0567261417612395,0.4339622641509434,0.6731758487408651,1.0,2/6,8.12%,NRP2;CTNNB1
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Undefined,0.5892722293619111,1.0565174891682916,0.4262295081967213,0.6735041174202886,1.0,5/14,15.22%,CD24;THY1;PODXL;ALPL;CD59
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.5991237059683686,1.056424869638347,0.3898305084745763,0.6735037698137111,1.0,3/14,5.16%,DUSP10;NFATC2;BCL6
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.5897454330794846,1.056102969581221,0.41379310344827586,0.673940729188717,1.0,8/20,18.21%,OGN;B3GNT2;CHST6;OMD;B4GALT5;CHST2;B4GALT6;B4GALT3
prerank,Reactome_2022__Keratan Sulfate Biosynthesis R-HSA-2022854,0.5897454330794846,1.056102969581221,0.41379310344827586,0.673940729188717,1.0,8/20,18.21%,OGN;B3GNT2;CHST6;OMD;B4GALT5;CHST2;B4GALT6;B4GALT3
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),0.6836043013558704,1.0559116485051747,0.49122807017543857,0.6741789091218225,1.0,4/7,28.33%,CRACD;CXADR;MUC4;PIWIL4
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),0.6656708931885033,1.0559004594218302,0.46774193548387094,0.6740292540864892,1.0,3/8,12.29%,SYK;MAPT;PRKCD
prerank,CellMarker_Augmented_2021__T cell:Bone Marrow,-0.5520265003376448,-1.0558797855634827,0.3333333333333333,0.9192592213812885,1.0,5/15,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__T cell:Synovium,-0.5520265003376448,-1.0558797855634827,0.3333333333333333,0.9192592213812885,1.0,5/15,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__T cell:Optic Nerve,-0.5520265003376448,-1.0558797855634827,0.3333333333333333,0.9192592213812885,1.0,5/15,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__T cell:Colorectum,-0.5520265003376448,-1.0558797855634827,0.3333333333333333,0.9192592213812885,1.0,5/15,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.4686484644087687,1.055863382931278,0.35714285714285715,0.6738863100284016,1.0,13/50,14.04%,THBS1;SNCB;TRPC3;PLSCR1;ITPR3;SNCA;NDRG1;HOMER1;MAPT;BCL2;PAM;ANXA11;KCNMA1
prerank,Reactome_2022__SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,0.4523149749964521,1.0557592254239103,0.38571428571428573,0.673995142273731,1.0,6/92,3.61%,TLR2;SFTPD;IRAK2;IRF7;NOD1;NLRP12
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),-0.585182050518567,-1.055582910845181,0.45652173913043476,0.9192369535804777,1.0,2/14,6.41%,NEU1;ASAH2B
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),0.6328023691830595,1.0554190923963942,0.4406779661016949,0.6746104686301295,1.0,2/10,9.04%,RPUSD1;GAR1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5791652914700471,-1.0553859926619669,0.4,0.9191159112014617,1.0,3/14,9.07%,SELENOS;HSPA1A;CREB3L1
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),-0.6229036885279178,-1.0552796600315324,0.4117647058823529,0.9186707143917952,1.0,1/8,4.02%,NEU1
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),0.6025363730035602,1.0552510116816554,0.48333333333333334,0.674834877735785,1.0,3/12,6.02%,PROX1;SOX4;DVL1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5990054577452003,1.0550977616679453,0.35714285714285715,0.6750128336260841,1.0,1/16,0.81%,TLR2
prerank,Reactome_2022__Synthesis Of PI R-HSA-1483226,0.7099496658434659,1.0549024716358304,0.4067796610169492,0.6752700797218514,1.0,3/5,17.43%,PITPNM3;PITPNM2;PITPNM1
prerank,GO_Biological_Process_2021__delamination (GO:0060232),-0.728179536588147,-1.0547406636671002,0.45454545454545453,0.9194099343692118,1.0,2/5,22.01%,METTL3;AKNA
prerank,Reactome_2022__FCERI Mediated MAPK Activation R-HSA-2871796,0.526336543550969,1.0547204004763038,0.4126984126984127,0.6754643451369757,1.0,9/25,27.26%,RNASE1;SYK;VAV2;MAPK9;SHC1;VAV1;FOS;MAPK3;MAP2K7
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),-0.4457954547638854,-1.054657733615012,0.3023255813953488,0.9188526724834494,1.0,4/41,5.85%,ID1;LAMA4;ALDH1A1;NR1D1
prerank,"Reactome_2022__Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",0.46416445165834985,1.0545990163684378,0.3448275862068966,0.6755560105178272,1.0,13/50,20.58%,LSR;AMN;VLDLR;SOAT1;LDLR;LPA;ABCG1;PCSK5;PRKCA;LDLRAP1;RPS27A;ANGPTL4;SCARB1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.5080344356073354,1.054431415260763,0.391304347826087,0.6757666094193083,1.0,5/42,9.88%,EGF;BLM;TSPYL2;GMNC;GLI2
prerank,CellMarker_Augmented_2021__B1 cell:Salivary Gland,-0.5506986353294067,-1.0543389582874616,0.3409090909090909,0.9180011921420691,1.0,5/15,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__T cell:Salivary Gland,-0.5506986353294067,-1.0543389582874616,0.3409090909090909,0.9180011921420691,1.0,5/15,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__Sertoli cell:Fetal Gonad,0.40206093673066917,1.0543184478919518,0.26506024096385544,0.6757920519985176,1.0,87/381,18.23%,SCN9A;CDH19;AMH;S100A10;B3GNT2;CD55;LIPH;ZYX;SHTN1;GMPR;SLC39A14;PRAME;PRPS2;TSPYL2;PCED1B;MYLK3;PLLP;NEDD9;GNG2;SYNGR2;RELL1;SERPINF1;MBNL2;TCEAL5;FOXO3;TCEA3;HR;MAP1B;LIMCH1;ATP1A1;GSE1;HK2;ASS1;MVP;ZFAND5;KIF5C;PLAAT3;HACD1;CORO2A;SEC14L1;BEX1;ATP1B1;RASL12;CYRIB;FSCN1;RNASE1;NIPAL3;HS6ST1;VWA5A;NR6A1;GAS6;ASTN2;SLC27A3;RAB20;ARHGAP18;SDK2;TMEM181;PDPN;OPTN;CMAS;MTM1;NANS;BEX5;IKBKG;TRIM47;CAMSAP3;LAMA3;LCMT1;SMARCA1;C21ORF91;TCEAL2;WIPF3;ATP2B4;SLC1A6;A2ML1;ANKRD6;SCRN1;IGF1R;GNAI1;PRDX4;TPST2;ANKRD18A;STK24;NCK2;SLC27A6;PDK3;AMIGO2
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.6296241782489885,-1.054177261242286,0.41935483870967744,0.9176292768121983,1.0,1/9,0.62%,DSCAM
prerank,Reactome_2022__Activation Of TFAP2 (AP-2) Family Of Transcription Factors R-HSA-8866907,0.6929122629645432,1.0541177112479438,0.4426229508196721,0.6761147750234,1.0,4/7,30.30%,TFAP2C;CREBBP;TFAP2E;CITED2
prerank,Reactome_2022__Acyl Chain Remodeling Of CL R-HSA-1482798,-0.6443564208266866,-1.053958941465333,0.48717948717948717,0.9174964781098099,1.0,3/6,23.72%,TAFAZZIN;PLA2G4A;HADHA
prerank,CellMarker_Augmented_2021__Follicular Helper (Tfh) T cell:Salivary Gland,-0.538154515692256,-1.0538284565172922,0.4,0.9169645742468119,1.0,6/19,6.16%,DPEP2;CD247;CD96;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__Neutrophil:Pluripotent Stem Cell,0.5768409429542125,1.0537222891088043,0.417910447761194,0.6768137804741274,1.0,6/23,4.31%,CTSS;P2RY13;MYO1F;PLEK;SLA;PTPRC
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.3738636557886884,1.0535968655743282,0.2553191489361702,0.67685210864144,1.0,266/1616,18.57%,LEF1;CDKN2A;NR4A3;SKOR1;MYT1;MLIP;FOSL2;FOSB;SIX3;MET;ST18;PRRX1;ZFP92;TEAD2;TLR2;IGF1;KLF2;MAFF;EBF1;PROX1;ZNF536;DCN;CREB5;SP100;SERPINE1;ATF3;ZIC4;ZNF93;STAT4;NR4A1;ZFP36;CASZ1;LMO2;PRKCB;HES7;WAS;ZSCAN1;APP;RPS6KA1;IRF7;DAB2IP;FOXO1;ZNF140;EFNA1;TGFA;SUV39H1;HIC1;CIC;ZNF282;KLF11;PPARGC1B;NFATC2;NFIL3;PLSCR1;SOX4;GCM2;ERFL;BCL6;TBX19;NKX6-2;AHR;ZSCAN31;SSBP4;LHX6;GZF1;CHD3;KLF10;ZNF704;DVL1;SKAP1;RFX4;CIITA;CCNQ;ZNF608;ZNF750;ZBTB16;TNFRSF1A;NEUROD2;PLAC8;ZIC1;AGRN;PGR;LDB2;PID1;TBX20;CDK9;FHOD1;FOXO3;SNCA;MSX2;GLIS2;SCX;GRIN1;HR;MAMLD1;HMBOX1;DBX2;ZFPM2;NLRC5;ZNF787;HIVEP2;PCGF3;DUSP22;SLC9A1;CTNNB1;CSRNP1;ZBTB7C;MYT1L;TBL1X;ZNF654;SMAD3;NR1I3;YAP1;RAI1;BEX1;TRAK1;PPARG;ETV6;CTBP2;HDAC4;PBX3;ZNF597;NAMPT;GLI2;OVOL3;STAT3;FLI1;KLF3;GLIS3;SMAD1;TLE6;TEAD1;ABCA2;NR6A1;PARP9;ASXL3;JAZF1;HDAC9;FBP1;NR4A2;ASXL1;NPAS2;GFI1B;MED12L;KLF9;ZNF850;SRA1;GADD45A;EIF5A;ZNF467;MLXIPL;KLF7;ZNF552;KLF6;RELB;ZNF667;MEIS3;BRD4;PER1;TFAP2C;KLF4;MEF2D;ZBTB26;CDKN1A;SOX13;CCND1;DEAF1;FGF2;SS18L1;FADD;TNIP2;ELF1;MAML2;SRCAP;PRDM1;ZNF746;DUXB;HIPK2;BCL9;BCL11A;IKBKG;IKZF2;AKIRIN1;PTPRN;ZNF182;PPM1D;SOX10;MRTFA;PRDM16;RARA;PRKAR1A;IER5;OTUD7B;SMARCA1;PHF6;RARG;ETS1;ZNF215;STAT6;TP53;ZNF513;OLIG2;PROX2;HIF3A;BACH1;ZNF571;RXRA;PKNOX2;MED13L;ZIK1;CBX7;BRCA1;ATP2B4;ETV3;ZMIZ1;ZNF20;ZEB1;TOX3;ZBTB46;ZKSCAN2;CUX2;SP140L;HMGA1;NPAS3;ZBTB38;RORA;TFEB;MESP1;GPS2;BACH2;RGMA;ZBTB1;LPIN3;NCOR1;DOT1L;HDX;ZNF668;MNT;UBP1;WWTR1;CHD2;CCNB1;NR2F6;WNT5A;CBFB;MLXIP;LAGE3;RHOQ;MECOM;NCK2;TBL1XR1;CPHXL;ZNF432;RLF;SEMA4D;ZNF524;PHF2;ZNF473;KLF8;BCLAF1;NFIA;LITAF;LOXL2;DMRTA1;PLK3;SBNO2
prerank,KEGG_2021_Human__Fructose and mannose metabolism,0.5433329736459012,1.0534558286507432,0.36065573770491804,0.6769927291017471,1.0,8/26,20.20%,ALDOB;HK2;PFKL;FBP1;HK1;PFKFB3;GMPPA;PFKP
prerank,Reactome_2022__Metabolism Of Carbohydrates R-HSA-71387,0.41291376291120674,1.053204249488987,0.3684210526315789,0.6774335254595094,1.0,32/236,11.92%,ABO;NDST4;CSPG4;PAPSS2;DCN;OGN;B3GNT2;PRPS2;CHSY3;CHST15;B3GALT2;CHST6;CHPF2;CD44;AGRN;ALDOB;SLC9A1;GALK1;BGN;OMD;PFKL;UST;HS6ST1;HS3ST4;HS3ST3B1;PYGL;PGK1;HS3ST3A1;B4GALT7;FBP1;B4GALT5;ENO2
prerank,Reactome_2022__LDL Clearance R-HSA-8964038,0.5943573922785482,1.0530597873068535,0.4074074074074074,0.6775771990051658,1.0,3/14,7.88%,LSR;SOAT1;LDLR
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.626806890984773,1.0530566135563124,0.4528301886792453,0.6773877293040707,1.0,3/9,18.75%,PIP4K2A;LRSAM1;ELAPOR1
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),0.5451061486134879,1.0529138565963931,0.39285714285714285,0.6775741912583133,1.0,5/25,11.84%,SLC4A10;SLC9A9;SLC9A1;SLC4A9;SLC9C2
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),0.6815952389107294,1.0529018347996641,0.49019607843137253,0.6774111962641832,1.0,3/8,17.81%,CDKN1A;IL12A;STK11
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),-0.654508627297428,-1.0528595195518635,0.35555555555555557,0.9190515336409737,1.0,1/6,3.87%,THEM4
prerank,Reactome_2022__Signal Attenuation R-HSA-74749,0.6792214300651834,1.0526297268019782,0.4727272727272727,0.6778479523579868,1.0,5/9,27.78%,IRS2;SHC1;GRB10;MAPK3;IRS1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.41556374000094,1.0525937177421454,0.38666666666666666,0.6777607316807002,1.0,49/206,24.49%,KREMEN2;EGF;DRAXIN;PTPRO;DAB2IP;LGR5;TRPM4;SOX4;NOTUM;DVL1;CTNNB1;TBL1X;TLE6;TLE3;HECW1;PRICKLE1;PLEKHA4;SOX13;STK3;FZD7;ANKRD6;WWTR1;WNT5A;STK11;DKK3;TBL1XR1;FRMD8;LGR6;UBE2B;LRRK1;UBR5;TLE2;MLLT3;AMFR;LYPD6;GLI1;RBMS3;AXIN2;CUL3;PIN1;RNF220;PSMB3;TMEM131L;PRKN;TLE4;CSNK1G2;DAPK3;PSEN1;UBAC2
prerank,Reactome_2022__Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.5199036014241023,-1.0525100322501373,0.39473684210526316,0.9193443784927272,1.0,8/19,22.92%,POLR2K;POLR2C;GTF2F1;POLR2D;GTF2F2;POLR2L;POLR2G;POLR2E
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6148621437317495,1.052496604987651,0.39285714285714285,0.6778118646474194,1.0,6/10,31.56%,PRKCH;MAPK9;CSF1;MSR1;CD36;IL18
prerank,Reactome_2022__Inflammasomes R-HSA-622312,0.5653410052254078,1.0523480210487506,0.43333333333333335,0.6779386850115117,1.0,7/17,24.74%,APP;BCL2L1;BCL2;P2RX7;TXNIP;NLRC4;HMOX1
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.5364853331992891,1.0522761744786477,0.417910447761194,0.6779041702183456,1.0,6/34,15.46%,NUAK2;NUAK1;FOXO3;SIK2;PICK1;TP53
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.5703453757079162,1.0522260686179081,0.41379310344827586,0.6778433538164197,1.0,3/10,9.73%,DUSP10;MAPK8IP1;HIPK3
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),-0.5554972123771604,-1.0519027703423793,0.3958333333333333,0.9203493369643004,1.0,2/13,4.54%,CCNE1;PDCD2
prerank,Reactome_2022__Synthesis Of PIPs At ER Membrane R-HSA-1483248,0.7045161066539397,1.051870012454919,0.5185185185185185,0.6784371260536299,1.0,2/5,18.09%,SBF1;MTMR2
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.4573367773700638,1.0518140857998983,0.36363636363636365,0.6783696163971388,1.0,26/95,18.09%,MTMR7;PLEK;MTMR11;SBF1;SYNJ2;PLAAT3;PLEKHA2;PIP4K2A;VAC14;PITPNM3;INPPL1;PITPNM2;INPP5J;PLEKHA4;PLEKHA8;INPP4A;FGF2;MTM1;BMX;PIK3CD;INPP5D;IMPA1;PIP5K1C;INPP5F;PITPNM1;MTMR2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.625442069478627,1.0517354648581334,0.46153846153846156,0.6781722699688962,1.0,2/10,12.47%,CD44;BCL2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.625442069478627,1.0517354648581334,0.46153846153846156,0.6781722699688962,1.0,2/10,12.47%,CD44;BCL2
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),0.6751412348024864,1.0515684665064404,0.48214285714285715,0.6781919279506843,1.0,5/6,22.87%,DUSP1;LCMT1;CCNB1;CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),0.6751412348024864,1.0515684665064404,0.48214285714285715,0.6781919279506843,1.0,5/6,22.87%,DUSP1;LCMT1;CCNB1;CDK5RAP2;USP44
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.5334526474984984,-1.0514286830724549,0.3902439024390244,0.9210662513872948,1.0,5/16,12.77%,CFAP53;ADCY10;SPAG17;AQP4;SPEF2
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.4967013412690995,-1.051362672866587,0.45714285714285713,0.9204567974432588,1.0,5/27,20.68%,MID1IP1;NCSTN;MT3;CHTOP;MSH3
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.49820479801645234,1.0513620605304774,0.390625,0.6784627968525321,1.0,4/38,6.02%,PROX1;SULF1;PTPRR;DVL1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),0.722322224642002,1.0512766328500038,0.46153846153846156,0.678418373512872,1.0,2/5,23.66%,SCARB1;MSR1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.6670649282566674,1.0511491572782645,0.4074074074074074,0.6785052459922699,1.0,2/5,19.33%,ABCG1;LDLRAP1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.6817868551296333,1.0507021760969049,0.4426229508196721,0.6794024362101432,1.0,2/6,16.20%,LRFN5;CD200
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.4490153927629302,-1.0506617608948807,0.325,0.9215485440279193,1.0,11/38,17.92%,PMVK;TM7SF2;AKR1C3;ABCB11;OSBPL3;CYP46A1;CYP7B1;SC5D;DHCR7;OSBPL6;PNPO
prerank,"Reactome_2022__Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.41000273854905045,-1.0506545136213867,0.34210526315789475,0.9207378924171377,1.0,1/65,0.09%,NGF
prerank,Reactome_2022__Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.4443187901246325,-1.05052169192624,0.34285714285714286,0.9202834203147294,1.0,7/33,22.33%,AAAS;NUP50;NUP54;BANF1;NUP85;NUP42;POM121C
prerank,Reactome_2022__Post-translational Protein Modification R-HSA-597592,0.370745499515009,1.0503930491936768,0.28735632183908044,0.6798825701923833,1.0,154/1117,16.67%,TGFBR2;CDKN2A;SERPINA10;C3;ST6GAL1;CHST8;ANK3;SOCS3;CHGB;ADAMTS4;CTSC;TTLL7;SPRN;GCNT7;SGPP2;ADAMTSL2;SP100;THBS1;FAM20C;PSCA;BLM;B3GNT2;CD55;CNTN4;THSD7B;RTN4RL1;APP;ASB16;NOD1;UHRF2;THY1;OPCML;TGFA;ADAMTS10;HIC1;CP;MDGA2;TPST1;INCENP;TUSC3;EGFL7;GALNT12;RAB15;GALNTL6;PMEPA1;RAB3C;SEMA5B;FBXW12;LAMB1;TFPT;CHD3;IGFBP7;NOTUM;ST8SIA3;GALNT8;ADAMTS19;ZBTB16;BIRC3;VGF;PGR;NRN1;ST8SIA1;PML;SLC17A5;SHISA5;RAB40B;MGAT5;GRIA1;ITIH2;SMAD3;TUBB6;IKBKE;PPARG;PIGA;AGTPBP1;HDAC4;FBXO32;ART3;TF;PEX14;KLHL5;ST8SIA4;LY6H;SMAD1;GAS6;CNTN5;NR4A2;TTLL12;FBXL16;ASXL1;WSB2;POMGNT1;BARD1;CHST4;ACTR1A;B4GALT5;RAB20;USP20;RAB30;JOSD1;SPSB1;RANGAP1;SYVN1;FN1;TFAP2C;ALPL;COPZ2;CMAS;NANS;GPS1;UBE2H;TUBA1B;ANKRD28;RNF152;TNIP2;RAB27B;THBS2;USP49;MAN1A1;POMGNT2;HIPK2;IKBKG;SERPIND1;STAMBPL1;STS;IFIH1;RAB40A;MRTFA;RARA;ST6GALNAC2;LARGE1;OTUD7B;CD59;SBSPON;RAB37;TP53;ST6GALNAC5;LSAMP;HIF3A;RAB3D;RXRA;CTSZ;BRCA1;FSTL1;BST1;B4GALT6;ST6GALNAC3;TAB1;NEU4;CXXC1;PIGB;SPTB;RORA;RHOT1
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),0.674946614903134,1.0503326627051222,0.46551724137931033,0.6798574693754825,1.0,2/8,12.13%,BLM;DONSON
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.583988882260984,-1.0502802786624115,0.4186046511627907,0.9201841492055618,1.0,4/9,19.57%,PLA2G4C;GNPAT;CHPT1;PLA2G4A
prerank,CellMarker_Augmented_2021__Oral Keratinocyte Stem cell:Oral Mucosa,0.4619457253343446,1.0501708186643264,0.3888888888888889,0.6800290660079549,1.0,13/57,9.28%,MET;EPHA2;EPS8L2;OSMR;ITGA2;RHBDF1;RHOD;HR;MYO1B;LAMA5;ITGA3;YAP1;TANC1
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),-0.6834889884239368,-1.0501668370999024,0.5106382978723404,0.9196824210041876,1.0,2/5,11.28%,ADAMTS12;TSPAN12
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Umbilical Cord Blood,-0.557861761746751,-1.050120160041019,0.37209302325581395,0.9190359603034022,1.0,5/15,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,KEGG_2021_Human__Citrate cycle (TCA cycle),-0.5045823410855055,-1.050080940049401,0.36363636363636365,0.9183629628818687,1.0,11/26,31.81%,PDHA1;CS;SUCLA2;IDH3G;IDH1;ACO1;FH;MDH1;PDHB;MDH2;SDHB
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),-0.48021091896469964,-1.0499282705564672,0.39473684210526316,0.9179542692794407,1.0,15/46,20.63%,DCLRE1B;FANCF;ATRIP;MCM9;ATR;RNF168;XPA;RNF8;RFWD3;FANCM;MUS81;RAD51;UBB;SLX4;FANCE
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),0.552788645049119,1.0499032471940895,0.43859649122807015,0.6804529044216642,1.0,9/23,26.78%,RBM24;VIP;NOCT;TAF15;AXIN2;FUS;DHX34;MEIOC;TENT5D
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),0.6755678376581519,1.0498546977892058,0.44642857142857145,0.680173167936822,1.0,3/7,19.17%,DNM1;MX1;DNM2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),0.6755678376581519,1.0498546977892058,0.44642857142857145,0.680173167936822,1.0,3/7,19.17%,DNM1;MX1;DNM2
prerank,CellMarker_Augmented_2021__Pit Progenitor cell:Stomach,0.5142903670722969,1.0498076756085417,0.42857142857142855,0.6800923565301445,1.0,13/43,18.42%,VSNL1;LAMA5;NRXN3;HACD1;MICALL1;FBXO32;TAFA4;BCL2;BCL11A;SBSPON;PPP1R14A;LDB3;ADRA1D
prerank,Reactome_2022__LRR FLII-interacting Protein 1 (LRRFIP1) Activates Type I IFN Production R-HSA-3134973,0.6775653368069721,1.049805054018916,0.37777777777777777,0.6799002943001163,1.0,1/5,8.12%,CTNNB1
prerank,"Reactome_2022__Synthesis Of IP2, IP, And Ins In Cytosol R-HSA-1855183",0.6263078857075555,1.0496759591737796,0.5,0.6799603231197661,1.0,5/13,15.60%,MTMR7;INPP5A;INPP5J;INPP4A;IMPA1
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.5542371172512751,1.049573963705073,0.45,0.6800203180535453,1.0,5/13,18.63%,HECW2;PRKCE;HECW1;YWHAE;CAV3
prerank,Reactome_2022__Orc1 Removal From Chromatin R-HSA-68949,-0.44423486034382376,-1.0494946336738575,0.3333333333333333,0.9184869966690898,1.0,15/59,20.20%,MCM6;SLC25A15;PSMD10;MCM4;PSMD12;PSMB5;PSMB6;ORC6;PSME3;SEM1;PSMD2;UBB;CUL1;SKP2;PSMB4
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),-0.5742909277511941,-1.0488750210961537,0.4186046511627907,0.9192122458798371,1.0,3/15,8.80%,FBXO5;FBXO43;KIF20B
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.4839701841843419,-1.0487296203843637,0.4523809523809524,0.9187762785441869,1.0,5/27,16.16%,CSKMT;SMYD5;KMT2A;PRDM7;WDR82
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),0.6840017672613657,1.0486992210501822,0.42105263157894735,0.6817712075223701,1.0,3/5,31.32%,MTHFR;SUPV3L1;SIRT1
prerank,CellMarker_Augmented_2021__Mesenchymal Stromal cell:Skeletal Muscle,0.6959062414229209,1.0486072101767228,0.42857142857142855,0.6816220321022278,1.0,2/5,6.44%,THY1;CD44
prerank,CellMarker_Augmented_2021__Stem cell:Deciduous Tooth,0.6959062414229209,1.0486072101767228,0.42857142857142855,0.6816220321022278,1.0,2/5,6.44%,THY1;CD44
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.5837556681783124,1.0486014053158381,0.5087719298245614,0.6814527387178152,1.0,7/17,20.78%,KIF5A;KIF5C;LIMK2;IKBKG;RAB11A;DNM2;SYNJ1
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),-0.5632118078063517,-1.0484835586731338,0.425,0.9185894272178615,1.0,2/9,15.09%,RPL11;DCUN1D2
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.6387460701031054,1.048354971961779,0.43137254901960786,0.6818193233859187,1.0,2/6,10.80%,SERPINE1;TFPI
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),0.5682907584504719,1.048253993721034,0.3870967741935484,0.6818231702881346,1.0,3/16,7.58%,LDB2;HMBOX1;NLRC5
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),-0.6653580992891803,-1.0481008615421439,0.5217391304347826,0.9187957368261392,1.0,1/5,11.16%,ZNF304
prerank,Reactome_2022__RNA Polymerase I Transcription Initiation R-HSA-73762,-0.4748433753425607,-1.0478788299918056,0.4,0.9185954362521374,1.0,12/44,20.27%,GTF2H5;POLR2K;GTF2H2;CHD4;POLR1F;TAF1D;ERCC2;ERCC6;POLR1B;ERCC3;TTF1;POLR2L
prerank,Reactome_2022__Drug-mediated Inhibition Of CDK4/CDK6 Activity R-HSA-9754119,0.7080498182837782,1.0477617784826923,0.43859649122807015,0.6829077719487386,1.0,3/5,19.61%,CDK6;CCND1;CCND2
prerank,Reactome_2022__HIV Infection R-HSA-162906,-0.3900223130300429,-1.0475549660281955,0.25925925925925924,0.9186087512615067,1.0,42/207,20.49%,SLC25A5;APOBEC3G;CD247;GTF2H5;POLR2K;AAAS;ELOC;NUP50;GTF2H2;SLC25A4;CXCR4;ELOA;VPS4B;TAF13;SUPT16H;ERCC2;GTF2A2;TAF11;POLR2C;AP1B1;NMT2;NUP54;PSMD10;PSMD12;CCNT1;GTF2F1;PSMB5;POLR2D;RNF103-CHMP3;PSMB6;GTF2F2;PSME3;SEM1;ERCC3;PSMD2;UBB;BANF1;PSMB4;POLR2L;POLR2G;NUP85;NUP42
prerank,KEGG_2021_Human__mRNA surveillance pathway,-0.4419384994083128,-1.0475399281264615,0.2857142857142857,0.917783550995559,1.0,13/81,16.39%,FIP1L1;NXT2;PABPC1L;RBM8A;CPSF1;CLP1;SAP18;PYM1;PNN;CPSF3;WDR82;DDX19A;TARDBP
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.438572975123176,1.0473975847003767,0.373134328358209,0.6835119242844403,1.0,19/95,23.35%,TEC;LAT2;NFATC2;GAB2;SYK;PAK1;IKBKG;VAV2;TAB1;MAPK9;SHC1;SKP1;NFATC3;VAV1;TAB2;CARD11;FOS;PPP3CB;PSMB3
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.596437797097095,1.046889525410832,0.47692307692307695,0.6844583817043736,1.0,2/16,3.34%,NELL1;DAB2IP
prerank,Reactome_2022__Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,0.4916223923258048,1.0468427388435828,0.390625,0.6843701351542137,1.0,8/50,10.41%,ELMO1;WAS;MYH9;WASF1;BAIAP2;ARPC3;RNASE1;SYK
prerank,Reactome_2022__Advanced Glycosylation Endproduct Receptor Signaling R-HSA-879415,-0.564839549597309,-1.0468081441994117,0.4117647058823529,0.9190679084677745,1.0,3/11,8.82%,AGER;S100B;DDOST
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.6427682772601864,1.0467092309815302,0.43636363636363634,0.684461318112825,1.0,3/8,28.03%,PHLDB2;RREB1;CLASP1
prerank,Reactome_2022__Maturation Of Nucleoprotein R-HSA-9683610,0.6069440147391215,1.0466972354633068,0.4426229508196721,0.6843046491615172,1.0,5/10,28.49%,PARP9;UBE2I;PARP16;PARP8;GSK3B
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),-0.6792067490625442,-1.0466794699597208,0.52,0.9185936682232911,1.0,2/6,5.92%,FOXJ1;ASCL1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.5256387534307282,1.0465743265705778,0.45161290322580644,0.6843762415470521,1.0,12/32,22.47%,ZFP36;FOXO3;CDK6;STAT3;MAPK11;ETS1;PRMT1;ZFPM1;HIF1A;ARNT;ACVR1B;MAFB
prerank,Reactome_2022__Release Of Apoptotic Factors From Mitochondria R-HSA-111457,0.6465779972706907,1.0464924994784248,0.37735849056603776,0.6843761022549933,1.0,2/6,11.73%,SEPTIN4;GSDMD
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.5453253415183537,1.0463910900540023,0.4482758620689655,0.6844085408929916,1.0,1/16,1.68%,THBS1
prerank,CellMarker_Augmented_2021__Merkel cell:Skin,0.4868671957957339,1.0463790306361689,0.3787878787878788,0.6842585765925232,1.0,15/54,19.02%,NPNT;PKP2;DAB2IP;EPB41L4B;CKMT1B;SYT13;YAP1;INPP5J;COBL;SLC44A3;NGEF;TOX3;PCDH1;B3GALT5;CXADR
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.48217518996740694,1.0462965145250116,0.423728813559322,0.6842487026049205,1.0,11/32,29.53%,PRKCG;OPHN1;UBXN1;MAP1A;WAC;DDRGK1;GABARAPL2;OGT;BAG6;USP25;NOP53
prerank,Reactome_2022__RHO GTPases Activate PKNs R-HSA-5625740,-0.4730565309008207,-1.0462865852548906,0.45714285714285713,0.9189427950963415,1.0,5/39,5.51%,H2AC20;H3-3B;H2BC4;H2BC21;H2AC6
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.5947600337482373,1.0462528266911406,0.3898305084745763,0.6841574581473878,1.0,8/19,18.63%,PKP2;TRPM4;CACNA1C;RYR2;FGF13;PDE4D;CTNNA3;CAV3
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.6497161943738619,1.0462131050961951,0.4339622641509434,0.6840825355559962,1.0,1/7,3.40%,FOXO1
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.6399188552052916,1.0461479725523786,0.46551724137931033,0.6840401871553822,1.0,4/12,20.87%,TERF2IP;H3-3A;TINF2;ACD
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.6935055344844105,-1.0461116259679406,0.45454545454545453,0.9185996370624255,1.0,1/5,10.96%,PDHA1
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.47283042090086175,1.0460313252498477,0.3275862068965517,0.6840824223372187,1.0,7/54,12.63%,ANXA1;PDGFRA;CYP1B1;MAPT;PXN;PRKCD;AGAP3
prerank,Reactome_2022__Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,0.5201743058687249,1.0458358901308524,0.43333333333333335,0.6843587337897021,1.0,6/20,17.21%,ACSL5;HACD1;SLC27A3;ELOVL7;ELOVL5;HACD4
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.5250682045191868,-1.045778248549499,0.4166666666666667,0.9186881370522642,1.0,1/20,0.21%,G0S2
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),-0.6768263800165014,-1.0456073993665904,0.5348837209302325,0.9183458267427733,1.0,4/7,20.06%,PEX11B;PEX11A;DNM1L;FIS1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.5096554368260828,1.0455900319045555,0.3898305084745763,0.6847421560009455,1.0,5/40,12.49%,HELB;WAS;TERF2IP;POLQ;CGAS
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),0.51275891304952,1.0455272305298176,0.4107142857142857,0.6846801727742095,1.0,6/32,11.89%,MET;DAB2IP;ITGA3;TGFB2;FBP1;KCTD13
prerank,Reactome_2022__Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.41947088602321814,-1.045513852551899,0.34285714285714286,0.9178060749828945,1.0,20/73,24.68%,FIP1L1;AAAS;RBM8A;NUP50;U2AF1;CPSF1;NUP54;SRSF2;CPSF3;SRSF9;UPF3B;CHTOP;NUP85;NUP42;POM121C;THOC3;THOC1;NXT1;SRRM1;SLBP
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.4245714911556288,1.045458367061031,0.36065573770491804,0.6846182242914346,1.0,24/98,15.90%,ABCA6;ABCA8;MYH9;ABCA5;AMN;SLCO1A2;SLC35F3;ABCA10;MFSD2A;RAMP3;SPNS2;ABCA9;CHMP1A;SLCO2A1;ABCA2;ABCB9;SLC29A4;PLEKHA8;PICK1;MFSD2B;MFSD12;NME4;SCAMP5;ABCA3
prerank,Reactome_2022__Netrin-1 Signaling R-HSA-373752,0.47040348169752244,1.045401844449471,0.39705882352941174,0.6845433195459371,1.0,10/48,10.74%,TRPC3;SLIT2;AGAP2;FYN;SLIT3;UNC5D;DCC;RNASE1;RGMB;TRIO
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4869085547391275,1.045397561514777,0.4,0.6843710517247574,1.0,12/50,19.70%,ANXA1;LSM11;CDC7;BRD4;CCND1;ADAMTS1;CDC25B;CCNB1;ADAM17;RAB11A;CCND2;CDC27
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),-0.6183281520840214,-1.0453325327199279,0.4418604651162791,0.9175538781915741,1.0,1/10,7.04%,SLC5A10
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.7288739157751648,-1.0453053057843666,0.4528301886792453,0.916777202293456,1.0,2/5,17.22%,PRIMPOL;DDX21
prerank,Reactome_2022__Dectin-2 Family R-HSA-5621480,0.6247593931147779,1.0451976776128236,0.4918032786885246,0.6845883914348977,1.0,2/8,10.41%,FYN;SYK
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.5527420363738627,-1.0451033999494503,0.46153846153846156,0.9165740601429423,1.0,3/18,10.58%,CSKMT;SMYD2;KMT2A
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.5344336448288903,1.0449695372449748,0.423728813559322,0.6848899798884959,1.0,2/26,3.34%,CTSC;DAB2IP
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.5932880117640958,1.0449489082047072,0.509090909090909,0.684776153639364,1.0,5/12,22.53%,LAMA5;ZDHHC7;LAMA3;SCRIB;AHI1
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.6083470631843105,-1.0449240604990309,0.5,0.9163236468540559,1.0,2/9,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5775802930139211,1.044859468142063,0.41818181818181815,0.6847726599142377,1.0,5/22,8.63%,HPN;DAB2IP;EFNA1;ZNF750;LDLRAD4
prerank,PanglaoDB_Augmented_2021__T Memory Cells,0.5061076160077366,1.0447375498995704,0.4461538461538462,0.6847821373180834,1.0,6/44,7.24%,LEF1;SP100;SLA;PTPRC;SKAP1;ACAP1
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.4861261792927517,1.0446417449802192,0.36231884057971014,0.6848823682553618,1.0,14/42,20.13%,THBS1;EPHA2;PPARG;GADD45A;FGF2;ETS1;ANGPT2;ATP2B4;MAP2K3;ADAM17;PRKCA;HIF1A;FGFR1;AKT3
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.6769899499881357,1.0446072983773609,0.5,0.6847686714209991,1.0,4/7,19.03%,GRIP1;GRIP2;SCRIB;RAB11A
prerank,Reactome_2022__HCMV Early Events R-HSA-9609690,-0.41943623517875483,-1.044504210641704,0.45454545454545453,0.9165020178472966,1.0,9/71,9.05%,H2AC20;H2BC4;H2BC21;AAAS;NUP50;H2AC6;USH2A;PCSK1;H2BC18
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.4387924543684591,1.0445031542461751,0.30985915492957744,0.6847911002935156,1.0,17/105,11.07%,MET;PDGFRA;EGF;THBS1;IRS2;TGFA;FYN;NRG1;RAMP3;NRG2;PDGFA;CHI3L1;KITLG;GAB2;P2RY12;GFRAL;GAS6
prerank,CellMarker_Augmented_2021__Endothelial cell:Liver,0.4551355604208281,1.0443970761461308,0.3888888888888889,0.684823232642205,1.0,8/56,10.05%,FOSB;RELN;IL1R1;PTPRC;MCAM;LDB2;MGAT5;RIN2
prerank,Reactome_2022__AURKA Activation By TPX2 R-HSA-8854518,-0.40758529501863056,-1.0443454199430013,0.38235294117647056,0.9161773956368942,1.0,6/65,10.46%,CEP72;TPX2;SSNA1;CETN2;HAUS1;CEP131
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),-0.6856519686169976,-1.044316989907428,0.5625,0.915459718954596,1.0,1/6,4.88%,PDZD11
prerank,Reactome_2022__Diseases Associated With Visual Transduction R-HSA-2474795,-0.6283919462036404,-1.0442353405733686,0.525,0.9149196244460238,1.0,3/6,25.46%,LRAT;NAPEPLD;RBP1
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),0.6731169091137534,1.0441476079460106,0.5434782608695652,0.685243878871901,1.0,3/6,26.28%,PHF19;MACROH2A1;OGT
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.4486569115470376,1.0441473868260749,0.3559322033898305,0.685052523418432,1.0,8/69,11.35%,TGFBR2;ZYX;PARD3;DUSP22;SMAD3;TGFB2;SMAD1;PXN
prerank,Reactome_2022__Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.5148954556331629,-1.0440670235513807,0.41935483870967744,0.9146243833879902,1.0,6/47,7.29%,FTL;VAMP8;FTH1;BLOC1S4;SNAPIN;PIK3C2A
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),-0.5334091741607504,-1.044021663866162,0.45,0.9139370873238156,1.0,6/18,26.71%,ACVR1C;DNASE2;DEDD2;KPNB1;EXOG;CASP3
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),0.5771351081899222,1.043709820182754,0.4576271186440678,0.685812646303803,1.0,7/17,31.53%,RBPMS;KIAA0319;WWTR1;BMP6;TGFB3;TGFB1;BMPR1A
prerank,CellMarker_Augmented_2021__Granulosa cell:Fetal Gonad,0.4362254127395604,1.0436926696675117,0.43478260869565216,0.6856697647376667,1.0,24/138,12.51%,GGT5;HLA-DRA;SCN9A;MLLT11;PDGFRA;IGF2BP2;ICAM1;OSMR;GNG2;TMEM132C;BIRC3;C1R;ATP1A1;LDHA;CHI3L1;TSC22D3;DHRS13;CDKN1C;PGK1;ENO2;HLA-DRB1;EIF5A;RELB;PLEKHA4
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.6803391036874201,1.0435938080048803,0.5357142857142857,0.6856951387924108,1.0,1/7,0.27%,MLIP
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),-0.7184681813059,-1.0434924937228787,0.5084745762711864,0.914502100759049,1.0,1/5,8.96%,GBA2
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.4627028626181357,1.0434359975992082,0.35714285714285715,0.6858627616719105,1.0,29/84,20.24%,THBS1;SERPINE1;FLT1;PRKCB;APLNR;PAK4;CYP1B1;HK2;CHI3L1;SMAD1;ADAM12;ITGB8;HIPK1;KLF4;FGF2;GAB1;HIPK2;PIK3CD;ETS1;BRCA1;WNT5A;F3;PRKCA;TEK;HIF1A;BTG1;RHOB;ANGPTL4;VEGFD
prerank,Reactome_2022__APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.4442500028275486,-1.0431629858796783,0.39285714285714285,0.9146607121585024,1.0,14/72,20.20%,CDC26;FBXO5;PSMD10;ANAPC15;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;CUL1;SKP2;PSMB4
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.7086663897054004,1.0430796966809952,0.5,0.6864763550775523,1.0,3/5,17.57%,NLRC5;FADD;WNT5A
prerank,CellMarker_Augmented_2021__Progenitor cell:Stomach,0.5020906699939646,1.0429597480725048,0.4406779661016949,0.6861544505102419,1.0,4/51,2.14%,ANLN;KIF14;CCNB2;TYMS
prerank,CellMarker_Augmented_2021__Oxyntic Stem cell:Stomach,0.5020906699939646,1.0429597480725048,0.4406779661016949,0.6861544505102419,1.0,4/51,2.14%,ANLN;KIF14;CCNB2;TYMS
prerank,CellMarker_Augmented_2021__Oxyntic Progenitor cell:Stomach,0.5020906699939646,1.0429597480725048,0.4406779661016949,0.6861544505102419,1.0,4/51,2.14%,ANLN;KIF14;CCNB2;TYMS
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),-0.45306071410896437,-1.042847341839807,0.3333333333333333,0.9147650366504466,1.0,6/50,6.14%,ADAMTS9;TPP1;APOE;NR1D1;USE1;FBXO27
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),0.6239820493844821,1.0427185768574097,0.4117647058823529,0.6865025217893548,1.0,3/13,13.62%,WASF1;PID1;MTM1
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.431330865648278,1.042589326010346,0.3442622950819672,0.6866179942052599,1.0,21/128,9.59%,MTMR7;SGPP2;PTPRO;DUSP1;PLPPR5;PTPRB;PXYLP1;PLPPR4;DUSP10;PLPPR1;PTPRR;PTPRC;DUSP8;DUSP16;PDP1;PTPN21;SBF1;PTPRD;SSH2;PTPN9;PPP1CB
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6597571387505325,1.0425428502382834,0.5081967213114754,0.6865139698167583,1.0,2/9,12.89%,MBP;KLF4
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.6328562014546276,1.0425121806873556,0.3684210526315789,0.6864100033321747,1.0,5/9,19.03%,GRIP1;GRIP2;STX1B;SCRIB;RAB11A
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.5598934231246349,1.0425081607818465,0.47058823529411764,0.6862254658797482,1.0,5/15,15.14%,MGAT3;CHST6;CHST4;CHST2;LARGE1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),0.5571032239817134,1.0422750023334104,0.4117647058823529,0.6865020996722981,1.0,9/21,18.07%,PROX1;HECA;CHI3L1;ITGA3;GLI2;PDPN;FGF2;ABCA3;PCSK5
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Blood,0.40268913721946137,1.0420104669187886,0.35294117647058826,0.6869655344416149,1.0,59/260,20.30%,TGFBR2;SCN9A;P2RY6;COBLL1;PPFIBP1;APP;ADA;IRF7;PTPRC;EMB;MFSD2A;PLAC8;SERPINF1;KIRREL3;EIF4A3;DAPK2;DAAM1;PLAAT3;TUBB6;ADAM19;PACSIN1;MCOLN2;CD83;ABCA2;GAS6;PLXNA4;FMNL3;MEF2D;PHEX;TEX2;GAB1;CD99;BCL11A;STAMBPL1;PIK3CD;GPR183;CD4;PDCD1LG2;SCAMP5;CNP;PTPRS;STMN1;P2RY14;CUX2;TP53I11;TPST2;ITPR1;TACC1;SETBP1;AHCY;FHIP1A;MAP1A;EGLN3;NIBAN3;ZFAT;NOTCH4;SUSD1;PFKP;MYO1E
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.5634931378531469,1.0419978189868364,0.37037037037037035,0.6867809964557572,1.0,3/15,4.73%,ABCA8;ABCA5;SOAT1
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Undefined,0.6259552329572443,1.0419814057090717,0.4827586206896552,0.6866287767224094,1.0,4/11,20.93%,SMAD1;PRDM1;SLC2A3;CCNA2
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.5172495432376643,1.0419715240751068,0.4153846153846154,0.6864476555282568,1.0,15/35,22.64%,WAS;ZNF750;EMP1;CERS3;OVOL3;HLA-DRB1;ALDH3A2;STS;LAMA3;RBP2;SVEP1;POU2F3;UGCG;FLOT2;GLI1
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.712856147718482,1.041618393212068,0.5454545454545454,0.6870232827123016,1.0,3/5,24.87%,ADAM9;PRKN;D2HGDH
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),0.5728321532231941,1.0415538559602884,0.3829787234042553,0.6869966589688237,1.0,5/14,11.18%,ADCY5;ADCY7;ADCY2;GUCY1A1;GUCY1B1
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.5575891704239171,1.0414268242651947,0.421875,0.6871502574430618,1.0,5/20,6.72%,SLIT2;EFNA1;SLIT3;TBX20;ROBO2
prerank,Reactome_2022__Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.43800463229434544,-1.0411451129223352,0.3939393939393939,0.918632653873594,1.0,4/28,13.52%,KSR2;VWF;ARAF;NRAS
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.4144901978692172,1.0411398678437582,0.37142857142857144,0.6876061777520767,1.0,32/134,14.43%,TAMALIN;COL4A1;SQOR;DCN;CALD1;SULF1;COL4A2;ANGPTL2;POSTN;FAS;COL12A1;IGFBP7;PTPN21;C1R;CYP1B1;SCARA3;ADGRF5;BGN;ITGA9;PXDC1;SLCO2A1;COL4A4;BACE2;FGD5;FN1;ROBO4;PALLD;TMTC1;COL5A1;NTN4;TRIM47;BMX
prerank,CellMarker_Augmented_2021__Medullary Thymus Epithelial cell:Thymus,0.51093006979963,1.0409689867533434,0.4603174603174603,0.6876555559485754,1.0,13/43,13.98%,ACSL5;TC2N;B3GNT2;RPS6KA1;TJP3;PTPRC;PCED1B;SKAP1;ANO9;RAB11FIP1;CD5;TMC8;ELF1
prerank,CellMarker_Augmented_2021__Cortical Thymus Epithelial cell:Thymus,0.51093006979963,1.0409689867533434,0.4603174603174603,0.6876555559485754,1.0,13/43,13.98%,ACSL5;TC2N;B3GNT2;RPS6KA1;TJP3;PTPRC;PCED1B;SKAP1;ANO9;RAB11FIP1;CD5;TMC8;ELF1
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.6403356011417882,1.0408368046192307,0.5,0.6877220119709045,1.0,1/11,3.83%,PGD
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.4901205724805188,-1.0407671549633815,0.40476190476190477,0.9189960707792619,1.0,3/17,8.40%,SNF8;SMPD3;VPS4B
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),-0.603087684379406,-1.0406921898556887,0.40476190476190477,0.9183758808956958,1.0,4/12,15.48%,AKR1C3;CYP46A1;TSPO;STARD3NL
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.520210340787076,1.0404138513995185,0.39285714285714285,0.6885179022626626,1.0,10/27,21.85%,SLC39A14;SOX4;RAB11FIP5;GAS6;MLXIPL;PTPRN;IGF1R;PDK3;KCNB1;ADCY8
prerank,Reactome_2022__ALK Mutants Bind TKIs R-HSA-9700645,0.6272502231327977,1.0402100434852728,0.41935483870967744,0.6887800533849494,1.0,4/11,15.05%,FN1;ALK;BCL11A;PRKAR1A
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),-0.5653623134449799,-1.0401801977700913,0.36363636363636365,0.919108846657925,1.0,5/14,16.85%,PYGM;AGL;PHKG1;GAA;PGM2
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.7009517227169606,1.0401267511767707,0.47058823529411764,0.6887433666379545,1.0,2/6,16.85%,DIO1;CTSK
prerank,Reactome_2022__Interleukin-1 Processing R-HSA-448706,0.7182114714999471,1.0396697228140597,0.5106382978723404,0.6896506926533724,1.0,1/5,11.73%,GSDMD
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.5375906329892703,1.0395898798148038,0.4,0.6896458848127149,1.0,3/13,9.35%,IRS2;PRKCE;PPARG
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.5514894752652633,-1.0395578738122846,0.35294117647058826,0.920183269115362,1.0,4/18,14.69%,FBXO5;RPL23;RPL11;BAG2
prerank,KEGG_2021_Human__Measles,0.4439604568528529,1.0395483520629956,0.39344262295081966,0.6895319708888299,1.0,22/93,17.07%,TLR2;IRF7;FAS;MYD88;CDK6;BCL2L1;IKBKE;STAT3;BBC3;TYK2;MX1;CDKN1B;BCL2;CCND1;FADD;IL12A;IKBKG;PIK3CD;IFIH1;TP53;CDK2;MAPK9
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),-0.39691889559832755,-1.0390377101853288,0.32142857142857145,0.9209133381344548,1.0,25/139,14.39%,PAK1IP1;SETD9;TPX2;RFC3;ATRIP;RPL37;HUS1;SMYD2;RPL23;CHD4;NOC2L;BRIP1;KMT5A;BRPF1;TAF13;SUPT16H;TTC5;TAF11;ATR;MAP2K6;RPL11;PIP4P1;RAD9B;BRD7;RMI2
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.7017827308676384,1.0388757715617318,0.5208333333333334,0.6908297247414233,1.0,4/7,18.42%,TRPM4;OXTR;SMTNL1;ADRA1D
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.7132734264928606,1.0388052616915626,0.47058823529411764,0.6907796923839568,1.0,3/6,23.69%,HK2;PINK1;PRKN
prerank,Reactome_2022__Activated NTRK2 Signals Thru CDK5 R-HSA-9032845,0.7032692088363212,1.0387678639341673,0.5272727272727272,0.6906623529371242,1.0,1/5,9.78%,RNASE1
prerank,GO_Biological_Process_2021__secretion (GO:0046903),-0.6080204762108269,-1.0387013152454825,0.47619047619047616,0.9210450325564222,1.0,3/10,6.23%,FBLN5;GUCA1B;ABCB11
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.6261249833683169,1.0385307999150815,0.47540983606557374,0.6909361531575775,1.0,5/10,14.04%,KCNJ2;ATP1A1;ATP1B1;ATP1B3;KCNMA1
prerank,CellMarker_Augmented_2021__Plasmablast:Blood,-0.4952173215540505,-1.0384739957903788,0.45454545454545453,0.9208614590467313,1.0,8/34,6.16%,GMFG;CD247;CD96;CD38;RHOH;PYHIN1;CD6;P2RY10
prerank,Reactome_2022__CTNNB1 S33 Mutants Not Phosphorylated R-HSA-5358747,0.5754668564302601,1.0383369403777079,0.4406779661016949,0.6911745508907058,1.0,1/13,8.12%,CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.3787117446614797,1.0382844347527984,0.27710843373493976,0.6910924409507965,1.0,65/531,13.21%,NR4A3;SKOR1;MLIP;FOSB;KLF2;PROX1;ZNF536;SP100;ATF3;ZFP36;IRF7;DAB2IP;ZNF140;EFNA1;SUV39H1;HIC1;ZNF282;KLF11;NFIL3;BCL6;GZF1;CHD3;KLF10;CIITA;ZNF608;ZNF750;ZBTB16;LDB2;TBX20;FOXO3;SNCA;MSX2;GLIS2;HMBOX1;ZFPM2;DUSP22;BAG3;MYT1L;TBL1X;SMAD3;NR1I3;YAP1;PPARG;ETV6;CTBP2;HDAC4;GLI2;STAT3;GLIS3;TLE6;NR6A1;PARP9;JAZF1;HDAC9;FBP1;NR4A2;GFI1B;GADD45A;KLF7;PER1;TFAP2C;KLF4;SOX13;CCND1;DEAF1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bone Marrow,0.4784705737584707,1.038086361807251,0.4126984126984127,0.6913082436353339,1.0,8/55,9.81%,TGFBR2;TLR2;SP100;AHR;STEAP4;TCP11L2;HIPK3;NAMPT
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.6366855448225015,-1.0380213251997095,0.5348837209302325,0.9214684510713124,1.0,3/7,16.24%,TWSG1;RUNX1;TARM1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.5377080514411677,1.037903802035051,0.5,0.6915239270918687,1.0,11/21,30.64%,LIMCH1;SLC9A1;CAMSAP3;EPHA3;VCL;DAPK3;CLASP1;MACF1;CORO1C;EFNA5;PEAK1
prerank,Reactome_2022__Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.4202697957359972,-1.0376773601752862,0.35294117647058826,0.9215323970164241,1.0,24/75,23.21%,RFC3;COPS8;GTF2H5;MCRS1;POLD3;GTF2H2;CETN2;COPS7A;ERCC2;RAD23A;POLR1B;SLC19A1;XPA;RUVBL1;ERCC3;NFRKB;UBB;UBE2V2;COPS3;COPS6;PARP1;PIAS3;GTF2H3;YY1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.5562292898503192,-1.0375885909837217,0.35714285714285715,0.9210279916024343,1.0,2/15,4.32%,NXT2;AAAS
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreatic Islet,0.4790571101897891,1.0375032056659026,0.4126984126984127,0.6922068526867187,1.0,10/44,12.14%,SLC43A1;ZDHHC9;YBX3;PDIA2;ALDOB;UGDH;GPT2;RNASE1;NIBAN1;TPD52L1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In8:Brain,-0.4441989163066562,-1.0374905761172644,0.36585365853658536,0.9204443229128864,1.0,8/46,8.33%,NUP62CL;KPNA2;TPX2;DNMT3B;DSCC1;KIF4A;MEX3A;HMGB3
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.37095572221685047,1.0372380321556565,0.32967032967032966,0.692610981975316,1.0,227/1648,16.69%,LEF1;CDKN2A;NR4A3;SKOR1;MYT1;FOSL2;FOSB;ELAVL2;SIX3;PTP4A3;ST18;MYRF;PRRX1;ZFP92;TEAD2;IGF1;KLF2;MAFF;EBF1;MLLT11;PROX1;YWHAH;EGF;ZNF536;CREB5;TESC;SP100;ATF3;ZIC4;ACTA2;PSRC1;MAEL;ZNF93;STAT4;TYMS;NR4A1;BLM;PRDM8;CASZ1;PRKCB;HES7;ZSCAN1;RPS6KA1;IRF7;DAB2IP;FOXO1;ZNF140;PRAME;TGFA;SUV39H1;HIC1;CIC;ZNF282;WTIP;TCEAL7;KLF11;PPARGC1B;NFATC2;NFIL3;SOX4;GCM2;ERFL;BCL6;TBX19;NKX6-2;AHR;ZSCAN31;LHX6;GZF1;CHD3;KLF10;ZNF704;DVL1;SKAP1;RFX4;ZNF114;CIITA;CCNQ;ZNF608;NRG1;ZBTB16;BAP1;NEUROD2;ZIC1;PGR;TBX20;FOXO3;KCNH2;MSX2;GLIS2;SCX;HR;MAMLD1;PML;HMBOX1;DBX2;ZFPM2;ZNF787;HIVEP2;PCGF3;CTNNB1;CSRNP1;ZBTB7C;MYT1L;TBL1X;ZNF654;SMAD3;BASP1;YAP1;RAI1;TRAK1;PPARG;ETV6;CTBP2;CHMP1A;HDAC4;PBX3;ZNF597;GLI2;OVOL3;DENND4A;RGMB;PEX14;STAT3;FLI1;KLF3;GLIS3;SMAD1;TEAD1;TERF2IP;ABCA2;NR6A1;CDKN1C;PARP9;GAS6;HDAC9;NR4A2;NPAS2;GFI1B;MED12L;L3MBTL3;RUNX1T1;KLF9;ZNF850;SRA1;HLA-DRB1;ZNF467;PRICKLE1;MLXIPL;KLF7;ZNF552;CDKN1B;KLF6;RELB;TRIM22;ZNF667;MEIS3;BRD4;PER1;TFAP2C;KLF4;MEF2D;JARID2;ZBTB26;CDKN1A;SOX13;DEAF1;FGF2;SS18L1;SPINDOC;ELF1;SRCAP;PRDM1;ZNF746;DUXB;HIPK2;BCL11A;RGS14;IKZF2;RBFOX2;SPP1;SNAI3;ZNF182;SOX10;PRDM16;RARA;CD4;PRKAR1A;ATXN1L;SMARCA1;PHF6;ETS1;ZNF215;STAT6;MAP3K5;TP53;OLIG2;PROX2;SAMD13;HIF3A;BACH1;ZNF571;RXRA;OGG1;PKNOX2;MED13L;ZIK1;BRCA1;FZD7;ATP2B4;ETV3;ZMIZ1;ZNF20;ZEB1;TOX3;ZBTB46;ZKSCAN2;SPTY2D1;CUX2;CXXC1;SP140L;HMGA1;NPAS3;ZBTB38;RORA;TFEB;MESP1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.6082011330442979,1.037191306129719,0.45901639344262296,0.692493396165244,1.0,6/12,14.92%,MSMP;HSD3B7;GAS6;CCL2;PIK3CD;GPR183
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.5964897241979497,1.037123686956509,0.5087719298245614,0.6924814242514918,1.0,4/17,16.62%,CACNA1C;CYP1B1;IFT122;C12ORF57
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.5640822428917232,1.0370609794801786,0.41935483870967744,0.6924374832197447,1.0,1/17,1.45%,EGF
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.47895551638299505,1.0370227759843353,0.45,0.6923552061389612,1.0,21/62,19.17%,CTAGE14P;MYLK3;GCM2;PTCHD1;DTNA;RYR2;ADCY2;SYNPO2L;GALNT16;ART3;COL9A1;SORBS1;MAPT;FGF13;HIF3A;WIPF3;SPTB;RGMA;CTNNA3;LDB3;CACNB2
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.5954158092830838,1.0364476172338726,0.3617021276595745,0.6933499620987564,1.0,1/15,2.30%,CORO7
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.6116224163015826,1.0363826833073655,0.41509433962264153,0.6932674788645226,1.0,5/8,25.55%,CHI3L1;CHI3L2;CTBS;AMDHD2;CHIT1
prerank,Reactome_2022__ChREBP Activates Metabolic Gene Expression R-HSA-163765,0.6762753573244105,1.0362988712361125,0.4666666666666667,0.6932936387150963,1.0,1/6,12.23%,MLXIPL
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),0.6745778450705096,1.0362550874106693,0.4807692307692308,0.6932112164422544,1.0,5/8,23.31%,PRKAR1B;PKIA;PRKAR1A;PRKAR2B;PKIG
prerank,Reactome_2022__RIP-mediated NFkB Activation Via ZBP1 R-HSA-1810476,0.5594546104543134,1.036146529047291,0.4339622641509434,0.6933139923034207,1.0,4/15,24.45%,MYD88;IKBKG;TLR3;DHX9
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.5919999923335039,1.036096818511158,0.5084745762711864,0.6932348012229282,1.0,3/15,11.77%,ZFP36;EPB41L4B;KLF9
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Peripheral Blood,0.5631038061209738,1.035982717732605,0.42857142857142855,0.693343895075509,1.0,5/24,11.14%,TMEM204;CD55;NELL2;TESPA1;ACTN1
prerank,Reactome_2022__HCMV Infection R-HSA-9609646,-0.40089826124446054,-1.035746531384476,0.4166666666666667,0.9249000991371784,1.0,10/95,9.05%,H2AC20;H2BC4;H2BC21;SNF8;AAAS;NUP50;H2AC6;USH2A;PCSK1;H2BC18
prerank,Reactome_2022__Interferon Signaling R-HSA-913531,0.43491258628208673,1.0351569033326424,0.4,0.6950860313155647,1.0,22/144,12.85%,HLA-DRA;SOCS3;SP100;ICAM1;IRF7;TRIM5;TRIM46;CIITA;SAMHD1;CD44;EIF4A3;PML;KPNA7;TRIM17;PDZD2;TYK2;HLA-DRB1;MX1;CAMK2B;PRKCD;TRIM22;B2M
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.6611019608066163,-1.034570654904268,0.4642857142857143,0.9275011365891225,1.0,3/6,23.08%,SAT1;SRM;SAT2
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6134417401311075,1.0345324154136433,0.4918032786885246,0.6961414380763327,1.0,5/12,23.17%,DMTN;ACTN4;SPRY4;AP1AR;GBP1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6134417401311075,1.0345324154136433,0.4918032786885246,0.6961414380763327,1.0,5/12,23.17%,DMTN;ACTN4;SPRY4;AP1AR;GBP1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.5424619830223626,1.0344326657025664,0.4,0.696099822719101,1.0,6/21,17.89%,NUMBL;SERPINF1;NAP1L1;TRIM32;RGS14;LRP2
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),0.6912448280777881,1.03423988178647,0.5094339622641509,0.6963354249541651,1.0,1/5,10.20%,SLC25A29
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.3955645343876228,1.034182828387995,0.32926829268292684,0.6962619264552125,1.0,52/302,18.98%,RECQL4;BOK;HELB;BLM;EPHA2;IRF7;FOXO1;RPA1;RBM24;SUV39H1;HIC1;NFATC2;BCL6;SAMHD1;POLD1;HROB;PML;BCL2L1;YAP1;IKBKE;BARD1;POLQ;GADD45A;MACROD1;BCL2;CGAS;PAK1;CDKN1A;CCND1;TRAIP;IKBKG;FMN2;POLE3;MRE11;TP53;SPATA18;BACH1;OGG1;BRCA1;ZBTB38;ZBTB1;DOT1L;STK11;DDB2;HPF1;RFC4;FANCL;PLK3;MMS19;NEK4;RAD18;FBXO31
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.7055388728338183,1.034136181181508,0.43478260869565216,0.6961725463625015,1.0,1/5,12.15%,PHF23
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.7226267613686702,-1.0340682624080857,0.5102040816326531,0.9283122755981423,1.0,3/5,25.16%,MUS81;SLX4;FBH1
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),-0.6183060145176077,-1.033886600302534,0.4418604651162791,0.9279638753878476,1.0,1/7,14.72%,PJVK
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.46376528469774414,1.0338437566777599,0.45454545454545453,0.6965798446291687,1.0,15/63,14.11%,OTOS;COL11A2;CDH23;KCNQ1;EPS8L2;PIEZO2;LHFPL3;CLRN1;CDC14A;TBL1X;EML2;CEMIP;USP53;PCDH15;NDUFB9
prerank,Reactome_2022__Translesion Synthesis By REV1 R-HSA-110312,-0.5213895583424127,-1.033499494922466,0.38095238095238093,0.9283143365747608,1.0,4/16,19.54%,RFC3;POLR1B;SLC19A1;UBB
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.5489520253132624,1.0334526134641246,0.4576271186440678,0.6972097045046702,1.0,3/16,5.94%,SLC15A3;VLDLR;MFSD2A
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),-0.3867254360634715,-1.0327616665921422,0.3333333333333333,0.9297870510202997,1.0,36/142,11.83%,MRPL10;RPL35A;RPS24;RPL34;RPL39;MRPS21;RPL13;RPL37;MRPL52;RPS28;MRPS7;RPL18;RPL12;RPL23;RPL31;MRPL36;MRPS16;MRPL18;RPS26;RPL6;RHCE;RPL41;RPS13;RPL22;RPL29;RPL30;ASMT;RPSA;PCSK1;RPL14;RPL15;EEF1A1;RPS2;IGF2BP3;RPL11;RPL23A
prerank,Reactome_2022__TRAF6 Mediated NF-kB Activation R-HSA-933542,-0.5036417452060464,-1.0326258342289245,0.4222222222222222,0.9292922308246988,1.0,2/22,2.62%,AGER;S100B
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.6391918798260241,1.0324185833801085,0.48148148148148145,0.6994746499973421,1.0,2/9,7.85%,PLK2;RAP2B
prerank,Reactome_2022__Calcineurin Activates NFAT R-HSA-2025928,0.6533739582384926,1.0323747052447312,0.49230769230769234,0.6993876672691985,1.0,4/7,25.85%,NFATC2;NFATC3;PPP3CB;PPP3CA
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.5746554628896985,-1.0320055250515716,0.4,0.9301911149542532,1.0,2/15,12.29%,MAPK7;HTRA2
prerank,Reactome_2022__Urea Cycle R-HSA-70635,0.6765587634557664,1.031854204099406,0.5,0.7003978417006494,1.0,2/6,8.93%,ASS1;CYP21A2
prerank,CellMarker_Augmented_2021__Interneuron:Embryonic Prefrontal Cortex,0.5477731755683882,1.031787288302026,0.4107142857142857,0.7003488033415742,1.0,4/21,8.27%,GAD2;LHX6;LDHA;NRXN3
prerank,Reactome_2022__Trafficking And Processing Of Endosomal TLR R-HSA-1679131,0.6308281359707614,1.0317027777564105,0.4745762711864407,0.7003411095594785,1.0,1/10,1.13%,CTSS
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.531205532687316,1.0315598436130575,0.4153846153846154,0.700463693895106,1.0,4/27,6.39%,DOC2B;IRS2;SOX4;NNAT
prerank,CellMarker_Augmented_2021__Dendritic cell:Placenta,0.5496498626507544,1.0315365876224023,0.41935483870967744,0.7003289111874902,1.0,7/27,4.31%,HLA-DRA;CTSS;MYO1F;PLEK;SLA;WAS;PTPRC
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.5330047634140669,-1.0312704879583612,0.4,0.9313336196645785,1.0,1/13,1.04%,FAM47E
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),-0.39710497680349377,-1.0311628077202744,0.35135135135135137,0.9308321242807466,1.0,5/67,5.35%,NUP62CL;KPNA2;NXT2;NUP50;RPL23
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.4755686795665456,1.0310152721559107,0.40625,0.7013310926010266,1.0,7/62,8.31%,IGF1;THBS1;SERPINE1;ICAM1;FAS;TMBIM1;BCL2L1
prerank,CellMarker_Augmented_2021__Transitional B cell:Peripheral Blood,0.5578984600710578,1.030994859587103,0.48214285714285715,0.7007900331754616,1.0,8/20,12.64%,CD24;NAPSB;WAS;PTPRC;CD37;ACAP1;ITGAL;TMC8
prerank,CellMarker_Augmented_2021__Regulatory B cell:Undefined,0.5578984600710578,1.030994859587103,0.48214285714285715,0.7007900331754616,1.0,8/20,12.64%,CD24;NAPSB;WAS;PTPRC;CD37;ACAP1;ITGAL;TMC8
prerank,CellMarker_Augmented_2021__Naive B cell:Blood,0.5578984600710578,1.030994859587103,0.48214285714285715,0.7007900331754616,1.0,8/20,12.64%,CD24;NAPSB;WAS;PTPRC;CD37;ACAP1;ITGAL;TMC8
prerank,Reactome_2022__Ovarian Tumor Domain Proteases R-HSA-5689896,-0.4687780322825478,-1.0309129139298137,0.3611111111111111,0.9307350317807275,1.0,2/34,1.79%,OTUD3;TNFAIP3
prerank,CellMarker_Augmented_2021__T cell:Eye,-0.48282629276439826,-1.030865828296476,0.3939393939393939,0.9301093518003828,1.0,9/34,6.16%,GMFG;APOBEC3G;CD247;CD96;RHOH;PYHIN1;PTPN22;CD6;P2RY10
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.6278550637901239,1.0308121065833777,0.5370370370370371,0.701020147986915,1.0,6/10,32.34%,SORBS1;PTPN11;IRS1;ECHDC3;SIRT1;PRKCZ
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.6033010400181915,1.030687858278257,0.38461538461538464,0.7011042558452109,1.0,2/13,8.06%,RAB11FIP5;SLC9A1
prerank,Reactome_2022__Translesion Synthesis By POLK R-HSA-5655862,-0.5118223566236088,-1.0306489607160683,0.3953488372093023,0.929947020293339,1.0,6/17,24.35%,RFC3;POLR1B;SLC19A1;UBB;MAD2L2;POLK
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),-0.66300494619072,-1.0305453527400954,0.5,0.9294484749798606,1.0,3/6,17.61%,ATP1A2;NLGN3;MTG2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.42020924569904244,1.03049106463582,0.4406779661016949,0.7013087951507728,1.0,25/119,18.14%,NR4A3;TEAD2;NR4A1;PGR;CDK9;TBL1X;NR1I3;YAP1;PPARG;TAF4B;TEAD1;NR6A1;HDAC9;NR4A2;MAML2;NOTCH3;RARA;RARG;RXRA;RORA;NCOR1;WWTR1;NR2F6;HDAC7;TBL1XR1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.5243443587147382,1.0304502291316922,0.390625,0.7012057721251269,1.0,2/26,9.62%,PLK2;CHMP1A
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.5983497339248056,1.0303893573295517,0.4915254237288136,0.7011598424947397,1.0,2/10,18.55%,STK25;PLK3
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Liver,0.4484158773794465,1.0301226839185549,0.4153846153846154,0.7016049562658052,1.0,9/90,6.44%,VRK2;SP100;B3GNT2;TEC;PTPRC;SOAT1;AHR;BIRC3;CD44
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),0.5722854122515287,1.0299369107583076,0.47540983606557374,0.7017869662666585,1.0,4/18,16.01%,PGD;HK2;HK1;PGM2L1
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.6828678510706903,1.0297936119951814,0.49019607843137253,0.7019878736119352,1.0,4/6,31.32%,DDB1;ARPP19;NNMT;SIRT1
prerank,Reactome_2022__HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,0.47940232675422356,1.0296998921657161,0.4098360655737705,0.7020145816683635,1.0,10/36,23.41%,PGR;FKBP5;ACTR1A;DYNC1LI2;DCTN1;DYNC1LI1;CAPZB;DCTN3;DYNC1I1;DCTN6
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.48893217760241786,1.0296511576209386,0.39344262295081966,0.7019178635160311,1.0,5/53,5.94%,MET;NELL1;TIMP2;DAB2IP;MFSD2A
prerank,Reactome_2022__STAT3 Nuclear Events Downstream Of ALK Signaling R-HSA-9701898,0.672027235189621,1.0295853140059155,0.49056603773584906,0.7018844688979298,1.0,3/9,19.28%,STAT3;PRDM1;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.6556535921902323,1.0290454055792495,0.5294117647058824,0.7029706790458318,1.0,1/6,1.68%,THBS1
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.6072093686592507,-1.0286118000330304,0.4523809523809524,0.9340465903597595,1.0,1/7,1.79%,TNFAIP3
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.501508162339274,1.0285385907114086,0.4666666666666667,0.7038697497502012,1.0,5/41,4.31%,PSCA;DAB2IP;DUSP10;PTPRR;PTPRC
prerank,Reactome_2022__Erythropoietin Activates STAT5 R-HSA-9027283,-0.6180397649798246,-1.0284481297032648,0.47058823529411764,0.9336507360558673,1.0,2/7,4.64%,EPX;EPOR
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.5285989118644867,1.028333804627632,0.47368421052631576,0.704104530825682,1.0,7/31,10.32%,ANK3;THY1;RNASE10;SKAP1;CD44;ADAM19;PODXL
prerank,Reactome_2022__RIPK1-mediated Regulated Necrosis R-HSA-5213460,0.523499938894118,1.0281585565072546,0.3898305084745763,0.7042665018809241,1.0,7/28,26.28%,BIRC3;TNFRSF10B;FADD;RPS27A;FLOT2;FLOT1;OGT
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.6455305666808818,1.02794031804737,0.5625,0.7045705498079031,1.0,2/8,7.88%,PTPRC;LDLR
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR1 R-HSA-5654687,-0.5058041529902784,-1.0279238482134483,0.4444444444444444,0.9342624301733538,1.0,1/22,0.15%,FGF6
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.672181498251241,-1.027756818077208,0.5384615384615384,0.9338210492361931,1.0,3/6,26.30%,DHX58;TKFC;RIOK3
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),-0.672585625915848,-1.0273968063170404,0.5217391304347826,0.93397167864608,1.0,2/5,10.84%,COQ3;GK
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),-0.6134479342737593,-1.0271701003432134,0.4772727272727273,0.9338135527197965,1.0,2/9,6.81%,CD200R1;MST1
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),0.6008507313691318,1.0268932502377321,0.4827586206896552,0.7067189172180308,1.0,3/9,7.88%,PDGFRA;PDGFA;LDLR
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.6742323015174922,1.026726400319805,0.4166666666666667,0.7067601411066753,1.0,4/9,20.87%,TERF2IP;H3-3A;TINF2;ACD
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.6742323015174922,1.026726400319805,0.4166666666666667,0.7067601411066753,1.0,4/9,20.87%,TERF2IP;H3-3A;TINF2;ACD
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.5697370021057689,-1.0266738514206686,0.47619047619047616,0.9344557815781144,1.0,2/14,6.00%,AR;AKR1C3
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.5811250073804144,-1.026608797138474,0.47368421052631576,0.9338126344794971,1.0,3/17,6.14%,ADAMTS9;BPGM;FBXO27
prerank,Reactome_2022__Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.4656358719430556,1.0263925556315652,0.4406779661016949,0.7073251091916997,1.0,8/52,6.28%,ADAMTS4;ADAMTSL2;THBS1;THSD7B;ADAMTS10;GALNT12;SEMA5B;ADAMTS19
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.4587299573548743,1.0263641961547418,0.3870967741935484,0.7072209253270214,1.0,10/47,18.55%,PLK2;SOX4;PML;GADD45A;CDKN1B;CDKN1A;TP53;CCNB1;PRMT1;PLK3
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),0.6627498133686882,1.0262100081238057,0.5098039215686274,0.7073344288484605,1.0,2/7,5.06%,TRPM4;TNFRSF14
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.6275104167214487,1.0261675158699632,0.44642857142857145,0.7072208395020371,1.0,2/11,1.31%,ANXA1;IL15
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.6131070814734565,1.026115846597442,0.46938775510204084,0.707164054281939,1.0,3/11,20.98%,B4GALT5;B4GALT6;ARHGAP35
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),-0.6468764674127796,-1.0260362579343267,0.5094339622641509,0.9346501577210583,1.0,3/6,17.56%,EDNRB;ARX;SOX8
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.5381923323075233,-1.0259460556454714,0.38461538461538464,0.934053739520407,1.0,2/14,9.16%,NUDT7;PPCS
prerank,CellMarker_Augmented_2021__Neural Stem cell:Brain,0.5433163201229158,1.0258621229541103,0.4166666666666667,0.7074602674120024,1.0,3/19,10.76%,CD24;MCAM;DCX
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.5887924655662131,1.0256263131382217,0.39655172413793105,0.7078413867569198,1.0,3/18,12.39%,TTLL7;AGTPBP1;CFAP20
prerank,GO_Biological_Process_2021__hyperosmotic response (GO:0006972),0.6988443295412587,1.0252953583590703,0.5370370370370371,0.7084553828778811,1.0,1/5,3.33%,YBX3
prerank,Reactome_2022__Signaling By KIT In Disease R-HSA-9669938,0.5724021658238576,1.0252577207551374,0.4838709677419355,0.708325898664417,1.0,2/17,10.27%,FYN;STAT3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.4752762152843433,1.0251414101691372,0.4426229508196721,0.7084105536538384,1.0,14/57,18.53%,PROX1;PTK6;PSRC1;APP;NUDT16;TGFB2;CDKN1B;CCND1;TRIM32;RARA;CDC25B;CCNB1;ADAM17;PRKCA
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),-0.5226053183071739,-1.02503891108444,0.5121951219512195,0.936007174310212,1.0,6/19,21.81%,NCOA4;ZFYVE16;CLU;AP4M1;GCC2;GNPTAB
prerank,KEGG_2021_Human__SNARE interactions in vesicular transport,-0.5130089574478647,-1.0248228980376557,0.358974358974359,0.9358154640221537,1.0,5/30,13.82%,VAMP8;USE1;STX16;VAMP5;VTI1B
prerank,KEGG_2021_Human__Hedgehog signaling pathway,0.4799919743746961,1.024648387088208,0.42105263157894735,0.7093354695713429,1.0,24/50,28.99%,BOC;GRK2;GLI2;BCL2;CCND1;EVC2;SMURF1;LRP2;CCND2;KIF7;GRK3;GLI1;CUL3;ARRB1;CSNK1G2;PTCH1;SUFU;IQCE;SCUBE2;GSK3B;TPTEP2-CSNK1E;HHIP;ARRB2;FBXW11
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.6042213794464811,-1.0244937948455823,0.45652173913043476,0.935898100287916,1.0,2/6,28.91%,GSTM3;GSTM4
prerank,Reactome_2022__Elastic Fibre Formation R-HSA-1566948,0.4899415503178629,1.0244247077691955,0.36923076923076925,0.7096211717640997,1.0,5/27,10.89%,LTBP4;ITGA8;LOXL1;TGFB2;ITGB8
prerank,CellMarker_Augmented_2021__Hepatic Progenitor-Like cell:Pluripotent Stem Cell,0.4641803677075343,1.024414179172988,0.3548387096774194,0.7094537656380434,1.0,9/47,10.54%,C3;CP;C1RL;TNS1;ALDOB;MMP14;RNASE1;ITGA9;VWA5A
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.4980702126163898,1.0241891227976108,0.47368421052631576,0.7097927398583902,1.0,11/48,17.57%,PLK2;DAB2IP;FOXO1;HECW2;BARD1;HECW1;CDKN1B;OAZ2;TRIM32;SMURF1;WNT5A
prerank,Reactome_2022__Signaling By NTRKs R-HSA-166520,0.43624984459884725,1.0241350917061331,0.4264705882352941,0.7097228358840805,1.0,14/114,6.48%,FOSB;KCNH8;SH3GL2;GRIN2B;RIT2;SH3GL3;SHC2;IRS2;RPS6KA1;FYN;CDK5R2;DNM1;NTRK3;VGF
prerank,Reactome_2022__MAP2K And MAPK Activation R-HSA-5674135,-0.4280366422090727,-1.0240546065663707,0.43333333333333335,0.9363977853658774,1.0,4/32,13.52%,KSR2;VWF;ARAF;NRAS
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),-0.499743559290671,-1.024007066280779,0.4186046511627907,0.9357112446383471,1.0,1/19,0.09%,NGF
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Dental Pulp,0.6386607913976998,1.0238751853398167,0.47058823529411764,0.7101024116708153,1.0,3/8,6.44%,THY1;PTPRC;CD44
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.47103864158033865,1.0237924732361388,0.4153846153846154,0.7101047299052938,1.0,8/44,9.87%,CSPG4;DCN;OGN;CD44;AGRN;SLC9A1;BGN;OMD
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),-0.557452190928105,-1.0235203182904695,0.4523809523809524,0.9362687997029211,1.0,3/17,5.09%,GINS3;RFC3;POLD3
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.6737656581024217,1.0235155024208649,0.5263157894736842,0.7104934202051381,1.0,1/7,4.88%,OSMR
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.5519839929038816,-1.0234976598788361,0.43902439024390244,0.9355250294537297,1.0,5/18,14.01%,SFXN2;SLC6A13;SLC36A1;SLC25A38;SLC47A1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.5377003291092544,1.0233269762117128,0.4852941176470588,0.7106903357665357,1.0,10/25,22.15%,TEAD2;YAP1;TEAD1;STK3;WWTR1;YWHAE;TJP2;AMOTL1;AMOTL2;TJP1
prerank,Reactome_2022__Retinoid Metabolism And Transport R-HSA-975634,0.49930278581578513,1.0232063979019068,0.40625,0.7107490046822185,1.0,3/30,7.88%,RIMBP2;AGRN;LDLR
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.5743965557123999,1.022943376072355,0.42857142857142855,0.7111277886878183,1.0,6/15,20.98%,TMEFF2;CD44;PDPN;MRTFA;FLNA;ARHGAP35
prerank,Reactome_2022__Disease R-HSA-1643685,0.3624529933950145,1.0229284806124914,0.38202247191011235,0.7109509690369227,1.0,156/1347,12.93%,GGT5;TGFBR2;CDKN2A;C3;CSPG4;ST6GAL1;PAPSS2;TLR2;ADAMTS4;PDGFRA;YWHAH;KCNH8;KREMEN2;ADAMTSL2;EGF;GNG3;DCN;PLK2;SH3GL2;THBS1;OGN;ELMO1;PCSK2;NR4A1;BLM;SH3GL3;ZDHHC9;PPFIBP1;SYT1;ADCY5;CSF2RA;WAS;THSD7B;IRS2;SFTPD;IRAK2;LMNB1;APP;ADA;IRF7;MAP3K11;FOXO1;NOD1;ABCC8;MYH9;ERBIN;NLRP12;AMN;DUSP10;IL1R1;TGFA;SV2B;ADAMTS10;CP;SH3KBP1;TPST1;DUSP8;TUSC3;EGFL7;GALNT12;PRKAR1B;WASF1;FYN;GIPR;SLC9A9;RXFP1;GNG2;SEMA5B;DUSP16;BAIAP2;CHD3;CHST6;ITPR3;ADAMTS19;NRG1;ABCC9;AGRN;CDK9;ADCY7;FOXO3;ALDOB;TPM4;ADCY2;MAMLD1;SLC20A2;PML;RAMP3;GLP1R;SLC7A7;NRG2;SLC17A5;CYP1B1;PDGFA;MYD88;CDK6;MRAS;CTNNB1;AP1S1;MGAT5;BCL2L1;YWHAG;RPL39L;CAPN1;KPNA7;KITLG;TBL1X;GALK1;CYP21A2;SMAD3;BGN;LMNA;ARPC3;TRAK1;GAB2;IKBKE;NEURL1;ETV6;ATP1B1;RPL3;CTBP2;PPP1CB;CHMP1A;CYP4F22;HDAC4;RNASE1;OMD;GNAZ;ATP1B3;STAT3;SYK;NOXA1;SLCO2A1;CDKN1C;PARP9;PGK1;B4GALT7;HDAC9;FGF13;TYK2;POMGNT1;BARD1;PRR5;GSDMD;PMS2;CAMK2B;RPL37A;CDKN1B;FXYD7;KLC1;BRD4;RANGAP1;ERC2;SYVN1;FN1;B2M;ALK
prerank,GO_Biological_Process_2021__pericardium development (GO:0060039),0.6674892535545479,1.022881067300465,0.48936170212765956,0.7108181630354137,1.0,1/6,6.64%,TBX20
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,-0.5272646739360803,-1.022738953555538,0.45,0.9369003207936526,1.0,5/17,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.67909897318926,-1.022720629698792,0.574468085106383,0.9361443013606264,1.0,3/6,24.36%,ZNHIT3;FBL;ZNHIT6
prerank,Reactome_2022__DNA Strand Elongation R-HSA-69190,-0.4873146788581751,-1.0226767882703869,0.3684210526315789,0.9354544260433423,1.0,9/25,16.47%,GINS3;RFC3;POLD3;MCM6;MCM4;PRIM1;POLR1B;SLC19A1;DNA2
prerank,Reactome_2022__Costimulation By CD28 Family R-HSA-388841,0.507469908616343,1.022435905548753,0.4126984126984127,0.7115917754085097,1.0,10/44,15.13%,HLA-DRA;MAP3K14;FYN;TNFRSF14;ARHGEF7;RNASE1;PRR5;HLA-DRB1;CD4;PDCD1LG2
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.5679998749955953,1.0223034573255776,0.4423076923076923,0.7116501211475029,1.0,4/11,31.32%,TERF2IP;TAOK1;GSK3B;SIRT1
prerank,Reactome_2022__Signaling By FGFR1 R-HSA-5654736,-0.4342100129326293,-1.0222615798727093,0.3888888888888889,0.9356663988598785,1.0,1/39,0.15%,FGF6
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts R-HSA-192105,-0.4663416783893797,-1.0222460589395665,0.43243243243243246,0.9349068933539665,1.0,6/25,11.63%,AKR1C3;ABCB11;OSBPL3;CYP46A1;PTGIS;CYP7B1
prerank,Reactome_2022__VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.5344237249810598,-1.022158603266118,0.4666666666666667,0.934297460428686,1.0,5/18,18.76%,CNGA4;RAB8A;EXOC7;ARF4;EXOC1
prerank,Reactome_2022__Pyrimidine Catabolism R-HSA-73621,-0.5862823983923605,-1.0221507176536508,0.47619047619047616,0.9335339517641607,1.0,2/8,11.02%,NT5E;NT5C
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),-0.5569646755437427,-1.0221451858353026,0.4146341463414634,0.9327588275268852,1.0,3/10,17.37%,SFRP2;BMP2;MEOX1
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.5842622281794154,1.022013246151833,0.5076923076923077,0.7122162163869745,1.0,1/16,2.21%,BLM
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4253963460312193,1.0218618658464187,0.3939393939393939,0.7123213658195016,1.0,16/108,11.07%,CDKN2A;PROX1;SP100;IRAK2;PIM1;DAB2IP;ERBIN;NLRP12;TCEAL7;GLIS2;CYP1B1;NLRC5;NLRC3;HDAC4;PEX14;GAS6
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.43904320451166845,-1.0217860388623903,0.4117647058823529,0.9327979848483059,1.0,12/61,12.64%,ADAT2;TRMT61A;TRMT10A;THUMPD1;METTL2A;QTRT2;TPRKB;FTSJ1;URM1;TRMT61B;OSGEP;TRMT5
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6219486298300894,1.0217616402224634,0.5094339622641509,0.7123450067412405,1.0,5/8,23.07%,SNCA;GFAP;EEF1A2;PLK3;SNRNP70
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.5247098354345917,1.021166783047646,0.45901639344262296,0.7136433223395754,1.0,6/23,16.80%,ABCA8;ABCA5;PPARG;RXRA;ABCA3;GPS2
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.6330761728633534,1.0209445621448245,0.5689655172413793,0.7139296027893334,1.0,1/8,5.25%,OXTR
prerank,Reactome_2022__Metabolism Of Nucleotides R-HSA-15869,0.43077911356671394,1.0209223190370957,0.3835616438356164,0.7137681073515179,1.0,9/77,10.78%,TYMS;GMPR;ADA;NUDT16;SAMHD1;NUDT13;AK5;GDA;PUDP
prerank,GO_Biological_Process_2021__aromatic compound catabolic process (GO:0019439),-0.6679731609816095,-1.0209041027996102,0.5689655172413793,0.9345131937208758,1.0,3/6,21.53%,PON3;EPHX2;PON1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.44130624417970576,-1.0205486858311457,0.37142857142857144,0.9346925002677438,1.0,8/56,16.42%,ERCC8;DCLRE1B;ABRAXAS1;SMARCAL1;ERCC6;PAXX;RNF168;RNF8
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.6450425454987061,-1.020388573029202,0.5510204081632653,0.9345175406703129,1.0,2/7,25.28%,CTH;MYOCD
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6808533606706488,1.0203301714591482,0.5454545454545454,0.7148803541520398,1.0,4/5,31.24%,PDE4D;CHGA;CAMK2D;PLN
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,0.4268056107787892,1.02005783783101,0.4393939393939394,0.7152255109635518,1.0,32/98,17.68%,COL4A1;COBLL1;DCN;SULF1;COL4A2;OSMR;POSTN;COL12A1;FRAS1;PTPN21;RHOD;C1R;SCARA3;MATN2;ADGRF5;BGN;YAP1;PXDC1;SLCO2A1;PRICKLE2;PARD3B;IL17RE;FN1;PALLD;NTN4;LAMA3;FSTL1;CALB2;FAM114A1;WWTR1;SVEP1;SRPX2
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.5764939705048565,1.0200561383708129,0.4520547945205479,0.7150356474148989,1.0,9/15,35.05%,ATG9A;WDR45;ULK1;ATG7;ATG5;ULK2;ATG13;RB1CC1;WDR45B
prerank,Reactome_2022__Translesion Synthesis By POLI R-HSA-5656121,-0.5203535978043764,-1.0199800895617337,0.41025641025641024,0.9348187137726092,1.0,4/17,19.54%,RFC3;POLR1B;SLC19A1;UBB
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.4361135747572774,1.0198782953267316,0.4626865671641791,0.7152648829978834,1.0,20/119,16.67%,IGF1;DCN;PLK2;IRS2;APP;FOXO1;TRIM5;FOXO3;SNCA;PLEKHF1;MLXIPL;PRKCD;TRIM22;OPTN;RNF152;PFKFB3;GRSF1;TRIM65;P2RX7;TFEB
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Undefined,0.5262282105326137,1.0198739228848954,0.4262295081967213,0.7150844892318708,1.0,9/33,8.28%,FOSL2;ANXA1;SP100;ZFP36;ZNF750;BIRC3;CD44;GPR87;MVP
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),-0.6426892348558297,-1.019857366901598,0.43243243243243246,0.934335554461581,1.0,3/6,26.16%,BHLHE41;MAD2L2;DACH1
prerank,Reactome_2022__MET Activates PTPN11 R-HSA-8865999,0.6508405630507735,1.019795568278666,0.4909090909090909,0.7151573302891678,1.0,2/5,24.02%,PTPN11;RNMT
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.6700139241240577,1.019337067788826,0.49019607843137253,0.7159830914097915,1.0,1/5,6.08%,FAAH
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.622508746953913,1.0192206350205582,0.5606060606060606,0.7160775153593812,1.0,4/12,15.17%,ANXA1;MAPKBP1;KLF4;OTUD7B
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),-0.4346899776954524,-1.0192154262546584,0.4230769230769231,0.9352783057411374,1.0,9/46,20.20%,PPM1K;PSMD10;PSMD12;PSMB5;PSMB6;NQO1;PSME3;PSMD2;PSMB4
prerank,Reactome_2022__Estrogen-stimulated Signaling Thru PRKCZ R-HSA-9634635,-0.6069229265011366,-1.0191397508717066,0.41304347826086957,0.9347057800053258,1.0,1/5,13.52%,NRAS
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.6337311083349253,-1.019131460478097,0.509090909090909,0.9339547835238441,1.0,1/5,0.58%,KCNE1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.47664451098154403,1.0190033550260753,0.4745762711864407,0.716374859333144,1.0,4/37,10.77%,HELB;CDK9;PDGFA;TERF2IP
prerank,Reactome_2022__Receptor Mediated Mitophagy R-HSA-8934903,0.6045449046116981,1.0189379003973003,0.5079365079365079,0.716334890015558,1.0,1/9,4.38%,MAP1LC3A
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.47395179958888717,-1.018850370051809,0.3902439024390244,0.9338901848162584,1.0,10/38,14.39%,PYHIN1;RPL23;PDCL3;CCDC22;RAD23A;RPL11;UFL1;ARAF;HFE;CLU
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),0.6456376350508732,1.0188126556071209,0.4897959183673469,0.7163823287563991,1.0,3/8,16.69%,NRG1;TGFB2;MESP1
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.5501694917543669,-1.018646565414783,0.48,0.9328727845183372,1.0,3/13,14.73%,COQ3;COQ10A;COQ6
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.5501694917543669,-1.018646565414783,0.48,0.9328727845183372,1.0,3/13,14.73%,COQ3;COQ10A;COQ6
prerank,CellMarker_Augmented_2021__Idiopathic Pulmonary Fibrosis cell:Lung,0.689573721357826,1.0186204012005884,0.4727272727272727,0.7166543897038994,1.0,3/5,12.96%,LTBP4;SLC26A8;PDPN
prerank,KEGG_2021_Human__Viral protein interaction with cytokine and cytokine receptor,0.5175704473038517,1.0184754395192905,0.5081967213114754,0.7167984142391866,1.0,6/26,13.54%,CXCL2;TNFRSF14;TNFRSF1A;CCR10;CCL2;TNFRSF10B
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),0.6775799752465157,1.018362685869427,0.5263157894736842,0.7168425715594998,1.0,1/6,3.40%,FOXO1
prerank,Reactome_2022__Processive Synthesis On C-strand Of Telomere R-HSA-174414,0.5653437428168889,1.0183396972101249,0.46875,0.7167090024959982,1.0,5/17,16.16%,BLM;POLD1;TERF2IP;LRIG1;TINF2
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.5967639192807265,1.0183287716013536,0.509090909090909,0.7165412209941835,1.0,2/12,20.64%,ABCA2;H6PD
prerank,Reactome_2022__Dual Incision In GG-NER R-HSA-5696400,-0.4624866450146585,-1.018041041837979,0.475,0.9337034281229172,1.0,10/37,19.54%,RFC3;GTF2H5;POLD3;GTF2H2;ERCC2;POLR1B;SLC19A1;XPA;ERCC3;UBB
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6552117434230252,1.0180384192444518,0.49122807017543857,0.7169904806469009,1.0,2/8,6.91%,APOD;SNCA
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Venous Blood,0.4567779351168253,1.0179412875853338,0.4393939393939394,0.7169971579641078,1.0,10/69,10.83%,PTP4A3;ST6GAL1;CD24;KCNQ1;MGAT3;TJP3;FAAH;CAPN1;SLC25A29;DHRS13
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.5946558768537051,1.0175811670694426,0.4852941176470588,0.7176173368873237,1.0,1/14,0.86%,IMPDH1
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),0.6659246656346388,1.0174891017453196,0.46808510638297873,0.7176362958558195,1.0,1/7,9.80%,AK5
prerank,Reactome_2022__Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,0.500481012161883,1.0174292140215793,0.421875,0.7175898807344362,1.0,5/26,16.90%,TYMS;NUDT13;AK5;NME4;DUT
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),0.6225062413799058,1.017399983900603,0.48148148148148145,0.7174501385903864,1.0,4/10,19.01%,MFSD2A;ABCA3;MTMR2;MTMR3
prerank,KEGG_2021_Human__Systemic lupus erythematosus,-0.44626838563043614,-1.0170344520615355,0.3617021276595745,0.935821746714155,1.0,7/38,2.82%,H2AC20;H4C3;C6;H3-3B;TRIM21;H2BC4;H2BC21
prerank,Reactome_2022__Cytochrome P450 - Arranged By Substrate Type R-HSA-211897,-0.4668187435299336,-1.0169878368887468,0.5142857142857142,0.9351246084456325,1.0,9/33,14.88%,CYP4F3;CYP3A43;VDAC2;CYP46A1;CYP4V2;PTGIS;CYP7B1;CYP4F12;CYP2C8
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.5890024379445808,-1.0168697533632207,0.5,0.9346643615371255,1.0,1/6,1.61%,SELENOS
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Thyroid,0.7347883394638797,1.016840582498977,0.5084745762711864,0.7184086178534218,1.0,2/5,6.44%,CD24;CD44
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.5492334271521304,-1.0168084181446844,0.5,0.9340521152243341,1.0,2/14,6.01%,ACOXL;ABCD1
prerank,Reactome_2022__DNA Double-Strand Break Repair R-HSA-5693532,-0.41335627613852366,-1.016537610455708,0.45161290322580644,0.9340005884138738,1.0,31/120,21.52%,KPNA2;RFC3;H2BC4;H2BC21;ATRIP;HUS1;POLD3;SIRT6;BRIP1;ABRAXAS1;RAD9B;RMI2;CLSPN;POLR1B;RNF168;SLC19A1;RNF8;DNA2;SEM1;BRCC3;MUS81;H2BC5;RAD51;SMARCA5;UBB;UBE2V2;RAD17;SLX4;XRCC2;PARP1;BRCA2
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.5490618549538229,1.0162661241264417,0.41818181818181815,0.7194692148063196,1.0,3/20,9.29%,SYCE1;IHO1;STAG3
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),0.639887095745338,1.015965132748599,0.5178571428571429,0.7200473125262341,1.0,2/7,9.45%,FOLH1;AGTPBP1
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),0.5243318752066812,1.0159364902698442,0.4807692307692308,0.7199319284229545,1.0,9/31,10.89%,COL11A2;SULF1;ZBTB16;CD44;SCX;SH3PXD2B;CHI3L1;NAMPT;ITGB8
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.5183887269471608,-1.0159295983697445,0.4,0.9349722742802176,1.0,1/13,2.14%,FSHR
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5541976514755604,1.015878325792916,0.42857142857142855,0.719875649832186,1.0,4/17,9.25%,PRKCB;PTPRC;TESPA1;PRKCH
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.5840950669370478,1.0157084838861439,0.5344827586206896,0.7200648328683253,1.0,3/10,23.55%,BRCA1;CDK5RAP2;CCNF
prerank,Reactome_2022__Intracellular Signaling By Second Messengers R-HSA-9006925,0.3993834658985772,1.0156026284503412,0.4507042253521127,0.7201421023048715,1.0,35/255,12.36%,PDGFRA;PDE1C;EGF;NR4A1;ADCY5;PRKCG;IRS2;FOXO1;TGFA;PRKAR1B;FYN;CHD3;ITPR3;PDE1A;NRG1;ADCY7;FOXO3;ADCY2;PML;NRG2;PDGFA;MYD88;GRK2;KITLG;PRKCE;GAB2;PPARG;RNASE1;PIP4K2A;PDE1B;FGF13;PRR5;CAMK2B;PRKCD;CDKN1B
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.5656562150842804,1.015508091994346,0.49230769230769234,0.7202131202176605,1.0,4/15,13.49%,SERPINE1;TFPI;PHLDB2;FGF2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.6689129281647239,-1.0154074500083945,0.5294117647058824,0.9358978873638677,1.0,2/5,18.41%,BDP1;POLR3H
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.6089633315961223,-1.0153419125042473,0.42857142857142855,0.9352993457122257,1.0,1/11,0.79%,ID2
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),0.6612609949076017,1.0152727678618951,0.5227272727272727,0.7205262301329481,1.0,2/6,16.36%,BCL2L1;RFFL
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),0.5499025602889663,1.015260130079967,0.49122807017543857,0.7203829725598184,1.0,5/13,19.18%,PIM1;VSTM2A;SOX13;FTO;FNDC5
prerank,Reactome_2022__Response Of Mtb To Phagocytosis R-HSA-9637690,0.5542174142780434,1.0152287625062797,0.4642857142857143,0.7202459968160403,1.0,4/17,21.38%,DUSP16;PGK1;RPS27A;RAB7A
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),-0.5708913266977083,-1.0150070888304608,0.425531914893617,0.9356906717945107,1.0,1/8,1.74%,VAMP8
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.4481576049158877,1.0150045550915006,0.47692307692307695,0.7204999135282761,1.0,18/61,17.63%,ZFP36;FOXO1;TRPM4;ZBTB16;ZFPM2;SMAD3;YAP1;PPARG;WDFY2;TRIO;ASXL1;RUNX1T1;SYAP1;RORA;GPS2;WWTR1;WNT5A;FTO
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),-0.6459821325674979,-1.014944135704863,0.46,0.9350299663050731,1.0,3/5,16.10%,ABCB11;SLC46A1;SLC19A1
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.5960935660469844,1.0149261884783112,0.5,0.7204963188962477,1.0,2/14,7.14%,ZBTB16;SCX
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.5986797662566228,-1.0147863285899692,0.5384615384615384,0.934674122348936,1.0,1/9,2.37%,DNMT3B
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.42904902941554146,1.0147624799622688,0.5068493150684932,0.7206725308353085,1.0,7/86,8.31%,SIX3;PLK2;NUDT16;FSD1;IHO1;CTNNB1;BCL2L1
prerank,Reactome_2022__MET Receptor Recycling R-HSA-8875656,0.5669362682632115,1.014613120243546,0.4576271186440678,0.7207556710060397,1.0,2/9,24.02%,ARF6;RNMT
prerank,CellMarker_Augmented_2021__Epithelial cell:Mammary Epithelium,0.5040039204967153,1.0145330696396655,0.4507042253521127,0.7207520108905625,1.0,8/36,8.44%,LSR;TJP3;EPS8L2;BAIAP2L1;RHOD;PAK4;LAMA5;CAPN1
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.5694050099647806,1.0144136923607954,0.5423728813559322,0.7208257926007474,1.0,3/10,21.03%,MAPT;NDFIP2;PPM1F
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.6084142067981289,1.0143827378709183,0.5,0.7206920514842259,1.0,4/9,16.20%,PTPRC;LDLR;LRFN5;CD200
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.6607594562684282,-1.014268894660132,0.5106382978723404,0.9354317279221515,1.0,2/6,15.20%,PLIN3;PLIN2
prerank,GO_Biological_Process_2021__regulation of germinal center formation (GO:0002634),-0.6147227502394476,-1.0141623679749172,0.5476190476190477,0.934918197442214,1.0,2/5,4.40%,TNFAIP3;FOXJ1
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Blood,0.6936147762465036,1.0140860509454386,0.5645161290322581,0.7211156510248315,1.0,2/7,19.21%,CD44;TEK
prerank,KEGG_2021_Human__Cell cycle,0.4379226308515037,1.0139337104620711,0.4861111111111111,0.7212852250458485,1.0,25/104,19.70%,CDKN2A;YWHAH;CCNB2;CDK6;CDC14A;YWHAG;SMAD3;TGFB2;CDKN1C;GADD45A;CDC7;CDKN1B;CDKN1A;CCND1;TP53;WEE2;CDK2;CDC25B;CCNB1;YWHAE;SKP1;SMAD2;CDKN2D;CCND2;CDC27
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.6341398400608277,1.0138969421833441,0.5081967213114754,0.7211885998361007,1.0,2/7,2.53%,HLA-DRA;CD55
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.5367752989175257,1.013859181882042,0.4482758620689655,0.7210982131237461,1.0,3/16,7.26%,GRIN2B;KCNC2;GRIN1
prerank,Reactome_2022__Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.5012261243254029,1.0137279084598751,0.45901639344262296,0.7211779696223026,1.0,9/30,19.42%,LMNB1;CTNNB1;LMNA;MAPT;PRKCD;BMX;PLEC;STK24;TJP2
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.5916148606783117,1.0136833083556425,0.46551724137931033,0.721059807665012,1.0,4/12,15.21%,NRP2;PLXNA4;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.5289576429307841,1.0135091175751716,0.4745762711864407,0.7213033541566943,1.0,7/21,17.57%,IL1RAPL1;EPHA4;SLITRK4;CDKL5;CAMK2B;ARHGAP22;WNT5A
prerank,"Reactome_2022__Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",0.4827761557081571,1.0133538464674412,0.4,0.721435524940407,1.0,10/44,16.42%,IRAK2;APP;NOD1;BIRC3;BCL2L1;BCL2;IKBKG;MAPK11;P2RX7;TAB1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.4913227068525675,-1.0131563122916276,0.4418604651162791,0.936816906800244,1.0,5/23,11.86%,ABCD2;ABCD1;PEX10;PEX11B;PEX11A
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),-0.6207270110746361,-1.0131238760400032,0.4878048780487805,0.9361390893569211,1.0,3/6,26.01%,DNAAF1;DNAH11;ODAD2
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),0.6006792707603065,1.0125692466915637,0.4909090909090909,0.7230937587007766,1.0,2/10,6.35%,PTPRC;NRG1
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.5520790747057616,1.0125128608768152,0.5254237288135594,0.7230060973710666,1.0,8/18,23.67%,APLNR;MYO1C;PRKCH;RAP1A;CBFB;RAP1B;TJP1;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.4695513821937134,1.0124800981956872,0.44776119402985076,0.7228814304278213,1.0,7/55,12.78%,IGF1;ACHE;TMED10;SYTL4;TGFB2;ARF6;OAZ2
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.5037336703732869,-1.0123131654687247,0.3225806451612903,0.937472749012342,1.0,9/37,7.12%,GMFG;CD247;CD96;CD38;PYHIN1;IL5;CD6;P2RY10;CXCR4
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Limbal Epithelium,-0.5115388885058193,-1.0121251600203043,0.4418604651162791,0.9372362891030744,1.0,1/14,0.22%,TRIM29
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.48785065142097256,1.0120525329071361,0.4576271186440678,0.7235779375038409,1.0,5/27,16.11%,BLM;DONSON;CDKN1A;MRE11;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.6687002247184647,1.0120150254390126,0.5084745762711864,0.7234562707452096,1.0,1/6,12.05%,STX4
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Tooth,0.48632038113823856,1.0119898857039153,0.5,0.7233254130721649,1.0,9/43,11.78%,DRAXIN;GRID2;FAM124A;GJC1;CHST6;TSSC2;PODXL;NR6A1;ZNF850
prerank,Reactome_2022__Leading Strand Synthesis R-HSA-69109,-0.5293688545126901,-1.0118335743084923,0.4444444444444444,0.9371826774457296,1.0,4/12,16.10%,RFC3;POLD3;PRIM1;SLC19A1
prerank,KEGG_2021_Human__Other types of O-glycan biosynthesis,0.49826979716085695,1.0117078857882003,0.38333333333333336,0.7237744934647521,1.0,6/40,8.53%,ST6GAL1;GALNT12;GALNTL6;GALNT8;GALNT17;GALNT16
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),0.5362886907112541,1.0116451299682059,0.4,0.723776214955801,1.0,3/19,5.85%,NOS1AP;STAC2;HPCA
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.512809740994171,1.0114624561742867,0.4827586206896552,0.7240153085028387,1.0,6/23,14.31%,PRKCG;EFNA1;PML;EPHA4;OPHN1;HIPK2
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),0.5071728238438012,1.0113450106663218,0.4307692307692308,0.7240416206185158,1.0,8/41,12.68%,RASGRP1;DAB2IP;FOXO1;FAS;STK25;MAPK8IP1;TGFB2;PER1
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),0.7000494948213046,1.0112794118591129,0.509090909090909,0.723987809444644,1.0,1/5,8.20%,BAG3
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),0.6313876233704765,1.0112571806059554,0.42857142857142855,0.7238477782420676,1.0,2/8,13.11%,ITPK1;HK1
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),0.7222579779423154,1.0112506932483125,0.5531914893617021,0.7236677880774505,1.0,1/5,1.62%,PKP2
prerank,CellMarker_Augmented_2021__Germ cell:Undefined,0.6192440853613311,1.0108746904541215,0.4716981132075472,0.7242360107937624,1.0,5/14,17.32%,PODXL;NR6A1;TFAP2C;PRDM1;TDRD1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.49154585168920945,1.0108502946850988,0.4393939393939394,0.7240929473799813,1.0,15/40,19.02%,RASGRP1;ADA;PTPRC;SOX4;CD44;NLRC3;KIF13B;CD276;PIK3CD;CD4;SCRIB;NCK2;TNFSF4;LFNG;CXADR
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),-0.5732314893094888,-1.0107945707877903,0.5151515151515151,0.9391345090487953,1.0,2/14,7.12%,ID2;CXCR4
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.5496925204052329,1.0107686787856918,0.453125,0.7240761184532498,1.0,7/16,16.45%,ST8SIA3;B4GALNT1;ST8SIA4;ABCA2;ST6GALNAC5;ST6GALNAC3;NEU4
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.5978640981850669,1.0107495953356653,0.5333333333333333,0.7239147160854433,1.0,1/8,4.89%,WASF1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.4442920719385871,-1.0104456629854568,0.3888888888888889,0.9393495052412364,1.0,3/54,4.07%,FGF6;GALNT3;POLR2K
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.5215916413612441,1.010433681913413,0.5,0.72444844078767,1.0,6/20,12.66%,SP100;DMTN;APOD;BARD1;CABP1;RANGAP1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),0.610029475668606,1.010399135983897,0.52,0.7243300695279756,1.0,1/7,12.08%,CDC7
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),0.61191376646165,1.0101740455600874,0.5084745762711864,0.7245898351816168,1.0,1/7,4.87%,ALOX12
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6573085995067725,1.0101319076567217,0.509090909090909,0.7244929999096521,1.0,1/5,17.76%,PIGK
prerank,CellMarker_Augmented_2021__Decidual cell:Placenta,-0.41323453978113095,-1.009947637455144,0.39473684210526316,0.9399783603359575,1.0,4/61,2.67%,NGF;RPSAP52;C1ORF53;MT1A
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.473438619550457,1.0095641782064653,0.46774193548387094,0.7254898992647807,1.0,20/57,20.24%,PROX1;EGF;NR4A1;NRP2;EGFL7;APLNR;PPP1R16B;FGF2;PIK3CD;WNT5A;ADAM17;F3;PRKCA;TEK;HIF1A;VIP;ARNT;FGFR1;AKT3;VEGFD
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.4331592747734001,1.009422911592379,0.4603174603174603,0.7256140125836166,1.0,27/118,24.74%,APP;TRAM1L1;RPA1;DVL1;OBSCN;LMNA;MICALL1;IFT122;ARF6;OPTN;ALDH3A2;IFT140;YWHAE;SNX10;RAB11A;DDRGK1;MTCH2;SIX4;BICD1;GBP1;TUB;ARFRP1;PRNP;DHX9;UBAC2;GABARAPL2;HMOX1
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.62361386490357,1.0090245182344193,0.4909090909090909,0.7263613749894716,1.0,5/8,20.36%,DYSF;SYK;IFI35;SBNO2;NMI
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.6015736394198725,1.0089550527835256,0.45454545454545453,0.7263224975021313,1.0,6/10,20.15%,SNCA;TF;BCL2;B2M;HIF1A;BMP6
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.6094508801066654,1.0089466093912742,0.4745762711864407,0.7261424716353378,1.0,1/7,4.35%,PDIA2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.6579984184637896,1.0088803388972438,0.5192307692307693,0.726091400357554,1.0,4/9,15.46%,SP100;RPS6KA6;HIPK2;TP53
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),0.6521781655008829,1.0088272593478718,0.4915254237288136,0.7260372888423795,1.0,2/6,25.13%,CRACD;MUC4
prerank,Reactome_2022__Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.4242392151556815,1.0087196146984163,0.4225352112676056,0.7260629337859568,1.0,30/98,22.59%,MAFF;PRKAR1B;DOCK10;ZFPM2;KIF5A;KIF5C;ITPK1;AK3;RNASE1;KIF13B;DOCK4;KLC1;KIFC2;PRKAR1A;SH2B2;TP53;CDK2;KIF3C;DOCK9;PRKCA;ZFPM1;KIF19;RCOR1;DOCK3;AKAP10;PHF21A;CAPZB;MICAL1;SH2B3;PRKAR2B
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),0.6546613528974998,1.0086616987562256,0.45652173913043476,0.7259812676272221,1.0,4/6,19.34%,FAP;YAP1;PAK1;PTPRJ
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.6546692520995736,1.0086208940747579,0.5185185185185185,0.725878190821932,1.0,2/8,5.50%,CD22;AHR
prerank,KEGG_2021_Human__PPAR signaling pathway,0.4649505121972419,1.008401605684348,0.5081967213114754,0.7261030189906794,1.0,12/55,20.94%,ACSL5;FABP3;PPARG;SORBS1;DBI;SLC27A5;RXRA;SLC27A6;HMGCS1;ANGPTL4;ACSBG1;CPT1C
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.4998728117106605,1.0081741636871027,0.4852941176470588,0.7264104350913432,1.0,8/35,17.83%,FOLH1;GPT2;ASS1;KYAT1;NAT8L;NOX4;MTHFR;GPT
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),0.6384641516148228,1.0081392912074647,0.46296296296296297,0.7262767025572268,1.0,2/6,5.16%,IRS2;BCL6
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.5967286626482645,1.0079861005780775,0.4716981132075472,0.7264185842423638,1.0,1/14,2.80%,ABCB1
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.5774328744298562,1.0079289877872428,0.5283018867924528,0.7263675614274513,1.0,4/15,14.71%,RASGRP1;CD160;IL12A;HLA-E
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,-0.44534826807506483,-1.0077317414830276,0.35135135135135137,0.9451650413853258,1.0,9/39,7.58%,DPEP2;GMFG;CD247;CD96;PYHIN1;CD6;P2RY10;CXCR4;S1PR1
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.6253346051431663,-1.0076780438882555,0.475,0.9445599954505276,1.0,1/9,3.42%,CEP19
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.6359376422785867,1.007649735442419,0.49122807017543857,0.7267602624762469,1.0,2/10,6.88%,STEAP3;STEAP4
prerank,CellMarker_Augmented_2021__FGFR1LowNME5- Epithelial cell:Esophagus,0.4535663549619775,1.007542669754954,0.37037037037037035,0.7267428273001865,1.0,7/40,15.06%,SH3KBP1;FABP3;RPL39L;PIP4K2A;L3MBTL3;PPP1R9B;SLC2A3
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.4599048069075809,-1.0073923856572535,0.42857142857142855,0.9445193878662538,1.0,3/28,4.01%,SLC25A5;FLT3;RABL3
prerank,CellMarker_Augmented_2021__Neuroepithelial cell:Undefined,-0.6731533763022279,-1.0072591411885659,0.4878048780487805,0.9441222961342665,1.0,2/5,25.71%,OCLN;HES1
prerank,KEGG_2021_Human__Phenylalanine metabolism,0.6214946819421969,1.0071296395145852,0.5254237288135594,0.7274563503267901,1.0,1/8,7.09%,MAOB
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5419371049761956,1.0070591060570437,0.5,0.7274051076029288,1.0,3/17,9.85%,CD22;THY1;CD160
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.6657933046630664,-1.0070551147706,0.43478260869565216,0.9440008643036727,1.0,1/5,4.54%,PDCD2
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.5030492972648186,1.0067364938235004,0.46774193548387094,0.7279163340832137,1.0,12/27,28.99%,TNIP2;IKBKG;MAPK11;MAP3K5;SKP1;RPS27A;MAP3K8;MAPK3;MAP3K7;MAP2K7;MAP3K20;FBXW11
prerank,Reactome_2022__Lagging Strand Synthesis R-HSA-69186,-0.4955068783169164,-1.0066053384042215,0.4,0.9444042111617174,1.0,6/17,16.47%,RFC3;POLD3;PRIM1;POLR1B;SLC19A1;DNA2
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),0.6256029361857693,1.0064709628338262,0.5263157894736842,0.7283814518242951,1.0,1/6,2.31%,RIT2
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.5562330454316693,1.0064367616194052,0.48148148148148145,0.7282566824359462,1.0,6/12,18.63%,RYR2;SLC9A1;CTNNB1;TCAP;SLC8A1;CAV3
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),0.6385126627903754,1.006334299119596,0.5471698113207547,0.728321347544946,1.0,4/7,28.74%,OPTN;PINK1;PRKN;HDAC6
prerank,Reactome_2022__Downregulation Of ERBB2:ERBB3 Signaling R-HSA-1358803,0.5413903851506883,1.0062449817410826,0.4807692307692308,0.7283218544550548,1.0,4/13,20.13%,NRG1;NRG2;RPS27A;AKT3
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.6506716161926889,1.00606595657515,0.5178571428571429,0.7283686463040709,1.0,1/8,6.88%,STEAP4
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.6506716161926889,1.00606595657515,0.5178571428571429,0.7283686463040709,1.0,1/8,6.88%,STEAP4
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),0.6014768086059916,1.0059269175760976,0.5614035087719298,0.7284637250409346,1.0,1/10,0.65%,MYRF
prerank,CellMarker_Augmented_2021__Cytotrophoblast:Endometrium,0.5107246215832366,1.0058315929256996,0.41379310344827586,0.7282969393859708,1.0,7/30,10.96%,CTSS;ACSL5;TNFRSF14;CASP10;ANO9;RAB11FIP1;PARP9
prerank,CellMarker_Augmented_2021__Trophoblast cell:Endometrium,0.5107246215832366,1.0058315929256996,0.41379310344827586,0.7282969393859708,1.0,7/30,10.96%,CTSS;ACSL5;TNFRSF14;CASP10;ANO9;RAB11FIP1;PARP9
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.5961413911818869,1.00574139475467,0.5614035087719298,0.728266964804796,1.0,2/10,3.55%,NOD1;ERBIN
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),0.5794590114074758,1.00560949160532,0.5172413793103449,0.7283436828181825,1.0,5/13,25.91%,CHKB;LPIN3;ETNK2;SLC27A1;ETNK1
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.593018378255271,1.0055869699842823,0.47540983606557374,0.7282283926784816,1.0,6/10,9.40%,KCNJ2;KCNQ1;KCND3;KCNH2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.419095453310144,1.0055022154098032,0.47435897435897434,0.7282228302044548,1.0,29/119,18.57%,TLR2;ANXA1;IL15;SERPINE1;APP;NLRP12;IL1R1;BCL6;BIRC3;TNFRSF1A;SNCA;MYD88;NLRC3;PPARG;PRKCD;BRD4;KLF4;TNFAIP6;ETS1;LRFN5;CD200;BST1;RORA;GPS2;MFHAS1;WNT5A;TNFSF4;IFI35;SBNO2
prerank,Reactome_2022__Cohesin Loading Onto Chromatin R-HSA-2470946,0.5782361991621533,1.005412334114961,0.5161290322580645,0.7282233616674377,1.0,1/10,5.06%,PMEPA1
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.5040563094825076,1.0054022440834043,0.46551724137931033,0.7280594786717023,1.0,6/23,10.90%,THBS1;ATP1A1;YAP1;TGFB2;TFPI;ABCA2
prerank,CellMarker_Augmented_2021__Induced Pluripotent Stem cell:Undefined,0.514312759347001,1.0053056611927857,0.48484848484848486,0.728075272289855,1.0,8/18,21.83%,SMAD3;STAT3;PODXL;KLF4;ALPL;SMAD2;ACVR1B;MAF
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),0.6182285413517408,1.0052897855188432,0.5283018867924528,0.7279267297650169,1.0,2/9,17.39%,ATP9A;INPP5F
prerank,GO_Biological_Process_2021__aspartate metabolic process (GO:0006531),0.6930379132875191,1.0052406091240351,0.5,0.7278360690980558,1.0,1/5,8.19%,ASS1
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.6795242033289974,1.0052171818025069,0.4807692307692308,0.7277028748509717,1.0,2/6,12.57%,ALOX12;ADIPOR2
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.5141254337109459,-1.0050913549235867,0.4864864864864865,0.9479517790431932,1.0,7/16,24.95%,GRPEL2;TIMM23;TIMM50;DNAJC19;TIMM17A;TOMM70;GRPEL1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.5743897414310122,1.0050486763052404,0.46153846153846156,0.7278586182628066,1.0,2/14,2.82%,NR4A1;SLIT2
prerank,Reactome_2022__Signaling By FGFR R-HSA-190236,-0.41108294089626474,-1.0050147906784241,0.4166666666666667,0.9474097734654228,1.0,3/66,4.07%,FGF6;GALNT3;POLR2K
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.467467001428646,1.0049082889718424,0.5084745762711864,0.7279778009920572,1.0,6/63,8.42%,TGFBR2;RFTN1;ZFP36;EIF4A3;THOC6;KIF5C
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.580046656168222,1.0048897278297793,0.5245901639344263,0.7278142831619342,1.0,2/14,3.61%,IGF1;NLRP12
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),0.6664745239379866,1.0046717008315775,0.5087719298245614,0.7278641578434869,1.0,1/6,19.70%,CDC27
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),0.6664745239379866,1.0046717008315775,0.5087719298245614,0.7278641578434869,1.0,1/6,19.70%,CDC27
prerank,Reactome_2022__COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.4265957588374628,-1.0046206222010003,0.36585365853658536,0.9478217872902774,1.0,16/65,16.71%,ARF5;KIF21B;KIF6;KIF4A;KIF20B;COPB2;KIF15;KLC3;COPE;TMED2;TMED9;ARCN1;ARF4;KDELR1;NAPSA;RAB1B
prerank,Reactome_2022__DSCAM Interactions R-HSA-376172,-0.5817936408722629,-1.004489040800108,0.4473684210526316,0.947473736913671,1.0,1/11,0.62%,DSCAM
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.5127958199564797,1.0044735570998544,0.43478260869565216,0.7281441609319887,1.0,3/15,11.71%,THBS1;CD160;CCL2
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.42304534772816255,-1.0044302189559808,0.3870967741935484,0.9468028487523795,1.0,27/89,20.88%,RFC3;H2BC4;H2BC21;ATRIP;HUS1;POLD3;SIRT6;BRIP1;ABRAXAS1;RAD9B;RMI2;CLSPN;POLR1B;RNF168;SLC19A1;RNF8;DNA2;SEM1;BRCC3;MUS81;H2BC5;RAD51;UBB;UBE2V2;RAD17;SLX4;XRCC2
prerank,Reactome_2022__Activated NTRK3 Signals Thru RAS R-HSA-9034864,0.6293774616130132,1.0042410092142795,0.6,0.7284422329549479,1.0,2/6,17.35%,NTRK3;SHC1
prerank,Reactome_2022__Collagen Degradation R-HSA-1442490,0.5084913258952772,1.0041828658763035,0.46153846153846156,0.7283728969385245,1.0,8/25,20.97%,COL23A1;COL12A1;MMP14;COL9A1;CTSK;ADAM17;MMP19;ADAM9
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.6585853380128494,1.0041681610033024,0.45161290322580644,0.7282095325144312,1.0,6/7,32.23%,ITPK1;IMPA1;ISYNA1;PPIP5K1;IMPA2;IPPK
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.517390124126261,1.0039854229892804,0.4666666666666667,0.7283860113487265,1.0,11/23,26.70%,PLSCR1;NLRC5;FADD;HLA-E;WNT5A;IFI35;NMI;SLC15A4;DHX9;POLR3C;UBE2K
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.5353932328485849,1.0038406644032265,0.5079365079365079,0.7285078081967649,1.0,3/17,9.61%,RAMP3;PPARG;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.49845606818699056,1.0037904486479543,0.4827586206896552,0.7284385275737036,1.0,8/25,13.90%,THBS1;SERPINE1;ICAM1;PAK4;CD160;GAS6;CCL2;TNIP2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.5418994654633315,1.0037405070345224,0.5076923076923077,0.7283783766996522,1.0,1/16,1.02%,CTSC
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),0.6413346698222395,1.0034867493978445,0.5192307692307693,0.728697054651412,1.0,1/5,13.49%,FGF2
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),0.71419462099877,1.0034451020780293,0.54,0.7286156605408419,1.0,3/5,27.63%,CDKN1A;STK11;MME
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.4846663685783731,1.0032412181699382,0.4264705882352941,0.7288856492231378,1.0,3/30,4.73%,NSDHL;ABCA5;SOAT1
prerank,Reactome_2022__Degradation Of DVL R-HSA-4641258,-0.4027783472278302,-1.0032230575812082,0.47058823529411764,0.9494949946351275,1.0,11/49,20.20%,PSMD10;PSMD12;DVL2;PSMB5;KLHL12;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.42896930244173453,1.0030776719474406,0.47761194029850745,0.7291191607964382,1.0,10/84,12.04%,PLD1;THBS1;YBX3;SAMD4A;SOX4;EIF4A3;LARP6;YTHDF1;NIBAN1;EIF5A
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.5516939217492876,1.002980306659314,0.47368421052631576,0.7290891828442219,1.0,7/21,18.29%,TMEFF2;CD44;PDPN;COL5A1;MRTFA;ADAM17;FLNA
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.4737664631736106,1.0029218520010814,0.5074626865671642,0.7290017185114422,1.0,10/35,13.49%,COL11A2;SULF1;SLC39A14;ZBTB16;CD44;SCX;CHI3L1;ITGB8;SNX19;FGF2
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),-0.5902227935405435,-1.0028863729099518,0.4864864864864865,0.9496990493936238,1.0,1/8,4.54%,RGN
prerank,KEGG_2021_Human__cGMP-PKG signaling pathway,0.3981616109683711,1.0028400806659565,0.4358974358974359,0.7289445561690632,1.0,21/124,11.18%,CREB5;ADCY5;IRS2;ATP2B3;KCNMB4;NFATC2;PRKG2;MYLK3;ITPR3;GUCY1A2;ADCY7;CACNA1C;ADCY2;ATP1A1;GUCY1A1;PRKCE;GNA12;ATP1B1;PPP1CB;ATP1B3;GUCY1B1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.5666645252525692,1.002794519452429,0.45901639344262296,0.728851125540884,1.0,4/13,17.86%,BAG3;GAS6;TP53;YWHAE
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),-0.5931505254695498,-1.0025746537430933,0.4888888888888889,0.9498035042894875,1.0,2/11,12.75%,IGSF1;FSTL3
prerank,Reactome_2022__Metabolism Of Amine-Derived Hormones R-HSA-209776,-0.5954367013473815,-1.0022990572208705,0.45098039215686275,0.9497962053066052,1.0,3/8,23.54%,ASMT;DIO2;TPH1
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.4634594913237673,-1.002148067751716,0.4090909090909091,0.9493986958467351,1.0,6/15,28.72%,EMC6;EMC4;UBL4A;EMC7;EMC8;GET3
prerank,Reactome_2022__MET Activates PTK2 Signaling R-HSA-8874081,0.5107251489266156,1.002145929233856,0.46153846153846156,0.7299885337129092,1.0,5/15,10.81%,LAMB1;ITGA2;LAMA5;ITGA3;LAMA2
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),0.6452768948119856,1.0020169378990682,0.5714285714285714,0.73004604279952,1.0,3/5,29.94%,TGFB2;TGFB3;TGFB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.5896135718678888,1.0020102231942234,0.5409836065573771,0.7298707911581848,1.0,4/13,17.04%,CACNA1C;RYR2;SLC8A1;CALM3
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5770774705890609,1.0018824683051204,0.4918032786885246,0.7300280166976174,1.0,4/10,25.70%,STX4;STX1B;SNAP25;STX3
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Lung,0.5214555630065878,1.0018472190730092,0.5230769230769231,0.7297563197602059,1.0,9/33,14.07%,ALS2CL;LIPH;PLEKHG6;ITGA2;TMBIM1;CAPN1;DUOXA1;ARHGAP18;RAB27B
prerank,CellMarker_Augmented_2021__Migrating Cancer Stem cell:Liver,0.5214555630065878,1.0018472190730092,0.5230769230769231,0.7297563197602059,1.0,9/33,14.07%,ALS2CL;LIPH;PLEKHG6;ITGA2;TMBIM1;CAPN1;DUOXA1;ARHGAP18;RAB27B
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),0.6015063853903366,1.001699843958142,0.47368421052631576,0.7298651430074495,1.0,6/11,31.53%,RBPMS;KIAA0319;BMP6;TGFB3;TGFB1;BMPR1A
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.3850057662682473,1.0015601590408156,0.4675324675324675,0.7299890022838037,1.0,26/257,11.17%,GPNMB;IGF1;SH3GL2;TYMS;ZFP36;IGF2BP2;ZC3H12D;APP;NLRP12;SAMD4A;NUDT16;CCDC3;SMCR8;PGR;ENC1;APLNR;EIF4A3;NPTN;CENPV;YAP1;TGFB2;SHMT1;ITGB8;MAPT;PARP9;HDAC9
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),-0.5156621723604924,-1.0014325387615937,0.46153846153846156,0.9505428844089354,1.0,3/13,10.55%,RPL23;SUPT16H;SMARCD1
prerank,CellMarker_Augmented_2021__Tuft Progenitor cell:Small Intestine,0.6282422299797852,1.0014251744391471,0.48214285714285715,0.7300614952199593,1.0,2/8,11.71%,GSS;CCL2
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.6452106320812638,1.0007415276973606,0.559322033898305,0.7314161627703419,1.0,2/7,0.79%,TLCD2;ANK3
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),-0.5147705696418544,-1.000546069830155,0.4090909090909091,0.952229392039213,1.0,2/14,6.01%,ABCD2;ABCD1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.5106085654460543,-1.0003413368292717,0.4523809523809524,0.9519915230033507,1.0,8/23,21.35%,COPS8;CETN2;COPS7A;XPA;UBB;COPS3;COPS6;PARP1
prerank,CellMarker_Augmented_2021__Bile Duct cell:Liver,0.460341512893613,1.0001965680871934,0.4852941176470588,0.7324956524638984,1.0,10/44,9.04%,MET;EPHA2;EPS8L2;BAIAP2L1;ITGA2;RHBDF1;RHOD;LAMA5;ITGA3;YAP1
prerank,Reactome_2022__Asparagine N-linked Glycosylation R-HSA-446203,0.3818093481941615,1.0001959141739603,0.4444444444444444,0.7323081122836674,1.0,46/251,21.47%,ST6GAL1;CHST8;ANK3;CTSC;CD55;TGFA;TUSC3;EGFL7;ST8SIA3;ST8SIA1;SLC17A5;MGAT5;GRIA1;ST8SIA4;ACTR1A;B4GALT5;SYVN1;COPZ2;CMAS;NANS;ANKRD28;MAN1A1;ST6GALNAC2;CD59;ST6GALNAC5;CTSZ;B4GALT6;ST6GALNAC3;NEU4;SPTB;DYNC1LI2;DCTN1;GMPPA;B4GALT3;RNF185;UBXN1;MARCHF6;KDELR3;DYNC1LI1;RPS27A;SLC35A1;MGAT4A;TRAPPC9;FUT8;CAPZB;AMFR
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),-0.5880343340281786,-1.000164716363327,0.5454545454545454,0.9517046502871224,1.0,1/8,4.02%,NEU1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),0.6722536107228759,1.0000568199917241,0.46774193548387094,0.732401028969068,1.0,1/5,2.14%,TYMS
prerank,GO_Biological_Process_2021__negative regulation of lipoprotein lipase activity (GO:0051005),0.6834601576379926,0.999974252322091,0.5084745762711864,0.7323673163723791,1.0,3/5,20.22%,HDAC9;SORT1;ANGPTL4
prerank,CellMarker_Augmented_2021__PROCR+ Progenitor cell:Small Intestine,0.5302114415994641,0.9997004630223758,0.5147058823529411,0.7327916047564235,1.0,2/18,1.63%,CDH9;ITM2A
prerank,Reactome_2022__Defective GALNT12 Causes CRCS1 R-HSA-5083636,0.6321654785391422,0.9993608901966459,0.6,0.7333120651290902,1.0,1/5,4.74%,GALNT12
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.3646373537563054,-0.9992860209304885,0.42857142857142855,0.9533860999590511,1.0,38/197,19.08%,TTC29;TMEM17;CATIP;CNGA4;UBXN10;CEP19;FOXJ1;CFAP221;INTU;TEKT5;WDR11;CFAP52;TMEM237;TEKT1;CEP131;RAB8A;SCLT1;EXOC7;IQCB1;CEP83;DYNC2I1;FAM149B1;TMEM250;ARF4;BBS9;CCDC66;AVIL;CFAP70;DYNLL1;MKS1;UNC119B;CEP78;CEP20;DNAAF1;FAM161B;ARL6;EXOC1;FBF1
prerank,Reactome_2022__Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.4037381452524055,-0.9992232264122087,0.42424242424242425,0.9527657143712529,1.0,14/50,25.39%,PSMD10;PSMD12;DERL2;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4;VCP;ERLEC1;PSMA1;PSMD11
prerank,KEGG_2021_Human__Pyrimidine metabolism,0.4617975943097094,0.9990899555305335,0.423728813559322,0.7337479335269299,1.0,2/45,2.14%,TYMP;TYMS
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),0.6714151873506068,0.9990611395085651,0.5178571428571429,0.7336235850746967,1.0,4/5,32.81%,MTMR2;MTMR3;MTMR1;MTMR9
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.6516675128502545,0.9989487625174057,0.4915254237288136,0.7337039757223078,1.0,3/6,10.44%,GRIN2B;FYN;HOMER1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.5019531469729943,0.9989056107221378,0.5079365079365079,0.7336188220390867,1.0,1/28,0.99%,HELB
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),-0.6115109503510643,-0.9987926673466138,0.5081967213114754,0.953131745988003,1.0,2/8,6.27%,BLOC1S2;VDAC2
prerank,KEGG_2021_Human__Lysine degradation,-0.4157459264717954,-0.9987471578496042,0.34285714285714286,0.9525310344457135,1.0,14/60,17.60%,PRDM6;SETDB1;SMYD2;PIPOX;HYKK;KMT5A;GCDH;KMT2A;ALDH7A1;PRDM7;ECHS1;EHHADH;EZH2;ALDH2
prerank,Reactome_2022__DNA Damage Recognition In GG-NER R-HSA-5696394,-0.43394003186920355,-0.9987302030090531,0.5121951219512195,0.9518144687118811,1.0,11/34,21.35%,COPS8;MCRS1;CETN2;COPS7A;RAD23A;RUVBL1;NFRKB;UBB;COPS3;COPS6;PARP1
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.525811916272351,0.9985107661274341,0.42105263157894735,0.7343429605995165,1.0,3/20,12.71%,SULF1;TBX20;ELAPOR2
prerank,Reactome_2022__Iron Uptake And Transport R-HSA-917937,-0.423144609093597,-0.998358779861391,0.42857142857142855,0.9521926691271084,1.0,7/51,13.77%,FTL;FTH1;ATP6V1E2;ATP6V1G1;SLC46A1;HFE;ATP6V1F
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.48869239939192444,0.9982715984829464,0.49056603773584906,0.7346306247885872,1.0,8/34,17.04%,THY1;SNCA;APLNR;JPH4;CEMIP;PDE4D;UBASH3B;CALM3
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.5295577935777249,-0.9977532429461894,0.4857142857142857,0.9529570071082304,1.0,3/17,15.20%,SELENON;RYR1;MYORG
prerank,Reactome_2022__TRIF-mediated Programmed Cell Death R-HSA-2562578,-0.6519220101469493,-0.9977521323587194,0.5208333333333334,0.9521866295762108,1.0,2/7,8.20%,TMED7-TICAM2;LY96
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.6262617298456655,0.9976146946522573,0.5581395348837209,0.7360246407662367,1.0,3/7,29.15%,PHF23;HDAC6;RUBCN
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5305098389779137,0.9975823215158391,0.4339622641509434,0.7358848652873422,1.0,6/26,13.63%,PDGFRA;FLT1;DAB2IP;P2RY12;FGF2;WASHC1
prerank,Reactome_2022__Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.405608182720133,-0.9973006568072393,0.3939393939393939,0.9526861921812553,1.0,14/49,25.39%,PSMD10;PSMD12;DERL2;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4;VCP;ERLEC1;PSMA1;PSMD11
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.6232098603615694,-0.9972858115248044,0.575,0.9519540208767756,1.0,3/6,14.81%,CFTR;AQP4;AQP6
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),0.4760171582692177,0.9972197207348555,0.49206349206349204,0.7364513930156245,1.0,8/40,14.96%,APP;GRM5;FOXO3;PARP9;ZC3H7B;PER1;MAPKAPK5;PUM1
prerank,GO_Biological_Process_2021__ganglioside catabolic process (GO:0006689),-0.6617284972903966,-0.9970662033760788,0.6,0.9516268896915303,1.0,1/5,4.02%,NEU1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),-0.4984814539089832,-0.9969376205283604,0.47368421052631576,0.9512269159361869,1.0,5/27,8.78%,MID1IP1;ABCD2;APOE;ABCD1;LCN12
prerank,CellMarker_Augmented_2021__T Helper cell:Salivary Gland,0.4777942038718492,0.9968692258120755,0.45588235294117646,0.7368176293276929,1.0,6/28,4.31%,CTSS;MYO1F;PLEK;SLA;SIGLEC1;PTPRC
prerank,CellMarker_Augmented_2021__T Helper cell:Eye,0.4777942038718492,0.9968692258120755,0.45588235294117646,0.7368176293276929,1.0,6/28,4.31%,CTSS;MYO1F;PLEK;SLA;SIGLEC1;PTPRC
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.5977370288222373,-0.9966984461010945,0.5116279069767442,0.9510291906914164,1.0,1/8,4.36%,APOE
prerank,Reactome_2022__Biological Oxidations R-HSA-211859,0.41250491984230864,0.9966073450143392,0.4492753623188406,0.737170269096703,1.0,11/122,7.56%,GGT5;PAPSS2;GSTT2;GLYATL2;TPST1;AHR;GGCT;MAOB;UGDH;CYP1B1;SULT4A1
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.5351630805015625,-0.9965513480507018,0.42857142857142855,0.950642549970523,1.0,5/10,20.44%,SLC6A13;SLC46A1;SLC19A1;SLC5A6;SLC1A4
prerank,KEGG_2021_Human__Phosphatidylinositol signaling system,0.41998639389303966,0.9964791801147116,0.4918032786885246,0.7372495329402485,1.0,30/87,21.28%,MTMR7;PRKCB;ITPKC;PRKCG;ITPR3;ITPKB;SYNJ2;DGKG;ITPK1;PIP4K2A;INPPL1;INPP5A;INPP4A;MTM1;CDS2;PIK3CD;INPP5D;IMPA1;PIP5K1C;CALM3;INPP5F;ITPR1;MTMR2;PRKCA;MTMR3;DGKI;DGKZ;SYNJ1;DGKD;MTMR14
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.5442273877550413,0.996098906056532,0.48333333333333334,0.7379680425111388,1.0,5/16,9.88%,PDGFRA;MYH11;MYLK3;ALPK2;TCAP
prerank,CellMarker_Augmented_2021__T cell:Fetal Liver,-0.4749986058406032,-0.9958134749706588,0.4411764705882353,0.9518484751093099,1.0,7/28,6.16%,DPEP2;GMFG;CD247;CD96;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Umbilical Cord Blood,0.48851715762954945,0.9956503331561797,0.45714285714285713,0.738235890548274,1.0,7/30,5.76%,CTSS;P2RY13;MYO1F;PLEK;SLA;PTPRC;GAB3
prerank,CellMarker_Augmented_2021__Platelet:Bone Marrow,0.48851715762954945,0.9956503331561797,0.45714285714285713,0.738235890548274,1.0,7/30,5.76%,CTSS;P2RY13;MYO1F;PLEK;SLA;PTPRC;GAB3
prerank,CellMarker_Augmented_2021__Endothelial cell:Embryonic Stem Cell,0.48851715762954945,0.9956503331561797,0.45714285714285713,0.738235890548274,1.0,7/30,5.76%,CTSS;P2RY13;MYO1F;PLEK;SLA;PTPRC;GAB3
prerank,CellMarker_Augmented_2021__Endothelial cell:Eye,0.48851715762954945,0.9956503331561797,0.45714285714285713,0.738235890548274,1.0,7/30,5.76%,CTSS;P2RY13;MYO1F;PLEK;SLA;PTPRC;GAB3
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5008890883826007,0.9956077019398016,0.4915254237288136,0.738140902831294,1.0,7/29,20.29%,ANXA1;LSM11;CCND1;ADAMTS1;ADAM17;CCND2;DDRGK1
prerank,Reactome_2022__Late SARS-CoV-2 Infection Events R-HSA-9772573,0.43824395098366786,0.9955708010327573,0.5285714285714286,0.7380219907032974,1.0,5/54,10.96%,ST6GAL1;ZDHHC9;TUSC3;MGAT5;PARP9
prerank,CellMarker_Augmented_2021__Monocyte:Peripheral Blood,0.5443899097310838,0.995470001413433,0.5671641791044776,0.7381278337571161,1.0,3/18,5.65%,CD22;PTPRC;ITGA2
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),0.570174701914555,0.9950221652874595,0.5076923076923077,0.7389434707727761,1.0,3/11,17.73%,PRKCB;GFI1B;CBFB
prerank,Reactome_2022__Glycogen Breakdown (Glycogenolysis) R-HSA-70221,-0.5494051403072453,-0.994850697565049,0.45714285714285713,0.9534973618212297,1.0,4/14,16.70%,PYGM;AGL;PHKG1;GAA
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In Cytochrome C Release R-HSA-6803204,0.541554209755563,0.9946551834576783,0.4838709677419355,0.739623939806379,1.0,3/16,15.46%,STEAP3;BBC3;TP53
prerank,CellMarker_Augmented_2021__T cell:Brain,-0.48898663701389933,-0.9946409793469776,0.45714285714285713,0.9503085953647311,1.0,7/25,6.16%,GMFG;CD247;CD96;RHOH;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__Memory T cell:Peripheral Blood,-0.48898663701389933,-0.9946409793469776,0.45714285714285713,0.9503085953647311,1.0,7/25,6.16%,GMFG;CD247;CD96;RHOH;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__Memory T cell:Liver,-0.48898663701389933,-0.9946409793469776,0.45714285714285713,0.9503085953647311,1.0,7/25,6.16%,GMFG;CD247;CD96;RHOH;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__T cell:Tonsil,-0.48898663701389933,-0.9946409793469776,0.45714285714285713,0.9503085953647311,1.0,7/25,6.16%,GMFG;CD247;CD96;RHOH;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__Naive T cell:Umbilical Cord Blood,-0.48898663701389933,-0.9946409793469776,0.45714285714285713,0.9503085953647311,1.0,7/25,6.16%,GMFG;CD247;CD96;RHOH;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.5429070122367365,-0.9946320944780108,0.5217391304347826,0.9495792825692962,1.0,3/12,16.16%,KMT2A;PRDM7;WDR82
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),0.6408881486834006,0.9943622856268999,0.49122807017543857,0.7400256530274661,1.0,1/5,17.55%,GNAI1
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),-0.6319998991621467,-0.9942730832762096,0.5333333333333333,0.9497177762197728,1.0,1/8,0.79%,ID2
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.4486618607017485,0.9942356443652919,0.48484848484848486,0.7401518191804463,1.0,9/56,16.91%,TBC1D24;LIMK2;YAP1;CDKL5;USP6NL;TBC1D1;TBC1D10B;TBC1D10A;IFT140
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),0.4699998272621497,0.9942174336882041,0.4852941176470588,0.7399966675482029,1.0,13/45,14.92%,CD22;RASGRP1;PRKCB;LAT2;PTPRC;TPD52;HDAC4;HDAC9;KLF6;BCL2;CD70;PIK3CD;GPR183
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.5138667882314174,0.9937139234051168,0.4528301886792453,0.740954351161182,1.0,5/24,11.71%,GPNMB;THY1;CYRIB;PAG1;CCL2
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),0.54741268263585,0.9934544958755864,0.4528301886792453,0.7413493255629837,1.0,6/16,18.06%,PTPRC;TNFRSF14;STX4;HLA-E;WNT5A;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.6764342814608995,0.9934223953286861,0.5645161290322581,0.7412179029856182,1.0,2/7,20.36%,GPS2;UBR5
prerank,CellMarker_Augmented_2021__T cell:Kidney,-0.5314712682958209,-0.9934155296219873,0.425,0.9512185571688238,1.0,5/16,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.45390990769093,0.9932983817537682,0.45588235294117646,0.7412688749477475,1.0,11/46,15.38%,GRIN2B;FYN;PRODH;SNCA;RAMP3;MAPT;CDKN1B;ZNF746;HEBP2;RARG;MAP3K5
prerank,Reactome_2022__Aryl Hydrocarbon Receptor Signaling R-HSA-8937144,0.6601767316160253,0.9932746680977634,0.5490196078431373,0.7411315644859937,1.0,1/6,5.50%,AHR
prerank,Reactome_2022__Erythropoietin Activates Phospholipase C Gamma (PLCG) R-HSA-9027277,-0.6109483724850566,-0.9930423869866155,0.4791666666666667,0.951500741028091,1.0,2/7,4.64%,EPX;EPOR
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.5026138025361878,0.9926484624312515,0.5,0.7421952686846963,1.0,1/27,0.99%,HELB
prerank,Reactome_2022__Immune System R-HSA-168256,0.34917218779179604,0.992579578531216,0.5268817204301075,0.7421205099930945,1.0,187/1314,15.13%,CXCL2;HLA-DRA;C3;RASGRP2;IL13RA1;TLR2;ANXA1;SOCS3;CTSC;CTSS;ADGRE5;IL15;KCNH8;IL1RAPL1;FYB1;SH3GL2;SP100;CD22;RASGRP1;NPDC1;ELMO1;STAT4;CD55;TIMP2;PRKCB;ICAM1;CSF2RA;WAS;PTPRB;TEC;IRS2;IRAK2;LMNB1;APP;RPS6KA1;COLEC12;IRF7;ASB16;FOXO1;NOD1;IL27RA;MYH9;SIGLEC1;IL1R1;ATP8B4;SH3KBP1;PTPRC;EGFL7;MAP3K14;NFATC2;OSMR;WASF1;FYN;TNFRSF14;TRIM5;HECW2;BCL6;FBXW12;PADI2;BAIAP2;DNM1;ITPR3;TRIM46;COLEC11;CIITA;RAP1GAP;CFH;SAMHD1;ZBTB16;BIRC3;CD44;TNFRSF1A;PLAC8;LNX1;GHR;FOXO3;CASP10;EIF4A3;TCP1;PML;C1R;NLRC5;MYD88;RAP2B;TRIM36;OSTF1;TMBIM1;LAMA5;CTNNB1;AP1S1;KIF5A;BCL2L1;ARIH2;KIF5C;CAPN1;NLRC3;CHI3L1;KPNA7;TRIM17;SMAD3;PTPN9;PLD2;ARPC3;PRKCE;GAB2;PDZD2;IKBKE;ARHGEF7;DNAJC5;FSCN1;RNASE1;FBXO32;CD160;PFKL;ORAI1;KLHL5;PAG1;STAT3;CPNE2;SYK;HMOX2;INPPL1;PYGL;PLPP4;FGF13;FBXL16;ENAH;TYK2;TSPAN14;DGAT1;ACTR1A;PRR5;CCL2;GSDMD;PIANP;HLA-DRB1;PILRA;ITGAL;STX4;MX1;PRICKLE1;CAMK2B;PRKCD;CDKN1B;RELB;SPSB1;TRIM22;BCL2;CGAS;IL17RE;KLC1;PDXK;FN1;STOM;B2M;IL4R;RAP1GAP2;CDKN1A;CCND1;RNF19A;TNFAIP6;FADD;HLA-DMA;UBE2H;FRMPD3;TNIP2;TRIM32;IQGAP1;CD70;IL12A;CD99;TRAIP;CCT8;IKBKG;SIPA1;MRE11;MAPK11;HEBP2;IFIH1;HLA-E;INPP5D;IST1;CD4;SERPING1;SLC2A3;ENPP4;PDCD1LG2
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.47476776196602477,0.9922808985950557,0.5081967213114754,0.7425504041245786,1.0,3/33,9.35%,GLRA2;FYN;NEURL1
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.6521028514709375,0.9921330587190453,0.5714285714285714,0.7426666398084382,1.0,2/5,16.76%,PLAAT3;LIPE
prerank,KEGG_2021_Human__Butanoate metabolism,0.5257427965305015,0.9917650094502408,0.5076923076923077,0.7432215144928233,1.0,5/22,12.48%,GAD2;HADH;OXCT1;HMGCLL1;ACSM5
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5749631421013596,0.9916059465056704,0.515625,0.7433673533722612,1.0,6/13,9.40%,KCNJ2;KCNQ1;KCND3;KCNH2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.41027529254314005,0.9914466010759159,0.4461538461538462,0.7435250484330851,1.0,19/140,11.07%,MET;PDGFRA;EGF;THBS1;EPHA2;IRS2;TGFA;FYN;NTRK3;NRG1;RAMP3;NRG2;PDGFA;CHI3L1;KITLG;GAB2;P2RY12;GFRAL;GAS6
prerank,Reactome_2022__MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,0.4129888777466246,0.9913300584370068,0.4393939393939394,0.7433810787508834,1.0,8/89,7.62%,KCNH8;IRAK2;APP;RPS6KA1;IRF7;NOD1;NLRC5;MYD88
prerank,Reactome_2022__Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,0.4129888777466246,0.9913300584370068,0.4393939393939394,0.7433810787508834,1.0,8/89,7.62%,KCNH8;IRAK2;APP;RPS6KA1;IRF7;NOD1;NLRC5;MYD88
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5237091516486742,-0.9913248274835833,0.425,0.9552830758153487,1.0,4/10,25.66%,EMC6;EMC4;EMC7;EMC8
prerank,Reactome_2022__Signaling By ROBO Receptors R-HSA-376176,-0.3430230625907405,-0.9910806174517188,0.2857142857142857,0.9551145307312657,1.0,34/190,14.26%,RPL35A;RPS24;RPL34;RPL39;RPL37;RPS28;ELOC;RPL18;RBM8A;RPL12;RPL23;RPL31;RPL6;RPS27L;CXCR4;CAP1;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;RPL14;RPL15;RPS2;DAG1;RPL11;RPL23A;PFN1;PSMD10;PSMD12;RPS21;PSMB5;RPS23
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),-0.4572237572592055,-0.9910192977333728,0.46511627906976744,0.9545237112273783,1.0,1/28,0.17%,FTL
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.5458839669280726,0.9910165304478576,0.5,0.7438873681930835,1.0,2/18,1.16%,SIX3;PROX1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5584532685323845,0.9909364792331641,0.5185185185185185,0.7438302259350681,1.0,3/12,10.22%,GPNMB;ASS1;PAG1
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.5256120541078848,0.990292178129499,0.4461538461538462,0.7451076947616918,1.0,5/23,4.31%,CTSS;MYO1F;PLEK;ICAM1;PTPRC
prerank,CellMarker_Augmented_2021__Basophil:Peripheral Blood,-0.6329317419749771,-0.9902785888719219,0.5882352941176471,0.9557432883336343,1.0,2/5,27.82%,ENPP3;CD63
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),0.6063783103446856,0.9902510035989726,0.5961538461538461,0.7449817694527676,1.0,2/7,12.96%,FSCN1;PDPN
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.4540257339266309,0.9901105179667717,0.5283018867924528,0.7450792173328507,1.0,2/40,1.15%,CTSC;CCBE1
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Undefined,0.577054962575696,0.9900746111772463,0.55,0.7449593173776395,1.0,4/14,8.72%,THY1;PTPRC;ITGA2;ITGA3
prerank,Reactome_2022__Activation Of AP-1 Family Of Transcription Factors R-HSA-450341,0.6066170430870904,0.9897995138404985,0.5555555555555556,0.7453691923489107,1.0,4/9,26.17%,MAPK11;MAPK9;FOS;MAPK3
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,-0.5139757442471313,-0.9896162520556884,0.5,0.9566836983180869,1.0,4/20,6.16%,CD247;CD96;S100B;P2RY10
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.5916136583481612,0.9895592677124485,0.5079365079365079,0.7456390246780448,1.0,4/11,27.34%,SMCR8;IGF1R;CALCOCO2;UVRAG
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.4330654692925592,0.9892779618176865,0.423728813559322,0.7460306685343102,1.0,15/70,12.17%,IGF1;KIF14;RASGRP1;RASGEF1A;IRS2;DAB2IP;ERBIN;EPS8L2;DENND3;TGFB2;DENND4A;FBP1;OPHN1;STARD13;ARF6
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.6027019157143707,0.9891663280024283,0.5084745762711864,0.7460474343904863,1.0,3/8,15.24%,GDA;SHMT1;DPYD
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.5205000669102828,-0.9889370219140136,0.4444444444444444,0.9578333838564776,1.0,7/19,20.06%,BCAP31;SLC8B1;SLC25A23;LETM1;MICU2;AFG3L2;FIS1
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.6346961189634893,0.9889104072695972,0.5660377358490566,0.7464387726049398,1.0,3/5,32.70%,BRCA1;SIRT1;AUTS2
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.45447850442454407,0.9888164172212155,0.515625,0.7460460885611652,1.0,7/56,16.00%,CTSC;TGFA;TMED10;GRIA1;ANKRD28;CD59;CTSZ
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.45447850442454407,0.9888164172212155,0.515625,0.7460460885611652,1.0,7/56,16.00%,CTSC;TGFA;TMED10;GRIA1;ANKRD28;CD59;CTSZ
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.45447850442454407,0.9888164172212155,0.515625,0.7460460885611652,1.0,7/56,16.00%,CTSC;TGFA;TMED10;GRIA1;ANKRD28;CD59;CTSZ
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),0.6240237489388726,0.9887295192126304,0.5283018867924528,0.7460776780783639,1.0,3/8,19.15%,SHANK1;ADCY3;MAP1A
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.5229803360351579,0.9886559240345126,0.5660377358490566,0.7460112725218747,1.0,7/23,17.04%,PLAAT4;PLAAT3;CHKB;PLAAT5;PNPLA8;PLAAT1;LPIN3
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),-0.524538876796981,-0.9885753846467589,0.4,0.9580726525217452,1.0,2/16,14.01%,SLC6A13;SLC25A22
prerank,Reactome_2022__Nef-mediated Downmodulation Of Cell Surface Receptors By Recruitment To Clathrin Adapters R-HSA-164938,0.5424652531397893,0.9883108953680713,0.5084745762711864,0.7465741799329021,1.0,4/16,15.01%,AP1S1;B2M;PACS1;CD4
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.6545003706942096,0.9882669012855022,0.5531914893617021,0.7464780058952813,1.0,2/6,7.88%,PTPRC;LDLR
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.6292984328849262,0.9880958550860017,0.484375,0.7466281236210368,1.0,2/6,17.02%,FADD;ZBTB1
prerank,CellMarker_Augmented_2021__Responder T cell:Peripheral Blood,0.49461364876544495,0.9880841833818196,0.4838709677419355,0.746457834540681,1.0,7/26,4.66%,CTSS;MYO1F;PLEK;SLA;WAS;PTPRC;CD37
prerank,KEGG_2021_Human__RNA degradation,-0.4110753327078936,-0.9879971583436131,0.4583333333333333,0.9589308199200973,1.0,11/70,14.33%,LSM7;EXOSC8;LSM3;PABPC1L;LSM2;EXOSC4;LSM5;EXOSC5;LSM4;CNOT7;CNOT1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.4024930453566351,0.9879559134808382,0.4927536231884058,0.7465396796503757,1.0,6/112,6.62%,RECQL4;HELB;BLM;RPA1;GINS2;POLD1
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.5948387308321579,0.987947407325379,0.4406779661016949,0.7461786617619304,1.0,3/9,7.19%,ADCY5;AHR;ADCY2
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.5948387308321579,0.987947407325379,0.4406779661016949,0.7461786617619304,1.0,3/9,7.19%,ADCY5;AHR;ADCY2
prerank,Reactome_2022__TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.44726046138856784,-0.98765644884734,0.5,0.9591868637235846,1.0,15/56,20.34%,GTF2H5;POLR2K;ELOC;GTF2H2;ELOA;SUPT16H;ERCC2;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;ERCC3;POLR2L;POLR2G
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.6171721412605146,-0.9876426491780839,0.4358974358974359,0.9584520249315729,1.0,4/10,15.33%,BLOC1S2;VDAC2;BAD;BCL2L11
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.6003232666249478,0.9874320833840233,0.6274509803921569,0.7471968189188374,1.0,5/10,25.99%,SH3PXD2B;NAMPT;ZNF516;PGRMC2;ARID5B
prerank,CellMarker_Augmented_2021__Astrocyte:Embryonic Prefrontal Cortex,-0.34344121180091647,-0.9874314038353704,0.5416666666666666,0.958336157219456,1.0,52/317,11.72%,ID1;MT1E;SPRY1;DCXR;ID2;BTBD17;CST3;MYO10;BCAN;S100B;EDNRB;SLITRK2;CXCL14;ENHO;CTSL;TM7SF2;C1ORF122;APOE;SLC3A2;RGCC;LRRN3;OAT;NT5E;ATP1B2;IL33;SDC3;PLAGL1;TSC22D4;ID4;S1PR1;S100A16;GULP1;GLUD1;TNC;HEY1;VIM;PRSS35;TRIL;PLIN3;ELOVL2;SPARCL1;AQP4;GRM3;GPR37L1;YIF1A;DAG1;LRRC17;SELENBP1;HES5;PHGDH;MRC2;MT2A
prerank,CellMarker_Augmented_2021__Adipose-derived Stromal cell:Abdominal Adipose Tissue,0.4774027592606292,0.9872163674786459,0.5072463768115942,0.7473036544593014,1.0,12/52,13.38%,STMN2;GAP43;SHC2;RELN;PLPPR1;SEMA5B;TAC3;KCNH2;BEX1;DCX;SORCS1;IGDCC4
prerank,CellMarker_Augmented_2021__Adipose Progenitor cell:Abdominal Adipose Tissue,0.4774027592606292,0.9872163674786459,0.5072463768115942,0.7473036544593014,1.0,12/52,13.38%,STMN2;GAP43;SHC2;RELN;PLPPR1;SEMA5B;TAC3;KCNH2;BEX1;DCX;SORCS1;IGDCC4
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.45759800727320765,-0.9871415345762772,0.5263157894736842,0.9584182550982119,1.0,5/32,12.24%,FAM47E;TPP1;MCM9;ATR;CENPA
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.430436210859279,-0.9871146726066902,0.4722222222222222,0.9577216949730766,1.0,14/51,17.99%,LSM7;EXOSC8;LSM3;LSM2;EXOSC4;LSM5;EXOSC5;LSM4;CNOT7;CNOT1;POLR2D;RC3H1;LSM1;CNOT9
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.6027285529698868,0.9869891972283393,0.52,0.7476693867404862,1.0,4/9,27.90%,CTNNB1;PIP5K1C;VCL;TBCD
prerank,Reactome_2022__Mitotic G1 Phase And G1/S Transition R-HSA-453279,0.4117750215317976,0.9869734381952779,0.4084507042253521,0.7475198993575549,1.0,10/124,13.23%,CDKN2A;PTK6;TYMS;CDK6;CDKN1C;CDC7;CDKN1B;CDKN1A;CCND1;CKS1B
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),0.631268566994629,0.9867768314599313,0.56,0.7477255927082123,1.0,4/7,15.55%,PLAAT4;PLAAT3;PLAAT5;PLAAT1
prerank,Reactome_2022__Vesicle-mediated Transport R-HSA-5653656,0.35243528133642826,0.9862175726160384,0.48717948717948717,0.7487654634239144,1.0,91/538,19.39%,COL4A1;ALS2CL;ANK3;CTSC;YWHAH;TBC1D24;EGF;SH3GL2;SH3GL3;CD55;COL4A2;SYT1;APP;COLEC12;MYH9;TGFA;SH3KBP1;DENND3;DNM1;COLEC11;CLTB;REPS2;SBF1;RAB3IL1;SYNJ2;TPD52;NAA38;LDLR;GRK2;AP1S1;KIF5A;YWHAG;KIF5C;TRIP10;GRIA1;ARPC3;RNASE1;TF;RIN2;DENND4A;PACSIN1;KIF13B;SPARC;USP6NL;ACTR1A;STX4;TPD52L1;ARF6;TBC1D1;RAB30;SYT12;KLC1;OPTN;COPZ2;KIFC2;VPS37B;GPS1;ANKRD28;RAB27B;HSPH1;MAN1A1;BIN1;PUM1;CD4;CD59;PIP5K1C;TBC1D10B;CTSZ;TBC1D10A;KIAA0319;KIF3C;SPTB;GGA1;DYNC1LI2;EPN1;WNT5A;DCTN1;TFRC;RHOQ;YWHAE;LRP2;TSC2;CLVS2;AP1G2;RAB39A;KDELR3;RAB11A;DNM2;EXOC2;LDLRAP1;KIF19
prerank,Reactome_2022__Signaling By NOTCH R-HSA-157118,-0.3498685215789524,-0.9861964787676359,0.5483870967741935,0.959623270922544,1.0,17/161,12.91%,H2AC20;HEY2;H3-3B;H2BC4;H2BC21;SIRT6;H2AC6;HEYL;POFUT1;MAML3;HEY1;NCSTN;RUNX1;HES5;TMED2;PSMD10;PSMD12
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.4263604072614689,0.9860621356488564,0.5,0.7489707339751924,1.0,20/60,19.74%,GRIN3A;THY1;PRAME;NEUROD2;ALPK2;DCC;CDK6;MAPT;GAS6;KLF7;ELAPOR2;RPS6KA6;BCL11A;PINK1;PTPRS;KIAA0319;TFRC;LOXL2;ADCK1;NOTCH4
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),0.4603364421900724,0.9859409094991146,0.47368421052631576,0.7490517083717133,1.0,4/35,13.49%,ITPKC;ITPKB;AGPAT4;FGF2
prerank,CellMarker_Augmented_2021__Hemangioblast:Germ,0.6447055810202564,0.9858999157407775,0.5423728813559322,0.748958226576322,1.0,3/6,23.19%,PODXL;TEK;PECAM1
prerank,Reactome_2022__Organic Cation/Anion/Zwitterion Transport R-HSA-549132,-0.5818651987087247,-0.9855908109629204,0.5434782608695652,0.9605292957903265,1.0,4/8,22.45%,RUNX1;SLC22A6;SLC22A15;SLC22A2
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.5660055556932234,-0.9855761002333306,0.5434782608695652,0.9598088207116972,1.0,1/7,1.48%,MID1IP1
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6386462087884369,0.9854631786457008,0.5714285714285714,0.7496923130795605,1.0,3/10,9.09%,MLIP;FOXO1;LMNA
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),0.6252580014106486,0.9853849568707173,0.49056603773584906,0.7496459904871712,1.0,1/5,2.98%,SLC39A14
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.5143712945868416,0.9852150390610435,0.484375,0.7498655447077814,1.0,8/25,19.47%,LTBP4;ITGA3;SMAD3;BCL9;FSTL1;DKK3;SMAD2;TGFBR3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.5071835515345777,0.9851149199289149,0.5,0.7498959840528717,1.0,5/24,15.53%,DCN;CYRIB;MAPT;SPIRE1;PINK1
prerank,Reactome_2022__MyD88-independent TLR4 Cascade R-HSA-166166,0.41529748388582516,0.9848865706206744,0.43333333333333335,0.7501832684034049,1.0,18/95,18.13%,KCNH8;IRAK2;APP;RPS6KA1;IRF7;NOD1;BIRC3;NLRC5;IKBKE;FADD;TNIP2;IKBKG;MAPK11;TP53;TAB1;MAPK9;MAP2K3;SKP1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),-0.4444770845449297,-0.9847353396505986,0.47368421052631576,0.9613818951922687,1.0,3/44,2.90%,NGF;PIK3C2G;PLCB4
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.6676923981173352,0.984717630966011,0.54,0.7503759530702895,1.0,4/8,31.04%,PDPN;EMP2;GSN;CAMK2D
prerank,CellMarker_Augmented_2021__Progenitor cell:Skin,0.45003820963785357,0.9846330360085709,0.4461538461538462,0.75035607364742,1.0,14/56,19.02%,PKP2;CD24;EPB41L4B;FRAS1;CKMT1B;SYT13;PLEKHH1;CAMSAP3;SLC44A3;TOX3;MAGI1;CAPN13;B3GALT5;CXADR
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.5995130033029534,0.9846313214616019,0.48333333333333334,0.7501709950843414,1.0,2/8,4.78%,PTPRC;NFIL3
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),0.6361619471707156,0.9845469785492026,0.5087719298245614,0.7501718238330806,1.0,1/5,5.33%,CTU2
prerank,CellMarker_Augmented_2021__Dopaminergic neuron:Midbrain,0.45384425223046926,0.9845284032643362,0.4393939393939394,0.7498492094753619,1.0,15/50,11.70%,NPNT;EPHA2;EFNA1;KCNK1;EPS8L2;SEMA3B;RHOD;SCARA3;LAMA5;ASS1;YAP1;EPB41L1;TEAD1;CTNNA1;GPRC5C
prerank,CellMarker_Augmented_2021__Epithelial cell:Uterus,0.45384425223046926,0.9845284032643362,0.4393939393939394,0.7498492094753619,1.0,15/50,11.70%,NPNT;EPHA2;EFNA1;KCNK1;EPS8L2;SEMA3B;RHOD;SCARA3;LAMA5;ASS1;YAP1;EPB41L1;TEAD1;CTNNA1;GPRC5C
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.4077657489162729,0.9844376737504026,0.5211267605633803,0.7498324364192267,1.0,22/129,19.49%,FOXO1;NUAK2;MAP1LC3A;FAS;NUAK1;MFSD2A;KLF10;FOXO3;SIK2;PDK4;PICK1;CDKN1A;RNF152;MAP3K5;TP53;TFEB;GABARAPL1;STK24;ELAPOR1;MTMR3;RRAGD;ATP6V1B2
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.5385137842700125,0.9842893780003906,0.5510204081632653,0.7499217428581908,1.0,5/22,11.93%,GPNMB;SFTPD;DLG5;PAG1;HLA-DRB1
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),0.6426984032150276,0.9842860582812568,0.6071428571428571,0.7497429482090842,1.0,2/6,20.41%,P2RX7;ANO6
prerank,Reactome_2022__Cell-extracellular Matrix Interactions R-HSA-446353,0.5600351728352672,0.9842319073193726,0.4915254237288136,0.7496525919692694,1.0,5/14,20.12%,FBLIM1;ACTN1;VASP;FLNA;ARHGEF6
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),0.5915655619004581,0.9841734209579642,0.5185185185185185,0.7495593374599154,1.0,4/9,23.56%,THPO;ZFPM1;SH2B3;CDKN2B
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Embryo,0.45470789227930264,0.9837574442179554,0.48214285714285715,0.7502167031692658,1.0,10/37,13.20%,CD24;CCKBR;CTBP2;RBPMS;PODXL;NR6A1;CHST4;PAK1;ALPL;SOX13
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.4532286372279243,-0.9834382998104775,0.5357142857142857,0.9641574544978279,1.0,3/46,4.07%,H1-2;H1-4;POLR2K
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.6359309760405534,0.9833140560860708,0.6166666666666667,0.7510385249459703,1.0,2/8,13.02%,ALOX12;LTC4S
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.6156159688211675,0.9832834945153398,0.55,0.7508979188214027,1.0,3/9,3.81%,ANK3;KCNE4;NOS1AP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),0.5587647778850247,0.9830677030664005,0.4807692307692308,0.7511426789407234,1.0,3/15,4.31%,ZFP36;SFTPD;PTPRC
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),0.5530909375866504,0.9830545065560794,0.5178571428571429,0.7509844751145623,1.0,2/9,9.10%,ZSWIM4;YTHDF1
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.4067636630946725,0.9829876383382817,0.4864864864864865,0.7509380597729497,1.0,15/90,16.90%,RECQL4;HELB;BLM;RPA1;RBMS1;POLD1;BARD1;CDC7;DONSON;NAP1L1;POLE3;MRE11;BRCA1;CDK2;DUT
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),-0.5822973532904361,-0.9829653388008004,0.6274509803921569,0.963882664767279,1.0,2/7,7.12%,CTSL;CXCR4
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),-0.5822973532904361,-0.9829653388008004,0.6274509803921569,0.963882664767279,1.0,2/7,7.12%,CTSL;CXCR4
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),-0.6380407171114628,-0.9826944054393688,0.5416666666666666,0.9637396420799973,1.0,3/7,30.48%,LSM1;PATL1;PATL2
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5046574583874348,0.9826134880802887,0.5517241379310345,0.7515940758584236,1.0,6/24,12.57%,C3;SORBS1;ASXL3;PDK4;MLXIPL;ADIPOR2
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.5491696424632069,0.9825893952471615,0.5,0.7514505689176466,1.0,6/13,22.69%,RAI2;TGFB2;CAMSAP3;BRCA1;FGFR1;CELF4
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.6234757270901795,0.9824839203145632,0.6226415094339622,0.7514393202126514,1.0,5/9,32.34%,SORBS1;PTPN11;IRS1;SIRT1;PRKCZ
prerank,Reactome_2022__Organelle Biogenesis And Maintenance R-HSA-1852241,-0.3464288837155001,-0.9824278409022636,0.43333333333333335,0.9637990225319399,1.0,49/246,19.36%,CEP72;TFB2M;CNGA4;SSNA1;DYNLRB2;ATP5PF;NR1D1;ALAS1;CETN2;ATP5MC1;GLUD1;APOO;ATP5PB;ATP5PD;HAUS1;POLG2;DYNLRB1;CEP131;RAB8A;SCLT1;DMAC2L;MICOS10;ATP5MC3;EXOC7;IQCB1;SAMM50;CEP83;DYNC2I1;ATP5F1B;ARF4;BBS10;BBS9;ESRRA;TFB1M;ATP5F1A;TMEM11;DYNLL1;MKS1;ATP5MC2;CEP192;UNC119B;MTERF1;CEP78;MAPK12;ARL6;EXOC1;FBF1;IFT57;TUBB
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.46705159074740743,0.9822504514324362,0.463768115942029,0.7517569888775228,1.0,2/39,1.98%,KIF14;PSRC1
prerank,CellMarker_Augmented_2021__Stem cell:Endometrium,0.5815661877900558,0.9821775979296189,0.5636363636363636,0.7516928208421438,1.0,2/9,4.39%,THY1;LGR5
prerank,CellMarker_Augmented_2021__Naive CD4+ T cell:Blood,0.5023316332947825,0.9820811116746136,0.5151515151515151,0.751702065905642,1.0,7/28,4.66%,CTSS;MYO1F;PLEK;SLA;WAS;PTPRC;CD37
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",-0.4891197056590234,-0.9820713401515345,0.5675675675675675,0.9639177278199421,1.0,7/20,26.71%,DNASE1L1;DNASE2;MUS81;KPNB1;FBH1;EXOG;CASP3
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.5746812512724937,0.9820081282477469,0.543859649122807,0.7516760925169893,1.0,3/11,16.21%,LIMK2;YAP1;MAP4
prerank,Reactome_2022__Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,0.4102886737389274,0.9819748980209159,0.4090909090909091,0.7515650538680878,1.0,8/93,7.62%,KCNH8;IRAK2;APP;RPS6KA1;IRF7;NOD1;NLRC5;MYD88
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.509632970236016,0.9819743102015228,0.4426229508196721,0.7513748805244977,1.0,4/25,7.49%,C3;CD55;CFH;C1R
prerank,GO_Biological_Process_2021__negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665),-0.6440621476932488,-0.9819260609187355,0.5,0.9635256537895397,1.0,1/5,15.12%,TRIB1
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.4304557693276182,0.9818674195807297,0.5396825396825397,0.7514369772332956,1.0,14/56,19.44%,PLK2;SOX4;PML;GADD45A;CDKN1B;CDKN1A;CCND1;TP53;CDK2;CCNB1;PRMT1;PLK3;FBXO31;WAC
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),0.5377607765679167,0.9818257299288671,0.5737704918032787,0.751331946331117,1.0,8/24,15.90%,PROX1;CHI3L1;ITGA3;BASP1;GLI2;PDPN;FGF2;ABCA3
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),-0.6542039914889197,-0.9818148199701173,0.5555555555555556,0.9630867329153685,1.0,2/5,16.31%,TRMT10C;TRNT1
prerank,Reactome_2022__Homology Directed Repair R-HSA-5693538,-0.4148459252388911,-0.9817317835590407,0.41379310344827586,0.962541796419287,1.0,29/93,21.52%,RFC3;H2BC4;H2BC21;ATRIP;HUS1;POLD3;SIRT6;BRIP1;ABRAXAS1;RAD9B;RMI2;CLSPN;POLR1B;RNF168;SLC19A1;RNF8;DNA2;SEM1;BRCC3;MUS81;H2BC5;RAD51;UBB;UBE2V2;RAD17;SLX4;XRCC2;PARP1;BRCA2
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.48176616486912704,0.9816747698350899,0.4461538461538462,0.7515083225664265,1.0,9/41,17.57%,TESC;PTK6;WNT8B;ASXL1;RARA;RARG;RXRA;FZD7;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.41217108132621616,-0.9813500546320184,0.42857142857142855,0.9627973467744475,1.0,2/59,4.10%,NGF;HAX1
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),0.4766748129320573,0.9813354722306045,0.5,0.7520450033531002,1.0,7/36,20.13%,WAS;PARP9;SPIRE1;FMN2;SPIRE2;MMS19;WRAP53
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.626769232367967,0.9813010086337276,0.543859649122807,0.7519252519728594,1.0,3/6,32.70%,BRCA1;ARRB1;AUTS2
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.46369148454647174,-0.9810488071719267,0.5161290322580645,0.9629637193093754,1.0,9/33,18.79%,MCAT;THEM4;ACBD7;ACOT2;ACSM6;ECHS1;PCTP;ACADS;DECR1
prerank,Reactome_2022__Defective RIPK1-mediated Regulated Necrosis R-HSA-9693928,0.6838309758783675,0.9810154001266287,0.5882352941176471,0.7523180572986652,1.0,1/5,13.58%,FADD
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.5416699368923674,0.9809044401785181,0.5081967213114754,0.7523241932723056,1.0,1/11,4.35%,PDIA2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Bladder,0.672540632270634,0.980446004751539,0.5535714285714286,0.7530913645082115,1.0,2/5,6.44%,CD24;CD44
prerank,Reactome_2022__Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,0.5908605148974981,0.9804193529190105,0.6071428571428571,0.752936353912746,1.0,2/14,6.82%,RPS6KA1;CCKBR
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),-0.6120122584932874,-0.9802383249280765,0.574468085106383,0.9641411259159831,1.0,3/9,19.36%,MICA;CEBPG;TUBB
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.6281749421325127,0.9800695107744994,0.5306122448979592,0.7535040430487758,1.0,4/6,18.63%,DYSF;BIN1;MYOF;CAV3
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Brain,-0.4963045372432876,-0.9800694235769829,0.46153846153846156,0.9630420430122631,1.0,8/22,11.84%,CD247;CD96;RHOH;PYHIN1;CD6;P2RY10;MAP4K1;BIN2
prerank,CellMarker_Augmented_2021__T Helper1 (Th1) cell:Brain,-0.4963045372432876,-0.9800694235769829,0.46153846153846156,0.9630420430122631,1.0,8/22,11.84%,CD247;CD96;RHOH;PYHIN1;CD6;P2RY10;MAP4K1;BIN2
prerank,CellMarker_Augmented_2021__Mesenchymal cell:Ovary,0.6254107124452905,0.979856594913498,0.5185185185185185,0.7537877347725197,1.0,5/10,17.57%,ACTA2;CD44;FN1;ZEB1;WNT5A
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.5226917917617621,-0.979753492541483,0.46511627906976744,0.9632077077817343,1.0,2/13,15.21%,DSCC1;RAD21L1
prerank,Reactome_2022__Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,0.472753692288438,0.9796740365545265,0.4918032786885246,0.7539864839701619,1.0,3/33,7.88%,RIMBP2;AGRN;LDLR
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.49901555529457403,0.9794232425867506,0.4745762711864407,0.7542845278184735,1.0,3/21,9.25%,ZFP36;PLAAT4;PRKCH
prerank,Reactome_2022__Oncogene Induced Senescence R-HSA-2559585,0.4943647507530826,0.9789436853089488,0.5573770491803278,0.7551611045573949,1.0,1/30,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.5022044374081728,0.978888594877085,0.47540983606557374,0.75493822214114,1.0,11/27,18.30%,TGFB2;IFT122;PRICKLE1;DEAF1;COBL;MTHFD1L;MTHFR;VASP;SCRIB;LRP2;TSC2
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.5022044374081728,0.978888594877085,0.47540983606557374,0.75493822214114,1.0,11/27,18.30%,TGFB2;IFT122;PRICKLE1;DEAF1;COBL;MTHFD1L;MTHFR;VASP;SCRIB;LRP2;TSC2
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Keratinocytes R-HSA-8939242,0.6340338483754417,0.9788619681940347,0.5483870967741935,0.7547976608340118,1.0,1/7,0.88%,SOCS3
prerank,Reactome_2022__Endosomal/Vacuolar Pathway R-HSA-1236977,0.5954443227596923,0.9785038117373445,0.5,0.7553053432161055,1.0,3/10,14.71%,CTSS;B2M;HLA-E
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.5038476434002446,-0.9784737078125021,0.575,0.9658374825514573,1.0,5/17,17.85%,CTSH;NCSTN;PRELID1;MAPK12;PSME3
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.46904985852668535,0.9783349332120362,0.49122807017543857,0.7554420616795245,1.0,7/44,6.79%,L1CAM;RIMS2;SYT4;SHTN1;SYT1;AGRN;GHR
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.6313781135648032,0.9781427848043313,0.5818181818181818,0.7556575034445,1.0,4/6,23.59%,WAS;NEB;ARHGAP35;CXCL12
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.43645654589138805,0.9779956966137323,0.603448275862069,0.7558057344177276,1.0,9/60,6.91%,FOSB;THBS1;TMCC2;MYO1F;CD55;GAB3;TUBB1;CD44;SNCA
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),0.5949901578080079,0.9779612390713931,0.5454545454545454,0.7557263836005418,1.0,5/10,17.95%,RTN4RL1;EPHA4;PTPRS;INPP5F;STK24
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.5000321510616181,0.9779018716951896,0.5166666666666667,0.7557024771846381,1.0,4/29,10.01%,ZDHHC9;ZDHHC22;ZDHHC7;ZDHHC1
prerank,Reactome_2022__TP53 Regulates Metabolic Genes R-HSA-5628897,-0.38843748746140055,-0.9777475989204614,0.40625,0.9670257604132594,1.0,14/70,16.80%,COX18;PRDX1;LRPPRC;COX7C;COX20;COX7B;RRAGC;COX5B;COX19;SLC38A9;RRAGA;TACO1;TXN2;AKT2
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.4117796634408473,0.9777059612105318,0.5362318840579711,0.7559176367105376,1.0,6/133,4.92%,TLR2;EGF;SULF1;LGR5;TRPM4;SOX4
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.5259780214405655,0.9776043878998447,0.5,0.7559694727514539,1.0,7/19,33.25%,BIRC3;FLOT2;FLOT1;OGT;BIRC2;HSP90AA1;NUPR1
prerank,CellMarker_Augmented_2021__Naive T cell:Bone Marrow,0.5023651493347489,0.9775261659607706,0.5555555555555556,0.7559192988225272,1.0,7/29,4.66%,CTSS;MYO1F;PLEK;SLA;WAS;PTPRC;CD37
prerank,KEGG_2021_Human__Homologous recombination,0.44911224126346755,0.9771092902302,0.49230769230769234,0.7565216830918323,1.0,6/35,16.11%,BLM;RPA1;POLD1;BARD1;MRE11;BRCA1
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),0.5372494158782685,0.9770174128412302,0.5818181818181818,0.7565645912047405,1.0,3/17,10.90%,ABCA8;ABCA5;ABCA2
prerank,GO_Biological_Process_2021__positive regulation of blood-brain barrier permeability (GO:1905605),0.637988118960139,0.9768214774575126,0.5161290322580645,0.7568316732833044,1.0,1/5,3.80%,TJP3
prerank,KEGG_2021_Human__Pyruvate metabolism,-0.4569775866647005,-0.9768132629012863,0.36666666666666664,0.9686713390829591,1.0,11/36,21.83%,LDHC;ADH6;AKR1A1;ADH4;ADH5;PDHA1;ALDH7A1;ALDH2;ACSS1;ME2;ACYP2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.6414448779204265,0.9767270669838879,0.6037735849056604,0.7568424621087612,1.0,4/10,15.46%,SP100;RPS6KA6;HIPK2;TP53
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.4925466704693773,0.9764899902256532,0.45614035087719296,0.7571937351878167,1.0,1/22,1.37%,KREMEN2
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),0.5526391032650717,0.976426077062665,0.47619047619047616,0.7571666050285644,1.0,5/12,20.13%,PML;USP50;HIPK2;ETS1;WRAP53
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.4302685945394908,0.9764020441012563,0.5,0.7570376837205954,1.0,5/74,10.25%,PDGFRA;LMO2;RBM24;YAP1;SLC4A11
prerank,CellMarker_Augmented_2021__Amnion Epithelial cell:Amniotic Membrane,0.4755263302688496,0.9763778892829561,0.5357142857142857,0.7567044466569016,1.0,8/41,13.06%,TPTEP1;SHISA9;DRAXIN;TSSC2;NR6A1;USHBP1;ZNF850;JARID2
prerank,CellMarker_Augmented_2021__Embryonic Stem cell:Hair Follicle,0.4755263302688496,0.9763778892829561,0.5357142857142857,0.7567044466569016,1.0,8/41,13.06%,TPTEP1;SHISA9;DRAXIN;TSSC2;NR6A1;USHBP1;ZNF850;JARID2
prerank,KEGG_2021_Human__Prolactin signaling pathway,0.44251080054126685,0.9762946540629477,0.4788732394366197,0.7566832794385921,1.0,11/53,20.13%,SOCS3;SHC2;FOXO3;STAT3;CCND1;PIK3CD;MAPK11;MAPK9;SHC1;CCND2;AKT3
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.6402664394159394,0.9762012041442362,0.576271186440678,0.7564986287664277,1.0,1/6,2.53%,CD55
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.6402664394159394,0.9762012041442362,0.576271186440678,0.7564986287664277,1.0,1/6,2.53%,CD55
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),0.6422395493318696,0.975912027782996,0.5576923076923077,0.7568841358832129,1.0,3/6,20.78%,GUCY1A1;GUCY1B1;PDE2A
prerank,Reactome_2022__MAPK1 (ERK2) Activation R-HSA-112411,0.6438104974566825,0.9759033754452296,0.5967741935483871,0.7567148608986708,1.0,3/8,22.15%,TYK2;IL6R;PTPN11
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),-0.536668589336097,-0.9757487483797489,0.5217391304347826,0.9707260998290331,1.0,3/18,3.49%,APOBEC3G;TEX15;SMYD5
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.5117980992821263,0.9754630492974566,0.532258064516129,0.7574020202863904,1.0,4/25,12.07%,SULF1;SLC39A14;SCX;SNX19
prerank,KEGG_2021_Human__Starch and sucrose metabolism,-0.44263659844405806,-0.9754125696595857,0.425,0.9708616615688491,1.0,4/27,6.28%,PYGM;MGAM;AGL;GANC
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Brain,0.48700419359982206,0.9754042184991345,0.532258064516129,0.7573749059049283,1.0,7/28,4.66%,CTSS;MYO1F;PLEK;SLA;WAS;PTPRC;CD37
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.4046720900848063,-0.9753455871920901,0.5135135135135135,0.9702511678553469,1.0,16/46,24.18%,ATRIP;HUS1;BRIP1;ATR;ERCC6;TRIAP1;CLSPN;HINFP;SESN2;USP10;RAD17;PAXIP1;CASP9;CHEK2;E2F7;MAD2L2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),0.5177017147717285,0.9753202042117624,0.5689655172413793,0.7573449036709273,1.0,5/18,16.80%,ABCA8;PPARG;RXRA;ABCA3;GPS2
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),-0.5783922061479012,-0.9752511497316259,0.5,0.969729642318376,1.0,3/7,20.44%,SLC36A1;SLC36A4;SLC1A4
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5548867400002787,0.9752026235119803,0.5333333333333333,0.7574454479807154,1.0,4/12,30.04%,AK3;RHOQ;GNAI3;ENTPD7
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.5305525872724725,-0.9750624911905933,0.5681818181818182,0.9693965619869997,1.0,6/11,25.35%,PHGDH;SEPHS1;CTH;SRR;PSPH;SEPHS2
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),0.5625893426083171,0.9748935792996777,0.5,0.7579925381144663,1.0,4/10,26.53%,SNCA;PCSK5;PCSK6;FURIN
prerank,Reactome_2022__Pregnenolone Biosynthesis R-HSA-196108,-0.5325883498910651,-0.9746730296677948,0.5098039215686274,0.9696850707460567,1.0,3/10,15.48%,CD163L1;TSPO;STARD3NL
prerank,CellMarker_Augmented_2021__Macrophage:Alveolus,0.4811640666026529,0.9745401683631858,0.5,0.7586263320524712,1.0,6/29,4.31%,CTSS;MYO1F;PLEK;SLA;WAS;PTPRC
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.5855682432173539,0.9744971923767339,0.5918367346938775,0.7585351778779892,1.0,4/10,16.69%,TBX20;RYR2;IFT122;MESP1
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.5364191030454456,0.9742809641345493,0.5,0.7588874326674301,1.0,4/16,19.81%,SHTN1;CYRIB;TEK;RAP1B
prerank,KEGG_2021_Human__Inositol phosphate metabolism,0.41030555158544946,0.973969069449953,0.4745762711864407,0.7593206294915585,1.0,16/68,15.87%,MTMR7;ITPKC;PLCH2;ITPKB;SYNJ2;ITPK1;PIP4K2A;INPPL1;INPP5A;INPP5J;INPP4A;MTM1;PIK3CD;INPP5D;IMPA1;PIP5K1C
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),0.6372259432809383,0.9739351431622216,0.5862068965517241,0.7591917175883305,1.0,3/5,27.50%,CAMSAP3;TJP1;PLEKHA7
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.6275981089387574,-0.9738891815389031,0.46511627906976744,0.9710503943130107,1.0,2/5,21.22%,ENPP3;PRPS1
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.6080670013480896,0.9736948553776006,0.4642857142857143,0.7594479886423926,1.0,3/8,24.74%,FADD;CD200;HMOX1
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.46883321970851144,-0.9736639832462215,0.5185185185185185,0.9709276718571822,1.0,9/23,23.61%,GAL3ST2;ALG11;GAL3ST4;GK;TNIP1;ST8SIA6;RRM2B;RRM1;ALG6
prerank,Reactome_2022__COPII-mediated Vesicle Transport R-HSA-204005,0.4449816065987169,0.9734315045850109,0.5483870967741935,0.759788083934195,1.0,6/59,16.00%,CTSC;TGFA;GRIA1;ANKRD28;CD59;CTSZ
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.37468968808046554,-0.9734205755485414,0.4838709677419355,0.9708343667612827,1.0,22/92,19.05%,UCP3;DHX16;CHD4;ABCB10;BRPF1;URB2;EIF3D;GANAB;GART;NEMP1;PRPF8;MCM3AP;NOL6;USP19;CNOT1;DDX11;RFWD3;RUVBL1;DDX21;SLC11A2;HDGF;TAF5L
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Ovarian Cortex,0.4897168995238183,0.9733400993060335,0.5081967213114754,0.7597633424351807,1.0,11/38,14.29%,SHISA9;DRAXIN;CHST6;TSSC2;COL9A1;NR6A1;FGF13;ZNF850;MAPKAPK5;JARID2;USP49
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.456770402856284,0.9731779187712357,0.47619047619047616,0.7599237947107477,1.0,4/40,7.51%,ANXA1;FYN;STK25;CYP1B1
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.3856446124879134,0.9729427049848481,0.5285714285714286,0.7602837657963227,1.0,22/147,12.98%,HPN;GPNMB;IL15;KREMEN2;PTPRO;DAB2IP;NLRP12;DUSP10;EFNA1;PTPRR;RAB11FIP5;ZNF750;ALPK2;NPTN;LDLRAD4;RAB11FIP1;GAS6;HDAC9;TLE3;KLF7;ELAPOR2;RPS6KA6
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),0.6719582020803001,0.9728903997397577,0.5396825396825397,0.7600172377980652,1.0,1/5,19.56%,DYNC1LI1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),0.6719582020803001,0.9728903997397577,0.5396825396825397,0.7600172377980652,1.0,1/5,19.56%,DYNC1LI1
prerank,Reactome_2022__HS-GAG Degradation R-HSA-2024096,-0.5322052556678386,-0.9728281203075225,0.5121951219512195,0.971646584026233,1.0,4/17,11.69%,HSPG2;SDC3;GPC6;HPSE2
prerank,CellMarker_Augmented_2021__Erythroblast:Fetal Liver,0.47450742299173465,0.9728183031555434,0.5,0.7597914335363256,1.0,9/30,13.30%,PRKCB;GAB3;TUBB1;DENND4A;ANKRD36BP2;GFI1B;GP6;MFSD2B;GYPE
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Plasma,0.47450742299173465,0.9728183031555434,0.5,0.7597914335363256,1.0,9/30,13.30%,PRKCB;GAB3;TUBB1;DENND4A;ANKRD36BP2;GFI1B;GP6;MFSD2B;GYPE
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.46924731723486157,0.9727087463570769,0.5079365079365079,0.7598071822257644,1.0,2/32,3.38%,APP;TRAM1L1
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),0.6104502233010676,0.9723498397457038,0.5555555555555556,0.7603486141546708,1.0,1/6,12.08%,CDC7
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.5163425670328914,0.9723389542725146,0.5555555555555556,0.7601880669156084,1.0,4/20,10.92%,L1CAM;SHTN1;CDKL5;MAPT
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),-0.578490942884672,-0.9721163879146749,0.5476190476190477,0.9729828511022878,1.0,1/6,3.20%,PHYH
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.5480529177671314,0.972070050077382,0.5769230769230769,0.7605963334814473,1.0,3/11,11.71%,THBS1;CD160;CCL2
prerank,Reactome_2022__Attenuation Phase R-HSA-3371568,-0.477777778483981,-0.9720125684941977,0.5365853658536586,0.9725090901942868,1.0,6/22,22.14%,MRPL18;HSPA1A;HSF1;UBB;HSPA2;DEDD2
prerank,Reactome_2022__COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,0.4735621610734264,0.9717322277570618,0.5,0.7610794393545371,1.0,9/33,23.41%,ACTR1A;DYNC1LI2;DCTN1;DYNC1LI1;CAPZB;DCTN3;BICD1;DYNC1I1;DCTN6
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.5965949936209514,0.9716476907599509,0.5555555555555556,0.7610342515386143,1.0,2/7,8.12%,NRP2;CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.41840312077186825,-0.9715569553239769,0.4772727272727273,0.972945177301665,1.0,11/54,15.60%,SELENOS;TPT1;NOC2L;SFRP2;HSPA1A;MAPK7;CREB3L1;HTRA2;NDUFS3;CLU;ARMC10
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.4829445940749427,0.9715568703751669,0.543859649122807,0.7610208192159332,1.0,6/30,17.86%,THBS1;BAG3;CLPB;MAPT;IER5;YWHAE
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5167881899881367,0.9709165787191227,0.5396825396825397,0.7622735136694548,1.0,10/24,20.13%,ANXA1;THBS1;HDAC9;STARD13;KLF4;FGF2;HDAC7;SRPX2;MAP2K5;AKT3
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.4778456887781802,-0.9707311026423009,0.475,0.9743414266031252,1.0,3/24,9.07%,SELENOS;HSPA1A;CREB3L1
prerank,CellMarker_Augmented_2021__Ciliated cell:Lung,-0.3488948134877819,-0.9707163330492858,0.5,0.973640782304535,1.0,20/188,9.79%,H1-2;RITA1;KCNE1;DYNLRB2;PRDX1;SRI;ERICH2;ENKUR;SMYD2;TPPP3;MSRB1;PIH1D2;IK;CETN2;DPCD;RSPH1;APOO;VIM;TEKT1;APOBEC4
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),0.5302173914826087,0.9706088638808678,0.5185185185185185,0.7627067041201991,1.0,3/18,7.53%,GPNMB;NEK10;PDGFA
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.5103210077498026,0.9705965186085267,0.6,0.7625343192641469,1.0,8/31,17.91%,DUSP1;FOXO1;DUSP10;PER1;PINK1;GPS2;NCOR1;MECOM
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),0.5543624078141478,0.9705125383052118,0.49056603773584906,0.7625493468266286,1.0,3/11,13.20%,PIM1;VSTM2A;SOX13
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.6400710577378375,0.9702526455496374,0.5660377358490566,0.762872658830584,1.0,2/5,20.72%,ST6GALNAC3;GAL3ST1
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),-0.6444991681713622,-0.9701330447454888,0.5909090909090909,0.9745575863712597,1.0,2/6,16.92%,WDR76;RFWD3
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),-0.5847185154647417,-0.9700531008942026,0.6,0.974032144873959,1.0,2/6,10.75%,VEGFC;VEGFB
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.4578837847906183,0.969919243321336,0.5333333333333333,0.7633859242523519,1.0,4/40,2.82%,SLITRK1;L1CAM;SHTN1;SLIT2
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.4465739731707737,0.9698932435117603,0.5072463768115942,0.7632740177843905,1.0,10/43,16.70%,PXYLP1;AGRN;UGDH;HS6ST1;HS3ST3B1;HS3ST3A1;B4GALT7;NDST1;HS2ST1;HS6ST2
prerank,Reactome_2022__MET Promotes Cell Motility R-HSA-8875878,0.4921713414661054,0.9698308738515371,0.5,0.7631938368527306,1.0,6/25,10.81%,LAMB1;ITGA2;LAMA5;ITGA3;RNASE1;LAMA2
prerank,KEGG_2021_Human__mTOR signaling pathway,0.39644201931842177,0.969650130987031,0.5063291139240507,0.7634072895755923,1.0,26/131,20.43%,IGF1;PRKCB;PRKCG;RPS6KA1;WNT8B;DVL1;TNFRSF1A;PRR5;CAB39L;RPS6KA6;RPS6KB2;RNF152;PIK3CD;TTI1;FZD7;LPIN3;IGF1R;WNT5A;STK11;TSC2;PRKCA;TELO2;RRAGD;ATP6V1B2;AKT3;RHEB
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.5959240119217092,-0.9695252237538232,0.5918367346938775,0.9747498629950225,1.0,1/6,4.46%,BLOC1S2
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Peripheral Blood,0.4541309513126184,0.9694978702621552,0.5671641791044776,0.7635285513117531,1.0,13/33,16.38%,B3GNT2;CORO7;PDP1;SAMHD1;BIRC3;TLDC2;LMNA;CCR10;CPNE2;CLDND1;IKZF2;CD4;HAPLN3
prerank,CellMarker_Augmented_2021__Gonadal Mitotic Phase Fetal Germ cell:Fetal Gonad,0.38461007751728615,0.9693890399792786,0.5569620253164557,0.7635375521121852,1.0,32/230,13.42%,COL4A1;TEAD2;A4GALT;TAGLN3;SLC43A1;MBP;COL4A2;FBLIM1;ADD2;THY1;TJP3;FABP3;PCED1B;RAB15;ENC1;FHOD1;CDC42EP1;MYO1C;MVP;PODXL;FLVCR2;RAB11FIP1;GPRC5C;GDPD2;FRAT2;DLG3;STOM;TFAP2C;PDPN;ALPL;SOX13;PNMT
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.5143987993618869,0.969237887422579,0.5,0.7636788549430312,1.0,6/23,3.55%,IGF1;RASGRP1;RASGEF1A;RELN;IRS2;ERBIN
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),-0.6149939942799646,-0.9692108211522975,0.5769230769230769,0.9748457808061888,1.0,1/5,4.10%,HAX1
prerank,Reactome_2022__MASTL Facilitates Mitotic Progression R-HSA-2465910,0.6002654445988969,0.9688592921564166,0.5740740740740741,0.7642887965578614,1.0,5/8,28.23%,CCNB1;PPP2R2D;ARPP19;ENSA;PPP2R1B
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),-0.4667704182007204,-0.9688407213200748,0.4666666666666667,0.9752255820317792,1.0,4/32,5.92%,NGF;BEND6;HEYL;ASCL1
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),0.5815461932114454,0.9685087887241145,0.5185185185185185,0.764812191577229,1.0,2/8,8.65%,PID1;CHI3L1
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),0.5805672591959337,0.9683620501824373,0.6111111111111112,0.7649013396493934,1.0,3/10,21.77%,ATG9A;PACS2;WDR45
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.5504642349864982,0.9682645042156153,0.509090909090909,0.7649128623653724,1.0,3/12,12.52%,ABCB1;ABCA2;PLEKHA8
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),-0.4706670060360961,-0.9682403145107424,0.5,0.9761898060212789,1.0,6/24,11.55%,HEY2;HES6;HEYL;HEY1;BHLHE41;HES5
prerank,CellMarker_Augmented_2021__B cell:Thyroid,0.5097943492641023,0.9680384924238955,0.5614035087719298,0.765226009100789,1.0,6/21,12.64%,NAPSB;WAS;CD37;ACAP1;ITGAL;TMC8
prerank,CellMarker_Augmented_2021__Endothelial cell:Bone Marrow,0.5503129865706425,0.9677449384814294,0.5178571428571429,0.765541872611772,1.0,3/10,11.10%,FLT1;MCAM;S1PR3
prerank,Reactome_2022__Synthesis Of diphthamide-EEF2 R-HSA-5358493,-0.5742162011409996,-0.9675850428795505,0.5681818181818182,0.977100469852979,1.0,5/8,23.80%,DPH2;DNAJC24;EEF2;DPH5;DPH3
prerank,Reactome_2022__MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,0.4108747968730913,0.967441693931439,0.46153846153846156,0.7659753005168265,1.0,15/84,18.13%,KCNH8;IRAK2;APP;RPS6KA1;NOD1;NLRC5;MYD88;TNIP2;IKBKG;MAPK11;TP53;TAB1;MAPK9;MAP2K3;SKP1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.627358041576162,0.9672087140857799,0.6078431372549019,0.7662793399027322,1.0,4/6,36.10%,HIF1A;PRKN;MCL1;FBXW7
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),-0.6209633723579424,-0.9671521603665679,0.5882352941176471,0.9774661175663484,1.0,2/5,10.75%,VEGFC;VEGFB
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.5893073853073908,0.967138733682769,0.5789473684210527,0.7662245013397023,1.0,2/11,13.12%,APLNR;AKAP8
prerank,Reactome_2022__Non-integrin membrane-ECM Interactions R-HSA-3000171,0.4733823230179941,0.967135535441231,0.45614035087719296,0.766040580027319,1.0,9/33,11.20%,THBS1;LAMB1;ITGA2;AGRN;PDGFA;LAMA5;LAMA2;ACTN1;FGF13
prerank,Reactome_2022__Regulation Of Signaling By CBL R-HSA-912631,0.5316337117487555,0.9670937662169283,0.5,0.7659198545167308,1.0,2/16,10.41%,FYN;SYK
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.5856911640647093,0.9668820521170924,0.48148148148148145,0.7661519145105189,1.0,5/10,31.31%,IFT122;C12ORF57;TENM3;TBX2;NF1
prerank,Reactome_2022__Synthesis Of PE R-HSA-1483213,0.5620677009179126,0.9667300228766037,0.49122807017543857,0.7662605795735159,1.0,4/12,25.91%,CHKB;LPIN3;ETNK2;ETNK1
prerank,CellMarker_Augmented_2021__Astrocyte:Brain,0.4073990127019766,0.9663193554943255,0.5070422535211268,0.7669338462690733,1.0,19/148,10.51%,ANLN;FOSB;L1CAM;ATF3;KCNH7;ZFP36;MTHFD2;IGFBP7;SLC39A11;RFX4;TNS1;DTNA;GFAP;DGKG;ZFAND5;GRIA1;ALDH1L1;LHFPL6;GLIS3
prerank,Reactome_2022__Signaling By NTRK1 (TRKA) R-HSA-187037,0.40852279498476046,0.9660976336570286,0.5277777777777778,0.767282971532121,1.0,11/98,6.48%,FOSB;KCNH8;SH3GL2;RIT2;SH3GL3;SHC2;IRS2;RPS6KA1;CDK5R2;DNM1;VGF
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.42509366406420634,-0.9660335918369326,0.5111111111111111,0.9797844667207096,1.0,9/38,12.47%,CST3;CSTB;FICD;PLXNB3;RRP1B;MAPK7;PPP1R35;TMED2;ZCCHC9
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),-0.5622896235279837,-0.9659722782828786,0.5555555555555556,0.9792351485270683,1.0,5/10,30.48%,PNRC2;LSM1;PATL1;EDC3;PATL2
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.5376294503686003,-0.9658733144793498,0.4594594594594595,0.9787501366988979,1.0,4/11,22.40%,EXOSC4;EXOSC5;FBL;LARP7
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.535305316463335,-0.9657378922418602,0.5555555555555556,0.9784445985872674,1.0,3/12,6.81%,PTPN22;CD6;BCL10
prerank,CellMarker_Augmented_2021__Red Blood Cell (erythrocyte):Placenta,-0.4522019086215186,-0.9654613097779491,0.4666666666666667,0.9783814998816662,1.0,4/20,8.27%,DPEP2;PADI4;CR1;SLC25A37
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.44124595290467683,0.9653866813780934,0.578125,0.7686202988788907,1.0,2/44,3.62%,ANK3;AMN
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.5711533824932421,0.9653859707501461,0.4838709677419355,0.7684303754049894,1.0,2/7,21.89%,STAU1;DDB1
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.3594898420559648,-0.9652360063000788,0.5,0.9783530386141093,1.0,9/114,5.85%,NGF;ID2;AR;HEY2;SMYD5;PDCD2;SERPINF2;NR1D1;GREM1
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.5444335822288937,-0.9649248142066751,0.475,0.9783936515045489,1.0,3/10,12.63%,PGP;DGKB;PLA2G15
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),-0.5169918696857678,-0.9648782709872418,0.4473684210526316,0.9777501640262407,1.0,2/23,3.78%,NGF;PYHIN1
prerank,Reactome_2022__ABC-family Proteins Mediated Transport R-HSA-382556,0.4055707361924618,0.9647128963362606,0.5362318840579711,0.7695691813004697,1.0,9/91,11.64%,ABCA6;ABCA8;ABCB1;ABCA5;ABCA10;ABCC9;ABCA9;ABCA2;ABCB9
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.3930024326227491,0.9645439078479925,0.5,0.7697140568693591,1.0,22/96,13.49%,CORO6;RBM24;FABP3;VLDLR;COL21A1;PDE1A;TBX20;RYR2;NEXN;ZFPM2;OBSCN;SYNPO2L;CTNNB1;RASL12;ART3;TCAP;LAMA2;SORBS1;ADIPOR2;CAP2;PNMT;FGF2
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),0.6785548039647727,0.9640879772293546,0.6,0.7704627480867037,1.0,4/6,29.33%,ATG9A;ULK1;ATG7;ULK2
prerank,Reactome_2022__Activation Of Arylsulfatases R-HSA-1663150,-0.5188867642740047,-0.9638630977184777,0.5135135135135135,0.9797498328661289,1.0,4/12,22.75%,ARSF;ARSK;ARSL;ARSG
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),-0.6062946552194921,-0.9637764136249847,0.6,0.9792440417398023,1.0,2/5,18.25%,GTF2H2;ADM
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.5865465204636221,0.9635903840646469,0.5522388059701493,0.7713541355766618,1.0,2/10,8.96%,TSPYL2;GMNC
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.4106965308336071,0.9635855951734628,0.5507246376811594,0.7711752142200592,1.0,15/76,16.08%,RASGRP1;TBC1D9;EPHA2;NTRK3;RAP1GAP;SIPA1L1;USP6NL;TBC1D1;RANGAP1;RAP1GAP2;SIPA1;ARHGAP22;NGEF;TBC1D10B;TBC1D10A
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.4058683217674545,-0.963569067578933,0.47058823529411764,0.9790085692015675,1.0,12/67,15.58%,CEBPA;SIRT6;TRIB3;CBFA2T3;BCAP31;HSPA1A;RAD23A;PSMD10;CLU;BAG2;TRIB1;HSPBP1
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.5884999113216058,-0.9634757852436958,0.5217391304347826,0.9784869093992224,1.0,1/8,0.29%,RAB7B
prerank,Reactome_2022__Potential Therapeutics For SARS R-HSA-9679191,0.41387715172193096,0.9634269298727645,0.5538461538461539,0.7713538694239535,1.0,18/78,22.83%,IL1R1;SH3KBP1;CHD3;ATP1B1;ATP1B3;SYK;TYK2;FXYD7;BRD4;VAV1;MTA1;MTA3;RCOR1;IL6R;PHF21A;TBK1;GATAD2A;CUL3
prerank,Reactome_2022__Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,0.5202290559811086,0.9633552139013325,0.5084745762711864,0.7713294332400893,1.0,7/22,15.01%,ELMO1;FYN;AP1S1;RNASE1;B2M;PACS1;CD4
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.5809899317087371,0.9632200973222987,0.58,0.7714450753929709,1.0,3/9,7.88%,IGF1;PTPRC;LDLR
prerank,Reactome_2022__Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,0.4201953952135334,0.9629553736094508,0.5588235294117647,0.771837866234785,1.0,12/67,16.45%,ST6GAL1;EGFL7;ST8SIA3;ST8SIA1;SLC17A5;ST8SIA4;CMAS;NANS;ST6GALNAC2;ST6GALNAC5;ST6GALNAC3;NEU4
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.39001947181634405,0.9628247874359939,0.5882352941176471,0.7719304693651013,1.0,28/189,12.47%,EGF;DCN;THBS1;PTK6;SULF1;PLEK;PRKCB;DAB2IP;NLRP12;PRAME;HIC1;PTPRC;EGFL7;APOD;NOTUM;PID1;SNCA;GLIS2;DCC;TMBIM1;NEURL1;MMP14;PIP4K2A;IFT122;NR4A2;ASXL1;PRKCD;BCL2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.6495101268101495,0.9626176833549713,0.5964912280701754,0.7721144310914566,1.0,1/5,15.53%,PINK1
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),0.5798586588349546,0.9624956925446194,0.52,0.7721612295985627,1.0,3/9,7.19%,ADCY5;ADCY7;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5719408528005121,0.9620990553427626,0.5,0.772759015282162,1.0,1/12,2.91%,WAS
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.47550172749031117,-0.9616980484664085,0.5588235294117647,0.9825415377373223,1.0,10/28,21.11%,SF3B4;HSPA1A;ZPR1;RBM22;NCL;RBMX;CIRBP;HABP4;PRDX6;SNW1
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),-0.5543072136357627,-0.9616287113887086,0.5555555555555556,0.9820122781562545,1.0,2/8,9.23%,IDO1;TDO2
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),-0.6270050906456669,-0.961515209763933,0.5909090909090909,0.9815181236732223,1.0,3/8,21.19%,GTF2A2;TAF11;TAF12
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.5819429947182452,0.9614706494332347,0.5714285714285714,0.7738417328471019,1.0,8/11,30.90%,CYP1B1;MTARC2;GCHFR;CYB5B;GCH1;CYB5R3;DDAH2;NOS1
prerank,CellMarker_Augmented_2021__Myeloid cell:Bone Marrow,0.4775807445118283,0.9613920884530324,0.5757575757575758,0.7738053180387733,1.0,4/28,4.31%,TLR2;CD24;SIGLEC1;PTPRC
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.6515918418544722,0.9612809993249319,0.5925925925925926,0.7738174198988583,1.0,3/7,26.65%,FN1;CXCL12;FERMT3
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.5628245209683356,0.9612389118651481,0.5507246376811594,0.7737011683661696,1.0,2/13,11.22%,GAR1;TRUB1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.49364386833212026,0.9610916002625568,0.5,0.7738359028292444,1.0,1/18,1.48%,DCN
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.49463138291531517,-0.9610683109844126,0.4594594594594595,0.9819560298127499,1.0,4/24,4.95%,ID2;CCNE1;CDK15;FBXO5
prerank,Reactome_2022__KEAP1-NFE2L2 Pathway R-HSA-9755511,0.4150334806588245,0.9610301919379113,0.5857142857142857,0.7737938237538078,1.0,1/89,0.12%,CDKN2A
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.47843441890743166,0.9610220889993256,0.5223880597014925,0.7736206625475578,1.0,8/37,20.36%,WAS;PML;TERF2IP;SPIRE1;FMN2;SPIRE2;WRAP53;UBR5
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.4129228952273816,-0.9609454775087738,0.5454545454545454,0.9814912077944171,1.0,9/57,6.81%,RAB7B;SELENOS;CD200R1;TNFAIP3;AGER;FOXJ1;PTPN22;IL33;BCL10
prerank,CellMarker_Augmented_2021__T cell:Ascites,-0.4628813517763965,-0.9608405594781125,0.48717948717948717,0.9810384947680746,1.0,4/20,5.61%,DPEP2;CD247;C1ORF162;CD6
prerank,CellMarker_Augmented_2021__Regulatory B cell:Peripheral Blood,0.5010395314387156,0.9607636415775999,0.46774193548387094,0.7739177310034575,1.0,5/22,4.66%,MYO1F;PLEK;NAPSB;WAS;CD37
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.5647713122568789,0.9604601214591963,0.53125,0.7743827244145758,1.0,8/12,30.90%,CYP1B1;MTARC2;GCHFR;CYB5B;GCH1;CYB5R3;DDAH2;NOS1
prerank,Reactome_2022__HSF1 Activation R-HSA-3371511,-0.4658660075090254,-0.9604323043454907,0.525,0.981470073524305,1.0,8/25,23.97%,MRPL18;HSPA1A;HSF1;EEF1A1;POLR1B;UBB;DEDD2;VCP
prerank,Reactome_2022__Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.4873888275145711,0.960424959580577,0.5737704918032787,0.7742522655615925,1.0,9/41,17.47%,CDH23;MYH9;EPS8L2;MYO15A;EPB41L1;PCDH15;KCNMA1;ATP2B4;WHRN
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.3815065996831797,-0.9603853890822978,0.47368421052631576,0.9808300736043455,1.0,4/67,6.79%,NUP62CL;NXT2;NUP50;GEMIN4
prerank,KEGG_2021_Human__Vasopressin-regulated water reabsorption,0.477165597742458,0.9602841102651939,0.5166666666666667,0.7743097900284301,1.0,11/36,23.41%,CREB5;ARHGDIG;STX4;ADCY3;DYNC1LI2;DCTN1;RAB11A;DYNC1LI1;ADCY9;DYNC1I1;DCTN6
prerank,Reactome_2022__Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,0.47379197330289524,0.9601916509389243,0.5714285714285714,0.7743701328034021,1.0,11/26,28.73%,NEURL1;DNER;DTX2;ADAM17;RPS27A;ARRB1;PSEN1;NUMB;MIB2;APH1B;ARRB2
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),-0.35631976817678784,-0.9600724297307859,0.5357142857142857,0.980857017379431,1.0,25/106,20.40%,H2BC21;PADI4;GTF2H5;GTF2H2;CETN2;MCM6;DMC1;H2BC18;ERCC2;PSMD10;MCM4;PSMD12;PSMB5;XPA;PSMB6;ORC6;PSME3;ERCC3;H2BC5;PSMD2;RAD51;SMARCA5;UBB;PSMB4;ORC2
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),-0.4830703816982228,-0.9597651003354236,0.5277777777777778,0.9810204303420534,1.0,8/20,19.42%,DHRS11;SRD5A1;MOCS2;NFS1;LIAS;PRLR;NOXRED1;MOCOS
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.43071866928071567,0.9597442962237764,0.4909090909090909,0.7751447575395979,1.0,13/62,18.73%,THBS1;SULF1;BMP8A;TBX20;TGFB2;RBPMS;CDKN1C;ELAPOR2;HIPK2;KIAA0319;STK11;ADAM17;SMAD2
prerank,CellMarker_Augmented_2021__Basal cell:Salivary Gland,-0.5370762630500661,-0.9595987060720373,0.5609756097560976,0.979267523583439,1.0,1/12,0.22%,TRIM29
prerank,CellMarker_Augmented_2021__Basal cell:Submandibular Gland,-0.5370762630500661,-0.9595987060720373,0.5609756097560976,0.979267523583439,1.0,1/12,0.22%,TRIM29
prerank,CellMarker_Augmented_2021__Buccal Epithelial Stem cell:Oral Mucosa,-0.5370762630500661,-0.9595987060720373,0.5609756097560976,0.979267523583439,1.0,1/12,0.22%,TRIM29
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),-0.6148270829737587,-0.9594961136281258,0.5208333333333334,0.9788248502028938,1.0,1/6,2.08%,CEL
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.5743529367567497,0.959489649693793,0.5797101449275363,0.7755036080000881,1.0,1/11,1.93%,VAPB
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.4227676113539118,0.9593358792034219,0.5606060606060606,0.7757029922319532,1.0,11/70,12.04%,RECQL4;TEAD2;KREMEN2;EPHA2;BAIAP2L1;AGRN;PAK4;LAMA5;PES1;TTLL12;EIF5A
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),0.6107813830951654,0.9592184742456118,0.6,0.7757999029711602,1.0,2/6,7.34%,CDK9;LARP6
prerank,Reactome_2022__Regulation Of Innate Immune Responses To Cytosolic DNA R-HSA-3134975,-0.5653780656689791,-0.9590499610270012,0.5957446808510638,0.9792725036323736,1.0,1/11,2.46%,TRIM21
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),0.5234830225210947,0.9590289759637763,0.5272727272727272,0.7759394122321625,1.0,4/11,20.78%,KIF5A;KIF5C;DNM2;SYNJ1
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.626982582132279,0.9590001533234874,0.6333333333333333,0.7758287241934503,1.0,3/8,19.03%,LIMK2;TPPP;RAB11A
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.5906813439708617,-0.9589171795289613,0.5952380952380952,0.9788984364149436,1.0,2/10,6.23%,ABCD1;ABCB11
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),-0.5814584415491499,-0.9588174869887734,0.5294117647058824,0.9784061047110677,1.0,3/8,12.21%,IFNLR1;PRELID1;ISCU
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.5679824329193297,-0.9587233869127616,0.6041666666666666,0.9779031987509305,1.0,3/8,23.22%,MAP2K6;MAPK12;CHEK2
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.5741553840934609,-0.9586803932254133,0.5348837209302325,0.9772710967266468,1.0,6/10,23.54%,SAT1;ASMT;MOXD1;SRM;SAT2;TPH1
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.5532422055706695,0.9583484884631199,0.41509433962264153,0.7769456948032791,1.0,3/10,5.44%,APP;TNFRSF14;APOD
prerank,Reactome_2022__Establishment Of Sister Chromatid Cohesion R-HSA-2468052,0.5898957341983772,0.9580958124126633,0.6166666666666667,0.7773007351560042,1.0,3/9,22.70%,PMEPA1;PDS5A;PDS5B
prerank,PanglaoDB_Augmented_2021__Eosinophils,-0.39502891563493353,-0.9580045907766177,0.5714285714285714,0.9784013558574697,1.0,6/34,5.85%,DPEP2;GMFG;EPX;C1ORF162;IL5;NR1D1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.5195300050617561,-0.957941579988156,0.6052631578947368,0.9778826510079409,1.0,4/14,21.45%,SEC24A;SEC31B;MIA3;SEC24C
prerank,CellMarker_Augmented_2021__Activated B cell:Peripheral Blood,0.5005707749906095,0.957869545378966,0.5588235294117647,0.7775760735555144,1.0,8/23,15.86%,ADGRE5;PCED1B;SKAP1;NLRC5;CD5;B2M;HLA-E;TAGLN2
prerank,"Reactome_2022__PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",0.42377469484313557,0.9577659612663959,0.4918032786885246,0.7776326287481902,1.0,14/74,11.20%,PDGFRA;EGF;IRS2;TGFA;FYN;NRG1;NRG2;PDGFA;MYD88;KITLG;GAB2;RNASE1;PIP4K2A;FGF13
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),0.6046755890904261,0.9573351001345752,0.5555555555555556,0.7783790072095369,1.0,2/9,15.80%,PRKG2;GCHFR
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),0.5865680621694769,0.9573046961914632,0.5166666666666667,0.7782650462358587,1.0,5/9,26.19%,APLNR;PDE4D;UBE2B;PDE2A;RNF157
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.5318921250600492,0.957186646216051,0.5714285714285714,0.7782674786790317,1.0,2/15,14.96%,ZC3H7B;PUM1
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),-0.3933262074829662,-0.9571663301778492,0.4418604651162791,0.9789882275955517,1.0,3/59,2.90%,NGF;PIK3C2G;PLCB4
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.5684122591588483,0.957097977110575,0.5081967213114754,0.7783011148254173,1.0,1/9,11.09%,DIP2B
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.5620625029346875,0.9570570225049173,0.5689655172413793,0.7782042732481765,1.0,3/11,10.69%,PLEK;SKAP1;P2RY12
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6111647820801945,0.9569863642402561,0.5862068965517241,0.778130162414674,1.0,3/7,10.32%,ADA;SKAP1;PODXL
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.42734385363240107,0.9568721653414299,0.5254237288135594,0.7782261714640321,1.0,7/52,12.46%,TRIM5;TRIM46;DVL1;TRIM17;MMD;ZDHHC7;TRIM22
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),-0.501774128054007,-0.9567520333411671,0.5333333333333333,0.9792472119029458,1.0,1/18,1.25%,KPNA2
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.4170143123583472,0.9566322895521192,0.5,0.7784950096480863,1.0,7/76,7.16%,TYMS;NELL1;IGF2BP2;DAB2IP;SAMD4A;ENC1;EIF4A3
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),0.5657737197237991,0.9564623801245534,0.6530612244897959,0.7786957162095279,1.0,2/9,11.62%,CDK9;BARD1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.4341165823000318,-0.9564548378329317,0.55,0.9794213795683205,1.0,2/29,2.52%,TMEM17;DISP3
prerank,Reactome_2022__Metabolism Of Vitamins And Cofactors R-HSA-196854,0.37508128858057777,0.9564229235738853,0.5394736842105263,0.7786187250731702,1.0,12/151,10.96%,ENPP2;RIMBP2;NMNAT2;AMN;PRKG2;MTHFD2;AGRN;LDLR;ALDH1L1;NAMPT;SHMT1;PARP9
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),-0.5759609028955336,-0.9563748413408094,0.5681818181818182,0.9789315798959328,1.0,3/7,25.07%,ZCCHC17;NRDE2;PHAX
prerank,Reactome_2022__Regulation Of PTEN Localization R-HSA-8948747,0.5704281774639329,0.9562010613737599,0.5,0.7789184218274792,1.0,3/9,26.81%,PML;RPS27A;NEDD4
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.4460226866543997,0.9561851490747582,0.5172413793103449,0.7787621384796635,1.0,13/50,12.93%,SLITRK1;SLIT2;THY1;EFNB3;PAK3;ROBO2;MAG;MCF2;SIPA1L1;EPHA4;KIF13B;PLXNA4;PAK1
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.5259736091251063,-0.9559718229556465,0.525,0.9793474042841583,1.0,5/12,25.31%,BCAP31;DERL2;YOD1;ERLEC1;SVIP
prerank,Reactome_2022__Nef Mediated CD4 Down-regulation R-HSA-167590,0.5900388066191908,0.955965248895643,0.6041666666666666,0.7790107035121849,1.0,3/7,32.85%,CD4;AP2A2;ATP6V1H
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5435863885921949,0.955847142230463,0.5531914893617021,0.7790129473776842,1.0,7/17,19.02%,MYH11;NRG1;ALPK2;TCAP;MESP1;SLC8A1;CXADR
prerank,GO_Biological_Process_2021__heat acclimation (GO:0010286),-0.6461497705632452,-0.955757432724525,0.56,0.9784823314938995,1.0,1/5,7.64%,HSPA1A
prerank,GO_Biological_Process_2021__cellular heat acclimation (GO:0070370),-0.6461497705632452,-0.955757432724525,0.56,0.9784823314938995,1.0,1/5,7.64%,HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),0.5388539063910358,0.9557088546170242,0.5333333333333333,0.7791142118680855,1.0,2/13,7.88%,MFSD2A;LDLR
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.5853688000923134,0.9556766443990835,0.5283018867924528,0.7790032893152538,1.0,2/8,10.96%,HMBOX1;PARP9
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.4730455812697039,0.9556258737841593,0.5483870967741935,0.7789093877536492,1.0,6/24,14.19%,OGN;APOD;PPARG;CDKN1B;CDKN1A;IL12A
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),-0.3997804811058584,-0.9555742416806511,0.43333333333333335,0.9781797387316262,1.0,6/78,7.12%,G0S2;KSR2;DISP3;LEPR;SIRT6;CXCR4
prerank,Reactome_2022__Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.3863711027403142,-0.9555125269755668,0.4375,0.9776478337253812,1.0,14/57,20.95%,FZD8;FZD9;PSMD10;PSMD12;DVL2;PSMB5;VANGL2;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4;FZD1
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.49729534231531985,0.9552634510317659,0.4909090909090909,0.7795251395863713,1.0,5/21,13.49%,PDGFRA;FLT1;P2RY12;EEF1A2;FGF2
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.5792498820802007,-0.9552355577513335,0.6382978723404256,0.9775814928485768,1.0,1/6,3.28%,LRPPRC
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.5479795386459554,0.9551712820378291,0.5964912280701754,0.7794961645170702,1.0,2/16,3.28%,RFTN1;COLEC12
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3836515227463352,0.9549473162050983,0.625,0.7798147700201257,1.0,53/188,23.94%,CDKN2A;PLK2;CCNB2;ABCB1;CCNI2;CDK6;HAUS7;YWHAG;PPP1CB;ACTR1A;CDC7;TPD52L1;CDKN1B;CDKN1A;CCND1;OPTN;LCMT1;NEDD1;CDK2;CDC25B;CCNB1;DCTN1;YWHAE;SKP1;CKAP5;CAMK2A;PLK3;DNM2;CDK5RAP2;CDKN2D;CCND2;PPP2R2D;CDC27;PPME1;CCNA2;FBXL8;ACVR1B;CEP76;MAX;TUBA4A;RCC1;PRKAR2B;TUBB4A;CUL3;DCTN3;ARPP19;PHF8;CEP70;ACVR1;CCNF;CDKN2B;BCAT1;ODF2
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),0.6271348799929053,0.95457767244578,0.65,0.7803846500926094,1.0,2/5,8.71%,ANXA1;SCG5
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.5518543660000405,0.9544840897410054,0.5555555555555556,0.7804063253665119,1.0,8/14,13.95%,CNTN2;CNTN4;EMB;NEXN;NPTN;VSTM2L;ROBO4;PALLD
prerank,KEGG_2021_Human__Pathways of neurodegeneration,0.36076370547359027,0.9544036420165888,0.6470588235294118,0.7803969296180604,1.0,53/382,15.53%,GRIN2A;CHRM3;CHRM1;GRIN2D;GRIN2B;VAPB;NEFL;TRPC3;PRKCB;PRKCG;APP;WNT8B;SEPTIN5;FAS;DNAH3;SMCR8;TUBB1;ITPR3;DVL1;GRM5;TNFRSF1A;SNCA;CACNA1C;RYR2;GRIA3;GRIN1;CTNNB1;KIF5A;BCL2L1;KIF5C;CAPN1;GRIA1;TUBB6;MAPT;ACTR1A;NEFM;NDUFB11;KLC2;CAMK2B;FRAT2;BCL2;KLC1;OPTN;FADD;TUBA1B;HAP1;GPR37;NDUFB9;MAPK11;NOX4;ATXN1L;MAP3K5;PINK1
prerank,Reactome_2022__Oncogenic MAPK Signaling R-HSA-6802957,0.4226938818671393,0.9541931300822092,0.5138888888888888,0.7806020857364725,1.0,19/71,19.92%,MAP3K11;DUSP10;DUSP8;DUSP16;MRAS;LMNA;TRAK1;PPP1CB;CAMK2B;FN1;IQGAP1;KIAA1549;FAM131B;RAP1A;AGTRAP;MPRIP;CAMK2A;RAP1B;APBB1IP
prerank,CellMarker_Augmented_2021__Cytokine Induced Killer cell:Blood,-0.46620000478588736,-0.953798951370895,0.48936170212765956,0.980071515211061,1.0,5/16,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Liver,-0.46620000478588736,-0.953798951370895,0.48936170212765956,0.980071515211061,1.0,5/16,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),-0.37627720734303316,-0.9537693907378267,0.47058823529411764,0.9794280363391621,1.0,9/72,9.85%,DAO;IDO1;SDSL;PIPOX;HYKK;ACMSD;GLUD1;TDO2;GCDH
prerank,Reactome_2022__Mitotic Telophase/Cytokinesis R-HSA-68884,0.5443741390901778,0.9537021694368641,0.53125,0.7815042508645642,1.0,1/11,5.06%,PMEPA1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.4748552200130522,-0.9536498235555844,0.5625,0.9790535011944099,1.0,2/14,4.74%,ORMDL1;SMPD3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.5681621886880046,0.953576897224785,0.603448275862069,0.7815989945146069,1.0,1/11,0.90%,IGF1
prerank,KEGG_2021_Human__Progesterone-mediated oocyte maturation,0.424318368128769,0.953391176450679,0.5492957746478874,0.7818319175990219,1.0,19/84,17.55%,IGF1;CCNB2;ADCY5;RPS6KA1;PGR;ADCY7;ADCY2;SPDYE1;RPS6KA6;CPEB2;PIK3CD;MAPK11;CDK2;ADCY3;CDC25B;MAPK9;IGF1R;CCNB1;GNAI1
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),0.5521286202467116,0.9532556624098872,0.5517241379310345,0.7819152544479312,1.0,4/10,18.35%,ABCA8;ABCA2;SGMS1;SMPDL3A
prerank,Reactome_2022__Metabolism Of Lipids R-HSA-556833,0.3382801447827044,0.9532311195493774,0.5977011494252874,0.7817842644061711,1.0,96/586,17.43%,GGT5;MTMR7;SGPP2;ACSL5;VAPB;AWAT1;LIPH;UGT8;FA2H;NSDHL;LPCAT4;ACHE;FABP3;PPARGC1B;EGFL7;SOAT1;ESYT3;ALOX12;AHR;SLCO1A2;PLAAT4;MFSD2A;SBF1;SYNJ2;TNFAIP8L1;HADH;CYP1B1;ACOT4;AGPAT4;PLAAT3;DHCR24;PLEKHA2;B4GALNT1;SPNS2;TBL1X;CYP21A2;OXCT1;HACD1;PLD2;HSD3B7;PPARG;CERS3;PPP1CB;CYP4F22;B3GALNT1;CHKB;PIP4K2A;VAC14;HMGCLL1;PITPNM3;OLAH;INPPL1;DBI;PITPNM2;DGAT2L6;INPP5J;SLC51A;ACOT7;NPAS2;DGAT1;SLC27A3;PLAAT5;PLEKHA4;PLEKHA8;SLC27A5;INPP4A;LTC4S;SGMS1;MTM1;CDS2;ALDH3A2;ELOVL7;BMX;STS;PLB1;PNPLA8;INPP5D;SLC44A3;CPNE7;PLAAT1;ELOVL5;STARD3;PIP5K1C;RXRA;MED13L;CDK19;NEU4;RORA;LIPE;GPS2;LPIN3;NCOR1;HACD4;SH2D3C;INPP5F;PITPNM1
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.6363672886586824,0.9532157127384896,0.5238095238095238,0.7816251493604047,1.0,1/5,9.15%,CLPB
prerank,Reactome_2022__Signaling By FGFR3 R-HSA-5654741,-0.4637718257015302,-0.9531203176020121,0.5135135135135135,0.9796447115236537,1.0,1/31,1.20%,GALNT3
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),0.4957689626861466,0.9529890357325977,0.6190476190476191,0.7818888396096704,1.0,6/29,13.49%,MET;THBS1;NTRK3;P2RY12;STX4;FGF2
prerank,Reactome_2022__Mitotic Spindle Checkpoint R-HSA-69618,-0.3739591254370357,-0.9529507493983339,0.53125,0.9792817176797209,1.0,9/87,12.86%,CDC26;SGO2;KNL1;SPDL1;MIS12;ITGB3BP;CENPA;CENPQ;ANAPC15
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.39632235963473084,0.9529151369182887,0.5625,0.781842476542786,1.0,15/99,14.44%,CDKN2A;TP53TG5;PSRC1;SLIT2;TSPYL2;SLIT3;BCL6;PML;SMAD3;TGFB2;FBP1;CDKN1B;CDKN1A;PPP1R9B;SIPA1
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.6428079391313455,0.9528950279329774,0.6379310344827587,0.7817003642505883,1.0,1/5,12.68%,PER1
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.41558778788494455,0.9527586516615063,0.5223880597014925,0.7818286696920022,1.0,4/64,3.38%,VAPB;SHTN1;APP;TRAM1L1
prerank,Reactome_2022__Prolactin Receptor Signaling R-HSA-1170546,0.5300471175534163,0.9527575783930404,0.5970149253731343,0.7816387671732526,1.0,3/10,22.15%,GHR;SKP1;PTPN11
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.5676882130476225,0.9525161339282463,0.5818181818181818,0.7819640587637929,1.0,5/10,19.02%,MYH11;ALPK2;TCAP;SLC8A1;CXADR
prerank,Reactome_2022__Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,0.49655159091177764,0.9524892085904662,0.5333333333333333,0.781816426798771,1.0,1/31,0.01%,LEF1
prerank,Reactome_2022__Phosphate Bond Hydrolysis By NUDT Proteins R-HSA-2393930,0.6219411267719066,0.9523822558599973,0.5272727272727272,0.7818376703782343,1.0,1/5,5.50%,NUDT16
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),0.6262544910228184,0.9523678217577312,0.5576923076923077,0.7816732644395116,1.0,1/6,3.34%,DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.4729846772599628,0.9522203915135196,0.6212121212121212,0.7818238859567161,1.0,6/29,12.89%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;KLF4
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),0.5753836755601246,0.952123444082665,0.5416666666666666,0.7818085647082819,1.0,3/6,28.99%,MTCL1;MAP2;FBXW11
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),-0.45633702869782367,-0.9519430174674202,0.4634146341463415,0.9810919341685389,1.0,1/30,0.63%,TAX1BP3
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),0.6396383664748657,0.951739819356689,0.625,0.7823722487390908,1.0,2/5,22.33%,THPO;SH2B3
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.41870305160041665,-0.951635042923356,0.5151515151515151,0.9811904622251362,1.0,6/44,5.43%,SLC25A5;FLT3;RHOH;RABL3;LEPR;PTPN22
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.5442575263972562,0.9512332612972858,0.6122448979591837,0.7831660784677709,1.0,1/12,3.05%,IRS2
prerank,CellMarker_Augmented_2021__Follicular Dendritic cell:Spleen,0.4811972026670419,0.9512286217696748,0.576271186440678,0.7829846939598938,1.0,7/27,4.66%,MYO1F;PLEK;NAPSB;WAS;LAT2;PTPRC;CD37
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.41019816101853795,-0.9511413441829494,0.42857142857142855,0.9817004929286322,1.0,17/60,24.64%,FIP1L1;RBM8A;U2AF1;CPSF1;CLP1;SRSF2;CPSF3;SRSF9;UPF3B;CHTOP;CSTF2;THOC3;CSTF2T;THOC1;TENT4A;CPSF7;SRRM1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),-0.5370012758575883,-0.9511010301941534,0.5714285714285714,0.9810869141758993,1.0,1/7,3.91%,SRI
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),0.5531051366472036,0.9507037124783123,0.5735294117647058,0.7839240391422752,1.0,5/12,9.86%,SCN3B;KCNQ1;TRPM4;RYR2;TGFB2
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Oral Cavity,0.4506592860105714,0.9504006213370894,0.53125,0.7842901083023317,1.0,18/49,15.22%,C3;IL13RA1;CD24;IL1R1;CP;IGFBP7;CD44;PID1;ARHGEF10L;MMP14;RIN2;DUOXA1;PDK4;BACE2;KLF4;S100A6;SERPING1;SLC44A3
prerank,Reactome_2022__Physiological Factors R-HSA-5578768,0.5960821052185006,0.9499187253308693,0.5531914893617021,0.7850265592052439,1.0,3/7,17.38%,HIPK1;HIPK2;WWTR1
prerank,Reactome_2022__SLBP Independent Processing Of Histone Pre-mRNAs R-HSA-111367,0.583369287070169,0.9496929262216429,0.5818181818181818,0.7852686943596735,1.0,2/9,18.35%,LSM11;ZNF473
prerank,Reactome_2022__Transcriptional Regulation By RUNX1 R-HSA-8878171,0.38045062771036314,0.9496813469590681,0.5753424657534246,0.7851010499401351,1.0,10/154,9.04%,NR4A3;SOCS3;THBS1;LMO2;PRKCB;NFATC2;LDB2;PML;CDK6;YAP1
prerank,Reactome_2022__Beta Oxidation Of lauroyl-CoA To decanoyl-CoA-CoA R-HSA-77310,0.6148410626855336,0.9495878725356037,0.56,0.7850597218984651,1.0,1/5,7.02%,HADH
prerank,Reactome_2022__Signaling By PDGFR In Disease R-HSA-9671555,0.5178477458173264,0.9493779487055041,0.5636363636363636,0.7852652141388654,1.0,3/17,10.27%,PDGFRA;ETV6;STAT3
prerank,Reactome_2022__Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,0.4210961682779333,0.949376574087258,0.5797101449275363,0.7850836728676581,1.0,3/72,4.64%,RASGRP1;PRKCB;NFATC2
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),-0.6232234463974936,-0.9493572870286467,0.6486486486486487,0.9851456979747826,1.0,1/6,6.31%,IL33
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.5353177848306601,0.9493184092272321,0.5645161290322581,0.7850115438985354,1.0,3/14,14.53%,EGF;FGF2;PIK3CD
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.41033855481672904,0.949084121564487,0.6229508196721312,0.785278554053275,1.0,8/87,11.35%,TGFBR2;ZYX;PARD3;DUSP22;SMAD3;TGFB2;SMAD1;PXN
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.5251801499281636,-0.9490194307735552,0.5333333333333333,0.9852687252356543,1.0,3/12,16.48%,CNOT7;CNOT1;RC3H1
prerank,Reactome_2022__Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,0.4776089676149722,0.9489608058158495,0.5625,0.7853409010232949,1.0,5/30,13.82%,TTLL7;TUBB6;AGTPBP1;TTLL12;TUBA1B
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),0.5839932094209312,0.9487076383297581,0.576271186440678,0.7856385152908378,1.0,4/12,23.69%,BMP8A;MIDN;KCNB1;PRKN
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.38236361846185946,0.9484208004076881,0.5967741935483871,0.7860396036242737,1.0,36/165,13.11%,EPHA7;PLPPR5;ITPKC;PRKCG;PTPRB;PLCH2;PXYLP1;PLPPR4;LPCAT4;DUSP10;PLPPR1;PTPRC;DUSP8;DUSP16;PLAAT4;ITPKB;ALDOB;HK2;ITPK1;PTPRD;PLAAT3;NUDT4;LIMK2;PFKL;PIP4K2A;STAT3;INPPL1;INPP5A;PGK1;FBP1;INPP5J;INPP4A;ALK;PAK1;ALPL;HK1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),-0.641740062561573,-0.9479651474028854,0.6578947368421053,0.9873328593128927,1.0,5/6,34.21%,MEPCE;METTL4;NOP10;METTL16;NHP2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.5364628628242059,-0.9477728160457182,0.5526315789473685,0.9871326452590385,1.0,3/9,10.05%,ZC3H8;FOXJ1;CLPTM1
prerank,CellMarker_Augmented_2021__Bone Marrow Stromal cell:Bone Marrow,0.47491300068474274,0.9475640212727012,0.609375,0.7873924324664822,1.0,9/39,9.04%,MET;FBLIM1;EPHA2;BAIAP2L1;ITGA2;GPR87;RHOD;ITGA3;YAP1
prerank,Reactome_2022__Erythropoietin Activates RAS R-HSA-9027284,-0.529955399640807,-0.9472442482487535,0.5853658536585366,0.98772471987146,1.0,2/13,4.64%,EPX;EPOR
prerank,GO_Biological_Process_2021__regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127),0.6039226697138915,0.9470549614855422,0.6363636363636364,0.7881595896386219,1.0,1/6,3.31%,IRF7
prerank,Reactome_2022__C-type Lectin Receptors (CLRs) R-HSA-5621481,0.396144316839376,0.9469328139652236,0.5571428571428572,0.7882211657804342,1.0,22/103,23.72%,MAP3K14;NFATC2;FYN;ITPR3;ARHGEF7;SYK;PRKCD;RELB;IKBKG;TAB1;ITPR1;SKP1;PRKCA;NFATC3;MUCL1;AHCYL1;RPS27A;TAB2;CARD11;PPP3CB;PSMB3;RPS6KA5
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.4983358220178965,0.9464667683987003,0.6,0.7889597747883893,1.0,1/23,0.47%,TMEM204
prerank,GO_Biological_Process_2021__vascular associated smooth muscle cell differentiation (GO:0035886),-0.6185219125924051,-0.9460827576274932,0.5818181818181818,0.9900481968885824,1.0,1/6,1.34%,HEY2
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),-0.5345969592862001,-0.9455749029034415,0.5581395348837209,0.9907755424489083,1.0,2/7,22.84%,ALDH18A1;ARG1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),0.4630577473535432,0.9455693012510348,0.5238095238095238,0.7905763180323284,1.0,6/28,21.87%,DYSF;DNM1;MX1;MYOF;DNM2;GCA
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.5500544056658647,-0.9453898461800792,0.627906976744186,0.9905070882502743,1.0,2/6,17.84%,PKD1L1;DNAAF1
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.47580759567508096,0.9452818498021505,0.5849056603773585,0.7909756345122679,1.0,7/27,12.16%,PTP4A3;NR4A1;MYH9;FAP;CYP1B1;PXN;STARD13
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.500573991381449,0.945199731957534,0.5692307692307692,0.7909721696648075,1.0,7/30,13.41%,KCNJ2;ABCC9;KCNH2;ATP1A1;ATP1B1;ATP1B3;SLC12A5
prerank,Reactome_2022__Regulation Of KIT Signaling R-HSA-1433559,0.5800762752049577,0.945044091122351,0.6101694915254238,0.7910972802004828,1.0,6/13,24.12%,FYN;KITLG;SH2B2;PRKCA;SH2B3;CBL
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.4214338404820543,0.9450362868923844,0.5833333333333334,0.790920534471958,1.0,2/76,1.69%,KLF2;ATF3
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.6076632582125882,-0.9449811239786834,0.6037735849056604,0.9908243899612805,1.0,2/5,29.39%,RC3H1;RC3H2
prerank,Reactome_2022__Interleukin-1 Family Signaling R-HSA-446652,0.3865465605850657,0.9448703026375271,0.6153846153846154,0.7910176598106128,1.0,15/122,16.42%,IL1RAPL1;IRAK2;APP;NOD1;IL1R1;NLRC5;MYD88;SMAD3;PTPN9;STAT3;GSDMD;TNIP2;IKBKG;TP53;TAB1
prerank,Reactome_2022__Molecules Associated With Elastic Fibres R-HSA-2129379,0.5024324554025213,0.9446240676824375,0.5172413793103449,0.7913661137560987,1.0,4/18,10.89%,LTBP4;ITGA8;TGFB2;ITGB8
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),0.6410974424380753,0.944353890010096,0.6428571428571429,0.7917674551710063,1.0,3/5,29.53%,FLNA;MACROH2A1;NOP53
prerank,GO_Biological_Process_2021__embryonic forelimb morphogenesis (GO:0035115),-0.6086670478788925,-0.944284398851681,0.6,0.9910936669185346,1.0,1/5,1.64%,ZNF358
prerank,GO_Biological_Process_2021__forelimb morphogenesis (GO:0035136),-0.6086670478788925,-0.944284398851681,0.6,0.9910936669185346,1.0,1/5,1.64%,ZNF358
prerank,CellMarker_Augmented_2021__Stem cell:Salivary Gland,0.4041855331493337,0.9441230505074644,0.4918032786885246,0.7919983086615797,1.0,19/92,17.73%,ANXA1;SP100;B3GNT2;FAS;AHR;BIRC3;CD44;ARF6;B2M;ELF1;IQGAP1;PRDM1;S100A6;ATL3;ETS1;NEDD1;SP140L;ZBTB1;CBFB
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),0.5350349024816246,0.9438010575607851,0.5522388059701493,0.7924327970830213,1.0,1/9,10.96%,PARP9
prerank,CellMarker_Augmented_2021__Granulocyte:Blood,0.46667703114265974,0.9437717291393947,0.5254237288135594,0.7923090021852497,1.0,5/31,8.05%,TSPAN16;MYO1F;NLRP12;LAT2;SLC26A8
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),0.5846766861419525,0.94369364253819,0.4909090909090909,0.7922856960425698,1.0,3/8,25.43%,THPO;SH2B3;ANXA2
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.6071523097823824,0.9433893858183563,0.58,0.7928062615421358,1.0,2/9,7.18%,P2RY6;RYR2
prerank,Reactome_2022__Signaling By NODAL R-HSA-1181150,0.5299216400622302,0.9429920421538495,0.5555555555555556,0.7934520526499563,1.0,7/14,26.53%,FOXO3;SMAD3;SMAD2;ACVR1B;PCSK6;MAPK3;FURIN
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5248423006305606,0.9429795439905834,0.5,0.793277953358298,1.0,3/13,10.51%,CACNA1G;MSX2;SMAD1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.5337863762522137,0.9429734088967063,0.5490196078431373,0.7930955767402671,1.0,4/12,25.29%,SLC26A8;SLC13A4;SLC26A11;SLC26A6
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),0.5070078542472561,0.9429165553325044,0.5081967213114754,0.7930163826079337,1.0,1/18,4.19%,WTIP
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.5414304210587657,0.9426030273382278,0.6296296296296297,0.7934330769464016,1.0,9/19,29.15%,ARF6;SCAMP5;MCTP1;LRSAM1;MTMR2;EPHA3;PICALM;ABCA7;RUBCN
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),0.4216758542572679,0.9424785570945546,0.5303030303030303,0.7934178949428868,1.0,7/72,4.31%,PSCA;DUSP1;DAB2IP;FOXO1;DUSP10;PTPRR;PTPRC
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.518173634709412,0.9424376678896037,0.5671641791044776,0.7933191900891035,1.0,5/17,18.13%,PML;HK2;HK1;PINK1;SKP1
prerank,CellMarker_Augmented_2021__Natural Killer cell:Undefined,-0.4009294158710599,-0.9416714097152349,0.43243243243243246,0.9970082973832494,1.0,4/30,4.91%,ID2;FLT3;CD38;LRRC36
prerank,Reactome_2022__VLDLR Internalisation And Degradation R-HSA-8866427,0.5053765195240061,0.9416474496729953,0.6,0.7946652570967725,1.0,1/15,4.38%,VLDLR
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),0.6174275755290578,0.9416435504572106,0.5102040816326531,0.7944828101200309,1.0,3/7,17.57%,CTNNB1;NR4A2;WNT5A
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.6218388548127438,0.9415674885949438,0.6065573770491803,0.7942516988076179,1.0,5/7,33.37%,ULK1;ATG7;ULK2;ATG13;RB1CC1
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.6218388548127438,0.9415674885949438,0.6065573770491803,0.7942516988076179,1.0,5/7,33.37%,ULK1;ATG7;ULK2;ATG13;RB1CC1
prerank,Reactome_2022__Immunoregulatory Interactions Between A Lymphoid And A non-Lymphoid Cell R-HSA-198933,0.44909413024351,0.941328520369623,0.55,0.7945200040485981,1.0,6/37,3.65%,C3;CD22;NPDC1;ICAM1;COLEC12;SIGLEC1
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),0.5667306837515396,0.9412584382062278,0.5714285714285714,0.7944267375539725,1.0,2/9,10.44%,GRAMD2A;HOMER1
prerank,CellMarker_Augmented_2021__Early Hematopoietic cell:Blood,0.4265246589196955,0.9411786268485304,0.5797101449275363,0.793275502116892,1.0,12/62,11.02%,CD24;CP;UNC5D;FRAS1;SEMA5B;SVOPL;ZNF608;MAOB;SYT13;PTPRD;ITGA9;ASXL3
prerank,CellMarker_Augmented_2021__Progenitor cell:Embryonic Stem Cell,0.4265246589196955,0.9411786268485304,0.5797101449275363,0.793275502116892,1.0,12/62,11.02%,CD24;CP;UNC5D;FRAS1;SEMA5B;SVOPL;ZNF608;MAOB;SYT13;PTPRD;ITGA9;ASXL3
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Pancreas,0.4265246589196955,0.9411786268485304,0.5797101449275363,0.793275502116892,1.0,12/62,11.02%,CD24;CP;UNC5D;FRAS1;SEMA5B;SVOPL;ZNF608;MAOB;SYT13;PTPRD;ITGA9;ASXL3
prerank,CellMarker_Augmented_2021__Dermal Papilla cell:Hair Follicle,0.4265246589196955,0.9411786268485304,0.5797101449275363,0.793275502116892,1.0,12/62,11.02%,CD24;CP;UNC5D;FRAS1;SEMA5B;SVOPL;ZNF608;MAOB;SYT13;PTPRD;ITGA9;ASXL3
prerank,CellMarker_Augmented_2021__Neural Stem cell:Bone Marrow,0.4265246589196955,0.9411786268485304,0.5797101449275363,0.793275502116892,1.0,12/62,11.02%,CD24;CP;UNC5D;FRAS1;SEMA5B;SVOPL;ZNF608;MAOB;SYT13;PTPRD;ITGA9;ASXL3
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Larynx,0.4265246589196955,0.9411786268485304,0.5797101449275363,0.793275502116892,1.0,12/62,11.02%,CD24;CP;UNC5D;FRAS1;SEMA5B;SVOPL;ZNF608;MAOB;SYT13;PTPRD;ITGA9;ASXL3
prerank,CellMarker_Augmented_2021__Ductal cell:Pancreas,0.4265246589196955,0.9411786268485304,0.5797101449275363,0.793275502116892,1.0,12/62,11.02%,CD24;CP;UNC5D;FRAS1;SEMA5B;SVOPL;ZNF608;MAOB;SYT13;PTPRD;ITGA9;ASXL3
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),0.40288909114707616,0.9411578190917773,0.5079365079365079,0.7931438621098669,1.0,23/73,22.88%,SLC7A2;ABCB1;MFSD2A;ABCC9;ABCA2;SLC29A4;SLC7A1;ABCC4;SLC2A3;SLCO3A1;ATP2B4;SLC8A2;SLC2A13;SLC29A1;TFRC;LRP2;SLC7A8;ABCC3;SLC6A9;ABCC1;SLC44A1;SLC27A1;SLC6A17
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.5601404277117057,0.9410585002808456,0.5942028985507246,0.7931815199628273,1.0,4/14,6.44%,MBP;THY1;SKAP1;CD44
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.5577153114569035,0.9406108556332461,0.603448275862069,0.793915352928951,1.0,5/11,33.94%,FBXL2;PRKN;FMR1;NUCKS1;VAPA
prerank,CellMarker_Augmented_2021__Corneal Epithelial Stem cell:Eye,-0.5447768528267247,-0.9404195621189981,0.6086956521739131,0.9995169670103933,1.0,1/9,0.22%,TRIM29
prerank,Reactome_2022__Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,0.45072027510712576,0.9403933283037432,0.5423728813559322,0.7941358271385528,1.0,12/49,11.20%,PDGFRA;EGF;IRS2;TGFA;FYN;NRG1;NRG2;PDGFA;KITLG;GAB2;RNASE1;FGF13
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.5539103375678913,-0.9403830594322159,0.5116279069767442,0.9989021999227161,1.0,4/9,31.53%,TPRKB;RAD51;SMC6;ERCC4
prerank,Reactome_2022__E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.41158809562724585,-0.9403615773020232,0.5526315789473685,0.9982058492621023,1.0,17/47,26.51%,SELENOS;H2BC4;BCL10;PEX10;RRAGA;PEX13;H2BC5;UBB;UBE2V2;UBE2A;HLTF;VCP;CTR9;DERL1;LEO1;SKIC8;PRKDC
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.49269407954130573,0.9402686861106835,0.49206349206349204,0.7942092612787504,1.0,7/22,14.61%,SERPINE1;ICAM1;PAK4;YAP1;GAS6;TNIP2;CAST
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.4820460075582132,0.940176534035062,0.5846153846153846,0.7942022813447491,1.0,8/28,14.31%,SIX3;C3;SH3PXD2B;PBX3;TGFB2;HIPK1;MEIS3;HIPK2
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.5380984107918598,0.9399852718091908,0.603448275862069,0.7943172298699218,1.0,2/12,5.06%,APP;TNFRSF14
prerank,CellMarker_Augmented_2021__Microglial cell:Brain,0.5556683792819028,0.9398343058651464,0.5833333333333334,0.7944736788964777,1.0,7/16,14.92%,HLA-DRA;KLF2;CD83;P2RY12;CCL2;BIN1;GPR183
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.5979191238275483,0.9397384971210813,0.6428571428571429,0.794455561978859,1.0,4/9,19.34%,APOD;SNCA;F3;PTPRJ
prerank,CellMarker_Augmented_2021__Mitotic Fetal Germ cell:Fetal Gonad,0.34816404482177454,0.939710387185237,0.6296296296296297,0.7943156159759509,1.0,71/534,13.23%,CLIC1;COL4A1;ST6GAL1;TEAD2;CTSC;TAGLN3;SLC43A1;CALD1;MBP;PIM3;CAMKV;COL4A2;ZYX;FBLIM1;GMPR;TEC;TMSB10;LPCAT4;ADD2;THY1;TJP3;PGD;RTN2;FABP3;PCED1B;RAB15;SMAGP;SOX4;PLLP;SLC39A11;PRODH;ENC1;ECE1;DPYSL2;LASP1;TPM4;SHISA5;MYO1C;LDHA;ASS1;THOC6;MGAT5;WDR54;TRIP10;JADE2;TUBB6;SMCO4;RPL3;SYTL4;CRIP2;PFKL;ORAI1;SLC4A11;STAT3;PODXL;ACTN1;ACTR1A;GPRC5C;GDPD2;ENO2;FRAT2;DLG3;STOM;TFAP2C;KLF4;PDPN;IL4R;ALPL;HK1;SOX13;CKS1B
prerank,Reactome_2022__Regulation Of HMOX1 Expression And Activity R-HSA-9707587,-0.6228933708724971,-0.9395990627237198,0.6382978723404256,0.9993565990167386,1.0,2/5,17.30%,BRIP1;HM13
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.5733989789550463,0.9394083867512346,0.5517241379310345,0.794531345845591,1.0,4/8,18.12%,PDP1;PDK4;PDK1;PDK3
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.5733989789550463,0.9394083867512346,0.5517241379310345,0.794531345845591,1.0,4/8,18.12%,PDP1;PDK4;PDK1;PDK3
prerank,Reactome_2022__Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,-0.5195343829747836,-0.9394021671149193,0.5681818181818182,0.9992593749745339,1.0,2/16,7.29%,PI4K2A;PIK3C2A
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.3639641692184865,0.9393815699664796,0.64,0.7943887149189507,1.0,22/277,11.53%,SERPINA10;C3;SOCS3;CHGB;FAM20C;APP;ASB16;CP;FBXW12;LAMB1;IGFBP7;NOTUM;ZBTB16;VGF;SHISA5;ITIH2;FBXO32;TF;KLHL5;GAS6;FBXL16;WSB2
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,-0.4170581151431067,-0.9388609903096675,0.4857142857142857,0.9999852478928215,1.0,5/45,7.81%,TRIM29;KRT8;PPIC;TMEM54;TUFT1
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),0.6230513535784812,0.938846763403559,0.6136363636363636,0.7952088579164358,1.0,1/5,13.90%,TNIP2
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),0.5525896360499727,0.9384729709590373,0.5925925925925926,0.795727144304882,1.0,2/14,12.17%,PLEK;ARF6
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.39380214644444056,-0.9383234488925565,0.4594594594594595,1.0,1.0,9/54,15.97%,CFTR;VIM;BECN1;UFL1;ATG14;TEX264;AUP1;PJVK;DYNLL1
prerank,Reactome_2022__Apoptosis R-HSA-109581,0.37513735913793844,0.9381429730262241,0.5694444444444444,0.7961898818942124,1.0,18/150,13.58%,CDKN2A;YWHAH;LMNB1;SEPTIN4;DCC;DAPK2;CTNNB1;BCL2L1;YWHAG;LMNA;STAT3;BBC3;MAPT;GSDMD;PRKCD;BCL2;TNFRSF10B;FADD
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.4743041164815641,0.9381032719398771,0.5333333333333333,0.7960580491517557,1.0,7/23,13.10%,NLGN1;THY1;DVL1;AGRN;ITGAL;DLG3;PICK1
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4464780614496686,-0.9377059183571073,0.5882352941176471,1.0,1.0,2/21,6.20%,KCNE1;ATP1B2
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.5104297151590996,0.9376891015376091,0.55,0.7966614388160556,1.0,6/12,17.50%,FSCN1;OPHN1;MYO9A;PATJ;CAMSAP3;SCRIB
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),0.5581074703870019,0.9376837922358902,0.559322033898305,0.7964770576385815,1.0,1/8,1.24%,YWHAH
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.5654805413908528,0.9376654087074637,0.5925925925925926,0.796312101427729,1.0,2/12,2.69%,CTSS;LMO2
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.40578200999141706,0.9371753236234585,0.532258064516129,0.7970558501487789,1.0,23/71,22.88%,SLC7A2;ABCB1;MFSD2A;ABCC9;ABCA2;SLC29A4;SLC7A1;ABCC4;SLC2A3;SLCO3A1;ATP2B4;SLC8A2;SLC2A13;SLC29A1;TFRC;LRP2;SLC7A8;ABCC3;SLC6A9;ABCC1;SLC44A1;SLC27A1;SLC6A17
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,0.41586739388260874,0.9369684877143224,0.6438356164383562,0.7973408979073914,1.0,11/90,7.37%,SIX3;C1ORF87;TEKT2;NME9;EFNB3;ANGPTL2;CFAP126;ERICH3;TMEM212;GFAP;ZMYND10
prerank,Reactome_2022__PI-3K cascade:FGFR3 R-HSA-5654710,0.5423192145766743,0.9369383582378829,0.5818181818181818,0.7972062189588821,1.0,4/11,32.83%,FGF13;PTPN11;FGF17;FGF1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.4631562784456397,-0.9368531498972482,0.5681818181818182,1.0,1.0,2/18,6.01%,ABCD2;ABCD1
prerank,KEGG_2021_Human__Protein processing in endoplasmic reticulum,-0.3439883055208866,-0.9366751052720115,0.6571428571428571,1.0,1.0,31/159,20.37%,SELENOS;ERP29;MOGS;SEL1L2;CKAP4;BCAP31;UBXN8;EIF2S1;BAK1;HSPA1A;SEC24A;DDOST;SEC31B;RAD23A;GANAB;STT3A;DERL2;EIF2AK1;BAG2;RNF5;DAD1;HSPBP1;PREB;ERO1B;DNAJB11;UBXN2A;HSPA2;CUL1;YOD1;SSR1;DDIT3
prerank,GO_Biological_Process_2021__oxaloacetate transport (GO:0015729),-0.5932568648262575,-0.9366248646018773,0.6041666666666666,1.0,1.0,1/5,19.13%,SLC25A11
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.6096787943683675,0.9365471658736588,0.5932203389830508,0.797863669453021,1.0,3/7,31.20%,TP53;TGFB1;MAP2K1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.5300606053951946,-0.9364718777468612,0.5576923076923077,1.0,1.0,1/8,2.70%,RNF6
prerank,Reactome_2022__Degradation Of AXIN R-HSA-4641257,-0.39744933315328373,-0.9361048559270848,0.5454545454545454,1.0,1.0,11/49,25.39%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4;PSMA1;PSMD11
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.5390546696037593,0.9357236030682407,0.6190476190476191,0.7993071654127458,1.0,6/15,28.13%,TGFB2;PCSK5;PTCH1;ZNF141;IQCE;FBXW4
prerank,Reactome_2022__Plasma Lipoprotein Assembly R-HSA-8963898,-0.5805575775419863,-0.9356761430677354,0.6153846153846154,1.0,1.0,1/9,4.36%,APOE
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.614532788989248,-0.9356742590484988,0.6346153846153846,1.0,1.0,1/6,4.36%,APOE
prerank,Reactome_2022__Glutamate And Glutamine Metabolism R-HSA-8964539,-0.5138472316821733,-0.9354824047100129,0.625,1.0,1.0,2/10,7.85%,OAT;GLUD1
prerank,Reactome_2022__Attachment Of GPI Anchor To uPAR R-HSA-162791,0.5997498412550849,0.9350628506666755,0.6296296296296297,0.8004437812787729,1.0,2/6,27.47%,PIGK;PLAUR
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.5213117618368097,-0.9349960656999045,0.5531914893617021,1.0,1.0,3/14,14.73%,COQ3;COQ10A;COQ6
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.4130644215469786,0.9348580172266251,0.631578947368421,0.8005953075638181,1.0,13/86,12.22%,RELN;DAB2IP;SHANK3;NRG1;NEUROD2;SNCA;NEURL1;ATP10A;TGFB2;TPPP;SYK;FRMPD4;CAMK2B
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.4657504069911412,0.9347688041486485,0.5245901639344263,0.8005592732805553,1.0,2/38,6.21%,NR4A3;MTFR2
prerank,Reactome_2022__RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,-0.417486715262576,-0.9346366831475424,0.6046511627906976,1.0,1.0,5/44,5.51%,H2AC20;H3-3B;H2BC4;H2BC21;H2AC6
prerank,Reactome_2022__ERKs Are Inactivated R-HSA-202670,-0.5331548252799956,-0.9344660803345382,0.5777777777777777,1.0,1.0,2/10,14.31%,MAPK7;DUSP6
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),-0.516349417137881,-0.9344594786330493,0.4772727272727273,1.0,1.0,3/12,15.22%,NRARP;SEMA5A;THAP1
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.5532956467018857,-0.9342351624610333,0.6,1.0,1.0,1/11,0.04%,ACP3
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.6606141128632887,0.9342022135898741,0.7049180327868853,0.8015983020018927,1.0,3/5,27.16%,GAS6;CXCL12;RAPGEF2
prerank,Reactome_2022__Ion Channel Transport R-HSA-983712,0.3811413634203322,0.9340602675919089,0.6166666666666667,0.8016419666877568,1.0,23/133,12.82%,TRPC3;ATP8B4;ATP2B3;ASIC3;TRPM4;ASIC4;ATP9A;RYR2;BEST3;ANO9;TTYH3;TSC22D3;ATP1B1;ATP10A;CLCN4;ATP1B3;MCOLN2;SLC9C2;TPCN2;CAMK2B;FXYD7;ATP8A2;STOM
prerank,Reactome_2022__Translation Of Structural Proteins R-HSA-9683701,0.46640803998545866,0.9340200454254635,0.6190476190476191,0.8015065214836753,1.0,1/27,0.62%,ST6GAL1
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.5423362909104035,0.933737569793042,0.5833333333333334,0.8018834893086799,1.0,2/15,7.68%,OPALIN;TENM4
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5546953705922657,0.9337148456526737,0.5789473684210527,0.8017563128066071,1.0,1/10,4.89%,WASF1
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.6007398907106754,-0.933547075553508,0.5333333333333333,1.0,1.0,2/5,15.74%,PTPN22;TIRAP
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),0.5772169579790132,0.9334986606961584,0.6,0.8020008860210526,1.0,3/5,33.65%,STX1B;NAPA;STXBP1
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),-0.45924460783146787,-0.9333736911344896,0.5,1.0,1.0,6/18,15.06%,SDSL;PIPOX;HYKK;GCDH;ALDH7A1;SDS
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.4498590988122778,0.9333429985829649,0.5806451612903226,0.8021434968670121,1.0,10/33,21.43%,ROBO2;YAP1;TGFB2;STAT3;TSPAN14;MAML2;ZMIZ1;MESP1;NOTCH4;TSPAN5
prerank,Reactome_2022__Recycling Of Bile Acids And Salts R-HSA-159418,0.5358338391694278,0.933175126182744,0.5833333333333334,0.802275032209573,1.0,5/11,18.74%,SLCO1A2;SLC51A;SLC27A5;RXRA;ABCC3
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.45198761562000417,-0.9328276639895087,0.5526315789473685,1.0,1.0,4/24,9.60%,EXOSC8;EXOSC4;NUDT16L1;EXOSC5
prerank,"Reactome_2022__Defective EXT1 Causes Exostoses 1, TRPS2 And CHDS R-HSA-3656253",-0.5274414813263715,-0.932722144760299,0.6086956521739131,1.0,1.0,3/12,10.93%,HSPG2;SDC3;GPC6
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),-0.4209895958099585,-0.9326918505989239,0.5263157894736842,1.0,1.0,5/28,9.35%,ABCD2;ABCD1;ELOVL4;ACOT2;ELOVL2
prerank,CellMarker_Augmented_2021__AXL+SIGLEC6+ Dendritic cell:Blood,-0.3889351940489722,-0.9326640630846489,0.5,1.0,1.0,2/62,1.04%,ACP3;ATF5
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Blood,0.4682913600017515,0.9323537675601135,0.5964912280701754,0.8036748514283873,1.0,5/25,6.44%,A4GALT;THY1;PTPRC;ZBTB16;CD44
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.5885023228874454,0.932326570455604,0.5882352941176471,0.8035418994448431,1.0,2/5,15.01%,PAG1;CD4
prerank,Reactome_2022__Membrane Trafficking R-HSA-199991,0.3394501224906398,0.9318913552119298,0.6712328767123288,0.804275256784088,1.0,85/516,19.39%,ALS2CL;ANK3;CTSC;YWHAH;TBC1D24;EGF;SH3GL2;SH3GL3;CD55;SYT1;APP;MYH9;TGFA;SH3KBP1;DENND3;DNM1;CLTB;REPS2;SBF1;RAB3IL1;SYNJ2;TPD52;NAA38;LDLR;GRK2;AP1S1;KIF5A;YWHAG;KIF5C;TRIP10;GRIA1;ARPC3;RNASE1;TF;RIN2;DENND4A;PACSIN1;KIF13B;USP6NL;ACTR1A;STX4;TPD52L1;ARF6;TBC1D1;RAB30;SYT12;KLC1;OPTN;COPZ2;KIFC2;VPS37B;GPS1;ANKRD28;RAB27B;MAN1A1;BIN1;PUM1;CD4;CD59;PIP5K1C;TBC1D10B;CTSZ;TBC1D10A;KIAA0319;KIF3C;SPTB;GGA1;DYNC1LI2;EPN1;WNT5A;DCTN1;TFRC;RHOQ;YWHAE;LRP2;TSC2;CLVS2;AP1G2;RAB39A;KDELR3;RAB11A;DNM2;EXOC2;LDLRAP1;KIF19
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),-0.6119384162953392,-0.9317310907200405,0.631578947368421,1.0,1.0,3/5,26.70%,JAM2;EIF2AK3;TNFRSF21
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.5112629279138028,0.9312641897935423,0.5932203389830508,0.8052639544585593,1.0,3/19,13.78%,ARHGEF3;SYNPO2L;LPAR1
prerank,CellMarker_Augmented_2021__Placenta cell:Placenta,-0.4948895778859646,-0.9312241849048479,0.6097560975609756,1.0,1.0,4/16,18.18%,KRT8;NOX1;EFNA2;CGN
prerank,Reactome_2022__Mucopolysaccharidoses R-HSA-2206281,-0.5991623003426011,-0.9311969657963628,0.5641025641025641,1.0,1.0,6/8,38.49%,GALNS;GNS;GUSB;SGSH;ARSB;HGSNAT
prerank,GO_Biological_Process_2021__modulation by symbiont of host autophagy (GO:0075071),0.6465823258725812,0.9311817889801778,0.6538461538461539,0.8052076833721655,1.0,4/5,29.33%,ULK1;ATG7;ATG5;ULK2
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.5642671803849932,-0.9308816442400384,0.6486486486486487,1.0,1.0,2/8,10.83%,SCPEP1;GPR37L1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),-0.5542153298630357,-0.9306890077093433,0.6818181818181818,1.0,1.0,2/6,15.19%,NAGK;GNPDA2
prerank,Reactome_2022__Caspase Activation Via Death Receptors In Presence Of Ligand R-HSA-140534,-0.5206114565901344,-0.9305695999220719,0.5918367346938775,1.0,1.0,2/13,8.20%,TMED7-TICAM2;LY96
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.42484222392509896,0.9302395507028127,0.5384615384615384,0.8067975102317224,1.0,11/57,14.94%,IGF1;ACHE;BAIAP3;SNCA;TMED10;GRK2;SYTL4;TGFB2;ARF6;RAB27B;STX1B
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),-0.4780396818289193,-0.929993903102331,0.5652173913043478,1.0,1.0,2/12,9.35%,ABCD1;ELOVL2
prerank,Reactome_2022__Phosphorylation Of CD3 And TCR Zeta Chains R-HSA-202427,0.5582657244380227,0.9299571768109424,0.543859649122807,0.8071227882656323,1.0,5/9,15.01%,HLA-DRA;PTPRC;PAG1;HLA-DRB1;CD4
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,-0.4256054061377949,-0.9298464568714154,0.5555555555555556,1.0,1.0,7/32,6.16%,DPEP2;GMFG;CD247;PYHIN1;C1ORF162;CD6;P2RY10
prerank,KEGG_2021_Human__Olfactory transduction,0.44368605518734516,0.9297689729808036,0.5753424657534246,0.8072528943252217,1.0,13/39,17.04%,PDE1C;NCALD;PRKG2;OR51M1;PDE1A;GRK2;OR52N2;PDE1B;CAMK2B;SLC8A2;SLC8A1;ADCY3;CALM3
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),-0.556273800359452,-0.9296391123811993,0.5555555555555556,1.0,1.0,2/8,7.58%,XG;S1PR1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.5671190957595682,0.9291231447832238,0.5932203389830508,0.8083083673764954,1.0,3/7,18.02%,MAPT;HEBP2;RNF122
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),0.6125012993944082,0.9290518427253585,0.6666666666666666,0.8082349692755538,1.0,2/5,30.19%,XRCC1;XRCC4
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),-0.45974488565990196,-0.9289716044403765,0.5777777777777777,1.0,1.0,3/26,2.46%,CST3;CSTB;TRIM21
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.423029919434077,0.9287922885281558,0.53125,0.8086446869538283,1.0,4/60,3.34%,CXCL2;SERPINE1;ZFP36;DAB2IP
prerank,CellMarker_Augmented_2021__Neutrophil:Lung,0.45588856487630897,0.9287017428194063,0.5882352941176471,0.8086096617865529,1.0,7/31,4.31%,CTSS;P2RY13;MYO1F;PLEK;NLRP12;LAT2;PTPRC
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.4417509012614196,0.9286874645717347,0.5671641791044776,0.8084457096764398,1.0,12/35,15.01%,CTSS;PLEK;SLA;IL1R1;PTPRC;ITGB8;CD5;ITGAL;IKZF2;HLA-E;GPR183;CD4
prerank,Reactome_2022__Programmed Cell Death R-HSA-5357801,0.37259231255939,0.9286859667400115,0.625,0.8082544068582485,1.0,19/172,13.58%,CDKN2A;YWHAH;LMNB1;SEPTIN4;BIRC3;DCC;DAPK2;CTNNB1;BCL2L1;YWHAG;LMNA;STAT3;BBC3;MAPT;GSDMD;PRKCD;BCL2;TNFRSF10B;FADD
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),-0.40176925202994174,-0.9284222425049374,0.5,1.0,1.0,10/43,25.39%,PSMD10;PSMD12;PSMB5;PSMB6;NQO1;PSME3;PSMD2;PSMB4;PSMA1;PSMD11
prerank,KEGG_2021_Human__Thermogenesis,-0.337637325308359,-0.928326755334566,0.5454545454545454,1.0,1.0,36/176,14.40%,NDUFAF3;UQCRFS1;NDUFS5;COX18;ADCY10;COX7C;NDUFA12;NDUFB4;UQCRB;COA4;CREB3L4;SIRT6;NDUFB1;ATP5PF;COX20;ATP5MC1;NDUFAF4;NDUFC2-KCTD14;UQCRHL;NDUFV3;COX7B;ATP5PB;ATP5PD;CREB3L1;NDUFA8;COX5B;SMARCD1;COX11;ATP5MC3;COX19;NDUFS3;NDUFC1;NRAS;ATP5F1B;COA6;CPT2
prerank,Reactome_2022__Impaired BRCA2 Binding To PALB2 R-HSA-9709603,0.4942477754542452,0.9282434845268633,0.6,0.808833747453572,1.0,4/20,16.11%,BLM;BARD1;MRE11;BRCA1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.4250658679708528,-0.9282295563018063,0.48,1.0,1.0,8/44,11.41%,TRIM29;AR;KRT8;IL20RA;ATP2C2;EHF;RUNX1;B3GNT3
prerank,Reactome_2022__FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.39733073430368804,-0.928023827334793,0.59375,1.0,1.0,10/49,20.20%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;CUL1;PSMB4
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),0.5939133093885266,0.9279086796720714,0.5686274509803921,0.8092784789040689,1.0,2/5,15.46%,PTPRC;TP53
prerank,Reactome_2022__Role Of Phospholipids In Phagocytosis R-HSA-2029485,0.4811312209595004,0.9278790318117072,0.6166666666666667,0.8091528960979295,1.0,6/19,12.29%,ITPR3;PLD2;PRKCE;SYK;PLPP4;PRKCD
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.5251192101234685,0.9278346942537603,0.5666666666666667,0.8090684762138821,1.0,3/10,11.18%,KCNC2;GUCY1A1;GUCY1B1
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.36491615929018084,-0.9278208269104126,0.6060606060606061,1.0,1.0,3/61,0.74%,TRIM29;KCNE1;TMEM229A
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.4801932339314545,-0.9275822563534715,0.525,1.0,1.0,8/21,14.29%,UCP3;SLC36A1;ATP12A;SLC46A1;DMAC2L;ATP1A2;ATP6V1F;ATP5F1B
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.42771122090454683,0.9272422593106375,0.5517241379310345,0.8100032232198702,1.0,3/33,4.92%,PROX1;PLEK;FYN
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),-0.5422736300294824,-0.9272201929225091,0.5714285714285714,1.0,1.0,2/7,13.34%,INTU;COL5A2
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),-0.5530043195705038,-0.9271641022378975,0.5384615384615384,1.0,1.0,4/10,12.96%,NT5E;ADSS2;NUDT2;AMPD3
prerank,Reactome_2022__PI Metabolism R-HSA-1483255,0.4033589964404824,0.9269454259436065,0.5555555555555556,0.8104280853889024,1.0,23/76,21.28%,MTMR7;SBF1;SYNJ2;TNFAIP8L1;PLEKHA2;PIP4K2A;VAC14;INPPL1;INPP5J;PLEKHA4;PLEKHA8;INPP4A;MTM1;BMX;INPP5D;PIP5K1C;INPP5F;MTMR2;MTMR3;TNFAIP8L3;SYNJ1;PNPLA6;MTMR14
prerank,Reactome_2022__ER To Golgi Anterograde Transport R-HSA-199977,0.3826270506800444,0.9268209806368845,0.6212121212121212,0.8104967685644081,1.0,4/120,3.84%,ANK3;CTSC;CD55;TGFA
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),-0.5308727914705345,-0.9268183615900681,0.55,1.0,1.0,1/8,3.77%,CXCL13
prerank,Reactome_2022__Golgi Cisternae Pericentriolar Stack Reorganization R-HSA-162658,0.5564099359923669,0.9267485713241362,0.6379310344827587,0.8104093733868827,1.0,1/13,1.73%,CCNB2
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),0.5629699101823584,0.926745740966596,0.5925925925925926,0.8102262244436904,1.0,2/9,16.96%,RYR2;UBASH3B
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.4000955830415643,0.9266576236709042,0.5540540540540541,0.8101963978514456,1.0,9/70,7.53%,EGF;RASGRP1;CD24;DUSP1;FLT1;DAB2IP;NEK10;DIRAS2;PDGFA
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),0.5418531928942906,0.9265361336009258,0.6346153846153846,0.8101747924657506,1.0,5/7,39.78%,SLC27A1;CD36;ACSL1;RPS6KB1;SLC27A4
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Blood Vessel,-0.394486821092231,-0.9264471347534282,0.5555555555555556,1.0,1.0,13/68,9.82%,CALCRL;SPRY1;FREM1;ADAMTS9;EDNRB;CFTR;CXCL14;ADGRL4;IL33;TDRD10;VWF;TRIL;SPARCL1
prerank,CellMarker_Augmented_2021__Circulating Progenitor cell:Blood,-0.394486821092231,-0.9264471347534282,0.5555555555555556,1.0,1.0,13/68,9.82%,CALCRL;SPRY1;FREM1;ADAMTS9;EDNRB;CFTR;CXCL14;ADGRL4;IL33;TDRD10;VWF;TRIL;SPARCL1
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),0.48378543185687,0.9261607334725516,0.5161290322580645,0.8106947398744463,1.0,4/17,14.38%,MYH11;LAMB1;GAS6;NTN4
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),0.600515758006355,0.9261605281939022,0.6166666666666667,0.8105034931795007,1.0,1/6,4.64%,NFATC2
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.5107761553852728,-0.9259235823010991,0.5348837209302325,1.0,1.0,1/12,1.04%,FAM47E
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),-0.593152707775206,-0.9257034166810382,0.65625,1.0,1.0,4/9,26.04%,WDR76;RFWD3;THOC1;CCAR2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.526588437858962,-0.9255503065921271,0.5333333333333333,1.0,1.0,3/9,17.35%,GREM1;EFNB2;BMP2
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),0.5909591545482848,0.9254437044114024,0.6140350877192983,0.8117065611821654,1.0,3/8,24.32%,TGFB2;SIX4;PTCH1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),0.5190762338480622,0.9254106072164644,0.5263157894736842,0.8115670955448815,1.0,2/13,12.50%,FAP;ANGPTL7
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.5055204952194896,0.9254026979255469,0.5862068965517241,0.8113976383317041,1.0,7/18,26.17%,SOX4;DIP2B;BRCA1;RPS6KA4;RPS6KA5;ARRB1;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),-0.39745551301731347,-0.9253224229865148,0.575,1.0,1.0,8/58,7.99%,SELENOS;TNFAIP3;TRIM21;APOE;NR1D1;MUL1;METRNL;MAPK7
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Synthesis-Dependent Strand Annealing (SDSA) R-HSA-5693554,0.4706017366112273,0.9251673324965938,0.6206896551724138,0.8116407689249039,1.0,4/22,16.11%,BLM;BARD1;MRE11;BRCA1
prerank,CellMarker_Augmented_2021__Extravillous Trophoblast cell:Placenta,0.42927315787077946,0.9250103761862561,0.6060606060606061,0.8117799994596427,1.0,19/55,16.20%,ENPP2;TMEM200A;MAP1LC3A;POSTN;FAP;PID1;MVP;MMP14;VWA5A;ADAM12;LAMA2;ARMCX2;PDPN;OPTN;ARMCX1;SERPING1;PDCD1LG2;EVC2;CD200
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.4067063632732553,0.9249381268170731,0.5357142857142857,0.8117089117765797,1.0,4/32,7.88%,ABCA8;ABCA5;SOAT1;LDLR
prerank,Reactome_2022__Binding And Uptake Of Ligands By Scavenger Receptors R-HSA-2173782,-0.4512833611845583,-0.9249324311966622,0.5652173913043478,1.0,1.0,5/24,5.28%,FTL;STAB2;FTH1;APOE;SCARF1
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.5261298655527085,-0.9247951276537296,0.575,1.0,1.0,7/11,21.42%,NT5E;NT5C;NUDT15;PNP;GPX1;ITPA;NT5C1A
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),-0.5821079667617324,-0.9247658989727258,0.6585365853658537,1.0,1.0,1/7,5.43%,PTPN22
prerank,CellMarker_Augmented_2021__Gastric Stem cell:Gastric Corpus,0.4083918165139864,0.9246931844837866,0.5753424657534246,0.8119982057538879,1.0,15/66,11.98%,ARHGAP39;EPHA2;DAB2IP;ITGA2;AGRN;SCARA3;LAMA5;YAP1;TANC1;DLG5;CMTM4;TEAD1;TNFRSF19;ENAH;PRICKLE2
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),0.44714912414314395,0.924510351087023,0.582089552238806,0.8121918391293812,1.0,6/32,14.53%,BLM;SAMHD1;CDK9;EME2;TRAIP;MRE11
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.6040840059114149,0.9243955426793928,0.6363636363636364,0.8122189352059672,1.0,1/6,8.19%,ASS1
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.5025253623367736,-0.9241092743721241,0.6041666666666666,1.0,1.0,6/14,7.64%,SLC25A5;CHCHD10;MUL1;FZD9;BAK1;HSPA1A
prerank,CellMarker_Augmented_2021__Limbal Stem cell:Corneal Epithelium,0.41873742172679373,0.924037100179283,0.5483870967741935,0.8128025270551205,1.0,10/51,10.90%,C3;ALS2CL;PLD1;LPP;ZNF750;STEAP4;SH2D3A;RIN2;RHBDL2;DUOXA1
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.4661663070048251,-0.9237676348026808,0.5526315789473685,1.0,1.0,7/23,16.77%,PPWD1;PPIC;PPIH;PPIL3;PPIL1;PPIE;FKBP7
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.4531221648546881,0.9235470177515072,0.546875,0.8135740308084043,1.0,8/44,8.04%,IGF1;RASGRP1;RASGEF1A;IRS2;ERBIN;ARHGEF3;MAPRE2;SYNPO2L
prerank,GO_Biological_Process_2021__cellular response to iron ion (GO:0071281),0.5737901458590721,0.9233941411925766,0.6111111111111112,0.8136362297115294,1.0,3/5,20.15%,TF;B2M;BMP6
prerank,GO_Biological_Process_2021__inhibition of cysteine-type endopeptidase activity (GO:0097340),0.6422115194940153,0.9233588441920205,0.6190476190476191,0.813521205572454,1.0,1/5,14.61%,CAST
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),0.4869981736166411,0.9233349943657202,0.6065573770491803,0.8133789813514885,1.0,2/19,7.00%,IGF1;MSX2
prerank,Reactome_2022__GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.4112999767351876,-0.9227798154822645,0.6551724137931034,1.0,1.0,10/47,20.20%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;CUL1;PSMB4
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),0.6111244325060318,0.9226665325909135,0.625,0.8145501663177713,1.0,1/5,12.57%,KLC1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.42599223260349994,0.9226305010193906,0.5671641791044776,0.814429560213126,1.0,8/54,4.66%,RASGRP2;CTSS;CD22;PLEK;NAPSB;WAS;PTPRC;CD37
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),-0.5713510047426379,-0.9225595264544497,0.5897435897435898,1.0,1.0,3/7,32.92%,ACADS;MMAA;MMUT
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),-0.5733536628392761,-0.92244279686806,0.5918367346938775,1.0,1.0,1/7,2.08%,CEL
prerank,CellMarker_Augmented_2021__Hepatocyte:Liver,-0.5568143809121132,-0.9222589348720415,0.5833333333333334,1.0,1.0,1/7,5.27%,KRT8
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.4051343510973795,-0.9220057431182737,0.5675675675675675,1.0,1.0,2/59,0.21%,NGF;G0S2
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),-0.6026159215535093,-0.9219348476996532,0.6888888888888889,1.0,1.0,1/5,3.36%,FBLN5
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.5356782741592561,0.9219117483087411,0.6037735849056604,0.8157225052911851,1.0,2/13,7.18%,BLM;RYR2
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),0.6001919810986049,0.9217536913679459,0.6545454545454545,0.8158984718047502,1.0,3/6,27.17%,SLC29A4;SLC29A1;SLC22A3
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),-0.6244075065651334,-0.9213092055666712,0.6,1.0,1.0,2/5,22.16%,AQP4;AQP1
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",-0.5936201164625048,-0.9212989650569161,0.6122448979591837,1.0,1.0,1/7,15.45%,GNGT1
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.5728260651478866,0.9212450377590349,0.603448275862069,0.8167358543782829,1.0,3/9,15.22%,CD55;SERPING1;CD59
prerank,Reactome_2022__Kinesins R-HSA-983189,-0.40229118787345575,-0.92116703934982,0.625,1.0,1.0,6/32,10.18%,KIF21B;KIF6;KIF4A;KIF20B;KIF15;KLC3
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.3739364431466029,-0.9211371933228799,0.575,1.0,1.0,8/63,8.80%,RITA1;NRARP;ENHO;BEND6;POFUT1;MAML3;METTL3;HEY1
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),0.5982453423973103,0.9211084412229473,0.6078431372549019,0.816783586173384,1.0,1/8,10.68%,LRMDA
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.6178528478870304,0.9209260331708303,0.6363636363636364,0.8169646215646226,1.0,2/5,20.96%,SMAD2;ACVR1B
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.47629948726424587,0.9208885854243585,0.6551724137931034,0.8168572201489377,1.0,6/24,18.15%,SLC4A10;SLC4A9;SLC4A11;SLC12A5;FHL1;SLC30A3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),0.5750541711258135,0.9207909674374885,0.62,0.8168423376424807,1.0,3/8,10.24%,LRRC55;ATP1B1;ATP1B3
prerank,CellMarker_Augmented_2021__Basal Progenitor cell:Breast,-0.43732255435063466,-0.9207506690323962,0.5172413793103449,1.0,1.0,8/29,11.41%,TRIM29;KRT8;IL20RA;S100A16;SCEL;ATP2C2;EHF;B3GNT3
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),-0.5896773205247647,-0.9206628663797113,0.6111111111111112,1.0,1.0,1/6,5.08%,MSRB1
prerank,Reactome_2022__Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.41179891953006187,-0.9206308921527218,0.5925925925925926,1.0,1.0,8/44,16.21%,STX16;ARFIP2;GOLGA1;PLIN3;RABEPK;COG6;NAPSA;GCC1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.4855108803709776,0.9205882645079452,0.5932203389830508,0.8171374308633939,1.0,5/14,18.32%,KCNMB4;CPLX2;CPLX1;MCTP1;CAMK2A
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),-0.4556063176392094,-0.9205088157432328,0.6046511627906976,1.0,1.0,5/18,21.31%,CNOT1;WNT9B;TAF5L;WDR43;TAF6L
prerank,Reactome_2022__Beta-oxidation Of pristanoyl-CoA R-HSA-389887,-0.547646658075178,-0.9203797326997678,0.525,1.0,1.0,1/8,5.93%,ACOXL
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.5633679962903712,0.9203012212480712,0.6333333333333333,0.8174921901738912,1.0,1/10,2.71%,IGF2BP2
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.5801057300045737,0.920250888034566,0.5370370370370371,0.8174065077814887,1.0,1/7,6.17%,CIITA
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.5881420392060477,-0.9201613588559315,0.6136363636363636,1.0,1.0,1/5,5.43%,PTPN22
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.4518274232603093,-0.9199437424565635,0.5652173913043478,1.0,1.0,6/32,8.69%,TNFAIP3;TRIM21;MUL1;CR1;FAM3A;METTL3
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),-0.4899165811818507,-0.9197946109717752,0.6363636363636364,1.0,1.0,2/9,15.06%,SDSL;SDS
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),0.5052294796423645,0.9196286290374721,0.5254237288135594,0.8184430328018023,1.0,5/14,17.11%,PID1;HDAC4;FBP1;MLXIPL;NCOR1
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.5800641410440646,0.9195687925063212,0.5714285714285714,0.8181572776757495,1.0,1/6,9.35%,PPARG
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.5800641410440646,0.9195687925063212,0.5714285714285714,0.8181572776757495,1.0,1/6,9.35%,PPARG
prerank,Reactome_2022__Phospholipase C-mediated Cascade; FGFR3 R-HSA-5654227,0.568793045436516,0.9195509506910872,0.5535714285714286,0.8179819180880848,1.0,1/6,11.20%,FGF13
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.5492540757384555,-0.9194138431162131,0.5833333333333334,1.0,1.0,1/8,5.15%,ZNF593
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.3208819332931686,-0.9193027960288704,0.6521739130434783,1.0,1.0,38/231,20.23%,AR;OTUD3;TNFAIP3;COPS8;CFTR;MCRS1;IL33;KDM1B;ABRAXAS1;COPS7A;BECN1;USP27X;RAD23A;USP51;PSMD10;FOXO4;PSMD12;USP19;PSMB5;TADA2B;CLSPN;PSMB6;USP9Y;RUVBL1;PSME3;TNIP1;BRCC3;ESR1;NFRKB;PSMD2;TADA3;USP18;UBB;YOD1;SKP2;USP10;PSMB4;COPS3
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.5615843446916998,-0.9186887610200565,0.5714285714285714,1.0,1.0,1/11,3.42%,CEP19
prerank,CellMarker_Augmented_2021__Lymphocyte:Blood,0.463735809650067,0.9186317445549331,0.6491228070175439,0.8196389731343466,1.0,7/37,14.71%,TLR2;CTSS;SAMHD1;OSTF1;B2M;TNFAIP6;HLA-E
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.5154566582285486,0.9186280582688346,0.5833333333333334,0.8194497790876414,1.0,8/11,35.37%,TGFB2;WNT5A;TGFB3;TGFB1;SIRT1;PLCG2;CD74;IRAK3
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.5964150458824912,0.9186240095707621,0.6595744680851063,0.8192606736149278,1.0,1/5,4.31%,PTPRC
prerank,KEGG_2021_Human__Oocyte meiosis,0.40372686650980555,0.9185491782434968,0.6323529411764706,0.8192317036420131,1.0,26/102,18.32%,IGF1;YWHAH;CCNB2;ADCY5;RPS6KA1;ITPR3;PGR;ADCY7;ADCY2;YWHAG;STAG3;PPP1CB;CAMK2B;SPDYE1;RPS6KA6;CPEB2;MAPK11;CDK2;ADCY3;CALM3;IGF1R;CCNB1;YWHAE;ITPR1;SKP1;CAMK2A
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.4565114627661328,0.9184719569924854,0.6527777777777778,0.8191810510164778,1.0,8/41,15.23%,ABCA8;FA2H;ASS1;CERS3;CYP4F22;PAM;SGMS1;CERS5
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.5555937837782823,-0.9177975904503056,0.5609756097560976,1.0,1.0,1/7,1.34%,HEY2
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),0.6010627294576919,0.9173531427807952,0.6875,0.8211205836196293,1.0,3/6,34.14%,MTA1;SASH1;TAF1
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.4742497068636715,0.917232166694987,0.625,0.8211671002206803,1.0,6/31,12.29%,APOD;ZIC1;BAG3;SMAD3;CABP1;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.5660179858328732,0.9171759585840293,0.6538461538461539,0.8210618281348179,1.0,6/8,34.66%,RARA;TNFSF4;IL18;CD81;PRKCZ;CD74
prerank,CellMarker_Augmented_2021__Thymic Emigrant cell:Blood,0.4709845978058533,0.9171604839365504,0.6176470588235294,0.8209024154578041,1.0,6/28,4.66%,CTSS;MYO1F;PLEK;SLA;PTPRC;CD37
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.45567038733080756,0.917000664756711,0.59375,0.8210031275745072,1.0,4/27,5.78%,CORO7;WAS;WASF1;FAM107A
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),0.5377853055245421,0.9168462227922548,0.546875,0.8210740021630685,1.0,2/11,10.10%,MICALL1;PACSIN1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.47290616698510735,0.916786484906621,0.5686274509803921,0.8210121716518134,1.0,3/22,10.25%,SLC4A10;SLC4A9;SLC4A11
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),-0.4386732194744326,-0.9167250227338155,0.5789473684210527,1.0,1.0,5/24,11.63%,ABCB11;OSBPL3;GBA2;CYP46A1;CYP7B1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),0.562906807788569,0.9166547244403309,0.5517241379310345,0.821077597106193,1.0,4/7,38.08%,RAB7A;MAPK3;MAPK1;TRIM27
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),0.39455782214847146,0.9166015043110305,0.5714285714285714,0.8209887313555078,1.0,8/66,15.37%,TLR2;IRF7;MYD88;CTNNB1;CGAS;MRE11;IFIH1;STAT6
prerank,KEGG_2021_Human__Mucin type O-glycan biosynthesis,0.4765811639374197,0.9164692063445834,0.6,0.8211055399524757,1.0,8/28,16.38%,GALNT12;GALNTL6;GALNT8;GALNT17;GALNT16;B4GALT5;ST6GALNAC2;ST6GALNAC3
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.5154518423158662,0.9163809923824402,0.639344262295082,0.8210708104402437,1.0,5/16,15.46%,DAB2IP;NLRC3;B4GALT7;TRIM32;TP53
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),0.4325806971349315,0.9163185652044906,0.582089552238806,0.8209928262067171,1.0,4/37,9.07%,ALS2CL;DNM1;HOOK1;PLEKHF1
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),0.5503487581105906,0.9161938437293119,0.6065573770491803,0.8210635874711,1.0,2/10,7.88%,MFSD2A;LDLR
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),0.527554155358375,0.9161576738126428,0.6440677966101694,0.8209342810356087,1.0,1/8,3.82%,CBLN2
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.5368363548060754,-0.9161213498363752,0.5686274509803921,1.0,1.0,2/6,15.16%,SLC6A13;MT3
prerank,Reactome_2022__Transport Of Nucleosides And Free Purine And Pyrimidine Bases Across Plasma Membrane R-HSA-83936,-0.5138155991186902,-0.9158987996915737,0.6086956521739131,1.0,1.0,2/11,5.98%,SLC25A5;SLC25A4
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),0.4528280036720573,0.9156653775275312,0.5970149253731343,0.8217887599318021,1.0,1/31,0.29%,ANLN
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.48325757720504436,-0.9156413550443546,0.5853658536585366,1.0,1.0,5/12,24.14%,SLC25A4;SLC25A24;SLC19A1;SLC25A17;ABCC6
prerank,Reactome_2022__Signaling By Hippo R-HSA-2028269,0.5013499209024699,0.9152398434284919,0.6451612903225806,0.8224401971189095,1.0,8/20,22.15%,YAP1;WWTR1;YWHAE;STK24;TJP2;AMOTL1;AMOTL2;TJP1
prerank,CellMarker_Augmented_2021__Leydig cell:Fetal Gonad,-0.314259233658803,-0.9151237151787714,0.8421052631578947,1.0,1.0,44/327,12.47%,C1ORF53;RITA1;DCXR;DIRAS3;LAMA4;ACTR3B;CCDC86;CPED1;CFAP97;CD320;APOE;POP5;COA4;RPL12;MRPL15;MRPS16;AGL;ALAS1;MPC2;RPS26;RPL6;TIMM13;PLAGL1;CXCR4;MRPS9;SLC31A2;RPL29;PRSS23;NOL8;RIOK1;RPL14;CCDC124;PTDSS1;TIMM23;RPS2;BICC1;ETFB;DNAJC30;POLR3B;CASK;P3H1;SLC39A8;RABEPK;ZCCHC9
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.5238782270134172,0.9150494817308091,0.5918367346938775,0.8225672820320462,1.0,3/11,9.86%,PROX1;TBX20;TGFB2
prerank,Reactome_2022__RA Biosynthesis Pathway R-HSA-5365859,-0.5182326596463003,-0.9149317803957135,0.6304347826086957,1.0,1.0,5/10,12.90%,ALDH1A1;AKR1C3;RDH14;RDH10;RDH11
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.5817538578082572,-0.91471887529105,0.5918367346938775,1.0,1.0,1/5,4.01%,RABL3
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.39933750918806205,0.9144884238477229,0.6307692307692307,0.8234801975439769,1.0,12/90,15.53%,FBLIM1;DAB2IP;SEPTIN8;NRG1;GFAP;TPPP;SYK;TMC8;NCLN;LCMT1;STX1B;PINK1
prerank,GO_Biological_Process_2021__heart process (GO:0003015),0.5499653144927241,0.9143951521012017,0.5932203389830508,0.823488179975141,1.0,4/10,18.79%,FYN;RAMP3;NOX4;SGCG
prerank,Reactome_2022__PD-1 Signaling R-HSA-389948,0.5685799302192776,0.9141122428594143,0.5357142857142857,0.8239010678519303,1.0,4/8,15.13%,HLA-DRA;HLA-DRB1;CD4;PDCD1LG2
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),-0.5475410751839632,-0.9140636806896099,0.5128205128205128,1.0,1.0,1/11,0.81%,AR
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.42202488430378526,-0.9140338970962915,0.575,1.0,1.0,10/34,13.27%,RIOK2;RPS28;DDX52;SNU13;RIOK1;DCAF13;RRP36;LOC102724159;SRFBP1;NGDN
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.43834925497931937,-0.9138527669865215,0.5588235294117647,1.0,1.0,7/25,24.64%,SF3B4;PRPF8;PRPF3;LSM1;MPHOSPH10;SCAF11;SRRM1
prerank,KEGG_2021_Human__Diabetic cardiomyopathy,-0.3471808822303125,-0.9137148726679709,0.6666666666666666,1.0,1.0,29/144,13.26%,SLC25A5;UQCRFS1;NDUFS5;AGER;PLCB4;COX7C;NDUFA12;NDUFB4;UQCRB;NDUFB1;ATP5PF;SLC25A4;MPC2;VDAC2;ATP5MC1;NDUFC2-KCTD14;UQCRHL;TBC1D4;NDUFV3;COX7B;ATP5PB;ATP5PD;NDUFA8;COX5B;PDHA1;MPC1;ATP5MC3;NDUFS3;NDUFC1
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Liver,0.4615446459412347,0.9136377936757798,0.6129032258064516,0.8244213773838209,1.0,6/26,4.31%,CTSS;MYO1F;PLEK;WAS;LAT2;PTPRC
prerank,CellMarker_Augmented_2021__Myeloid-derived Suppressor cell:Blood,0.4615446459412347,0.9136377936757798,0.6129032258064516,0.8244213773838209,1.0,6/26,4.31%,CTSS;MYO1F;PLEK;WAS;LAT2;PTPRC
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),-0.5712715543577125,-0.9133787878582299,0.5918367346938775,1.0,1.0,1/6,7.26%,RAB5IF
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.49099519655335844,0.9130921477257014,0.639344262295082,0.825297731511428,1.0,1/16,0.81%,TLR2
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.5518527165424653,0.9129277542328986,0.58,0.8254212477115728,1.0,4/7,29.94%,PPARG;NCOR1;NCOR2;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.5559161066451893,0.9123881667249735,0.6296296296296297,0.8263535829078448,1.0,4/8,22.33%,PTPRC;KLF4;MAP2K5;SH2B3
prerank,Reactome_2022__Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.41002569729673133,-0.912307344156593,0.5641025641025641,1.0,1.0,13/34,21.52%,RFC3;ATRIP;HUS1;BRIP1;RAD9B;RMI2;POLR1B;DNA2;SEM1;RAD51;RAD17;XRCC2;BRCA2
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.537836682587332,-0.912169955699163,0.5869565217391305,1.0,1.0,1/12,2.37%,DNMT3B
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.46104928622294256,-0.9119676757319976,0.5428571428571428,1.0,1.0,2/28,1.74%,AR;VAMP8
prerank,Reactome_2022__UCH Proteinases R-HSA-5689603,0.4045906405618677,0.9118573834006638,0.5384615384615384,0.8271453118128387,1.0,1/75,0.06%,TGFBR2
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.4836151865839411,0.9117860833950374,0.6153846153846154,0.8270796622132133,1.0,4/21,13.49%,HMBOX1;PDGFA;CDKN1A;FGF2
prerank,CellMarker_Augmented_2021__Epithelial Hair Follicle Stem cell:Hair Follicle,-0.40025577223338027,-0.9114864118415233,0.46875,1.0,1.0,8/35,11.41%,TRIM29;KRT8;IL20RA;S100A16;SCEL;ATP2C2;EHF;B3GNT3
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),0.4951054774330979,0.9112768852342448,0.5714285714285714,0.8279705461275401,1.0,4/15,11.62%,FABP3;MFSD2A;PPARG;SLC27A3
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.5669332286065505,0.9107005746326762,0.5714285714285714,0.8286953679597777,1.0,1/6,8.21%,THOC6
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.5669332286065505,0.9107005746326762,0.5714285714285714,0.8286953679597777,1.0,1/6,8.21%,THOC6
prerank,Reactome_2022__Polymerase Switching On C-strand Of Telomere R-HSA-174411,-0.4462582054375074,-0.9106277597467006,0.5555555555555556,1.0,1.0,3/22,5.09%,RFC3;DSCC1;POLD3
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.5371910197365369,-0.9105998966442669,0.6744186046511628,1.0,1.0,1/9,1.00%,MADCAM1
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.4063355333387915,0.9104271442838835,0.5970149253731343,0.8290790663008671,1.0,13/63,10.30%,GRIN3A;CDH23;TRPC3;CACNG3;TUSC3;FYN;CACNA1C;CACNG8;RYR2;RAMP3;CACNA1E;NIPAL2;NIPAL3
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.44379091422707856,0.9103781313846464,0.5084745762711864,0.8289834332589047,1.0,5/31,12.70%,LIPH;FABP3;PLAAT3;DGAT1;SLC27A5
prerank,Reactome_2022__Mitotic Prophase R-HSA-68875,-0.3573922643207886,-0.9102773506270678,0.6363636363636364,1.0,1.0,9/87,8.06%,H2AC20;H3-3B;H2BC4;H2BC21;AAAS;NUP50;H2AC6;BLZF1;KMT5A
prerank,Reactome_2022__Defective HDR Thru Homologous Recombination (HRR) Due To BRCA1 Loss-Of-Function R-HSA-9701192,0.4709874728172524,0.9102332512147057,0.6727272727272727,0.8290466281820634,1.0,4/21,16.11%,BLM;BARD1;MRE11;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.5114662900991974,0.9102196137620763,0.639344262295082,0.8289026158713911,1.0,1/12,4.31%,PTPRC
prerank,KEGG_2021_Human__Phosphonate and phosphinate metabolism,-0.6004046298188062,-0.9099797712414917,0.6585365853658537,1.0,1.0,4/6,36.31%,CHPT1;PCYT1A;SELENOI;CEPT1
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.5732404704721363,0.9098612589708013,0.5714285714285714,0.8294284798055376,1.0,3/6,15.19%,CDK6;STAT3;EIF2B5
prerank,CellMarker_Augmented_2021__Pluripotent Very Small Embryonic-Like cell:Ovary,0.4483459722895814,0.9098317373969352,0.6206896551724138,0.8293032713395493,1.0,12/33,20.33%,CD24;UNC5D;CHST6;COL9A1;NR6A1;CHST4;GDPD2;PLEKHG4B;TOX3;B3GALT5;CXADR;LRRK1
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.568511932190898,0.9096759817470967,0.5849056603773585,0.8293959096815071,1.0,4/7,29.33%,ULK1;ATG7;ATG5;ULK2
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.47579130074721004,0.9091596759896086,0.5555555555555556,0.8302358041059413,1.0,5/26,18.73%,SMAD3;SMAD1;ZC3H7B;PUM1;SMAD2
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.5041751976824228,-0.9091167258450917,0.5348837209302325,1.0,1.0,1/12,1.49%,RIOK2
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.5178513933018276,0.9090151258044838,0.5454545454545454,0.8303147457616644,1.0,1/11,2.53%,CD55
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.3771651400188279,0.9089229695762486,0.6885245901639344,0.8303022969047287,1.0,20/107,17.85%,SLC39A14;IRS2;FOXO1;RAB15;BAIAP2;PPARG;NAMPT;ZDHHC7;SORBS1;HDAC9;PDK4;CPEB2;GAB1;BCAR1;SH2B2;SYAP1;LPIN3;SHC1;IGF1R;RHOQ
prerank,"Reactome_2022__TICAM1,TRAF6-dependent Induction Of TAK1 Complex R-HSA-9014325",0.5234995719971692,0.9089049968656439,0.6458333333333334,0.830142109673898,1.0,5/11,26.96%,TAB1;TLR3;RPS27A;TAB2;MAP3K7
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),-0.5561300482846596,-0.9088756272280494,0.6470588235294118,1.0,1.0,4/10,17.29%,METTL3;PRELID1;IKZF3;ZFP36L2
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.5265771547275606,0.908767962493668,0.5789473684210527,0.8301995330887079,1.0,3/13,18.35%,AK3;AK5;SMPDL3A
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.5663085403800141,0.908616548893048,0.5862068965517241,0.8302864650393954,1.0,2/8,24.91%,PINK1;DYRK1A
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.458907516442209,0.908382200557874,0.532258064516129,0.8305693172566359,1.0,5/24,23.03%,DUSP16;XPO6;SMURF1;XPO5;CCHCR1
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),-0.5634206077037887,-0.908259017811806,0.6595744680851063,1.0,1.0,1/7,8.29%,GAS1
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.6031799131775031,0.9081385998130476,0.6078431372549019,0.8309567054966,1.0,4/5,30.53%,CAV3;FLOT1;EMP2;PACSIN2
prerank,Reactome_2022__P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.35744051201131377,-0.908043875018487,0.6,1.0,1.0,1/86,0.09%,NGF
prerank,CellMarker_Augmented_2021__Stromal cell:Adipose Tissue,0.5614448095847102,0.907840783503415,0.6610169491525424,0.8313787953150468,1.0,2/5,6.44%,THY1;CD44
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.4507248957907529,0.9078278646287623,0.6515151515151515,0.8312051687476495,1.0,11/31,23.29%,NELL1;ZBTB16;PKDCC;TGFB2;P2RX7;SLC8A1;WNT5A;BMP6;ANO6;PTPN11;ACVR1
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),-0.4395094166355503,-0.9076395716990071,0.5121951219512195,1.0,1.0,10/31,24.68%,FIP1L1;CPSF1;CLP1;CPSF3;LSM10;CSTF2;SSU72;CSTF2T;CPSF7;SLBP
prerank,Reactome_2022__Cellular Response To Chemical Stress R-HSA-9711123,-0.34161380983668943,-0.9076378100564805,0.6071428571428571,1.0,1.0,39/149,20.83%,SOD3;COX18;TRIM21;PRDX1;LRPPRC;COX7C;COX20;MUL1;BLVRA;BRIP1;COX7B;GPX7;NUDT2;COX5B;PHGDH;PSMD10;PSMD12;COX19;PSMB5;TACO1;TXN2;PSMB6;AKT2;GSTP1;NQO1;HM13;PSME3;SEM1;IDH1;PSMD2;GPX2;SESN2;PRDX3;UBB;CUL1;SKP2;PSMB4;GPX1;UBL4A
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.58449399851378,0.9073054362561014,0.6296296296296297,0.8321017031973308,1.0,2/6,23.14%,SMURF1;FCHO2
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),-0.41701149104671376,-0.9072699758331014,0.6486486486486487,1.0,1.0,3/17,5.13%,TPX2;ANKRD53;RAE1
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.43270457583958355,0.9072100901966997,0.5535714285714286,0.8320915481830812,1.0,8/41,13.20%,ZFP36;PIM1;TRPM4;ZBTB16;VSTM2A;PPARG;WDFY2;SOX13
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.5941104744427017,0.9070281304972464,0.6491228070175439,0.8320203313653627,1.0,3/6,25.83%,HLA-E;HLA-F;HLA-A
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.5941104744427017,0.9070281304972464,0.6491228070175439,0.8320203313653627,1.0,3/6,25.83%,HLA-E;HLA-F;HLA-A
prerank,Reactome_2022__eNOS Activation R-HSA-203615,-0.5325334471578744,-0.906924072321726,0.6222222222222222,1.0,1.0,2/8,23.30%,TACR1;CALM1
prerank,Reactome_2022__Resolution Of D-loop Structures Thru Holliday Junction Intermediates R-HSA-5693568,0.47131984634133345,0.906821908461841,0.6181818181818182,0.8320884783676983,1.0,5/27,16.11%,BLM;EME2;BARD1;MRE11;BRCA1
prerank,Reactome_2022__Resolution Of D-Loop Structures R-HSA-5693537,0.47131984634133345,0.906821908461841,0.6181818181818182,0.8320884783676983,1.0,5/27,16.11%,BLM;EME2;BARD1;MRE11;BRCA1
prerank,CellMarker_Augmented_2021__Endothelial cell:Plasma,-0.4007057007318724,-0.9067159665721275,0.7333333333333333,1.0,1.0,5/33,6.37%,DPEP2;GMFG;C1ORF162;PRAM1;CR1
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.5058250653875115,0.9066377929503879,0.640625,0.8322202821292483,1.0,6/13,20.41%,MYLK3;PLSCR1;TNFSF4;F3;IL6R;ANO6
prerank,Reactome_2022__CDC6 Association With ORC:origin Complex R-HSA-68689,-0.5650697103957396,-0.906542135346481,0.5714285714285714,1.0,1.0,4/5,30.86%,SLC25A15;ORC6;ORC3;ORC5
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.613726087408415,0.9065072969407417,0.6170212765957447,0.8322797306128519,1.0,2/5,15.19%,CDK6;EIF2B5
prerank,Reactome_2022__Infectious Disease R-HSA-5663205,0.32563680688298213,0.9063086855679255,0.8333333333333334,0.8325051226257152,1.0,60/750,10.48%,GGT5;C3;ST6GAL1;TLR2;YWHAH;KCNH8;GNG3;PLK2;SH3GL2;ELMO1;PCSK2;SH3GL3;ZDHHC9;SYT1;ADCY5;WAS;SFTPD;IRAK2;IRF7;NOD1;MYH9;NLRP12;IL1R1;SV2B;SH3KBP1;TUSC3;PRKAR1B;WASF1;FYN;GIPR;RXFP1;GNG2;DUSP16;BAIAP2;CHD3;ITPR3;AGRN;CDK9;ADCY7;ADCY2;PML;RAMP3;GLP1R;CTNNB1;AP1S1;MGAT5;YWHAG;RPL39L;KPNA7;TBL1X;ARPC3;IKBKE;ATP1B1;RPL3;CHMP1A;RNASE1;GNAZ;ATP1B3;SYK;NOXA1
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.40134711698189335,-0.9062600640383247,0.5588235294117647,1.0,1.0,9/46,8.15%,DPEP2;GMFG;CD247;CD96;PYHIN1;CD6;P2RY10;CXCR4;HSD11B1
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.4158734584558308,0.9062288910941866,0.5901639344262295,0.8324279848890667,1.0,6/50,7.78%,PROX1;ZFP36;PLSCR1;TRIM5;PML;APOBEC3H
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5389274105835178,0.9060924357132725,0.6029411764705882,0.8324873442572015,1.0,2/14,9.86%,STK25;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.6231213976330329,0.9060542237396186,0.6363636363636364,0.832151319085372,1.0,2/6,12.89%,MBP;KLF4
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.6231213976330329,0.9060542237396186,0.6363636363636364,0.832151319085372,1.0,2/6,12.89%,MBP;KLF4
prerank,CellMarker_Augmented_2021__Pluripotent Stem cell:Undefined,0.5443202459796269,0.9057414200772775,0.676923076923077,0.8326304978153674,1.0,4/10,28.19%,PODXL;KLF4;PECAM1;EPCAM
prerank,Reactome_2022__Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,-0.473983250049877,-0.9057182174785259,0.5853658536585366,1.0,1.0,1/15,1.01%,FLT3
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),-0.5434363783797564,-0.9056873179245863,0.5681818181818182,1.0,1.0,1/6,8.77%,VPS11
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.5098248776425266,0.9056829796704411,0.6818181818181818,0.8325293608897407,1.0,1/18,1.34%,SGPP2
prerank,Reactome_2022__Cytoprotection By HMOX1 R-HSA-9707564,-0.38903004191170115,-0.9056773958226961,0.6111111111111112,1.0,1.0,8/48,10.43%,COX18;LRPPRC;COX7C;COX20;BLVRA;BRIP1;COX7B;COX5B
prerank,Reactome_2022__Generic Transcription Pathway R-HSA-212436,0.32436984118349754,0.9054199398142561,0.7764705882352941,0.8328425283728083,1.0,80/975,12.89%,LEF1;NPY;CDKN2A;NR4A3;MOBP;TEAD2;SOCS3;ABCA6;GRIN2A;YWHAH;PLK2;THBS1;SERPINE1;GRIN2B;NR4A1;BLM;STEAP3;TRPC3;LMO2;PRKCB;FOXO1;ZNF140;TGFA;GAD2;ZNF282;PPARGC1B;NFATC2;NUAK1;BCL6;CHD3;ZNF704;ZNF114;ZNF750;PGR;LDB2;CDK9;FOXO3;MSX2;CASP10;MAMLD1;PML;CDK6;CTNNB1;YWHAG;FKBP5;TBL1X;SMAD3;NR1I3;YAP1;PDZD2;PPARG;HDAC4;ZNF597;FBXO32;NDRG1;GLI2;PIP4K2A;GPRIN1;TP53I3;SMAD1;BBC3;TEAD1;NR6A1;HDAC9;NR4A2;BARD1;PRR5;GADD45A;ITGAL;CDC7;PMS2;PLXNA4;CAMK2B;ZNF552;CDKN1B;HIPK1;ZNF667;MAPKAPK5;TFAP2C;KLF4
prerank,Reactome_2022__Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.38390687600859075,-0.9052561364710843,0.6341463414634146,1.0,1.0,3/33,12.49%,AAAS;NUP50;NUP54
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.46318821483424444,0.9051511579082565,0.6166666666666667,0.8332089917660073,1.0,8/27,17.91%,DUSP10;MAPK8IP1;HIPK3;PER1;PINK1;GPS2;NCOR1;MECOM
prerank,Reactome_2022__Microbial Modulation Of RIPK1-mediated Regulated Necrosis R-HSA-9686347,-0.5739462497720461,-0.9049840805649205,0.5510204081632653,1.0,1.0,2/5,28.82%,RRM1;CASP8
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.43384922700598855,0.9049519415956802,0.5789473684210527,0.8333669171320246,1.0,10/33,24.62%,MAP1LC3A;ATG9A;PINK1;CTSK;GABARAPL1;WDR45;ULK1;ATG7;PRKN;GABARAPL2
prerank,CellMarker_Augmented_2021__Specialist Antigen Presenting cell:Undefined,0.46988659714817327,0.9049488624563664,0.6166666666666667,0.8331802386716973,1.0,5/20,11.83%,TLR2;SIGLEC1;PTPRC;CD83;CD5
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Small Intestine,0.46322306260596224,0.9049083834814424,0.6333333333333333,0.8330523899163572,1.0,4/25,6.30%,PCDH8;TRPC3;GFRA2;ZNF608
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.4388103728414678,-0.9048622689217346,0.6388888888888888,1.0,1.0,6/25,14.39%,TPT1;FBXO5;SFRP2;YJU2;PSMD10;CLU
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),-0.5396391819328853,-0.9048007895590843,0.6052631578947368,1.0,1.0,1/7,3.77%,CXCL13
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),-0.5396391819328853,-0.9048007895590843,0.6052631578947368,1.0,1.0,1/7,3.77%,CXCL13
prerank,Reactome_2022__Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.3749606944654215,-0.9044703240753578,0.6111111111111112,1.0,1.0,12/46,25.39%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4;CDK4;PSMA1;PSMD11
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.523225733296439,0.9043027597384726,0.6612903225806451,0.8339950908522888,1.0,2/10,7.85%,TJP3;RAP2B
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.4334152633585037,0.904125206202754,0.6333333333333333,0.8341660344540254,1.0,12/44,18.23%,CCDC3;BIRC3;TNFRSF1A;SYK;GAS6;HIPK1;FADD;TRAIP;IKBKG;RFFL;GPS2;ADAM17
prerank,Reactome_2022__Estrogen-dependent Gene Expression R-HSA-9018519,-0.3868111583422965,-0.9041155338296075,0.5,1.0,1.0,14/90,13.25%,H2AC20;KPNA2;H3-3B;H2BC4;H2BC21;POLR2K;H2AC6;GTF2A2;USF1;POLR2C;RUNX1;EBAG9;CCNT1;GTF2F1
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.5283059441988812,-0.9040155867597499,0.6153846153846154,1.0,1.0,4/9,14.39%,APOE;PFDN4;VBP1;CLU
prerank,KEGG_2021_Human__Nitrogen metabolism,-0.5167235756633305,-0.9037979563427111,0.5681818181818182,1.0,1.0,5/11,26.93%,GLUD1;CA5A;CA3;GLUL;CA2
prerank,Reactome_2022__TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,0.3792835546453811,0.9034827700032464,0.6060606060606061,0.8351667481307532,1.0,7/88,7.62%,KCNH8;IRAK2;APP;RPS6KA1;NOD1;NLRC5;MYD88
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),-0.5641065574013077,-0.9034452151610697,0.5681818181818182,1.0,1.0,2/5,13.49%,BECN1;ATG14
prerank,Reactome_2022__Signaling By Hedgehog R-HSA-5358351,0.3634675264877859,0.9034032225821288,0.6811594202898551,0.835115923466456,1.0,28/124,24.61%,ADCY5;PRKAR1B;NOTUM;ADCY7;ADCY2;BOC;GRK2;GLI2;IFT122;SYVN1;PRKAR1A;EVC2;SMURF1;IFT140;SKP1;ADAM17;PRKCA;RPS27A;KIF7;ADCY9;ADCY8;PRKAR2B;GLI1;CUL3;PSMB3;ARRB1;PTCH1;SUFU
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),-0.46338067310736475,-0.9031685807474628,0.5675675675675675,1.0,1.0,5/14,8.25%,TNFAIP3;FGL1;FOXJ1;PTPN22;MICA
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.34954370908557253,-0.9031409312802736,0.6666666666666666,1.0,1.0,41/155,20.06%,PTCD2;ATAD3C;TFB2M;MSTO1;TIMM8B;HAX1;MGME1;ALAS1;SLC25A4;CHCHD10;MUL1;AIP;TIMM13;BCAP31;RAB5IF;MTFR1L;POLG2;TIMM23;SAMM50;YME1L1;TSPO;ATP5F1B;TIMM50;TIMM10;SLC25A33;CHCHD2;ESRRA;TFB1M;TMEM11;OXA1L;MTFR1;AFG3L2;MTERF1;TRAK2;MIEF1;TMEM70;PRDX3;DNM1L;AFG1L;DNAJC19;FIS1
prerank,Reactome_2022__Metabolism Of Porphyrins R-HSA-189445,-0.46337774117151204,-0.9030671235566337,0.6190476190476191,1.0,1.0,4/19,11.79%,ALAS1;BLVRA;HMBS;FECH
prerank,KEGG_2021_Human__Maturity onset diabetes of the young,-0.524346497527688,-0.9030511708217726,0.6190476190476191,1.0,1.0,4/7,25.71%,PAX6;NR5A2;ONECUT1;HES1
prerank,Reactome_2022__Transport Of RCbl Within Body R-HSA-9758890,-0.5183054579348075,-0.9028326602332979,0.6136363636363636,1.0,1.0,1/7,4.11%,CD320
prerank,CellMarker_Augmented_2021__Enteroendocrine cell:Large Intestine,0.39252289659382794,0.9027602851266038,0.6086956521739131,0.836195970938239,1.0,13/86,12.92%,CCDC122;WTIP;MYLK3;FRAS1;TMEM212;ABCC9;EPB41L4A;LRRTM4;CDKL5;ASTN2;OPHN1;CEP112;MYO9A
prerank,KEGG_2021_Human__Glucagon signaling pathway,0.37869716864043157,0.9027096728984219,0.6857142857142857,0.8361289339961838,1.0,10/80,12.22%,CREB5;FOXO1;ITPR3;ADCY2;LDHA;SIK2;PFKL;PYGL;FBP1;CAMK2B
prerank,CellMarker_Augmented_2021__Paneth cell:Pyloric Gland,0.5085427726672849,0.9025640765026479,0.6271186440677966,0.83618988961562,1.0,4/12,18.21%,ALDOB;CDH17;RBP2;MEP1B
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD Domain Mutants R-HSA-2691232,0.5115035223376011,0.9024440078863539,0.5555555555555556,0.8362294951526267,1.0,3/13,19.96%,NEURL1;ADAM17;RPS27A
prerank,CellMarker_Augmented_2021__Beta cell:Undefined,-0.42269327822670083,-0.902265800626681,0.6060606060606061,1.0,1.0,4/24,7.40%,DPEP2;PADI4;PRAM1;S100Z
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),0.5434152713771726,0.9021669628694663,0.625,0.8365515347016899,1.0,5/10,18.24%,ARHGEF7;EML2;PAK1;DCTN1;CKAP5
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.3765303552638858,0.9021223172705715,0.6865671641791045,0.836447181232129,1.0,18/111,12.19%,SFTPD;COLEC12;AMN;VLDLR;WASF1;DNM1;COLEC11;CLTB;SNCA;RAMP3;LDLR;GRK2;AP1S1;MICALL1;SYK;SPARC;MX1;TPCN2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.5805433455194121,0.9019533891701828,0.6610169491525424,0.8365452955660568,1.0,1/5,19.28%,HIF1A
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",0.6037820413552478,0.901896074708844,0.6379310344827587,0.8364409914753326,1.0,3/5,28.45%,STOML2;TNFSF4;CDH26
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),-0.40305002458079836,-0.9017147858435997,0.65625,1.0,1.0,12/68,15.58%,CEBPA;PYHIN1;TRIB3;CBFA2T3;CCDC22;HSPA1A;RAD23A;PSMD10;CLU;BAG2;TRIB1;HSPBP1
prerank,Reactome_2022__Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.34349174636282964,-0.9015572588167361,0.7297297297297297,1.0,1.0,17/98,16.71%,ARF5;KIF21B;KIF6;KIF4A;KIF20B;COPB2;KIF15;KLC3;COPE;TMED2;TMED9;ARCN1;ARF4;KDELR1;NAPSA;DYNLL1;RAB1B
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),0.5739377555655671,0.9012778597048423,0.6964285714285714,0.8373670049948495,1.0,2/9,12.93%,MFSD2A;ALK
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.35986931211707224,0.9012400048411479,0.703125,0.8372598985388202,1.0,32/164,18.61%,C3;GPNMB;RASGRP1;APP;EFNA1;NOS1AP;FAS;NTRK3;LIMCH1;NPTN;PPP1R16B;LIMK2;NIBAN1;WDFY2;TERF2IP;GAS6;HLA-DRB1;PRKCD;PAK1;CCND1;FGF2;CD4;THPO;PINK1;SLCO3A1;CALM3;PPP1R7;FAM20A;TFRC;ADAM17;SEMA4D;RAMP1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.4710585655498963,0.9010778109236993,0.55,0.837405633721959,1.0,1/25,1.93%,VAPB
prerank,Reactome_2022__Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.40749530001377837,-0.900903889125198,0.6111111111111112,1.0,1.0,13/37,21.52%,RFC3;ATRIP;HUS1;BRIP1;RAD9B;RMI2;POLR1B;DNA2;SEM1;RAD51;RAD17;XRCC2;BRCA2
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.5776621958956726,0.9008769409408467,0.660377358490566,0.8376098299842949,1.0,2/7,27.63%,CCND1;MME
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),0.5653065001713857,0.9004604606465908,0.5961538461538461,0.8381650198129563,1.0,1/6,7.77%,RPUSD1
prerank,CellMarker_Augmented_2021__Type I pneumocyte:Undefined,-0.4082591788525514,-0.9003000247336739,0.6363636363636364,1.0,1.0,5/56,7.61%,TRIM29;BCAM;KRT8;IL20RA;S100A16
prerank,Reactome_2022__Metabolic Disorders Of Biological Oxidation Enzymes R-HSA-5579029,0.4529640410799948,0.9002358474822617,0.5892857142857143,0.8383822438843457,1.0,3/19,9.63%,CYP1B1;CYP21A2;CYP4F22
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.46070342255581426,0.9001538213784536,0.6461538461538462,0.8383308565765191,1.0,7/28,15.01%,ANXA1;PTPRC;SOX4;SOX13;FADD;PIK3CD;CD4
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.5952040019314476,0.9001198306439528,0.6122448979591837,0.838194439318137,1.0,1/5,6.17%,CIITA
prerank,Reactome_2022__Highly Calcium Permeable Nicotinic Acetylcholine Receptors R-HSA-629597,0.5661573826501428,0.9001156437441605,0.5932203389830508,0.8378181809455335,1.0,1/5,1.59%,CHRNA5
prerank,Reactome_2022__Highly Calcium Permeable Postsynaptic Nicotinic Acetylcholine Receptors R-HSA-629594,0.5661573826501428,0.9001156437441605,0.5932203389830508,0.8378181809455335,1.0,1/5,1.59%,CHRNA5
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.46926565544402465,0.9000879132868934,0.5833333333333334,0.8376766627540843,1.0,4/19,13.40%,CYP1B1;SERINC1;TEX2;FUT2
prerank,Reactome_2022__Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.38743235145453864,-0.9000860775102044,0.5882352941176471,1.0,1.0,11/45,25.39%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4;PSMA1;PSMD11
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.3595746615595544,0.8998009847675018,0.6753246753246753,0.8380636512677655,1.0,33/147,23.76%,KREMEN2;DRAXIN;PTPRO;DAB2IP;HIC1;NOTUM;DVL1;ALPK2;TLE6;TLE3;HECW1;PRICKLE1;SOX13;STK3;ANKRD6;WWTR1;WNT5A;STK11;DKK3;TSC2;FRMD8;TLE2;MLLT3;GRB10;AMFR;GLI1;RBMS3;AXIN2;CUL3;PSMB3;TMEM131L;PRKN;TLE4
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.33211687307444065,-0.8994595237003653,0.7575757575757576,1.0,1.0,20/176,16.54%,CDC26;PCYOX1L;RNF6;ELOC;FBXO45;RNF114;PPP1R11;SPSB4;FEM1A;ANAPC15;UBL7;PCYOX1;WDR91;KLHL8;RNF5;RNF126;RNF168;RNF8;RC3H1;RNF167
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.4299748996442352,-0.8994333698759899,0.5625,1.0,1.0,8/21,25.55%,DHX33;NCL;DDX11;WDR43;NOL11;PWP1;UBTF;EIF2AK3
prerank,Reactome_2022__VEGF Binds To VEGFR Leading To Receptor Dimerization R-HSA-195399,0.5956723158269206,0.8994322039162549,0.6545454545454545,0.8385832064341643,1.0,1/5,2.54%,FLT1
prerank,KEGG_2021_Human__Signaling pathways regulating pluripotency of stem cells,-0.34557526344570694,-0.8993804073086822,0.75,1.0,1.0,9/104,7.28%,ID1;ID2;SETDB1;HESX1;OTX1;FZD8;WNT2B;FZD9;ID4
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.4699706741632596,-0.8992414313583112,0.7105263157894737,1.0,1.0,1/17,3.55%,NIFK
prerank,Reactome_2022__Nectin/Necl Trans Heterodimerization R-HSA-420597,-0.5786064036866555,-0.8986649979537119,0.75,1.0,1.0,1/6,11.60%,PVR
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.4881647665106925,-0.8985159423888359,0.6326530612244898,1.0,1.0,4/14,21.95%,NCL;DDX11;NOL11;PWP1
prerank,KEGG_2021_Human__Propanoate metabolism,-0.38845216024598633,-0.8983936687019621,0.575,1.0,1.0,8/31,20.92%,LDHC;SUCLA2;DBT;ECHS1;EHHADH;ACADS;ACSS1;MLYCD
prerank,Reactome_2022__TBC/RABGAPs R-HSA-8854214,-0.39738047763560486,-0.8983778416384711,0.5333333333333333,1.0,1.0,1/37,0.29%,RAB7B
prerank,Reactome_2022__SLBP Dependent Processing Of Replication-Dependent Histone Pre-mRNAs R-HSA-77588,0.5398875081755167,0.898239134380199,0.6785714285714286,0.8407720598540986,1.0,2/10,18.35%,LSM11;ZNF473
prerank,Reactome_2022__Negative Regulation Of PI3K/AKT Network R-HSA-199418,0.3887988639508583,0.8980385656999502,0.6153846153846154,0.8409643565322679,1.0,14/81,11.20%,PDGFRA;EGF;IRS2;TGFA;FYN;NRG1;NRG2;PDGFA;MYD88;KITLG;GAB2;RNASE1;PIP4K2A;FGF13
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),0.6071652449824047,0.898034991906029,0.6607142857142857,0.8407745251848482,1.0,3/6,19.28%,SMAD3;TGFB2;HIF1A
prerank,Reactome_2022__PCP/CE Pathway R-HSA-4086400,0.38061501610962784,0.8979609111470039,0.6571428571428571,0.8407545374165288,1.0,12/79,18.53%,PRKCB;PRKCG;CLTB;DAAM1;RNASE1;PRICKLE1;SMURF1;FZD7;RORA;SCRIB;WNT5A;PRKCA
prerank,Reactome_2022__STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,-0.5062859684447626,-0.8976285306062645,0.6153846153846154,1.0,1.0,1/10,1.01%,FLT3
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.5553232788428728,0.8972712954536466,0.5925925925925926,0.8417449104453754,1.0,2/9,4.92%,EFNA1;SOX4
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),0.6158374146021134,0.8971711592953788,0.7169811320754716,0.8415242757684419,1.0,3/5,16.11%,CTNNB1;CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),0.6158374146021134,0.8971711592953788,0.7169811320754716,0.8415242757684419,1.0,3/5,16.11%,CTNNB1;CTNNA1;BRCA1
prerank,Reactome_2022__Pentose Phosphate Pathway R-HSA-71336,0.5549703876110037,0.8971175074018489,0.639344262295082,0.841387533865608,1.0,1/11,3.96%,PRPS2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.5391485227901267,0.8969441998866118,0.673469387755102,0.8415369915162909,1.0,2/8,17.46%,PPARG;ABCG1
prerank,Reactome_2022__Miscellaneous Transport And Binding Events R-HSA-5223345,0.454226787370496,0.8967350768954588,0.6610169491525424,0.8417128689753051,1.0,4/20,10.30%,ADD2;TUSC3;NIPAL2;NIPAL3
prerank,Reactome_2022__Glucose Metabolism R-HSA-70326,-0.3869565918552117,-0.896574715683177,0.5357142857142857,1.0,1.0,12/78,15.87%,GOLT1A;PGP;AAAS;BPGM;NUP50;SLC25A1;PCNX4;NUP54;G6PC3;GNPDA2;PFKFB1;ADPGK
prerank,CellMarker_Augmented_2021__T cell:Peripheral Blood,0.5724066127280883,0.8965441013539763,0.6551724137931034,0.8418701286247442,1.0,3/6,15.01%,PTPRC;CD5;CD4
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.4094547071014823,-0.8964896340307021,0.6,1.0,1.0,3/30,11.25%,TNFAIP3;ABRAXAS1;USP27X
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.49690383790711284,0.8964881934537212,0.6779661016949152,0.8417625562767227,1.0,3/16,10.94%,MRAP2;PID1;PYGL
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.5386954771675838,0.896476116348513,0.6031746031746031,0.8415994461237055,1.0,4/9,10.24%,ATP1A1;SLC9A1;ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.5701862859665703,0.8960943096908607,0.6779661016949152,0.8421138869597752,1.0,3/6,18.02%,MAPT;HEBP2;RNF122
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),0.4934989172565059,0.8960420774517415,0.6458333333333334,0.8420433736745,1.0,4/14,24.60%,PPARG;ABCG1;ITGAV;OSBPL8
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),0.5792286578371821,0.895973854393957,0.639344262295082,0.842004634789599,1.0,2/6,12.57%,MCAM;ADIPOR2
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.4949045322208858,-0.8959591203548043,0.525,1.0,1.0,3/17,12.12%,GMFG;ARFIP2;BRK1
prerank,Reactome_2022__Host Interactions Of HIV Factors R-HSA-162909,-0.3446059272899899,-0.8958835992122607,0.6,1.0,1.0,7/118,5.98%,SLC25A5;APOBEC3G;CD247;AAAS;ELOC;NUP50;SLC25A4
prerank,Reactome_2022__Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.39415561054275455,-0.8958619355518005,0.6382978723404256,1.0,1.0,4/48,7.29%,PI4K2A;PIK3C2G;PIP5K1B;PIK3C2A
prerank,Reactome_2022__Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,0.4404765148404609,0.8958030313033348,0.6190476190476191,0.8420954980632438,1.0,6/50,6.48%,FOSB;KCNH8;SH3GL3;RPS6KA1;CDK5R2;VGF
prerank,KEGG_2021_Human__Drug metabolism,0.41679631394789407,0.8957523610510743,0.6081081081081081,0.8420065293790546,1.0,3/56,2.43%,IMPDH1;TYMP;GSTT2
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4417296026935406,-0.8956531737196083,0.631578947368421,1.0,1.0,3/18,7.50%,SELENOK;BCAP31;BAK1
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.52055333989618,0.8954789606270807,0.578125,0.8423035340328632,1.0,5/10,27.85%,CCDC91;SORT1;GAK;AP1G1;ANKFY1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.5496745406958792,0.8953730728749041,0.6779661016949152,0.8423229121538012,1.0,2/10,6.43%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.48840030462410183,-0.8953723787848752,0.6060606060606061,1.0,1.0,2/13,8.76%,STX16;TMED5
prerank,Reactome_2022__SARS-CoV-2-host Interactions R-HSA-9705683,0.35589989831129537,0.8950599898560773,0.6973684210526315,0.8426936900463338,1.0,7/158,3.61%,TLR2;YWHAH;SFTPD;IRAK2;IRF7;NOD1;NLRP12
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),0.5590552406627813,0.894756168767875,0.7021276595744681,0.843090714620902,1.0,3/7,24.80%,MSRA;MTHFR;SMS
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.3945367626873268,0.8947351516925656,0.65625,0.8429593650828441,1.0,7/52,10.25%,TLCD2;SLC4A10;IRS2;VGF;SLC4A9;PPARG;SLC4A11
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.4458742831956153,0.8947312288901962,0.5964912280701754,0.8427726277330101,1.0,9/25,24.85%,TRPM4;CDK6;PPARG;HDAC7;SEMA4D;NOCT;PTCH1;SUFU;SMAD6
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),-0.4042799001283134,-0.8945755812199844,0.575,1.0,1.0,8/48,6.23%,TLCD1;CEBPA;TLCD3A;ORMDL1;APOE;ACOXL;ABCD1;ABCB11
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),-0.36386375565692153,-0.8944940415472413,0.6756756756756757,1.0,1.0,7/54,7.78%,SLC25A5;SFXN2;SLC3A2;SLC6A13;SLC25A4;SLC25A19;SLC25A1
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),-0.5450616317549695,-0.8943018610465331,0.5263157894736842,1.0,1.0,3/7,26.01%,DNAAF1;DNAH11;ODAD2
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.5289198277987042,0.8943000444017393,0.6530612244897959,0.8433699850706011,1.0,4/13,23.66%,PPARG;ABCG1;SCARB1;MSR1
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.49683021982383146,-0.8942452623361051,0.6428571428571429,1.0,1.0,3/13,13.90%,ISCA2;CIAO2B;NFU1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.3111475364141622,-0.894213774011955,0.7368421052631579,1.0,1.0,59/258,21.79%,ERCC8;DCLRE1B;KPNA2;FANCF;APEX2;RFC3;ATRIP;HUS1;GTF2H5;POLD3;GTF2H2;MGME1;CETN2;WDHD1;BRIP1;PMS1;GTF2H2C;ABRAXAS1;SMARCAL1;ERCC2;ATR;PRIMPOL;RAD23A;NSMCE4A;ERCC6;RAD9B;TEX264;PNKP;RMI2;RNF168;MEN1;XPA;RNF8;DNA2;HINFP;RFWD3;FAM111A;FANCM;NABP2;BRCC3;MUS81;ERCC3;APEX1;RAD51;SMARCA5;UBB;UBE2V2;INTS3;RAD17;SLX4;FANCE;MSH3;XRCC2;MPG;PARP1;BRCA2;CHRNA4;UBE2T;UBE2A
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.42642175465675847,0.89396626725523,0.6,0.8437902465312306,1.0,5/30,11.84%,SLC4A10;SLC9A9;SLC9A1;SLC4A9;SLC9C2
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),0.526184589868569,0.8939465844505647,0.59375,0.8436377488641025,1.0,5/6,24.68%,CBLN2;ERC2;DCTN1;RAB3A;ERC1
prerank,CellMarker_Augmented_2021__FOXP3+ Natural Regulatory T (Treg) cell:Blood,-0.42830429349034765,-0.893629623956244,0.6944444444444444,1.0,1.0,6/29,6.16%,DPEP2;GMFG;CD247;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.3911431180844829,-0.8934016425661334,0.6341463414634146,1.0,1.0,9/28,24.95%,GRPEL2;PEX10;TIMM23;TIMM50;PEX1;DNAJC19;TIMM17A;TOMM70;GRPEL1
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),-0.5328614693468854,-0.8933876077922344,0.5365853658536586,1.0,1.0,3/9,25.16%,DNASE1L1;MUS81;FBH1
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.42916999513080567,-0.8933575626645291,0.5882352941176471,1.0,1.0,6/27,19.18%,TMEM17;BBS10;VANGL2;TBC1D32;IFT57;RPGRIP1
prerank,Reactome_2022__trans-Golgi Network Vesicle Budding R-HSA-199992,-0.39559228635583643,-0.8932819709943458,0.53125,1.0,1.0,6/63,7.29%,FTL;VAMP8;FTH1;BLOC1S4;SNAPIN;PIK3C2A
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),0.5614876517208127,0.8932710133817725,0.6666666666666666,0.8447357140172298,1.0,1/9,2.58%,PLEK
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),0.6072419142774201,0.8930413064237471,0.68,0.8450155977542896,1.0,3/6,18.06%,HLA-E;RARA;TNFSF4
prerank,CellMarker_Augmented_2021__Eosinophil:Sputum,0.40805645093957016,0.893027027595407,0.6610169491525424,0.8448629254151365,1.0,13/56,13.20%,BOK;EPHA2;EFNA1;EPS8L2;RHBDF1;RHOD;CDC42EP1;ASS1;YAP1;PXDC1;CTNNA1;CD276;CCND1
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),-0.48850845055517517,-0.8930183585777777,0.6888888888888889,1.0,1.0,1/9,10.54%,CLP1
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.421235417819985,0.8927909831627002,0.6491228070175439,0.8451136551437619,1.0,3/42,4.11%,STEAP3;SLC39A14;CP
prerank,CellMarker_Augmented_2021__pro-Natural Killer Cell (pro-NK cell):Peripheral Blood,-0.4104554929188395,-0.8923542792774007,0.6153846153846154,1.0,1.0,4/33,4.08%,ID2;RGS2;CD247;C1ORF162
prerank,Reactome_2022__NGF-stimulated Transcription R-HSA-9031628,0.4494525869577338,0.8919757513239955,0.65625,0.8465450024227189,1.0,5/31,6.48%,FOSB;KCNH8;SH3GL3;CDK5R2;VGF
prerank,KEGG_2021_Human__Parkinson disease,-0.3225985847730866,-0.8917690271016612,0.75,1.0,1.0,30/196,14.29%,SLC25A5;UQCRFS1;NDUFS5;COX7C;NDUFA12;NDUFB4;UQCRB;TUBB2B;NDUFB1;ATP5PF;SLC25A4;VDAC2;ATP5MC1;NDUFC2-KCTD14;EIF2S1;UQCRHL;NDUFV3;COX7B;ATP5PB;ATP5PD;NDUFA8;KLC3;COX5B;ATP5MC3;HTRA2;PSMD12;NDUFS3;NDUFC1;PSMB5;ATP5F1B
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),-0.43450791539491984,-0.891626752472263,0.6060606060606061,1.0,1.0,2/21,1.54%,MID1IP1;TPX2
prerank,Reactome_2022__PECAM1 Interactions R-HSA-210990,0.5674125841803215,0.8913845088462953,0.6290322580645161,0.8475488350304315,1.0,5/9,23.19%,FYN;INPP5D;PTPN11;ITGAV;PECAM1
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),0.5740270213683863,0.8913042531739854,0.6666666666666666,0.847511637745128,1.0,2/5,33.42%,KIF13A;KIF3A
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.5665646443194319,0.8912645426252822,0.7068965517241379,0.8473822755897076,1.0,2/9,9.98%,CACNA1C;ORAI1
prerank,CellMarker_Augmented_2021__Alpha cell:Pancreas,0.5557849982995986,0.891078273747529,0.6,0.847603183374891,1.0,3/8,15.20%,PGR;LDB2;SMARCA1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.45175966539528906,-0.8907863688633041,0.5945945945945946,1.0,1.0,2/16,8.10%,POLR2K;DHX33
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.424513484205421,0.8907111169611952,0.696969696969697,0.8481135733646102,1.0,15/40,27.64%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;KLF4;TP53;WRAP53;ACD;PARN;PARM1;PIF1;MAPK3;MAP2K7;NVL
prerank,Reactome_2022__Class B/2 (Secretin Family Receptors) R-HSA-373080,0.3988561043530992,0.8906516724212816,0.6891891891891891,0.8480394340392579,1.0,8/53,7.44%,ADGRE5;GNG3;CD55;WNT8B;GIPR;GNG2;RAMP3;GLP1R
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.5276470696513698,0.8905432131646919,0.5862068965517241,0.8479916421089587,1.0,4/17,13.41%,KCNH2;SLC9A1;PDK4;SLC12A5
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.5931473756355059,0.8903105296098274,0.6617647058823529,0.8482122110385677,1.0,2/5,22.23%,AKIRIN1;SIX4
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Serum,0.42727286265733916,0.8900346318836587,0.6911764705882353,0.848516845602651,1.0,8/33,11.97%,TC2N;CD24;TJP3;CD44;CAPN8;ANO9;FBP1;KRTCAP3
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),0.5730340033590148,0.889840644242894,0.6833333333333333,0.8486372711728511,1.0,1/6,2.14%,NR4A1
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.47545263356041767,0.8893239737395106,0.6379310344827587,0.8494096306653711,1.0,7/18,17.79%,IRS2;PTPRC;NFATC2;BCL2;GPR183;BST1;TFRC
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.4116208696379158,-0.8890394725346507,0.6666666666666666,1.0,1.0,5/33,9.66%,RFC3;GTF2H5;POLD3;GTF2H2;ERCC2
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3902313313339332,0.8887363921391468,0.625,0.8503787691273247,1.0,9/66,12.36%,CDKN2A;DUSP1;DAB2IP;PRKAR1B;PKIA;CDKN1C;GADD45A;PRKCD;CDKN1B
prerank,Reactome_2022__ESR-mediated Signaling R-HSA-8939211,0.361879124124339,0.8886780155992006,0.72,0.8502963505411577,1.0,17/140,13.20%,FOSB;KCNH8;EGF;GNG3;TGFA;PMEPA1;GNG2;PGR;CDK9;FOXO3;FKBP5;ZDHHC7;S1PR3;TLE3;CDKN1B;BCL2;CCND1
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),-0.5502578295841819,-0.8884789882277667,0.5531914893617021,1.0,1.0,2/5,36.27%,RBBP4;ASF1A
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),-0.5502578295841819,-0.8884789882277667,0.5531914893617021,1.0,1.0,2/5,36.27%,RBBP4;ASF1A
prerank,CellMarker_Augmented_2021__Dendritic cell:Blood,0.48099587674727207,0.8884614253507378,0.6451612903225806,0.8504977067510023,1.0,6/25,4.31%,CTSS;P2RY13;PLEK;SLA;LAT2;PTPRC
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),0.5668369682229436,0.8883176136492493,0.6274509803921569,0.8505623883416485,1.0,1/5,7.99%,ACOT4
prerank,Reactome_2022__Nef Mediated Downregulation Of MHC Class I Complex Cell Surface Expression R-HSA-164940,0.5712038567532405,0.8883170152008687,0.6666666666666666,0.8503696918331887,1.0,3/9,14.00%,AP1S1;B2M;PACS1
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),-0.5897985800571038,-0.8882042997887006,0.6666666666666666,1.0,1.0,2/6,19.18%,RORB;RPGRIP1
prerank,CellMarker_Augmented_2021__Endothelial Progenitor cell:Bone Marrow,-0.5808618477646623,-0.888141385843113,0.627906976744186,1.0,1.0,1/5,1.01%,FLT3
prerank,Reactome_2022__Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.40778639848294196,-0.8880023684617108,0.6285714285714286,1.0,1.0,13/35,21.52%,RFC3;ATRIP;HUS1;BRIP1;RAD9B;RMI2;POLR1B;DNA2;SEM1;RAD51;RAD17;XRCC2;BRCA2
prerank,KEGG_2021_Human__African trypanosomiasis,0.4848212840226091,0.8879916099014955,0.5517241379310345,0.8507966801518625,1.0,5/16,7.62%,PRKCB;ICAM1;PRKCG;FAS;MYD88
prerank,Reactome_2022__NOD1/2 Signaling Pathway R-HSA-168638,0.4439118975953166,0.8876988549171729,0.6065573770491803,0.8511814779879433,1.0,6/27,16.42%,IRAK2;NOD1;BIRC3;IKBKG;MAPK11;TAB1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.44866381628874547,0.8876263994809322,0.5483870967741935,0.8511173591980741,1.0,6/21,19.17%,HPCA;JPH4;PDE4D;YWHAE;CAV3;CACNB2
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.4607045303338406,0.8876259895568918,0.7049180327868853,0.8509247115386812,1.0,4/27,9.85%,IGF1;NYAP2;NYAP1;CD160
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.483195344480128,0.8875979530166807,0.6307692307692307,0.8508423186158496,1.0,1/15,2.58%,PLEK
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.5064816462358903,0.8875847078022115,0.6326530612244898,0.8506734223439686,1.0,3/11,10.83%,RDH13;CYP1B1;DHRS13
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.42682968289150036,-0.887535336280917,0.6,1.0,1.0,2/16,4.92%,RGCC;SERPINF2
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),0.5042548449006948,0.8875125335676858,0.6,0.8506278294370208,1.0,3/9,28.13%,TGFB2;PTCH1;FBXW4
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.4043320554795587,0.8873563761144797,0.6060606060606061,0.8507316688155083,1.0,10/61,9.39%,SIX3;YWHAH;NLGN1;VWC2;CASZ1;CNTN4;PCP4;NEUROD2;YWHAG;MMD
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.5528166928857814,0.8873270342165738,0.6964285714285714,0.8506127047462224,1.0,1/8,7.37%,ZMYND10
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.5382136263966856,0.8873146471153632,0.5932203389830508,0.8502544418280451,1.0,3/7,26.85%,PRKN;MAPK3;GABPA
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.5382136263966856,0.8873146471153632,0.5932203389830508,0.8502544418280451,1.0,3/7,26.85%,PRKN;MAPK3;GABPA
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),0.5824268455049866,0.8871024201275036,0.6491228070175439,0.8504682650329316,1.0,4/6,34.19%,SND1;PARN;DIS3L2;LIN28B
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),0.5702385804352944,0.8870273158316689,0.66,0.8504306351514456,1.0,4/5,42.78%,PSIP1;PRPF39;SNRPC;SFSWAP
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.4045271634326505,0.886780977101306,0.671875,0.8506600282204244,1.0,14/45,20.23%,AMH;BMP8A;SCX;SMAD3;TGFB2;RGMB;SMAD1;SMURF1;RGMA;SMAD2;TGFBR3;SMAD9;BMP6;HJV
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,-0.3955900523796335,-0.8867273416981409,0.5897435897435898,1.0,1.0,10/34,14.91%,TRIM29;CFTR;IL33;IL20RA;TEKT1;EHF;CYP4F12;MAP3K19;ERBB3;MUC20
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.5259391282242311,0.886623044058032,0.6415094339622641,0.8507820160123595,1.0,2/12,1.62%,PROX1;PKP2
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.46672349538429325,0.886607129915629,0.6190476190476191,0.8506239807029946,1.0,6/19,18.74%,SLCO1A2;SLC51A;SLC27A5;ABCC4;RXRA;ABCC3
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.4129130834496879,0.886585863009998,0.6216216216216216,0.8504712485915378,1.0,8/42,13.31%,IGF1;APP;NLRP12;MYD88;STAT3;GSDMD;USP50;NLRP2
prerank,PanglaoDB_Augmented_2021__Enterocytes,-0.3467331530917132,-0.8864536386134064,0.7,1.0,1.0,4/88,3.67%,SLC2A5;G0S2;CES2;SDSL
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.4410416783476153,0.886302814664793,0.6567164179104478,0.8507815010927402,1.0,6/34,10.55%,PLSCR1;ALDOB;RYR2;ATP1B1;ATP1B3;AHSA1
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),0.5611370544455463,0.8860757565642301,0.6612903225806451,0.8510210152912786,1.0,2/8,12.70%,HMGCLL1;SLC27A5
prerank,Reactome_2022__Glucagon-type Ligand Receptors R-HSA-420092,0.4545586763033057,0.8858894440421143,0.6567164179104478,0.8511192566414155,1.0,4/20,7.44%,GNG3;GIPR;GNG2;GLP1R
prerank,CellMarker_Augmented_2021__Dental Pulp Stem cell:Premolar,0.5546463896665185,0.8856724401120522,0.6382978723404256,0.8513376780820751,1.0,1/6,4.31%,PTPRC
prerank,Reactome_2022__Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.3216908235663952,-0.8856131269170336,0.7567567567567568,1.0,1.0,15/90,19.36%,CEP72;SSNA1;CETN2;HAUS1;CEP131;RAB8A;SCLT1;IQCB1;CEP83;DYNLL1;MKS1;CEP192;CEP78;FBF1;TUBB
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),-0.5579715424407923,-0.8853160148094201,0.6410256410256411,1.0,1.0,2/9,19.57%,HSPA1A;HSPA2
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),-0.5312276197803734,-0.8852501028774544,0.631578947368421,1.0,1.0,2/6,19.43%,TMX3;PRDX3
prerank,Reactome_2022__Antimicrobial Peptides R-HSA-6803157,-0.4842689194457114,-0.885199677433982,0.5384615384615384,1.0,1.0,5/17,4.88%,TRIM21;CHAMP1;PRSS3;PGLYRP2;PDZD11
prerank,CellMarker_Augmented_2021__Exhausted T cell:Undefined,-0.6091439930949398,-0.8848958770212897,0.6666666666666666,1.0,1.0,1/5,2.00%,CD96
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),0.5975317341298685,0.884823827132369,0.64,0.8526142598062635,1.0,2/6,22.72%,CDS2;SLC27A1
prerank,Reactome_2022__M Phase R-HSA-68886,-0.3110220621644819,-0.8846611879950069,0.85,1.0,1.0,29/306,12.91%,H2AC20;CDC26;CEP72;SGO2;H3-3B;SSNA1;H2BC4;H2BC21;AAAS;FBXO5;NUP50;H2AC6;TUBB2B;CETN2;BLZF1;KNL1;KMT5A;SPDL1;MIS12;HAUS1;ITGB3BP;CEP131;GORASP2;CENPA;NUP54;PSMD10;CENPQ;ANAPC15;PSMD12
prerank,Reactome_2022__Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.41842948082042575,-0.8844469792685344,0.7297297297297297,1.0,1.0,10/42,19.72%,H2BC4;H2BC21;ABRAXAS1;RNF168;RNF8;BRCC3;H2BC5;SMARCA5;UBB;UBE2V2
prerank,Reactome_2022__Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.4080933402638884,-0.8843075019704241,0.6206896551724138,1.0,1.0,5/55,2.82%,H2AC20;CDC26;H3-3B;H2BC4;H2BC21
prerank,Reactome_2022__TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,0.3872868485541072,0.8842429718174097,0.6521739130434783,0.8535297555002616,1.0,10/75,19.96%,MAP3K14;TNFRSF14;BIRC3;TNFRSF1A;RELB;CD70;TNFRSF11B;TNFSF4;SKP1;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),-0.3790486687397231,-0.8841641281056002,0.7037037037037037,1.0,1.0,1/57,0.09%,NGF
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),0.565805621624161,0.8840317309005006,0.7142857142857143,0.8536952500016922,1.0,2/8,6.35%,EGF;NRG1
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),0.4553429754877191,0.8838832830538379,0.6290322580645161,0.8537457763179778,1.0,9/33,18.29%,PRKCG;AGAP2;HDAC4;ZDHHC7;FBP1;ALK;FMN2;NCOR1;FLNA
prerank,GO_Biological_Process_2021__C-terminal protein lipidation (GO:0006501),-0.5242906982237125,-0.883742135043557,0.5813953488372093,1.0,1.0,1/5,8.86%,GPLD1
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.6207153881771961,0.8834225507959802,0.6981132075471698,0.854435884360175,1.0,2/5,30.71%,PLAT;AAMP
prerank,Reactome_2022__Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.4034499510017129,-0.883372333179759,0.631578947368421,1.0,1.0,8/29,26.48%,SNF8;VPS4B;RNF103-CHMP3;UBB;VPS25;CHMP2A;VPS28;VTA1
prerank,KEGG_2021_Human__Synthesis and degradation of ketone bodies,0.5720202606606689,0.883356535006735,0.7230769230769231,0.8543452788438989,1.0,3/8,19.18%,OXCT1;HMGCLL1;HMGCS1
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.5817472637794526,-0.8833512760127099,0.7380952380952381,1.0,1.0,2/5,12.37%,TPRKB;OSGEP
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.4779679049200003,0.8833086720129957,0.65625,0.8542181817508219,1.0,2/21,6.43%,YBX3;BIRC3
prerank,Reactome_2022__Activation Of Caspases Thru Apoptosome-Mediated Cleavage R-HSA-111459,-0.5490511742328914,-0.8831348477752784,0.6730769230769231,1.0,1.0,2/6,26.71%,CASP9;CASP3
prerank,Reactome_2022__SMAC (DIABLO) Binds To IAPs R-HSA-111463,-0.5490511742328914,-0.8831348477752784,0.6730769230769231,1.0,1.0,2/6,26.71%,CASP9;CASP3
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),-0.45947025451731205,-0.8830122326424844,0.5641025641025641,1.0,1.0,5/19,21.37%,APOE;ARV1;FMO5;EPHX2;GNB3
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.4804267994765982,0.8829247607467567,0.6190476190476191,0.854826842590928,1.0,3/11,14.93%,FOLH1;AGTPBP1;LCMT1
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.5425630716642459,0.8826777484300887,0.7121212121212122,0.8551613600274466,1.0,2/7,9.87%,OGN;OMD
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.5326535617954827,0.8825455951069764,0.625,0.8551958421444388,1.0,7/15,31.55%,BASP1;LARGE1;SIX4;FXR1;MYH14;IGSF8;MEF2C
prerank,Reactome_2022__Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.36986180270591507,-0.8824571021502933,0.6206896551724138,1.0,1.0,15/73,22.33%,AAAS;NUP50;MRPL18;HSPA1A;HSF1;HSPA13;NUP54;BAG2;POLR1B;UBB;HSPA2;NUP85;NUP42;DEDD2;POM121C
prerank,Reactome_2022__Fatty Acid Metabolism R-HSA-8978868,0.36350063446618863,0.8823929691472603,0.6666666666666666,0.8552954864357815,1.0,14/137,11.62%,GGT5;ACSL5;AWAT1;FA2H;ALOX12;HADH;CYP1B1;ACOT4;HACD1;CYP4F22;OLAH;DBI;ACOT7;SLC27A3
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.5257047814819364,-0.8823613867622837,0.575,1.0,1.0,3/7,21.06%,BRPF1;MEAF6;BRPF3
prerank,CellMarker_Augmented_2021__Luminal Progenitor cell:Breast,-0.4194632355409279,-0.8822231511134937,0.6,1.0,1.0,6/30,11.41%,TRIM29;KRT8;IL20RA;ATP2C2;EHF;B3GNT3
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),0.544855893601195,0.8821962983053826,0.6086956521739131,0.8554811011116666,1.0,4/8,36.98%,ARRB1;CTBP1;TAF7;IWS1
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),0.5610043325107812,0.8821772682166652,0.6727272727272727,0.8553252548198658,1.0,2/7,8.63%,PMEPA1;LDLRAD4
prerank,Reactome_2022__Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.36541715378595113,-0.8821547757997419,0.6904761904761905,1.0,1.0,8/35,25.44%,AAAS;NUP50;NUP54;NUP85;NUP42;POM121C;KPNB1;NPM1
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.5278511408262831,-0.8818692242767284,0.625,1.0,1.0,1/7,3.78%,PYHIN1
prerank,Reactome_2022__HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.4078157254907926,-0.8818298688083609,0.6285714285714286,1.0,1.0,8/32,16.47%,RFC3;ATRIP;HUS1;BRIP1;RAD9B;RMI2;POLR1B;DNA2
prerank,CellMarker_Augmented_2021__T2 (Transitional) B cell:Bone Marrow,-0.4264644132965453,-0.8817452940955132,0.7567567567567568,1.0,1.0,6/26,6.37%,DPEP2;GMFG;CD247;PYHIN1;P2RY10;CR1
prerank,CellMarker_Augmented_2021__Transitional B cell:Bone Marrow,-0.4264644132965453,-0.8817452940955132,0.7567567567567568,1.0,1.0,6/26,6.37%,DPEP2;GMFG;CD247;PYHIN1;P2RY10;CR1
prerank,CellMarker_Augmented_2021__T1 (Transitional) B cell:Bone Marrow,-0.4264644132965453,-0.8817452940955132,0.7567567567567568,1.0,1.0,6/26,6.37%,DPEP2;GMFG;CD247;PYHIN1;P2RY10;CR1
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),-0.4637306908543392,-0.8817315905419449,0.6578947368421053,1.0,1.0,2/13,2.25%,HEY2;ADAMTS9
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),0.5907309326922979,0.8812595911956378,0.6041666666666666,0.8568395075777339,1.0,1/5,7.09%,MAOB
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",0.5355444173112793,0.8812582001408764,0.65,0.8566469593737838,1.0,2/7,14.71%,MAPK8IP1;HLA-E
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.5759339592366464,0.881232788112133,0.6818181818181818,0.8564961645490521,1.0,3/5,35.63%,CTBP1;SIRT1;TAF7
prerank,KEGG_2021_Human__Coronavirus disease,-0.31699729971113366,-0.881205646183474,0.72,1.0,1.0,25/159,10.26%,RPL35A;RPS24;C6;RPL34;RPL39;RPL13;RPL37;RPS28;RPL18;RPL12;RPL23;RPL31;RPS26;RPL6;RPS27L;RPL41;RPS13;RPL22;RPL29;RPL30;RPSA;VWF;RPL14;RPL15;RPS2
prerank,Reactome_2022__Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.4052953078234738,-0.8811734993069944,0.5853658536585366,1.0,1.0,12/30,21.52%,RFC3;ATRIP;HUS1;BRIP1;RAD9B;RMI2;POLR1B;DNA2;SEM1;RAD51;RAD17;BRCA2
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.5435360658781261,0.8811702219383326,0.7142857142857143,0.8564027165307172,1.0,6/12,19.28%,NEFL;SYBU;MAPT;RHOT1;RHOT2;HIF1A
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.5061658349055205,0.8811431208729731,0.68,0.8562728683553769,1.0,3/15,7.23%,TYMS;POLD1;HROB
prerank,Reactome_2022__Diseases Associated With Glycosylation Precursor Biosynthesis R-HSA-5609975,-0.4539318393591627,-0.8811293860441684,0.6595744680851063,1.0,1.0,3/13,16.74%,GALT;DOLK;DPM2
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),0.595160432694846,0.8810922156684159,0.6779661016949152,0.8561691027334511,1.0,3/5,39.64%,VPS13D;VPS13C;GOLPH3
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.5158785101822156,-0.8810838126512309,0.7142857142857143,1.0,1.0,3/17,6.61%,APOE;ABCB11;ARV1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),-0.3888279293848415,-0.8810596393666982,0.6,1.0,1.0,5/32,8.40%,TPX2;ANKRD53;RAE1;HSPA1A;VPS4B
prerank,Reactome_2022__RNA Polymerase II Transcription R-HSA-73857,0.31386062656294056,0.880967753417722,0.9647058823529412,0.85619287388243,1.0,87/1087,13.20%,LEF1;NPY;CDKN2A;NR4A3;MOBP;TEAD2;SOCS3;ABCA6;GRIN2A;YWHAH;PLK2;THBS1;SERPINE1;GRIN2B;NR4A1;BLM;STEAP3;TRPC3;LMO2;PRKCB;COLEC12;FOXO1;ZNF140;TGFA;GAD2;ZNF282;PPARGC1B;NFATC2;NUAK1;BCL6;CHD3;ZNF704;ZNF114;ZNF750;PGR;LDB2;CDK9;LSM11;FOXO3;MSX2;CASP10;EIF4A3;MAMLD1;PML;CDK6;CTNNB1;THOC6;YWHAG;FKBP5;TBL1X;SMAD3;NR1I3;YAP1;PDZD2;PPARG;HDAC4;ZNF597;FBXO32;NDRG1;GLI2;PIP4K2A;GPRIN1;TP53I3;SMAD1;BBC3;TEAD1;NR6A1;HDAC9;NR4A2;BARD1;PRR5;GADD45A;ITGAL;CDC7;PMS2;PLXNA4;CAMK2B;ZNF552;CDKN1B;HIPK1;ZNF667;MAPKAPK5;TFAP2C;KLF4;DHX38;CDKN1A;CCND1
prerank,Reactome_2022__MET Activates PI3K/AKT Signaling R-HSA-8851907,0.5205210871297967,0.8809274003964118,0.6545454545454545,0.8560605589628164,1.0,1/6,24.02%,RNMT
prerank,Reactome_2022__RHO GTPase Effectors R-HSA-195258,0.3480600646475358,0.8806449083807019,0.7887323943661971,0.856383421195909,1.0,45/206,18.53%,KIF14;YWHAH;PRKCB;WAS;MYH9;MYH11;INCENP;WASF1;BAIAP2;RHPN1;CENPP;RHOD;DAAM1;ERCC6L;CTNNB1;KIF5A;YWHAG;LIMK2;ARPC3;PDZD2;ARHGEF7;PPP1CB;RNASE1;NOXA1;CTNNA1;PRKCD;CDKN1B;CENPH;FMNL3;KLC1;RANGAP1;IQGAP1;MAPK11;MRTFA;WIPF3;PFN2;PPP1R14A;FMNL1;DYNC1LI2;SKA2;RHOQ;YWHAE;CKAP5;FLNA;PRKCA
prerank,KEGG_2021_Human__Sphingolipid metabolism,0.4146837927449769,0.8806279964987115,0.6470588235294118,0.856209521459793,1.0,10/44,20.81%,SGPP2;UGT8;CERS3;SGMS1;CERS5;B4GALT6;NEU4;ACER3;GAL3ST1;UGCG
prerank,Reactome_2022__SARS-CoV Infections R-HSA-9679506,0.3306431525730309,0.8805809149332686,0.85,0.8561006873865763,1.0,30/307,15.08%,ST6GAL1;TLR2;YWHAH;ZDHHC9;SFTPD;IRAK2;IRF7;NOD1;NLRP12;IL1R1;SH3KBP1;TUSC3;CHD3;AGRN;MGAT5;YWHAG;IKBKE;ATP1B1;ATP1B3;SYK;PARP9;TYK2;FXYD7;BRD4;B2M;IKBKG;PATJ;IFIH1;HLA-E;ST6GALNAC2
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),-0.5554672323076044,-0.8804280749951949,0.7567567567567568,1.0,1.0,1/6,6.98%,RHCE
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.4023760118077563,0.8803559220164802,0.6065573770491803,0.8563375589686004,1.0,6/55,10.01%,ZDHHC9;ZDHHC22;PGAP4;PIGA;ZDHHC7;ZDHHC1
prerank,CellMarker_Augmented_2021__PROM1High Progenitor cell:Large Intestine,-0.3501835841828949,-0.8801620589838034,0.6666666666666666,1.0,1.0,4/90,3.38%,NGF;RPSAP52;MYO10;ADAMTS12
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.37021467524284396,0.8801297224010962,0.703125,0.8565327508963635,1.0,14/70,19.38%,GPNMB;FYN;SOX4;SNCA;INPP5A;NPAS2;FGF2;IKBKG;PINK1;CD200;MECOM;AMIGO2;RAD18;PACRG
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.4954695432803198,-0.879901983282742,0.6744186046511628,1.0,1.0,5/13,11.31%,RGCC;SERPINF2;VIM;CREB3L1;RUNX1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.5511851958850338,-0.8794402549350144,0.660377358490566,1.0,1.0,5/7,30.26%,CLU;ATXN3;DNAJB12;DNAJC18;DNAJB14
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.531042036630871,0.8792954208088789,0.6909090909090909,0.8578864557471765,1.0,4/9,33.05%,CSRP2;PTCH1;NF1;SRPK3
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.47264917342532414,-0.8791630107516524,0.6764705882352942,1.0,1.0,1/12,3.78%,PYHIN1
prerank,Reactome_2022__Triglyceride Catabolism R-HSA-163560,0.5035414244524761,0.8791244992937802,0.7049180327868853,0.8580240752633193,1.0,8/15,28.47%,FABP3;PPP1CB;LIPE;PRKCA;GPD2;PNPLA4;FABP6;PPP1CA
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.44430893896532564,-0.8790127189444422,0.6,1.0,1.0,2/18,2.08%,CYP4F3;CEL
prerank,KEGG_2021_Human__Cysteine and methionine metabolism,-0.39227312747087395,-0.8789154517016031,0.5952380952380952,1.0,1.0,11/41,20.29%,DNMT3B;SDSL;LDHC;PHGDH;CTH;SDS;MAT2A;SRM;MAT2B;MPST;ADI1
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.5244504597057947,0.8789139668757354,0.6415094339622641,0.8582732867028866,1.0,4/7,23.95%,PRKAR1A;PDCD1LG2;SCRIB;PRNP
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),-0.5153271270417388,-0.8789120516324412,0.6666666666666666,1.0,1.0,2/10,19.57%,HSPA1A;HSPA2
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),-0.5600061905925029,-0.8788531028425871,0.6363636363636364,1.0,1.0,1/6,10.83%,GPR37L1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.34396819954291313,-0.8784966050847488,0.7073170731707317,1.0,1.0,21/85,17.29%,LSM3;SF3B4;SF3A1;LSM2;U2AF1;PRPF18;HSPA1A;NUDT16L1;LSM5;METTL3;RNH1;KIN;HSF1;PRPF8;SRSF2;PRPF3;CPSF3;LSM10;NUDT12;SRSF9;ZFP36L2
prerank,Reactome_2022__Metabolism R-HSA-1430728,0.30737603117724316,0.8784859454288282,0.9587628865979382,0.8588442921703253,1.0,172/1618,12.81%,GGT5;ENPP2;RIMBP2;ABO;MTMR7;CARNS1;NDST4;CSPG4;PAPSS2;SQOR;SGPP2;CHRM3;GNG3;DCN;ACSL5;OGN;FOLH1;NMNAT2;VAPB;AWAT1;TYMS;B3GNT2;GSTT2;LIPH;UGT8;ADCY5;ITPKC;FA2H;SLC25A21;GMPR;PLCH2;KCNC2;ADA;NSDHL;LPCAT4;SYT5;ABCC8;AMN;ACHE;PRPS2;GLYATL2;TPST1;FABP3;PPARGC1B;EGFL7;PRKG2;CHSY3;SOAT1;PRKAR1B;ESYT3;ALOX12;CHST15;B3GALT2;GNG2;AHR;NUDT16;SLCO1A2;GGCT;PLAAT4;CHST6;MTHFD2;ITPR3;MFSD2A;CHPF2;SAMHD1;PRODH;CD44;SBF1;AGRN;POLD1;ITPKB;ADCY7;SYNJ2;TNFAIP8L1;CACNA1C;HADH;ALDOB;MAOB;ADCY2;UGDH;TYR;GLP1R;GPT2;CYP1B1;SULT4A1;LDLR;HECA;ACOT4;SLC9A1;LDHA;ASS1;CACNA1E;RPL39L;GNA14;ITPK1;AGPAT4;PLAAT3;DHCR24;PLEKHA2;NUDT4;NUDT13;B4GALNT1;SPNS2;TBL1X;GALK1;CYP21A2;BGN;ALDH1L1;OXCT1;HACD1;PLD2;FTCD;HSD3B7;PPARG;RPL3;CERS3;PPP1CB;CYP4F22;B3GALNT1;CHKB;AK5;NAMPT;OMD;PFKL;UST;PIP4K2A;GDA;VAC14;SHMT1;HMGCLL1;HS6ST1;PITPNM3;OLAH;HMOX2;INPPL1;HS3ST4;INPP5A;PUDP;HS3ST3B1;PYGL;PARP9;PGK1;DBI;HS3ST3A1;B4GALT7;FBP1;PITPNM2;DGAT2L6;KYAT1;INPP5J;SLC51A;ACOT7;NPAS2;DGAT1;PDK4;SLC27A3;B4GALT5;SERINC1;NDUFB11;ENO2;PLAAT5;MLXIPL;RPL37A;ACSM5;PLEKHA4;PLEKHA8;ADIPOR2;PDXK;SLC27A5;OAZ2;INPP4A;NAT8L
prerank,Reactome_2022__Nef And Signal Transduction R-HSA-164944,0.562744209460894,0.8782547791593882,0.6612903225806451,0.8590983992121153,1.0,3/6,9.78%,ELMO1;FYN;RNASE1
prerank,Reactome_2022__FGFR3 Mutant Receptor Activation R-HSA-2033514,0.5720514559977903,0.8782153901458952,0.5925925925925926,0.8589683545272099,1.0,1/5,11.20%,FGF13
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.5347201404803449,0.8781275715852982,0.6842105263157895,0.8589291675140425,1.0,1/11,7.37%,ZMYND10
prerank,Reactome_2022__Biosynthesis Of DHA-derived SPMs R-HSA-9018677,0.5576884701379659,0.8779792898664993,0.6984126984126984,0.8589885582500241,1.0,2/10,13.02%,ALOX12;LTC4S
prerank,KEGG_2021_Human__Huntington disease,-0.31407930533551986,-0.8776258155016065,0.8888888888888888,1.0,1.0,36/252,14.29%,SLC25A5;UQCRFS1;NDUFS5;PLCB4;COX7C;NDUFA12;POLR2K;NDUFB4;UQCRB;CREB3L4;TUBB2B;NDUFB1;ATP5PF;SLC25A4;VDAC2;ATP5MC1;NDUFC2-KCTD14;UQCRHL;NDUFV3;COX7B;ATP5PB;ATP5PD;CREB3L1;NDUFA8;GPX7;KLC3;COX5B;POLR2C;BECN1;ATP5MC3;PSMD12;NDUFS3;NDUFC1;ATG14;PSMB5;ATP5F1B
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.3314673654037943,0.8774071683455255,0.75,0.8599632900815404,1.0,36/278,18.35%,NR4A3;PRRX1;TEAD2;NR4A1;GCM2;PGR;CDK9;LSM11;PIR;TBL1X;NR1I3;YAP1;PPARG;TAF4B;GLIS3;TEAD1;NR6A1;HDAC9;NR4A2;DEAF1;MAML2;NOTCH3;RARA;RARG;RXRA;TAF1C;RORA;ZBTB1;NCOR1;MNT;WWTR1;NR2F6;HDAC7;CBFB;TBL1XR1;ZNF473
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.39183506720325056,0.8773173410511808,0.6944444444444444,0.8599239068316215,1.0,8/58,12.48%,EPHA2;TPST1;SULT4A1;ACOT4;AK3;DBI;ACOT7;ACSM5
prerank,Reactome_2022__Regulation Of Beta-Cell Development R-HSA-186712,0.45035946401682847,0.8770916298370487,0.6896551724137931,0.8600996730311514,1.0,3/23,14.00%,FOXO1;MAMLD1;MAML2
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.516947636185527,0.8770861978105332,0.6825396825396826,0.8599177515300542,1.0,5/12,11.42%,ATP1A1;SLC9A1;ATP1B1;ATP1B3;TMPRSS3
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),-0.4320740844816489,-0.8769582696495474,0.55,1.0,1.0,5/14,31.07%,CLP1;NRDE2;AGO4;PRKRA;TSN
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),0.43707029129332015,0.8769395856133181,0.6101694915254238,0.8599716733485108,1.0,9/29,18.03%,BMP8A;RAB11FIP5;SERGEF;RHBDF1;RAB11FIP1;RHBDF2;IL12A;CD200;MIDN
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.5463259868067922,-0.8768157564602588,0.6326530612244898,1.0,1.0,2/5,15.16%,SLC6A13;MT3
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.5878942816326806,0.8767276668739539,0.7142857142857143,0.8601654425273646,1.0,1/5,12.10%,DEUP1
prerank,CellMarker_Augmented_2021__Luminal cell:Prostate,0.3830026698564185,0.8766534789534085,0.6129032258064516,0.8600872136047395,1.0,14/64,9.04%,PKP2;EPHA2;EFNA1;EPS8L2;BAIAP2L1;EPB41L4B;PTPN21;RHBDF1;RHOD;PAWR;MYO1B;LAMA5;ASS1;YAP1
prerank,Reactome_2022__Reproduction R-HSA-1474165,-0.38338369294110036,-0.8765198635859222,0.5714285714285714,1.0,1.0,5/68,2.82%,H2AC20;H3-3B;TEX15;H2BC4;H2BC21
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.30629613564863223,-0.8764653641888955,0.8928571428571429,1.0,1.0,49/273,19.36%,TMEM17;CEP72;CNGA4;SSNA1;UBXN10;DYNLRB2;CEP19;FOXJ1;CETN2;CFAP221;INTU;TEKT5;WDR11;CFAP52;RSPH1;TMEM237;HAUS1;TEKT1;DYNLRB1;CEP131;RAB8A;SCLT1;EXOC7;IQCB1;CEP83;DYNC2I1;FAM149B1;TMEM250;ARF4;BBS10;BBS9;VANGL2;CCDC66;AVIL;CFAP70;DYNLL1;MKS1;TBC1D32;CEP192;UNC119B;CEP78;CEP20;DNAAF1;ARL6;EXOC1;FBF1;IFT57;RPGRIP1;TUBB
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.3103955335281619,-0.8760576353056925,1.0,1.0,1.0,36/223,20.20%,AR;OTUD3;TNFAIP3;CFTR;MCRS1;ENY2;IL33;KDM1B;ABRAXAS1;BECN1;USP27X;RAD23A;USP51;PSMD10;FOXO4;PSMD12;USP19;PSMB5;TADA2B;CLSPN;PSMB6;USP9Y;RUVBL1;PSME3;TNIP1;BRCC3;ESR1;NFRKB;PSMD2;TADA3;USP18;UBB;YOD1;SKP2;USP10;PSMB4
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.5651646964134343,0.8758604140323529,0.6530612244897959,0.8614329999308425,1.0,4/8,12.33%,SFTPD;P2RY12;CCL2;TAFA4
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.5566581551883929,0.8758317694054086,0.6779661016949152,0.8612691031457339,1.0,2/9,6.43%,YBX3;BIRC3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.4694249212072173,0.8757858573486053,0.6721311475409836,0.8611466859292931,1.0,5/29,16.34%,HELB;POLQ;CGAS;OGG1;RADX
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.5192454266562755,0.8756780106657132,0.6981132075471698,0.8611769753231487,1.0,3/13,17.58%,CLMN;SYNE3;DCTN1
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.4515691395769902,0.8755426023015475,0.6785714285714286,0.861173623526575,1.0,7/27,9.52%,ABCB1;ATP8B4;PLSCR1;ATP9A;MFSD2A;PLSCR2;ATP10A
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.4337006540828404,0.8753751930354349,0.6461538461538462,0.861296995399508,1.0,4/24,11.08%,ANK3;KCNIP4;KCNH2;KCNAB3
prerank,Reactome_2022__Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.38495903452254804,-0.8753040135603392,0.6666666666666666,1.0,1.0,10/49,20.20%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;CUL1;PSMB4
prerank,Reactome_2022__Keratan Sulfate Degradation R-HSA-2022857,0.560029164935971,0.8752999696279808,0.6865671641791045,0.8612600056569139,1.0,2/7,9.87%,OGN;OMD
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.3391953403881702,-0.8750837916629032,0.6666666666666666,1.0,1.0,14/89,15.58%,CEBPA;TRIB3;CBFA2T3;HSPA1A;RAD23A;RPL11;UFL1;ARAF;PSMD10;HFE;CLU;BAG2;TRIB1;HSPBP1
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Bone Marrow,0.5828073028110352,0.875025523644231,0.6226415094339622,0.861569424195624,1.0,2/7,4.31%,THY1;PTPRC
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),0.48003347451792183,0.8746907240528546,0.6792452830188679,0.862018264349571,1.0,2/20,3.05%,IGF1;IRS2
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.496487389854673,0.8744482587522037,0.6833333333333333,0.8622472762264217,1.0,6/13,32.70%,ARF6;ARHGAP17;KBTBD6;OGT;RASGRF1;AUTS2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.35067759368679796,0.8743946388257227,0.7076923076923077,0.8621558586891699,1.0,27/147,18.14%,NR4A3;TEAD2;NR4A1;PGR;CDK9;TBL1X;NR1I3;YAP1;PPARG;TAF4B;TEAD1;NR6A1;HDAC9;NR4A2;MAML2;NOTCH3;RARA;RARG;RXRA;TAF1C;RORA;POLR1E;NCOR1;WWTR1;NR2F6;HDAC7;TBL1XR1
prerank,Reactome_2022__Defective Factor VIII Causes Hemophilia A R-HSA-9662001,0.5992501704541339,0.8734319779638926,0.7457627118644068,0.8636631789910533,1.0,1/5,4.32%,TPST1
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.4381080031913292,-0.8732824644530761,0.6097560975609756,1.0,1.0,1/17,3.91%,SRI
prerank,Reactome_2022__Synthesis Of Dolichyl-phosphate R-HSA-446199,-0.5796417915979132,-0.8732112716138078,0.717391304347826,1.0,1.0,1/5,10.99%,DOLK
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),0.5841250722337055,0.8731567246887394,0.6346153846153846,0.8640078674181916,1.0,1/6,7.18%,RYR2
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.4497078972103803,0.8726938539772616,0.6379310344827587,0.864680260295093,1.0,5/21,19.01%,ENO2;MTM1;ENO3;ELAPOR1;MTMR3
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),0.49106274077151707,0.8724975417574615,0.6721311475409836,0.8648645477342954,1.0,5/16,12.96%,DMTN;ALOX12;SYK;PRKCD;PDPN
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.33049122401077363,0.8720809128924891,0.7794117647058824,0.8654358145531721,1.0,33/184,17.79%,TLR2;PRKCB;RELN;IRAK2;APP;NOD1;EPHA5;PPARGC1B;TRIM5;NEUROD2;MYD88;CTNNB1;SMAD3;PRKCH;BEX1;IKBKE;PPARG;HDAC4;STAT3;TERF2IP;TRIM22;ALK;TRIM32;HIPK2;IKBKG;STK3;SLCO3A1;CD200;TAB1;TRAF5;CAMK1D;WNT5A;TFRC
prerank,Reactome_2022__Formation Of Fibrin Clot (Clotting Cascade) R-HSA-140877,0.46058984351070037,0.8720508258962251,0.6470588235294118,0.8652896328881936,1.0,5/18,23.00%,TFPI;SERPIND1;SERPING1;F3;PRCP
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),0.5108186782589605,0.8715936376259216,0.6792452830188679,0.865888922755006,1.0,2/12,11.94%,MGAT3;BACE2
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),-0.48543953355119523,-0.8714397436233965,0.6666666666666666,1.0,1.0,3/12,9.33%,HEY2;HEYL;PEF1
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.5335896293154977,0.8713358997586361,0.6666666666666666,0.8661888182414376,1.0,4/11,23.89%,FAM107A;KCNB1;ULK1;EIF4G1
prerank,CellMarker_Augmented_2021__CD4+ Regulatory T cell:Undefined,-0.417434964471485,-0.8711621648891831,0.5897435897435898,1.0,1.0,5/22,6.16%,DPEP2;GMFG;CD247;CD6;P2RY10
prerank,CellMarker_Augmented_2021__Regulatory T (Treg) cell:Ascites,-0.417434964471485,-0.8711621648891831,0.5897435897435898,1.0,1.0,5/22,6.16%,DPEP2;GMFG;CD247;CD6;P2RY10
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.49915573033942306,0.8711014001138873,0.631578947368421,0.8663957682255152,1.0,3/12,15.46%,PXK;PAM16;TP53
prerank,Reactome_2022__Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,0.3495820401451902,0.871066170964443,0.7397260273972602,0.8662701234451787,1.0,8/102,10.96%,ENPP2;NMNAT2;AMN;MTHFD2;ALDH1L1;NAMPT;SHMT1;PARP9
prerank,Reactome_2022__Oxidative Stress Induced Senescence R-HSA-2559580,-0.3850917543680811,-0.8710171843198028,0.6944444444444444,1.0,1.0,6/68,5.51%,H2AC20;H3-3B;H2BC4;H2BC21;RNF2;H2AC6
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),0.4965936626014132,0.87093784568267,0.5970149253731343,0.8663094604495318,1.0,3/16,10.04%,MOB3B;WTIP;DLG5
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.4078593174121314,0.8709220618491592,0.6533333333333333,0.8661400919979766,1.0,5/45,4.40%,CXCL2;C3;S100A10;EFNA1;EPS8L2
prerank,Reactome_2022__Lysosome Vesicle Biogenesis R-HSA-432720,0.4677992373275963,0.8708318980352983,0.6615384615384615,0.8661098932171588,1.0,4/30,8.16%,SH3GL2;APP;CLTB;AP1S1
prerank,Reactome_2022__Metabolism Of Proteins R-HSA-392499,0.30187591047716517,0.8705142869799719,0.9361702127659575,0.8665355270816743,1.0,186/1507,16.67%,TGFBR2;CDKN2A;SERPINA10;C3;ST6GAL1;CHST8;ANK3;SOCS3;IGF1;CHGB;ADAMTS4;CTSC;TTLL7;SPRN;GCNT7;SGPP2;ADAMTSL2;GNG3;SP100;THBS1;FAM20C;PSCA;PCSK2;BLM;B3GNT2;CD55;CNTN4;CSF2RA;THSD7B;SFTPD;DLGAP3;RTN4RL1;APP;ASB16;NOD1;UHRF2;THY1;ACHE;OPCML;TGFA;RGS6;ADAMTS10;HIC1;CP;MDGA2;TPST1;INCENP;TUSC3;EGFL7;GALNT12;RAB15;GALNTL6;PMEPA1;RAB3C;GNG2;SEMA5B;FBXW12;LAMB1;TFPT;CHD3;IGFBP7;NOTUM;ST8SIA3;GALNT8;ADAMTS19;ZBTB16;BIRC3;VGF;PGR;NRN1;EIF2B2;SNCA;ST8SIA1;TCP1;PML;SLC17A5;SHISA5;ENPEP;RAB40B;CTNNB1;MGAT5;KIF5A;KIF5C;RPL39L;GNA14;GRIA1;ITIH2;ADGRF5;SMAD3;TUBB6;IKBKE;PPARG;PIGA;RPL3;AGTPBP1;HDAC4;FBXO32;ART3;TF;PEX14;KLHL5;CCT4;STAT3;ST8SIA4;LY6H;SMAD1;GAS6;CNTN5;NR4A2;TTLL12;FBXL16;TSPAN14;ASXL1;WSB2;POMGNT1;BARD1;CHST4;ACTR1A;B4GALT5;RAB20;USP20;EEF1A2;RPL37A;RAB30;JOSD1;SPSB1;RANGAP1;SYVN1;FN1;TFAP2C;B2M;AOPEP;KLF4;ALPL;COPZ2;CMAS;MSRA;NANS;GPS1;UBE2H;TUBA1B;ANKRD28;RNF152;TNIP2;RAB27B;THBS2;CCT8;USP49;MAN1A1;POMGNT2;HIPK2;IKBKG;SERPIND1;STAMBPL1;STS;IFIH1;RAB40A;MRTFA;RARA;ST6GALNAC2;LARGE1;OTUD7B;EIF2B5;CD59;SBSPON;RAB37;TP53;ST6GALNAC5;LSAMP;HIF3A;RAB3D;RXRA;ABCA3;CTSZ;BRCA1;FSTL1;BST1;B4GALT6;ST6GALNAC3;TAB1;NEU4;CXXC1;PIGB;SPTB;RORA;RHOT1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.42945735068063007,0.8704755840161204,0.6176470588235294,0.866412565478748,1.0,10/32,17.57%,APP;NLRP12;TMED10;MYD88;STAT3;GSDMD;USP50;NLRP2;P2RX7;WNT5A
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),0.5074434242352595,0.8704342297772657,0.6851851851851852,0.8663153995497644,1.0,3/11,20.85%,DGKG;WNT5A;DGKD
prerank,Reactome_2022__Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.39960199333969415,-0.8703951873468236,0.6666666666666666,1.0,1.0,2/30,5.09%,RFC3;POLD3
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.49870088949620406,-0.8703821904643055,0.6739130434782609,1.0,1.0,5/12,11.31%,RGCC;SERPINF2;VIM;CREB3L1;RUNX1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.3052176547566203,-0.8701623712205095,0.9523809523809523,1.0,1.0,60/291,22.42%,FBXO48;CDC26;ERCC8;SELENOS;DMAC2;SEL1L2;FBXO45;TMUB2;FBXO5;KCTD2;FBXO27;UBXN8;ZFAND2B;SPSB4;RAD23A;FBXL22;FEM1A;FOXRED2;PSMD10;ANAPC15;PSMD12;DERL2;ERLIN2;USP19;PSMB5;FBXO9;AUP1;RNF5;RNF103-CHMP3;RNF126;DCAF11;PSMB6;TRIM3;FEM1C;PSME3;RNF34;GID8;PSMD2;UBXN2A;UBB;UBE4A;CUL1;YOD1;SKP2;PSMB4;KLHL20;SHARPIN;DNAJB9;DDIT3;NHLRC3;TMUB1;UBE3D;DNAJC10;KBTBD7;RHBDD2;UBE2A;GID4;FBXL14;ATXN3;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.44493235434727063,-0.8699143863292481,0.65,1.0,1.0,5/22,8.80%,RITA1;NRARP;BEND6;METTL3;HEY1
prerank,Reactome_2022__TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,0.4414646786708459,0.8698773558483662,0.5806451612903226,0.8671421756741345,1.0,1/20,1.60%,PLK2
prerank,Reactome_2022__GP1b-IX-V Activation Signaling R-HSA-430116,-0.5214588097084734,-0.8698627064594149,0.6666666666666666,1.0,1.0,1/6,9.04%,VWF
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5228943645389477,0.8698605871919005,0.6271186440677966,0.8669702749907988,1.0,5/11,10.69%,SKAP1;TGFB2;PODXL;SYK;P2RY12
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.5818887746145934,0.869759483000287,0.7222222222222222,0.8670093867737625,1.0,4/6,32.91%,TGFB2;TGFB3;TGFB1;MSN
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),-0.48715855452040946,-0.8697365238671435,0.7058823529411765,1.0,1.0,2/11,13.28%,TRIB3;ERLIN2
prerank,CellMarker_Augmented_2021__Epithelial cell:Bladder,-0.42391978638427424,-0.8693857160896226,0.5945945945945946,1.0,1.0,7/29,11.41%,TRIM29;KRT8;CRACR2B;TMEM54;ATP2C2;EHF;B3GNT3
prerank,CellMarker_Augmented_2021__Type II pneumocyte:Undefined,-0.42391978638427424,-0.8693857160896226,0.5945945945945946,1.0,1.0,7/29,11.41%,TRIM29;KRT8;CRACR2B;TMEM54;ATP2C2;EHF;B3GNT3
prerank,CellMarker_Augmented_2021__LGR5+ Stem cell:Large Intestine,-0.39066570320049493,-0.8692857674165684,0.6666666666666666,1.0,1.0,3/29,3.17%,ATP10B;GOLT1A;CFTR
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.4462578442083995,0.869200226388499,0.6774193548387096,0.8677583039442226,1.0,10/29,28.03%,TLE6;PHLDB2;B4GALT5;RPS6KA6;TDG;NIBAN2;BAG6;CRB2;NLRP5;CLASP1
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.535076940201604,0.8691739035542485,0.7288135593220338,0.8676043797407827,1.0,5/9,20.82%,SLCO2A1;ABCC4;SLCO3A1;ABCC3;ABCC1
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant R-HSA-2660826,0.5533670220211188,0.8690997543727546,0.7272727272727273,0.8675173615119401,1.0,4/6,36.72%,ADAM17;ADAM10;DLL1;JAG2
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.42406271355713443,-0.8688285653611683,0.6,1.0,1.0,3/24,11.86%,ID2;PER3;FBXL22
prerank,Reactome_2022__PINK1-PRKN Mediated Mitophagy R-HSA-5205685,0.4634387819500896,0.8688267945101993,0.7101449275362319,0.8678261789335314,1.0,5/20,23.69%,MAP1LC3A;PINK1;RPS27A;TOMM40;PRKN
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),-0.5652389345317644,-0.8686339460534334,0.6346153846153846,1.0,1.0,1/5,3.74%,ORMDL1
prerank,PanglaoDB_Augmented_2021__Follicular Cells,-0.3796717958175958,-0.8686151574954858,0.6470588235294118,1.0,1.0,17/42,18.79%,CYP4F3;PIK3C2G;C6;ADH4;NCMAP;FRK;CYP4F12;SPTLC3;ACKR2;SLC3A1;TSHR;KCNIP3;FMO5;PON3;PRLR;F11;TTF1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.49653891092586827,0.8683726694248082,0.6666666666666666,0.8684971647250251,1.0,2/14,12.47%,CD44;BCL2
prerank,Reactome_2022__Translocation Of ZAP-70 To Immunological Synapse R-HSA-202430,0.5502851479614045,0.8683126942656599,0.6923076923076923,0.8684177133996999,1.0,1/5,0.56%,HLA-DRA
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.38346204313342136,0.8681477432547057,0.6428571428571429,0.8685463378720197,1.0,9/55,13.58%,IGF1;SP100;THBS1;FAS;PML;STX4;TMC8;TNFRSF10B;FADD
prerank,Reactome_2022__TNFR1-induced Proapoptotic Signaling R-HSA-5357786,-0.4660385375606976,-0.8679685555085007,0.6153846153846154,1.0,1.0,1/12,1.79%,TNFAIP3
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.41948711714865544,-0.8679572590655839,0.6842105263157895,1.0,1.0,3/23,2.28%,DAO;GOLT1A;FGL1
prerank,Reactome_2022__Beta Oxidation Of octanoyl-CoA To hexanoyl-CoA R-HSA-77348,0.568602354161876,0.8678736619689644,0.7017543859649122,0.8688110005217466,1.0,1/5,7.02%,HADH
prerank,Reactome_2022__Diseases Of Programmed Cell Death R-HSA-9645723,-0.3953913981758595,-0.8678516612611196,0.7297297297297297,1.0,1.0,7/48,5.51%,H2AC20;H3-3B;DNMT3B;H2BC4;H2BC21;PRDX1;H2AC6
prerank,Reactome_2022__Antigen processing-Cross Presentation R-HSA-1236975,0.3767187281355911,0.8678429921550512,0.6842105263157895,0.8686442454821092,1.0,2/82,1.13%,TLR2;CTSS
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),0.39121013819397715,0.8677736671206205,0.6212121212121212,0.868567398657271,1.0,10/45,10.74%,CNTNAP1;SHTN1;DAB2IP;CNTNAP2;NYAP2;WASF1;NYAP1;MINK1;PACSIN1;TRIO
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.375029054423617,0.86767619846456,0.6851851851851852,0.8685316439041935,1.0,27/99,24.36%,INCENP;PADI2;TBL1X;HDAC4;MORF4L2;HDAC9;PRKCD;CDK2;TBL1XR1;PRMT1;RPS6KA4;MTA1;TAF10;MORF4L1;MTA3;RCOR1;UBE2B;ATXN7;CCNA2;TRERF1;MIDEAS;CARM1;NSD1;RPS6KA5;UHRF1;SUPT3H;HDAC5
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),-0.38853925670949474,-0.8675379285701228,0.6538461538461539,1.0,1.0,5/68,7.12%,G0S2;KSR2;LEPR;SIRT6;CXCR4
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.46567697921320933,0.8675240848458948,0.6666666666666666,0.868613920734488,1.0,8/23,17.46%,PROX1;CHI3L1;ITGA3;GLI2;PDPN;FGF2;ABCA3;RCN3
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.5083254789550058,0.8674650007273564,0.6440677966101694,0.868567911542111,1.0,3/13,5.50%,CD22;SH3KBP1;AHR
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.41241015566051187,-0.8673954371489455,0.6470588235294118,1.0,1.0,2/24,1.54%,MID1IP1;TPX2
prerank,Reactome_2022__G Alpha (S) Signaling Events R-HSA-418555,0.3871336023017115,0.8673681479642561,0.7230769230769231,0.8685014073101628,1.0,16/81,11.72%,GNG3;ADCY5;PRKAR1B;GIPR;RXFP1;GNG2;PDE1A;ADCY7;PDE8B;ADCY2;RAMP3;GLP1R;GRK2;GNAZ;PDE1B;PDE10A
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.3870997691045097,0.8671259227146398,0.6521739130434783,0.8687733616853888,1.0,12/75,12.47%,KIF14;EPHA7;GRID2;PRKCG;AGAP2;FOXO3;MAG;CTNNB1;TGFB2;VSTM2L;CCL2;BCL2
prerank,Reactome_2022__Regulation Of Signaling By NODAL R-HSA-1433617,-0.5439839087047749,-0.8670301588821775,0.5681818181818182,1.0,1.0,1/5,9.26%,ACVR1C
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.4513379967198141,-0.8666397313114568,0.6744186046511628,1.0,1.0,2/12,10.58%,DNMT3B;KMT2A
prerank,CellMarker_Augmented_2021__Late Transit-Amplifying Prostate Epithelial cell:Prostate,-0.43881334591815696,-0.8666355860817306,0.6,1.0,1.0,6/22,11.41%,TRIM29;TMEM54;S100A16;ATP2C2;EHF;B3GNT3
prerank,CellMarker_Augmented_2021__Early Transit-Amplifying Prostate Epithelial cell:Prostate,-0.43881334591815696,-0.8666355860817306,0.6,1.0,1.0,6/22,11.41%,TRIM29;TMEM54;S100A16;ATP2C2;EHF;B3GNT3
prerank,Reactome_2022__Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.3232263808932238,-0.8665835501708442,0.8387096774193549,1.0,1.0,25/159,16.71%,ARF5;KIF21B;KIF6;KIF4A;STX16;ARFIP2;KIF20B;GOLGA1;PLIN3;COPB2;KIF15;KLC3;COPE;TMED2;RABEPK;TMED9;ARCN1;ARF4;COG6;KDELR1;NAPSA;DYNLL1;GCC1;RAB33B;RAB1B
prerank,Reactome_2022__Beta Oxidation Of decanoyl-CoA To octanoyl-CoA-CoA R-HSA-77346,0.5636983755786305,0.8664960313103215,0.6727272727272727,0.8698321259645492,1.0,1/6,7.02%,HADH
prerank,CellMarker_Augmented_2021__Suppressor T cell:Peripheral Blood,0.44400491276863957,0.866420245991466,0.6875,0.8697807626780374,1.0,6/22,4.31%,CTSS;MYO1F;PLEK;SLA;WAS;PTPRC
prerank,CellMarker_Augmented_2021__Eosinophil:Sinonasal Mucosa,0.4430625301497415,0.8664055707576847,0.6461538461538462,0.8696166871770507,1.0,5/25,5.76%,PRSS57;PLEK;WAS;LAT2;GAB3
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),0.4618203586593612,0.866217772130718,0.7192982456140351,0.8697011585307862,1.0,3/14,12.68%,HDAC4;HDAC9;PER1
prerank,Reactome_2022__Organic Anion Transporters R-HSA-428643,0.5825410059402966,0.8661965762473545,0.6538461538461539,0.8695653443977543,1.0,1/5,7.49%,SLC17A5
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.5158564037989355,0.8661476747414424,0.6724137931034483,0.8694628762386106,1.0,4/11,22.96%,RNF152;STK11;SPAAR;SESN1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.598453651133571,0.8659489605743987,0.6779661016949152,0.8692376236390817,1.0,2/5,27.80%,MAN1A1;EDEM1
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.598453651133571,0.8659489605743987,0.6779661016949152,0.8692376236390817,1.0,2/5,27.80%,MAN1A1;EDEM1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.598453651133571,0.8659489605743987,0.6779661016949152,0.8692376236390817,1.0,2/5,27.80%,MAN1A1;EDEM1
prerank,Reactome_2022__Organic Cation Transport R-HSA-549127,-0.5511735627685801,-0.8650605042211359,0.6976744186046512,1.0,1.0,3/7,22.45%,RUNX1;SLC22A15;SLC22A2
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.3901981351628049,-0.8650484362081134,0.7045454545454546,1.0,1.0,4/37,5.43%,SPRY1;RGS2;APOE;PTPN22
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.4317026574683027,0.864992640839411,0.5964912280701754,0.8707086106513653,1.0,7/30,17.07%,BICDL1;TRAK1;PEX14;MAPT;HAP1;RHOT1;RHOT2
prerank,CellMarker_Augmented_2021__T cell:Skin,-0.45028490180916647,-0.8649744411088872,0.6,1.0,1.0,6/22,6.16%,APOBEC3G;CD96;PYHIN1;PTPN22;CD6;P2RY10
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.542821358407527,0.8648528664699671,0.6,0.870815729307385,1.0,2/6,30.91%,UBE2E1;UBE2E2
prerank,Reactome_2022__CLEC7A (Dectin-1) Signaling R-HSA-5607764,0.3724044452678119,0.8646751912909174,0.7272727272727273,0.870976499177934,1.0,17/86,23.35%,MAP3K14;NFATC2;ITPR3;SYK;PRKCD;RELB;IKBKG;TAB1;ITPR1;SKP1;NFATC3;AHCYL1;RPS27A;TAB2;CARD11;PPP3CB;PSMB3
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.41051281407618506,0.8643592348577727,0.71875,0.871380066231448,1.0,10/44,13.58%,BOK;SEPTIN4;DAB2IP;FAS;PML;BCL2L1;BBC3;TPD52L1;BCL2;FADD
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),-0.45715382624774153,-0.8643192820360772,0.6122448979591837,1.0,1.0,2/15,4.36%,DISP3;APOE
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.41967110955705644,-0.8641905622277298,0.5909090909090909,1.0,1.0,3/25,11.86%,ID2;PER3;FBXL22
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),-0.30251294052949806,-0.8639738952437874,0.9166666666666666,1.0,1.0,67/326,14.02%,MRPL10;RPL35A;RPS24;CST3;RPL34;CTSH;RPL39;MRPS21;PADI4;RPL13;RPL37;MRPL52;RPS28;MCRS1;APOE;MRPS7;RPL18;MSRB1;CCN1;RPL12;RPL23;RPL31;MRPL36;MRPS16;MRPL18;RPS26;CKAP4;RPL6;RPL41;RPS13;RPL22;RPL29;PRSS23;RPL30;TNC;ASMT;RPSA;TMEM132A;UBE2M;FUCA2;RPL14;YES1;SPCS1;SPARCL1;SERP1;RPL15;ICMT;EEF1A1;RPS2;ADA2;NCSTN;IGF2BP3;CALU;RPL11;SEPHS1;RPL23A;HTRA2;ARAF;CCDC59;FSTL3;MRPS18B;RPS21;MRPS33;SCG3;SPCS2;GGCX;YME1L1
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.520417168769564,-0.8638588128639783,0.6744186046511628,1.0,1.0,2/5,9.84%,AGBL1;AGBL2
prerank,KEGG_2021_Human__Thiamine metabolism,0.5360579337796727,0.863487118916875,0.6785714285714286,0.8727956085726367,1.0,2/11,13.04%,AK5;ALPL
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.47744270188704957,-0.8634135004691007,0.6857142857142857,1.0,1.0,4/19,13.40%,EXOSC8;ERI2;UTP20;RPS21
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.36569667758845664,0.8629870003645694,0.6545454545454545,0.8735563497241041,1.0,15/85,13.58%,ST18;BOK;NOD1;NLRP12;FAS;SNCA;CASP10;SMAD3;PPARG;SYK;BBC3;MAPT;NLRP2;TNFRSF10B;FADD
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.40440544173276255,0.8629096099228972,0.6753246753246753,0.8735145433388208,1.0,11/37,24.62%,MAP1LC3A;ATG9A;PINK1;SPATA18;CTSK;GABARAPL1;WDR45;ULK1;ATG7;PRKN;GABARAPL2
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),0.5588551594319162,0.8628020809031324,0.6666666666666666,0.8735289489423431,1.0,5/7,34.82%,NCAM1;NFIB;NRP1;EPHB2;VEGFA
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.4853993290037609,0.8628015377952181,0.6440677966101694,0.8733390529852411,1.0,1/13,2.01%,MAEL
prerank,Reactome_2022__Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.3356994588265391,-0.8627894258055048,0.7435897435897436,1.0,1.0,5/62,10.46%,CEP72;SSNA1;CETN2;HAUS1;CEP131
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.46528319048459854,0.8625319642979252,0.6557377049180327,0.8735934848986301,1.0,4/18,24.82%,TINF2;EXOSC10;ACD;PIF1
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.41653910297015956,0.8624575220128551,0.7142857142857143,0.8735185238106034,1.0,4/31,13.71%,GLRA2;GRIN1;NEURL1;GLRA3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.4629036099747041,0.8624050667310571,0.6779661016949152,0.8734180756960721,1.0,4/22,16.16%,PML;TERF2IP;MRE11;TINF2
prerank,Reactome_2022__BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,0.5002304500618571,0.8622587994941578,0.7450980392156863,0.873496272721787,1.0,3/19,14.26%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),0.5056971098640661,0.8622467510008222,0.7,0.8729427821759748,1.0,2/11,22.83%,CDC27;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.5056971098640661,0.8622467510008222,0.7,0.8729427821759748,1.0,2/11,22.83%,CDC27;CUL3
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.5056971098640661,0.8622467510008222,0.7,0.8729427821759748,1.0,2/11,22.83%,CDC27;CUL3
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),0.5390277342028365,0.8620419327531966,0.6938775510204082,0.8731306304202113,1.0,3/8,27.19%,LMTK2;ARFGEF2;NSG1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.5405697396285047,-0.8619907415556558,0.625,1.0,1.0,1/6,1.49%,RIOK2
prerank,Reactome_2022__Protein Repair R-HSA-5676934,-0.5368071872851029,-0.8619788984000006,0.6739130434782609,1.0,1.0,2/6,16.42%,MSRB1;TXN2
prerank,Reactome_2022__Insulin Receptor Recycling R-HSA-77387,-0.44136267497690773,-0.8612395193749984,0.6590909090909091,1.0,1.0,3/20,13.77%,ATP6V1E2;ATP6V1G1;ATP6V1F
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.4607891794348008,0.8611680320505865,0.6727272727272727,0.8744346989267102,1.0,8/18,24.47%,MYH9;ADAM19;BACE2;ADAM17;ADAM9;SPPL2B;PSEN1;SPPL3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),0.4763230183757441,0.8609780182965264,0.6,0.8746425212276645,1.0,3/9,26.17%,IL12A;CSF1;MAPK3
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.3879362650522112,0.860889835229508,0.6911764705882353,0.8746235232178554,1.0,7/84,8.72%,TLR2;SULF1;APP;HIC1;NOTUM;CTNNB1;ITGA3
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.49764438675752376,-0.8608888649839643,0.5333333333333333,1.0,1.0,2/6,9.35%,ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.49764438675752376,-0.8608888649839643,0.5333333333333333,1.0,1.0,2/6,9.35%,ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.49764438675752376,-0.8608888649839643,0.5333333333333333,1.0,1.0,2/6,9.35%,ELOVL4;ELOVL2
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.49764438675752376,-0.8608888649839643,0.5333333333333333,1.0,1.0,2/6,9.35%,ELOVL4;ELOVL2
prerank,Reactome_2022__Anchoring Fibril Formation R-HSA-2214320,-0.5425818131717882,-0.8605371432543325,0.6909090909090909,1.0,1.0,1/5,1.26%,LAMA4
prerank,CellMarker_Augmented_2021__Urothelium cell:Undefined,-0.45039678361680463,-0.8605321993074642,0.6774193548387096,1.0,1.0,4/19,5.08%,DPEP2;CEBPA;PRAM1;MSRB1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),0.5657507485994523,0.8605131776097289,0.71875,0.8751495822773432,1.0,3/5,40.16%,NUCKS1;VAPA;YTHDC2
prerank,CellMarker_Augmented_2021__Interstitial cell:Dorsolateral Prefrontal Cortex,0.3768124037678728,0.8601752894934448,0.8225806451612904,0.8755480903480545,1.0,10/76,16.59%,CTSS;SP100;MYD88;OSTF1;PARP9;APOL3;B2M;IFIH1;CTBS;SP140L
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.38362638454375647,0.8601726093138086,0.6571428571428571,0.8753608806641017,1.0,16/67,21.89%,PLK2;DAB2IP;FOXO1;HECW2;BARD1;HECW1;CDKN1B;OAZ2;TRIM32;SMURF1;WNT5A;PLK3;VIP;ADAM9;RAB7A;DDB1
prerank,Reactome_2022__Miro GTPase Cycle R-HSA-9715370,0.5538628566286558,0.8600061568486199,0.7241379310344828,0.8754690055386571,1.0,3/8,17.07%,TRAK1;RHOT1;RHOT2
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.45870714737116647,-0.859979376598974,0.717391304347826,1.0,1.0,2/11,16.32%,POLD3;XPA
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),0.5461210352129467,0.859955825638331,0.6851851851851852,0.8753709606169726,1.0,2/6,37.89%,LIN28B;NFKB1
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),0.5238937408713187,0.8598818949011058,0.6610169491525424,0.8752984003498979,1.0,6/12,26.53%,HDAC9;PCSK5;SORT1;ANGPTL4;PCSK6;FURIN
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.35805296738093884,-0.8598740664128305,0.7105263157894737,1.0,1.0,25/81,23.21%,ERCC8;GTF2H2;NOC2L;EIF2S1;BAK1;METTL3;ERCC2;USF1;ATR;PRIMPOL;ERCC6;TRIAP1;MEN1;XPA;CIRBP;SMPD1;ERCC3;GPX1;CAT;PARP1;UBE2A;AQP1;CASP9;MAP3K4;YY1
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5313268160993003,0.8597814616352072,0.6779661016949152,0.8753021800236196,1.0,1/9,9.20%,SEC14L1
prerank,CellMarker_Augmented_2021__Hematopoietic cell:Undefined,0.4293089321130963,0.8596266366292615,0.6617647058823529,0.87516735510724,1.0,8/39,7.24%,CTSS;MYO1F;PLEK;SLA;WAS;PTPRC;CD37;ACAP1
prerank,CellMarker_Augmented_2021__White Blood cell:Blood,0.4293089321130963,0.8596266366292615,0.6617647058823529,0.87516735510724,1.0,8/39,7.24%,CTSS;MYO1F;PLEK;SLA;WAS;PTPRC;CD37;ACAP1
prerank,Reactome_2022__HDL Assembly R-HSA-8963896,0.5679434152557565,0.8592159897548022,0.6415094339622641,0.8756846308416416,1.0,2/5,24.08%,PRKCA;BMP1
prerank,CellMarker_Augmented_2021__Plasmacytoid Dendritic cell:Peripheral Blood,-0.4181005152251187,-0.8591880829082686,0.7,1.0,1.0,4/23,4.08%,DPEP2;GMFG;CD247;C1ORF162
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.5099052432141429,-0.8590915010962961,0.7254901960784313,1.0,1.0,1/11,5.74%,HEYL
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.5224048996316033,-0.8583050410994836,0.6666666666666666,1.0,1.0,5/8,32.55%,MT3;OXA1L;SIRT4;ECSIT;SZT2
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),0.5342374189026131,0.8580472161612923,0.7142857142857143,0.8774977796900553,1.0,1/8,15.51%,CPNE7
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.5222277677594942,0.85760439280588,0.7222222222222222,0.8780803790138917,1.0,3/9,21.30%,HLA-DRB1;CD4;CSF1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.450373727421639,0.8575283614659536,0.625,0.8780022557628504,1.0,4/19,15.46%,PML;HIPK1;HIPK2;TP53
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),0.5456779524715905,0.8574557252281929,0.7450980392156863,0.8779038491308396,1.0,3/10,9.88%,STAC2;PVALEF;TCAP
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.5761074510508357,0.8573640556647436,0.6842105263157895,0.8778562685243232,1.0,3/5,23.95%,IL12A;TNFSF4;PRNP
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.4382525334403569,-0.8573192783959702,0.6296296296296297,1.0,1.0,2/16,7.36%,HEYL;MAML3
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),0.5279164668959049,0.8571588209925749,0.7021276595744681,0.8780701834775446,1.0,2/8,14.07%,SLC7A7;SLC7A1
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.508304168353147,-0.8571266340497222,0.627906976744186,1.0,1.0,5/8,28.83%,DERL2;YOD1;ERLEC1;SVIP;OS9
prerank,Reactome_2022__Rab Regulation Of Trafficking R-HSA-9007101,0.3533285316585176,0.8570764353215248,0.7903225806451613,0.8780403535223217,1.0,27/106,24.62%,ALS2CL;TBC1D24;DENND3;SBF1;RAB3IL1;RIN2;DENND4A;ARF6;OPTN;RAB27B;TBC1D10B;TBC1D10A;GGA1;YWHAE;TSC2;RAB39A;RAB11A;AKT3;TRAPPC9;RAB7A;DENND6B;ULK1;TRAPPC6B;RAB3A;GGA2;RIN3;GABARAPL2
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),-0.4858484244667452,-0.856985718672949,0.6511627906976745,1.0,1.0,1/9,1.47%,ADAMTS18
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.367828025937766,0.8567927157791493,0.6307692307692307,0.8782338346944243,1.0,10/64,19.14%,SEPTIN4;FAM107A;BIRC3;HDAC4;PHF23;PRICKLE1;PINK1;BRCA1;NDFIP2;PIAS1
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),0.5357779393174049,0.8565120095070959,0.6981132075471698,0.8785692988427544,1.0,3/10,19.03%,PADI2;ZMIZ1;ARID1A
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),-0.4543350244775489,-0.8564027053208256,0.6739130434782609,1.0,1.0,5/13,30.51%,DNASE2;KPNB1;EXOG;CASP3;ENDOG
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),0.5591350906430642,0.8563883429886942,0.75,0.8786078611775113,1.0,1/6,0.85%,ANXA1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",-0.39491583877903447,-0.8563009578946946,0.7368421052631579,1.0,1.0,5/35,9.66%,RFC3;GTF2H5;POLD3;GTF2H2;ERCC2
prerank,KEGG_2021_Human__Non-alcoholic fatty liver disease,-0.3466323899544406,-0.8556634486560009,0.6923076923076923,1.0,1.0,20/118,13.26%,UQCRFS1;NDUFS5;CEBPA;COX7C;NDUFA12;NDUFB4;LEPR;UQCRB;NDUFB1;NDUFC2-KCTD14;EIF2S1;UQCRHL;NDUFV3;COX7B;NDUFA8;COX5B;ADIPOR1;MLX;NDUFS3;NDUFC1
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.3824042680204373,0.8553178233518087,0.6785714285714286,0.8802465044263272,1.0,7/56,12.53%,ACSL5;LIPH;AGPAT4;CYP21A2;OLAH;ACSM5;PAM
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),-0.44578552079921835,-0.8549676746219189,0.5555555555555556,1.0,1.0,2/14,7.09%,TPT1;SFRP2
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.4740983024018443,0.8548902964023181,0.6666666666666666,0.8808424398131469,1.0,1/15,7.43%,RAMP3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.3179760598779231,-0.8548455710879654,0.8333333333333334,1.0,1.0,9/163,6.18%,CDC26;ID2;RIOK2;CEP72;TPX2;SSNA1;RGCC;FBXO5;CETN2
prerank,CellMarker_Augmented_2021__Class-switched Memory B cell:Peripheral Blood,0.43751873312783385,0.8548212740202239,0.7142857142857143,0.8796427002414821,1.0,7/24,12.64%,NAPSB;WAS;CD37;ACAP1;CD5;ITGAL;TMC8
prerank,CellMarker_Augmented_2021__Double-negative Memory B cell:Peripheral Blood,0.43751873312783385,0.8548212740202239,0.7142857142857143,0.8796427002414821,1.0,7/24,12.64%,NAPSB;WAS;CD37;ACAP1;CD5;ITGAL;TMC8
prerank,CellMarker_Augmented_2021__Memory B cell:Blood,0.43751873312783385,0.8548212740202239,0.7142857142857143,0.8796427002414821,1.0,7/24,12.64%,NAPSB;WAS;CD37;ACAP1;CD5;ITGAL;TMC8
prerank,CellMarker_Augmented_2021__Switched Memory B cell:Peripheral Blood,0.43751873312783385,0.8548212740202239,0.7142857142857143,0.8796427002414821,1.0,7/24,12.64%,NAPSB;WAS;CD37;ACAP1;CD5;ITGAL;TMC8
prerank,CellMarker_Augmented_2021__Non-switched Memory B cell:Peripheral Blood,0.43751873312783385,0.8548212740202239,0.7142857142857143,0.8796427002414821,1.0,7/24,12.64%,NAPSB;WAS;CD37;ACAP1;CD5;ITGAL;TMC8
prerank,CellMarker_Augmented_2021__Double-negative B cell:Peripheral Blood,0.43751873312783385,0.8548212740202239,0.7142857142857143,0.8796427002414821,1.0,7/24,12.64%,NAPSB;WAS;CD37;ACAP1;CD5;ITGAL;TMC8
prerank,CellMarker_Augmented_2021__IgG Memory B cell:Undefined,0.43751873312783385,0.8548212740202239,0.7142857142857143,0.8796427002414821,1.0,7/24,12.64%,NAPSB;WAS;CD37;ACAP1;CD5;ITGAL;TMC8
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.4788714597157058,0.8547581701383675,0.6428571428571429,0.8795746491678783,1.0,5/19,11.18%,PSCA;LIPH;CAPN8;KPNA7;CLDN18
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.44969114608921706,0.8546943422573917,0.746268656716418,0.8795218094673551,1.0,7/25,25.78%,CDKN1A;TP53;TINF2;EXOSC10;ACD;PIF1;NIBAN2
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),0.6000825257538938,0.8542867198819555,0.7307692307692307,0.8801039537897513,1.0,1/6,3.96%,PRPS2
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.3711140014808868,0.8541657769404579,0.7868852459016393,0.8801420718815889,1.0,5/73,3.45%,MET;IGF1;EGF;APP;ADD2
prerank,KEGG_2021_Human__Chemical carcinogenesis,0.3394453174484327,0.8540169101199038,0.7848101265822784,0.8802105167970927,1.0,25/152,13.84%,EGF;CREB5;GSTT2;PRKCB;ADCY5;PRKCG;RPS6KA1;BCL6;AHR;AIPL1;PGR;ADCY7;CACNA1C;ADCY2;CYP1B1;KPNA7;NR1I3;IKBKE;STAT3;BCL2;KLF4;RPS6KA6;CCND1;FGF2;RPS6KB2
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.3777328930505839,0.8539707462727596,0.7272727272727273,0.880114607324928,1.0,7/46,11.17%,CD24;ABCA5;FABP3;SOAT1;LDLR;ABCA2;HDAC9
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.40985567262045786,0.8538291769510197,0.7538461538461538,0.8801451156028148,1.0,6/35,14.26%,BLM;POLD1;CDK9;EME2;DONSON;TRAIP
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.34216137822481973,-0.8537796734423737,0.7045454545454546,1.0,1.0,15/74,16.71%,ARF5;DNAJC28;TMEM115;KIF4A;USE1;COPB2;KIF15;COPE;TMED2;TMED9;ARCN1;ARF4;ERGIC3;KDELR1;RAB1B
prerank,CellMarker_Augmented_2021__Migration Phase Fetal Germ cell:Fetal Gonad,-0.31866975032606043,-0.8536076025747841,0.7307692307692307,1.0,1.0,19/117,10.80%,LAMA4;NDUFS5;VAMP8;CD38;MRPS21;CXCL14;RBM8A;NLRP9;SAT1;IGSF1;ZNF593;WDHD1;RPS27L;COX7B;HMGB3;BOLA3;PPIH;APRT;ETFB
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.3834515455537408,0.8534481228045653,0.7014925373134329,0.8806203568484086,1.0,11/57,20.43%,SMCR8;TNFAIP8L1;GNA12;GAS6;MAPKAPK5;TTI1;RFFL;TSC2;TELO2;RRAGD;RHEB
prerank,Reactome_2022__Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,0.46631710253808206,0.8532183505577902,0.7213114754098361,0.8808907511771293,1.0,1/18,3.17%,APP
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),0.538591986173573,0.8531937878790916,0.6222222222222222,0.8807442597503757,1.0,1/7,14.96%,PUM1
prerank,KEGG_2021_Human__Arginine biosynthesis,0.47759698261186145,0.8531158316119889,0.7313432835820896,0.8806660156816963,1.0,2/13,8.19%,GPT2;ASS1
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.43212038991579993,0.8527024443064745,0.7719298245614035,0.8811912247181977,1.0,5/30,15.38%,ANXA1;CYP1B1;RNF112;PRKCD;MAP3K5
prerank,KEGG_2021_Human__Renin-angiotensin system,0.48325175155075645,0.8526385208706925,0.6440677966101694,0.8810952478806984,1.0,5/12,32.02%,ENPEP;PRCP;MME;REN;THOP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.5289510044106336,0.8524115478090378,0.6666666666666666,0.8812895344688678,1.0,1/6,8.06%,SLC9A1
prerank,CellMarker_Augmented_2021__Induced Regulatory T (Treg) cell:Peripheral Blood,-0.4182720032589802,-0.8524096667818157,0.6904761904761905,1.0,1.0,6/22,6.16%,GMFG;CD247;CD96;PYHIN1;CD6;P2RY10
prerank,Reactome_2022__ABC Transporter Disorders R-HSA-5619084,-0.3392914773693817,-0.8521087029529124,0.7941176470588235,1.0,1.0,23/67,25.95%,CFTR;ABCD1;ABCB11;PSMD10;PSMD12;DERL2;ERLIN2;PSMB5;RNF5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4;ERLIN1;VCP;ERLEC1;ABCC6;PSMA1;DERL1;PSMD11;ABCA1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.42147796919933794,0.8520707894304944,0.6727272727272727,0.8816729702518592,1.0,8/32,17.79%,LIMK2;YAP1;PARP9;CTNNA1;OTUD7B;MFHAS1;WWTR1;TFRC
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),0.5164559056503767,0.851909391984882,0.7454545454545455,0.8817585761260465,1.0,5/11,16.81%,TYMS;MTHFD2;SHMT1;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.38602624268307867,0.8518869828599853,0.6470588235294118,0.8816196850504693,1.0,14/65,16.31%,STMN2;SLIT2;SHANK3;SNCA;LDLR;SHANK1;SSH2;CYRIB;EML2;FGF13;PRKCD;CAMSAP3;STMN1;PFN2
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.5025929420986325,0.8518314978894593,0.7241379310344828,0.881533805281162,1.0,4/12,12.29%,PDGFRA;ALOX12;PDGFA;PRKCD
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.5306057587653368,-0.851708194456417,0.6382978723404256,1.0,1.0,2/7,8.25%,PTPN22;MICA
prerank,Reactome_2022__PI5P Regulates TP53 Acetylation R-HSA-6811555,0.49830736221500316,0.8516436879912196,0.6428571428571429,0.8816193855675606,1.0,3/9,15.46%,PDZD2;PIP4K2A;TP53
prerank,CellMarker_Augmented_2021__Epithelial Progenitor cell:Lung,0.4390827119574905,0.8515013705325238,0.6785714285714286,0.881692326767451,1.0,5/27,8.03%,PTK6;LIPH;TJP3;POF1B;CAPN8
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.5248091465562045,0.8514579703492189,0.7254901960784313,0.8815712096508415,1.0,3/7,10.92%,GRID2;SHANK3;MAPT
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.3910608964944329,-0.8514061076165768,0.65,1.0,1.0,2/28,6.51%,MEOX2;SCPEP1
prerank,Reactome_2022__ROS And RNS Production In Phagocytes R-HSA-1222556,-0.4337359916937014,-0.8513639758408503,0.6041666666666666,1.0,1.0,4/21,16.67%,ATP6V1E2;ATP6V1G1;ATP6V1F;NANOS1
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.44076330643271755,-0.8513173122184075,0.6052631578947368,1.0,1.0,1/12,2.32%,HSD17B8
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.47270747335148716,0.8512145499812823,0.6666666666666666,0.8817902477586986,1.0,3/12,9.40%,KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.48042388562077587,0.8511760656122953,0.6379310344827587,0.88165656834634,1.0,3/15,15.19%,YTHDF1;RPS6KB2;EIF2B5
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.3568860192832999,0.8510853101418345,0.7763157894736842,0.8816362652849127,1.0,15/108,14.29%,NLGN1;ZDHHC9;ZDHHC22;CACNG3;PARD3;MYO1C;TRAK1;MICALL1;ZDHHC7;ZDHHC1;NACAD;KIF13B;VPS37B;HAP1;MAN1A1
prerank,PanglaoDB_Augmented_2021__Clara Cells,-0.3855068023288964,-0.8507748524823945,0.627906976744186,1.0,1.0,10/36,11.41%,TRIM29;LEPR;ALDH1A1;TMC5;SCEL;TEKT1;ATP2C2;EHF;TFCP2L1;B3GNT3
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),-0.5046716971162272,-0.8504866101373003,0.723404255319149,1.0,1.0,1/12,0.79%,ID2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.43530281459776193,-0.8503817070718219,0.7027027027027027,1.0,1.0,3/22,15.08%,SNF8;VPS4B;RNF126
prerank,Reactome_2022__Phase 2 - Plateau Phase R-HSA-5576893,0.49790479696644296,0.8497770863112056,0.6610169491525424,0.8836854684622394,1.0,5/12,9.70%,KCNQ1;KCNE4;CACNA1C;CACNG8;CACNG4
prerank,Reactome_2022__HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.3347939865272079,-0.849755900980053,0.7222222222222222,1.0,1.0,18/57,21.52%,RFC3;ATRIP;HUS1;POLD3;BRIP1;RAD9B;RMI2;POLR1B;SLC19A1;DNA2;SEM1;MUS81;RAD51;UBB;RAD17;SLX4;XRCC2;BRCA2
prerank,Reactome_2022__InlA-mediated Entry Of Listeria Monocytogenes Into Host Cells R-HSA-8876493,0.530223040857317,0.8496611348533369,0.6851851851851852,0.8837201096132846,1.0,2/8,19.96%,CTNNB1;RPS27A
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),0.5138912449253903,0.849510014163494,0.76,0.8837572522661435,1.0,3/12,11.54%,GLYATL2;OLAH;ACOT7
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.3156942297850268,-0.8492946621072535,0.8378378378378378,1.0,1.0,14/88,19.36%,CEP72;SSNA1;CETN2;HAUS1;CEP131;SCLT1;IQCB1;CEP83;DYNLL1;MKS1;CEP192;CEP78;FBF1;TUBB
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.46840123520613075,0.8491257307177247,0.7115384615384616,0.8842170663444149,1.0,5/14,26.48%,NRG1;MESP1;SORT1;KDM6B;MYEF2
prerank,Reactome_2022__Signaling By RAF1 Mutants R-HSA-9656223,-0.36601832270154466,-0.8491044025057992,0.7241379310344828,1.0,1.0,4/33,13.52%,KSR2;VWF;ARAF;NRAS
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),-0.46178266115188527,-0.8490278737252829,0.6428571428571429,1.0,1.0,1/12,6.62%,BCAP31
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),-0.3993138087931389,-0.8490245818395507,0.7368421052631579,1.0,1.0,10/23,27.12%,PPP1R35;PPP1R11;ZCCHC9;BOD1L1;PTPA;PPP1R26;SH3RF2;GPATCH2;MASTL;STYXL1
prerank,Reactome_2022__TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,-0.48835672022916343,-0.8489916129282921,0.6190476190476191,1.0,1.0,1/11,1.41%,CCNE1
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.425772020555525,0.8489770410440223,0.7666666666666667,0.8843094249587303,1.0,6/33,16.61%,BLM;GADD45A;CDKN1A;RGR;TP53;RRH
prerank,Reactome_2022__Acetylcholine Binding And Downstream Events R-HSA-181431,0.5286423145295324,0.8488964382886363,0.5714285714285714,0.8840439515387535,1.0,1/6,1.59%,CHRNA5
prerank,Reactome_2022__Presynaptic Nicotinic Acetylcholine Receptors R-HSA-622323,0.5286423145295324,0.8488964382886363,0.5714285714285714,0.8840439515387535,1.0,1/6,1.59%,CHRNA5
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 27-Hydroxycholesterol R-HSA-193807,-0.4619021606050032,-0.8488075363942982,0.6875,1.0,1.0,3/10,11.63%,AKR1C3;PTGIS;CYP7B1
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.45077964249598745,-0.8488069513981996,0.6511627906976745,1.0,1.0,7/11,21.42%,NT5E;NT5C;NUDT15;PNP;GPX1;ITPA;NT5C1A
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),-0.4907434953859781,-0.8487899177643154,0.6428571428571429,1.0,1.0,3/12,23.68%,TMED9;SNX2;SURF4
prerank,Reactome_2022__SARS-CoV-2 Infection R-HSA-9694516,0.3285819066320251,0.8485657989963958,0.8354430379746836,0.8844731387787129,1.0,14/238,9.30%,ST6GAL1;TLR2;YWHAH;ZDHHC9;SFTPD;IRAK2;IRF7;NOD1;NLRP12;TUSC3;AGRN;MGAT5;YWHAG;IKBKE
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.32389192306251924,-0.8485612082802022,0.7391304347826086,1.0,1.0,3/64,5.18%,NUP62CL;NXT2;NUP50
prerank,Reactome_2022__Amino Acids Regulate mTORC1 R-HSA-9639288,-0.3883183274771608,-0.8479935964142402,0.7222222222222222,1.0,1.0,16/46,29.33%,ATP6V1E2;ATP6V1G1;RRAGC;SLC38A9;ATP6V1F;RRAGA;MIOS;SESN2;NPRL2;WDR24;FNIP2;LAMTOR3;ATP6V1A;ATP6V0D2;NPRL3;ITFG2
prerank,CellMarker_Augmented_2021__Conventional Dendritic cell:Undefined,0.5358052667415899,0.8479906142041634,0.7272727272727273,0.8852715905405566,1.0,1/7,0.81%,TLR2
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.5437729876243318,0.8479868574496341,0.6862745098039216,0.8850796825434742,1.0,1/8,8.17%,OCIAD2
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.5484331834467487,-0.8479729710566448,0.6666666666666666,1.0,1.0,1/7,5.99%,PRDM4
prerank,Reactome_2022__Removal Of Flap Intermediate R-HSA-69166,-0.4274401815300919,-0.8479562662251199,0.6,1.0,1.0,4/11,16.47%,POLD3;PRIM1;POLR1B;DNA2
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),0.47638339516321593,0.8478571957720769,0.7285714285714285,0.8851114417733889,1.0,3/18,4.31%,FLT1;PLEK;PTPRC
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),-0.526694959148812,-0.8478414986970156,0.6470588235294118,1.0,1.0,1/8,1.34%,HEY2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.4285614835715303,-0.8476912890960071,0.7435897435897436,1.0,1.0,6/21,11.69%,RHOH;CR1;METTL3;CLPTM1;RUNX1;PRELID1
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.3712668623044318,0.847658366322684,0.84,0.8853064435730044,1.0,16/83,16.11%,SPATA12;MARCHF11;CREB5;MAEL;DNAH3;HOOK1;NR6A1;MORN5;PLAAT5;TFAP2C;TSACC;SPATA20;ATL3;GSG1;SPATA18;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.3468692936435866,0.8470861879569633,0.7761194029850746,0.8860889563595928,1.0,17/143,13.49%,IGF1;SH3GL2;APP;CCDC3;SMCR8;PGR;APLNR;LDLR;WDR54;YAP1;TGFB2;ITGB8;MAPT;PARP9;KLF4;OPTN;FGF2
prerank,CellMarker_Augmented_2021__Oocyte:Ovary,0.4189727923655428,0.8470413559350731,0.7377049180327869,0.8859849067671292,1.0,1/28,0.32%,FOSB
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.5351024343953155,0.846897794142896,0.6923076923076923,0.8860415425096931,1.0,2/6,12.75%,MYD88;USP50
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.5057538523517799,0.8467653782948518,0.6842105263157895,0.8860931348076162,1.0,3/9,12.75%,MYD88;NLRC3;USP50
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),0.5172764810213081,0.8467012484145569,0.6923076923076923,0.8860067142991179,1.0,1/8,6.65%,CDK9
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.4918434538169302,0.8466878602444275,0.6440677966101694,0.8858275213287609,1.0,3/12,19.87%,PLAAT3;LIPE;PEX7
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.49097700717876924,-0.8466612720896584,0.6666666666666666,1.0,1.0,3/7,14.10%,APOE;PRELID1;TRIAP1
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.4837527815822443,0.8462903372992995,0.7377049180327869,0.886348091034717,1.0,6/15,17.73%,CD22;PRKCB;PRKCH;ELF1;GPS2;CBFB
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),-0.42525820473332104,-0.8462208624496256,0.7391304347826086,1.0,1.0,2/18,12.29%,HAX1;HTRA2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.3736576656210674,-0.8460599623155972,0.7407407407407407,1.0,1.0,9/59,20.20%,VAMP8;PSMD10;PSMD12;PSMB5;TAP1;PSMB6;PSME3;PSMD2;PSMB4
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),0.5505960598257424,0.8455055827065311,0.6851851851851852,0.8875403891352985,1.0,2/5,20.15%,CDK6;BMP6
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.3835882592456496,0.8454434263410948,0.7903225806451613,0.8874737843761412,1.0,8/49,10.51%,AMH;BMP8A;SCX;VSTM2A;SMAD3;TGFB2;RGMB;SMAD1
prerank,Reactome_2022__Deubiquitination R-HSA-5688426,-0.29373906486555335,-0.8450456604949206,0.9565217391304348,1.0,1.0,13/217,7.38%,H2AC20;OTUD3;TNFAIP3;H2BC4;H2BC21;CFTR;MCRS1;H2AC6;MUL1;VDAC2;IL33;KDM1B;ABRAXAS1
prerank,GO_Biological_Process_2021__membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915),-0.5258684328795576,-0.8448698826183733,0.6341463414634146,1.0,1.0,1/5,0.58%,KCNE1
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.4486748217742018,0.8447903327108567,0.6833333333333333,0.888364578855481,1.0,10/22,21.56%,APP;DYSF;SNCA;SYK;MAPT;IFI35;SBNO2;CRTC3;NMI;C5AR1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.48280131523150643,0.8445468565294613,0.6842105263157895,0.88856342506548,1.0,5/14,13.90%,SERPINE1;ICAM1;PAK4;GAS6;TNIP2
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.579859841424302,-0.84453047903895,0.7037037037037037,1.0,1.0,1/5,10.64%,PLEKHH2
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),-0.504195655488348,-0.8445230347449373,0.6428571428571429,1.0,1.0,2/9,13.38%,ASIP;CDH3
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Skin,0.5153624679860649,0.8445037507498644,0.7346938775510204,0.8884565604368293,1.0,3/9,16.20%,YAP1;FZD7;CD200
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.39891063910403524,0.8444954410973886,0.6666666666666666,0.8882821183100259,1.0,4/39,9.07%,ALS2CL;DNM1;HOOK1;PLEKHF1
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),-0.523414555841593,-0.844240355867727,0.7115384615384616,1.0,1.0,1/6,3.91%,SRI
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.5077206409896281,0.8442203930098052,0.7192982456140351,0.8885985433287826,1.0,3/7,29.59%,RIN3;PICALM;RAB5A
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),0.5744776238693525,0.8439303091972242,0.72,0.8889148316628662,1.0,3/5,41.62%,ASH1L;SETD2;SETD5
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.49956220644024835,-0.8438125970312327,0.7804878048780488,1.0,1.0,1/10,1.00%,MADCAM1
prerank,Reactome_2022__Tie2 Signaling R-HSA-210993,0.4281292684520438,0.8436758461502547,0.631578947368421,0.8891458828203213,1.0,4/13,22.15%,ANGPT2;SHC1;TEK;PTPN11
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.4923667218734903,-0.8435210525622115,0.6875,1.0,1.0,2/9,13.37%,RIOX1;RIOX2
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.37135328919245847,0.8432766190458937,0.671875,0.8897096557938192,1.0,2/67,2.21%,ANXA1;BLM
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.46483515578339474,0.8431857372293141,0.6610169491525424,0.8896627272214568,1.0,4/18,9.88%,MYLK3;OBSCN;SYNPO2L;TCAP
prerank,Reactome_2022__S Phase R-HSA-69242,-0.32020348125965364,-0.8429990643699851,0.9166666666666666,1.0,1.0,27/139,20.20%,CDC26;CCNE1;GINS3;RFC3;POLD3;MCM6;SLC25A15;PSMD10;MCM4;ANAPC15;PSMD12;PRIM1;PSMB5;POLR1B;SLC19A1;PSMB6;DNA2;AKT2;ORC6;PSME3;SEM1;SMC3;PSMD2;UBB;CUL1;SKP2;PSMB4
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),0.4966278176025242,0.8429305296965663,0.7115384615384616,0.8899009714194678,1.0,3/10,19.79%,ATP23;STOML2;PMPCB
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),0.5541989704639827,0.8429127657525256,0.6981132075471698,0.8897439866996754,1.0,1/5,12.46%,SLC29A4
prerank,CellMarker_Augmented_2021__Endocrine cell:Pancreatic Islet,0.3560909992540633,0.8427359347187948,0.7794117647058824,0.8898795999801359,1.0,3/89,2.62%,CLIC1;S100A10;ZYX
prerank,Reactome_2022__Aggrephagy R-HSA-9646399,-0.4096551577779002,-0.8426691329119519,0.7073170731707317,1.0,1.0,4/22,19.54%,CFTR;HSF1;DYNLL1;UBB
prerank,Reactome_2022__DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,0.35479067064773506,0.842374431280122,0.6721311475409836,0.8903376185935795,1.0,9/63,14.66%,APP;IRF7;CASP10;NLRC5;PDZD2;IKBKE;FADD;IKBKG;IFIH1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),0.4197906931780242,0.8418731416290736,0.6825396825396826,0.8910453577607872,1.0,6/23,20.26%,SLC7A2;SLC25A29;SLC7A1;SLC1A6;SLC7A8;SLC6A9
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.40608367709549936,0.8417478796779768,0.6101694915254238,0.8910731612123829,1.0,5/24,21.84%,RHBDF1;RHBDF2;NDFIP2;PPM1F;DNAJC1
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),0.518329162643336,0.8415856874293247,0.7037037037037037,0.891120937506725,1.0,1/9,2.65%,DMTN
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.41772005073104534,0.8414395359198189,0.7450980392156863,0.8912111518190724,1.0,6/25,13.58%,GRIN2A;C1RL;C1R;MMP14;PGK1;FADD
prerank,CellMarker_Augmented_2021__Effector CD4+ Memory T (Tem) cell:Blood,-0.3812048724463224,-0.8413973059600923,0.7096774193548387,1.0,1.0,6/34,6.16%,DPEP2;GMFG;RHOH;PYHIN1;PTPN22;P2RY10
prerank,CellMarker_Augmented_2021__Germ cell:Gonad,-0.3652087486289382,-0.8404631790835936,0.7428571428571429,1.0,1.0,15/46,19.99%,ZNF665;ZNF766;ZNF99;ACOXL;ZNF90;KIN;GNRHR2;MIPOL1;DNAJB7;CA5A;ORC6;ZNF66;ZNF121;LRRC69;SYCP3
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.3928786479573496,0.8403739464195102,0.6774193548387096,0.8927371178275595,1.0,5/49,11.38%,PRKCG;DAB2IP;RHBDF1;GNA12;OPHN1
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),0.5566992541991789,0.8403393946168516,0.8035714285714286,0.8926172400916543,1.0,1/5,1.69%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),0.39504034114770387,0.8402604913520848,0.7571428571428571,0.8925648046783544,1.0,22/56,27.85%,PLK2;BLM;FSD1;BCL2L1;TLE6;CALM3;PLK3;RAB11A;RAB11FIP4;PRPF40A;MLLT3;KIF13A;KLHL21;PIN1;TXNIP;CSPP1;RAB11FIP3;SH3GLB1;NLRP5;HTR2B;UVRAG;CDK2AP2
prerank,Reactome_2022__MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,0.4514095429366687,0.8402348703808391,0.75,0.8924250523399463,1.0,8/16,31.51%,TNIP2;IKBKG;SKP1;RPS27A;MAP3K8;FBXW11;MAP2K1;BTRC
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),-0.344478750245211,-0.8402302268148863,0.7142857142857143,1.0,1.0,1/77,0.09%,NGF
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.49529492908238865,0.8400791954592041,0.6481481481481481,0.8924849503410011,1.0,5/10,16.58%,BAIAP3;TRPM4;HLA-DRB1;STX4;C2CD2L
prerank,Reactome_2022__RAB Geranylgeranylation R-HSA-8873719,-0.35741559331146044,-0.8399912201404585,0.75,1.0,1.0,1/50,0.29%,RAB7B
prerank,KEGG_2021_Human__Fc epsilon RI signaling pathway,0.4000368159281274,0.8399158011721225,0.6956521739130435,0.8925448225628426,1.0,12/48,20.13%,FYN;GAB2;SYK;PIK3CD;MAPK11;INPP5D;VAV2;MAPK9;MAP2K3;PRKCA;VAV1;AKT3
prerank,Reactome_2022__Meiosis R-HSA-1500620,-0.3888326077673783,-0.8394648192453937,0.6176470588235294,1.0,1.0,5/57,2.82%,H2AC20;H3-3B;TEX15;H2BC4;H2BC21
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.4900442995090034,0.8393656222233155,0.7090909090909091,0.8932929588467687,1.0,2/11,19.68%,BARD1;AHCYL1
prerank,CellMarker_Augmented_2021__Leukocyte:Peripheral Blood,-0.37779142649836717,-0.8390608641717132,0.68,1.0,1.0,8/43,6.16%,DPEP2;GMFG;CD96;RHOH;PYHIN1;PTPN22;CD6;P2RY10
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.4025263180581339,0.8389893894382227,0.7205882352941176,0.8937390879397024,1.0,10/41,15.22%,CD24;EFNA1;TJP3;EPS8L2;CCKBR;CAPN8;GPRC5C;ALPL;SPP1;SLC44A3
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.33687352008610527,0.8388393980003818,0.8571428571428571,0.8937936663650762,1.0,13/89,12.48%,ST6GAL1;PLAAT4;MTHFD2;ACOT4;PLAAT3;ALDH1L1;SHMT1;ABCA2;DBI;ACOT7;ABCB9;PLAAT5;ACSM5
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.4747691385311643,0.8387462175045792,0.7222222222222222,0.8937460413196394,1.0,2/12,7.56%,TPST1;SULT4A1
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 7Alpha-Hydroxycholesterol R-HSA-193368,-0.44237322447338745,-0.8386722356492051,0.75,1.0,1.0,4/16,11.63%,AKR1C3;ABCB11;PTGIS;CYP7B1
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.5244551113285825,0.8385782940970627,0.6379310344827587,0.8938030864452335,1.0,3/7,21.12%,TRPM4;GPR183;TRPM2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.5195601244005627,0.8385632954558545,0.6730769230769231,0.8936408881450885,1.0,2/7,14.71%,PTPRC;HLA-E
prerank,Reactome_2022__tRNA Modification In Mitochondrion R-HSA-6787450,-0.4713103444376733,-0.8384864767005875,0.7,1.0,1.0,2/8,11.66%,TRMT10C;TRMT61B
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.3523280301126708,0.83844441375505,0.7428571428571429,0.8936207231017083,1.0,34/122,23.94%,CCNB2;ABCB1;HAUS7;YWHAG;PPP1CB;ACTR1A;TPD52L1;AKAP8;CDKN1A;OPTN;LCMT1;NEDD1;CDK2;CDC25B;CCNB1;DCTN1;YWHAE;SKP1;CKAP5;PLK3;DNM2;CDK5RAP2;PPME1;CCNA2;FBXL8;CEP76;TUBA4A;PRKAR2B;TUBB4A;DCTN3;ARPP19;CEP70;CDKN2B;ODF2
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),0.4955167269706997,0.8384202353656832,0.703125,0.8932866557793099,1.0,5/9,26.94%,MAP1LC3A;GABARAPL1;ATG7;GABARAPL2;ATG5
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),0.4955167269706997,0.8384202353656832,0.703125,0.8932866557793099,1.0,5/9,26.94%,MAP1LC3A;GABARAPL1;ATG7;GABARAPL2;ATG5
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),0.5834242883379351,0.8383121588159874,0.7407407407407407,0.8932491569008222,1.0,1/6,18.61%,RAMP1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.3600432246001836,-0.8382063203878323,0.7045454545454546,1.0,1.0,8/42,12.85%,ERCC8;GTF2H2;DCT;ERCC2;USF1;PRIMPOL;FECH;ERCC6
prerank,KEGG_2021_Human__Glycerolipid metabolism,-0.3826894494798776,-0.8380802826283469,0.75,1.0,1.0,8/46,13.74%,CEL;MOGAT1;AKR1A1;DGKB;DGKE;AGPAT2;GK;ALDH7A1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.3952134850736476,0.8378997775303741,0.734375,0.8937516677524919,1.0,8/32,21.12%,GLRA2;SYVN1;GLRA3;RCN3;UBXN6;RNF185;MARCHF6;TRPM2
prerank,Reactome_2022__G1/S-Specific Transcription R-HSA-69205,-0.4202395828905565,-0.837819746579108,0.6666666666666666,1.0,1.0,2/20,4.95%,CCNE1;FBXO5
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.4083233793290536,0.8376722722412143,0.676056338028169,0.8939678525723687,1.0,9/29,17.57%,APP;NLRP12;MYD88;STAT3;GSDMD;USP50;NLRP2;P2RX7;WNT5A
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.38178295639338905,0.8376317814848259,0.7428571428571429,0.8938332237611051,1.0,14/45,22.28%,CORO7;WAS;WASF1;FAM107A;ENAH;COBL;SPIRE1;SPIRE2;MICALL2;DSTN;CAPG;WDR1;PREX1;MICAL1
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.31313155989461394,-0.837559049450372,0.8823529411764706,1.0,1.0,47/191,23.41%,TFB2M;BRF2;GTF2H5;POLR2K;ELOC;BTF3;GTF2H2;ELOA;TAF13;SUPT16H;HSF1;RRAGC;ERCC2;GTF2A2;TAF11;POLR2C;ERCC6;CCNT1;GTF2F1;NFKBIB;SLC25A33;POLR2D;RBMX;MLF1;THAP1;TEFM;GTF2F2;MTERF1;DDX21;POLR3H;ERCC3;GTF3A;POLR3K;TTF1;TAF5L;SMARCA5;POLR2L;POLR2G;RO60;TAF12;PARP1;PWP1;TBPL1;POLR2E;GTF2H3;GTF3C6;EAF1
prerank,Reactome_2022__RND3 GTPase Cycle R-HSA-9696264,0.4186307735812354,0.8372841275868145,0.7540983606557377,0.8942731146619465,1.0,14/35,27.47%,EPHA2;DLG5;KCTD13;UBXN11;PKP4;NISCH;SCRIB;ARHGAP35;DST;FLOT2;DEPDC1B;RASAL2;TNFAIP1;PICALM
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),0.39988179173111027,0.8371791773458566,0.7571428571428571,0.8942702528127792,1.0,6/42,12.81%,GRM5;CDK9;PML;PPP1R16B;ABCA2;FN1
prerank,KEGG_2021_Human__Various types of N-glycan biosynthesis,-0.35909393419300634,-0.8370527542273853,0.6857142857142857,1.0,1.0,8/37,11.57%,B4GALNT3;MGAT4D;ALG3;ALG11;ALG9;DDOST;MGAT2;STT3A
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.35566423589052054,0.8369143596074076,0.7833333333333333,0.8944662547200272,1.0,11/70,17.85%,SLC39A14;IRS2;FOXO1;RAB15;PPARG;SORBS1;HDAC9;CPEB2;SYAP1;LPIN3;RHOQ
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),0.5506441230409831,0.8368999005585535,0.7254901960784313,0.8942943557797457,1.0,2/6,16.70%,SPIRE1;SPIRE2
prerank,KEGG_2021_Human__Glycosaminoglycan degradation,-0.4917251253648575,-0.8362875342988363,0.7380952380952381,1.0,1.0,4/12,27.90%,HPSE2;GALNS;GNS;GUSB
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.536724230799727,-0.8361977897992642,0.72,1.0,1.0,2/6,4.36%,SELENOS;APOE
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.4628336303178914,0.8361150248438415,0.7169811320754716,0.8955189408704313,1.0,2/14,7.88%,ABCA8;LDLR
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Blood,-0.4016872988301728,-0.8358405527542027,0.6060606060606061,1.0,1.0,7/27,11.84%,CD247;CD96;PYHIN1;CD6;P2RY10;CLEC2D;BIN2
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.46769942932242037,0.8358256686072201,0.7358490566037735,0.8957940430124003,1.0,3/13,9.40%,KCNJ2;ATP1A1;ATP1B1
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.5712423260636382,0.8358161859289641,0.75,0.8956244537160408,1.0,1/5,10.92%,MAPT
prerank,Reactome_2022__Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.3355977806200462,-0.8357799018775275,0.631578947368421,1.0,1.0,15/64,23.20%,AAAS;RBM8A;NUP50;U2AF1;NUP54;SRSF2;SRSF9;UPF3B;CHTOP;NUP85;NUP42;POM121C;THOC3;THOC1;NXT1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.3883203842498649,0.8357064471132594,0.7049180327868853,0.8956436541267156,1.0,9/34,13.97%,ANXA1;WDR62;GCM2;CDK6;TRAK1;TGFB2;MAPT;LPAR1;HAP1
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.43875852537579835,0.8355398785650076,0.7543859649122807,0.8957298761672655,1.0,5/31,3.00%,GRIK1;NLGN1;GRIK2;GRID2;RELN
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.49434918991711035,0.835236034416134,0.7636363636363637,0.8960617847863693,1.0,2/10,10.44%,SLIT2;EPHA4
prerank,CellMarker_Augmented_2021__Myoepithelial cell:Breast,0.5968673570329551,0.8352196343166536,0.7857142857142857,0.8958798757762723,1.0,1/5,6.44%,CD44
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.43655224541579696,-0.8351877611834408,0.6222222222222222,1.0,1.0,2/12,10.82%,AKR1C3;PTGIS
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.5505410373185977,0.8349831702307877,0.6774193548387096,0.8960652316135822,1.0,2/5,31.91%,LRP1;HIP1
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.45841429931658667,-0.8349177245798685,0.7272727272727273,1.0,1.0,2/8,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.4214875925596346,-0.8345007300226092,0.6808510638297872,1.0,1.0,3/12,9.35%,ABCD1;ELOVL4;ELOVL2
prerank,Reactome_2022__Late Endosomal Microautophagy R-HSA-9615710,-0.376989887131565,-0.8342492939376275,0.75,1.0,1.0,4/29,15.20%,CFTR;PLIN3;RNF103-CHMP3;PLIN2
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),-0.4294219132832652,-0.8341125122760693,0.6190476190476191,1.0,1.0,4/22,13.28%,MID1IP1;TRIB3;ADIPOR1;ERLIN2
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),0.5107624614958106,0.8340140972240092,0.6481481481481481,0.8976470083142692,1.0,3/6,33.62%,PLK3;STX5;PLK5
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.3963768213772016,0.8338266354373604,0.7288135593220338,0.8977723884057611,1.0,6/25,12.68%,APOD;ADCY7;MYD88;NLRC3;STAT3;PER1
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.5750042485768933,0.8337988450062433,0.7413793103448276,0.8976200219471703,1.0,3/7,6.44%,THY1;SKAP1;CD44
prerank,CellMarker_Augmented_2021__T Helper cell:Undefined,0.4673799113004605,0.8337244865766913,0.7321428571428571,0.8975767909714224,1.0,3/19,4.31%,IL13RA1;PDGFRA;PTPRC
prerank,Reactome_2022__Zinc Transporters R-HSA-435354,-0.5009084279260282,-0.8336840151439036,0.6086956521739131,1.0,1.0,6/11,15.14%,SLC30A8;SLC39A10;SLC30A6;SLC30A5;SLC39A8;SLC39A6
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.3815276713003262,0.8336507581290211,0.6833333333333333,0.8975385351637875,1.0,7/35,9.88%,TBX19;TBX20;ALPK2;RYR2;SYNPO2L;TGFB2;TCAP
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),0.5599882221962008,0.8336249210507262,0.7457627118644068,0.8973863164077654,1.0,2/6,9.25%,PRKCB;PRKCH
prerank,Reactome_2022__Methylation R-HSA-156581,-0.4889088622191037,-0.8335116495030384,0.6857142857142857,1.0,1.0,4/10,23.60%,TPMT;MAT2A;MAT2B;TRMT112
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),0.518308640718479,0.8334625029519196,0.660377358490566,0.8974843681374781,1.0,3/7,28.59%,CCNB1;RAD18;SMC5
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.5171509866799386,0.8334581043408213,0.7454545454545455,0.8972975514774726,1.0,7/11,22.60%,SMAD3;TGFB2;ITGB8;FN1;CD200;HIF1A;ITGAV
prerank,Reactome_2022__RHOBTB GTPase Cycle R-HSA-9706574,-0.38658860810536577,-0.8332568279025687,0.7777777777777778,1.0,1.0,5/34,14.93%,CCT7;VIM;PDE5A;TWF1;RBMX
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.489977756685925,-0.8332518645654762,0.6341463414634146,1.0,1.0,1/11,6.62%,BCAP31
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),-0.33261401348246444,-0.8332254135503461,0.7222222222222222,1.0,1.0,11/92,13.73%,FIP1L1;AAAS;RBM8A;RAE1;NUP50;U2AF1;CPSF1;DDX25;NUP54;MCM3AP;SRSF2
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),0.566937350615506,0.8332075721321528,0.7333333333333333,0.8969668215315967,1.0,1/5,5.48%,RNASE10
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),0.566937350615506,0.8332075721321528,0.7333333333333333,0.8969668215315967,1.0,1/5,5.48%,RNASE10
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),0.566937350615506,0.8332075721321528,0.7333333333333333,0.8969668215315967,1.0,1/5,5.48%,RNASE10
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.566937350615506,0.8332075721321528,0.7333333333333333,0.8969668215315967,1.0,1/5,5.48%,RNASE10
prerank,Reactome_2022__Glycosphingolipid Metabolism R-HSA-1660662,0.41437060573881723,0.8329879740387455,0.7313432835820896,0.8970747336632563,1.0,5/39,9.64%,UGT8;EGFL7;ESYT3;B4GALNT1;B3GALNT1
prerank,KEGG_2021_Human__Vitamin digestion and absorption,0.47130789880802126,0.8329619030285518,0.6551724137931034,0.8969302944954795,1.0,6/16,21.92%,FOLH1;PLB1;RBP2;SCARB1;ABCC1;SLC19A3
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.5086699713213396,0.8329591833323468,0.7166666666666667,0.8967389289536626,1.0,4/8,17.57%,SYK;NOXA1;FZD7;WNT5A
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.5058082775667553,0.8329407278517338,0.75,0.8965723703076739,1.0,6/13,23.31%,PRKAR1B;PKIA;PRKAR1A;ATP2B4;PRKAR2B;PKIG
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),-0.5342278538631694,-0.8329230012483508,0.6363636363636364,1.0,1.0,2/6,8.94%,TTPA;CPTP
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.38338068239882794,0.832904489588079,0.7692307692307693,0.8964652106612655,1.0,7/47,11.92%,SLC39A14;IRS2;APOD;ALDOB;PGK1;FBP1;ENO2
prerank,Reactome_2022__Protein Ubiquitination R-HSA-8852135,-0.3434856467557707,-0.8328405121524356,0.7948717948717948,1.0,1.0,18/64,26.51%,SELENOS;H2BC4;BCL10;PEX10;RRAGA;PEX13;H2BC5;UBB;UBE2V2;UBE2T;UBE2A;HLTF;VCP;CTR9;DERL1;LEO1;SKIC8;PRKDC
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),0.5556282727170969,0.8327827192250321,0.7608695652173914,0.8965162708650205,1.0,1/7,2.45%,NELL1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.44779262361477046,-0.8323919489576488,0.6666666666666666,1.0,1.0,1/17,0.09%,NGF
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),0.4336500934163835,0.832319013387496,0.6885245901639344,0.8971035042098775,1.0,8/21,27.34%,VLDLR;SMURF1;CLTC;AP2A2;SH3GLB1;KIF16B;NEDD4;UVRAG
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.4963141027014769,0.8320677215086784,0.7049180327868853,0.8973396879345684,1.0,4/13,9.88%,PDGFRA;PKDCC;TGFB2;GLI2
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,-0.3611122221768127,-0.8319674860181039,0.7941176470588235,1.0,1.0,3/40,5.08%,GMFG;EPOR;MSRB1
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.3461776300243718,-0.8318645499871311,0.8,1.0,1.0,9/81,12.07%,FTL;VAMP8;FTH1;BLOC1S4;CCDC22;GOPC;DOP1B;AP1B1;LLGL1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.5535798692853319,0.831698050012171,0.7833333333333333,0.8978202902398005,1.0,3/6,24.42%,AHCYL1;PACS2;VMP1
prerank,Reactome_2022__ISG15 Antiviral Mechanism R-HSA-1169408,-0.34360231401718977,-0.8316413765382109,0.8125,1.0,1.0,3/68,5.18%,KPNA2;AAAS;NUP50
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.35297151769396473,0.8312671441084281,0.7910447761194029,0.8983945236448004,1.0,34/121,23.94%,CCNB2;ABCB1;HAUS7;YWHAG;PPP1CB;ACTR1A;TPD52L1;CDKN1A;OPTN;LCMT1;BACH1;NEDD1;CDK2;CDC25B;CCNB1;DCTN1;YWHAE;SKP1;CKAP5;PLK3;DNM2;CDK5RAP2;PPME1;CCNA2;FBXL8;CEP76;TUBA4A;PRKAR2B;TUBB4A;DCTN3;ARPP19;CEP70;CDKN2B;ODF2
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),0.4817793436536878,0.8311101869578117,0.6607142857142857,0.8984870888070532,1.0,1/9,0.90%,IGF1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.4030898051733538,0.8310223394610566,0.671875,0.8984339840566103,1.0,6/29,14.26%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;CCT8
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.48108941283194856,-0.8309712581776338,0.723404255319149,1.0,1.0,5/9,28.83%,DERL2;YOD1;ERLEC1;SVIP;OS9
prerank,CellMarker_Augmented_2021__Malignant Mesothelioma cell:Pleura,-0.39849404472397576,-0.8305834279600599,0.6842105263157895,1.0,1.0,3/22,8.35%,TRIM29;TMC5;SCEL
prerank,CellMarker_Augmented_2021__Malignant Mesothelioma cell:Lung,-0.39849404472397576,-0.8305834279600599,0.6842105263157895,1.0,1.0,3/22,8.35%,TRIM29;TMC5;SCEL
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.41125127032266556,0.830577033795171,0.7692307692307693,0.8989756387965991,1.0,6/32,10.51%,CACNA1G;NRG1;TBX20;MSX2;TCAP;SMAD1
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.48278606579645855,-0.8305535935824673,0.7878787878787878,1.0,1.0,2/14,17.87%,EXOSC4;LSM1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),0.42733911486968446,0.8304131664709993,0.6875,0.8990532175798451,1.0,9/29,26.78%,RBM24;VIP;NOCT;TAF15;AXIN2;PARN;FUS;MEIOC;TENT5D
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),0.5294334221890986,0.8303273648041628,0.734375,0.89899509277964,1.0,5/7,34.75%,KYAT1;CYP2E1;KMO;KYAT3;KYNU
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.4350166875477766,0.8301799756922527,0.6779661016949152,0.8990529047099505,1.0,7/29,22.96%,TNFAIP8L1;MAPKAPK5;RNF152;STK11;TSC2;SPAAR;SESN1
prerank,Reactome_2022__Signaling By Nuclear Receptors R-HSA-9006931,0.3260682156041218,0.8300433754835295,0.8904109589041096,0.8991156234208294,1.0,35/192,18.48%,FOSB;KCNH8;EGF;GNG3;TGFA;RDH13;PMEPA1;GNG2;APOD;PGR;CDK9;FOXO3;FKBP5;TBL1X;ZDHHC7;S1PR3;TLE3;PDK4;CDKN1B;BCL2;CCND1;RARA;RARG;RXRA;GPS2;NCOR1;SHC1;ABCG1;IGF1R;GNAI1;CBFB;PDK3;TBL1XR1;PRMT1;ALDH8A1
prerank,KEGG_2021_Human__Porphyrin and chlorophyll metabolism,-0.4014861219751867,-0.8300349041611285,0.725,1.0,1.0,6/22,11.79%,ALAS1;BLVRA;HMBS;MMAB;EPRS1;FECH
prerank,Reactome_2022__Common Pathway Of Fibrin Clot Formation R-HSA-140875,0.518682910658319,0.8300312307320801,0.7166666666666667,0.8989391945766172,1.0,1/9,14.41%,SERPIND1
prerank,Reactome_2022__FGFR2 Alternative Splicing R-HSA-6803529,-0.4536201607265386,-0.829795463445232,0.6764705882352942,1.0,1.0,8/22,22.92%,POLR2K;POLR2C;GTF2F1;POLR2D;GTF2F2;POLR2L;POLR2G;POLR2E
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),0.5339394798684248,0.8297426522961658,0.7333333333333333,0.899179364839257,1.0,1/6,7.41%,TCP1
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),0.5077226833841433,0.8296635403948942,0.6714285714285714,0.8991114185420531,1.0,1/8,4.20%,GLYATL2
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),-0.542538916061682,-0.8295356122187895,0.6976744186046512,1.0,1.0,1/5,6.81%,MST1
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.5118349227196187,-0.8295314660172597,0.6923076923076923,1.0,1.0,3/6,32.20%,PLA2G4A;HADHA;PLA2G5
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.48740522419450016,-0.8294856591753328,0.5909090909090909,1.0,1.0,2/9,8.23%,GREM1;EFNB2
prerank,KEGG_2021_Human__One carbon pool by folate,0.4586776976604578,0.829379046748602,0.7164179104477612,0.8994869476605016,1.0,7/18,16.81%,TYMS;MTHFD2;ALDH1L1;FTCD;SHMT1;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.5224842775222402,-0.8290679338748088,0.7142857142857143,1.0,1.0,1/5,1.69%,CD200R1
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.47312989490508855,0.8289116440697336,0.6909090909090909,0.9000938456079797,1.0,7/12,28.56%,ADAM19;ABCG1;ADAM17;PSEN1;DYRK1A;APH1B;ABCA7
prerank,Reactome_2022__Killing Mechanisms R-HSA-9664420,0.5216016546549422,0.8288563480007911,0.7627118644067796,0.8999961977943647,1.0,4/9,17.57%,RNASE1;NOXA1;FZD7;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.3160391614710881,-0.8288078849488439,0.7941176470588235,1.0,1.0,10/113,8.10%,RAB7B;AR;AGER;TRIM21;RNF25;TRIM52;BCL10;TRIM68;HSPA1A;DHX33
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.40586662470049006,-0.8287716598965368,0.6744186046511628,1.0,1.0,2/27,5.01%,TPX2;TPPP3
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.44681591260984227,0.828738953053857,0.7258064516129032,0.9000143064972006,1.0,3/18,7.18%,PDGFRA;TBX20;RYR2
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.5009721695262956,0.828309586864642,0.6727272727272727,0.9005247073456647,1.0,3/7,30.22%,CALM3;JPH2;AKAP6
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.46719532815893106,-0.828251003275863,0.7777777777777778,1.0,1.0,1/12,1.81%,COX18
prerank,Reactome_2022__PCNA-Dependent Long Patch Base Excision Repair R-HSA-5651801,-0.4205710075229334,-0.8281834747458083,0.717948717948718,1.0,1.0,6/19,18.86%,RFC3;POLD3;POLG2;POLR1B;SLC19A1;APEX1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.3649317304181733,0.8281675952721091,0.8208955223880597,0.9005845327506646,1.0,22/76,24.09%,SNCB;SOX4;PRODH;SNCA;DCC;RAMP3;DHCR24;NPAS2;CDKN1B;FGF2;CTSZ;RILPL1;RAD18;PACRG;ACER3;RRAS2;TBK1;AXIN2;PRKN;PARP16;EIF4G1;CCN4
prerank,Reactome_2022__Neddylation R-HSA-8951664,-0.29752526671498086,-0.8280374788328223,0.9615384615384616,1.0,1.0,38/203,20.55%,ERCC8;COMMD6;COPS8;ASB8;COMMD2;ELOC;ASB4;FBXO27;MUL1;ASB13;CCDC22;COPS7A;UBE2M;DCAF13;SPSB4;FBXL22;PSMD10;ASB7;PSMD12;PSMB5;FBXO9;DCAF4;DCUN1D2;DCAF11;PSMB6;FEM1C;PSME3;SEM1;PSMD2;UBB;CUL1;FBXO15;SKP2;PSMB4;COPS3;KLHL20;NUB1;DCAF17
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.4435416750312697,0.8280029085448773,0.7090909090909091,0.9006689372993174,1.0,2/23,3.38%,APP;TRAM1L1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),0.3597848566563722,0.8278800391787116,0.7945205479452054,0.9006672084020764,1.0,10/63,19.12%,GOLGA8O;MAPRE2;HAUS7;GOLGA8A;KIFC2;NEK6;NCOR1;FLNA;RAB11A;TUBGCP6
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.3683846390656014,0.8278600387416852,0.7123287671232876,0.9005056185840131,1.0,4/61,8.22%,ST6GAL1;MGAT3;TUSC3;MGAT5
prerank,CellMarker_Augmented_2021__Ciliated Epithelial cell:Esophagus,0.3186903420775262,0.8278497734281507,0.8777777777777778,0.9003416384350167,1.0,50/323,16.58%,TTLL7;ADGRE5;C1ORF87;TEKT2;SLC7A2;ARHGAP39;CLDN16;ODAD1;NRP2;NEK10;CP;CES4A;BAIAP3;NELL2;OXTR;CFAP126;SSBP4;SVOPL;RHPN1;DTNA;CSMD1;ZMYND10;SYBU;WDR54;KIF17;BASP1;SLC25A29;ASTN2;TNFRSF19;SPAG1;CFAP61;POLQ;PRICKLE2;ITGAL;ARHGAP18;ECT2L;LRIG1;COL4A5;RSPH4A;C6ORF118;ENPP4;ST6GALNAC2;NWD1;UBXN11;TXNDC11;SPATA18;AKAP14;PFN2;FAM81B;C2CD2L
prerank,Reactome_2022__TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,0.3788234834791743,0.827791259411597,0.7636363636363637,0.9002465621143682,1.0,4/39,7.58%,IRAK2;APP;NOD1;NLRC5
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.39051995311924126,0.8277040233382175,0.703125,0.900217887944557,1.0,4/41,6.02%,ADCY5;EPHA5;TRIM46;DVL1
prerank,GO_Biological_Process_2021__regulation of response to wounding (GO:1903034),0.5609632382281919,0.8276986739243033,0.7547169811320755,0.9000344144891878,1.0,1/5,17.95%,STK24
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.5145835434714419,-0.8273976396867115,0.7209302325581395,1.0,1.0,3/7,11.53%,SELENOS;TMEM106A;CD47
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.5484782637089844,0.8270875248626988,0.7142857142857143,0.900838653880058,1.0,2/5,4.49%,WAS;TRPM4
prerank,Reactome_2022__Death Receptor Signaling R-HSA-73887,-0.3101019888608201,-0.8268839675019806,0.8620689655172413,1.0,1.0,4/125,5.99%,NGF;TNFAIP3;SMPD3;PRDM4
prerank,Reactome_2022__ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,0.37928860272735365,0.8267186940870358,0.8125,0.9012298968689443,1.0,10/60,7.44%,GNG3;ADCY5;PRKAR1B;GIPR;RXFP1;GNG2;ADCY7;ADCY2;RAMP3;GLP1R
prerank,CellMarker_Augmented_2021__Cancer cell:Lung,0.3832349495169748,0.8265386522846268,0.7428571428571429,0.9011672822028821,1.0,8/43,9.04%,EPHA2;EPS8L2;BAIAP2L1;EPB41L4B;RHBDF1;RHOD;LAMA5;YAP1
prerank,CellMarker_Augmented_2021__Epithelial cell:Blood,0.3832349495169748,0.8265386522846268,0.7428571428571429,0.9011672822028821,1.0,8/43,9.04%,EPHA2;EPS8L2;BAIAP2L1;EPB41L4B;RHBDF1;RHOD;LAMA5;YAP1
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),-0.31647919062913826,-0.8261531774655883,0.8214285714285714,1.0,1.0,15/112,17.85%,ID2;PMVK;TM7SF2;APOE;NR1D1;ADIPOR1;SC5D;PSMD10;PSMD12;PSMB5;DHCR7;PSMB6;NQO1;TGS1;PSME3
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.39969467160333816,-0.8258969411818562,0.7045454545454546,1.0,1.0,2/22,3.26%,ATP10B;RFT1
prerank,Reactome_2022__Cellular Response To Heat Stress R-HSA-3371556,-0.32554449419020837,-0.8257841488717003,0.7857142857142857,1.0,1.0,19/90,24.05%,AAAS;NUP50;MRPL18;HSPA1A;HSF1;HSPA13;EEF1A1;NUP54;BAG2;POLR1B;UBB;HSPA2;NUP85;NUP42;DEDD2;POM121C;CRYAB;VCP;RPS19BP1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),0.5759375464412595,0.8255910976310262,0.8095238095238095,0.9024569862895263,1.0,2/5,3.05%,ANK3;KCNE4
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),0.5759375464412595,0.8255910976310262,0.8095238095238095,0.9024569862895263,1.0,2/5,3.05%,ANK3;KCNE4
prerank,Reactome_2022__AMPK Inhibits chREBP Transcriptional Activity R-HSA-163680,0.5037059527994214,0.825530619763606,0.71875,0.902329745435327,1.0,3/7,17.81%,MLXIPL;ADIPOR2;STK11
prerank,Reactome_2022__Gene Expression (Transcription) R-HSA-74160,0.29006413485265686,0.8252693560754715,0.9888888888888889,0.9024944849495411,1.0,90/1212,13.20%,LEF1;NPY;CDKN2A;NR4A3;MOBP;TEAD2;SOCS3;ABCA6;GRIN2A;YWHAH;PLK2;THBS1;SERPINE1;GRIN2B;MAEL;NR4A1;BLM;STEAP3;TRPC3;LMO2;PRKCB;COLEC12;FOXO1;ZNF140;TGFA;SUV39H1;GAD2;ZNF282;PPARGC1B;NFATC2;NUAK1;BCL6;CHD3;ZNF704;ZNF114;ZNF750;PGR;LDB2;CDK9;LSM11;FOXO3;MSX2;CASP10;EIF4A3;MAMLD1;PML;CDK6;CTNNB1;THOC6;YWHAG;FKBP5;TBL1X;SMAD3;NR1I3;YAP1;PDZD2;PPARG;HDAC4;ZNF597;FBXO32;NDRG1;GLI2;PIP4K2A;GPRIN1;TP53I3;SMAD1;BBC3;TEAD1;NR6A1;HDAC9;NR4A2;BARD1;PRR5;GADD45A;ITGAL;CDC7;PMS2;PLXNA4;CAMK2B;ZNF552;CDKN1B;HIPK1;ZNF667;MAPKAPK5;TFAP2C;KLF4;DHX38;JARID2;CDKN1A;CCND1
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),0.5407301819516669,0.8252454607726114,0.7407407407407407,0.9023329529797823,1.0,3/6,18.85%,GRK2;GRK5;TAC4
prerank,CellMarker_Augmented_2021__Endocrine cell:Embryonic Stem Cell,0.3870769314960851,0.8251495577837978,0.7419354838709677,0.9021008035028464,1.0,18/50,20.69%,FBLIM1;THY1;TMEM200A;SHROOM4;POSTN;C2CD2;PDLIM4;VWA5A;ITGB8;FUT2;EVC2;CD200;RARRES1;F3;B3GALT5;TEK;LRRK1;ZNF518B
prerank,CellMarker_Augmented_2021__Endocrine cell:Undefined,0.3870769314960851,0.8251495577837978,0.7419354838709677,0.9021008035028464,1.0,18/50,20.69%,FBLIM1;THY1;TMEM200A;SHROOM4;POSTN;C2CD2;PDLIM4;VWA5A;ITGB8;FUT2;EVC2;CD200;RARRES1;F3;B3GALT5;TEK;LRRK1;ZNF518B
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.4322097303797471,0.8249569815505295,0.7,0.9022507455516217,1.0,4/20,6.91%,EGF;THBS1;APP;SNCA
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.5113343601827476,-0.8248022568535225,0.7142857142857143,1.0,1.0,2/5,11.31%,PTPN22;RUNX1
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),0.5475995203767042,0.8244769321615049,0.7166666666666667,0.9029005406333134,1.0,3/6,38.12%,ACVR1B;VEGFA;SMURF2
prerank,CellMarker_Augmented_2021__Natural Memory B cell:Undefined,-0.4142745328895199,-0.8243146100097368,0.7714285714285715,1.0,1.0,7/23,11.84%,CD247;RHOH;PYHIN1;CD6;P2RY10;MAP4K1;BIN2
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),0.584908637997501,0.8239593314601997,0.7446808510638298,0.9036284627069355,1.0,2/5,18.35%,LSM11;ZNF473
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.3076682810084125,-0.8236158547874056,0.8709677419354839,1.0,1.0,14/83,20.20%,FBXO48;DMAC2;FBXO27;FBXL22;PSMD10;PSMD12;PSMB5;FBXO9;PSMB6;PSME3;PSMD2;CUL1;SKP2;PSMB4
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),-0.5099145331421844,-0.8234160737279047,0.6862745098039216,1.0,1.0,2/5,16.53%,SLC25A23;LETM1
prerank,Reactome_2022__Negative Feedback Regulation Of MAPK Pathway R-HSA-5674499,0.5643018541617054,0.8233354795386911,0.7090909090909091,0.9044883520115947,1.0,4/5,40.40%,MAPK3;MAP2K1;MAPK1;BRAF
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.509250264089067,0.8232584324981966,0.7017543859649122,0.9044172513209388,1.0,1/8,9.80%,AK5
prerank,Reactome_2022__Separation Of Sister Chromatids R-HSA-2467813,-0.3013245188845896,-0.8229889666785277,0.8888888888888888,1.0,1.0,21/139,20.43%,CDC26;SGO2;KNL1;SPDL1;MIS12;ITGB3BP;CENPA;PSMD10;CENPQ;ANAPC15;PSMD12;PSMB5;DYNLL1;PSMB6;PSME3;SEM1;SMC3;PSMD2;UBB;PSMB4;NUP85
prerank,CellMarker_Augmented_2021__T Helper cell:Blood,0.40762559821240923,0.8229596962250533,0.803030303030303,0.9048016016943652,1.0,7/32,7.24%,MYO1F;PLEK;SLA;WAS;PTPRC;CD37;ACAP1
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),-0.32911628314780034,-0.8229486042100941,0.71875,1.0,1.0,4/75,2.45%,ATF5;CEP72;TPX2;SSNA1
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.5198703601971156,-0.822731618059907,0.6875,1.0,1.0,1/6,13.94%,MPI
prerank,CellMarker_Augmented_2021__SLC16A7+ cell:Lung,-0.2668961597263457,-0.8225792935238905,1.0,1.0,1.0,125/807,15.09%,FBXO48;NIPAL1;LRRC2;TMEM17;ATAD3C;PRR11;NEK8;COX18;AGER;CD96;PDCD7;SCN11A;TIGD1;PGP;ABHD15;PRELP;GOLGA6L10;IDO1;IKBIP;ZNF665;ZNF766;NCR3LG1;NPIPA5;CEP19;SIDT1;ST6GAL2;ADGB;THEM4;GUCA1B;COMMD2;PABPC1L;WDR17;GTF2H5;ACBD7;CARF;LEPR;MYO3B;LRRC36;TUBD1;ZNF862;PIPOX;GTF2H2;ZNF554;TRIM52;GOLGA6L4;ARL16;NSUN7;ARIH2OS;TMC5;STX16;BLZF1;BRIP1;ARFIP2;RPL7L1;PMS1;METTL8;INTU;PIK3C2A;CCDC142;C3ORF62;ZNF461;SEMA5A;ABCA13;METTL2A;PDPR;DGKE;SPAG17;DMC1;GOPC;MANEAL;VPS11;ZNF302;LYRM7;ZNF426;FAM76A;AGBL2;ZNF865;STXBP4;ZNF761;MAP4K1;ATR;C17ORF75;DNASE2;ERAP2;AASDH;MMACHC;ICA1L;SLC25A15;DMAC2L;CTH;ZNF669;GMEB1;SRFBP1;TONSL;LRAT;MEAK7;RPUSD2;SPEF2;DSC1;CNTN3;COX19;ZNF320;GTF2F1;NOM1;ATG14;CYP4F12;ZNF875;ZFYVE16;NFS1;ADAT1;FSD2;CEP104;ZNF555;OCLN;NFKBIB;CPT2;VWA3A;NAPEPLD;IKZF3;ZNF83;GSTM3;YARS2;TADA2B;CLK4;DCUN1D2
prerank,PanglaoDB_Augmented_2021__Keratinocytes,0.42972702890920633,0.8225623649611078,0.6612903225806451,0.9052690211464721,1.0,7/24,11.71%,IL13RA1;CD24;ICAM1;GPR87;LAMA5;DUOXA1;CCL2
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.40336568912439985,-0.8224219609738999,0.7317073170731707,1.0,1.0,11/19,30.29%,AUP1;RNF5;RNF126;POMT2;ATXN3;VCP;DERL1;DNAJB12;DNAJC18;DNAJB14;UGGT1
prerank,Reactome_2022__RAS Signaling Downstream Of NF1 Loss-Of-Function Variants R-HSA-6802953,-0.5219245497800649,-0.822311766211334,0.7142857142857143,1.0,1.0,2/6,18.12%,NRAS;SPRED1
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.42646010081945873,0.8223010902985327,0.7,0.9055428933832674,1.0,4/25,10.69%,PLEK;PDGFA;KIF17;P2RY12
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.5117234568714262,-0.8222216147021213,0.673469387755102,1.0,1.0,1/6,23.33%,RPUSD4
prerank,Reactome_2022__Response Of EIF2AK1 (HRI) To Heme Deficiency R-HSA-9648895,-0.44248459704475995,-0.8221377576451863,0.7435897435897436,1.0,1.0,3/13,6.99%,ATF5;TRIB3;EIF2S1
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),0.47968030621875146,0.8220524285372003,0.7115384615384616,0.9056943025152991,1.0,2/12,7.26%,GRIN2B;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.4925815925042091,0.8218469047999161,0.7333333333333333,0.905801611940267,1.0,4/9,29.22%,ZFYVE28;CBL;ERRFI1;TSG101
prerank,Reactome_2022__Vitamin D (Calciferol) Metabolism R-HSA-196791,0.510509635235173,0.8215544988693421,0.7241379310344828,0.9060874280029274,1.0,3/9,21.11%,LRP2;LDLRAP1;UBE2I
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),-0.5068845406746532,-0.8213045666741278,0.7647058823529411,1.0,1.0,2/10,9.68%,HSD17B6;SRD5A1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.3579830663810948,0.8213011822428299,0.875,0.906343778658838,1.0,7/47,11.17%,CD24;ABCA5;FABP3;SOAT1;LDLR;ABCA2;HDAC9
prerank,CellMarker_Augmented_2021__Pancreatic Stem cell:Pancreatic Acinar Tissue,0.411045355503362,0.8212094794058227,0.7540983606557377,0.9059244689903456,1.0,7/33,4.66%,ARHGAP4;MYO1F;PLEK;SLA;WAS;PTPRC;CD37
prerank,CellMarker_Augmented_2021__Definitive Endoderm cell:Germ,0.411045355503362,0.8212094794058227,0.7540983606557377,0.9059244689903456,1.0,7/33,4.66%,ARHGAP4;MYO1F;PLEK;SLA;WAS;PTPRC;CD37
prerank,CellMarker_Augmented_2021__Endocrine Progenitor cell:Pancreatic Acinar Tissue,0.411045355503362,0.8212094794058227,0.7540983606557377,0.9059244689903456,1.0,7/33,4.66%,ARHGAP4;MYO1F;PLEK;SLA;WAS;PTPRC;CD37
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.3578518125317758,-0.8211674635428375,0.7567567567567568,1.0,1.0,4/31,13.67%,MTIF2;MTIF3;UFL1;TEX264
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.34425844084340645,0.820830075324503,0.8142857142857143,0.9064151983822066,1.0,18/112,15.14%,B3GNT2;MGAT3;TUSC3;B3GALT2;ST8SIA3;ST8SIA1;MGAT5;TRAK1;B3GALNT1;ST8SIA4;B4GALT7;POMGNT1;B4GALT5;FUT2;PLOD2;POMGNT2;ST6GALNAC2;LARGE1
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),0.47701739537896287,0.8207726666891274,0.7288135593220338,0.9063072290650132,1.0,9/17,35.55%,USP6NL;CAMSAP3;MAPK3;PDCD10;MAP2K1;STX5;CAMSAP2;STX18;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),0.47686357114524625,0.8207249275065944,0.7377049180327869,0.9061944206284184,1.0,1/10,2.58%,PLEK
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),0.5464057591237506,0.8207082798847704,0.7272727272727273,0.9060352656199704,1.0,1/5,4.20%,GLYATL2
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.368432122538676,0.8200253086793519,0.7761194029850746,0.9070675225201296,1.0,8/73,7.53%,HTR2C;SLC24A2;VAPB;SLC39A14;ATP2B3;GCM2;RYR2;NPTN
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4196953351997636,0.820012928710043,0.7407407407407407,0.9068936060903698,1.0,2/24,3.44%,IRAK2;NOD1
prerank,KEGG_2021_Human__Herpes simplex virus 1 infection,-0.2784982916766058,-0.8200117680002339,1.0,1.0,1.0,88/389,17.52%,ZNF492;ZNF676;ZNF404;ZNF354A;ZNF559-ZNF177;ZNF441;EIF4EBP1;ZNF665;ZNF766;ZNF615;ZNF658;ZNF99;ZNF300;ZNF517;ZNF778;ZNF627;ZNF195;ZNF415;ZSCAN32;ZNF554;ZNF324;ZNF208;ZNF699;ZNF480;ZNF74;ZNF2;ZNF558;ZNF730;ZNF616;ZNF25;ZNF181;ZNF707;ZNF155;ZNF107;EIF2S1;ZNF808;ZNF534;BAK1;ZNF461;ZNF416;ZNF90;RNASEL;ZNF425;ZNF302;ZNF783;ZNF426;ZNF764;ZNF12;ZNF684;ZNF225;ZNF761;ZNF624;ZNF304;ZNF669;ZNF677;ZNF334;ZNF320;ZNF98;EIF2AK1;ZNF596;ZNF875;SRSF2;BAD;ZNF136;ZNF133;ZNF555;ZNF600;ZNF641;ZNF83;ZFP82;C5;TAP1;ZNF486;ZNF649;ZNF212;ZNF549;ZNF682;OAS3;AKT2;ZNF688;ZNF613;ZNF583;SRSF9;ZNF10;ZNF556;ZNF786;ZNF749;ZNF620
prerank,Reactome_2022__Hedgehog Off State R-HSA-5610787,0.34324580076745304,0.8198107115545286,0.875,0.9070199139533526,1.0,19/91,24.61%,ADCY5;PRKAR1B;ADCY7;ADCY2;GLI2;IFT122;PRKAR1A;IFT140;SKP1;PRKCA;RPS27A;KIF7;ADCY9;ADCY8;PRKAR2B;GLI1;PSMB3;PTCH1;SUFU
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),-0.47978049923975796,-0.8192849497987512,0.717391304347826,1.0,1.0,3/8,17.99%,VPS11;CNOT1;CNOT9
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.38098434687046656,0.8190844008977877,0.7538461538461538,0.9080464323103954,1.0,10/53,12.00%,PROX1;MYO1F;PLEK;WAS;ACHE;ALOX12;SYP;PPARG;FLI1;PILRA
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.40859063095202475,0.8188992022140178,0.76,0.9081285383560906,1.0,4/20,13.91%,TRIM5;PML;VPS37B;TRIM32
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),-0.41599819159584484,-0.8188885953950421,0.6578947368421053,1.0,1.0,3/15,16.59%,LY96;BECN1;KLRG1
prerank,KEGG_2021_Human__Glyoxylate and dicarboxylate metabolism,-0.3893712383385768,-0.8187103611564113,0.6666666666666666,1.0,1.0,5/24,20.96%,PGP;CS;ACSS1;ACO1;CAT
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.4642224162745723,0.8185567729498691,0.6721311475409836,0.9082755794264744,1.0,7/11,27.16%,RAP2B;MINK1;RAP1A;RAP1B;MAP4K4;RAP2A;RAPGEF2
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.4642224162745723,0.8185567729498691,0.6721311475409836,0.9082755794264744,1.0,7/11,27.16%,RAP2B;MINK1;RAP1A;RAP1B;MAP4K4;RAP2A;RAPGEF2
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.4877467414352812,-0.8185196901999379,0.7021276595744681,1.0,1.0,2/8,12.24%,MIS12;CENPA
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),0.4686162049534327,0.8184398972798155,0.75,0.9082966433151456,1.0,6/14,37.63%,RTN4;GBP1;SH3GLB1;CD81;KPTN;SH3BP4
prerank,Reactome_2022__Platelet Adhesion To Exposed Collagen R-HSA-75892,0.536827679553539,0.8179008700698681,0.7777777777777778,0.9089343033739494,1.0,3/9,12.34%,FYN;ITGA2;GP6
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.5372158496518566,0.8178221566070377,0.6862745098039216,0.9088601901261264,1.0,2/5,16.77%,SMAD3;SLC8A1
prerank,CellMarker_Augmented_2021__Ureteric Bud cell:Fetal Kidney,0.3776750481130293,0.8175392001819907,0.7567567567567568,0.9091125520738432,1.0,13/66,16.70%,TEAD2;EFNB3;TUSC3;B4GALNT4;FRAS1;GLI2;ENAH;MEIS3;COL4A5;PLEKHG4B;SEZ6L2;FZD7;HS6ST2
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.4852182430856132,0.8174312703357677,0.7962962962962963,0.9090847096331764,1.0,3/12,18.77%,IHO1;PUM1;RAD18
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),0.3789045858207047,0.8173725942708638,0.734375,0.9090033061194958,1.0,8/41,16.10%,SLC16A14;SLCO1A2;SLCO2A1;SLC51A;SLC27A5;ABCC4;RXRA;SLCO3A1
prerank,Reactome_2022__CD28 Co-Stimulation R-HSA-389356,0.44891843727527664,0.8172493311954766,0.8,0.9089998444659314,1.0,5/27,11.69%,MAP3K14;FYN;ARHGEF7;RNASE1;PRR5
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.41539717542839105,0.81717477886642,0.6923076923076923,0.908906322446143,1.0,7/23,20.32%,IRAK2;NOD1;IKBKG;IFIH1;TAB1;RPS27A;TAB2
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),0.41802434959906154,0.8171564188475975,0.7241379310344828,0.9087325311539206,1.0,1/19,3.97%,PTPRR
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.3102337731997792,-0.8171247530847916,0.875,1.0,1.0,22/111,20.26%,CSDC2;EXOSC8;EXOSC4;HSPA1A;VIM;EXOSC5;IGF2BP3;PSMD10;PSMD12;CNOT7;PSMB5;CNOT1;PSMB6;RC3H1;ZFP36L2;PSME3;APEX1;PSMD2;UBB;PCBP4;PSMB4;DIS3
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.45622425266810407,0.8170243980840435,0.6730769230769231,0.9087729239826676,1.0,4/14,19.14%,CTNNB1;HDAC4;ZMIZ1;PIAS1
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.4751263591939331,0.8167031557440262,0.6964285714285714,0.9090760174991739,1.0,2/12,12.13%,BLM;DONSON
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.4787950665835306,0.8162934228320682,0.7115384615384616,0.9095492280506942,1.0,3/10,18.73%,SMAD3;SMAD1;SMAD2
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),0.5205573233550048,0.8159625387116056,0.6825396825396826,0.9098957994574258,1.0,4/7,9.86%,SOX4;TBX20;ZFPM2;TGFB2
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.3588050538064971,0.8158408088678767,0.8636363636363636,0.9099188971441405,1.0,16/62,14.71%,TLR2;SERPINE1;SFTPD;COLEC12;NOD1;TNFRSF14;MYD88;LYG1;TF;SYK;GSDMD;PRKCD;OPTN;LYG2;IL12A;HLA-E
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.4530222549790931,0.8150480385018202,0.7543859649122807,0.9108423010059639,1.0,1/16,3.45%,ADD2
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.4530222549790931,0.8150480385018202,0.7543859649122807,0.9108423010059639,1.0,1/16,3.45%,ADD2
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.5103692962838696,0.8149926975332443,0.7166666666666667,0.9107364216697551,1.0,3/6,38.08%,MAPK3;MAPK1;TRIM27
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Peripheral Blood,0.42324316473822565,0.8149442074777171,0.7931034482758621,0.9104567982761256,1.0,5/21,4.31%,MYO1F;PLEK;SLA;WAS;PTPRC
prerank,CellMarker_Augmented_2021__Cytotoxic T cell:Blood,0.42324316473822565,0.8149442074777171,0.7931034482758621,0.9104567982761256,1.0,5/21,4.31%,MYO1F;PLEK;SLA;WAS;PTPRC
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),0.32147658042425126,0.8149312483125731,0.8591549295774648,0.9102806546648267,1.0,20/146,19.41%,RECQL4;BLM;RPA1;SAMHD1;BAP1;ATP23;EME2;PARP9;BARD1;POLQ;IFFO1;MRE11;ZSWIM7;XRCC1;BRCA1;MEIOB;HPF1;UBXN1;MTA1;MORF4L1
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),-0.35709308956398317,-0.8149288215972774,0.8095238095238095,1.0,1.0,8/53,8.97%,CEL;PMVK;TM7SF2;APOE;SCARF1;ARV1;GBA2;CYP46A1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.35738000475763765,0.8148619498773978,0.7727272727272727,0.910201683885665,1.0,12/61,13.31%,EPHA7;THBS1;RPS6KA1;NOD1;NLRP12;CD44;SNCA;DHCR24;SYK;GAS6;KLF4;NLRP2
prerank,Reactome_2022__PIWI-interacting RNA (piRNA) Biogenesis R-HSA-5601884,0.40363392465193054,0.8148334550618128,0.6911764705882353,0.9100644989418926,1.0,1/24,2.01%,MAEL
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.400495939883879,-0.8148016455945815,0.8,1.0,1.0,2/19,5.59%,SRI;SELENON
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.36943616782917044,0.8147728224361889,0.8285714285714286,0.9099564889543181,1.0,7/63,7.99%,ACSL5;AWAT1;GLYATL2;ALOX12;FAAH;CYP1B1;ACOT4
prerank,Reactome_2022__Resolution Of AP Sites Via Multiple-Nucleotide Patch Replacement Pathway R-HSA-110373,-0.3975273837216506,-0.8146047298287052,0.7837837837837838,1.0,1.0,6/23,18.86%,RFC3;POLD3;POLG2;POLR1B;SLC19A1;APEX1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.40440634679610044,0.8145822975758861,0.7586206896551724,0.9100523041637018,1.0,10/30,24.83%,STEAP3;TF;TFRC;DNM2;ATP6V1B2;LMTK2;CLTC;ATP6V1C1;ATP6V1C2;ARHGAP1
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.3830195616591003,0.8144167516706305,0.8333333333333334,0.9101626319421408,1.0,4/39,16.18%,SUN3;CHMP1A;BIN1;IRAG2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.38597067487256653,-0.8144135350851959,0.8372093023255814,1.0,1.0,4/26,9.66%,GTF2H5;GTF2H2;CETN2;ERCC2
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),-0.508027567087097,-0.8142723061447156,0.6923076923076923,1.0,1.0,1/5,15.29%,LYPLA2
prerank,Reactome_2022__Beta Oxidation Of hexanoyl-CoA To butanoyl-CoA R-HSA-77350,0.5450502733676421,0.8140685025249919,0.7735849056603774,0.9105372317094773,1.0,1/5,7.02%,HADH
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),-0.44231788540283223,-0.8139989567045615,0.7435897435897436,1.0,1.0,1/12,9.26%,ACVR1C
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),-0.43965948868338134,-0.8137894009939564,0.7073170731707317,1.0,1.0,2/11,16.63%,GOPC;NFKBIE
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.5183098500413654,-0.8133278371336169,0.7045454545454546,1.0,1.0,4/7,14.17%,ABCB10;SLC25A37;EIF2AK1;LDB1
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),0.5098357792757736,0.8132995152018747,0.7037037037037037,0.9116753702118178,1.0,1/9,0.65%,MYRF
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.3991151234339255,0.8132926023739302,0.7096774193548387,0.9114919946845814,1.0,6/31,14.26%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;CCT8
prerank,Reactome_2022__Coenzyme A Biosynthesis R-HSA-196783,-0.503160547393761,-0.8131310166277106,0.75,1.0,1.0,1/8,9.16%,PPCS
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),0.5149573381177588,0.8128580072129047,0.7142857142857143,0.9120187567802209,1.0,1/8,8.12%,CTNNB1
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.3734109123864816,0.8128379661888967,0.782608695652174,0.9118571923235089,1.0,11/64,19.55%,IGF1;APP;HDAC4;FBP1;MLXIPL;GCKR;PFKFB3;P2RX7;NCOR1;HIF1A;ARNT
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.4419306439273081,-0.8125879957720906,0.6923076923076923,1.0,1.0,1/11,1.03%,NIPAL1
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.37859282879246825,-0.8125140139237522,0.6818181818181818,1.0,1.0,7/29,11.55%,HEY2;HES6;HEYL;ASCL1;HEY1;BHLHE41;HES5
prerank,Reactome_2022__PKMTs Methylate Histone Lysines R-HSA-3214841,-0.3393894205457169,-0.8124720239805375,0.7659574468085106,1.0,1.0,4/43,10.58%,SETDB1;SMYD2;KMT5A;KMT2A
prerank,Reactome_2022__Defects Of Contact Activation System (CAS) And Kallikrein/Kinin System (KKS) R-HSA-9651496,0.5164222235320736,0.8120460450593535,0.7580645161290323,0.9129989483566099,1.0,3/10,17.79%,TPST1;SERPING1;TPST2
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.33808681761312476,0.811468905365922,0.7323943661971831,0.9137599894172844,1.0,14/103,18.24%,PLK2;WDR62;INCENP;CENPP;ERCC6L;CENPH;RANGAP1;NEK6;STMN1;MAP4;DYNC1LI2;SKA2;CCNB1;CKAP5
prerank,Reactome_2022__Pyruvate Metabolism R-HSA-70268,-0.38213517665214974,-0.8111637212408332,0.7352941176470589,1.0,1.0,5/26,12.07%,LDHC;MPC2;PDPR;PDHA1;MPC1
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.35617272507698955,0.8111276579125064,0.8208955223880597,0.9141381327073836,1.0,3/63,5.54%,CTSC;CTSS;FAP
prerank,CellMarker_Augmented_2021__Proximal Tubular cell:Kidney,-0.39317261415400284,-0.8110946531826526,0.7105263157894737,1.0,1.0,5/24,6.16%,CD247;CD96;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.38543525311954663,0.81094105627432,0.7333333333333333,0.9142691877244093,1.0,9/36,18.02%,PID1;BCL2L1;SLC4A11;MAPT;BCL2;STOML2;HEBP2;PINK1;RNF122
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.5246988123813355,0.810693687421344,0.74,0.9144752197886885,1.0,3/6,12.33%,SFTPD;CCL2;TAFA4
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.34786038457653506,-0.8105961190098392,0.7804878048780488,1.0,1.0,5/62,7.42%,ERCC8;TRIM21;ASB4;TRIM52;TRIM68
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.36445407969473165,0.8105248857948838,0.8382352941176471,0.9145238739736864,1.0,7/69,10.41%,PLEK;DAB2IP;NRG1;SYNPO2L;SMAD3;TPPP;SYK
prerank,Reactome_2022__Innate Immune System R-HSA-168249,0.2874327526248581,0.8105089735636983,1.0,0.9143571839554405,1.0,104/692,16.42%,C3;RASGRP2;TLR2;CTSC;CTSS;ADGRE5;KCNH8;RASGRP1;ELMO1;CD55;TIMP2;WAS;PTPRB;TEC;IRAK2;APP;RPS6KA1;IRF7;NOD1;MYH9;ATP8B4;PTPRC;EGFL7;MAP3K14;NFATC2;WASF1;FYN;PADI2;BAIAP2;DNM1;ITPR3;COLEC11;CFH;BIRC3;CD44;PLAC8;CASP10;C1R;NLRC5;MYD88;RAP2B;OSTF1;TMBIM1;CTNNB1;BCL2L1;CAPN1;NLRC3;CHI3L1;PLD2;ARPC3;PRKCE;GAB2;PDZD2;IKBKE;ARHGEF7;DNAJC5;RNASE1;PFKL;CPNE2;SYK;HMOX2;PYGL;PLPP4;TSPAN14;DGAT1;GSDMD;ITGAL;PRKCD;RELB;BCL2;CGAS;PDXK;STOM;B2M;TNFAIP6;FADD;FRMPD3;TNIP2;TRIM32;IQGAP1;CCT8;IKBKG;MRE11;MAPK11;HEBP2;IFIH1;HLA-E;IST1;CD4;SERPING1;SLC2A3;ENPP4;CD59;STAT6;RAB37;TP53;RAB3D;VAV2;WIPF3;CTSZ;P2RX7;IRAG2;BST1;TAB1
prerank,Reactome_2022__Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.3522047706981924,-0.8104153479434967,0.7352941176470589,1.0,1.0,9/48,17.12%,TFB2M;NR1D1;ALAS1;GLUD1;POLG2;ATP5F1B;ESRRA;TFB1M;MTERF1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.42577691002849094,-0.8097860384940865,0.74,1.0,1.0,2/17,1.69%,MADCAM1;CD200R1
prerank,Reactome_2022__mRNA Editing R-HSA-75072,0.5505872001780552,0.8093464781630644,0.8166666666666667,0.9161522627812937,1.0,1/5,7.78%,APOBEC3H
prerank,KEGG_2021_Human__Non-homologous end-joining,0.4736788943709031,0.8093264347668221,0.7551020408163265,0.9159998127357507,1.0,1/9,14.53%,MRE11
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),0.5344034731923373,0.8092138422074926,0.8032786885245902,0.9160045869033325,1.0,1/5,11.20%,FGF13
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.4569063285321583,0.809173309418041,0.7301587301587301,0.915869152702119,1.0,6/14,23.95%,THY1;CD160;PTPRJ;DGKZ;GBP1;PRNP
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),-0.39133983931283434,-0.8089592608644685,0.8,1.0,1.0,4/20,11.63%,ABCB11;OSBPL3;CYP46A1;CYP7B1
prerank,KEGG_2021_Human__Prion disease,-0.28670518377819787,-0.8088673061128908,0.9565217391304348,1.0,1.0,36/202,14.29%,SLC25A5;UQCRFS1;NDUFS5;C6;COX7C;NDUFA12;NDUFB4;UQCRB;CREB3L4;CACNA1S;TUBB2B;NDUFB1;ATP5PF;SLC25A4;VDAC2;ATP5MC1;NDUFC2-KCTD14;EIF2S1;UQCRHL;HSPA1A;NDUFV3;COX7B;ATP5PB;ATP5PD;CREB3L1;NDUFA8;KLC3;COX5B;RYR1;ATP5MC3;PSMD12;NDUFS3;NDUFC1;BAD;PSMB5;ATP5F1B
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.5771163007873928,0.808865362240221,0.8113207547169812,0.9161470558673671,1.0,2/5,10.69%,FLI1;P2RY12
prerank,CellMarker_Augmented_2021__Microglial cell:Optic Nerve,0.41949662637887986,0.8088357145612722,0.7777777777777778,0.9159995667153842,1.0,5/24,4.31%,MYO1F;PLEK;SLA;WAS;PTPRC
prerank,"Reactome_2022__SUMO Is Transferred From E1 To E2 (UBE2I, UBC9) R-HSA-3065678",0.5595530551806269,0.8083876978670786,0.7586206896551724,0.9165382375635185,1.0,3/5,35.45%,UBE2I;UBA2;SAE1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.3268635637591861,0.8083394818435352,0.8714285714285714,0.9164100510566395,1.0,10/153,11.67%,ANK3;CTSC;VAPB;CD55;TGFA;TMED10;GRIA1;ERGIC1;GAS6;ACTR1A
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.3364773140494186,-0.8082764512227033,0.78125,1.0,1.0,4/50,5.53%,AAAS;RAE1;NUP50;RNF212
prerank,CellMarker_Augmented_2021__T Helper cell:Bone Marrow,-0.3976528046658246,-0.80812270605967,0.71875,1.0,1.0,6/26,6.16%,CD247;CD96;RHOH;PYHIN1;CD6;P2RY10
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),-0.37056907274252493,-0.8079830989076789,0.7878787878787878,1.0,1.0,6/43,9.26%,TTC29;CFAP53;ADCY10;TEKT5;SPAG17;TEKT1
prerank,Reactome_2022__Resolution Of Sister Chromatid Cohesion R-HSA-2500257,0.34878447643608523,0.8079271521072541,0.7794117647058824,0.9168783817764287,1.0,18/82,23.53%,CCNB2;INCENP;PMEPA1;CENPP;ERCC6L;CENPH;RANGAP1;DYNC1LI2;SKA2;CCNB1;CKAP5;DYNC1LI1;KANSL1;PDS5A;PDS5B;DYNC1I1;TAOK1;CENPU
prerank,Reactome_2022__RUNX1 Regulates Estrogen Receptor Mediated Transcription R-HSA-8931987,-0.47935259304107936,-0.8078783883056206,0.7254901960784313,1.0,1.0,2/6,18.33%,RUNX1;ESR1
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.5575899757937754,-0.8078446303951975,0.7884615384615384,1.0,1.0,1/5,10.15%,USF1
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.46368045722112883,-0.8077266797997671,0.68,1.0,1.0,2/8,6.01%,APOE;ABCD1
prerank,KEGG_2021_Human__Mitophagy,-0.34650685950378507,-0.8073348989769624,0.7647058823529411,1.0,1.0,1/62,0.29%,RAB7B
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),-0.36194008503474207,-0.8072384047077079,0.7222222222222222,1.0,1.0,4/32,8.40%,CFTR;SNF8;SMPD3;VPS4B
prerank,Reactome_2022__Sulfur Amino Acid Metabolism R-HSA-1614635,0.41126565990878683,0.8070988359459674,0.7192982456140351,0.9180128725552829,1.0,1/20,1.04%,SQOR
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.5450112204260587,-0.806929016740681,0.7692307692307693,1.0,1.0,1/6,1.74%,VAMP8
prerank,Reactome_2022__Regulation Of Cytoskeletal Remodeling And Cell Spreading By IPP Complex Components R-HSA-446388,0.5071079143180047,0.8069107310536692,0.7931034482758621,0.9180727375889463,1.0,4/8,28.57%,ACTN1;ARHGEF6;LIMS1;RSU1
prerank,CellMarker_Augmented_2021__Natural Regulatory T (Treg) cell:Peripheral Blood,-0.35342689198238897,-0.8068546526826725,0.8387096774193549,1.0,1.0,7/38,6.16%,GMFG;CD247;CD96;PYHIN1;PTPN22;CD6;P2RY10
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.5020154162200493,0.8065243706527366,0.7454545454545455,0.918576629482199,1.0,5/10,23.29%,SMAD3;SMAD2;HJV;ACVR1B;ACVR1
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),-0.4401543436267052,-0.8062036742859654,0.6470588235294118,1.0,1.0,4/15,11.37%,CD320;PRSS3;MMAB;MMACHC
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),-0.4401543436267052,-0.8062036742859654,0.6470588235294118,1.0,1.0,4/15,11.37%,CD320;PRSS3;MMAB;MMACHC
prerank,Reactome_2022__Meiotic Synapsis R-HSA-1221632,-0.3896663339738795,-0.8059829590593084,0.7222222222222222,1.0,1.0,4/37,5.51%,H2AC20;H2BC4;H2BC21;H2AC6
prerank,GO_Biological_Process_2021__one-carbon compound transport (GO:0019755),-0.48030655317294674,-0.8057763029621904,0.7,1.0,1.0,3/6,26.93%,AQP6;AQP1;CA2
prerank,Reactome_2022__Uptake Of Dietary Cobalamins Into Enterocytes R-HSA-9758881,0.5316381201989477,0.805736177698135,0.7755102040816326,0.9197993327230065,1.0,1/5,3.62%,AMN
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),0.5064833830443236,0.805728723488747,0.7254901960784313,0.9196247935065377,1.0,1/8,2.98%,SLC39A14
prerank,CellMarker_Augmented_2021__Exhausted CD8+ T cell:Liver,0.31170112835867897,0.8052979478491643,0.9473684210526315,0.920123224282248,1.0,44/210,18.19%,HLA-DRA;TYMP;ITM2A;SLA;ATP8B4;LAT2;PLSCR1;BTG3;NEDD9;SYNGR2;MTHFD2;MAPRE2;CTNNB1;LDHA;TTYH3;PRKCH;STAT3;CTNNA1;NR4A2;MX1;PAM;PHEX;RNF19A;HLA-DMA;PRDM1;CD70;PRKAR1A;CLSTN3;CD200;SARDH;SRGN;TRAF5;UBASH3B;CALM3;GABARAPL1;INPP5F;ABCG1;WHRN;MAP2K3;TFRC;NDFIP2;TNFSF4;TBL1XR1;IFI35
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.3875885283259034,0.8051622437471243,0.7301587301587301,0.9201753540806582,1.0,9/39,14.31%,SIX3;CACNA1C;SH3PXD2B;PBX3;TGFB2;HIPK1;MEIS3;COL5A1;HIPK2
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),-0.5221902957188933,-0.804931628931164,0.6511627906976745,1.0,1.0,1/6,11.55%,HES5
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),-0.5221902957188933,-0.804931628931164,0.6511627906976745,1.0,1.0,1/6,11.55%,HES5
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Unsaturated Fatty Acids R-HSA-77288,-0.5262150911225774,-0.8049231847061032,0.7441860465116279,1.0,1.0,3/6,23.72%,DECR1;ACADM;HADHA
prerank,Reactome_2022__Cellular Hexose Transport R-HSA-189200,0.47277299035843545,0.8048666986812781,0.72,0.9204179165981229,1.0,2/14,15.06%,SLC5A4;SLC2A3
prerank,Reactome_2022__SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,-0.32482919783224895,-0.8047576859843201,0.875,1.0,1.0,3/49,5.18%,AAAS;RNF2;NUP50
prerank,Reactome_2022__Ion Transport By P-type ATPases R-HSA-936837,-0.3421074139192749,-0.8043767220121136,0.7272727272727273,1.0,1.0,8/41,12.61%,ATP10B;SRI;PDZD11;ATP1B2;ATP12A;ATP2C2;ATP1A2;ATP8B3
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.3901231422217287,-0.8043675612915098,0.7777777777777778,1.0,1.0,3/30,7.68%,RAB7B;HSPA1A;ABCB10
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4055157113006742,0.8038742491702164,0.8305084745762712,0.9218342011175337,1.0,3/38,5.50%,ZFP36;ZC3H12D;NUDT16
prerank,Reactome_2022__Gluconeogenesis R-HSA-70263,-0.36334548067937616,-0.8037751565649676,0.575,1.0,1.0,4/26,14.32%,GOLT1A;SLC25A1;PCNX4;G6PC3
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.46796565789570377,0.8037368624867103,0.7192982456140351,0.9218738936260249,1.0,3/11,20.94%,SHMT1;CRAT;CPT1C
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),-0.37699761192562453,-0.8036883825243455,0.7045454545454546,1.0,1.0,6/28,11.31%,APOE;RGCC;SERPINF2;VIM;CREB3L1;RUNX1
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.3373401432676895,0.8034872381960326,0.8382352941176471,0.9220484911014067,1.0,17/104,15.53%,VRK2;PDGFRA;MGAT3;FOXO1;FOXO3;SNCA;SLC4A11;MAPT;PXN;STX4;PRKCD;AGAP3;CPEB2;MSRA;NOX4;TP53;PINK1
prerank,Reactome_2022__Unwinding Of DNA R-HSA-176974,-0.5146058194727554,-0.8034750551831084,0.7555555555555555,1.0,1.0,3/8,12.80%,GINS3;MCM6;MCM4
prerank,Reactome_2022__Vitamin C (Ascorbate) Metabolism R-HSA-196836,0.5254652592059659,0.8033694638917775,0.7636363636363637,0.9220399463555095,1.0,2/6,27.93%,SLC2A3;CYB5R3
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.440329194950874,-0.8033531771394976,0.717948717948718,1.0,1.0,1/9,4.53%,RGCC
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.4249295204569861,0.8032322124361567,0.6666666666666666,0.9220892046183866,1.0,6/18,21.14%,ST8SIA3;ST8SIA1;ST8SIA4;MAN1A1;MGAT4A;FUT8
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.4618227508899262,-0.8032241334736511,0.8333333333333334,1.0,1.0,1/11,1.47%,ADAMTS18
prerank,Reactome_2022__Hyaluronan Uptake And Degradation R-HSA-2160916,-0.4806036624014683,-0.8029432111320102,0.7804878048780488,1.0,1.0,1/9,1.21%,STAB2
prerank,Reactome_2022__PIP3 Activates AKT Signaling R-HSA-1257604,0.3192611213152624,0.8025126348295978,0.9014084507042254,0.9230823041252529,1.0,22/219,12.36%,PDGFRA;EGF;NR4A1;IRS2;FOXO1;TGFA;FYN;CHD3;NRG1;FOXO3;PML;NRG2;PDGFA;MYD88;KITLG;GAB2;PPARG;RNASE1;PIP4K2A;FGF13;PRR5;CDKN1B
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),-0.3894119343448148,-0.802246881223515,0.6818181818181818,1.0,1.0,2/22,8.40%,HSPA1A;VPS4B
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.4568901236956828,0.8021964696576448,0.7321428571428571,0.923379278419336,1.0,1/12,0.33%,CXCL2
prerank,Reactome_2022__Fatty acyl-CoA Biosynthesis R-HSA-75105,0.37677702004189495,0.8021475332170475,0.746031746031746,0.9232717852111831,1.0,7/31,17.21%,ACSL5;HACD1;OLAH;SLC27A3;ELOVL7;ELOVL5;HACD4
prerank,CellMarker_Augmented_2021__Acinar cell:Pancreas,-0.32184659913582236,-0.8021473526659503,0.8648648648648649,1.0,1.0,13/86,17.24%,RNF6;CFAP97;TMEM267;TMEM263;EBAG9;UFL1;AGGF1;TWF1;KRR1;GNPDA2;MBLAC2;SLC25A46;ZBTB33
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),-0.3943960867339948,-0.8018102188218328,0.6153846153846154,1.0,1.0,10/19,31.94%,TTPA;LRAT;CYP4F12;VKORC1L1;CUBN;RBP1;LGMN;GC;RLBP1;UBIAD1
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),-0.3610711602379201,-0.8017317364976606,0.85,1.0,1.0,1/27,0.79%,ID2
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),-0.4988129576941259,-0.8016345156443717,0.7636363636363637,1.0,1.0,3/8,30.90%,AGA;NGLY1;ENGASE
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.3483938106840021,0.8016111063804243,0.8923076923076924,0.9238958551505889,1.0,8/95,6.91%,CCNB2;BLM;DAB2IP;THY1;INCENP;CCNI2;CDK5R2;SNCA
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),0.5391005796591292,0.8015767734767989,0.7611940298507462,0.9235557119431816,1.0,1/5,11.48%,KYAT1
prerank,Reactome_2022__Phenylalanine Metabolism R-HSA-8964208,0.5391005796591292,0.8015767734767989,0.7611940298507462,0.9235557119431816,1.0,1/5,11.48%,KYAT1
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),0.4356659914847691,0.8013890659482306,0.6842105263157895,0.9236598948987261,1.0,1/10,2.82%,KCNQ1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.3418394380791036,0.8012537533807066,0.7794117647058824,0.9232752225139272,1.0,14/82,23.72%,PAK3;FYN;SYK;PRKCD;RELB;PAK1;IKBKG;TAB1;SKP1;MUCL1;TAB2;CARD11;PSMB3;RPS6KA5
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3418394380791036,0.8012537533807066,0.7794117647058824,0.9232752225139272,1.0,14/82,23.72%,PAK3;FYN;SYK;PRKCD;RELB;PAK1;IKBKG;TAB1;SKP1;MUCL1;TAB2;CARD11;PSMB3;RPS6KA5
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3418394380791036,0.8012537533807066,0.7794117647058824,0.9232752225139272,1.0,14/82,23.72%,PAK3;FYN;SYK;PRKCD;RELB;PAK1;IKBKG;TAB1;SKP1;MUCL1;TAB2;CARD11;PSMB3;RPS6KA5
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell proliferation (GO:0046642),0.5273057852047575,0.8012254960840409,0.7543859649122807,0.923136692491107,1.0,1/5,5.06%,TNFRSF14
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.39566413031801473,0.8012149788824628,0.78,0.9229573804301303,1.0,9/41,18.12%,PID1;CYP1B1;MKLN1;CNDP1;ABCA2;PDK4;PINK1;ABCG1;PDK3
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),0.5144482494363042,0.8010445781462534,0.78,0.9230087177249521,1.0,1/6,3.40%,FOXO1
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.4398392754030892,0.800897365451267,0.7241379310344828,0.9230312178392354,1.0,6/14,23.69%,PDK4;PDK1;RORA;PDK3;FOXK1;PRKN
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),0.4965596011718023,0.8006281664504492,0.7254901960784313,0.9232913906473251,1.0,2/8,18.61%,ABCA2;RAMP1
prerank,KEGG_2021_Human__Neurotrophin signaling pathway,-0.3163479226909609,-0.8002436387006252,0.9032258064516129,1.0,1.0,2/104,2.95%,NGF;SHC4
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),0.3549511635228229,0.8001596327516525,0.8428571428571429,0.9238202928022444,1.0,10/92,10.41%,PLEK;DAB2IP;RPA1;SKAP1;NRG1;SNCA;MYD88;FSCN1;TPPP;SYK
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.4670755973054877,-0.7998265050308522,0.725,1.0,1.0,3/9,29.23%,DUSP6;DUSP9;SOD1
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.3787256558380101,0.7997414151475282,0.7878787878787878,0.9242553824124662,1.0,4/42,8.75%,NELL1;TRPM4;NOTUM;PKDCC
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.42369539877035867,-0.7996927440005047,0.7058823529411765,1.0,1.0,2/13,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.3916250978076416,0.7995720361419753,0.7741935483870968,0.9243087972297883,1.0,10/31,20.87%,RPA1;GAR1;TERF2IP;ANKRD28;MRE11;TINF2;CDK2;TELO2;WRAP53;ACD
prerank,Reactome_2022__PTEN Regulation R-HSA-6807070,-0.3076964540062215,-0.799361375667671,0.9032258064516129,1.0,1.0,19/125,20.20%,OTUD3;RNF2;CHD4;RRAGC;PSMD10;PSMD12;FRK;SLC38A9;PSMB5;RRAGA;NR2E1;PSMB6;AKT2;EZH2;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4149338251943024,0.7993007849617546,0.7450980392156863,0.924498923874666,1.0,2/22,3.44%,IRAK2;NOD1
prerank,CellMarker_Augmented_2021__Lake Et al.Science.Ex4:Brain,-0.4524256698683059,-0.7992421162401072,0.7755102040816326,1.0,1.0,3/10,3.65%,LYPD6B;PLCXD2;CXXC4
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.36124615782456027,-0.7991547887538625,0.775,1.0,1.0,2/42,5.15%,SF3A1;CRNKL1
prerank,KEGG_2021_Human__Ferroptosis,-0.3754392159308106,-0.7981483570822551,0.9142857142857143,1.0,1.0,6/36,7.89%,FTL;FTH1;SLC3A2;SAT1;VDAC2;NCOA4
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),0.46440801186766056,0.7979068527002402,0.76,0.9264493568084109,1.0,5/12,26.45%,IFT122;CILK1;IFT140;IFT43;DYNC2I2
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.5331100785936732,0.7978429549255502,0.7307692307692307,0.9263512201575563,1.0,3/5,21.12%,TRPM4;GPR183;TRPM2
prerank,Reactome_2022__Interleukin-1 Signaling R-HSA-9020702,0.33389492064329185,0.7977770254056029,0.90625,0.9262459320432758,1.0,6/99,7.62%,IRAK2;APP;NOD1;IL1R1;NLRC5;MYD88
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.45823747191177305,-0.7973639892817981,0.7380952380952381,1.0,1.0,2/12,6.01%,SELENON;ABCD1
prerank,Reactome_2022__Biosynthesis Of Specialized Proresolving Mediators (SPMs) R-HSA-9018678,0.4929632623955732,0.7973582830160524,0.8412698412698413,0.926665599119412,1.0,2/11,13.02%,ALOX12;LTC4S
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.504677639817527,-0.7973434980642672,0.7380952380952381,1.0,1.0,5/7,31.25%,MDH1B;ME2;FH;MDH1;MDH2
prerank,KEGG_2021_Human__Asthma,0.4970875216832055,0.796693250552601,0.7777777777777778,0.9274541323135653,1.0,1/7,0.56%,HLA-DRA
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.38711446106400066,0.7966623418258756,0.8392857142857143,0.9272983683331031,1.0,14/49,22.96%,DCN;SMCR8;BAG3;PIP4K2A;OPTN;IKBKG;PINK1;LRSAM1;TSC2;ELAPOR1;WAC;TBK1;SUPT5H;SESN1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.4179123808642164,0.7962507825085446,0.7611940298507462,0.9277103716281926,1.0,5/29,9.05%,DMTN;KCNQ1;AHR;VGF;HCN1
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.411826089144485,0.7962130459719428,0.782608695652174,0.9275665934508142,1.0,2/22,6.62%,RPA1;POLD1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),-0.4798933543347519,-0.795908337077597,0.72,1.0,1.0,2/8,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.5292944251211489,0.7958553886924093,0.7843137254901961,0.9279376666434751,1.0,2/7,17.57%,CTNNB1;WNT5A
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),0.47794497893173715,0.7957794894706849,0.7592592592592593,0.9278585358539627,1.0,1/6,6.91%,SNCA
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),0.5309547129447185,0.7957224994219388,0.7894736842105263,0.9277507170334177,1.0,1/5,20.60%,HYOU1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4075545538878824,-0.7956967815478652,0.7777777777777778,1.0,1.0,4/21,13.23%,SUPT16H;HMGN1;ERCC6;CCNT1
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.36320946889515615,0.795673338585087,0.8813559322033898,0.9276237995424338,1.0,21/67,15.22%,TYMP;A4GALT;EPHA2;EPS8L2;ITGA2;RHOD;EMP1;MYO1C;CTNNB1;CAPN1;ITGA3;LMNA;FBXO32;DUOXA1;BACE2;BCL2;ANXA11;OPTN;HEBP2;LAMA3;CD59
prerank,GO_Biological_Process_2021__negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128),-0.4903362315062022,-0.7956125156395403,0.75,1.0,1.0,2/5,21.21%,LY96;CD14
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.3563996635066097,0.7955951758213813,0.859375,0.9275567445543144,1.0,19/79,17.39%,SERPINE1;GRID2;RTN4RL1;NLRP12;TNFRSF1A;NLRC3;PPARG;EPHA4;MAPKBP1;PRKCD;KLF4;TNFAIP6;FGF2;LRFN5;PTPRS;RORA;GPS2;MFHAS1;INPP5F
prerank,KEGG_2021_Human__Cardiac muscle contraction,0.3672063583750966,0.7954340651438441,0.7692307692307693,0.9275949613150255,1.0,10/56,10.24%,CACNG3;CACNA1C;TPM4;CACNG8;RYR2;ATP1A1;SLC9A1;ATP1B1;CACNG4;ATP1B3
prerank,Reactome_2022__Chaperonin-mediated Protein Folding R-HSA-390466,0.35443339465956536,0.7953927187404963,0.84,0.9274585888435523,1.0,11/73,15.46%,GNG3;RGS6;GNG2;TCP1;GNA14;TUBB6;CCT4;STAT3;TUBA1B;CCT8;TP53
prerank,Reactome_2022__Nuclear Signaling By ERBB4 R-HSA-1251985,0.4097074362247403,0.7952385548491891,0.75,0.927530283021213,1.0,13/27,24.44%,NRG1;PGR;GFAP;NRG2;YAP1;SPARC;STMN1;NCOR1;ADAM17;TAB2;CXCL12;NRG3;PSEN1
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.3654591910481232,0.7949030644782817,0.7457627118644068,0.9278864089107088,1.0,7/39,20.12%,TRAF3IP2;TRIM5;ARIH2;RNF152;TRAF5;BFAR;UBE2B
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.469308199350044,0.794879605416412,0.7580645161290323,0.9277333311345404,1.0,2/8,10.24%,ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.435917085647194,0.7948280268404868,0.7833333333333333,0.9276185475966826,1.0,4/16,9.24%,THBS1;SULF1;NPTN;LRIT3
prerank,KEGG_2021_Human__Collecting duct acid secretion,-0.40931900155060164,-0.7946427611503099,0.7555555555555555,1.0,1.0,3/18,13.77%,ATP6V1E2;ATP6V1G1;ATP6V1F
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.4815269944462768,0.7945067485915487,0.7735849056603774,0.9279314339486582,1.0,1/10,2.58%,PLEK
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),0.4488987382799091,0.7943532149868485,0.6825396825396826,0.9279742952988176,1.0,3/11,24.53%,PARP9;PARP16;PARP8
prerank,Reactome_2022__Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.3517313320753067,-0.7941513740421532,0.7878787878787878,1.0,1.0,2/37,5.09%,RFC3;POLD3
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),0.47662892953891195,0.7939168925979592,0.72,0.9284827928686284,1.0,2/8,6.59%,PRKCB;PID1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),-0.5106687570436355,-0.7938216680466497,0.7906976744186046,1.0,1.0,1/6,10.99%,DOLK
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),-0.5106687570436355,-0.7938216680466497,0.7906976744186046,1.0,1.0,1/6,10.99%,DOLK
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),-0.41280436722618724,-0.7936427441574008,0.7111111111111111,1.0,1.0,4/17,15.71%,PRDX1;ATP1B2;CDH3;CCDC66
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.4634454478339698,0.7936306064064541,0.7192982456140351,0.9287165211376028,1.0,3/11,10.92%,APP;SNCA;MAPT
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.4600007029707494,0.7935569818332442,0.75,0.928642232064703,1.0,2/12,2.41%,THBS1;SULF1
prerank,CellMarker_Augmented_2021__Common Myeloid progenitor:Undefined,-0.5351355924243655,-0.7932814286492177,0.75,1.0,1.0,2/5,2.67%,FLT3;CD38
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),-0.47158982342130606,-0.7932540482745576,0.7272727272727273,1.0,1.0,3/9,17.30%,SPCS1;SPCS2;HM13
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.47041694725669136,0.7930652788918179,0.7037037037037037,0.9292003943994505,1.0,2/12,3.70%,CHRNA5;ACHE
prerank,Reactome_2022__SUMOylation Of Transcription Cofactors R-HSA-3899300,0.3832126451856719,0.792978012505632,0.7333333333333333,0.9291451243265777,1.0,15/39,32.22%,UHRF2;HIPK2;MRTFA;PIAS1;UBE2I;PHC2;CBX4;CREBBP;CTBP1;NCOR2;NRIP1;PCGF2;DDX17;NCOA1;MBD1
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),-0.4396225840322053,-0.7925707889825551,0.6730769230769231,1.0,1.0,3/10,15.29%,APOE;ABHD17A;LYPLA2
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.3954339605277563,-0.7921542774044541,0.7,1.0,1.0,1/12,1.76%,CST3
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3894076152440818,0.7919810400207822,0.7666666666666667,0.9304901721664693,1.0,8/30,16.66%,DAB2IP;NLRP12;CARD19;NLRC3;MAPKBP1;PER1;OTUD7B;RORA
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.3663594889778318,-0.7919099816273842,0.7105263157894737,1.0,1.0,5/26,22.08%,CFTR;VIM;DYNLL1;UBB;ACBD5
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.4512969623893487,-0.7914607358715091,0.8378378378378378,1.0,1.0,4/9,27.11%,CYP2C8;NUDT15;CYP2D6;CYP2U1
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.4745262881426733,0.7913532931940125,0.7346938775510204,0.9313028069160457,1.0,2/9,7.04%,TMEM204;APLNR
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.38206992047837035,0.7912135317292632,0.8421052631578947,0.9313568268209286,1.0,3/49,4.82%,PROX1;VAPB;PLSCR1
prerank,Reactome_2022__Regulated Necrosis R-HSA-5218859,0.362586744277101,0.7909979737854864,0.873015873015873,0.9313941362286086,1.0,8/45,23.67%,BIRC3;GSDMD;TNFRSF10B;FADD;TP53;RPS27A;FLOT2;FLOT1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.45412958449258783,0.7905539975718622,0.6666666666666666,0.9317260794079454,1.0,1/8,8.97%,ARHGEF10L
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.45412958449258783,0.7905539975718622,0.6666666666666666,0.9317260794079454,1.0,1/8,8.97%,ARHGEF10L
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.398353112122683,0.7905207922121662,0.7941176470588235,0.9315798320727045,1.0,17/40,29.94%,ZIC1;BAG3;SMAD3;GAS6;PRKCD;TP53;YWHAE;FLNA;UBR5;PSEN1;DHX9;NEDD4;TCF7L2;HDAC3;GSK3B;DMAP1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.3487801651081177,0.7904699425540966,0.8095238095238095,0.9314574656440046,1.0,10/57,22.94%,DVL1;PEX14;PRKCD;TMC8;B2M;CDKN1A;CTSZ;ZFPM1;TTBK2;PIN1
prerank,Reactome_2022__Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,0.3674446323523762,0.7903986627648697,0.855072463768116,0.9313851628942919,1.0,1/51,1.73%,CCNB2
prerank,CellMarker_Augmented_2021__Dendritic cell:Synovium,0.395649911509401,0.7902546045493423,0.765625,0.9314033716878044,1.0,4/28,4.31%,P2RY13;MYO1F;PLEK;PTPRC
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.35847080857399244,0.7901244624873477,0.8181818181818182,0.9314168117779081,1.0,9/48,13.20%,CCNB2;BLM;CCNI2;CDK5R2;CDKN1C;GADD45A;CDKN1B;CDKN1A;CCND1
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.3282851876769895,0.789771905620191,0.8571428571428571,0.9317729840795641,1.0,22/152,16.31%,IGF1;TESC;EFNA1;SOX4;DVL1;TCP1;BAG3;TBL1X;ATP1B1;ATP1B3;CCT4;EPHA4;PRKCD;SYVN1;CDKN1A;NCLN;TNIP2;CCT8;STK3;PINK1;ZSWIM7;PFN2
prerank,Reactome_2022__Apoptotic Cleavage Of Cell Adhesion Proteins R-HSA-351906,0.517200564289907,0.7894860543156934,0.7368421052631579,0.9320433432972101,1.0,3/6,22.15%,CTNNB1;TJP2;TJP1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.32578991084108344,-0.7894207285485375,0.8648648648648649,1.0,1.0,9/56,10.79%,HSD17B8;MCAT;ABHD1;ABCD1;ASAH2B;ELOVL4;ACSBG2;ELOVL2;ACSM6
prerank,Reactome_2022__Sodium/Calcium Exchangers R-HSA-425561,-0.4618295725387399,-0.7892776496823803,0.7727272727272727,1.0,1.0,2/10,10.25%,SRI;SLC8B1
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.39488452942397234,-0.7891032248027927,0.8260869565217391,1.0,1.0,2/19,10.58%,MCRS1;KMT2A
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),-0.5026063242947425,-0.78888037630368,0.7777777777777778,1.0,1.0,4/6,35.14%,NPM1;ABCE1;RAN;TSC1
prerank,CellMarker_Augmented_2021__Colorectal Stem cell:Colorectum,0.5497740490429095,0.7887264096639155,0.7592592592592593,0.9330416102275512,1.0,1/5,4.39%,LGR5
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.4977415296865649,0.7882534513290176,0.7755102040816326,0.9335328133244111,1.0,1/6,8.44%,CAPN1
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.4336908219499213,0.7882496749789033,0.8461538461538461,0.933346036464745,1.0,4/22,6.65%,SEMA3C;SEMA5B;SEMA3D;SEMA3B
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),0.5370421522661912,0.7879794265563485,0.7843137254901961,0.9335778082600833,1.0,1/5,7.04%,ALDOB
prerank,Reactome_2022__G2/M DNA Damage Checkpoint R-HSA-69473,-0.34111344458284343,-0.7878470890570967,0.8,1.0,1.0,7/57,7.38%,RFC3;H2BC4;H2BC21;ATRIP;HUS1;BRIP1;ABRAXAS1
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.4717285937788373,-0.787128139014504,0.673469387755102,1.0,1.0,3/6,14.17%,ABCB10;SLC25A37;LDB1
prerank,Reactome_2022__RUNX2 Regulates Bone Development R-HSA-8941326,-0.3547425335722662,-0.7861436847752941,0.7948717948717948,1.0,1.0,3/25,9.39%,HEY2;HEY1;YES1
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5131169234407603,0.7859989754181312,0.7708333333333334,0.9363744776938672,1.0,4/7,29.94%,STAT3;NCOR1;NCOR2;TGFB1
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.4691212422561683,0.7859971357913988,0.7758620689655172,0.9361824796463597,1.0,1/8,9.88%,GLI2
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),-0.3079405344911905,-0.7858493760706865,0.926829268292683,1.0,1.0,9/74,11.55%,MEOX2;ZNF358;TPP1;FOXJ1;NDRG4;CDHR2;EHF;DAG1;HES5
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.4208620092262047,-0.7856762773282597,0.7777777777777778,1.0,1.0,4/10,27.11%,CYP2C8;NUDT15;CYP2D6;CYP2U1
prerank,CellMarker_Augmented_2021__Neural Stem cell:Undefined,-0.3467073680636289,-0.7856581354608301,0.8181818181818182,1.0,1.0,8/43,11.31%,ID2;SOX21;ASCL1;SFRP2;CXCR4;FZD9;VIM;RUNX1
prerank,Reactome_2022__Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.31834693651680507,-0.7855555671966822,0.8387096774193549,1.0,1.0,4/73,8.55%,KPNA2;AAAS;NUP50;RNASEL
prerank,PanglaoDB_Augmented_2021__Thymocytes,-0.37701633661306116,-0.7853179446364243,0.7878787878787878,1.0,1.0,6/32,7.12%,DPEP2;GMFG;CD247;CD38;P2RY10;CXCR4
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.4188691541125584,0.7852135465316049,0.71875,0.9372119372403438,1.0,8/23,20.96%,FOXO3;STAT3;MAPK11;ETS1;PRMT1;HIF1A;ARNT;ACVR1B
prerank,KEGG_2021_Human__Arginine and proline metabolism,0.3791028849188678,0.7850628644616717,0.8275862068965517,0.9372597952497719,1.0,6/41,9.60%,CARNS1;P4HA2;PRODH;MAOB;CKMT1B;CNDP1
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),0.47737181677052043,0.7849360450192601,0.782608695652174,0.9372720049577948,1.0,3/9,7.78%,ADARB2;NUDT16;APOBEC3H
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),-0.3980308909069957,-0.7847799233919946,0.7446808510638298,1.0,1.0,5/20,16.53%,UQCRB;UQCRHL;MTFR1L;OXA1L;MTFR1
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),0.48338991609886095,0.7847608683183601,0.7358490566037735,0.9373412038836675,1.0,2/6,5.50%,ADARB2;NUDT16
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.4718191915329703,0.7846194381633831,0.75,0.9373510176417305,1.0,2/7,10.90%,LDLR;ABCA2
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.44839200685590824,0.7844951477948845,0.7540983606557377,0.9373204730091182,1.0,3/19,12.78%,BOK;BCL2L1;SYVN1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.35896417316525525,-0.7842297943403728,0.7222222222222222,1.0,1.0,6/48,11.81%,TNFAIP3;TRIM21;PRR7;HSPA1A;RPL11;UFL1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.525394779353964,0.7841995783382211,0.7924528301886793,0.9371672335739386,1.0,3/5,38.28%,MACROH2A1;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.525394779353964,0.7841995783382211,0.7924528301886793,0.9371672335739386,1.0,3/5,38.28%,MACROH2A1;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.525394779353964,0.7841995783382211,0.7924528301886793,0.9371672335739386,1.0,3/5,38.28%,MACROH2A1;SMC5;NSMCE2
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.37171862858997706,0.7841860068728933,0.7538461538461538,0.9369968127765841,1.0,9/57,14.32%,SIX3;SLC4A10;TYR;GRM6;EML2;RP2;CABP1;MYO9A;SLC24A1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),-0.48051528139794214,-0.7839063632926443,0.7608695652173914,1.0,1.0,1/8,1.20%,GALNT3
prerank,"Reactome_2022__Synthesis, Secretion, And Inactivation Of Glucagon-like Peptide-1 (GLP-1) R-HSA-381771",-0.4348730323928534,-0.7838680916692284,0.7906976744186046,1.0,1.0,4/11,15.00%,PCSK1;SPCS1;SPCS2;PAX6
prerank,Reactome_2022__Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.3635424604783278,-0.7838319702658583,0.8125,1.0,1.0,2/28,5.09%,RFC3;POLD3
prerank,Reactome_2022__Alpha-protein Kinase 1 Signaling Pathway R-HSA-9645460,0.4496653913428407,0.7837208803223038,0.7708333333333334,0.9375212697085167,1.0,4/10,26.96%,TAB1;RPS27A;TAB2;MAP3K7
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.3147765950919288,-0.7836949562976234,0.90625,1.0,1.0,9/79,11.93%,TNFAIP3;TRIM21;POLR2K;PTPN22;DHX33;PQBP1;POLR3E;POLR3B;POLR3F
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),0.38490853730190955,0.7836269447113666,0.7192982456140351,0.9374622772583262,1.0,1/25,2.91%,WAS
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),-0.46579400798138476,-0.7833762947936137,0.7333333333333333,1.0,1.0,3/14,7.89%,AR;ESR2;NCOA4
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,0.3893710762305157,0.7831767149709085,0.7592592592592593,0.9379793133360027,1.0,8/28,21.99%,CHD3;PML;PDZD2;PIP4K2A;TP53;ING5;AKT3;GATAD2A
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.49096504722833645,0.7830999492802654,0.8166666666666667,0.9378965523200207,1.0,1/9,1.91%,NLGN1
prerank,Reactome_2022__Activation Of AMPK Downstream Of NMDARs R-HSA-9619483,0.46705982787342665,0.782809362384447,0.7272727272727273,0.9381431744344955,1.0,1/8,10.92%,MAPT
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.39972265576532323,-0.7825125796311998,0.7435897435897436,1.0,1.0,2/19,12.38%,SRI;ATP1A2
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.47978821250585807,0.782415987944571,0.8070175438596491,0.9384820842134599,1.0,1/8,17.53%,CCNB1
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),-0.3490709226279918,-0.7823632735869427,0.8285714285714286,1.0,1.0,11/57,14.87%,KPNA2;POLR2K;PPIH;POLR2C;RAD23A;CNOT7;CCNT1;GTF2F1;TMEM250;POLR2D;PPIE
prerank,KEGG_2021_Human__Phototransduction,-0.4569270093525083,-0.7821371414911678,0.7560975609756098,1.0,1.0,1/8,3.89%,GUCA1B
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.5069945179752711,0.7819693146457067,0.7272727272727273,0.9388942774762358,1.0,2/6,12.19%,SIGLEC1;TPCN2
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.4324887997286251,-0.7818818742135781,0.6590909090909091,1.0,1.0,6/13,21.25%,ENTPD1;DCTPP1;NUDT15;ENPP3;ENTPD5;ITPA
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.32871258914133145,0.7817263573440733,0.8888888888888888,0.939128704781767,1.0,19/106,20.60%,SUV39H1;SCN2A;LMNA;NDRG1;PGK1;CPEB2;HIPK2;FMN2;TP53;PINK1;HIF3A;BACH1;RORA;PLK3;HIF1A;ARNT;EGLN3;RPS27A;HYOU1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.4123919238011265,0.7816820891955206,0.7678571428571429,0.9390197512039835,1.0,8/31,21.03%,MBP;ASS1;PODXL;KLF4;MAP2K5;NOTCH4;BMP6;PPM1F
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),0.49069425753785223,0.7813646745444758,0.7636363636363637,0.9393369021483988,1.0,4/9,33.31%,PNMT;PRKN;PAH;LRTOMT
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.2940256052126261,-0.7812878910647568,0.9166666666666666,1.0,1.0,5/115,4.15%,FAM47E;PADI4;BRDT;CHRAC1;SETDB1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.47958724037702305,-0.7811421144028137,0.7755102040816326,1.0,1.0,1/7,10.01%,CDHR2
prerank,"Reactome_2022__Cobalamin (Cbl, Vitamin B12) Transport And Metabolism R-HSA-196741",-0.3987322597730405,-0.7808983094574872,0.7631578947368421,1.0,1.0,4/16,11.37%,CD320;PRSS3;MMAB;MMACHC
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.3188196262877506,0.7808283999585981,0.927536231884058,0.9398811092106318,1.0,28/135,19.98%,STEAP3;SEPTIN4;FAS;BCL6;BIRC3;CASP10;ALPK2;DAPK2;NDRG1;TP53I3;ACTN1;SRA1;ALK;TNFRSF10B;BCAR1;LCMT1;RARG;TP53;PINK1;TOX3;MECOM;AMIGO2;RTN4;ACER3;DNAJA3;RTKN;DDX42;ACTN4
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.4491581014383904,0.7808093745879086,0.71875,0.939727114126999,1.0,1/12,0.85%,ANXA1
prerank,Reactome_2022__SARS-CoV-2 Modulates Autophagy R-HSA-9754560,-0.44660201576699676,-0.780711799517334,0.723404255319149,1.0,1.0,1/9,8.77%,VPS11
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),0.4788006644264483,0.7807082237481983,0.8333333333333334,0.9397080183026622,1.0,4/9,37.30%,CREBBP;BAG6;SIRT1;KAT5
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.41363523196378144,0.7805368561002922,0.8,0.9398000884802581,1.0,9/26,23.95%,THY1;TESPA1;CD160;IKBKG;PTPRJ;DGKZ;CARD11;GBP1;PRNP
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.4053478798984079,-0.7805051352333543,0.6862745098039216,1.0,1.0,4/17,8.86%,ID1;GREM1;EFNB2;GPLD1
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.5233196887645211,0.7804306704348993,0.7536231884057971,0.9397431521872965,1.0,1/6,20.36%,UBR5
prerank,Reactome_2022__Mitotic Anaphase R-HSA-68882,0.31292836992283257,0.7804091429576605,0.948051948051948,0.9395845826672057,1.0,33/190,23.53%,VRK2;CCNB2;LMNB1;INCENP;PMEPA1;CENPP;ERCC6L;LMNA;TUBB6;CENPH;RANGAP1;TUBA1B;IST1;DYNC1LI2;SKA2;CCNB1;CKAP5;DYNC1LI1;CDC27;RPS27A;KANSL1;UBE2E1;PDS5A;UBE2I;TUBA4A;RCC1;PDS5B;TUBB4A;DYNC1I1;PSMB3;TUBA1C;TAOK1;CENPU
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),0.4327616547215746,0.7803842636156579,0.7413793103448276,0.9394189869521867,1.0,3/14,14.66%,COLEC12;CGAS;IFIH1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.47225007536460933,0.7803729323310524,0.7719298245614035,0.93924873247919,1.0,1/8,3.44%,NOD1
prerank,CellMarker_Augmented_2021__B cell:Spleen,0.3920794765117109,0.7802990226888131,0.7702702702702703,0.9391919549920117,1.0,7/33,7.24%,MYO1F;PLEK;NAPSB;WAS;PTPRC;CD37;ACAP1
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),-0.3423066465240806,-0.7802659954665009,0.9,1.0,1.0,3/43,5.09%,APEX2;RFC3;POLD3
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.4757991777608557,-0.7800623185879683,0.72,1.0,1.0,3/6,23.80%,DPH2;DPH5;DPH3
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.4757991777608557,-0.7800623185879683,0.72,1.0,1.0,3/6,23.80%,DPH2;DPH5;DPH3
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.3058019550600941,-0.7798244934380923,0.8787878787878788,1.0,1.0,9/82,10.54%,SOD3;SELENOS;PRDX1;BRF2;EIF2S1;HSPA1A;GPX7;NUDT2;NOX1
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.34625060808545405,0.7797017061961755,0.8695652173913043,0.9399312540972509,1.0,18/60,19.28%,FOXO1;SOX4;HK2;PPARG;STAT3;PYGL;PDK4;BACE2;MLXIPL;KLF7;ADIPOR2;HK1;GCKR;IGF1R;STK11;HECTD4;CAV3;HIF1A
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),-0.38585055387319306,-0.7791890535378301,0.8,1.0,1.0,2/24,1.54%,MID1IP1;TPX2
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.4797656108912447,0.7791528169944962,0.7090909090909091,0.9405143800615985,1.0,5/10,31.20%,TP53;NCOR1;NCOR2;TGFB1;MAP2K1
prerank,Reactome_2022__Hyaluronan Metabolism R-HSA-2142845,-0.43766847506488604,-0.778848764710535,0.7380952380952381,1.0,1.0,1/11,1.21%,STAB2
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH3 (MutSbeta) R-HSA-5358606,0.4388677791258142,0.7787502758343154,0.8166666666666667,0.9409107325436197,1.0,3/12,13.05%,POLD1;PMS2;LRIG1
prerank,Reactome_2022__Visual Phototransduction R-HSA-2187338,0.3600544431645923,0.7786208492893021,0.8405797101449275,0.940891434548168,1.0,1/57,0.10%,RIMBP2
prerank,Reactome_2022__Protein Folding R-HSA-391251,0.34814016528592995,0.7783709738469002,0.8378378378378378,0.9410609646057522,1.0,11/78,15.46%,GNG3;RGS6;GNG2;TCP1;GNA14;TUBB6;CCT4;STAT3;TUBA1B;CCT8;TP53
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.4792674229917927,-0.7783575429824604,0.7317073170731707,1.0,1.0,1/5,10.60%,NCSTN
prerank,Reactome_2022__Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,0.40741086579409413,0.7781006651411625,0.8363636363636363,0.9412988590220299,1.0,14/27,34.52%,UBE2H;RPS27A;UBE2B;UBE2E1;UBE2R2;UBE2K;UBA6;USP5;OTULIN;UBE2Q2;UBE2Z;USP9X;UBE2G2;UBE2S
prerank,Reactome_2022__Transcriptional Regulation By TP53 R-HSA-3700989,-0.2720606296823569,-0.7779846433017052,1.0,1.0,1.0,48/310,14.43%,CCNE1;SETD9;TPX2;COX18;RFC3;ATRIP;PRDX1;LRPPRC;COX7C;HUS1;GTF2H5;POLR2K;ELOC;RGCC;SMYD2;GTF2H2;CHD4;COX20;NOC2L;BRIP1;PLAGL1;ELOA;COX7B;KMT5A;TAF13;SUPT16H;RRAGC;ERCC2;TTC5;TAF11;COX5B;TMEM219;POLR2C;MAP2K6;PRELID1;PIP4P1;CNOT7;COX19;CCNT1;GTF2F1;RAD9B;SLC38A9;TRIAP1;BRD7;RRAGA;CNOT1;RMI2;TACO1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.5249413212602861,0.7779598405387962,0.7692307692307693,0.941310164601387,1.0,2/6,18.63%,FGF13;CAV3
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),0.4942845338324878,0.7776860754020498,0.6842105263157895,0.9414865823835824,1.0,2/8,20.62%,PLEKHA4;MLLT3
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.48267455236954854,0.7776053140229413,0.75,0.9414058702373853,1.0,2/7,10.24%,ATP1B1;ATP1B3
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.30598311892905544,-0.777411456117573,0.967741935483871,1.0,1.0,6/91,9.50%,NUP62CL;NXT2;NUP50;CHCHD10;NOL8;RANBP6
prerank,Reactome_2022__Triglyceride Metabolism R-HSA-8979227,0.3964164398542534,0.7771729831678934,0.8135593220338984,0.9418297712219127,1.0,6/23,18.53%,FABP3;PPP1CB;DGAT1;LIPE;LPIN3;PRKCA
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),0.4291078475809551,0.7771226506552986,0.7777777777777778,0.9417278057583576,1.0,2/14,6.42%,KCNB2;PVALEF
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.4392128648097296,0.7768993660957163,0.7910447761194029,0.9418827830954155,1.0,5/15,11.42%,ATP1A1;SLC9A1;ATP1B1;ATP1B3;TMPRSS3
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.4447578710465889,0.7768506928551766,0.8166666666666667,0.9417384328636653,1.0,4/14,9.86%,SLIT2;TNFRSF1A;ROBO2;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.40927410155180843,0.7768031277929611,0.7457627118644068,0.9416365481388803,1.0,2/19,8.12%,PROX1;CTNNB1
prerank,Reactome_2022__Transport Of Fatty Acids R-HSA-804914,0.5231280856571998,0.7766986537514979,0.7307692307692307,0.9415959466818259,1.0,3/5,22.72%,APOD;SLC27A6;SLC27A1
prerank,KEGG_2021_Human__Tyrosine metabolism,-0.4008511323117776,-0.7766665428041005,0.8421052631578947,1.0,1.0,5/18,10.61%,ADH6;DCT;ADH4;AOX1;ADH5
prerank,Reactome_2022__GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.3367753666665724,-0.7766525422476808,0.7857142857142857,1.0,1.0,10/53,20.20%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;CUL1;PSMB4
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),-0.4344724832379791,-0.7764870716597398,0.7674418604651163,1.0,1.0,4/14,12.46%,TRIM21;TRIM68;FUCA2;EXOC7
prerank,Reactome_2022__Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.3419310414014773,-0.7763893330493435,0.7741935483870968,1.0,1.0,9/46,20.20%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.37712567375208694,0.7763313717971109,0.8571428571428571,0.9418732836962164,1.0,9/46,16.45%,UGT8;ESYT3;B4GALNT1;B3GALNT1;ABCA2;FUT2;STS;ST6GALNAC3;NEU4
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.4293849416204892,-0.7760419986873504,0.8125,1.0,1.0,2/14,10.58%,TPP1;ATR
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.4134168521940643,0.7759704446593778,0.7166666666666667,0.9422376245117926,1.0,5/18,17.04%,CACNA1C;RYR2;SLC8A1;PDE4D;CALM3
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.3847646268423409,-0.7757963781800585,0.8108108108108109,1.0,1.0,3/22,5.43%,SELENOS;TNFAIP3;PTPN22
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.4569399972555639,-0.7756368002029408,0.6976744186046512,1.0,1.0,2/7,12.38%,SRI;ATP1A2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.38267658300399854,-0.7755875761964501,0.8611111111111112,1.0,1.0,3/23,5.43%,SELENOS;TNFAIP3;PTPN22
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),0.4310557025496551,0.7753389496092582,0.75,0.9427516898559248,1.0,2/12,14.60%,SLC20A2;SLC37A2
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),0.4310557025496551,0.7753389496092582,0.75,0.9427516898559248,1.0,2/12,14.60%,SLC20A2;SLC37A2
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.48001898096079865,0.7753276616973239,0.7619047619047619,0.9425814846401406,1.0,1/7,2.53%,CD55
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.3270973692189139,-0.7751736296423186,0.8620689655172413,1.0,1.0,9/77,10.20%,TPX2;RFC3;ATRIP;HUS1;NOC2L;BRIP1;TAF13;SUPT16H;TAF11
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),0.36847265854103095,0.7751081921461058,0.7857142857142857,0.9427195375054089,1.0,6/35,15.68%,NLRC5;NLRC3;IKBKE;RELB;IFIH1;PTPRS
prerank,Reactome_2022__Mismatch Repair (MMR) Directed By MSH2:MSH6 (MutSalpha) R-HSA-5358565,0.4560661575784612,0.775093270362306,0.8214285714285714,0.9425423515598792,1.0,3/12,13.05%,POLD1;PMS2;LRIG1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.28145987602612116,-0.7749569899220305,0.9473684210526315,1.0,1.0,23/134,20.26%,CSDC2;EXOSC8;EXOSC4;HSPA1A;METTL3;VIM;EXOSC5;IGF2BP3;PSMD10;PSMD12;PSMB5;PSMB6;RC3H1;ZFP36L2;CIRBP;PSME3;FASTKD1;APEX1;PSMD2;UBB;PCBP4;PSMB4;DIS3
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.34165579513339056,0.774660533100575,0.8333333333333334,0.9429743104881076,1.0,12/60,13.58%,BOK;NOD1;NLRP12;FAS;SNCA;CASP10;SMAD3;PPARG;BBC3;MAPT;TNFRSF10B;FADD
prerank,Reactome_2022__TFAP2 (AP-2) Family Regulates Transcription Of Growth Factors And Their Receptors R-HSA-8866910,0.4655500118291374,0.7745851045092347,0.7846153846153846,0.9428888398337515,1.0,2/10,12.83%,TGFA;TFAP2C
prerank,"Reactome_2022__Tetrahydrobiopterin (BH4) Synthesis, Recycling, Salvage And Regulation R-HSA-1474151",0.48189669996959417,0.7744242237980147,0.75,0.9428903789803638,1.0,2/9,15.80%,PRKG2;GCHFR
prerank,Reactome_2022__Keratinization R-HSA-6805567,0.42070260460154657,0.7743950120261898,0.8070175438596491,0.9427344539227518,1.0,2/18,8.44%,PKP2;CAPN1
prerank,Reactome_2022__RHOT1 GTPase Cycle R-HSA-9013425,0.5372814827872356,0.7742510561590487,0.8363636363636363,0.9427477723732149,1.0,2/5,16.67%,TRAK1;RHOT1
prerank,Reactome_2022__COPI-mediated Anterograde Transport R-HSA-6807878,0.33777619398142544,0.7742062013100395,0.8507462686567164,0.9426177811731093,1.0,2/72,2.53%,ANK3;CD55
prerank,Reactome_2022__Scavenging By Class F Receptors R-HSA-3000484,-0.5176943097921658,-0.774130227149638,0.8181818181818182,1.0,1.0,1/5,5.28%,SCARF1
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),-0.5206898180547108,-0.7738422502970284,0.8409090909090909,1.0,1.0,1/5,1.02%,RGS2
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),0.4272275233124723,0.7737679058586227,0.7962962962962963,0.9430186655767766,1.0,5/19,11.23%,SLIT2;DAB2IP;CYRIB;TGFB2;FBP1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.4765544309194132,-0.7736760196962311,0.7678571428571429,1.0,1.0,2/6,17.35%,GREM1;BMP2
prerank,Reactome_2022__SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,-0.3193893274985591,-0.7736647845217659,0.9142857142857143,1.0,1.0,2/37,5.18%,AAAS;NUP50
prerank,CellMarker_Augmented_2021__Endothelial cell:Fetal Gonad,0.31291466000811563,0.7734741907004227,0.9384615384615385,0.9432667481679566,1.0,29/178,16.25%,ST6GAL1;PLK2;ITM2A;SLIT2;THY1;SOX4;LDB2;DPYSL2;ST8SIA1;MYD88;MYO1C;ADGRL2;LDHA;TUBB6;ZCCHC24;SMAD1;CDKN1C;ARMCX2;FN1;CKS1B;ELF1;MAN1A1;SMTN;BIN1;HLA-E;SERPING1;STMN1;ZEB1;FSTL1
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),0.48242214145126716,0.7733441664315691,0.7837837837837838,0.9433057740577895,1.0,1/7,11.48%,KYAT1
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),0.4534258690077078,0.7729273489328642,0.76,0.9437180123197362,1.0,1/7,7.62%,MYD88
prerank,KEGG_2021_Human__Alzheimer disease,0.298533410138021,0.7728940811307945,0.9876543209876543,0.9435691812975627,1.0,33/284,14.73%,GRIN2A;CHRM3;CHRM1;GRIN2D;GRIN2B;IRS2;APP;WNT8B;FAS;TUBB1;ITPR3;DVL1;GRM5;TNFRSF1A;SNCA;CACNA1C;GRIN1;CTNNB1;KIF5A;KIF5C;CAPN1;TUBB6;MAPT;NDUFB11;BACE2;KLC2;FRAT2;KLC1;FADD;TUBA1B;NDUFB9;PIK3CD;NOX4
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.43595241766320236,0.7728036228232711,0.8064516129032258,0.9435259983819798,1.0,1/15,2.72%,TIMP2
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),-0.508590933601734,-0.7726689861876374,0.875,1.0,1.0,2/6,21.59%,NLGN3;CHRNA4
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.4187503862218079,-0.7724384737894874,0.7959183673469388,1.0,1.0,6/10,33.97%,NMD3;NPM1;SDAD1;ABCE1;RPS15;RAN
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.44803639335275436,-0.7718204664649276,0.8529411764705882,1.0,1.0,6/15,21.11%,SF3B4;NCL;RBMX;CIRBP;PRDX6;SNW1
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.3220960178366282,-0.7717926256233709,0.8571428571428571,1.0,1.0,4/52,7.38%,ERCC8;RGCC;SIRT6;ABRAXAS1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.3833414039089078,-0.771510954944885,0.85,1.0,1.0,5/17,24.10%,CEP131;CEP83;CEP192;STIL;PCM1
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),0.49924730921211724,0.7713358549778668,0.7962962962962963,0.9453619163144353,1.0,2/8,4.36%,TLCD2;FABP3
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.5403863468009809,-0.7709285022011018,0.7727272727272727,1.0,1.0,1/5,4.36%,APOE
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.42247204837820224,-0.7704872413208314,0.7441860465116279,1.0,1.0,2/17,6.17%,MSTO1;MUL1
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),0.45017521942821004,0.7703980471223174,0.7090909090909091,0.946488766231527,1.0,1/8,3.40%,DYSF
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.3299310627946782,-0.7701624911385838,0.9117647058823529,1.0,1.0,4/31,7.16%,BLOC1S4;BLOC1S2;KIF4A;SNAPIN
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.2974348019401044,0.7700369419580804,0.9861111111111112,0.946794419794304,1.0,9/239,6.62%,RECQL4;HELB;SP100;TYMS;BLM;UHRF2;RPA1;SAMHD1;POLD1
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.37957455832988984,0.7700186018806001,0.8181818181818182,0.9466240165534276,1.0,4/27,11.94%,TJP3;GALNT12;CAPN8;BACE2
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.31640946067020176,-0.769919013413584,0.8709677419354839,1.0,1.0,3/79,4.36%,NGF;CD200R1;APOE
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),-0.420138987061528,-0.7696394544447052,0.7555555555555555,1.0,1.0,5/10,21.51%,CR1;GPLD1;SPG21;SLA2;FPR3
prerank,CellMarker_Augmented_2021__Granulocyte-monocyte progenitor:Umbilical Cord Blood,0.35092844862040123,0.7696150594871591,0.8732394366197183,0.9469857757247573,1.0,11/74,13.37%,ANXA1;PLD1;PLEK;CP;IGFBP7;LDHA;B3GALNT1;NIBAN1;PYGL;TPSD1;MAMDC2
prerank,Reactome_2022__Downstream TCR Signaling R-HSA-202424,0.34230449447621064,0.7694349022745646,0.90625,0.9470192915741782,1.0,1/75,0.56%,HLA-DRA
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.38426502062520895,0.7692793740892655,0.8181818181818182,0.9470645092563422,1.0,2/30,10.92%,MAEL;MAPT
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.4056272188202591,-0.7692746736213866,0.7631578947368421,1.0,1.0,8/25,21.37%,APOE;ABCB11;ARV1;ADIPOR1;FMO5;MLYCD;EPHX2;GNB3
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.4397499357813432,0.7691069819866226,0.75,0.9471354772943774,1.0,4/13,15.01%,ORAI1;CAMK2B;BCL2;CD4
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.3574810504643737,-0.7687174127507327,0.8108108108108109,1.0,1.0,7/36,14.01%,SFXN2;SLC3A2;SLC6A13;SLC36A1;SLC38A9;SLC47A1;SLC25A22
prerank,KEGG_2021_Human__Base excision repair,-0.3645793485533716,-0.7686718045177285,0.7948717948717948,1.0,1.0,2/29,5.09%,APEX2;POLD3
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),-0.35127229076063676,-0.768406313368392,0.84,1.0,1.0,3/28,6.61%,PMVK;TM7SF2;ARV1
prerank,Reactome_2022__Diseases Of DNA Repair R-HSA-9675135,-0.346416031483543,-0.7681401318010327,0.7567567567567568,1.0,1.0,14/43,21.52%,RFC3;ATRIP;HUS1;BRIP1;RAD9B;RMI2;POLR1B;DNA2;SEM1;RAD51;RAD17;MSH3;XRCC2;BRCA2
prerank,CellMarker_Augmented_2021__Endometrial Progenitor cell:Endometrium,0.3365172860330456,0.7679523347280035,0.875,0.9486374578710346,1.0,18/99,17.87%,CENPB;DVL1;SBF1;ERI3;PEX14;ACAP3;POMGNT1;KLC2;AGAP3;GPS1;FAM219A;IPO13;PLXNA1;TAB1;ANKRD52;SCRIB;DCTN1;RNF187
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),-0.4476840850296897,-0.7679014673907261,0.7777777777777778,1.0,1.0,5/9,26.89%,MCM6;MCM4;MCMDC2;ORC3;MCM3
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.37323783044767345,-0.767678613949338,0.8292682926829268,1.0,1.0,3/24,10.54%,FIP1L1;CPSF1;CLP1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.37323783044767345,-0.767678613949338,0.8292682926829268,1.0,1.0,3/24,10.54%,FIP1L1;CPSF1;CLP1
prerank,Reactome_2022__Scavenging By Class A Receptors R-HSA-3000480,0.45632250985791667,0.7676418730998084,0.8135593220338984,0.9488977536439046,1.0,4/11,6.01%,COL4A1;COL4A2;COLEC12;COLEC11
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.44843628087872905,0.7676115175681579,0.7301587301587301,0.9487365312326507,1.0,4/14,14.15%,RASGRP1;PTPRC;BCL2;CD70
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.4633139694489481,0.7676095562241589,0.7741935483870968,0.9485496261171578,1.0,3/9,33.56%,RTN4;AHCTF1;NUP98
prerank,Reactome_2022__Phenylalanine And Tyrosine Metabolism R-HSA-8963691,0.4660480382865606,0.7672519177646457,0.803030303030303,0.9488753086323654,1.0,1/9,11.48%,KYAT1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),-0.3829624304769008,-0.7672489072005875,0.8,1.0,1.0,3/36,7.50%,CST3;CSTB;BAK1
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.32350968695874566,0.7671960012314621,0.84375,0.9487539644016514,1.0,12/97,18.72%,PRKCG;SEPTIN4;SOX4;FAM107A;BIRC3;PHF23;PRICKLE1;WASHC1;PINK1;BRCA1;NDFIP2;UBXN1
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.39166173435303175,0.7671473432778004,0.8333333333333334,0.9486116155072762,1.0,5/24,15.01%,TRIM5;CIITA;HLA-DRB1;TRIM22;CD4
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.46461805178499627,0.7670472629601528,0.8181818181818182,0.9485815874928987,1.0,2/9,11.93%,NOD1;HLA-DRB1
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),-0.47498650344067417,-0.7666194842116456,0.75,1.0,1.0,3/7,24.99%,VPS4B;VCP;CHMP3
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.35041761577865865,-0.7665950445262841,0.7857142857142857,1.0,1.0,3/36,4.15%,APOBEC3G;BTBD17;SETDB1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.3368359317192207,0.7665032535205604,0.948051948051948,0.9491314823291723,1.0,22/134,17.21%,SGPP2;VAPB;FA2H;ACHE;MFSD2A;ASS1;SPNS2;HACD1;CERS3;CHKB;B4GALT5;PAM;SGMS1;ALDH3A2;ELOVL7;LARGE1;SLC44A3;CERS5;ELOVL5;GSTM5;LPIN3;HACD4
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.4391537454789327,0.7664618400815572,0.803030303030303,0.9489844676682468,1.0,5/12,22.00%,CNTN4;EPHA4;RTN4;ARHGAP35;EPHA3
prerank,Reactome_2022__HDR Thru MMEJ (alt-NHEJ) R-HSA-5685939,0.4587234466903284,0.7662953460472823,0.7450980392156863,0.9490151552059836,1.0,2/9,15.82%,MRE11;XRCC1
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.40842822386070055,-0.7662521420614237,0.8378378378378378,1.0,1.0,5/19,21.65%,ENY2;USP51;EPOP;BRCC3;ATXN7L3
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.38411064837285425,0.7661971620765317,0.828125,0.9489266466635746,1.0,4/32,10.04%,SOCS3;ITPKC;ITPKB;PIP4K2A
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.43355417179911016,0.7661963509868877,0.7746478873239436,0.9487353693713626,1.0,6/15,12.43%,MYH9;PIR;PPARG;PDE1B;GAS6;RELB
prerank,Reactome_2022__Metabolism Of Steroid Hormones R-HSA-196071,-0.40774560556914186,-0.7661923407266452,0.851063829787234,1.0,1.0,5/17,15.48%,CD163L1;HSD11B1;SRD5A1;TSPO;STARD3NL
prerank,Reactome_2022__NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,0.35528263073469585,0.7659324591520354,0.8833333333333333,0.9489062481656559,1.0,7/32,18.14%,APOD;TBL1X;RXRA;GPS2;NCOR1;ABCG1;TBL1XR1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.4045048562013703,0.7659299196001048,0.7543859649122807,0.9487197231104768,1.0,8/20,21.77%,CFAP20;PDPN;TRIM32;ETS1;STK11;ADAM17;ACTN4;CCDC25
prerank,CellMarker_Augmented_2021__Naive Regulatory T (Treg) cell:Peripheral Blood,0.3936832856740219,0.7658795219302653,0.828125,0.9485939845664101,1.0,6/35,4.66%,CTSS;MYO1F;PLEK;SLA;PTPRC;CD37
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.3407225237953834,0.7657647075152592,0.8333333333333334,0.9485710182805399,1.0,11/51,19.44%,BLM;EME2;DONSON;CDKN1A;CCND1;MRE11;TP53;BRCA1;CDK2;FBXO31;WAC
prerank,Reactome_2022__EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,-0.3572563180270485,-0.7654071496799236,0.9024390243902439,1.0,1.0,4/24,11.06%,POU3F1;PXMP2;POU3F2;DAG1
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),-0.4420532950273044,-0.7652173377084718,0.7916666666666666,1.0,1.0,1/7,7.85%,GLUD1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.43712588277111686,0.7651876982922658,0.7450980392156863,0.9491736032311449,1.0,4/12,19.47%,NRG1;TGFB2;TEK;TGFBR3
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),0.4784192686922637,0.764995052835108,0.7592592592592593,0.9492298733258273,1.0,1/8,4.49%,TRPM4
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.4165308699585855,0.764754610729384,0.7288135593220338,0.9493164520065277,1.0,5/13,39.49%,DGKD;SMAP1;SCYL2;UBQLN2;NEU3
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.3519150593451374,-0.7647233311243651,0.8787878787878788,1.0,1.0,4/29,13.82%,VAMP8;ATG14;VIPAS39;VTI1B
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.5127678396821808,0.7647102293847363,0.8070175438596491,0.9491837217870448,1.0,3/7,11.71%,TLR2;NAMPT;CCL2
prerank,CellMarker_Augmented_2021__Hematopoietic Stem cell:Germ,-0.4536439716634266,-0.7646825445173607,0.7446808510638298,1.0,1.0,2/10,7.12%,CD38;CXCR4
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.3445173179220302,0.7646534526387855,0.8873239436619719,0.9490603739134496,1.0,2/80,3.69%,SIX3;NEK10
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.4502234579872022,0.7643937671778942,0.7636363636363637,0.9492425367722347,1.0,2/8,10.27%,MYD88;STAT3
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.3667286543691634,0.7642593295130024,0.7727272727272727,0.9492334601504292,1.0,11/59,15.86%,C1ORF87;CYP4X1;DNAH3;ZBTB7C;ATP1B1;MORN5;NEBL;FUT2;KCNMA1;NWD1;AKAP14
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,0.3705164410751121,0.764238175989272,0.8382352941176471,0.949068221810607,1.0,6/31,8.68%,PSCA;LIPH;TJP3;POF1B;CAPN8;KPNA7
prerank,Reactome_2022__Regulation Of TP53 Activity R-HSA-5633007,0.3090618562858446,0.7640685272152434,1.0,0.9491267642596147,1.0,26/137,20.13%,CDKN2A;BLM;NUAK1;CHD3;PML;PDZD2;PIP4K2A;BARD1;PRR5;HIPK1;MAPKAPK5;PRDM1;HIPK2;MRE11;MAPK11;TP53;BRCA1;CDK2;RFFL;STK11;RFC4;PLK3;TAF10;ING5;RPS27A;AKT3
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.4599522514974397,0.7640022959618631,0.7407407407407407,0.9490152012493711,1.0,2/11,10.96%,HMBOX1;PARP9
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),-0.3823086465072235,-0.7638624945366999,0.725,1.0,1.0,3/16,6.31%,CEBPA;KARS1;IL33
prerank,Reactome_2022__Reduction Of Cytosolic Ca++ Levels R-HSA-418359,0.4790095548490619,0.7636986017325813,0.7846153846153846,0.9492437785678604,1.0,4/9,16.77%,ATP2B3;ATP2B4;SLC8A2;SLC8A1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.3638033068270544,-0.7635506143950835,0.8333333333333334,1.0,1.0,8/23,19.91%,NPC2;SLC25A19;MTTP;PRELID1;TRIAP1;PCTP;PRELID2;PRELID3A
prerank,Reactome_2022__Cytosolic Iron-Sulfur Cluster Assembly R-HSA-2564830,-0.4387126723640655,-0.7634601236789038,0.8367346938775511,1.0,1.0,4/11,13.35%,BRIP1;ERCC2;CIAO3;CIAO2B
prerank,Reactome_2022__CTLA4 Inhibitory Signaling R-HSA-389513,0.4295610702966845,0.7631719542253618,0.8333333333333334,0.9498472254844915,1.0,1/16,4.92%,FYN
prerank,CellMarker_Augmented_2021__Basal cell:Epithelium,0.37739000134081435,0.762864575897328,0.8421052631578947,0.9500848577687802,1.0,12/35,10.90%,MAP3K6;EPHA2;EPS8L2;RHOD;CDC42EP1;MYO1C;CAPN1;ITGA3;LMNA;ZDHHC1;PXDC1;DUOXA1
prerank,Reactome_2022__Regulation Of FZD By Ubiquitination R-HSA-4641263,0.3921421481030467,0.7625807700346733,0.8305084745762712,0.9502874743351727,1.0,1/17,4.39%,LGR5
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),-0.376855653809821,-0.7624269954552946,0.7659574468085106,1.0,1.0,3/25,6.61%,PMVK;TM7SF2;ARV1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.4615614330797276,0.7624134188911852,0.7761194029850746,0.9503480289714168,1.0,1/10,4.96%,FAS
prerank,Reactome_2022__Cilium Assembly R-HSA-5617833,-0.2862675001854863,-0.7623248981129058,1.0,1.0,1.0,27/166,19.36%,CEP72;CNGA4;SSNA1;DYNLRB2;CETN2;HAUS1;DYNLRB1;CEP131;RAB8A;SCLT1;EXOC7;IQCB1;CEP83;DYNC2I1;ARF4;BBS10;BBS9;DYNLL1;MKS1;CEP192;UNC119B;CEP78;ARL6;EXOC1;FBF1;IFT57;TUBB
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),-0.49531683653210984,-0.7620778092300514,0.7105263157894737,1.0,1.0,2/6,22.49%,VANGL2;FUZ
prerank,Reactome_2022__APC Truncation Mutants Have Impaired AXIN Binding R-HSA-5467337,0.42098824086897835,0.7620236161655476,0.78125,0.9507599488031556,1.0,7/12,40.01%,PPP2R1B;GSK3B;PPP2R5C;PPP2R5E;CSNK1A1;AMER1;PPP2R1A
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.45983702763943946,-0.7615820861095776,0.8333333333333334,1.0,1.0,3/7,22.28%,VPS11;RDX;PTPN23
prerank,Reactome_2022__Centrosome Maturation R-HSA-380287,-0.30276463315047836,-0.7610997417100738,0.9166666666666666,1.0,1.0,5/73,10.46%,CEP72;SSNA1;CETN2;HAUS1;CEP131
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.41923066519355834,0.760970235335479,0.8545454545454545,0.9520325510983622,1.0,2/16,9.96%,FAP;ZDHHC7
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),0.5094437404790293,0.7609285731999317,0.7678571428571429,0.9518903441229807,1.0,1/6,3.94%,SUV39H1
prerank,Reactome_2022__Biosynthesis Of Maresins R-HSA-9018682,-0.4735201026859069,-0.7608184462678348,0.813953488372093,1.0,1.0,2/5,21.27%,CYP2C8;EPHX2
prerank,Reactome_2022__RHOT2 GTPase Cycle R-HSA-9013419,0.4980835190399727,0.7607073448357496,0.8333333333333334,0.951983088106506,1.0,2/7,17.07%,TRAK1;RHOT2
prerank,Reactome_2022__p130Cas Linkage To MAPK Signaling For Integrins R-HSA-372708,0.44762407103369206,0.7604269267919446,0.8181818181818182,0.9521781043662377,1.0,5/11,19.92%,FN1;BCAR1;RAP1A;RAP1B;APBB1IP
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.39655741645084114,0.7604008805449576,0.8064516129032258,0.9520173557683956,1.0,10/26,24.98%,PLSCR1;PUM1;IFI35;PRKCA;BMP6;NMI;SCIMP;SLC15A4;DHX9;POLR3C
prerank,CellMarker_Augmented_2021__CD141+CLEC9A+ Dendritic cell:Blood,-0.33530836220109766,-0.7602782386040982,0.7837837837837838,1.0,1.0,7/70,7.10%,ID2;FLT3;RGS10;CD38;IDO1;SCARF1;OSBPL3
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.41030734579732486,0.7600615171059917,0.7540983606557377,0.9523215282510357,1.0,11/22,33.38%,PPP1R16B;PRKCD;CALM3;PPP1R7;PIN1;SPPL3;DLC1;TGFB1;CAMTA1;MTMR9;NSMF
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.4083295768124088,-0.7599933352542754,0.8444444444444444,1.0,1.0,2/16,10.58%,DNMT3B;KMT2A
prerank,Reactome_2022__CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.4327284401792038,0.7598750106885619,0.8225806451612904,0.9523699588918335,1.0,3/17,11.69%,MAP3K14;FYN;PRR5
prerank,Reactome_2022__Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.30256401464464244,-0.7593301362411111,0.918918918918919,1.0,1.0,5/73,10.46%,CEP72;SSNA1;CETN2;HAUS1;CEP131
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.3626536805970375,0.7593237441552579,0.8513513513513513,0.9529132439454221,1.0,9/48,10.27%,EPHA2;LSR;EPS8L2;BAIAP2L1;NEDD9;PADI2;RHOD;MMP14;STAT3
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),0.46300656204271495,0.7591814366810179,0.7777777777777778,0.9529475992806268,1.0,4/9,27.17%,SLC29A4;OAZ2;SMS;SLC22A3
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),-0.4706529025861883,-0.7589737177449606,0.7796610169491526,1.0,1.0,1/6,5.79%,CRACR2B
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),0.5158146523366589,0.758950381189229,0.8596491228070176,0.9530260668343828,1.0,2/5,30.48%,TSG101;STAM
prerank,Reactome_2022__Regulation Of BACH1 Activity R-HSA-9708530,-0.42531256289156794,-0.7589162563938662,0.75,1.0,1.0,4/11,19.96%,BRIP1;UBB;CUL1;SKP2
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.3876697766459581,0.7589116973960383,0.7971014492753623,0.9528815952651285,1.0,10/25,23.69%,NLRC5;PARP9;GAS6;FADD;WNT5A;ADAM17;HIF1A;CSF1;TRIM44;PRKN
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),0.47700962240059264,0.7587898046183057,0.7540983606557377,0.9528161122261039,1.0,1/8,14.09%,COBL
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.35837715903273487,0.7586016692484812,0.8548387096774194,0.9528899169214462,1.0,10/47,22.75%,TCP1;HMBOX1;CTNNB1;CCT4;MAPKAPK5;CCT8;TINF2;EXOSC10;ACD;PARN
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),-0.35402191641787045,-0.7585260439666667,0.8809523809523809,1.0,1.0,2/37,5.40%,CALCRL;GTF2H2
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),0.49630284842320177,0.7582711591145178,0.76,0.9530820406504336,1.0,2/5,36.52%,NBN;WDR18
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),0.46097565191839135,0.758258215855904,0.7272727272727273,0.9529167926831724,1.0,3/11,14.66%,COLEC12;CGAS;IFIH1
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.33233458818246553,-0.7581704160076671,0.875,1.0,1.0,8/27,14.39%,SLC25A5;MUL1;FZD9;HSPA1A;PRELID1;PSMD10;TRIAP1;CLU
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),0.512274255636548,0.7578345244472969,0.8166666666666667,0.9533222402554895,1.0,1/5,9.91%,NFKBID
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.38403156928858506,0.7577501223471754,0.8545454545454545,0.9532289045502652,1.0,4/25,13.63%,SLCO1A2;SLC17A5;SLC26A8;SLC13A4
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.3290134669867616,0.7577082032075639,0.9041095890410958,0.953098506928041,1.0,12/135,11.35%,ANLN;CLTB;NRG1;PSMG3;SNCA;TCP1;TESPA1;SMAD3;SMAD1;MAPT;SPAG1;PXN
prerank,CellMarker_Augmented_2021__Megakaryocyte Erythroid cell:Undefined,0.38265440118173627,0.757682720739109,0.8360655737704918,0.9527474748507905,1.0,7/34,11.83%,IL13RA1;PDGFRA;PTPRC;CCR10;CD160;CD83;CD5
prerank,CellMarker_Augmented_2021__T cell:Undefined,0.38265440118173627,0.757682720739109,0.8360655737704918,0.9527474748507905,1.0,7/34,11.83%,IL13RA1;PDGFRA;PTPRC;CCR10;CD160;CD83;CD5
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),-0.3512044110891389,-0.7576123359209732,0.8709677419354839,1.0,1.0,7/51,10.58%,RFC3;CCT7;RGCC;DSCC1;GREM1;POLG2;ATR
prerank,KEGG_2021_Human__Amyotrophic lateral sclerosis,0.29258038904910055,0.7576112481324699,0.9879518072289156,0.9526357901873456,1.0,35/294,15.53%,GRIN2A;GRIN2D;GRIN2B;VAPB;NEFL;DNAH3;SMCR8;TUBB1;ITPR3;NRG1;TNFRSF1A;GRIN1;NRG2;KIF5A;BCL2L1;KIF5C;GRIA1;TUBB6;NUP210L;ACTR1A;NEFM;NDUFB11;KLC2;BCL2;KLC1;ANXA11;OPTN;TUBA1B;HAP1;NDUFB9;MAPK11;PFN4;MAP3K5;TP53;PINK1
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.3980654338572176,0.7575420555700129,0.7704918032786885,0.952545001819369,1.0,3/19,9.88%,LAMB1;TGFB2;GLI2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),-0.4335766309083358,-0.757437787414348,0.75,1.0,1.0,1/7,1.84%,AGER
prerank,CellMarker_Augmented_2021__Basophil:Umbilical Cord Blood,0.3945008857285924,0.757097565412128,0.8253968253968254,0.9529059451679442,1.0,5/30,4.31%,CTSS;MYO1F;PLEK;SLA;PTPRC
prerank,Reactome_2022__Mitotic Metaphase And Anaphase R-HSA-2555396,0.3010106094837578,0.7569763856644375,0.9493670886075949,0.952847562038117,1.0,9/191,9.11%,VRK2;CCNB2;LMNB1;INCENP;PMEPA1;CENPP;ERCC6L;LMNA;TUBB6
prerank,Reactome_2022__Transferrin Endocytosis And Recycling R-HSA-917977,0.3778104041836661,0.756797590317869,0.7586206896551724,0.9529281299162023,1.0,2/26,10.02%,STEAP3;TF
prerank,CellMarker_Augmented_2021__Cancer cell:Undefined,-0.4398400115887011,-0.7565948231245911,0.7692307692307693,1.0,1.0,2/7,9.00%,ALDH1A1;VIM
prerank,Reactome_2022__Mitophagy R-HSA-5205647,0.3913630888288576,0.7564647664237796,0.8472222222222222,0.9531730305364104,1.0,6/25,23.69%,MAP1LC3A;PINK1;RPS27A;TOMM40;ULK1;PRKN
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),-0.463984054173138,-0.7563401720995625,0.8333333333333334,1.0,1.0,1/6,3.36%,FBLN5
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.36950919657237424,-0.7561674505180797,0.7368421052631579,1.0,1.0,7/21,28.10%,VPS11;AFG3L2;MIEF1;FIS1;GDAP1;VPS18;MFN2
prerank,CellMarker_Augmented_2021__Thymocyte:Undefined,0.40638454467175306,0.7560657559906845,0.8412698412698413,0.9535266165764634,1.0,5/25,7.24%,PLEK;WAS;PTPRC;CD37;ACAP1
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),-0.5042313330129717,-0.7560176266031856,0.7843137254901961,1.0,1.0,1/5,5.70%,KRT10
prerank,Reactome_2022__Nef Mediated CD8 Down-regulation R-HSA-182218,0.45888967662305846,0.7559139051167201,0.8113207547169812,0.9535236939483033,1.0,2/6,32.85%,AP2A2;ATP6V1H
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),0.49138019387625437,0.7555594719343505,0.8148148148148148,0.9538192285259038,1.0,3/7,18.12%,PID1;PDK4;PDK3
prerank,CellMarker_Augmented_2021__Naive B cell:Undefined,0.3931827309402648,0.7555326488678131,0.8615384615384616,0.953466366582332,1.0,8/31,12.64%,PLEK;WAS;PTPRC;CD37;ACAP1;NLRC3;ITGAL;TMC8
prerank,CellMarker_Augmented_2021__Naive B cell:Peripheral Blood,0.3931827309402648,0.7555326488678131,0.8615384615384616,0.953466366582332,1.0,8/31,12.64%,PLEK;WAS;PTPRC;CD37;ACAP1;NLRC3;ITGAL;TMC8
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.35636238372908857,0.7555082469816099,0.921875,0.9533016023353007,1.0,12/56,20.29%,FYN;NECAB2;LIMK2;YAP1;MAPT;PARP9;STX4;WWTR1;TFRC;MAP1A;RTN4;DDRGK1
prerank,Reactome_2022__Gap-filling DNA Repair Synthesis And Ligation In GG-NER R-HSA-5696397,-0.3595348801369131,-0.7555034369113917,0.8,1.0,1.0,2/24,5.09%,RFC3;POLD3
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.438335380726829,0.7553039868871376,0.7936507936507936,0.9533657687413252,1.0,3/15,14.19%,SERPINE1;GAS6;IL12A
prerank,Reactome_2022__FGFR2b Ligand Binding And Activation R-HSA-190377,-0.4179248921814323,-0.7552569480514907,0.7272727272727273,1.0,1.0,1/6,7.01%,FGFBP3
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.38043477735836245,0.7546517132479368,0.8,0.9540770752412326,1.0,10/34,27.42%,PPP1R16B;PRKCD;CALM3;PPP1R7;MFHAS1;PIN1;ARPP19;SPPL3;ENSA;DLC1
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.35330660518609314,0.7545192607455986,0.8857142857142857,0.9540578710345521,1.0,13/57,16.51%,C1ORF87;TEKT2;DNAH3;CFAP126;TMEM212;ZMYND10;MORN5;ECT2L;DNAJB13;RSPH4A;C6ORF118;AKAP14;FAM81B
prerank,Reactome_2022__Insulin Processing R-HSA-264876,0.37572252731287475,0.7544157148774733,0.8135593220338984,0.95400170832955,1.0,3/24,8.42%,PCSK2;KIF5A;KIF5C
prerank,Reactome_2022__OAS Antiviral Response R-HSA-8983711,-0.5173522379831368,-0.7543894092984172,0.813953488372093,1.0,1.0,2/5,16.78%,RNASEL;OAS3
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),0.4581045812639013,0.7542735510476946,0.7846153846153846,0.9540033161141466,1.0,2/10,10.44%,CNTN4;EPHA4
prerank,Reactome_2022__WNT Ligand Biogenesis And Trafficking R-HSA-3238698,-0.37833658113516133,-0.753976101373455,0.8709677419354839,1.0,1.0,8/16,21.48%,VPS29;WNT2B;TMED5;VPS35;WNT7A;WNT7B;WNT9B;WNT5B
prerank,Reactome_2022__Telomere C-strand Synthesis Initiation R-HSA-174430,0.44313523529165016,0.7539300980816522,0.7903225806451613,0.9543143914297876,1.0,3/11,20.87%,TERF2IP;TINF2;ACD
prerank,CellMarker_Augmented_2021__Epiblast cell:Embryo,0.3637568320505359,0.7538586771876846,0.85,0.9542305031414886,1.0,17/61,19.42%,CAMKV;VSNL1;FAM124A;ANKRD45;PBX3;FBP1;PITPNM2;GPRC5C;CDHR1;CHST2;NGEF;SERINC5;ST6GALNAC3;ATP8B2;CAPG;LDLRAP1;SH3PXD2A
prerank,Reactome_2022__Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.3885992571306101,-0.7537346633864161,0.8235294117647058,1.0,1.0,6/21,16.95%,VDAC2;SLC8B1;YME1L1;LETM1;MICU2;AFG3L2
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.3460429117441477,-0.7536591258540231,0.8648648648648649,1.0,1.0,11/46,18.19%,ERCC8;ABRAXAS1;ATR;NSMCE4A;ERCC6;CEBPG;RNF168;RNF8;PLA2R1;SPRED1;BRCC3
prerank,Reactome_2022__Unfolded Protein Response (UPR) R-HSA-381119,-0.3142134255607556,-0.753547650232125,0.8648648648648649,1.0,1.0,21/80,20.77%,SRPRA;EXOSC8;SRPRB;CREB3L4;EIF2S1;EXOSC4;CREB3L1;EXOSC5;SERP1;YIF1A;CEBPG;DDX11;CREB3L3;HDGF;PREB;DNAJB11;SSR1;DIS3;DNAJB9;DDIT3;FKBP14
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Embryonic Stem Cell,-0.39683339397546696,-0.7535156526585959,0.8285714285714286,1.0,1.0,3/19,11.38%,FGL1;ADH6;MTTP
prerank,CellMarker_Augmented_2021__Pancreatic Progenitor cell:Embryo,-0.39683339397546696,-0.7535156526585959,0.8285714285714286,1.0,1.0,3/19,11.38%,FGL1;ADH6;MTTP
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.40112415210396235,0.7534954398674601,0.8461538461538461,0.9544790786108109,1.0,4/26,16.86%,BAP1;ARIH2;PINK1;MICALL2
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.5290335785554545,-0.7531036610633668,0.7659574468085106,1.0,1.0,1/5,14.39%,CLU
prerank,CellMarker_Augmented_2021__FGFR1HighNME5- Epithelial cell:Esophagus,0.2997778204555187,0.753094318605532,0.9090909090909091,0.9548060299537613,1.0,44/160,20.07%,PCDH18;SH3TC2;SYT1;COLEC12;NOD1;ACKR1;HIC1;PRKG2;POSTN;SLIT3;GHR;GLT8D2;PDGFRL;CYP1B1;TENM4;SH3PXD2B;PKDCC;CERS3;TRIO;LAMA2;CRMP1;PIANP;IFFO1;TNFAIP6;GRK5;GPR37;THBS2;USP49;ATXN1L;TRIM65;CTSK;ADAMTS1;SVEP1;CMTM3;PIGK;SNX10;PCOLCE;KDELR3;FNDC5;GFRA1;TGFBR3;FGFR1;SLC35A1;NOMO1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.43366684549112866,-0.7530829166567309,0.675,1.0,1.0,1/7,1.61%,SELENOS
prerank,Reactome_2022__Extension Of Telomeres R-HSA-180786,0.3605473349197822,0.7530688915774852,0.8923076923076924,0.954634404145936,1.0,13/43,20.93%,BLM;POLD1;GAR1;TERF2IP;LRIG1;ANKRD28;CHTF18;TINF2;CDK2;RFC4;WRAP53;ACD;CCNA2
prerank,Reactome_2022__Chaperone Mediated Autophagy R-HSA-9613829,-0.3767243064436399,-0.7529593592294375,0.8648648648648649,1.0,1.0,4/19,15.20%,CFTR;PLIN3;EEF1A1;PLIN2
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),-0.3831934060383165,-0.7528264693592894,0.7659574468085106,1.0,1.0,3/17,9.00%,TTN;TNNT1;VIM
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),-0.3831934060383165,-0.7528264693592894,0.7659574468085106,1.0,1.0,3/17,9.00%,TTN;TNNT1;VIM
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.3480041698464298,0.7525971658124548,0.8923076923076924,0.9550304093824881,1.0,8/54,15.71%,IGF2BP2;SRRM4;MBNL2;FAM50A;CLK1;HNRNPH1;GRSF1;NOVA2
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.3006903259637561,-0.7524012197327552,0.9487179487179487,1.0,1.0,13/58,19.54%,RFC3;GTF2H5;POLD3;GTF2H2;ERCC2;DNASE1L1;PNRC2;XPA;DNA2;MEI4;MUS81;ERCC3;UBB
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),-0.44724818851174825,-0.7523458404807631,0.7368421052631579,1.0,1.0,1/7,0.58%,KCNE1
prerank,Reactome_2022__DNA Damage Bypass R-HSA-73893,-0.30643406125631534,-0.7522427896918958,0.90625,1.0,1.0,2/45,5.09%,RFC3;POLD3
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.4389089842193934,-0.7521140351150977,0.782608695652174,1.0,1.0,3/13,6.23%,ABCD2;ABCD1;ABCB11
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.4040530277291813,-0.752097795785933,0.8108108108108109,1.0,1.0,6/20,21.11%,SF3B4;NCL;RBMX;CIRBP;PRDX6;SNW1
prerank,CellMarker_Augmented_2021__Natural Killer T (NKT) cell:Fetal Kidney,-0.2405688706911656,-0.7518936345132236,1.0,1.0,1.0,472/3959,13.90%,H1-2;FTL;H2AC20;TLCD1;IMP4;TMA7;RITA1;H4C3;CCDC141;EYS;ZNF525;MRPL10;SPRY1;CDC26;NDUFAF3;SAMD9;AKR7A2;DCXR;ID2;GMFG;YIPF5;SLC25A5;GALNT3;KPNA2;ATAD3C;UQCRFS1;APOBEC3G;RPL35A;COMMD6;RPS24;NDUFS5;ERP29;CD247;RBM23;VAMP8;FIP1L1;TNFAIP3;FCF1;CSTB;H3-3B;CD96;NMB;TRPT1;PDCD7;TPT1;METAP1D;ARF5;RPL34;HSD17B8;POMP;SSNA1;INPP1;LSM7;FTH1;SRPRA;PPDPF;ABHD15;CD38;RNF6;RPL39;MRPS21;EXOSC8;DNTTIP2;TMEM126A;CCZ1B;MOGS;CFAP97;SMIM15;PDGFD;COPS8;SNRPB2;ASB8;KIF21B;TIMM8B;ZC3H8;MIF4GD;CCT7;LRPPRC;RPL13;RHOH;RPL37;MAGED2;HSPG2;NIFK;H1-4;LSM3;SF3B4;CCDC43;COX7C;HUS1;SRPRB;SF3A1;ORMDL1;PMVK;PYHIN1;NUDT7;SLC39A10;DHRS7;THEM4;SRI;COMMD2;NSA2;MRPL52;NDUFA12;RABL3;GTF2H5;POLR2K;CHRAC1;HGH1;HAX1;TTN;CD320;MIEN1;RPS28;MCRS1;RBIS;AIMP1;DDX18;SNF8;MRPS7;SLC3A2;RPL18;BLOC1S4;POP5;ZNF195;ZCRB1;BLOC1S2;RBM8A;RGCC;PDCD2;GLT8D1;ENY2;DDX52;SMYD2;NDUFB4;GALT;ATAD2;PDZD11;PPWD1;STK16;KARS1;OAT;LSM2;NACA;TRMT10C;RAE1;CRNKL1;UQCRB;MED10;CREB3L4;EIF5A2;RPL12;BTF3;RPL23;PDCL3;PTPN22;RPL31;MRPL36;SH3BGRL3;CD6;CCDC137;KRT10;NDUFB1;TMX1;EMC6;NR1D1;U2AF1;USE1;ALAS1;SF3B6;CDADC1;CHD4;AKR1C3;ARL16;PTRHD1;IK;P2RY10;CETN2;MPC2;VDAC2;RAP2C;AIP;RPS26;ARIH2OS;DTYMK;NCBP3;BNIPL;NOP56;STX16;NOC2L;RPL6;TIMM13;PRPSAP1;BCAP31;BUD31;POLR1F;CCNG2;RNF114;PRPF18;C12ORF43;TAF1D;YIPF3;SSBP3;PRR7;EIF2S1;MRPL40;RPL7L1;PMS1;RPS27L;RPF1;SFRP2;CXCR4;ZNF808;CD72;MRPL47;GFER;TSC22D4;CAP1;FASTKD2;METRNL;C4ORF33;RPL41;MCM6;UQCRHL;JAGN1;RSRC2;BAK1;RAD54L2;SPECC1L;S1PR1;ANKRD49;MRPS9;NUDT16L1;RPS13;MTRF1L;C5ORF63;GLUD1;ADSS2;RPL22;NCOA4;ATRAID;ABHD17A;THUMPD1;GATC;COX7B;C14ORF119;RPL29;SLC25A37;C2ORF49;ZNF90;VPS4B;EIF1;ELP6;TFIP11;LSM5;FRG1;RPL30;DDX46;TPMT;SMIM8;PPM1K;SNU13;RIOK1;NBPF12;NOC3L;VPS11;R3HCC1;ATP6V1G1;DDOST;RPSA;RNH1;TMEM263;ACOT2;VIM;HAUS1;ATXN7L3B;EEFSEC;SNRK;SUPT16H;UBE2M;HSF1;MRFAP1;PEF1;RPL14;URB2;ZNF302;YES1;SPCS1;COPB2;ECH1;RANBP6;ILK;LYRM7;TBC1D19;FAM120AOS;EXOSC5;BOLA3;MGAT2;VAMP5;PPIH;PQBP1;ZDHHC20;DYNLRB1;PFDN4;GCDH;FOXRED1;GTF2A2;SERP1;SYF2;CLEC2D;LRRC47;PPP1R35;ZNF684;LPXN;PTDSS1;CLPTM1;RPL15;ZNHIT3;NUDT8;ITGB3BP;IGBP1;TAF11;NAAA;RPS2;DCAF13;GTPBP8;MIS18BP1;GOLGA8M;APRT;COX5B;MAP4K1;CLP1;SMARCD1;PPIL3;ATR;KMT2A;PPP1R11;ADH5;OARD1;POLR2C;OCEL1;MDN1;MTERF4;SLC25A38;ZFAND2B;SAP18;ETFB;EIF3D;POLR3E;PDHA1;RAB8A;IMP3;NT5C;ZPR1;SCLT1;EPRS1;APEH;ERAP2;URM1;POLR3B;COPE;BCAS4;EIF1AY;C12ORF75;RAD23A;NOA1;MRPL21;CASK;EEF1B2;CD47;RPL11;CCDC107;STT3A;DMAC2L;GORASP2;P3H1;PRELID1;COX11;MT2A;SNRNP25;C19ORF53;UFL1;RPL23A;BIN2;GLI4;VBP1;EIF1AX;NARS1;MPC1;TMED2;BRK1;MICOS10;HMGN1;NMT2;GMEB1;GART;ISCU;SRFBP1;LSM4;NIP7;SLC2A4RG;ARL14EP;TONSL;SLC39A8;PFN1;ARAF;FKBP3;OSGEP;NSMCE4A;EXOC7;ZCCHC9;NUP54;GMCL1;PAICS;PDRG1;SC5D;TMED9;CCDC59;ERICH1;NKAP;ANAPC15;AGGF1;RSPRY1;PSMD12;UBL7;DERL2;CCNJL;FBLN1;SMC2;CNOT7;COX19;WARS2;PRIM1;NDUFS3;TRMT10B;P2RY11;ATF7IP2;EIF2AK1;CCNT1;GTF2F1;NGDN;LLPH;PRPF8;DVL2;CNPPD1;CIAO2B;RPS21;ZCCHC17;FAM184A;MRPS34;GALNT14;MRPS33;SAMM50;COQ10A;CEP83;HFE;TEX264;SPCS2;APBA3;NLRP1;ETFDH;SRSF2;DEGS1;MED19;ATP6V1F;BAD;PNKP;SLC20A1;ARCN1;PNN;RWDD1;NFU1
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),0.4887583080881518,0.7517810414681114,0.7692307692307693,0.9559752531280183,1.0,1/5,12.29%,PRKCD
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.3697006378684494,0.7517643900985566,0.828125,0.9557942721382642,1.0,6/32,14.07%,NEFL;KIF5A;KIF5C;TRAK1;HAP1;RAB27B
prerank,Reactome_2022__G2/M Checkpoints R-HSA-69481,-0.29497148544500956,-0.7515729921715082,1.0,1.0,1.0,31/116,20.25%,RFC3;H2BC4;H2BC21;ATRIP;HUS1;BRIP1;ABRAXAS1;MCM6;SLC25A15;PSMD10;MCM4;PSMD12;RAD9B;PSMB5;RMI2;CLSPN;POLR1B;RNF168;RNF8;PSMB6;DNA2;ORC6;PSME3;SEM1;BRCC3;H2BC5;PSMD2;UBB;UBE2V2;PSMB4;RAD17
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),-0.4839726813134873,-0.7515674311311731,0.7894736842105263,1.0,1.0,2/5,28.09%,PNRC2;EDC3
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.32985169913878387,-0.7515439043539877,0.9069767441860465,1.0,1.0,3/40,9.78%,SAXO1;IL5;ENTR1
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),-0.41448392423721386,-0.7514952902053388,0.8301886792452831,1.0,1.0,2/11,6.53%,THAP7;NOC2L
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.41458935903688343,0.7514096799227687,0.7636363636363637,0.9560445456338136,1.0,7/13,27.56%,OGG1;NEIL2;DUT;NEIL1;TDG;NTHL1;UNG
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.4526883190795403,0.751342873059206,0.8,0.9559765840260424,1.0,3/9,11.63%,SULT4A1;UST;CHST4
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),-0.5182714155139062,-0.7513361039753224,0.7777777777777778,1.0,1.0,2/5,10.71%,SLC36A1;SLC25A38
prerank,Reactome_2022__SLC Transporter Disorders R-HSA-5619102,0.34258866573772845,0.7513256506104659,0.8823529411764706,0.9558072350924325,1.0,6/66,10.66%,CP;SLC9A9;SLC20A2;SLC7A7;SLC17A5;SLCO2A1
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.5117992114809955,0.7510191106439267,0.803921568627451,0.9559720934447001,1.0,1/5,4.11%,GAD2
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.3932834809629693,0.7508305431272936,0.8688524590163934,0.9560147766233517,1.0,1/23,1.95%,SLC7A2
prerank,KEGG_2021_Human__Nicotinate and nicotinamide metabolism,-0.33776300537679216,-0.7507524474711395,0.8157894736842105,1.0,1.0,5/32,11.02%,CD38;SIRT6;NT5E;AOX1;NT5C
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),-0.3919944726023521,-0.7507496748031335,0.7941176470588235,1.0,1.0,5/14,20.96%,PRDX1;NOX1;PRDX3;GPX1;CAT
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),-0.45770058720416057,-0.7506707137274208,0.8163265306122449,1.0,1.0,1/6,4.53%,RGCC
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.3777997145811943,0.7503937715155204,0.7741935483870968,0.9564075744644295,1.0,4/22,18.32%,TMBIM1;PARP9;TP53;CAMK2A
prerank,Reactome_2022__Nucleotide Catabolism R-HSA-8956319,0.374665940673858,0.7503345956835062,0.8,0.9562889413658533,1.0,4/25,15.24%,NUDT16;SAMHD1;GDA;DPYD
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.28565627993657655,0.7501775410382259,0.987012987012987,0.9563476542425846,1.0,36/352,12.40%,GOLGA8O;ARHGAP4;VAPB;CNTNAP1;DMTN;THY1;ATP8B4;SH3KBP1;WTIP;NEDD9;CFAP126;MTFR2;DPYSL2;PAK4;TMED10;KIF5C;PCLO;PLAAT3;PLEKHF1;YTHDF1;PLD2;GOLGA8A;ARHGEF7;AGTPBP1;CHMP1A;PEX14;PACSIN1;SYNE3;CFAP61;USP6NL;CCL2;RNF112;STX4;FGD5;RAB30;FMNL3
prerank,Reactome_2022__MTOR Signaling R-HSA-165159,-0.35042934967444916,-0.7501700151145393,0.8181818181818182,1.0,1.0,5/36,16.80%,EIF4EBP1;RRAGC;SLC38A9;RRAGA;AKT2
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),-0.45117068520327425,-0.7500927022756533,0.7894736842105263,1.0,1.0,3/8,6.31%,CEBPA;KARS1;IL33
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.48010235466603524,-0.7499400951409578,0.8181818181818182,1.0,1.0,2/6,29.75%,SENP2;SENP5
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.41081898477217016,-0.7498148283126088,0.7368421052631579,1.0,1.0,1/15,1.21%,STAB2
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),-0.45738525749398057,-0.7496257608571673,0.7142857142857143,1.0,1.0,3/11,14.14%,GTF2A2;TAF11;BDP1
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.35905655679363996,-0.7495284788641166,0.875,1.0,1.0,3/18,13.77%,PDZD11;TSPAN33;BAD
prerank,KEGG_2021_Human__Fatty acid biosynthesis,-0.4000837345318248,-0.7494612584006987,0.7954545454545454,1.0,1.0,3/16,8.06%,HSD17B8;MCAT;ACSBG2
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.3986939047352729,-0.7493805680023872,0.825,1.0,1.0,10/25,24.01%,POLR2K;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;POLR2L;POLR2G;POLR2E;CTDP1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),0.4162817285423847,0.7492190278682621,0.7903225806451613,0.9574031639465699,1.0,6/12,19.44%,CCND1;TP53;CDK2;PLK3;FBXO31;WAC
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.4396618593097881,0.7491742158630067,0.8,0.9572613871453043,1.0,5/15,18.06%,GAS6;HLA-DRB1;RARA;PDCD1LG2;TNFSF4
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.4683113301980579,-0.749071160410376,0.696969696969697,1.0,1.0,1/7,0.45%,EYS
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),0.40015498102202846,0.7489961759848516,0.8571428571428571,0.9573060647267516,1.0,3/16,12.46%,SEC14L1;SLC25A29;SLC29A4
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.2602935635210663,-0.7488676865602696,1.0,1.0,1.0,31/276,13.83%,NUP62CL;ERP29;COX18;ARF5;SRPRA;NXT2;RABL3;SNF8;NUP50;VPS29;STX16;ARFIP2;TBC1D4;WDR11;TMED5;RABL2A;COPB2;DNAJC27;RANBP6;SEC31B;ARL1;C17ORF75;RPL11;TMED2;SNX31;TMED9;RANBP17;VPS35;FAM53A;VIPAS39;ARCN1
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.37252829679500915,0.7488041294945428,0.8095238095238095,0.957353025326161,1.0,8/25,14.71%,TLR2;TNFRSF14;MYD88;LYG1;GSDMD;LYG2;IL12A;HLA-E
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.49926723250225974,0.7487129188992586,0.8,0.9572803518110037,1.0,1/6,4.11%,GAD2
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),-0.4433523156685494,-0.748659443144634,0.8780487804878049,1.0,1.0,3/10,6.31%,CEBPA;KARS1;IL33
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.5219191670216972,0.7484395228470161,0.7407407407407407,0.9574583898255122,1.0,2/5,24.96%,TTBK2;MAP2
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),-0.43639781200052064,-0.7480650807668603,0.78,1.0,1.0,1/6,1.84%,AGER
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.45602298503205596,0.7479002201571445,0.8095238095238095,0.9579030858610579,1.0,3/11,9.88%,PROX1;TBX20;TCAP
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),-0.40479964208299213,-0.7478496385555904,0.7674418604651163,1.0,1.0,2/17,8.40%,HSPA1A;VPS4B
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),-0.41244759077807996,-0.7476444746014417,0.7446808510638298,1.0,1.0,2/11,11.30%,FBXO5;ZKSCAN3
prerank,CellMarker_Augmented_2021__Radial Glial cell:Undefined,-0.45839574998670496,-0.7475195786133592,0.8157894736842105,1.0,1.0,5/10,18.59%,TNC;VIM;HES5;PAX6;FABP7
prerank,CellMarker_Augmented_2021__Pit cell:Stomach,0.476786136746235,0.7474533941430085,0.8653846153846154,0.958260246200651,1.0,4/9,32.22%,FAHD2B;TMEM135;GREM2;MBD1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.29985077383197456,-0.7474063541441649,0.84375,1.0,1.0,9/65,20.20%,ELOC;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;PSMD2;UBB;PSMB4
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.34318810642252795,-0.7474003043271414,0.8333333333333334,1.0,1.0,2/31,1.54%,MID1IP1;TPX2
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.38038659967403926,-0.747310521577981,0.8823529411764706,1.0,1.0,4/12,20.55%,SAXO1;DAG1;SAXO2;GCC2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.329232600923442,-0.7472547918882394,0.9642857142857143,1.0,1.0,9/61,20.20%,VAMP8;PSMD10;PSMD12;PSMB5;TAP1;PSMB6;PSME3;PSMD2;PSMB4
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.4495767849179921,0.7471562068916102,0.86,0.9584655656721172,1.0,6/12,28.10%,PCGF3;BRCA1;CDYL;RBM15B;PCGF5;LRIF1
prerank,KEGG_2021_Human__Autophagy,-0.28930811032521303,-0.7470520331770586,0.967741935483871,1.0,1.0,12/126,14.28%,RAB7B;VAMP8;CTSL;EIF2S1;RRAGC;IGBP1;BECN1;RAB8A;ATG14;NRAS;BAD;RRAGA
prerank,Reactome_2022__Diseases Of Mismatch Repair (MMR) R-HSA-5423599,0.49638454678396804,0.7468808021079274,0.8235294117647058,0.9586409295062976,1.0,1/5,12.11%,PMS2
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),-0.4443150577586436,-0.7468136990001991,0.7073170731707317,1.0,1.0,2/13,17.42%,ATL2;ZFYVE27
prerank,Reactome_2022__N-glycan Trimming And Elongation In cis-Golgi R-HSA-964739,-0.4799453916281349,-0.7466357633555255,0.7755102040816326,1.0,1.0,1/5,6.91%,MOGAT1
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),0.4784720443236308,0.7466283328711932,0.8679245283018868,0.9587702725831371,1.0,1/7,8.19%,ASS1
prerank,Reactome_2022__SUMO Is Proteolytically Processed R-HSA-3065679,-0.4781439813775795,-0.7466240009213321,0.8,1.0,1.0,3/5,37.49%,SENP2;SENP5;SUMO2
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),0.46833072098759554,0.7465610284596449,0.7894736842105263,0.9586399913541376,1.0,3/7,18.31%,XRCC1;TINF2;HPF1
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.4272987396799176,0.7464689355896111,0.7333333333333333,0.9585602880833087,1.0,2/12,7.88%,APP;LDLR
prerank,Reactome_2022__Mismatch Repair R-HSA-5358508,0.43132948266244964,0.7464040998600822,0.8421052631578947,0.9584484696404036,1.0,3/13,13.05%,POLD1;PMS2;LRIG1
prerank,Reactome_2022__Endogenous Sterols R-HSA-211976,0.3975409117015419,0.7460866415805756,0.75,0.9586397333903005,1.0,6/18,21.42%,AHR;CYP1B1;CYP21A2;RXRA;ARNT2;CYP39A1
prerank,Reactome_2022__FLT3 Signaling In Disease R-HSA-9682385,-0.370927805982861,-0.7451753132489027,0.8372093023255814,1.0,1.0,1/26,1.01%,FLT3
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.43681214623680376,0.7451515880022411,0.8448275862068966,0.9596526341598587,1.0,1/9,15.29%,ETS1
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.37918494216559356,0.744942430845284,0.8727272727272727,0.9597288421436079,1.0,1/25,0.93%,KIF14
prerank,CellMarker_Augmented_2021__Sertoli cell:Seminal Plasma,0.34916356730807546,0.7447578289788261,0.8813559322033898,0.9597820761739673,1.0,11/48,12.48%,PROX1;RELN;PLPPR1;CP;MAOB;ITIH2;ALDH1L1;CNDP1;TF;SORBS1;ACSM5
prerank,KEGG_2021_Human__Lysosome,0.31179279166805013,0.7446579193674264,0.890625,0.9597458260850631,1.0,7/105,11.64%,CTSC;CTSS;CLTB;SLC17A5;AP1S1;ABCA2;ABCB9
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),0.462597297546683,0.7445330171452487,0.8148148148148148,0.959707296870817,1.0,4/7,35.72%,TJP1;NLGN2;F2R;CSF1R
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.4076751923376089,0.7443789126187919,0.7547169811320755,0.9597100572020176,1.0,2/12,12.47%,PDK4;BCL2
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.38933273407516983,-0.7436877315383578,0.7291666666666666,1.0,1.0,5/14,11.31%,RGCC;SERPINF2;VIM;CREB3L1;RUNX1
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.4897771963232369,-0.7436573895414021,0.803921568627451,1.0,1.0,1/5,19.13%,SLC25A11
prerank,KEGG_2021_Human__Cholesterol metabolism,0.3726708244032295,0.7434952815976015,0.8596491228070176,0.9605702350867432,1.0,10/34,20.58%,VAPB;SOAT1;LDLR;LPA;STARD3;LRP2;LDLRAP1;SORT1;ANGPTL4;SCARB1
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),0.46460453326930523,0.7432928142952925,0.7924528301886793,0.9606209579913856,1.0,2/7,35.37%,RABEP1;RAB29
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.46529937585730297,-0.743220765416781,0.78,1.0,1.0,1/6,19.13%,SLC25A11
prerank,Reactome_2022__NOTCH4 Intracellular Domain Regulates Transcription R-HSA-9013695,0.3763531414281059,0.7429054386461418,0.7678571428571429,0.9608870765705712,1.0,3/19,8.94%,ACTA2;MAMLD1;SMAD3
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.3665777709595331,-0.7427562744362213,0.8478260869565217,1.0,1.0,3/16,8.80%,HEY2;GREM1;HEY1
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.3937215853657728,-0.7425914972299517,0.8148148148148148,1.0,1.0,2/13,10.84%,MOGAT1;GK
prerank,Reactome_2022__Surfactant Metabolism R-HSA-5683826,0.43936401556114774,0.7424075985344439,0.7407407407407407,0.9613249302232948,1.0,3/13,8.82%,CSF2RA;SFTPD;ADGRF5
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.34631772921769216,-0.7423459810746634,0.7333333333333333,1.0,1.0,4/27,20.55%,NCOA4;ZFYVE16;AP4M1;GCC2
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),0.35074642968504566,0.7423230047737164,0.8,0.961258645608906,1.0,3/34,16.11%,DAB2IP;CDC7;BRCA1
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),0.5194744531120111,0.7420538801194034,0.8367346938775511,0.9613870625436131,1.0,1/5,19.79%,PMPCB
prerank,Reactome_2022__AKT Phosphorylates Targets In Cytosol R-HSA-198323,0.4284175905202899,0.741856765241079,0.8,0.9614810810530521,1.0,4/12,20.13%,CDKN1B;CDKN1A;TSC2;AKT3
prerank,Reactome_2022__ER-Phagosome Pathway R-HSA-1236974,0.3257897204157665,0.741786848662911,0.9736842105263158,0.9613621488208336,1.0,6/74,14.71%,TLR2;MYD88;STX4;B2M;IKBKG;HLA-E
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.3725682540685222,0.741639011706073,0.8823529411764706,0.9613851779320445,1.0,7/29,13.11%,IRS2;CHST15;APOD;ALDOB;GALK1;FBP1;HK1
prerank,Reactome_2022__FCGR Activation R-HSA-2029481,-0.46887915592135976,-0.7416264069404751,0.8048780487804879,1.0,1.0,2/6,9.39%,CD247;YES1
prerank,Reactome_2022__Activated NTRK2 Signals Thru PI3K R-HSA-9028335,0.4693656097316052,0.7412170148979357,0.8035714285714286,0.9616873936769751,1.0,1/5,29.47%,NTRK2
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.3360385729715707,0.7411805078662851,0.9516129032258065,0.9615204423550013,1.0,6/66,7.22%,FLRT3;NR4A1;ZFP36;ANOS1;CD44;FLRT1
prerank,Reactome_2022__Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.34166138681953007,-0.7411061658611147,0.8888888888888888,1.0,1.0,2/38,4.25%,PMVK;TM7SF2
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.3598648558910683,0.7410967431965053,0.84375,0.9614221845187824,1.0,5/35,10.06%,BMP8A;PMEPA1;LDLRAD4;TGFB2;RBPMS
prerank,CellMarker_Augmented_2021__Mesoderm cell:Undefined,0.31765861968170417,0.740922149741043,0.9142857142857143,0.9614520450125555,1.0,16/95,17.58%,DVL1;AGRN;STK25;GLIS2;TTYH3;FSCN1;KLC2;ZC3H7B;RANGAP1;NCLN;GPS1;PLXNA1;NRSN2;SCRIB;NR2F6;DCTN1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.34666623954303577,0.740883380697492,0.8857142857142857,0.9612989590290244,1.0,4/46,8.12%,WNT8B;MAP1LC3A;DVL1;CTNNB1
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.45844014706353453,0.7405229986551302,0.8333333333333334,0.9615505966176927,1.0,2/9,12.08%,GINS2;CDC7
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.32583605499517004,0.7404108105259396,0.859375,0.9615026975409906,1.0,11/74,14.23%,ZDHHC9;ZDHHC22;PARD3;MYO1C;MICALL1;ZDHHC7;ZDHHC1;PEX14;NACAD;VPS37B;ALDH3A2
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.3024954878408908,-0.7403102064476885,0.9210526315789473,1.0,1.0,11/69,15.04%,RBM23;BRDT;RPS26;RRP1B;HSPA1A;RPS13;PQBP1;ZPR1;RBM22;RBM39;CLK4
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.41011921727465506,-0.7402325798924798,0.7755102040816326,1.0,1.0,4/14,19.75%,SAP18;RBMX;SRSF9;PCBP4
prerank,Reactome_2022__Aspartate And Asparagine Metabolism R-HSA-8963693,-0.4211720655524861,-0.7399398811863378,0.8444444444444444,1.0,1.0,1/8,0.95%,GOLT1A
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),0.416128207444571,0.7397747994734784,0.7966101694915254,0.9620490034541688,1.0,5/16,22.47%,CDK6;RARA;ZFPM1;TLR3;MAFB
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.41990067356824373,0.7396715870386965,0.7971014492753623,0.9619621820429839,1.0,5/14,23.35%,SMAD1;KLF4;FGF2;TJP1;BMPER
prerank,Reactome_2022__Negative Regulation Of FGFR3 Signaling R-HSA-5654732,0.38405850203947894,0.7395787146306582,0.8070175438596491,0.9618913858664092,1.0,10/21,35.55%,FGF13;RPS27A;PTPN11;CBL;MAPK3;FGF17;FGF1;MKNK1;SRC;MAPK1
prerank,Reactome_2022__Uptake And Function Of Diphtheria Toxin R-HSA-5336415,-0.4818076510328714,-0.7393858436546242,0.8135593220338984,1.0,1.0,1/5,19.60%,EEF2
prerank,KEGG_2021_Human__N-Glycan biosynthesis,0.35145747061460497,0.7393370251841429,0.8985507246376812,0.9620079039684815,1.0,4/49,8.22%,ST6GAL1;MGAT3;TUSC3;MGAT5
prerank,KEGG_2021_Human__Proximal tubule bicarbonate reclamation,0.4138964420822214,0.7392415323699342,0.7758620689655172,0.9619394102091808,1.0,3/15,10.24%,ATP1A1;ATP1B1;ATP1B3
prerank,Reactome_2022__Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,0.3219602034663261,0.7391541490170261,0.8333333333333334,0.9618481126269456,1.0,9/58,15.37%,IRF7;MYD88;CTNNB1;NLRC3;CGAS;TRIM32;IKBKG;MRE11;STAT6
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.4458528099972276,0.7387819674033568,0.7868852459016393,0.9621289198377524,1.0,1/11,1.91%,NLGN1
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),-0.35455836275121744,-0.7387500419105838,0.88,1.0,1.0,3/26,6.61%,PMVK;TM7SF2;ARV1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.34760508499635245,-0.7385990026080291,0.8409090909090909,1.0,1.0,2/23,5.09%,RFC3;POLD3
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),-0.4079703848721083,-0.7384337109601262,0.7619047619047619,1.0,1.0,5/11,25.33%,AUP1;RNF5;POMT2;VCP;DERL1
prerank,KEGG_2021_Human__Steroid biosynthesis,0.4192373385728167,0.7384089750233495,0.7936507936507936,0.9624073342913079,1.0,3/15,8.62%,NSDHL;SOAT1;DHCR24
prerank,Reactome_2022__RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,0.31841543666223243,0.7382057165714215,0.95,0.962443775518008,1.0,6/80,10.06%,ALS2CL;DENND3;SBF1;RAB3IL1;RIN2;DENND4A
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.3420382905998278,-0.7378733904834219,0.85,1.0,1.0,11/36,22.92%,POLR2K;RRAGC;POLR2C;NFKBIB;POLR2D;MLF1;THAP1;POLR2L;POLR2G;PWP1;POLR2E
prerank,"Reactome_2022__Incretin Synthesis, Secretion, And Inactivation R-HSA-400508",-0.40450832781922025,-0.7377647689651234,0.825,1.0,1.0,4/12,15.00%,PCSK1;SPCS1;SPCS2;PAX6
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),0.48110068359082625,0.7377128740369949,0.7818181818181819,0.9628908333665539,1.0,1/6,5.37%,GNG2
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),0.43825360908884026,0.7374282988027443,0.7424242424242424,0.9630936660126455,1.0,4/10,21.56%,HIPK3;TP53;ZBTB1;C5AR1
prerank,CellMarker_Augmented_2021__T Helper17 (Th17) cell:Undefined,0.4215512517127325,0.7369316529364797,0.7454545454545455,0.9635062143193796,1.0,5/10,16.66%,IL1R1;AHR;STAT3;CD4;RORA
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.2933083877717484,0.7365116781563346,0.9864864864864865,0.96382968279071,1.0,36/186,23.80%,KIF14;PRAME;HECW2;ENC1;PML;CTNNB1;TBL1X;KCTD13;HECW1;SPSB1;AGAP3;SYVN1;UBXN11;SMURF1;RFFL;RCN3;RNF187;RNF122;TBL1XR1;UBXN6;BFAR;RNF185;UBXN1;MARCHF6;MTA1;UBE4B;UBE2B;TRIM9;DDB1;FBXW5;CUL3;USP44;PSMB3;PRKN;KCTD10;ARRB1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),0.4444513130435717,0.7359498493932919,0.8181818181818182,0.96430347028669,1.0,4/13,9.86%,SLIT2;TBX20;ROBO2;TGFB2
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.3837281516521487,-0.73587227751397,0.8333333333333334,1.0,1.0,11/20,21.42%,NT5E;PRPSAP1;NT5C;GART;PPAT;NUDT15;PNP;GPX1;PRPS1;ITPA;NT5C1A
prerank,GO_Biological_Process_2021__neuron fate specification (GO:0048665),-0.4943163451236142,-0.7358222809546539,0.82,1.0,1.0,2/5,10.31%,ASCL1;POU3F2
prerank,Reactome_2022__Phase 3 - Rapid Repolarisation R-HSA-5576890,0.4791156457186159,0.7357559740858428,0.8727272727272727,0.9643326585872551,1.0,3/6,6.95%,KCNQ1;KCNE4;KCNH2
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.45689271910763185,-0.7355280134485604,0.9024390243902439,1.0,1.0,2/6,23.21%,MAP3K4;YY1
prerank,CellMarker_Augmented_2021__Stem cell:Undefined,-0.45392362184782686,-0.7352061683332239,0.8,1.0,1.0,2/6,5.07%,DNMT3B;ALDH1A1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.346962204901197,-0.7351623710617302,0.8372093023255814,1.0,1.0,10/23,30.29%,YME1L1;AUP1;RNF5;POMT2;ATXN3;VCP;DERL1;CLPP;NGLY1;UGGT1
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.43301374952883154,-0.7349561294674828,0.7755102040816326,1.0,1.0,3/6,24.68%,TNIP1;VCP;SART3
prerank,Reactome_2022__Signaling By NOTCH4 R-HSA-9013694,-0.2888096400853485,-0.7348788888628963,0.9411764705882353,1.0,1.0,16/73,21.11%,HEY2;MAML3;HEY1;NCSTN;HES5;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;CUL1;PSMB4;SNW1
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.3463778672937434,-0.7343012658082636,0.8235294117647058,1.0,1.0,4/48,7.64%,TNFAIP3;FBXO5;PRR7;HSPA1A
prerank,Reactome_2022__CHL1 Interactions R-HSA-447041,0.4540012055984529,0.7340020333996423,0.7796610169491526,0.9662712958626564,1.0,1/9,5.65%,ITGA2
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.45344488940098265,0.733955195500874,0.7647058823529411,0.9657518837810926,1.0,1/6,7.26%,TMED10
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.45344488940098265,0.733955195500874,0.7647058823529411,0.9657518837810926,1.0,1/6,7.26%,TMED10
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.45344488940098265,0.733955195500874,0.7647058823529411,0.9657518837810926,1.0,1/6,7.26%,TMED10
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.49954731024594395,0.7338690034074766,0.7962962962962963,0.9656464275845664,1.0,1/5,1.17%,PDGFRA
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),-0.32139212694790315,-0.7338240470201957,1.0,1.0,1.0,3/32,9.05%,H2BC21;PADI4;H2BC18
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.4130773627244391,-0.7338210544408916,0.8,1.0,1.0,1/14,1.21%,STAB2
prerank,Reactome_2022__Other Interleukin Signaling R-HSA-449836,0.4034209794427836,0.7336324665175491,0.7540983606557377,0.9657709246633018,1.0,6/14,25.70%,TYK2;STX4;CD4;CSF1;SNAP25;STX3
prerank,Reactome_2022__RHOBTB2 GTPase Cycle R-HSA-9013418,-0.38305973168185625,-0.7331791546712573,0.8947368421052632,1.0,1.0,3/22,14.93%,CCT7;TWF1;RBMX
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3132042926991274,0.733127496597899,0.9545454545454546,0.9662822772196213,1.0,4/113,4.92%,EGF;LGR5;TRPM4;SOX4
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),-0.40253088219962696,-0.7331005167096181,0.825,1.0,1.0,2/13,11.30%,FBXO5;ZKSCAN3
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.3284248924525634,0.7330598772280258,0.8793103448275862,0.9661471980116356,1.0,9/46,14.52%,NUMBL;HES7;SERPINF1;CTNNB1;YAP1;B2M;NAP1L1;TRIM32;RGS14
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.43290828839409645,0.7330238861041608,0.7647058823529411,0.9659939717106507,1.0,3/10,21.75%,SRA1;PRICKLE1;ANKRD2
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.4393318677748317,-0.7329945161804532,0.84,1.0,1.0,2/7,9.66%,USH2A;ERCC2
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),0.46285465973219875,0.7327573817719251,0.8507462686567164,0.9660932826181431,1.0,1/9,11.16%,B4GALT7
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),0.35287151264742633,0.7327398870299944,0.7777777777777778,0.9659173857994882,1.0,3/42,5.50%,ZFP36;ZC3H12D;NUDT16
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.42340192056121073,-0.7324373854560344,0.847457627118644,1.0,1.0,2/10,15.81%,SAT1;SRM
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Control Bile Acid Homeostasis R-HSA-9623433,0.4776400656767108,0.7321726284571052,0.8571428571428571,0.9664714079457534,1.0,5/8,31.76%,RXRA;NCOR1;FABP6;NCOR2;NCOA1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.41120416149513267,0.7320707756162973,0.8148148148148148,0.9663955280820246,1.0,1/10,8.12%,CTNNB1
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.42150492769250003,0.7319953570971979,0.9,0.96629240456415,1.0,3/12,13.91%,TRIM5;PML;TRIM32
prerank,Reactome_2022__Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,0.40208395971602384,0.7319468914717112,0.8333333333333334,0.9661734151081152,1.0,6/17,26.17%,STAT3;FN1;ALK;SKP1;CLTC;MAPK3
prerank,Reactome_2022__Branched-chain Amino Acid Catabolism R-HSA-70895,0.3910732179713952,0.7317596633551676,0.7936507936507936,0.9661930577880896,1.0,6/20,24.41%,SOAT1;ACAD8;AUH;LDHD;BCAT1;BCAT2
prerank,Reactome_2022__Zinc Influx Into Cells By SLC39 Gene Family R-HSA-442380,0.4859209217474348,0.7311429094364552,0.8392857142857143,0.9667305829364494,1.0,1/5,2.98%,SLC39A14
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),-0.37028365167964994,-0.7309591066535569,0.8157894736842105,1.0,1.0,3/17,12.49%,KPNA2;RGPD8;NUP54
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.4225581035662489,0.7309358986471083,0.8181818181818182,0.9667819027994162,1.0,3/11,12.89%,THBS1;STARD13;KLF4
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.3967569061062456,-0.7305668274684165,0.8909090909090909,1.0,1.0,2/13,6.01%,ABCD2;ABCD1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),-0.2945038796066911,-0.730474382901329,0.8857142857142857,1.0,1.0,2/54,2.70%,TNFAIP3;RNF6
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.30976528213906823,0.7304641520772044,0.9523809523809523,0.9671488101476788,1.0,22/96,24.47%,APP;ADD2;DVL1;HDAC4;PEX14;PRKCD;TMC8;B2M;CDKN1A;HIPK2;STK3;CTSZ;ZFPM1;LDLRAP1;AMFR;BTBD1;PIN1;FLOT1;PRKN;HDAC5;PSEN1;SPPL3
prerank,Reactome_2022__Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.3694274811581666,0.7304490635950527,0.8305084745762712,0.9669752867609658,1.0,1/33,1.73%,CCNB2
prerank,Reactome_2022__Regulation Of TNFR1 Signaling R-HSA-5357905,0.33731226212973936,0.730079201478414,0.8970588235294118,0.967199023406864,1.0,5/33,15.17%,BIRC3;TNFRSF1A;FADD;IKBKG;OTUD7B
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),-0.3272172751839701,-0.729873205778342,0.9142857142857143,1.0,1.0,1/46,0.40%,CALCRL
prerank,Reactome_2022__Inhibition Of Replication Initiation Of Damaged DNA By RB1/E2F1 R-HSA-113501,-0.4338637325104907,-0.7297024708055999,0.8125,1.0,1.0,2/10,22.42%,PRIM1;PPP2R3B
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),-0.484219955832638,-0.729698398885922,0.7959183673469388,1.0,1.0,2/5,21.72%,TMEM167B;TRAPPC11
prerank,Reactome_2022__RHO GTPases Activate Formins R-HSA-5663220,0.30564415143808776,0.7291396999222662,0.9436619718309859,0.9681919396161993,1.0,18/97,20.17%,INCENP;CENPP;RHOD;DAAM1;ERCC6L;RNASE1;CENPH;FMNL3;RANGAP1;MRTFA;PFN2;FMNL1;DYNC1LI2;SKA2;CKAP5;DYNC1LI1;RHOB;KANSL1
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),-0.3955101030972161,-0.7285929029589402,0.8409090909090909,1.0,1.0,2/14,6.01%,ABCD2;ABCD1
prerank,Reactome_2022__PTK6 Regulates Cell Cycle R-HSA-8849470,0.45153820716825477,0.7285118198339695,0.7540983606557377,0.9688191934694947,1.0,4/6,16.30%,PTK6;CDKN1B;CCND1;CDK2
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.4122716123795718,0.727954636625563,0.8870967741935484,0.9692828815922759,1.0,5/14,17.02%,MMP14;SYK;GAS6;ZMIZ1;ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),0.4730696004511311,0.7277551036216336,0.8,0.9693222923306143,1.0,1/7,5.69%,STAC2
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.4154854808276576,0.7277440245283849,0.8333333333333334,0.9691417450900613,1.0,4/9,29.94%,TGFB2;HLA-F;TGFB3;TGFB1
prerank,Reactome_2022__Glycolysis R-HSA-70171,-0.31602928094589455,-0.7275477952540577,0.9259259259259259,1.0,1.0,4/62,5.18%,PGP;AAAS;BPGM;NUP50
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.36092856326779266,0.7275020576855512,0.8518518518518519,0.969271848240146,1.0,5/30,12.05%,EGF;RAB11FIP5;CTNNB1;ABCA2;STX4
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.4069881008386659,-0.7272008672738961,0.8636363636363636,1.0,1.0,2/11,15.19%,NAGK;GNPDA2
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.4069881008386659,-0.7272008672738961,0.8636363636363636,1.0,1.0,2/11,15.19%,NAGK;GNPDA2
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.41395249706365717,-0.7271840221492677,0.8409090909090909,1.0,1.0,2/11,12.75%,LRRC17;FSTL3
prerank,CellMarker_Augmented_2021__Semilunar Valve cell:Heart,-0.38516687742877054,-0.7266809614074935,0.875,1.0,1.0,1/19,0.22%,TRIM29
prerank,CellMarker_Augmented_2021__Oocyte:Embryo,0.3238511117527623,0.7266806615448949,0.9166666666666666,0.9700161388952037,1.0,13/82,18.13%,CLSTN2;ABCA5;LAMB1;GGCT;HOOK1;CNN3;TRAK1;SPIRE1;ABCC4;IRAG2;RHOT1;HOOK2;SKP1
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),0.46861833997041563,0.7265626664489966,0.8070175438596491,0.969928472784865,1.0,2/10,6.91%,RASGRP1;SNCA
prerank,Reactome_2022__RUNX3 Regulates NOTCH Signaling R-HSA-8941856,0.4346178234454491,0.726441041502903,0.8181818181818182,0.9698906858232068,1.0,2/13,14.00%,MAMLD1;MAML2
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.4839897913327113,0.7261240383701272,0.8363636363636363,0.9700749065105999,1.0,3/6,24.70%,COL5A1;ADAM17;PLET1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.3526614449371875,0.7260100675962164,0.8656716417910447,0.9700416352854615,1.0,10/34,22.29%,DAB2IP;GFAP;NCLN;PINK1;SPTY2D1;RAP1A;RAP1B;PTPN11;TJP1;FAM110C
prerank,Reactome_2022__N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.3231392079186719,-0.7258078237520015,0.8333333333333334,1.0,1.0,4/34,14.78%,MOGS;GANAB;DERL2;RNF5
prerank,CellMarker_Augmented_2021__Immune cell:Undefined,-0.42638891933651174,-0.7257703070592026,0.82,1.0,1.0,2/8,5.61%,CD96;CD6
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),0.4643400062479871,0.7257643319248259,0.7931034482758621,0.9701012153454062,1.0,2/5,19.68%,CAMK2A;AHCYL1
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.36304476511897227,0.7257277723310399,0.8979591836734694,0.9699434371383431,1.0,5/18,17.46%,EFNA1;EPHA4;ABCA2;SLC2A13;ABCG1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.34944802909937905,-0.725224191538463,0.8372093023255814,1.0,1.0,5/17,24.99%,VPS11;RDX;PTPN23;SNX12;CHMP3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.3298044331895093,0.7251613602143975,0.9324324324324325,0.9704194904993425,1.0,13/55,18.29%,ZIC1;TCP1;BAG3;SMAD3;LIMK2;YAP1;CCT4;PARP9;PRKCD;CCT8;WWTR1;TFRC;FLNA
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.47937864662224894,0.7250575594880564,0.8490566037735849,0.9703182873162262,1.0,1/5,15.82%,XRCC1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.41920817548888006,0.7250326945211132,0.85,0.9701628217116043,1.0,5/11,20.36%,DYSF;SYK;IFI35;SBNO2;NMI
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.33630253269024457,-0.7248913006053175,0.9777777777777777,1.0,1.0,7/47,13.69%,SNF8;VPS29;CCDC22;WASHC2C;ENTR1;SNX31;VPS35
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.40924221204314093,0.7247169409462243,0.7586206896551724,0.9703716211490976,1.0,1/18,6.60%,ENC1
prerank,Reactome_2022__Choline Catabolism R-HSA-6798163,0.46057835312605033,0.7247140447838478,0.803921568627451,0.969995274671797,1.0,5/6,28.68%,SARDH;CHDH;SLC44A1;BHMT;DMGDH
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.46057835312605033,0.7247140447838478,0.803921568627451,0.969995274671797,1.0,5/6,28.68%,SARDH;CHDH;SLC44A1;BHMT;DMGDH
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.2925003461908807,0.7246615440252752,0.9538461538461539,0.9698693839590394,1.0,18/97,18.87%,THBS1;ATF3;DAB2IP;PDIA2;NIBAN1;BBC3;BCL2;SYVN1;TNFRSF10B;EIF2B5;SCAMP5;MAP3K5;TP53;RCN3;ITPR1;UBXN6;RNF185;MARCHF6
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.39082197705892885,-0.723678875750755,0.9210526315789473,1.0,1.0,5/15,24.10%,CEP131;CEP83;CEP192;STIL;PCM1
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.391760053673017,0.7228163801836858,0.8507462686567164,0.9718524716121795,1.0,4/24,12.29%,ZIC1;BAG3;SMAD3;PRKCD
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.30225942567400105,0.7226755915643124,0.96,0.9718799433796484,1.0,9/111,13.24%,GOLGA8O;ATP8B4;STK25;TMED10;GOLGA8A;ARHGEF7;USP6NL;RAB30;OPTN
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.3617844098132008,-0.7224466530082059,0.8461538461538461,1.0,1.0,1/21,1.84%,AGER
prerank,CellMarker_Augmented_2021__Gonocyte:Gonad,-0.36059040428798084,-0.7222252591760434,0.8461538461538461,1.0,1.0,6/28,12.88%,DNMT3B;ACOXL;ZNF90;CALB1;VASH2;ABHD12B
prerank,CellMarker_Augmented_2021__Ovarian Germ Stem cell:Ovary,-0.36059040428798084,-0.7222252591760434,0.8461538461538461,1.0,1.0,6/28,12.88%,DNMT3B;ACOXL;ZNF90;CALB1;VASH2;ABHD12B
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.39311471347563953,0.7221690431264927,0.8367346938775511,0.9722553663758629,1.0,3/16,9.88%,PIEZO2;CTNNB1;TCAP
prerank,CellMarker_Augmented_2021__T Helper2 (Th2) cell:Undefined,0.4134529173477483,0.7220999913420525,0.847457627118644,0.9721494648012947,1.0,4/11,15.37%,IL1R1;TNFRSF1A;CD4;STAT6
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.2779056447759676,0.7219812479388774,1.0,0.9721000698117896,1.0,24/293,13.30%,ANK3;YWHAH;TBC1D9;STEAP3;PRKCB;MYH9;AMN;VLDLR;RAB15;RAB3C;TMED10;RAMP3;SCG5;PPARG;CHMP1A;TF;USP6NL;RAB20;STX4;ARF6;TBC1D1;PICK1;OPTN;COPZ2
prerank,Reactome_2022__RUNX1 Regulates Transcription Of Genes Involved In WNT Signaling R-HSA-8939256,-0.45028690374989616,-0.7213927311904104,0.8490566037735849,1.0,1.0,2/5,18.33%,RUNX1;ESR1
prerank,Reactome_2022__Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.3274833200541164,-0.721342053157431,0.8409090909090909,1.0,1.0,5/51,15.68%,PMVK;TM7SF2;SEC24A;SC5D;DHCR7
prerank,KEGG_2021_Human__Biosynthesis of unsaturated fatty acids,0.37384502413390686,0.7211573600833707,0.9090909090909091,0.9728929924263384,1.0,6/25,17.21%,ACOT4;HACD1;ACOT7;ELOVL7;ELOVL5;HACD4
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.3210785752264347,0.7208095097244767,0.9402985074626866,0.9730782760551742,1.0,9/67,14.93%,CHRM3;BAP1;ST8SIA4;FBXL2;B4GALT7;PHEX;MSRA;PLOD2;LCMT1
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.42144999623125096,-0.7207647452474627,0.8285714285714286,1.0,1.0,1/11,3.20%,PHYH
prerank,CellMarker_Augmented_2021__Lake Et al.Science.In5:Brain,-0.4588323620178552,-0.7204224431069257,0.8260869565217391,1.0,1.0,1/5,2.99%,PDGFD
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.42138356558862494,0.7203274962051381,0.851063829787234,0.9732048866803295,1.0,2/9,14.86%,CHMP1A;IST1
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.42138356558862494,0.7203274962051381,0.851063829787234,0.9732048866803295,1.0,2/9,14.86%,CHMP1A;IST1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte migration (GO:0002686),-0.4365250382182531,-0.7195733605597547,0.7954545454545454,1.0,1.0,1/5,1.69%,CD200R1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.36468055351227513,0.7195720354272281,0.896551724137931,0.9738412842250748,1.0,8/35,14.31%,SIX3;ECE1;SH3PXD2B;PBX3;TGFB2;HIPK1;MEIS3;HIPK2
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.4792514509788878,0.719338558666092,0.7916666666666666,0.9739044163926943,1.0,1/5,7.34%,LARP6
prerank,Reactome_2022__Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.3120539727560965,-0.7192369106790139,0.896551724137931,1.0,1.0,10/53,20.20%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;CUL1;PSMB4
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.36821944049661204,-0.7191537155623625,0.8444444444444444,1.0,1.0,2/19,4.36%,ERP29;APOE
prerank,CellMarker_Augmented_2021__4-Cell Stage Cell (Blastomere):Embryo,0.3659170211713868,0.7191470783018489,0.8450704225352113,0.9739336909500446,1.0,5/29,21.02%,TRAF3IP2;VWA5A;ARHGAP17;ARIH1;CSRP2
prerank,KEGG_2021_Human__Ascorbate and aldarate metabolism,-0.42557110794045283,-0.7190334078813239,0.7777777777777778,1.0,1.0,4/9,17.60%,RGN;AKR1A1;ALDH7A1;ALDH2
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.3848861556929316,0.7183325693239064,0.8421052631578947,0.9747026260011694,1.0,2/14,7.43%,PRKAR1B;RAMP3
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.4929471550105752,0.7181580242818726,0.875,0.9747294792478063,1.0,3/7,9.88%,RYR2;HDAC4;TCAP
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.3466456684688397,0.7180097149793883,0.8620689655172413,0.9747134918682363,1.0,5/45,15.46%,BLM;YAP1;GADD45A;CDKN1A;TP53
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.43222950932876586,0.7178967553999959,0.8275862068965517,0.9746479275068136,1.0,1/10,6.44%,CD44
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.4206068661496716,0.7177785409992546,0.8478260869565217,0.9746004153860537,1.0,1/13,2.35%,ZFP36
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.4715753293815657,0.7177439631975152,0.8421052631578947,0.9744492880738599,1.0,1/5,2.98%,SLC39A14
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),0.44958670911646115,0.717733945433561,0.8148148148148148,0.974079648715491,1.0,2/9,12.29%,TNFRSF1A;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),0.44958670911646115,0.717733945433561,0.8148148148148148,0.974079648715491,1.0,2/9,12.29%,TNFRSF1A;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.3433461717015473,-0.7174902295547899,0.9210526315789473,1.0,1.0,3/19,9.75%,APOBEC3G;PTPN22;PQBP1
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.31824129055963296,-0.7169918146747317,0.9354838709677419,1.0,1.0,13/55,26.08%,PSMD10;PSMD12;PSMB5;PSMB6;NABP2;PSME3;PSMD2;CUL1;INTS3;PSMB4;PSMA1;PSMD11;NABP1
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),0.4720907001839141,0.7168851410183567,0.78,0.974770806333346,1.0,2/5,10.20%,SLC16A10;SLC25A29
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.30582127510426693,-0.7168095013651862,0.9,1.0,1.0,8/41,19.72%,ERCC8;ABRAXAS1;ERCC6;CEBPG;RNF168;RNF8;BRCC3;UBE2V2
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),0.43003957323680586,0.7160155826343589,0.8571428571428571,0.9755539928637383,1.0,3/8,26.00%,LOXL1;LOXL2;SUMF1
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.3833979714892002,-0.715691247993729,0.8478260869565217,1.0,1.0,6/16,15.14%,SLC30A8;SLC39A10;SLC30A6;SLC30A5;SLC39A8;SLC39A6
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.38448506980763614,-0.7154345868529752,0.8478260869565217,1.0,1.0,1/15,4.21%,MCRS1
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.38448506980763614,-0.7154345868529752,0.8478260869565217,1.0,1.0,1/15,4.21%,MCRS1
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.41750183598551927,0.7152560817153304,0.7894736842105263,0.9762265900434125,1.0,1/7,26.93%,MVD
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.4573362904167153,-0.7149262534018533,0.7884615384615384,1.0,1.0,6/6,54.29%,BBS4;MKKS;PPARA;NENF;BBS2;SPX
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.3841493008443333,-0.7145438535305858,0.7804878048780488,1.0,1.0,2/12,15.16%,UFL1;MT3
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),-0.41362457592673263,-0.7142544757649982,0.813953488372093,1.0,1.0,2/8,12.38%,SRI;ATP1A2
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.3671066621868353,-0.7142180752274248,0.9375,1.0,1.0,6/27,20.68%,COPB2;COPE;VTI1B;COG6;RAB33B;COPG2
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.4785970114905411,0.714135278663642,0.8727272727272727,0.9773017264473222,1.0,1/8,1.17%,PDGFRA
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.3709994850953895,0.7140578007874312,0.7857142857142857,0.9771997767307324,1.0,2/20,5.66%,AMN;SLC35F3
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.3592073801221004,0.7140427107583804,0.9074074074074074,0.9770191373016411,1.0,5/23,19.28%,EIF5A;IL12A;MAPK11;IFIH1;HIF1A
prerank,Reactome_2022__Activation Of Pre-Replicative Complex R-HSA-68962,-0.34241940467623655,-0.7140242795813669,0.8421052631578947,1.0,1.0,6/24,16.97%,MCM6;SLC25A15;MCM4;PRIM1;POLR1B;ORC6
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.3264626256356147,-0.7137186571718643,0.926829268292683,1.0,1.0,7/48,11.93%,TNFAIP3;TRIM21;PTPN22;MUL1;RNASEL;POLR3B;POLR3F
prerank,Reactome_2022__HSF1-dependent Transactivation R-HSA-3371571,-0.3463707441685893,-0.713449658940435,0.918918918918919,1.0,1.0,3/31,9.24%,MRPL18;HSPA1A;HSF1
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.35778594699030697,-0.7133676646803242,0.7857142857142857,1.0,1.0,1/15,2.55%,XG
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.4333143729961916,-0.7129307270019172,0.8095238095238095,1.0,1.0,3/8,35.17%,ATP6AP2;GRN;TMEM9
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.2961837427230417,0.7126672602685205,0.9459459459459459,0.9783386320303503,1.0,26/112,26.32%,ATF3;RPA1;NUAK1;BAG3;MAPT;NPAS2;CAMK2B;HSPH1;NEK6;PINK1;YWHAE;CAMK2A;NEK4;AMFR;ADCY8;DNAJB6;DNAJC2;MAPKAPK2;CHORDC1;PRKN;EIF4G1;NUP160;NUP88;CREBBP;MAPK3;NUP35
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3833614505879166,0.712422907593153,0.8615384615384616,0.9784074291842574,1.0,7/20,19.03%,CDC7;BRD4;CCND1;ATAD5;CDC25B;CCNB1;RAB11A
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),0.47617264783516994,0.7123945593105321,0.8688524590163934,0.9782379011330001,1.0,3/7,28.16%,KYAT1;THAP4;PAH
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.48225345750574444,0.7123851311621271,0.8103448275862069,0.9780549528486943,1.0,1/6,8.80%,ATP23
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.3760010842688734,0.7123416878965249,0.8245614035087719,0.9779012894601028,1.0,7/21,26.95%,CLRN1;FSCN1;AKIRIN1;ARPC2;ACTR3;PLCE1;CYFIP1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),-0.37599847389850855,-0.7122665005536387,0.8085106382978723,1.0,1.0,2/17,13.28%,APOE;ERLIN2
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.3797035656768023,0.7121848388654333,0.8787878787878788,0.977884739951291,1.0,4/24,9.05%,DMTN;KCNQ1;AHR;HCN1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),0.4883610541891396,0.7117215954860953,0.8627450980392157,0.9781781940571153,1.0,2/6,28.49%,BICD1;GSK3B
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.3761927500048105,0.7114002598622703,0.8412698412698413,0.9783637302222902,1.0,3/19,13.97%,SEPTIN9;ZMYND10;HAP1
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.48944933644978383,0.7113686237990947,0.9016393442622951,0.9781921621996295,1.0,2/5,12.04%,GRM5;EIF5A
prerank,Reactome_2022__Caspase Activation Via Extrinsic Apoptotic Signaling Pathway R-HSA-5357769,0.38515790404914774,0.7112065294196651,0.8035714285714286,0.9781845493795487,1.0,4/23,13.58%,DCC;DAPK2;TNFRSF10B;FADD
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),0.44446826230258646,0.7111998916601013,0.8245614035087719,0.9780041040366446,1.0,4/8,29.59%,CALM3;GNB5;CBARP;FMR1
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.3145743454463139,0.7107709150099331,0.9444444444444444,0.9782703207696744,1.0,2/77,1.98%,KIF14;PSRC1
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.44058249914474873,-0.7107638056881873,0.8222222222222222,1.0,1.0,3/6,35.17%,ATP6AP2;GRN;TMEM9
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),0.43266199919204584,0.7103191881326075,0.7931034482758621,0.9785543844178766,1.0,3/7,31.58%,KIF11;RANBP1;NSFL1C
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.4252910659573684,0.7097882360982077,0.7884615384615384,0.9789190973906993,1.0,3/8,9.86%,SOX4;TBX20;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.34199950361997455,0.7097587939680045,0.8208955223880597,0.9787633212485642,1.0,3/37,7.88%,PRKCG;AGAP2;LDLR
prerank,Reactome_2022__Reversal Of Alkylation Damage By DNA Dioxygenases R-HSA-73943,0.465205889879038,0.70907981639404,0.8688524590163934,0.9792287627223999,1.0,4/7,32.44%,FTO;ALKBH5;ASCC1;ASCC3
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.33163637252524303,0.7088706344585138,0.9852941176470589,0.9793083981568251,1.0,15/48,18.63%,SOX4;VGF;PPARG;STAT3;PYGL;PDK4;BACE2;MLXIPL;KLF7;ADIPOR2;GCKR;IGF1R;STK11;HECTD4;CAV3
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),0.41615231284402093,0.708826250517005,0.864406779661017,0.9791593618380566,1.0,1/12,5.50%,NUDT16
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),0.4117490173885084,0.7081945305454903,0.875,0.9796154921820326,1.0,2/17,3.51%,ICAM1;THY1
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.25656798492653354,-0.7081643436790506,1.0,1.0,1.0,21/132,20.20%,CEP72;TPX2;SSNA1;FBXO5;CETN2;VPS4B;HAUS1;CEP131;PSMD10;PSMD12;PSMB5;HMMR;DYNLL1;PSMB6;CEP192;CEP78;PSME3;PSMD2;TUBB;CUL1;PSMB4
prerank,Reactome_2022__Assembly Of Active LPL And LIPC Lipase Complexes R-HSA-8963889,0.4214260728398019,0.708024443490123,0.86,0.9795919339532195,1.0,5/11,30.83%,PCSK5;ANGPTL4;PCSK6;FURIN;ANGPTL3
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.41053894646770717,-0.7078969440404967,0.782608695652174,1.0,1.0,3/7,27.30%,MSH3;PRKDC;MSH2
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.38508239179655357,-0.7076799949962563,0.8333333333333334,1.0,1.0,4/12,13.74%,PIPOX;HYKK;GCDH;ALDH7A1
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.38508239179655357,-0.7076799949962563,0.8333333333333334,1.0,1.0,4/12,13.74%,PIPOX;HYKK;GCDH;ALDH7A1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),0.405207717260206,0.70734809222921,0.8387096774193549,0.9801777405142877,1.0,3/13,19.01%,PPP1R16B;MTMR2;MTMR3
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.34791551771064644,-0.7073403584516805,0.96875,1.0,1.0,8/32,15.16%,FTH1;SLC30A8;SLC31A2;SLC30A5;ATP2C2;SLC39A8;CUTC;MT3
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.4782127476254171,0.7067015489876259,0.8627450980392157,0.9806042916572523,1.0,2/5,20.15%,DKK3;BMP6
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),-0.4387333865270269,-0.7065397065625652,0.82,1.0,1.0,1/7,4.10%,HAX1
prerank,Reactome_2022__Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.36637525348278493,-0.7064541306320905,0.7857142857142857,1.0,1.0,2/19,10.22%,FIP1L1;CPSF1
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),0.4227321337309703,0.7063853357305316,0.8666666666666667,0.9807238784541705,1.0,2/7,19.74%,GAS6;BTG1
prerank,"Reactome_2022__Cell Cycle, Mitotic R-HSA-69278",-0.25040717683414887,-0.7061721018388747,1.0,1.0,1.0,40/423,13.12%,H2AC20;CDC26;CCNE1;GINS3;CEP72;TPX2;SGO2;H3-3B;RFC3;SSNA1;H2BC4;H2BC21;AAAS;FBXO5;POLD3;NUP50;H2AC6;TUBB2B;CETN2;BLZF1;KNL1;MCM6;KMT5A;SPDL1;MIS12;HAUS1;CDKN2C;ITGB3BP;CEP131;RAB8A;SLC25A15;GORASP2;CENPA;NUP54;PSMD10;MCM4;CENPQ;ANAPC15;PSMD12;PRIM1
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.333003717174948,0.7060090808397069,0.8939393939393939,0.9809777578540936,1.0,11/47,16.86%,CORO7;WAS;WASF1;FAM107A;TPPP;MAPT;FGF13;COBL;SPIRE1;SPIRE2;MICALL2
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.4035803776360206,0.7058463885907064,0.7833333333333333,0.9809606749293438,1.0,1/10,8.20%,BAG3
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.47265421176589195,0.7058291379311985,0.8163265306122449,0.9807891686390015,1.0,2/5,20.64%,DKK3;H6PD
prerank,KEGG_2021_Human__Tryptophan metabolism,-0.32807658841306525,-0.7057585262931905,0.9,1.0,1.0,10/33,17.60%,IDO1;ACMSD;ASMT;TDO2;AOX1;GCDH;ALDH7A1;ECHS1;EHHADH;ALDH2
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),0.4233243345484953,0.7057363992686736,0.8363636363636363,0.980671432967254,1.0,5/11,27.17%,SLC29A4;SLC1A6;SLC29A1;SNAP25;SLC22A3
prerank,Reactome_2022__SHC-mediated cascade:FGFR3 R-HSA-5654704,0.40724207196353995,0.7056693661655874,0.8181818181818182,0.9805671662530973,1.0,2/10,17.35%,FGF13;SHC1
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),0.43399504380810705,0.7055519339836925,0.8163265306122449,0.9805054393550134,1.0,2/6,29.35%,UBXN1;USP25
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.28512254354731315,-0.7055263251619313,0.967741935483871,1.0,1.0,13/62,20.20%,PDCD2;METTL3;KMT2A;RUNX1;PSMD10;PSMD12;LMO1;PSMB5;LDB1;PSMB6;PSME3;PSMD2;PSMB4
prerank,Reactome_2022__SARS-CoV-1 Infection R-HSA-9678108,0.34199930368053755,0.7055147987968717,0.8787878787878788,0.9803632263033866,1.0,1/46,0.62%,ST6GAL1
prerank,CellMarker_Augmented_2021__Enterocyte:Large Intestine,0.3938655395716907,0.7055019329086576,0.8983050847457628,0.9801830568536027,1.0,4/24,12.23%,IGF2BP2;NOXA1;DGAT1;MLXIPL
prerank,Reactome_2022__Activation Of SMO R-HSA-5635838,0.40130815189567404,0.7054302767875149,0.9032258064516129,0.9801035555471962,1.0,6/14,25.48%,BOC;GRK2;EVC2;ARRB1;PTCH1;IQCE
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.3592092469767778,0.7052878803443535,0.864406779661017,0.9800509060337868,1.0,8/23,18.63%,KCNQ1;RYR2;SLC9A1;ATP1B1;SLC8A1;PDE4D;CALM3;CAV3
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.3599408549990518,0.7052451240809787,0.8983050847457628,0.9798977169627361,1.0,5/23,12.24%,WAS;PAK3;FCHSD1;PLEKHG2;ARHGAP18
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.41207547111760723,0.7049751042636172,0.9,0.9800216318113973,1.0,2/12,7.04%,ROBO2;APLNR
prerank,Reactome_2022__Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.2947203039378531,-0.7048479495740947,0.9777777777777777,1.0,1.0,6/52,11.55%,HEY2;HEYL;MAML3;HEY1;NCSTN;HES5
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),0.46758377047961774,0.7047571611009573,0.8269230769230769,0.9800293411846681,1.0,1/6,30.19%,XRCC4
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.35832366526515647,-0.7046876014022597,0.8478260869565217,1.0,1.0,3/18,9.66%,GTF2H5;GTF2H2;ERCC2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.35832366526515647,-0.7046876014022597,0.8478260869565217,1.0,1.0,3/18,9.66%,GTF2H5;GTF2H2;ERCC2
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.39885159072883375,-0.7044873417173354,0.8297872340425532,1.0,1.0,1/10,2.65%,TPP1
prerank,PanglaoDB_Augmented_2021__Trichocytes,0.3592710045234893,0.7044856071139636,0.8823529411764706,0.9801107488565702,1.0,10/30,12.83%,EPHA2;EPS8L2;BAIAP2L1;GPR87;RHOD;HR;KPNA7;ITGA3;PSORS1C1;TFAP2C
prerank,CellMarker_Augmented_2021__Spermatogonial Stem cell:Testis,0.4417576367689722,0.7044749042381384,0.8518518518518519,0.9799264051174941,1.0,1/7,5.16%,BCL6
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.42542436157983277,0.704361389390753,0.8518518518518519,0.9798537579636006,1.0,2/9,23.67%,ADAM9;FLOT1
prerank,Reactome_2022__Defects In Vitamin And Cofactor Metabolism R-HSA-3296482,-0.3482599715318203,-0.70389808583726,0.9111111111111111,1.0,1.0,3/18,11.37%,CD320;MMAB;MMACHC
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),-0.43853041823885636,-0.7035024494270433,0.8947368421052632,1.0,1.0,3/5,25.10%,UFL1;UFC1;UFM1
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),-0.43853041823885636,-0.7035024494270433,0.8947368421052632,1.0,1.0,3/5,25.10%,UFL1;UFC1;UFM1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),-0.43853041823885636,-0.7035024494270433,0.8947368421052632,1.0,1.0,3/5,25.10%,UFL1;UFC1;UFM1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.33690677557061055,0.7029628033722144,0.9310344827586207,0.9811226198194257,1.0,7/42,16.38%,FA2H;CERS3;CYP4F22;ABCA2;SGMS1;CERS5;ST6GALNAC3
prerank,Reactome_2022__Pre-NOTCH Processing In Endoplasmic Reticulum R-HSA-1912399,-0.42707400096065695,-0.7029385373460739,0.78,1.0,1.0,1/6,7.20%,POFUT1
prerank,Reactome_2022__Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.3140581461215082,-0.7028997357717952,0.8936170212765957,1.0,1.0,1/33,1.79%,TNFAIP3
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.4041135660442603,-0.7027338237205908,0.7619047619047619,1.0,1.0,2/6,19.64%,BCL2L11;STK17B
prerank,CellMarker_Augmented_2021__Epithelial cell:Amniotic Membrane,0.33947613831813767,0.7025744795374366,0.9365079365079365,0.9813242635082884,1.0,4/37,8.19%,PLEKHG6;LSR;TJP3;HOOK1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.4777611493579369,0.7022508444356509,0.8771929824561403,0.9814923612332981,1.0,2/6,24.54%,DSEL;CHST14
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.39037150580830426,0.7020222110326279,0.8813559322033898,0.9815332390630361,1.0,2/11,10.96%,NAMPT;PARP9
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),0.4066601764218285,0.7019033654402194,0.8428571428571429,0.9814893473444611,1.0,5/11,22.15%,TJP3;TJP2;BMP6;PDE2A;TJP1
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.4673880215541488,0.7018965754949891,0.8793103448275862,0.9813094465078468,1.0,1/5,12.05%,STX4
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.4219559477689674,0.7016767476867612,0.7894736842105263,0.98135033593236,1.0,4/8,31.04%,WNK1;NEDD4;NEDD4L;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),0.35785309593581316,0.7015926545750009,0.9354838709677419,0.9812552359419009,1.0,6/38,10.41%,TLR2;MBP;APP;MYD88;STAT3;SYK
prerank,Reactome_2022__ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,0.3775192794223885,0.7015306554138695,0.8769230769230769,0.9811423433351633,1.0,1/23,1.69%,ATF3
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.3337222942247021,-0.7012700711565518,0.8913043478260869,1.0,1.0,3/26,17.03%,SF3A1;KHDC4;SRSF9
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),0.3816410742345631,0.7010613103539072,0.9402985074626866,0.9813949221872432,1.0,2/21,7.51%,IGF1;CYP1B1
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.45960938120375616,0.7010034342434965,0.847457627118644,0.9812642237957123,1.0,1/7,17.47%,WHRN
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),-0.38931120171777533,-0.7009379940613613,0.86,1.0,1.0,2/12,5.92%,EDNRB;ASCL1
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.36002519998924265,0.7007700770568065,0.8870967741935484,0.981347402530189,1.0,6/27,20.41%,NELL1;PKDCC;P2RX7;SLC8A1;BMP6;ANO6
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.3785244185133322,0.6997820666347627,0.8805970149253731,0.9822656501433343,1.0,4/25,12.29%,ZIC1;BAG3;SMAD3;PRKCD
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),-0.32800290663500414,-0.6996418328905754,0.8958333333333334,1.0,1.0,5/29,15.02%,THAP7;NOC2L;KMT2A;BRD7;TADA2B
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.3362216184844584,0.6995963876836506,0.875,0.9822550912348297,1.0,3/39,7.23%,RPA1;POLD1;HROB
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.4047718073109367,-0.6995586097246965,0.8979591836734694,1.0,1.0,2/10,17.35%,GREM1;BMP2
prerank,Reactome_2022__GRB2:SOS Provides Linkage To MAPK Signaling For Integrins R-HSA-354194,0.3915777763797364,0.6994292673297826,0.84375,0.9822178234194584,1.0,4/11,19.92%,FN1;RAP1A;RAP1B;APBB1IP
prerank,Reactome_2022__Signaling By Retinoic Acid R-HSA-5362517,-0.3389645019546753,-0.6992885700671793,0.8529411764705882,1.0,1.0,6/27,12.90%,ALDH1A1;AKR1C3;RDH14;PDHA1;RDH10;RDH11
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.4824727651453762,0.6992839398217606,0.8103448275862069,0.9822028264436011,1.0,1/5,8.80%,ATP23
prerank,Reactome_2022__Synthesis Of Bile Acids And Bile Salts Via 24-Hydroxycholesterol R-HSA-193775,-0.44028357197246926,-0.6991980781535413,0.8837209302325582,1.0,1.0,3/9,10.82%,AKR1C3;CYP46A1;PTGIS
prerank,Reactome_2022__Folding Of Actin By CCT/TriC R-HSA-390450,0.4083848970047017,0.6988621650980941,0.8166666666666667,0.982430384805897,1.0,3/9,14.26%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.32641465407036907,0.6986972477461006,0.9014084507042254,0.9824398255706884,1.0,14/52,24.62%,MAP1LC3A;ATG9A;SMURF1;GABARAPL1;ELAPOR1;PACS2;TMEM41B;RAB7A;ATG16L2;WDR45;ULK1;ATG7;VMP1;GABARAPL2
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),-0.32958497380937635,-0.6985955291017695,0.8837209302325582,1.0,1.0,1/30,1.04%,FAM47E
prerank,Reactome_2022__Metabolism Of Steroids R-HSA-8957322,-0.2668697634733627,-0.6981997814378998,1.0,1.0,1.0,17/112,15.68%,PMVK;TM7SF2;AKR1C3;ABCB11;ARV1;OSBPL3;CD163L1;SEC24A;HSD11B1;CYP46A1;SRD5A1;PTGIS;CYP7B1;SC5D;TSPO;STARD3NL;DHCR7
prerank,Reactome_2022__Triglyceride Biosynthesis R-HSA-75109,-0.4267279938982383,-0.6980231650172138,0.9230769230769231,1.0,1.0,2/8,10.84%,MOGAT1;GK
prerank,"Reactome_2022__Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.3130429785553821,-0.697946040749564,0.8809523809523809,1.0,1.0,4/33,8.78%,SLC25A5;PDZD11;SLC25A4;LCN12
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),-0.41474059937280205,-0.6979112783674524,0.85,1.0,1.0,3/8,14.10%,APOE;PRELID1;TRIAP1
prerank,"Reactome_2022__Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.33254790268032697,-0.6977365221514455,0.9743589743589743,1.0,1.0,7/26,21.45%,SEC24A;BECN1;ERAP2;ATG14;ERAP1;PIK3R4;SEC24C
prerank,Reactome_2022__Regulation Of Gene Expression In Late Stage (Branching Morphogenesis) Pancreatic Bud Precursor Cells R-HSA-210744,0.4144930400734107,0.6977131584749676,0.8490566037735849,0.9833301138085526,1.0,2/13,14.00%,MAMLD1;MAML2
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),-0.46950114582053615,-0.6970305325192643,0.88,1.0,1.0,1/7,4.36%,APOE
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.2669787608695003,0.6968823713523243,1.0,0.983855333489235,1.0,25/263,14.18%,YWHAH;TBC1D9;CNTN2;GRID2;CNTNAP1;SEPTIN4;CNTNAP2;SEPTIN5;SEPTIN8;SEPTIN9;TMED10;CTNNB1;SH3PXD2B;SCG5;PACSIN1;DUOXA1;USP6NL;RAB20;STX4;ARF6;TBC1D1;PICK1;COPZ2;ATG9A;SEPTIN10
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.3809482547627332,-0.6967842122949954,0.8571428571428571,1.0,1.0,5/13,23.22%,HUS1;RAD9B;MUS81;RAD17;CHEK2
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),0.421615818306713,0.6966574165400194,0.8421052631578947,0.9838800601022163,1.0,1/12,2.82%,SLIT2
prerank,KEGG_2021_Human__Galactose metabolism,-0.32885538245827567,-0.6962888768792866,0.9142857142857143,1.0,1.0,6/24,16.85%,GALT;MGAM;GANC;G6PC3;GAA;PGM2
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.3783511290046248,-0.696221003707605,0.9024390243902439,1.0,1.0,4/11,23.07%,NLRP9;NLRP1;AIM2;NAIP
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.42007998942946245,-0.6961621061600356,0.8108108108108109,1.0,1.0,3/6,21.81%,PHGDH;SRR;PSPH
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.30594147974709374,-0.6956904367636062,1.0,1.0,1.0,15/40,24.95%,GRPEL2;PEX10;TIMM23;ZFAND2B;TIMM50;AKT2;PEX1;DNAJC19;TIMM17A;C2CD5;SEC62;TOMM70;SEC61A1;SRP54;GRPEL1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.42099444030618216,0.6952610092770644,0.8490566037735849,0.9849829766614684,1.0,3/14,11.39%,SAMHD1;NLRC5;TTLL12
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),-0.39310164943287107,-0.695257344034731,0.7843137254901961,1.0,1.0,1/12,1.97%,MSTO1
prerank,Reactome_2022__Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,0.3320483443603497,0.6948436961364297,0.9285714285714286,0.9851563961374492,1.0,1/43,2.85%,SLC25A21
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.456875278334787,-0.6947412094997225,0.8157894736842105,1.0,1.0,1/6,7.64%,HSPA1A
prerank,KEGG_2021_Human__DNA replication,-0.33043593641481056,-0.6943363975811758,0.9375,1.0,1.0,5/29,13.12%,RFC3;POLD3;MCM6;MCM4;PRIM1
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),0.44662286645391414,0.6941377981708392,0.8181818181818182,0.9856030845395642,1.0,1/6,7.51%,CYP1B1
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),-0.36953954215269547,-0.6936204626474498,0.9148936170212766,1.0,1.0,3/12,20.37%,EIF2S1;EIF2AK1;DDIT3
prerank,Reactome_2022__NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,0.3181598456682314,0.6935516520543357,0.9833333333333333,0.9859896127408913,1.0,7/40,18.14%,APOD;TBL1X;RXRA;GPS2;NCOR1;ABCG1;TBL1XR1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.33613050735032496,0.6934629174263832,0.8275862068965517,0.9858828447789374,1.0,7/31,22.96%,SMCR8;RNF152;STK11;TELO2;RRAGD;SPAAR;SESN1
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),0.4301671461485341,0.6934535490014393,0.8181818181818182,0.985700605030746,1.0,2/6,11.54%,OLAH;ACOT7
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.3788128654116434,-0.6934281838425157,0.9523809523809523,1.0,1.0,5/19,12.33%,TRIM29;IL20RA;SCEL;EHF;MGP
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.4146541029380424,0.6933949133336562,0.8666666666666667,0.9855517431512009,1.0,2/10,3.51%,ICAM1;THY1
prerank,Reactome_2022__Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,-0.3793888185844409,-0.6932679185027483,0.85,1.0,1.0,1/15,1.41%,CCNE1
prerank,Reactome_2022__STING Mediated Induction Of Host Immune Responses R-HSA-1834941,-0.3723683502046171,-0.6931546430446744,0.8536585365853658,1.0,1.0,1/13,2.46%,TRIM21
prerank,Reactome_2022__mRNA 3-End Processing R-HSA-72187,-0.30052670011907745,-0.6930895764054367,0.975609756097561,1.0,1.0,15/50,24.64%,FIP1L1;RBM8A;U2AF1;CPSF1;SRSF2;CPSF3;SRSF9;UPF3B;CHTOP;CSTF2;THOC3;CSTF2T;THOC1;CPSF7;SRRM1
prerank,KEGG_2021_Human__Fatty acid elongation,0.36078831867533045,0.6920567828319235,0.875,0.9866084585819179,1.0,7/24,17.21%,HADH;ACOT4;HACD1;ACOT7;ELOVL7;ELOVL5;HACD4
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),0.3544323385449438,0.6919054735853752,0.9076923076923077,0.9865726838438237,1.0,5/30,15.46%,PTPRC;TGFB2;JARID2;PUM1;TP53
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.2746495888388157,-0.6918971843869086,1.0,1.0,1.0,6/65,9.40%,AR;APOM;HSPA1A;TFIP11;HSF1;WASHC2C
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.35310177065231996,0.6912426927336929,0.9137931034482759,0.9870384757669767,1.0,3/24,15.53%,FYN;GPR37;PINK1
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),0.42620486223817244,0.6912062092156469,0.8909090909090909,0.9868850340975138,1.0,3/9,15.21%,PLXNA4;PLXNA1;PLXNA2
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.36059918953791337,-0.6910443353569231,0.8857142857142857,1.0,1.0,4/12,25.10%,UFL1;TEX264;UFC1;UFM1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),0.3177771007225444,0.6909813944798433,0.9857142857142858,0.9869268713664344,1.0,6/35,14.64%,FAM107A;TRIM36;TPPP;MAPT;PHLDB2;CAMSAP3
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),0.4566310984752237,0.6908092032265363,0.9322033898305084,0.9869198969118634,1.0,3/5,23.69%,GCKR;MIDN;PRKN
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.3467172350762237,0.6907979905489775,0.953125,0.98673995524393,1.0,6/27,24.47%,PPP1R16B;PRKCD;CALM3;PPP1R7;PIN1;SPPL3
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),-0.41890330116186836,-0.6904303440338926,0.8085106382978723,1.0,1.0,1/7,1.76%,CST3
prerank,Reactome_2022__Activation Of IRF3/IRF7 Mediated By TBK1/IKK Epsilon R-HSA-936964,0.3867830160076019,0.6903851139634704,0.8846153846153846,0.9869347788065193,1.0,2/16,9.30%,IRF7;IKBKE
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.415806962687709,-0.690367521589364,0.8367346938775511,1.0,1.0,2/9,6.53%,THAP7;NOC2L
prerank,KEGG_2021_Human__Ubiquitin mediated proteolysis,-0.25399414489610206,-0.6902743798329042,1.0,1.0,1.0,4/126,6.19%,CDC26;ERCC8;ELOC;ANAPC13
prerank,Reactome_2022__Metabolism Of Polyamines R-HSA-351202,0.31468587607988896,0.6902664406501653,0.9178082191780822,0.9868657388376166,1.0,1/48,2.85%,SLC25A21
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),0.32074459357671115,0.690168456856202,0.8833333333333333,0.986759048330624,1.0,3/36,16.11%,DAB2IP;CDC7;BRCA1
prerank,Reactome_2022__TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,0.3471487975579226,0.6901428478859382,0.8793103448275862,0.9865903543425858,1.0,5/24,16.42%,BIRC3;TNFRSF1A;IKBKG;OTUD7B;TAB1
prerank,Reactome_2022__RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,-0.34008566177070265,-0.6900386463202649,0.8717948717948718,1.0,1.0,3/29,11.31%,RNF2;SMARCD1;RUNX1
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),-0.3584140398079106,-0.6899034273277035,0.8837209302325582,1.0,1.0,9/26,26.67%,SUPT16H;LDB1;RNF168;RNF8;WDR43;LARP7;EAF1;LEO1;NELFCD
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),0.4054593428170488,0.6893752184183377,0.7708333333333334,0.9871373130450696,1.0,2/9,5.57%,APOD;PADI2
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.2816645983835032,-0.6891262542938423,0.9736842105263158,1.0,1.0,13/59,19.71%,PGP;PIGW;GDE1;PLA2G4C;GPLD1;PLA2G15;ENPP6;DPM2;GPCPD1;GDPD1;PRDX6;PLA2G4A;PIGF
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.3215699677487616,-0.6890562726405971,0.8857142857142857,1.0,1.0,6/30,17.45%,OAT;GLUD1;ART4;SLC39A8;ALDH18A1;GLYATL1
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),-0.44576425938197994,-0.6888241337523316,0.7884615384615384,1.0,1.0,3/5,21.25%,DCTPP1;ENPP3;ITPA
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.41195516089647194,0.6887912060151569,0.8679245283018868,0.9874647757255142,1.0,2/11,14.40%,TESPA1;IKBKG
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.3344162906631277,-0.6887407832897172,1.0,1.0,1.0,1/25,0.81%,AR
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.35602470666374453,-0.6885970143212821,0.8461538461538461,1.0,1.0,2/16,7.85%,OAT;GLUD1
prerank,Reactome_2022__DNA Damage Reversal R-HSA-73942,0.46176488028795537,0.6882625771951163,0.8793103448275862,0.9878651949713543,1.0,4/8,32.44%,FTO;ALKBH5;ASCC1;ASCC3
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.4289292999409011,-0.688084761116041,0.8958333333333334,1.0,1.0,1/8,4.05%,GTF2H5
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.32466907922570637,0.6880404207628729,0.9180327868852459,0.9878868375257638,1.0,6/41,12.89%,APP;GRM5;FOXO3;CNDP1;MAPKAPK5;KLF4
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.3526401482466648,0.687762018987081,0.9322033898305084,0.9879239680695701,1.0,2/24,10.92%,FOXO1;MAPT
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.4104063445042071,0.6874855234095919,0.7857142857142857,0.9879942843559292,1.0,3/8,14.52%,EFNA1;EPHA4;BIN1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.3477800753722485,0.6874815878412511,0.9295774647887324,0.987807876741439,1.0,5/35,9.04%,PPARGC1B;PMEPA1;PADI2;PGR;YAP1
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.44541657106643584,0.6870402292332054,0.864406779661017,0.9880109373374195,1.0,1/7,10.12%,SHMT1
prerank,Reactome_2022__FGFRL1 Modulation Of FGFR1 Signaling R-HSA-5658623,0.468780060103878,0.687016004510914,0.8793103448275862,0.9878599906688722,1.0,1/6,11.20%,FGF13
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.28915318901854514,0.6869904830508206,0.9850746268656716,0.9877135248804333,1.0,8/77,17.57%,DVL1;DAAM1;PRICKLE2;PRICKLE1;CELSR3;SMURF1;FZD7;WNT5A
prerank,Reactome_2022__Nicotinate Metabolism R-HSA-196807,0.3499181450171164,0.6868360980599746,0.9285714285714286,0.9876467187866124,1.0,3/27,10.96%,NMNAT2;NAMPT;PARP9
prerank,"Reactome_2022__Tristetraprolin (TTP, ZFP36) Binds And Destabilizes mRNA R-HSA-450513",0.38141883689123174,0.6866676052660992,0.8225806451612904,0.9876241540823213,1.0,1/16,2.35%,ZFP36
prerank,Reactome_2022__Signaling By NOTCH1 R-HSA-1980143,0.3101147296772897,0.6862721275757081,0.967741935483871,0.9878137938586498,1.0,30/67,28.74%,MAMLD1;TBL1X;NEURL1;HDAC4;DNER;DTX2;HDAC9;TLE3;MAML2;NCOR1;HDAC7;NBEA;SKP1;TBL1XR1;ADAM17;HIF1A;RPS27A;TLE2;TLE4;ARRB1;HDAC5;PSEN1;NUMB;CREBBP;MIB2;NCOR2;HDAC3;APH1B;ARRB2;HDAC6
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.32256796605637833,-0.68547797832798,0.9130434782608695,1.0,1.0,5/36,15.97%,DYNLRB2;DYNLRB1;CEP131;DYNC2I1;DYNLL1
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.4600838239848455,0.6854427746015151,0.8409090909090909,0.9884497716809126,1.0,2/5,25.29%,SLC2A13;SLC26A6
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.4024089604607729,-0.685151687906622,0.9333333333333333,1.0,1.0,5/12,28.97%,RNF168;RNF8;LARP7;NELFCD;RECQL5
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),0.46986607788256185,0.6849594247219674,0.8627450980392157,0.988703258177193,1.0,3/5,41.55%,ANGPT1;SLC10A7;GLCE
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4046640839793517,0.6849574383917717,0.9180327868852459,0.988514826071575,1.0,4/12,20.13%,TCP1;CCT4;CCT8;WRAP53
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.29817953619305215,-0.6849241024437344,1.0,1.0,1.0,4/34,13.61%,RPL23;PDCL3;RPL11;HFE
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.2876030894411515,0.6848085633234724,0.9848484848484849,0.9884744479372134,1.0,8/77,17.57%,DVL1;DAAM1;PRICKLE2;PRICKLE1;CELSR3;SMURF1;FZD7;WNT5A
prerank,Reactome_2022__Cell Cycle Checkpoints R-HSA-69620,0.26921889128346665,0.6845797007076798,1.0,0.9884804588196247,1.0,14/214,13.18%,CDKN2A;YWHAH;CCNB2;BLM;INCENP;CENPP;ERCC6L;YWHAG;BARD1;CDC7;CDKN1B;CENPH;RANGAP1;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),-0.33833871976758323,-0.6842892207962892,0.7894736842105263,1.0,1.0,1/17,1.84%,AGER
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.4458663048807718,0.6842581053756208,0.8478260869565217,0.9885306243632457,1.0,1/7,1.94%,ACTA2
prerank,Reactome_2022__Cell Cycle R-HSA-1640170,0.25424835835636855,0.6840842500778178,1.0,0.9884726068723548,1.0,86/534,21.15%,CDKN2A;VRK2;SYCE1;YWHAH;CCNB2;PTK6;TYMS;BLM;PRKCB;LMNB1;GINS2;INCENP;PMEPA1;POLD1;CENPP;MIS18A;CDK6;ERCC6L;HAUS7;CDC14A;YWHAG;GAR1;LMNA;TUBB6;STAG3;PPP1CB;NCAPD3;TERF2IP;CDKN1C;BARD1;ACTR1A;CDC7;CDKN1B;CENPH;RANGAP1;LRIG1;CDKN1A;CCND1;CKS1B;OPTN;TUBA1B;ANKRD28;POLE3;MRE11;NEK6;IST1;LCMT1;CHTF18;TP53;NEDD1;BRCA1;TINF2;CDK2;LPIN3;CDC25B;DYNC1LI2;SKA2;CCNB1;DCTN1;YWHAE;SKP1;CKAP5;RFC4;PRKCA;SET;GINS1;TUBGCP6;CDK5RAP2;CDKN2D;DYNC1LI1;CCND2;PPP2R2D;CDC27;RPS27A;AKT3;WRAP53;KANSL1;PPME1;MLH3;UBE2E1;PDS5A;ACD;CCNA2;CEP76;UBE2I;MAX
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),-0.2935877880748716,-0.683961529243296,0.9459459459459459,1.0,1.0,7/48,12.99%,ADAMTS9;GAL3ST2;FBXO27;GANC;GAL3ST4;GANAB;AGA
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),0.3863112062637517,0.6839416244054846,0.8823529411764706,0.9884035764410034,1.0,3/13,10.43%,CTU2;GTPBP3;TRMT9B
prerank,Reactome_2022__Laminin Interactions R-HSA-3000157,0.362727914983141,0.6837507401619375,0.9016393442622951,0.9883963567180523,1.0,5/20,10.81%,LAMB1;ITGA2;LAMA5;ITGA3;LAMA2
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.4433997368417518,-0.6832754955855677,0.8958333333333334,1.0,1.0,1/5,7.28%,CAP1
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.34059686674486295,0.6831937281139345,0.9016393442622951,0.9886803537431059,1.0,4/26,9.86%,ECE1;CACNA1C;CTNNB1;TGFB2
prerank,Reactome_2022__Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.3091902859495591,-0.6831847824431538,0.8823529411764706,1.0,1.0,8/45,16.36%,LDHC;MPC2;PDPR;PDHA1;CS;MPC1;SUCLA2;IDH3G
prerank,KEGG_2021_Human__Amino sugar and nucleotide sugar metabolism,0.32939842987781703,0.6830466426484059,0.896551724137931,0.9886377921491082,1.0,6/42,13.68%,UGDH;HK2;GALK1;HK1;CMAS;NANS
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.4181003414636118,0.6829989461243959,0.8813559322033898,0.9884893910459226,1.0,2/10,12.17%,MICALL1;ARF6
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.32004267814896625,0.682982533581913,0.9393939393939394,0.9883123826014167,1.0,6/39,20.16%,CHD3;SRCAP;SMARCA1;SPTY2D1;ARID1A;SMARCD2
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.3810150888103737,0.6827297634729206,0.8620689655172413,0.9883889576444177,1.0,6/12,22.72%,SYNJ2;INPP5A;INPP5J;IMPA1;SYNJ1;OCRL
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.36893666833882827,0.682677997407892,0.8333333333333334,0.9882737495499128,1.0,3/16,12.18%,DNM1;MTFR2;MX1
prerank,CellMarker_Augmented_2021__Primordial Germ cell:Ovary,-0.3664824849013621,-0.6826528139223559,0.7619047619047619,1.0,1.0,2/17,2.85%,ACTR3B;MGAT4D
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.35091993470100336,0.682550738342984,0.9122807017543859,0.9882026582632606,1.0,3/23,16.27%,SLC26A8;PDPN;SLC1A6
prerank,KEGG_2021_Human__Fatty acid degradation,0.33262677145636765,0.6823338603727681,0.9016393442622951,0.9882373491028305,1.0,2/36,7.02%,ACSL5;HADH
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),-0.43512244399218913,-0.6820635785996745,0.9090909090909091,1.0,1.0,1/7,6.17%,MUL1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.36385935275439424,0.6816314285980335,0.8867924528301887,0.9886839527044607,1.0,8/23,27.80%,SYVN1;MAN1A1;RNF185;MARCHF6;RPS27A;AMFR;MAN1C1;EDEM1
prerank,Reactome_2022__TNF Signaling R-HSA-75893,0.3028903881190618,0.6807916187150355,0.9558823529411765,0.9892096727758625,1.0,10/42,21.37%,BIRC3;TNFRSF1A;FADD;IKBKG;OTUD7B;TAB1;ADAM17;RPS27A;TAB2;SPPL2B
prerank,KEGG_2021_Human__alpha-Linolenic acid metabolism,0.4181701542601045,0.6807240368868999,0.8771929824561403,0.9890988221518462,1.0,2/12,14.74%,PLAAT3;PLB1
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),0.41557671136626434,0.6806754383186008,0.90625,0.9889615949476548,1.0,2/13,15.53%,PID1;PINK1
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),-0.43944932929786684,-0.6804323260007202,0.9166666666666666,1.0,1.0,2/8,14.29%,VAX2;AMER2
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.3223567318244555,-0.6802928969279248,0.8888888888888888,1.0,1.0,1/16,5.04%,TUBD1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.449769011310393,-0.680255004156252,0.7959183673469388,1.0,1.0,2/7,14.94%,WARS2;YARS2
prerank,"Reactome_2022__Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.30965759149197325,-0.6801970511693395,0.9642857142857143,1.0,1.0,12/33,23.80%,ARSF;EIF5A2;ICMT;GGCX;DPH2;ARSK;DNAJC24;ARSL;EEF2;ARSG;DPH5;DPH3
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.26063065278630837,0.680132662431939,1.0,0.9892800557007682,1.0,64/241,26.95%,TEKT2;PTPRO;SHTN1;DMTN;CYS1;RHOD;EMP1;RAP2B;CDC14A;ARHGEF7;MINK1;MAK;FSCN1;RP2;P2RY12;IFT122;OPHN1;FGD5;ARF6;CFAP20;TRAPPC14;PPP1R9B;ABCC4;P2RX7;CILK1;TXNDC15;IFT140;RAP1A;SNX10;FLNA;RILPL1;RAB11A;EXOC2;RAP1B;ARHGEF6;EHD4;ANO6;TTBK2;ASAP1;MTSS1;ABLIM2;AHI1;OCRL;CFAP44;WDR90;VCL;CDH13;MAP4K4;CFAP54;ACTR3;CC2D2A;RAB11FIP3;EMP2;RFX3;IFT43;CARMIL1;SRGAP2;KIAA0586;EXOC4;DYNC2I2;RAP2A;GSN;TTC39C;CYFIP1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.3698484033870619,0.6801089184786066,0.921875,0.9891186382601321,1.0,5/18,18.63%,RYR2;GRK2;C12ORF57;CALM3;CAV3
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.3980485597612997,-0.6799245609383904,0.8636363636363636,1.0,1.0,1/7,11.87%,CTH
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),0.41592137045902466,0.6795799857254199,0.9104477611940298,0.98937093918893,1.0,5/11,24.45%,GAS6;IFIH1;WNT5A;TRIM44;DHX9
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.3543400042601145,0.6792362334617079,0.9180327868852459,0.9894911511860127,1.0,4/26,12.40%,CENPP;MIS18A;CENPV;CENPH
prerank,Reactome_2022__Integration Of Provirus R-HSA-162592,0.41333288564816906,0.6789952777935011,0.8387096774193549,0.9895233388168282,1.0,4/10,34.11%,HMGA1;PSIP1;XRCC4;XRCC5
prerank,Reactome_2022__2-LTR Circle Formation R-HSA-164843,0.4349479069486443,0.6788609070203996,0.8387096774193549,0.9894301683076998,1.0,4/8,34.11%,HMGA1;PSIP1;XRCC4;XRCC5
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),-0.4371700463701536,-0.6782595168945115,0.9215686274509803,1.0,1.0,1/5,11.31%,RUNX1
prerank,Reactome_2022__Beta Oxidation Of butanoyl-CoA To acetyl-CoA R-HSA-77352,0.4485168581385104,0.6780143762154613,0.8421052631578947,0.9900076165838616,1.0,1/5,7.02%,HADH
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),0.43420778397996596,0.6778868050768634,0.9038461538461539,0.989934173527825,1.0,1/7,7.38%,TYR
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),-0.3158284253181876,-0.6778134793726672,1.0,1.0,1.0,5/26,9.58%,BAK1;HSPA1A;ABCB10;HSF1;HSPA13
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),-0.3027837469799729,-0.6777969514684219,0.8947368421052632,1.0,1.0,2/27,8.40%,SNF8;VPS4B
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.3180838099627029,-0.6777250271822599,0.9117647058823529,1.0,1.0,3/24,8.52%,FOXJ1;RSPH1;SPAG17
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.2682773739829017,-0.6777238819384108,1.0,1.0,1.0,7/89,12.85%,PADI4;BRDT;CHRAC1;CHD4;SMARCD1;MPND;ERCC6
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.3127481405600587,-0.6769327598730246,0.9,1.0,1.0,6/28,17.42%,SETDB1;SMYD2;KMT2A;MEN1;WDR82;EZH2
prerank,Reactome_2022__Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,0.29819635692319624,0.6768223166243947,0.9583333333333334,0.9906080104810978,1.0,15/70,23.06%,EBF1;TBL1X;PPARG;ZNF467;KLF4;RXRA;MED13L;CDK19;NCOR1;TBL1XR1;MED24;ANGPTL4;MED27;CARM1;MED13
prerank,KEGG_2021_Human__Mismatch repair,0.35597292668408825,0.6762200729321487,0.890625,0.9909080367015936,1.0,3/20,12.11%,RPA1;POLD1;PMS2
prerank,CellMarker_Augmented_2021__Meiotic Prophase Fetal Germ cell:Fetal Gonad,0.23867096690250492,0.6761192262547527,1.0,0.9908234799061278,1.0,56/877,11.06%,SYCE1;IL13RA1;PLK2;TC2N;ZIC4;C5ORF47;MAEL;CSMD3;GABRB2;P4HA2;CD55;NECAB1;ABCA5;PRAME;CCDC122;TSPYL2;TDRD5;GINS2;WASF1;BTG3;DNAAF8;KLF10;COLEC11;SKAP1;ABCC9;PGR;FAM107B;CENPP;PAWR;RNF32;BOC;IHO1;ADGRL2;CTNNB1;HOOK1;CLGN;ZFAND5;ARIH2;LIMK2;OXCT1;FTCD;AK3;TAF4B;NRIP3;PBX3;ART3;RP2;KLHL5;CCDC83;TEX30;HMOX2;NUP210L;TERF2IP;PXT1;IFT122;C1ORF105
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.34843566854618824,0.6758936440935274,0.9,0.9908334068511951,1.0,8/24,16.14%,THBS1;PPARG;GADD45A;STARD13;KLF4;FGF2;ANGPT2;ATP2B4
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.45519087394779456,0.6756622650173745,0.8913043478260869,0.9908433300346309,1.0,1/5,1.94%,ACTA2
prerank,Reactome_2022__Signaling By NOTCH3 R-HSA-9012852,-0.3048274063630497,-0.675616109636552,1.0,1.0,1.0,6/42,11.55%,HEY2;HEYL;MAML3;HEY1;NCSTN;HES5
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.3605127564410632,-0.675400134377236,0.9,1.0,1.0,6/20,22.92%,POLR2K;POLR2C;POLR2D;POLR2L;POLR2G;POLR2E
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.3605127564410632,-0.675400134377236,0.9,1.0,1.0,6/20,22.92%,POLR2K;POLR2C;POLR2D;POLR2L;POLR2G;POLR2E
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),-0.3256045764275663,-0.6752456578834555,0.9583333333333334,1.0,1.0,4/25,11.69%,HSPG2;SDC3;GPC6;HPSE2
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3964702946181347,0.675209985365547,0.828125,0.991114539998267,1.0,3/8,17.73%,PTPRC;ELF1;CBFB
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),-0.3557522634591004,-0.6751796021723256,0.8809523809523809,1.0,1.0,3/11,15.74%,LY96;TRIL;TIRAP
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.3409089182913243,0.6749704117622599,0.9818181818181818,0.9911112343602164,1.0,5/35,16.11%,BLM;DONSON;CDKN1A;MRE11;BRCA1
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),-0.302774165118684,-0.6743117306911991,0.8974358974358975,1.0,1.0,2/28,8.40%,SNF8;VPS4B
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.43976731899273924,0.674235644809251,0.8490566037735849,0.9915534920892196,1.0,3/7,16.42%,ATP2B3;ATP2B4;SLC8A2
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.3067315941308359,-0.6740919692041387,1.0,1.0,1.0,4/30,7.95%,FBXO5;CCN1;FZD9;ATRAID
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.42122406967373716,-0.6740464595500205,0.9259259259259259,1.0,1.0,2/8,15.16%,LEPR;MT3
prerank,"Reactome_2022__Regulation Of Glycolysis By Fructose 2,6-Bisphosphate Metabolism R-HSA-9634600",0.41178639602800166,0.6740415730618197,0.9,0.9915479101277174,1.0,4/10,28.23%,PFKFB3;PRKCA;PFKFB4;PPP2R1B
prerank,Reactome_2022__Downstream Signaling Of Activated FGFR3 R-HSA-5654708,0.3655556901730984,0.6734260316737594,0.9056603773584906,0.991862662505355,1.0,4/17,27.64%,FGF13;SHC1;PTPN11;FGF17
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),0.47018942432856586,0.673233252190025,0.8636363636363636,0.9918021831180599,1.0,3/5,39.01%,GSK3B;CSNK1A1;AMER1
prerank,"KEGG_2021_Human__Valine, leucine and isoleucine degradation",0.32339462230752164,0.6727520504564111,0.9565217391304348,0.9920575511686487,1.0,10/42,24.41%,HADH;OXCT1;HMGCLL1;ACAD8;ALDH3A2;AUH;HMGCS1;ABAT;BCAT1;BCAT2
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),0.3743942626485378,0.6725286378030528,0.8793103448275862,0.9918971241710952,1.0,2/12,17.47%,DAPK2;CAMK1D
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),0.3743942626485378,0.6725286378030528,0.8793103448275862,0.9918971241710952,1.0,2/12,17.47%,DAPK2;CAMK1D
prerank,Reactome_2022__Creatine Metabolism R-HSA-71288,0.4122235815021841,0.6724334309254547,0.8275862068965517,0.9917818844707307,1.0,3/9,32.68%,SLC6A7;SLC6A11;CKM
prerank,Reactome_2022__Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.2617577271342839,-0.6723222278763712,1.0,1.0,1.0,10/57,20.20%,ELOC;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.38774621750091376,0.6721371695225326,0.9016393442622951,0.991868312542674,1.0,4/12,28.03%,TLE6;MAP4;NLRP5;CLASP1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.32291064797858415,-0.6720387555771759,1.0,1.0,1.0,4/21,14.39%,TPT1;SFRP2;TRIAP1;CLU
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),-0.4318418473728115,-0.6718746110447132,0.8260869565217391,1.0,1.0,4/6,23.97%,BAD;MTLN;AKT2;VCP
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.37652582475630053,0.6717670010836156,0.8363636363636363,0.9920182513771649,1.0,1/12,6.62%,ECE1
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.2965054566172501,0.6711346880294122,0.96875,0.9923258667373696,1.0,5/61,10.66%,SLC4A10;SLCO1A2;SLC4A9;SLC4A11;SLCO2A1
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),-0.3545332953983681,-0.6709784112328636,0.8913043478260869,1.0,1.0,2/13,19.13%,SLC25A22;SLC25A11
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),0.47207427292334314,0.6708958870105041,0.8372093023255814,0.9923267203472834,1.0,1/5,16.11%,BRCA1
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.3095272688162851,-0.6706900051546255,0.9534883720930233,1.0,1.0,6/36,12.42%,SMYD2;FBXO5;KMT5A;WDR76;USP51;NSMCE4A
prerank,Reactome_2022__Defective HLCS Causes Multiple Carboxylase Deficiency R-HSA-3371599,-0.4681328053617979,-0.6705975958122732,0.8809523809523809,1.0,1.0,2/6,29.55%,MCCC2;MCCC1
prerank,Reactome_2022__Defects In Biotin (Btn) Metabolism R-HSA-3323169,-0.4681328053617979,-0.6705975958122732,0.8809523809523809,1.0,1.0,2/6,29.55%,MCCC2;MCCC1
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.39603947875552686,0.6698058759561748,0.9433962264150944,0.9930392947546521,1.0,4/11,17.21%,HACD1;ELOVL7;ELOVL5;HACD4
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.3530257125216371,0.6697987354952203,0.8909090909090909,0.9928626639846341,1.0,6/26,15.61%,FABP3;MFSD2A;LDLR;SORBS1;MLXIPL;ELOVL5
prerank,Reactome_2022__FLT3 Signaling R-HSA-9607240,0.33420353978066075,0.66949383753716,0.8727272727272727,0.9929203319161675,1.0,11/32,22.33%,FYN;FOXO3;GAB2;SYK;CDKN1B;PTPRJ;RPS27A;AKT3;GRB10;PTPN11;SH2B3
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.4064743108156233,0.6692084129349204,0.875,0.9929757893991513,1.0,1/11,3.17%,APP
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),-0.4104407819622894,-0.6692083673385522,0.7804878048780488,1.0,1.0,2/7,30.97%,PEX1;PEX12
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),-0.39473684127223796,-0.6691501773587898,0.8421052631578947,1.0,1.0,2/11,13.83%,TBCCD1;ARCN1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.35839638988737244,0.6688033289443556,0.8857142857142857,0.9931362623000157,1.0,6/25,20.58%,NOS1AP;ATP2B4;CAV3;DNM2;HIF1A;SCARB1
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.3818615905392031,0.6687866289161212,0.8955223880597015,0.9929663101171065,1.0,4/16,13.13%,GABBR2;CACNA1C;ORAI1;CAP2
prerank,CellMarker_Augmented_2021__Astrocyte:Undefined,-0.44441502489063806,-0.6687060540843468,0.8974358974358975,1.0,1.0,1/6,2.62%,S100B
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.32947715362393915,0.6686515193251603,0.967741935483871,0.9928904816348137,1.0,6/35,14.92%,PSRC1;TPPP;DCX;RSPH4A;CFAP74;MTCL1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3278113216895766,-0.6686174038155451,0.9302325581395349,1.0,1.0,2/26,5.53%,GDF9;TWSG1
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),-0.36609593348641284,-0.668491611933984,0.9024390243902439,1.0,1.0,2/12,15.19%,NAGK;GNPDA2
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.36426788735009374,0.6680948080954191,0.9361702127659575,0.9931361735310819,1.0,3/15,14.52%,LDLR;SHANK1;RGS14
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),-0.3547818290802715,-0.6680856448812933,0.8205128205128205,1.0,1.0,2/12,10.55%,SUPT16H;SMARCD1
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),-0.3547818290802715,-0.6680856448812933,0.8205128205128205,1.0,1.0,2/12,10.55%,SUPT16H;SMARCD1
prerank,Reactome_2022__SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.263801889718454,-0.6679334839344452,1.0,1.0,1.0,2/39,5.18%,AAAS;NUP50
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.3436080230993608,0.6679261892375152,0.8301886792452831,0.9931084469514452,1.0,4/24,26.37%,MORF4L2;MORF4L1;CREBBP;BAG6
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.41299510122643057,0.6678601344406531,0.8793103448275862,0.9929801659148091,1.0,2/10,20.40%,TP53;THRA
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),-0.35462615143902704,-0.6678248478013379,0.8392857142857143,1.0,1.0,1/11,6.59%,ZNF502
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.369407746260915,0.667735796788407,0.921875,0.992878162637544,1.0,6/17,19.03%,CDC7;BRD4;CCND1;CDC25B;CCNB1;RAB11A
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.3950513600602292,-0.6673462331816568,0.8636363636363636,1.0,1.0,4/13,22.42%,TRIB3;ERLIN2;APPL2;ERLIN1
prerank,CellMarker_Augmented_2021__Follicular T cell:Undefined,0.3627908623959117,0.6672595201123501,0.9166666666666666,0.9931127447210545,1.0,6/19,12.64%,WAS;CD37;ACAP1;CD5;ITGAL;TMC8
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),-0.4659048075006089,-0.6670290718403127,0.875,1.0,1.0,1/5,10.96%,BECN1
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.39856555354122103,0.6669620357113164,0.847457627118644,0.9931440373168815,1.0,1/12,2.53%,CD55
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.3810925981102167,0.6669076394827437,0.9508196721311475,0.9930049235504118,1.0,3/13,15.61%,ALOX12;PNPLA8;ELOVL5
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.4125595048080721,-0.6668480055194165,0.8409090909090909,1.0,1.0,2/6,11.13%,VPS4B;APEH
prerank,CellMarker_Augmented_2021__Goblet cell:Large Intestine,0.34023608197756205,0.6667845770078634,0.8852459016393442,0.9929073607583144,1.0,3/24,8.03%,BCAS1;SLC17A5;CAPN8
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.44282511260326973,0.6666591938377213,0.875,0.9928163858947308,1.0,1/7,7.32%,UGDH
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.358379767647677,-0.6664363153600518,0.8484848484848485,1.0,1.0,6/19,16.95%,SLC8B1;YME1L1;SLC25A23;LETM1;MICU2;AFG3L2
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.3252802567894455,-0.6663445175983769,0.9069767441860465,1.0,1.0,3/24,12.24%,SPDL1;LLGL1;CENPA
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.4306518932224408,0.6660279339938678,0.8653846153846154,0.9932057737876009,1.0,3/10,18.23%,PTPRC;FADD;ADAM17
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.44387205024067133,0.6660147717862839,0.890625,0.9930296438863752,1.0,1/7,11.22%,TRUB1
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.39320625964434686,0.6653206119656125,0.8421052631578947,0.9932056459619585,1.0,6/11,22.72%,SYNJ2;INPP5A;INPP5J;IMPA1;SYNJ1;OCRL
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.39320625964434686,0.6653206119656125,0.8421052631578947,0.9932056459619585,1.0,6/11,22.72%,SYNJ2;INPP5A;INPP5J;IMPA1;SYNJ1;OCRL
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.3182424085149947,0.6651692401181653,0.9333333333333333,0.9931605155896015,1.0,9/43,24.78%,DAB2IP;BAG3;OPTN;HSPH1;PACRG;HSPA4;HSPB1;PRKN;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.37515362529408247,0.6648222316074887,0.90625,0.9932768152201195,1.0,3/15,14.26%,TCP1;CCT4;CCT8
prerank,Reactome_2022__Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.22918790513834203,-0.6646556183656234,1.0,1.0,1.0,12/273,6.91%,CDC26;TRIM21;RNF6;ASB8;ELOC;RNF25;ASB4;UBAC1;FBXO27;ANAPC13;RNF114;ASB13
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.36615784948704794,0.6645060270728207,0.9333333333333333,0.9933341882297589,1.0,2/17,9.30%,PLSCR1;IKBKE
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.3656185080318233,-0.6643538495028065,0.9142857142857143,1.0,1.0,1/11,3.65%,CXXC4
prerank,Reactome_2022__VEGFR2 Mediated Vascular Permeability R-HSA-5218920,0.36678853623235647,0.663444273436897,0.9655172413793104,0.9940151444515035,1.0,8/23,20.13%,CTNNB1;ARHGEF7;RNASE1;CTNNA1;PRR5;VAV2;VAV1;AKT3
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.30287584905913073,0.6634346586450495,0.9692307692307692,0.9938325541289269,1.0,2/64,1.68%,IGF1;THBS1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.3367991771442166,0.6633515291141204,0.9032258064516129,0.9937067024997871,1.0,4/26,15.61%,ACSL5;HACD1;ELOVL7;ELOVL5
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.35560748980484413,0.663028232002947,0.9285714285714286,0.9938097148802584,1.0,6/15,20.58%,MLXIPL;GCKR;PNPLA8;RORA;ANGPTL4;SCARB1
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.3663043119893402,0.6625449425361855,0.9361702127659575,0.994034701162227,1.0,2/13,9.86%,TBX20;TGFB2
prerank,KEGG_2021_Human__Notch signaling pathway,0.3243463759399842,0.6624139053770325,0.9841269841269841,0.9939524502474211,1.0,13/50,20.56%,NUMBL;DVL1;CTBP2;TLE6;DTX2;TLE3;MAML2;NOTCH3;ATXN1L;ADAM17;LFNG;NOTCH4;TLE2
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),0.4051318059842195,0.6623741079363944,0.8214285714285714,0.9936181907496399,1.0,3/8,17.11%,HDAC4;FBP1;NCOR1
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),0.4051318059842195,0.6623741079363944,0.8214285714285714,0.9936181907496399,1.0,3/8,17.11%,HDAC4;FBP1;NCOR1
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.41804270520791176,0.6622753010354852,0.86,0.9935295329347945,1.0,2/6,9.88%,CTNNB1;TCAP
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),-0.3819549657964042,-0.6622383349841936,0.8043478260869565,1.0,1.0,1/8,18.58%,ERCC3
prerank,Reactome_2022__Processive Synthesis On Lagging Strand R-HSA-69183,-0.34722640955012396,-0.6619643121385808,0.875,1.0,1.0,4/12,16.47%,POLD3;PRIM1;POLR1B;DNA2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.443790275951253,0.6618609412362304,0.8958333333333334,0.9936847045428756,1.0,1/6,9.91%,NFKBID
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),0.4096584487629808,0.6618202664796927,0.8490566037735849,0.9935242482325727,1.0,4/7,26.04%,BIN1;YWHAE;SESTD1;CBARP
prerank,CellMarker_Augmented_2021__Clara cell:Lung,0.3294840865636089,0.6618114064227858,0.9420289855072463,0.9933399168924983,1.0,8/29,16.51%,C1ORF87;DNAH3;CFAP126;DUOXA1;MORN5;C6ORF118;AKAP14;FAM81B
prerank,KEGG_2021_Human__Sulfur relay system,0.39910861089042093,0.6617359973185507,0.8666666666666667,0.9932165694587759,1.0,1/8,5.33%,CTU2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.3482531934674835,0.6616305554283162,0.9655172413793104,0.9931367706623182,1.0,6/23,17.94%,DAB2IP;BBC3;BCL2;TNFRSF10B;MAP3K5;ITPR1
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.3979692317058226,0.6615339546750556,0.8545454545454545,0.9930743994821531,1.0,2/7,13.58%,FAS;FADD
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.36262443772061714,-0.6615078576434216,0.8775510204081632,1.0,1.0,4/20,19.33%,CARF;MT3;BMP2;SESN2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.31253123818128925,-0.6615014944341479,0.926829268292683,1.0,1.0,6/28,13.79%,NUDT16L1;TFIP11;HSF1;USP51;ERCC6;PNKP
prerank,CellMarker_Augmented_2021__Pyramidal cell:Undefined,0.401686375572867,0.6613926214846986,0.875,0.9929924829906879,1.0,2/9,6.22%,NRGN;GRM5
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.3301494966383983,-0.661304045750306,0.9761904761904762,1.0,1.0,3/17,10.37%,DHFR2;ALDH1L2;SLC46A1
prerank,Reactome_2022__Bile Acid And Bile Salt Metabolism R-HSA-194068,-0.3104563244500581,-0.6612726478497563,0.972972972972973,1.0,1.0,6/31,11.63%,AKR1C3;ABCB11;OSBPL3;CYP46A1;PTGIS;CYP7B1
prerank,Reactome_2022__APEX1-Independent Resolution Of AP Sites Via Single Nucleotide Replacement Pathway R-HSA-5649702,0.4026753013515298,0.6611087782180213,0.8490566037735849,0.9930214657894384,1.0,4/7,19.78%,XRCC1;OGG1;NEIL2;NEIL1
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),0.41678986673912854,0.6610748646007405,0.864406779661017,0.9928656914278018,1.0,1/9,3.81%,NOS1AP
prerank,CellMarker_Augmented_2021__Villous cytotrophoblast:Placenta,0.3013889038812908,0.6609741731866173,0.9807692307692307,0.9927643024317668,1.0,3/84,4.45%,RECQL4;GINS2;INCENP
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.40081814642669933,0.6609354720249417,0.9152542372881356,0.9926151526832604,1.0,7/15,27.47%,CLTB;NSG2;FCHO2;CALY;CLTC;NSG1;PICALM
prerank,Reactome_2022__TNFR1-mediated Ceramide Production R-HSA-5626978,0.4469935551089622,0.6608512553929397,0.8,0.9924921260036007,1.0,1/5,6.47%,TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.3869866865855273,-0.6603249663973167,0.8085106382978723,1.0,1.0,2/6,25.28%,FOXO4;MYOCD
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.34385392818747623,0.6602315539935769,0.9482758620689655,0.9927644233619253,1.0,7/27,24.96%,PGAP4;PIGA;PIGB;PIGK;PIGQ;PIGH;PIGX
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.39758147523755305,-0.6599360178839022,0.8666666666666667,1.0,1.0,4/6,33.97%,NMD3;NPM1;SDAD1;RAN
prerank,Reactome_2022__NOTCH2 Intracellular Domain Regulates Transcription R-HSA-2197563,0.40867436795285395,0.6594474254534691,0.8360655737704918,0.9931734200427679,1.0,2/10,14.00%,MAMLD1;MAML2
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),-0.40954981169843196,-0.6593252521679781,0.9166666666666666,1.0,1.0,2/9,10.81%,EDNRB;GRM3
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),-0.40954981169843196,-0.6593252521679781,0.9166666666666666,1.0,1.0,2/9,10.81%,EDNRB;GRM3
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.4333044683718104,-0.6588871145621785,0.9322033898305084,1.0,1.0,1/5,5.92%,ASCL1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.35146288897686695,0.6588671285979008,0.9076923076923077,0.9935214743029839,1.0,9/23,22.87%,DUSP1;HECW2;NEK6;LCMT1;CCNB1;CDK5RAP2;CDC27;CUL3;USP44
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.36957278168363217,-0.6588426122339787,0.875,1.0,1.0,3/15,6.81%,PGP;CBFA2T3;MST1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.4216651189527456,0.6587648587211016,0.8846153846153846,0.9934157351481082,1.0,1/6,5.06%,TNFRSF14
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.32740734464953314,-0.6587032349235873,0.8974358974358975,1.0,1.0,2/17,5.85%,ADAMTS12;GREM1
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.40620091699371375,0.6586759284138818,0.9152542372881356,0.993292673746661,1.0,4/10,20.13%,TCP1;CCT4;CCT8;WRAP53
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.34787935517493185,0.6584148239413933,0.953125,0.9932716401450319,1.0,2/21,6.44%,HIC1;CD44
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.38012867601153993,0.6581934759596478,0.8771929824561403,0.9932484449988674,1.0,5/8,31.32%,ASXL1;GPS2;ASXL2;CITED2;SIRT1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.34519280353788506,0.6580228038921535,0.8947368421052632,0.9931710332357299,1.0,3/22,12.11%,RPA1;POLD1;PMS2
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),0.3701763540782964,0.6579379398664551,0.9310344827586207,0.9930437724981194,1.0,6/12,20.58%,MLXIPL;GCKR;PNPLA8;RORA;ANGPTL4;SCARB1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),0.3946022560810442,0.6578824127547259,0.9636363636363636,0.9928883727642405,1.0,4/10,23.69%,PID1;TFRC;ADCK1;PRKN
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.3555434955912419,0.6574675368047819,0.9230769230769231,0.9930582004004465,1.0,2/24,13.24%,TMED10;OPTN
prerank,Reactome_2022__Lysine Catabolism R-HSA-71064,-0.36605120848449213,-0.6567789028503418,0.9111111111111111,1.0,1.0,4/12,13.74%,PIPOX;HYKK;GCDH;ALDH7A1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.40989844173147955,0.656642117855262,0.8888888888888888,0.9935162273446094,1.0,4/10,20.24%,MYO1C;GAB1;PIK3CD;VEGFD
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),0.4319893182578782,0.6565545398037956,0.8958333333333334,0.9934041661296074,1.0,2/5,31.93%,CTPS1;CTPS2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.3937180579309431,0.6564800655639359,0.9354838709677419,0.9932834804891486,1.0,3/11,14.26%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.4588603526055103,0.6562651048279673,0.9230769230769231,0.9932343237143081,1.0,1/6,12.99%,PHACTR1
prerank,Reactome_2022__IRAK2 Mediated Activation Of TAK1 Complex Upon TLR7/8 Or 9 Stimulation R-HSA-975163,0.36380698184251803,0.6560384677085741,0.92,0.9932479926314649,1.0,1/14,3.09%,IRAK2
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.41567531686794984,0.6559063012379301,0.803921568627451,0.993166380374945,1.0,1/5,18.63%,CAV3
prerank,Reactome_2022__Processing Of Capped Intronless Pre-mRNA R-HSA-75067,0.33065877353780454,0.6557828720677723,0.8888888888888888,0.9930739738013227,1.0,2/27,6.73%,COLEC12;LSM11
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.40445949178973295,-0.6556725739009533,0.8064516129032258,1.0,1.0,1/7,4.40%,FOXJ1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.2715191692841909,-0.6556343690994888,1.0,1.0,1.0,12/58,20.20%,METTL3;KMT2A;RUNX1;PSMD10;PSMD12;LMO1;PSMB5;LDB1;PSMB6;PSME3;PSMD2;PSMB4
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),0.4278276217130058,0.6549756968731961,0.9464285714285714,0.9934924370562577,1.0,1/6,17.55%,GNAI1
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.39403491370934307,-0.6549648309847048,0.8367346938775511,1.0,1.0,1/8,4.99%,RNF2
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.31756584278839306,-0.654822065225603,0.9761904761904762,1.0,1.0,4/30,8.96%,ARHGAP28;HAX1;TPPP3;GBA2
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),0.40248113408455083,0.6547680394550199,0.9622641509433962,0.9934757494416385,1.0,1/12,2.45%,NELL1
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.37517538172662224,-0.6546059479838431,0.8076923076923077,1.0,1.0,1/12,3.01%,COPS8
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.3739639643814329,-0.654460628450665,0.8205128205128205,1.0,1.0,3/10,22.28%,VPS11;RDX;PTPN23
prerank,Reactome_2022__Signaling By FGFR3 In Disease R-HSA-5655332,0.3600763880783559,0.6544459331512347,0.9122807017543859,0.9935607642274399,1.0,1/14,11.20%,FGF13
prerank,Reactome_2022__Metal Ion SLC Transporters R-HSA-425410,0.3540249351939373,0.6543739252513777,0.9259259259259259,0.9934402295550712,1.0,2/20,4.11%,SLC39A14;CP
prerank,Reactome_2022__Nicotinamide Salvaging R-HSA-197264,0.3394162618347949,0.6537288074775998,0.95,0.9936917656813865,1.0,2/16,10.96%,NAMPT;PARP9
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.3065433814441344,-0.6534941309377862,0.926829268292683,1.0,1.0,5/27,24.10%,KIF20B;CEP131;TENM1;GCC2;PCM1
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.3440266457880029,-0.6532761207325837,0.9148936170212766,1.0,1.0,5/15,23.90%,ASAH2B;SPTLC3;DHFR;SPHK2;ASAH2
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),0.3227371838387198,0.6531690277366528,0.9117647058823529,0.9939821336214244,1.0,4/32,7.51%,AWAT1;ALOX12;FAAH;CYP1B1
prerank,KEGG_2021_Human__Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,-0.3017426763036381,-0.6526491869994128,0.9565217391304348,1.0,1.0,5/23,19.71%,PIGW;GPLD1;DPM2;PIGO;PIGF
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.34909811579355843,0.6524192964468127,0.9444444444444444,0.9943502300546035,1.0,5/21,17.14%,HOOK1;KIF5A;KIF5C;TUBA1B;HOOK2
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.4170350383226935,-0.6523254568980213,0.875,1.0,1.0,1/7,4.92%,SERPINF2
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.3114899456582111,0.6522460345141525,0.9558823529411765,0.9943052986386347,1.0,13/50,24.62%,MAP1LC3A;ATG9A;GABARAPL1;ELAPOR1;PACS2;TMEM41B;RAB7A;ATG16L2;WDR45;ULK1;ATG7;VMP1;GABARAPL2
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.3711939940805337,-0.6521779433416708,0.8723404255319149,1.0,1.0,6/10,28.70%,SLC25A23;MICU2;AFG3L2;MCU;MICU1;MICU3
prerank,Reactome_2022__Defects In Cobalamin (B12) Metabolism R-HSA-3296469,-0.3643909413178438,-0.6520259154122372,0.8947368421052632,1.0,1.0,3/12,11.37%,CD320;MMAB;MMACHC
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.3286321626021843,-0.6519845034361319,0.9333333333333333,1.0,1.0,5/32,10.47%,AR;CFTR;AKR1C3;NCOA4;MAP4K1
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),-0.2641584153823635,-0.6518880048535992,1.0,1.0,1.0,12/67,17.53%,ARRDC4;TRIB3;BCL10;PEF1;RPS2;SPSB4;TBC1D7;PSMD10;DCUN1D2;HSPBP1;TSPYL5;FANCM
prerank,Reactome_2022__Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,0.32190866974652604,0.651753939907049,0.9565217391304348,0.9944462581481243,1.0,7/29,18.43%,BLM;POLD1;TERF2IP;LRIG1;CHTF18;TINF2;RFC4
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.3284350276824244,-0.651608049591468,0.95,1.0,1.0,6/20,17.60%,ABCA13;CPTP;SLC46A1;TAP1;SLC19A1;SLC5A6
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.43797633727612184,0.6516015233940763,0.9137931034482759,0.9943948428089212,1.0,2/5,22.15%,WNT5A;PTPN11
prerank,CellMarker_Augmented_2021__M1 macrophage:Brain,0.2990802207011341,0.6508789083292679,0.9736842105263158,0.994715056392641,1.0,14/76,19.29%,ADGRE5;CARD19;MVP;ETHE1;TNIP2;IKBKG;TAGLN2;VASP;MAP2K3;AGTRAP;IFI35;ZNF524;FRMD8;CAPG
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),-0.4109355305672576,-0.650737369023136,0.9069767441860465,1.0,1.0,2/5,18.78%,WASHC2C;CARMIL2
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),0.4505904743021899,0.650606568676144,0.9074074074074074,0.9947564952497917,1.0,1/5,10.34%,HMGCLL1
prerank,Reactome_2022__Cholesterol Biosynthesis R-HSA-191273,-0.3550321804759971,-0.6504180224015005,0.9772727272727273,1.0,1.0,3/22,6.61%,PMVK;TM7SF2;ARV1
prerank,Reactome_2022__IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.33269480737615714,-0.6502909874748763,0.9130434782608695,1.0,1.0,2/20,8.20%,TMED7-TICAM2;LY96
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.2721697686417835,-0.6502353102314976,0.96875,1.0,1.0,8/51,20.20%,PSMD10;PSMD12;PSMB5;PSMB6;NQO1;PSME3;PSMD2;PSMB4
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.22278998428128385,-0.6499307170953396,1.0,1.0,1.0,54/312,22.36%,CDC26;ERCC8;TNFAIP3;RNF6;ELOC;FBXO45;KCTD2;RNF114;VPS4B;PPP1R11;ZFAND2B;SPSB4;RAD23A;FBXL22;FEM1A;PSMD10;ANAPC15;PSMD12;UBL7;PSMB5;WDR91;KLHL8;RNF5;RNF126;DCAF11;RNF168;RNF8;PSMB6;RC3H1;RNF167;TRIM3;FEM1C;PSME3;RNF34;GID8;PSMD2;UBXN2A;UBE4A;SKP2;PSMB4;COPS3;KLHL20;SHARPIN;NUB1;DDIT3;NHLRC3;UBE3D;KBTBD7;RCHY1;UBE2A;GID4;FBXL14;PTPN23;ATXN3
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.3337087228521105,-0.6497047818788871,0.9210526315789473,1.0,1.0,4/24,17.99%,HEYL;VPS11;CNOT1;CNOT9
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.46323749421939037,0.6494816580308878,0.8979591836734694,0.9954307156648792,1.0,2/5,24.41%,BCAT1;BCAT2
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),-0.408553293760383,-0.6494344804755269,0.9,1.0,1.0,2/7,14.30%,PLA2G4C;AUP1
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.318010120756212,0.6484378390124521,0.9824561403508771,0.9960139936756491,1.0,5/46,8.93%,NSDHL;ABCA5;SOAT1;CYP1B1;CYP21A2
prerank,Reactome_2022__Pyrimidine Salvage R-HSA-73614,-0.3565944596242908,-0.6480322583501182,0.8913043478260869,1.0,1.0,1/8,7.09%,UCK1
prerank,Reactome_2022__Other Semaphorin Interactions R-HSA-416700,-0.3418324127834157,-0.6478633595314215,0.9767441860465116,1.0,1.0,4/17,8.87%,PLXNB3;CD72;SEMA5A;ITGA1
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),-0.3634506507908714,-0.6477836506098045,0.8043478260869565,1.0,1.0,7/7,63.68%,PRKRA;TSN;TARBP2;DROSHA;MRPL44;AGO2;DICER1
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),-0.3692994492079188,-0.647329725731285,0.8723404255319149,1.0,1.0,1/10,9.24%,HSF1
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),0.3580564097369017,0.6469421217443051,0.896551724137931,0.9968366936655172,1.0,2/16,6.05%,SLC39A14;SLC39A11
prerank,Reactome_2022__TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,0.29830656890198093,0.646873673542934,0.9672131147540983,0.9967028672405777,1.0,12/44,22.61%,PLK2;GADD45A;CDKN1B;CDKN1A;TP53;CDK2;CCNB1;PRMT1;PLK3;CCNA2;ARID3A;CARM1
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.3090186376371047,0.6467539416823294,0.9375,0.9966381501140623,1.0,4/29,16.30%,RPA1;CDC7;POLE3;CDK2
prerank,Reactome_2022__Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,0.2783617946498887,0.6464477346328877,0.9850746268656716,0.9966770269968049,1.0,22/79,23.94%,CCNB2;HAUS7;YWHAG;PPP1CB;ACTR1A;OPTN;NEDD1;CCNB1;DCTN1;YWHAE;SKP1;CKAP5;PRKCA;CDK5RAP2;RPS27A;CEP76;TUBA4A;PRKAR2B;TUBB4A;DCTN3;CEP70;ODF2
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.2698632780189687,-0.6462474722377038,1.0,1.0,1.0,8/62,11.37%,GSTT2B;TPP1;RHCE;PCSK1;SPCS1;APEH;ERAP2;MMACHC
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle cell differentiation (GO:2000726),0.41507240029003745,0.6461890521283193,0.8888888888888888,0.9967115747983867,1.0,2/5,24.81%,FZD7;SOX6
prerank,Reactome_2022__Removal Of Flap Intermediate From C-strand R-HSA-174437,0.3658115371183603,0.6459526431890595,0.9047619047619048,0.9966792457326565,1.0,4/15,20.87%,POLD1;TERF2IP;TINF2;ACD
prerank,Reactome_2022__Xenobiotics R-HSA-211981,-0.3384268271276324,-0.6457352713473612,0.8888888888888888,1.0,1.0,1/10,2.98%,CYP3A43
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),0.42385076713461106,0.645453086737032,0.9215686274509803,0.9968582659179782,1.0,1/6,25.75%,MACROH2A1
prerank,Reactome_2022__PP2A-mediated Dephosphorylation Of Key Metabolic Factors R-HSA-163767,0.41834649852139205,0.6450360916486906,0.8620689655172413,0.9969445071550909,1.0,1/6,12.23%,MLXIPL
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.3479976192961973,0.6450078837427871,0.94,0.9967655651970869,1.0,2/16,12.47%,PDK4;BCL2
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),0.4133042732648746,0.6446606143907443,0.98,0.9968108409125903,1.0,3/7,18.24%,PAK1;DCTN1;CKAP5
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),0.36552675118785893,0.6445417890822699,0.9433962264150944,0.9967246509782636,1.0,1/13,6.35%,NRG1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),-0.3066277790890391,-0.6445321901405031,0.9310344827586207,1.0,1.0,10/41,17.18%,CYP4F3;ABCD1;PLA2G4C;ELOVL2;EPHX1;CYP4F12;DEGS1;PTGR1;FAAH2;GSTP1
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.33059874767635417,0.6445157572833639,0.9420289855072463,0.9965630856520993,1.0,7/29,24.57%,NUDT16;RNASEH2C;SUPV3L1;SND1;ENTPD2;EXOSC7;DNASE1L2
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.32154195214829223,0.6439442904255194,0.9682539682539683,0.9967483901039023,1.0,5/31,15.78%,CENPP;MIS18A;CENPH;CABIN1;H3-3A
prerank,"Reactome_2022__Gamma-carboxylation, Transport, And Amino-Terminal Cleavage Of Proteins R-HSA-159854",0.43131945516671666,0.6438337599799606,0.9076923076923077,0.9966385691447515,1.0,1/5,11.07%,GAS6
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),-0.3841957639351201,-0.643757006067172,0.9142857142857143,1.0,1.0,2/11,10.81%,EDNRB;GRM3
prerank,Reactome_2022__E2F Mediated Regulation Of DNA Replication R-HSA-113510,-0.3714761853339257,-0.6435796810163106,0.8837209302325582,1.0,1.0,5/16,26.14%,SLC25A15;PRIM1;ORC6;PPP2R3B;ORC3
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.327127052337287,0.6433888231480915,0.9692307692307692,0.9967505786159313,1.0,5/25,11.08%,FGF12;KCNIP4;KCNH2;HOMER1;KCNAB3
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.23736051642169378,0.6429697652311165,1.0,0.9968431704021473,1.0,54/351,23.33%,ANLN;GOLGA8O;TEKT2;MAP1LC3A;CYS1;MAPRE2;HAUS7;CDC14A;SH3PXD2B;YTHDF1;GOLGA8A;CHMP1A;MAK;RP2;MAPT;IFT122;CFAP20;TRAPPC14;VPS37B;ATG9A;CDS2;ABCC4;NEK6;IST1;ABCA3;CILK1;TXNDC15;IFT140;NCOR1;GABARAPL1;SNX10;FLNA;RILPL1;ELAPOR1;RAB11A;TUBGCP6;EXOC2;EHD4;PACS2;TTBK2;ASAP1;TMEM41B;RAB7A;ATG16L2;RCC1;WDR45;MAPRE3;AHI1;OCRL;CDS1;CFAP44;BICD1;WDR90;ULK1
prerank,Reactome_2022__Metabolism Of Folate And Pterines R-HSA-196757,-0.33801115327894327,-0.6419858070479829,0.9736842105263158,1.0,1.0,3/14,10.37%,DHFR2;ALDH1L2;SLC46A1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),-0.2874958021956703,-0.6419824801035174,0.9772727272727273,1.0,1.0,5/38,11.18%,CST3;HSPG2;CALB1;NCSTN;TSPAN33
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.2843547307372635,0.6415804826680642,0.9836065573770492,0.9976051545577957,1.0,5/79,8.33%,RBM24;SRRM4;KHDRBS2;MBNL2;CELF3
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.3833723203646462,0.6415584523115118,0.9047619047619048,0.9972476897144358,1.0,3/11,14.26%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.3833723203646462,0.6415584523115118,0.9047619047619048,0.9972476897144358,1.0,3/11,14.26%,TCP1;CCT4;CCT8
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.31479911217031575,-0.6415490523774618,0.9285714285714286,1.0,1.0,4/28,13.84%,ATP6V1E2;ATP6V1G1;ATP6V1F;GPR89A
prerank,Reactome_2022__Purine Catabolism R-HSA-74259,0.3668851345447455,0.6415329547957437,0.9180327868852459,0.9970755107070528,1.0,2/12,10.08%,NUDT16;GDA
prerank,Reactome_2022__EGFR Transactivation By Gastrin R-HSA-2179392,-0.3964599098855635,-0.6414155703909624,0.9019607843137255,1.0,1.0,1/6,13.52%,NRAS
prerank,Reactome_2022__Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.3011859103882027,-0.6413178518258851,0.9090909090909091,1.0,1.0,9/35,21.35%,RFC3;POLD3;POLG2;PNKP;POLR1B;SLC19A1;APEX1;MPG;PARP1
prerank,Reactome_2022__Striated Muscle Contraction R-HSA-390522,0.3581042162331598,0.6412880304510867,0.896551724137931,0.9970561094939877,1.0,3/16,16.40%,TPM4;TCAP;NEB
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),0.3368997210590361,0.6412295525875913,0.9322033898305084,0.9969119864297887,1.0,1/23,3.94%,SUV39H1
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.34447183874089377,-0.6410077907311434,0.9512195121951219,1.0,1.0,4/12,20.69%,GLUD1;IDH3G;IDH1;ACO1
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),0.42406891267459923,0.6405560101429565,0.9019607843137255,0.997182886511519,1.0,1/5,14.30%,ABCC4
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),0.36644003564026806,0.6402156257398234,0.8813559322033898,0.9972301169781955,1.0,1/13,10.77%,TERF2IP
prerank,Reactome_2022__TRAF6-mediated Induction Of TAK1 Complex Within TLR4 Complex R-HSA-937072,0.35762737381650767,0.6401626868844021,0.9583333333333334,0.9970731459933164,1.0,1/15,3.09%,IRAK2
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.32019370822727916,-0.6392812261912525,0.8837209302325582,1.0,1.0,1/17,3.35%,RHOH
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.34942777909744577,-0.6392666326970167,0.9230769230769231,1.0,1.0,5/9,24.39%,CYP2C8;PLA2G4A;FADS1;MGST2;LTA4H
prerank,KEGG_2021_Human__Circadian rhythm,-0.31671487715286306,-0.639122388493332,0.9736842105263158,1.0,1.0,3/27,9.14%,NR1D1;PER3;BHLHE41
prerank,Reactome_2022__Regulation Of TP53 Activity Thru Association With Co-factors R-HSA-6804759,0.3831529581254889,0.638614819984555,0.9655172413793104,0.9979412614336887,1.0,3/11,24.91%,TP53;AKT3;PPP1R13B
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),-0.257002070379504,-0.6384815254038747,1.0,1.0,1.0,10/75,15.58%,CEBPA;TRIB3;CBFA2T3;HSPA1A;RAD23A;PSMD10;CLU;BAG2;TRIB1;HSPBP1
prerank,Reactome_2022__Disorders Of Transmembrane Transporters R-HSA-5619115,0.25803820937404276,0.6381909849147869,1.0,0.9980377407466602,1.0,7/133,7.49%,ABCC8;CP;SLC9A9;ABCC9;SLC20A2;SLC7A7;SLC17A5
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.32378828734501663,-0.637923524359425,0.95,1.0,1.0,1/22,2.86%,EIF4EBP1
prerank,Reactome_2022__Mitotic Prometaphase R-HSA-68877,0.26247037846985133,0.637818853138194,1.0,0.9980632966817093,1.0,37/154,24.33%,CCNB2;INCENP;PMEPA1;CENPP;ERCC6L;HAUS7;YWHAG;ACTR1A;CENPH;RANGAP1;NEK6;NEDD1;DYNC1LI2;SKA2;CCNB1;DCTN1;YWHAE;CKAP5;PRKCA;TUBGCP6;CDK5RAP2;DYNC1LI1;KANSL1;PDS5A;CEP76;TUBA4A;MZT2B;PRKAR2B;PDS5B;TUBB4A;DCTN3;DYNC1I1;CEP70;TAOK1;CENPU;ODF2;NUP160
prerank,Reactome_2022__Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.2648545922013832,-0.6374772691057765,0.9629629629629629,1.0,1.0,4/36,13.52%,KSR2;VWF;ARAF;NRAS
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.3715219435201379,0.636986417270096,0.875,0.9983723410812203,1.0,1/14,3.17%,APP
prerank,CellMarker_Augmented_2021__Natural Killer cell:Peripheral Blood,-0.4356062234695953,-0.6365518850420431,0.9130434782608695,1.0,1.0,2/6,8.87%,CD247;ITGA1
prerank,KEGG_2021_Human__Mannose type O-glycan biosynthesis,0.33073635023017584,0.636074607873842,0.9242424242424242,0.9987371011350947,1.0,4/20,18.21%,POMGNT1;POMGNT2;LARGE1;B4GALT3
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.27574869520992895,-0.635053459943285,1.0,1.0,1.0,3/49,4.36%,ATP10B;NPC2;APOE
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),-0.33670851308845484,-0.6349212634084012,0.9629629629629629,1.0,1.0,4/17,17.35%,TRIB3;AKR1C3;ERLIN2;BMP2
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.291233723649356,0.6346000892158342,0.9833333333333333,0.999417322724309,1.0,5/65,13.54%,MAP3K14;BIRC3;CHI3L1;RELB;TNFRSF10B
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),-0.30872448052229656,-0.6339425098891273,0.95,1.0,1.0,3/24,7.68%,SLC6A13;SLC25A19;SLC36A1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.33278571754872677,-0.6336409103497602,0.9767441860465116,1.0,1.0,4/20,22.96%,SPDL1;CENPA;DYNLT1;PLK1
prerank,Reactome_2022__Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,0.2741900273380875,0.6335854772741644,1.0,0.99991269179249,1.0,12/76,21.15%,PTK6;CDKN1B;CDKN1A;CCND1;CKS1B;CDK2;CDC25B;SKP1;RPS27A;AKT3;CCNA2;MAX
prerank,CellMarker_Augmented_2021__Cancer Stem cell:Embryo,0.3058565122871819,0.6335199434378602,0.95,0.9997554566330256,1.0,12/53,19.10%,CD24;FA2H;CD44;ATP1B1;COBL;SLC44A3;TOX3;PCDH1;CAPN13;B3GALT5;CXADR;ITGB4
prerank,CellMarker_Augmented_2021__Epithelial cell:Kidney,0.3758241962003558,0.6334308811021981,0.8870967741935484,0.9996175912009254,1.0,6/10,28.19%,CTNNB1;TEK;TJP2;TJP1;MME;EPCAM
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),-0.4139480595272833,-0.6333597460174856,0.9069767441860465,1.0,1.0,5/5,58.62%,ACSL3;ATP2C1;RACK1;CLN3;CNST
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),-0.3563096403895357,-0.6333578984434869,0.9333333333333333,1.0,1.0,2/14,14.30%,PLA2G4C;AUP1
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),-0.31173876432933456,-0.6331807457863398,0.9393939393939394,1.0,1.0,4/19,15.19%,HSPA1A;CLU;BBS10;TMEM35A
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),-0.40018142390271194,-0.6330414473722443,0.9210526315789473,1.0,1.0,1/5,20.44%,SLC1A4
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.33078949815954733,0.6319539460342599,0.9491525423728814,1.0,1.0,6/25,18.74%,SLCO1A2;SLC51A;SLC27A5;ABCC4;RXRA;ABCC3
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.3170700889056633,0.6318727524626337,0.95,1.0,1.0,3/30,13.24%,DAB2IP;BAG3;OPTN
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),0.4218190647361254,0.6315371842004385,0.9464285714285714,1.0,1.0,2/6,21.56%,ZBTB1;C5AR1
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.4114933637927176,0.6312252088390055,0.88,1.0,1.0,1/7,17.47%,WHRN
prerank,Reactome_2022__RUNX2 Regulates Genes Involved In Cell Migration R-HSA-8941332,0.39299374439230683,0.6309717827387258,0.9245283018867925,1.0,1.0,2/7,20.13%,CBFB;AKT3
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),0.3634917844282733,0.6309242289062951,0.9516129032258065,1.0,1.0,10/13,42.09%,ATG7;UBA2;UBA6;UBA5;SAE1;ATG10;UBA1;UBA3;UBA7;DESI1
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.3616462975357581,-0.6304071142205926,0.9333333333333333,1.0,1.0,4/11,28.72%,SEC62;SEC61A1;SEC63;GET3
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.2560721554017062,0.6301537719178943,1.0,1.0,1.0,26/143,21.89%,PIM3;APP;BTG3;CDK9;HECA;SMAD3;CDKN1C;TTLL12;SRA1;CDKN1B;CKS1B;IQGAP1;NEK6;CDC25B;SCRIB;CCNB1;SKP1;PRKCA;CDC27;BTG1;TTC28;TFAP4;MEIS2;UBE2E1;RCC1;DDB1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.365216323929914,0.6299228167114799,0.9464285714285714,1.0,1.0,7/11,28.56%,TMED10;ABCA2;RANBP9;FLOT2;PRNP;PICALM;ABCA7
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.43498968338121075,0.6297683756401925,0.8703703703703703,1.0,1.0,3/7,10.44%,APP;FAM107A;EPHA4
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.3185621454588682,0.6294492687777098,0.9538461538461539,1.0,1.0,4/29,12.40%,CENPP;MIS18A;CENPV;CENPH
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),0.38365644392109655,0.6294158034905039,0.9242424242424242,1.0,1.0,5/9,23.81%,NTRK3;F3;VEGFD;CXCL12;CDH13
prerank,Reactome_2022__Regulation Of NF-kappa B Signaling R-HSA-9758274,-0.3304180864923222,-0.6292522863184049,0.9069767441860465,1.0,1.0,1/18,3.03%,IKBIP
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.3415430585023987,0.629135095864376,0.9166666666666666,1.0,1.0,1/18,1.95%,SLC7A2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),-0.40689863574030855,-0.6288202390595139,0.8775510204081632,1.0,1.0,1/5,11.16%,ZNF304
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.400705191776334,0.628669588003827,0.8793103448275862,1.0,1.0,2/6,18.42%,PDE4D;ADRA1D
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),-0.34137184688846445,-0.6286443834730899,1.0,1.0,1.0,6/19,29.14%,NEMP1;TARDBP;UBXN2A;PLK1;CHMP2A;SPAST
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.3059593040098872,-0.6285773347317722,0.9787234042553191,1.0,1.0,7/20,21.42%,NUDT7;NT5E;AMPD3;PRTFDC1;PNP;MLYCD;NT5C1A
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.341217319752588,-0.6283167697324625,0.8372093023255814,1.0,1.0,2/17,12.29%,MAPK7;HTRA2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.21368073255914974,-0.6282167097741036,1.0,1.0,1.0,24/341,11.81%,SELENOS;ARRDC4;TRIM21;RNF6;AAAS;ELOC;FBXO45;RNF25;RAE1;NUP50;RNF212;TRIM52;MUL1;ABCB11;BCL10;CCDC22;TRIM68;VPS11;UBE2M;PEX10;TRIM7;SPSB4;URM1;UFL1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),-0.34214982191860804,-0.6279588004631493,0.9523809523809523,1.0,1.0,13/13,65.82%,AGO4;PRKRA;TUT4;TUT7;TARBP2;ADAR;AGO3;DROSHA;MRPL44;AGO2;DICER1;AGO1;LIN28B
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),0.40029648370254967,0.6277272196771778,0.9310344827586207,1.0,1.0,3/8,19.69%,APOD;KLF4;MAP2K5
prerank,Reactome_2022__Macroautophagy R-HSA-1632852,-0.2354587986628941,-0.6276434690078246,1.0,1.0,1.0,14/103,17.09%,CFTR;HSF1;PLIN3;RRAGC;BECN1;MTERF3;ATG14;SLC38A9;RRAGA;RNF103-CHMP3;PLIN2;FUNDC1;DYNLL1;ATG4A
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.2946379657734965,0.6275039893909884,1.0,1.0,1.0,6/46,10.12%,MTHFD2;GPT2;ACOT4;ASS1;ALDH1L1;SHMT1
prerank,PanglaoDB_Augmented_2021__Spermatocytes,-0.3212608275793605,-0.6272179301480633,0.9302325581395349,1.0,1.0,3/17,11.94%,MGAT4D;WDR87;SPATA33
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.33471337024176606,0.6268257200123233,0.9137931034482759,1.0,1.0,1/13,7.99%,ACOT4
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.34174809505447146,-0.6267900315780165,0.8461538461538461,1.0,1.0,4/12,23.90%,ASAH2B;SPTLC3;SPHK2;ASAH2
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.34174809505447146,-0.6267900315780165,0.8461538461538461,1.0,1.0,4/12,23.90%,ASAH2B;SPTLC3;SPHK2;ASAH2
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),0.39145214235715686,0.6267105482101499,0.9272727272727272,1.0,1.0,1/8,3.52%,ABCA5
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.36588161476567216,-0.6258226422760387,0.8636363636363636,1.0,1.0,1/7,10.60%,NCSTN
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),0.35657825937777704,0.625444416095118,0.9032258064516129,1.0,1.0,1/13,3.34%,DAB2IP
prerank,Reactome_2022__Metabolism Of Nitric Oxide: NOS3 Activation And Regulation R-HSA-202131,-0.34856614058033764,-0.6253121521114429,0.8604651162790697,1.0,1.0,1/11,10.63%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),-0.3243675349991304,-0.6252791765559191,0.9019607843137255,1.0,1.0,3/15,18.34%,PIP4P1;RRAGA;LARS1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),0.3668312488207599,0.6250939179652936,0.9538461538461539,1.0,1.0,5/10,34.52%,SKP1;RAB1A;BTRC;FZR1;UBE2S
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.39401562383742883,0.6247493925005655,0.8666666666666667,1.0,1.0,1/6,8.19%,ASS1
prerank,Reactome_2022__Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.2579871310319841,-0.624729022589943,1.0,1.0,1.0,7/72,12.81%,SGO2;KNL1;SPDL1;MIS12;ITGB3BP;CENPA;CENPQ
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),-0.36602251817842557,-0.6242182232651623,0.8461538461538461,1.0,1.0,2/7,11.70%,UNC80;COX11
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.3411418200905873,0.6242066368419338,0.9272727272727272,1.0,1.0,5/18,21.47%,SYVN1;RNF185;MARCHF6;RPS27A;AMFR
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.4151132690648661,-0.6240417795567089,0.8717948717948718,1.0,1.0,2/5,25.34%,CTR9;LEO1
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),-0.4151132690648661,-0.6240417795567089,0.8717948717948718,1.0,1.0,2/5,25.34%,CTR9;LEO1
prerank,Reactome_2022__Transcriptional Regulation By RUNX2 R-HSA-8878166,0.2623249146570361,0.6238490599364717,1.0,1.0,1.0,16/100,20.13%,PPARGC1B;MSX2;YAP1;HDAC4;GLI2;SMAD1;CDKN1A;CCND1;PPM1D;SMURF1;WWTR1;CCNB1;CBFB;SKP1;RPS27A;AKT3
prerank,Reactome_2022__Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.31793305001226957,-0.6230551194681908,0.9534883720930233,1.0,1.0,4/23,11.98%,CCT7;TUBB2B;PFDN4;VBP1
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.300368477760119,0.6230081252366423,0.9423076923076923,1.0,1.0,2/23,9.67%,NOTUM;HDAC4
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.4112468452708081,0.6224182116562172,0.8979591836734694,1.0,1.0,1/6,3.08%,SFTPD
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.4112468452708081,0.6224182116562172,0.8979591836734694,1.0,1.0,1/6,3.08%,SFTPD
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),0.3258666673794011,0.6222980555127986,1.0,1.0,1.0,5/24,17.57%,SAMHD1;NLRC5;TTLL12;FADD;WNT5A
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.3585335264054924,0.6220766996553052,0.9272727272727272,1.0,1.0,1/10,15.29%,ETS1
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.340803074698125,-0.6218612615514302,0.8787878787878788,1.0,1.0,6/18,19.54%,RPL37;RPL23;ATR;PLA2R1;SPRED1;UBB
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),-0.33164042042542585,-0.6215588220541611,1.0,1.0,1.0,4/16,12.08%,FICD;PLXNB3;RRP1B;TMED2
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.360133607964548,-0.6205986934844382,0.9210526315789473,1.0,1.0,2/9,8.34%,DGKB;DGKE
prerank,Reactome_2022__Selective Autophagy R-HSA-9663891,-0.26109991296945473,-0.6204149252622455,1.0,1.0,1.0,7/54,15.97%,CFTR;HSF1;PLIN3;MTERF3;PLIN2;FUNDC1;DYNLL1
prerank,CellMarker_Augmented_2021__Erythroid cell:Umbilical Cord Blood,0.2689340915782323,0.6201268421020176,1.0,1.0,1.0,13/78,23.27%,KIF14;POLQ;GYPE;BRCA1;ATAD5;AMMECR1;TFRC;ALG10;CDC27;PRPF40A;CEP76;POLE2;CA1
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.4071015201074887,0.6198845454645165,0.9047619047619048,1.0,1.0,1/7,7.04%,ALDOB
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.29635029059996754,0.6190163887952351,0.9682539682539683,1.0,1.0,2/40,4.86%,DAB2IP;DENND3
prerank,Reactome_2022__Prevention Of Phagosomal-Lysosomal Fusion R-HSA-9636383,0.3891223130349628,0.6188295875605604,0.9148936170212766,1.0,1.0,3/7,29.59%,RPS27A;RAB7A;RAB5A
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",0.38039306177518006,0.6188267807173018,0.90625,1.0,1.0,2/7,14.71%,MAPK8IP1;HLA-E
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),-0.35003067922580855,-0.6184125190954666,0.9056603773584906,1.0,1.0,1/13,4.34%,NPC2
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.23318620811594298,0.6183506600850025,1.0,1.0,1.0,89/445,24.31%,UHRF2;MARCHF1;PRAME;TRIM61;TRIM5;HECW2;FBXW12;NEUROD2;ENC1;TRIM36;CTNNB1;SH3RF3;ARIH2;TRIM17;NEURL1;FBXO32;PEX14;FBXL2;DTX2;FBXL16;BARD1;KCTD13;RNF112;HECW1;SPSB1;TRIM22;BCL2;SYVN1;RNF19A;UBE2H;RNF152;TRIM32;TRAIP;TRIM47;PDZRN3;PINK1;HIF3A;SMURF1;FBXO24;BRCA1;BSPRY;LRSAM1;CBFB;ARIH1;RNF187;RNF122;DDB2;SKP1;BFAR;FANCL;RNF185;RAD18;RUSC1;FBXO41;MARCHF6;FBXO31;UBE4B;GAN;RNF144A;HIF1A;WAC;CDC27;UBE2QL1;RPS27A;UBE2B;TRIM54;UBR5;ZNRF2;UBE2E1;FBXL8;KLHL7;TRIM44;AMFR;FBXO2;DDB1;RNF181;FBXW5;KLHL21;CUL3;RNF220;PSMB3;CCNF;PRKN;KCTD10;ARRB1;UHRF1;CBL;FBXL4;SDE2
prerank,Reactome_2022__Competing Endogenous RNAs (ceRNAs) Regulate PTEN Translation R-HSA-8948700,0.3621464247986943,0.6175814476333858,0.864406779661017,1.0,1.0,5/10,39.44%,MOV10;VAPA;AGO1;TNRC6B;CNOT6L
prerank,Reactome_2022__SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,0.2804824045963648,0.617289339481261,1.0,1.0,1.0,9/54,20.93%,PTK6;CDKN1B;CDKN1A;CCND1;CKS1B;CDK2;SKP1;RPS27A;CCNA2
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),0.39593000772959164,0.6170223152130424,0.8846153846153846,1.0,1.0,1/5,12.85%,B2M
prerank,Reactome_2022__Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,0.24044966548028082,0.6168825036772858,1.0,1.0,1.0,23/327,14.71%,TLR2;SOCS3;CTSS;ASB16;HECW2;FBXW12;ZBTB16;LNX1;MYD88;TRIM36;ARIH2;FBXO32;KLHL5;FBXL16;STX4;SPSB1;B2M;RNF19A;UBE2H;TRIM32;TRAIP;IKBKG;HLA-E
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.26738824234554315,0.6167749289997422,1.0,1.0,1.0,16/72,19.11%,BLM;HK2;ERCC6L;NR6A1;CDC7;CENPH;ALPL;NAP1L1;TRIM32;PHF6;ATAD5;FUBP1;RFC4;SET;GINS1;HELLS
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.2741821975448386,0.6161663639928843,1.0,1.0,1.0,8/60,17.98%,ATF3;EIF2B2;YTHDF1;RPS6KB2;EIF2B5;GLE1;EIF3B;NCK2
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.2721785368666059,-0.6157734881993004,1.0,1.0,1.0,2/39,5.09%,RFC3;POLD3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.3187214855859583,0.615706382776348,0.9552238805970149,1.0,1.0,4/23,12.48%,ACOT4;DBI;ACOT7;ACSM5
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.3187214855859583,0.615706382776348,0.9552238805970149,1.0,1.0,4/23,12.48%,ACOT4;DBI;ACOT7;ACSM5
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.368502843599974,0.615663380684756,0.9354838709677419,1.0,1.0,1/12,3.81%,NOS1AP
prerank,Reactome_2022__XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.28847389034638676,-0.615514017556255,1.0,1.0,1.0,11/42,20.77%,SRPRA;SRPRB;SERP1;YIF1A;DDX11;HDGF;PREB;DNAJB11;SSR1;DNAJB9;FKBP14
prerank,Reactome_2022__NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,0.27631144220389836,0.6154696409514991,0.9827586206896551,1.0,1.0,14/46,20.56%,MAMLD1;TBL1X;HDAC4;HDAC9;TLE3;MAML2;NCOR1;HDAC7;NBEA;SKP1;TBL1XR1;HIF1A;RPS27A;TLE2
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),0.3997048146045593,0.6154334174456658,0.9038461538461539,1.0,1.0,3/7,24.41%,HMGCLL1;BCAT1;BCAT2
prerank,Reactome_2022__Caspase-mediated Cleavage Of Cytoskeletal Proteins R-HSA-264870,0.3464096332745395,0.6152729278006424,0.9137931034482759,1.0,1.0,2/12,16.97%,MAPT;PLEC
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.3578938972975387,-0.6148533820492064,0.9047619047619048,1.0,1.0,3/8,20.39%,MTRF1;SHFL;JMJD4
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.38713207913661474,0.6146842443455297,0.9166666666666666,1.0,1.0,1/9,12.09%,EEF1A2
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.371760970219853,0.6146100879837597,0.9322033898305084,1.0,1.0,2/13,19.03%,RAB27B;RAB11A
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.371760970219853,0.6146100879837597,0.9322033898305084,1.0,1.0,2/13,19.03%,RAB27B;RAB11A
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.2919069812158827,0.6145789052320643,1.0,1.0,1.0,6/44,16.77%,ZIC1;GLIS2;DLG5;IFT122;RORA;TXNDC15
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),-0.3768970347886995,-0.6136652336407347,0.9607843137254902,1.0,1.0,8/8,62.33%,LRP6;LRP5;FGFR3;SFRP4;SKI;BMPR2;BMPR1B;FGFR2
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.33295306285134973,-0.613407141335748,0.9230769230769231,1.0,1.0,4/18,12.63%,MOGAT1;DGKB;DGKE;PLA2G15
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.31342803074240716,-0.6133584645905463,1.0,1.0,1.0,4/21,17.30%,HSF1;ATR;MEN1;TSPYL5
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),0.333587992499656,0.6130550319875332,0.9508196721311475,1.0,1.0,6/18,16.81%,MTHFD2;ALDH1L1;FTCD;SHMT1;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.32901350524640277,-0.6128962441842619,0.9565217391304348,1.0,1.0,3/17,16.42%,RNF2;RNF168;RNF8
prerank,Reactome_2022__Intraflagellar Transport R-HSA-5620924,-0.2915536745778693,-0.6123761670235038,0.9767441860465116,1.0,1.0,5/35,19.10%,DYNLRB2;DYNLRB1;DYNC2I1;DYNLL1;IFT57
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.313362584530416,0.6120334778941829,0.9016393442622951,1.0,1.0,9/28,21.39%,DGKG;PLAAT3;DGAT2L6;DGAT1;CAV3;DGKI;DGKZ;DGKD;GK5
prerank,Reactome_2022__POLB-Dependent Long Patch Base Excision Repair R-HSA-110362,-0.37321938851702424,-0.6119225972928871,0.9111111111111111,1.0,1.0,4/7,26.86%,POLG2;APEX1;PARP1;ADPRS
prerank,Reactome_2022__Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,0.33217112938140236,0.6116119249191929,0.953125,1.0,1.0,5/20,14.26%,TCP1;TUBB6;CCT4;TUBA1B;CCT8
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.362662099721677,0.6106498722063092,0.9047619047619048,1.0,1.0,1/11,4.08%,HIC1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.4001887510553095,0.6104049643450205,0.9038461538461539,1.0,1.0,1/5,11.24%,PHLDB2
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.4001887510553095,0.6104049643450205,0.9038461538461539,1.0,1.0,1/5,11.24%,PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.3593955837800174,0.6102412862833816,0.9180327868852459,1.0,1.0,2/13,18.06%,TFRC;TNFSF4
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.32712986035657327,-0.6101792260694202,0.9166666666666666,1.0,1.0,2/14,14.47%,ABCD1;SLC25A33
prerank,Reactome_2022__Regulation Of PTEN mRNA Translation R-HSA-8943723,0.35227951813033487,0.6101561950575117,0.9137931034482759,1.0,1.0,5/11,39.44%,MOV10;VAPA;AGO1;TNRC6B;CNOT6L
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.35706791414784417,-0.6100736611804491,0.9523809523809523,1.0,1.0,1/13,4.15%,SETDB1
prerank,Reactome_2022__Mitotic G2-G2/M Phases R-HSA-453274,-0.22061035628940692,-0.6095847469777312,1.0,1.0,1.0,30/161,23.35%,CEP72;TPX2;SSNA1;CETN2;HAUS1;CEP131;RAB8A;PSMD10;PSMD12;PSMB5;HMMR;DYNLL1;PSMB6;CEP192;CEP78;PSME3;SEM1;BORA;PSMD2;TUBB;UBB;CUL1;PSMB4;TUBGCP5;NME7;MZT1;PPP2R3B;PHLDA1;PLK1;LIN54
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),-0.35756542895063775,-0.6094527895077096,0.9318181818181818,1.0,1.0,2/9,11.06%,RGCC;DAG1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.3866874916536742,0.6094406584259744,0.9111111111111111,1.0,1.0,2/7,12.85%,ABCB9;B2M
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.34920941699563324,0.6091528597110778,0.9259259259259259,1.0,1.0,5/12,27.78%,HDAC4;FZD7;HDAC5;SOX6;HDAC3
prerank,Reactome_2022__IRE1alpha Activates Chaperones R-HSA-381070,-0.2804298037393334,-0.6089629118657561,0.975609756097561,1.0,1.0,11/44,20.77%,SRPRA;SRPRB;SERP1;YIF1A;DDX11;HDGF;PREB;DNAJB11;SSR1;DNAJB9;FKBP14
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.37281222440257644,0.6089349394370085,0.9649122807017544,1.0,1.0,2/12,19.03%,RAB27B;RAB11A
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.37281222440257644,0.6089349394370085,0.9649122807017544,1.0,1.0,2/12,19.03%,RAB27B;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.30872579905219244,0.6088047845782866,0.9411764705882353,1.0,1.0,3/16,12.96%,SMAD3;FSCN1;PDPN
prerank,Reactome_2022__PERK Regulates Gene Expression R-HSA-381042,0.3272608485205738,0.6087038759961642,0.9848484848484849,1.0,1.0,1/28,1.69%,ATF3
prerank,Reactome_2022__Reversible Hydration Of Carbon Dioxide R-HSA-1475029,-0.36109690833917363,-0.6086665339663423,0.9166666666666666,1.0,1.0,3/7,26.93%,CA5A;CA3;CA2
prerank,Reactome_2022__TP53 Regulates Transcription Of Death Receptors And Ligands R-HSA-6803211,0.3978360299424666,0.6086300412692686,0.9137931034482759,1.0,1.0,2/7,15.46%,TNFRSF10B;TP53
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),0.4139193655830933,0.6082622636659425,0.9411764705882353,1.0,1.0,1/6,4.26%,MYH11
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.3103964543479814,-0.6081908889481991,1.0,1.0,1.0,1/21,2.21%,RFC3
prerank,Reactome_2022__Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,0.32066028267054003,0.6081488872331026,0.9846153846153847,1.0,1.0,11/26,33.56%,RANGAP1;UBE2I;RCC1;NUP160;NUP35;TNPO1;SEH1L;AHCTF1;POM121;NUP188;NUP98
prerank,Reactome_2022__Displacement Of DNA Glycosylase By APEX1 R-HSA-110357,0.3711550961319059,0.6074790588190795,0.9152542372881356,1.0,1.0,4/8,27.56%,OGG1;TDG;NTHL1;UNG
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.305707593130414,-0.6074091445105269,0.9487179487179487,1.0,1.0,5/24,25.11%,SPDL1;CENPA;DYNLT1;PLK1;KPNB1
prerank,Reactome_2022__Cyclin E Associated Events During G1/S Transition R-HSA-69202,0.26439073442072986,0.6070630359935575,1.0,1.0,1.0,11/74,21.15%,PTK6;CDKN1B;CDKN1A;CCND1;CKS1B;CDK2;SKP1;RPS27A;AKT3;CCNA2;MAX
prerank,CellMarker_Augmented_2021__Keratinocyte:Skin,0.39808449507707755,0.6069364759756132,0.8928571428571429,1.0,1.0,2/5,17.79%,CD44;TFRC
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.41763555060525903,0.6067717191353116,0.9333333333333333,1.0,1.0,1/5,14.15%,CD70
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),0.38785158302596234,0.6067419724693055,0.896551724137931,1.0,1.0,3/7,28.87%,LRP2;TGFBR3;NRP1
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),0.414989564939072,0.6066950651933651,0.8983050847457628,1.0,1.0,2/5,23.80%,FTO;TDG
prerank,Reactome_2022__EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.24332627460139122,-0.6065927837270781,1.0,1.0,1.0,7/76,12.81%,SGO2;KNL1;SPDL1;MIS12;ITGB3BP;CENPA;CENPQ
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.35445671380151567,-0.60648972809121,0.8913043478260869,1.0,1.0,2/6,20.72%,ADRA1A;SPHK2
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.33883134091343126,0.6064550499467527,0.8723404255319149,1.0,1.0,2/13,9.86%,TBX20;TGFB2
prerank,KEGG_2021_Human__Cytosolic DNA-sensing pathway,-0.28215454326775197,-0.6063534900471464,1.0,1.0,1.0,10/35,20.27%,POLR2K;IL33;POLR3E;POLR3B;POLR3F;NFKBIB;POLR3H;POLR3K;AIM2;POLR2L
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.40240351989318857,0.6062874559358044,0.9285714285714286,1.0,1.0,3/5,32.65%,CAV3;NEDD4L;CAB39
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),-0.37065344003274103,-0.6057755780580277,0.9555555555555556,1.0,1.0,1/5,14.03%,USP19
prerank,Reactome_2022__G2/M Transition R-HSA-69275,-0.22071772071313922,-0.605670198323365,1.0,1.0,1.0,30/160,23.35%,CEP72;TPX2;SSNA1;CETN2;HAUS1;CEP131;RAB8A;PSMD10;PSMD12;PSMB5;HMMR;DYNLL1;PSMB6;CEP192;CEP78;PSME3;SEM1;BORA;PSMD2;TUBB;UBB;CUL1;PSMB4;TUBGCP5;NME7;MZT1;PPP2R3B;PHLDA1;PLK1;LIN54
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.25355812926528876,0.6055309727490231,1.0,1.0,1.0,18/127,19.56%,PLK2;WDR62;INCENP;CENPP;ERCC6L;CENPH;RANGAP1;KIFC2;NEK6;STMN1;MAP4;DYNC1LI2;SKA2;CCNB1;CKAP5;FLNA;RAB11A;DYNC1LI1
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.3287783228217706,-0.6053962946544406,1.0,1.0,1.0,16/16,67.16%,ATP6V0D2;ATP6AP2;ATP6V0A2;GRN;TMEM9;DMXL1;ATP6V0D1;ATP6V0E2;ATP6V0E1;PPT1;SLC11A1;CLN3;CLN6;DMXL2;ATP6V0A1;ATP6V1H
prerank,Reactome_2022__Recycling Of eIF2:GDP R-HSA-72731,0.37794668163687783,0.6052283205995179,0.9122807017543859,1.0,1.0,2/8,15.19%,EIF2B2;EIF2B5
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),-0.23932496466123065,-0.6048929137617621,1.0,1.0,1.0,7/76,12.49%,AAAS;RAE1;NUP50;HSPA1A;HSF1;ATR;NUP54
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.3443063094612736,-0.6044617575793326,0.9523809523809523,1.0,1.0,7/7,65.59%,AGO4;TARBP2;ADAR;AGO3;AGO2;DICER1;AGO1
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),-0.2713794606966506,-0.6043880261267927,1.0,1.0,1.0,13/47,24.35%,NOC2L;EIF2S1;BAK1;METTL3;ATR;TRIAP1;GNGT1;SMPD1;PARP1;AQP1;CASP9;YY1;POLK
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.318390044624462,0.6043149258080094,0.9166666666666666,1.0,1.0,8/19,32.02%,UGDH;NANS;AMDHD2;SLC35D1;PMM1;GFPT2;GNPNAT1;UAP1L1
prerank,Reactome_2022__Mitochondrial Fatty Acid Beta-Oxidation Of Saturated Fatty Acids R-HSA-77286,0.35665438024609836,0.6042354516270849,0.9322033898305084,1.0,1.0,1/11,7.02%,HADH
prerank,Reactome_2022__ER Quality Control Compartment (ERQC) R-HSA-901032,0.31965393443160567,0.6038335742741424,0.9629629629629629,1.0,1.0,5/20,21.47%,SYVN1;RNF185;MARCHF6;RPS27A;AMFR
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),-0.3880301986747295,-0.6034884614928228,0.8775510204081632,1.0,1.0,1/6,10.82%,PTGIS
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),-0.3880301986747295,-0.6034884614928228,0.8775510204081632,1.0,1.0,1/6,10.82%,PTGIS
prerank,GO_Biological_Process_2021__positive regulation of receptor binding (GO:1900122),0.38026666634308076,0.6031122613824541,0.8909090909090909,1.0,1.0,3/5,28.87%,B2M;ANXA2;NRP1
prerank,CellMarker_Augmented_2021__Platelet:Blood,0.3137912788586447,0.6029613445086327,0.96875,1.0,1.0,1/24,5.65%,ITGA2
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),-0.3761644338859773,-0.60288689929358,0.8611111111111112,1.0,1.0,1/6,23.97%,VCP
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),-0.33951521511117344,-0.6028793535590949,0.9347826086956522,1.0,1.0,1/9,6.99%,EIF2S1
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.360556016304783,0.6026058136321168,0.9245283018867925,1.0,1.0,3/9,28.49%,ATP2B4;PRNP;GSK3B
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),0.360556016304783,0.6026058136321168,0.9245283018867925,1.0,1.0,3/9,28.49%,ATP2B4;PRNP;GSK3B
prerank,Reactome_2022__Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.26536504592156035,-0.6024731230751799,1.0,1.0,1.0,10/53,20.20%,PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;CUL1;PSMB4
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),-0.3779826261682385,-0.6020287443224515,0.8409090909090909,1.0,1.0,3/6,29.45%,VPS35;CAV2;DRD2
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.28108317368675184,-0.6019696325999363,0.9574468085106383,1.0,1.0,6/25,24.63%,KMT2A;PRDM7;MEN1;WDR82;PAXIP1;CTR9
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.31614564932802086,0.6018830336881839,0.9516129032258065,1.0,1.0,9/21,27.56%,TERF2IP;OGG1;TINF2;NEIL2;NEIL1;ACD;TDG;NTHL1;UNG
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),0.39172217280682387,0.6017710593506882,0.9090909090909091,1.0,1.0,1/6,7.60%,SCARA3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),-0.34232919272644313,-0.6011571623493251,0.9565217391304348,1.0,1.0,3/11,16.74%,RIC3;TMEM35A;RANGRF
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),0.2572797285397,0.6010526734155622,1.0,1.0,1.0,9/90,14.66%,TRPM4;NNAT;LOXL1;HDAC4;HDAC9;RANGAP1;PLOD2;BCL11A;IFIH1
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.3340875346345421,0.6009063611678076,0.9655172413793104,1.0,1.0,2/14,10.08%,SAMHD1;GDA
prerank,Reactome_2022__Pre-NOTCH Processing In Golgi R-HSA-1912420,0.3338692466015254,0.6001983977494029,0.9629629629629629,1.0,1.0,4/14,26.53%,NOTCH3;LFNG;NOTCH4;FURIN
prerank,CellMarker_Augmented_2021__Activated CD4+ T cell:Blood,0.3772043305520129,0.5999914343312038,0.8833333333333333,1.0,1.0,3/6,17.79%,PTPRC;CD4;TFRC
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),0.3621462660287688,0.5999659429567323,0.9245283018867925,1.0,1.0,2/10,9.83%,PADI2;ART3
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),0.3955150129280587,0.5999100553804133,0.9183673469387755,1.0,1.0,1/7,12.29%,PRKCD
prerank,Reactome_2022__Serine Biosynthesis R-HSA-977347,0.3730452153543331,0.5998695118467003,0.8064516129032258,1.0,1.0,2/7,16.09%,SERINC1;SERINC5
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),-0.2310172206382107,-0.5993998718336349,1.0,1.0,1.0,29/107,26.48%,VAMP8;SNF8;VPS4B;BECN1;MTERF3;ATG14;VIPAS39;VTI1B;FUNDC1;DYNLL1;YOD1;PRKAB2;PIK3R4;ACBD5;TOMM70;ATG16L1;VCP;CSNK2A2;VAMP7;RUBCNL;CHMP3;PIP4K2B;VPS25;SNAP29;CHMP2A;PRKAB1;PGAM5;VPS28;VTA1
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.32329352067791167,0.5991410727777605,0.96875,1.0,1.0,2/19,10.92%,YTHDF1;MAPT
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.40326639076229703,0.5987965392807458,0.9615384615384616,1.0,1.0,1/5,12.68%,PER1
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.40136926712728466,0.5987900065251317,0.9615384615384616,1.0,1.0,3/5,38.02%,NPHP4;TCTN1;TMEM107
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.33029190772426276,0.5985543652941236,0.984375,1.0,1.0,1/22,4.28%,TDRD5
prerank,Reactome_2022__E2F-enabled Inhibition Of Pre-Replication Complex Formation R-HSA-113507,-0.373657916237445,-0.5982460981405707,0.8723404255319149,1.0,1.0,2/6,16.97%,SLC25A15;ORC6
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.29967074446854536,-0.5978765197900546,0.9655172413793104,1.0,1.0,3/17,12.63%,MOGAT1;GK;PLA2G15
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),-0.31001090452090146,-0.5975557094585373,0.9512195121951219,1.0,1.0,2/27,4.36%,EDNRB;APOE
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),0.31100674311822374,0.597388060557499,0.958904109589041,1.0,1.0,3/20,13.02%,ALOX12;ACOT7;LTC4S
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.3335540355658725,0.5971361082224754,0.9411764705882353,1.0,1.0,5/18,22.75%,TCP1;CCT4;CCT8;EXOSC10;PARN
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.374820339863436,0.5967630431146291,0.9016393442622951,1.0,1.0,1/9,8.61%,PLAAT3
prerank,Reactome_2022__NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,0.31863304869851256,0.5966211628215312,0.9516129032258065,1.0,1.0,5/17,27.95%,NEURL1;RPS27A;PSEN1;MIB2;APH1B
prerank,Reactome_2022__Negative Regulation Of Activity Of TFAP2 (AP-2) Family Transcription Factors R-HSA-8866904,0.3875545116417892,0.5964973759558062,0.9016393442622951,1.0,1.0,3/7,28.66%,TFAP2C;UBE2I;TFAP2E
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),0.3716009979867385,0.5962278293323869,0.9107142857142857,1.0,1.0,4/8,24.74%,HIF1A;ARNT;ANKRD2;HMOX1
prerank,Reactome_2022__G1/S Transition R-HSA-69206,0.24965637709820865,0.5961245962477664,1.0,1.0,1.0,15/109,21.15%,PTK6;TYMS;CDC7;CDKN1B;CDKN1A;CCND1;CKS1B;POLE3;CDK2;CCNB1;SKP1;RPS27A;AKT3;CCNA2;MAX
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.3275916841231769,0.5948683843189172,0.8958333333333334,1.0,1.0,1/15,9.62%,CHMP1A
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),-0.36390505499204595,-0.594612601481127,0.8888888888888888,1.0,1.0,1/5,8.20%,LY96
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),0.4099264060587466,0.5943698609283625,0.8888888888888888,1.0,1.0,1/5,7.04%,ALDOB
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),0.4099264060587466,0.5943698609283625,0.8888888888888888,1.0,1.0,1/5,7.04%,ALDOB
prerank,Reactome_2022__Fructose Catabolism R-HSA-70350,0.4099264060587466,0.5943698609283625,0.8888888888888888,1.0,1.0,1/5,7.04%,ALDOB
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.381173995127453,0.5940364792615188,0.9166666666666666,1.0,1.0,1/5,7.38%,TYR
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.36510493375015574,0.5937367447880741,0.9272727272727272,1.0,1.0,3/7,31.86%,BCAR1;NRP1;APPL1
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.36510493375015574,0.5937367447880741,0.9272727272727272,1.0,1.0,3/7,31.86%,BCAR1;NRP1;APPL1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.37077214150061927,0.5935641489498203,0.9206349206349206,1.0,1.0,3/7,20.82%,ABCC4;ABCC3;ABCC1
prerank,Reactome_2022__Platelet Sensitization By LDL R-HSA-432142,0.3453142614725669,0.59355480646089,0.953125,1.0,1.0,6/13,34.48%,PTPN11;PECAM1;PPP2R1B;PPP2R5C;LRP8;PPP2R5E
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.2530465433070457,-0.5932059695005896,1.0,1.0,1.0,19/70,24.68%,FIP1L1;RBM8A;U2AF1;CPSF1;CLP1;SRSF2;POLR2D;CPSF3;SRSF9;UPF3B;CHTOP;CSTF2;SSU72;THOC3;CSTF2T;THOC1;CPSF7;SRRM1;SLBP
prerank,Reactome_2022__RHOH GTPase Cycle R-HSA-9013407,0.30787108673239244,0.5929798689255706,0.9833333333333333,1.0,1.0,4/30,13.82%,ARHGDIG;PAK4;STOM;TUBA1B
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.33512087341986085,0.592762613643983,0.9180327868852459,1.0,1.0,2/12,14.53%,PML;MRE11
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.24832247013061878,0.5927433282618549,1.0,1.0,1.0,20/114,23.21%,ELAVL4;RBMS1;ADARB2;RNASE1;RBPMS;HNRNPH1;RNASEH2C;WTAP;RBFOX2;FTO;LAGE3;RBM5;CELF2;RBM6;SUPV3L1;SND1;PARN;EXOSC7;BICD1;POLR2I
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.3388614364808747,0.5922323998530572,0.9666666666666667,1.0,1.0,5/14,24.78%,RYR2;DDRGK1;UBAC2;GABARAPL2;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),0.36090561238318225,0.5919840367758784,0.9538461538461539,1.0,1.0,2/11,15.88%,SYNGR3;RXRA
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.27264531950263166,0.5919467339239856,1.0,1.0,1.0,4/60,10.27%,ZFP36;WTIP;PPARG;STAT3
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.2794497848113997,0.5917288296909122,1.0,1.0,1.0,8/41,20.12%,RPA1;POLD1;BRCA1;ZBTB1;RFC4;RAD18;RPS27A;UBE2B
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.3242425102440829,0.5909919182521559,0.9245283018867925,1.0,1.0,2/16,19.41%,MORF4L2;MORF4L1
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),0.3906229080274803,0.59087209148843,0.8653846153846154,0.999976551008008,1.0,2/7,12.96%,SLC4A11;PDPN
prerank,Reactome_2022__MECP2 Regulates Transcription Of Neuronal Ligands R-HSA-9022702,-0.36682603922386636,-0.5905550220684045,0.9166666666666666,1.0,1.0,1/7,16.73%,CRH
prerank,Reactome_2022__Signaling By NOTCH2 R-HSA-1980145,0.3097406337313066,0.590460307815882,0.9852941176470589,0.9999550004328515,1.0,3/26,14.00%,MAMLD1;NEURL1;MAML2
prerank,Reactome_2022__Small Interfering RNA (siRNA) Biogenesis R-HSA-426486,-0.3443264067242587,-0.5900878056307777,0.9512195121951219,1.0,1.0,8/8,65.59%,AGO4;PRKRA;TSN;TARBP2;AGO3;AGO2;DICER1;AGO1
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.285865632513984,0.5896759692166946,0.9833333333333333,1.0,1.0,6/32,19.78%,RPA1;POLD1;XRCC1;OGG1;RFC4;NEIL1
prerank,GO_Biological_Process_2021__establishment of monopolar cell polarity (GO:0061162),0.38739756074421605,0.5896701166215357,0.8958333333333334,0.9999266057069037,1.0,3/5,17.50%,FSCN1;PATJ;SCRIB
prerank,Reactome_2022__Plasma Lipoprotein Remodeling R-HSA-8963899,-0.30864640790966935,-0.5895981599675714,0.9523809523809523,1.0,1.0,1/17,4.36%,APOE
prerank,Reactome_2022__Ligand-receptor Interactions R-HSA-5632681,0.3923981209339567,0.5884625907775107,0.9259259259259259,1.0,1.0,1/5,7.61%,BOC
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),0.388270418048826,0.5879567109937802,0.96,1.0,1.0,2/5,37.01%,EIF4G1;IMPACT
prerank,Reactome_2022__Fructose Metabolism R-HSA-5652084,0.37122139844093466,0.5875225618375758,0.9508196721311475,1.0,1.0,1/7,7.04%,ALDOB
prerank,Reactome_2022__MET Activates RAS Signaling R-HSA-8851805,-0.3246192989303974,-0.5873289402535573,0.9333333333333333,1.0,1.0,2/9,14.91%,NRAS;MUC20
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),-0.349664212084079,-0.5871236974593065,0.9318181818181818,1.0,1.0,2/7,23.13%,POLR2L;GTF3C6
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),-0.2644643818876369,-0.5868889177734459,1.0,1.0,1.0,3/47,3.69%,SRPRA;TPP1;SRPRB
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),-0.3455615581984075,-0.5868773054260938,0.9318181818181818,1.0,1.0,1/8,6.34%,BLVRA
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),-0.3455615581984075,-0.5868773054260938,0.9318181818181818,1.0,1.0,1/8,6.34%,BLVRA
prerank,Reactome_2022__Arachidonate Production From DAG R-HSA-426048,0.37804659832320525,0.5866147188004653,0.9152542372881356,1.0,1.0,1/5,31.42%,MGLL
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),-0.37166282890550517,-0.5865941326132494,0.8947368421052632,1.0,1.0,2/5,17.15%,GPLD1;JAM2
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.26965861907916666,0.5865280096235883,1.0,1.0,1.0,2/46,3.45%,APP;ADD2
prerank,Reactome_2022__Post-transcriptional Silencing By Small RNAs R-HSA-426496,-0.3443063094612736,-0.5854074050132696,0.9772727272727273,1.0,1.0,7/7,65.59%,AGO4;TNRC6C;AGO3;TNRC6A;AGO2;TNRC6B;AGO1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.38760093934698286,0.5849498563588584,0.9019607843137255,1.0,1.0,1/5,6.47%,TNFRSF1A
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.27936845423062295,0.5843156863143324,0.9838709677419355,1.0,1.0,9/29,23.69%,IRS2;FBP1;PDK4;PDK1;RORA;PDK3;FOXK1;ZNF692;PRKN
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.3838373061864205,0.5841987572231185,0.8870967741935484,1.0,1.0,1/6,7.68%,TENM4
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.2966209290106673,0.5840894262418924,0.9803921568627451,1.0,1.0,7/24,25.08%,HR;KDM6A;PHF2;KDM3A;PHF8;KDM4C;KDM6B
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.3247446844709799,0.5840776113246459,0.9682539682539683,1.0,1.0,1/14,9.80%,AK5
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.34209530289462575,0.5836583767620199,0.9433962264150944,1.0,1.0,1/12,9.62%,CHMP1A
prerank,KEGG_2021_Human__Glycolysis / Gluconeogenesis,0.28144011478612885,0.5827998381842461,1.0,1.0,1.0,9/47,14.23%,ALDOB;HK2;LDHA;PFKL;PGK1;FBP1;ENO2;HK1;ALDH3A2
prerank,Reactome_2022__NOTCH4 Activation And Transmission Of Signal To Nucleus R-HSA-9013700,-0.3279347625863669,-0.5827612705165492,0.8837209302325582,1.0,1.0,1/8,10.60%,NCSTN
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),-0.3747957734698699,-0.5826750589021144,0.9444444444444444,1.0,1.0,4/6,25.53%,TEX264;FAM111A;VCP;SPRTN
prerank,Reactome_2022__Regulation Of PTEN Gene Transcription R-HSA-8943724,0.2703639738878049,0.582432959755841,1.0,1.0,1.0,15/53,26.17%,CHD3;PPARG;TP53;HDAC7;MECOM;MTA1;RRAGD;MTA3;RCOR1;RHEB;GATAD2A;PHC2;HDAC5;CBX4;MAPK3
prerank,Reactome_2022__Activated NTRK2 Signals Thru FRS2 And FRS3 R-HSA-9028731,-0.3382545779123688,-0.5820333127784276,0.9555555555555556,1.0,1.0,2/8,25.45%,NRAS;FRS3
prerank,Reactome_2022__Early Phase Of HIV Life Cycle R-HSA-162594,0.3378238727755883,0.5820098189842551,0.9491525423728814,1.0,1.0,3/13,16.60%,LRIG1;CD4;HMGA1
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.373287919399314,0.5817804494739764,0.8983050847457628,1.0,1.0,3/7,33.19%,RARG;TBX2;FBN2
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.22405059170193442,0.5817441847791557,1.0,1.0,1.0,46/285,20.95%,TRAF3IP2;MARCHF1;PRAME;TRIM5;HECW2;FBXW12;TRIM36;CTNNB1;ARIH2;FBXO32;FBXL16;BARD1;HECW1;SPSB1;TRIM22;BCL2;SYVN1;RNF19A;UBE2H;RNF152;TRIM32;SMURF1;BRCA1;RFFL;TRAF5;LRSAM1;CBFB;ARIH1;RNF187;DDB2;SKP1;BFAR;RUSC1;FBXO41;MARCHF6;FBXO31;UBE4B;RNF144A;CDC27;UBE2QL1;RPS27A;UBE2B;UBR5;ZNRF2;UBE2E1;FBXL8
prerank,Reactome_2022__Hedgehog Ligand Biogenesis R-HSA-5358346,-0.23296642423435274,-0.5814986209278143,1.0,1.0,1.0,14/56,25.39%,PSMD10;PSMD12;DERL2;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;PSMB4;VCP;ERLEC1;PSMA1;PSMD11
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.25600155225143173,-0.5814119955614417,1.0,1.0,1.0,1/35,2.46%,TRIM21
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.241349584130466,0.5813900698702266,1.0,1.0,1.0,26/105,27.85%,CORO7;BAIAP3;HOOK1;WASHC1;TBC1D10B;TBC1D10A;GGA1;HOOK2;DCTN1;CCDC91;SORT1;LMTK2;TMEM87B;RAB7A;ARFRP1;CLTC;ERC1;EMP2;WDR81;DENND5A;ANKRD27;SLC66A2;KIF16B;GAK;AP1G1;ANKFY1
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.28564139170091934,0.5812383606479159,0.9666666666666667,1.0,1.0,5/29,23.30%,IFT122;IFT140;ODAD4;SNX10;TUB
prerank,Reactome_2022__RNA Polymerase II Transcription Termination R-HSA-73856,0.26904711696301997,0.5807113670151395,1.0,1.0,1.0,4/58,8.21%,COLEC12;LSM11;EIF4A3;THOC6
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),0.32657065442421096,0.5799083514396228,0.9814814814814815,1.0,1.0,6/13,29.36%,P3H2;PLOD2;EGLN3;OGFOD1;ASPH;PLOD3
prerank,Reactome_2022__Heme Signaling R-HSA-9707616,0.27567999191898246,0.5796258817954401,0.9846153846153847,1.0,1.0,19/38,31.78%,TBL1X;NPAS2;MEF2D;RXRA;RORA;NCOR1;TBL1XR1;CRTC3;CARM1;HMOX1;CREBBP;MAFK;HDAC3;NRIP1;CRTC2;SIRT1;MEF2C;NCOA1;CLOCK
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.2933734133414276,0.5794815788203325,1.0,1.0,1.0,5/32,16.39%,CENPP;MIS18A;CENPH;SRCAP;SPTY2D1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.29291734581999374,0.5791644443015409,0.9818181818181818,1.0,1.0,7/22,24.96%,MAP1B;MAPT;CAMSAP3;MAP1A;AEBP1;MAPRE3;MAP2
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.3268233120921141,0.5788026961871944,0.9824561403508771,1.0,1.0,5/19,23.69%,WASHC1;PINK1;ZMIZ1;HIF1A;PRKN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.3781757819969492,0.5787928773213524,0.9074074074074074,0.9998981019633962,1.0,4/7,33.25%,CAMK2A;CAMK2D;BMPR1A;NUPR1
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.3374145842791818,0.57876885619026,1.0,0.9997263560514114,1.0,1/15,3.81%,NOS1AP
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.3218551102050613,-0.5787154446870902,0.9272727272727272,1.0,1.0,2/11,20.72%,KMT2A;SPHK2
prerank,CellMarker_Augmented_2021__Platelet:Undefined,0.3282626360647744,0.5786283653798027,0.9152542372881356,0.9996089437758169,1.0,7/14,33.17%,SLC44A1;ITGAV;PECAM1;CD36;TGFB1;LAMP2;ITGA6
prerank,Reactome_2022__NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.24297457833620872,-0.578236926132757,1.0,1.0,1.0,11/53,20.20%,UBE2M;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;CUL1;PSMB4
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),-0.3798228248525049,-0.5780577191069549,0.9047619047619048,1.0,1.0,1/6,4.85%,IL5
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.3477521367207134,0.5775872971215028,0.9375,0.9998359288296721,1.0,2/8,25.63%,MESP1;FZD5
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.37626043885923155,0.5765710584095987,0.9516129032258065,1.0,1.0,1/7,15.46%,TP53
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),0.29445959280410877,0.5755616321404502,0.9830508474576272,1.0,1.0,6/25,19.66%,CYP1B1;ABCA2;MTARC2;GCHFR;CYB5B;ACER3
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),0.27675187392181777,0.5755475107888284,0.9672131147540983,1.0,1.0,8/43,16.70%,PRKCG;FAM168A;NPAS2;SPIRE1;FMN2;XRCC1;BRCA1;SPIRE2
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.2969190509171796,-0.5751785517521113,1.0,1.0,1.0,3/20,14.12%,SNF8;BECN1;WDR91
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.3638383834144832,0.5751209848513542,0.9444444444444444,0.9999735033786523,1.0,1/8,3.52%,ABCA5
prerank,Reactome_2022__Citric Acid Cycle (TCA Cycle) R-HSA-71403,0.30276212562120114,0.5750236897501337,0.9655172413793104,0.999845747754982,1.0,1/18,7.88%,LDLR
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.3506550855264988,-0.5748881044980922,0.8666666666666667,1.0,1.0,3/7,23.97%,TFIP11;DHX8;VCP
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.30136872732497183,0.5746985633813675,0.9833333333333333,0.9995945430951356,1.0,3/24,12.40%,CENPP;MIS18A;CENPH
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.30136872732497183,0.5746985633813675,0.9833333333333333,0.9995945430951356,1.0,3/24,12.40%,CENPP;MIS18A;CENPH
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),0.3977267193284185,0.574163261739779,0.9166666666666666,0.9996440643858668,1.0,2/5,23.89%,COL5A1;EIF4G1
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.36045290066534375,-0.5740611916628602,0.9318181818181818,1.0,1.0,6/6,63.97%,LMOD1;TMOD1;FLII;PGM5;TMOD3;TMOD2
prerank,Reactome_2022__Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.24276133842952727,-0.5737727585616684,1.0,1.0,1.0,11/54,20.20%,UBE2M;PSMD10;PSMD12;PSMB5;PSMB6;PSME3;SEM1;PSMD2;UBB;CUL1;PSMB4
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.3412533301377536,0.572647377790621,0.9838709677419355,1.0,1.0,2/10,15.78%,CABIN1;H3-3A
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.31887955471103663,0.5722355148473967,0.9180327868852459,0.999982627246387,1.0,5/11,21.14%,FGF2;ADAM17;FGFR1;AKT3;APLN
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.3852396819742485,0.5714218250941282,0.9607843137254902,1.0,1.0,2/5,31.62%,DDRGK1;PLCG2
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),-0.34497025428032957,-0.5714179526240339,0.8974358974358975,1.0,1.0,3/6,27.30%,RMI2;MSH3;MSH2
prerank,Reactome_2022__Regulated Proteolysis Of p75NTR R-HSA-193692,-0.33506344660488896,-0.5712064193475312,0.94,1.0,1.0,1/8,10.60%,NCSTN
prerank,Reactome_2022__Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.2581474826516863,-0.5711393673342959,1.0,1.0,1.0,9/43,18.76%,CNGA4;RAB8A;EXOC7;ARF4;BBS10;BBS9;UNC119B;ARL6;EXOC1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.28471132516040953,0.571078868154612,1.0,1.0,1.0,8/31,19.36%,SLC39A14;SLC7A1;SLC1A6;SLC29A1;LRSAM1;LRP2;SLC7A8;SLC12A7
prerank,Reactome_2022__Deadenylation Of mRNA R-HSA-429947,0.2955404479256335,0.5709307285708756,0.96875,0.9999767711713295,1.0,1/23,7.16%,EIF4A3
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.2964473862442444,0.5703206979260736,1.0,1.0,1.0,10/23,25.76%,CTNNB1;ARF6;SMURF1;GGA1;PIGK;FLNA;VCL;GGA2;PTPRK;EMP2
prerank,Reactome_2022__Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,0.2939236932965741,0.5697704195348864,0.972972972972973,1.0,1.0,3/26,13.18%,TGFA;TFAP2C;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),-0.3483132952025213,-0.5697547155249582,0.8974358974358975,1.0,1.0,6/6,65.19%,MAPK8;FNTA;C6ORF89;PRKD2;PRKD1;VEGFA
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),0.3497171812704817,0.5697298390550614,0.9,0.9998398180690069,1.0,1/8,9.67%,HDAC4
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),-0.34823930603953734,-0.5695217859789626,0.9523809523809523,1.0,1.0,3/6,21.22%,GART;PAICS;PRPS1
prerank,Reactome_2022__DNA Replication Initiation R-HSA-68952,0.3394113536311158,0.5693427566996352,0.9310344827586207,0.9998205544817571,1.0,3/7,27.56%,POLE3;POLE2;POLA1
prerank,Reactome_2022__Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.2393514067906766,-0.568974119332614,1.0,1.0,1.0,13/61,20.20%,BCL10;PSMD10;PSMD12;PSMB5;NFKBIB;PSMB6;NFKBIE;PSME3;SEM1;PSMD2;UBB;CUL1;PSMB4
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),-0.2982604949277816,-0.5688651444915154,0.975,1.0,1.0,9/22,20.06%,WASHC5;MUL1;MTFR1L;PEX11B;PEX11A;MTFR1;MIEF1;DNM1L;FIS1
prerank,Reactome_2022__Budding And Maturation Of HIV Virion R-HSA-162588,-0.26354657094069056,-0.5688051453534669,0.975,1.0,1.0,6/27,26.48%,VPS4B;RNF103-CHMP3;UBB;CHMP2A;VPS28;VTA1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.36206530862909525,0.5684563536740819,0.9661016949152542,0.9999261133113277,1.0,3/6,36.43%,PPM1F;CORO1C;ADARB1
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),0.2923881507457586,0.5680563035312768,0.9454545454545454,0.9998881221868502,1.0,7/21,28.49%,MSRA;NOX4;MTHFR;AHCY;SMS;BHMT;BHMT2
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.34537615151734263,-0.5679751196568532,0.9591836734693877,1.0,1.0,1/6,8.15%,HSD11B1
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated immunity (GO:0002716),-0.3640017001051076,-0.5677081754464894,0.9166666666666666,1.0,1.0,1/5,8.25%,MICA
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),0.31070518377915785,0.56632863403587,0.984375,1.0,1.0,7/22,24.18%,APP;CDC25B;CCNB1;PRKCA;MEIS2;CUL3;USP2
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),-0.320845455515143,-0.5652109717838707,0.9423076923076923,1.0,1.0,2/7,16.42%,RNF168;RNF8
prerank,Reactome_2022__Hedgehog On State R-HSA-5632684,0.24057687942443515,0.5641062651216985,1.0,1.0,1.0,15/76,26.10%,BOC;GRK2;GLI2;EVC2;SMURF1;RPS27A;KIF7;GLI1;CUL3;PSMB3;ARRB1;PTCH1;SUFU;IQCE;NUMB
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.30853673876123255,0.5628940560535951,0.9824561403508771,1.0,1.0,2/15,20.13%,PARP9;WRAP53
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),-0.3787892026199722,-0.5626629204421632,0.9375,1.0,1.0,2/6,11.12%,CACNA1S;RYR1
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),-0.3787892026199722,-0.5626629204421632,0.9375,1.0,1.0,2/6,11.12%,CACNA1S;RYR1
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.3295771850102004,0.5619973196639217,0.9454545454545454,1.0,1.0,5/10,28.68%,SARDH;CHDH;SLC44A1;BHMT;DMGDH
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.384617160287209,-0.5618473491471668,0.9534883720930233,1.0,1.0,2/5,23.60%,FBL;TRMT112
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.3397835919345397,0.5616361209938259,0.9344262295081968,1.0,1.0,4/9,17.91%,ARIH2;ETV6;WNT5A;MECOM
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.3128654943149318,0.5612726181841777,1.0,1.0,1.0,1/11,7.99%,ACOT4
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.33131616638843353,0.5612543545187881,0.9433962264150944,1.0,1.0,1/7,12.85%,B2M
prerank,Reactome_2022__Regulation Of RUNX2 Expression And Activity R-HSA-8939902,0.24985771641984672,0.5609108146068826,1.0,1.0,1.0,6/63,19.96%,PPARGC1B;MSX2;SMURF1;CBFB;SKP1;RPS27A
prerank,Reactome_2022__Phosphate Bond Hydrolysis By NTPDase Proteins R-HSA-8850843,-0.3385354739874091,-0.5602615049961356,0.9318181818181818,1.0,1.0,2/7,20.83%,ENTPD1;ENTPD5
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.3780258138908571,0.5600455748321159,0.9444444444444444,1.0,1.0,1/5,22.75%,PARN
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),0.39423950171023286,0.5598752070876383,0.9310344827586207,1.0,1.0,2/5,31.57%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),0.39423950171023286,0.5598752070876383,0.9310344827586207,1.0,1.0,2/5,31.57%,DPY19L1;DPY19L3
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.273137930192609,0.5598297755381679,1.0,1.0,1.0,5/34,20.43%,SMCR8;GAS6;TELO2;RRAGD;RHEB
prerank,Reactome_2022__Intrinsic Pathway Of Fibrin Clot Formation R-HSA-140837,0.33583957824319005,0.5597060603141034,0.9857142857142858,1.0,1.0,3/12,23.00%,SERPIND1;SERPING1;PRCP
prerank,Reactome_2022__Transcriptional Regulation By E2F6 R-HSA-8953750,-0.27087954651829993,-0.5591198814782514,1.0,1.0,1.0,1/31,4.99%,RNF2
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.3363442655356387,0.5586793066402977,0.9107142857142857,1.0,1.0,2/10,14.48%,IHO1;FMN2
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),-0.2736948951439995,-0.5586066165249335,1.0,1.0,1.0,2/23,9.58%,HSPA1A;HSPA13
prerank,Reactome_2022__Heme Degradation R-HSA-189483,-0.33098618984765193,-0.5585553140069367,1.0,1.0,1.0,1/9,6.34%,BLVRA
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.31845747112337264,0.558190996396597,0.9152542372881356,1.0,1.0,1/12,5.25%,OXTR
prerank,KEGG_2021_Human__Primary bile acid biosynthesis,0.3281163439222495,0.5580756707111685,0.9807692307692307,1.0,1.0,5/11,27.44%,HSD3B7;SLC27A5;CYP39A1;HSD17B4;ACOT8
prerank,Reactome_2022__Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.28336290932021735,-0.5570833091855875,1.0,1.0,1.0,4/25,11.98%,CCT7;TUBB2B;PFDN4;VBP1
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.32395151894383534,-0.5568455905025048,0.9285714285714286,1.0,1.0,2/8,20.83%,ENTPD1;ENTPD5
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.2545089198250291,0.5565578947698036,1.0,1.0,1.0,19/70,26.36%,CLIC4;NEXN;CENPV;MAPT;USP6NL;MTM1;CAMSAP3;PINK1;RHOT1;RHOT2;PDE2A;TJP1;SAR1A;TAOK1;PRKN;PLXNB1;MAPK3;DIAPH1;PDCD10
prerank,GO_Biological_Process_2021__B cell chemotaxis (GO:0035754),0.3724333996879063,0.5564393678005063,0.9629629629629629,1.0,1.0,3/5,14.53%,HSD3B7;GAS6;PIK3CD
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),-0.348081023550109,-0.5553149404824508,0.851063829787234,1.0,1.0,1/5,10.82%,PTGIS
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3125111151447725,-0.5537959543765846,0.9534883720930233,1.0,1.0,1/8,5.40%,GTF2H2
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.2844251927722869,-0.5537221008851585,0.9777777777777777,1.0,1.0,3/21,13.77%,ATP6V1E2;ATP6V1G1;ATP6V1F
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.2310526300468964,-0.5534373043018608,1.0,1.0,1.0,12/66,19.35%,EIF2S1;ATP6V1E2;ATP6V1G1;RRAGC;SLC38A9;ATP6V1F;RRAGA;MIOS;DAP;LARS1;SESN2;NPRL2
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.2339983624434716,-0.5529979775331989,1.0,1.0,1.0,12/65,19.35%,EIF2S1;ATP6V1E2;ATP6V1G1;RRAGC;SLC38A9;ATP6V1F;RRAGA;MIOS;DAP;LARS1;SESN2;NPRL2
prerank,Reactome_2022__Beta-oxidation Of Very Long Chain Fatty Acids R-HSA-390247,-0.3042044209537823,-0.5524264691706556,0.9411764705882353,1.0,1.0,4/11,20.92%,ABCD1;EHHADH;ACOT6;MLYCD
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.3020431990659661,-0.5523159448248047,0.9787234042553191,1.0,1.0,10/10,69.82%,PRKDC;HMGB1;LIG3;LIG4;LIG1;DCAF1;RAG1;TCF3;HMGB2;XRCC4
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.3358418823524744,0.5520558454285399,0.9310344827586207,1.0,1.0,4/12,27.16%,PDE4D;ADRA1D;ADCY9;RAPGEF2
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.27901008356358026,0.5519810474988246,0.967741935483871,1.0,1.0,5/30,18.97%,RAP1GAP2;RARG;VAV2;NEB;VAV1
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.35336840707344364,0.5513332893760703,0.9454545454545454,1.0,1.0,4/6,34.66%,WNT5A;SIRT1;PLCG2;CD74
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),0.293409929037441,0.5511265687291207,0.9310344827586207,1.0,1.0,3/11,24.60%,PPARG;OSBPL11;OSBPL8
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression Linked To Lipogenesis R-HSA-9029558,0.3443607618340339,0.5508510273202866,0.9682539682539683,1.0,1.0,5/9,35.26%,RXRA;NRIP1;SCD;ANGPTL3;FASN
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),-0.2705985401459854,-0.5499187183608751,0.9782608695652174,1.0,1.0,15/15,72.97%,MEPCE;INTS3;MTREX;INTS4;INTS2;INTS9;INTS11;INTS8;ZCCHC8;INTS7;INTS1;INTS10;INTS12;INTS6;INTS5
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.2813105977338696,0.5497352374242781,0.9841269841269841,1.0,1.0,4/32,16.86%,BAP1;ARIH2;PINK1;MICALL2
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.29538624491029053,0.5486481730413757,1.0,1.0,1.0,6/19,23.34%,LAMA5;SOX10;LAMA3;PRKX;AHI1;VCL
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.3486889662546335,-0.5484781699977714,0.875,1.0,1.0,1/6,4.81%,GALT
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),-0.3082126811601966,-0.5480891872670558,0.8695652173913043,1.0,1.0,3/8,21.52%,MST1;GPX1;BRCA2
prerank,KEGG_2021_Human__Vibrio cholerae infection,0.25032745100021925,0.5472605396341816,1.0,1.0,1.0,11/43,25.97%,KCNQ1;ADCY3;PRKCA;KDELR3;TJP2;ATP6V1B2;ADCY9;TJP1;ATP6V1C1;ATP6V1C2;ERO1A
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.2890404027144881,0.5467229076295704,1.0,1.0,1.0,7/18,36.34%,XPO5;SND1;PARN;DDX17;DIS3L2;LIN28B;DICER1
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.36661803326524667,0.5464271306386128,0.9245283018867925,1.0,1.0,5/5,63.35%,CHM;RABGGTA;RABGGTB;PGGT1B;FNTA
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.23278409490413782,-0.5461899581707859,1.0,1.0,1.0,12/58,23.21%,NOC2L;EIF2S1;BAK1;METTL3;ATR;TRIAP1;XPA;SMPD1;PARP1;AQP1;CASP9;YY1
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.28554503234681244,0.5449818100798439,1.0,1.0,1.0,5/21,22.06%,TMTC1;POMGNT2;LARGE1;SDF2L1;DPY19L1
prerank,Reactome_2022__Spry Regulation Of FGF Signaling R-HSA-1295596,0.2927174723127782,0.5449408548665635,0.9811320754716981,1.0,1.0,7/15,35.55%,RPS27A;PTPN11;CBL;MAPK3;MKNK1;SRC;MAPK1
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.33184340318284933,-0.544835691766671,0.9534883720930233,1.0,1.0,1/9,10.83%,GPR37L1
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression Linked To Triglyceride Lipolysis In Adipose R-HSA-9031528,0.39670631658212874,0.5446985511673584,0.9423076923076923,1.0,1.0,1/5,15.88%,RXRA
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.3380780137627669,0.5443204440869007,0.9824561403508771,1.0,1.0,2/12,9.00%,ROBO2;BASP1
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),-0.33749645306416853,-0.5440419498819307,1.0,1.0,1.0,1/8,8.81%,ATP6V1G1
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.2547270880922254,-0.5437475084606499,1.0,1.0,1.0,3/28,13.77%,ATP6V1E2;ATP6V1G1;ATP6V1F
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.35262211789430037,0.5437300987274641,0.9411764705882353,1.0,1.0,1/7,8.19%,ASS1
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",-0.33812503280740636,-0.543690434208559,0.9347826086956522,1.0,1.0,3/7,27.64%,SEC62;SEC61A1;SEC63
prerank,Reactome_2022__Multifunctional Anion Exchangers R-HSA-427601,0.3123489524531709,0.5422336080612619,0.94,1.0,1.0,2/7,25.29%,SLC26A11;SLC26A6
prerank,KEGG_2021_Human__Pantothenate and CoA biosynthesis,0.29915605267827455,0.5422263192652912,0.9615384615384616,1.0,1.0,5/14,24.41%,ALDH3A2;DPYD;PANK3;BCAT1;BCAT2
prerank,Reactome_2022__FRS-mediated FGFR3 Signaling R-HSA-5654706,0.30509447457644107,0.5416293730337735,0.9491525423728814,1.0,1.0,3/12,27.64%,FGF13;PTPN11;FGF17
prerank,Reactome_2022__Acyl Chain Remodelling Of PI R-HSA-1482922,0.3344026853343547,0.5407645150596453,0.9830508474576272,1.0,1.0,1/8,8.61%,PLAAT3
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.2705985401459854,-0.5406766816622898,1.0,1.0,1.0,15/15,72.97%,INTS3;INTS6L;INTS4;INTS14;INTS2;INTS9;INTS11;INTS8;INTS7;TOE1;INTS1;INTS10;INTS12;INTS6;INTS5
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.26182136230032066,-0.5406414346217214,0.9761904761904762,1.0,1.0,3/21,13.03%,TTN;KMT5A;SMC2
prerank,Reactome_2022__Synthesis Of 5-Eicosatetraenoic Acids R-HSA-2142688,-0.3375754323329437,-0.5403088657748465,0.8888888888888888,1.0,1.0,4/8,21.53%,PON3;GPX2;GPX1;PON1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),-0.31682953244984013,-0.5402301337249313,1.0,1.0,1.0,1/9,4.81%,GALT
prerank,Reactome_2022__Processing Of SMDT1 R-HSA-8949664,0.2868940092792368,0.539915496654389,0.96875,1.0,1.0,3/15,19.79%,MCUB;STOML2;PMPCB
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.3592407379927614,-0.5398620362340544,0.9056603773584906,1.0,1.0,1/5,11.60%,PVR
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.2480681877007989,-0.5397554192986571,1.0,1.0,1.0,3/53,7.46%,FBXO5;RNF2;FBXO43
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.29003668957015966,0.5394984964579281,0.9655172413793104,1.0,1.0,6/19,28.49%,PPP1R16B;MFHAS1;YWHAE;ARPP19;ENSA;GSK3B
prerank,Reactome_2022__Signaling By BRAF And RAF1 Fusions R-HSA-6802952,0.2503256102397642,0.5384827197370414,1.0,1.0,1.0,18/56,24.01%,LMNA;TRAK1;CAMK2B;FN1;IQGAP1;KIAA1549;FAM131B;RAP1A;AGTRAP;MPRIP;CAMK2A;RAP1B;APBB1IP;SND1;VCL;ATG7;ARRB1;PAPSS1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.32669459302719167,-0.5383559265224488,0.9811320754716981,1.0,1.0,2/7,19.70%,SLC25A46;DNM1L
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.2748650835733239,-0.5376282017686161,0.975,1.0,1.0,3/16,17.30%,HSF1;ATR;TSPYL5
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.3560700756715338,-0.5374084313615483,1.0,1.0,1.0,1/6,4.81%,GALT
prerank,KEGG_2021_Human__Fanconi anemia pathway,0.2680045213518367,0.5371398796574613,1.0,1.0,1.0,4/45,12.11%,BLM;RPA1;EME2;PMS2
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.28364110605930204,0.5370972736791974,0.9864864864864865,1.0,1.0,1/17,8.22%,MGAT5
prerank,Reactome_2022__Aspirin ADME R-HSA-9749641,0.29320254042155025,0.5368587789991747,0.9402985074626866,1.0,1.0,2/15,12.48%,GLYATL2;ACSM5
prerank,Reactome_2022__NR1H2 And NR1H3 Regulate Gene Expression To Limit Cholesterol Uptake R-HSA-9031525,0.37946875477442366,0.5358122073708435,0.9259259259259259,1.0,1.0,1/5,15.88%,RXRA
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.3533702947184125,0.5356858060329379,0.95,1.0,1.0,5/5,64.67%,NAA25;NAA16;NAA30;NAA20;NAA15
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.34952965898140875,0.535594805684973,0.9344262295081968,1.0,1.0,2/6,25.93%,MAPKAPK2;CARMIL1
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.3379764126586062,-0.5352962804231387,0.9767441860465116,1.0,1.0,1/8,10.83%,GPR37L1
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.34248067986331887,0.534648201792714,0.9672131147540983,1.0,1.0,2/8,25.93%,MAPKAPK2;CARMIL1
prerank,Reactome_2022__Synthesis Of UDP-N-acetyl-glucosamine R-HSA-446210,-0.323740679929677,-0.5340425846249479,0.9512195121951219,1.0,1.0,1/8,12.95%,NAGK
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.324958080384165,-0.5336874932338154,0.9767441860465116,1.0,1.0,2/12,6.53%,THAP7;NOC2L
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.25742362168201527,0.5336519573233885,0.9833333333333333,1.0,1.0,6/39,17.07%,PID1;CYRIB;MAPT;PINK1;RHOT1;RHOT2
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.32653035716558637,-0.5336497562194195,0.9361702127659575,1.0,1.0,1/8,14.39%,CLU
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.29761664829800943,-0.5330945926586104,0.9787234042553191,1.0,1.0,2/15,7.99%,HSPA1A;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.29761664829800943,-0.5330945926586104,0.9787234042553191,1.0,1.0,2/15,7.99%,HSPA1A;MAPK7
prerank,Reactome_2022__Activated NTRK2 Signals Thru RAS R-HSA-9026519,-0.3152407607721045,-0.5328950205795574,0.9361702127659575,1.0,1.0,1/6,13.52%,NRAS
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),0.3111771998720506,0.5327703604505812,0.9615384615384616,1.0,1.0,5/7,39.59%,SRF;F2R;CTTN;GPER1;SPHK1
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),-0.32689389517917594,-0.532585793609387,0.9565217391304348,1.0,1.0,6/6,67.33%,CKMT2;CKB;SLC6A8;GAMT;GATM;CKM
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),0.37370341717752265,0.5325276626427493,0.9464285714285714,1.0,1.0,2/5,26.16%,FTO;ALKBH5
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.32538137670259915,0.531994324712251,0.9365079365079365,1.0,1.0,2/10,16.09%,SHMT1;SERINC5
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.33319715186179527,-0.5315347113605994,0.8888888888888888,1.0,1.0,6/6,66.70%,SLC4A7;USH1C;PDZD7;MYO6;JAG2;LRTOMT
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.2744151772799045,0.5312256013890932,0.9682539682539683,1.0,1.0,6/23,32.00%,TINF2;EXOSC10;ACD;PIF1;TNKS2;TNKS
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.2557258522831497,0.5310951075269137,1.0,1.0,1.0,3/30,11.94%,MYH9;ADAM19;BACE2
prerank,KEGG_2021_Human__Linoleic acid metabolism,0.33167209630375516,0.5306685296382615,0.984375,1.0,1.0,2/12,14.74%,PLAAT3;PLB1
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.291659724747813,0.528891692381289,0.9508196721311475,1.0,1.0,4/17,21.17%,TMTC1;POMGNT2;LARGE1;SDF2L1
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.3324967900081709,-0.5269254744388896,0.8809523809523809,1.0,1.0,6/6,66.77%,ERCC4;ATM;ERCC1;SMG6;TERF2;NBN
prerank,CellMarker_Augmented_2021__Cardiomyocyte:Undefined,0.23099597783406106,0.5262632963983197,1.0,1.0,1.0,25/93,33.89%,MKLN1;MYO9A;CEP350;BCLAF1;REV3L;UBR5;TTBK2;PDS5B;TAOK1;CSPP1;PHIP;KIAA0586;MACF1;SMC5;ANKRD36;RANBP2;UBR3;ZMYM2;UBR1;TNKS;TTC3;USP34;ASH1L;ATRX;TRIP11
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),0.30939173883609994,0.5261430580487185,1.0,1.0,1.0,1/7,14.22%,PLOD2
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.3487542258749299,-0.5255400449139727,0.9787234042553191,1.0,1.0,2/5,17.92%,AOX1;PNPO
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.27488232239781885,0.5254024819479116,1.0,1.0,1.0,5/24,22.24%,PGAP4;PIGA;PIGB;PIGQ;PIGH
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.27941099283815235,-0.5247337559430704,1.0,1.0,1.0,2/14,7.82%,RPS26;RPS13
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),0.32987370045741465,0.5244520770237315,0.9090909090909091,1.0,1.0,4/8,27.52%,DYRK1A;SPRED3;NNMT;BRMS1
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.2696295348511517,0.5236604897299185,1.0,1.0,1.0,4/28,12.48%,ACOT4;DBI;ACOT7;ACSM5
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.2631413562671974,-0.5235375984511484,1.0,1.0,1.0,12/39,22.92%,TRIM21;POLR2K;POLR2C;CCNT1;GTF2F1;POLR2D;GTF2F2;POLR2L;POLR2G;TRIM14;LARP7;POLR2E
prerank,Reactome_2022__Signaling By Activin R-HSA-1502540,0.3154783521303208,0.5235228287445746,0.9824561403508771,1.0,1.0,3/12,20.96%,SMAD3;SMAD2;ACVR1B
prerank,Reactome_2022__IRAK1 Recruits IKK Complex R-HSA-937039,0.31892519351736287,0.5222514182643947,0.9629629629629629,1.0,1.0,1/9,14.40%,IKBKG
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.26886316793999254,-0.5222003813607402,0.9714285714285714,1.0,1.0,5/27,15.67%,BCAP31;SEC24A;ERAP2;HFE;TAP1
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),-0.3634082287715203,-0.5220020236099923,0.9347826086956522,1.0,1.0,5/5,63.68%,HES1;NOTCH1;RNF10;SKI;DICER1
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.30936041248434576,-0.5213669908181733,1.0,1.0,1.0,5/13,28.97%,RNF168;RNF8;LARP7;NELFCD;RECQL5
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),-0.30425568546928994,-0.5213268870575148,1.0,1.0,1.0,1/10,14.01%,SLC25A22
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),0.2693799726052758,0.5209506186168978,1.0,1.0,1.0,3/26,14.53%,PML;MAPKAPK5;MRE11
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.263553216663646,-0.5206146544579312,0.9743589743589743,1.0,1.0,5/18,28.10%,AFG3L2;MIEF1;FIS1;GDAP1;MFN2
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.28227532842398184,0.5205854249892103,0.9848484848484849,1.0,1.0,2/11,16.03%,P2RY12;P2RX7
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),-0.321781443156419,-0.5204829287395322,0.9534883720930233,1.0,1.0,1/10,8.69%,METTL3
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.3326776420533425,-0.5194349793492773,1.0,1.0,1.0,3/8,31.49%,NR1H2;PROM2;NR1H3
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),-0.2458226278308662,-0.5193166010235966,0.9722222222222222,1.0,1.0,2/28,9.58%,HSPA1A;HSPA13
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.22870189565967186,-0.5192831229327813,1.0,1.0,1.0,3/33,15.82%,KIF20B;CEP131;TENM1
prerank,Reactome_2022__Metabolism Of Cofactors R-HSA-8978934,0.30225842948137593,0.5192563907033056,0.9830508474576272,1.0,1.0,1/18,4.69%,PRKG2
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),-0.3106615721766128,-0.5187730423492647,0.9333333333333333,1.0,1.0,2/9,16.97%,GPLD1;GRAMD1B
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.3464059892445906,0.518501923179636,1.0,1.0,1.0,1/5,11.77%,KLF9
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.27519535895440933,-0.5178917580925138,1.0,1.0,1.0,4/12,21.21%,LY96;IPMK;DNM1L;CD14
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),-0.31418724305789614,-0.5177797193363879,0.96,1.0,1.0,2/6,19.81%,YME1L1;AFG1L
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),0.22998457398814745,0.5175582213760908,1.0,1.0,1.0,13/84,19.96%,SUV39H1;PADI2;FAM50A;CENPV;CENPH;GPS1;POLE3;H3-3A;MTHFR;DOT1L;DDB2;PHF19;RPS27A
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.3147495640603473,0.5171927509002404,0.9830508474576272,1.0,1.0,2/12,16.79%,EME2;MEIOB
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),-0.3601943995981522,-0.5171571033506395,0.9555555555555556,1.0,1.0,2/5,19.25%,NKAP;PNP
prerank,Reactome_2022__p38MAPK Events R-HSA-171007,-0.2828025744201814,-0.5149939654837913,1.0,1.0,1.0,3/12,17.65%,NRAS;RALA;MAPK12
prerank,Reactome_2022__Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,0.274842612811208,0.5149405729724065,1.0,1.0,1.0,6/22,23.43%,TUBB6;TUBA1B;IST1;TUBA4A;TUBB4A;TUBA1C
prerank,Reactome_2022__Autophagy R-HSA-9612973,0.21580231266041863,0.5148787874031219,1.0,1.0,1.0,22/117,23.69%,MAP1LC3A;GFAP;RNASE1;VPS37B;ATG4B;ATG9A;PINK1;DYNC1LI2;GABARAPL1;TSC2;MTMR3;RRAGD;DYNC1LI1;RPS27A;RHEB;TOMM40;MTMR14;WDR45;DYNC1I1;ULK1;ATG7;PRKN
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.27123953630125264,0.5146849220270058,0.984375,1.0,1.0,5/19,27.93%,ACAD8;AUH;BCAT1;BCAT2;SLC25A44
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.27123953630125264,0.5146849220270058,0.984375,1.0,1.0,5/19,27.93%,ACAD8;AUH;BCAT1;BCAT2;SLC25A44
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),-0.3205230286249684,-0.5142864772022369,0.9777777777777777,1.0,1.0,1/9,6.17%,MUL1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.3039467538533395,-0.5130571657817026,1.0,1.0,1.0,12/12,69.63%,WNT5B;TIAM1;DAAM2;SFRP4;SFRP1;CSNK1E;GPC3;ZNRF3;RNF213;CSNK1D;SPEF1;RSPO3
prerank,Reactome_2022__Post-chaperonin Tubulin Folding Pathway R-HSA-389977,0.2927294507852374,0.5120466002496517,0.9836065573770492,1.0,1.0,7/16,27.90%,TUBB6;TUBA1B;TUBA4A;TUBB4A;TUBA1C;TBCA;TBCD
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.27166797138287735,0.5120165954913254,1.0,1.0,1.0,1/29,5.12%,NUAK1
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),0.36176819870479515,0.5112871857359743,1.0,1.0,1.0,1/5,10.27%,STAT3
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.2875028098678285,0.5111609101130927,1.0,1.0,1.0,2/11,21.35%,ACOT7;PANK3
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.2875028098678285,0.5111609101130927,1.0,1.0,1.0,2/11,21.35%,ACOT7;PANK3
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.2875028098678285,0.5111609101130927,1.0,1.0,1.0,2/11,21.35%,ACOT7;PANK3
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),0.32709555659248035,0.510432307219732,0.98,1.0,1.0,1/6,18.13%,SKP1
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.31051187766298954,-0.5099473830518049,1.0,1.0,1.0,7/7,68.97%,SPHK2;KDM5A;C6ORF89;PRKD2;PRKD1;VEGFA;CAMK2D
prerank,CellMarker_Augmented_2021__Macrophage:Bone Marrow,-0.30406119116338637,-0.5099219377721478,0.9473684210526315,1.0,1.0,2/5,22.84%,CD14;ARG1
prerank,Reactome_2022__Regulation Of RAS By GAPs R-HSA-5658442,0.2332756326479998,0.509527550553114,1.0,1.0,1.0,1/58,3.34%,DAB2IP
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.29247650732504527,-0.5086832904783851,0.9736842105263158,1.0,1.0,7/7,70.77%,MYOCD;UQCC2;DDX5;NR1D2;MEF2C;DDX17;GPC1
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.2612170394758205,-0.5079008163065082,1.0,1.0,1.0,2/18,12.75%,LRRC17;FSTL3
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.3210530724197772,-0.5061080803436472,1.0,1.0,1.0,1/7,10.60%,NCSTN
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.26947685655467163,0.5058372067406643,0.9615384615384616,1.0,1.0,1/18,6.65%,CDK9
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),0.2833311596050802,0.505740335013086,1.0,1.0,1.0,5/17,23.82%,PCGF3;DDB2;SKP1;DDB1;BCOR
prerank,Reactome_2022__FBXW7 Mutants And NOTCH1 In Cancer R-HSA-2644605,0.3412243724543289,0.5050279199139668,0.98,1.0,1.0,1/5,18.13%,SKP1
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),0.31622661724114587,0.5039644429463077,0.9516129032258065,1.0,1.0,1/5,23.59%,CXCL12
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),0.33740159493622296,0.503489301451654,0.9814814814814815,1.0,1.0,2/8,30.98%,CARD11;LARP1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.2831176379083479,-0.50306167533682,1.0,1.0,1.0,3/18,12.29%,HSPA1A;MAPK7;HTRA2
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),0.323857905231843,0.5020287087730432,0.9696969696969697,1.0,1.0,2/6,31.62%,SCIMP;PLCG2
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.2473262728272526,0.5019412974587686,0.9846153846153847,1.0,1.0,7/26,24.10%,YAP1;PAK1;BRCA1;CBFB;DDRGK1;CARM1;DNAAF4
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.33675011233333196,0.5019385961106764,1.0,1.0,1.0,2/5,34.42%,MOV10;AGO1
prerank,CellMarker_Augmented_2021__Epidermal Stem cell:Foreskin,-0.20342438385287193,-0.5016816812507879,1.0,1.0,1.0,5/88,9.77%,WDR11;NCOA4;VPS4B;TMED5;ZDHHC20
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.29456401616518807,0.5015802527025027,1.0,1.0,1.0,4/14,24.91%,CD44;RFFL;PRKN;DYRK1A
prerank,Reactome_2022__Cation-coupled Chloride Cotransporters R-HSA-426117,0.3427165663897531,0.5013974917125719,0.9661016949152542,1.0,1.0,5/6,31.91%,SLC12A5;SLC12A7;SLC12A4;SLC12A6;SLC12A2
prerank,Reactome_2022__Synthesis Of Glycosylphosphatidylinositol (GPI) R-HSA-162710,-0.2699404675885363,-0.49895055765391405,1.0,1.0,1.0,4/16,19.71%,PIGW;DPM2;PIGO;PIGF
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),-0.29740955536237135,-0.4988985383771939,0.95,1.0,1.0,2/10,16.46%,TARDBP;ZNF639
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),-0.30586518821126346,-0.498560973519046,0.9574468085106383,1.0,1.0,5/5,69.43%,MYOCD;HMGCR;IFNGR1;LRPAP1;SRF
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.2576471773905159,-0.4979066454326978,1.0,1.0,1.0,7/21,26.48%,VPS4B;TMEM50B;TMEM50A;VCP;CHMP3;CHMP2A;VTA1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.3125051655045443,0.4971615361541474,0.9636363636363636,1.0,1.0,2/8,23.69%,EIF5A;PRKN
prerank,Reactome_2022__Fertilization R-HSA-1187000,-0.27047696888318057,-0.49672351392889624,1.0,1.0,1.0,11/11,72.98%,ZP3;CATSPERB;CATSPER2;IZUMO4;ADAM21;CD9;CATSPERG;B4GALT1;CATSPERD;OVGP1;HVCN1
prerank,Reactome_2022__Suppression Of Phagosomal Maturation R-HSA-9637687,0.3001124338854155,0.49572107130809556,1.0,1.0,1.0,4/10,32.85%,RPS27A;RAB7A;RAB5A;ATP6V1H
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",0.267865130014975,0.49395449616281,0.9824561403508771,1.0,1.0,4/15,30.26%,SART1;PSIP1;WBP11;WBP4
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),0.2841461219641981,0.4939214447708228,1.0,1.0,1.0,4/13,34.34%,TFRC;SLC15A4;SHLD1;HMCES
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),0.287323779114356,0.4932032938793533,0.9833333333333333,1.0,1.0,7/18,32.16%,SGCG;SIX4;TBX2;MYH14;IGSF8;MEF2C;SGCZ
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),0.26538358090986375,0.4930568171027139,1.0,1.0,1.0,7/17,29.94%,ADAM17;ADAM9;SPPL2B;PSEN1;APH1B;RHBDD1;TGFB1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.26663447090322745,-0.49206818967222976,0.9705882352941176,1.0,1.0,4/14,21.21%,LY96;IPMK;DNM1L;CD14
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.26047616460712986,-0.4919716070662547,1.0,1.0,1.0,6/18,25.23%,PPP1R35;ZCCHC9;PTPA;PPP1R26;SH3RF2;GPATCH2
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),-0.27058273969403246,-0.4917213313949107,0.9767441860465116,1.0,1.0,14/14,72.97%,TRNT1;INTS6L;ERI1;INTS14;INTS2;PTCD1;ELAC2;INTS8;INTS7;SSB;TOE1;INTS12;INTS6;INTS5
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.3058830395704447,-0.4912628103911164,0.9166666666666666,1.0,1.0,6/6,69.43%,MYOCD;ENO1;SPHK1;CTTN;F2R;SRF
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.30138812401471493,-0.4906296623479434,1.0,1.0,1.0,1/9,8.25%,MICA
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.3277336751742838,-0.4902954579931993,1.0,1.0,1.0,2/6,17.37%,UFL1;MEOX1
prerank,Reactome_2022__HDMs Demethylate Histones R-HSA-3214842,0.2450353494114328,0.4892044759816884,1.0,1.0,1.0,7/22,25.99%,KDM6A;PHF2;KDM3A;PHF8;KDM4C;KDM6B;ARID5B
prerank,Reactome_2022__Regulation Of Pyruvate Dehydrogenase (PDH) Complex R-HSA-204174,0.2699163536525003,0.4874820863901402,0.9841269841269841,1.0,1.0,4/15,21.51%,PDK4;RXRA;PDK3;LDHD
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),0.3014250007706649,0.48715007081791956,0.9795918367346939,1.0,1.0,1/6,12.28%,MACROD1
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),-0.3001264730351604,-0.4869167285784984,0.9782608695652174,1.0,1.0,1/5,15.32%,NMD3
prerank,Reactome_2022__Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,0.24866417176209832,0.4865121117228883,1.0,1.0,1.0,5/26,20.43%,CAB39L;STK11;TSC2;RRAGD;RHEB
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.26566966444534046,0.4864836250167623,1.0,1.0,1.0,3/16,23.06%,BCLAF1;MED24;MED13
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),0.2674356610591368,0.4864713109570901,0.9803921568627451,1.0,1.0,4/12,24.32%,GRAMD1A;RORA;OSBPL7;PTCH1
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.30374131792447323,-0.4852071839088242,1.0,1.0,1.0,7/7,69.64%,THBS4;ITGB1BP1;MEGF10;DDR1;ROCK1;AAMP;PLAT
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),-0.2579023695256475,-0.48507325649423755,1.0,1.0,1.0,1/15,4.94%,PIGW
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),0.30547063305015604,0.4849854812675121,1.0,1.0,1.0,2/10,22.72%,PNPLA8;SLC27A1
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),-0.2981137368548966,-0.48377309065933854,0.9565217391304348,1.0,1.0,1/5,19.74%,NRDE2
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),-0.2981137368548966,-0.48377309065933854,0.9565217391304348,1.0,1.0,1/5,19.74%,NRDE2
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),-0.30596997001658666,-0.4822772782841288,1.0,1.0,1.0,2/8,23.13%,POLR2L;GTF3C6
prerank,Reactome_2022__Assembly Of HIV Virion R-HSA-175474,0.2528180281546626,0.4820451199987247,1.0,1.0,1.0,5/17,29.22%,VPS37B;RPS27A;FURIN;MVB12B;TSG101
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),0.34117303764225276,0.4812312296888821,1.0,1.0,1.0,5/5,65.89%,ABCA7;PPP1R15A;PPP1R15B;PTPN1;NCK1
prerank,Reactome_2022__Defective C1GALT1C1 Causes TNPS R-HSA-5083632,0.28265893381666246,0.48016313855200893,1.0,1.0,1.0,2/6,25.13%,MUCL1;MUC4
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.30352598674804054,0.4796124944047457,0.9636363636363636,1.0,1.0,2/8,26.75%,LRP2;CYP3A4
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),-0.3245004613541357,-0.4782894396958506,0.9545454545454546,1.0,1.0,1/6,14.01%,SLC25A22
prerank,Reactome_2022__Pyroptosis R-HSA-5620971,-0.24663606026637802,-0.47794121332270917,1.0,1.0,1.0,2/17,14.94%,BAK1;RNF103-CHMP3
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.2922325374655871,-0.47716183104034365,0.9743589743589743,1.0,1.0,1/5,15.74%,GNPAT
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.2922325374655871,-0.47716183104034365,0.9743589743589743,1.0,1.0,1/5,15.74%,GNPAT
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.31609028890310586,0.4770064216502283,0.967741935483871,1.0,1.0,5/9,31.91%,SLC12A5;SLC12A7;SLC12A4;SLC12A6;SLC12A2
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.31609028890310586,0.4770064216502283,0.967741935483871,1.0,1.0,5/9,31.91%,SLC12A5;SLC12A7;SLC12A4;SLC12A6;SLC12A2
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),0.32663230268845367,0.47608851256446727,0.9636363636363636,1.0,1.0,2/5,33.94%,PRKN;VAPA
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),-0.29426343992812315,-0.47554389865789254,0.9565217391304348,1.0,1.0,2/5,22.28%,RDX;PTPN23
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),-0.3002042602859644,-0.47509585793151465,0.9787234042553191,1.0,1.0,5/5,69.99%,HS3ST5;GP1BA;PROCR;F2R;EPHB2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),0.2940636022986104,0.47496830533028145,1.0,1.0,1.0,2/8,22.05%,CPEB2;DPH6
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),-0.2825391813670239,-0.473620141961834,1.0,1.0,1.0,1/7,12.39%,LRAT
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperone Genes R-HSA-381183,0.28808435131021004,0.4707420231868057,0.9838709677419355,1.0,1.0,2/9,25.33%,HSPA5;NFYB
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.2617598006603217,0.4702275398029454,0.9841269841269841,1.0,1.0,5/11,33.24%,RNF185;UBXN1;BAG6;USP25;RNFT1
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),0.31398051806640825,0.4697930669898489,0.9636363636363636,1.0,1.0,2/5,28.07%,XRCC1;RAD21
prerank,Reactome_2022__Downregulation Of ERBB4 Signaling R-HSA-1253288,0.27885606931875523,0.46959517147471685,1.0,1.0,1.0,5/9,38.33%,RPS27A;NEDD4;ITCH;SRC;ERBB4
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.28748314363269306,-0.46921779185548457,0.9803921568627451,1.0,1.0,1/8,10.19%,IGBP1
prerank,Reactome_2022__Activation Of PPARGC1A (PGC-1alpha) By Phosphorylation R-HSA-2151209,0.2910668758396904,0.46916129270141754,0.9661016949152542,1.0,1.0,1/8,14.62%,MAPK11
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),0.3224394514152317,0.46815399398670055,0.9636363636363636,1.0,1.0,5/5,67.77%,NUCKS1;XRCC5;XRCC6;NIPBL;ATM
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.22742949642367039,-0.4671971212607752,1.0,1.0,1.0,5/26,21.35%,SIRT6;ART4;ARF4;PARP11;PARP1
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.2388486688463335,-0.46710602266611534,1.0,1.0,1.0,12/12,76.14%,PARP11;PARP1;PARP6;PARP2;PARP10;PARP3;TIPARP;PARP12;TNKS;TNKS2;PARP8;PARP16
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.24555188822154028,0.4647153155560791,1.0,1.0,1.0,3/26,20.04%,LSM11;ZNF473;EXOSC10
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.2995214194000233,0.46428630904458523,1.0,1.0,1.0,6/6,70.06%,DHX9;SSB;DCP1A;DDX3X;YBX1;DDX1
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.2801311712585224,-0.46410113028642097,1.0,1.0,1.0,1/8,9.59%,JUP
prerank,Reactome_2022__Noncanonical Activation Of NOTCH3 R-HSA-9017802,-0.2887538541769804,-0.4640420465827431,1.0,1.0,1.0,1/6,10.60%,NCSTN
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),0.2760571301208128,0.4624826034331471,1.0,1.0,1.0,2/10,16.81%,NOX4;MTHFR
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.2982548298605031,-0.4618518279905445,1.0,1.0,1.0,7/7,70.19%,PRPS1;TPK1;CAD;UMPS;DHODH;CTPS2;CTPS1
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),0.2977326544342948,0.46179661934956784,0.9846153846153847,1.0,1.0,3/7,32.81%,WNT5A;NF1;SLC16A2
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.2844255910587431,0.46063739240169954,1.0,1.0,1.0,2/7,22.82%,SIX4;PAX8
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.2844255910587431,0.46063739240169954,1.0,1.0,1.0,2/7,22.82%,SIX4;PAX8
prerank,Reactome_2022__Cytochrome C-Mediated Apoptotic Response R-HSA-111461,-0.261851938346567,-0.4604114237281733,1.0,1.0,1.0,12/12,73.84%,CASP9;CASP3;UACA;CARD8;XIAP;CASP7;APAF1;CYCS;MAPK1;AVEN;APIP;MAPK3
prerank,Reactome_2022__Intra-Golgi Traffic R-HSA-6811438,-0.2127746551812208,-0.4599224226456739,1.0,1.0,1.0,4/38,16.56%,STX16;COG6;NAPSA;RAB33B
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.2446286781877627,-0.4596615139898059,1.0,1.0,1.0,12/12,75.56%,NRDE2;NSUN2;NCBP2;TPR;SUPT6H;CPSF6;KHDRBS1;NUP153;SETD2;IWS1;AKAP8L;DHX9
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.23325102972078007,-0.45932511648446017,1.0,1.0,1.0,1/24,4.99%,RNF2
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.2844765224846114,0.4591200087970421,0.9836065573770492,1.0,1.0,2/9,24.82%,TP53;PIF1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.22251593416845486,0.4587142719870263,1.0,1.0,1.0,7/27,29.53%,UBXN1;MAP1A;WAC;DDRGK1;OGT;BAG6;NOP53
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.2906281754755897,0.4558772452235693,1.0,1.0,1.0,2/5,22.72%,ADIPOR2;SLC27A1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),-0.27852681958792974,-0.45525175310723837,0.9722222222222222,1.0,1.0,7/7,72.16%,APPL2;CDC42;PPT1;CLN3;AXL;APPL1;ANKFY1
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.25478184622612143,-0.453594323787317,1.0,1.0,1.0,2/10,21.52%,NABP2;BRCA2
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.23971899797417046,-0.4522399886766209,1.0,1.0,1.0,1/13,12.49%,NUP54
prerank,Reactome_2022__Formation Of Apoptosome R-HSA-111458,-0.2618213660245184,-0.4511283516083839,1.0,1.0,1.0,10/10,73.84%,CASP9;UACA;CARD8;XIAP;APAF1;CYCS;MAPK1;AVEN;APIP;MAPK3
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.2828459697659488,0.44821472268885193,1.0,1.0,1.0,7/7,71.73%,DHX9;AGO1;AGO2;AGO3;DDX3X;DHX36;AGO4
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),0.2868912732363208,0.44812930819880276,0.9838709677419355,1.0,1.0,1/6,17.12%,DOT1L
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.2631448227432109,-0.4477719000607582,1.0,1.0,1.0,2/8,19.57%,PTGIS;PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.24680994043947396,0.4464842994492656,1.0,1.0,1.0,5/14,25.12%,ATAD5;DDRGK1;GLI1;CUL3;ZNF16
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.271711705109391,0.4433935101587332,0.9824561403508771,1.0,1.0,3/9,27.16%,ADRA1D;ADCY9;RAPGEF2
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.24416539264528264,-0.4433531801670044,1.0,1.0,1.0,3/11,19.87%,PEX10;PEX13;PEX1
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),-0.2615940695935101,-0.4431384903200121,1.0,1.0,1.0,1/11,9.17%,SUPT16H
prerank,Reactome_2022__Processing And Activation Of SUMO R-HSA-3215018,0.2940546412355691,0.4427731131421367,1.0,1.0,1.0,3/8,35.45%,UBE2I;UBA2;SAE1
prerank,Reactome_2022__Calnexin/calreticulin Cycle R-HSA-901042,0.228456551109369,0.4427708167457118,0.9818181818181818,1.0,1.0,5/25,21.47%,SYVN1;RNF185;MARCHF6;RPS27A;AMFR
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.24828756596279888,-0.44222254931366983,1.0,1.0,1.0,4/13,23.12%,PNKP;NABP2;PKIB;MAP3K4
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),0.2940841870868654,0.4419292118655848,0.9818181818181818,1.0,1.0,3/5,34.52%,PRKN;ITCH;UBE2S
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.26832013945979816,-0.4416763528148252,0.9791666666666666,1.0,1.0,1/5,17.39%,WNT7B
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.2944849722789612,0.4416747942252577,1.0,1.0,1.0,5/5,70.56%,GHRHR;CHD7;SELENOT;GHRL;DRD2
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.26849804599800264,0.44090422539661356,1.0,1.0,1.0,4/10,26.76%,DSTN;WDR1;MICAL1;GSN
prerank,Reactome_2022__Uptake And Function Of Anthrax Toxins R-HSA-5210891,-0.24201488308386843,-0.43976026669693086,1.0,1.0,1.0,1/11,10.95%,MAP2K6
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),-0.26391927622853856,-0.43968883531650904,0.9803921568627451,1.0,1.0,1/10,12.38%,ATP1A2
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),-0.23971060144343873,-0.43744543287459126,1.0,1.0,1.0,2/10,19.33%,LARS1;SESN2
prerank,Reactome_2022__Sperm Motility And Taxes R-HSA-1300642,0.3003209804493725,0.437053064592453,0.9583333333333334,1.0,1.0,5/5,69.98%,HVCN1;CATSPERD;CATSPERG;CATSPER2;CATSPERB
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),-0.2500437751707232,-0.4253166990954452,1.0,1.0,1.0,7/7,75.01%,ACTN2;EHD2;EIPR1;SORL1;EHD1;ZDHHC2;AKAP5
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.26567059647484537,-0.42526030755268507,0.9795918367346939,1.0,1.0,6/6,73.45%,ADI1;ENOPH1;MRI1;APIP;BHMT2;BHMT
prerank,Reactome_2022__Adrenoceptors R-HSA-390696,-0.28968954697862126,-0.4229703430580433,0.9772727272727273,1.0,1.0,2/5,26.66%,ADRA1A;ADRA1B
prerank,Reactome_2022__Josephin Domain DUBs R-HSA-5689877,0.24337673228752638,0.4226579458324778,1.0,1.0,1.0,3/11,23.69%,JOSD1;RPS27A;PRKN
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),0.26635131080607427,0.42175264268526397,0.9811320754716981,1.0,1.0,3/6,28.49%,CPT1C;BHMT;BHMT2
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.25207566795701863,-0.4191074459519723,0.9777777777777777,1.0,1.0,3/7,21.22%,PNP;SLC16A9;PRPS1
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),0.24095189144296544,0.41903303598708597,1.0,1.0,1.0,4/12,34.34%,TFRC;SHLD1;TGFB1;HMCES
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.23468744695056637,0.418546907527467,1.0,1.0,1.0,5/19,26.17%,BRCA1;RPS6KA4;RPS6KA5;ARRB1;MAPK3
prerank,Reactome_2022__ATF6 (ATF6-alpha) Activates Chaperones R-HSA-381033,0.2510928934340652,0.41805026971576537,1.0,1.0,1.0,2/11,25.33%,HSPA5;NFYB
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By P107 (RBL1) And P130 (RBL2) In Complex With HDAC1 R-HSA-1362300,-0.24920140587443385,-0.41674308178642033,1.0,1.0,1.0,4/12,27.81%,LIN54;LIN9;RBBP4;E2F4
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),-0.23400269149404784,-0.41416803461799967,1.0,1.0,1.0,2/10,19.33%,LARS1;SESN2
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),-0.23400269149404784,-0.41416803461799967,1.0,1.0,1.0,2/10,19.33%,LARS1;SESN2
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),-0.2479131399217792,-0.41404961329498036,1.0,1.0,1.0,9/9,75.23%,DDIT3;XBP1;CALR;ATF6B;MBTPS2;ATF6;HSP90B1;MBTPS1;HSPA5
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),0.27063149293801775,0.41387691821730804,0.96,1.0,1.0,6/6,72.95%,AKAP8L;IWS1;SETD2;SUPT6H;TPR;NSUN2
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),0.27063149293801775,0.41387691821730804,0.96,1.0,1.0,6/6,72.95%,AKAP8L;IWS1;SETD2;SUPT6H;TPR;NSUN2
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.22648707269289925,0.41219707145285994,1.0,1.0,1.0,4/15,28.74%,GLE1;IGF1R;OGFOD1;HDAC6
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),0.276944472744391,0.4117455010152541,0.9830508474576272,1.0,1.0,3/5,24.78%,BFAR;DDRGK1;HSPA5
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.23724205247167351,0.40847337438663467,1.0,1.0,1.0,4/13,28.56%,BFAR;DDRGK1;HSPA5;ABCA7
prerank,Reactome_2022__Transcription Of E2F Targets Under Negative Control By DREAM Complex R-HSA-1362277,0.2335630036202264,0.4075185122870905,1.0,1.0,1.0,14/14,76.66%,MAX;RBL2;HDAC1;TFDP2;RBL1;LIN52;CDC25A;TFDP1;E2F5;PCNA;E2F4;RBBP4;LIN9;LIN54
prerank,Reactome_2022__Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,0.22695293194712923,0.4072577245869699,1.0,1.0,1.0,4/15,29.22%,VPS37B;RPS27A;MVB12B;TSG101
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.2675538434599897,0.4053670064339692,1.0,1.0,1.0,7/7,73.26%,FLOT1;RIPOR2;EHD1;MAPK14;CFLAR;ADGRB1;EHD2
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.22020383182119074,-0.4046030046185428,1.0,1.0,1.0,4/18,23.12%,PNKP;NABP2;PKIB;MAP3K4
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.24000169421942638,0.40202392526716296,1.0,1.0,1.0,2/6,29.94%,MRTFB;TGFB1
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),-0.26174496644295303,-0.40126028933884506,1.0,1.0,1.0,5/5,73.84%,IL34;PTK2;CSF1R;MAPK1;MAPK3
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.2634404250590975,-0.4012045283030258,1.0,1.0,1.0,1/5,19.11%,NR1H2
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),0.27814414940180904,0.4003392918104647,1.0,1.0,1.0,5/5,72.19%,AP1G1;AP3D1;RAB32;AP1M1;CD63
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),0.27814414940180904,0.4003392918104647,1.0,1.0,1.0,5/5,72.19%,AP1G1;AP3D1;RAB32;AP1M1;CD63
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.23596661379513012,-0.39972702971878193,0.9782608695652174,1.0,1.0,2/7,20.72%,ENPP3;SPHK2
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.24017747679374157,0.39921813030547604,1.0,1.0,1.0,11/11,76.00%,PPP2R2D;CLASP1;UBE2S;EPS8;CHMP7;CHMP4B;CLASP2;SIRT7;SPAST;CHMP2A;CTDP1
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.2675382280845106,0.3978761635125564,1.0,1.0,1.0,6/6,73.26%,FLOT1;RIPOR2;EHD1;MAPK14;ADGRB1;EHD2
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),0.2543480798412514,0.39774162694192283,1.0,1.0,1.0,6/6,74.57%,NUP88;XPO1;LTV1;RAN;RPS15;NPM1
prerank,CellMarker_Augmented_2021__Megakaryocyte:Undefined,0.23402962117890289,0.39634747808517584,1.0,1.0,1.0,2/9,23.19%,ITGAV;PECAM1
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.21729320065143498,-0.3959303341337175,1.0,1.0,1.0,4/10,26.15%,RNF8;CTR9;LEO1;DTX3L
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.22564072625372178,-0.3913037548472181,1.0,0.9999637237364029,1.0,11/11,77.46%,GCC2;SAR1B;SLC51B;TMEM30A;SORL1;BRSK2;INSIG1;TM9SF4;CD81;SEC16A;SAR1A
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),-0.2447181043539162,-0.39053984468953823,1.0,0.999621012394733,1.0,6/6,75.54%,GTF3C6;GTF3C4;GTF3C3;GTF3C2;GTF3C1;GTF3C5
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),0.24121345261713076,0.3887210726869351,1.0,1.0,1.0,1/9,15.46%,TP53
prerank,CellMarker_Augmented_2021__Plasma cell:Kidney,0.2366499442722381,0.3868722914345201,1.0,1.0,1.0,3/8,26.77%,KIF19;PARM1;BRSK1
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.20006221457227297,0.3802798799202403,1.0,1.0,1.0,4/20,23.86%,WAC;UBE2B;UBE2E1;UHRF1
prerank,Reactome_2022__Gap Junction Assembly R-HSA-190861,-0.26142475956818473,-0.3766094532802579,1.0,0.9999159901544201,1.0,3/5,32.63%,GJB2;GJB6;GJA1
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.21330577850736743,0.37463491304902263,1.0,1.0,1.0,3/19,23.06%,TP53;MED24;MED13
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),-0.2434782608695652,-0.37342414988833444,1.0,0.9996440294313753,1.0,5/5,75.67%,DHFR;MTHFS;QDPR;FPGS;GCH1
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),0.23326491095678614,0.35908120010472916,1.0,1.0,1.0,4/10,32.44%,FTO;ALKBH5;ASCC1;ASCC3
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),0.23326491095678614,0.35908120010472916,1.0,1.0,1.0,4/10,32.44%,FTO;ALKBH5;ASCC1;ASCC3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2045082924550339,0.3579967252762407,1.0,1.0,1.0,16/16,79.57%,TINF2;TNKS2;TNKS;NAF1;TERF2;SMG6;HNRNPA2B1;SMG5;PINX1;POT1;ATM;ERCC4;DHX36;TERF1;PARP1;SLX4
prerank,Reactome_2022__Pexophagy R-HSA-9664873,0.21354883799472046,0.35579875328932725,1.0,1.0,1.0,1/11,19.96%,RPS27A
prerank,Reactome_2022__Transport Of Nucleotide Sugars R-HSA-727802,0.21557094095566426,0.35346483742649043,1.0,0.9998854057945652,1.0,2/8,25.69%,SLC35A1;SLC35D1
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),0.21899753856266382,0.34978462043656505,1.0,0.999771771116726,1.0,1/8,19.88%,FGFR1
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.19969645671589514,-0.349495371417669,1.0,0.9997948454144888,1.0,9/9,80.05%,UBB;UBA52;TUT4;TUT7;ISG15;UBC;CHFR;DIS3L2;RPS27A
